>ACH58992.1|FEATURES|farme|beta_lactam|WS86_03395|antibiotic inactivation|1
MMPSDVLALRFLLASCGSVAVGLVVWALLAVCRRCLPEFSLQRSTWLLSQMTVVAAFLVI
LLPHSERLRLIPPIDLPGAAAAHPAGPDKTGAPASAASQAGAVSAEVDYRAWLASGAQAW
LLLYPLGLAYALARLWRARRTLNGLAAAGRRLSALNRHDGFTAPGTRPPALAVIEVDAPI
SPMLFGLFHPRLLLPRHLRSFEASQQQMIVEHELTHMRRHDLQWMCIGLLLQTLLWFNPC
MRLLRARLSWAQELGCDRDVLRGRPQTERKAYAAALVAQLKLQHRQVNAALAFGGVSAST
VAARIGLIREPAAASRGPWARCAALAGLAAVFAASLAFQPAFAWRIAPLSRAAPAATETL
FSCTEMADADSGRRLVHDGHCDERVTPASTFNIAVSLMGYDSGILRDEHTPRLPFKPGYT
DWNPSWRAATDPTSWIRNSTVWYAQQVTSQLGAERFQRYVNSLNYGNRDVSGDPGKDNGL
AMSWIGSSLKISPVEQVAFLRSMLNRKLPLSAHAYEMTVRLTELDTLPNGWEIHGKTGTA
APVLANGRDDEMHRYGWFVGWATKGRRTVVFARLVLEDRRQAAAGIRTKNAFLHDLPAQL
DAL
>ACH58989.1|FEATURES|farme|beta_lactam|LRA-9|antibiotic inactivation|1
MKLRYLLAAALLMTTASAFGADAPKRLPVNITNKEWLMPFPGFKIVGNMYYVGTYDLGCY
LIDTGAGLILVNTGIMGSYPLMKASIESLGFKTSDIKIITATHGHSDHVGDIALFKKDAP
GATVYMSERDVESLESGGNFDYRRPAPEGRGGLVYDPIHVDVKTKPGDHIKLGNVDMTVL
QAYGHTPGATSFSFQQTDAGKTYNVLIVNMNGINAGVKLLGSPHYPTIVEDFKNTIDMQA
TYKPDIWVSSHSGQFNLHQVYKPGDAYNPARFGDLAAYQKKIATAKANYEKQLAEERAAA
K
>ACH58980.1|FEATURES|farme|beta_lactam|LRA-1|antibiotic inactivation|1
MNPPIHRRTLLLAASVLPLASACTAWSAKGPQQDASAQLAALEAASGSRLGVVGFNTATG
ARVQHRAEERFPFCSTFKLMLAAAVLERSAKEGDLLARRVNYSKGDLVSYSPITEKNVAT
GMTVAELCAATVQYSDNGAANLLMKILGGPSAVTAFARASGDEVFRLDRWETELNTAIPG
DLRDTTTPAAMAASVQRLVLGNALGAAQREQLKTWLLGNTTSTQRFLAGVPAGWKVGDKT
GSGSYGTTNDVGVLWPPAGAPLVLAVYLTFPQKEAKGRSDVVASATRIAVSALAS
>ACH58999.1|FEATURES|farme|beta_lactam|blaLRA-10|antibiotic inactivation|1
MAIAILSSCFAPLASRAADDSARIRAIVDQAIRPVMAEHDVPGMAVAVTVDGQPFVFNYG
VASRESNTPVSDATLFELGSISKTFAATLASYAQVTGKLSLDDHPGKYMPQLKGSAIDKA
TLLNLGTYTAGGLPLQFPDDVSDQQMASYFQHWKPKAAPGVQRTYSNPSLGLFGHLTSLA
LKSRFTDALETNVLTQMGMKSTYVHVPQSAMANYAWGYDQANKPGRMNPGVLADGIYGIR
STAADMIRYVQANIAPGKLETPLRRAVEGTHVGYFKVGGMVQGLGWEQYPYPVSLQQLQA
GNSTTMAWEANPAQKLTPPSVPSGATLFNKTGSTSRFGAYVAFVPEKKIGIVILANKNIP
GPDRIKAAHAILEQL
>ACN58964.1|FEATURES|farme|quinolone|qacB|antibiotic efflux|0
MRHIDVHKLADEAKFNRFHGGILLWCALIIICDGYDLAVAGIALPSIMKGMGVTAQNAGF
MVSSALFGMMFGAIFLGTIADKIGRRKAIAICIGLFSVFTAAAGCTSDPYTFSAMRFLAG
LGIGGVMPNVVAQMTEYSPKKIRATMVTLMFSGYAVGGMVAALLGKGLIEAYGWSSVFLA
AGLPVLMIPFVLKSLPESMPFLIRENRLDELKAIVTRMEPGYRADRGDRFALPSKDQAGG
APIGKLFQDGRGFSTVMFWVAFFMCLFMVYALSSWLTKLMASAGYSLGSALTFVLVLNFG
AVIGAVGGGWLADRFHIKYVLIGMYALAAVSITLLGYKVSTEVLFILVGLAGASTIGTQI
VTYAYAGQFYPMAIRSTGIGWASGVGRSGAILAPIVIGTLVGMALPLEQNFMAIAIPAVI
AVIAVSLIRHGRSASAFELRAATA
>ACN58756.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MLPKVSSIGQIAITVADVPTALGFYRDVLGLDFLFSPAPTLAFLASGDVRIMLSTPQGAG
AVGANSILYFKVMDIESAHAAFVARGARADEAPHLVAKMPDHDLWLGFLRDPDGNLVGLM
EEKRR
>ACH58982.1|FEATURES|farme|multidrug|farB|antibiotic efflux|1
MAEARTAPLPPGEYPPLRGIALVLLSIAIGVSSFMEILDMTIVNVSIPAIAGSMGVSPSE
GTWAISSYLLAAAVVQPLAGWIGRRFGEVRTFVISNLLFIVFSALCGLATSMPMLIACRL
LQGLVSGPMMSVAQALLLRNYPVHLRGLAMGLWAMVVIVAPIMGPILGGWITDNYSWPWL
FYINVPVGLGSAAITWFLLRRRETLRVKVPIDAIGLSLLVIGVGALQFMLDNGNEKDWFQ
STEIVTAAVIGVVALVFFIPWELTDKHPIVDLALFRRRNFRVGTITLAIAYFAFTGVNII
FPLWLQTAMGYTATWAGLAMAPIGLVAIVMAPIVGRNLHRINLRAAPTIGFMVLAFALLW
FSQQNDQASFSQMATPRFVMGIGLALFFLPLNQIIMSGLPSSQIASAAGLSNFLRTFAGS
ASTAICVFYWNDRSEHHYARLTEHIRPDSPAWIDYQAQLAAQGITGDTAYAATSQVLSVQ
SMTMGANDIFLMIAVMFIVLIPVIWFAKGPFRAVGTGSSH
>ACS83742.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MTGIRKLAQLQRGSQRRKHMRITDLPQDNESIIEQTARVLYDAFKEHSPTWTTMEAAIEE
VRESFAEHRISRVAIDDEGSVLGWIGGQPIYDGHVWELHPLAIAPRAQGRGIGRKLVEDL
EAQVAARGGVTLWLGSDDEGDRTSLGGVDLYPNPLAHLANIKNLRSHPYEFYQKLGFVIV
GVLPDANGAGKPDIFLAKRVRQK
>ACS83728.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MQNDRIFFGAIMMRLFKVFIVLFFSLLIPIHSYAVSNDKINDLARNFMKENQVEGMSVAV
LDKNRILILNYGIADEFKKTPVTNDTIYTIASFSKTVTATLAAIASVENKLNLDEPFIQH
FPGLNNDKDMGSITTRELLGHVSSLPFDFTPRPKTYPELVSALNHFDPKWPPGTEYSYSN
ASIGVVGYVLQNVYSEKYQDILNGKILKPLHMTSTFLTVPAEKEKYIALGHEKDNKIVPY
SKDNGVWFAAASLKSTISDMAKYLNAHINYASLQDKNLARGIAVVHENNYCFADKLSCEQ
LAWQAHVISELKNSSGDSYFVAYDSNDMPTFARKQIMENGGLDKSKIFIDKTGSGFGMSS
YMAYIPADKVGVVILLNKGIADERIKLGRDILRSLGSA
>ACS83743.1|FEATURES|farme|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|0
MFALRVDDEIELRLLEEQHAEEIFALVDSNRAHLREWLPWVDEEVSANAARDYIKMMRER
FTAFTGMAMGIWHQDRLAGAVSFVNIDQQSRWAEIGYWIDAPSQGHGIITRSCRAMINYA
FDDLKLNRIVIRCADGNHRSRAIPERLGFRQEGRLRQTIWLYDRFWDALIYGMLADEWKA
QKQKGRL
>ACS83695.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MKITVDNIGKKFVREWIVRGATFDLEPGSKYTFVGPNGSGKSTLLQLLTGMLPVSEGSIV
YTSTDGTPVGVDDWYKHLVIAAPYLELIEEFTLRELVNFHSEFKKLKNGMNAADFEDFIE
LAHVKNKIIRHFSSGMKQRVKLGLAFMSDVPLIFLDEPTTNLDSTGINWYLKNVIENTKG
QMILLGSNVKQEYEFCENIISVSAFK
>BAG82770.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MTQTVIPQFRITNAERSIAFYVEGLGFEIDWEHRFEPGFPVFMQLTRSGQTIFLTEHAGD
CEVGGAAYFVVSDVDACYRQFMARGVTAIEPPEDTPWETREMVVTDPDGNRLRFASPATT
>ACT97620.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MSTNLSVIKNPRVQSDQRRLVRRPDVKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDL
VHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPF
LWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMG
GFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAAL
MAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLG
ERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQ
LQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQ
RADR
>ACT97617.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHFFSGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>ACT97558.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MCLIKPKHDNSIKEKRTKMNIVVLAGGLSTERDVSFKTGSMVAKALKENGHKVILLDVFM
GYSDREEDLTGIFDRADEISVQVSDIPTEAPDLAKVKASRKDQSPCFFGPNVIKICQMAD
IVFMALHGENGENGKIQAAFDLFGVKYTGSDYLSSAIAMNKETSKQFFLANGIPTPKGIS
MTRATRQDDITKLDLTLPCVVKPCCGGSSIGVTIVRDAAEFKAALDDAFKWENELVIEEF
VQGREFSVGVIEGKALPIIEIAPKEGFYDYKNKYKAGSTVETCPAELPEQVTKDMQHYAE
EVARVIGLDTYSRSDFLLNDKNEMFCLEANTLPGMTPTSLLPQEAAVIGMSFNQLCEHLI
DISRKNMRCSMSDKYMKSLTFAN
>ACT97556.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELVVSLRSAQGLYSFIDKERYNLYIVEMEGHRWEVVLPDGSKTPID
RNDFSFMENGEKKQFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTC
NQYLKGFGIRVAESLILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQP
AIEKAFEESDEVMIEAFMKGTEITCGCYKTSDKEVVFPITEVVSANEFFDYGAKYNGESQ
EITPARLPEDTAERVRLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENKF
>ACT97543.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMKETIAVLFGGQSSEHVVSCMSAANVIDQIDKDKYDLLLIGITEEGEWILTPSVEEIRN
DTWRDGRTHAVLSPDATRKCVIISEGDATKEVRVDVVFPVLHGLRGEDGTVQGLLELARI
PYVGCGVLASAVSMDKLYTKLIVDSLGIRQADYVPVRRSQLQDMNSVIASVENKLSYPVF
VKPSNAGSSRGVNKADNREELVFALNEAAKHDRKILVEETIIGHEVECAVFGGGLQEVKA
SGVGEIMAAAEFYDFDAKYYNAESKTVVDPELPGHAAEDVRKAAVEIFKAVDGYGLSRVD
FFVTDAGEVVFNEINTLPGFTAISMYPMLWEARGISKSRLVDDLINHAKERYDV
>ACT97541.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MENSKRTIAIVCGGDSSEHDVSLRSGQGLYSFFDKERYNIYLVDVKGTDWHVALDNGETI
EIDKNDFSFVMNGKHVYFDYAYITIHGQPGENGVMQGYFDLIHLPYSTSGVLVEAMTFDK
YVLNNYLRGFGINVADSILLRRGEAYDEEEIAKRIGMPCFVKPAADGSSFGVSKVKNADQ
LAPALRVAFMESNEVMIEGFLDGTEISQGIYKTAEKTVVLPATEVVTTNEFFDYDAKYNG
QVQEITPARLSPETAEEVAKTTSRIYDILHANGIIRIDYIISKDKDGKDKVNMLEINTTP
GMTVTSFIPQQVRAAGLDIKDVLSEIVENQF
>ACT97535.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEFKMNIVVLCGGNSTEREVSINSGSMVCEALRKKNHNAILMDVYFGLEDIDIFEKSASK
YDVESVKKNIQSLSDKVSEDRRSFFGNNVIEICQKADIVFMALHGKNGEDGKCQAAFDLY
GIKYTGSGHLASAIGMDKGVTKQIFMSKGVPTAKSVWIKKGESTDLKDYGMKVPVVVKAC
NGGSSVGVVLVHQESEYEDAVKTCFELDNQILVEDFIKGREFSIGVINKKALPVVEIIPR
DGWYDYKNKYNGATEEVCPANLNDELTKKIQKVAEDACNAIGCEPYARADVMMDADGNMF
CLEVNTLPGMTATSLVPQEAKAVGMDFPTLCDYLVELSLKKNN
>ACT97503.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>ACT97381.1|FEATURES|farme|beta_lactam|CfxA6|antibiotic inactivation|1
MSNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSIS
QIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVK
INREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFI
AKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNAL
KECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFV
KDFKGNESQASQFVAHISAVVYSLLINTALN
>ACT97372.1|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MLASASGKDKFRAGLPKEVEVGHKTGMSYRTPEGIRMCDADVGVIYMPGGEKCYLAVLVK
DSKETDAANAKIMADIAKKVYSHYTENAGKNSAPAK
>ACT97683.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MDGITKDSIKTARLMKQLWPQLTDKEAIDEVKRYTNGKNTAIFTEVESDTIVGLALCSLR
FDYVEGCKYSPVGFLEGIIVDEEYRLKDIAKNLCTKCEEWAKNKGCKEFASDCTLTNTDS
IRFHLNIGFQEANRIIHFKKKL
>ACT97628.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKXYIAAFVMXSYETDEDNANIIARISRMVYDAMR
>ACT97596.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKNIAILMGGYSSEAEVSLKSAATVVECLDKNKYRPYPILIAKDRWVYTDPKGQEFPIDK
NDFSLTIGGEKITFACAFNAIHGTPGEDGHLQAYFSFVGIPITGCSMYASALTFNKRDML
SVLKPYGIPRAKAYYLNRGEHFSTREIIKTVGLPCFVKANRSGSSIGVFKAYNEKDIDEA
IEKAFEVDSEIIIEEFLKGTEVSVGVITYRGKKRVLPITEIVSENDFFDHEAKYEGKSQE
ITPARLSEEERKKVEEIALRVYNLLQMKGFSRSEYILVNGQPHLLEMNTTPGLTKASILP
QQAKAAGITLANLFDNAIEEAMNSD
>ACT97566.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVCGGDTSEFEVSLRSAQGIYSFIDKERYTLYIVEMRGTDWHVQLPDGTKTPVD
RNDFSFRLDGAKVVFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAAALTYDKFAC
NQYLKAFGVRIADSLLLRQGQSVSDEDVIGKIGLPCFIKPSLGGSSFGVTKVNVKEQIHP
AIAKAFAEAKEVLVEAFMDGMEITCGCYKTKEKSVVFPITEVVSHNEYFDYKAKYNGESD
EITPARIPDELRDRVQKLTSAIYDILGASGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAANLEIKDVMTDIIENQS
>ACT97375.1|FEATURES|farme|multidrug|mexf|antibiotic efflux|1
MGIPLNSVFTALGYYMGEAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGEM
VPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGY
EWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCY
VMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMT
SLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSK
KQ
>CBI71203.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRHVMETGTDRGDRTGKGTRSIFGYQMRFDLAEGFPVLTTKKLHLRSIIHELL
WFLKGDTNVAYLTENGVSIWDEWADEKGELGPVYGYQWRSWPAPDGRHIDQISQLIEGLK
VNPNSRRHIVSAWNVGQLDEMALPACHCLFQFYVADGKLSCQLYQRSADVFLGVPFNIAS
YALLTMMVAQVTGLKPGDFVHTLGDTHIYSDHFEQAKLQLTRTPKALPTMRINPAVKDIF
SFRFEDFALEGYEADPHIKAAVAV
>CBI71192.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNPTILRAALVLGLLSAIGPFAIDMYLPALPAIGASLGADTAGVQASLMAFMAAIAVCQL
FYGPVSDMVGRKPPLYFGLALFTAGGIACALAPSIEWLVVARFVQGIGACAAMALPRAIV
RDGYTGADAAQLQSLLMLVFSVSPILAPLGGSLIVQFGDWRVIFYAVAGIGLLGILLVAF
FLKETRPASARLESSVGSAIKGYGVLLRDRNFLGLSMIGAFGMASFMAYLANSSFILIDH
YGLNPTQYSIMFSINAVSFIGVSQLTGVLTRRYGLNAVVRTAVNGFILVMVALAAVFALG
VDRLDVLAALLFVGYGFLGLVIPTTAVLALEEHGAIAGTASALMGTLQLVTAAVVMGIVG
SFFDGTARPMVLGIAACAIVAFALTRLTIKRSRAPLAAAAE
>CBI71198.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNAQIVKAAVVLGLLSVIGPLAIDMYLPALPAIGADLEAGVAEVQQTLMAYMAAIAVCQL
LYGPISDMYGRKPPIYFGIGLYVVASLGAAWAPSIEWLTVFRFLQGVGACASMSLPRAIV
RDGYTGAQAAQLMSLLMLVFSISPILAPLSGSIVLQFGDWRVMFYVMAVVGVLSLLLLMF
GLKETRPKEARLESSLGGALSAYWTLLRDWRFIGLSLIGAFGMASFMAFLGNSSFVYIEH
YGLTPTLYSLAFSVNAVSFFAVSQATGYLVGRFGLPRVVRVAVGGYVTAMLALLALFLLG
VDSIWALAILMFIAFGFLGLVLPSTGVLAMEEQGEIAGSASALMGTLQMVIASVVMGIVG
AFADGTAMPMVIGFAACALAALAITLVTLRRNSGSEPAAVAAPAE
>AET35518.1|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>AET35485.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETILHNNEVH
YPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSSQDLDISLGE
LLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPQKAYANWS
TPSEMVRLLKMADEKDLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKTGSSDRN
LKGVKMADNDAGIVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEMK
>AET35498.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAP
LQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLIEVSMKKYPTQDFTL
>AFQ60597.1|FEATURES|farme|chloramphenicol|catB3|antibiotic inactivation|1
MKNYFESPFKGKLLVEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDKLIIG
SFCSIGTGASFIMAGNQGHRYDWVTSFPFFYMNEEPAFSESVDAFQAAGNTVIGSDVWIG
SEAMIMPGVKVGHGAVIGSRALVTKDIEPYTIVGGNPAKEIKKRFSEQEISMLLDMKWWD
WPLEQIKEAMPLLCSSDIAGLYHFWQRSSA
>ACI02031.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVIGDQTRIPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKY
>ACI02015.1|FEATURES|farme|tetracycline|tet40|antibiotic efflux|1
MFAKNSKAYSVYLLFRFVFSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFE
IPTGVVADLYSRRRSVLIGMFLYGLGLLMEGALPWFAPVLLAQVVWGCGDTFITGALEAW
IASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPVILGGSLCLLLGLVLVR
IMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLST
AHFLDDTVIPVIGPLNSVTWFGVISLIGSGLGILASQLLIARMEKKGTVSRTSVVMSTSA
GYILCLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLD
SFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLLPVAGKKRD
>ACI02049.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MNAIVAVDNNWAIGNKGKLLVSIPNDMKRFREITTGKVVVLGRKTMATFPNGMPLKNRTN
IVLTKDEKYKAGDAVVVHSIDELLEELKKYYTADVYIIGGDSVYKQMLPYVDTCEVTKIN
YCYEADSYFPNLEKDDEWKKTGESEEFTYFDTEYTFERWKRKN
>AFH53888.1|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MTFTPIDMETWHRKPYFLHYHKDIPCTYSMTVSLDITVLKKTGVSLYPALLYLLTKNVNH
YEQFRTAFDEKGNVGIYSNMEPCYTIFHKEQETFSNLWTEYSEDFSTFLARYKADLETYG
NVLDMDAKPNTPPNTFPVSMVPWTTFTGFHLHLQKGYDYLLPIFTLGKAWEHHGHWKMPL
AIQYIMCLRWVPCEPFXNPSADLHIQHNKIES
>AFH53883.1|FEATURES|farme|beta_lactam|BN477_01630|antibiotic inactivation|1
MKRFLMSAVCSFYSIMAFGQIQIGDIKEVIQEKKATVGVAILYQDKIFTLSDNQQYPLMS
LFKFHVTVAALKKMDREHIPLDSTVYITREQMHENTYSPLRNKYPNQGIHISLRDIITYT
IIYSDNNTCDWLIDFAGGIKKVDTFIKSLGIKKLNLTETEHSMHENIMNSYNNWSSPLSV
VQLIKKIYTDEILSATSFAFLEETMLNCSSGEK
>AGC09671.1|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MSAIRWDSCSFTQLSQASTSLKGRGKLYALDLFIGVPEYWGKGIGTQFIRLLLGYLFDEK
GADWVILDPHVDNVRAIRAYEKCGFRKIKLVPRHEWHEGKYVDCWLMGIRWDQQA
>AGC09627.1|FEATURES|farme|multidrug|mdtc|antibiotic efflux|1
MAAAHSGSAQRSVDDGGWVGIFVRRPILALVLNLLIIIAGIAAYQGIEVRELPDVDRPVV
TVRATYAGATPESIDSQITAVLESAVSRVQGVTSISSNSSYGSARISIEFSSSTNLDTAA
MDVRDAVAGVVNQLPKDMEDEPRVVKADADATPIMQMSVSAEKLSEGELTDLVTNVIEDK
LAAVEGVAAANSYGLRAKTIEVRVNQTALASRGISLADLIAAIGKASVTAPSGALENATQ
QLLVRAEAPVATPEDVADLEINPQTKVKDVAFVRWGFQEATAMTRLDGKTAIGIDIIRQA
QANTIDISEGVHQAVDELRRTLPAGV
>AHN92778.1|FEATURES|farme|aminoglycoside|BN682_00261|antibiotic inactivation|1
MRIEKATPADVNAAVSLMMKLWPGHDAEERTAEMEQMIGSPEAAIFLAWDGEQAVGYAQC
QLRHDYVEGCDSSPVGYLEGVYVEEECRGNGVAAALLDACQQWSRSMGCMEFASDCELEN
EASLRFHLKNGFEEANRIICFVKRL
>AHN92776.1|FEATURES|farme|aminoglycoside|BN682_00261|antibiotic inactivation|1
MLHMTEIRKAAAADISTVAKLAAQLWPHHTPQEMEAEFSHIPENSNSALFLAFSGSTAVG
FAQCSLRHDYVEGTSSSPVGYLEGIYTSDGCRGAGVARALLAECESWAKERGCSEFASDC
ELTNTQSLHFHLSVGFEEANRIICFKKKL
>AHN92772.1|FEATURES|farme|aminoglycoside|LS69_04805|antibiotic inactivation|1
MVRIAINGDSRVLAEMAVQMWDSNTVDELEAEFAETLNDKQSAFFIKYINDLPVGFAQCG
LRTDYVEGTESSPVGYLEGIFVKEEYRKNGYAKELLLACEIWAKEIGCSEFASDCEIDNI
DSFKFHMAMGFDEANRIICFKKRL
>AHN92768.1|FEATURES|farme|aminoglycoside|APH(3')-VIIa|antibiotic inactivation|1
MIPERKETNEFLIMSEIKGKSIDDFAEEPMQYITYLADAIKLLHAVDVSNCPFSSQVDMR
LEELDYLLKNNLADTDTDNWEDSTEFTDPQELYSWLCDNKPQEELVFSHGDISNLMIQDD
EIFFFDLARCGLADKWLDISMCVREIRNYYHNPDYENLFYDMLGMEPDYEKIDYYLLLDE
MF
>AHN92765.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MKIEKDEITIRDFTETDLPLMFQWLTDQRVLEYYEGRDVKFTMDTLSAHFLEAIPDGFRM
IIEYQKSPIGYAQAYQLSGELFDEYDYPDDGHIVYAMDQFIGEPKYWSKGIGSSFLKMMA
SHLKENMAAERVLLDPHQDNKRAIRAYEKAGFKIIKSLPKHEMFEGEKVDCWLMELAL
>AHN92759.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRKAERRDISAIAELMVRLWPHQTVEAMEEELHEMMENEEIAFFLAGNVGFAQCQLRHD
YVEGTDSSPVGYLEGIYVAEGFRHQGIARELVHACENWAKEKGCGEFASDCELTNTQSLQ
FHLGVGFGEANRIICFTKKL
>AHN92757.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRKATMNDLPRLTELALELWPENAVDTMYYDLGTIMTGGESVFFLAYREDVAVGFAQCQ
LRHDYVEGTSTSPVGYLEGIYVRKEDRALGFASQLMKACEEWARTEGCAEFASDCEIHNE
ESLAFHLKLGFKEANRIICFAKHL
>AHN92753.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MENVVFIRRAQRSQAYIAARLANKLWDEDPDREEEMAEIIESADSDVLLAFCGEQAVGFA
QVGLRHDYVEGKESDGPVGYLEGVYVEEAFRRGGVARRLVQAAEYWARERKCAQFASDCE
LHNEDSIRFHLGSGFEEAGRIVCFIKNL
>AHN92752.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRKAEIKDLSILAELACQLWPDHTVEEMCAEFAEILAKPDAAFFLAYAEETAVGFAQCQ
LRYDYVEGTDSSPVGYLEGIYVTEEYRKQGVARELLTACESWAKAKGCSEFASDCELDNV
QSLQFHLNVGFEEANRIICFTKKL
>AHN92733.1|FEATURES|farme|beta_lactam|cepA|antibiotic inactivation|1
MRKLLFIIIYLSFISPAFADGNKAIENALHEYIKGKDARIGVAVIINGKDTVSVNGNRDF
PMMSVFKFPLALTVAHWINTNGMSLNDTVTFSEKAMKEDTYSPMLKKYGKSRNTMTIREL
LEWSLVESDNNAADILLHRVGGTSGVTSIMRQMGISDEIVIGASEEDMHRDPYLSYLNRT
TPLAMAQLFDRFYHELRNASQSYSEISVMLEQCRTGLDRLALPLLPTNALIGHKTGTGFP
TPEGRISAVNDCGYVNLPNGTRYSIAVFVADSNYDIATTSAIIAEVSKIVLEGLIKQK
>AHN92728.1|FEATURES|farme|chloramphenicol|cat8|antibiotic inactivation|1
MAFRLIDIENWERKEFYQHFISQVVCTYSVVVNLDITNLKKHRLYPAMIWLLTKTVNDMP
EFRTSLTSEGLGIYDEMHPMYTVFNKENKNFSGIWSYFSEDYDTFLKDYEVDAEKYGTST
CYAPKDGTPSNSFNISMVPWLEFSGFNINVFDDGHFLLPIFTMGKYFERKGKRMLPLAIQ
VHHAVCDGYHVGLFVEKLQKYIDHFG
>AHN92724.1|FEATURES|farme|chloramphenicol|cat22|antibiotic inactivation|1
MAFRLIDLENWERREFYEHFISQVVCTYSVVVNLDITNLKGQKLYPAMIWLLTKTVNDMP
EFRTSLTPEGLGIYDDMHPMYTVFNKENKNFSGIWAYFSEDYETFLKDYEDDVARYSTST
RYTPKEGTPANSFNISMVPWVEFTGFNINVFDEGKFLLPIFTMGKFFERDGKRLLPLAIQ
VHHAVCDGYHVGVFVEKLQDHINEFTQ
>AHN92713.1|FEATURES|farme|chloramphenicol|cat23|antibiotic inactivation|1
MAFQLIDLENWDRKEYYEHFIKEVVCTYSAVVNIDITNLKGQKLYPAMIWLLTKTVNDMP
QFRTSLTPEGLGIYDDMHPMYTVFNKEDKNFSGIWTYFSEDYGTFLKDYEDDVARYSTST
RYTPKEGTPANSFNISMVPWVEFTGFNINVFDEGKFLLPIFTMGKFFERDGRRFLPLAIQ
VHHAVCDGYHLGVFVEKLQQDID
>AHN92712.1|FEATURES|farme|chloramphenicol|cat14|antibiotic inactivation|1
MTFRLIDIDNWKRKEFYEHFISQVVCTYSVVVNLDITNLKNQRLYPAMIWLLTKTVNDMP
EFRTSLTAEGLGIYDDMHPMYTVFNKDNKNFSGIWSYFSEDYDTFLKSYEIDAEKYSTST
RYAPKDGTPANSFNISMVPWLEFSGFNINVFDDGHFLLPIFTMGKFFERDGKRMLPLAIQ
AHHAVCDGYHVGLFVEKLQSYIDAFK
>AHN92704.1|FEATURES|farme|chloramphenicol|cat15|antibiotic inactivation|1
CTYSVVVNLDITNLKKHRLYPAMIWLLTKTVNEMPEFRTSFTEEGLGIYDDMHPMYTVFN
KENKNFSGIWSYFSEDYDTFLKNYEIDAETYSTSTRYAPKSGTPANSFNISMVPWMEFTG
FNINVFDDGHFLLPIFTMGKFFERDGKRMLPLAIQVHHAVCDGYHVGLFVEKLQRLIDCF
DC
>AHN92702.1|FEATURES|farme|chloramphenicol|cat29|antibiotic inactivation|1
MAFHLIDMENWDRREFYEHFINEVVCSYSVTVNLDITNLRDARLYPAMIWLLTKTVNEMP
EFRTSLTKAGLGIYDSMHPMYTVFNKENKNFSGIWSYYSENYIDFLKNYDEDVRVYSKST
RYAPKDGTPENSFNISMVPWLEFTSCNLNVYDDGKFLLPIFTMGKYFERDGKRLLPLAIQ
VHHAVCDGYHVGLFVEKLQTNIIRFSAK
>AHN92700.1|FEATURES|farme|chloramphenicol|cat6|antibiotic inactivation|1
MAFRLIDIENWERKEFYEHFISQVVCTYSVVVNLDITNLKNYRLYPAMIWLLTKTVNDIP
EFRTSLTSEGLGIYDEMHPMYTVFNKENKNFSGIWSYFSEDYDAFLKNYEVDTEKYGTST
CYTPKDGTPPNSFNISMVPWLEFTGFNINVFDDGHFLLPIFTMGKYFEREGKRMLPLAIQ
VHHAVCDGYHVGLFVEKLQKHIDNFG
>AHN92696.1|FEATURES|farme|beta_lactam|blaP|antibiotic inactivation|1
MKKFCFLFLIICGLMVFCLQGCQARQKLNLADLENKYNAVIGVYAVDMENGKKICYKPDT
RFSYCSTHKVFTAAELLRQKNTSDLNEIRKFSAEDILSYAPITKDHVADGMTLAEICSAS
LRWSDNTAANLILQEIGGVENFKVALKNIGDKTTKPARNEPELNLFNPKDNRDTSTPRQM
VKNLQVYIFGDILSDDKKKLLIDWMSDNSITDTLIKAETPQGWKVIDKSGSGDYGARNDI
AVIYPPNRKPIVMAIMSRRTEKNAKSDDAMIAEAAKRIFDNLVF
>AHN92695.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKKVAVVFGGRSTEHDVSRISAYSIIKNIDKTLFDVVMIGITKNGEWLPYSGSIEALPD
GSWEKFVNPTGRISLEKGIAALEECDVILPVLHGQNGEDGTVQGLFELLDIPYVGCGILA
SAAGMDKAYTKIILNDAGIPQCRHIVAYRHVLEENPDAYADVVAEKIGFPCFIKPSNRAR
QLAFISQTLQ
>AFQ60594.1|FEATURES|farme|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>AFQ60596.1|FEATURES|farme|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV
>AIA17720.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHAYLDLMRYVMQHGVTKTDRTGTGTLSVFGYQMRFDLSKGFPLVTTKKCHLTSIIHELL
WFLKGDTNIKYLTDNKVTIWNEWADANGNLGPVYGKQWRSWPDKTGKVIDQITQLIHNIK
TNPDSRRLIVSAWNVAEIPDMALPPCHALFQFYVANGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAQVTNLAPGEFVHTFGDAHLYSNHKEQAKLQLTRTPLALPQMRFKRKVSNIF
DFQYEDFELVEYNPHPSIKAEVAV
>AIA14672.1|FEATURES|farme|puromycin|pur8|antibiotic efflux|1
MSVETGVVPAAEIVSGSEVVNRERSASLAQTIGLIVLLAWQLMVVLDGTIVNIALADIRQ
SLGFSQTSLSWVVNAYALAFGGLLMLGSRAGDMFGRRRLLVVGVLVFTVASALGGIASNQ
EMLIIARVLQGVGAAMAAPSTLSLIVTNFEAGSPRNRALSLFASVSGVGASMGLILGGVL
TSGLSWHWIFFVNVPIGIAV
>AIA14412.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|1
METTTTSEARGYRYRWYVLAVVLIADVMDLLDATVANLAGPSIRAELGGSESTLQWILAS
YTLTFAIGLIISARLGDLIGRKQMFVVGMAGFTLASLLCGLAPTPGLLIAARVLQGLLGA
VMIPQGFAMVKQAFHPDDLQKAFIPFGPIMALSAVAGPILAGVLIDGDLFGTGWRMIFLI
NVPIGLVGAYLSWRYLPDIERDSSARLDVSGSLILALASGLLVYPLVQGRELDWPLWTFG
MIAAALVLFVVFARHERRSAHPVIEPSLFGHRGYVAGLFFLGVFFVAMTGFSLVSNLFIQ
IGLGYSPFDTGLAQTPLALGMALGAVVSGAVLGPRLGRHVLHLGLAVAALGLAWLALVVG
RGTGIDGWDLAPALFLSGFGVGLIFAPLFDIILADLGDREVGSGSGLLNAVQQFAGAFGV
AVLGTLLFGWVPDAGWFVATQHLIWVCVGCYAAAFVAVFALPMRARGDAVV
>AIA13957.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKSGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVM
IIITRNERTAFEGCFIARSIEEAVSLARERGESELFICGGAEIYAQTLGAADRLYLTLVH
ADCDADTFFPDWNSDEWIETESEHHTADEKNQYSFTFKVLERKHVDLLQSPGEH
>AIA13936.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKGDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRSSDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKSIF
EFDYSDFELSDYEPHPHIRAEVAV
>AIA13150.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKGDRTGTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNINYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRASDGRTIDQISRLIEQIK
SNPDSRRLIINAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRALPQMKINPAVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA12693.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDMKRFRQLTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRNESISFEGCFIAHSVSDAISLARERGESELFICGGAEIYAQSFGAADRMYLTLVH
ADCDADIFFPEWDRDEWIEVESEHHAADEKNQYSFTFKVLEKKSKT
>AIA11934.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDMKRFRELTMGHHIMVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSIPDAISFARERGESELFICGGAEIYAQMLGVADRMYLTLVH
ADSEADTFFPEWGRDEWIEVESEQRAADEKNQHPFTFKVLEKRNQRLDR
>AIA10577.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNFSEGFPLLTTKKLHIKSIIYELL
WFLRGDTNIKYLQEHGVNIWNQWADERGDLGPVYGAQWRAWRASDGRTMDQISRLIEQIK
SNPDSRRLIINAWNVGELSKMRLAPCHLLFQFYVADGQLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA10481.1|FEATURES|farme|beta_lactam|blaVEB-11|antibiotic inactivation|1
MQTPNIFKLSFSIANCSHSLGHLFMLRLLSPILIFILFLAPAISEAQLKSLAPSLLALQK
ESGGILGVSIQNMETGDTISLNGEKPLVMQSSFKFPIALAVFNEIENNRLSLEKKVKITK
SKLPKETWSPLRDQLKENTSEVSVRELLVFMVSHSDNIACDYLLDIIGGPSTVQNFIHQK
GIKNIAIKYSEAEMGKTWEAQYQNWVHPKAMSDLFIKLFHEELLSPEHTKHLIKLMEETT
TGAGRLKGLLPENTIVAHRTGTSGRNKDGMIAAVVDAGVLFLPNGQHAAISVFVTGSGKE
TPEIEAVIAKIGRAVWDLYVK
>AIA19113.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MAPVLTVADVRSAVAWYIEVFGFVEHVRIGDGHRSQLGLPDGPPAELVVAEVRPGRRTPE
QERSHQVMLKVADVASVVETAVARNARLVDPPHDWEYGERQATIDDPFGHQWVLNQTLTD
VAPEQWGGNTVTPREPSA
>AIA19090.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MFDNRTPFEAEEEAMTTTNPATAPRTYPSLRAAWIPLAALCLAFFVEMVDNTLLTIALPT
IGRDLGGSTTALQWVTGAYSLTFGGLLLTAGSTADRLGRRRVLLVGLAAFGVISLGVVAV
TTSGELIALRALLGIAAAAMAPITNSLVFRLFDEQVLRMRAMTVMIVVGMSGFVLGPLLG
GTALAHVSWEWLLLVNAPVALIAWLGVRIGVPGDRPEDLTHDRLDLPGAVLSMATIGLAC
YSLTSGVQHGWAAPLTIASMIGAGAALVGFILRERTADSPMLDLTLFSRGTVRGAAIAQV
GTSIAMAGVMFGLILHFQYAWGWSPMRAGLANLPLIITMIAATPLSEWLARRFGHRVACL
IGSACLVASLVGLAWGVEHGYLAIAVCMVVMTIGLRTVMTICAVALVEAMPANRTSIGTA
LNDTAQEVGTSVGTAVVGTMVAVLVTKVLPSGTWGADLLETFFRGERITYLVLALIVGVV
ATWGASTLTNSRAVDEHGTEPRSAEEATEELVTSADPAR
>AIA18885.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSADDDRQATPPSGSKVPEDSEQATAEPGDQPRDGDDVPTPWELKEQERAEAAGDDGDSD
AAVTWESPPGAHDDEEYKWHTAKRTRSETAETDAVEFIDVKKAFGRNTVLNGLNLGIPEG
QISMILGPSGTGKSVCIKHMVGLLYPDEGDVLVHGESVPNMRDDDLFEMRKKFGVLFQDG
ALFGSLNLLDHVAFPLRQHTDKGEDEIMEIVTRRLKEVGLGGAGDKMPNELSGGMRKRAG
FARALVLDPQIVLFDEPDSGLDPVRTALLCELIKEIHEENGGAYVVITHDIMSARRVAEY
IAILWKGRIVESGPASELFNSDNQFVRQFLSGEARGPLGME
>AIA17532.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MTSLNPSPSTRGTQRAWVMLVVLTMLTVIGMTVVLPVLPFVILRYVGNENDLAIWVGVLE
AINGLCAFLVAPFLGRLSDRFGRRPVIIVAAFGAAFAMTLFGIGGAIWVLVLARAIQGVT
AGDLPALFAYLADITPPEERAKRFGILGALSGIGMMVGPAVGGLLAAVSLELPVFLTAGI
SLLVAVLSIFLLPESLKPENRISTISMRDVQPFAVFKAAFGRKELRGLLIGFGLLALSFG
FFVNNFSVLALDSITWGPTEIGLMTASIGIIDILIQGVLLGILLPRIGERGVIISGIVGQ
AIGLVALALVASVLAQPWVFIVGALMLAAGQGAAQAAMDGA
>AIA17256.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MPKKQAPIQVQNSYPEQQFIDILKKILDQGVWRPVKQRLAGETVPEAKTVTGVQMRFQPE
DGMPLTTLRSMKGAFYMFLGEMLWILSGHTDVDMLHKFNVRYWDDWCDAEHCGWYDLPVG
QFGRTYGAQWRSFNAGGPEPVDQIKRLFNAIKKNPYDRGLLVNPWNPYDVDHIVIKPCHG
QFRLLLVDDKWTMIVTQRSGDVPVGIPSNVVMYKFLQQLICMKTGFAEGELIYDIHDAHY
YSDQEKGVEELISREPRAYPTCTINPILVEILDAMLEGDDDPFANKRFNPDNKPYSDLLK
EWVVLENYNPHPPVPRDILPVAI
>AIA17257.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MISIFVAMTKNRVIGEKDQLPWRLSSDLKRFKELTTGHPVIMGRQTYESLPIKFRPLPNR
TNIVLTRNKDFDAPECIVAHSLAQGIEEAKLHNGSDEIFIMGGGQIYEQALPLTDRIYLT
EVETTAQKGDTFFPKLHKNDWYIKKAGGFEQDEKNQYAATFYIYDRKETND
>AIA16277.1|FEATURES|farme|multidrug|mexV|antibiotic efflux|0
MSRAPSFVVLAASLAAGACGANATGTRAAAEPAAVSVSAVTVAEQPITRFIRVSGTLTAQ
EDAQVAAEIAGRVVATPVERGTLVNEGDNLIRISADEVEAQAHEAQANAAQIEARLGLTG
GIAFDAERVPEVANAKAASALARIDFGRAEKLHAGKLLSQSEFDQRAAQLDAAERQYDVA
KNGAAQQYQALLGARARVALAQKAVADTVVKAPFAGAVGERFVSVGDYVTRGMKVATVMR
INPLRVELTVPEQYVSAVAPGRAVSFDVDAYPGESFSGQVRYVSPSVTAATRALMLEAVV
PNPNGRLKPGFFAVARIEEAGKQSAILAPAAAVRTTAGTARVFVLSGDRAEERIVTTGQA
VGDQLGRY
>AIA15924.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MTSPISTTAARVDQRAWVMLIVLTMLTVIGMTVVLPVLPFVVLQYVSNENDLAIWVGVLE
AINGLCAFLVAPFLGRLSDRFGRRPVIIAAAFGAAFAMSLFGIGGALWVLVLARAIQGLT
AGDLPALFAYLADITPPEQRARRFGILGALSGIGMMIGPALGGLLATVSINLPVFITAGV
SLTVAVLSVFLLPESLKPENRISRITLHDVQPFAVFKKAFGRKELRGLLIVFGLLALPFG
FFVNNFSVLALDSIQWGPTAIGLLTACVGVVDIVVQGVLLGILLPRIGERGVIVSGIVAQ
TIGLIALALVASLFAQPWVFIIGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQS
LQAAMSTVAPLIAAALYATVSHAAPYWLGVAIMVVAAVVISRTHIVSTARKPADEQPAEP
VGARG
>AIA15446.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTPTTTSPIRTYSSLRAAWIPLTALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTGLQWV
TGAYSLTFGGLLLTAGSAADRLGRRRVLLVGLAAFGLISLCVVAVSTVGELIGLRALLGV
TAAAMAPITNSLVFRLFDDQALRMRAMTVMIVVGMSGFILGPLLGGTALAHVRWEWLLVV
NAPIALIAFIGVRLGVPADHPDDLTHDALDLPGALLSIAAIGLACFSLTSGVEHGWLSAL
TLASILGAVAAGIVFVRHERRTASPMLDLALFSNGTVRGAAIAQIATSIAMAAVMFGLIL
HFQYAYGWSPVRAGLANLPLIVTMILATPVSEWLARRFGHRIACLVGAGFLAGALAGLAW
GVSHGYLAIAIAMVVMTVGLRTVMTICAVALVSAMPDNRTSIGTALNDTAQEVGSSIGTA
VVGTMIAVLVTAQLPAGTWSSELVASFFHGERITYAVLAAAVGLIGVLGARTLTDSRAVE
EH
>AIA15217.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
MQRKIFDMRKILASLTALVATLSLFAPAMAGQPAAWSQPTKPFQILDNIYYVGTKGLASY
LIVSNGKAILFDGTLAENAGYIEANIKALGFRLEDIKIILNSHAHYDHAAGIAKLKQDTG
AQVMAMEEDRSALEHGKQEGDTNYGGARFPAVKVDRALHDGDVVALGDVKMTAVLTPGHT
KGCTTWTTISADNGAPRQVVFPCSITVAGNILVGNKSYPGIVEDFRDSFERLGSMEADVV
LTAHPEFADVFQRKARRDAGDKEAFVDKGLLHRMVEKARIGFDRDLKAAQK
>AIA14798.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MVKESTNKTLIMIGLLLGLVFSELDQTAVSTALPTIIRELHGLSLFGWVAGIYMLAITVF
MPIFGKMADLYGRKRIYLGCVALFMVGSILCGLSDSMTQLLIGRCVQGIGAGGLMPLAMI
IIGDSFPLEQRAKVQSLIGPMLILPQLIGPTIGGYFVSHINWHWIFLINIPVGLVAALFV
AKGLRESVSPEKKQIDWAGAATLVLAILSLLFAPVLIDVKGYAWSSPIIIGLLVLSALFV
LLFIRIEARAAEPIIPLSLFRNRSVVVLSIIVFITMLGVMGGMSGMPFFAQIVMGLTPTA
SGYLSLGFMAGAIPMSIVCGFLITRVAYKYLFIGSFVLPIVGYFLLSRVAVDTTVLYILA
AFFILGLGIGVLFGSDNLIVQETVSPEHTGVGVATVQLFQSLGATLGFSIFGSLLSRRIH
DGIAGLSDQFPADAADSIMNGGLPSGLASGLVLQIKTVFADAFQEMFLIGAIFAAAAFLA
CWFMKREVLTPKPEAKAEQAAVIQG
>AIA14071.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MSIRTSRRIERVPASGIRRFFDIAAQMGNVISLGVGEPDFVTPEPFRQAGIRSIQEGRTA
YTSNSGLLELRVAVADHIERRYGVRYDPETELLITVGVSEGLQNAMLATIDPGDEVIVPE
PCFVAYPACVIFADGVPISVPSFVEDSFQVSPKAIEQAITPRTRALLIGYPNNPTGAVMS
REGLLELAALAEKHDLLVFSDEIYDRLIYGVEHTCFASLPGMRERTLLMGGFSKAYAMTG
WRLGWIAGPAEVISATRKVHQYGIMSAPTMSQYAGLAALREGEAACQEMVAEYDRRRRVI
VNGFNSIGLKCFEPQGAFYAFPSVAHLGLSSEEFCERLLQEQRVAIIPGDIFGPSGAGFV
RACYAASMDKIEAALDRIEHFVRTIT
>AIA13074.1|FEATURES|farme|bacitracin|uppP|antibiotic efflux|0
MAGRIGALLGIILMALSLRAAVVSVPPLLGSIGPELGFDSFSTGLLAMLAPVVFAGFGLL
TPRLIRWWGLEKVLVAAVLLAVAGQLLRAVVGDVTSFLLLSAITLAGYGMGNVVLPPLVK
KYFPDRLAIVTSGYVTMLAVGTWMAPQFSVPLANLTENWRASIAAWALLSAVVLVPWGIQ
LVRDRKLPRPDTPLVNGLVPAPPVRINPWKSPVAWGLAIFLAGNSAQTYVYFTWLPPYLS
EQGLDTQTAGSMLALFAILGLPVSLLVPLWVPRLRHPIVAVLVFTAFWIAGHLGMYLSPT
EHTALWVVFAGLGQGTFAIALLMMNLRSRSTYGSGVLAGFSQGVGYAGAAVAPLLFGIVK
DATGGWSASFAMLGICLVVMLTGAMMINGPRKIEDGQGEAKRLGELEQVN
>AIA12885.1|FEATURES|farme|beta_lactam|PMI41_04644|antibiotic inactivation|1
MNLKLLAPIIATAFVSMTAASPGGAAENQRDKVGVWVNDAVRPVMSQYDIPGMAVGVILD
GKSYVFNYGSMAKDGSKPITDKTLFEIGSISKTFTATLATYAQANGDLALTEPAGKYVPA
LQGSPFGDVEILHLATHTPGGFPLQVPDNVKNERQMLKYFKEWQPAYLPGTHRTYANPSI
GMLGYITAHSMKGDFPTLVEQKLFRPMGMANSYINVPSDRMADYAQGYTKAGKPVRMSNA
VLSSEAYGVRTTAADLVQFLKANMKLVPLDEKLARAIRDTHAGYFRVGEMTQDLVWEQFD
YPAALPALLEGNSQRTSRPALPVKRISPPMSPRQDVLINKTGSTNGFGAYVAFVPEKRMG
IVILANRFYPNEDRVKIVHQLFARFESGGVGHEPAPVE
>AIA12863.1|FEATURES|farme|beta_lactam|PMI41_04644|antibiotic inactivation|1
MNLKLLAPIIATAFVSMTAASPGGAAENQRDKVGVWVNDAVRPVMSQYDIPGMAVGVILD
GKSYVFNYGSMAKDGSKPITDKTLFEIGSISKTFTATLATYAQANGDLALTEPAGKYVPA
LQGSPFGDVEILHLATHTPGGFPLQVPDNVKNERQMLKYFKEWQPAYLPGTHRTYANPSI
GMLGYITAHSMKGDFPTLVEQKLFRPMGMANSYINVPSDRMADYAQGYTKAGKPVRMSNA
VLSSEAYGVRTTAADLVQFLKANMKLVPLDEKLARAIRDTHAGYFRVGEMTQDLVWEQFD
YPAALPALLEGNSQRTSRPALPVKRISPPMSPRQDVLINKTGSTNGFGAYVAFVPEKRMG
IV
>AIA12371.1|FEATURES|farme|beta_lactam|HMPREF1568_2704|antibiotic inactivation|0
MKLRRLYTFFALQLIAALLLSPLAAAQTASVAKPNQPATVVELPASPVGKLGRAFIEAVN
SGDKTALANFIASSFSEIAMKNAPASEYIANLQKVYAQSGGFDVMEVMPTTDANMLRLKL
RSKRGNRWVMLVTRLDKAQPDRLDGFGVRLLPDPEIEKADVWSEAKMDEAGAVKEIERHV
EMAASQDRFSGVALVMKGDRVIFNKAYGIAERGFGAPNKLDTKFNLGSMNKMFTSVAIAQ
LVQAGKLSYDETLAHALPDYPNKQTAEKITIHQLLTHTSGLGDFFKPEF
>AIA12241.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|0
MNRLPARLLCIALCLITAAVNLPAPLYPVYAQLSGAGAGATAIAFAGYVVGVVPVLLLWG
GLADRVGRRPLIVTALALSMLATVLLLRAPGLYSLAIARCLLGLGTGLASATGIAYMTEL
LALEGQEPARAASWVTASTSLGFGLGAAATSVCLLHTPGLAPASFWIQLVLAGLALVSML
KLPDPAPRRASAMVRLPCYPVGCVRYGLAILLAWATTGVVIAILPSVLQVAGLGAWAGFS
TFSVISCGLMFQPLARRMPARRAVALGLAILPPSYALIAWGALNGQLALVLVGTVAASSA
CYGFIYLGGLGAIAAQAGAEMPRASAGFFLLAYAGFSVPVVFTGLIADRFTPSTGLWAFA
GALTLGTLALLAAMARRPPLRASIANKA
>AIA19301.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPKISKKAQAMPASPIRKLVPFADAAKKRGTKIFHLNIGQPDMETPKQFWDKLKNLDMKV
LEYCPSNGLESYRKKFAEYYNRIGIQVDASHFMITEGASEALSFGMMSCLNEDDEIIIPE
PMYANYIGFATAGHIQVKPIPTSIESGFALPPIADFERAITPKTKAILVCNPNNPTGYFY
SKEEIMTLREICLKHDLYLFVDEVYREFLYSDKTFFSALNLEGMDQHVIVFDSISKRFSA
CGARIGALVTRNKEVLQAVLKFGQARLSPPSLGQIAGEELFDLGKEYYDSIIAEYKKRRD
VLVEGLNKIPGVYCPNPGGAFYAVASLPVKDTDVFCQWMLEKFSHNGATVMMAPASGFYS
TPGSGKNQVRIAYVLNANDLKTAIACLEAGLKEYAAQKEVSAQVH
>AIA19292.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MILSIIVAAAENGVIGKDGKMPWRLPAESAYFRGTTLGHPVITGRKNYEGMGRPLPDRLN
VVITRQPDYKVPPGVIVVHTLADALGLPQVRDQAEVFIIGGSQIYDEAMPMTDKLYLTKI
HADIEGDTFFRYDPDEWELEW
>AIA19283.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVAIDDKRAIGKDNKLMWHIPRDMKRFKSLSAGHVVIMGRKTYESIGKPLPNRTNIVIT
RDLNFFAPGVLVTHSFEEALKKSRETEKEEICIIGGGQVYEESLPYADRIYLTIVHDDFE
GTVFFPDYSQFSREIEREDHEEDGHRFTFLTLEKP
>AIA19278.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISTIVATAEGSVIGKEGGMPWYLPAELAHFKELTMGHPIIMGRKTHESIGRSLPGRYNI
VITRDKGYGPAEGSVVANSLGEALKMAKKQDGADEIFIIGGEQIYAHAIPLLERIYLTRV
KAKVDGDRFFKYDPTKWEEVSSEQHKADDKNKYDYEFVILERA
>AIA19256.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ASDEWRAGIQEFTQKIKEDDKFAEKWGELGPVYGYQWRKWPAPGGQHIDQIARAIDLIRN
NPASRRIIVSAWNTADIDEMSKAGIPPCHLLFQFYVADGKLSCQMYQRSADTFLGVPFNI
ASYSLLTVMMAQVTGLQPGDFVHTFGDTHLYVNHLEQVDEQLSRQPRKLPIMKINPRVES
IDDFKFEDFELVGYDPHQAIKAPIAV
>AIA19248.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKEAFIMSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGEDLHAGTAAVQMSLLIFFLS
MGFGQIVVGPISDMVGRKLPLYGGLALFMVGGIGSAMSPTIEWLIAFRFLQGLGASAGMA
VPRAIVRDLHTGTEAAKLMSLLMLVFSVSPILAPLTGSQIIENFGWRAVFWTVTGAALLA
TILLATSLKETRPAEERVGSSFGTALAGYRFLMGDRNFLGLVAIAGFGIASFFVYLSSSS
FILIDHYGLSPSVYSVFFSINAVAFIGMSQLTGLLSERFGLKRVVWVAVTGYASTMVVLF
AVMATGIDRLDVMAALLFVGYGFLGLVIPTTSVLAMEEHGEIAGTASALMGTLHFAIGAV
AMGVAGIFFDGTPLPMVAGITLCAVISFTLAKFTLGRTREAVEAPAE
>AIA19208.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTEMNSSKKHGEYQYLDLLDEILKNGERKVDRGTDVVLYSLFGRQTRYDLSEGFPLLTTK
KVYWKGVLHELYWFMSGQTNIKYLVDNNVHIWDDYPFKIYNWKRESDKKLPELTKEEFVE
KIHTDAAFAEKWGELPRIYGEMWRHWPTRSGRTIDQLKWILQEMKDDPDAKNLIVNSWNP
EYLYTMATYEDASRFPICHNMYQISNRNGKLSLQLYQRSADIFLGVPFNIASYALLTIIL
AQISGLEPGEFVHTFGDVHVYENHIEQAKEQLSRKPRPFPTVTIDPAVKNLDDFRPEHVM
LENYDPYPVPKGELTVAGGFYEKKK
>AIA19137.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGKPRAELQYLSIARQILEEGEPTDDRTGVGTLDLFGEPQMAYDLRKEFPLLTSKNVATK
AVRSELAWMLHGDTNLKYLAKHDNHIWDEWPFVAYLKKTDQAIPEQGSEEWKSAKDDYLQ
KIKDDANFAEEYGNLGPIYGHQWRAWADYDGKPIDQLRIAQDQIRSGKASRRIIVSAWNV
SDLDEMSKAGLPPCHTLFQFNASNQTDPKTGKKYLDMKMYQRSADWFLGVPFNMVQYAML
LSAMAQTTGRTPRYFYHTFGSAHIYKNHTEQIKEQLSREDNLYEAPRLKLNPEITDIGDF
EAEDFKIVGYKHHPSIKGQVAI
>AIA19085.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKKRLGLVYGGKSAEHEVSLSTARAVSQAVDFKRFEVIPVYITYDGEWRKGKPLEKPVET
IEELRLQGDGTTKPDSIHDFLNGGESLPDVIFPLLHGTNGEDGTVQGLFEVMNIPYVGNG
VLASSAGMDKVSMKQLFAQVGLKQVPYVHFNRSGWMEEREPLIEQMEKELGWPMFVKPAN
LGSSVGISKAEDRESLITAIELALKFDRRIIVEQGVTAREIELSVKGNDDPVCSVPGEIK
PVTDFYDYEAKYKDGNTELIIPAEVTPEVLETMEDMAIRAFKVLDCSGLVRADFFVTAEN
EVL
>AIA19008.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MISIIVAVGNDNVIGKDNSLIWHLPADMKFFKEKTTGHCIITGRKNYESIPEKFRPLPNR
TNIVITRQKDYSAPGAIIVDSIKKAFDLAKEVKDDEIFIIGGAEIFKQTLNVTDKIYLTK
IHHSFDGDVFFPELNKQQWKETQRTKGITDDKNKYEYEFLTFEKIV
>AIA18979.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FMGNCGVDGRPEPIEQSINSKWVISELTEDPYARNAIVTSWNPEYLYTMATNKDASRFPI
CHNMYQVSVKANKVNLQLYQRSADLFLGVPFNIASYALLTIILAQVLGYKPGEFVHTFGD
AHIYENHIEQAREQLKRDPKPFPKVTIDPSVKTIDDFRPEHVVLENYDPHPILKGELTVA
GGLYEG
>AIA18932.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQARISAIAALGHNLAIGKGNELLWHIPEDLKRFKALTLGHPVVMGRKTFESIAAMLGKP
LPGRPNIVITRDPTWRYEGVHVAHTVEDALALAKELDQEEIFVIGGAQIYEAALPHTDRL
YLTLIDDTKEGDAYFPAYENIFTKKLSEEVREHDGLKYTWVDLER
>AIA18861.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MILSIVVAAAENGVIGRDNSLPWRLPDDLKRFKELTMGKPMIMGRKTFESIGRPLPGRTN
IVVTRQGDLRFEGCIMVDSLDGALAAAGAASEVMLVGGAQLYRDAMPRVDRIYLTRVHAA
VAGDVFLPSLDAHEWRETIIATHPADERHAYSFTFVNLDRVAS
>AIA18837.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSLIVALDRRRGIGKDNRLPWRLSADLKRFRELTMGHHLIVGRKTFESIGKPLPGRQM
IIVTRQAGLQVESCFVAQSVDEALRLARERGESEVFVIGGAEIYAQTLALADRLYLTLVE
AEVEADTFFPEFDEAEWLAQETVQHEADEKNQYPFTFKSLVKT
>AIA18811.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YLNLLQDIIDNGSDKPLFFTPEVLEEYKKKGQEPPFIRSVFGRIMRFDLSKGFPLLTTKK
VFMRGITHELLWFLKGDSNIKYLVDNNVHIWDEWAWKRYHKAALKSEGKIKDMAQDEFIA
KLKEGDVKSTFVKKWGDLVTIYGRMWRKWPASDGREIDQLGWVIQGLKDKPFRKSYVVSA
WNPDFIYAMASKGNANEVPPFCHTTYQFAVVDGKLNLGLYQRSADSFLGVPFNIASYAMM
LLMVSQVTNIPPGEFVHFFGDVHIYSNHFDAVKEQLSRKPKPLPTLKLNPKIKDIDDFTF
EDITVENYDPHPPIKAEIANIGGF
>AIA18804.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKPYHDLLEKVLVDGHKKLDRTGTGTLSIFGHQMRFNLEKGFPLLTTKKVHFKSIAHELL
WFLSGSTNIAYLKENGVTIWDEWADAQGNLGPVYGYQWRSWPSEDGKTVDQISRVIEEIK
HNPDSRRLIVSAWNVGMLEQMALPPCHSFFQFYVAGGKLSCQLYQRSADLFLGVPFNIAS
YALLTHMIAQVTGLGVGDFVHTLGDAHLYLNHIEQTKTLLAREERALPKLRINPSVKNIF
EYRYEDFSIEGYDPHPALRAPVAV
>AIA18773.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|1
MKPYLDLMRHVLEQGTPKTDRTGTGTLSVFGHQLRFDLRQGFPLLTTKKLHMRSIIYELL
WFLRGDTNIGYLQEHGVRIWNEWADEQGELGPVYGRQWRSWQAADGRSIDQISQVIEQIK
TNPDSRRLIVSAWNVGELERMALMPCHLLFQFYVANGRLSCQMYQRSADIFLGVPFNIAS
YALLTMMMAQVCGLEPGEFIHTLADAHLYSNHLEQARLQLERAAAPFAAHADQPGGHFDI
RLRLFRLRADGLRSAPAYQGGGGRLIVSLLVAMDERRGIGRRGGLPWRLSSDLKRFRELT
MGHHIVVGRKTFEAIGKPLAGRQMIIVTRDPDYHIAGCFTVHSIAEALELARQHGETELF
ICGGAEIYARTMELAERLYLTRVHADCDADTFFPEFNPEDWLETASETHAADEKNQHPFT
FSLLERKA
>AIA18713.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGEQPSSAGRRPEVIGIAAVARNGVIGAGNDIPWRIPEDWARFKAITTGHVLIMGRKTYD
SIGRALPGRTTIVVTRDQTWRAGGVIIVADPDAAFERAYALTPAKIFVAGGGQIYASSWD
RLDTLEITAVDAEPVGDVLFPTIGSDWHEADRDEHDGFSFITFRRQSD
>AIA18697.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIHSIIVAQSQNRVIGINNTLPWHLPADLKRFKAITMGHHMIMGRKTYESIGKPLPGRTS
IVITRNNDLQYEGCVMAHSLEEAFKIAEGNNETEAFVIGGADLIKQSIDSCDKLYLTTIH
QDFEGDTFLNELSSDWKVIEHTDHVPDEKNLYSYSFITYGK
>AIA18665.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVNVFFQRGLPVKQYHDLLKHVLAHGEKKNDRTNTGTISVFGYQSRYNLAEGFPLLTTKK
LHTRSIFYELLWFLRGETNIKFLKDNKVSIWDEWAAENGELGPIYGKQWRYWETADGRTV
DQNVIQQIKTNPDSRRHLVIAFNPGDVDKMALPPCHAFFQFYVANGKLSCQLYQRSADIF
LGVPFNIASYALLVHMVAQVCDLEVG
>AIA18652.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MILSHIVAVIENEVIGKDNDLLWHYSEDLNYFKKRTTGKIMIMGRKTFESLKKPLPKRFH
IVVSRHNIDSEYPNVKFVGSLSEAYRLAEKMTLSDEWPEEVMIVGGGQIYKESLKDADFL
YITRIPGEYQGDTYYSLNIPPEFRIAFSQFSNEVPGLRYEIWSKVRPDED
>AIA18625.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKTSIVGFAKNMVIGKNQDMPWGHGLKDDLRHFKELTTGQAIIMGSKTYESLGRPLPNRQ
NIVISRTPSVIEGVTVVDSLDKAYAAVEPGRETFVIGGGQIYKLAMDTIDRIIATEVEGE
YGGDVFFPPIDPSVWREVSREHHDADERNTHAFDFVTYERI
>AIA18597.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
FARAFIALHGRGGEDGSIQGLLDSMNIPYTGSGVLGSALSMDKVRSKRIWQCLGLATPPF
ALWEPGTGADDYVKIFGLPLSVKPVFEGSSIGVTRVNSASRFDAACELAARYGAVMIEPW
IIGDEYTVGILGTQALPSIQIASSEIFYDYHAKYLAEDTQYICPSPLSLQEEENLQLLSL
QAFRAVGAAGWGRVDFIRDLNGDFWILEVNTVPGMTSHSLVPMAAKVAGLSFDELVLEIL
SLTVGVAAKVDYAKGANA
>AIA18484.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MREERFLASMIKPASDRTPDAQYQNLLRSILEKGVRTNSQQGVDALTLMGPGPMHFKFDN
GFPIINERNMAPQESERLPVTVWKQAVAEICAFANGVRTQEGLEQFGCTWWKSWVTKEKC
EKRGLAEGDLGPGSYGAAFHDFPTSEGGTYNQFQNIIEQIREFPHLRTHFISPWIPQYII
RGTGKQQKVVVAPCHGWIHLRVLDNKLTLHMF
>AIA18410.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GLWFLQGSTNIKYLVDNDVHIWDDWPYKAYLMKQGKKVPTPNSDEWKKGITEFTDRIKKD
ADFARWHGELGPVYGYQWRSWPAPDGRHIDQISQAVNAIKHSPDSRRIIVSAWNVADVEE
MAISGLPPCHLLFQFYVANGKLSCQMYQRSADTFLGVPFNIASYALLTLMMAHVAGLKPG
DFVHTLGDTHLYANHLKQVEQQLKRKPRPLPKMKLNQDVKSIFDFTIDDFELSGYNPDPA
IYAPIAV
>AIA18354.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MRQYLELMRNVLEHGARKEDRTGTGTLSIFGYQMRFDLSEGFPLLTTKKLHLKSIIYELL
WFLRGDTNVKYLQDHGVKIWDEWAEENGDLGPVYGAQWRSWKDPNGGSIDQISQLIDQIK
TNPDSRRLIISAWNVVDIPRMHLAPCHCLFQFYVSEGRLSCQLYQRSADIFLGVPFNIRL
LCVAHDDGGAGLRSETGRFRSHLRRRPSLPEPHRAGKTAVVAPALQSPSNEDQPRRQIHL
RIQIRRISN
>AIA18237.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKSRGIGKAGGLPWRLSSDMKRFRELTMGHHIMVGRKTFESIGKPLPGRQMIIVTRSESI
AVEGCFIVRSVEEAVDLARERGEIELFVCGGAEIYAQTLGLADRLYLTLVHADCAADTFF
PEWNSDDWIEMESEHRAADEKNQHPFTFKTFARKSQV
>AIA18156.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYQDLLRHVLDKGVRKSNRTGIDTISTFGYQMRFDLSEGFPLVTTKKVHMKSIVHELL
WFLKGDTNIKYLKENGVRIWDEWADENGDLGPVYGQQWRAWKTADGRTIDQISDVIHQIK
TNPDSRRMLVVAFNPGDIANTPKAPPPCHSFFHFYVSEGKLSCQLYQRSADVFLGVPFNI
ASYALLTMMIAQVTGLKPGEFVHSFGDVHIYTNHLEQVNLQLSRQPLPLPRMELNPYVKD
IFGFKYEDFELLNYQHHEAIKGQVAV
>AIA18152.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELIKTILEQGERREDRTGTGTISMFGMQAKYDLRDGFPLLTTKKVLFGSVVRELL
WFLRGSTNINDDLTQHTPIWDAWADDNGELGPVYGYQWRSWPKYIKQENGLYSRVHVDQI
SNIIETIKTNPDSRRLIVSAWNVADLDEMALPPCHMMFQFYVINGRLDCQLYQRSADMAL
GVPFNIASYALLMMMIAKECNLTPGIFTHTLGDAHIYLNHLDGVMKQLERTPKGLPTVEI
ADKPFFELRYEDFALHNYDPYPFIKFPVSV
>AIA18119.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTQYLDLIRLVLGQGKFKGDRTGTGTYSVFGAQARFPLRDSFPLLTTKKLHLRSIIYELL
WFLRGERNIRYLKDNKVSIWDEWADKKGDLGPVYGKQWRNWTKASRTRKSGSIASQMAFD
LGESEDEDEGVIPPGPRVRRSEHGIDQIAAVIEQIRRNPDSRRLIVSAWNVADIDSMALP
PCHALFQFYVSDGELSCQLYQRSADLFLGVPFNIASYALLTMMVAQVTGLKPGDFVHTFG
DLHLYSNHLDQAHEQLTREPRLLPKMKLNPKVKHIDRFKFEDFELVGYDPYPSIKAPIAV
>AIA18088.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SNRNGKLSLQLYQRSADIFLGVPFNIASYALLTIILAKITGLEPGEFIHTFGDVHIYENH
MEQAKEQLKRKPRGFPTVTLDKAVTSLDTFKPEHVTLEGYDPYPMLKAELTVAGGLYDPI
TGKMAA
>AIA18089.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MISIIVAIDEKRGIGKNNHLLFKIPEDFKRMQHITTGHPIIMGKKTFESIGRVLPNRTNI
IVTRDPDFEFDKTLVVHSLEEAIMQAQTCAGNEEIFIFGGGQLFKESIEKGLVDRIYLTV
VKGDYHADTFFPDYSEFTKVIEKEERDAEGFNYTFLTLEK
>AIA18079.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MKRLAALTAALCLSFSASANDPNHIDCGSCAAWNVAQKPFKIVGNTYYVGTKELSAMLVT
TPKGHVLLDGALPQSAAQIEANIKALGFNIRDVKYILNSHAHWDHAGGISALQKASGATV
LASEWGARVLRAGTVEADDPQYNPKHIEHFPKVANVRAVKDNEVIRVGDVAITALMAPGH
TPGSTTWTWKSCEAGKCHDIVYADSLTAVSADDFRFTGGAGKPDLSDSFRSTIDRIGKLQ
CDVIVSTHPGFTDTLDKLAKTTPTHNGFLVGGCAEYAAASLKRFDERIATERR
>AIA18035.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSEIRKTIVVAVSENGIIGRDGDMPWRLSTDLKRFKALTLGKSVIMGRKTYESIGKPLPG
RANVVISRQAAAIDHPDVRMARSLTEAIGLAEDIAKRSGEDEICIIGGGQIYTQALDLAD
RLCVTHVETSVDGDTSFPTIDPTLWRATETIEVPAGDKDSYPTKFVVYDRR
>AIA18027.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRFDLSEGFPLLTTKKLHLKSIIYELLWFLKGDSNVKYLRDHGVNIWNEWADEAGDLGPV
YGAQWRSWRTADSGAIDQIALVIDQIRTNPNSRRLIVSAWNVGEIEKMALPPCHVVFQFY
VAGGRLSCQLYQRSADVFLGVPFNIASYSLLTLMVAAVCDLKPGEFIHTFGDVHLYLNHL
EQARIQLRREPLVLPRMKLNPSVKSIFDFDYPDFEITGYEAHPHIKAEVAV
>AIA17879.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MQVSYIFAMDRNRGIGFENKLPWRLPADLAFFKKTTLGHPVVMGRRTFDSLGGRTLPGRT
NIVLTQNRSYTAEGCEVVHSADEAVERFGGAGELFVIGGTEAFRLFMPYVMRMYITRIEH
EFVCDVFFDGLPEREWKLVSSEKGPRDEKNPYDYYFEVYERVDV
>AIA17874.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VLSSTAQYPRLTTLSEEIKNAVSEVHPIIAERLAEAAQTTSQNTKTALTVSHSKGIETSE
MEYLNLLRDIRDNGQGKDDRTGTGTRSIFGRQLRFDLSKGFPAITTKKLYTRSIVHELLW
FLAGDSNIEYLVQNNVGIWNEWPYRNYVQKTEKRTVTPEETHSEAWAKGMKKFTDKVATD
HDFAMKWGDLGPVYGYQWRHWPDGKGGEIDQIQRVIDTLKNNPTSRRNIVSAWNVADIDE
MAIAGLPPCHTMFQFNVRGDKLDCQLYQRSADTFLGVPFNIASYALLTAMVAQVVGLKPG
EFMHTFGDAHIYNNHIDQVNEQLSREPFPLPTLWLNPDIKNIFDFKFEDIELRDYQSHPP
IKAPIAV
>AIA17864.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MSLSFIAAISKNGVIGRANDLPWRLPDDMKYFRETTKGHAVIMGRKNYESVPEKFKPLPY
RVNIIVTRQKGFVAPGCHVVHSLEEGIKIGEASNTGEIFDIGGAELFKLGLPLAKRMYLT
EIKAEVEGDVYFPGFDRKEWKEISRTAHGADERHAFAFDFVVYERLR
>AIA17854.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MEFPRGELSAVMGPSGCGKSTLLRCINFLEIFDSGRITIGNVSVAWSAGETAALSEEKKL
ALQQLRLKTGMVFQGFNLFPHLTVLDNVTLAPMLVKRTPASQAKELGRAILDRVGLGDKT
DRYPSTLSGGQQQRVAIARSLAMQPEVMLYDEPTSQLDPRLVDEVFQVMRELANEKMTQI
VVTHHEHFAREAAGRALVLEEGRAVWRKL
>AIA17715.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MITIIAAVAANRVIGAAGKGMLWRIPADMNHFVELTTPHPVLMGRKTYESIPAKFRPLKD
RLNVVITTNTDYQTSPGVLICSSLDEALKIAQQYDDNIFVAGGGSIYSQAIDKTDRLEIT
EVHQDYEGDVLFPIIDSTNWKEVHREDHEGFSFVRYERQ
>AIA17580.1|FEATURES|farme|beta_lactam|ampC|antibiotic target alteration|0
KNNMEKQHSEYQYLSLMKKLIDSGDKQTDKGTGVVTYSSFGDQMRYDLSEGLPLLTTKKV
YWKGVLQELYWFMSGQSNIKYLVDNNVHIWDDYPYKIYNEKVGKGEMEAMTKEEFVAKIA
ADSDFAKIHGELPHIYGESWRRWQARDGREVDQLGWVVSELTKDPDA
>AIA17522.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MSDTVEIPSAEAVNNSVWNVLREAFVGTQRDFTKGSIPAALIILAIPMILEMSMESLFAI
VDTFFVSKLGTEAIAVVSLTESILVLTYAVAIGLAIGATATVARRFGEQDKEGAARTATH
VVYLGIIVAVVMGAAGVIFAPQLLHLLGAEPHVIELGTPFMRIMLGTNAVIVFLFLLNGI
FRGAGDAAIALRVLIIANLLNIFFCPMFIFGIGPFPELGVTGAAVATVCGRGIGVMYAAW
ALFIRKNGRLHVRGDHWKFDSTLLWSLMSLSSTAVLQFLIATLSWTGLVMIVAGFGSVAI
AGYQIGLRVIMFVLLPAVGLANAAATLVGQNLGAEQPDRAERSVWTAGFLNAGILGIAGL
FFIIFPGLVINIFTQDPEVAAYGRDCLRIVGYGYAFYGLGMVMESSFNGAGEHLDAYISQ
LFRFLAF
>AIA17496.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMCHVLEQGVKKEDRTGTGTLSVFGYQMRFDLQQGFPLVTTKKLHLKSIIYELL
WFLRGETNVGYLREHGVTIWDEWAEANGELGEGIYGRQWRAWPNPDGTHIDQLSQVIEQI
KHKPNSRRLMVVAYNPSFADKTPLPPCHSFFQFYVAAGKLSCQMYQRSADIFLGVPFNIA
SYALLTLMVAQVCDLQPGEFIHTFGDAHLYLNHLEQARLQLTRAPLPLPQMKLNPTVKDI
FAFTYDDFELVNYQFHPHIKAAVAV
>AIA17484.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAVKHQEYQYLDLLQEVLDDGQKKVDRGTDIELRSLFGKKIRFDLSKGFPLLTTKKVYWS
GVLHELYWFMSGQTNIKYLVDNNVHIWDDYPYKIYSKKAEEGKVPVLTKDEFVGKVKDDK
KFATKFGNLPRIYGEMWRHWPTRTNRTIDQLAWVMQEMKDDPDAKNLIVNSWNPEYLYTM
AINKDASRFPICHNMYQISNRNGKLSLQLYQRSADLFLGVPFNIASYSLLAIILADIAGL
EPGEFVHTFGDAHVYGNHIDQVKEQLSRKPRPFPTLKIKRKLKSIDDFRTDDVILENYDP
YPAVKAELTVAGGLFDKKTGKMAG
>AIA17354.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKVILVAAVAENGVIGTHNALPWYIPADLKHFKRITSGKTVLMGKNTFDSIMKRLGKPLP
DRLNVVVSHQNLTLPEGVLLFHGIDEALDALHDKDEIMVIGGGQIYNQIMDKADKLILTE
VHESVEGDVFFPKFDKNEWNETSRENFDEFSFVEYERK
>AIA17327.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSLIVAMDRRRGIGKDNRLPWRLSADLKRFRELTMGHHLIVGRKTFESIGKPLPGRPM
IIVTHQAGLQVESCFVAQSVDEAIRLARARGESEVFVIGGAEIYAQTLALADRLYLTLVE
AEVEADTFFPEFDEAEWLAQETVQHEADEKNQYPFTFKSLMKT
>AIA17322.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRTNIIHPGAGHLKYEIRSIVEFANSLQKTGVDVIWENIGDPIAKGEEVPAWIKDIVVDA
AKDSMSYAYSPTKGLNEARDYLAKTRSQSTGATLNSEDIIFFNGLGDAITKLYTWLNPTA
RVLGPSPAYPTHSSVEGAHGRSRHHTYDLDPENGWIPDVEDIKKKIEKNPNIAALLIINP
DNPTGMVYPRHILEEFVALAKKNDLFLIADEIYANLAYEPDEFTSLVEIADGVPTVIMRG
LSKEVPWPGSRCGWLEFYNTKRDSDFARYAQSIEEAKMIEVCSTTLPQTVLPKILSDHRY
PDHLRHRTEQYKQRADIAEQMLADIEGVDVIKPKGAFYLVVNFKSGFLDESKKLTPANAA
AADLLNKALAETEEDELDKIFCLQLLAHNGLCTVPLTTGFNSHIPGLRMTLLESDEKKFR
HNLTLLAQALQNYQQQ
>AIA17324.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKVLVIGGGISDEREVSLRSANAIFEGAKSAGHEVEFYDWDGSKDWLNKNIQDFDVCLPI
LHGKGGEDGQIQSILEKSGSHFLGSSSDVSRVCFDKRLVLDTLKRNQIMIPEGVLVNHDQ
YKKHKLINRPHILKPNKGGSSLGVVFVRDPSHIDSTMVDRVFSEWREMLLEEIIEGTEIT
VPVLDGLQMPIIKIIPPEAGEFDYENKYNGATKEIVNPEEIDQKLKDESQKLGKKIHNLL
KCRHLSRTDMILTAEGELYVLEVNTMPGMTNQSLFPKAAGIAGLSFDQLADYFIKLAAGK
L
>AIA17276.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLREIRTTGTRKAQRAALRSDGRRPEVLSVFGRQIRFDLAAGFPMVTTKRMPWN
AVVHELLWFLSGSTNVGYLREHKVSIWDEWATSEGELGPVYGKQWRCWEGPQGKVDQIAN
LIAGIRKVIENPHASEARRLILSAWNPADMPDPKVPTGCHTLVQFNVTEGRLSSQLYQRS
ADMFLGVPFNIASYALLTHILAKLTGLGVGEYVHTFGDAHIYDNHLDAVDEQLRREPMPL
PTLQIVGEIASIDDVKAEQLKLIGYQSHGRLPGEVAV
>AIA17238.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLTIRRAQKGEAGLVLSFVRELAEYEKLLHEMEATEADIDAALFCASPRLFCEIAEWNG
EPVGFAVWFVNFSTFSGRSGIYLEDLFVRPAQRGNGIGKALLVHLAKHCVENGWSRLQWS
VLDWNTPSIAFYKSLGAELMDEWTTCRVGGPALTALAQGKL
>AIA17213.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLVAAASENNVIGKNNWMPWDLPAELAHFRAYTRGKTVIMGRKTYDSVGRPMPNRHN
IVITQQNLTIPGVDVVHSIEDALELAKKDGLEEICVIGGGSVYKAALPYANRIHLSRIHT
TIEGGEAFFPDIDWSQWQEVSRAEHPADAENAIPYTMLVYERK
>AIA17122.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
ATIGGATKMPRWEFIALAAALMALNALAIDIMLPGLQQIGASLGVENENHRQYVISAYIS
GFGLAQLVYGPVSDRFGRRGPLLFGLVIYVAAALTAAMAPSFGFLLAVRFIQGIGAASTR
VIAVSVIRDTFGGRAMAEIMSLVFMVFMVIPVIAPSVGQLVMLFSEWHMIFLFMATIALL
ITIWTAVRLPETLPPEYRRPFPAKSVMGGFAIVLTNRVSLCYTLATTIVFGALFGFINSA
QQIFVGLYRLGVWFPIAFACMAGMMAVSSFANSQLVGRFGMRRLSHAALLGFASMSTLMF
ILSLFGPVPLPIFFLLFMLAMVQFGWIGSNFNSIALEPLGHVAGTASSVTGVVQTIGGGI
IGAGIGQAFDGSVRPLTGGFCAVSLLAVLIVLYAEHGKLFQAHSKPLR
>AIA17084.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKKPCISIIVSIGKNMVIGRRDKLMWPISEDLKRFKRLTMSHPVIMGRKTFESILTSLGK
PLPGRTNIVVTRDTTYAPEGAIITHSLEEAIQKASEVDQEEIFIGGGAQIYEQALPITDR
LYLTLIDDAKEGDAYFPPYKHLFKKVIAEEPHDQNGLKYKWVDLERE
>AIA17076.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDEARGIGRNGRIPWRLSSDMKRFRELTMGHHIIVGRKTFESIGRPLPGRQTIIITRNPE
FRAEGCSIVRSVDEALNLAKSRGESEAFICGGSQIYAETIGAAQRFYFTLVHARVESDAF
FPEWDESEWTGKSSTYHEADDRDEYSSTFSLLEREGRPG
>AIA17074.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIDQIKRNPDSRRLIVSAWNVGEIEQMALPPCHAFMQFYVVDGKLSCQLYQRSADIFLGV
PFNIASYALLTMMIAQVCDLAPGHFVHTLGDAHIYLNHLEQAQLQLARQPYPAPQMRLNP
AVKSIFEFKYEDFELVGYEAHPHIKAKVAV
>AIA16921.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHQYLDLLARIRNTGTRKDDRTNTGTLSIFGHQMRFDLAEGFPLVTTKKLHVKSIIHELL
WFLQGSTNVRYLREHGVTIWDEWADENGDLGPVYGRQWRAWPTLDGRHIDQIARVVESLK
GDPDSRRHIVSAWNVGELDKMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTQMMARVTGFEPGEFVHTFGDAHLYLTHLDQARLQLEREPRALPKLVLNAGVSSID
EFTSDDIAIEGYDPHPGIRAPIAV
>AIA16887.1|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|0
MPSLLYGDTEVVNNRAATRDARKRGIPYGQALEESTARFQADWEQWQSLYNLPNNLYQPG
AQDHNGTPFYDVEIDVTHLAKDQTAEVLHQALLESGLVERRNVVEPVQIFPVPVNGLFF
>AIA16888.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MISVIAAIDEKRGLGKGNDLLFKIPSDMKRLKELTTGHPLVMGRKTFESLGRKLPNRLHI
VITRDAKSLKDLSFQPDVIVGSLEEALRQAQGENKEIFIFGGGQVFTEAVEKGLVDRLYL
TVVQGDYGADTFFPDYSMFTKVVKEEEHEEGDYHYTFFILEK
>AIA16889.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNKHQEYQYLDLLKDILKNGDKNVDRGTGVTSYGVFGRQTRYDLSEGFPLLTTKKVYWKG
VIAELYWFMSGNSNIKYLVDNNVHIWDDYPYKIYKAKSEKLKTKNILSKEEFIEKIATDD
AFAKKWGELPKIYGELWRRWPTRSGRTIDQLRWVINELKEDPYAHNTIVNSWNPEYLYTM
ATYEDASRFPICHNMYQVNIKNNRLNLQLYQRSADIFLGVPFNIASYALLTVILAKVLKL
EPGEFVHTFGDVHIYENHIEQVKEQLKRKPRPFPTVKIDKAVKDIDDFRPEHVILENYDP
HPIIKGELTVAGGLYEGKKKKK
>AIA16847.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTISLILAADENNCIGKNNTLPWHLPADMKLFREKTMGHCVVTGRKNYESIPDRFRPLPG
RTNIVITRNKEYAAPGATIVHSLDAGIDTARQLGETEVFVIGGGEIFRQALPIAEQIYLT
RIHHVFTGDVFFPALEPLEWKETERHDFPPDERNKYGFSFRVYHRAAPAISESQ
>AIA16834.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MWAMGRNRVIGAGGDIPWRLPADWAYLKATTMGHPILMGRKTYESIGKPLPGRTNIILTK
NANFAPEGCVIVHSIEDAIKRYGSDDELFVLGGAEIYKLALPCADRLYATQIDHEFAGDT
YFPVIDLSQWEVVSRRPGTRDEKNPYDYEFIVFWRKKEVSE
>AIA16823.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLQDIKDNGTVKSDRTGTGTKSVFGRQLRYDLSKGFPAVTTKKLYLRTITHELL
WFLAGDSNIEYLVKHGVHIWDEWPFKAYLQATGQDIPQTGSDEWDQKLKTFTDQIKTDHQ
FAKKYGKLGPVYGHQWRHWPDGKGGEIDQITEVIDTIKNNPDSRRIIVSAWNVADIKEMA
KAGLPPCHTLFQFYVADGKLSCQLYQRSADTFLGVPFNVASYALLTMMVAQVTGLKPGEF
VHTLGDAHIYLNHQEQVDLQLSREPRPLPTLKLNPNIKNIFDFTIDDFTLEDYDSYPPIK
APIAV
>AIA16786.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRSYLNLLQDILDHGVEKGDRTGTGTISVFGRMLRFDLSQGFPLLTTKKMHLPSIVHELL
WFISGETNIRYLQENNVRIWNEWADENGELGPVYGSQWRAWPTPEGDHIDQISRVVESIR
HNPDSRRHLVVAWNVAEVDRMALPPCHYAFQFYVAEGKLSCLLNMRSVDTFLGLPFNIAS
YSLLTHMMAQQCGLEVGEFVWSGGDVHIYSNHLEQVKLQLTREPYPLPKLNIKRKPETIF
DYKYEDFEFVGYECHPSIKATIAV
>AIA16754.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKKLKIALIFGGTSQEREVSLRSGQTIAENLSKAKYEMIPVEISQNGKWLISSPTIKQI
EASTKSKKVSTNRDIIPVDKNTESKIDLAFLALHGPGGEDGTIQGVLESLGVKYTGSGVL
ASALAMDKAKTKRMVASEGILVAPHILLSKTDYKKNPKKLLNKLKGKLVIKPNRIGSSIG
VTISSDKAEIKKGIEAAFKHDDELLIEPYVSGRELTVPVLGNKSLKALPVIEIVPKVSEF
FDYRAKYETGGSDEIVPAPIPKSLALKLQDIAVLVHKLIGGRGVTRSDFIVTKEGKIYFL
EINTIPGMTPNSLVPKSAKAAGMSYSQFLDKLIQLALNKE
>AIA16656.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MAKNRVIGASKKIPWHLPAELAMFKRITMGHHIIMGRNTWESIGRLLPGRTTVIVTRQSD
YNVAGALIAESLEAALSMCRGDDEIFVIGGGQLYVGALAVSNRIYLTEVDAEVGGDTFMP
EFSLSDWRAVSVESHPADDRNQYNYKVTVYDRIVS
>AIA16627.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTTREELPKKIAVLMGGPGSEREVSLATGRGVAKALRSLGAELVEIDVRDENFQLPDDVD
LAFNTIHGTFGEDGHLQKILEGRGIAYTGEGVAGSEIAFDKIRTKEKFQEHGVTTPPWEV
IHAGQRPSISLPIVVKAPRQGSTVGVVIVKNEGDIDSAIAEATKYGRELLIEKFVSGREL
TIGILGDQVLPILEIIPKGGFYDFNNKYPFLNPQGGGGAEHVCPANIDAGKTKEIQNLAL
RAFRSAGLQVYARVDAILAEDGRPYILEINTIPGMTEASLLPEAAAAAGIAYPDLCARII
ALSGLRQGASGQVRGRTEDKR
>AIA16619.1|FEATURES|farme|multidrug|mepA|antibiotic efflux|0
MLSIQRSTNRISHIFSIIRLSLNGEQQDYTTGSIRRAVILLAIPMMLEMCMESVFAVVDI
FFVSHLGKHATSTVGLTESVITIVYSLAIGISMAATAMVARRVGEKDAQAASKAGMQAIF
VSIAITLAVSIPGFIYAPGILRLMGAEEAAVEMGTGYTRIIMGGSMVIMLLFLINGIFRG
AGDAMMAMKSLWLANICNIILCPLLIRGWGPVPAFGLTGAAMATTLGRGIGVAYQLYHLF
NGKRLVQFTLKHLTPDWKVIRSLIDIAWPATIQFLIGSGSWIVLASLVVTTGHSEASAGY
QIAIRIVMFFLLPAWGLSNAAATLVGQNLGAKQPGRAELSVIRTAKYNAIFMAAVSTILL
GFTPYIISFFTKEEAVANYAILAVRIVSAGYLFYGIGMVMANAFNGAGDTRTPTIINLFG
FWFFQIPLAFILSKALGMGPTGVFIAIPVAETAITIAAYILFKQGKWKLKQV
>AIA16551.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNGLPWHLPDDMKYFMTTTRGHHAIMGRRNYDSLPDAFKPLPN
RTNIVITRQRAFSAPGCIVVHDIAGALEFARTHSETEAFVIGGAEIYTLAMATADKLYLT
EIDAEVQGDTYFPSFEKTQWQEVSRKHHDADERHAYAFDFVIYERIV
>AIA16465.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKNKNTLTIILLGMLTAVVPFSIDMYLPGFTDIAKTYNTQVSKVALSLSSFFVGMGIGQL
LYGPLLDRFGRKGPLYVGLLIYCLASIGCAFAPSIEMLIGLRFVQALGGCAATIAATAMV
RDLFPPQENARIFSVLILVLSVSPMLAPTAGSLLAVCFGWRSIFFVLTILIVLIMAGSFF
YLPESKGVDKTYSLKPSAILTSYRNVLRQSYFIVYAFACSLAFAGLFTYIATSPGIFMQH
FGLTQKQYGLLFAFLASGLIVASQVNTLLLKRFRSEDIVKAAFLSQLVVTAVFLFLILSG
VNTLVTTIALLFLFLAAAGLIMPNATSLAMKPFDSNAGSASALLGFIQMGLGSIITIVIG
MLNIQSVLPMVLCMMGSSVVGMLLLLLSGSLFREKRMNEWAIN
>AIA16377.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MAFMLAFAVGQLVYGPLSDMFGRKPPLYAGIGVFLIGTVGAGLAPSIEWLVFFRFVQGMG
ACAPMSLPRAIVRDNYTGAPAAQLMSLIMLVFSVSPILAPLSGSFVIQFGDWRTLFYVMA
ATGVLGLLLVAFVLKETRPKSARTGSTLSSALGSYWQLLRDWKFMGLTLIGTFGMSSFMA
FLGNSSFIYINHYGLTPTQYSIAFSVNAVSFFAVSQATGYLVGRFGLNRVVRIAVGGYVA
SMIALLAVYLAGVDSVWVLGAFMFVAFGFLGLVLPSTSVLAMEEQGEIAGSASALMGTVQ
MVVASVVMGIVGAFSDGTARPMVIAFAACALAALAITLATLRGGNGERMLEVPAE
>AIA16355.1|FEATURES|farme|aminoglycoside|sat-3|antibiotic inactivation|0
MISIHKGSPADFDQFYASFENSLASNFKHYSKKIISYLLKNDYPASWLKERVNIGKKVYF
LATFEDQIIGYFLVSKPFAGVSLGDWLSVDKKFQKQGIATQLIQQWEDYAKNEGAHALQL
WTTEENVDFYKKRGFLLAGKFPESWYGIDRYLFYKNIQKPLQQNYLKD
>AIA16325.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEKELCMITATDLDGVIGNDLEIPWPKLKADLQNFKNLTIGHTVMMGMKTFLSMNSKPLK
DRTNIVVTRNRTWKPEQDNILVAHSLYEALYLAQDYGKGEKIWNIGGGMLYSAGLHSLTF
DEIHVTTIQGHFEGNIKFPGVPKHLYELKRNELHHADEQNPYKFCYQLYRPYRYRA
>AIA16247.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRHVMNHGTEKSDRTGTGTKSVFGYQMRFDLKEGFPLLTTKKVHTKSIIHELL
WFLKGDTNIKYLKENGVSIWDEWADENGNLGPVYGSQWRSWQAADGRTIDQITQVIEQIK
KNPDSRRLIVSAWNVGEIDKMKLPPCHAFFQFYVAEGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLRPGEFVHTLGDAHIYSNHFDQVELQLSRDPRPLPTMRLNPSVKNIF
DFKFEDIELLNYNPHPAIKAPVAV
>AIA16141.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKIYNDLLQRIMDEGVDRQGRNAVTRSIFAHQMRFNMADGFPAMTTKKLAFKAVKSELLW
FLEGSNDDNRLKELNGSERTIWTANAQADYWKPKAKFDGDLGRIYGVQWRSWQKTDGTTV
DQLKEAIEKIKKDPSNRRIIVSAWNPGEIDQMALPPCHMLFQFYVANGKLSLHMVQRSCD
MFLGVPFNI
>AIA16063.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKANRLPWRLSSDMKRFRQLTMGHHIVVGRKTFESIGKPLPGRQM
IIVTRNENFRPAECLIARSVEDALALARAAGESEVFICGGAEIYAESLSAADRMYLTLVH
ADCDADVFFPEFGDEWAEIESERRDADEKNQYPFTFKLLVKKQS
>AIA16064.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GVRIWDEWADERGELGPVYGAQWRRWPTADGQTIDQISQAIEQIKSNPDSRRLIVNAWNV
GELSRMRLAPCHLLFQFYVAQGKLSCQLYQRSADIFLGVPFNIASYALLTMMIAQACDLE
PGDFVHTLGDAHLYSNHLEQARLQLAREPRRLPQMKINPQVKSIFEFDYSDFELSGYDPH
PHIKAEVAV
>AIA15932.1|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
MSALPKKIAVLMGGPGSERDVSLATGAGVVKALRSLGCDVTEVDVKGADFDLPDDIELAF
LTIHGTFGEDGQIQQILENRGVPYTGEGVASSALAFNKIHSKEAFRQHDVPTPYYQTISA
GQRPTIPIPLVIKAPRQGSTVGVHIIRNEREIDAAIADASTYDRDLLVEKFVPGRELTVG
ILGDQA
>AIA15915.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MVKHTNNTDFAVEARGLVKVFGENRAVDGVDLLVPTGSIYGVLGPNGAGKTTTINMLATL
LKADDGAAKIFGHDIQEEPQIVRQLIGVTGQYASVDESLSATENLVIFSRLLGLNKAEAK
QKAKDLLEEFGLTEAAKRPLAKFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRNQ
MWDTIRRLVSTGSTVLLTTQYLDEADQLADRIAVIDHGRVVAEGTPDTLKKSVGVATLQL
RVVAKKDVLSAIEVVQKVLKVATQNPDATLITAPMADPERVTDLLIALRTNGIHLAEVSV
QKPTLDEVFLTLTGHATTEEKGEKA
>AIA15883.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKTRVAVIYGGRTGEHEVSVRSAKAILAGLDRAKYETTEYFIDKQGKWSPSPILPEPGAH
PEIDVVFPVLHGTFGEDGTMQGLLELADLPYVGAGVMASAIGMDKEMMKRVCKERMLPVV
EYVTAFRHTGSILDVCRKMPFPVFVKPANLGSSVGISKAHDAAELEAAFALARQYDRKVI
VERAIEGRELECSVLGNAEPVASLPCEILPSREFYDYEDKYLLDMARTQVPADLPADRTE
ELRRLAVECYRAVECEGMARVDFFLEKETNQLYINEINTIPGFTSISMYPKMWEHSGIAF
SDLLDRLIALALDRDKLKKATRFTR
>AIA15824.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISFVVAIAENNAIGKNNELLWSLPKDMKHFKTITSGHTIIMGRKTFDSMGKPLPNRRN
IVITRKKDLQIPGAEVVNSLDQALALCNNEPEIFVIGGAEIYKEALPKTNRIYLTRVHQS
FDGDAYFPELNMDEWVETGREEHLPDEKNQIAFTFLTLESK
>AIA15820.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HELIWFLQGSTNIKYLVDNDVHIWDEWPYRHYLMEQGKAVPDSASAEWQTGIQEFTQKIK
EDSKFAKKWGELGPVYGYQWRNWPAPDGRHIDQIARAIDLIKNNPASRRIIVSAWNTADI
DEMSKAGIPPCHLLFQFYVADGKLSCQMYQRSADTFLGVPFNIASYSLLTMMMAQVTGLQ
PGDFVHTFGDTHLYVNHLEQVDKQLSRQPRKLPTMKINPKVKSIDDFKFEDFELVGYDPH
PGIKAPIAV
>AIA15774.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
PLAGRINIVVTRQQGYQPEGVLVFSSLSAAIEHARTMAAADGHDEVFIGGGAEIYSEAMP
QADRLYITHVDLTPEGETRFPEIDPDVWNAVAEADVPLTGKDSATFRTLIYERRQPRAH
>AIA15768.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKASIVAYDHNRTIGNHGDIPWQGKMKSDSRYFRDTTMGHPVIMGRGTYEAMGRLLPKRL
NIIVTRGELAVEGAIVVHTLEEAYRAANGDDKVFVIGGGQIYQAAMDSIDMIYATEIDAH
TDGDAHFPVVDPSVWREVKRQHYDPDEQNVYAYDFVVYERI
>AIA15607.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MYFVLIFAVLAFAALVVRLGYVQLWKGSEITKKAEDSWRRDIPFQAKRGEILDRNGTRLA
YNISSPSIMAIPVQVKDVRETARKLAKPLGMSEEQLVKLLSKRESSVELKPGGRKITTEK
ALEIRKLELPGIVVSEDNKRFYPYGSLASHVLGFTGSYNQGLTGLELQYDQRLTGLRGSV
SYLSDAAGRKMPQSSDQFIPPQDGLSLELTIDQTIQSIVERELDQAMLVHQANSIIAIAM
NPNTGEIYAMGSRPTFQPDKYQEVSSEVYNRNLPIWMTYEPGSTFKIITLAAALQEGKVD
LEHEHFYDPGYIEVAGAKLRCWKKGGHGSQTFLEVVENSCNPGFVALGQRLGKDKLFSYI
YNFGFGKKTGIDLKGEENGIMFKPKQVGPVELATTAFGQGVSVTPIQQITAVSAAINGGK
LFKPYVSKSWIQPGTGMILEEAKPQFVRQVISPETSKLVREALEKVVAQGTGGKAFLDGY
RVGGKTGTAQKVVNGRYSKDEHIVSFIGFAPADDPQLIVYVAVDNPQGIQFGGVVAAPIV
RNIMADALPYLGVKPRTKQVEKEYKYGSGEPPIVTVPNLVGKTVSDLYEDMNANFQLATS
GSGSTVIRQAPAAGARVDKGSVIRIYLGAAD
>AIA15599.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKRDLPKKIAVLKGGPGSERNVSLATAAGVSKALRSAGIEVVDVDVRDENFQLPKDVDLA
FDCIHGTFGEDGTLQKILEDLGVPYTGEGVEGSRIAFDKFLTKEKFIEHQIATPDSETIE
VGQRPKMSTPLVVKPARQGSTVGIVIVKDESELDAALKEAAKFDDKLLIEKFVSGRELTI
GILGDQALPILEIIPKGGFYDFNTKYPFLNPQAGASAEHVCPAKIAPALTKKIQELALRA
FRALGLEVYGRVDVLLSESDQPYVLEANTIPGMTEASLLPEAAAAAGINYVDLCLRIIEL
SRARTERARQ
>AIA15556.1|FEATURES|farme|macrolide-lincosamide-streptogramin|vgaALC|antibiotic target protection|0
MEAIIDIPVTKAKTSGLHEVDWKHLEFGKYVSDHMFICTYKNGEWQEPEIKPFQNISISP
TALALHYGQSIFEGMKAFRMQDGSINIFRIEKHFERINASLDRMCMPPVPYDLFATALQQ
LVQVDRDWVPQGEDVALYIRPFVFASEARFGVKVSDEYTFIIVTGPVPTLYQKPIKVKVE
RKYIRAAKGGVGYAKCAGNYGGAFYPTQKAREEGFDQVLWTDAFEHEYFEESGTMNLMFV
IDEKVITPPLSDSILDGITRDSLLTIAKDLGYQTEERKIGINEVLQAINEGRSVEAFGAG
TAAVVAPISVIGVDGDLYHLPTYSNASVMFKLKKELETIRTGRKEDVHGWNNVV
>AIA15497.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTQPRITLIAAVSENGVIGRDLDMPWKLSTDLKRFKALTMGKPMIMGRKTFESIGKPLPG
RETIVLTRDGAFSAEGVHVAHTWEEAVAKGEELAGKAGADAVAVAGGAEIYALALPHVQT
LFLTQVHTALEGDAVFPSFDRSQFREVKREDHPQGPDDEHPFTFIDLERRR
>AIA15481.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MADKVAVLMGGTSAEREVSLNSGQAVLAGLREMGIDAHGIDTRDVSVLTLKEQGFTKAFI
ALHGRGGEDGTLQAVLEFLQLPYTGSGVMASAVTMDKLRTKLLWQGRGLPSGKFVWLTRQ
QFDAGLDAENNAAIAALGLPLFVKPACEGSSVGISRVNDLSALPAALDMAFKHDNDVLVE
AFLSGAEYTVAIVGDRILPSIEIKSASEFYDYEAKYISDDTQYVCPADLSAEREAELQQL
VLAAWRALGCRGWGRVDVMTDGEGRFQLLEANTSPGMTSHSLVPMAAKQAGMSFPQLVAH
ILELAD
>AIA15465.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MRKGEFIALAAFLMAINSLAIDIMLPALQQIGASLNVESENHRQFVVSSYLLGFGFAQLI
YGPLSDRFGRRIPLLAGIGIYICSSLGSALIPTFEGLLILRFVQGLGSAATRVITISIVR
DIYGGRQMAEVMSLIMMVFMIVPVIAPGSGQIIMLFGSWHLIFLFIAVMAAIIAGWAYLR
LPETLRPENVRPFTAKSVLGGFKLVLTNRIALCYTIASTFIFGSLFGFINSAQQIYVGIY
GLGVYFPFAFAGVAVFMSMSSFLNSRLVGKFGMRRLSHGALLGFITINTIWLLALVFGPH
PMPFFLFIGFFGLAMFQFGWIGSNFNSLAMEPLGHVAGTASSVLGFMSTVGGALIGAGIG
QAFNGTALPMVAGYFTVSIIGLVFVLIAEKGKLFQPHNPAV
>AIA15441.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAAELVFEKRSRLYLAISDSLIMIKRSGRHIIRNRDQLLGAFFQPIMFLVLFSTVFGGAI
SKALPPGVSYLNFLMAGIIVQTAAFGSTTTAIAVCNDLQKGIVDRFRSLPMSNLAVLNGH
VISDLFRNSISTIVMLLAGLAIGFRPHTNFVEWLQIAGILFLFTLAFSWLSAIVGILAKS
VEGVQWLTFVLVFPLTFASTAFVPAQGMNRVLRAFAENQPITQVVDAVRALILGTPLGNH
GWLAVAWSVGTLVVAMPLASWLFRRKTTS
>AIA15442.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MTQSKYVVAAEGLAKSYGSNQVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLKFD
SGTVTVEGHDVRTEPDKVRSVIGLTGQSAAIDDLLTGRENLQMMGRLYRLTPASATARAQ
ELLEEFDLVAAADRPAKTYSGGMRRRLDLAVSLIAAPPVIFLDEPTTGLDPRSRLAMWEI
IKGLMAAGTSILLTTQYLEEADQLADRIVVIDGGKVIAEGTATELKRKVGKDRLELTFKD
STALARVKQILGTDIIDTNGKEYTATVIVQDTSVDIKRTLDLLAQEKVAIQSMAIHKPTL
DDVFLSLTGKQKEAEEEKV
>AIA15436.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGRVTIVVAIGQNGVIGADGDMPWPRTGDQVQFKALTMGHPMIMGRTTYESIGRPLPGRT
SIVLTRNPSWAAEGVEVAGDLPAGLARAAELDDEVFLIGGAQVYAAAIEAGVVDRMVVTH
VHLSPEGDAWFPDVDWTAWHETSREKYDTYDIATYDRS
>AIA15437.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRAYLDLVQRILDEGVAKGDRTGTGTLSVFGHQMRFPLSEGFPLVTTKKVHLKSVVAELL
WFIKGDTNTSYLRDNGVSIWDEWADENGDLGPVYGYQWRSWPAPNGEHIDQLAQIIEQIK
VNPDSRRHIVSAWNVADLDAMALMPCHAFFQFYVADGKLSCQMYQRSADVFLGVPFNIAS
YALLTHMVAQVVGLEAGDFVHTLGDAHLYVNHLDQAREQLTREPRALPELWLDPAVTSID
DFTLESIKVTNYDPHPGIKAPIAV
>AIA15341.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKYIIVAYDRNRAIGADNTLPWAGKMKADMARFKQLTTGNAIIMGRKTFESIGRALPSRQ
NIVLSSKAVDATEVQAVDSLDKAYAAVRPGAETYVIGGGQIYALARDTVDEILATEIDAT
IDGADAFFPVLGPEWRETSREHHGADENNAYAFDFVSYRRD
>AIA15342.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NAIETIKNNPNSRRIIVSAWNPAEIDTIVEIGGLPPCHSLFQFNVSGDWLDLHLYQRSAD
TFLGVPFNIASYSLLLAMVAQVTGKKPREFVHTLADTHLYLNHAAQVDEQLSRTPKELPT
LWLNPDVKNLDDFTFDDIRLENYEPYPPIKAPIAV
>AIA15327.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAEKKVKTPGGPLKITVLMGGASSERDVSFASGTRVAAALREKGHTVTAFDPAGDVMTRE
EETRYLSGAVKTAPPTPEFLATLRIPGTLGDHPAVRDADVVFLALHGGQGEDGTVQALLD
LAGITYTGSGHLASALAMDKDLSKLLFRAGGVRTADWLMAPAAEDEIVSALGLPVVVKPS
KQGSTVGLSVVKRREDLAAAIELAYKHDDEVMIEAFVPGRELTVGILGDEALAVGEIIPK
HEIYDYERKYTAGMAIEEFPAKLDRAQTGAVQQQAVAAFRALKLGGYARIDFRMSPEGHF
YCLEANTLPGMTETSLIPQSAQACGISFADLCERVVRLALEQRRPVAGAGAGA
>AIA15315.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefC|antibiotic efflux|0
RGIDDTDFQLPHQTAARPMTANILARMPRGWILLASIGLIALNMRGPFVAVAPVVGPMQQ
DLGFSPVELGLLTGIPVLCFSLAAPLASFAGRKFGAEFAIMLTLLGVLAGVIVRSAGNGA
LVLVGTVIIGVAITIGNIAVPLIIRRDFSPRRQGTAMGIYTAALNIGSFLTSVVTAPLAE
LAGWRLALAASGLFAVAATGFLGDVRGTRCLRSGRRR
>AIA15252.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MKFPTASALALTSLALALGLSTSLAQAAEVSGVTEHTALATKAAKTDLLGALGLCKTATP
QPAASFMDNYNKLKQKPPLEPMQVMDELYFLGNYWTSAWAVKTSQGIVIIDALDNADEAQ
HYIEDGLKKLKLNPADIKYVIVSHAHGDHYGGAAYLKKKFDPKIVMSDIDWKTFDDPKFD
PKRIPLFDAPPKRDMAVNDGDTIKLGNTEFKLYVIPGHTLGTLATVFTVHDEGKAHRAVA
WGGTAYNFGPLADRLQIYADTTAKYRDVMKKENADVLLSNHVSYDNAVAKMGTLKERKPN
QPNPFVVGEDTVDRFLTVLGECALATKAYVEAGQPGKEQAEKKDAPAPAAEKK
>AIA15099.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQRKLRVGIVFGGRSGEHEVSVASARSVMAAIDQTKYEVIPIAIARSGQWLPGVAPQALM
APTDIAPAEAVSSDTPQAVISDDTPTGFALLPQLRDEQHATEVDVIFPVLHGTYGEDGAL
QGMLEMAGLPYVGNGVLGAALGMDKDKAKLLFQVAGLPVVPWITVTRKEVESALDASITA
IAARFGFPVFAKPANMGSSVGVTKAHDAAELRAALTMAARYDRKIVVEPAINCREIECGV
LGNDDPEASVVGEILPSNEFYDYQAKYLDGASQLLIPAPIADAIALDVRRMAIVAFRALD
LNGLARVDFFLDRDTDQVYLNEVNTMPGFTEISMYPKLWEVSGLTYPALIDRLIMLGIER
HQERARNEIGVDF
>AIA15022.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDIAIYVAIAENGVIGRAGGLPWRLSSDLKRLKADTMGKPVIMGRKTYDSIGKPLPGRLN
IVVTRNRDWRAEGVEAVRSLDEAVRLAEARARAMPGAGEIVVLGGGMLYAEALPMTDKLY
VTHVRARIEGDTTFPEIDPAVWMIVSSLDVPAGEKDDYPTRHVVYRRRSGRR
>AIA15010.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGGGNVQAYLDLLSHVLEHGALKEDRTQTGTKSVFGYQMRFDLSKGFPLVTTKKCHLKSI
IHELLWFLKGETNIRYLNENGVTIWDEWADQDGNLGPIYGKQWRSWSTPSGETVDQIASL
IHAIKTNPNSRRLIVSAWNVQDVDKMKLPPCHCLFQFYVANGKLSCQLYQRSADIFLGVP
FNIASYALLTLMIAQVTGLQPGEFVHTLGDAHLYLNHVEQAKTQLTRTPFPLPTMLLNPD
IKAIDDFRFEDFVLKDYQSHPAIKAPIAV
>AIA14912.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKPRITLIAAVAENGVIGRDLDMPWKLSSDLKRFKALTMGKPMIMGRKTFLSVGERPLP
GRPHIIISRNPDYRPQGVDVVSSLEDALSLAAAKAAELGVDEVFVAGGGEIYRQAMPFAD
QLSVTHVEVSLEGDTFFPEIDPALFEKIDEVALPAGEKDNYPVRFTTYRRYHAYQ
>AIA14848.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAEKKLRVGVVFGGRSGEHEVSLASAKAIMENLDRNKYDVVPIGITKAGTWLLGTNPEQL
LAAGQDVSQSAAEEQHETTTAVTLTGDPTVRRLIPLQGSEQLRNNGALDVIFPVLHGTYG
EDGTLQGLLEMANVPYVGCGVLGSALGMDKEKMKMVFQAVGLPSADYLVYRRNQWERRPE
EIMDAIEQRLGYPNFVKPVNLGSSVGISKAHNRSELHHAINLAGEYDHKIIIEKNINCRE
LECAVMGNDEPLASVVGEVIASNEFYDYNAKYIDNKSQVIIPANIAAETASAVRSQAVQA
FLALDLSGLARVDFFLEKETGQVYINEVNTMPGFTQISMYSKLWQASGVAYPELLDRLIE
LAQERHADRQRNRTSL
>AIA14841.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MKMENPAPVQWQFSRRAEQLQSSVIREILKVTVRPEVISFAGGLPSPATFPVERMRAAYD
SVLSKQGKVALQYGPSDGYAPLREWVAQSLSTDGARILPEQVLMVSGSQQGLDLLAKVLI
DEGSKVLVETPSYLGALQAFSVYQPEFVSVPTDDHGLLPDQVASVGQGARLLYALPNFQN
PTGRTLSVERRIALVETCARLGLPL
>AIA14774.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKASIVAYDHNRTIGNHGDIPWQGKMKSDSRYFRDITMGHPVIMGRGTYEAMGRLLPKRL
NIIVTRGELAVEGAIVVHTLEEAYRAANGDDKVFVIGGGQIYQAAMDSIDMIYATEIDAH
TDGDAHFPVVDPSVWREVKRQHYNPDEQNVYAYDFVVYERI
>AIA14699.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
TSEVTPRKIRVGVLYGGKSSEHEVSLRSATNVIQQLDRSRFEVIPIGIDKQGAWFLGQDL
NALEQSPVIALEQDLEKELFNPNRIGQAQNLTAKSFADHTDRLFDVVFPVIHGPLCEDGT
IQGLLELADVPYVGCGVLASAVGMDKDVAKRLVMQQGLPVAPYQAIKRGEWNKNSNAFCD
SVNETLRYPVFVKPANTGSSVGVHKVKQPADLIAAIEDAFQYDTKILVEQGIDAIELELS
VLESLDYGAEPIVSIAGEVKPQNGHEFYSYASKYLDDHGAETLIPAPISSALQQSAGKIA
QQIFSLLECEGMARVDLFLERDTHQIYFNEINSIPGFTQISMYPKLMMASGMSYPDLLTH
L
>AIA14666.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MKKSVAIVFGGQSSEHEVSLQSARNVINAIDRERYALTLIGVDKLGHWLHFDEADYLLNA
TDPARIKLSASGKPLSLLPGSIGGQFVEVESGQPLAAIDVVFPLIHGAFGEDGALQGLLR
MLAVPFVGADVLSSAVCMDKDVTKRLLRDAGIAVAPFRVLSRGESLSFTEAADQLGLPMF
VKPANQGSSVGVSKVSDEAGFAAALALGFEFDHKLLIEQGIVGREVECAVLGNVDVQVSV
CGEVIANDEFYAYDTKYLNGDQARIAIPAELPADLSDQVREVALQAYKVLGCAGLSRVDF
FVTEGRDIIINEVNTLPGFTSISMYPKLWQASGLSYAELIHRLIVLALERADQARLLKTE
IFA
>AIA14569.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MAPRWPTRRWEWLLVVNAPIALIAFIGVRLGVPADRPEDLTNDKLDLPGAVLSIITIGLA
CYAATSGVEHGWLSPITLASIVGAVAAGIAFVRHERRTASPMLDLDLFSNGTVRGAAIAQ
IATSIAMASVMFGLILHFQYAYGWSPVRAGLANLPIIVTMIAAMPVSEWLAKRFGHRVAC
LVGAALLAGSLGGMAWGVSHGYLAIAVCMVVMTVGLRTVMTICAVALVSAMPDNRTSIGA
ALNDTAQEVGTSVGTAVVGTMIALLVTTRLPAGTWSTDLVASFFHGERITYAVLAVVVGV
IAAYGALSLTDSHAVEEPA
>AIA14552.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MGTERSLPKKIAVLMGGPGSERDVSLATGRGVSKALHSLGADIVDVDVRDENFALPKDVD
LAFITIHGTFGEDGQLQKILEERGVAYTGDGVEASRMAFDKILSKEKFREHSVATPEWEV
IEVGQHPTISIPLVVKPARQGSTVGVVIVKNASELDSALEEAGKYDRKLLIEKFVSGREL
TIGVLGDQALPILEIIPKGGFYDFNNKYPFLNPQGGGGAEHVCPAKIEPNKTKEIQEEAL
RAFRALGLVVYGRVDILLSDAGDPFVLEVNTIPGMTEASLLPEAAAAAGINYVDLCARII
ALSRVRTERRRR
>AIA14547.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSIVVAIAENNAIGKDNQLLWHLPKDLKHFKEITSGHTIIMGRKTYESVGKPLPNRRN
IIITRQNITIDGCEVVNSIDEALKLCVGEDEIFIVGGAEIYKQAMALTDRIYLTIVHQKF
DGDTYFPEIKEDIWNETEREDHESDEKHLFPYSFITLERH
>AIA14453.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
VVEVKNLKKAYGSNKVLKGINFKVPRGSMLALLGPNGAGKTTTVRILSTLLKYDEGTVSV
NGFDVKTDPNGVRSTIGLTGQSAAVDEMLTGRENLVMMGKLYRLTAKSAKARAEELLKEF
DLIKAADRPLKAYSGGMRRRLDLAVSLIATAPIIFLDEPTTGLDPRSRLAMWNIIKKLME
SGTTILLTTQYLEEADQLADNIIVIDGGKVIAEGTAKELKSKIGNDRLELTVSDLKTYEA
AKSSLGKKVVESNEKEYTVTTMLKNTNKDIREVLDILEKAGISLQSMNVHKPTLDDVFLS
LTGKQATKLDTKKKKEKK
>AIA14314.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISAIAAVAENGVIGDKGQLPWHLPDDMKFFQRTTVNHHVITGRKNYESIPERFRPLRD
RVNIVVTRAQGYQAPGAWVCASLEAAIDIARVADQKEVFIIGGGQIYAEALEKGLVTRLY
LTTVHGKPKGDVKFPDIGKGWKEVWTERHEKDERHAFAFTFKVLQR
>AIA14297.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MVLYGGRSGEHEISLRSAASVIRYLDRTRFDVIPVGIDKKGVWRLGDFNLIEESLSNKLQ
ESLVIYENAPVVVVGDFKSLAIDAVFPVMHGPLCEDGAIQGLFELAEIPYVGSGVLGSAA
GMDKDVSKRLARDGGLKIVPYISLKRGRWQGGSSVGDSDPASGISASTSSGLSSGSFSKT
PSDVPAGASVGSPEVFAEVSKQVVSQLGYPVFVKPANLGSSVGVHKVKESNGLRAALKDA
FRYDTKVLIEKAINAREIEFAVLEASHYGDPAKVSLAGEIAPTHEFYSYEAKYLDEQGAK
LMIPAELEPKQMALGQKIAREAFELIECEGMARVDLFLDKDSGEFYFNEVNTIPGFTSIS
M
>AIA14211.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLEHGAAKDDRTGTGTLSTFGYQMRFNLDEGFPLLTTKKLHIKSIIYELL
WFLRGETSIKYLQEHGVNIWNEWADEHGELGPVYGAQWRSWHTADGRTIDQITQVIDQIK
TNPDSRRLIVSAWNVGEIPKMALPPCHLLFQFYVANGKLSCQLYQRSADFNIASYALLTM
MIAQVCGLKAGEFVHTLGDTHLYSNHIDQAKLQLTREPLTLPRMRLNTSVRSIFDFDYDD
FELVDYDAHPHIKAEVAV
>AIA14133.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLKERGVNIWNEWADESGDLGPVYGAQWRTWRACDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLF
>AIA14134.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGSLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPAGCFIAHSISDAINLARERGESELFVCGGAEIYAQMLGVADRMYLTLVH
ADCDADTFFPDWNSDEWIETESEHHTADEKNQYSFTFKVLERKHVDLLQSPGEH
>AIA14121.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTSKRYFLLVLILGTLSAIGPFSIDMYLPGFPGIAASLNTTVANVSLSLSSFFIGISAGQ
LVYGPLLDRFGRKKPLYFGLTLYLAASLGCAIAGSIESLIIFRFLQALGGCAGMVAARAL
VRDIFPVEENARVFSLLMLVIGVSPMIAPTVGGYVTDNFGWHYIFLILTAMGLLILTAVH
FTLPEGRQPDGTFSLRPSQIMKNYVEVLVNPQFYTYVLTGSLAGAGLYAYISGSPYVFME
L
>AIA14080.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
YGEDGSLQGALEQLGIPYTGSGVMASSVGMDKITTKIIWLAHGVPTPKYAVIDSVESAGL
DARLDAVVADLGLPLIVKPPLEGSTIGITKVTEAAGLKAAVELAHQYDKQVLVEQFIEGR
EFSVPLLGSGPGARALPIIEIVAPEGNYDYQNKYFTDDTKYLCPAPLDAQVTAAIQADVV
KAYRSLGCEGWARVDVLIRESDGKHFLLEVNTSPGMTGHSLVPMAARAEGTSYEDLCVQI
LRTASLKIGQSKQKAG
>AIA14064.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLTRGAEKSDRTGTGTLSTFGYQMRFDLREGFPLLTTKKLHTRSIIGELL
WFIQGSTNVKWLHEQGVTIWDEWADADGELGPIYGYQWRSWPTPAGAHVDQLAGVINSIK
AAPDSRRHIVSAWNVADLADMALPPCHTLFQFYVAQGRLSCQLYQRSADIFLGVPFNIAS
YALLTHLVAQVCDLEVGDFVHTLGDAHLYLNHLDQARLQLGREPRALPKLLLNTGVSSID
EFGFNDIAIEGYDPHPGIKAPIAV
>AIA14060.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVRYILDNGERKADRTGTGTLSVFGYQSRYDLRDGFPLLTTKKVLFDAVVRELL
WFLKGSTNINQGLKQFTPIWNAWADPSGELGPIYGYQWRKWERFVWDESTQTYRKEHIDQ
IQTAIDTIKTNPDSRRIIVNAWNVADIDRMALPPCHSFFQFYVANGRLDCQLYQRSADVA
LGVPFNIASYALLMSMVANECRLTPGIFVHTLGDAHVYMNHVEGLRTQLERSPKPLPRLK
LADKPVLQMNFEDIELTGYQHHDFIKFPIAV
>AIA14043.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MILSAVVAVTEDNAIGKEGGIPWYLPADLAHMRDVTMGHPIIMGRKTHESIGRTLPGRTN
IVISRNPAYQVFEGSLLVSSLEEALSKEDIQLEDEVFIFGGQEIYDQAMPQLQRIYLTRV
HAKIPADKFFNYHPSQWQQISIEEHKADDKNQYDYDFCVLEKIQP
>AIA14044.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RTGVGTYSVFGRQMRFDLSEGFPAVTTKKLAMRAIIYELLWFLRGDTNIKFLVDNDVKIW
NEWSYQVYLEKNDLDKKYERYSDKWKSEMDKFVENMKSDDEFAKKWGELGPIYGKQWVRW
QAADGSEINQIQNVIDLIKNDPTSRRLLVSGWNVGEIQELIKNHHHAPPSCHSLFQFMVI
NGKLSCQLYQRSGDFFLGVPFNIASYALLTMMVAQVTGLEPGEFVHTFGDAHIYTNHVDQ
VTEQLSRKPKSLPKMKINPKVKNIFDFKFDDFELVDYDPHPAIKAPIAV
>AIA14026.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGRLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTHSESFAPEGCFSVHSISDAISFARERGESELFVCGGAEIYAQMFGVADRMYLTLVH
ADSEADTFFPEWDSSEWIEVESEHRTADEKNQYPFTFKVLARKSQV
>AIA13949.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QWRSWPTADGRHVDQIGEVVERIKNDPDSRRLIVSAWNVGEISKMALPPCHVMFQFYVAD
GRLSCQLYQRSADVFLGVPFNIASYALLTLMVAQATHLAPGEFIHTFGDAHLYTNHLEQA
RLQLSREPQREPHPLPQMKLRPGVESILDFRFEDFELVGYQPWPHISAPVAV
>AIA13853.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MPETLEAIKEQEQLVEIVDETPKMKLCIVAAIGENRELGKDNHLLWHLAEDMRFFKEVTM
RHYVIMGRKSFESIPAKYRPLPDRVNVIISRDPDYMVEECYTCTSLEEGMRLAEENGEQR
AFLIGGGQIYKLAMDADMVDEMYITHVHGSFPDAQVYFPEFDETQWRKTAVKSMVADLQN
QFSFDIYLYEKLRPELNHQLDGTSEGQIPN
>AIA13847.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SIFGHQMRFDLADGFPLVTTKKLHVKSIIHELLWFLQGSTNVRYLNEHGVTIWDEWADER
GDLGPIYGRQWRSWPTPDGGHIDQIANVVEGLKRDPDSRRHIVSAWNVGELDRMALSPCH
CLFQFYVADGRLSCQLYQRSADVFLGVPFNIASYALLTQMMAQVTGFEPGEFVHSFGDAH
LYLTHLDQADEQLKRSPRALPRMEVNPDVRSLFDFAYEDFKLVGYDPYPAINAKVAV
>AIA13825.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SIFGHQMRFDLAEGFPLVTTKKLHVKSIIHELLWFLQGSTNVRYLREHGVTIWDEWADEN
GDLGPVYGRQWRAWPTPDGRHIDQIARVVESLKRDPDSRRHIVSAWNVGELDKMALSPCH
CLFQFYVADGRLSCQLYQRSADVFLGVPFNIASYALLTQMMARVTGFEPGEFVHTFGDAH
LYLT
>AIA13786.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLGKVRNRGAKKGDRTNTGTLSIFGHQMRFDLADGFPLVTTKNLHVKSIIHELL
WFLQGSTNVRYLNEHGVTIWDEWADERGDLGPIYGRQWRSWPTPDGGHIDQIANVVEGLK
RDPDSRRHIVSAWNAAEIDEIVETGGLPPCHTLFQFNVRDDKLDLHLYQRSADTFLGVPF
NIASYALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSV
KSIFEFDYSDFELSGYE
>AIA13719.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MNKKYAIEVKGLTKSYGSNDVLRGIDIQVEEGTMLALLGPNGAGKTTTVRILSTLLKHDS
GTVRVAGYDVAEDADKVRTVIGLTGQSAAVDELLTGRENLVMMGRLYRLTKASAQARANE
LLQEFDLQKAADRPTKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRLAMWDII
KKLMAAGTTVLLTTQYLEEADQLADQIVVIDGGKVIAQGTASELKSKVGKDRLELVFQDT
STLKAARKALGASAVDIANNSLALSMTIEDI
>AIA13675.1|FEATURES|farme|macrolide-lincosamide-streptogramin|SPM24T3_16860|antibiotic efflux|1
MLLEIKDLHAGIEGREILKGLNLSVGKGEIHAIMGPNGSGKSTLAKVLTGHPSYEVISGE
VLYEGKNLLELDPDERAREGVFLAFQYPVEIPGVSNSQFLRLAYNEKMRHLGQEELDPLE
FADHLKEKMKIVDMDKSFMNRAVNEGFSGGEKKRNEILQMAVLEPKLAVLDETDSGLDID
ALRIVAEGVNKLRSPENAVVVVTHYQRLLDYIVPDFVHVLAGGKIVKDGGKELALELEAK
GYDWVKSAGV
>AIA13666.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
SGEHDVSLMSARSVLNALDAERYEVIQIGITLDGDWLTGANTLDAFEKGNIKDLDRVVPP
LQPSHQSLYVLRSTKTGDKLETLADVDVFFPVLHGPFGEDGTIQGLLELADVAYVGAGVV
GSAVGMDKGIFKDVMRANDIPIVNSLLVLRSEIEKNIDTVIEKTEKMGAYPFFAKPANLG
SSVGISKCNSRSDLAEGLMEASRYDRRVIIERGAGDVREIEVSVLGNEEPQTSVCGEVLP
SREFYSYESKYIDGTSGLEIPAQIPADVSDKVREYAVRAYKAIDCAGMARADFFVENNTN
KIFLNELNTLPGFTSISMYPKLWQASGLTYPQLVDRLIELALERKAQRDHTEHRRTA
>AIA13585.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSALPKRIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEVDVHDENFELPQNIDVAF
LTIHGTFGEDGQIQQILEDRGVPYTGDGVNESRTAFDKIESKKKFEAAGVTTPRWQIIGS
NERPTLPLPFVVKAPRQGSSVGVYIIKNADLLENGLAEARKFDRRLLVEEFVPGRELTVG
ILGDQALPIIEMIPKSGFYDFTNKYPFLNPQAGGGAEHVCPARIEEALTRQIQDLALRAY
RSIGLRVYSRVDVLLPENAAPTVLEVNTIPGMTEASLLPEAAAAAGISYEDLCLRIIELS
RARRGSGK
>AIA13548.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKIAVMFGGTSEERDVSIASGSQVVRALRKKGHDVVPIDTAIGVLDAAAEQKLLGSDVQS
APPGAEQLDVLRTGDSTKIMRAPEMAGVDVIFLALHGGAGEGGTLQALLELTGVPFTGSG
MLGSAMAMDKDVSKRLFEIAGVPTPAWLMAPVEVQDVDTQIGWPAVVKPSKQGSTVGLSI
VKKPEDLAAAIELAYRFDDEVMIERFIPGRELTVPVLGDDVLPVGEIFPKNEIFDYESKY
QAGGAEEVFPADLTGPETVQVTMLAIKAHRALKLRGFSRIDFRLDEHGGFWCLEANTLPG
LTAASLSPKGAQAAGIPFPDLCEKLCQLAIEEHANRRRV
>AIA13450.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAVKKHPEYQYLNLLQEVLDTGIKKVDRGTDITLYSLFGRQVRYDLSQGFPLLTTKKVYW
KGVLHELYWFMSGQTNIKYLVDNNVHIWDDYPYKIYTKKHESRGTNQELTKDQFVEKIKI
DEKFAKKYGNLPRIYGEMWRHWPTRSAGSGQGRTIDQLKWVMQEMKDDPDAKNLIVNSWN
PEYLYTMATNKDASRFPICHNMYQISNRNGKLSLQLYQRSADLFLGVPFNIASYSLLAII
LANIAGLEPGEFIHTFGDVHIYGNHIEQVKEQLRRKPRPFPTISIARKLKDIDDFKTDDV
ILENYDPHPMMKAELTVAGGLFDKKTGKMAG
>AIA13309.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
WPTPSGEHIDQISAALQLLRSDPDSRRNIVSAWNVGEIPQMALPPCHAFFQFYVAGGRLS
CQLYQRSADLFLGVPFNIASYALLTHMMAAQAGLEVGEFVWTGGDCHIYDNHVDQVTEQL
SRDPRPYPELVLAPRDSIFDYTYEDVVIKNYEPHPAIKAPVAI
>AIA13279.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MTHKQRIGVVFGGRNSEHEVSLKSARSVMAALDQAKYEIVPIGIDKLGRWVMGGDPLFAL
EQAADPHLLSRDPEPGVINSSTALVMSEGRLPGAQPSELDVIIPVLHGMYGEDGALQGLL
ELADVAYVGCGVLGAAVGMDKGIAKAAFAAASIPQVPYVLVRRTDWEQDRAAVIAEIEQT
LTYPVFTKPANAGSSVGVAKCANQAELHAGLDLAAQHDRRLLIEQGVRPREIEVAVLGND
APEASVPGEVIPANEWYDYADKYLEGKTGYVIPADLSPEQTAAVQALALAAFKAIDGAGL
ARVDFLLDRETGALYLNEVNTFPGFTAGSMYPKLWAASGLPYPALLDRLIALAVERHQDR
RVRA
>AIA13247.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTNEHTSQKEFIFLVALLTALVAMSIDTMLPAIGTMASEFGVSDPNKRQYIIGAFFAGMT
IGTLLSGPISDSTGRKPAIFAGLLIYVAGSLLSLFSTSFEMLLAGRALQGVGASSPRIVS
LAMVRDGQGGAAMARIMSFVMSVFMLVPILAPSIGQLVLFVASWRMIFVGFLAMALIAAL
LLQFRQEETLPKEKRVAFSAGTLFRSAIEFFRFPSAWGYTVSVGFVFASFICYLGTSQQI
FAEQYAQGEWFAVWFGVFAIAIAFAMIFNGRMVMRPRHAYACQMGGARLHRVFRHLPCCS
LELRRPSAALDPRSLHVRHLLLFRHPIRQLQRHGHGACGPHCRHGGGHFRHPLNPRGALH
RHLVRPAV
>AIA13172.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSSRSDQLANVIEQIKTNPNSRRHIVVAFNPGDIDKMALPPCHAFFQFYVANGNLSCQLY
QRSADVFLGVPFNIASYALLTHMVAQVCGLGVGDFVHTLGDAHLYSNHIDQAKLQLGRNE
FPLPKLKLNPNIKNISDFKFEDIEIVGYESHPAIKAEIAV
>AIA13108.1|FEATURES|farme|aminoglycoside|Krm|antibiotic target alteration|1
MPNEEMVSELVTSITNSKKYRSVYPKTIERIVQQAVAKQPNEKQAQHYARNVLHQVWGAY
WGTRPNFKKVWQKFEENIQDGMSVQEAVLKILVLQSSTRERAPIVTEFYNQIFAITGQPE
TILDHACGLNPLSFFWMDLPNTTQYQAYDIDIEQIELLNKIAQTTGISNQLTATVADIVT
DSYGYADVVFLLKTLPCLEQQEKGISLDILRKQQCKYIVVSYPIKSIGGKEKGMAAFYTQ
QFQELTKHEKWQTEKLNFETELVFVVQK
>AIA13020.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DLMKHVLDNGARKDDRTGTGTLSIFGHQMRFDLSEGFPLLTTKKLHVKSIIYELLWFLRG
DTNVKYLQEKGVNIWNQWADERGNLGPVYGAQWREWRTADGRAIDQISHAVEQIKSNPDS
RRLIVSAWNVGELDRMALMPCHLLFQFYVAGGKLSCQLYQRSADIFLGLPFNIASYSLLT
MMVAQVCGLQPGDFVHTLGDAHLYSNHLEQARLQLTREPRRLPQMRINPSVNSIFEFDYS
DFELSDYEPHPHIKAEVAV
>AIA12975.1|FEATURES|farme|sulfonamide|sul3|antibiotic target replacement|1
MIYIAIGSNLGDRHQNLERAIGLLKKRYFPNLHSSKILETEAIVPEGAPSEWSTPYLNML
VWGQCDIEPYELLRALQRIESEIGRPEVRDKWAPRIIDLDIILWDGISMNEPELKIPHHE
LQNRPFWLQLLKEAMQAKLVGIVNITPDSFSDGGLYNSPINAITRALELAQDGANIIELG
AQSTRPGATLIGHRDEIDLLRPVLDGLAGSGINLSVDSFEPEVIDMILRNYDDVKWINDV
RGDLSKRTLSVIAEKGLDIVTMHSLAIPADKNICISDAAPPIETIMNWAKLKIEFLMGCG
FHLDKIIVDPGIGFSKNPAQDIALLKEAGKLKRLGCRTMIGHSRKSFISSFSYSEAKDRD
IETLAISDYLNDKTDYLRVHNIKDHVKFFRARGVVG
>AIA12968.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSAIAAMAQNRVIGKDGTLPWKIPEDFKFFKDKTTGHIMIMGRKTFDSLGGPLPKRLH
VVITRQKDYAPEGAIVARSVEHAVELTREILAKKEWPEEVFIIGGGQIYEEMLSKTDRIY
LTEIHRTFDGDARFPEFSKNEFSEVERSHRDQPVPFDFVTYERNRR
>AIA12947.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMRHIMENGVQKTDRTGTGTLSVFGYQMRFDLSKGFPLVTTKKCHLRSIIHELL
WFLRGETNVRSLQAENVKIWNEWADENGNLGPVYGAQWRSWPTPDGRYIDQIAQLIHQIK
TNPDSRRLLVNAWNVGMLDKMALPPCHCLFQFYVANGKLSCQLYQRSADVFLGVPFNIAS
YAILTSMIAQVTGLEVGDFVHTLGDAHLYLNHMEQVAEQLSREPYGLPKLRLNAEIKQLE
DFKFEDIEVLNYESHPTIKAPIAV
>AIA12948.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSFSLIVAMSENGVIGKDNQLPWHLPNDLKHFKALTMGKTIIMGRKTFESIGKVLPGRKN
IIISSDTNYTVPDGTVIHNINELIAQDKHDSESEKMIIGGATLYNYFLDKANIIYLTKVH
SVIEGDTFFPELSNEWEIAGVEHFEVDPKHEFAYSFITLKKVKL
>AIA12852.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISMVVAAADNNVIGKDNRLLWRLPNDMAFFKNVTWGMPVIMGRKTFQSLGKPLRGRTN
IIITANKHFNPGNGVIVANSIAEAVEQAEATDAKECFVIGGGEIYKQSMGKANRIYMTRV
HVSPSGDAFFPSINESEWKKISSAPFNADEKHAYSYTFEIWQRK
>AIA12814.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MEGTSKAEVQKQDTEKPRLEMSSRRRWAVTIGVMTGMFIAALEATVVGTAMPTVIATLGG
LNRYSWVFTAYIVTSTVTVPVWGKLSDLYGRRLLYQVGIGVFLLGTLLSGLSASMNQLIV
FRAIQGLGAGALIPLAMTIIGDIFTLKERARMQALFSGVWGLSSVIGPIIGGFITDNISW
RWVFFINLPIGVVAAIIIGFALKEPKLDEKPKIDYAGAAILMAAISLLMLAMVEGGTSIA
TLLAPLNLLLFGASVLLLGLFVWVEKRAADPIIPFALFSNRTVSVSVIAGFLAGFAMFGG
ISFIPLFAQGGLGATATEAGSLLTPLMLSWVTMSVIGGRVLLKIGYRTISIIGFIILSAG
FLMLTQFERTTPYFWLYFDLVLIGSGLGLTMLTLLIAVQQAVERTKLGIATSLNQFTRSI
GGAFGVAIMGAVLTAGLATQLHNVALSGTTSLTVEQAEVFASNPNALIDPEAKASLPPGT
LVILQDAMAAAIHPAFWVAAFISVLALIATFFLPRDQHDMYSEIHRTDGNAGERMIMAEQ
TTINARNQPVAEQDSSG
>AIA12808.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MTSKDTAISVTGLKKSYGDNHVLKGVSFSVKRGTMLALLGPNGAGKTTMVRILSTLLRHD
AGKVSIEGYDISKDSDKVRGVIGLTGQSASVDELLTGRENLVMMGRLYRLTKASATARAA
ELLTDFDLNDAADRQVKTYSGGMRRRLDLAVSLIAAPPIIFLDEPTTGLDPRSRIAMWEI
IRKLMTDGTTILLTTQYLDEADQLADNIIVIDGGTVIAEGTANDLKSKVGKDRLELVFPN
AKSLEQAVKALSEDKLDANTKLHSASLPINNTNHDIKRVLDRLSQQSVSIESLSVHKPTL
DDVFLSVTGKQKPKEDEEADT
>AIA12748.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAQGENEFIFRIKYFLMSKKKKVAILYGGRSVEHAVSVNSARNIYEYLDKNQFEPIPMGI
NKSGQWFLTNGVSKDMEQGKALGLMLDPVSPGFVLLSSGDRFKVDIVFPVLHGTDGEDGS
IQGLIKAMDMPMVGTGVLGSALSMNKIVAKRLMRQAGLPVTDFLTFRYAEKDKITFTSIS
KKLGTPFMVKSASLGSSVGVTKVKNKEDFKKAVEEAFKYDDEMLAEEFVTGREIECAILG
NTPGEASYPGEIVISKNYEFYTFDAKYVDPKAVEIHVPAKLSKAVAEKIRAVSIRAYEAL
HCQDFSRIDLFLDKKGKVYINEINTIPGFTNSSMYPMMWKERGISFSDLITRLLNLAQER
YNRGKRIERDFQSALKF
>AIA12645.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MRNYFPNPIPALALAIFLLAFASFASGQSNAPASSCADCPEWNKPQQPFRIYGNTYYVGP
HGLTSILLTSKAGHVLLDGALPESVPQIVANIRALGFRIEDVKLIVNSHVHFDHSGGISE
LQRLSGAKVAASPWSVEVLTKSGVGKGDPQFGVVTPVALVPRADTLRDGQTLRVGDIKLT
AHFTPGHTPGGTSWTWRSCEGKRCLNLVYSDSMTPVSADGFRYSDSREYPTAVQDFEKSF
AFLKTTQCDILLTSHPDASGLWQRLEGRERGVRPNPMVSPDACKKLAERAAGQLRRRLES
EKGR
>AIA12550.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLARIREHGIRKDDRTNTGTLSIFGYQMRFDLADGFPLVTTKKLHVKSIVHELL
WFLQGSTNVRYLNEHGVSIWDEWADDKGELGPIYGRQWRSWPAPDGRHIDQIANVVEGLK
RDPNSRRHIVSAWNVGELDRMALSPCHCLFQFYVGEGRLSCQLYQRSADVFLGVPFNIAS
YALLTLMMAQVTGLETGEFVHTFGDAHLYLTHLDQADEQLKRTPRALPRMEINPEVRSLF
DFAYEDFKLVGYDPHPVIGAKVAV
>AIA12515.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISAIAAVADNGVIGRDNDLPWHLPDDMKYFQRVTMGHPVITGRRNFESIPPKYRPLKG
RLNIVVTHDAEYDAPGAAVVTSLDAALDRAKQEPGNEIFVIGGGQIFKEALGSDRIDRLY
LTLVHAIIQGDTLFPVIDPMDWVERSREHHEADERHAHPFSFVVLDRRH
>AIA12481.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDMKRFRQLTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSISDAISFARERGESELFVCGGAEIYAQMLGAADRMYLTLVH
ADSQADTFFPEWDKDEWIEVESEHRTADEKNQYSFTFKVLARRSQV
>AIA12468.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MYCNARIIVAALTADGFIGRDSGHLADWTSKEDKQLFVRLTKEAGVLVMGANTYKTIGRP
LPGRRNLVYSRSSLDFPGVEVVTEPPQALIARLEREGHTALAVCGGQAIYDMFLQAGVVT
ELYLTIEPVLFGSGIPLLKAPLAASLALKEFEKLNEHTILLHYEVTN
>AIA12428.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIAAIGKNRELGKDNALLWHIPGELPRFKRITTGHPIIMGRKTFESIGRILPNRTSI
IITRDREGFLQMANSKWHIDPKQFIVVTSLEQAIEEAKKVEEKRLAVIASEAKQSHKDKI
AAVADSSLAMTKEGEIFIIGGGQIFAQALPLTDKLYLTHVDQAFEADTFFPDYSAFTKVV
EKDDHEDGGYRYSFVTLTK
>AIA12360.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DQLKSFPMKQYLDLMRHVLENGTDRTDRTGVGRRCIFGHQMRFDLREGFPLLTTKKVFTK
GIFHELLWFIRGETNIRYLVQNDVHIWDEWPFQNYLKANKLEEKSPMYSPEWEEQKKMFV
GKIKEDEVFANQWGNLGPVYGYQWRHWQGADGSQHDQLKNVLEQLKKNPYSTRHIVCAWN
VADVSKMALPPCHCLFQFYVANGELSCQLYQRSADIFLGVPFNIASYALLTHMMAHVLGL
KVGDFVHTTGDTHLYLNHLEQAKEQLSREPRPLPQIKLNSNVKDLFDFAYEDIEILNYDP
HPAIKAPIAV
>AIA12308.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MQTVIIAALDEERGIGKDNALPWRISEDLKRFKALTMGNPIIMGRKTHQSIGRPLPGRTN
IVITRDEGFQAAGCTVVHSLEQAQKAAKAEKAKQVFVIGGAEIYRSSLPEVDRLELTLVD
GFYEADAFFPEYEDDFVVTKEESSKDDLHQYRFVTLERKK
>AIA12228.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VVWRLPCRLAARCHNIPLNSIDQETPMKQYLDLMRHVLEHGTPKDDRTGTGTLSVFGYQM
RFDLQEGFPLLTTKKLHTRSIITELLWFLRGDTNVRYLQEHGVRIWNEWADENGELGPVY
GAQWRSWQAADGRRIDQISQVIEQIKTNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYV
ANGKLSCQMYQRSADIFLGVPFNIASYALLTMIIAQVCDLEPGEFVHTLGDAHLYANHLE
QARLQLTREPRPLPRMRINPAIKSIFEFDYSDFELAGYDPHPHIKAEVAV
>AIA12222.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLTRGAEKSDRTGTGTLSTFGYQMRFDLREGFPLLTTKKLHTRSIITELL
WFLRGDTNVRYLQEHGVRIWNEWADENGELGPVYGAQWRSWQAADGRRIDQISQVIEQIK
TNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVANGKLSCQMYQRSADIFLGVPFNIAS
YALLTMIIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFGLSGYEPHPHIKAEVAV
>AIA12187.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSASSAGETPIVALVVAMGENRAIGRGGDLPWHLRSDMRYFRAITMGKPIVMGRLTFKSL
PRVLDGRLNVVLTRDLGFVAPDAVMAHSLEEGLAAARASAARTGAAEIMVIGGEDVFREV
LPQTDRIYLTEVHASPDADTWFPELDMSEWREISREAHPAGPKDDHPFSFVVLDRMRKAS
S
>AIA12132.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISLVAAVAQNGIIGKKNDLPWRLPDDMKFFMETTKGHVVILGRKNYESLPPKFQPLPG
RTNIIVSRQENYEAPGSFVVNSIKKALEIAIESGETEAMVIGGSEIYALSMEYADRLYIT
EVLADVDGDVSFPQYNKKEWKEISRLHHEADQRHVYAFDFVVYERIEENLKYGDIDK
>AIA12080.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MSFDGQNPPVEAVDNSFRSVMREAFVGTSRDFTKGSILIGLIILAIPMILEMSMEALFAI
VDTFFVSKLGAEAIAVVGLTESVLALIYAVGVGLSIGATATVARRIGEKDADGAARTATH
AVYLGVMVSLIMAAIGVALAPTLLGLLRAEPQVIEMGVPFMRIMLGTNVVIVFLFLLNGI
FRGAGDAAIALRVLIIANGLNILFCPLFIFGVGPFPELGVTGAAVATVCGRGVGVIYAAW
MLFGRNNGRLNVTREHWTFRPELLVSISRLSMTAVLQFLVGTASWSALVTIVAGFGTVAV
AGYQIGLRVIIFVLLPAVGLANAAATLVGQNLGANQPERAERSVWTAGFLNAGLLGLAGL
SFVIFPDLVVSIFTTDPGVARYASDCLRIVGYGYAFYGLAMVMESAFNGAGDTWTPTYLN
FFIFWLFEIPLAYVLANYYGFGPQGVFWAITLSFSSLAVVSALMFKRGKWKLKAV
>AIA12025.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAAKTTTNLAFDRRPKWLLAFNDSLIMIQRSSMHILRNQDQLLGTFLQPIMFMVLFATVF
GGAIAMALPPGVPYLNYLLAGIIVQMLAFGSTTTAIAIANDLQKGIIDRFRSLPMNNLAV
LNGHVVSDLFRNGISTIVMIIVGVIMGFRSGASFTDWLLIAGMIALFTIAFSWVSAVLGV
VSKSVEGVQWLSFLIVFPLTFASSAFVPTEGMNKYLKAFAENQPITHIIETLRALMLGKP
VGDHGWWAVGWCLVMLVVAVPLAGWLFRRKTAQ
>AIA11940.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNLGKGTGERPVIALVVAIGENGAIGRGGELPWRLSSDMRYFRKVTMGKPVIMGRRTFKS
LPRVLDGRLNIVLTRDQGFVAPDAVMAHSLDEGLAAARDSAARTDAGEIMVIGGEDVFRE
VLPQAHRIYLTEVHASPEADTWFPDFDKREWREVFRERHEAGPRDEHAFSFVVLERTDGP
>AIA11938.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELMQRVLSEGVKKEDRTGTGTLSVFGHQMRFNLSEGFPLITTKKCHMRSIIHELL
WFLKGESNIKYLKDNGVSIWNEWADENGNLGPVYGVQWRSWKTHDGRTIDQIKNLIEMIK
KNPDSRRLIVSAWNVSDVDKMALPPCHTMFQFYVANNKLSCQLYQRSA
>AIA11929.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLATIRERGTSKDDRTHTGTLSIFGHQMRFDLAEGFPLVTTKKLHVKSIVHELL
WFLQGSTNVRYLREHGVRIWDEWADPKGDLGPVYGRQWRSWPAPDGRHIDQITQVVEGLK
RDPNSRRHIVSAWNAGELDRMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTLMVAQVTGYEPGEFIHTFGDAHLYLNHLDQADEQLMREPRKLPRMEINPEIRSLF
DFAYEDFKLVGYDPHPAIKAPVAV
>AIA11861.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
WTSKEDKKVFVELTKRARVMIMGRNTFETIGRALPGRRNIVYSSKPIDVEGIEVTNEKPT
TLLEKLENEGYQEVAICGGQKIYDLFLAEGLVNTLYLTLEPKLFGNGLSIAKTSVDVDLH
LKDVSKLNDDTLLLEYEVQNGSNPS
>AIA11821.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MISFIVAITKNHVMARDGGLPWHLKTDKEYYRAKANGHIVVMGSTTFEQVGTSITNREII
VLTRDSSYHPDGVTVAHSIQEALPKTDEEVMVLGGGQVFAAALPYADRMYITEIDAELQG
DVFFPQFNRDEWREVSREHHRKDADNEYDFDFVVYDRTK
>AIA11815.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLTHGVEKSDRTGTGTLSTFGYQMRFDLGEGFPLLTTKKLHTRSIIGELL
WFIQGSSNVKWLHEQGITIWDEWADSDGELGPIYGYQWRSWPTPAGGHIDQLAGVINSIK
TVPDSRRHIVSAWNVGDLADMALPPCHAMFQFYVAQGRLSCQLYQRSADIFLGVPFNIAS
YALLTEMVAQVCGLEVGDFVHTLGDAHLYLNHLDQARLQLSREPRPLPRLVLNPSISSID
DFTFDDVAIEGYDPHPGIRAPIAV
>AIA11816.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPEIIESEIVKPEIIGIAAVAANGVIGASNDIPWRIPADWQRFKALTMGNVLIMGRKTFE
SIGKPLPGRTSIVVTRNTSVEIEGAMVVHSLEDALAEARKIEASEVFIIGGGELYTQAQH
LADRLYVTEVHSAFEGDTYFAIEDPTTWTENKRVHHGTDERHIFPFDFVDYFRQE
>AIA11789.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MLKTSKAFSGFSVTDIKIAKDFYGDVLGLEVSEQKGMGLDLHLGGGAHVFLYPKEDHKPA
TYTVLNFPVDDIDKVVDELTKRGIKFEVYADSEFIKQDGKGIARSDDPSRGPSIAWFKDP
FGNILSVLK
>AIA11785.1|FEATURES|farme|multidrug|PmpM|antibiotic efflux|0
MSGPITNAPVADNTEKLATESLWQALKDAIRGTSADYTKINLKRAIFLLAVPMIIELVGE
SLFALADIYFVGRLGSWAVETVGLTETYMFLLYSIGMGVSFAVTATVARRIGEKNKEEAG
KAAVQAIFLAILISLPFAIAGIFFAKDMLTIMGGKPEVIEKGYHFTQWMLGGNMVIMLLF
IINAIFRGAGDAAVAMRVLLIANAINIFLDWVLINGVGPFPELGIQGAGIATTTGRGIGV
LMQLWILFRAGKHIRVLATHVKANWKLLGSIIKTSLGGVGQMIVAMTSWIFIMRILASDN
AVAGATIALRIMMFTMMPAWGLSNAAAALVGQNLGAGQPDRAEQSVWKIGFYNMYFMVAV
SVLYFFANEWLVSIFTNDPNDLKVGSTWLRILSYSYFVYGWWMVSVQAFNGSGDTRTPTW
INIIFFWLIQIPLAYLLAVHWNGGYKGVFWAVFVSETGVGLFTLYLFTRGKWKQAKV
>AIA11687.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|1
MKVFIIAAVTADGFIGKDEKHAAFWTSKEDKKRFVELTKRAGVVVMGSNTYATLPRPLKE
RTNIVYSRSKTFEGAETTQKSPQELILELERREFKEVAICGGASIYTMFMKAKVVDHLYL
TVEPLIFGKGIKLFNEELTSQLTLVSAVQGENGSLLIEYKVNNSGSL
>AIA11686.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GLGTGNIEYLAQNNVHIWDEWPYKAYLQKNNLPVPSSDSDEWKTGIKEFIARIASDHEFA
EQWGDLGPVYGVQWRKWPDGKGGYIDQIAQVIDTIKNNPSSRRIIVSAWNVAEIDEIVSI
GGLPPCHSLFQFNVANGKLDLHLYQRSADTFLGVPFNIASYSLLLAMIAQVTGLKQGEFV
HTLADAHIYLNHFDQVDEQLARQPKELPKLWLNPEVKSIDEFTFDDIRLEGYDPHPPIKA
PIAV
>AIA11651.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KSNPDSRRLIVSAWNVGELDRMALMPCHVLFQFYVAGGKLSCQLYQRSADVFLGVPFNIA
SYSLLTMMVAQVCDLEPGEFIHTLGDAHLYSNHLEQARLQLTREPYKLPRMNIDPKVTSV
FEFGYEDFELVGYEAHPHIKAEVAV
>AIA11644.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YPERDGVDQIARLIHNIEHEPNSRRLIVTGWDPAQSELVDLPPCHTLFQFKVEEDAKLIH
CQLYQRSADAFLGVPFNISSYALLTHLIAHVCDLRVGDFVYTLGDYHIYQNHLKQVEELL
SRQPLALPRLEIKDEEGRLRGLRGLLSFRYEHLNLVGYNSHSKIAAPVAV
>AIA11643.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLKERGVNIWNEWADESGDLGPVYGAQWRTWRACDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVSDLRPGEFVHTLGDAHLYSNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA11626.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRFNLSEGFPLLTTKKLHTKSIIYELLWFLRGDTNIKYLQEHGVNIWNEWADESGDLGPV
YGAQWRTWRACDGRTIDQISQVIEQIKSNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFY
VAGGHLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLKPGDFVHTLGDAHLYSNHL
EQARLQLAREPRPLPQMKINPSVKSIFEFDYSDFELSGYEPHPHIKAEVAV
>AIA11612.1|FEATURES|farme|aminoglycoside|Krm|antibiotic target alteration|1
MATSTELTEITGRIIKSKKYSHLSQQTIHRIVEWAAVRFNKLKEIEDNSRKKLHQVYGAY
MQVYTPKVFSEFTGAGDLNNDDLKTVCKNILLRHNSTKERMGFIDDFYAAIHSAIPSAQK
IIDIGCGFNPFSYPWLATHLGQIEYAGFDIDVLLTEMMNNAWKQVGLPVSVQYNDVFFGL
PGHTENDVLFFLKFFPCLEQQEKGISAKIFNAVKSNAFVVSFPSVSLTGKNKGMRENYDG
FLNQLTAGMNLHSEYFDFPTERVYILKRAK
>AIA11407.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSHIVAAAQNGVIGTEGGLPWNIPEDMKFFKDKTKGHAMIMGRKTFESVGHPLPNRLN
VVITRQTDFNANGATVVSSLDEAIEVCKQQTAKYGDEVFIIGGGEIYRQSMHIVDRIYLT
RIYQDYDGDARYPEVDLDEFKEVSRQERTEPVPFTFLVFERKNRLH
>AIA11408.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRPQQTIQPKEPTVQQYHDLMKRILDTGTAKSDRTGTGTISVFGHQMRFDLQNGFPVITT
KKLHLKSIIHELLWFLSGDTNIQYLKDNQVRIWDEWADADGNLGPVYGAQWRSWRTPDGH
VVDQISNVIQQIKTNPDSRRLLVVAFNPGEIDKMALPPCHAFFQFYVADGRLSCQLYQRS
ADVFLGVPFNIASYALLTMMVAQVCKLAPGEFVHTLGDAHLYNNHIDQARLQLSREPKPL
PQMIINNKIDDIFAFRFEDFQLINYDAHPHIKAEVSV
>AIA11391.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSGADENGDLGPVYGSQWRSWPTPDGRYVDQISQVMEQIKRNPDSRRHLVVAWNPGEVDH
MALPPCHYAFQFYVAGGKLSCMFQMRSVDTFLGLPFNIASYALLTHMMAQQCGLEAGELI
WTGGDVHVYLNHLEQVQRQLTREPFPLPKLVIQRKPESIFDYKYEDFVIEGYQSHKGIKA
PIAI
>AIA11349.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDKIRVGVIFGGRSGEHEVSIRSAKTVIEQINKDKYEVIPIAITKAGNWLNPVESLGLMP
ESVQNLLMADIGKYPRNAIALIGDTQYRGLTKLEAAVGEERTTIFDVVFPVLHGTYGEDG
TIQGLFEMAGIPYVGCGVLASSCGMDKVVMKVLFRDAGLPMCKYVWFLRSEWEKASDTVI
DQVKTKLGFPCFVKPANLGSSVGVTMAHDDLSLRQGIELAAEFDRKIIVEEGLNMREIEC
AVLGNDEPRASLPGEYIIKDESKTFLDYTEKYAGTGNNEFVVPALVSEELSKKIQQMAIQ
AFKAVDGSGLARVDFFLRNDTGALLINEINTLPGLTDASGYPKMWAGSELHFTQVIDTLI
TLARERFDDKARNKTSFSEA
>AIA11229.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB_3|antibiotic efflux|1
MLLEIKNLHAGIEGREILKGLNLSVNKGEVHAIMGPNGSGKSTLAKVLTGHPGYNVISGE
VLYEGKNLLELDPDERAREGVFLAFQYPVEIPGVSNSQFLRLAYNEKMRHTGQEELDPLE
FNDYLKEKAKIVEMDKSFMNRAVNQGFSGGEKKRNEILQMAVLQPKLAVLDETDSGLDID
ALRIVAEGVNQLRSPENAVILVTHYQRLLNYIVPDFVHVLAGGQIVKDGGKELALELEAK
GYDWVKTAANGK
>AIA11224.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTVISNIEVRGARVHNLANIDVSLPRNQLIVITGLSGSGKSSLAFDTIYAEGQRRYVESL
SSYARQFLQLQDKPDVDLIEGLSPAISIEQKTTSKNPRSTVATITEIYDYLRLLFARIGM
PHCYHCHKPITQKSATAITDEIMSLGQGVRISILAPIVRAKKGEHKLELSKLSKEGFVRV
RVDGELRYLEEDIELNPKTKHSIDLVVDRLVVDIQERPRLSDAVELSLKKSGGLVLVLKH
LADDTMVEELFSEHFGCVDCGTSFPEIEPRMFSFNAPQGACQTCNGLGNFLHFTEEKVIK
NQSLSLDQGAISPYAANQKGYYYSQINSVAKAYDAPLDLPWKKLSKKVRDFILFGSDKRI
NFVFKSEKSGRTHRASRVYEGLINQLKRRYEETDNDTIRLELETYMSRDFCPDCQGARLN
LFARSVKIEGKAIYELTDMAIKESVQFFNDLKVLERQQKIADPILKEIRARLSFLEAVGL
DYLTLSRAARTLSGGEAQRIRLATQIGSALVGVLYVLDEPSIGLHQRDNEKLLNTLKNLR
DLGNTVLVVEHDEDTILASDYVVDMGPGAGALGGQVVAVGSPKAIMKNKASLTGRYLSRE
LAIKTPKTRRTGTGKVLSIKNAKGNNLAGVDLNIPLGVMTAITGVSGSGKSSLIIDTLYA
ELASQLYASSIDVLP
>AIA11077.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDLKRFRQLTMGHHIIVGRKTFESIGRPLPGRVM
IIITRSESIAVEGCFIARSVEEAVGLARERGESELFICGGAEIYAQMLGAAGRMYLTLVH
ADSKADTFFPEWDTDEWIEVESEHHAADEKNQYSFT
>AIA11048.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MDTLAGLKVAVLKGGPGSEREVSLRSAQTVERSLKEAGASEVIPVDVRDAGFDLPDGVDI
AFVIIHGTFGEDGEIQKALELKGVKYTGEGVDVSRCAFDKLLSKDAFIAAGIPTPGYEKV
AAGARPAMKLPLVVKAPREGSSVGVYIIKTEAELAPALEGVKNYAQEFLVEEYIAGRELT
VGIVGDLALPIIEICPKEGFYDFRNKYPWLSPGGAADHYCPADLPEETTRKLQELALKAH
RALGCQVYSRVDFILTEAGDPYVLEINTIPGMTDSSLLPEAAGVAGIALPELVTRIVNLS
LRRWNA
>AIA10927.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MSQSKYVIEVEGLRKAYGSNQVLKGIDFNVERGTMLALLGPNGAGKTTTVRILSTLLPFD
EGSVHIEGNDVRADADKVRSVIGLTGQSAAVDELLTGRENLVMMGRLYRLTPESAKARAE
ELLEDFALVEAADRPAKTYSGGMRRRLDLAVSLIATPPVIFLDEPTTGLDPRSRIAMWEI
INKLKAQGTTILLTTQYLEEADQLADRIIVIDGGKVIADGTAKELKGKVGKDRLELTFAD
AAALKAGAKVLGKRVADTNEKEFSVSVVMQDLNVDTKEALTLLFDAGVQIAAMTVHKPTL
DDVFLSLTGKQKQTEESEEETK
>AIA10610.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
GFPLLTLRKIPVKMFVAEQIWFVSGARKPADFLRDYTKIWDIFTNPADVVTVAYGYRWRK
HFGRDQLGALVKLLKADPTSRHGVIVTWDPAGDGLGGTTRKNVPCPYTFTVNIIGGRLHF
HNIVRSNDMVLGFPSDVAGFALLQLMLAQKLGVKPGMYSHSISNAHIYDNQYDAVKEMLK
RKNTHKPIHAELPRNAFDRAEKKDAKLVQQIVSTFSSQYEPQEAIKGLQIVL
>AIA10442.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MIIVFGILNALTPFTIDLYLPAFPQIAADLGVAVSRMSLSVSVYFIGFALGQVIYGPLLD
RFGRHRPIYGGLAIYVLATLGCMTTTSFEGLLVFRFISALGGSAASVGAIALVRDHIPAE
KAARAFATLMLVLSVSPLLAPTIGSLITTAASWRAIFAVLAVLAIANLALVMFAVPRTYS
PDPSVSLRLAPILRTFRDALAQPQFRTYTLAGSLSFAGLFVFVSGSPAVFMDGFGVGPSG
FGAIFAILAGGMILGGQLNHLLLKHFASEQVFRRALFVQVISGVTFLALSLTLDLGKWPT
VVLLFAFLHCAGITYPNAAALALQPFTKNIGSASSLLGFLQLGMGAIAAALVGVLDLTGP
TPMAFVMAVCSTAGWILLNSARRLGEASAVEQTSTQ
>AIA10432.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MGKGEFIALAAFLMAVNSLAIDIMLPALQQIGASLGVESENHRQFVVSAYLLGFGSAQLF
YGPLSDRFGRRLPLLVGLVIYICSALGIALVPSFAGLLMLRFIQGIGSAATRVITISIVR
DIYGGRQMAEVMSLIMMVFMIVPVIAPGSGQIIMFFGSWHMIFVFIAIMAALISAWAYLR
LPETLNPSNVRPFTARSVIGGFKLVLTNRIALCYTIASTFIFGSLFGFINSAQQIYVGIY
GLGVYFPFAFAGVAVFMSLSSFLNSRLVGKFGMRRLSHGALTGFITINTIWLAALVLGPH
PMPFPLFIGFFGLAMFQFGWIGSNFNSLAMEPLGHVAGTASSVLGFMSTVGGALIGAGIG
QAFNGTALPMVAGYFIVSIIGLIFVLIAEKGRLFQPHNPA
>AIA19290.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MRIVLLAAVAENGVIGRDGDLPWRLSTDLKRFKANTMGKPIVMGRKTWESFPKRPLPGRL
NIVITRNAGYRAEGAEVVGSLDDALKLARVRSRCDGAEEICIVGGGEIYRQAMPLADCLK
ITHVLTEVEGDTSFPAIDAEPWREVSSEPFEAGEKDSHRTRYAVYERRREP
>AIA19259.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTISLVVAASENNVIGKNNGLPWTLPDDMKFFKNTTWGLPVIMGRKTFESMDNKALPGRI
NIIITRQKDYKAKDCVVVQSWNDAMFVAQETDCNEICVIGGGEIFKETITKADIIYLTRV
HTVVDGDVFFPEIDEKKWKKASSREHAADEKHNFAFTFEKWERV
>AIA19223.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTSGVEHGWLSAITIGSVLGAVAAGIGFVWHERRSAAPMLDLRLFSNGTVRGAAIAQIGT
SIAMAGVMFGLILHFQYAYGWSPVRAGLANLPLIVTMIVATPLSEWLAKRFGHRIACLVG
AACLAAALAGLAWGVDHGYAAIAVCMVVMTIGLRTVMTICAIALVDAMPANRTSIGTALN
DTAQEVGTSVGTAVVGTMIAALVTTQLPAGVWSSSLVQSFFHGERITYAVLAVVVGVVAA
GGALTLTDSHSVEESA
>AIA19172.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GFPAVTTKKLAFKAVKSELLWFLEGSGDDNRLKEINGSERTIWTDNAAAPYWTPKAKFPG
DLGRVYGVQWRTWKTPDGKEVDQIATLISKLKTDPNDRRLVVTAWNPGELDQMALPPCHM
IFQFFAANGKLSLHMVQRSCDMFLGVPFNIASYALLLSMIAQVVGMKPHECILTLNDAHI
YHDHFEAAKEQLSREPFPLPELWLNPDVKDINGFKMEDIELKNYQSHPSIKAPMIV
>AIA19173.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIALIAAVSKNGVIGNKGKLPWKLSTDLKRFAELTRGRPVIMGRKTFESIMAQLGKPLPG
RKNIVLTRETSLAVPPEVHVVHSVEEAIKITDGEGEVFVIGGEAVYRSFFPHADRLYLTE
VQTECEGDARFPEWDRTDWALRMGTRYFKKDDMDDFDFVFLEYVRKPIPHPH
>AIA19152.1|FEATURES|farme|beta_lactam|CARB-10|antibiotic inactivation|0
MPNVHAAGGGCPSIRGSPLSKHAQLGALAVHIVNAGRARLGSSNVPTRTNIKCGLASASL
KSGVPHAPQNRRRMRFPLSETLKYSLASPVLEKVDVRKHEFTVPLPAPRYWQSRHQHTRV
TIGNSELVQRTNPQRHLPVIVM
>AIA19040.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKIYNDVLKKIMDEGVDRKGRNAVTRALFSIQMRFNLENGFPAVTTKKLAFKAVKSELLW
FLEGSGDDNRLKEINGSERTIWTDNAAAPYWTPKAKFPGDLGRVYGVQWRTWKTPDGKEV
DQIATLISKLKTDPNDRRLVVTAWNPGELDQMALPPCHMIFQFFAANGKLSLHMVQRSCD
MFLGVPFNIASYALLLSMIAQVVGMKPHECILTLNDAHIYHDHFEAVKEQLSREPFPLPE
LWLNPDVKDINCFKMEDIELKNYQSHPSIKAPMIV
>AIA19041.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIALIAAVSKNGVIGNKGKLPWKLSTDLKRFAELTRGRPVIMGRKTFEAIMAQLGKPLPG
RKNIVLTRETSLAVPPEVHVVHSVEEAIKITDGEGEVFVIGGEAVYRSFFPHADRLYLTE
VQTECEGDARFPEWDRTDWALRMGTRYFKKDDMDDFDFVFLEYVRKPIPHPH
>AIA19024.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRIYAVAALTVDGFIGRYSGHFADWTGEEDKKVFVRLTKEAGTMVMGSNTFATIGRALPE
RRNIVVTSKPDKIKVEGVEATNETPEALVKRLEKEGVETLAVLGGAGIYTAFMQAGLMDE
LYITYIPVVFGGGLTMFKGELDTKLELHDQETLADGSVLLHYIVKK
>AIA19023.1|FEATURES|farme|aminoglycoside|AAT_like|antibiotic inactivation|0
WDQVANLCEANGLIPFVDMAYQGFGDGLEEDTYGLRMLSARLPEVIVATSCSKNFGLYRE
RTAALSFVFADEQQANAGLSNLLSVARSIYSMPPAHGSALVDIILHSSELTTVWSNELTT
MRERIAGLRVDLVQSLNQLQSQRDFTFIAKERGMFSFLGLSVEQVHKLKNDYSIYMTDTS
RISVAGLTKEKMDYVSRAIVSVL
>AIA19001.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MSIIGIVAIAKNLAIGKNGKLPWHYSADLKFFKQTTLNNTIVMGWNTWKEIGGKPLPKRL
NVILSRSKNLENQPSLILLRNKQEVLALKNYLKGDLFLIGGAQTFADFSDVIDKWIVTEI
PESPADADTFMPANFLEDFEMKEIVSLAEDLNAKIYERK
>AIA18968.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSDFIIRAAAPSDAPAIVSLLKELADYEKLLDHFTLTEAEAARDMLGAACHCDLAFQGGE
SVGIAVWYWTYKSFRARRGLFVEDLFVRRAHRGRGIGKALLVHLAAKARKAGGFLEWQVL
DWNAPSIDFYKSLGAKPWENWLIYRLEGEALERLNP
>AIA18908.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTISLIAAMAQNRVIGKDGQMPWHIPGELKIFRDYTTGTNLIMGRKTHESIGRVLPNRTT
IIVTRQKGYEAPGAHVVHSVEEALALAGKLGGDVMIGGGGEIFDQTLDIADFMYLSIIHA
DFEGDAYFPEWSPEAFRETSCKEIEASIPYRFVVYERNR
>AIA18839.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MRHHASTRERLPILESFYASTLASLGPVRSVLDLACGLNPLALPWMPLAPDARYYACDIY
ADMIAFLNSFFAQAGIRGQARVCDLVAGAPDEQVDLALVLKALPPLDQQAKHAGRDLLRA
LNARHILVSFPAHSLGGRGKGMAENYEQRFRALADAEGWSIERFVFRTELAFLIRKE
>AIA18823.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MAKIVAIAAIGKDRELGLKDKLLWSIPEDLKRFRELTRGHPVIMGRKTFESIVGYRGKPL
PDRTNIVVTRDAKYHAKLEEQGFTEVLVAGSVEEAIEIAKKQPGADVICVIGGAQIYEQS
LPYLDKLCLTLIDDSAPADAFFPEYEKEFTEKTFQENREWNGIKYTWMDLERATA
>AIA18819.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSHTPGPRIYLVAAVASNGIIGSNGRLPWHFPEELKHFKEVTLGHPVIMGRRTWESLKGA
LPGRKNIVVTRTPGYQAPGASVATSLHAALALCPDAPKAMVIGGSQLFAESLPIAAGLEL
>AIA18803.1|FEATURES|farme|multidrug|qepA|antibiotic efflux|1
MATTEPKANFTNPITPARAGRREWIGLAVLMLPTLLIVMDLTVLHLALPHLSADLKPSST
QMLWIVDIYGFMIAGSLITMGTLGDRIGRRRLLLIGAGAFGVASVIAAFSTSAGMLIAAR
ALLGIAGATLMPSTMSLIRNMFLDPRQRTVAIGIWVSGFSVGSAIGPLLGGLLLEHFWWG
SVFLLGVPVMVLLLIAGPLLLPEYKDPNPGHFDLISAGLSLVGMLSVIYGLKQIAQNGVA
WLPILFIVAGLSLGVIFVRRQRTLADPLIDLRLFRVPAFSTSLITYTFGIFFAFGSFLFI
AQYMQLVLGLSPLQAGLWTVPGAIASIIGSNIAPRLVRRVRPAFVIGGGLALATVGLGLL
TQASVNSLAVVVIGWVAMSLGFGMTFTLTADLVVGTAPPERAGAASALSETGAEFGGALG
LAVLGSIGIAIYRSQVAATLPAGIPPEAAAAARETLAGAVAAAGQLPDQLGAALLNSAHL
AFVHALQLVALVGVVGFIGLTILAPVLLRDVLIHAEPEDHPEKAHAVPNVTARPLHDAQV
GD
>AIA18800.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MASSRPAALGFIFITLMIDVTGLGIIIPVFPKLIQEMIHGDLSRASEYSGWLTFAYAIMQ
FLFAPLLGNLSDQYGRRPVLLGSLLGFGVDYLFLALAPSIGWLFLGRIIAGITGASFSTA
TAYIADISTPEKRAQNFGLVGAAFGLGFIIGPVVGGLLGQFGPRIPFYVAAGCSLLNALY
GYFILPESLAPENRRRFDWKRANPLGTLLQLKKYPATLGLVSSLAILYIASHAVQSTWAF
YNMQKFGWNSAWVGYSLGFVGLMVALVQGGLIRLVIPRIGQEKSIYAGLFLYSAGMLLFA
FATKGWMMFAFMVPYALGGISGPAMQGMISNKVPPNEQGELQGALASLMSATSIVGPLIM
TYLFGYFTSNRAPFYFSGAAFVVGSVLILIGIWVAARTIKRHR
>AIA18765.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEQRELMAVAIYVAIANDNVIGREGGLPWRLSSDLQRFKATTMGKPIVMGRKTWESFPKR
PLPGRRNIVVSRDAAYQAPGAEVATSLEAALSLARTADGVPIDSGEICILGGGQIYGQAL
PLADRLYVTHVLADIPDGDTRFPAIDPSEWEAVSSEEFPAGPKDNFPTRYVVYERRHRV
>AIA18752.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNVFIIAAVSVDGFIAEESDQISTSWTSEEDRKFFVERTKQARVMVMGSTTYKTIGRPLP
GRLSVVYSKDTAQFSEAQQKYDESQLRVSQEDPAELIKKLEREGFDEVAICGGASIYSLF
MKAGVVNKLYITLEPVIFGKGVKLFQEGISAKLKLIEMKKLNDHTLLLDYDVLGKLG
>AIA18746.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKSILVAYDKRRGIGADNDLLWSRDMPADLRRFKELTTGNAIIMGWGTYKSIGRSLPNRQ
NIVMSRSSHDAVAGVTVVKSLEAAYAAVEPGKEVFVVGGGQIYAHAINTVDRIYATEVDA
TFGQADVFFPEIDTGVWHEISREHHDIDERNLYGYDFVVYERVFR
>AIA18722.1|FEATURES|farme|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MPSFDVKVLRPGSAGALREMLTVFGRAFADVATYTARQPGGDYLEGLLASSTFIGLAALA
DGQVIGGIAAYVLPKFEQVRSEIYIYDLAVDEEHRRRGVATALIAELRHVAAARGAYVIF
VQADREDEAAISLYAKLGVREDVLHFDIAPIPGVAP
>AIA18710.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKLSIVVAMAQNGVIGVENRLPWRLPADLARFKALTMGKPILMGRKTYDSIGRALPGRTN
IVVSRQPLTIAGCSVVSSIDTGIEAAGAVDEVMVIGGGEIYRQALPRVSTIHLTLVHTEL
SGDARFPSLAPEEWRTTEVAAHAADATHGYAFTFQTLERVRFD
>AIA18691.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTVDRAAELHPRAPHPEYQYLDLLGEIKDKGRDKGSLSSGQAIRYVLGRTHHYDLQTEGF
PLLTTKDVFWKGVRVELEWFLKGDTHIKFLVDNNVTIWNGDVFEKKYQPAVKKGLTPNLD
RKDFDAKLKEDEEFLMRWGDAGPIYGHQWRRWKRPDGVEVDQLEWIVEKLRKEPHRKHLV
FTAWNPANIYEMAASEEDEMALVPCHMISQVDVSSDGELSLMMTQRSCDMFLGVPFNIAS
YALFTHLLAESAGLKPGTFVHTLNNTHLYHKHFAAADLQRTRTPYPFPKLEFRRKVSEPW
DFKWQDAKVVDYKHHPKIEEELITVGGKSGRIARRS
>AIA18692.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKTPELCMIAAIDEARGLGRDNSLLWRIPEDMKHLQELTVPHSVIMGRKTFDSLHPKFRP
LPRRHNFVITRNPNFSYERTNITHSLDEALKLAMEFEDTRIAIIGGGEIYNQALPYVNSL
YLTLVQGTYDVDTYFPEYSQQFPHIVEESDWMESKEHWYKFVTLDRG
>AIA18657.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MILSAVVAASDNDVIGNKGDIPWSIKGEQARVKQISMGKPLIMGRKTHDSIGRSLPGRLN
IVISRNPNYQVHDGSVLVGSLDEALGLKAVASADEVIIFGGQKIFEAAMPLLGRIYLTRV
HANFEGDSWFKFNSGQWKVISEERHQKNLSLGHPYDFDYLLLERK
>AIA18638.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELMRNVLEHGARKEDRTGTGTLSIFGYQMRFDLSEGFPLLTTKKLHLKSIIYELL
WFLRGDTNVKYLQDHGVKIWDEWAEENGDLGPVYGAQWRSWKDPNGGSIDQISQLIDQIK
TNPDSRRLIISAWNVVDIPRMHLAPCHCLFQFYVSEGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAQVCDLKPGDFVHTFGDAHLYLNHIEQAKLQLSRRPYSLPQMKINPAVKSIF
EFKYEDFELIGYQAHPHIKAEVAV
>AIA18615.1|FEATURES|farme|chloramphenicol|catA16|antibiotic inactivation|1
MKFELIDVSTWSRREYFDHYLNKIPCTYSMTANLDATHLLREIKKKDIKLYPTMLYLLSM
VVNRHDEFRTAIDPNGDVGVFDLMHPIYTIFQKESESFTNIWTEYHVDFSEFYKAYLDDI
QKYSDVKKFIAKPDGPPNVFTISSIPWVSFTGFNLNIAKADNYLLPIFTTGKYFEQNDRK
WLPISIQVHHAVCDGFHAARFMNELQEAMNHFEC
>AIA18616.1|FEATURES|farme|streptothricin|sat-1|antibiotic inactivation|0
MNEHKPFLNLLEESFPGLKANISRCETLGFQWTSKPFLKGINEEILSHVGFLEYPILIEG
RECKAAALHAICTRATHRGQGFASELIQEALKWAKDRYEFVMLFTEIPGFYEKLAFRSIQ
EYRFHLPCRHLNGSQSTQPVVSPKDDALFLRTFHERAPLSNLLWIKDTGTIAAFNTLFAT
YPTYWSLHYSPSINGMISYEIKDKTLHLYDVIASRIPSLDLILDQIPAAIEGIYFYFSPD
LLTNAAVAEPYLYDHGQLMVYGDWPEVKPFMIQPLGRC
>AIA18617.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
PSTKGRIALVGDAGYAVSPIAGQGTSVALVGAYVLAGELAEAHGDYAKAFQGYEECLSEF
VQINQKLAKTSLTLLEGGDVSWFKSAILWLHRNLMRFLPGCWIEFLKKRGLKQTAEAANA
ITIKDYQYGNTH
>AIA18582.1|FEATURES|farme|aminoglycoside|APH(2'')-IVa|antibiotic inactivation|0
MQDTETQSVLQVKLWGTRGSLPSPLSPDELYSHVRSLLSDFRVWTESNPIQNPTDMDRFL
KELPRYRVSGYGGNTPCVEVKTKTNQVIIDAGSGIRKLGAELMKGPCGSGQGEVHLLFTH
FHWDHLIGLPFFTPIFIPGNVIHVYAVQKDLERRY
>AIA18543.1|FEATURES|farme|tetracycline|tetPA|antibiotic efflux|1
MFRKFDAYKLYLGLQFFTGLFFSMIFVVASLYEATIAGLTGTQLVLVGTTLELTVLLFEV
PTGIVADAYSRRLSIIFGYLLMGLAFLVEGYFPVFSMILLTQLLWGIGYTFTSGATQAWL
SDEIGEENANRAFLRGNQYDLAGSLIGMLLAIPLGNIAVNVPILVGGAAVASIGLFLLPF
MPENGFKPVRPEDRNSFQHMGDIFKKGISVVRSRPVLLSVLGIGFIYGLYSEGWDRLWVK
YLVDNFTLPSIFGMNEVAFFGLLRAGGMLLSILATRQVEKRLDANHAPSIARAMLWITVL
LSAAIFTFAFSPALAISILAVTAVSILRNVMGPLYSAWVNQRLDSDARATVLSMSSQVDA
IGQVMSGPIAALISLASVQAAITMASLLLLPAIPLIKRANRLHAEDESRITPEIQSAD
>AIA18539.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIRAIAAIDDKRGLAAPNHPPYNVPWYIPEDLAEFKSKTLNSTVVMGRSTYDTLQKPLPN
RRNVVASRVNQVLRPGFELITDLPGFLKDAEGDIWVIGGGEIYKTALPYCDELHITHVKG
DFGCDVFFPEYEPDFELVGSTPEQHSNGYDFNFAVYKQIINRRALRGDPPVLPS
>AIA18488.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRLSALKQYLDLIRYVLENGERREDRTGTGTISVFGLQAKYDLREGFPLLTTKKVLFGSV
VRELLWFLRGSTNINDDLTQHTPIWDAWADEHGELGPIYGFQWRHWPKYVMDEAHGGLYR
KEQVDQIADVLHRIKTDPTSRRLIVSAWNVADLDRMALPPCHSFFQFYVSNGRLDLQLYQ
RSADMALGVPFNIASYALLLMMVAQECNLTPGVFTHTLGDAHIYLNHVEGLQSQLQREPK
ALPEVKIAKKPLFDLRYEDFELLNYNPHPFIKFPISV
>AIA18477.1|FEATURES|farme|bacitracin|uppP1|antibiotic inactivation|0
MHTQSKIIFLNGVGSVGKTSIAKMLQSLLDEAYLHVGVDQFIDMLPEKYINNSEGISFNP
LKINQINNKPTIEITTGKIGKNALRGMRHAIAALADQGNNLIIDEVIIGNEMDEYKKLLS
PFQVFYVGIFAPLEVIEERERSRKDRLIGLGRWQYNLVHQDKSYDLEIDTTTLSPLDCAK
LIKNKFNLS
>AIA18455.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MRDKTKGNGVPKIGIVLGGMGSEREVSLNTGAAFEKAVKSLGYSYILIDAKEDFPKKISE
SKIDCALLALHGKYGEDGTVQGILEYLKIPYTGSGVMASSLAMNKVATKQILTHWDVPTA
EFGILDLTITKNSEIKSEVQKIVKKTGIPLVVKPNQEGSAVGVTIVHNEKEIAAAVKLAS
QYDKVIIIEKYIPGMEITVPIWFGEALPIIEIRPKSEFYDYKRKYTAGQTEYILPAPLNN
TRGQPFCFRNQYVTWLYRDQSFS
>AIA18433.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSAIVAASDNDVIGNQGKVPWFIKGEQQRVKEITWGQPLIMGRKTHESIGRTLPGRLN
VVISRDPQYKPYTGAIAVSSINSALDLPEVKAANEAFIFGGEKIYELAMPQLDKIYLTRV
HADLPGDSFFKFDPTDWKVISQENYRKDPQLERPYDFDYLVLERK
>AIA18423.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MRISIIVAVDEKRGIGKNNDLLFKIKEDMQRLRKLTDGHPIVMGRKTFDSFPGLLPNRTH
IVITRDPETYAAMPVKPHFVVSSLEEGIKKAKTAPGADEIFIFGGGQIFAEAVEKGLVDR
IYLTIVKGDYKADTFFPDYGEYTKVIEHEEMVTTEHQFTFLTLEK
>AIA18397.1|FEATURES|farme|aminoglycoside|Krm|antibiotic target alteration|1
MRSSQKYAAISEAMIRSIGLRELAARRNLKEAIKATKNKLHQVAGAYLDARLPYDEWLAL
LESAVADDRRMTNDERRVASDGEPPANSVLGTQSSALARACLTIMRHHASTRERLPILES
FYATTLASLGPVRSVLDLACGLNPLALAWMPLAPAVRYYACDIYADMIAFLNGFFAQAGI
RGQARVCDLVAGAPDEQVDLALVLKALPPLDQQAKHAGRDLLRALNAQHILVSFPAHSLG
GRGKGMTENYEQRFRALADAEGWSIERFIFPTELAFLVRKE
>AIA18383.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLVVAMDEKRGIGKGGKLPWRLSSDLKRFREVTMGHHLIVGRKTFESIGRPLPGRHT
ILVTRNPNLKPEGVLVVGSVEDALELAQERGETEAFVIGGADIYAQALEAADRIYLTRVH
AEVDADVFFPDFDRDKWIETQHFEHSKDEKNEYGFTSVLLERAIISP
>AIA18356.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MYQISNRNGKLSLQLYQRSADLFLGVPFNIASYALLTIILAQIAGLEPGEFVHTFGDVHI
YENHVEQVKEQLSREPRSFPTIKIDPSVKTLEDFTPDKVELINYDPHPTLKGDLTVAGGF
YEKK
>AIA18352.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKISLIAAIGKNRELGRGNELVFKIPEDMKHFKETTMGHAVIMGRVTFESIGRALPNRTN
IVVSRDSNYPVPEGVLKASSIEDAIEIAKQHETEEVFVIGGEQIYKLSLPFAERLYLTLV
DSEVPDADAFFPEYSDFKTKIYERKSSDENYVYNFLVLSR
>AIA18344.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLSIIVALSENNVIGRDNGLPWKLSADLKRLKSVTMGHHIIMGRRTWESLGRPLPGRVNV
VITRDKNFKAEGGVVVHSLQDALQVAKEDSEAFIFGGGKVFSEALSQVDRIYETIVHTTI
DGDTFFPELNNREWKETFRESHAADEKNEFDYTFVTLERIKI
>AIA18299.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKPTISMIVAMSENRVIGHDGGIPWKIPGEQKRFKEITMGHPMIMGRKTYESIGRPLPGR
TNIVVTHDVTRVNAWQNEHKQYAQEIVPSLKDAIDKAMKSPGSDEMFIIGGGQLFEEGLK
DTDRIYLTIIHKDMDGDVFFPEYRDFKEVSREEHEFDGLHYSYILLER
>AIA18295.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|0
MKVTMVAVVTIDGKLARNSAHFSDWSSREDKKIFVSLTKRAGVMIIGHNTYQTLPAPLPG
RLHVVLTREAANKEDIPGLVEFTDQQPEDVLAGLEARSYTEAVLGGGSQINALFLQRGLV
DEISLTIEPIVFGTGIDLLEGMELDLRARLLEVERLNEGGTVWLRYALDRTPGQPAPGDS
GSV
>AIA18257.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIIGIAAVDKQGAIGKGGKLPWHYSSDMKFFRETTTGNAVVMGRRTWSTLNKPLKNRLNI
VLSRDFNIEPAESLLVLRDLDSVLSFNQSLTTDLFVIGGAQIYNAFLPHIERWFITAVPL
TVKGADTFMPENYLKGFKRYKKQRLEEDLVVGFYEREE
>AIA18248.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRKVTKIWDAWADADGNLETAYGRYWRRFPRPIQKSHAPLSVTGEQVAPVEEIDQIQYVV
DEIRRNPFSRRLVVTAWEPGNAERSKLPPCHYTFAFNVSPDETGQPRRLNCHLTQRSGDI
ALGIPFNLACYATLTQILAQEVGLEVGHFAHTIIDAHIYCADAGSTMAAYDHVAGLKEQL
ARAPRPLPRLVVAKKPMKELTFEDFRVEGYDPHPAITFKVAV
>AIA18243.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MFLGFLMLISIIVAMTPERLIGAVGRLPWYLPEDLRRFRKLTMGHAMVMGRKTFSSLGRA
LPGRRNLVVSRNPDPPEVAGVEWFNSLDAALAFARQSGESECFIAGGTEIYAEALEKSNR
MYVTYVQR
>AIA18242.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MVHSFIIAAVTADGFIARDPSQPSTDWTSKEDKKHFMELTKRAGVVVMGSKTYETFRRPL
KDRKNIIYSRTKKFEGTESTSESPQELFTRLEKEGFKEVAICGGGSIYTLFLENKCVDKI
YLTIENKIFGQGVKLFDKSLDVNLELVGNTKLGENTVLLEYNVIK
>AIA18230.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAHPEYEYLKLVAEILKNGKSKPTRGVHGIKSIFGYQMHFDLRKGFPLLTTKKMPFKILL
HELLWFVSGDSNIKYLQDHNIHYWDEFADKDLNLGPVYGVQWRHWKDHDGSEIDQLAWVI
KQIKENPHSKAILVSAWNVADLEAMRLPPCHTFFQFDVTKGKLRMELYQRSSDVFLGLPF
NIAQYAMLLHMVAYLTDLEPRELIVSIGNAHLYQNHLEQAKEQLQRKPYPFPTLKISGKV
KTIDDFTADNFELLNYEAHPHIKAPLVIL
>AIA18204.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MTTTSQPRIAAIVAMSQNRVIGKNNQLPWHMPADLKHFKLLTTNHAIIMGRKTYETIGRP
LPNRTNIILTRAAHYQAEGCFTANSFEQALEIAAEKNPNQEIFVIGGAQIYQQLLPLVQH
IYLTIIHHDFMGDAFFPEIDKLKWKELECITHLADEANPYNYSFIQLGKRPPLVSI
>AIA18194.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MNIQIIYLNGPTSSGKSTLAKALQEALDSPFLHIGIDKIIGMMPDKVNNWVGCSAPLGFS
WKESKDNDGNLIQELQMGPFAKQISDTYREVVALLVKLGHYVIIDDVSFGSEEMARWRKL
LQNYRVLYVGVKSPLDVLELREKQRGNRMIGSAREQYHKVHLGNEYDVEVDTSKSPVKEC
VDLILKRL
>AIA18188.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MVDMVSIIAAIDDKRGIGKNGSLLFRIKEDMQRLRKITDGHPLVMGRKTFDSFPGLLPNR
THIVITRDPKAYHPEEVSPHVVVSSLEDGIAAAKNAAGADEIFIFGGGQIFTEAIEKGLV
DRLYLTIVKGDYSADTFFPEYGQFTKVIEKIDRDVDGYQYSFLTLEK
>AIA18174.1|FEATURES|farme|tetracenomycin|tcmA|antibiotic efflux|0
MHSRRTKRKVFVLEALNSMATSYYFYYLFFFLRAEFKFGDLGNLVFCASNGFVYMFAAWF
GGRFAQKHGYLFALRLGFSIAALALGVGSQVANVPAHLIVMVGWTIGVCFIWPTLEALVS
ERESGRQLQRMVGIYNIVWAAANAVAYFTGGAMLEHFGLRSIFYVPLGLHVLSLVLLFNL
ERRVRAFPTAPPSDLVSGAETSTVVERLASPVHPKVFLKMAWIANPFAYIAINAVVPVIP
RLAHRLDLSATFAGFLCSVWFFARAGAFVFLWLWTGWHYRFRWLATAYVTMIL
>AIA18123.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
AAMSSNRVIGRDGDLPWNLPRDMKFFMNTTKGHHVIMGRNNFASMNYTPLKNRVNIVLTR
DPFFITSSALVMHSIEEALNYAYEAGEEEAFIIGGGEIYTQALHLTEKIYLTEVITELPG
DTYFPELDQREWEVVSSEYVEADAKNEFPMRFDVLLRKE
>AIA18098.1|FEATURES|farme|beta_lactam|CARB-14|antibiotic inactivation|1
MCSTFKALAAALVLVRVDEGEEKLDRRIKFSKKELVSGSPVTQARVGEPGMTVAELCDAA
VTRSDNTAGNLLLASFKGPAALTAFCRTLGDDVSRLDRIETELNYHDRSDDIRDTTTAAV
MLENLRKLLFTDILSGGSRSQLVAWLITSKTGDARLRAGLPKSWLVGDKTGTNGDKYGNA
NDIAVIWPPDRAPIIVTAYCEIPSIPADERDAVIADIGRIASEI
>AIA18093.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MHMNLEGSISRPRILAKFAKQAGAWQGYGQTDRRFGMKEDDVLRLRDELDLSLMVAMTPY
QVIGRGNTIPWRIPSDMKRFQDVTLGIGTMLMGRLTWESLPRRPLRDRHHIVLTRTGGIE
ATEQVTPVDSFEAACEVVRRLGGKACVIGGTQVYELFFPIVSRLYVTCVHGKIEGDKLFP
IAIDDLHENGWNWVSYNPQPKLRDERDEYPTLWFEWVRD
>AIA18074.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPGISHKAQAMPASPIRKLVPFAEAAKKKGTKIYHLNIGQPDIETPAVFLDAIKNAGMKI
VEYSHSAGNESYRKKLCDYYREYNINIDPSEVIITCGGSEAIEFAMLACFNPGDEIIIPE
PFYANYNGFSRAADVVVKPVRSYIDSGFALPPIAEFEKAITPKTRGIMICNPGNPTGYLY
TKAELEALRDLVKKHDLFLLSDEVYREFCYDGKEYVSVMHLTGIEQNVVLLDSISKRYSA
CGARIGALISKNKEIMSAALKFAQARLSPPSYGQIGAEAALNTPKSYFEGVKKEYVARRN
FLIESLNKMKGVFCPSPSGAFYCIAKLPIDNADKFCQWLLEEFSYNGQTVMLAPATGFYS
TPGA
>AIA18046.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MIRYCFLNNTPVNALHHAFLRAFADYQVDMQMSLEDFEFRLRRDGVDTSISVGAFDDDQL
VGFCLNGSGTWQGEPTVYDAGTGVLPQHRGKGIAAEMFRFMNPQLKERGFSRYLLEVLTS
NEPAVNLYRRLGFEETRRLAVFRTTNSLSYRVNAVAEVRHVEVPEWKLYQTFWTGYPSWQ
NSIEAVQRVVDTTATVECLVDHRCVGYGVVSKTSGQLIQLAVDPSNRRRGLASKLLDELQ
NCVTGSASIKVNNVDENLKDATAFFEAVGFSLVLEQYEMILNL
>AIA17987.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MDAPPTEELFAMHTRFVRNAVILGLISAIGPFAIDMYLPALPTIGKSFTADIGTVQLSLM
LFFVSFGTFQLIFGPISDMFGRKLPLYLGLVLFAAGGIGCAFAPDITTLNVFRFIQGIGA
CAGMVIPRAVVRDLHTGIDAARMMSLLMLVFSISPILAPVTGSLIINFAGWRAVFWVVTA
AAVLGLILIATMLPETRPKLARVESGIGSALSAYRLLLGDWNFLGLSFIGGFGIASFFVY
LANSPFVLIDHFGLTPTLYSIFFSINAVSFFAVAQFTGKLADRFGLRRVVRVAVIGYFAA
MTVLFALTTSGFDRLDVIAACLFVGYGFLGLVIPTTAVLAMEEHGEIAGTASALMGTLHF
ATGAVAIAVIGLFADGTVLPMVAGIAACALITFILGQVTLRQRQAIEVPAE
>AIA17964.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTNQSLAARALSRPEFIALIAALMAMNALAIDVMLPALPYMGEALGVDNVNERQLVVSAY
MLGFGAAQLAFGPISDRFGRRAPLFVGLVIYVLCAFAAVFAPTFAILLALRFAQGLGAAA
TRVVAISVVRDRFSGRDMAEVMSLTFMVFMVIPIIAPGIGQIILLTGPWHYIFLLMGGLA
TVITAWAYLRLPETLHPEYRRSLSLSSVTDGFRIVFTNRVAPCYGLAGMLLFGGMFGFII
SSQQIFVDIYGLGPWFPLAFAFMAITMAIASFLNSRLVQGLGMRRLSHGALVIYLATSAV
WLVASLVGPIPFWMFYALFLVIQFMFGFMASNMNSLSMEPLGKVAGTAAAVFGFTQTVGG
ALIGTYIGQHLNGTLTPNALGYVVVGALVLGCALIAERGKLFGVSPEYAHAPAAID
>AIA17917.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MILSIVVAAAENGVIGRDNSLPWRLPDDLKRFKELTMGKPMIMGRKTFESIGRPLPGRTN
IVVTRQGELRFEGCIMVDSLDGALAAAGAASEVMLVGGAQLYRDAMPRVDRIYLTRVHAA
VAGDVFLPSLDAHEWRETTIATPPADERHAYSFTFVNLDRVAS
>AIA17801.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTSFDLQYQQLLKEILEDGIEEISERTKHGVKALPGKTLELEAGSGFPLLTLRKIPLKIF
IAEQIWFLMGSRRPAEFLNNFTKIWDDFTNLDGVVSTAYGYRWRHHFGRDQITLLVELLE
KEPSSRHGVVITWDPSNDGLSATRKKANIPCPYTFTVNIIGGMLHMHNIVRSNDMILGCP
HDVAGFALLQRILAARLGVKVGKYTHSISNAHIYDIHYDAAREIIKRT
>AIA17729.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VSRRSAAYIWKNIDRQRFDAFAIAIDKDGRWHAQNRQELEKSQPKEMPLQAGDKADAESA
ALLKKIWTQGADNSDIVICDIVHGTTGEDGMMQGFFDLQRIPYVGPGILGSACAMDKVVA
KQLVEYAGVPVVPYVALRLHDWLERKSAVLDEAVRKLKFPMFVKPSSLGSSVGINKVENQ
AALEKAISHALE
>AIA17711.1|FEATURES|farme|beta_lactam|TLA-2|antibiotic inactivation|1
HRYAQQAAQARAKGMAALSEVINHRGRDTQRKAMKTLLHGALILGISVMGLAEDHLAARY
EQIAAQAKGRVGAASVVLEGGEETCIRCDEHFPMQSVYKFPIAMAVLARVDAGELKLDQK
VAVSKNEYLADGAVSQLRDRSRDKDQTVELRELLELAVVKSDGTASDVLMRLLNNQAKAI
SGPYSVGAKEVMRFLASIGIDATSINVQDPEMALQKDWQVQYRNWMSPRGALKLLRAFHE
GKGLSKQSHALLRDMLERSIRGEKRLKGLLPKETVMAHKTGTSGSRSGVTAATNDIGIIT
LPNGKHLAVAVFVSDSKGDQPMREGAIAALARLAWDEEVGKDPRVAFQKMYDEWLSLTKI
VLYDGTELPKEKLRY
>AIA17697.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHAYLDLMRYVMQHGVTKTDRTGTGTLSVFGHQMRFDLSKGFPLVTTKKCHLTSIIHELL
WFLKGDTNIKYLTDNKVTIWNEWADANGNLGPVYGKQWRSWPDKTGKVIDQITQLIHNIK
TNPDSRRLIVSAWNVAEIPDMALPPCHALFQFYVANGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAQVTNLAPGEFVHTFGDAHLYSNHKEQATLQLSRTPLALPTMQINPTIKSIF
DFSFADFALQNYHCHEAIRAPIAV
>AIA17688.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISAIVAVANKGVIGKEGGLPWYLPSELARFKAITMGHPIVMGRKTHESIGRALPGRTNI
IITRDKKFKAEDCVVCNSLDEALEAAAKSPGSEEIFVIGGESVYSEALPKVGKLYLTKVA
ASVNGDKFFRYNKSEWNQLSSEAHKADEKNQYAYEFKVLERR
>AIA17680.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MKQLLIIILFVIIVSAVAATKHVDNLQKPAPDLSPFFKDTTGAFVLYDLKNDRYIRYNEQ
RCRERFSPKSTFKIPNSLIGLESGVIRDADFVIPWNRLKYPPQDNWNQEPFSHWGQDHTL
RSAIKYSVVWYYRELALRVGESRMKKLVSAFRYGNENVSGEIDDFWINGTLKISADEQVE
FLKAFYAERLPVSKRSIDIVKDILVLEKTPAYTLRGKTGGGSIAEGKYIGWFVGYLETNG
DVYFFASNIEGSNFNAIRDKRIEITKQILRQLGYLTT
>AIA17666.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISIIVAVSKNNVIGRNNDLPWHLPTDMKFFKDTTMGHCVIMGRKNYDSIPPKYRPFSG
RTNIVVTRQKGFQAEGTTVVHSIEDAIEFAKSRNETECFIIGGGEIFTQSLKYCDRIYLT
RIHETIEGDVYFPALNQDKWKEVFRKDIPADEKNKYPFSFLTYEKVH
>AIA17662.1|FEATURES|farme|macrolide-lincosamide-streptogramin|lmrD|antibiotic efflux|0
MLLEVKDLHAGIEGKEILKGLNLQVRKGEVHAIMGPNGSGKSTLSKVLAGHPSYEVISGE
VLYEGKNLLDLEPDERAREGVFMAFQYPVEVPGVSNSQFLRLAYNEKMKHLGEEELDPLE
FNDYLKEKAKIVDMSSDFFKRSVNEGFSGGEKKRNEILQMAVLRPKLAVLDETDSGR
>AIA17658.1|FEATURES|farme|beta_lactam|blaOXA|antibiotic inactivation|1
MNKLLTLILTATFISSTANAITTKEYSELFKNYNGCFILYNLNEHKVVNEYNPNNYCNQR
IAPDSTFKVALSLMAFNQGIINQHTVFKWDGKKAELPDWNQDQTPASWLKYSVLWVSQQI
TPQLGYARIKRYLADFDYGNQDFSGDPDKNNGLTHAWLSSSLKISAMEQLHFLKAMLSNE
LPINSDAIKNTKENMYLGKLDNGADYYGKTGSGRHGRNERLTDPSLLRDGWFVGFVENKD
KQYIFVSNLTDKTVQAIDRSNGGLKPYGSQLLKPITMKLLNDYFVK
>AIA17651.1|FEATURES|farme|chloramphenicol|F938_04047|antibiotic inactivation|0
MKGEDCLQKKARIVFLNGVGSVGKTSLAKALQDVTTRPFLYVAMDAFMDMMPAGYFDHPD
GFVFETIDDGGKPSVVIKSGIVAERTLRGMRQAVVAMAAAGNDLIVDEVLLGDEKAEYRQ
LLAPFDVHWVGVFAPLDVLETRERSRGDRLIGLSRWQYDKVHRDMTYDLEIDTSNATPLE
CAERIKQRFGL
>AIA17643.1|FEATURES|farme|aminoglycoside|Mmwyl1_0154|antibiotic inactivation|0
MVEIRRAVPGDEETIAALILEAFAPFRDEYTADAFEYTAAKADRIRERFDEGPMWIAEID
GQPVGTVSGLPEEERFYIRSMAIKPSAQRGGIGQRLLEVLETFARDAEFEKLYLYTTFVL
PGAKRLYEKNGFYVLRETPPEEWYDMGGLEMEKILE
>AIA17637.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|1
MKKSIYIMALGAFGIITTEFGIIGIMPAIAKHFQVSIDTAGWLLSGFALTIALTGPFSVL
LTSKINRKWMMCLVLLTFVLSNILSAVSPNFTVLMIARILPAFLHPVFWAVATVAASKQV
EPKDAPKAVSVVLAGLSIATVLGVPITTYVAELINWKASFVVSGVINLIAFAALLAFVPS
MPVTEKQSVKSQLVILKKGQMWVNLVATMIMIAGIFATYSYLAEYLGKISSMNGKQISIM
LLLFGATGIAGNWVTGLALSKNVLLTTRFFLLSLIAVHMLAYMFGGLFIPMTAIIGIWGF
IHTGGFLIGQTRSTSEAPEAPELAASLMVSFGNAGVTLGTCLGGLVITRFGVHEVIWISI
LLLVVSLALTWVFIGRRRAVAEEQQIAAVETAEEELPEEAMLGI
>AIA17632.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
MAQKITFTLALLALVLLTVFYFYPRELMFDYYADAAATPLSADEIKTLKSIHIECFADTY
RKYLSTYYKERYELHQPGQLAALDSKMTEVMASYREYIDRKYKDIKNLYIVKLAGEVIGE
FTCMTDNDFTDGNPILYDVCLDSTKRGHGYGSQMTEYAIEHCSKPGKPLVLTVYKDQSGL
VKLYEKLGFEVVNFEHAPDESFKYYNKYLMRYKGKP
>AIA17620.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MVFGLSCLVMAGCNRTNAPASANPTATANGTNTQAADADLSNRLTTLAKSLGDEVALSVV
HVESGRAVAVEGAKKLQLYSVFKVPLAIAVLKAVEEKKLSLDQKVHVTPGDVAPGSQFNT
DLWRQPVDKSVAELLEFSIVRSDNTSSDKLLGLVGGPAGVTQRMRALGYSDIDIVSTVRG
YASKQGNPNVGAPVDLARLLTQLQKGELIQPANALLLLGFMERARTGGERRLRASLPPGT
PVADKTGSGTAATNDIGVITLPDSKGHLAIAVLINGTKSKTEAQEKLIAEIARAAYDAFV
ANTAAVK
>AIA17614.1|FEATURES|farme|beta_lactam|SPM-1|antibiotic inactivation|1
MKNALLFAVLILAGCTHNEGLQPALSMEPAKETTPSASTALDDNLSAKLIRPDVWLVQDR
SFYDTNVMLARMPDGTVVIASSFIDTPKTARLIAWIKKNLKPKEIRAINTHFHFDGTGGN
EAYHREGVQTWSTQETLSLYKGRADSMRSSLAATLPDKQQGQDLRETKNTFADHIFSAAA
GLEWDLQGEKVIVYYPGPAHSPDNLVVYLPAKKILFGGCMVRALDYDLGNTQDGDLKNYR
KSVLSLRRFPAEIVIPGHGRMGGMDLIEHTIQLASMPTQKP
>AIA17593.1|FEATURES|farme|aminoglycoside|AAC(6')-IIc|antibiotic inactivation|1
MKQAFRFRPLTRQDLPRIHEWLNRPHVAEWWEEPRDLESVVQEFGADLESPVIRMFLVCL
DEEPIGYIQVYRVMGANPEWWTDETDPGARGIDQFLANAEQLGRGLGSSMVRQFVAELFA
DPEVTVVQTDPSPRNARAIRAYEKAGFRRIDEIVTPDGPALLMRVRRAEFG
>AIA17586.1|FEATURES|farme|beta_lactam|OXA-20|antibiotic inactivation|1
MFGGNGVAMRFWILVIFLTLGFCATASAQVWQERLDWAHFFADAGVKGTIVVSDERTHTH
WVYGEERARTRFLPASTFKIPHALFALDGGIVRDEFQIFPWDGTRRDLESWNKDQSLRSS
MRNSVVWVYQLFARQLGERRERNYLRRIAYGNADASGGIDRFWLEGGLRISAHEQVEFLE
RLYRNKLPFRVEHQRLVKDMLIVEAGRDWILRAKTGWGVRMDPQVGWWVGWVERPEGAIF
FALNMEMPHQGDDLPKREAIARAVLRSIDALPSN
>AIA17531.1|FEATURES|farme|beta_lactam|mrdA|antibiotic target replacement|1
GRFDTTLFCKLLDITKAEFVTRMTKDWRSLRFSKSIPFNFMEHITADKYQYIQEYMHLFP
GFYGELRSARGYFDSHSPHILGYMSEVDQKKIDDSDGIYAPGDYHGMTGVESYYEDVLRG
AKGSKYVLKDNLGREIESLDGGRHDSAAISGDNLILTLDHVLQEYGEQLLKNKRGSIVAI
EPSTGEILCMLSSPGYDPNILSISRERGQAFASLEQDTLKPLFDRSVQAMYPPGSIFKPL
LSLIAMQQGILDENRTIYCGGAYYSGTLRRGCHNHPTPHNVAAAIQYSCNTYFFTVYKEV
IDEAGYTLPEIGMRKLNAHLTEFGLGRKISVDLPSEKAGNLPGPSYFDQIYGAGTWR
>AIA17514.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKIYLDAVKKIMDEGNDREGRYGPTRALFALPLRFKMKDGFPAMTTKKLAFRTVAAELLW
FISGSGDNRELNRLGCHIWDANGNADYWKPKAKYEGDLGRIYGVQWRHWKRPDGKEVDQL
KDVIERIKSNPYDRRLVVSAWNPGELDQMALPPCHMIFQFFVSDGKLSMHMFQRSADMFL
GVPFNIASYALLLHIVARLTNLEADELVMTLGDAHVVHNHFDAVKEQLARESFPLCQLWL
SPDIKSLEDLNTEQFKEPDDIFKIIKLENYQSHPTIKAPMGV
>AIA17498.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELVQRVLDQGERREDRTGTGTLSVFGTQTRYDLREGFPLLTTKKVLWAGVVRELL
WFLRGSTNIKEDLAQHTPIWDAWADEQGELGPIYGHQWRKWGAPFRTHARDKQPETAARS
GAGIDQIQEAIQLIRKDPTSRRIIVSAWNVADLPHMALPPCHAFFQFYVQQGRLDMQLYQ
RSADIALGVPFNIASYALLLMMVAQECGLTPGVFIHVLGDAHIYLNHVEGLKVQLTRQPY
PLPRVTIAQKPLDEIGFEDIQLHDYQHHPFIRFAVSV
>AIA17478.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEVYLKAVREALEKGTRKENRTGVDTISTFNINYEIDLREGFPLLTTKEISWKNIVVENL
WFLSGDTHIGLLQKHKCKFWDPWADESGRVPSAYGNFWRHFPVHGPGGEPAFNDQLAWVL
AELKRNPMSRRLVVSAWAPGNAQTSKLPPCHCLFMFNVQLDRSGEPLLCLHLTQRSCDIA
LGIPYNIAGYSFLLELFSRFTGIRAGIFAHTLVDAHVYTKKPDGSMAEYDHVPGLELQLS
RTPRALPRLSIDPKIRGLDDIKPLLEASTEEVMRHFVLTGYDPYPAISFKVAV
>AIA17454.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPWRLSADLQRFKKLTMGHAIIMGRKTFESIGRALPGRTSIVITRQPNYRVDGVLTARNL
FESLRLCGNADQAFVIGGGEIYSQALPLADRLYLTAVDAEVEGDTYFPPWDEQQWRMVEE
TTHPCDAKNSFAMRFQIYDRKYPV
>AIA17443.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGSKTWGSIGKALPGRQSI
VLSRTQIEDLPDDVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVDDADVYMPLQFLDDFELVDSKEIDNGLIVETFDRRT
>AIA17437.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|1
MLLDLSPLKVSRDYRLLFFGQLVSFFGSMMTFIVVPWQMYQLTQSSAMVGYIYLAEFVPM
VALAFVGGALADYLDKRKMLRITEIGQTSVTAILLLNSLLPQPRVWILFLSVALHAGLAA
LQRPAFESFIQKVIPPEMMSSVMALNSIRYSVGAIVSPAVAGIIATQLSSSVAYSIDLVT
FLASLTAVFMLRHVPRPENAERPSWEGIKKAWRYAFSRQELLGTYFIDIAAMFFAMPQAL
YPALAVIYGDKYVGFFPASIAAGALVASLTSGWTKKIQRHGLMVTIAATLWGVAIIFFGL
VDSLALALFFLAAAGFFDMISGIFRGSIWNQTIPNYLRGRLASIEMMSYLTGPMLGSAKM
GIVAEKFGVKTALVSGGVLCVVSVVGAAFFLPKFLRYDGREGVKEREREEAARAELMRVS
ESEF
>AIA17435.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MRYFSKKSPAEARNRKRSFRHLNNHNQQINRSTNKMARKKSALIFIFITLLIDIIGLGII
IPVLPRLITELTGGTLSDASVYGGWMSFAYASMQFLFAPIMGGLSDRFGRRPVLLASLFG
FGLDYIFLAFAPSMAWLFVGRVIAGIMGASFTTAAAYIADVSTPETRAQNFGIIGAAFGL
GFIIGPLLGGFLVEYGSRVPFMFSAGLSLINWLYGFFILPESLKPENRRKFEWSRANSVG
TLLRLKRYPVILGLVVSLILVYIAAHAVQTNWAYYTMEKFDWTEKTVGISLAVVGFMFAI
VQGGLIRIIIPKLGQERSVYVGLGFSAMGFVLYALATQTWMMFTFTAVYCMGGIAGPALQ
GIISTQVPPNEQGELQGGLTSLMSATSIVGPILMTTIFAIFTKPGASVYLPGAPMLLGAV
LTLTATLLARRSLKRTMHKAAPAGSAAS
>AIA17349.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNLIHRSRRQWPFDPGQLPHSKNKGEKVSPIPILSHVVACSDNGIIGRDGGMPWHLPDEL
RRFKAITMGKVLVMGRKTFDSIGRPLAGRYSIVVSRSKEMLPRIVTPATSLEAALEHARE
IAPNWGNEICIIGGGEIYRQTIDIVQKIYLTRIHQEITGDTSYPLEALKAFECQESEEVT
SSALPYAVTIWLRK
>AIA17345.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSRISFVVAVSRNGVIGRNGGLPWHISTDLKRFKAITMGKPLIMGRKTWESLPKKPLPGR
PNIVITRQKNYRAEGARVVADVPSALAAAGQVEEVCVIGGGEIFDMFLPQTERIYLTEVD
LDVDGDTFFPSLDPSQWTETAREIHPRGPNDSAGFVLRVLDRNA
>AIA17312.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MQRARVSAIAAIGKNRELGTKNQLSWRISDDLKRLKTLTTGHPLIMGRTTYESIGHPLPN
RTNIVVTRDQEFTAEGCIVVHSIEQALEEAHRIDTEEIFIFGGAQMYAATLSVTDRLYLT
LIDAEDPGADVFFPEYSEFTEVVEKEKRDQNGLVYEWVTLERAK
>AIA17272.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|0
MPSLGRKISVDLPSEKSGNLPGPDYFDKEYNGKWRSPYILSMAIGQGELQLTTLQMAHAA
SIIANEGTYTDPHILKARVPPGQKPVVEYYPRRRVSIDYRHFEPVIEGMSGAVRAGTATL
AYNPQFEVCGKTGTSQNPHGEDHSVFFGFAPRDNPKIAIAVYIENAGWGGAYATPVAGLM
MEKYLKGEIIESRKALEERMLTADLIHKPKS
>AIA17260.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MVSLVVAKAENNIIGRNGQLPWGRLPADLRHFKELTLGHPVVMGRKTYDSIGRALPGRAN
LVVTRQADWAAPGCETLTSVLAALARAQELAGANGTVCIIGGGEIYREALPAADIVYLTE
VHNTFEGDASFPTLSPTEWREIARQRHAADAQNPYAYSFVTLQRR
>AIA17162.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKTLLILCGGRSDEHEISLISAHCVLEALDRSLFTPVVVGISKKGTWHLLDEKSFYTGGL
RADTIKLNETGPTVMLAPFSKNGRGKLEANGKAVEFDAVFPILHGPFGEDGTLQGMLDMI
GVPYVGANCGASWNCMDKVITKTICKENQIRTADFVALDSIEDFAPKKSKILALGTPMFV
KPARLGSSVGVSKVSDPSQLEAAVRTAFKYDGKILIERGVKGREIECAVLGLRQNAKASL
PGEIVVSPKIGWYSYEAKYLLKDGAETLAPAPLPEKTTKAVQEFVLKTFRAMECDGMARI
DLFLEEKTDALYLNELNTIPGFTPISMYPKMWEATGVAYPKLITELVRLGYERIGKPF
>AIA17131.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|0
MEIGLFYFLSRDGFKTLLQTSFDFSCLENVRFAHFAHPMYVLTTLTVLRNAVKKTSVQTN
KIARRQKCFTKITRHKNYDRIIAMNVFIIAALTVDGFIAEERKQTSLEWTSKEDKKWFNE
RTKQAKVMVMGRTTYETIGRGLPSRVTIVMSSQADEKPFPRLEEGEVYFTKLAPKNLLAE
LKKQNYSEVALCGGSSIYTQFLQAGVVNKLYLTIEPILFGSGVGLLNESLNINLKLVETK
KLNDQTLLLEYDVLS
>AIA17126.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
DNKKAAIGFIFITLLIDITGWGLIIPVMPKLIEQLIQGDLSHAATYSGWLGLAYAGTQFL
FAPLVGNLSDKFGRRPVLLCSLFGFGVDYLFLTFAPTIGWLFVGRIIAGITGASITTASA
YIADISTPENRAQNFGMIGAAFGVGFILGPVIGGLLGSFGPRVPFIVASGLCLLNWLYGY
FVLPESLSKENRREFSRAKANPLGSLRFLIRYPAIGELAISFLLLYIGGQAVQSTWAFFG
IEKFQWDSKMIGISLGVVGLLVGVVQGGLIRVINPRLGNEKSVYTGLILYAIGLVLFAFA
GATWMMFVFLIPYCLGGIAGPALQSIISGHAPANEQGELQGALTSLMSATAMIGPPVMTN
LFAFFTKKNALVHFPGAPFLLGAIAMLASAVIAWYVLRTEHYTEPAASTAKE
>AIA17123.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKLTFVVAVAKNGVIGTHNTLPFYIPEDLKHFKKVTLGKTVLMGKNTYDSIFKRLGKPLP
ERINVVISHQNLQLPEGVLLFHSIDEALQELKDTEEIMVIGGGQIYTQMIDKADKLILTE
VHHDVEGDVLFPPYDRTKWKEIAREDHEEFSFVEYERK
>AIA17111.1|FEATURES|farme|trimethoprim|dfrA13|antibiotic target replacement|1
MTTGQVVVMGRKTFVSIGRPLPNRETVIVSRAGFRVPGVRTIASLDELDPAMESREIFIC
GGAEIYALALPKCSDLFLTHVKRTVEGDVFFPPFENQFEPREVLADNVDFRIVHYRRSDL
TLSK
>AIA17108.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MIIGIVAISENYAIGRDGKLPWHYSADLKHFKETTMGGTLVMGSKTWRSIGKALPGRQSI
VLSRSEIIDLPDGVLLCHSAKQVLERSERFPGSPFIIGGAAVYETFQDDINRWIVTRIPQ
TIDDADVYMPLQFLDDFERVDSKEIGEGLIVETFDRRT
>AIA17036.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKDIPKKIAVLKGGPGSERKVSLATAAGVSKALRSLGADVVDIDVQGPDFQVPSDAELGF
ITIHGTFGEDGQIQKILEDRGVPYTGEDMEGSKLAFDKIRSKEKFREHGVTTPEWEVIEP
GQHPKIPLPIVVKPPREGSTVGVMIVKSPDQLDYAIAEAAKYGRDLLIEKFVSGRELTIG
ILGDQALPILEIIPKGGFYDFNNKYPFLNPQSGGGATHVCPAEIDEAKTREIQDLALGAF
RALNLKVYGRVDVLLPENGPPTVLEVNTIPGMTEASLLPEAAAAAGIDYVSLCARIIELS
AARTKGASK
>AIA17005.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVELVFERKPKWLAAINDSLLMIKRSSTHILRNTDQLLGAFFQPIMFLVLFATVFGGAI
SKALPEGVTYLNFLMAGIIVQTVAFGSTTTAIAVCNDLQKGIVDRFRSLPMSNLAVLNGH
VISDLFRNSISTIVMLVTGLIIGFRSHASVVEWLYIAGLLLLFTLAFSWLAAIVGVYAKS
VEAVQWLTFIIIFPLTFASTAFVPAEGMNSVLKVFALNQPITHIVEAVRALILGTPMGDH
GWLAIVWCVGILIFA
>AIA17002.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MQSTSKKRSLWIIVGITVLNAIGMTIVLPLFPFLLEKYVPSTSVAVVMSALVSVFAVATF
LAAPIFGALSDRYGRKSILLISLLGSAIGYLLLGVGGALWVLFLGRIIDGLTAGNQSTLF
AYITDSTEPHERGKWFGYLGGAIGLGFMIGPSIGGLLGSASITLPFYITAGITLVSMLCI
MLLVPESLPAEKRSTRLTLRSFNTFSHFRDIFSLKEARALFLMGAFFYIGLNIWQFNAAI
FLKDVFLWGPSFIGGVFVLVGVCDILSRVIVLPQLLKRWSEQTVGTIGLSGLAVGLGLLF
LSAYIPSAFLIIGAVACIVLGEGLFDPSYNARLSLAVDESKQGLLQGANQSLQALYHAIV
PLGAAAIYTFNHGAVFGVAALFMVCGLILFIQLKTKQQERN
>AIA16998.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MPQTDWAIEAKNLKKSYGKVEVLKGLNLQVKRGTMLALLGPNGAGKTTTVKILSTLLSFD
GGTARVEGFDIVSDADKVRSVIGLTGQSAAVDELLTGRENLIMMGRLYRLTKASATARAE
ELLEEFDLVKAANRPAKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRLAMWNI
IKKLMESGTTIL
>AIA16996.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
SVINFTLWFAITFYVYLETKSVFAVSLIAGLYLVATASTGIWFGSLVDHHKKKTMMIVSN
IASLFLYITSFAIYQSAEPGAFKDPASVSLWALVVTLMLGVIAGNIRGIAMPTLVTILIP
ESKRDKANGLVGTASGVSFLVTSVISGFLVAAGGMLYALLLGLGILVVSLIHLFLVSVPE
KGIAHLEGAPKKIDLKGTYKIVRGVPGLMALILFSTFNNFLGGVFMALMDAYGLSLVSVQ
VWGLLWGVLSTGFIIGGLVIAKVGLGKNPVRALLLSNIVLWAVSIIFPLQASIILLAGGM
FIYMCLIPYIEASEQTILQKVVPFERQGRVFGFAQSVEQAASPLTAFLIGPIAQFIFIPF
MTTGFGVQAIGSWFGTGPDRGMALVFIIAAVIGLIATVIAFRSKQYKQLSKRYTEGHGDD
SSPPALDQPVQEGLVQ
>AIA16974.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNLGKGTGERPVIALVVAIGENGAIGRGGELPWRLSSDMRYFRKVTMGKPVIMGRRTFKS
LPRVLDGRLNIVLTRDQGFIAPDAVMAHSLDEGLAAARDSEARTDAGEIMVIGGEDVFRE
VLPQAHRIYLTEVHASPEADTWFPDFDKREWREVFRERHEAGPRDEHAFSFVVLERTDGP
>AIA16948.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLKPNSPKVYLVAALAANGVIGRNGQLPWHLPEDLKHLKQLTLGHPVIMGRRTWESLPKK
PLPGRDNIVVTRRPGYDAPGAAVASSLDAALALCVGESVVFVIGGEQLFAESLPTAAGLV
LTEIHRDYEGDVSFPKYDRSRWRATQRESHTAADGTKFDFVLYEPTP
>AIA16939.1|FEATURES|farme|bacitracin|BcrA|antibiotic efflux|1
MGLILPDRLINCERSLVTFRQDFGVYPNLNAIEFLEYLAAAKGLDRKTARQRIQELLQVV
NLVEAQKRPLGSYSGGMRQRVGIAQALLNAPELLIVDEPTAGLDPEERVRFRNLLSELSG
ARIVILSTHIVSDVEAAATNIALIARGHLVTCAAPEELLQSVEGKVWERVVPSAELPALR
QRYLTSSTMRRSDGVP
>AIA16897.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|0
MSFLASASETRNLKASKIPAFAGMTPSIIMPIYIAIAAITLDGKIAKDSHHMSTTWTSQE
DKVFFRNILKECDVCLVGRSTYETSKEPLSKRNTIVLSRSPYAKASGDVPSVSVTFCDPA
KTDLKKLIEERDYQKVAVLGGSQIYTYCLQNEMIDELYLTVEPIVFGQGIGLFSADVDLN
EKFQLISSQSLNTQGTLLLRYKK
>AIA16891.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMRHVLESGASKQDRTGTGTLSVFGYQMRFNLAEGFPLLTTKKLHIKSIIYELL
WFLRGETNVRYLQEHGVNIWNQWARENGELGPVYGAQWRSWNTADGRPIDQISQLIDQIK
TNPDSRRLMVSAWNVGEIPKMALPPCHLLFQFYVANGKLSCQLYQRSADIFLGLPFNIAS
YSLLTMMVAQACDLEPGEFIHTLGDAHLYSNHLEQARIQLSREPLTLPRMKINPAVHSIF
KFDYDDFEFVGYEAHPHIKAEVAV
>AIA16866.1|FEATURES|farme|beta_lactam|OCH-8|antibiotic inactivation|1
MGKISFPKLGILAIAFSLCGASAHAAESPAPGDLDRIVGEAIKPVMEEHKVPGTAVAVMV
GGKRYFFNYGVASRESGQKVSENTIFEIGSISKTFTAILASRAQVAGTLSFSDNASKYFP
ALAGSSFDAISLLDLGTYAAGGLPLQFPDDVTTHEKMIAYFRNWRPAYAAGTHRLYSNPS
LGLFGYLAASSMGKPFAELMEQQIIPALGLTRTYITVPPDRMDDYAWGYSKDDKPIRVSP
GVLDAPTYGVKTTAADMIRYVEANIDGSRLDETLQRAIAATHTGYYKVGDMTQGLGWEMY
AYPADLDRLLAGNSPQVVLKANDVSRLDLPQPSQQAVLINKTGSTNGFGAYAAFVPARGI
GIVMLSNRNYPTPARVKAAHRILTALDGLAGPAGGR
>AIA16840.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIVLVVAIADNDVIGKAGSIPWHIPEDLKRFKALTLGHTIVMGRKTWDSLPKRPLPGR
VNVVVTRQGDWNAAGAVTAGSLGQATSGTSGTVMVIGGAEIYERALPLASRIELTEVHRA
FDGDALVHLDRTGWTETFRETHVTPDGLSYSYVTLTR
>AIA16826.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKGSTMGGTLVMGSKTWRSIGKALPGRQSI
VLSRTEIEDLPDDVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVDDADVYMPLQFLDDFELVDSKEIDEGFIVETFDRRT
>AIA16809.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKRMN
IYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGGFAEILTGAIEGIP
CHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVC
FGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQ
LLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQ
GNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSK
EVAEERSNKILQEVKIVSNMISLPEYE
>AIA16725.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
MRKILSSVIAALFVAGMATAAMAGQPAAWTRPAKPFKILDNIYYVGTEGLASYLIVSDQG
AILLDGTLAENAGHIEKNIRALGFKLSDVKIILNSHAHFDHAAGISQLKQDTDAKVMARE
ADRSALENGKQEGDTNYGGASFPAVKGDRALKDGDVVELGKVKMVAIATPGHTKGCTTWQ
TTATDNGISRRVVFPCSITVAGNILVGNKGYPGIVEDFRRTFEKMASLEADVVLPAHPEF
ADVFQREAKQEAGDKDAYVDTQLLPRLVKKSKIAFEKELKAAQK
>AIA16723.1|FEATURES|farme|aminoglycoside|APH(2'')-IIIa|antibiotic inactivation|1
MEIFWLKSMRGREIDDSPIQSAAELRVEISAKEAAELIVREFPELQIETIKKLGGGLDNL
AFEVNGEYIFRFPKRDEDNQKLLREGKVLELVKDLSSVPVPEPTFKSTKFMGYRKIEGVS
LLEGRETFDGYEELAETLAKFLSQTHSLSLEEARRIGVPENSQSFSEWLADAPQFFEQAK
TRVPVELHAPIEKFLREESLDGNWQPFFSHNDLGIEHIIVKDNSVTGIIDWADAEITDPA
YDFGKLLRDLGEDLVKEILARYTVEANNKEEIFRRAVFYAKCSALEDLAYTAGDGKDKLY
WDNSRAALKRLFRSE
>AIA16708.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIAIVAVDRNGAIGRDGKLPWHYSSDMRFFKETTTGNSCVMGYKTWLTLKRPLPNRLNI
VLSRQSEIAPQDSVVLLRDVESVLSLAEELNGDLFVIGGEQVYRSFQPHIQKWIVTEVPL
SVEGADAFVPKDYLEGFELTGTRKLEDNLNVSFYERK
>AIA16668.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMG
IYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVP
CHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAY
FSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAIAGFCFRAQNVLNNLRDENEQRR
FLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQ
GSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSK
EVAEERSNKIMQEIKIVSNMISLPNYE
>AIA16665.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
NETSASITINIMNETTDKKALKIPGLNGIGIAMVVAAANNNAIGKDNQLLWHLPNDLKFF
KNVTWGFPVIMGRKTFEAVNKPLPGRTNIVITSKAEWKADGVVTASDLEDAIQKAGETNA
RQIFIIGGGEIYKQSMLVADTIYLTRVDAELDGDTYFPVIDENSWKLDSEEDFPADAKHA
YAYSFQVWKKK
>AIA16623.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPKVSLKGLSMPASPIRKLVPYAEKAKQEGKKIFHLNIGQPDIETPETMLNAIHTFSPKV
VEYSHSAGIESYRRKLTEYYRRNQIELDYTEIMITTGGSEAIEIAMMSCLNEGDEVIIPE
PFYANYNGFGTQAGIKVTPVQSHIENGFALPPVSEFEKVITPKTRAIMICNPNNPTGYLY
TKDELESLRKIVARHDLWFFSDEVYREFCYDGKEHFSVLNMKGIEQNVVMLDSISKRYSA
CGARIGALISKNKEVMATALKFAQARLSPPTFGQVAAEAAIDTPDSYFKKVKEEYVARRN
FVVEALNKMEGVFCPKPSGAFYCIARLPIDNADDFCQWLLEEFSYRNETVMLAPATGFYT
HSNLGTDEVRIAYVLNINDLKKAMECLDEALKVYPGRKVIAEELKSQG
>AIA16588.1|FEATURES|farme|aminoglycoside|ABB27_14230|antibiotic inactivation|0
MTIEIRPIKPGEGPALLVLTRALAEAHDYLDKYTATAGDLERALFAPVPIVGCLIAFCDG
EPAGCAFWHRSFTTARGREIMYLEDLSVLPAYQRRGIGRALLQRLAVEARDRGFPSIYWL
TMGWNAKAQALYDQTGATCDEGMRYYRLADEALIRLAEAKP
>AIA16582.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNKPVISLIACISKNRALGKDNDLIWKIPLDQKRYLSLTTGHPLIMGRKTYESIGRPLPN
RTNIVITHDQNYHPEGVIVVHSYEDAIAEAKKVETEEIFINGGAQIYTEAIAKGADKIYL
TLVDQETPADVYFPDYSEYKTEVFQENHEENGIKFSFIDLVK
>AIA16560.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRISLIAAVAENGIIGRSGTLPWRLSDDLRRFKQLTIGHTIIMGRRTWESIGRALPGRRT
VVVSRNADFRTNIDGVATATSLDKALELAAAAGDEEAFIVGGAELYRESLSRANRLYLTR
VCAAVDGDTSFPNIEWNNWQLVESEDHDANEKNEFAYRFETYDRR
>AIA16558.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MGYMKKYSLVAYDRNRAIGANGGIPWMGKMKTDIQFVRQRTTGNALIMGRRTYDSIGRAL
PNRQNIVITHRPFTADNVTVVDNLDDAYAAVEPGRDAYIFGGGEIYKLANDTVDEILATE
IDTVAEGADAFFPPLSEGWVEVSREHHDADEDNAYPFDFVVYRNPNTKPSTLADAEPL
>AIA16516.1|FEATURES|farme|aminoglycoside|ASD14_09375|antibiotic inactivation|0
MHVTAARREDCLAIASIHVASWQAAYASLFPAEYLASLSVPERENSWLAILEASASRTLV
VKRDGQVLGFISFGRCRDEGAAPNRGEVWALYVKPQAWSAGAGWALWEAARVQMLHAGFA
EVSLWVLSGNDRGLRFYEAVGFRREPHSEQYFERGGAKLQEVRLLIHPRPH
>AIA16511.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKDKLLWHIPEDLKRFKDLTSGHPIIMGRKTFESIVGYLKKPFPNRTNIVVTRDNNYKMG
LDERGMHDVIAVGSLWEAIEVAKKSPGSEVITISGGAQIYSQALAHIDKLYLTLIDDSKE
ADTFFPEYETQFKNKVFEEVREWNGLKYQWVDLER
>AIA16498.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
RISMIAALGRNRALGNGNELLWRIPDDLRRFKALTMGHPIIMGRKTFESIGKPLPGRTNL
VVSRAGLSLEDAIAQAKALDTEEVFVIGGAQIYEQALPYADRLYLTLIDDEKEADVFFPE
YETIFTKVIAEESREHEGLKYRWVDLEK
>AIA16396.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MICSPNNPTGYLYTKSELESLRDIVLKHDLWFFSDEVYREFCYDGKEHISVMHLKGLEQN
AVMLDSISKRYSACGARIGALISKNKEVMSTALKFAQARLSPPTFGQVAAEAAIDTPDSY
FKKVKDEYVARRNFVVEALNKIDGVFCPKPSGAFYCIARLPIDNADKFCQWLLEKFSFKN
ETVMLAPATGFYTHSNLGTD
>AIA16381.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefC|antibiotic efflux|1
MNDVTTVTKEKPAGLRDLLRNRNFRYIWTGQIISDFGDSLTNLALLIVINQLTGSTAALA
TMLIVLTIPQITFGLVSGVYVDRWNRKHIMIVSDLLRGALVLGFVFVHSADQLWLLY
>AIA16375.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|1
MKKSIYIMALGAFGIITTEFGIIGIMPAIAKHFQVSIDTAGWLLSGFALTIALTGPFSVL
LTAKINRKWMMCLVLFTFVLSNILSAVAPNFTVLMIARILPAFLHPVFWAVSTVAAARQV
EPKDAPKAVSVVLAGLSIATVLGVPLTTYVSELINWKASFWVSGVINLIAFAALAAFVPS
MPVTEKQSTKSQLVILRKGQMWVNLIATMIMIAGIFATYSYLAEYLGKISSMNGKQISLM
LLLFRTTGIAGNWITGLALSRNVMITTRFFLLSLIAVHVMAYLFGGLFIPMTAIVGIWGF
IHTGGFLIGQTRFTSEAPEAPELAASLMVSFGNAGVTLGTFLGGIIIAHFGVHQVIWISI
LLLLVSLALTFVFIGRRAVTPARETALPSAGMLEI
>AIA16370.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIVLVVAIADNGVIGKDGAIPWHISDDMKRFKALTMGHTMVMGRKTWDSLPKKPLPGR
VNVVVTRQKDWRAEGAVTAGSLGQATAGTSGTVMVIGGAEIYERALPLASRIELTEVHRA
FAGDAKFHLDRSGWKETFREDHVTQDGLRYSYVTLTR
>AIA16314.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISFVAALAKNRVIGNHNAIPWYIKEDLKHFKDITTGHTVLMGKNTFDSIMNRLGKPLPN
RKNVVVSRDENYKAPEGVFVYKSLDEALEAIKDDGEIMVAGGGQIYSQLIEKADKLYLTE
VDQEIDGEVFFPEWDKSKFKETSREDHEGFSFVTYERIS
>AIA16281.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MVSNSAAATNSPIPPAADVALLSETLKKLCDTVGGKVSVAVVHVETGKLATVDASNELPL
FSVFKLPLAITVLKRVEEGSLKLDQNVHIGPDELIVGTRANSQRWQNPIDFTIKQLLEFS
IIESDNTSSEKLLQLVGGPQAVTERMLSFDLQQINIKTTIRDYVATRSNPNTGSAAALVK
LLSKLQNGELLQRAQTDLVIGMMERAKTGLHRLRGNLPQGTKVGDKTGSGDPNPKTNFAI
STNDVGLITLPNGRGHLAMAVLLHESTLSDEAQEKLIADLARTAFDAYSTVR
>AIA16279.1|FEATURES|farme|multidrug|farA|antibiotic inactivation|0
MAGMLFSPSWYRVAALKPRLRGHVEIHRHSYRDAIWFVLQDHSSGRSHRLAPAAYAFMGL
MDGKRGVQNLWDLCNEHSGTDAPTQDDVVRLLGQLHAADALICDVPPDTRELFRRFQRQQ
RQTWRQRLWTPLAIRVPLFDPDRFLERTAFLVRPLFGWLGAVIWLSIVSAGLVLAGLNWS
ALSENVVDRALAPQNLLVLFFVYPLVKAVHEFGHAYATKIYGGEVHEVGVMFLVFVPVPY
VDASAASNFPNKRERMVVGAIGIGVEMLLAAVAVFVFAYATIGTVHAVAYNVILIGGVST
LLFNGNPLLRFDGYYVLADALELPNLGQRANRYLGYLIERYAFGSRDASFPETDRRARAW
FVFFGIASFGYRLFISVAIIISLGSRFFIIGVLLLIWAAASQLIIPIGKGFSFLSSSPRL
QRNRPRAVALTALVVGFAGLFLFVMPFPLRTVAEGITWPSERSQIRAGTDGFIGRLLVAN
GSQVEPGQPLIEAYDPFLDARVEVLEAQLRGLRRQYTAVRATDQAEAGVLQEEINGVVSD
LERARERRRELVITSRRAGVFVAPVEQDMPGRFVKKGQLVGFVID
>AIA16236.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MDFVRSLALTLVAATLVLAPPTSLASQKPRGDAALETELRRLAATLPGTVGIAVHHVGTG
RLVTVDADRAFSMARVFKLPVAIAVLRRVQTGGLTLETPITIAPEAYYPGYSPLRDAKNR
AEATVTVRDLVETMMVDSDNTAVDVLMARMGGADAVNAELRAAGVPDVSVHRTEGEVMAD
LDGLGAAPAGGWTYSALVAGEARATAEGKRAGRAKFLADSRDTATPTALANLLARLDRGE
VLDAERTKILVGMLDRNKTGGRRFRAGLPAGVRIGDKTGTNPTVGTYNDAALVTLPSGAR
IALVVMTREAGDTGAAAEQLMASVARTVYAHFARP
>AIA16158.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MITIVVATDRNGVIGREDRVPWRLRNDLIMLREFTKGHTVILGRKTYESMDGYYNRSGRP
MPGKTYIVVSRNPDYRPARDNARVAHSIDAAIALAKELGDEEVFSIGGGGVFAEILPHAD
RIYLTEVHAEVEGDSYFPVLDKTQWREISREAHQKDEKNEYDYDTLVLERA
>AIA16159.1|FEATURES|farme|aminoglycoside|cfr|antibiotic inactivation|0
MTKTASKTPITEPMTLADKVLHAYGLEYSRILTPQKGYRNQSFPVVLASGEMRNLILYKR
EPGIVKRIKAANAVSDFLAGQNFPTRQTADERIIKLDSGSGRPAQYGALYSYLDGHTIPW
EAYTQDHIKALGEMMGNMHAALAAFPPRAADSLPAVTDEYLAIVARMKRYFGEAPVQRSL
GQKLQLAVGLERLEYFEQLLVGANMLPGQQALHMDFVRGNILFVREPVEESGPRITGILD
FEKTAYGHPLMDVARTLAFL
>AIA16066.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIVLVVAIARNGVIGSNGLIPWHISDDMKRFKALTLGHTVVMGRKTWDSLPRKPLPGR
INVVVTRQKDWQAEGAVVVHTLEEAMAETSGAVMVIGGAEIYQRALPLATRIELTEVHKD
VEGDAKFMLDRIGWHESLREDHVTPDGLRYSYVRLTR
>AIA16054.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MNKTLRLKSSFIPHPSSVILSLLGRFWLWLFGWKIHGETPSYRKFVLIAAPHTSNWDFPF
MLATAYAMRVRISWFGKHTLFIPPWGWFMRKLGGIPVDRGAPHTLVMQMAENFKNSEDLV
LAVPPEGTRSKSTYWSVAQPVPPSHARVATFSYTLRAHQRNDPQFQAELDMLDREIRAAS
FAPRLADDAR
>AIA15969.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MILSSIVAMSKNGVIGKDNHLPWRLPAESAYFRGTVKGHPVITGRRNWDSMGRPMPGCLN
IVVTTQPDFKVPAPHIVVHSVEEALELPEVKEADEVFILGGQTIYEQTMDKIDLLYLTIV
DAEVEGDTFFKYNPDEWRKIWSEKHEADEENKYAFELMKFERKK
>AIA15953.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQEGFPLVTTKKVHMKSIVHELLWFLKGETNIAYLKENGVSIWDEWADENGELGPVYGKQ
WRSWEGNGGEVIDQISDVIAQIKKNPDSRRLIVSAWNVADLPKMALMPCHSLFQFYVAEN
KLSCQLYQRSADVFLGVPFNIASYALLTLMMAQVCDLQPGDFVHTFGDVHIYSNHLEQVK
LQLSRTPFTLPTMKLNPAVKNIFDFRFEDFTLENYQSHPAIKAPVAV
>AIA15933.1|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
MKQKKIVFLFGGPGAEHEVSVATAKSALPKFDAQYSILPVFITKENTWVASQEYIPPAES
WAVAQKLITQSGIAQDVAIDMIEHTDPYVVFIGLHGTYGEDGTLQALLESHGLAFTGSNS
EASSLAMDKPKVLQILQDEEITVPEFLELTSEMPEGAALEFGHYHGFPVVVLPADSGSSV
GVTIVRNQEQLPMAIDTARQYSDRILLSQFIPGREVSCGMLVTDKNELTALPPTELIPNE
NYEFFDYDAKYKPGATKEITPPHMDEAIIAEIKSLARRVHHLLEADGYSRTDMIVGEDGK
IYVLELNTLPGLTETSILPQQAAAFGLNFTDFLTTICENVDRSSREYLTAV
>AIA15920.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
RLYGDEGWRGIKGFFKWLETKKYKLHVRVFLAKYRGYTRCPECDGARLRQEARDVKIGGK
SLPEIVEMSISDAAAFFEDLKLSEEREKIAEKILLEIRRRLKFLVDVGLDYLTLSRVAAT
LSGGEAQRIQLATNLGSLLVGTLYVLDEPSIGLHPRDNARLIKILENLRDIGNTLLVVEH
DEDTMRAADHILDIGLFAGELGG
>AIA15906.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MPAISFVHVAKTYASARGDVRALDDVSFDIEEGEFFGLLGPNGAGKTTLISILAGLARAT
AGSVAVLGHDVYSDYAAARRKIGVVPQELVFDPFFTVREALRIQGGYFGVHANDAWIDEL
LANLGLADKGDANMRQLSGGMKRRVLVAQALVHRPPVIVLDEPTAGVDVELRQTLWQFVA
RLNKEGHTVLLTTHYLEEAEALCSRIAMLKQGRVVALDRTSALLAGTASTMLRFKLDKPL
PPALTANSRVAGRIVQITAHDAREVESILAVLHAAGCEPEDLEIGRADLEDVFIEIMRGE
TPQRVAA
>AIA15905.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNGTNGPAVAPAKRPRVALVVAVAENGVIGQGGKLPWRLKSEMRHFRDVTWGKPVIVGRK
TYESFARKPLPGRTNIVVTRDRTLTIPGVVVVTSVAAALDAARGDALRRGIDEISVVGGA
DIYAQTIGEADRLVVTRVKLQPAGDTVFPPIDPGIWREVQHTDHAAGPEDEAGYSIHIYE
RILPP
>AIA15845.1|FEATURES|farme|aminoglycoside|Mmwyl1_0154|antibiotic inactivation|0
MSAEPTIRLATIEDAETISQILREAFEPLKDGYAPEAFDVVRPSATEIVGRFDDGPQWLA
QIDGTPVGTVSVVPEPEWLYIRSMAVLPSAQGFGIGGSLLDAVETYALDQGFKKLFLYTT
YFSESALRLYEKKGFYWVRDTPADEWFDTPGLAMEKVVGRKAENAVGS
>AIA15796.1|FEATURES|farme|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|0
MSPSAIRKARPDDAALVCKLLYELAEYEKLAANFALTEDMVRRDMLTPNTTCHCALGFAA
GEPVGIATWFFTYRSFRARRNLYVEDLFVRPQFRGQGHGKALLAWLAREATAIGAGMEWQ
VLDWNLPAIAFYRGIGAAPLENWITYRLEDQAVAALAAT
>AIA15797.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTITLVVAAADNGVIGDQGRIPWHISDDLKRFKALTLGKTVVMGRKTWDSLPRKPLPGRD
NIVVTRQQGWEAPGAQVAATPQAALAMAKDDVMVIGGAEIYHALLPHATRIELTQVHAAF
NGDAVFSFDPGCWKQTAR
>AIA15794.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSQLIRITMIAALGENRAIGHNGDLPWDLPEDKKFFREKTRDHVIVMGRKTLEALPQGQP
LPNRPNIVISRHKPSFQHPLLYWSENIASALDQGCRLSKEMKQEELFVIGGGEIYAQCLE
KADRMYLTHVACAPKADAFFPEFDLLSWEKNILQEFLTTSEKPAFKMVEYNRVRSGGLPL
VNAA
>AIA15795.1|FEATURES|farme|bacitracin|BcrA|antibiotic efflux|1
MTALEQNSTQNVSVIDIRLLSTAYGKVKVLHDIEFSVPAGICCGLIGLNGAGKTTLIKVL
LGLRDATSGTASILGYAPGHAEAKAQIAYLPEKFDPPPFLTGYEFIRFTQKLYGRSISQD
AILEAASLLQLQAEALPRRVTSYSKGMRQKLGLMAALLTDCQLVILDEPMSGLDPRARSL
VKEAILTFQKRGRTVIICSHILADLDEICAQIAVIHEGYLAYNGSPEGLKEQTGQNNLER
AFLSCIDQRQAA
>AIA15770.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFIIAAVTVDGFIGRSSDHLADWTGGEDKKIFVKLTKEAGVIVMGSRTFATIGRALPG
RRNIVYTNTPEKITAEGVETTHESPGELIDRLAAEGHTAMAICGGTTVYNLFMDSGRVTE
LYLTFVPMAFGEGLRLFTTEQATHLRLADSSVLADGGLLAHYELAR
>AIA15764.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKKISLIVATDKNGGIGKDGDIPWKLPQDMKLFRRITIGNGNNAVIMGRKTWDSLPEKFK
PLVKRTNIVISGREDLVFPPKVIQCSNVESCLTHLDSRSNVEDVFVIGGAQVYQECIQKD
LVNTLYLTRIDTSFDCDVSVDLEELLNSFKLI
>AIA15758.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIRAIAAIDDKRGIAQAGNPPWNIPWEIPTDLKHFQQLTKEHIVLMGRHTYELFNQPLPN
RQNVVVSRSLDAVRPGFQLEPDAEAFLQQTTDDVWIIGGAALYAAGLQYCDELYLTHVRG
DFACDTFFPEYADQFTLCDQSPSQQENGFDFHWAIYKKNR
>AIA15756.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPRISAIAAIVNNRGLGKDNELLVRIPEDLARFKKLTSGHTVIMGRKTYESIGKPLPNRS
NIVVTRDAKYEAEGCQVVFSVEEALDLARQLEPEEIFVIGGGKIYAEMLPYTERLYLTQV
EKDAEADTFFPEYAEFSKELEREEKEHEGMKYTWVTLERV
>AIA15721.1|FEATURES|farme|beta_lactam|BL2a_III2|antibiotic inactivation|1
MKSWNTIFRISKFKKIVPALLLTCVTLAGCSEGNDQSVQAKQKNKESVIKHHFVKLEDKF
DARLGVFALDTSTNQTVTYRADERFTYASTSKALAVGALLQQKTIEDLNQRITYTQDDLV
NYNPITEKHVDTGMTLKELCDAALRYSDNTAMNLILKQIGGPNGLEKALRDVGDNATMPE
QFEPELNEVKPGETHDTSTPRALATSLQSFTLGDVLPIEKRELLIDWMKRNTTGDSLIRA
GVPKGWVVADKTGSGSYGTRNDIAIIWPPKGEPIMLAILSSRDKKDANYNDKLIAEATKE
VINAYQANHK
>AIA15712.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MTTVGLIWAQSTSGIIGRGGGIPWRLPEDQARFKEITMGRTVVMGRLTWESLPERVRPLP
GRKNVVLTRQADYMADGAHVVPTLQDALTDDITWVIGGEQIYSLALPIATRCEVTEVEID
LPRDDGDAVAPVLDESWIGNEGEWLTSASGLRYRFFSYVRP
>AIA15706.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MKTRMHTLALGLLLSTLGQPASAQDAITCSSCEEWNQPAKPFNIYGNAYYVGTAGLSAIL
VTGPEGHVLLDGALPQSAPLIQKNIEALGFKMKDVKLILNSHAHFDHAGGIAALQKASGA
TVAHSPHGAQVLRDGTPGLDDPQYDPKERFTIPKVAQVKEVADGDTLAVGPLRFTVHYTP
GHTPGGTTWTWQSCEAGRCLDMVYADSLTAISTDGFYYTGGANYPDRSASFRKTIDTVAN
LKCDIVIAAHPSATDAFKKAAARTAQSNPFIDPEGCRKLAAHAGKNFDARLQREREEKAK
APGG
>AIA15693.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VAQSGLFGYRNRMQPYLDLMRRILDEGVEQHDRTGTGTLSVFGHQMRFDLSKGFPLLTTK
KLHIRSIMIELLWFLSGDTNVQWLQENKVSIWDEWADAAGELGPVYGKQWRRWETADGRE
IDQIRELIALIKRDPGSRRQIVSAWNPGDIGRMALPPCHLLFQTYVANGKLSLQMYQRSA
DVFLGVPFNIASYALLTHMLAQQCGLEAGDFVWTGGDCHLYSNHLDQAREQLTRDCRKLP
KLAILRRPTDIADYRYEDFEISGYDPHPHIKAAVAV
>AIA15670.1|FEATURES|farme|beta_lactam|Lqui_2697|antibiotic inactivation|1
YSRILTSKLGMPKFQKYVTQFSYGNMDLSGGLTDAWITSSLKISPDEQTIFLQKVVEQKL
PVSAASYAKTKKIMFIQEMAGGWKLYGKTGNGDQIDQDGNHTDLQQGWFVGYIEKDQRRI
VFASHITDSEKQDTFASFRARNEALIKLWYVIDQLEKSVS
>AIA15631.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MEDEKLAKVLVAVRDSSRYASVADDTVRRIATASLSAARGDVNDAVKRTKRGLHEIFGAY
LPSTPRYDKLLGLLREAQSVEERRDVLSRTMSSHASTKERLPILTEFYAAVFERLPQPPR
VIADLACGMNPLTVEWMPVGEDVLYRASDIDSRLMAFLDEALTVLGVPHEVAVHDLLTGP
DPKPADVTLLLKAVPCIETQQKKLGWGLIDAINSPVVVVSFPTKTLGQKSKGMYRTYSSG
FAAHAEGRPWQVEELEFGNELVYVVQK
>AIA15618.1|FEATURES|farme|beta_lactam|mecB|antibiotic target replacement|1
AYSPIANGGKLIYPKLINNQKTPISKRIIEKNTANTIKQALHEVVSRPDGTAHSLQIKGQ
SIAAKTGTAELKKKKGTDGIENGFLFAFDDKHSNYVVVSMIENVKGRGGSSYVVQKMKPV
IESFYQK
>AIA15581.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
VAVSENHAIGRHGKLPWHYPADLKNFKETTMGGTLVMGSKTWRSIGRALPGRQSVVLSHS
EMADLPNGVLLCHSVKQVMERSERFDGDVFIIGGAGVFESFQDEIGRWIVSRIPETIEDA
DVFMPVQFLDDFELKDRKEIGDGLVVETFDRRPQR
>AIA15540.1|FEATURES|farme|beta_lactam|SD53_15990|antibiotic inactivation|1
MFCSLSSAPKEFVVKAHWHLASYIRHMRLLLLFGVLVSLLSCADSPQPGQQKSSDSVTEN
TPRESALEAQLLKNVINGKQATVGVAIKNFQSGEEHYILPDERFALMSVAKFPQVLLLLH
LADEGKYDPKAPVSFDAEDLKQRTASSLRKDHPQSAFSLPLTEALRYCIGQSDNITSNKI
FELEGGPRAVEDYVHSLGIADIGVTTDYAHMRPDSPRQNWGTPRAMLALLEKFHNGKLLS
DSSKAMLWKAMVEATSGHNRIRGGVPAGTLVADKTGTSGRDEKTGVTAAFNDVGIVQLPD
GGYYGLVVFVGDSKEPDSVNAAIIAGVSKTVWEHFNAAKR
>AIA15508.1|FEATURES|farme|tetracycline|tet(30)|antibiotic efflux|1
MTRSLFVIILIVALNAIGVGLIFPILPDLLRELTGSAEISTTYGLILAAYAAMQFLLSPI
LGMLSDRFGRRPVLLVSLLGCTIDYLVMAFAPTLAVLVIGRLIAGATSANMAVASAYIVD
ITEEKDRAQRFSWMSAAFGVGFIVGPMLGGVMSTWWLHAPFLAAAVLNGGALLLAWFMLK
ESRVPSGEKLDAKALNPFAPLRWAFSFPALAPLLAMFLIFAINGDIPGTIWVLYGAEKFN
WDGVTVGISLTFFGVFATLAQAFITGPLTKRLGEKRTMMVGVCADAIAFLLIGLATEWWM
PFALAPLFALGGVGLPALQSLMSAEVSEDRQGELQGVLASAMSLTSIIGPLLATGVYFWT
KPFFIGAVWILAAALYLLAIPVLGWIGRRRVQPA
>AIA15471.1|FEATURES|farme|aminoglycoside|AAC(6')-32|antibiotic inactivation|0
MKVLETERLVLRRMSGEDAEFIFDLLNQPSFIKYIGDRNVRTIEDARQYILSRFVASYKK
FGYGFYLVELKQNKTPIGICGLVKRDTLPDVDIGFAFLPEYWSQGYAFESAQAVMDYARK
DLKLERILAITTKDNHSSGKLLNKIGLKFERLISVNDEELKLFSTD
>AIA15468.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
PRLEVGQPPQGEQLSGLQASPQYRDGAFHNALPTPGYNGDKNMLVAMWEFLTKKTENARP
AQPLPLVNTDLASLPLAQDTLVWLGHSSWYLQLAGKRILIDPVLGNYAAPFSFLNKAFEG
DYPWRAASMPEIDLLIISHDHYDHLDYATIKALLPKVKRVVTPLGVGSHLRYWGMDPTII
DERDWNQSVRISEALTVHVLPARHFSGRGIKRNQTLWGSFMFVTPEQKVYYSGDSGYGPH
FRDIGEQFGAVDLAIMENGQYDQDWKYIHMLPDETAQAAADLNAKAVVPGHNGRFVLAKH
TWNDPLIQLAKASRDKGYRLLTPELGEPVRVNDTAQQFRPWWE
>AIA15457.1|FEATURES|farme|trimethoprim|dfrA23|antibiotic target replacement|1
MIDAESAIIVAVDECYGFGKDGKIPWHFKEDFQYFKKMTKGATCVMGRKTYEDLLGYAKT
DELLPGRKCYVVTSSEEPLQKGAKRLSDPYEDLPEDCVGGPVFYIGGAGIFDAALDFVDE
VYMTHIRRNYDCDVSFPYAKLEEKFQLADNPYAPVLDQELARTLLFERWVRK
>AIA15422.1|FEATURES|farme|multidrug|mdtL|antibiotic efflux|0
RGESEMIPAAKEETAHLSIIPFIFVLFGLFMITTAVNLQVPLYTLYAEQAGYGKAATALV
FAAYVFGLIPVLLFLGGISDRAGRKPVLLVALSFSLCATLLMIVHPTIQILFLARLLQGV
GLGLSVGTCTAYLIALYPEKSSWIPTFIALCSSVGFGGGALFTALLSFQYVTLAPLSYWI
VMGFLILTIVGVFFFVPPVQGDADKPMMNMPTFPKGTMPANAAIAVAWSVCGLVISVLPA
QLKLNGYELWVGPALFLINMSGVLMQPFVRKMNSTAALLAGFICLPCGYGLLLFGANGGS
IILVLAGTMLAGTACYGFTYLGGLQLIVERGKKEAARAVAGFYLFAYLGLGLPSVFVGLF
ADLFGTQVVLTVFFLVVLAACLILLMSSVRQKQK
>AIA15420.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MSRERISRRVRSVPPSGIRRFFDIAATMPDVISLGVGEPDFVTPGDIREAAMASIEQGKT
AYTSNSGLLELRYALAAHLSSLYGVSYDPEDELLITVGVSEGMQNAMVALIDDDDEVIIP
EPCFVAYPASVIFADGVPVNVPTRVENQFQVTGAEIEAAITPKTKAILIGYPSNPTGAVL
SRERMQEIADIAERHDLVVISDEIYDRLVYGVEHTCFASLPGMRERTVLLGGFSKAYAMT
GWRLGWLAGPSEIVQAVRKVHQYAIMSAPTASQYAGLEALRFGEESVQAMVAEYDRRRRR
IVDGFNAMGLPTFEPQGAFYAFPYVGHLGLSSEAFAERLLMEEQVAVVPGDAFGQSGAGY
VRACYATSMEKIEQALERIERFVRRVEQTG
>AIA15374.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MFRLFEDKALRMRAMTVMIVVGMSGFVLGPVLGGSVLTHVRWEWLLVVNAPIALIACVGV
RLGVPADRPEDLTDDVLDLPGALLSVTTIGLACYSLTSGVEHGWLSALTLASIVGAVLAA
VAFVRHERRSASPMLDLGVFSDGIVRGASIAQIGTSIAMASVMFGLILHFQYAYGWSPVR
AGLANLPIIVTMIAATPVSEWLARRFGHRIACLVGAAFLAGSLAGLSWGVEHGYVAIAAC
MVLMTVGLRTVMTICAVALVDAMPSNRTSIGAALNDTAQEVGTSVGTAVVGTLIAALVTT
QLPAGTWGSDLVASFFHGERITYALLAIVVGVVAAGGALTLTDSHATEEPV
>AIA15345.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNYSFVVAAAENDAIGKDNGMLWHLPNDLKFLKNITWAMPVLMGRKSFDALGNKPLNGRA
NIILTRRRNYKPEGVVVVNNLKDASFFAKQNDYKEIMVLGGGEIYKMLLPKATKIYLTRV
HASFPEADAFFPSIDEAKWTRTSKQDFDADEKHAYAYSFEVWERK
>AIA15275.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKAIIAVNNLGFIGLGKNMLWRSSEDFKHFKALVTDGSYCVVGGNTFDSIAMVGKRCNLL
RLSRNPRVGLSLGEIESINEASGIDWCLGGKLTYQVLAPYFTELHISHINDNSIGDVTFP
DFKNINPSCKVFNYNFEINKPK
>AIA15268.1|FEATURES|farme|beta_lactam|PMI41_04644|antibiotic inactivation|1
MKYRTVRLMAAAVATTCVMMAATCHAADESHGRHIVNEAVRPAMEKYDIPGMAVGIAVDG
ASYIFNYGVASRETRKPVDAATLFEIGSISKTFTVTLASLAEVEGHLSWSDKTSQYLPSM
KDTPFGDVRLLYLATHTPGGFPLQLPDDVTNDAQLTAYLEHWKPAYKAGTMRTYANPSIG
MLGRIAARSMDGDFAALMEHRIFAALGLSGTYLHVPKSRMPDYAQGYTKRDEPARMTEAV
LSSEAYGVRSTASDMLRFLTANMGQLPLQPALQRAITATHTSYFRAGVLTQDLIWEQYDE
PVALDTLLRGNSSEMAYNATPAAPLIPPQAPRADAWINKTGSTNGFGAYVAFIPERRLAI
VLLANKNYPNDARVALAHEILSRLARKNGSPSD
>AIA15209.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MIDKRSTALKLAMIVAMSENRVIGYQNQMPWHLPADLKHFKMLTTGNPILMGRKTYLSIG
KPLPNRHNLILTRDQHFTADGCDTVHSLAEARMLAEKEGAQTLFIIGGAEVYREYLSEVD
ILYLTIVHAQFTGDAFFPELDVADWRVVSHVEQPSDASNAYACTFLHWQRKSS
>AIA15199.1|FEATURES|farme|beta_lactam|LRA-3|antibiotic inactivation|1
MSDTDQKMRIFMRSKLLLAAALLALSASVPLQAATPQRIHPPITNKEWETPFPGFKIVGN
MYYVGTYDLGCYLIDTGQGLILINSGAPGSYPLIKANIEKLGFKTSDIKIITSTHGHWDH
VGDLASFEKDAPNAKMYMSERDAPVLESGGNLDYRRAEGRGIIYDPVRVDVKTKPGDHIK
LGNVDMTVHAAYGHTPGATSFTFTQQDSGKTYNVLIVNMDGINAGVKLLGSPGYPTIVED
FANTLKDQATYKPDIWVSSHSGQFNLHTVYHPGDAYNPSRFGDLAAYQKKIADYQKAYEK
QLTEERAAKKS
>AIA15196.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSAINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMG
IYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVP
CHFNQWIDGIKQSDNDVEVQFKDGRTEHYGLVIGADGLHSKTRRMVFNEDEYKLTNLGLY
FSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQK
FLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQ
GNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNESTLVYDEVSQ
EVAEERSNKIMQEVEIAANMISLPNYE
>AIA15192.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MNKALIVILSAVLLDAIGMGIIMPILPGLLRELSHTSTTSSTHYGALLAAYALMQFLFAP
ILGALSDRFGRRPVLLISLAGAAADYLFMAAAPSLAWLYVGRILAGITGANLAVATAYIT
DITAEPDRAKRFGQMGAVMGIGFIIGPLLGGTLGEWSLRAPFVAAAALNAANLVLAYFVL
PESRAPQAAPARRISFNAFASLHRLQGKPALLPLTSIFIIIALVGQVPMTLWIIYGQDSF
GWSTTVAGISIAGYGAFHALSQAFMIAPAVRWLGERGALLLGLLADGTGLLLLALIMRSW
IPFALLPLFAMGGMTLPALQAMLSRQVDESRQGELQGTLASIASLIGVAGPLAATAAYAA
SRSTWPGMVWAIAAALYLPVVPLLYSRRLREI
>AIA15173.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MDKLLVLQGGKSSEREVSLRSAATVTQQLHALGYDVVVADPAEADFNLEQVARDCNVVLP
MIHGADGEDGVWQKQLEAMDKTFLGSGSAACALTFDKSKYREFVTAQGVRMAAGETVDRA
GFTSSGLHQKPYVLKPIDGGSSVDTVIVHQLADEPDEAYFDELFARHPSMLLEELIEGDE
ITVAVLDTQALPIILIVPPGDETFDYENKYNGRTQEIVDPPQLAEETKQKAQELALRLHR
MTGCRHLSRTDMIVNGDGNLYVLETNTLPGLTDQSLFPKAAAAVGYDMRALVKCFVTLAK
EV
>AIA15160.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MAAADNDVIGNSKQTALPWHQATDMARVCQITKGHPVIMGRTTYETMGKPLPHRQNIIVT
RKEGYTAEGCDVVHSLDEALTVAESNPEVFIIGGGEIYQLAMPKADRIYLTRVHARPEGD
VFFTYDVAEWIETSREDYPADETNQYPYSFINLTRRK
>AIA15156.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|0
MKTAMKVILLATQSADGFIGRDTEHLSTTWTTASDKRLFVRITKQAGTVIMGYTTFATFG
RALPGRRLIITTRQNRPPVKGVEFTNEGPVEVLRRLEAEGAKSVIVGGGRQIYNQVMQAN
LMTELYLSIQPVLFGHGIPLFDQELNTKLELLDTTTEAT
>AIA15126.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAQRKTARVAVLGGGNSPEREVSLRSARAVSAALSQAGYEVSELDPSHYDTDSLIAQLAG
FDVVFPVLHGKGGEDGTVQALLESIGMPFVGAGADVSALCFDKTAYKAHLQELGLSLPFG
VVVDRNTVWSQELTKSPFVLKPYDGGSSVDTFIIRDPQACDRAAIEDALDRHHTMLLEEL
IIGTEITVGVVGEEALPVIEIIPPADQEFDYENKYNGQTQELCPPQHVEESVQITARQLA
AHIHTRLNIRDFSRTDLMIRQGDDRLFILETNTIPGMTDQSLLPKAAKTAGYDMAVLCDR
LVSAALERK
>AIA15111.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSPVAPAPPIIALVVAIAENGAIGRGGDLPWRLSSDLRYFRKVTMGKPVIMGRRTFKSLP
RVLDGRLNIVLTRDRGFVAEGAVMAHNLEEALDVARASAARTGADEIMVIGGEDVFHAVL
PKAQRIYLTEVHAKPHADTWFPPFDITE
>AIA15101.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVAQAAGRVIGKSNDLPWYLPADLKRFRILTTGHRVVMGRKTYESILARLGKPLPDREN
IVISRSLTAPGCVNVRSLDEALALGHDDEIFILGGASIYEQALPHTQRIYLTQVMAEIEG
DTFFPELKSSEWHEVSREDHPADDKNLYAYSFRVLERV
>AIA15087.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
SAGCRMMLTLVVAMAKNRAIGKDGQLPWRLPEDLKRFKQITLGHPIIMGRKTYESIGRLL
PGRENIILSRQSGFVVPGAVIARSLDESIRHCEAKGIDEAFVIGGAEIYTQAMKRAQRIH
LTEIHHEVEGGDAFFPEIDPEAFREVSREERMEPFPHSFVLLEKK
>AIA15072.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MKLTITLSHVVACTENGVIGRDGGMPWHLPDELKRFKATTVGKVLIMGRKTFESIGRPLP
GRYTIVVSRSREMLPRIVTPATSLEEAMTHAREMAPGWLNEICVVGGGEIYRQTLAMVDK
IYLTRIHQEIDGDTTYPLEGLKDFECIQSEEVTASAIPYAATIWVRRKAE
>AIA15066.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKIAVALVALMSLTTAVEAQTAKDLLETFKVKWNTPTEPFKMIGNVYYVGTDGLASY
LITSPQGHILVDTVMPESTSQIKASIEKLGFKVADIKYLLNTHAHIDHTGGLAELKQASG
GKLVAGDADKSLLEGGYYPGAEDDTALAFPPVKVDRTVREGDTVTVGDVTLTARETPGHS
PGCTSWAFSVKDGDATRSVLIFCSGTVALNRLGADPSYSGIVADYRKTFARAKDMKVDVL
LAPHPEMYKMAEKRAKLAEGAPNPFVNPGEFNAHAATLEKAFEDALAKQTADAQEKKG
>AIA15064.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MLHHLSFAVRDLERAASFYDAVLAPLGFVRVWSDNTAVGYGYPGGGDKLALKLVPEGIVI
PGPGFHLAFAAQAHEQVDRFHAAALEHGGRDNGPPGLRPAYGPHYYAAFVIDPDGYRIEA
VLNTAG
>AIA15007.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLIAAVSKNSVIGKNNDLPWKLPDDMKYFMETTRQHAVIMGRKNFDSLPPKFKPLKD
RLNIVLTRNQSVPGDHDIRVVGSIDEAFQQAPQGEEVFVIGGAEIFKQTLSRADRLYITE
IDAVVDGDVYFPEY
>AIA14984.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MAIDEQAPAQQRATGEQFVSDRVNNVPPSGIRKFFDIVATMKDVISLGIGEPDFVSPEPI
LNAGIDSLKAGHTAYTSNSGILELRELLSKHIERLYKVHYDPEREILVTVGVSEALLLAF
MATLEPGSEVIVPEPCFVAYQPTVVFAGGVPVPVPTYVSQDFQVTVEDLEKARTPRTRAI
LLGYPNNPTGAVLERSRLEEIAAWAVKHDLLVVSDEIYDRLVYDIDHTCVSSLPGMWERT
ILLGGFSKSHAMTGWRIGYVAAPPALLAAMRKIHQYIIMSAPTTGQEAAIEALKSGEPFV
ESMRQEYDRRRRLIVDGFNRLGLKCFEPRGAFYAFPSIESTGLSDEEFCDRLLMEEKVAV
VPGSAFGMSGTGHVRASYATAYERIEEALVRIERFLNKLK
>AIA14961.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSDFTLRKAMPGDESIIQALLKELAEYEKLQDRFHLTQSAITRDMFGDACHCELAFQDDI
PAGIVTWFWTYKSFRAVRGLFVEDLYVKPEFRGRGLGSRFFAHLAARARQANGFMEWQVL
DWNTPSIEFYKSLGAGLSPEWITCRLEGEALEKLS
>AIA14957.1|FEATURES|farme|beta_lactam|carB6|antibiotic inactivation|1
MIVPFLLASSAECTAKVLSAPGLKSVIESFEKNLGGRVGVALLDVRNASGWYYRADERFP
MASTSKALVCALLLKSGPAALTKKVKVLESDILEYAPVSKTLTGQYVTASDLCAATMRTS
DNTAVNKILDTLGGPKAVTAFLRQIGNTSTRLDRNEPTLNEGRPGDVRDTTTPRAMAKTL
QELIFGDTLNQQARSTLINWLKGNEVGGPLLRAGLPNDWQIADRTGAGGFGTRGVVAAVW
PTERSPVVIVIYLTNTKASMDQRNAAIARIGREIAATLKQQ
>AIA14870.1|FEATURES|farme|aminoglycoside|N184_17645|antibiotic inactivation|0
MITVRPMQRGEGAALLSMVRALAESHNLLHTVLATPEMFETAMFSEAPIVGTLMAEYDGR
LAGCAVWHRSFSTNRGAEVMYLEDLSVLPEFRRRGVARALLKAVARLALAKNYPSIYWLM
MDWNKEASALYQSIGAEIEPGTTFCRIRDDALKALAA
>AIA14863.1|FEATURES|farme|aminoglycoside|AAT_like|antibiotic inactivation|0
MKARYKGIVDRYAGLIRSAQIPAGTRLPTHRTLAAREHISLATATRVYAELEKMGLVSGE
TGRGTFVREILLPSGQGIDQHAVATDVLDLNFNYPALPGQGELLREALRQVASGGDIESH
LRYQPHAGRQTEREIIAAHLAGAHFQPTGDNVLIVNGAQHGLTITVMGLLRPGDVVAVDA
LTYPGFKALAALYHLELLAIPCTENGPDLAALRQLCQRRHVRAVYTMPTLHNPLGWVLSR
EQRRTLADIARQHDLLIIEDTAYGWLIRRPPPPVASFAPERTVYVTGFSKNVATGLRGRC
SDLPTRSAPGAGAGYPGHHLEYPVGHDRHGVSLDPGRHRGPV
>AIA14826.1|FEATURES|farme|chloramphenicol|catA15|antibiotic inactivation|1
MIFNPIVIDNWSRKPYFEHYLNNVRCTYSMTANIDITRLLSELKKKGIKLYPALIHMITT
VVNRHSEFRTCFDSEGRLGYWDSLSPSFTIFHDDDKTFSSIWTLYGEEFNDFYSRYLDDM
KMYRSVKQFAAKANEPPNTFPISSIPWVSFTGFNLNVYNEGTYLLPIFTMGKYFHHDEKI
LLPLSGQFHHAVCDGYHAGLLYNELQLRADTCKEWLPNN
>AIA14810.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQTTILFGGSNKERLVSVASAQALNAALPEADLWFWDADDTIYATKPEALRAHARPFEE
PFTAYETRVGTLAEALDRAASDGRVLVLGLHGGRAENGELQAMCELRGVAFTGTGSAGSH
LAFDKIAAKRFAALAGVAAPAGVSLADIDRAFAEYGRLIAKPARDGSSYGLIFVNAKQDL
VAVRSAAKTEDYVIEPFVSGIEATCGVLERSDGTVIALPPIEIVPAEGAFDYTAKYLLKS
TQEICPGRFSPDVTAAIMDHALRAHRALSCRGYSRTDFIVSGKGPVYLETNTLPGLTAAS
LYPKALKAQGIGFADFLRDQIVLAERAVRPA
>AIA14807.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSKVDKAEDLKEALTTAFKYADEVMVEQYVKGKSLTVGVVEVNGQPKVTPILELRPTKSE
WYDLEAKYTEGGTEFIMPAELPDTVTTVIQDATLRAHLAAGCRGMSRIDFVVDAQNRFYI
LEINTIPGMTPLSDLPAQAKAMGIDYDQLVECILMTAVN
>AIA14771.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNNPKISIIAALSKNYVIGKDNKIPWNIPSDVKRFREITKNHVIIMGRKTYESIGKPLPH
RTNIVVTSNPNYQAEGTIVCHSLNEAIDIAKEIEEDEIFIIGGGKIYEEVLPITDKLYLT
IVDTQVEGDASFPHYDQFKNITLQEEHEENNYKFTYLNLEK
>AIA14757.1|FEATURES|farme|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MKVTSQAELVAQLRALGIREGGVLLAHSSFRAVRPVEGGPLGLIAALRAALGPEGTLAMP
SATGDDDLPFDPTTTANREDLGIVPSLFWQQPGVVRSAHFDAVAAVGPMAEWITGGPFVV
PPAAPGSAIDRIREAAGQILLLGVGHDANTMLHLAELMGGAPYRSDYHYTRADGVRVDYG
ENDSCCEKFALADDWLRAEGLQREGRIGNAHARLIEAEDLIRVAVPRLRADPLVFLHGAD
QGCEECGEARESLSR
>AIA14742.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
LYREMSSCTSRIKLLLPEPGIGRGYSMAATGRLGDMDAMIEAKGLKRTYTARGKSIEAVR
GIDLTVQKGEIVGFLGPNGAGKTTTLKMLATLLEPTGGKATVAGSDLRTDAVGVRRKIGY
VSQAGSTSPEARAGEEIMSHAELYGIDRATARKRGEKLLAALDLSDVWDRACGSLSGGQK
RRLDIVMGLIHEPTLVFLDEPSTGLDPQSRANLWKHIRSLRDELGTTVFLTTHYMDEADS
LSDRILIIDNGTIVAEGTPAELKKRVSGDAITLTLRHEEDARRAGEIAAGLEGADTPKTE
AHVVRLHVPDGGRALPVLLAELTRSDIDAIGVDVNRPTLDDVFLTLTGRSLRD
>AIA14737.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MNVLVLAGGSSSEREVSLRSGANIEQSLRGLGHMVVTADPSGPDFNLKQLIAGIDAVFPI
LHGAGGEDGVLQEELEKLDVPFLGSGSKSSKLAFDKFAHKKLLVEKGILTPGWEMVDDRS
FSGSQLARQPYVLKPFDGGSSVDTFIVRDPTNPPSGINRALEGHGKMLIEELIEGNELTV
GVLGDESLPAILIVPPEGEEFDYENKYNGKTKEIVNPDTVSTNLQQQAQALALRVHQITG
CRHFSRTDFMLSQSNQVYVLEINTIPGMTSESLFPKAAAAAGHDMNALTKKLLELTLAS
>AIA14721.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MATFDGVYQRLLTDIMSNGIREVNQRTGHETAGLPGVSFSIDVEKDGFPLLALRKIPTKI
FIAEQIWFISGARKPEVFLRDFTKIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGMLVSLL
QKDPSSRHGVVVTWDPSSDGLGGANKANIPCPYTFTVNIMGGRLNMMNVVRSNDVILGLP
HDVAGFCLLQLVLAQKLGVQPGVYTHTIANAHVYDIHYDAAQEMTKRTPDSPKITLQLPE
NAYARAEAKDVSLVEDINGPLVAQYHPGEAIKGLRIVL
>AIA14700.1|FEATURES|farme|chloramphenicol|catB|antibiotic inactivation|1
MAVHFKPIEISQWNRREYFEHYLNQVPCSYSMVLNLDLTALLKEIKKRDIKLYPTMIYLL
STVVNGHEEFRTAIDKDAGVGVFDFLHPSYTIFQNPTETFTNIWTEYNRSFLEFYRQYES
DVKDYGATKGFMGKPDTPSNVFTISSIPWVSFTGFNLNLPKSTDYLLPIFTTGKYFYEND
KTWLPIAIQVHHSVCDGFHLARFVSELQEAMNTFHMN
>AIA14696.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
AKLMRTTILFGGTNKERLVSVASAQALHQALPDADLWFWDADGTVHETRSEALLKHARPF
EDAFKPGTPGIGPIEQALDQARAQDRVLVLGLHGGSAENGELQAMCEMRGIPFTGSGSAC
SHLAFDKIAAKRFAEIAGVKGPPGVALHDIEGALAQHGRLIAKPIRDGSSYGLLFVNSTQ
DLVAVRLAAKTEDYLIEPFIAGTEATCGVLEQLDGSLIALPPIEIIPAEGPFDYVAKYLA
KATQEICPGRFTPEISRQLMEQSLKAHRALSCGGYSRSDFIITDKGPVYLETNTLPGLTK
ASLYPKALKAQGIDFADFLKDQITLAARRARK
>AIA14687.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRIGIFFGGPSREREISFAGGKTAFEYLDKSLFEPVPVFVDSFGRFILLQKELMYSTEIR
EFYPAPAHQKGGFKTYIESFPELANESVPPSIGTLISPEQFAEHFDFAFLAMHGPDCEDG
AIQGLLEWYKIPYSGPGLMGSAVGIDKILQNDMIALVNGQDKKSWTLKYSQWVPREYPLL
FQVLKKHLGLPLVIKAPHQGSSIGVAIVKEDSLDEFVSAVNQCFFQIELTSATWKEFDQA
EKLAWGQKIANLDEGIGFPVIVGGKTIHHPSTLIDELESHFAAGNADALVSSANAEDQVL
VEEFVNGQEFSCGCIQFDDGSPLALPPSEVIKMVTVFDFNAKYKPGASRKRIPVDTTLEK
NQEIQQVIASVFQQLGIDVCARIDGFLTENGTILLHDPNTIPGMSPTSFIFKQMAEIGLN
VTHALTYLVRQSIRERIRTGKQTWRLRDLLAGLDDQITANNAVSKPTEQIVFGATDEEYI
QARLRYGKLNGEGKVKPVPVLKISESEYYKLPNPLMFKEYVADVEALLHTERHPLLTETS
EKAARLTAFYAGEVSYEVEAFSELSALG
>AIA14674.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MPNNPYVIEVENLTKSYGSNNVLKGIDLKVARGTMLALLGPNGAGKTTTVRILSTLLSFD
GGKVTVEGQLLTGRENLVMMGRLYRLTAESAKARAQELLEEFNLVDAAERPAKTYSGGMR
RRLDLAVSLIATPPIIFLDEPTTGLDPRSRIAMWEIIKRLMANGTTILLTTQYLEEADQL
ADRIVVIDGGKVIAEGTANELKSKVGNDRLELTFKTEKERTEAGKVLGKTVVSTDEKENS
VTVVIKDTNTDVKDALEALAKKRILVQSMAIHKPTLDDVFLSLTGKQKQPSTEGEEA
>AIA14662.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|0
MKTTILFGGTSRERLVSVASAQALTQALPEADLWFWDLDGTVHVASQAVLLGHEKPFEVP
FKADSVTLGSMEAALDVAATEDRILVLGLHGGTAENGQFQVLAEARGVPFTGSGSAASHL
AFDKTAAKLFAGLA
>AIA14637.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MRARCPVIEIRAPEGNYDYQHKYFGDETKYLCPAPLDQALTLRIQDLAVKAFNSLGCRGW
SRVDFMLRSADNEPFLLEINTSPGMTGHSLVPMSASESGMSYEDLCVKILRSAALDLKPS
ADRKPV
>AIA14543.1|FEATURES|farme|beta_lactam|PMI41_04644|antibiotic inactivation|1
MKRKIATALAGSLLITGVSATLSHAADDANRIKSLVDAAIRPVMDKNAIPGMAVGVIADG
KSYIFEYGVASKDTGTAVTPSTIFEIGSISKTFVVTLATYAQANGQISLSDPASNYLPAF
RGTEFGKIPLLHLGTHTPGGFPLQVPDNVKNDDQMITYLKNWKPAYKLGTTRTYANPSIG
MLGVITAKAMNKDFTSLMEGTLFPGLGLASTYIDVPKSKMKDYAQGYTSKDKPARVNKAV
LSSEAYGVKTTAPDMVRFMQANMNMVKLESKLQQAIADTHKGYFKVGAMTQDLLWEQYSY
PVSLSALRLGNSREISSKPVPVKQINPPTEPRSDVWINKTGSTNGFGAYVAFVPEKKIGI
VILANKYYPNEERINAAYEVLTKLDSK
>AIA14540.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
MKVDRALHDGDVVALGDVRMTAVLTPGHTKGCTTWTVMSADNGAPRQVVFPCSITVAGNI
LVGNKSYPGIVEDFRDSFERLGSMEADVVLTAHPEFADVFQRKARRDAGDKDAFVDKDLL
HRMVEKARTAFDRNLKAAQE
>AIA14533.1|FEATURES|farme|tetracenomycin|tcmA|antibiotic efflux|1
MQNVHGYSPVQAGVRLLPLSISMMVGSPLGGVLTEKFGPRPPLVAGLALLGAALLLMTGL
EPDSGYGALWPPLLMVGLGLGFVITASAEAIVGNAPVDDAGVASGLQSTAIQVGGVMGTA
ILGSILSSQVGTVLYEKLTNAGVPDAVAKQLEGREGAGRPGPGPGPRRPRQPPERRRHRQ
PRSLHGGPPHPSMLVGGVLALLAAAAALFVQRTENPGTATATV
>AIA14507.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MINYPCNPTGTVMTEQDWLPIVELIIKHNLVVISDEVYAELTYGRKHVSIASLPGMKERT
IVISGFSKAFAMTGWRVGYACGPHELIAGMLKIHQYTAMCAPTIAQIAALESLRHGLAAK
DEMMASYNERRKLFVAGLNAIGLACHEPEGAFYAFPSIASTGMSSEQFARRLLEEAKVAV
VG
>AIA14508.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MFSEEGIGQFLSSRVRDIRPSGIRAFFDLNAAGGDTIALGVGEPDFVTPEKVREACIQAL
REGQTKYTSNAGLMELREELSAYFASSFALSYDPEQEIIVTVGSSEAVDLALRAVINQGD
EVLIPAPSYIAYEPITHLHGGKIVEVAATAEEQFKLTPQVLQAAITPHSRL
>AIA14501.1|FEATURES|farme|chloramphenicol|catA15|antibiotic inactivation|1
MIFNPIDLDTWSRKPYFDHYVNNVRCTYSMTANIDITRLLEAIKKKGIKLYPALIHMITT
VVNRHREFRTCLDSRNRLGYWDSMSPSFTIFHDDDKTFSSVWTPYCEDYKEFYRRYLDDM
EKYGCVKQFTAKTNEPPNTFPVSSIPWVSFTGFNLNVYTEGTYFLPIFTMGKYFKQDEKI
LLPLSVQLHHAVCDGYHAGLMFNELQARADTCKEWLPN
>AIA14470.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSMIVAASEKGVIGKDGTMPWRLPAESAYFREVTLGHPVITGRKNYEAMGRPLPGRLN
IVITRQTDYEVPKGVIVVHSLAEALKLPQVQSEQEVFIIGGAEIYQQAMPLADKLYLTTV
HAQIDGNTFFKYDPGQWQLEWSQHHPADAENKYSFTLQRFQRIQ
>AIA14447.1|FEATURES|farme|beta_lactam|OXA-129|antibiotic inactivation|1
MKQWENDFTLRGAVQNSVVPIFQQFARDIGERRMSSYLHKFHYGNEAVEGGIDHFWLDGA
LRISATQQVQFLQRLNLGQLPASKINQLRVKDILISDATPDYVIHGKTGYSLGAPGYGDR
NAPGVAWWVGWIEKGTATWYFAGNIDVTRDTDVAARKSIPLKILQGRGILP
>AIA14425.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGKNRVIGRDGGLPWRLSSDMKRFKALTMGKPIVMGRKTWDSLGRPLPGRPHVVVTRNAD
FSAEGVERAESLDAAIERAATLAQESGADEICIIGGGEIYAQAMEKADSLHVTHVEIEPE
GDTVFPEIDPATWECIDDERLPAGEKDSHATRYAVYRRRRAV
>AIA14422.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
VIGADNSIPWRVSEDMAYFKRVTMGHPVIMGRRTWDSIPSKFRPFSGRRNIVVTRDPQWH
AEGAEVVRSLDDALALPDGDVFVVGGGQIYSAALPFATHLLVTEIDLDIAGDAFAPEIGP
EWNLKSDEPWQTSEKSGLRFRWLEYTR
>AIA14409.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|1
MFAAFMDLLDVTIVNVALPAIRSDLDASPAHLEWILGGYTLTFAVLLITGGRLGDIFGRQ
RIFVIGVAGFTIASLAACLSGNGDTLVAARVVQGGFAALMVPQLLSTVQVMYAPKERANV
FGIVGAVSGTAAVVGPLLGGWLITSDAFGVGWRSIFLINIPVGIVLIVLALRYVPNTVSE
RATRLDLPGVVLATAGVFLLVFPLIEGP
>AIA14386.1|FEATURES|farme|beta_lactam|blaA|antibiotic inactivation|1
YKKINIMKFLSFILILVCAQHIFANKYPSARKQLNKLEHSLDGKIGIFAMNTANQQTIHY
RSKERFPIQSTFKLMVVAAILKKSATDPELLQKKIFYTKNDLVTWSPITEKRIDSGMSIL
ELCDATMKYSDNTATNLLMKQVGGPAVITDFAHSLGDSVFNVLHYEAELNSNPNSTDDTS
TPENMGINLKKIAFNPILPSSYIHLLLNWMKENTTGDAQIRAGVPKEWVVADKTGSSSFG
TSNDIGIIWPTGCDPIIIAIYTVQNKEDATKRNDILKDATRTVINEFARADLCIKQALKN
EKA
>AIA14342.1|FEATURES|farme|beta_lactam|BL2a_III2|antibiotic inactivation|1
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSEPPKQTKQIKQIKQENTGHDSFAKLE
KEYNAKLGIYALDTGTNQTIAYHSNDRFAFASTSKSLAAGALLRQNSIEALDEGITYTRE
DLSNYNPITEKHVYTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLIADT
TKVVLDTLKVTNKN
>AIA14284.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MANTTFQTSALTAEKHSKFYWGVRDSLVLIKRSITHIVRSMDQLLGVILQPIMFMLLFRY
VFGGAIEVKGTEYVNFLTVGVIIQAAAFGATTTAIGICNDLQRGIVDRFRSLPMLSWTVL
NGHVVADLVRNTLSTVVMILVALLVGFRPTADFLGWVGAFGILLLFTLAISWLSAILGII
SKSVEGVQWFSFVAIFPLTFASSAFVPTEGMVTPLKVFAENQPVTHVIEAIRALLIGTPA
SDHIWLAAIWCTGILIISIPLAAWLFRRKANN
>AIA14246.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISLVAAVAQNGIIGKKNDLPWRLPDDMKFFMETTKGHVVILGRKNYESLPPKFQPLPG
RTNIIVSRQENYEAPGSFVVNSIKKALEIAIESGETEAMVIGGSEIYALSLEYADRLYIT
EVLADVDGDVSFPPYNKKEWKEISRLHHEADQRHVYAFDFVVYERIEENLKYGDIDK
>AIA14153.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTTPTVAQELGKVGVLYGGRSAEREVSLMSGEGVLAALRSRGVDAHGFDPARQNLAQLAE
QAYDRVFIALHGRYGEDGTLQGALEQLGIPYTGPGVMACALSMDKTMSKRVWMSHGLPTP
RFMVLEKDANPAQLDAVASEL
>AIA14091.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLIKHVLDNGTKKGDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTSIKYLKERGVNIWNEWADESGDLGPVYGAQWRTGGACDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVSDLNPGEFVHTLGDAHLYSNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA14089.1|FEATURES|farme|aminoglycoside|APH(9)-Ib|antibiotic inactivation|0
MGRGAKLSNLARAIYVVWTLFSFALYVYLDSKGWLGGSKQGRETRLRRQAARLRGRLIAL
GPTFIKMGQMLATRADLLPLEYIDELSELQDRVPAFPDEQAFRIIESELNRPLEDVFAQV
GERPIASASLGQVYHARLVTGEDVAVKVQRPHLDEHIRFDLELLRRIGRFLDRYPKLFPG
AEWLGAVEEFDRVIHEELDYRREAANADEFRRNFASWPTIHVPRMFNDYSTGRVLVMEFI
SGTKVTDLEGLRLAGHDARRINELIYRAYFKQLLEDGFFHADPHPGNLLVMADGRLAVFD
FGMVGRISEELQRRMIEDGI
>AIA14082.1|FEATURES|farme|beta_lactam|bla|antibiotic inactivation|1
MMKLLAITFLLLVSITETVAQAQDLSPFFKDTKGAFVLYDLKNNRYLRFNEARCRERFSP
KSTFKIPNSLIGLDTGVIQDADFVIAWNREKYPPQDNWDQEPFKHWGQDQTLRSAIKYSV
VWYYQELALLVGEKRMKKYVTALNYGNQNVSGGITQFWLNGGLKISADEEVEFLKALYAN
RLPVSKRSTDIVKDILVLEKAPTYTLSGKTGGGSIAAGTYIGWFVGYLETNGNVYFFATN
IEGPSFAAVREKRIDVTRQVLSYLGYLPK
>AIA14057.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKKLVLLIVLLSLSIACSRIMSKRDEFRDKVSEFQEPKIEDQELADLTALIEKTAAPAKG
RVGVFAVVLETGESVDLDPDGQYPMQSVFKLPISMAVLRQVEEGKLKLDQKVKVEKADYV
RIGMRSPLRDKNPNGAEVTVEELIRLSIVESDGSASDVLTRLAGGAGEIQAYLTGINIGE
MIVANTEKEIGQDWETQYRNWASPEGAAALLRALHEKRGISEPHQKLVLKFMVESVPGAK
RLKGMLPAGTQVAHKTGTSGTNKDGITAATNDIGIITLPNGKHLAIAVFVSDSPADEATR
EGVIAGIAKACWDTWSK
>AIA14036.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTTTHPEYQYLDLIRRIIEKGFYRPSPHAPLPGKGANPGTYTLINQNMEFDLSTGQFPLM
TLRQAFFKSILKELLWFLSGSTDNADLKAMKAGLWHPWDTPDTNQSIGWAPGQLGPIYGK
QWRHWRATMSRPDGTLDSPGFDQITNLVEGIKSAPHSKRLFVSSYDPQDAKDCFVTTCHG
TFFVSVFDDRLNLHQIQRSGDVPVGIPYNIASYSLLIYMLAQV
>AIA13983.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MIPAIKKAWFYTFCLLLLTLGCTSVNSSNREDTPNNETSAPSGITISNADRTNELRDRIE
QISQAARGRVGVTATVLETGESVTLNGDRQFPMQSVYKFPIAMAVLAQVDQGKLKLDRKI
RVETSDVLQGSRILDEKSQGMEFSLAELLKYMVSESDGTSCNVLLRQVGEPRIVTEYLRS
LGINDIVVANTEKELAQDPAVKYRNYATPDATVVLLRAFHEGKGLSKSSQALLLQLMTET
TTGPQRIKGLLPDGTVVAHKTGTSSTVNGVTAATNDVGLVTLPNGRHMAIAVFVSDSGAN
NATREGVIAKVTKAAWDEWSK
>AIA13798.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MPNYKPVSERTPDTQYRDILKHIYDNGEYGTTRQGPRAKTIIGVQAHYQIANGFPMIPDR
DLSKFYAKPIDELAAFINGVRTREGLEEYGVTWWDAWTTPEKSQKRGLEPGDIGPGSYGA
AFHDFPTADGGAFDQFKHLVEQMKELPELRTHFVTPWVPQYIVRGEGKQQKVTLAPCHGW
VHVRIYNNAIHLHMFQRSADWPVGVPSNMVQYGALGLVLEHLTGYEFKEFVHTASDAHIY
EDQMEKLPPLFDREPKPFPTMQLNAEGKKIKDIHEFRSHHFELTDYDPHPSIGRLPVAT
>AIA13785.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGLNLIRAITTIDEQGGIAAAGYPPYDLPWNIPADMHYFKEQTMSSTIVMGRGTYETFLK
PLPGRRNIVVSKNLNSVTNGFELIDDLPSFLSEAAVDIWIIGGAKLYTSALQYCEELYIT
HINGSYGCDRFFPSYADNFELFKTSRPQVDNGYEFRYAVYVKNR
>AIA13710.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVTLEFEKKPAVLLRVIDSWIMIKRSSTHIIRNKDQLLGAFFQPIMFLVLFAAVFGGAV
KASLPHGVNYLDFLMAGIIVQTVAFGSTTTAVAICNDLQKGIVDRFRSLPMSNLAVLNGH
VVSDLLRNTISTVVMIVTGLVIGFRSDASFFSWILITAILLLFTFAFSWLMAIMGVYAKS
VEAVQWLTFVIIFPLTFASSAFVPASSMPHYLRIFAENQPITQVVEAVRMLMLDRPVGDY
VWHSVAWSIGMLLVGVPIALYLFRRKSAQ
>AIA13706.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
DLKFFKQQTTGHACVMGHRTWLSLAKPLPQRLNIILSRASEVSPQPSVILLRDRLSVLSL
KPYLSCDLYIIGGAQVYSAFLADIDRWIVTEVPLAIEGAEAVMPEGFLDGFRATQSRQLE
DNLKATFYERS
>AIA13696.1|FEATURES|farme|macrolide-lincosamide-streptogramin|RlmA(II)|antibiotic target alteration|0
MAVSKKTFTTVDDDKLHQLLGKFVTDFGAAFHAGMVVIGMELGLYKDMANEGPTLPSELA
ERTGTNERYVREWLNSQAAGGYVEYDTDTGRYFLTAEQAFTLADETSPAYMPGAFLLAIS
ALRAVPKITERFRTGDGLGWHEHDSGLFRGTELFFRPGYAANLVSSWIPSLEGVEAKLKD
GAKVADVGCGLGASTILMAQAYPNSTFTGFDYHDASIEMAKERAREAGVSDRVNFEVAKA
KDYPGTGYHLVTFFDCLHDMGDPVGASAHVLESLAPDGAWMIVEPFAEDNVEGNINPIGR
AFYGASTLLCTPASLSQEVGLALGAQAGESKIREVVTEGGFTRFRRATQTPFNLVYEAKP
>AIA13568.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSITLIAAVASNGIIGKDNSLLWRLPADMAFFKSQTLGKPVLMGRKTFESLPSPLKDRTN
IILSRVMTSPPEGCVLVGSLAEAFERYGDQELMVIGGADIYAQAIDKADRLIITEIEQAF
DGDTSFPLIDSAKWKLVSRTPGVLDERNKLAHSFCVYERQ
>AIA13538.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
LASGQNGAPVSSCANCPEWNKPQKPFRVYGNTYYVGPHGLSSILITSRAGHILIDSALPE
SVPQVVANIRSLGFRIEDVKLIVNSHVHFDHGGGIAELQRLSGAEVAASPWSVEVLTKTG
VGKADPQFGSVLPVALIQRATTLRDGQTLRIGDIKLTAHFTPGHTPGGTSWTWESCEGKR
CLSLVYADSMTPVSSDGFGFTDSRESPTAVQDFEKSFSFLRATPCDILLTSHPDASGLWQ
RLEGRQGGVRPDPLVSPNACKELAGRASEQLRRRLESEKAR
>AIA13518.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFG
IAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIE
ILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKE
EYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDN
IRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVAIQIKMKSWTKGRIALVGDSG
YCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINET
FLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK
>AIA13507.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MNTTNPHEKRKLIRISMRVIINLVVALMLPGVAGCNRAPSAAQSTTTQQASAVRSDSADR
ELTEQLRSLCDAVAGDIGVAVVHVESGKTVAVAGDKKLPLYSVYKLPLAMTVLRDVEAGK
LRLDQKVKVTPADVAGTLFNTDLWRSAQEKTVRELIEYAIVRSDNTSADKLLGLIGGPPI
VTQEMRTIGLANIDVVVSSREFTAHRDKPNTGTTTDLAQLLARLQKGELLQPANFSLLRD
YMERAKTGGERRLRANLPAGTQVADKTGTGDVATNDVGLITLPENKGHLAIAVLISGSKL
PVDKQEKTIADIARGLRLVRFPACATLITISTCR
>AIA13495.1|FEATURES|farme|aminoglycoside|ASE98_04520|antibiotic inactivation|0
MQPYEITSDKSRMSVEAAHAFLSQAYWARGVPISTVRKAFDNSICFATLAGSEQIGFARV
VTDKATFAYLSDVYVLPAHRGKGVAKRMVEAIQRHPELQGLRRFMLATRDAHDLYAKFGF
APLSAPGMFMELHNPDAYAQD
>AIA13491.1|FEATURES|farme|multidrug|emrB|antibiotic efflux|0
MVPPTSDVRDALPLIFVPIMAASYDGIEPSKTDQASALINAARNTGGSIGVSIVSNVLTH
REQFHQSRLVEQVIPSSTTYQDAPQQITNYFTAHGSSLAQAHDQAIQWIGQQVQSQASFL
GYMDAFWVLMLISLSAVPLALALRNVKLGGPVHMGH
>AIA13455.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MDHTCVASLPGMWERTVLLGGFSKSHAMTGWRIGYTAAPPAILAAMRKVHQYIIMSAPTT
GQEAAIEALKSGEPFVESMRQEYDRRRRLIVDGFNRLGLKCFEPRGAFYAFPSIESTGLS
DEEFCDRLLMEEKVAVVPGSAFGMSGTGHVRASYATAYERIEEALVRIERFLNKLK
>AIA13432.1|FEATURES|farme|aminoglycoside|Y886_30125|antibiotic inactivation|0
MPLLLEIQQLAAQTDGTTTASPTDFAAWLSNPALEAAHNVFVVTDDDETNTWGQGDTLEG
IEGEIIGYTALTLHQDERAYHFLCQGAVSPQYRRQNAGRALLICALNRARICAAEFEFEA
EQEGKPLYLEALLPLADAASSRLAAKCDMQPADEPAPAGMQLYRRELYD
>AIA13385.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIAAMAQNRVIGKDNDLPWRLPDDMKFFMQKTKGHYVIMGRKNYDSLNAKFKPLPN
RTNIVVTRQQNFQAPGCIIVNSVEKGIDIARENKEQEAFIIGGAEIYKIALPVADRIYLT
EIHAEVKGDTFFPSFSRAEWGEVSRQPHPSDDKHQFSFDFVVYDKIH
>AIA13376.1|FEATURES|farme|beta_lactam|OXA-129|antibiotic inactivation|1
MTLALRAFVLLIAFLSMSAAEAAAQNLDRVFGNTKGAFVLYDMKSNRYVRHNPGRARLRF
TPASTFKITNSLIGLETGVVRDADFRISWDRQRYPNEDRPNTAPFIHWWQDHTLRSAIKY
SVVWYYIEIARNVGAERMQKYVRQFRYGNGDTSGGIEQFWRNSSLQISAEEQVDFLRRFY
TGKLPVSSRSTGIVKDILLLEETPSYRLSGKTGAAPFEGGTLAWFVGYLEREGNVYFFAL
NMDGANYEAIRDERINLTKRILVELGYLPRRY
>AIA13354.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|0
AALRDKHPARLALPSGTNESAPLPQQARALIVVPGTSPEHFRIPVEAAQFLHSKLPDSSA
IIDYSTLFSYALDNGLHNQYVVECLYGTEAIEWDEPIWRGAMDALGLRRVGSPIITCALA
IDKLIQKRLFDALEVPTASWSLCSATSEALRLGWPMIVKPRRESQSKGVALLHDAREWEQ
FLKIVPVAELDCWLAESYLPGREFCVGVCSLSESQHEVLPILEIPHDAGHSINDPEDKAQ
RRGVVSFPEELPARLKSALETETLKVHRAFGSPPLARAEWRLDADGIPHIFEYDCTPGLT
RSSYLTSMFEKTGRSVSDVLADLARSPQFRACRPAHASDSQPAA
>AIA13348.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|0
MKVFIIAAMTADGFIAKNEHQHIDWTSKEDKKFFVDMTKESGVMVMGGNTYRTFKKPLPG
RRHIVYTHGEVEGEAFEKTLEPPKDLVKRLRSEGYDNIAVIGGSSIYSMFLKAGVLTDIY
LTVEPLFFGKGIKLLSDEFGGVELKLNNVKKINDNTILIHYEV
>AIA13288.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKIVVAFVALLSLAGTVQAQTVKDLLETLKVKWNTPTEPFKMIGNVYYVGTDGLASY
LITSPQGHILVDTVMPEATSQIKANIEKLGFKVTDIKYLVNTHAHIDHTGGLAEMKQASG
AQMVAGEADKPLLEGGYYPGAQEDTALAFPPVKVDRTVREGDTVTVGDVTLTAHETPGHS
PGCTSWAFSVKDGDATRSVLIFCSGTVALNRLVANPTYSGIVTDYRKTFARAKDMKVDVL
LAPHPEMYRMQDKRAMLSDGAPNPFVNPGEFNAYAATLEKAFDDALAKQTAAAQAKKG
>AIA13266.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MISLIAAIGANRAIGKDNRLLWDLPQDRRRFWVLTKERPVIMGRKTWESKLAFDGKPFGS
GRTNIVVTSQESVGYPGAVVCKTVEEALAAALKINQYPYVIGGENIYLDALRHAEQIHLT
LVDDAPDAHAFFPYFENLFEEDAREEDAPMRAVRKEGAVSYRWAVFKRRRVPL
>AIA13260.1|FEATURES|farme|aminoglycoside|sat-3|antibiotic inactivation|0
MENINIKKATLKDIDQLHKISRQTFFETFSAGNTEENMKKYLDEVFSVEKLTDELNNENS
TFYFAELDNNIIGYLKLNSGQSQTELKDDKALEIERIYVLQEFHGKKVGQLLYEKAMQIA
RQTNADYVWLGVWEENARAINFYKKNGFVEFDKHIFKLGNDEQTDIMMRLRLI
>AIA13250.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNVFIIAALTADGFIAKTSDHGADWTSAEDKKLFVQLTKEAGVMVMGSKTFATIGKALPG
RRNIIYTSRPETITAEGVETTAEDPKELLQRLEREGAQGVAIIGGATIYAMFLKAGLVND
LYLTIEPLLFGSGVSLADSDLSASLKLKEVQQLNENAVLLHYTVVN
>AIA13166.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MSRSSGDDITELITSVRSSQKYAAISGAMIRSIGLRELAARRNLKEAIKATKNKLHQVAG
AYLDARLPYDDWLALLEAAVADDRRTTNDDESLANSKLRQACREIMRHHASTRERLPILE
SFYASTLASLGPVRSVLDLACGLNPLALPWMPLAPDARYYACDVYADMIALFE
>AIA13138.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKRPGPNAATRLKPFRKKYIMTTNFLRIAVVLGLLSAIGPFAIDMYLPALPSIGADLQAS
TVAVQMSLLVFFLSMGFGQIVIGPLSDMYGRKALLYAGLVLFVAGSIGSALAPTIEWLIA
FRVLQGFGASPGMVVPRAVVRDLHTGNEAAKLMSMLMLVFSVSPILAPLAGSFIIDGFGW
RAVFWAVTIAAVLAVLLLATSLKETRPAEHRTGSSLGGAMAGYRYLMKDRNFLGLTLIGG
FGISSFFVYLSSSSFVLIDHYGLSPSVYSMFFSINAVAFFAMSQMTGMLAERFGLRRVVR
VAVVSYATVMVALLAVMASGMQSLAVLASLLFVGYGFLGLVIPTTSVLAMEEHGEIAGTA
SALMGTLHFATGAVAMAVSGIFFDGKPLPMVISIAACAVLAFVLTQLTLGRGREVAEAPA
E
>AIA13136.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTTSFFRNALILGLLTAIGPFAIDMYLPAMPSIGRELGAENSAVQLSLLAFFISFAIFQL
LYGPLSDMWGRKAPLYIGIGLFAVASIGCALAQDIETLVAFRFLQGIGGAAGMVIPRAIV
RDMHTGVQAARLMSLLMLVFSISPILAPLTGSAVIEFYGWRGVFWAVMIAAFIGLILLST
QLKETRPSAARAESGLGSAMSAYRLLLGDRNFLTLTFIGGLGISSFLVYLANSPFVLIDH
YGLTPTQYSIAFSINAVSFFAVSQLTGWLGDRFGLVRVMRMAVTAFALTMAAMVVVMSLG
INQLPVMAAFLFVGYGFLGLVIPTTSVLALEDHGEIAGTASALMGTLHFVTSAIAMVIAG
VFFDGTALPMAIGIALCAVGAFVLTQATIGRRRVVEAGAAAE
>AIA13133.1|FEATURES|farme|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|1
MLIYRRLTEADAEAMRQMNQMFGAAFKDTKTYRYDQGDDAYFQRILGKDHVIVLACFHAG
QVVGGLVAYVLDKLEMARSEIYIYDLAVDESHRRQGIATELINELKAIAAKTGAWVIFVQ
ADREDEPAIQLYEKLGVREEPLHFDINLEEGNG
>AIA13090.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MALNKKAALGFIFFTLLLDVTGLGIIVPVFPKLIGELIHSDVSTAARYGGWLTFAYAIMQ
FFFSPVLGNLSDKFGRRPVLLFSLLGFGIDYIFLSFAPTIGWLFVGRIIAGITGASFTTA
TAYIADISAPEDRAKNFGMVGAAFGLGFIIGPVVGGLLGQYGARVPFLAAAGLTFINLLY
GYFVLPESLPVEHRRPFEWKRANPFGAFKQLKKYPAVGALAISFFLVYMAAQAVQSVWAY
FGIERFAWSEKVIGISLGMVGLLVGLVQGVLIRYVNPRLGNTRSIYVGFGLYAVGLILFA
FANHGWMMFVFLVPYCLGGIAGPSLQSIITGHVPANEQGELQGALTSLISATSIISPPIM
TNLFAHFTSKSTSLYFPGAPYLLGAILMMAAGFVAYYVLSKEKEGKDYVVKVPGGIA
>AIA13069.1|FEATURES|farme|multidrug|arpA|antibiotic inactivation|0
MKPDDLTPAFGWTLARRAARMNPSVIREILKVTERPGIISFAGGLPSPLTFPVDAFAAAC
RKVLADDGPGALQYAASEGYAPLREAVAAWLPWPVDPAHVLITTGSQQGLDLVAKVLIDA
DSEVLVETPTYLGALQAFAPMEPQVIGVASDSEGIDMSDLRRRRGSARFLYVLPNFQNPT
GRTMSEPRRQALVNTARELALPIVEDNPYGDLWFDAPPPAPLAARNPEGTIYLGSFSKVL
APGLRLGYLVAPAALTPKLLQAKQAADLHSPSFNQRLVSEVLRDGFLDRHVPTIRALYRS
QRDAMLAALQREMQGLDVSWNAPDGGMFLWARLPAGMDAAALLPHAVERGVAFVPGAAFY
ADAADTRTLRLSFVTATPQQIDTGMAALAAAIRSALRRPS
>AIA13035.1|FEATURES|farme|beta_lactam|LRA-2|antibiotic inactivation|1
MRAAGWIDNKSTRVRQKIMAMRSRWSGQVKTGLAVLLGAGIAAGAAYAAAKSSCAECAAW
NAPHKPFKIYGDTYYVGTAELSAILITTEFGHVLIDGGLPESAPVIKANIETLGFKLKDV
KAIFNSHVHPDHAGGIAELQKESGADVYALRPAYEVLISGKPNADDPQAARKGGPGVPKV
ERAWVAQDDQQIGIAGVRMHVVATPGHTPGGTTWTWDACEGTKCLHMVYADSLSPVSADK
YRFSDHPEVLQGFEKSFARIASLPCDVLLTPHPSASQLFERLDLGKENTEAVRDPEGCKK
YVATARDALAKRLESEKTV
>AIA13031.1|FEATURES|farme|aminoglycoside|rmtD|antibiotic target alteration|0
MSVSKETLTTVNEDKLHQLLGKFVSDFGAAFHAGMVVIGMELGLYKDMANEGPTLPSELA
QRTGTNERYVREWLNSQAAGGYVEYDASTGRYSLSAEQAFTLADENSPAYMPGAFLLATS
ALKAVPELTKRFRTGEGFGWHEHDTGLFRGTELFFRPGYAANLVSSWIPSLEGVEAKLNN
GAKVADVGCGLGASTILMAQSFPNSTFTGFDYHDRSIELAKERATEAGISDRINFEVAKA
KDYPGNRL
>AIA12996.1|FEATURES|farme|beta_lactam|VEB-3|antibiotic inactivation|1
MTKILFTFFACTFLVGAVNVSELKKKLEHVDVSSVQSEVGIGVLDLSSGESWFLNGEQRF
PMQSVCKVPVAIAILKLVDDGALSLGQSVTINPEQYAPSWSPLRDELKGGSGQFTVRNLL
ERSVADSDNTAVDVLIELAGGAGKVDAILKAMGIRGVRVDRRERDLQTESQGLEDFRPEQ
ASTEQFDAVLAQVPEEKKRAAVRKFLSDPRDTATPEGMVHLLSQLYQNKLLSPSSTQLLL
QIMTDTPYGQYRLKAGLPPKWSLAHKTGTGPDVLGVNTGTNDAGLACAPAGQCFALTVFI
AGSKVPLQNREALMRDVAAAVTK
>AIA12957.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MKVFLVAAITADGFIGRDSGHLADWTSPEDKKLFVRLTKQAGTMVMGSKTFATIGRALPG
RKTIVYTSKPDEFNTEGVEATNESPIELVARLENEGVEALAVCGGASIYALFMSAGVVDE
LYLTVEPLLFGTGVPLFSDQLDCKLSLLELDKLNEHSVLLHYAVQKA
>AIA12914.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTRVGVIFGGRSGEHEISIRSAKTVIEQIDKDKYDVIPIAIGKNGNWLNPSDSVGLLPT
TSGEALGDAVDGYTQDSVVVAGDTSYKGLTRLGGSDDEERTLGLDVIFPVLHGTYGEDGT
LQGLLEMAGLPYVGGGVLASACGMDKVVMKTLFRDADLPICKYVWFLRSEWERGNDAVVR
QVESKLGYPCFVKPANLGSSVGVSRADNADSLKAAIELAAEYDRKIIVEEALDMREIECA
VMGNDEPEASLPGEYIIRDDAKKFLDYTEKYAGTGNNEFTVPAPISGELSDKIRKMAVNA
L
>AIA12913.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTEREKLPKKIAVLMGGPGSERKVSLATGRGVAKALRSLGAEVVDVDVRDENFQLPDNVD
LAFITIHGTFGEDGQIQKILERRGIAYTGEGVSASEIAFDKIRTKEKFREHGVTTPPWEV
IRTGERPTIPLPIVVKTPRQGSTVGVVIVKNESELESAINEASKYDRELLIEKFVAGREL
TIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQAGGGAEHVCPANIDARKTKEIQQLAL
RAFKAADLQVYGRVDVILSDSGEPFVLEINTIPGMTEASLLPEAAAAAGIGYVDLCARII
ALSGVRQGCREQAPARTEGKQ
>AIA12874.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTRKLNQRNEMMRTTILFGGTNKERLVSVASAQALHRALPEAELWFWDVADTVHEVASQK
LLGHARPFEDEFKPGNRGLPLEAALDKAKSEDRVLVLGLHGGRAENGELQAMCELCGIPF
TGSGSASSNLAFDKAAAKRFAAIAGVAAPADVGLENLDAAFAECGRLIAKPARDGSSYGL
IFVNAKQDLVAVRNAARTEEYLIEPFVAGVEATCGVLEQSDGTLLSLPPIEIVPGEGTFD
YAAKYLLKSTQEICPGRFSADISAQLQDQALRAHRALSCSGYSRTDFIVSAKGLVYLETN
TLPGLTAASLYPKALKAQGIEFSDFLRDQIALAERRNRDRI
>AIA12872.1|FEATURES|farme|beta_lactam|ampC_1|antibiotic inactivation|0
DPLRFEPGKGWSYSNAAFIVLGAVVEKVSGQNYFDYIREHIYKPAGMKDTDSYAADEVTP
NLAYGYTRFGGDDPLGIEPRRANFMSLPLKGSPAGGGYSTAPDLLRFAQALRGHKLLNAE
FTEKVTSAKVDTDFGAKYGYGFFDESVEGKVVRGHSGGAPGINSELKMFWDGSYTVIVMG
NYDPPAAQGLAGKIARFLARQ
>AIA12806.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MNKPLVVILAAVVLDSIGIGLIFPVLPALLRDVGHLSDVATLLGLMLALYSACQFLFSPV
LGVLSDRFGRRPVLLISLAGAAIDYLIMAFAPQLWMLVLGRAISGITSANMAVATAYITD
ISTEEERAKRFGLFHAMFGIGFIIGPVLGGLLGDIWVRAPFIAAATLNAFNFALALFVLP
ESRRGEAGARVDFETLNPFKPLAWAFTFAALIPMMAIFVIMNFVGTMYGTIWALFSEDSF
GWSGLMIGLSLGAFGVCHAGAQAFLTGPAVSKLGERWALIVGMACELTALLILGMATQGW
VLFALAPLFALGGVGMPALQSLVTAQVGPDKQGQLQGVLASLVSLAAVFGPLFFSFSYFA
VQGTWPGLIWMIGAAIYLLALPLMLGIKRRPATVPAGTI
>AIA12793.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKPMKTFIIAATTADGFIGQSAHHLSTRWTSHVDKVFFTETTKKAGVIVMGRSTFDTIGR
ALPGRRTIVLTTRPLDVEGVETTQESPKDLAERLAKEGCAQLAVCGGASVYAQFIDAGVV
DEIYLTVHPILFGVGVLLLSEPLTRQLTLIETKDIGDGTVLLHYAVKAE
>AIA12791.1|FEATURES|farme|aminoglycoside|ASE98_04520|antibiotic inactivation|0
MQPYEITSDKSRMSVEAAHAFLSQAYWARGVPVSTVRKAFDNSICFATLAGSEQIGFARV
VTDKATFAYLSDVYVLPAHRGKGVAKRMVEAIQRHPELQGLRRFMLATRDAHDLYAKFGF
APLSAPGMFMELHNPDAYAQD
>AIA12705.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MWATVSLSRGLWGKWENPAYVAKVLKELSLLDRKDSKLMTLSGGMKRRVLIAKALSHEPT
VLFLDEPTAGVDVELRKDMWEVIRQLRNSGVTIILTTHYIHEAEDMADRIGVISKGNLIL
VEDKAELMHKLGKKQLTLQLHDSLRAIPAELEGHHLRSPMAAASSSTPTTRTARAPASPD
FLPISASPGSGSRTWTRRKARSRTSSSIW
>AIA12670.1|FEATURES|farme|multidrug|hmrM|antibiotic efflux|0
FSTNDIGLSLGSSYFEKVYAKHMQETTDPTPDVAAPLPPSSNWQALKDAIRGTEADYTQI
GLKRAIFLLAVPMILELVMESTFAVADIFFVGKLGPSAVATVGLTETYLFLLYSLAMGLA
MAVTAIIARRVGEKNMANAGTSAVQSIFLGVLCSVPFAIAGIFFAKDLLAVMGADAWTIE
HGYRFTQWMLGGNVVIVLLFVINAIFRGAGDAAIAMRVLWIANGINIILDPILIFGWGPI
PAFGIEGAGIATTTGRGIGVIIQLWTLLKGGKHIRVKLSQLYWDAKTILNIVRTSLGGVG
QMIVAMTSWIFLMRILADVGSEAVAGSTIALRIMLFTLMPAWGLSNAAATLVGQNLGAGN
PDRAESAVWTTGIYNMIFLFLVSVVYFTFNESLMEIFTKDARVIAIGAEWLQILSYSYLV
YGWWMVSGAAFNGSGDTKTPTKINLVFFWLIQIPLSYYLAITLDWKHSGVFWGVFISETS
VGLFTLWLFTRGKWKTTKV
>AIA12658.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MPFQFISDKELISDKFSDDPMKKALTVIYATVILDAAGIGLTLPIFPRLLQDVGHTDNLG
WRFGAFLALYALMQFIFSPVLGSLSDRFGRKPVLMLSLAGAAVDYVFMALAPSLWLLFIG
RAIAGITGASNAVAAACVTDITEDAERTRRFGQLSACFGIGFIAGPAIGGVLGEFSVRLP
FIAAAVLNAANLLMALFLLPETRKIGAEAEKQEFSPLAHFRWLLGYRLLLPLAGAYFVLA
LVGEVGGTIWVLYGQDKFSWSPMMVGISLAAFGFFHAVVQAFIAGPISERWGEHRTLLIG
IIADSAAYIIIALLTEGWMAFLLTPLFCLGGIGAPALQSLVTGRVDNDHQGRAQGMLASM
TSLASIIGPLAISTIYFASRDVFPGLVWVLGAAFYVLCLPVAFTRRPKNATA
>AIA12654.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MWNKQQEPFKIYGNTYYVGPHGLTSILLTSKSGHVLIDSALPESAPQVVANIRSLGFRIE
DVKLIVNSHVHFDHGGGIAELQRLSGARVAASPWSVEVLTKSGVGKGDPQFGSIPPVALV
PRAETLRDGQTLRVGDIKLTAHFTPGHTPGGTSWTWRSCEGKRCLNLVYSDSITPVSSDG
FRFSDSREYPTAVQDFEKSFAFLRSTPCDILLTSHPDASGLWQRLENRQKGVRPDPLVSP
NACKELAERAAGQLRRRLESEKGR
>AIA12627.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MVIGIIAIDRNRAIGKDGKLPWHYSADMKFFKETTTGHACVMGYNTWLSLKRPLPNRLNI
VLSRKAELEPQESVLVLRDVESVLAKAKTLSCDLYVIGGEQVYRAFLPHVEKWLVTEVPL
SVEGADTFAPEGFLDGFRLDGTQTLDEDLNVSTYSRVASHMF
>AIA12595.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MTTTTSAVRAQQQPPLERAIKRLAESSGGIVGVSAIHIESGRRVSVNGDLRFPMASVYKL
PIALRLLQRIDRGELRLDGPITLSTHDFRPGHSPIAEFANNKPVTLPLERLLELMLGESD
NSASDKLLALAGGPAAVTARMRALDITGLDISRPEGRLALDFWGVREPPPESEWTLAFFE
RMSESGTPAAREAAAAAFADDPRDTSTPDAMAQLLVRVERREVLEPASMERLLQITTATQ
TGPLRLKGLLPAGTPVAHKTGTMGATTNDVGIITLPDGAGHVALAVFVKGSTLDVPSRER
VIAEIARTIYDYYLLVG
>AIA12586.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MTLPLERLLELMLGESDNSASDLLLRLAGGPAAVTNRMQALGIMGINVSRPEGQLILNHR
GVRELPPESEWTMALLDSLSAKITPAAREAAAAAFADDPRDTSTPDAMAQLLVRVERREV
LEPASMERLLQITTATQTGPLRLKGLLPAGTPVAHKTGTMGATTNDVGIITLPDGAGHVA
LAVFVKGSTLDVPSRERVIAEIARTIYDYYLLVG
>AIA12582.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MRIVLAIAAIACLGALTWAGFSARDGARRAEAGNPTTSSPENAVQQKGSDADGQLTERLK
AITSSAGGVVGLAVTHIESGRTVNIQGTLPLPLYSVFKLPLAVAVLKDVEENRLRLDRKV
LTTPAEIVPGSQENTDLWRKPVERTVTELLELSVMRSDNTSADKLLQLVGGASAVTERMR
SLGYQNLLIHSSVREYVADRKKVNTGTASDLTRLLVDLHQGRILQPPQLSVLLGFMQRAT
TGQRRLRDLLPAGTQVADKTGSGAAGVATNDVGLITLPKGQGHLAIAVLVSDAKLPTEEQ
EKLIAEVARVSYDAHLSQAAPATP
>AIA12535.1|FEATURES|farme|tetracycline|tetC|antibiotic efflux|1
MPESLSKENRRKFEWKRANPFGSLQLFKRYPTIGGLAFSFFLIYLAAQAVQGNWNFFTIY
RFGWNEKMVGISLAVVGLLVGVVQGVLTGFTTKKLGNERSVYLGLLLYSLGLVLFAFATE
GWMMFVFLIPYCLGGVAGPALQSILAGHVPPTEQGELQGALTSLMSLTTIIGPLIMNNLF
YFFTKDNAPVHFPGVSFLLGGIFMLLSTLVAWRVLSREKKTHPELLNVIEGSTESTPGMH
>AIA12475.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LMKQYHELLQSILDNGYEHEDRTGVGTISHFGYQTRFDLRSGFPIVTTKKIPFRWIAEEL
FWFLSGDTNELNLRAKGVDIWAEWADEAHTERFGRSAGDLGPVYGYLWRSFGGHYPKFDG
VDQIKNLIDQIESNPNSRRLIVTGWDPHQADNVDLPPCHTLFQFKVEQSGLLHLQLYQRS
ADAFLGVPFNISSYALLLHMVAHVTGLKAGEFVYTLGDYHIYKNHLQQVRELLRREPLHL
PRLEIVDEGKRFRGLAGLLAITYDNLKLVGYQSHGKIAAPVAV
>AIA12433.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLTKMQRDRKLMILTAIAAMAENYTIGVENHLPWHLPADMKHFKEITSGHPVIMGRKTYA
SIGRPLPNRTNIVITRDEAFKAPGCIVTNTIGDAISIAEQHTDDEAFVIGGAEIYQQMWT
>AIA12373.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
CKHTIENLGLPLFVKPCAMGSSVGIHKVTTKEKLISAIQDARQYDHTVLIEAFVPGREIE
LAVLENRNSVENPKVSIPGEIRVFHPDGFYSYSAKYLESEQTELIVGPALEGNLQQQLQK
AAADIFVRLKCKGMARVDFFLCENKIYFSEINTLPGFTTISMYPKLWQASGITYGELLNE
LILLGMEEFARKKSLKTDY
>AIA12367.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HIAFLHGARTQEQLEEFGCKWWSRWVTKERTAIFNLPEGDLGDGSYGAAWAAFPTAEGKP
FNQIEHLMKQIKERPYLRTHILSPWIPQYTLQHEGLTRRVVVAPCHGYVHVLCFPETKEL
VIHHFQRSGDLPVGVPFNFMQYAAFGMMVSKLIGYTLKEVVYTFSDVHIYESQYEKVSQI
ITREPRKLPTVQFTEAAQNITDIMDFRPEHFELTDYDPHPKMGIPTPV
>AIA12356.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIATVAAIDRNRAIGKADRIPWRLQRDLRMLKQLTEGPVVILGRKTYDSMVWYYDRSDRP
MPGKMYLIVTRDVEYKPTRDNARTATSPEDALRQAHELGDDAFVIGGEHIFEAFLPYTDR
VYLTEVDTEVDGDAYFPTLRPEEWYEVSREHFDADEKNEHASDVVILQRS
>AIA12357.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MEKSIVLKAREVVKTYGKKENTFVALKGVSLAIKEGESVAIIGKSGSGKSTLMHILAALD
RPDSGELEFNGKDVETFKDRDLDKLRNHDFGFIFQQFFLNYRETVLENVMLPLKIAGVSG
RDRKKRAMEAMAEVDLTNKAGNKASDLSGGQKQRVCIARALVTSPKVIFADEPTGNLDSE
NG
>AIA12320.1|FEATURES|farme|beta_lactam|ATN06_17210|antibiotic inactivation|1
MKLLLILCISLLFRASTLAQPPTIQVSKLAENFYVHTSYNTYQGQLVPSNGMIVNTPKGV
ILIDTAWGDEQTQQLLTWIKKELRQKVILVIVTHAHSDRMGGIRTITKEKIRIVSTPFIR
ERAGQINENYGEFRPEPALSSDTTLTFGSLKTRVFYPGKGHAPENIVVWFPAQKILFGGC
FIKSVASTNLCNLSDADIPEWKLSLHRTEEKFPKPNVVIPGHGDPGGPELLTRTRELLDI
GK
>AIA12285.1|FEATURES|farme|beta_lactam|HMPREF1562_2717|antibiotic inactivation|1
MRISTLARRLSCGTLAALLFACAVAPRADARQAKAFDPAELDKVVEAELKAGHTPGAAVA
VVSGDRVVYAKGFGVTSAEEGGAPVNADTLFRMGSTTKMFTAAALVTLASEDRIRLDQPV
GNYVKSLPPKIAALTAHQLLSQSSGLRDFAPSVTSDDDAALSKNIRAWTDDLFFTEPSRI
YSYSSPNYWLAGFMVEEL
>AIA12281.1|FEATURES|farme|beta_lactam|BH160DRAFT_5418|antibiotic inactivation|0
MIGNRYLRAKRSLYVLWTLVSFALYVYLDSKGWFGKSQQKREMRLRRQAARLRERLIRLG
PTFIKMGQMLATRADLLPLDYIKELSALQDQVPPFSDKQAIGIVESELGRPIKEIFAEMS
ERPIASASLGQVYRATLAGGEDVAVKVQRPGLSEKIRFDLDLLRWVGHLLDRYPKLFPGA
EWMGAIDEFDRVIHEEMDYRRELANANEFRQNFHDWHSIHVPRVFDELSSERVLVMEFVS
GTKVTDLEGLRAAGHDPRRVNELIYRAYFKQLLEDGFFHADPHPGNLLVMRDGRLAFFDF
GMVGRISDELQRQMIDAFFHLYSRDINAIVSDLVGLGFLAPEADTEAFRAIVAEVFARKL
NLKLGEVRFKELTYDLAPIVYEHPITTPARFTYLIR
>AIA12257.1|FEATURES|farme|beta_lactam|PHAMO_510100|antibiotic target alteration|0
MLGYARRLGFGEPTGINDANEAMGKLPSSGLGVDAGRLGAYGEGIEVTPIQLAAITSAIA
NGGTLLVPRTPRTEQEGAQFEAQIRRHSVSRARSSLIRIKRIRKDLKGGQLLKAPLRIYS
EQPAYFMCVYSSRTDICITV
>AIA12232.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIa|antibiotic inactivation|1
MSESNIPFTQTQLMDHLKALGLHAGQTVMLHASVKAVGPVMGGPNTILQAILDVLTPAGT
LMMYAGWQDIPDFLYELPEDVRQVYYEHHPAFDPATSRAVRDNSILVEFFRTWPGTHRSL
NPEASIVAFGAQAASITQDHPINYGYGAGSPLEKLVGLRGLVVMLGAPLDTITLLHYAEW
RAKLRHKNVIHYPCPILQEGKKVWIEVEDYNTGDHHDDYTFEEIAHEYLAQGKTSHGTVG
DADTYVFDAADLSEFAVQWLEARFGA
>AIA12192.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
SLIAACSENRVIGNKGSIPWHLKDDFRRFRERTTGHTLIMGRKTYDSIGRPLPNRTNIII
SRDKALSIPGVVVVSSLDEALEVARTIENEEIFIGGGGQIYAEALPKASRLYLTKVHAIM
EGDTLFPPYEDLFSR
>AIA12184.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
TSCLYFLVFGTVLGNRIGDMQGVDYMTFVVPGLVMLAIVTTSYANTSFTFFSSKFFARNI
EEILVSPTPPWLMIAGFIGGGVIRGIITGTIVLLVSVFFTGLHLAIHNILIILGFAVLTC
LVFALAGLVNGIYAKTIDGINIVPTFVLTPLVYLGGVFYSVHSLPDWWQAITYANPLFYL
INGFRYGFLGITDVNLMLSVGILAGMIVVLIG
>AIA12172.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTRKLNQRNEMMRTTILFGGTNKERLVSVASAQALHRALPEAELWFWDVADTVHEVASQK
LLGHARPFEDEFKPGNRGLPLEAALDKAKSEDRVLVLGLHGGRAENGELQAMCELCGIPF
TGSGSASSNLAFDKAAAKRFAAIAGVAAPADVGLENLDAAFAEYGRLIAKPARDGSSYGL
IFVNAKQDLVAVRNAARTEEYLIEPFVAGVEATCGVLEQSDGTLLSLPPIEIVPGEGTFD
YAAKYLLKSTQEICPGRFSADISAQLQDQALRAHRALSCSGYSRTDFIVSAKGLVYLETN
TLPGLTAASLYPKALKAQGIEFSDFLRDQIALAERRNRDRI
>AIA12164.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MIEKWIEGSDFFVTLVGDEVFPAVQVKSAGEFYDYHAKYHSEETIYQCPPPLSDDEARKL
AKIAQQAYFSLGCKGWGRVDLVRDRLGAFWILEVNTIPGMTSHSLVPMSAKAAGLSFDDL
VIKILSTSLTQTEKERKQAYGAEI
>AIA12140.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MAIIGIVAVDKNGAIGKNGSIPWHYSADVKFFKQQTIGHACVMGYKTWLSLKKPLKERLN
IVLSRKSEVKPQPNVIVLRDTLSILSLKKFLACDLFIIGGEQVYRSFLPHMDRWIVTQIP
VAVEGADTFMPEGYLKNFSPYDSQQLEENLKVTFYE
>AIA12114.1|FEATURES|farme|beta_lactam|OXA-247|antibiotic inactivation|1
MKLIRMVALLLIVIGGLGLSEARAQDLSPFFKDTRGAFVLYDQNNNRYVRYNEARCRERF
SPKSTFKIPNSLIGLETGVITDADFVIKWNREKYPPQENWNQEPFINWGRDHNLRSAIKH
SVVWYYRELALRVGEQRMKKFVKGFDYGNEDISGGIDNFWLNGGLKISADEQVEFLKRFY
AGRLPVSRRSIDIVKDILVLEKTPAYTLSAKTGGGSIAEGVYIGWFVGYVETRGNVYFFA
TNIESTSYQAIRGKRIEVTKQVLTSLGLLPK
>AIA12106.1|FEATURES|farme|beta_lactam|Shewana3_3440|antibiotic inactivation|1
FSTKSTFKIPNSLIGLETGVIRDADFVIPWNRQKYPPQDNWDQYPFKHWGQDHNLRSAIK
YSVVWYYRELALRVGEQRMKKHVTAFKYGNQDISGGVNNFWLNGGLKISADEQVEFLKKF
YEGRLPVSKRSTGIVKDILVLEKTPEYTLSAKTGGGSIAEGVYIGWFVGYVETKGNVYFF
ATNIEGTSYPEIREKRIDVTKLVLAELGILPK
>AIA12070.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MINQSVSKSIGMPNPRPRWLTELIAAWGFAQRNFFLTRRYFLWELVWLVYTTVSAMSIGF
IGVGVDDAGGNAQRLTTFLLIGSLLWSYLSMIFDLLSETVGWERWEGTIEYTFMSPASRA
TQLIGTSIYAVTYGVVRTAVIFGVISLFFDMDLSNANYVTALVLLVICSVSLVGFGMVSA
VMPLLSPEKGQQVTSIFTAVLLLISGVYYSVDVLPGWMQPLSKISPVTYALRGMRGALLD
GDGLGEVWGDVWPLLIMGALLVPAGLLIFRAGERYAKRTGLLKRSG
>AIA12063.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MQKTSLLRHQLIKLLPVVLLFLPSIAKAQADETSRAWNRPVEPFRIVGNIYYVGATEVSS
FLITTPEGHILLDSGMAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELT
GASLMTSEADAALLANGGKGDFQWGDTLSYKPVKVDRVLRDNDKVELGGVTLIARLTPGH
TKGSTTWMMKANEAGKQLDVIFTGSTSAPGYKLVDNPKYPNIVADYTYAFRLLKSLHCDV
FLGPHGSFFSLLDKAARLKQGEKNNPFIDPKGYRAFLENSEKNFLEQLEKQRQASKTK
>AIA12029.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MNKKFWLILSIALLNAVGLTIVFPLFPFLIGLYVPADKVALYLGILVSIYAFCKFFMAPI
MGALSDYFGRKPILFFSLLATAVGYFTLGIGGALWILFLGRVIAGISAGDISALYAYVAD
STQGKERTKLYGYLGAANGLGFMIGPAIGGVLGIEYISLPFYIAGGISIITALFIYLSLP
ETLIEGKRKKNITINAFNPISHFKDIFSLKEARKV
>AIA12010.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYQDALRQILADGVRHEDRTGVGTTSVFGEVQMSFDLEKNFPIMTTKKVPLRWIFEEL
MWFLGGRTDNQWLNERKISIWDEWSTVEQTARFGRKEGDLGPVYGYLWRSFGGHYPEMDG
SDQIARLMRDLKENPNSRRHLVSGWDPRVADEVALPPCHTLFQFKVEQINNEQYLSCKLY
QRSADFFLGVPFNISSYALLTCMIAHIMGMKPRKFIHTFGDAHIYSNHHAAVDELLARTP
LDLPNLEFVNTEHLVGKGLEGLLGFKWENINLI
>AIA11975.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKISIIVAMTENRVIGKENDIPWRIPGEQKRFRSLTTGKTVIMGRKTFESIGKPLPNRRN
LVITRDRTYVAEGCEIVGSLQEALALTKDEAEVFIGGGETIYREALPIADRIYLTTIHSK
IDGDTFFPEIGDEFQPVECIDVNGEPSYTYQTLERTRRGH
>AIA11971.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTQQPSRISIIAVLGEDTRAIGIDGDLIWTRLRADKIRFRKLTYGHPVIMGRKTWDSLPD
MYRPLPGRTNIIISRDASLVIPGAIVVRSLDDAIAAARKSLGSDEIFIIGGGIVYAKALP
YVDRLYLTLVQSDAAGDVFFPEYEVDFPEEIERIRDSEHDPTLTFLTLER
>AIA11887.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTRGVREVNKRTGHETAALPGLSFSIDLEKDGFPLLALRKIPTKLFIAEQIWFVSGARKP
EIFLREFTHIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGKLVELLAKDPSSRHGVIVTWD
PSSDGLGGVSKSNVPCPYTFTINIIGGRLNMMNVVRSNDMILGFPHDVGGFALLQLMLAQ
KLGVKPGVYTHTIANAHIYDTHYAAAEELMARPTDSQKIALKLPKDSYDRAEAKDASLVT
EINDVLSAQYNPA
>AIA11885.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQHVLQHGARKADRTGTGTLSVFGAQLRFDLDAGFPLLTTKKVHLKSIIHELLWFLRGDT
NTRYLKENGVTIWDEWADANGELGPIYGYQWRSWPAPDGRHIDQITQALEQLKTNPDSRR
ILVSAWNVADLDRMALLPCHAFFQFYVADGRLSCQLYQRSADL
>AIA11810.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TGSDGRSIDQISQVIDQIKTNPNSRRLIVSAWNVGEIPRMELPPCHLLFQFYVANGKLSC
QLYQRSADIFLGLPFNIASYSLLTMMVAQACDLEPGEFVLTLGDAHLYSNHFEQARLQLS
REPLKLPRMKINPAVHSIFDFDYNDFELVGYEAHPHIKAEVAV
>AIA11811.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLMVAMDEKRGIGKAGKLPWHLSSDLRTFRELTMGHHLIVGRKTFESIGKPLPGRHT
VVVTRNSNFKPEGCSVSHSVEDAIALARERGETEAFVIGGAEIYARALASADRIYLTEVH
AEVDADVFFPEFDRADWVETQHIDHPAGEKNQYAFTFKVLERGSQKVEV
>AIA11769.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKNIIVAYGQNREIGKDGDLLWQRDLPADLQHFKQLTTGNAIIMGRVTFTDDLKERILPN
RQTIVVTRQPEKFDGATVTHSMQEAYDAVELGRETFVIGGAQIYEQALNDADRVYATEVD
VSLPADKYFPKLDELQWREVSREHHEADEKNKYDYDYVVFDRIKN
>AIA11751.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLISLIVAVSDNGVIGKDNQLLWRLPDDLKRFKQLTLGHPMIMGRKTFESIGKPLPGRTS
IVVTRNTSVEIEGAMVVHSLEDALAEARKIEASEVFIIGGGELYTQAQHLADRLYVTEVH
SAFEGDTYFAIEDPTTWTENKRVHHGTDERHIFPFDFVDYFRQE
>AIA11748.1|FEATURES|NCBI|tetracycline|tet(30)|antibiotic efflux|1
WNFKALLPLVVVAVVFGLVAAVPGTVWVLYGAERFGWDPVHIGLSLSVFGISGAISQMFL
VGPLTKRFGDLGTLMIGVVFDTLAYVLMAFASQGWMGYALAPLFALGGVAMPALQSLLTS
RVSDEHQGQLQGVLASLMGLAGIVGPVLTTAVFFSTKSLWLGTIWIVGAGLYILAFPLFA
TVRRPQPAAA
>AIA11749.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MNKALVVILAAVTIDAIGIGLIFPILPSLLREVTHEGQVATLFGLMLALYSAMQFLFSPV
LGVLSDRFGRRPVLLISLAGAAIDYVIMAVAPDLWMLVVGRAIAGLTSANMAVATAYITD
ISAEEERARRFGYFHAMFGIGFIIGPVLGGLLGDYWVRAPFIAAAVLNAINFSLALFVLP
ESRPGRAVQFEWSSLNPFIPLKWALTFKALIPLMAIFVIMNFVGTMYGTVWALVSEDSFG
WTGLTIGLSLGAFGFFHAGAQAFLTGPAVKQLGERWALVVGMACEVTALLILGCTNQGWV
MFAMAPLFALGGIGTPALQSLTTTQVDGDKQGQLQGVMASFVSLAAVFGPLFFSFAYFAV
RPTWPALIWIIGASVYLLALPLILGIRRRGPLPS
>AIA11637.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MYFAINEKYERGSMRVFIIAAITADGFIGRNSGHSADWTGGEDKKVFVRLTKEAGTIVMG
SRTFATIGRALPGRRNIVYTTRPKEITAEGVETTKEAPADLLARLEKEGVKAVAICGGGA
IYNLFMSEGLVDELYLTVVPLLFGQGVTLFNGELDSKLDLTETTPLADGSLLLHYRVQKA
>AIA11603.1|FEATURES|farme|beta_lactam|SPG-1|antibiotic inactivation|1
MIQKPSLLHQKLRVLLPVVLLFLPSIAKAQADETSRSWNRPVEPFRIIGNIYYVGATEVS
SFLITTPEGHILLDSGFAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKEL
TGAKLMASEADAALKKRAGNSMSSSQAAHPLPAIS
>AIA11580.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTMTIRSAAPDDAALIIQFIEALAEYEKLTHEAKATEADILRDLFGADPKVFCEIAEWEG
KPVGFSLWFYTYSTFQGRHGIWLEDLFVDPEARGLGVGKALLVNLAQRCVREGLGRFEWW
VLDWNEPSIQFYKSQGGVMQDEWTKVRVYGEALAKLGAL
>AIA11537.1|FEATURES|farme|beta_lactam|LRA-18|antibiotic inactivation|1
MATIKLGLSTAILATLASSAFAEGGERAQIAAAVDKAIRPIMREHKVPGMAVAVTVEGRH
YFLNYGVASKETNEPVTENTLFELGSISKAFAATLASYAQVTGKLSFDDHPGKYIPAFAG
TSIDKATLLHLATYTAGGLPLQFPDAVKSDADMVGYFSTWKPEAKPGKTRRYSNPSIGLF
GHTAALAMGGSFSAVLESEIFPKLGLKHSYVRVPDSQMGSYAWGYGKADKPIRVTAGTFD
AEAYGVKSSAADMIRFVETNIQPERLDGAIRKAVEGTHVGYFDSGKMVQGLGWEQYPYPV
SLERLLDGNSRDMALKSNPVKALDPPKRPDGSTLYNKTGSTNGFGGYVAFVPEKKIGIVL
LANRNYPNPERIKAAHAILKSLEAAAK
>AIA11495.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MNKKQSGIGFIFVTLLIDVMGWGLIIPVMAPLIAELKQIPINQASTYGALLLSVFAIMQF
VFAPVVGNLSDRYGRRPILLAALFGFGVDYIVLALAPSYGWLFLGRIIAGMTGASFTTAA
AYIADVSTNENRAKNFGMIGAAFGLGFVLGPALGALLATWGIRAPFYGAATLCLLNFLYG
YFVLPESLDKKNRRPFEWKRANPFGSLKFLTKHPEIGELAICFFLVYLGAQAVQANWNFF
TVYRFGWREAMVGISLAVVGVLVGAVQAGLTRVVNPKIGDNNSIYVGLALYTVGLVLFAF
ATETWMMFAFLVPYCLGGICGPSLQSVISAHVAPNQQGELQGALTSLMSVTTIIGPPLMN
STFAYFTSEKAPFHLPGVHFLIGAACMLVSFLVAYRILSREKAAPALSNK
>AIA11492.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MTAHLTPGHTPGSTTWTWRSCEETRCLDIVYADSLNPVSAPGFEYTRSPGVVDAFRRSIA
TVESLPCDVLLTVHPELSDLSGKLQRRTAAANENPFIHSQACRVYAAAAARSLDRRLEEE
Q
>AIA11481.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTSRPEIVFYVARADNGVIGCDGGLPFHLPGEQKRFKDMTMGKPMLMGRKTFISLPGLLP
GRRHIVLTRDTSWSAAGAEVAHEVEEAIHIAGDVPEIAVIGGADIFRLLMDRADRIELTE
AHRDVAGDVIMPPLGDGWAETHREYGGPDWEYVTLTRER
>AIA11431.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MYIYSAMKNILLILAILMGTAAAAQDTLTRTRINQDLEIIALSSNAYLYTSWFTSPTFGR
VGDNGLIYVNNNEAVFLDAPTNDTISNLLLDWFAKTFPGATIKAVVVNHFHDDALGGLKA
FHQKGITSYANFMTNESIHNDSTEKPKQTFTKQLVFRVGKSIIINAYLGEAHTKDNIVTY
IPAEKILFGGCMVKSLDAGRGFLGDANLKQWSATVTKVKNAFPEAKIVIPGHGDPGGIPL
LDYTIKMFEGEAK
>AIA11418.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MSNPDAQGAETAKPAGLRDLLKNSNFRFLWLGQIISDFGDSLTNLSLLILVNQLTGSTAA
LATMLIVLTIPQITFGLIAGVYVDRLDRRRIMMASDALRGAMVLGFTLVGSADQLWLLYL
IGFAQASIGTLFTPARGALLPNLVPGSALL
>AIA11412.1|FEATURES|farme|beta_lactam|SPM-1|antibiotic inactivation|1
MRCLIPALLLTLSSCSTLSHSGSDAFTQQFSVKEVAPKTFVVTDQSYHNSNVMVAVMPDQ
TVLIASSPFETEGAEQLVQWIHSQWNPKKIVAINTHFHADGTGGNEAYQKNGVEIWASDL
TRKLQSEFGEAKKKGEAADFASKPELQARILKRKIVLADHTFKLQDGKTFEFAGKKVEVI
YPGPAHSQDNVVVYLPERKVLFGGCMIRPTDTLGYTGDASIKTWAASATRLKPLAPKVVI
AGHEVIGGPELIENTARTASKAAAQPM
>AIA11283.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDLKRFRQLTMGHHIIVGRKTFESIGRPLPGRVM
IIITRSESIAVEGCFIAHSISDAISLARERGESELFICGGAEIYAQMLGVADRMYLTVVH
ADSEADTFFPEWDKDEWVELESEHRTADEKNQYSFTFKVLARRSQV
>AIA11263.1|FEATURES|farme|beta_lactam|OXA-48|antibiotic inactivation|1
MKLLKLSFVCLVFICGTRAAVGRAQDLSPFFQNTTGAFVLYDSKNDRYVRYNDERCRRRF
SPKSTFKIPNSLIGLETGVIKDAAFVIPWDRRKYPPQDNWDTEPFVHWAQDHTLRSAIKY
SVVWYYRELALRVGPQRMKKYLGDFKYGDRRMGGRVDEFWLDNSLKISADEQVEFLKAFY
AGKLPVSKRSTDIVKDILLLEQTPTYRLSAKTGGGSIAEGKIIGWFVGYVETGGNVYFFA
TNIEGPNYAAIRDRRIEITKQILASLGYLPNQ
>AIA11185.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
SKSYSMNTSRKSAMAFIFVTLLIDIMGWGLIIPVMADLIAELKNIPINQASSYGALLLSA
FAVMQFLFAPVVGNLSDKFGRRPVLLTALLGFGIDYIILALAPTYGWLFLGRIIAGMTGA
SFTTASAYIADVSTPENRAKNFGLIGAAFGLGFVLGPALGALLSTWGIRAPFYAASALCL
LNFIFGFFLLPESLDKAHRRPFEWKRANPFGSLKFLTKHPEIGALALCFFLIYLGAQSVQ
GNWNFFTIYRFNWSEKMVGISLAVVGVLVGSVQAGLTRVVNPRIGDVKSIYLGLSLYAFG
LVLFAFANQSWMMFAFLIPYCLGGICGPSLQSVISGHVPSNQQGELQGALTSLMSVTTII
GPLIMNNAFAYFTSDKAPFHLPGIHFLIGALCMLISIFLAHRTLSREANRAGINPA
>AIA11161.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VIGKNNRLPWHLPNDMRFFKNTTWGLPVIMGRKTYDSLKAEPLPGRVNIVITRQKDWQPK
GIIVAHSLQQAISAAQQTDSNEIFILGGGEIFKEAITTADRIYITRVHAVVEGDVFFPEI
DADKWKLVSKRDCFADEKHAYDYTFETWERKEG
>AIA11156.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSNVQLPKKIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPQNVDI
AFLTIHGTFGEDGQIQQILEDRGVPYTGDGVNESRIAFDKIESKKKFDAAGVTTPRWQIV
AADERPTFSPPIVIKAPRQGSSVGVYIIKSADQLENGLAEARKFDRRLLVEEFVPGRELT
VGILGDQALPVIEMIPKSGFYDFTNKYPFLNPKAGGGAEHVCPANIEETLTHQIQELALR
AYRSIGLCVYSRVDVLLPENGVPTVLEVNTIPGMTEA
>AIA11133.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MAIIGIVAVDKNNAIGKGGQLPWHYSSDMKFFRGQTMGHACVMGYKTWRTLKKPLPGRLN
LVLSRRSEITPQASVVVMRDKLDVLSLLPFHSCDLFIIGGRQIYDAFLGEIDRWLVTEVP
LVIDGADTFMPANFLEGFDVTQTLPLEEGLSVKFYDRNRGATASNVHP
>AIA11109.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MYFAINEKYERGSMRVFIIAAITADGFIGRNSGHSADWTGGEDKKVFVRLPKEAGTIVMG
SRTFATIGRALPGRRNIVYTTRPKEITAEGVETTKEAPADLLARLEKEGVKAVAICGGGA
IYNLFMSEGLVDELYLTVVPLLFGQGVTLFNGELDSKLDLTETTPLADGSLLLHYRVQKA
>AIA11089.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNTYTKTPISKSSRIAVLYGGLSSEREVSLISGKNCFDAIQRLGYDNAILIDVGHDIARK
LVEEKVEIAYIALHGKYGEDGCIQGLLELMGIPYTGCRVAASALTMNKALTKSILKDAGL
PVIKSVVLKSGSVNGKPLNLDVQYPVMVKPINEGSSIGMSKVDKPEDLKEALQTAFKYAD
EVMVEEYVKGKSLTVGVVEVDGQPKVTPILELRPTKSEWYDLEAKYTEGGTEFILPAELS
EEVTVAIQDATFKAHITAGCRGMSRVDFVTGPGNQFYILEINTIPGMTPLSDLPAQAKAM
GISYEQLVECILKTAIN
>AIA11061.1|FEATURES|farme|tetracycline|tetA(60)|antibiotic efflux|1
EHRTGDLMARATNDLAAVRQLAGPMIMYSLQTVFVVVLVLPLMLRISVRLTLLLFVTMPL
VSLTVKYFGQQVHVRFEKIQDFFAQISARAQENFTGVRVVRAYAQEGAEITAFDALNRQY
AERNLSLVRISALMRPLMQFLIGVGYVLIIWYGGTLVIQGAITLGQFTQFNLYLSRLIWP
LIALGYVVNLYQRGTASLKRINSISAIEPTIIDPPNVREQPPIKGRIELRDLTFSYNEHA
EPVLRDINLTIEAGQTVAFVGRTGSGKSTLISLITRLVEAPPGTIMIDGISVRDYPLAQL
RSAIGYVPQETFLFSDTLAKNIAFGVEHAGRADIEWAAEIAGLTDDIRGFPDGFDAMVGE
RGLTLSGGQKQRTAIARAVMRQPKILILDDALSSVDTYTEEKILAQLRGVMTERTSLIVS
HRISTVRDADLICVLDEGRIIERGTHDELLALGGEYADLYERQLLEEELAAS
>AIA11000.1|FEATURES|farme|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|0
MIITVRPEQQGDIDEIYALNKLAFGQDNEARLVDLLRTGPGYVPGLSLIATAENAVVGHI
LFSKIFVVSGDARHETLALAPMSVHPNYQKQGVGARLITAGLETARDMGFGSVVVLGHEH
YYPKFGFVPASRWGIRAPIDVPDNVFMAIELMPGSLKNVSGIVEYPVEFSAI
>AIA11001.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MKNALLILAILISNIVAAQDTLKKIRVSDDFDIIPLSKNAFIHSTWTSTPSFGRFNNNGV
IYINENEALILNTPPDDRLSKELLDWFSKTFPSVKIIGVVGNHFHGDGIGGLRVFHAANI
PSYANALTNAQSDTIVKAQNTFTGKLDIKVGKKNVRCQYFGEGHTRDIIVTWIPDEKILY
GGCLVKALGAGRGYLGDANLKQWSATVAKVKKAFPDAKIVIPGHGDYGGVELLDFTIKMF
AGDAQ
>AIA10991.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MGRRFRLEGEEAEGMAIIGIVAVDQNGAIGKEGGLPWHYSADMKFFKQQTMGHACVMGYR
TWRSLKKPLKDRLNIVLSRKSEVEPQPSVVVVRDILSVLSLKDYLSCDLFVIGGEQVYRS
FLPHVDKWMVTEIPLAVEGTDTFIPGDYLRGFKLSGSQQLEENLRVTFYEKHTVERKDES
MVTQFE
>AIA10975.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSIVLEQLTKRYEDHPVVNKVSLDVANGEFFVLLGPSGSGKSTILRMIAGLATIEEGRVL
LNGRDVTGLPPQQRGVGFVFQNYSLFRYMSVAENVEFGLRIRKISAAERRQRCDALLELV
GLAGLGKRMPRQLSGGQQQRVALARALAYQPEVLLLDEPFGALDAQIRVDLRRTLKRIQR
ELGVAAIFVTHDQEEAFELADRMGVMTGGRLLEVGQPDELYLRPQTEFVAAFLGTANLLV
GQATDSGIQLGPVHFA
>AIA10925.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MRNSKQAAMGFIFVTLLIDIMGWGLIIPVMANLIAELKHIPVNQASTYGALLLSVFAVMQ
FLFAPVMGNLSDRFGRRPILLLALLGFGADYIILALAPTYGWLFLGRVIAGMTGASFTTA
AAYIADVSTPENRAKNFGLIGAAFGLGFVLGPALGALLSTWGIRAPFYAAAALCLLNFLF
GFFLLPESLDKSHRRPFEWKRANPFGSLKFLT
>AIA10889.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISQIAAVASNGVIGKDNDLPWRLPDDMKFFMETTKGHHVIMGRKNYDSLLDKFKPLPNR
TNIVVTRQKNLQAPGCIVVNDINKGISIAEDGGEKETFIIGGAEIYKMTLPVSHRLYLTE
IDAEVDGDTYFPKFDKNEWKEKSRVHHPADARHKFAFDFVIYERA
>AIA10881.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
DPCADRGVKTEMEEERKIAVLNNVLETSLRFIAIAAMTPHRVIGLHKDIPWHLPEDLKFF
KKITGGHPILMGRKTWESLPGSLPNRRNLVLSRKLNTAPGAEILRNPEQIDKLGLQGTVY
VIGGGEIYRLLMPRTSEILLTIVESAAEGDTLFPPFEEEFELAEVLDRMPGVAEWRRYVR
RGA
>AIA10877.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIVSAIAALSKNRVIGRNNDLPWRLPDDMKFFMETTKGHHVIMGRKNYDSLLPKFKPLPQ
RTNIVITRQRDFNAPGCTVMHAVQPALELARKNLEEECFIIGGAEIYKLAMPFTTRLYLT
EIDADVEGDTYFPDVDINKWREVSRRHHPSDQRHAYAFDIVVFDRN
>AIA10854.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKIAVALVALMSLTTAVEAQTPKDLIEALKVRWNTPTEPFKMIGNVYYVGTDGLASY
LITSPQGHILVDTVMPESTSLIKASIEKLGFKITDIKYLLNTHAHIDHTGGLAELKQASG
GKLVAGDADKSLLEGGYYPGAEDDTTLAFPPVKVDRTVREGDTVTVGDVTLTARETPGHS
PGCTSWAFSVKDGDATRSVLIFCSGTVALNRLGGADPTYFGIVSDYRKTFARAKDMKVDV
LLAPHPEMYRMQDKRAMLSDGAPNPFVNPGEFNAYAATLEKAFEDALAKQTADAQEKKG
>AIA10839.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MAAASRNPFYFKSLLRRRIEMFTSNRKPRAARWAGGIIGTTAVTLTIALAYGAEQSMRKD
EIQPVNPGTAVVDPAIQKIAEAALGEAIKTHKAKGGFAIVAEPSSGKILAVANIDTTNKM
SGRWALSQLLEPASIAKTLVVAQAIESGLTTPQEKHSCENGNYRYGSRVYHDWKPEGWNQ
LTTEETIAHSGTICTIKIAEKVSGDGLVKMLKDFGFGPEGTAKNFPEARTGVLPPLGNPY
YPDVVPAVSAGFGFKITPIELVQAYGAIANGGSLMNPLPANADSSEIQAIRRVLSSQNAA
KVKDILRQVVLKGTGQGTASSNLYSTAGKTASSHIPDLAKADGKKIGNFAGFIGFAPVNE
PKVEVYVGIFAPGAGATPAHGSSHAAPVFKRIAEDVLKHWKVAPDQPQS
>AIA10834.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MNLDKIVLSGLLSMAAVAFPAQGTPLLQADPPKSCKACDEWNGKQQPFQVFGNTYYVGVA
GLSSVLIASDTGHVLLDGGLPQSASPIAENIRALGFRIEDIRLIVNSHAHFDHAGGIAAL
QRASGAVVAASASGARALEQGAPTPDDPQQGFGRESTGFPPVNAVRVVSDGETLRVEDLA
ITAHLTPGHTPGSTTWTWRSCEETRCLDIVYADSLNPVSAPGFEYTRSPGVVDAFRRSIA
TVESLPCDVLLTVHPELSDLSGKLQRRTAAANENPFIHSQACRVYAAAAARSLDRRLEEE
Q
>AIA10821.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVTLIAAITADGFIGRDSGHTADWTSKEDKKLFVKITKEAGAMVMGSRTFETIGRALPG
RRNIVLTSRPEEYHAEGVEFTSESVLELVKRLEGEGQKSLAVCGGANVYHQFMQAGLVSE
LYLTVEPVLFGSGVKLFSGELDVTMQLVSSEKLNDDVILLHYKVT
>AIA10792.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDVAIYVAIADNGVIGRDNGLPWRLSTDMKRFKAGTMGKPVVMGRKTWESFPRRPLPGRP
NIVISRDRAYRAEGAETVTSLQDALTLARAKGRCLAGADEICVIGGGEIYRQAMPVADRL
YVTHVLARVDGDTRFPEIDPKIWREVSAEEYPAGEKDTHATRYVIYERRGGDAKTA
>AIA10790.1|FEATURES|farme|beta_lactam|OXA-55|antibiotic inactivation|1
MKFIKLLFVQIMFLCSLPGAMPVQAQDLSPFFKDINGAFVLYDLKNDHYIRYNEARCRER
FSPFSTFKIPNSLIGLESGVIKDADFIIPWDRRKYPPDDWTIEPFIHWGRDHTLRSAIKY
SVVWYYRELAGRVGERAMKEYVSKLHYGNQDISGGVDRFWLNSTLKISADEQVAFLKALY
KEELPVSSRPMKILKDILVLEETPQYKLSGKTGGGPNNGKGLGWFVGYVETKGNVYFFAT
NIEGADYLAIRDKRIALTKRILAELGHLPKS
>AIA10763.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MTKLISPSLLLLAFLYLLPYAAFSQKEALRKRMEEITQTAKGKVGVAVLGIEDRDTLSVF
GKDRFPMQSVYKFPVAIAVLHQVDQRKLSLQQKIHLRPEDLLPNTWSPLREKYPQGNVDI
PLSEVLLNTVALSDNNGCDVLFRLLGGPPKVDAYIRSLGVRGMAIAATEEQMHQEEQVQY
TNWSEPTAMLRLLDVFYARKALSPASTDFLWKVMVETSTGPRRMKGLLPPGTIVAHKTGS
SGTNSQGITAATNDVGIVTLPNGKHVALVVFVSDASADEATREGVIAQITKAVWDYFVAK
P
>AIA10728.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISQIAAVASNGVIGKDNDLPWRLPDDMKFFMETTKGHHVIMGRKNYDSLLDKFKPLPN
RTNIVVTRQKNLQAPGCIVVNDINKGISIAEDGGEKETFIIGGAEIYKMTLPVSHRLYLT
EIDAEVDGDTYFPKFDKNEWKEKSRVHHPADARHKFAFDFVIYERA
>AIA10723.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLVAAASENNVIGDTNAPNHAIPWDLPNDMQHFRDVTRGKPVIMGRKTLGFIGRALP
GRVNIVVTRQKDFAFDGVEVAESLEKALEIAIKNNPEEICIIGGGEIYRQALPLADRVYL
TRVHATIQGDTTFPELGREWKAVWQERHEADENHAYAYTFLRFERTSK
>AIA10692.1|FEATURES|farme|beta_lactam|WS68_16125|antibiotic inactivation|1
ELERHAGGRLGVAAVDTATGQRLEHRGNERFAMCSTFKFLLAAALLQRVDKGVEHLNRRI
EYGEADLLEYAPVSKQNVKQGGMALAEMCSAAVEWSDNTAANLLLQALGGPDRLTAFIRT
LGDEVTRLDNNEPKLNVVLPGEVHDTTSPLSMVRLLSTLLFGQVLSPDSRTRLQGWMLDA
KVGQHRLPAGLPPFWRIAHKTGTGSDQTNDVGVLWPPDRAPIVVAALYARGDIPQDRREA
VLADVGRIVSSVF
>AIA10655.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MQKSSLLRHQLIKLLSVVLLFLPAIAKAQADETSRAWNRPVEPFRIIGNIYYVGATEVSS
FLITTPKGHILLDSGFAETVPLIQANLKKLGFKIEDVKILINSHAHLDHAGGLADLKELT
GAKLMTSEADAALLANGGKGDFRWGDDLSYKPVKVDRVLRDNDEVELGGVTMTARLTPGH
TKGSTTWMMKVNEAGKQFDVIFAGSTSAPGYKLVDNPKYPGIVADYTYTFRLLKSLHCDV
FLGPHGSFFSLLDKAGRLKQGEQNNPFIDPKGYREFLEKSEKDFLEQFEKQRQAGKTK
>AIA10654.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MHMRNHLPNPTRVLALAGFLLILAALAWGQTGAPPSSSCDNCLEWNKPQQPFRIYGNTYY
VGPHGLSSILITSRAGHILIDSALPESVPQVVANIRALGFRIEDVKLIVNSHVHFDHGGG
VAELQRLSGAKVAASPWSVEVLTKSGVGKGDPQFGSIPPVALIPRATTLRDGQTLRVGGI
KLKAHFTPGHTPGGTSWTWNSCEGKRCLNLVYSDSMTPVSAEGFRFSDSREYPNAVKDFE
KSFAFLRSTPCDILLTSHPDASGLWQRLEGRERGVRPNPVISPNGCKSLAERAGEQLRRR
LAAEKGR
>AIA10649.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MFTSNRKPRAARWAGGIIGTTAVTLTIALAYGAEQSMRKDEIQPVNPGTAVVDPAIQKIA
EAALGEAIKTHKAKGGFAIVAEPSSGKILAVANIDTTNKMSGRWALSQLLEPASIAKTLV
VAQAIESGLTTPQEKHSCENGNYRYGSRVYHDWKPEGWNQLTTEETIAHSGTICTIKIAE
KVSGDGLVKMLKDFGFGPEGTAKNFPEARTGVLPPLGNPYYPDVVPAVSAGFGFKITPIE
LVQAYGAIANGGSLMNPLPANADSSEIQAIRRVLSSQNAAKVKDILRQVVLKGTGQGTAS
SNLYSTAGKTASSHIPDLAKADGKKIGNFAGFIGFAPVNEPKVEVYVGIFAPGAGATPAH
GSSHAAPVFKRIAEDVLKHWKVAPDQPQS
>AIA10642.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
DLLRRMMEAEGFTVNKNEWWHFDYKDWENYAIYDIAFSQVGANRVFQAEVEERRDWKQFF
DAANVTGGIYIYDLRKNKFSIYDRQRFNKGFVPASTSKIIHSLIFLETGALEDENETLKW
DGVKRQVAAWNQDHNLRSALKTSAVWFYVEVSKRVGREKMQQFYDKAEYGNRNTNGFGAD
YWNTGDLRLTPLEQIDFLVNFYENRLPFSKRSMEIVKDILVFEKTDKYILRAKTGWSNSF
TPQVGWFVGYVEKGSETYFFADEFDIKKDEDAAKRIEITKNALKSLQIID
>AIA10627.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MGFIFVTLLIDIMGWGLIIPVMANLIAELKHIPVNQASTYGALLLSVFAVMQFLFAPVMG
NLSDRFGRRPILLLALLGFGADYIILALAPTYGWLFLGRVIAGMTGASFTTAAAYIADVS
TPENRAKNFGLIGAAFGLGFVLGPALGALLSTWGIRAPFYAAAALCLLNFLFGFFLLPES
LDKSHRRPFEWKRANPFGSLKFLTRHPEIGELALCFFLIYLGAQAVQGNWNFFTIYRFHW
SEKMVGISLAVVGVLVGGVQAGLTRVVNPKIGDVKSIYLGLSFYVLGLILFAFATQSWMM
FAFLLPYCLGGICGPSLQSVISGHVPPNQQGELQGALTSLMSVTTIVGPLIMNNAFAYFT
SDKAPFHLPGIHFLIGALCMLVSIYLAHRTLSREADPSKVKTANM
>AIA10625.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
YRPVREAILFFKETNKLVNKLKVIEAVGLGYLRLGQSATTLSGGEAQRVKLAAHLATKTK
SKTLFIFDEPTTGLHFDDINKLLAAFRALIENGGSLLVIEHNLDVIKTADYVIDLGPEGG
SGGGEIVATGTPEEIIKIEDSHTGRYLKDYLT
>AIA10575.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIRFVSVSKQYTDDIKALDNVSFEVQEGEFVFLVGPSGSGKTTAMKLLIREDAPSDGKIF
FEDLDVAALKRKYVYDLRRKIGVVFQDFKLIEDKNAYENVAFALEAAGKSDNDIKETVPY
VLEIVGLAHRMEAFPKELSGGEKQKVAIARALANNPKVLLADEPTGNLDPASTWDIVQIL
DG
>AIA10572.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
PMIMGRKTFESIGKPLPGRTSIVITSQKEFSADGVVVAHSLDEALEKARSIESSEAFIIG
GGEIYKQALPLTDRLYVTEVKTSIDGDTFFEIPDPAAWTESERIVHEADDRHIYQFEFVN
YIKQKF
>AIA10538.1|FEATURES|farme|fosfomycin|FosX|antibiotic inactivation|0
MFKFAIPVLHVTSSAAAEEFYCDRLGFSQTFAYRPFGRADPCYMGLTRDDVELHVSSFSG
DGVAGGVVFLGVEDVDELHNELKAKGVTIDLEPTDQSWGNREMYVHDADNNSIRFVHRGR
>AIA10536.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MFKFAIPVLHVTSSIAAEEFYCDRLGFTQTFAYRPFGRADPCYMGLARDDVELHVSSFSG
DGVAGGVVFVGVEDVDALHEELKATGVVVDLEPTDQSWGNREMYVHDPDGNSIRFVHRGE
>AIA10537.1|FEATURES|farme|streptothricin|sat-1|antibiotic inactivation|0
MIAIRPAVETDIDALYSLDLIARQENERREFIRREVVSGNCFVAVMNETVIGYGVLNYTF
YRSGCIDMVYVDSEHRRRGVGAALLKHMESLCKTPKLFTSTNLSNLPMQSLLAKLDYVLS
GVIHNLDDGDPEIVYFKRLRG
>AIA10459.1|FEATURES|farme|multidrug|efmA|antibiotic efflux|1
MMSETEDDKKIHWKRNIILFLSSQTLSLFGSALVQYAIMWYITLTTQSGMMMTLYIICGF
IPTFLLSPFAGVWADRFNRKSLIMIADAMIAVVTLILAITFMLGYQAVWLLFVISAVRAL
GAGIQTPAVGAILPQIVPQEKLTKVNGINGSLQALTMFVAPIVSAALLTMATIEMILFID
VVTAAIAIFTLFVFLKIPLHKKASVTQSTGYLDDFKEGLVYIKQHAFLKSFFIFFAFFFV
LMAPAAFLTPLQVTRSFGDDVWRLTAIEIAFSVGMMAGGGIIASWGGFKNKVYTMAIASF
IMAASTFALGIVPVFWIYLAIMAVFGVAMPIFNTPTTVMLQEKVDENYLGRIFGVFGMIS
TSMMPIGMLIFGPLADVVKIEWLLIGTGLFMLVLTVFFARNKRLVEAGLPLPKEQEATSD
>AIA10454.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MEEIARVSNGPVGAAAMEVETGEVVALNGKQRFPMQSVYKFPIGMAVLHQVDTGVLKLDQ
KVRVKPTDLAPKSLRSPLRDLHARGAELTVRELLTFMMVDSDSSASDVLLATVSGPQQAT
KYLRELGIEGINVATSEKQMATDDQVQYQNWSTPEAMLGLLKILQEGRSMSPASRDLLLE
LMRKTWTFPTRIKGLLPAGTVVAHKTGSSGTRDGLTRATNDVGLITLPNGHHLAVAVFVS
DTKVDEKTRDAVIAKIARAAWDCWQ
>AIA10430.1|FEATURES|farme|tetracycline|otrB|antibiotic efflux|1
MIDNQGLSWSSPIIIGLLVLSAALIALFIRIESRAKQPIIPLHLFRNRNVVVLSLLVFTL
MLGLMGGIATFPFFAQNVMGLTPTEAGYLMFAFMAGAIPSSIVNGFLITRIAYRNLFITC
FLLPIVGFYLLTQIGIATSILYVVITFFILGLGIGVLFGSDNLIVQESVDKADSGSALGT
VQLFQALGATIGLSIFGSLLARHINQGVSKMADQLPEGTAKNIATGGIPQGLSHDLLIKV
QTVFASAFQNIFTISFVFVIAAFIACWFLKKEVLQKREEETAAQAVTAAAAE
>AMJ38568.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTTRPHSSFKIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAL
GQLFYGPMADSLGRKPVILGGTLIFAAAAVACALAQSIDQLIVMRFFHGLAAAAASVVIN
ALMRDVYPKEEFSRMMNAAGRATSEVSRSHHAWQLCLAVSP
>AMJ38538.1|FEATURES|farme|multidrug|adeB|antibiotic efflux|1
MPQFFIERPVFAWVIALFIVLAGVIAIPQLPVAQYPSVAPPSVSITVTYPGATPETMNDS
VISLIEREISGVDGILYFGSSSDTSGTASITVTFKPGTDIKLAQVDVQNKIKVVESRLPQ
TVRQNGLEVEAANSGFLMIVGLRSPTAQYTEQDLSDYFARNVSEELKRVPGVGKVQLFGA
EKAMRVWLDPIKLFNYKLSVSDVTAALSQQNAQVSPGRIGDEPTQPGQRVTYPLTVRGQL
SSVEDFRNITLKALNNGSRVRLADVARVEQGLQSYAFAIRENGHAATAAAIQLVPGANAV
STAQGVRSRLNELSAVLPQGMSFSVPFDTAPFVKLSIEKVIHTFIEAMVLVFLVMLLFLQ
NLRYTFIPAIVAPVALLGTFTVMLIGGSSINVLTMFGMVLAIGIIVDDAIVVVESVERLM
AEKGLSPKEATREAMREITPAIIGITLVLTAVFIPMGFAAGSVGIIYRQFTISMAVSILF
SAFLALTMTPALCASLLKPIEQHGEKKKGFAGWFNRRFSALTNRYERGLHATLRRSGRVM
LIYAVLCAVMFMAYSALPSSFLPDEDQGYFMTSVQLPSDATQERTRHVVDRLEKAIMARP
GIDNNISIFGFGFSGSGSNTAMTFTTLKDWGERQGATADGEAERVQREMSNDPAAIVMSL
MPPAISDMGTSSGFELYLEDRAGYGYTALLQAASTLTEKANNSSAVNDVYIEGLPAGVSA
SIEVDREKAQAMGVSFDEINQMLSASIGSNYINDYVDNGRVQQVIVQADSAYRMQLADLL
KLYVRNVSGEMVPLSAFVTTNWIQSPQQLNRYQGYPAIKITGSTAAGYSSGAAMAEMDKL
AASLPTGYFVEWTGASLQERSSAAQMPLLIALSVLVVFLVLAALYESWSVPLSVILVVPL
GMAGALLAVFIAGMSNDVFFKVGMITLIGLSTKNAILIVEFARQLYAQGKPLLEATKEAA
RLRLRPIIMTSLAFTLGVVPLMLANGASKSTQNAIGTGVFGGMISGTLLAIFFVPVFFVI
ITSAVQRLSNSLKKVK
>AMJ38518.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
MKLTQIRNATLLLNYAGVKFLIDPMLADKEAWEGFPGTARSHLRNPLVALPLPLETLLDV
DAIIVTHTHRDHWDEAAAAHISKDMLIFTQNAADAELIRAQGFTRIQVLEEHNTFAGITL
IRTDGQHGSDEAYSNPEIAALLGDACGLVFQHPDEKTLYIAGDTIWVKSYIDSLNAWRPD
VVVVNAGFAQVDHIGAIIMGKEDILRTHQALPQATIVASHMEAVNHCILSRDELREYASE
QGLQACLRIPADGESCYF
>AMJ38460.1|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|0
YDHLDYATIKALMPKVKRVVTPLGVGSHLRYWGMDGALISEADWQQAIPVSDEFTVHVLP
ARHFSGRGLKRNQTLWASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQY
DQDWKYIHMMPDETAQAADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLL
TPMQGEPLWVADKTQSFNAWWR
>AMJ38332.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MIEKSEMNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQ
VIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVA
ASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVAFLV
VMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLF
TENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAF
ISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFA
VIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>AMJ38291.1|FEATURES|farme|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCAWLLTASFSTFAAAKTEQQIADIVNHTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGVCRFRYPTTLQIKRHCCAFIKTGSRNGL
>AMJ38288.1|FEATURES|farme|beta_lactam|ACT-27|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQIADIVNHTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDAYLD
>AMJ38239.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRFQLEVDVIGYALSLALV
VGVLFSMGFGILADRFDKKRYMVWSVLVFILGFSAIPLVNNAPLVVIFFALIRR
>AMJ38198.1|FEATURES|farme|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|0
MEIRVFRQEDFEEVITLWERCDLLRPWNDPEMDIERKVNHDVSLFLVAEVNGEVVGTVMG
GYDGHRGSAYYLGVHPEYRARGIANALLNRLEKKL
>AMJ38193.1|FEATURES|farme|multidrug|mdtD|antibiotic efflux|0
AAYTVMQPVAGYVLDILGTKIGYAFFAIAWAVFCGSTALAGSWGGLALARGAVGAAEAAM
IPAGLKASSEWFPAKERSIAVGYFNLLWSEKKMVSCFSPPFCLGKEVSLARLSPFTLSPN
VKGGFVALLINKLCKKVLNSQKSI
>AMJ38098.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
MQDDLQTRLFTGDGPNFPEPDMSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAM
IVSMALLAGAMKSLPVGTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIG
LKLSTH
>AMJ38080.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLAGVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ38055.1|FEATURES|farme|beta_lactam|ACT-32|antibiotic inactivation|1
EVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAAKKPATPQTLFEL
>AMJ37975.1|FEATURES|farme|beta_lactam|WG5_05196|antibiotic inactivation|1
ADASLKQGIALAQSRYWRIGSMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPITP
PTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARV
>AMJ37945.1|FEATURES|farme|tetracycline|tetL|antibiotic efflux|1
MKCNECNRVKYNQILIWLCVLSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFMLT
FSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAFP
ALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITIIT
VPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHIR
KVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIFP
GTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLGG
LSFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPME
VDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRDF
>AMJ37944.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPVYHGSAKNNIGIDNLIEVIT
NKFYSSTHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKP
QQREMLLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKE
PTIIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>AMJ37927.1|FEATURES|farme|beta_lactam|mecR1|antibiotic target replacement|1
MSYNPLVHIVKRKIIHDNEVEADRFVLNNINKNEFKTYAESIMDSVLKTPFSNKNILSHS
FNGKKSLLKSRLINIKEADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPL
QSDYQILDESKNFGSNSGSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRH
IISDKNSRMSWNHKHYLFESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNY
GNENLGSYKSYWMEDSLKISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYEL
YGKTGTGIVNGKYNNGWFVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLN
DQ
>AMJ37865.1|FEATURES|farme|multidrug|MdtN|antibiotic efflux|0
MKSLLSLLGRYALTLIAVAVAAFVAFIFWKQYAQTPWTRDGRVRADVVQIAPDVSGPVTS
VAVRDNQWVNRGDVLYAIDPRWLKLAVLSALADVEAKRHEMVMRQDAARRRALIKGVISS
EDIQQTGSAARVAAANYQGALAALELAQLNLSHATVRAPVAGYVTHLRLRPGDYATAGET
KVAVVDAHSFWVVGYFEETKLRHIRIGSAARISLMGFDPLITGHVESIGRGIDDNNDATG
GLGLPDVNPTFSWVRLAQRVPVRIQLDKIPE
>AMJ37809.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALANTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNILFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>AMJ37802.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>AMJ37764.1|FEATURES|farme|beta_lactam|BL2_len|antibiotic inactivation|1
MRYVRLCVISLLATLPLAGDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>AMJ37659.1|FEATURES|farme|beta_lactam|ampC|antibiotic target alteration|0
LDEVQANYILDMQLRRLTKFSTIELESERDELRERIEGLVLIVNDESELRRVVSEDLAEV
STKYGTPRRTVLLGAAPAVAAASAPLEVPDDPCWVLLSATGLLARIDTEDDLPSGGDRAS
HDVIISRARTTARGDFGIITSTGRLIRAHAIELASLPMTATAPSVAGGTPLADLVGLEKD
EKALAVTSLSGEGPSLALGTRNGIVKRVNPELLGKDFWEVISLKDGDEVVGAVELDDENL
ELCFVTEGASLLHFPATAVRPQGRSGGGVTGIKAKDPVVFFGAAPSHGSSVVTIAASSPA
AAGKEPGSVKVTPFDQFPPKGRATGGMRCQRFLKGETALVLAWIGPDPAVACAASGVPVE
LPEPSLRRDGSGDQGRQPILAVGTRNHGGDDVANPAERLDPDTSDDDLQPTDVRSGATPD
AGGALIPAPESTLAKDSEESKPHRRRRRTRTEHDDKSEPDLFS
>AMJ37645.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
LARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDK
WLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAE
SGSAVLVDVNTGEVLAMANSPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMVVMTAL
QRGIVNENTVLNTIPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVD
TYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSY
GIYRPLSITKVDPPVPGERVFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTA
KKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVL
RTMNIEPDALATGEKSEFVINQGEGTGGRS
>AMJ37639.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MKAAPKTPKAKRQEEQANFISWRFALLCGCILLALTFLLGRVAWLQVVSPDMLVRQGDMR
SLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDTRWKALANALNIP
LDQLSARINANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIG
FTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLTLSIDERL
QALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNLSGTPKEAMRNRTIT
DVFEPGSTVKPMVVMTALQRGVVRENSVLNTVPYRINGHEIKDVARYSELTLTGVL
>AMJ37597.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRYQLDVDVIGYALSLALV
VGVLFSMGFGILADKFDKKRYMVWSVLVFILGFSAIPLVNNAILVVIFFALINCAYSVFS
TVLKAWFADRLTPEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFWLAAACAAFP
LVFIQLFLQREVVVAQPGAVAWSPSVLLHDRALLWFTCSGLLASFVSGAFASCLSQYVLV
VASSDFAEKVVAVVLPVNAAVVVALQYAVGRRLSARNIRPLMTFGTVCFVIGLVGFMFSG
ASLWAWGISAVIFTLGEVIYAPGEYMLIDHIAPPGMKASYFSAQSLGWLGAAFNPMFTGM
ILTHLPHWSLFVILIVAIVAAWLMIFRGMNDG
>AMJ37592.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MDKIEVRGARTHNLKNINLVIPRDKLIVVTGLSGSGKSSLAFDTLYAEGQRRYVESLSAY
ARQFLSLMEKPDVDHIEGLSPAISIEQKSTSHNPRSTVGTITEIHDYLRLLYARVGEPRC
PDHDVPLAAQTVSQMVDNVLAQPEGLRLMLLAPIIKERKGEHTKTLENLASQGYIRARID
GEVCDLSDPPKLELQKKHTIEVVIDRFKVRDDLAQRLAESFETALELSGGTAIVANMDDE
KAEELLFSANFACPICGYSMRELEPRLFSFNNPAGACPTCDGLGVQQYFDPDRVVQNPEL
SLAGGAIRGWDRRNFYYFQMLKSLAEHYKFDVEAPWGTLSASVQKVVLYGSGKENIEFKY
MNDRGDTSVRRHPFEGVLHNMERRYKETESSAVREELAKFISNRPCASCDGTRLRREARH
VFVENTPLPTISDMSIGHAMDFFNNLKLSGQRAQIAEKVLKEIGDRLKFLKKA
>AMJ37566.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPDIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALISEADWQQAIPVSDEFTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPMQGEPLWVADKTQS
FNAWWR
>AMJ37488.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGEFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ37407.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
YFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAK
QWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFG
ALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAE
AYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVN
P
>AMJ37380.1|FEATURES|farme|beta_lactam|CMY-51|antibiotic inactivation|1
WQPQWKPGTTRLYANASIGLFGALAVQPSGMSYEEAMTRRVLQPLKLAHTWITV
>AMJ37359.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
TVLVIAGLLEVVWAIGLKYTHGFTRLTPSVITIAAMIVSIVMLSWAMRTLPVGTAYAVWT
GIGAVGAAITGILLLGESASLARIASLALIVAGIIGLKLSTH
>AMJ37326.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
MQDDLQTRLFTGDGPNFPEPDMSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAM
IVSMALLAGAMRTLPVGTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIG
LKLSTH
>AMJ37324.1|FEATURES|farme|beta_lactam|CMY-51|antibiotic inactivation|1
PPMAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTIAPLIEQQKIPGMAVA
GIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDDIARGEIKLSDPVTK
YWPELTGKQWRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYA
NSSIGLFGALAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHV
SPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGW
EMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPE
KELGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ37276.1|FEATURES|farme|beta_lactam|SHV-123|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAIT
>AMJ37171.1|FEATURES|farme|beta_lactam|blaOXY|antibiotic inactivation|1
LAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPA
>AMJ37170.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
VRDISFSVCRGEILGFAGLVGSGRTELMNCLFGV
>AMJ37119.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
GGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLCFIG
AVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAALAAI
SFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIAQSP
IIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAA
AATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLIFTV
GIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIF
>AMJ37079.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDRGTTKTDNTLLERQRGIT
IQTAITSFQWKNTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKIGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVMNFTESEQW
DMVIEGNDYLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVIT
NKFYSSTHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKP
QQREMLLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKE
PTVIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAQLPLGSGVQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>AMJ37051.1|FEATURES|farme|quinolone|qacH|antibiotic efflux|0
MSWIILFIAGLLEVVWAIGLKYTHGFTRLTPSVITVTAMIVSIVLLSWAMRSLPVGTAYA
V
>AMJ36990.1|FEATURES|farme|beta_lactam|CMY-66|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AMJ36964.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MMKLLNKALLRMSDWSRTTWCLAILMTVAFVLIGRLAQLQVFDTFDLEKKNLLQVQVDRK
LQSPRGTIYDRNGKPLAMSVVTKSLYADPKMIKQSPQEIADLISPYVTMSKENIVKALQE
DTAFVWLNRMMDADKSKAVQQVIKDNNIAGLNFVEESKRYYPNGVLAAQVLGFVGTDDKG
LDGLEMVLDDELKGGVQQEIVATDNKGNAIFGSVLSKFLPDKGKSVTLTIDATIQFIAER
ALDKAMVDTGAKHASVIVMDPKNGEILAMANRPSYDPNNYNQSGEEAFKNIAVTNLYEPG
STFKPIIASAALAAGKWKLDTVYNDKGAFAANGHIIRNWNGEGYGPVRLLDILKYSINTG
MAEIGTLTGADILSKYIRDYGFGSETGIELPGEGAGILYNPEDMSKLDVATMSIGQGIAV
TPLQMVRAFGALSNGGAMMKPHIIKSYSNSQGDVTSTTETSVVGQPVPAETAKTIVDILE
KEVSEGGGTKAMVEGYHFGGKTGTAQKLDTKHGGYLDGQYIASFIGFGPVEDPKFVVLVV
IDDPQKGSYYGSQIVAPVFKDIVSQLVRYYQMSPYVKESTPVAVKAANTLPEPKPGSDGS
VTLPNFTGFTYGEVRDWLHKAGLAFKPDGTGTATSQDESSGTTVQAGTAITVHFRR
>AMJ36957.1|FEATURES|farme|beta_lactam|MIR-5|antibiotic inactivation|1
LGGDAIARGEIALGDPVAKYWPELTGKQWQGIRML
>AMJ36896.1|FEATURES|farme|beta_lactam|MIR-12|antibiotic inactivation|1
MMTKSLSCALLLSVTSSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEVALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEVHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLEAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AMJ36796.1|FEATURES|farme|quinolone|qacH|antibiotic efflux|0
MSWIILFIAGLLEVVWAIGLKYTHGFTRLTPSV
>AMJ36785.1|FEATURES|farme|beta_lactam|MIR-10|antibiotic inactivation|1
YQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEVALDDPVAKYW
PELTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANA
SIGLFGALAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSP
GMLDAEAYGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEM
LNWPVDAKTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQ
LGIVMLANKSYPNPARVEAAYRILDALQ
>AMJ36754.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|tlrC|antibiotic target protection|1
MCIQVQQITYIHPDKEVLFRNLSFTVGKGRQLALIGNNGCGKSTLLQIMAGKLQPSSGNV
LRPDDLYYVPQHFGQYDEMSIAQALGIDRKQKALHEILNGNASIDHFNILDDDWNIEEKA
LAALNGWGLGNRSLSESMHTLSGGEKTRVFLAGLELQEPPAVLMDEPT
>AMJ36746.1|FEATURES|farme|beta_lactam|ACT-32|antibiotic inactivation|1
GMAVAVIYQGKPHYYTFGKADIAASKPVTPQTLFELGSISKT
>AMJ36721.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAGI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ36715.1|FEATURES|farme|beta_lactam|CMY-85|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFE
>AMJ36707.1|FEATURES|farme|beta_lactam|SHV-12|antibiotic inactivation|1
RTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEKLERKIHYRQQDLVDYSPVSEKHLA
DGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETEL
>AMJ36649.1|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MTFNIINLETWDRKEYFNHYFNQQTTYSVTKEFDITLLKSMIKNKGYELYPALIYTIVNI
INQNKVFRTGINSEGNLGYWDKLNPLYTVFNKETEKFSNIWTESNVSFNSFYNSYKSDLL
EYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKNNKIY
LPVSLQVHHAVCDGYHVSLFMSEFQNIVDSVNEWI
>AMJ36637.1|FEATURES|farme|tetracycline|tet39|antibiotic efflux|0
MTVNSSRNALKRRTWALFMFFFLPGLLMASWATRTPAIRDILSVSIAEMGGVLFGLSIGS
MSGILCSAWLVKRFGTRNVILVTMSCALIGMMILSLALWLTSPLLFAVGLGVFGASFGSA
EVAINVEGAAVEREMNKTVLPMMHGFYSLGTLAGAGVGMALTAFGVPATVHILLAALVGI
APIYIAIQAIPDGTGKNAADGTQHGEKGVPFYRDIQLLLIGVVVLAMAFAEGSANDWLPL
LMVDGHGFSPTSGSLIYAGFTLGMTVGRFIGGWFFYHYNRGAVGRGRALMGALGIGLIIF
VDSAWVAGVSVVLWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLVGPPLLGY
LGEHYGLRSAMLVVLALVILAAIVAKAVAKPDTKTQTAMENS
>AMJ36594.1|FEATURES|farme|beta_lactam|bla|antibiotic inactivation|1
QQKLADLEKRSGGRLGVALINTADDSQTLYRGDERFAMCSTGKVMAAAAVLKQSESHPDV
VNKRKIGFSGLEPDYRKTSAKRNDPGGTQRGGAAVQRQYRDE
>AMJ36593.1|FEATURES|farme|beta_lactam|OXY-1-1|antibiotic inactivation|1
MNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTTPLAMAESLRKLT
LGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGTTNDIAVIWPENH
APLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AMJ36558.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKAGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ36407.1|FEATURES|farme|beta_lactam|UUU_18620|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AMJ36374.1|FEATURES|farme|beta_lactam|ACC-5|antibiotic inactivation|1
LMQKNNIPGMSVAVTVNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQ
VSGKLSLDQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWK
PADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENY
AWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHT
GYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGST
NGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAY
>AMJ36360.1|FEATURES|farme|beta_lactam|BL2a_pc|antibiotic inactivation|1
KYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQIPYNKLNKKIHINKDD
IVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTN
PVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLI
KDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISE
TAKSVMKEF
>AMJ36257.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MKTISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMAN
SPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTVPYRIN
GHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGER
SGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGER
VFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAG
VAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFV
INQGEGTGGRS
>AMJ36252.1|FEATURES|farme|beta_lactam|ACC-5|antibiotic inactivation|1
MRKKMQNTLKLLSVITCLAATAQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVT
VNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYV
PELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIG
TGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNM
EILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWE
QLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSSLEGNK
>AMJ36217.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRFQLEVDVIGYALSLALV
VGVLFSMGFGILADRFDKKRYMVWSVLVFILGFSAIPLVNNALLVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIF
>AMJ36213.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHILPWEMMFVLFAVL
AAISFFGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLI
LSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG
>AMJ36166.1|FEATURES|farme|beta_lactam|HMPREF0864_03634|antibiotic inactivation|1
MIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNMEILGN
EAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPYP
VSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVML
ANKNYSIDQRVTVAYKILSSLEGNK
>AMJ36064.1|FEATURES|farme|beta_lactam|BL2a_pc|antibiotic inactivation|1
MIYKNYNCNIGGFILKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTK
SGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGK
DITLKALIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPK
SKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKTGDTLIKDGVPKDYKVADKS
GQAATYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>AMJ36037.1|FEATURES|farme|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFK
PAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQ
SADGTVWLIGTALYGLLLAICLLIRKPAPVAATC
>AMJ36016.1|FEATURES|farme|beta_lactam|MIR-2|antibiotic inactivation|1
WEMLNWPVDAKTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIP
EKQLGIVMLANKSYPNPARVEAAYHILEALQ
>AMJ36014.1|FEATURES|farme|beta_lactam|MIR-10|antibiotic inactivation|1
YFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAK
QWNGITLLHLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAE
AYGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILDALQ
>AMJ35990.1|FEATURES|farme|beta_lactam|CMY-115|antibiotic inactivation|1
MVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVS
>AMJ35980.1|FEATURES|farme|quinolone|qacH|antibiotic efflux|0
IGLKYTHGFTRLTPSVITIAAMIVSIVMLSWAMRTLPVGTAYAVWTGIGAVGAAITGIL
>AMJ35968.1|FEATURES|farme|beta_lactam|CMY-85|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPLHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQLGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AMJ35966.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
QAMNKKVEIHFLPGKNAISHISFVGRPANASFTGDGPIVLEPDMSWIVLLIAGLLEVVWA
IGLKYTHGFTRLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYAVWTGIGAVGAAITGILL
LGESASPARLLSLGLIVAGIIGLKLSTH
>AMJ35904.1|FEATURES|farme|beta_lactam|OXY-1-1|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPDVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AMJ35790.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MKAAAKTQKPKRQEEHANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVKEGDMR
SLRVQQVSTSRGMITDRSGRPLAVSVPVKAIWADPKEVHDAGGISVGDRWKALANALNIP
LDQLSARINANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIG
FTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLTLSIDERL
QALVYRELNNAVAFNKAESGSAVLVDVSTGEVLAMANSPSYNPNNLSGTPKEAMRNRTIT
DVFEPGSTVKPMVVMTALQRGVVRENSVLNTVPYRINGHEIKDVARYSELTLTGVLQKSS
NVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYG
LMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGG
GVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASQPRFALVVVINDPQAGKY
YGGAVSAPVFGAIMGGVLRTMNIEPDALTTGDKNEFVINQGEGTGGRS
>AMJ35761.1|FEATURES|farme|beta_lactam|ACT-14|antibiotic inactivation|1
QVPDEVKSSSDLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYERAMTTGCR
CLT
>AMJ35759.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
ALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVT
AAWQILNTLQ
>AMJ35577.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MINRSSSGNRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYNAGIEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLTI
>AMJ35556.1|FEATURES|farme|beta_lactam|MIR-9|antibiotic inactivation|1
MTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQR
LYANSSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKA
VHVSPGALDAEAYGVK
>AMJ35283.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRYQLEVDVIGYALSLALV
VGVLFSMGFGILADKFDKKRYMVWSVLVFILGFSAIPLVNNAILVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFWLAAACAAFP
LVFIQLFLQRDGAA
>AMJ35247.1|FEATURES|farme|multidrug|mdtG|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRYQLEVDVIGYALSLALV
VGVLFSMGFGILADKFDKKRYMVWSVLVFILGFSAIPLVNNAILVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFWLAAACAAFP
LVFIQLFLQRDGAAAAQPGAAVWTPSVLVRDRALLWFTCSGLLASFVGGAFASCISQYVL
VVASSDFAEKVVAVVLPVNAAVVVALQYAVGRRLSARNIRPLMTFGTVCFVIGLVGFMFS
GASLWAWGISAAVFTLGEVIYAPGEYMLIDHIAPPGMKASYFSAQSLGWLGAAFNPMLTG
LILTHLPHWSLFV
>AMJ35191.1|FEATURES|farme|beta_lactam|SHV111|antibiotic inactivation|1
MTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGD
ARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTG
AGERGARGIVALLGPNNKAERIVVIYLRDTP
>AMJ35106.1|FEATURES|farme|beta_lactam|lactamase_B_2|antibiotic inactivation|0
DSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQAADDLRARAVLPGHAG
RFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQSFNAWWR
>AMJ35037.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGGTGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ35023.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MKAAAKTQKPKRQEEHANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVKEGDMR
SLRVQQVSTSRGMITDRSGRPLAVSVPVKAIWADPKEVHDAGGISVGDRWKALANALNIP
LDQLSARINANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIG
FTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLTLSIDERL
QALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNLSGHAERSDA
>AMJ34951.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGVTGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ34880.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGRFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ34843.1|FEATURES|farme|beta_lactam|blaP|antibiotic inactivation|1
MKKFCFLFLIICGLMVFCLQDCQARQKLNLADLENKYNAVIGVYAVDMENGKKICYKPDT
RFSYCSTHKVFTAAELLRQKNTSDLNEIRKFSAEDILSYAPITKDHVADGMTLAEICSAS
LRWSDNTAANLILQEIGGVENFKVALKNIGDKTTKPARNEPELNLFNPKDNRDTSTPRQM
VKNLQVYIFGDILSDDKKKLLIDWMSDNSITDTLIKAETPQGWKVIDKSGSGDY
>AMJ34788.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRSLQGISLC
FIGAVGYAAI
>AMJ34776.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRFQLEVDVIGYALSLALV
VGVLFSMGFGILADRFDKKRYMVWSVLVFILGFSAIPLVNNAPLVVIFFALINCAY
>AMJ34765.1|FEATURES|farme|beta_lactam|SHV-67|antibiotic inactivation|1
MLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAA
LIEHWQR
>AMJ34736.1|FEATURES|farme|beta_lactam|SHV-33|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLAPDRRQRHPP
>AMJ34702.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
QLSHLLDRKPKQLSGGQRQRVAIGRAIVRNPRVFMFDEPLSNLDAELRVDMRLHIARLHQ
ELKTTMVYVTHDQVEAMTL
>AMJ34620.1|FEATURES|farme|beta_lactam|BL2a_pc|antibiotic inactivation|1
ACNSNSSHAQELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLE
QVPYNKLNKKVHINKDDIVGYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGG
IKKVKQHLKELGDKVTNPVRYETELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNK
NFLLDLMFNNKTGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIF
TNKDNKSDKPNDKLISETA
>AMJ34362.1|FEATURES|farme|beta_lactam|ACU81_15235|antibiotic inactivation|1
ASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQ
QTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGG
LPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQT
RVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQS
NLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAAR
PVKAITPPTPAVCASWVHKTGAAGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQI
LNALQ
>AMJ34261.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMAAGLSLYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLLLMVIFLKDKQMGNSHEG
>AMJ34218.1|FEATURES|farme|aminoglycoside|strA|antibiotic inactivation|1
PPLNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWL
KGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVD
QCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDM
VVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAF
AVLFNVLGIEAPDRERLAFYLRLDPLTWG
>AMJ34175.1|FEATURES|farme|aminoglycoside|K531_00085|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>AMJ34122.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MKKPLFICVVLIMILASAASLPCVLNAGFGQPPQGEQLTAVEASPQYREGKFHNTLPTPG
YNGDKNMLVAMWDFLTKKTENARPARPLPLVKTDLASLPLEQDTLVWLGHSSWYLQLAGK
RILIDPVLGNYAAPFSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATIRALLPR
VKRVVTPLGVGSHLRYWGMNPEIIDERDWNQSVRISDELTVHVLPARHFSGRGIKRDRTL
WGSFMFVTPEQKVYYSGDSGYGPHFKAIGEQFGEVDLAIMENGQYDQDWKYIHMLPEETA
QASADLGAKAVVPGHNGRFVLAKHAWNDPLIQLANASKDQNYRLLTPELGEPVRVSDTTQ
TFRTWWE
>AMJ34089.1|FEATURES|farme|multidrug|efrB|antibiotic efflux|1
YDPKKPLIQDLNFEVKAGQTVAVVGPTGAGKTTLINLLMRFYDVDKGAIRIDGIDTKSMS
RSDVRSLFGMVLQDAW
>AMJ34070.1|FEATURES|farme|beta_lactam|ACT-29|antibiotic inactivation|1
MMKKSLSCALLLSVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTRYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSFEEAMTKRVFKPLRLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGIKTNVKDMASWVMANMAPDALQDSSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVETAYRILDALQ
>AMJ34009.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
IGRFTGGWFIDRYSRVTVVRASAVMGALGIGLIIFVDNPWVAGVSVLLWGLGASLGFPLT
ISAASDTGPDAPKRVSVVAITGYLAFLVGPPLLGFLGEHFGLRSAMMVVLGLVMVAALVA
RAVAKPQHEPVMENS
>AMJ34008.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
FVDVGWIAGVSVILWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLVGPPLLG
FLGEHYGLRSAMLVVLGLVIIAALVARAVARPETKQTTLEKGYER
>AMJ33973.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
LQLAGKRILIDPVLGNYAAPYSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATI
RALLPKVKRVVTPLGVGSHLRYWGMNPEIIDERDWNQSVRISDELTVHVLPARHFSGRGI
KRDRTLWGSFMFVTPEQKVYYSGDSGYGPHFKAIGEQFGEVDLAIMENGQYDQDWKYIHM
MPEETAQAADDVRARAVLPGHAGRFVLAKHTWDDPYIRLAEASTGRPWRLLTPMLGESVW
VADKTQSFNAWWR
>AMJ33949.1|FEATURES|farme|beta_lactam|ACT-29|antibiotic inactivation|1
MMKKSLSCALLLSVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGYAIARGEISLGDPVTRYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSFEEAMTKRVFKPLRLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGIKTNVKDMASWVMANMAPDALQDSSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVETAYRILDALQ
>AMJ33701.1|FEATURES|farme|tetracycline|tetL|antibiotic efflux|1
EGVGPAIGGMIAHYIHWSYLLLIPMITIITVPFLMKLLKKEVRIKGHFDIKGIILMSVGI
VFFMLFTTSYSISFLIVSVLSFLIFVKHIRKVTDPFVDPGLGKNIPFMIGVLCGGIIFGT
VAGFVS
>AMJ33619.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MLPARHFSGRGLKRNQTLWASFLFVTRQQKIYYSGDSGYGPHFKAIGNEFGPVDLAIMEN
GQYDQDWKYIHMMPDETAQAADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAW
RLLTPVQGEPVWVADKTQSFNAWWR
>AMJ33545.1|FEATURES|NCBI|pleuromutilin|TaeA|antibiotic efflux|1
LEKPDMLLLDEPTNHLDAESVAWLERFLHDFEGTVVAITHDRYFLDNVAGWILELDRGEG
IPWEGNYSSWLEQKDQRLA
>AMJ33499.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MVGRIYHVGLTVSDLDRSIAFYRDILGLEFQGEIFMEGEETDKMFRKENCKARVAYLNGS
KALEAPPVELIQFVDSKIHKEQSDLFTTSISEVCFYTDDIDSAYKTLIENHVECLSEPQY
FDFRTDGFGESRAFYFRDPDGIILGLMQPL
>AMJ33498.1|FEATURES|farme|chloramphenicol|catD|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEYRTVINQAGELGTYDEMIPSYTIFHK
DTETFSNLWTEYMPNIEEFSRAYENGIQRYGSNHGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYKEDKKTILPLAIQVHHAVCDGFHICRFVNELQELINS
>AMJ33414.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVIFSVVAIMLLASATTLPFVLNAGFGQAPQGAQLSLVEQSPHYHDGQFHNQLPTPGF
TGQKNMLAAWWEFLVARRENARPAQPLPLVNTDLAGLPSGQDAMVWLGHSSWYLQLAGKR
ILIDPVFSNYAAPFSFINKAFTGDYPWHAEGMPEIDLLIISHDHYDHLDYATIKALMPKV
KRVITPLGVGSHLRYWGMESAIISEADWNQALQVSDELTVHVLPARHFSGRGLKRNQTLW
ASFMFVTPQQKIYYSGDSGYGPHFKAIGEQFGEVDLAIMENGQYDQDWKYIHMMPEETAQ
AADDIHARAVLPGHAGRFVLAKHTWDDPYKRLAEASTGRPWRLLTPMLGEPVWVADKTQS
FNAWWR
>AMJ33409.1|FEATURES|farme|tetracycline|tetB(60)|antibiotic efflux|1
QQAVVAGERVFELMDKPRQAWGDDSEPLRSGSITIEHLSFAYRDDSLVLQDINLDIPSRS
FVALVGHTGSGKSTLASLMMG
>AMJ33220.1|FEATURES|farme|beta_lactam|CMY-66|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISPLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AMJ33210.1|FEATURES|farme|quinolone|qacH|antibiotic efflux|0
MNKKVEIHFLPGKNAISHISFVGRPANASFTGDGPIVLEPDMSWIVLLIAGLLEVVWAIG
LKYTHGFTRLTPRNHFCGRIAGDRITSTVWLTMPVMMS
>AMJ33037.1|FEATURES|farme|multidrug|acrF|antibiotic efflux|0
IAAGIVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVE
SVFTVNGFSFSGQAQNAGMAFVSLKPWEERSGDENSAEAVIHRAKMELGKIRDGFVIPFN
>AMJ32984.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MGSHYYISQPTPLAALPLQVPDEVKSSSDLLRFYQNWQPQWKPGTTRLYANASIGLFGAL
AVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAY
GVKTNVQDMANWVMANMAPEKVADASLKQGI
>AMJ32974.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MGSHYYISQPTPLAALPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGAL
AVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPARVTAAWQILNTLQ
>AMJ32916.1|FEATURES|farme|beta_lactam|CMY-48|antibiotic inactivation|1
NWQPQWTPGAKRLYANSSIGLFGALAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQ
KNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQ
SRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKT
GSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>AMJ32889.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
LCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAGAVIYQGKPYYFTWGYADIA
KKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHL
ATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLS
FEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIED
MARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDN
KIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPAR
VTAAWQILNTLQ
>AMJ32752.1|FEATURES|farme|beta_lactam|CMY-51|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSGTKKLCLGLSRREACTRFSGTT
>AMJ32733.1|FEATURES|farme|beta_lactam|BL1_ampc|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADVSLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEALQ
>AMJ32662.1|FEATURES|farme|beta_lactam|CMY-101|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTKRVLHPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AMJ32622.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
WGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIALGD
>AMJ32542.1|FEATURES|farme|beta_lactam|ACT-17|antibiotic inactivation|1
PLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDA
IARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQN
WQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEA
HYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQS
RYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTG
STGGFGSYVAFIPEKQIGIVMLANTSYPNPARVEAAYHILEALQ
>AMJ32516.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
VMNRVTFSVVAIMLLASATTLPFVLNAGFGQAPQGAQLSLVEQSPHYRDGQFHNQLPTPG
FTGQKNMLAAWWEFLVAKRENARPAQPLPLVNTDLASLPLGQDAMVWLGHSSWYLQLAGQ
RILIDPVFSRYAAPFSFINKAFAGDYPWHAEGMPEIDLLIISHDHYDHLDYATIKALMPK
VKRVVTPLGVGSHLRYWGMESAIISEADWNQAVPVSDELTVHVLPARHFSGRGLKRNQTL
WASFMFVTPQQKIYYSGDSGYGPHFKAIGEQFGAVDLAIMENGQYDQDWKYIHMMPEETA
QAADDVRARAVLPGHAGRFVLAKHTWDDPYIRLAEASTGRPWRLLTPMLGEPVWVADKTQ
SFNAWWR
>AMJ32512.1|FEATURES|farme|chloramphenicol|cmx|antibiotic efflux|1
VTVTAFVAMFASLFITQTIQATDRRYVVILFAVLLTLSCLLVSFANSFSLLLIGRACLGL
ALGGFWAMSASLTMRLVPPRTVPKALSVIFGAVSIALVIAAPLGSFLGELIGWRNVFNAA
AAMGVLCIFWIIKSLPSLPGEPSHQKQNTFRLLQRPGVMAGMIAIFMSFAGQFAFFTYIR
PVYMNLAGFGVDGLTLVLLSFGIASFVGTSLSSFILKRSVKLALAGAPFVLALSALVLTL
WGSYKIVATGVAIIWGLTFALIPVGWSTWITRSLADQAEKAGSIQVAVIQLANTCGAAIG
GYALDNIGLTSPLMLSGTLMLLTALLVTAKVKMKKS
>AMJ32503.1|FEATURES|farme|multidrug|bepE|antibiotic efflux|1
ATNAGTVSITVYFKQGTDPDMAAVNVQNRVSKATGQLPSEVNQVGVTTSKRQTSILQMFS
LHSPDDSYDEAFLANYISINLKPEILRISGVGDMMIMGGDYSLRIWMKPDVMAQYRLIPS
DVSTVLAEQNIESATGSFGENSDETYQYTMKYKGRRITPEEFGEIVIRSTDDGQVLKLKD
IATIELGQESYAYSGTTDGHNGVSCMLFQTAGSNATEVNNQINRFLEEARKELPQGVELT
QLMSSNDFLYASIHEVVKTLLEAILLVILVVYVFLQDIRSTLIP
>AMJ32461.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVGFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLF
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLLLMVIFLKDKQMGNSHEG
>AMJ32408.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MLNRSSSGSRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVAQYNAGIEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQNIEQFTLLRFLQGVSLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHMAPWEGMFVLFAVL
AAIAFFGLHRAMPETATRIGEKLSLKELGRDYKEVLKNGRFVAGALATGFVSLPLLAWIA
QSPVIIISGEKLSSYEYGLLQVPIFGALIIGNLVLARLTSRRTVRSLIIMGGWPIAAGLI
LAAGATVASSHAYLWMTAGLSIYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIEVSKHAYAMGGNGLFSLFNLANGVLWVGLMVVFLKDKRVGNALQP
>AMJ32334.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
ELDGLLKRRPRELSGGQRQRVAMGRAIVRDPAVFLFDEPLSNLDAKLRVQMRLELQQLHR
RLKTTSLYV
>AMJ32276.1|FEATURES|farme|beta_lactam|AE24_04439|antibiotic inactivation|1
TASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVT
QQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAG
GLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQ
TRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQ
SNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAA
RP
>JX009307.1_1068|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
TVRSYSNVSIGALGWLTARAMQGDFATLMAEHVFKPLDLRHTFIRVPEAEQANYAWGYKD
GKPVRVTPALFEPDRCAAILPPTTVNSLTCCASSKPISDSRYPIANCAMRSTPRAPAITS
MPP
>JX009233.1_1133|FEATURES|farme|beta_lactam|BL1_sm|antibiotic inactivation|1
MTKINRLAAALFAALILPAGHAADKADIDAIIQPLMQKYAVPGMAIAVSVEGKQQFYHYG
VASRQTGKPITNQTLFEIGSLSKTFTATLATYAVSEGKMSFADPASRYLSALRGSAFDHV
TLLNLATHTSGLPLFVPDDVTNDAQLMAYYRQWQPPHAVGSYRVYSNLGIGMLGMITAKS
LNQSFTQAMEKQLLPALGMNHTYIKVPAEEMANYAQGYNKKDQPVRVTPGPLDAEAYGIK
SNAQDLIRYLDANMQVVKVGDPWRKALAATHTGYYRTGVFTQDLMWESYAYPEKLATLTE
GNNAGMIMNGAPATAITPPKQDQGAAWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFP
NDDRVAATYRIVQALDKR
>JX009215.1_1148|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
MPHKIQFAVRHITTLGFFLTAGHCLAADDLRAVVDASVKPLMQQQSIPGLVVGVVKDGKA
QYFNYG
>JX009213.1_1150|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
AGRFVWKPDPMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIY
QGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWP
ELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSS
IGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPG
ALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEML
DWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFI
>JX009324.1_1201|FEATURES|farme|beta_lactam|AK972_2544|antibiotic inactivation|1
MYTSLFPTVRNTAIFALLLGAGNCMAATDIRQVVDSTVEPLMQQQDIAGLSVAVIQNGKA
QYFNYGVANKDSQQPVTENTLFEIGSVSKTFTATLAGYALANGKLKLSDPASQYLPALRG
DKFDHISLLNLGTYTAGGLPLQFPEESDNTGKMISYYQHWKPDFAPGTQRLYSNPSIGLF
GHLAAQSLGQPFDRLMEQTLLPKLGLKHTFITVPKAQMNLYAQGYDKAGKPVRVGPGALD
AEAYGIKTSTSDLIQYVEVNMHPAKLEKPLQQAIAATHTGYYTVDGMTQGLGWEMYPYPI
TLDALTEGNSAQMAFQPHKVSWLTPPQAPHADTLVNKTGATGGFGAYVAYVPSKGVGVVI
LANKNYPNAERVKVAHAILSALDH
>JX009322.1_1204|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MNHSLQKILFSALLISSGSCMAATDLRTVVDAGVKPLMQQQGIPGLSIAVVNQGKVQYFN
YGVASKETKQAVNQDTLFEIGSISKTFTATLGGYAQATGKLKLSDTASQHLPALAGVFDH
ISLLQLATYTAGGLPLQFPQSADTAQAMLGYFQHWTPTYAPGEQRLYSNPSIGLFGYLAA
QSLGQPFNVAMESTLLPKLGLSNTHVRVPTGKSEQYAQGYDKDQKPVRVTPGALDSEAYG
IKTSTQDLARYVIANLHPETLEKPLQQAIATTHAGYYTVNGMTQGLGWERYPYPIKLQAL
LDGNSTEMAMQPHKVNWLTPAQPQPANVLYNKTGSTGGFGGYVAYVPSKDMGVVILANRN
YPNAERVKLAYAILSAMDH
>JX009300.1_1219|FEATURES|farme|beta_lactam|PMI39_02504|antibiotic inactivation|1
VKLISQTLIATALTSACSLAFAETADVQATVDQAIKPLMQQQAIPGMAVAVVVKGQPHYF
TWGMADVKQQRPVTQDTLFELGSVSKTFTGVLGGVAVNKGEIALSDPARKYWPALNTPQW
RDITLLQLATYTAGGLPLQVPDAVTDEKALANFYQQWQPQWAPGNTRQYANSSIGLFGWL
ATKPSGLTFEQAMQQRVFMPLQLKHTFITVPNTAKENYAWGYREGKPVRVSPGMLDAEAY
GVKSSIKDMARWMQANMNPQQINDKTLQQALDFAQTRFYRTDALYQGLGWEMLDWPAQAE
MAVKGADNKVALGPQPVRDAKSHPRVTASWVHKTGATGGFGAYVAFIPAKQVGIVILANK
NYPNTERVKAAMQILKALQ
>JX009294.1_1229|FEATURES|farme|chloramphenicol|cmlv|antibiotic inactivation|1
QHWGWRITFGLVAVLVFICLLALVRLLPAIAAGRTLKMAEEIKAFKNKAYWKACTTSCLI
LGASFAAFSYFVPVLVDVSGFSMQTVPFILMLYGLANIVGNMITGRLAYRHSLAIMVVGL
SILSLSLFGMALFAEYPLIAICAVILIGLSGVPMNPAMMARIVSVAHPGPMVNAVHTSVI
NIGLGGGSYLGGMAIASGYGLRSALWIGMALAVLALLSILPYLRRGQQGWR
>JX009220.1_1291|FEATURES|farme|beta_lactam|AV650_28380|antibiotic inactivation|1
HKTGATEGFGAYVAFIPEKQIGIVMLANKNYPNQERIKTSYAILEALQ
>JX009214.1_1295|FEATURES|farme|beta_lactam|AV650_28380|antibiotic inactivation|1
MKKNFNKVLAITSLMVSMAPFAAQKSLTAEQISQIVNGTVKPLLEAQSIPGMAVAVIYQG
QPYYFTYGQADIKKNLPVTKKTIFELGSVSKTFTGVLGGDIITRGEMKLSDPVTKYWPQL
TGSQWKGINMLHLATYTAGGLPLQVPDSVTDDASLLNFYQNWQPQWKPGTMRLYANASIG
LFGHLAVKPSSMTFEQTISQRVFQPLQLTHTWINVPKSAEKEYAWGYSNGQPVRVSLGML
GAESYGVKSTIEDMTVWLKANMTPQHLNDSTLKQGILLAQSRYWRVGNMYQGLGWEM
>JX009212.1_1296|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
PAGHAADKVDIDAIVQPLMQKYGVPGMAIAVSVEGKQQFYHYGVASKQTGKPITNQTLFE
IGSLSKTFTATLASYAQQQGKLSFSDPASRYLPQLRGSAFDGVTLLNLATHTSGLPLFVP
DDVTNNAQLMAYYKNWRPQQPAGSVRVYSNLGIGMLGMITAKSLNQPFAQAMERQLLPAL
GMSHTYIHVPTDQMANYAQGYDKGDKPVRVNPGPLDAESYGIKSNAQDLIRYLDANMQQV
KVADKWRGALAATHVGYYKAGVFTQDLMWENYPYPVDLARLTEGNNAGMIMNGTPATAIT
PPQPEQTAGWYNKTGSTGGFSTYAVFIPAKKIGVVMLANKWFPNDDRVAATYRIVQALEQ
R
>JX009206.1_1305|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALLAALILPAGHAAEKQDIDAVIQPLMKKFGVPGMAIAVTVDGQQRFYHYG
VASKQTGQPITNQTLFEIGSLSKTFTATLAAYANDEGKLSFAEPASRYLPELRGSAFDHV
SLLNLATHTSGLPLFVPDEVTNDAQLMAYYKQWQPSQPAGSTRVYSNLGIGMLGMITAKS
LNQPFAQAMEQRLFPALGLTHSYINVPTGQMANYAQGYNKKDQPVRVTPGPLDAESYGVK
SNAQDLIRYLEANMQVAKVGDKWRKALDETHTGYYRAGVFTQDLMWESYPYPVALARLTE
GNNAGMIMNGTPATAITPPQREQGAAWFNKTGSTGGFSTYAVFLPKQKIAVVMLANKWFP
NDDRVAATYRIVQALEKP
>KF630355.1_11331|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQTGEYQTNLICMSKISIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTIVMGRKT
FESLPKGALPNRRNVVLSSNPAAECPGAEVFPSLEAALQSCKEDEHVYIIGGASVYQQAL
PFADELCLTEIDNTAPEADAFFPEVSPAVWHEKNREAHPADEKHLCSYAFVDYVKA
>KF630338.1_11371|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
VAGMTCKLSAIVAVCEDWGIGCEGDMVVSNRADMRHFVTCTKGRPVIMGRKTLLSFPGGR
PLKNRRNIVLTRDKGFAAEGVDVVHSIDEALAAVADEPVAWVIGGGEVYRQFLPYCAEAE
VTHNHCVHVVDTYFPDLEADPAWEIAQRSGVATIAAGEGDEGVDYEFVTYRRIEA
>KF630332.1_11390|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
VIQLTDINKTYNNGAPLHVLKGINLTIGRGEFVSIMGASGSGKSTLLNILGILDNYDTGD
YYLNNVLIKDLSETKAAEYRNRMIGFIFQSFNLI
>KF630311.1_11445|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRNPLSRKIVEIQPSGIRKFFDVANEMKDAISLGVGEPDFDTPWRIREEGIFSLEKGRTF
YTSNAGLKELREEICSYLERKIGVSYDPMQETMVTVGGSEAIDVALRCMLDPGDEVLIPQ
PSYVSYLPCTIMADGVPVIIPLQYENEFKLTVEDLKKAVTPKTKVLVMPFPNNPTGSIMT
KADLEPVAEFIKEHDLYVLSDEIYSELSYQGDHVSIAALPGMRERTIVINGFSKGFAMTG
WRLGYCCGPKLIIEQMVKLHQYAIMCAPTNSQYAAIEGLRHCGDEVEEMRKSYNQRRRFL
MHEFKRMGLECFEPFGAFYVFPNISEFGMASEEFATRLFDGRKSCGGAGNCIWRVWRGIL
AYFLCIFSGRSERWRWEDWSALLKN
>KF630291.1_11494|FEATURES|farme|beta_lactam|ACT-1|antibiotic inactivation|1
MLDAEAYGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEML
NWPVDAKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGVGSYVAFIPEKQL
GIVMLANKSYPNPARVEAAYRILSAL
>KF630280.1_11517|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
VQKKEEMNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNG
LPLKNRTNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESIYRMMLPYCS
KVYVTKIDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF630279.1_11521|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALKSAMDEILWIWQKKSNNIHDLHSHIWDSWADESGSIGKAYGYQLGVKHQYKEGMM
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNDKLTLNAIL
NQRSQDILAANNWNVCQYALLLMMMAQVCDMEAGELLHVVADCHIYDRHIPLIKELIQRK
PYPAPVVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPIAV
>KF630279.1_11522|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRIN
IVITSNKEYEVKGAIIVHSIEEALEEIKKYPAEDVYCIGGDSIYAQMLPYCDVAHVTKID
FAYEADSHFPNLDEDDEWEITGESDEQTYFDLEYQFVKYERKK
>KF630255.1_11571|FEATURES|farme|multidrug|mexf|antibiotic efflux|1
DQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTT
TTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGII
LLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFAT
GAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQERFSKKQ
>KF630242.1_11594|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>KF630240.1_11599|FEATURES|farme|chloramphenicol|BN452_01100|antibiotic inactivation|1
MGYQEIDLETWPRKEHYLHFTKQAKCFVSITKDVDVTQLRAAAKTCGRSFYIAFLYVICK
VINRHGEFKLAYLPEEEKLVQWDEVLPSHLVFHEEDETFTCIWSRWEPDFEAFYRGCQED
IAAG
>KF630239.1_11602|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKAILSADRKWGLGYQGRLLVSIPSDLRFFRETTMGHVVVMGRKTLATLPAGQPLKGRTN
IILSRDPEWTVRGATVVHSIKELMEVLKPYEDDDIYVAGGGEIYRQLLPYCDTAYVTRID
MTYQADTFFEDLDESPDWEMVEEGDEQTCFDIEFYFTEYRRKNEKAERPR
>KF630237.1_11605|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTK
>KF630210.1_11669|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|0
VVNSSSAYATGTYMKSSTVTIAGKTGTAETYAVDANGNAVTTVNLSVLAYDYSTSDDSHI
AVAVIVPHLTSSDNHTNQYIARDIINLYMSTYVNQ
>KF630174.1_11749|FEATURES|farme|multidrug|MdtO|antibiotic efflux|0
MRAFIYQIGLNWKLNLRSKELFVHYYVVPLVFYLFIGGVFISILPDADKTIIQVMSVFAI
TMGGVLGSPYPLVEFYHSDIKKAYQVGKIPLWTIAASNFISGIMHLFVMSLIILISAPII
FKAQIPENIFIYLFVVILFIIVSLSIGMVFGVFFKSAAKMGMATQLVFLPSIML
>KF630174.1_11752|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQKLLVLCGGQSSEHIVSRMSCTSVLNNLDANKYEITLVGIDLDGGWHYLDAKQTDLAK
NTWLDNSSMVEDVYGLLKNQDVAFPVLHGMYGEDGTIQGLFELAKLPYVGCRVMGSSVAM
DKIYTKKILDTVGVPQVKSVYVKKRYDEKLVVVTNTFDEIEEIEDYIVRELGMPCFIKAS
RSGSSVGCYRCDNQTELIGKLSEAAKYDRHVVVEECIDCIELETAVLGNDDVIVSRVGQI
MPHGEFYTFESKYEDEESKTCIPALVDEQIQEQIRQYAIKVFKAVDGHGLSRVDFFLDKK
TNKIYLNEINTMPGFTKISMYPQLMNDFGITYPELLDRLIVLALQK
>KF630173.1_11762|FEATURES|farme|tetracycline|tet39|antibiotic efflux|0
MTVNSSRNALKRRTWALFMFFFLPGLLMASWATRTPAIRDILSVSIAEMGGVLFGLSIGS
MSGILCSAWLVKRFGTRNVILVTMSCALIGMMVLSLALWLTSPLLFAVGLGVFGASFGSA
EVAINVEGAAVEREMNKTVLPMMHGFYSLGTLAGAGVGMALTAFGVPATMHILLAALVGI
APIYIAIQAIPDGTGKNAADGTQHGEKGVPFYRDIQLLLIGVVVLAMAFAEGSANDWLPL
LMVDGHGFSPTSGSLIYAGFTLGMTVGRFTGGWFIDRYSRVAVVRASALMGALGIGLIIF
VDSAWVAGVSVVLWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLVGPPLLGY
LGEHYGLRSAMMVVLALVILAAIVAKAVAKPDTKTQTAMENS
>KF630166.1_11775|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HVFDNNVDQFLEQLGRKPYPYPTIEIRKADSLFDYQYEDFKVVGYQHHPTIKAPVAV
>KF630142.1_11841|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELVVSLRSAQGLYSFIDKERYNLYIVEMEGHRWEVVLPDGSKTPID
RNDFSFMEDGEKKQFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTC
NQYLKGFGIRVAESLILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQP
AIEKAFEESDEVMIEAFMKGTEITCGCYKTSDKEVVFPITEVVSANEFFDYGAKYNGESQ
EITPARLPEDTAERVRLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF630139.1_11849|FEATURES|farme|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQ
IPTIIFINKIDRAGVNLERLYMDIKTNLSQDVLFMQTVVDGSVYPVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQVASSKAITDLQKLMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSMSLK
>KF630136.1_11857|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVHDLKSHVWDEWADEDGSIGKA
>KF630136.1_11859|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIVNADKNWGIGKNNELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGMPLPKRTN
IVLTHDKDYDAKGAIVVGSKEELLDELEEYKDEDIFIIGGESIYRMMLPYCDKAYVTRTD
FAYDADTYFPNLDEMPEWKLVKESEEETYFDIEYQFVVYGK
>KF630135.1_11863|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
AMDKSITKQFFRAHHVPTPNGVTLKKGQESEPLSGFGLELPVVVKPCCGGSSVGVYIAHT
NEEYWQAMKDAFSYEPEVVVEEYIEGREFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAG
ATVDTCPAVLTEEQTKEMQKHAEDGAAALGIENYCRLDFMMRKDGRMYCLEANTLPGMTP
TSLLPQEAQVLGISYPELCELLIQLSLRKRGKNE
>KF630132.1_11871|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEEGVWSEQARPKYKDGTTANSKYITGAFAEYDLSKGEFPITTLRPIAIKCAIKEVFWIY
QDQTNSLDVLEDKYNVHYWNDWEVEGVPANNGDKRSIGQRYGAVVKKHDIINRLLAQLEA
NPWNRRNVISLWDYEAFEATAGLQPCAFQTMFDVRRVGEDIYLDATLTQRSNDMLVAHHI
NAMQYVALQMMIAKHFGWKVGKFFYFINNLHIYDNQFEQAEELLKRQPSDCQPRLVLNVP
DGTNFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF630126.1_11892|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
VVFDEPTIGLHPLDVLVLLRVFDSLVASGATVVVIEHDLDVIANADYLIDMGPGGGMAGG
RIVCEGTPETVRACPDSVTGRYLRG
>KF630118.1_11910|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|1
VRIFETLDVTPEIRNKPDAADLPQIRGRVDFNDVVFRYEKDGRNILNLVDFHVEPGRTIA
LVGPTGAGKTTIINLLSRFYDVSEGSVTIDGYDVRDVTLASLRRQMGVMLQDTFIFSGNV
RENIRYGKLDATDEEIEAAAKAVHAHEFIMELPDGYDTVVEERGSTLSAGQRQLIAFARV
LLADPRILILDEATSNIDTRTEEALQAGLQHLLKGRTSFIIAHRLSTIENADEIFYIDHG
QIVEHGSHAQLLSGK
>KF630114.1_11923|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GSIGKAYGYQMQVKHQYKEGMMDQVDRVLFDLKNNPYSRRIMTNIYVHQDLHEMNLYPCA
YSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQACDMEAGELVH
VIADCHIYDRHIPVIKELISRKPYPAPTVKLNPEIKDFYKFTTNDLIVENYETWPQIKNI
PIAV
>KF630108.1_11931|FEATURES|farme|chloramphenicol|cmx|antibiotic efflux|1
MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAA
FARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLV
PANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTN
NVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEA
WVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLV
LVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLA
PVWVASVLTAIALVIMLLTRRALTKTAAEAN
>KF630104.1_11939|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKDRKIIVLMGGPSKEAEVSRRTGAAIAEALESKGYNAQTLELNPRTVLKDIESLGGEIV
FNAIHGRYGEDGALQGLLEMAEIPYTGSGIMAHAVGMNKKVSKDVFKGANIPTATSESFN
GNLESAEAIIGHIRRQFTIPVVVKSATQGSSIGVTIVRDEAQLEAAVTEALKYDPILVVE
QFLDGREFTVSVLDGKALSVIEIRPHSGEYDYTSKYTVGATEYLVPAPISEEMTAEMQRI
GELVYREVQGSGVIRVDIMTDHADNMYVLEYNTVPGMTATSLVPKAAKEMGIDFPTLCEK
ILLTASIGKF
>KF630094.1_11963|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVAVDKNWAIGKDNKLLVSIPADMKMFRQETTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTGNKDYNVKDAIIVHTVEELLEEIKKYPSEEVYCIGGDSVYKQLLPYCDTAHVTKID
FAYDADTYFPDLDADPEWEMTKISDEQTYFDLEYVFVIYERR
>KF630093.1_11967|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EGVEKSDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIYELLWFLQGDTNVKYLQ
DNGVRIWNEWADENGDLGHIYGYQWRSWPNYKGGFIDQISEAVETIKHNPDSRRIIVSAW
NVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTG
LKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRDLPQMRINPDVKNIFDFKFEDFELVNYN
PHPHIAGKVSV
>KF630090.1_11971|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
HVPMIEELIKREPLPAPKFWLNPEIKDFYQFTRNDVKLIDYETHEQIKDIPVAV
>KF630086.1_11981|FEATURES|farme|beta_lactam|Reut_A1684|antibiotic target alteration|0
MQQYLDLLRKIQQDGIVKSDRTGTGTRSIFGYQMRFDLEAGFPLLTTKKVFLKGVIYELL
WFLQGDTNIKYLLDHGVHIWDNDAYRYYNEL
>KF630080.1_11993|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRPVWEDGTSAYTIKKFGIVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTKEEGSEQLTLNGILNQRSQDVLTA
NNWNVCQYAVLLHMFAQVCGMKAGELVHVIADAHIYDRHIPLIEELISREPLPAPKFWLN
PEVKDFYDFTPDDVRLEDYETHPQIKNIPVAI
>KF630080.1_11994|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKAIVAADRNWGIGYQNRLLVSIPSDMKFFRQTTTGHVVVMGRKTLESFPNGLPLKNRTN
IVLTANKDYAVKDAIIVHSEKELLEELKKYDTDEIYVIGGESVYRMMLPYLDTIYVTKID
HAFQADTFFPNLDELEDWEMTEEGDEQTCFDLEFAFTRYERR
>KF630074.1_12008|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QYAAKMHMLAQVCDMKVGELVHVIADAHIYDRHVELVKELITRQQHPAPKFWLNPEIKDF
YQFTPDDIKVTDYVTGPQIKNIPVAI
>KF630067.1_12027|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPAPK
VNLNPEVKDFYKFTVDDFTIEDYEAGPQIKNIPIAI
>KF630061.1_12037|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVCD
MKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYEFTPDDVRLDGYE
THPQIKNIPIAV
>KF630054.1_12057|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLKNRRNIVLTRDEDFAVEGVDVVH
SIDEALAAVADEPVAWVIGGGEVYRQFLPYCAEAEVTHNHCTHAVDTYFPDLDADPAWEI
AWRGGVATIASGEGDEGVDYEFVTYRRVEA
>KF630054.1_12058|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVSMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWIYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRELI
>KF630041.1_12088|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VKEVLSLWQKRETERQENRMSYADKVFINMCRDIIENGTSTEGEKVRPKWEDGTAAYTIK
KFGVVNRYDLSKEFPALTLRRTAIKSCVDELLWIWQKKSNNVHELKSHIWDSWADENGSI
GKAYGYQMQVKHQYKEGMMDQVDRVLYDLKENPYSRRIMTNIYVHEDLHEMNLYPCAYSM
TFNVTKEEGSEQLTLNGILNQRSQDVLTANNWNVCQYAVLLHMFAQVCGMKAGELVHVIA
DAHIYDRHIPLIEELISREPLPAPKFWLNPEVKDFYDFTPDDVRLEDYETHPQIKNIPVA
I
>KF630032.1_12116|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
CYGDVVGRKFLYKGEQIDQMDYVLKQLKENPYSRRIMTNLYQFEYLHSGALDPCCYSMTY
NVTKERNSEKLALNGVLNQRSQDVLAANNWNVCQYALLLMMVAQVNDMIPGELVHVIADA
HIYDRHVDAVKELIARETYPAPKVSLNPEIKDFYDFTTEDLVVENYEAGPQIKNIPIAV
>KF630019.1_12153|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
SRPTEYQANVPHYFLNIDRDKGQLMGIPLNSVFTALGYYMGEAYVNDYVQFGHIYQVKLG
AGDRAQRVIDDVLKLSVPNASGEMVPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPG
SSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYE
SWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFR
AQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALN
TLLATVYIPNFYELMQKLQEKFSKKQ
>KF630011.1_12171|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SSHVWDEWADETGSIGKAYGYQMGVKHKYKEGMFDQVDRVIYDLKNNPFSRRIMTNIYVH
QDLSEMHLYPCAYSMTFNVTQKKGDDKLTLNAILNQRSQDILAANNWNVCQYAVLMHMLA
QVCDMRVGELVHVIADAHIYDRHIPIIKELIQRPTYDAPTFWLNPDVKDFYEFTRNDVRL
DNYVTGPQIQDIPIAI
>KF630010.1_12173|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
HKSGDPYLNHTRPSSAVRLLEKFIQQELLSPVYQKFLENTMIATSTGSDKLKGLLPAETI
IGHKTGSSDRDSTGMKAGDNDMGFVYLPHGGDHYTIAVFITDSMEDDKTNAAIIAQISKA
VYDYINEISS
>KF630003.1_12189|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VESCNTGKRIGMNIIALADKNWAIGNNGRLLVDIPEDKKLFRGETYGKVVVMGRKTYEGL
PNQSALEGRKNIVLTNNLNYKAKDVLICHSVQEVLEQLKSYDSKDVYIIGGGQIYEQFLP
YCDTAHITRVDYKYQADTYITDFD
>KF630000.1_12198|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SSHVWDEWADETGSIGKAYGYQMGVKHKYKEGMFDQVDRVIYDLKNNPFSRRIMTNIYVH
QDLSEMHLYPCAYSMTFNVTQKKGDDKLTLNAILNQRSQDILAANNWNVCQYAVLMHMLA
QVCDMQVGEFVHVIADAHIYDRHIPLVEELISREPLPAPTFWLNPEVKNFYEFTPDDVRL
DNYETGSQIKNIPIAV
>KF630000.1_12199|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAVDKNWAIGLHNKLLVSIPADMKFFRETTMGKVVVMGRKTLESFPGGQPLKKRTN
IVLTSDKNYKVKDAVVVNSVEALLEELRQYNDEDIYVIGGESIYRQLLPYCKVAHITKID
HAYEADTYFPNLDEMPEWKITGVSEEQTYFNLEYEFVKYERIG
>KF629997.1_12204|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLYDEQYLTIAQNILDHGYYDTNRTGVPTYKLPHQIMQFDLEREFPILTTKKVAFKTAV
KELLWIFKEQSNDVKRLQEQNVHIWDEWEMEDGTIGTSYGWVVQKFHQMDTLLQQLKTNP
QDRRMMLNLWQIPYLDTGALYPCCFLTMWDVTDGRLNCMLVQRSADWGLGVPFNTSQYAV
LVHLLALVSNLRPGLLTHVINNAHIYENQVEGIRLQLTRRAEAYEAPTLWVNPEIQNFYE
FQIQDIKLMGYKSHDKISMEVAV
>KF629993.1_12220|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIVAVARNGVIGGGNTLLWHISEDLKRFKALTTGHPVVMGRKTFESLGRPLPNRTNV
VVTRQHIEIPGCTVAGSLEEALALFPAQEEVFVTGGGQIYAQALPLADRIYLTTVMRDYE
GDTRFPDWNRSGWTEVFREYHERGKDFPYPFEYTDWVREE
>KF629992.1_12222|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YFKTCIDELLWIWQQKSNNIHDLRGHIWDSWADGTGSIGKAYGYQLAVKHQYPEGEFDQV
DRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVTGDTLNANAILNQRSQDM
LAANNWNVVQYAVLVHMLAQVSDLVPGELVHVIADAHIYDRHVPIIEKMLAQTPSSAPVF
RMDPSVTDFYAFTRDSFSLEDYIPAPFEDQIPIAI
>KF629992.1_12223|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
VNAIVVVDQNWAIGRDNDLLFSLPTDMKRFRSLTLGGTVILGRRTLDSFPGGRPLPKRRN
IVITHCPDFSREGAETVSSLAAMREATAGTPPDQLWVIGGGSIYAALLSQCARAYVTRVD
AAAEGADSFFPNLDKLPGWTVRAVSEPVTENGLTYRFYDYVNTKLCD
>KF629990.1_12230|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
LQVSHIYDKHVPLVEELITREQHPAPKFWINPEIKNFYDFTVDDLKLIDYETGPQIKNIP
VAV
>KF629983.1_12248|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKSRSLLSKAVVSSLLLFQVLSVSASDLTSDIQEVIKGKKAQVGVAVLYKDDAFTANNDD
QYPLMSVFKFHIALAVLKKMEKEGIPLTAVVTLGPSDIDTKTWSPMYKKYKSKKITLSYG
DLINYMVSQSDNNACNWLINFVGGIQNVNDFIKNLGIDRIQLIETEKSMEQDIRKSYNNW
STPLSVTQLLRKVYTEKVLSDEHFAFLGRAMLASASGKDKFRAGLPKEVEVGHKTGMSYR
TPEGIRICDADVGVIYMPGGEKCYLAVLVKDSKESDAANAKIMADIAKKVYSHYTENAGK
NSAAAK
>KF629976.1_12271|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSKIALIAAVAEKGAIGRDQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTSLSWTNVTVVHTLNEILIQDTTEDEIFIMGGATLYNETIKIADTLYITHIH
HTFDDADTFFPTINPSEWEIANSQEMPADEKHAYPYTFVTYTRRRIENREPSDK
>KF629974.1_12277|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MISLIVAVAENGVIGDRNALLWHISEDLRHFKAVTTGHPVVMGRKTWESLGRPLPNRTNV
VITRQNIEIPGCTVAHSLEEAVALFPADEEVFVIGGAQIYAAALPLARKFYLTRVFRAYE
GDTRFPAWDEREWRLVSSESFSGGKDYPWPFAFELYERR
>KF629973.1_12280|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPREYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLNKVRHMFQKVM
>KF629968.1_12295|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MTNDTIVASQAIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVLSSSVA
MDKIMTKHILEVAGVPQVAYTVYIEGEDLEAAVAETLEKLTFPVFVKPANMGSSVGISKA
ENEAELRAAIDLALKYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAFYDYQA
KYIDNKITMDIPAHVPAEVMTQMRAYAAKAFRALGGCGLARCDFFLTEDGAIYLNELNTM
PGFTQWSMYPLLWENMGLSYSDLIKELVALGQEMFEKRESHLI
>KF629966.1_12300|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAADANWGIGRENKLLVSIPADMKFFRTTTTGKVVIMGRKTLESFPGGLPLKNRVN
IVITRDKNYKVKDAVVVHSIEEALEEAKKYSQEDVYVIGGDSIYKQMLPYCTKAHVTKID
FAYEADTFFPNLDEDEQWEVTERSEEQT
>KF629965.1_12301|FEATURES|farme|multidrug|ABC_transporter|antibiotic target protection|1
KTLLFPGVTDLTKTVGDGKVLGHVSFTIRPNEKVAFVGSDTVAKTTLFQILAGELEPDEG
SYKWGVTTSLAYFPSDNSAFFDGCELTLIDRLRQFSREQLETDIRGWLGRMLFAGEEATK
KAKVLSGGERVRCMLCKMMVSGANVLILDEPTNHLDLESITALNNGLISFPGTLLFTSHD
HQFVQTIADRIIEILPDRVIDRKETYDEYLASLAEEDLKKLR
>KF629964.1_12302|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
GRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQ
GKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPE
LTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSI
GLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGA
LDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLD
WPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELG
IVMLANKNYPNPARVTAAWQILNTLQ
>KF629953.1_12337|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGLSPERDVSLSSGSLIANALIENGHDVLLLDLYLGYDGDAAQAEFLNRSDSE
RYSYTIPEREPDLEALKASSGNGRRLVGNGVLELCQRADVVFIALHGDIGENGQLQAMFD
VLGVCYTGTDYTGCLLAMDKDISKKLMAANGISTAGWRSFPIRQQEECDFSQVRYPCVVK
PCNGGSSVGVTMVDDADGLEEAIRAARVYEDQVIVEDRIFGREFSVGILNGEALPVIEVI
PKEGFYDYKNKYQTGMTQEICPAQLPDRLTRRLQESALAVHQLLRLGCYSRIDFMLDRNN
QVYCLEANTLPGMTPTSLIPQEAEAAGISYPQLCERIVQQAWSEKRA
>KF629922.1_12430|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LLEWIVNLKRKGNTLSKQLIAIWAEARNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMG
RVTFDGMNRRCLPGRETLILTRDEDFDCEGVTTVTSVEEALAWFEQQDKDLYIAGGAGVY
KAFDGHYDALIKTTIEADLEGDTYFPQLDMTAFKEVSHERVAKDDKNAYDFIISRYEKEG
D
>KF629921.1_12432|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELLDRVLREGVKKEDRTGTGTYSVFGHQMRFNLEDGFPLLTTKKLHLKSIIYELL
WFLQGDTNAKYLQEHGVRIWNEWADPDGNLGHIYGFQWRSWPDYKGGNIDQISEAVETIK
HNPDSRRIIVSAWNVADLDNMNLPPCHAFFQFYVANGRLSLQMYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFVHTLGDAHIYTNHLEQVKLQLTRDPRPLPRMEINPDVKDIF
GFQYEDFNLTGYDPHPHIKGEVAV
>KF629920.1_12437|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|0
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPCDSDKLEEVFDRPDG
GLEISKGISTSVPDLDALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTVKTKDTRLDELGYLPS
TGCKAMLKRI
>KF629911.1_12464|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYEFT
PDDVRLDGYETHPQIKNIPIAV
>KF629908.1_12474|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KQKLMVVCGGQSSEHIVSRMSCTSVMNNLNKENYDVTLVGIDQDGSWYILDQNQEDLAKD
TWLENAKAFQDVFGLLKQQDVVLPILHGAFGEDGTIQGLFELAGVPYVGCRVLASAVSMD
KIYTKKILETAGIPQVKSLYVKKRYDGKLVVVNKQFDEIEDIEKTVEEELGFPCFIKASR
SGSSVGCYRCDHKEDLMTKLIEASKYDRHIVVEECVDCIELETAVLGNDDPVVSRVGQIM
RHGEFYTFESKYEDEESKTCIPALVDQEIQDKIREYALRVFKAVDGHGLSRVDFFLDKKT
NQIYLNEINTLPGFTKISMYPQLMNDFGISYSELLDRVIQLAFDK
>KF629901.1_12497|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYNAFEVKTYFITQSGDFIKTQEFIETPG
DDEKLMTNDTVEASQAIKPSDIYEEDAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKRILEVAGVPQVAYTVYIEGEDLEAAVAETLEKLTFPVFVKPANMGSSV
GISKAENESELRSAIDLALKYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAF
YDYQAKYIDNKITMDIPARVPVEVMTQMRAYAAKAFRALGGCGLARCDFFLTEDGAIYLN
ELNTMPGFTQWSMYPLLWENMGLSYSDIIKELVVLGQEMFDKRESHLI
>KF629900.1_12501|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKKLNIALLAGGNSSEREVALASAAMILDAFDRSRYNVIPVDVHGLHWTCKGAGDRKVEV
DKTDFSVPVGDGKIRFDYAFIMIHGTPGEDGKLQGYLEMMGIPYSTSGFVSSVETF
>KF629897.1_12512|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
KRLEMPVFPEDRFVDAIVQTVKANAAYVPPYGSGATLYVRPYMMGTNPVIGVKPADEYMF
RVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDEN
MYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEER
EIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGIRW
DVSRLRKDG
>KF629894.1_12520|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELLDKIMKEGAVKGDRTGTGTKSIFGYQMRFDLAEGFPLLTTKKLHLRSIIHELL
WFLAGDTNIKYLHENKVTIWDEWASPEGDLGPIYGYQWRSWPAPDGRHIDQIAAVVESIR
TNPDSRRHIVSAWNVADIDRMALPPCHALFQFYVAEGRLSCQLYQRSADVFLGVPFNIAS
YALLTMMMAQVTGLRPGDFIHTLGDAHIYLNHTEQAAEQLRRTPRPLPVMKLNPAVDSIF
GFRYEDFTLEGYDPYPSIKAPIAV
>KF629893.1_12521|FEATURES|farme|multidrug|sav1866|antibiotic efflux|1
QRISIARVFLKNPPIIILDEATSALDNESEYEVAKSLGRLSEGRTTLTIAHRLSSIRNSD
RILVLTHDGIVEEGNHEELLEKHGIYDQFYRMANELK
>KF629893.1_12523|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MELKSGGIKDKHMSMADEIFINMCRDILENGTSTEGEKVRPHWPDGTSAYTIKKFGVVNR
YDLSKEFPLLTLRRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQ
LGVKHLYKEGLFDQVDRVIYDLKNNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQK
IGHDKLTLNAILNQRSQDILAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIADAHIYDR
HIPIIKELIQRPTYDAPTFWLNPDVKDFYEFTRNDVRLDNYVTGPQIQDIPIAI
>KF629893.1_12524|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIVAVDKNWAIGNKGELLVRIPADHKMFRQETTGKVVVLGRKTMDTFPGGQPLKNRDN
IILSRNEAYQQKDAQVVHSVEELLEAVKGYDTKEVYVIGGSSVYEQLLPYCDTAHVTKID
FAYEADTFFPNLDEDEQWEVTADSDEQYYFDLTYHFLKYERKKG
>KF629890.1_12536|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSKIALIAAVAEKGAIGRDQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTSLSWPDVTVVHTLNEILIQDTTEDEIFIMGGATLYNETIKIADTLYITHIH
HTFDDADTFFPTINPSEWEIANSQEMPADEKHAYPYTFVTYTRRRIENREPSDK
>KF629886.1_12550|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MAMSTISIVAAISDNNAIGKNLGLLWHMPADMKRFKDLTTGHAVIMGRKTFESLPKGGLP
NRKNVVLTTMPEAGFINCFACESMHDALDICEKEENIFIIGGSLVYRQGLGIADKMYLTR
IHGEFPDADAFFPVVNWDLWEEVERQEFPADEKNPYPYTFLTYVRKK
>KF629878.1_12571|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKLIAAADKNWAIGKDGELLVRISEDMKNFSAMTTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHKKDYNGKGAIVVHSEEELWEELSKYDTESIFVTGGESIYHMLLPYCDTAYITRLD
YEYQADTWMPNLDKEENWSIVEKSEERYCFDLIYHFTTYKNAVPELH
>KF629863.1_12611|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADQNWGIGKDNKLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRTN
IVITKNKDYDAKGAIVVHSIEEALEEIKKYPTEDVYCIGGDSIYEQMLPYCDVAHVTKID
FAYEADSHFPNLDEDDEWEITAESDEQTYFDLEYQFVRYERK
>KF629862.1_12612|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQSEKMCVVLLFGGMSSEHEVSRVSVGNFVNNIDREKYEVLTVGITKEGRWLYTEATAAQ
MADGSWEELAGNMACVISPDRADHGMILFTPEGHVEKVHVDVVIPVLHGLWGEDGTVQGL
LELAGIPYVGCGVLASAVCMDKAVANALFEANGVPHTRWLAADRWEIESDLEGVCDDVEK
KLGWPVFVKPANAGSSVGISKVSSRDELKKAIDLALENDRKVVFEAFVDGHEVECAVIGS
DPAVSTRPGEILAGAEFYTYDDKYKNGVSQVVIPARLPE
>KF629845.1_12660|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGDFI
HTLGDAHIYLNHLEQVKLQLSREPRDLPQMRINPDVKNIFDFKFEDFELVNYNPHPHIAG
KVSV
>KF629845.1_12661|FEATURES|farme|beta_lactam|CblA-1|antibiotic target alteration|0
MKQYLDLLNRVLTEGVEKSDRTGTGTISVFGPQMRFNMDEGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQDNSVRI
>KF629843.1_12664|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAP
LQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAK
>KF629838.1_12678|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKVSIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTILMGRKTFESLPKGALPNR
RNIVLSSNPDIVCPGAEVFPSLEAALKSCREDEHIYIIGGASIYQQAISFADELCLTEIN
STASEADAYFPEVSQELWQEKSREAHPADEKHLCSYAFVDYVRK
>KF629832.1_12690|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAVDKNWAIGCKNKLLVSIPADMKFFRETTTGKVVVMGRKTLESFPNGQPLKKRVN
IVLTHDKNFKAGDAIIVHSMEELREELKKYPSEDIYVIGGETIYKQLLDDCDVAHITKID
YAFEADAYFPNLDEMPEWKITQDSEEQTYFDLEYYFYKYEKIK
>KF629829.1_12695|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IYGYQWRSWPDYNGGFIDQISEAIETIKQNPDSRRIIVSAWNVADLNNMNLPPCHAFFQF
YVADGRLSLQLYQRSADIFLGVPFNIASYALLLQMVAQVTGLKAGDFVHTFGDAHIYLNH
LEQVKLQLSREPRPLPQMKINPDVKSIFDFKFEDFELVNYDPHPHIAGVVAV
>KF629827.1_12704|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADTQYLGIIKNILDAGSLGDNRTGMPAYKLPHQIMQFDLEKEFPILTTKFVAFKTSV
KEILWIWQKQSNDVRLLQQWNCHVWDEWMREDGTIGKAYGYQLGKYHQVDTLLETLKKDP
QSRRMVVDLWNVKDLPDMALYPCAFLTMWDVSDDGRLNCMLVQRSGDMGLGVPFNMAQYA
ALVHMIAQVSGLRVGLFTHVINNAHVYRNHVDAMKTQLARLPKAYDTPVLKLNPDVHDFY
DFKPEDIVLENYKHHEKIAMEVSV
>KF629821.1_12722|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MSRISIIAAVDSRMAIGFQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSSNPAAECPGAEVFTSLEAALESCQAEEKVYIIGGASIYRQAISLADELCLTEVN
DTAPEADAFFPAVDTTIWHEKSREVNPADEKHLCSYAFVDYVRGID
>KF629820.1_12728|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
ILKTETRKSRKENGIPMSKQTLILLYGGRSAEREVSVLSAESVMRAVDYNAFEVKTYFIT
QSGDFIKTQEFTETPGDDEKLMTNDTVVASQAIKPSDIYEEGAVVFPVLHGPMGEDGSIQ
GFLETLKLPYVGTNVLSSSVAMDKIMTKHILEVAGVPQVAYTVFIEGEDLEAAVAETLEK
LTLK
>KF629811.1_12755|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTTGHVIIMGRKTFESLPFLLPNREHW
VITRDKGFDAPEGVKIFHSPEAAAEAARALDAAYVIGGAQVYEAFLHYVDTMYITEVDHE
FEGDAFFPEFPEEAFTIESVVDGAVDEKNKYPHRFVTYRRKASK
>KF629805.1_12772|FEATURES|farme|aminoglycoside|AAC(2')-Ia|antibiotic inactivation|0
MKNKSSFTVRQEREAEFPAIYELIRTAFATAEVSDGDEQDFANRLRIHGNYIPELALVAE
CQGKLIGHIMLTRTVVTQDDGTPYEALMIAPLSVLLDYRNQGVGSALLKEGLRLAQSMGY
RAAFLCGNPAYYGRFGFKAIGEYGIRQAGLPEELAPYFMVHELIPGSLKSVHGTIDLHA
>KF629803.1_12775|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
PTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVLTSLGHV
DAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGIPTAPGV
TVDARNFTAADVLAEIEDAGLTYPLFVKPSRAGSSFGVTQVEKADDRET
>KF629801.1_12780|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEFKMNIVVLCGGNSTEREVSINSGSMVCEALRKKNHNAILMDVYFGLEDIDIFEKSASE
YDVESVKKNIQSLSDKVSEDRRSFFGNNVIEICQKADIVFMALHGKNGEDGKCQAAFDLY
GIKYTGSGHLASAIGMDKGVTKQIFMSKGVPTAKSVWIKKGESTDLKDYGMKVPVVVKAC
NGGSSVGVVLVHQESEYEDAVKTCFELDNQILVEDFIKGREFSIGVINKKALPVVEIIPR
DGWYDYKNKYNGATEEVCPANLNDELTKKIQKVAEDACNAIGCEPYARADVMMDADGNMF
CLEVNTLPGMTATSLVPQEAKAVGMDFPTLCDYLVELSLKKNN
>KF629799.1_12789|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PPSMSVCDMEVGEFVHVIADAHIYDRHVPMIEELISREPLPAPQFWLNPEIRDFYQFTRD
DVKLIDYQTHDQIKNIPVAV
>KF629795.1_12796|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
DVKDLGKIAVVMGGSSGEREVSLMSGSGVLKALQSVGADVVKFDPAEQPLSDLAGIDRAF
LILHGKGGEDGVIQGVMEFLKIPYTGSGVQASAIGIDKEMTKAVWEAQGIPVPRGMVLRN
ETDCEEAHRRFNGNLVIKPSKEGSSLGLYKLKNATLDQVKEAFAKSQEAGMTVLAEEYVF
GRELTVAV
>KF629793.1_12799|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLKNRRNIVLTRDMGFTHEGVDVVH
SVDEALSAVADELVAWVIGGGDVYRQFLPYCVEAEVTHNHCVHVVDTYFPDLDADPAWEI
AQRSGVATIAAGEGDEGVNYEFVTYRRIEA
>KF629791.1_12806|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKFIAAVDKNWAIGNKGRLLIRISEDQRNFRQTTMGHVVVLGRKTLEEFPGGRPLKGRAN
IILSRNPEYAVEDAVVVHSMNELFTELAKYDTDDIFVIGGQTIYDELIPYCDEAVITKID
REFEADAFISNLDKLDNWDVTDERPGEDVSEVNFTFVTYKNSDLKK
>KF629791.1_12807|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
METRRKKTGMSLADHIFIDMCKDVIENGTSTEGEKVRPVWEDGTSAYTIKRFGVVNRYDL
RKEFPALTLRKTALKSAMDEILWIWQKKSNNIHDLHSHIWDSWADENGSIGKAYGYQLGV
KHKYKEGMLDQVDRLIYDLKNNPYSRRMLTNIYVHQDLSEMNLYPCAYSMTFNVTGDRLN
AILNQRSQDVLAANNWNVVQYAVLVHMLAQVTGFKPGELVHVIADAHIYDRHIPIVKELI
TRPTHPAPKFYMNPDVKDFYDFTLDDFRIEDYETGPQIKNIPIAI
>KF629788.1_12816|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSFKTGEMVTKALRENGHQVILLDVFMGYSDKEEDLTGIFDRAEA
VSVKVAAIPETAPDLEKVKAQRKDQSDNFFGPNVIELCRMADIVFMALHGENGENGKIQA
AFDLFGIRYTGTGYLGSALAMNKGMAKQLFLENGIPTPRGTSLKRGEDAAKIETCGIHFP
CVVKPCSGGSSIGVSIVHDKAEYEQALKEAFRWENELVIEEYVKGREFSVGVIDFQALPI
IEIAPVEGFYDYKNKYKAGSTVETCPAELSEQITKEMQGYAEKVAEVLGLNAYSRTDFLL
DAEDHIFCLEANTLPGMTPTSLLPQEAKVTGVDFNQLCEKLIESSMRKYKN
>KF629785.1_12825|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MAICMIAAVGKNLELGKGNDLIWHFKDDMAFFKETTMGSSVIMGRKTFESLPKALPRRKN
IVITTRKDYEAEGATVVNSIENALKEVDSDNAFIIGGGDIYKQFLPMADKLYLTEIEAEC
DDAQVFFPAFNKDEYDKELLASYYDKGIHFSHICYTKK
>KF629784.1_12827|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
TTLEVPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKV
EETGGANFIFVTKDGKVVTPKSDSILPSITRRSLIYVAKEYLGLEAEEREVYFDEVKDFA
ECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIQAPEGWLK
VIE
>KF629784.1_12828|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADQNWGIGKDNKLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRTN
IVITKNKDYDAKGAIVVHSIEEALEEIKKYPTEDVYCLGGDSIYEQMLPYCDVAHVTKID
FAYEADSHFPNLDEDDEWEITAESDEQTYFDLEYQFVKYERKK
>KF629783.1_12832|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIAAVDRHMAIGYENKLLFWLPNDLKHFKALTTGNTIIMGRKTFESLPKGALPNRRN
IVLSTRPDTLCPGAEIFPSLEEALKHCEQDEQIYIIGGASVYRQALPLADALCLTEIDAE
APQADAYFPEVAPEIWQEKSRESHPIDEKHPCPYAFVNYIRR
>KF629782.1_12834|FEATURES|farme|polymyxin|arnA|antibiotic inactivation|0
IVTFRPDLNGERMEHSAARLEMPVFPKDRFVDAVVQTIKANAAYVPPYGSGATLYVRPYM
FGSDAVIGVKPASEYQFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPNGTGHIKAGLNYA
MSLHAIVDAHKNGFDENMYLDSKTRTKVEETGGANFLFVTKDGKVVTPKSDSILPSITRR
SLIYVAKEYLGLEAEEREVYFDEVKDFAECGLCGTAAVISPVGKINDHGKEICFPSGMNE
MGPITKKLYETLTGIQMGRIQAPEGWLKVIE
>KF629782.1_12835|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKIIVAADKNWGIGKDNKLLVSIPADMKMFRQETTGKVCVMGRKTLESFPGGLPLKNRTN
IVLTRNENYKVKDAIIVHSIEELMEELKKYPAEDVYCIGGDTIYKQLLPYCDAAQVTKID
FAYIADSYFPNLDEDPQWHVAAESEEQTYFDLEYKFVRYERNK
>KF629776.1_12850|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGTEKSDRTGTGTISVFGHQMRFNLDDGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHIYGYQWRSWPNYKGGFIDQISEAVETIK
HNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRDLPQMRINPDVKNIF
DFKFEDFELVNYNPHPHIAGKVSV
>KF629761.1_12893|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGQPLP
>KF629758.1_12901|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VNDLHSHVWDEWADETGSIGKAYGYQMGVKHKYKEGMFDQVDRVIYDLKNNPFSRRIMTN
IYVHQDLSEMHLYPCAYSMTFNVTQKKGDDKLTLNAILNQRSQDILAANNWNVCQYAVLM
HMLAQVCDMRVGELVHVIADAHIYDRHIPIIKELIQRPTYDAPTFWLNPDVKDFYEFTRN
DVRLDNYVTGPQIQDIPIAI
>KF629752.1_12919|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIAAIDRNLGIGFQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSSNPAIQCPGAEVFPTLEAALQSCQPEEQVYIMGGASVYKQAMPLADMLCLTEIDAE
APQVDAYFPAVESAIWHEKSRESHLIDEKHPCPYAFVDYIRK
>KF629749.1_12930|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIKELKSMKKNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGRWLLVDS
VKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGL
FELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEKE
IPYPIFVKPSCAGSSKGVSKAENRKELEAALYEAVKHDRNILCEETIVGREVECAVLGDR
TQVKSTCVGEILAAEEAAFYDFDAKYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVDG
FGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRYR
>KF629746.1_12941|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRKSGKGIDKRRRYMSYADKVFIDMCRDIIDNGTSTEGEKVRPVWEDGTSAYTIKRFGV
VNRYDLSKEFPALTLRRTAIKSCVDELLWIWQKKSNNVNELKSHIWDSWADETGSIGKAY
GYQMGVKHQYKEGRMDQTDRVIFDLKNNPYSRRIMTNIYVHNDLHEMHLYPCAYSMTFNV
TKEKDSEKLTLNAILNQRSQDVLAANNWNVCQYAVLVHMLAQVCGMKAGEFVHVIADAHI
YDRHVPMIEELISREPLPAPTFWLNPEITDFYDFTPDDVRLDRYETHPQIKNIPIAV
>KF629736.1_12968|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLQAGDFIHTL
GDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIFDFQFEDFELVNYDPHPHIAGKVA
V
>KF629727.1_12991|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SLSPPYSHIWDEWADEDGSIGKAYGYQLGVKHLYKEGLFDQVDRVIYDLKNNPFSRRILT
NIYVHQDLHEMNLYPCAYSMTFNVTQKIGHDKLTLNAVLNQRSQDVLAANNWNVVQYSVL
LHMLAQVCDMEVGELVHVIADAHIYDRHVPIIKELISRTPYPAPKFWLNPEIKDFYQFTR
NDVRADDYVTGEQIKDIPIAI
>KF629726.1_12995|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
DVFMGYGEEEQDITGIFEHSEEASVKVTDIPETAPDLDKVRKSRKDQSACFFGPNVIAMC
RMADIVFMALHGENGENGKIQAAFDLFGIRYTGSGYLSSAIAMNKNMAKQFFEANGIPCP
KGIYMKKKDRKDSLAEIGITLPCVVKPCCGGSSIGVSIVKEESNFTKALDDAFFWEDEIL
IEEYVEGREFSVGVIKGRALPVIEIAPKEGFYDYKNKYKAGSTVETCPADIKDSVAKEMQ
KHAVKVAEALGLDTYSRIDFLVNAKDEVYCLEANTLPGMTATSLLPQEAKVEGVNFEELC
QQLVDISMEKYGA
>KF629723.1_13002|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSQLFFRNPLQIFVNYDKIENEISAPLCVLSDFCERSWHFSCFRQHIGSKSSLPADMMHQ
ASNRPQYCPAAGYQLIKEFRHMAKIRVAVLFGGVSSEHDVSLISAENVIRSIPKDKYEVL
CIGITKKGRWLYFPGDITEISTGAWEQNPDCSAAILSPDPLHGGIITIENGETYIKKVDV
VFPVLHGRNGEDGRLQGIMEMARIPYVGCGVLSSAVCMDKGMTHTVLDYNGIQTAKWASV
HQRDLNKLDEKCVAIAETLGFPLFVKPANAGSSVGVNKANDLESLKDAVQIAFTHDEKVI
IEEFIDGRELEVAVFGYDAPIASYVGEIEPAAEFYDYDDKYVNGTSKLYIPARITDQESD
RIRETALRAYQALGCKGLSRVDFFLAKDGSVILNEINTLPGFTSISMYPKLMEHLGMSQE
YLVDKLIEQAMENVART
>KF629715.1_13032|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGDFI
HTLGDAHIYLNHLEQVKLQLSREPRPLPQMRINPDVKNIFDFKFEDFELVNYDPHPHIAG
KVSV
>KF629714.1_13037|FEATURES|farme|beta_lactam|OI25_4698|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALRSAMDEILWIWQKKSNNIHELHSHIWDSWADENGSIGKAYGYQLGVKHQYKEGMM
DQVDRDIYDLKNNPFSRRIMTNIYVHHDLSVSVCIQHDL
>KF629713.1_13042|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
WGEDGTVQGLLELAGIPYVGCGVLASAVCMDKAVANALFDAAGIPHTKWLSACRWEIESD
LDGVCDGAIAKLGWPIFVKPANAGSSVGITKAHDRDELKAAIRLALANDRKVVFEAFVDG
HEVECAVIGSDPAVSTRPGEILAGAEFYTYDDKYKNGVSQVVIPARLPEEKLDEVKTYAA
MAYTALGCEGLARCDFFVEKDTGRVLINEINTFPGFTPISMYPKLMEHEGIPVPALIDRL
IALALERTEKQHG
>KF629702.1_13068|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
MYLLDAATRTKVEETGGANFIFVTKDGKVVTPKSDSILPSITRRSLIYVAKEYLGLEAEE
REVYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGIQ
MGRIQAPEGWLKVIE
>KF629700.1_13074|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
AALQCMIAQVTGLKPGKFTHVINNAHVYENHVEALREQLARRDQALLAPKIIVNPEVKDF
YDFTPEDIILDGYEHLGKLSMTVAV
>KF629696.1_13088|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSLTSGAGICRTLRENGHQAFLLDVFLGFPYDSDKLEEVFTLPNA
GLEIADGIKTTEPDLAAIKASREDQSDCFLGPNVIDICRLADIVFMGLHGDVGENGKLQA
TFDILGIKYTGPNYLGSALAMDKGVTKQIFTMAGVPTPLGTNLTKDRKDTALSDLGLTLP
VVVKPCSGGSSIGVYIVDTMDAYKEAVENSFRYEDEIVIEPYIKGREFAVGIIDGKALPV
IEIIPKTGFFDYANKYQDGCTEEICPANIDEEVTERMQRAAELAFKALKLDIYSRADFLL
DENNDIYCLEVNSLPGMTAASLLPKEARAAGI
>KF629694.1_13094|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|0
MTRMAILGYEAAECSGVVRFDFRTDKRGTPFLLEANSIPGMTETSLVPKAAAAIGMDFPS
LCENILLKAGVGKV
>KF629690.1_13104|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LSTERDVSFKTGSMVASALKENGHRVILLDVFMGYSDKEENLDGIFDRADEISVKVDDIP
EVAPDLAAVKASRKDQSPCFFGPNVIRMCQMADIVFMALHGENGENGKLQAAFDLLGVKY
TGSDYLSSAIAMNKGMAKQLFASAGIPAPRGIAMKKENREDDVTKLPLTLPCVVKPCCGG
SSIGVTIVRDAAEFKKALDEAFHWEDELVIEEYVKGREFSVGVIEGKALPVIEIAPIQGF
YDYKNKYKAGSAVETCPADLPEEVSAQMRKYAEQVAEVIGLDTYSRSDFLLDENNHMYCL
EANTLPGMTPTSLLPQEAAVIGINFNELCEKLIAI
>KF629688.1_13108|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSLLNNKKVAIIGGGPVGLTMANLLQQNGIDITVYERDENPKARVWGGTLDLHKNSGQEA
MKKVGLLQTYYDLALPMGVNFADEKGNIIATRNPTLENKFDNPEINRNALRKMLLGSLKN
DTVVWDRKSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFI
IQGDIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKG
LDFKDTKSVSEFLTNRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLI
GDTAHLMPPFVGQGVNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADST
KNEIEMRNPSFTFQQLMNV
>KF629687.1_13116|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
GYYMGEAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGEMVPFSSFTRVEEQ
LGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQA
GTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQI
GIILLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLL
FATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF629684.1_13122|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNLKQEKIAVLLGGTSAEREVSLNSGAAVLNALLSQGYNAYGIDPKEYNVANLKADGFDR
VFNILHGRGGEDGTMQGLLEQIGLPYTGCGVMASALTMDKMRTKMLWKAFGLPVADMEIV
TKENAHELNPQAVVEKLGLPLMVKPSLEGSSVGLTKVKAVEELRSAVDYALKFDNTILIE
EWLAGDELTVPVLGGEVLPAVRIVPEGEFYDYDAKYISDNTQYFCPAGLSAEREQELAKL
VKRAYDVVGCRGWSRIDVMTDAQGDFRLVEVNTNPGMTSHSLFPKSASTVGISFKQLVVK
ILELSA
>KF629679.1_13131|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELVVSLRSAQGLYSFIDKERYNLYIVEMEGHRWEVVLPDGSKTPID
RNDLSFMENGEKKQFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTC
NQYLKGFGIRVAESLILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQP
AIEKAFEESDEVMIEAFMKGTEITCGCYKTSDKEVVFPITEVVSANEFFDYGAKYNGESQ
EITPARLPEDTAERVRLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF629679.1_13132|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNIPAEFNEIRPYTPEELPQIYEELIADPAFRTVVESVMPGVPFEGLAMKMRQCKTNLEF
QKAFFYGLLWDLVKKTANGLTFDCSALSDLTRNYTFISNHRDIILDSAFLSILLIDNGMT
TVEIAIGDNLLIYPWIHKLVRVNKSFIVKRGLNMRQKLEASALMSRYMHFAMKEKHENLW
IAQRQGRAKDSNDRTQDSVLKMMAMAGEGDVTERLKELNIVPLAISYEYDPCDFLKAKEL
QQKRDDEHFQKSPEDDLINMQTGLYGYKGRIHFQTSACLNHELDELKELNLPKCDLFTAI
SETIDRHIHSSYRLWRGAGVGRTACNKRR
>KF629677.1_13141|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|0
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMRGPSLGGTITGRK
>KF629676.1_13144|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLYSQYCGKRCFNMDIVVLCGGLSPERNVSLSSGTKIASALMELGHRVVLCDMFFGLEDY
AGELDGIFNDPPALGGTRIEEAAPDLEAVRAARKLRSDSMFGDRVLELCGMADIVFMALH
GRCGEDGRVQAAFDLLGIKYTGSGHLGSAIAMDKDLTKRVVAPLGVLTPEWKLYDCRTLE
PETVCAESPLPCVVKPVDSGSSIGVEIARTRQELLEALTRACAEGGAVVVERYIAGREIQ
IGLLDGRALPSIEIRPLQGFYDYKNKYQPGAAEEITPAPIPAEAEERLAKAALTVYKALG
LAAYSRADFIYDGEGNFWFLEINTLPGMTPTSLVPQEAAVLGIS
>KF629667.1_13166|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
ASTVLSGFNSLTLTPALCALMLQPTRPSKNPLYRGFNHLYDKTQGVYDRIVEYLLQRPVA
SIVSYAVFTLIAVLLFVKWPSTFVPEEDDGYFLAVVQLPPASSLERTQAVGKQINKILDS
YPEIKDYIGISGFSVMGGGEQSNAATYFIVLKNWNERKGKEHTAEAVVQRFNMEVYGIQE
AEIFAMVPPAIPGLGATGGLQLQLEDRHNLGATEMQRAVETLMEHYRNYPALASVSSQYQ
ANVPQYFLNIDRDKVQLMGIPLNSVFTALGYYMGEAYVNDYVQFGHIYQVKLGAGDRAQR
VIDDVLKLSVPNASGEMVPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPGSSSGEGI
RQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVA
AVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIR
DAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVY
IPNFYELMQKLQEKFSKKQ
>KF629666.1_13167|FEATURES|farme|bacitracin|uppP|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWIYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCG
>KF629655.1_13190|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
RRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSFIPQQVRAAGMEM
KDVMTDIIENKFKD
>KF629655.1_13191|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNANVEFDEIRPYHDEELPQVYEELIADAAFRQAVDTVMPGVPFEVWSQKMRACKTKLEF
QKTFCYGLLWKLAKEATDGLTLDHTALPDKSAAYTYVSNHRDIILDSGFLSILLVDQGMD
TVEIAIGDNLLVYPWIKKFVRVNKSFIVQRALTMRQMLEASARMSRYMHYTISEKKQSIW
IAQREGRAKDSNDRTQDSVLKMLAIGGEGDVIDRLMEMNIAPLAISYEYDPCDFLKAQEF
QLKRDIEGYKKTTADDLLNMQTGLF
>KF629649.1_13205|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
PKRKSVIRTAKWRKCMKIVVLGGGISTERDVSLSSSRMIYEALKKKGHQAILLDVYLGYE
GDYEDIFEKNIDWAENIGGITESNPDISSIKALRKDGGKSFFGPGVIPVCQMADVVFLGL
HGEDGENGKVQAAFDLLGIRYTGTDYVSSALAMDKSLAKELFAFHSIPTPAGTHLKKGEE
STQRVPFPCVVKACRGGSSVGVCIAHD
>KF629626.1_13253|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
KPCSGGSSVGVSKVENADQYKKAVKEALKYEDEIVVEQFVTGREFSVGLIGGKALPPIEI
APKSGMYDYAAKYQAGATVETCPADIDEETDKKLRDAATEAYEALHLESYARIDFLLDKG
GFTYCLEANTLPGMTPTSLLPQEAAVEGISYPDLCEKIIEISLAKYPKEKSDF
>KF629625.1_13257|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGLSTERDVSFKTGSMVAKALKENGHKVILLDVFMGYSDREEDLTGIFDRADE
ISVQVSDIPTEAPDLAKVKASRKDQSPCFFGPNVIKMCQMADIVFMALHGENGENGKIQA
AFDLFGVKYTGSDYLSSAIAMNKETSKQFFLANGIPTPKGISMTRATRQDDITKLDLTLP
CVVKPCCGGSSIGVTIVRDAAEFKAALDDAFKWENELVIEEFVQGREFSVGVIEGKALPI
IEIAPKEGFYDYKNKYKAGSTVETCPAELPEQVTKDMQHYAEEVARVIGLDTYSRSDFLL
NDKNEMFCLEANTLPGMTPTSLLPQEAAVIGMSFNQLC
>KF629620.1_13271|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGEPAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHIPIIKEMIKRE
TYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF629616.1_13284|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
RTKVEETGGANFIFVTKDGKVVTPKSDSILPSITRRSLIYVAKEYLGLEAEEREVYFDEV
KDFAECGLCGTAAVISPVGKINDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIEAPK
GWIHVIE
>KF629613.1_13290|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQTEEYQTNLICMSKISIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTIVMGRKT
FESLPKGALPNRRNVVLSSNPAAECPGAEVFPSLEAALQSCKEDEHVYIIGGASVYQQAL
PFADELCLTEIDSTAPEADAFFPEISPAVWHEKNREAHPADEKHLCSYAFVDYVKA
>KF629611.1_13295|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
NSAKRLEMPVFPEDRFVDAIVQTIKANAAYVPPYGSGATLYVRPYMMGTNPVIGVKPADE
YMFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGF
DENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEA
EEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTG
IQMGRIQAPEGWLKVIE
>KF629598.1_13327|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MELKSGGIKGKHMSMADEIFINMCRDILENGTSTEGEKVRPHWPDGTSAYTIKKFGVVNR
YDLSKEFPLLTLRRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQ
LGVKHLYKEGLFDQVDRVIYDLKNNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQK
IGHDKLTLNAVLNQRSQDVLAANNWNVVQYSVLLHMLAQVCDMEVGELVHVIADAHIYDR
HVPIIKELISRTPYPAPKFWLNPEIKDFYQFTRNDVRADDYVTGEQIKDIPIAI
>KF629595.1_13336|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVAALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGVAC
>KF629590.1_13355|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNLIVAVDKNWAIGLHNKLLVSIPADMKFFRETTMGKVVVMGRKTLESFPGGQPLKKRTN
IVLTSDQNYKVKDAVVVNSVEALLEELRQYNDEDIYVIGGESIYRQLLPYCKV
>KF629580.1_13372|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic target alteration|0
MELKSGGIKGKHMSMADEIFINMCRDILENGTSTEGEKVRPHWPDGTSAYTIKKFGVVNR
YDLSKEFPLLTLRRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQ
LGVKHLYKEGLFDQVDRVIYDLKNNPFSRRILTNIYVHQDLHEM
>KF629577.1_13379|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
TGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKTCCGG
SSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAPLQGF
YDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGDMYCL
EANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLIEVSMKKYPTQDF
>KF629576.1_13381|FEATURES|farme|aminoglycoside|1-acyl-sn-glycerol-3-phosphate_acyltransferase|antibiotic inactivation|0
PPLEVVTMFDVFVPMISIFHQGRRPRYMAKAEMASWPLIGKWFQLVGMQPVQRRSGKAKA
IEETSIEILTSGRPLTVWPEGTVTRDPQKWPMSMKNGVGVIALESSRRLGYQIPLYCAVT
WGAASINHWWPWPRKNVVMCYDEALDYADLLADCDSWGEEVPEDLANELTRRIRVRMTEV
TAEIRGEQAPDGYWDYRTMSRVKD
>KF629565.1_13416|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLDLPFCTVKLATMALTPEQLADIRTRIPARPETDIPMPYEDLVRKILTEGTLKSDRTGT
GTVSLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQERNVHIWDEWA
DENGDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVENHPDSRRMVVSAWNPAEVEN
MALPPCHALFQFYVADGRLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQAGLQPGEFV
WTGGDCHVYDNHIDQVLEQLSRDPYPYPQ
>KF629556.1_13444|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIVSAWNPAEVEKMALPPCHALFQFYVADDKLSCQLYQRSCDMFLGVPFNIASYSLLTMM
MAQQAGLKPGEFVWTGGDCHVYDNHVDQFLEQLGRKPYPYPPIEIRKADSLFDYQYEDFK
VVGYQHHPTIKAPVAV
>KF629552.1_13460|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
QASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANLPEETLNLVRETAKKAFVAV
DGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEATGVRYTDLITMLIEGVLR
>KF629547.1_13475|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
EPEASWPGEIVLDHQNDDQFYDFDSKYMDASASHVEVPANLPVSVLEDVRDVARRAFKAV
DGAGLSRVDTFVTPDGTVMVNEINTMPGFTSISMYPKAWDATGVSYTELITRLIEGVLR
>KF629545.1_13478|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
NAIDAERFDVVPVGITKTGQWIVGGEDPRSWSLNDGTLPEVVATADSRAVTLDVSRGQDG
FFADDPGQPDHVISLGHIDAVFPVLHGVYGEDGTVQGLLEMMGVPYVGCGVFASAACMDK
HYTKIVLNAAGIPTAPGIMVDARHATGESVYDEVKKAKLAYPLFVKPSRAGSSFGVTKVE
QADDEQAQIAALEAAVAEAGKHDWKVLVEQGIDAREIECAVLCAAPGDEPEASWPGEIVL
DHRDQGDDQFYDFDSKYMDSSASHVEVPANLPVSVLEDVRDVARRAFAAVDGAGLSRVDT
FVTPDGTVMVNEINTMPGFTPISMYPKAWDASGIGYTELITRLIEGVLC
>KF629544.1_13481|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVDGE
DPRKWNMSEGLPVVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRNYDAAS
EFATEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHV
EVPASLPEETLNRVRETAKKAFIAVDGTGLSRVDTFVTADGEVMVNEINTMPGFTPISMY
PKAWEATGVSYTDLITTLIEGVLR
>KF629542.1_13486|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIVATDDDLLIGKKDSSNGMPWHNKEDLQHFKKTTLHQTILMGKTTYMAIGRPLPHR
KTIVVTRGELDDERVEVRHDLVETIQEYKNKKEDLFICGGASIYKQALPYVDELIISRIP
GKHEGETYFPSFNEYNFQLEKETQMET
>KF629534.1_13506|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
AIGFEGGMPWHLPEDMRRFKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYT
APGATVVDSLDDALDLARQEAIPDDGLDRSEIWIIGGGQLFREAMPFADKAYVTQISMHA
DADTYAPDVKSLVESGAWKVLEEGVWQNTQKGSGDIAGFRFMTYANAHVR
>KF629522.1_13541|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKAILSADRKWGLGYQGRLLVSIPADMKFFRETTMGKVVVMGRKTLESFPGGQPLKKRTN
IILSRDPEWTVRGATVVHSIKELMEVLKPYEDDDIYVAGGGEIYRQLLPYCDTAYVTRID
MTYQADTFFEDLDESPDWEMVEEGDEQTCFDIEFYFTEYRRKNEKAERPR
>KF629520.1_13549|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKKNDSDKLVLNGILNQRSQDVLAANNWNVC
QYAVLMHMLAQVCDMQVGEFVHVIADAHIYDRHIALVEELISREPLPAPTFWLNPKVKDF
YEFTPDDVRLDNYETGPQIKNIPIAV
>KF629518.1_13555|FEATURES|farme|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK
>KF629517.1_13558|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MEHDSNSRSGYHEPEPGSAGLEESEDWGDDFPKTFSVNLIWAQARSKSGQQGAIGYKGGM
PWHLSEDLKHFQELTVSHPVIMGRRTWESLSPKYRPLPNRDNIVITHDTQYRAVGATVVG
SLEDALDLARQEAIPDDGLDRSEIWVIGGAELFREAMPIANKVYVTDIDAEVDADTYAPD
IDALAERGEWSVTDRSARLTPKNADSGIEGYRFRTFERVR
>KF629514.1_13566|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQVKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF629503.1_13601|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIAAVDKNWAIGRNNKLLVSIPDDMKFFRETTTGKVVVMGRKTLESFPGKKPLKNRVN
IVLTGDRSYQADGAVIVHDMEELHEELKKYPSEDIYVIGGESIYKQLLDECDVAHITKID
FAYEADAWFPNLDEKEAWMVTADSEEQTYFD
>KF629501.1_13605|FEATURES|farme|aminoglycoside|M001_13480|antibiotic inactivation|0
VKLKLVKATNKYRNQIVDMLDEWNNSGEEIIPYVIGRLDYSDFDYYCNNLEVRDTSEGLV
PDSTFFCLDEERNIVVGAVNIRHYLNEALLLNGGHIGDGVRPSERRKGIATKMISLALKE
CRKLGINKVLMVCDKGNIGSAKSIENNGGILENEVVVDGVVEQRYWIDLDKVRSVE
>KF629500.1_13607|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIAAVGKNLELGKDNNLIWHFKDDMAFFKETTTGSSIIMGRKTFESLPKVLPRRKNIIIT
KKEDYKAEGATVVHSISEALNEVESDTAFIIGGGDIYRQFLPKAEKLYLTEIEAECPDAD
AYFPAFNKADYKKELLASYHDKGIHFSHVCYTKK
>KF629493.1_13628|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQDILAANNWNVVQYAALLMM
FAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPAPRVTLNPEVKDFYKFTVDDF
TIEDYEAGPQIKNIPIAI
>KF629487.1_13646|FEATURES|farme|aminoglycoside|1-acyl-sn-glycerol-3-phosphate_acyltransferase|antibiotic inactivation|0
MNIPAEFNEIRPYTPEELPQIYEELIADPAFRTVVESVMPGVPFEGLAMKMRQCKTNLEF
QKAFFYGLLWDLVKKTANGLTFDCSALSDLTRNYTFISNHRDIILDSAFLSILLIDNGMT
TVEIAIGDNLLIYPWIHKLVRVNKSFIVKRGLNMRQKLEASALMSRYMHFAMKEKHENLW
IAQRQGRAKDSNDRTQDSVLKMMAMAGEGDVTERLKELNIVPLAISYEYDPCDFLKAKEL
QQKRNDEHFQKSPEDDLINMQTGLYGYKGRIHFQTSACLNHELDELKELNLPKCDLFTAI
SETIDRHIHS
>KF629480.1_13664|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MTKKIVAIWAEDENRLIGVNDRLPWRLPKELKHFKETTMGQALLMGRVTFDGMKRRILPG
RETLILTRDKNFRADGVTIVHDVEQVLDWFKTHDKTLYIVGGASIYETFLPYCDAIVKTT
VHGEFEGDTYFPGLDLKAFKKVSESFNKKDDKNAYDFTITVFEK
>KF629471.1_13694|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKIKLAIIFGGKSSEYPVSLHSAGSLIHKINKEHYELIFIGISKDGKWYAYDGDVDGIE
HDTWLCEEHCTPCVLSSSEGCRGFLKLHADGTFTRIEVDCIFPILHGKNGEDGTIQGLFE
LSGIPYVGCGHMSSAICMDKEMAHIVMEHAGISCAPFVCVYEADDLDYRKVYEHAKETLG
LPIFIKPANAGSSFGIHRMESFDGFEEAMKDAFYHDGKGKVILETTIEGFEIGVAVMGNK
ELFAGSVDEIETAAPFFDYEGKYEMVDSHIYCPARISPKLFEEAREIAKKAYRAMNCKGM
TRVDMFVTPEDTIILNEVNTIPGFTDTSRYPTMMKEAGIPFPELIDKLVALAMEE
>KF629467.1_13705|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNKRLKEILKEYEERKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDAIEEIKRTRRSFFGPNVLELCQA
ADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKG
VSMLKENCTRNIHDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVE
EYIRGREFSVAVVDGKAYPIIEIAPKQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHY
AEAGAKALCIEGYARFDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEE
LIRISFKKYSK
>KF629458.1_13722|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PPSRLELLHVIADAHIYDRHIPLVKELISRETHPAPKVWLNPEVKDFYAFTVDDLHVEDY
VTGPQIKNIPIAV
>KF629445.1_13758|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADKIFVTMCQDILENGTSTEGEKVRPHWEDGTSAYTIKKFGVVNRYDLSKEFPAITL
RKTAIKTCTEEMLWIWQRKSNNIHDLNSTVWDEWADENGSIGKAYGYQLAQKHQYREGMM
DQVDRVIYDLKNNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNDKLTLNAIL
NQRSQDILAANNWNVCQYALLLMMMAQVCDMEAGELLHVVADCHIYDRHIPLIKELIQRK
PYPAPVVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPIAV
>KF629441.1_13770|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
QTIVVSATKNFDQPGCRTVGSLTEALALSAGEDVYISGGSRLYEEALPLADVLYLTEIES
RIEGDAYFPEFDAQKYQKCVEERHEGEIPYTYVTYRKDCK
>KF629438.1_13774|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYSAFEVKTYFITQSGDFIKTQEFTETPS
DDEKLMTNDTVVASQVIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKHILEVA
>KF629435.1_13783|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSASNIIQCIDAQRYNIILVGITKEGHWVEAADLNAVQDGSWRQSKTSIVLSPDATRKGL
YRMSEDEKAQFVHLDVIFPVLHGLYGEDGTVQGLFKLAGIPFVGCGLFASAAGMDELYTK
IIVDTLGIRQAKYVPVYKEELPKMDEVVARVESALEYPVFVKPSRAGSSKGVNKAANREQ
LKNALIEAADNDRKILVEETIIGREVECAVLGNLDVKASGVGEILSADEFYDFDAKYYNS
ESKTLVDPPMPENMREQIREDAVKIFMALDGRGLSRVDFFLTESGVVFNEINTLPGFTAI
SMYPMLWEAQGIPKKELVQKLIDLAFER
>KF629425.1_13811|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DGTYAYTIKKFGVVNRYDLSKEFPAITLRKTYIRSAIDEILWIWQKKSNNVHDLSSHIWD
EWADEDGSIGKAYGYQLGKKHKYKEGEMDQVDRVLFDLKENPFSRRIMTNIYVHEDLHEM
NLYPCAYSMTFNVTGNRLNAILNQRSQDILAANNWNVVQYAALLMMFAQVSGFEPGELVH
VIADAHIYDRHIPIVKELIQRPVYPAPKVTLNPEVKDFYKFTVDDCTRED
>KF629407.1_13863|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
FPKERFIDAVEQVVKANAAWVPPYGSGATLYLRPYMFGSNAVIGVKPADEYQFRILTTPV
GPYFKGGAKPITIRVSDYDRAAPCGTGNIKAGLNYAMSLHAIVDAHKQGFDENMYLDPKT
RTKVEETGGANFIFVTKDGKVVTPKSDSILPSITRRSLIYVAKEYLGLEAEEREVYFDEV
KDFAECGLCGTAAVISPVGKINDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIEAPK
GWIHVIE
>KF629406.1_13865|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAVDQNWAIGNKNELLVRIPADQKFFRETTTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTHDHTYKVLGAVVVHDMDELHEELKKYDSQDIYVIGGETIYRQLLDECDVAHITKID
YAYDADAYFPNLDERPEWKITADSEEQTYFDLEYYFYRYERVK
>KF629398.1_13891|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MQAILSADQNWGIGKDGGLLVRVREDMKFFRETTRGHAVVMGRKTFESLPGALPGRRNIV
LSRGGFCAPGAEVAADVPALFALLGEQKEDAFVIGGGEIYRLLLPYTNRIFITKWDAAFD
ADTFFPNLDESEEFFLAEQSPRQQSNGLGFCFCEYQRKEQGAAETGPDSG
>KF629394.1_13902|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNLIVAVDNHWAIGNKNKLLNSIPEDMKFFRTTTTGKVVIMGRKTLESFPNGLPLKNRVN
IVISSKEGYSVKDAIVVQSIEAALEKAKKYATEDVYVIGGDSIYRQMLPYCDVAHVTKMN
YVYEADTWFPNLDQDDAWEVVARSEERTYFDLEYEFDMYVRKTSYEAMKPYIQAHCMD
>KF629389.1_13914|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LEDKKKRIGVIFGGKSGEYEVSLLSAASVIRVLNTQKYEPVYIGITKEGKWKRYDGDADS
IENGSWLAEAEDLNPGDLKQYIDFALPIVHGPYCEDGKLQGFLETMDIPYGGCGVLASAV
AMDKQVARQVFLRAGLPMCKHVFLTKAEWQDEQETVLARIEQRIGYPNFVKPANLGSSVG
ISKAKDRTSLIEALALALSYDSRVIVEEFVDCRELETGILGNDYPAAAEVGEILSSAEFY
DYEAKYSDGASRICIPAEISAEDREEIRMMAVKACKAIGGEGYCRVDFFKDRRTGKLYLN
EINTIPGFTKYSMFPLLWEAAGVKYPDTVERIIELGYERYYTKNHRETML
>KF629387.1_13918|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MHFGSQREGSEQLQADNESGKQKNKNVSDRRIIMNLIVAADKNWGIGKDNKLLVSIPSDM
KFFRQETMGKVVVMGRKNLESFPNGLPLKNRTNVVLTSDKNYQVKDAVIVHSIDEVLEEL
KKYDDDEIYVIGGGKVYEELLPYCDVAHVTKIDFAFEADAHFPNLDEDPEWEITAASDEQ
TYFDLEYTFVKYERK
>KF629358.1_14006|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIASYALLLQMVAQGTGLQTGDFV
HTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIFSFKYEDFELVNYDPWPHIAG
KVSV
>KF629351.1_14024|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
LNIIVAADKNWAIGENGKLLVSIPSDMKFFRQMTEHKVVVLGRKTLATFPNGLPLVNRKN
IILTRNPEMKVKGATIVHSVEEALEELAGYEDEDIFIIGGGHIYEEFLPYCKVAHVTKID
HAYQADTFFPNLDETGEWEITADSDEQTYFDLEYAFLKYERKGEAKPRIRK
>KF629346.1_14041|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNGLPLKNR
TNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESIYRMMLPYCSKVYVTK
IDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF629342.1_14056|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSAINVIKNIDTERYDVTLIGITEEGKWLLVDSVEQIEDESWRKNTTTAILSPDATEKSV
IVLKDGKAEMIRIDVVFPVLHGLWGEDGTIQGIFELAKIPYVGCGVLASSVSMDKVYTKQ
IVDHTGVRQAAYELVIRKELEKMDEVVARIENRFAYPVFIKPSNAGSSRGVSKASDREEL
IAGLKEAAHHDRKILVEETIVGREIECAVFGNGTEPVIASGVGEILAAADFYDFDAKYYN
AESRTVVNPELPGDAAERVRQAARRIFKAVDGYGLSRVDFFVTKDGEVIFNEINTMPGFT
AISMYPMLFEAAGIPKPEMVTKLIEHGLKRYEA
>KF629340.1_14063|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNKRLKEILKEYEKRKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQA
ADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKG
VSMLKENCTRNIHDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVE
EYIRGREFSVAVVDGKAYPIIEIAPKQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHY
AEAGAKALFMEGYCTF
>KF629335.1_14076|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKIKVAVLFGGQSSEHDISCISAATVIESIDREKYDVITVGITKDGRWIKTDNVEDIKS
GKWREGKVTMILSPDRIHKGFVEIEDGKAEVTEVDVVFPVLHGLYGEDGTIQGILELAGI
PYVGCGVVASAVSMDKLFTKKIVDGLKDVRQAKYVPVRRYELKEMDKILDGIEERLPYPV
FVKPSNAGSSKGVSKAGDRAGLEKALRLAAEHDEKILVEETIVGREIECAVLGTSDVKAS
GVGEILAADSAAFYDFDAKYNNAESKTVINPELPDGKTDEVRNDAVRIFKAVDGFGLSRV
DFFIENGTNDVVFNEINTMPGFTSISMYPMLWADRGIEKKELVDELINEAFTRHKI
>KF629325.1_14112|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCMATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKLPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF629320.1_14127|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERFEPIPVGITKDGKWIINGEDPRGWN
LDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVL
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLNAAGI
PTAPGIMVDARAFTAADVVAQIEVAGLAYPLFVKPSRAGSSFGVTKVDKAEDLETQQDRV
AAAIATAGEHDWKVLIEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFD
SKNMDASASHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTVMVNEIN
TMPGFTPISMYPK
>KF629317.1_14133|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
REELLVGIEEALKYDSRIVLEKGINAREIEVAVIGNEEVKASIAGEIKPAKDFYDYEDKY
INGTSTYDIPANIKAEDMEDIRRMAIEAFKGIDGKGLSRVDFFIDKDSGEIFINEINTLP
GFTNISMYPKMWEATGLEYSKLIDRLIELALDSKK
>KF629304.1_14171|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGIHKEDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIYELL
WFLNGDTNAKYLQDHGVRIWNEWADENGELGHIYGYQWRSWPDYKGGSIDQISEAVETIL
HNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQITGLKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIF
DFQYEDFELVNYDPHPHIAGKVSV
>KF629303.1_14173|FEATURES|farme|beta_lactam|ampC-EC68|antibiotic inactivation|1
ITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPV
TQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTA
GGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAM
KTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWV
QSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPLNPDIIINGSDNKIALA
ARPVKAITPPTPAVCASWVHKTGAPGGFGSYVAFIPEKE
>KF629299.1_14182|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVSIIAAVDRNLGIGFQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSTQKDLICPGTEVFPSLEEALSSCQPDEHVYIIGGASVYRQALPFADTLCLTEVDAE
APQVDAYFPEVAPTVWQEKSRESHPADEKHPCPYAFVDYIHR
>KF629292.1_14200|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|0
LPEKALPLVEIIPKDGVFNYENKYQAGGAQEICPPVSIDEETQQRMMRAGEEAFAALRMD
VYARADFIIDDEDGEFYSLEMNALPGMTAASLLPKAAKAAGIEYNELCERIIEESMNARY
R
>KF629289.1_14212|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGSDKLTLNAILNQR
SQDILTANNWNVCQYALLLMMMAQVCDMEAGELLHVVADCHIYDRHIPLVKDMIQRKPYP
APIVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPVAI
>KF629272.1_14254|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKKNLAVIFGGRSSEHEVSCVSVVTIAKAVDLEKYNMFLIGITKDGEWKLVEDIAGIEDG
SWKESPVSAIISPDTKGGLIISQDDMMKVQPIDVIFPVLHGMYGEDGTIQGLFEMADIPY
VGCGVFASAASMDKFYTKLVVDTLGIRQAVYVPVLAEQLDDIDEVTARVEAKLSYPVFVK
PSKAGSSKGVSKADDRAALVVALKEAAKHDYKILVEETIVGREIECAVLGYGKNTKASRV
GEILAAAEFYDFDAKYNNAESKTVIGADLPDGKEAEVQKDAVAIFNALDGFGLSRVDFFL
EKDTNEVIFNEINTLPGFTSISMYPMLWKDKGYSIESLVETLIEMAKERP
>KF629271.1_14257|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VLTEGIEKSDRTGTGTISVFGHQMRFNMDESFPCLTTKKLHLKSIIHELLWFLKGDTNVK
YLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYKGGTIDQISEAVETIKHNPDSRRIIV
SAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMVAQ
VTGLKAGDFVHTLGDAHIYLNHLEQVKLQLSREPRALPQMKINPDVKHIFDFKYEDFELV
NYNPHPHIAGKVAV
>KF629266.1_14269|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLQRFGGEFLQQFLHSLRRWKNMKIVVLAGGTSTERDVSIVSGTGICQALRQKGHQAILV
DVFCGLESVDWANPFPAEYDVEKAAEYIKSFNSQMKELKKTRRDFFGPNVIELCKKADFV
FLGLHGANGEDGKLQAAFDLMGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVSTPGGKSMK
KKDRQDSLAALGMEFPVVVKTCCGGSSIGVYIVDDQEAYRKALDEAFEYENEVVVEEFIK
GVEYTVAVVDGTAYPVVQIVPKEGFYDYENKYKPGAVQETCPAPISEELTKRLQEAAVDG
YHALEMESYARLDFIVTEDEKIYCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIRV
SQKKYE
>KF629265.1_14272|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNMNAIVVVDQNWAIGREGDLLFSLPTDMKRFRSLTMGGTVILGRKTLDSFPGGRPLPGR
RNIVITRNVDFDRDGCEIAASLGAALDLAADTEDDKLWIIGGGSVYTAMLSRCKRVYLTK
VDAVADGADTFFPNLDKLPAWEVEHTSDPITENGVTYQFIDYVNTKL
>KF629253.1_14304|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GGIVTIENGETYIKKVDVVFPVLHGRNGEDGRLQGIMEMARIPYVGCGVLSSAVCMDKGM
THTVLDYNGIQTAKWASVHQRDLNKLNEKCVAIAETLGFPLFVKPANAGSSVGVSKATDL
ESLKDAVQIAFTHDEKVIIEEFIDGRELEVAVFGYDAPIASYVGEIEPAAEFYDYDDKYV
NGSSKLYIPARITDQESDRIRET
>KF629250.1_14311|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
KEVVFPLTEGVTNNEFFDFDAKYNGQVDEITPARISTELTELIQRETSRIYDILGAKGLI
RVDYIIPADGEPVLLEINTTPGMTATSFIPQQVRAAGLDIKDVMTDIIEDELKNRKTK
>KF629249.1_14314|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
GASVCRALRENGHRAILLDLFLGLEEVPADLEKLFDAPDGLCPDVRIDAQAPDLETVRKS
RKDQSDRLFGPHVLEVCAACDIVFLGLHGMDGEDGRVQAAFDLLGIRYTGSGYLGSGMAM
DKSITKYIMERAGIPTAPWRDIPAYTEADIPALTAELEVPCAVKIVNGGSSIGVALPDTK
EELSQALRELLRYGNHVIVEKKIKGRELTVGVLGERYLPAVEIVAKSGNFDYEAKYQTGG
SEEICPAPITEEQQRRMGEYALRLHRALGLSVYSRTDFILDEEGNPWCLEVNSLPGLTPA
SLVPKEAAAVGMTYGQLCEEIVQRSYQIKRRG
>KF629243.1_14329|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
IMNLIVAVDEKWGIGCDNDLLASIPGDMQYFKEKTTDGVVVMGRRTLESLPKQRGLPKRI
NYVLTSNSGFEAERCIAVHSEEELFKELEQYDPEHVFIIGGESIYRKFYKNCDKCFVTKM
HADLHADKFMVNLDEDDDFKETWKSEMHSENGIDYEFTLYERV
>KF629233.1_14351|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLHRIRTEGVRKDDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYEGGFIDQISEAVETIR
KNPDSRRIIVNAWNVADLKNMNLPPCHMFFQFYVADGRLSLQMYQRSADSFLGVPFNIAS
YALLLQMMAQVTGLKPGDFIHTLGDAHIYLNHLEQVDLQLSREPRPLPRMILNPDVKNIF
DFKYEDFQLEGYDPWPHIAGKVSV
>KF629223.1_14376|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
PYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATR
TKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEEREVYFDEVK
DFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIQAPEG
WLKVIE
>KF629221.1_14379|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELLDRVLREGVKKEDRTGTGTYSVFGHQMRFNLEDGFPLLTTKKLHLKSIIYELL
WFLQGDTNAKYLQEHGVRIWNEWADPDGNLGHIYGFQWRSWPDYKGGNIDQISEVVETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQMYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIF
DFKFEDFELVNYDPHPHIAGAVAV
>KF629206.1_14422|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYKGGTIDQISEAVETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAQVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF629204.1_14430|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
FVIGGESIYRMMLPYCSKVYVTKIDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYV
FSTYERRQ
>KF629201.1_14437|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIAVLCGGRSSERDVSLSTGIQVARALRETGHDVVLVDACVDFPLDCRPEEVFEKALPI
ENHAIGAAAPCVKSFFDRASGFFGKNVLEICKSADIVFNALHGDEGENGKLQAVFDLLNI
CYTGSGAQGCMLAMNKSLSKQLFRTHGIPTPEAVILSESDKCRAAELCEKLGLPCVVKPA
SLGSSVGVSIVRTNDEFFTALDSAFSLENTVIVEKYIKGREFAVGIVGSRVLPAIEIIPK
HGFYDYKNKYQPGCTVEICPADIDSDTAERMAEATRKVFRVLGLGAYARADFMVDENGIY
CLEANTLPGMTPVSLLPQEAAADKVDFPALLEAIIKESLLLRETERRH
>KF629193.1_14455|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLISGAGICKTLRESGHQAYLLDVYFGLPYDADKLDEVFDLPDA
GLGIAEGIKTTMPDLDALKKSRPDQSDCYLGPNVIELCRMADITFMALHGSVGENGKLQA
TFDILGIRYTGPNSLGCSLSMNKLVAKQIFKMSRVATPRGTSLNRQTKDTPLDELGYYLP
LVIKPCSGGSSIGVFIVHTEEEYLDAIHQSFDVHQEEEVVIEPYIKGREFACGILAGKAL
PIVEIIPKDGVFNYENKYQAGGAQEICPPVSLDEKTQKKMKRMAEKAFRTLRMDVYARAD
FIVDDTDGKFYCLEMNGLPGMTPASLIPKAAKAAGLEYGDLCEQIIDESIKARYQ
>KF629181.1_14495|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MNIVVLAGGTSTERDISIMTSVKVCESLRRNGHNANIIDVFFVIEDKAAETFFDDNGNDL
EKIAADMKKKDILVDDELADRKKSGKGFFGDNVLALCLKADIVFMGLHGSNGEDGKIQAV
FELMGIKYTGTDYISSAISMSKELTKKVLVPDGIPMPKGVALKKGHKIEYVPYPCVVKPC
CGGSSVGVSIVSNESEFKSALTEAFSYEDNILVEEYIKGREFSVGVLDGKALPVIEIEPL
EGFYDYKNKYKAGATKETCPADLPKEISEKMQRWAEKACESAGVTTYARVDQLLTEDGSI
YCLEINTLPGMTATSLLPQEAQAAGISYDELTEKIIEISLKRYE
>KF629179.1_14500|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VVEKKIKGREIQIAVLGDTYLPAVEIIPRGEYFDYVSKYQKGGAQEICPAPITEEEWHQI
GEMALKLHRGLGLSVYSRSDFLLDEEGKAWCLEINTLPGMTPTSLVPQEAAQVGLSYADL
CERIVEESLKARGVQRT
>KF629177.1_14506|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSAAGICRTLLEKGHDAFLLDVFMGLEHTPENLEDVFTLPDH
GLDIVKNISTEEPDLAAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
AFDLLGIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTLYKNGSDLSYQSLGLTLP
VVVKPCSGGSSIGVYIVNTDEEYQNALEHSFHYEDEVVVEPYIKGREFACGIIDGEALPP
IEIIPKTGFFDYANKYQDGATMEVCPADIPEEVAERMKALTVKAFDALKLNVYSRADFLL
DAEGNLYCLEMNTLPGMTSASLMPKEAKVAGIEYSDLCELIIKKSMEARYSS
>KF629175.1_14510|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MIKKRILVIFGGQSSEHIVSCMSAVNVINNIDRDTYDVLIVGITEEGHWLLVDSVEAIQD
ESWRDGTVQAVLSPDATEKSVIVIDGAGIKKIKVDGAFPVLHGLYGEDGTIQGLFELAKL
PYVGCGVLASAVSMDKFFTKIIADRVGVRQAAYEPVMKEEIAGTEGMAEAVKRVEARFAY
PVFIKPSNAGSSRGVSKAENREQLTEGLTEAARHDRKILVEETIVGHEIECAVFGNGKEP
VIASGVGEVLAAAQFYDFEAKYFNAESRTVVNPELPGDSAERVRRAAVEIFKAVDGYGLA
RVDFFVTKDGDVVFNEINTMPGFTAISMYPMLFEAAGISKTELVGKLIEHGMKRY
>KF629169.1_14528|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HEMNLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQAC
DMEAGELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNPEIKDFYKFTTDDLIVENY
ETWPQIKNIPIAV
>KF629161.1_14546|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLSGGFCTERHVGLVSGSGVCRALREKGHQAIFVDMFMGLENYQGKLEDIFDAPDG
LLEKVAIEETAPDLEAVRAARQDKSPSLLGKDVLKVCAMADAVFLAMHGANGEDGRIQAT
LDLLGVPYTGSGYLGSAMAMDKAVTKRMMDSLGIRTAPWVDVHYKKEDIPRLTQELMVPC
AVKMVNGGSSIGMALPDTREELEKALYDLLPYGGHVVVEKKIKGREIQIAVLGDTYLPAV
EIIPKGEYFDYVCKYQKDGAQEICPAPISDEEWRQVGEMALKLHQGLGLSVYSRSDFLLD
DEGKAWCLEINTLPGMTPTSLVPQEAAQVGLSYADLCEKIVLDSIEARKAEYR
>KF629160.1_14548|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MISIIAAYAHGRVIGRGGQIPWNIPEDKTHFRELTTGHVIIMGRRTYEEIGRPLPNRETI
LISSTCSVEREHCTTVSSLRDALERAAGRDVFICGGERLYQEALPLADRLYLTEIDADIA
GDRYFPAFDEQDYTLLEERRVDGEIPVVFRTYDRRPMTAEQAQEYLREITKQSGMILGLG
PLKELLDGSDKIE
>KF629149.1_14576|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVCKPDPIFQTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAM
>KF629125.1_14639|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
VQTDYRYVSKFKDGAWDAGELTTDPNVTLNECAGVFQYAQTVFEGMKAYTTEDGHIVTFR
PDLNAERMAASAARLEMPVFPKERFIDAVEQVVKANAAWVPPYGSGATLYLRPYMFGSNA
VIGVKPADEYQFRILTTPVGPYFKGGAKPITIRVSDYDRAAPCGTGNIKAGLNYAMSLHA
IVDAHKQGFDENMYLDPKTRTKVEETGGANFIFVTKDGKVVTPKS
>KF629118.1_14650|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IYDRHVPLVEELLGRTPYPAPRLRLDPAVTDFYAFTPDSVQLENYRYHPLKEKIPVAI
>KF629109.1_14666|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNKRLKEILKQYEERKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQA
ADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGITKQMFLMNNVPTPRG
VSMVKEEMTTDLKALGMEFPVVVKTCCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVE
EYIKGREFSVAVVDGKALSDHRNCSASGIL
>KF629106.1_14673|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMDQVDRVIYDLKHTPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGDDRLTLNG
ILNQRSQDVLAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHVPIVKELIE
RPQYDAPKFWLNPDIKDFYQFTTDDIKITDYVTGEQIKDIPIAV
>KF629102.1_14688|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLCGGNSTEREVSIDSGSNVCEALRSKGHNAILIDVYFGLDDIEIFEKSNREYNVE
EEKKKIQELSKYVDEKRREFFGKNVIEICSKADIVFMALHGKNGEDGKCQATLDLFGIKY
TGSGPLASAIGMDKAVTKQIFLSKNVPTAKSAWIKKGEPSDLNTIGMEIPVVVKACNGGS
SVGVVLVKDESEYDGALKECFDLDDTVLVENYIEGREFSIGVIDNKALPVVEIIPKTGWY
DYKNKYAPGATDHVCPANLDEELTKKMQKVAEDACAAIGCEPYARADIMMDKDNNMYCLE
VNTLPGMTKTSLIPDEARAIGIDYPTLCDNLVKLSMK
>KF629089.1_14723|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MDLIVAVDNNWAIGNKGDLLVSIPEDHKFFRQTTMGNVVVLGRKTLAGFPNGLPLAGRDN
IILSTDPNYTVRGGTVVHSKEELFEELKKYEDKEIFVIGGGQIYEMLLPYCKYAHVTKIN
YDYAADTHFPNLDELENWEMIADSDEHTYFDLEFYF
>KF629086.1_14735|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
LGYHAVKVEYNPSCVLKQLKAVGAEVVFIALHGKYGEDGTIQSILELSRIPYTGSGVSSS
AITMDKIISSRVFKDAGVRMAFSKPYYLKNGIDTVAESIEKNFKFPVVLKPACEGSTIGL
EIVYEKEKLKEALKRVFAIESRILAEAYLDGKEFTIAVLNGKALPIIQICPHSGQYDFHS
KYTSGATDYIVPAPLPEAAADEMTHMAILGYEAAECSGVVRFDFRTDKRGTPFLLEANSI
PGMTETSLVPKAAAAIGIDFPSLCENILLKAGVDKV
>KF629067.1_14782|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAEKTNLLVMFGGASSEHEVSCVSAASVLQHISEEKYNIYKTGITKEGNWFLTSSPVVNI
SDGSWENDENNRRICILPHRGDENILVENEDGTYEKLRVDVVFPVLHGKNGEDGTMQGLL
QIAGIPFVGSEAAASAASMDKAVTKAVISQHGIVAQAECCVSSRHTYDADREREAARIKE
FFEGRLPLFVKPANAGSSVGISKVKSYDDLAAALDTAFAEDRKVLVEEMIEGREIEVAVL
GNEEPQASCIGEIFAANEFYDYNAKYENMKSETAIVKDLSEEKEEEIRRAAVDVYEAMGC
RGLARVDFFLEKGGRVVFNEINTLPGFTQISMYPKLWEECGLSYSDLIDRLIELALEEAG
QW
>KF629066.1_14784|FEATURES|farme|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|0
CYGILWKIAADHTAGLTLDHTAIPDKSKAYTYISNHRDIILDSGFLSILLIDQGMDTVEI
AIGDNLLIYPWIKKLVRVNKSFIVQRALTMRQMLESSARMSRYMHYTISEKNQSIWIAQR
EGRAKDSNDRTQDSVLKMLAMGGEGDLIDRLMEMNIAPLAISYEYDPCDFLKAQEFQLKR
DIEGYKKTTQDDLINMQTGLFGYKGRVHFQVAPCLNDDLQSLDR
>KF629051.1_14820|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
TERDVSIVSGTGICSALRQKNHQAILVDVFCGLENVDWADPFPESYDVEEAVSYIRSFNR
HIEELKKSRKEFFGPNVLELCKKADFVFLGLHGSNGEDGRLQAVFDLMGIPYTGTGYLSS
AMAMDKGVTKAMFQMRGVPTPGGKAMKKKDRVETPQELGLDFPVVVKTCCGGSSIGVYIV
DNQADYTKALDGAFTYENEVVVEEFVEGTEYTVAVVDGKAYPVVQIVPVQGFYDYENKYK
PGAVKETCPAPISEELTRRLQEYAVEGYHALEMESYGRLDFIVTKDEKIYCLEANTLPGM
TPTSLIPQEAAVLGMDYPTLCEELIRVSMKKSTNEEN
>KF629049.1_14824|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
KVAAHIESELGYPVYIKPANMGSSVGITKATDKKTLTEGLQLAAKYDRRVLAEEGINCRE
IETAVLGNYNIEASVTGEIVATDDFYDYDSKYIDDGKPKMKIPADLPAEISDKIREYAVK
AFGAIDGAGFARCDFFLDKDNGNIYINEINTIPGFTAFSMFPLLWENTGSPYSETIERII
RLGYERYNAKN
>KF629048.1_14830|FEATURES|farme|multidrug|bepE|antibiotic efflux|1
LTIAASTVLSGFNSLTLTPALCALMLQPTRPSKNSLYRGFNHLYDKTQGVYDRIVEYLLQ
RPVASIVSYAVFTLIAVLLFVKWPSTFVPEEDDGYFLAVVQLPPASSLERTQAVGKQINK
ILDSYPEIKDYIGISGFSVMGGGEQSNAATYFIVLKNWNERKGKEHTAEAVVQRFNMEVY
GIQEAEYLPWSRLPSPDWELPEACNSNWKTATTSAPPRCSVL
>KF629046.1_14835|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTTNYVSKADKIFIENIQDILNNGTSTVGHKIRPIYKDGTPAHTIYVNQIVEKYDISKGE
FPITTLRPIAIKSAIKEILWIYQDQSNDLSVLEEKHNIMWWRDWEVDNTNTIGQRYGATV
KKYDLMNKLLDGLTNEPYTRRHIIDLYQYADFEETAGLHPCAFLTVWSARGEYLDMTLHQ
RSSDYLVAGHVNKMQYVALLMMVARHVGLKPGVFMHVVDNLHIYDRHIDQAKELLSRTPS
EKQPKLILKEGKTNFYDFSLDDFELIDYEPVKPQLKFDLGI
>KF629035.1_14861|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
GRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQ
GKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPE
LTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSI
GLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGA
LDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLD
WPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELG
IVMLANKNYPNPARVTAAWQILNTLQ
>KF629019.1_14902|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTKADTIFKENITKIMEEGVWSEQARPKYKDGTTANSKYITGAFAEYDLSKGEFPITTLR
PIAIKSAIKEVFWIYQDQTNSLDVLEDKYNVHYWNDWEVEGVPANNGDKRSIGQRYGAVV
KKHDIINRLLAQLEANPWNRRNVISLWDYEAFEATAGLQPCAFQTMFDVRRVGEDIYLDA
TLTQRSNDMLVAHHINAMQYVALQMMIAKHFGWKVGKFFYFINNLHIYDNQFEQAEELLK
RQPSDCQPRLVLNVPDGTNFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF629016.1_14912|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNANVEFDEIRPYHDEELPQVYEELIADAAFRQAVDTVMPGVPFEVWSQKMRACKTKLEF
QKTFCYGLLWKLAKEATDGLTLDHTALPADKSAAYTYISNHRDIILDSGFLSILLVDQGM
DTVEIAIGDNLLVYPWIKKFVRVNKSFIVLRALTMRQMLEASARMSRYMHYTISEKKQSI
WIAQREGRAKDSNDRTQDSVLKMLAIGGEGDVIDRLMEMNIAPLAISYEYDPCDFLKAQE
>KF628992.1_14988|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
YKIGKGDGIMDIVVLAGGLSTERDVSFVTGNMVSKALRKNGHRVILLDVFMGYSDKKEDI
SDIFEHTEEVSVQIEEIPTVAPDLAAVKASRADQSDNFFGPNVIEICQKADVVFMALHGE
NGENGKIQAAFDLFGIRYTGTGYLGSALAMDKNIAKQFFVANGIPTPGGIRMKRDEQIRD
FAKTGLNLPCVVKPCCGGSSIGVSIVRTIEEYEAALEEAFRWEEEILIEDYIEGREFSVG
VLEGKALPIIEIAPVEGFYDYKNKYKAGSAVETCPAQLSEAVTKQMQQYAVEVTKALGLG
AYSRMDFLLDSDEKMYCLEANTLPGMTPTSLLPQEAQAVGVSFEQLCEKLIELSLKKYA
>KF628990.1_14995|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MAKRVTVKKLNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAIL
VDIFCGVENVDWENPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVLELCEKCDI
VFLGLHGANGEDGKVQAAFDLMGIRYTGTGYLSSAMAMDKRITKEVFLMNNVPTPGGFTM
TRDNLEKDIAKYNLQFPVVVKTRRGGSSVGVYIVNDQKEYEEALIDAGQYGADIVVEEYI
KGREFSVAVVDDKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVK
AAKALGLTGYSRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIR
ISLKKYE
>KF628987.1_15004|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKDAFSYEPEVVVEEYIEGREFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAGSTVETCP
AVLTEEQTKEMQKHAEDGAAALGIENYCRLDFMMRKDGRMYCLEANTLPGMTPTSLLPQE
AQVLGISYPELCELLIQLSLRKRGKNA
>KF628987.1_15005|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGTSTERSVSITSGTMVCKALREKNHQAVLVDVFCGTDVKGNLEDVFAEEAYD
IDKAAEYMHSFDAGLNEMIASRRRFFGPNVLELCEAADVVFLALHGANGEDGKVQATFDL
LGIPYTGTGYLSSALAMDKSITKQFFRAHHVADPERRDPEKRPGERAFVRLWPGASGCRK
TVLRRFQCRCLYCTHERRILAGYEGCFLLRTGGCR
>KF628985.1_15009|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ASNEGPSHDLKSHVWDEWADEDGSIGKAYGYQLGVKHQYKEGMMDQVDRVIYDLKHTPFS
RRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGDDRLTLNGILNQRSQDVLAANNWNVC
QYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHVPIVKELIERPQYDAPKFWLNPDIKDF
YQFTTDDIKITDYVTGEQIKDIPIAV
>KF628961.1_15067|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LRSDFLRGKEPFIMKKTVCVIFGGASSEYEVSLMSSASIIRNLDTEKFDILPLGITKDGR
WLLYSGAVENIENNTWMNSETARPAFISPDKATNGLVVLNADGSYTVLKVDVLFPVLHGK
NGEDGTIQGLFKLSGIPYVGCGTLASAVCMDKAVTHTLLSAANIEQAHYLWFYADRYFAD
GEKIRNKIAARLNFPVFVKPANAGSSVGVSKVTAPEKLDAAIRLAAENDTKVVVEEGIVG
QEVECAVLGNRGKSVASPVGEIGAGAEFYDYDDKYKNGVAQLFIPARLPEDVAEEVRKTA
VRAYNLLGCDGLSRVDFFVTEKEHRVILNEINTLPGFTSISMYPKLWENAGIPYSELLEK
LIDCAFTRED
>KF628958.1_15077|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VEKAAAYIRGFNLQMAELKKTRKNFFGPNVIDLCKKADFVFLGLHGANGEDGKLQGAFDL
MGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVPTPAGKAMKKKDRVETPQELGMDFPVVVK
TCCGGSSIGVYIVDNQEDYTKALDGAFTYENEVVVEEFVEGVEYTVAVVDGKAYPVVQIV
PVQGFYDYENKYKPGAVKEACPAPISEELTKRLQEAAVDGYHALEMESYARLDFIVTKDE
KIYCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIKVSQKKYA
>KF628956.1_15084|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLKLGVVFGGQSSEYSVSLHSVASFLRQIHNEKYDITMIGIDQNGQFYVYDGSIDDIEHD
HWIPQATKAAWVHKGIMALDGKNTVKELDCVFPVLHGKNGEDGCVQGLLELMNIHYVGCD
VMSSAISMDKEIMHILCDEANIPCADYVCLKANEENPSFEMIQEKISLPWIVKPCNAGSS
YGVHKVENKEEFEEACKDAFFYDGRGKILVEKAIEGFEIGCAVMGNEEVFTGSCDEIQIS
GGIFDFEGKYEMKGAEIICPARIDEETFTKAKALAAKTYKAMNCCGMARVDMFVTPQKEV
ILNELNTIPGFTATSRYPSMMKEAGIEFGDLIDKLIDLAMQRTISAC
>KF628955.1_15086|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKVSIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTILMGRKTFESLPKGALPNR
RNIVLSSNPDTVCSGAEVFPSLETALRSCREDEHIYILGGASIYQQALSFADELCLTEID
STAPEADAYFPEVSSKVWQEKSREAHPADEKHLCSYAFVDYVRK
>KF628933.1_15131|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|0
VALTSGTGVCRALRERGHKAILVDMFLGLENYEGRLEDIFDAPDGLCPDNRVESAAPDLE
AVRRSRKDQSPSMLGKDVLTVCRMADIVFLALHGACGEDG
>KF628914.1_15186|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
SPELTAKMQENAVKAAKALGLTGYSRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKV
LGMDYPTLCEELIRISLKKYE
>KF628908.1_15197|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLAS
>KF628904.1_15204|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MEYRVIDRNNWQRKEYFEHYLKEVPCTYSITTKLDITAIKKQRLKLYPTMLYYITKTVNR
YEQFRTAFRTDGTLVIYNEMLPCYTVFHQDTKTFSNIWTDFSDDYDTFCKQYNEDVLQFG
TRETMMAKPNMPENAFTVSMIPWTSFDGFNLNVKSFDYLIPIFTIGKYKEENEQYSIPFS
VQVHHAVCDGYHASCFINDLQEAISGIMYTENK
>KF628903.1_15207|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIKHNPDSRRIIVSAWNVADL
NNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIASYALLLQMVEQVTGLQTGD
FVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKDIFSFKYEDFELVNYDPWPHI
AGKVSV
>KF628890.1_15242|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VTQHPGDDKLTLNAILNQRSQDVLTANNWNVCQYAVLMHMLAQVCDMKVGELVHVIADAH
IYDRHVELVKELITRQQHPAPKFWLNPEIKDFYQFTPDDIKVTDYVTGPQIKNIPVAI
>KF628883.1_15258|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
SWGIGRDGALLFLISDDHKRFRSLTVGKTVILGHKTLDTFPGGKPLKDRRNIVLSHRDLD
VPGAEIAHSFDAAAALGGDDAIVIGGASVYMALLSRCDRVYVTKVDADPDADSFFPNLDD
NPDWRIESESETFEENGLKFRYVDYVRK
>KF628871.1_15285|FEATURES|farme|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGSVYPVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDMEDFRIGDYLGAKPCLIQGLSRQHPALKSSVRPDRPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTIEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQVASSKAITDLQKMMSEIEDIICNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK
>KF628867.1_15296|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICKTLLEKGHDAFLLDVFMGLPDAPENLEDVFTLPNH
GLEIAKNISTTEPDLAAVKASRPDQSDCFLGPNVIELCRLADITFLGLHGGEGENGKLQA
TFDLLGIRYTGPDSLGCALAMDKGVTKVIFQRCNVSTPGGGWLYKKDLDKPLSEMGLSLP
VVVKPCSGGSSIGVYIVNTEEEYREALEKSFQYEDELIIEPYIKGREFACGIIDGKALPP
IEIIPKTGFFDYANKYQDGGSEEICPANISEEISQKMQELTVRAFHALKLNVYSRADFLL
DENDNLYCLEVNTLPGMTAASLLPKEAKAVGIEYGDLCELIIQKSLEARYQ
>KF628857.1_15320|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNIPAEFNEIRPYTPEELPQIYEELIADPAFRTVVESVMPGVPFEGLAMKMRQCKTNLEF
QKAFFYGLLWDLVKKTANGLTFDCSALSDLTRNYTFISNHRDIILDSAFLSILLIDNGMT
TVEIAIGDNLLIYPWIHKLVRVNKSFIVKRGLNMRQKLEASALMSRYMHFAMKEKHENLW
IAQRQGRAKDSNDRTQDSVLKMMAMAGEGDVTERLKELNIVPLAISYEYDPCDFLKAKEL
QQKRDDEHFQKSPEDDLINMQTGLYGYKGRIHFQTSACLNHELDELKELN
>KF628857.1_15321|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELVVSLRSAQGLYSFIDKERYNLYIVEMEGHRWEVVLPDGSKTPID
RNDFSFMENGEKKQFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTC
NQYLKGFGIRVAESLILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQP
AIEKAFEESDEVMIEAFMKGTEITCGCYKTSDKEVVFPITEVVSANEFFDYGAKYNGESQ
EITPARLPEDTAEHVRLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF628841.1_15364|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNVCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVIT
NKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMY
TSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIEIKE
PTVIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAQLPLGSGVQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFK
>KF628828.1_15396|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MAFSKAYYLKDGKENIEEDIRKSFTLPVVLKPACEGSTIGIEIVKEEKDLKEAIDRVFSV
EPRILAEAFLSGDEFTVSVLDGKALPVIQICPHSGSYDYHSKYTKGATDYLVPAPIPEAL
AEEMSRLAETGYRMAECDGACRFDFKTDRDGRPHLLEANSIPGMTATSLVPKAAAAAGIS
FPALCEKILLEAGLDKV
>KF628824.1_15407|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LYLNHADQVAEQLSRTPRPLPTLRLNPAVRSVFDFRYEDFTLENYDPWPAIKAPMSF
>KF628810.1_15443|FEATURES|farme|aminoglycoside|GLE_1155|antibiotic inactivation|0
NIILLKLLFIDDNMVFDIDNLKGFLNDTSSFGFIAKENNKIIGFAYCYTLLRPDGKTMFY
LHSIGMLPNYQDKGYGSKLLSFIKEYSKEIGCSEMFLITDKGNPRACHVYEKLGGKNDYK
DEIVYVYDYEKGDK
>KF628810.1_15444|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFR
VIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLI
FEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKE
KAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKR
DIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNA
TTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTN
FGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVY
>KF628809.1_15448|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
PPPGHYRYVSNYKDGAWDEGAMITDDTVTISECAGVLQYAQTVFEGLKAYTTEDGRIVTF
RPDLNGERMENSARRLEMPVFSKERFVQAVIETVKANAAYVPPYGSGATLYIRPYMFGSN
PVIGVKPADEYQFRVFTTPVGPYFKGGVKPLTIRVSDFDRAAPNGTGHIKAGLNYAMSLH
AIVDAHSQGFDENMYLDPGTRTKVEETGGANFLFITKDNTVVTPKSHSILPSITRRSLIY
VAEHYLGLKVEEREVLLDEVKDFAECGLCGTAAVISPVGKIVDHGREILLPAGMEQMGPV
TQKLYDTLTGIQMGRLEAPEGWIQVIE
>KF628808.1_15449|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRNPLSDKIVDIKPSGIRKFFDIVSEMEDAISLGVGEPDFDTPWHIRDEGIYSLEKGRTF
YTSNAGLKELKVEICNYLKRRFDLTYDYAKEVLVTVGGSEAIDIALRTMVNPGDEVLIPQ
PSYVSYEPCAILADAVPVIINLKAENEFRLTAQELRDAITDKTKVLVLPFPNNPTGAIME
REDLEAIAEVILEKDLFVISDEIYGELTYKEDHVSIANIPGMQERTILINGFSKSYAMTG
WRLGYACGPSVIIEQMLKIHQFAIMCAPTTSQYAAVEALRNGDEDVREMREAYNQRRRYL
MYTFREMGLPCFEPYGAFYVFPCIKEFGMTSDEFATRFLQEEKVAVVPGTAFGDCGEGFI
RISYAYSLENLKVAIGRLADFVERLKKEQKK
>KF628802.1_15462|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MGKLQAAVIFGGQSSEHIVSCMSAVNVIEHIDRTRYDVLLVGITEDGHWIKADSLEDVKN
GTWRDKTVSALLLPDATKKCILLMDGDSVREVRVDVVFPVLHGLYGEDGTIQGLLELAKI
PYVGCGVLSSAVSMDKLYTKIIVDDLGVRQAAYEAVYREQLVHMESVVERVEKHFSYPVF
IKPSNAGSSRGVTKADDRQALEAGLSEAARHDRKILVEETIIGREIECAVFGGGLKEVVA
SGVGEILAAAEFYDFEAKYYNEESRTVTDPELPAGAAERVRQAAMDIFRAVDGYGLARVD
FFVKDDGEVVFNEINTMPG
>KF628800.1_15467|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRNPLSQKVVGIQPSGIRKFFDVVNEMKDAISLGVGEPDFDTPWRIREEGIYTLEKGRTF
YTSNAGLKELKIEICKYLDRKVNVQYDYNHEVIVTVGGSEGIDIALRAMLDPGDEVLIPQ
PSYVSYLPCTILADGVPVVIPLQHKNEFKLTAEELEAAITPKTKILVMPFPNNPTGSIMT
KEDLEPIVELVKKHDLFVISDEIYSELSYKGEHVSIASFEGMKERTILINGFSKGYAMTG
WRLGYACGPANIIEQMVKIHQFAIMCAPTNSQYAAVEALRNCDEEVKEMRESYNQRRRFL
VHEFKRMKLECFEPFGAFYIFPNIKEFGMTSEEFATRLLEEEKVAVVPGTAFGDCGEGFL
RISYAYSLEDLKEAIGRLGRFIDRLRNER
>KF628787.1_15501|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADTQYLGIVENILDHGIYGQNRTGIATYKLPQQIMQFNLQEEFPILTTKFVAFKTAV
KELLWIWQMQSNDVRKLQEMNVHVWDEWMREDGTIGKAYGYQIAKYKQLDKLIKTIKEDP
DSRRMIVTLWNIEDLDDMALQPCAYETLWDVGDGYLNCMLIQRSGDMGLGVPFNTAQYAA
LQCMIAQVTGLKPGKFTHVINNAHIYENHVEALREQLARRNQALPAPKIIVNPEVKDFYD
FTPEDITLDGYEHLGKLSMTVAV
>KF628777.1_15528|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MTKERDKMNIIVAVDKNWGIGKDNRLLVSIPADMKFFRTTTTGKVVVMGRKTLESFPGGQ
PLKNRTNIVLTRDVNYKVKDAVIVHSVEELLEELKKYDSEEVYVIGGDSVYSAMLDHCDT
AYVTKIDFAYEADTWFPNLDEREDWSPAEASEEQTYFDLEYQFVKYKKNGK
>KF628776.1_15530|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DEILWIYQKKSNNIHDLNSHIWDAWADEDGSIGTCYGDVVGRKFIYKGQETDQMDYVLQQ
LKENPYSRRIMTNLYQFEYLHSGALDPCCYSMTYNVTKDTGEDRLILNGVLNQRSQDILA
ANNWNVCQYSILLMMVAQVNGMIPGELLHVIADAHIYDRHVPAVRELISRTPYAAPKVSL
NPEIKDFYDFTTKDLIVKDYQAGPQIRNIPIAV
>KF628776.1_15532|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
TPVGPYFKGGVKPLTIRVSDFDRAAPNGTGHIKAGLNYAMSLHAIVDAHSQGFDENMYLD
PGTRTKVEETGGANFLFITKDNTVVTPKSHSILPSITRRSLIYVAEHYLGLKVEEREVLL
DEVKDFAECGLCGTAAVISPVGKIIDHGREILLPAGMEQMGPVTQKLYDTLTGIQMGRLE
APEGWIQVIE
>KF628771.1_15543|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKNIAVIFGGRSSEHEVSCVSAATVIRSLDEEKYNVILVGITKDGRWLLVDKLKEIEDG
SWRESRVNAIISPDTEDRALVLLAEGTYRLQPVDVIFPVLHGLNGEDGTIQGLFEMARIP
YVGCGVLASAVSMDKVYTKIIVEDLGIRQARFVHIRRSDLDQMEDALDRAEAKLSYPMFV
KPSRAGSSVGVSKAEDREGLSKALLKAAEHDRNILVEETIVGREVECAVLGGKEIKASGV
GEILAAADFYDYDAKYNNEESKTLIDPPMSEETREEIRKSAADIFKAVDGYGLSRVDFFI
AEDGEVVFNEINTLPGFTSISMYPMLWAAQGIKTPALADELIRLAEERFE
>KF628769.1_15546|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKVFIDMCRDIIDNGVSTEGEKVRPKWEDGSFAYTLKKFCVVNRYDLSKEFPALTL
RRTGIKSCVDELLWIWQRKSNNVHDLKPHIWDSWADEDGSIGKAYGYQMSVKHQYKEGMM
DQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKKKDSDKLVLNGIL
NQRSQDVLAANNWNVCQYAVLMHMLAQVCDMQVGEFVHVIADAHIYD
>KF628761.1_15563|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSRISIIAAVDSRMAIGFQNKLLFRLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSSNPAAECPGAEVFTSLEAALESCQAEEKVYIIGGASVYRQAISLADELCLTEVN
DTAPEADAFFPAVDTTIWHEKSREVHPADEKHLCSYAFVDYVRGID
>KF628758.1_15574|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MERSGIMNIIVAVDENWAIGCRGDLLVRIPADHKMFRNETLGKVVVLGRKTMDTFPGGLP
LQGRTNIVLTRNPEYQVKDAVAVHSVEELLEEVKKYDSRDVYVIGGDSVYRLLLPYCDTA
HVTKIDRAYEADAYFPNLDEDGEWEITADSEEQTYFDTTYHFVKYERKKISK
>KF628752.1_15590|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADMTFIQMCKDILENGTSTEGEKVRPKWPDGTPAYTVKKFGVVNRYDLSKEFPLLTL
RRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQLGVRHQYKQGMM
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGEEKLTLNAVL
NQRSQDVLVANNWNVVQYSVLVHMLAQVCDMQVGELVHVIADAHIYDRHIPIIQELIARQ
PYPAPKFSLNPEVKDFYQFTRNDVSVEDYITGEQIKDIPIAI
>KF628742.1_15625|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MSRISIIAAVDSRMAIGFQNKLLFRLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSSNPAAECPGAEVFTSLEAALESCQAEEKVYIIGGASVYRQAISLADELCLTEVN
DTAPEADAFFPAVDTTIWHEKSREVPPADEKHLCSYAFVDYVRGID
>KF628737.1_15642|FEATURES|farme|chloramphenicol|catD|antibiotic inactivation|1
MAVTFHKIDMQAWERKKRYEHYAEAVPCTYSMTVALDVTKLLCGVREKELPFFPVVLYGL
AREVNRHAEFRMAQDEMGNVGYY
>KF628726.1_15664|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIVNADKNWGIGRENQLLVHIPNDMKMFRQTTTGKVVVMGRKTLESFPNGMPLPKRTN
IVMTTDQDYDGRGAIVVHSEEELFEELKKYADEDIFIIGGESIYRMMLPYCDTAYVTRLD
YAYDADTYFPDLDALEGWEIVKESEEQTYFDLE
>KF628724.1_15668|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VVSTTTEYQGDNLVSVKSLED
>KF628718.1|FEATURES|farme|aminoglycoside|1-acyl-sn-glycerol-3-phosphate_acyltransferase|antibiotic inactivation|0
MKRIALIVIRVIWRLPYWWGYKVNKYKHIDKYSADERYGFIHQVVAIVTRKARVELECYG
VENLPKKSGYFVAPNHQGLFDPLAIFQTHSRPIRAIVKKELASVILVKDVIKMLEFIPMD
RSNVRESAKIIKYVANEVAAGKNFFVFPEGTRSRDGNNILEFKGGTFKIATKAKAPIVPV
ALIDCYKVFDNNTIKKTTAQIHYLKPIYYEEYKDLHTNDIAKLVHDRIEKCIKENDKG
>KF628711.1_15697|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
EDGRIVTFRPDLNGERMENSARRLEMPVFSKERFIQAVKETVKANAAYVPPYGSGATLYI
RPYMFGSNPVIGVKPADEYQFRVFTTPVGPYFKGGVKPLTIRVSDFDRAAPNGTGHIKAG
LNYAMSLHAIVDAHNQGFDENMYLDPGTRTKVEETGGANFLFVTKDNTVVTPKSSSILPS
ITRRSLIYVAEHYLGLKVEEREVLFEEVKDFAECGLCGTAAVISPVGKIVDHGKEIILPA
GMEQMGPVTQKLYDTL
>KF628696.1_15732|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNLIAAVDLNWAIGRDGDQLCYIPADLKRFQALTTGHPVILGRKTLATFPGGRPLKNRRN
LILSRDPSFAPEGAEVFRSLEALRAAAPADSFVIGGESVYAALLDWCDTAYITKIGRAWE
GADAFFPDLDAGPDWEMAEEEEPQEHAGIPFRYVTYRRRKPHVCG
>KF628693.1_15750|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLYDKKYLNIVEDILNNGYYDNNRTGMPTYKLPHQVMQFNLEKEFPILTTKFVAFKTAV
KEMLWIYRDQSNDVTKLQEQNVHIWDEWVDENNTIGRGYGYQIAKFHQIDKLIETLKTNP
QDRRMLMTMWNIEDLPHMTLQPCCFMTMWDVTDGKLNCMLIQRSGDIPLGVPFNTSQYAV
LVHLIAQVTGLKPGLFTHVINNAHIYENQVEGMKLQLTRANDEYEAPKLWINPEITNFYD
FTADDIKLIDYKYHPAIKMEVSV
>KF628692.1_15752|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLVREEQRRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRHMFQKIM
>KF628690.1_15759|FEATURES|farme|chloramphenicol|catQ|antibiotic efflux|0
MKFRKTYKRKQAAVLLSVFLLVTSVAGCQRVGAVKETGEEKVNVVTTIFPQYDFVRQIAG
DNVEVSMLLKPGEETHSYEPTPQDILKIQNCDLFIYVGGENDEWVEDILDSIDTEHIRLL
RLIDCVDTVNEEHVEGMKEERGHEHEEEEGEEHEHGEEAHETHETLTPDEHVWTSPENAI
AIVEQIADVLGELDPEQTAVYEENEKAYVSLLEELDDEFREVVSSAKRDVLLFGDRFPFR
YFADEYGLEYYAAFPGCASDTEPSAATMAFLINKAKEEQIPAILKMELSNENIANAIAET
THAKVKTFYSCHNLTAKEFADGETYLSMMKKNVETLKEALN
>KF628678.1_15793|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHV
EVPASLPEETLNRVRETAKKAFIAVDGAGLSRVDTFVTADGEVMVNEINT
>KF628677.1|FEATURES|farme|aminoglycoside|1-acyl-sn-glycerol-3-phosphate_acyltransferase|antibiotic inactivation|0
SNLQATVPPTSKKLREKVYNMIRFICVVVFLILFLILTIPVFFIEWLIGKFNRNARDYSC
LRIVQWGFKAILKVTGVHTTVIGFENIPDEPVLFIGNHRSFFDILLTYSRCPRLTGYVAK
KEMEKIPLLSTWMRFVYCLFLDRENPKEGLKTILQAIDYVKQGISICIFPEGTRNKGEEL
SMLPFKEGAFKIAAKTGCAIVPISMHNTTAIFENQFPRIKKVNVVVEYGTPIYTKDLAPE
DKKHIGAYVQNIIQETINKNAELI
>KF628677.1_15797|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEAGVDTPSGVCLYKEDSDCSLESLGLSFPVVVKPCSGGSSIGVYIVNTEEEYRQALKNS
FRYENEVVVETYIKGREFACGVIDGKALPPIEIIPKNGWFDYANKYQANATEEVCPADIS
EEIAERMKALTVRAFQALKLNVYSRADFILDADGNLYCLEMNTLPGMTSASLLPKEALAD
GIEYGDLCELIIQKSMEARYQ
>KF628672.1_15811|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNIIVNVSKNWAIGKNGGLLFHISADMRFFKKHTTGNVIVMGRKTLDSLPGGRALPDRTN
IVLTRSAGLTRENVAVCHSFDELNDMLAGFDSKSVYVTGGESLYRKLLPLCDTAYVTKVD
KEIHDADAFMVDLDEHPDWAAAEESELFSDNGLDYRFVTYRKKS
>KF628668.1_15824|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAVIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>KF628662.1_15837|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDVFTLPDH
GLEIVKNISTEEPDLEAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
SFDLLGIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTIYKNSEDQSYQSLGLTLP
VVVKPCSGGSSIGVYIVNTDEEYAEALKKSFHYEDELVVEPYIKGREFACGIIDGTALPP
IEIIPKTGFFDYANKYQDGATSEVCPADIPEEVAERMKELTV
>KF628647.1_15882|FEATURES|farme|bacitracin|bcrA|antibiotic efflux|1
VNDMLALEQVTASYGGSRVLFGVDIKAKKGEVTCLVGRNGVGKTTTVKSIMGLVSTPSGS
ITLDGKNIFKMPTYARAKTGIGYVPQGREIFPQLTVRENILLGMEANKKVREIPEHIFEI
FPILKEFLDRKGGDLSGGQQQQLAIARAIVSNPKVLILDEPTEGIQPSVIWEIGRTITKL
KEYMAVLMVEQYLEFVLEVSGKCYVMEK
>KF628644.1_15888|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVAVDKNWGIGKDNRLLVSIPADMKFFRTTTTGKVVVMGRKTLESFPGGQPLKNRTN
IVLTRDENYKVKDAVIVHSVDALMEELKQYDSEEVYVIGGDSVYSALLDYCDTAYVTKID
FAYEADTWFPNLDERKDWSAAEASEEQTYFDLEYQFVKYKKNGK
>KF628642.1_15892|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MKITVLAGGYSPERDVSLSSGSLIANALMEQGHEVFFLDPWLGIKAGERVHYRTREEGPG
FAYDIGGEAPDLELLGAEAGAEKSLIGPGVLEACREADMVFIALHGSTGENGQIQAVLEA
YGIPHTGSGYMGSLLAMDKNISKILMRAAGVATPDWYLAEKGKSSQPEFLPCVVKPLDCG
SSVGVTIVDKEEEWHTALEAAFSYGDRVLVEKKITGREFSVGVLGGRALPAIEIIPEKGF
YDYKNKYQPGMTREICPAGIDEKQESRLEAAALTVHRILELGYYSRVDFLMDGDGAIYCL
EANTLPGMTPFSLLPQEAKAAGITYQELCEAIVKNGKGAAL
>KF628640.1_15900|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIVAVDEKWGIGKDGGLLAHLPEDMKYFRETTRGRTVVMGRRTLESFPGGKPLKNRVN
MVLSRDEAYAPEGVRVYHSVEDVLEALRDCREEDVFIIGGGMIYREFLPYCSKAYVTYIH
RAFDVDTAFENLDQDENWKLESVSDGKEHEGISFEFRVYRRVR
>KF628604.1_15995|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIVAKAQNNIIGGNNKLLWHISDDLKRFKEITSGNTIIMGRKTFESLPGVLPNRKHV
ILTRDKNFSVDNENVEVIRSVDEIINNYKDSSVEAFIIGGGEIYKEFLPHANNLYLTEVL
KDFEGDTSFPQVNLENWVVDYSSDILTNAKDGLQYKFINYIKKS
>KF628602.1_16001|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLQDGSKTPVD
RNDFSFMNGAEKVVFDFAYITIHGTPGEDGRLQGYFDMIRIPYSCCGVLAAAITYDKFVC
NQYLKAFGVRISESLLLRQGQAVSDEDVVEKIGLPCFIKPNLGGSSFGVTKVKTREQIQP
AIAKAFSEAEEVMIEAFMGGTELTCGCYKTKEKSVVFPLTEVVTHNEFFDYDAKYNGQVD
EITPARISEELTRRVQTLTSAIYDILGCSGIIRVDYIITEGEKINLLEVNTTPGMTAT
>KF628601.1_16003|FEATURES|farme|aminoglycoside|AAC(6')-Ib8|antibiotic inactivation|0
MEHQGTKTIETERLILRKFTADDLSAIFHNWTSDEKVTEFLRWPTHKSIDITKRVLESWL
LEYEKPDFYQWAIIPKEIGEPIGTISVIELNEKTEKVHIGYCLGSRWWHCGFISEAFTAV
IAFLFEEVKVNRIETWHDPQNPNSGKVMQKCGLIYEGTLRQADWNNKGIVDACVYGILAS
DYRANKK
>KF628601.1_16004|FEATURES|farme|beta_lactam|LRA-12|antibiotic inactivation|0
VKDWFTVEKIDEDTYAISEYQHWEETHCYLLCGTKRALLIDTGLGVANIKEVVDKLTMLP
IFVVTTHVHWDH
>KF628590.1_16029|FEATURES|farme|bacitracin|BcrA|antibiotic target protection|1
MDIALQINNLSKAYGKHQVLENISFTVVKGEIFALLGTNGAGKTTTLECLEGIRRYDTGK
ILINGKLGVQLQSSSLPADITAKEAIMLFAKWQDLEVTDDYFIYLGIKAFLKKQY
>KF628587.1_16042|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTKQYKDLLRKILEEGTTKTDRTGTGTKSVFGYQMRFDLQKGFPLLTTKRVAFGLIKSEL
LWFLHGDTNIKYLLEHNNHIWDEWAFERYVSSPKYTGPDMTDFGRRCLEDEAFNEVYQEV
KKDFCEKILTDDAFAVEFGELGNIYGSQWRHWKTTKGETIDQIADLLNLLKNSPDSRRMI
VSAWNPEDEPSMELPPCHTMFQFYVADGKLSCQLYQRSADVFLGVPFNIASYALLTHLIA
NEVGLEVGEFVHTLGDAHIYLNHMEQVETQLAREERELPTLVLKHPEKSMFDIDVDDVIV
EGYNPHPTIKAPIAV
>KF628573.1_16069|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
SMDKVYTKIIVEDLGIRQAQFVHIRRSDLTQMEDALDRAEAKLSYPMFVKPSRAGSSVGV
SKAEDREALSKALSKAAEHDRNILVEETIVGREVECAVLGGKEIKASGVGEILAAADFYD
YDAKYNNQESKTLIDPPMPEETREEIRKSAAEIFKAVDGYGLSRVDFFIAENGEVVFNEI
NTLPGFTSISMYPMLWAAQGIKTPALADELIRLAEE
>KF628571.1_16074|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
VVMGRKTLESFPNGLPLKNRTNIVLTGNKDYKVKDAVIVHSMEELQEELKKYDSDDIYVI
GGDSIYHQMLPYCSLGHVTKIDHEYVADSRFPDLDKMEEWEVTGESEEQTYFDLEYTFIR
YERKKN
>KF628563.1_16092|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
AVDKNWGIGKDNRLLVSIPADMKFFRTTTTGKVVVMGRKTLESFPGGQPLKNRTNIVLTR
DVNYKVKDAVIVHSVEELLEELKKYDSEEVYVIGGDSVYSAMLDHCDTAYVTKIDFAYEA
DTWFPNLDEREDWSPAEASEEQTYFDLEYQFVKYKKNCV
>KF628556.1_16109|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>KF628550.1_16124|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
PLKNRRNIVLTRDMGFTHEGVDVVHSVDEALSAVADELVAWVVGGGDVYRQFLPYCVEAE
VTHNHCVHPVDTYFPDLDADPAWEIAQRSGVATIAAGEGDEGVNYEFVTYRRIEA
>KF628542.1_16145|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PRSWIDLKHNPASRRILTSLYNFEDLHDMNLYPCAYSMTFNVSNGTLNAILNQRSQDMLA
ANNWNVCQYAVLVHMFAQVSGLKAGELVHVIADAHIYDRHIPIIEKMLAEPEHPAPQFTL
DPAVTNFYAFTPDSIRLENYQFSPFEDKIPIAV
>KF628540.1_16151|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VKIVVLAGGISTERTVSLVSGTGVCQALRRKGHQAILVDLFMGLENPPADLNTLFDAPDG
LCPDVKIAVQAPDLEAVRRSRPDQSASRIGPHVLDICRLADVVFLGLHGQDGEDGRIQAA
LDLLGVPYTGAGYLGSAIAMDKIASKQMMDANGIPNPKWQ
>KF628533.1_16165|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAAKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF628525.1_16186|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMQSEDKLCVVVLFGGMSSEHEVSRVSVGNFVNNIDREKYEVLTVGITKEGRWLYTEATA
AQMADGSWEELAGNMACVISPDRADHGMILFTPEGHVEKVHVDVVIPVLHGLWGEDGTVQ
GLLELAGIPYVGCGVLASAVCMDKAVANALFEANGVPHTRWLAADRWEIESDLEGVCEGV
EKKLGWPVFVKPANAGSSVGISKAPDRDELKQAIALALENDHKVVFEAFVDGHEVECAVI
GSDPAVATRPGEILAGAEFYTYDDKYKNGVSQVVIPARLSEEKLDEVKTYAAMAYTALNC
EGLARCDFFVEHGTNRVMINEINTFPGFTPISMYPKLMEHEGTPRARPDRSPDRTCAGKD
GKAAWITAPSAYLTAAWAA
>KF628509.1_16233|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGVPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEVGDEVDIDHIVEVCGERSFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPEEIRHTDDM
TFPQVCDSLIRMGLRRAGIAC
>KF628508.1_16237|FEATURES|farme|macrolide-lincosamide-streptogramin|ErmH|antibiotic target alteration|0
MEYSKEDLMEAKKQIWGVGENMGTEESKKIWEENAQFWDNAMGDESNEFHREVVRPKVTE
LLSPNPADYILDIACGNGNYSSYLAQRGASVVAFDYSKKMIEL
>KF628501.1_16257|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
SEHDVSLVSAENVIRSIPKEKYEVLCIGITKKGRWLYFPGDVSEISTGAWEQNPDCTAAI
LSPDPLHGDIVTIENGETYIKKVDVVFPVLHGRNGEDGRLQGIMEMARIPYVGCGVLSSA
VCMDKGMTHTVLDYNGIQTAKWASVHQRDLNKLNEKCVAIAETLGFPLFVKPANAGSSVG
VSKATDLESLKDAVQIAFTHDEKVIIEEFIDGRELEVAVFGYDAPIASYVGEIEPAAEFY
DYDDKYVNGSSKLYIPARITDQESDRIRETALRAYQALGCKGLSRVDFFLSKDGSIILNE
INTLPGFTSISMYPKLMEHLGMKQEYLVDKLIEQAIENAART
>KF628492.1_16283|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MMAQVCDMEAGELVHVIADAHIYDRHIPIIKEMIKRETYPAPKVTLNPEVKDFYEFTTDD
FKIEDYQAGEQIKDIPIAI
>KF628491.1_16289|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
VGLAVLDKMDKGHIALDSLIEVKSSQLKSNTYSPLRDKFPDQDITISLGELLKYSISQSD
NNACDILIEYAGGIDQVNEYVKSLGIKDCNLAATEDLMHTSGDAYLNWSTPEEVVRLLNI
ADKQPLFGTQYKDFLQAIMQETSTGKDKLKGQLPADVIVGHKTGSSDRTPEGIKIADNDA
GFVILPNGQKYYIAVFVMESQETDADNAAIIANISKIVYDTLNSDIQ
>KF628487.1_16298|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGC
>KF628486.1_16301|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWIYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRELTERP
QFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF628479.1_16320|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MPPLAGQGVNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTKNEIEM
RNPSFTFQQLMNV
>KF628465.1_16356|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VKEVWSLWQKRETERQENRMSYADKVFINMCRDIIENGTSTEGEKVRPKWEDGTAAYTIK
KFGVVNRYDLSKEFPALTLRRTAIKSCVDELLWIWQKKSNNVHELKSHIWDSWADENGSI
GKAYGYQMQVKHQYKEGMMDQVDRVLYDLKENPYSRRIMTNIYVHEDLHEMNLYPCAYSM
TFNVTKEEGSEQLTLNGILNQRSQDVLTANNWNVCQYAVLLHMFAQVCGMKAGELVHVIA
DAHIYDRHIPLIEELISREPLPAPKFWLNPEVKDFYDFTPDDVRLEDYETHPQIKNIPVA
I
>KF628462.1_16364|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRIIVLAGGLSTERDVSLSSGAGICRTLREKGHDAFLLDPFLGLPDAGDNLEAVFTRPDA
GLSLASGIRSTEPDLEAVKASREDKSDCFFGANVIELCRLADIVFMGLHGDVGENGKLQA
AFDVLGIRYTGSGSLGCALSMDKEITKVIFEANHIPTPKGTWMKRSTADHSLASTGLPLP
LVVKPCSGGSSIGVYITQTEEEFDKAVKESFRYEDEIIIEEYIKGRELACGVIDGKALPV
IEICPKTGWFDYANKYQDGMTEEICHARIPEETAKKIQAISEHAFQALKLDVYARADFLL
TEDGNIYCLEYNSLPGMTAASLLPKEAKAAGIEFGELCELLIEKSMDARYCG
>KF628457.1_16376|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPSPK
FTLNPEVKDFYKFTVDDFTIEDYEAGPQIKNIPIAI
>KF628454.1_16382|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLQRFGGEFLQQFLHSLRRWKNMKIVVLAGGTSTERDVSIVSGTGICQALRQKGHQAILV
DVFCGLESVDWANPFPAEYDVEKAAEYIKSFNSQMKELKKTRRDFFGPNVIELCKKADFV
FLGLHGANGEDGKLQAAFDLMGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVSTPGGKSMK
KKDRQDSLAALGMEFPVVVKTCCGGSSIGVYIVDDQEAYQKALDEASEYENEVVVEEFIK
GVEYTVAVVDGTAYPVVQIVPKEGFYDYENKYKPGAVQETCPAPISEELTKRLQEAAVDG
YHALEMESYARLDFIVTEDEKIYCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIRV
SQKKYE
>KF628453.1_16384|FEATURES|farme|chloramphenicol|C169_09248|antibiotic inactivation|1
MDYKVLDMEKYYRKDIYRHFTMDCKCSVMITSKIDVSELVAYSKQTGTKFYINFLYVLTK
ALNTRDDYKMRYLYQEDKLVVFDKINTSHYVFHEDTETFTVVYTEFSEDYQAFYDRCCAD
MEKAKQTRSYGLDGSKLNYFDASYIPWLSYEALHVELPDGHLHFPPIINWGKYQS
>KF628448.1_16398|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMACWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>KF628437.1_16428|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAKFFLSCMALAILFSACNTTNRTPKQKIEQQIDSLLKDKKATVGVAVLANGETVAVYN
NQIHFPLLSVFKFHVGLAVLDKMDKGHIALDSLIEVKSSQLKSNTYSPLRDKFPDQDITI
SLGELLKYSISQSDNNACDILIEYAGGIDQVNEYVKSLGIKDCNLAATEDLMHTSGDAYL
NWSTPEEVVRLLNIADKQP
>KF628431.1_16440|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VAETETAKIILERKSRRRKMKIVVLAAGTSTEREVSIVSGTEVCKALRSRGHQAILVDVF
FGKEGADPATAFDGDYDVDAEAAYISGFNAQVKDAVASGREFFGPGVIELCKAADVVFMA
LHGANGEDGRVQAYFDLCGIPYTGTGYLSSAMAMDKGITKKIFRTSGVPTPRGVELKKGK
DSMNLADYNMELPVVVKTCCGGSSVGVYITKTPEEYEEALKGAFSYEDEVVVEEYIEGRE
FSVGVVDGKAYPIIEIAPVEGFYDYKNKYSAGATIDTCPAVLTEEQTRKMQTYAEAGCKA
LAVEGYARLDFLMKEDGSMYCLEANTLPGMTPTSLLPQEAAVLGIDYAQLCEKLIEISMR
KYQK
>KF628424.1_16456|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VKILVLAGGLSPEREVSLSTGTMVCNALREKGQDAILVDLFYGVEELPGDIESFFADKTP
LPPYVIESAVPDLSRLREESRNRPYGTIGKNVIELCKAADIVFMALHGEPGENGMVQAML
DMLDIKYTGAGYRGSAVAMDKALTKHILVSRGINTAEGIMLKRGEPLPDVPLPCIVKPCS
GGSSIGVRKVFNKADVLPAVEEAFKYEDDILIESFVNGREITCGVLGDTALPPAEVIPKG
GFYDYAHKYQSGLITEICPAELPAEVTAEVQDISLRVFRALGLEVYARMDFIYDGRDFYC
LEANTLPGMTPTSHLPQEAKAMGISYPELCMRIIKLSLEKYNK
>KF628410.1_16485|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKSLSVCILFGGVSPEHEVSLRSAESVLNNIDESKYNVFPVGITKEGKWILYGGKDYSDL
PSGRWLTHPDNRQTAISPIRGQGLLTFEGDCVVRQQIDVVFPVLHGENGEDGTIQGLLQL
AGIPYVGPHVAASAVAMDKTLTKLVVDQAGITQAAWKLVRRSDMGSRMEGTLDALEARFA
YPMFVKPAGTGSSVGVSKATEREDLKKALLEAGKYDDKVLVEEFIRGREIEVAVMGNESP
VASVCGEIDSGADFYDYDAKYITDTSVSYIPARIPEDVAETVRDTAVKVYKAIGCQGLSR
VDFFVTWQENRVVFNEINTIPGFTSISMYPKLFGASGVPYSQLIDKI
>KF628404.1_16499|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VYDNHVDQFLEQLGRKPYPYPTIEIRKADSLFDYQYEDFKVVGYQHHPTIKAPVAV
>KF628398.1_16512|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MAKRVTVKELNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAIL
VDIFCGVENVDWENPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVLELCEKCDI
VFLGLHGANGEDGKVQAAFDLMGIRYTGTGYLSSAMAMDKRITKEVFLMNNVPTPGGFTM
TRDNLEKDIAKYNLQFPVVVKTSCGGSSVGVYIVNDQKEYEEALTDACQYGADIVVEEYI
KGREFSVAVVDEKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVK
AAKALGLTGYSRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIR
ISLKKYE
>KF628396.1_16517|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VNLAFEHDSKVLIEEFVAASEVESAVIGNTDPMVAENIGEIAPANEFYDFDAKYNDSSSK
ITIPANVTKDVEDKLKDYAIRAYKICECGGLSRVDFFVDKESGAVRLNEINTLPGFTSIS
MYP
>KF628389.1_16535|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVSGHTLNAILNQRSQDMLAANNWNVVQYAVLTHMMAQVAGLKVGELVHVIADCHIY
DRHIPAVKAMLEKDGYPAPTFRMDESITDFYAFTKDSFSMENYQFHPFNFEIPMAI
>KF628387.1_16539|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSVVVLFGGMSSEHEVSRVSAGTFVDQLDRQRYELLTIGITKEGRWLYTEADSAQMADGS
WEELPGNMPCVLSPDRADHGLILFTPAGQVEKVHVDVVIPVLHGLWGEDGTVQGLLELAG
IPYVGCGVLASAVCMDKAVANAMFDASGIPHTKWLSATRWEIESDPDGVCDGVIAKLGWP
IFVKPANAGSSVGTKATNREQLKEAIQLALANDRKVVFEAFVDGHEVECAVIGSDPAVAT
RPGEILAGAEFYTYDDKYKNGVSQV
>KF628383.1_16547|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MIAHALKRLGHRPALVDLYFGLEDPAGPLEACFDQPVPDRWKQVDPQAPDLEAVKAARPG
ESPSQFGPGVLELCRQADLVFLALHGACGEDGRVQAAFDLMGIPYTGSGYVGSALAMDKD
LTKRLVAPLGVKTPQWKRADYTDRDIDRLTSTTPVPCVVKPVASGSSIGVSIAHTKKELH
AALVEGLAYGGQCVLEQYVAGREIQVAVLAGKALPSIEIIPSDGFYDYENKYQPGAAREV
CPAPIPPAWEQAVGQAAVTVYQALGLAVYARADFIVDQGGTPWFLEINTLPGMTPTSLVP
QEAAAVGMDYETLCQTIIDESLKARQGGR
>KF628371.1_16579|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATLGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF628368.1_16589|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|0
KALTVKAFHALKLNVYSRADFLLDDSGNLYCLEMNTLPGMTAASLLPKEAKAIGIEYGDL
CELIIQKSLEARYSS
>KF628364.1_16600|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
MKIVVLAGGISTERDVSLVSGMGIYKALKSKGHQVMLLDVFLGYEHDDWKDVFEKNVDWV
ASVGAIKDQNPDIDAVKALRPDWKKNFFGPHVIEICQHADVVFMALHGENGENGKIQACF
DLNGIRYTGTDYVSSAICMNKAISKDLFVTGGVPTPVGLRLKKGQTPDVKVPYPCVVKAC
CGGSSVGVVMANNDEEYAKALEEAFKYDDEVVIEQYIKGREFSVGVVDGKAYPIIEIAPL
HGFYDYKNKYQAGSTIETCPAELSEEKTLAMQAAAELAFKVLRLKNYARMDFMMDEKGDF
YCLEANTLPGMTPTSLLPQEAKVLGIEYEDLCQLLIDISMRDE
>KF628350.1_16640|FEATURES|farme|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|0
LKTNFNHVMDLTEFNEIRPYNDEELPQIFEELIADPAFQKAATGAIPNVPFELLAQKMRA
CKTKLDFQEAFCYGILWKIAADHTAGLTLDHTAIPDKSKAYTYISNHRDIILDSGFLSIL
LIDQGMDTVEIAIGDNLLIYPWIKKLVRVNKSFIVQRALTMRQMLESSARMSRYMHYTIS
EKKQSIWIAQREGRAKDSNDRTQDSVLKMLAMGGEGDLIDRLMEMNIAPLAISYEYDPCD
FLKAQEFQLKRDIE
>KF628340.1_16666|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
NRPRTRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETG
GANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVKDFAECGL
CGTAAVISPVGKINDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIEAPKGWIHVIE
>KF628332.1_16685|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYNAFEVKTYFITQSGDFIKTQEFIETPG
DDEKLMTNDTVEASQAIKPSDIYEEDAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKRILEVAGVPQVAYTVYIEGEDLEAAVAETLEKLTFPVFVKPANMGSSV
GISKAENESELRSAIDLALKYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAF
YDYQAKYIDNKITMDIPARVPVEVMTQMRAYAAKAFRALGGCGLARCDFFLTEDGAIYLN
ELNTMPGFTQWSMYPLLWENMGLSY
>KF628331.1_16690|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|0
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGL
>KF628330.1_16692|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MNIIVAVDKNWAIGKDNKLLVSIPADMKMF
>KF628329.1_16693|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPSRSEHGTHKSDRTGTGTRSVFGYQMRFNLAEGFPLVTTKKLHLRSIIHELLWFLQGSS
NIKYLHDNGVTIWDEWADENGDLGPVYGVQWRSWPAPDGSHVDQIENLMQQLRTNPDSRR
MIVCAWNPGLVDQMALPPCHCLFQFYVADGRLSCQLYQRSCDIFLGVPFNIASYALLTHM
VAQQAGLEVGDFVWTGGDCHLYDNHMEQTELQLSREPRPYPQLVIRRKPDSIFDYRFEDF
EITGYDPWPHIKAPVAV
>KF628325.1_16707|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MAKRVTVKELNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAIL
VDIFCGVENVDWENPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVLELCEKCDI
VFLGLHGANGEDGKVQAAFDLMGIRYTGTGYLSSAMAMDKRITKEVFLMNHVPTPGGFTM
TRDNLEKDIAKHGLEFPVVVKTSCGGSSVGVYIVNDQKEYEEALTDACQYGADIVVEEYI
KGRDFSVAVVDDKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVK
AAKALGLTGYSRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIR
ISLKKYE
>KF628304.1_16758|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTNIYVHEDLHEMNLYPCAYSMTFNVTKKPGHDKLTLNAILNQRSNDVLAANNWNVCQYA
VLIHMLAQVCDMEVGEFVHVIADAHIYDRHVPMIEELISRKPLPAPKFWLNPEVKDFYQF
TRDDVKLIDYQTHDQIKNIPVAV
>KF628302.1_16766|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWAEARDKEGRAGAIGLNGGM
PWHCAEDMKHFKELTVSHPVIMGRKTWESLGVKYRPLPNRDNIVVSHDPMYRAPGATVVT
SLDDALDMARQEAIPDDGLDRSEIWIIGGAQLFAKALPFADKAYVTDLAATVDADSYAPD
MASLVEAGMWREAEVGEWHTPAKEESGIDSYRFRILAKTK
>KF628284.1_16818|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TPWGCPSELGLNAALNKRPQDSLAANNWNVCQYSLLLMMIAQACDMEAGELVHVIADCHI
YDRHIPVIKELISRKPYPAPTVKLNPEIKDFYKFTTDDLIVENYETWPQIKNIPIAV
>KF628280.1_16831|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGISTERDVSLISGTQIYRALKAKGHQVVLLDLFMGLEQETGDLSDIFEWNRD
WSANIGGITEKDPDISKIKAMRKDQSANVFGAHVLDVCRMADIVFLGLHGSNGEDGRIQA
TFDLMGIRYTGCGYISSALSMDKGLTRKFLQMSGIPVAKGLTVHKGEPVADSEGKVGYPC
IVKPCCGGSSVGVSVANDAAGIYESAGNCFFF
>KF628261.1_16874|FEATURES|farme|fosfomycin|FosC2|antibiotic inactivation|0
MMNFKMAHTEIHVLDLDASLNFYERALGLVPVREKGPEDGSWKLVFLGNDSSDHLLELTW
NRGRVEPYNQGGRDIHLAFEVDDIDAAHELHESMGCIVKENPSMGIYFIEDPNGFYIEIV
PAR
>KF628261.1_16875|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MTCQLKAIVAVCDDWGIGRDGDMVVSNRADMRHFVACTKGHPVIMGRKTLESFPGGRPLK
DRRNIVLTRDGSFTREGVEVVHSVDEALTAVADEDVAWVIGGGAVYEQLLPYCVEAEVTR
NHVVHPADTFFSNLDEDSAWIAAERQGERTIEEGQGDAGLRYEFVTYRKVSS
>KF628259.1_16880|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRNIVLSTRPDTLCPGAEIFPSLEEA
LKHCEQDEQIYIIGGASVYRQALPLADALCLTEIDAEAPQADAYFPEVSPEIWQEKSRES
HPIDEKHPCPYAFVNYIRR
>KF628240.1_16923|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVAVDKNWAIGMDNKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVN
VVLTSDKKYNVKGTVVVHSIDEMVEELKKYNDEDIFVIGGESIYRQLLPYCKTAYITKID
HAYQADTFFPDLDQDPQWQMTKISDEQTYFDLEYVFTI
>KF628234.1_16937|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCNNILENGTDTKGEKVRPHWADGTPAYTQKLFCVVNRYDLKKEFPALTL
RRTALKSCVDEILWIWQKKSNNIHDLHSHIWDSWADENGSIGKAYGYQLGVKHKYKEGMF
DQVDRVIYDLKNNPFSRRIMTNIYNHHDLSEMGLYPCAYSMTFNVTEGENGKLVLNGILN
QRSQDGFDRQQLECRSVQRADAYARTGV
>KF628234.1_16939|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKLIAAVDNEWNIGNKGGLLFSLPDDMKFFRTTTSGKIVVMGRKTLESFPGSKPLKNRVN
IVLSRCNRHVDGAEFATSVDELLDKLKAYNSDDIYVIGGAQIYSLLLPYCDTALITHVDA
VASEADSKFPELKTDEWKITEQSDIHENNGLKFSFTTYKRI
>KF628228.1_16952|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTAIVCVSKSWGIGRDGALLFLISDDHKRFRSLTVGKTVILGHKTLDTFPGGRPLKDRRN
IVLSHRDLDIPGAEIAHSFDEAAALGGDDAIVIGGASVYMALLARCDRVYVTKVDADPDA
DSFFPNLDDNPDWRIDSESEVFEENGLKFQYVDYVRN
>KF628222.1_16973|FEATURES|farme|chloramphenicol|catD|antibiotic inactivation|1
MFFEKIDINSWTRHEYFEHYFTNVPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNR
HSEFRTAINQEGELGIYDEMMPSYTIFHEDTETFTNLWTPYIPDFEAFSMAYANDMQRYG
SNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPL
AIQVHHAVCDGFHICRFVNELQELINS
>KF628219.1_16987|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLD
>KF628214.1_17002|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MTAIVCVDKNWAIGRENRLLFRISADLKHFRALTTGKTVVMGKNTLLSLPGGRPLPNRRN
LVVSTTMAPREGVEIARSIEEAAALAGEDAVLMGGAQLYRALLPHCERVLVTQVDAAAEG
ADAFFPNLDAAPDWTVETVGEWQEENGLRFRYVDYVRRT
>KF628213.1_17005|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGCIARYRLEALMSKADELFVSMCQDILDNGTTTEGQKVRPHWEDGTPAYTIKNFGVTNR
YDLREEFPALTLRRTALKSAMDEILWIYQRKSNNINDLHSHIWDEWADETGSIGKAYGYQ
IAQKSHYVEGDFDQMDRVLYDLQHTPFSRRIMTNMYTFSDLSEMHLYPCAYSVTYNVTEQ
PGDEKPTLNMVLMQRSQDILAANNWNVCQYAILLMMVAQSCGMIAGELLHVIVDAHIYDR
HVDIVRELIARPQYSAPRVSLNPEVTNFYDFTTDDLIVEEYEHGPQIKNIPIAV
>KF628205.1_17028|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
VYAIVAVDEKWGIGRDNALLFHLPADLKRFKELTSGHTVLMGRRTLQSLPGGRGLPNRRN
IVLTGQRGFTAERAEVVHSPAEAVLTADEDAWVIGGESVYRMFLPLCDRVYVTRIAADGS
ADAFFPDLEHDPGWRLDKRSADMEENGLRFRYEEYVPDG
>KF628196.1_17050|FEATURES|farme|multidrug|efmA|antibiotic efflux|1
VRETPEVSGDDNANARAAVHSANKPGAAYAAAVANGESERAWIRRVVLLLTGQAFSLLGS
NIVQYAIWWWIVLQTKTGSAMLLATLFGVVPQAIVSIFGGSWADRHSRKLLIMLPDMVIA
VVTVVLSLSFAMGWASLTMIFVVLFIRSAGGGVQTPAVQSFIPDVVPSGKLLRVNSIYGV
INSANMIVAPAVAAVLINTVPLWSILLVDVTTAIIGVGFVALIKAPKKSAEHVARRMAEA
ENSGQPTLEPMSDANADRSLIAGVRRVFADLKDGFSYTWRRANLRNAVLGGALVCFVAVA
PMNLTLLLMTREYEGIDLNLGFINLTTASDKLAANELGWSIGMLLGGALMSTIGAKLIRN
NMRVVAFGIALVGVSVVGLGVVHNLLAYLLIDVVNGLASAICTGPMRTIIQTEADEKMVG
HVFGLDTTLSALGMPLGMLIFAPLADAIPISLVFIIGGVLTLPIGIYLFGQARRNVSAQV
TRTAA
>KF628192.1_17063|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HHYPEGDMDQVDRILYDLKHNPGSRRIISNIYNHADLSEMRLYPCAYSMTFNVSGNRLNA
ILNQRSQDMLVANNWNVCQYAVLVYMMAQVSGLEAGMLMHVIADAHIYDRHVPLVEELIS
REPLDAPRFIIDKSIDDFYKFTVDSFSLEGYESHGSIGKIPVAV
>KF628189.1_17073|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNMIVAADKNWAIGKDNSLLVVIPADQKTFRNMTLGHPVVMGRKTFESLPGGLPLDLRKN
IVLTTNPEFHPKGVTVVHSLKELFEELGEEKDEAFVMGGQSIYEQLLPYCDVVHVTRIDQ
AYEADTYFPDLDQKPEWKITAESDEQTYFDLEYTFVRYERKKS
>KF628188.1_17075|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKAIVAVYDDWGIGANGTQPVALSADRKFFREMTRGACVIVGRRTLADFPGGRPLPGREN
RVLTRDKNRIIPGAVLCGSPEEAAENAPENTFVIGGGSVYARMLPYCREAIVTKVHAAPM
SDTFFPNLDTDPGWTAAETLQRGEENGIAYEMVRYVRK
>KF628186.1_17082|FEATURES|farme|trimethoprim|dfrA|antibiotic target replacement|1
MDAIVSVTSDWAIGRDGGLLVPNRADMRRFVQLTRGCTVLMGRKTLESFPGGPLKGRRNV
VVSRQEGYAPEGVEVFSTPEGALEATNADEKVWLIGGASIYQALLDKCERAYVTVNECVR
EADAWFPNLDESPDWEVEAREKGGVTEAGVPFEFVTYRHG
>KF628186.1_17083|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADKIFVAMCEDIINNGTTTEGQKVRPHWEDGSAAYTIKQFGVCNRYDLREEFPALTL
RRTALKSAMDEVLWIYQKKSNNIHDLKSHIWDEWADEAGSIGKAYGYQIGVKSHYPEGDF
DQMDKVLYDLRNTPFSRRIMTNTYVFADLSEMNLYPCAYSVTYNVTQCADDERPTLNMVL
NQRSQDVLAANNWNVCQYAILLMMVAQTVGMVPGQLVHMIADAHIYDRHVDIVRELISRP
QHPAPRVSLNPEVTDFYAFTTDDLLVEGYEHGPQVKNIPIAV
>KF628181.1_17094|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKNLSIIAAVAKGGAIGKNGGLLCHMSADLQRFKALTTGHTIVMGRRTFDSLPKGALPNR
RNIVITRNPQFSAPGAEVALSVEDAFRMAESDGEVFVIGGEQIYRATLPFASRLYLTEID
ATFFGADAFFPDVNWKEWRETLREHHQSDDRNPHPYSFVNYER
>KF628174.1_17109|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVTKEPGKDKLVLNAVLNQRSQDVLTANNWNVAQYSMLLMMIAQVSGMEAGELLHVI
ADAHIYDRHVPLVEELIAREQHPAPKVWLNPEIKDFYEFTVDDLHVEDYITGPQIKNIPV
AV
>KF628167.1_17134|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
WNVCQYAILLMMVAQSVGMITGELVHVIADAHIYDRHVDIIRELISRPQYDAPRVSLNPE
VTNFYDFTTADLIVEGYEHGPQVKNIPIAV
>KF628167.1_17135|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MTTQNDPTEKNAPLETLADRPLPNLFAIVAVCDDWGIGLDGDMVVSNRADMRHYVRHTKG
HTILMGRRTLESFPGGRPLKDRRNVVVTRDESWAPDGVDVAHSLAEALDMVAEDDEVWVV
GGGQVYRALLPMCSRAVVTKNHCVRACDTFFPNLDADPAWRVESRVTTDDEGNPLVTDEQ
IPFEFVTYVRA
>KF628164.1_17143|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LFLQNCREILSHGVWDTDLPVRPRWEDGTPAHTIKKFGIINRYQLQEEFPILTLRRTYWK
SAVDELLWIWQKKSNNIHDLSSHIWDQWADESGSIGKAYGYQLSVKHHYPEGDMDQVDRV
LYDLKHNPASRRILTSLYNFEDLHDMHLYPCAYSMTFNVSGKVLNAILNQRSQDMLTANN
WNVVQYAILVHMFAQVSGLV
>KF628159.1_17153|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SMTFNVTDNRLNAILNQRSQDVLVANNWNVVQYAVLVHMLAQVCGYEAGELVHVIADAHI
YDKHVPLVEELIGRTQYPAPKFEMNPDVKDFYEFTLDDFKLENYQAGPQIKNIPVAE
>KF628158.1_17156|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQTEEYQTNLICMSKISIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTIVMGRKT
FESLPKGALPNRRNVVLSSNPAAECPGAEVFPSLEAALQSCKEDEHVYIIGGASVYQQAL
PFADELCLTEIDNPAPEADAFFPEISPAVWHEKNREAHPADEKHLCSYAFVDYVKA
>KF628147.1_17190|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
TVRYGKLLFQSVFERSRTMSYADEVFIRNCRDILQNGVWDTDQAVRPRWEDDGAPAHTVK
KFGIVNRYDLSREFPLLTLRRTYWKTAVDELLWIWQQKSNNIHDLRGHIWDQWADETGSI
GKAYGYQIGQKSHYAEGDFDQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSV
TYNVTQRPQDDKPTLNMILNQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIA
DAHIYDRHVNIVRDL
>KF628145.1_17195|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MDAIVAVYSDWGIGADGTQPVILKADRQHFVELTRGRTVIVGRRTLADFPGGRPLKGRRN
IVLTRQSAAIDGAEIAHSPEEACLLCADDAMVLGGQSVFRDMMPYIDRVFVTKINCCPQS
DSYFENLDVSADWRIASQSKALREGDIEYSFVCYERIKP
>KF628137.1_17211|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
LNPDVKSIFDFKYEDFELTDYNPHPHIAGKVAV
>KF628132.1_17222|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|0
RTNLILSATAGFQVEGATVYRSASALLQALQEYPQEQLCVIGGASVYELLLPYCHTAQIT
KTFQQVPADRFFPNLDTLKHWTLTAASDVMEEDGVRFQYLDYRNQAPLPLSAACRTSDLA
F
>KF628131.1_17225|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIVNADKNWGIGKNNELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGMPLPKRTN
IVLTHDKDYDAKGAIVVGSKEELLDELEEYKDEDIFIIGGESIYRMMLPYCDTAYVTRTD
FAYDADTYFPDLDEMPEWKLVKESEEETYFDIEYQFLVYGK
>KF628130.1_17228|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTAIVCVSQSWGIGRDGALLFRISADHKRFRTLTVGKTVILGHKTLDTFPGGKPLKDRRN
IVLSHRDLDVPGAEIAHSFDAAAALGGDDAIVIGGASVYMALLSRCDRVYVTKVDADPDA
DSFFPNLDDNPDWRIESESETFEENGLKFRYVDYVRK
>KF628119.1_17262|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKLIVAVDKNWAIGKNNKLMWSIPADMKFFRETTQGNVVIMGRKTLESFPQGQPLKNRVN
IVISRKPDYQVKGAVVVHSVEEAVEESKKYEGEVFVIGGESIYRAMLPYCDTALVTKIDH
AFDADTYFPSLDQDDEWQMIKISEEQTCFDLEYYFTVYERVQK
>KF628109.1_17288|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
YGEDAVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPENYARAQELACAAHKA
LGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDMTFPQVCDSLIRMGLR
RAGVAC
>KF628093.1_17324|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGEWIVDGEDPRKWN
MSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVGAVLP
>KF628088.1_17337|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
TKALRKNGHQVILLDVFMGYGEEEQDITGIFEHSEEASVKVTDIPETAPDLDKVRKSRKD
QSACFFGPNVIAMCRMADIVFMALHGENGENGKIQAAFDLFGIRYTGSGYLSSAIAMNKN
MAKQFFEANGIPCPKGIYMKKKDRKDSLAEIGITLPCVVKPCCGGSSIGVSIVKEESNFT
KALDDAFFWEDEILIEEYVEGREFSVGVIKGRALPVIEIAPKEGFYDYKNKYKAGSTVET
CPADIKDSVAKEMQKHAVKVAEALGLDTYSRIDFLVNAKDEVYCLEANTLPGMTATSLLP
QEAKVEGVNFEELCQRLVDISMEKYGR
>KF628068.1_17391|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FVWTGGDCHVYDNHVDQVLEQLSREPYPYPKIEIRKADSLFDYQYEDFTIVDYRHHPTIK
APVAV
>KF628068.1_17392|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRNGYHEPEPGFAGQEKADDWGDDFPKTFSVNLIWGEADDKDGRPGAIGFDGGMP
WHLPEDMKRCKELTASHPVIMGRRTWESLNVKYRPLPNRDNIVVSHNPQYLALGATVVTD
LDAALDIARQEAIPDDGLDRSEIWVIGGAQVFQEALPFASKAFVTKIQTSVDADTYAPDM
DALVDAGLWEVADPGHWKRTQKDDSGIKRYRFVTYRKIG
>KF628067.1_17394|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPASTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWIYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRELIERP
QFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF628052.1_17434|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MKIIVLAGGYSPERDVSLSSGSLIANALMERGHEVFFLDPWLGIKAGERVHYRTREEGLG
FAYEIGGEAPDLELLGAGTGAKISLIGPGVLEACREADMVFIALHGSAGENGQIQALLEA
YGISHTGSGYMGSLLAMDKNISKILMRAAGVATPDWYLAEKGKCSQPEFLPCVVKPLDCG
SSVGVTIVDNEEEWHTALEAAFSYGDRVLVEKKITGREFSVGVLGGRALPAIEIIPEKGF
YDYKNKYQPGMTREICPAGIDEKQESRLEAAALTVHRILELGYYSRVDFLMDEDGAIYCL
EANTLPGMTPFSLLPQEAKAAGITYQELCEAIVKNGKGAAL
>KF628051.1_17435|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
KNINTPSGELYKNEKDALAWNMFPCIVKPCSGGSSVGVSKVENADQYKKAVKEALKYEDE
IVVEQFVTGREFSVGLIGGKALPPIEIAPKSGMYDYAAKYQAGATVETCPADIDEETDKK
LRDAATEAYEALHLESYARIDFLLDKGGFTYCLEANTLPGMTPTSLLPQEAAVEGISYPD
LCEKIIEISLAKYPKEKSDF
>KF628038.1_17465|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LLEWIVNVKRKGNTVSKQLIAIWAEAHNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMG
RVTFDGMNRRCLPGRETLILTRDKDFSCEGVRVVTSVEEALAWFEQQDKDLYIAGGAGVY
KAFDGHYDALVKTTIEADLEGDTYFPQLDMTAFKEVSRHLVVKDDKNAYDFSVSRYEKEG
D
>KF628022.1_17506|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMV
>KF628009.1_17536|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MEETKMNLIVAVDENWAIGNRNKLLVSIPADMKFFREMTKGNVVVMGRKTMESFPGGQPL
KKRTNIVLSRDESYQVKDAVVVHSLEELLEQLKSFPEESIYVIGGESIYRMLLPYCKEAY
ITRIRHSYAADTYFPDLDADPEWELEDESDEQTCFDLEYVFTRYRRKQAEKKLDN
>KF628006.1_17543|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MEKKTVAVLFGGQSSEHVVSCMSAANIVEQIDTDTYNLLLIGITEEGRWLKALSLDSIRD
GSWKESCEEAVILPDATKKCALLKCGTSWQEVPVDVAFPVLHGLYGEDGTVQGLFELARI
PYVGCGVLASAVSMDKLYTKIIVDDLGIRQAAYEPVMKEQLSNMDEVVKRIEARFSYPVF
IKPSNAGSSKGVSKAENRDGLVKGLLEAARHDRKILVEETIIGREVECAVFGGGSVPVEA
SGVGEILAAADFYDFDAKYYNEESRTVVDPELPEDAAETIRRNAAAIFKAVDGYGLSRVD
FFVKEDGEVVFNEINTLPGFTAISMYPMLWEARGIDKKTLVNRLIEHGLARF
>KF628004.1_17548|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNLIAAVDLNWAIGRDGDQLCYIPADLKRFQALTTGHPVILGRKTLATFPGGRPLKNRRN
LILSRDSAFAPEGAEVFRSLEALRAAAPADSFVIGGASVYAALLDWCDTAYITKIGRAWE
GADAFFPDLDAGPDWEMAEEGEPQEHAGIPFRYVTYRRRKPHVCG
>KF627994.1_17577|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
IQGFLETLKLPYVGTNVLSSSVAMDKIMTKHILEVAGVPQVAYTVFIEGEDLEVAVAETL
EKLTFPVFVKPANMGSSVGISKAENEAELRAAIDLALKYDSRILIEQGVVAREIEVGIGI
LGNTNVKTTDPGEVVKDVAFYDYQAKYIDNKITMDIPAHVPAEVMTQMRAYAAKAFRALG
GCGLARCDFFLTEDGAIYLNELNTMPGFTQW
>KF627991.1_17584|FEATURES|farme|chloramphenicol|TQ39_15890|antibiotic inactivation|1
MEFHRIDLEQYPRKEHYRHYRQAVPCTYSMTVTLDMTHMLQKIKEKGFPFYPVIIYGISR
VVNAHQEFRMALDELGRLGYYDVVHPNYTIFHPKTETFSSLWTPYQENLSAFLRQYQENL
VRYGDQPTAFSPMPDIPNQFFISCIPWVSFTEFHLNIQHGYNHFAPIFTIGKYQRSGEKI
LLPLAVQVHHAACDGFHTARLTNELQAWADYFSLPE
>KF627989.1_17590|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICNTLLEKGHDAFLLDVFLGLENAPENLEDVFTLPGH
GLEIAKNISETEPDLAAVKASRPDQSDCFFGPNVIELCRLADMTFLGLHGGEGENGKLQA
SFDLLGIRYTGPDSLGCAVAMDKGLTKQIFMEAGVDTPSGVCLYKEDSDCSLESLGLSFP
VVVKPCSGGSSIGVYIVNTEEEYRQALKNSFRYENEVVIETYIKGREFACGVIDGKALPP
IEIIPKNGWFDYANKYQANATEEVCPADISEEIAERMKALTVRAFQALKLNVYSRADFIL
DADGNLYCLEMNTLPGMTSASLLPKEALADGIEYGDLCELIIQKSMEARYQ
>KF627987.1_17595|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GESAYTIKRFGVVNRYDLRKEFPALTLRKTALKSCMDEILWIYQKKSNNIHDLNSHIWDA
WADADGSIGTCYGDVVGRKFIYKGEETDQMDYVLRQLKENPYSRRIMTNLYQFEYLHSGA
LDPCCYSMTYNVTKDAAEDRLVLNGVLNQRSQDVLAANNWNVCQYSILLMMVAQVNDMIP
GELVHVIADAHIYDRHVPAVRELISRTPYAAPKVTLNPEIKDFYDFTTKDLIVEDYQAGP
QIRNIPIAV
>KF627987.1_17597|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
HPPGQYQFRVLTTPFGPYFKGGVKPLTIRVSDFDRAAPNGTGHIKAGLNYAMSLHAIVDA
HNQGFDENMYLDPGTRTKVEETGGANFLFVTKDNTVVTPKSSSILPSITRRSLIYVAEHY
LGLKVEEREVLFEEVKDFAECGLCGTAAVISPVGKIVDHGKEIILPAGMEQMGPVTQKLY
DPLTGILMGRLEAPEGWIQVIE
>KF627978.1_17624|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGTKKDDRTGTGTISIFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHIYGYQWRSWPDYNGGFIDQISEVVETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMRINPDVKSIF
DFKFEDFELVNYDPHPHIAGAVAV
>KF627950.1_17699|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VYLPKARRKDDRTGTGTISVFGHQMRFNLDEGFPCLTTKKLHLKSIIYELLWFLQGDTNV
KYLQEHGVRIWNEWADENGDLGHIYGYQWRSWPNYKGGFIDQISEAVETIKHNPDSRRII
VSAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMMA
QVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRDLPQMRINPDVKNIFDFKFEDFEL
VNYNPHPHIAGVVAV
>KF627944.1_17712|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
DLDGGWHYLDAKQTDLAKNTWLDNSSMVEDVYGLLKNQDVAFPVLHGMYGEDGTIQGLFE
LAKLPYVGCRVMGSSVAMDKIYTKKILDTVGVPQVKSVYVKKRYDEKLVVVTNTFDEIEE
IEDYIVRELGMPCFIKASRSGSSVGCYRCDNQTELIGKLSEAAKYDRHVVVEECIDCIEL
ETAVLGNDDVIVSRVGQIMPHGEFYTFESKYEDEESKTCIPALVDEQIQEQIRQYAIKVF
KAVDGHGLSRVDFFLDKKTNKIYLNEINTMPGFTKISMYPQLMNDFGITYPELLDRLIVL
ALQK
>KF627939.1_17728|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|0
MDVYARADFIVDETDGKFYCLEMNGLPGMTPASLIPKSARAIGVDYGDLCELIIEESMKT
RYQD
>KF627933.1_17745|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWIYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVNIVRELIARP
QFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF627926.1_17763|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
CAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEF
VHVIADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYEFTPDDVRLDGYETHPQIK
NIPIAV
>KF627913.1_17795|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
FRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDE
NMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEE
REIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGIQ
MGRIQAPEGWLKVIE
>KF627911.1_17803|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAVDKNWAIGKNNKLMWSIPADMKYFRETTKGNIVIMGRKTLESFPQGQPLKNRTN
IVITKNPNYKVKDALIVHSIEEAMEEAKKYEGEIYVIGGESIYRAMLPYCEKALVTKIDH
AYDADTYFPNLDEDPEWTMTKISEEQTCFNLEYYFTIYERNARK
>KF627880.1_17875|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TYEDPNRTIDQIGNVLDLIRNHPDSRRMVVSAWNPAEVENMALPPCHALFQFYVADGRLS
CQLYQRSCDMFIGVPFNIASYSLLTMMIAQQTGLEPGEFVWTGGDCHVYDNHVDQVLEQL
SREPYPYPKIEIRKADSLFDYQYEDFTIVDYRHHPTIKAPVAV
>KF627864.1_17911|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNAIVAADQNWAIGKDNGLLFSIPTDMCRFRKLTTNGTVIMGRKTLDSLPGGRPLPKRRN
IVLTHNPAFAREGVEFADNIEAALRMAVTENPENVWVIGGASVYAAMLGQCRKVFLTRVF
AEAEGADAFFPNLDADPTWRRLSVSRPVFENGLSFQFVTYERTPNLF
>KF627857.1_17929|FEATURES|farme|beta_lactam|blaR1|antibiotic inactivation|1
PTLEVINGELSSYWMESSLKISPIEQVELLTSLYFNDFGFTPENIQTTKESIQLFSDVNC
TIYGKTGTGCIEEKNVNGWFIGFVESKNHTYFFATNIQAIDNATGSIASEITLSILSDMN
IYKL
>KF627852.1_17943|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
VLSSNPDTVCSGAEVFPSLETALRSCREDEHIYIIGGASIYQQALSFADELCLTEIDSTA
PEADAYFPEVSSKVWQEKSREAHPADEKHLCSYAFVDYVRK
>KF627848.1_17954|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNCIVNVTEDWGIGRENQLIAPISADLKRFRRLTSGKVVILGRKTLSTFPNGAPLKNRVN
LVLSSDQALAINGATVAHNLQELFAQCRQYPEDDLCVIGGASIYELLLPYCEKALVTKTF
SRPQADRFFPDLDALENWSIAHASEQMEEDGVFFQYLDYVNSLPRSYR
>KF627832.1|FEATURES|farme|aminoglycoside|ilvE_1|antibiotic inactivation|0
TPSRSFGTNRVIGVKPADEYQFRVFTTPVGPYFKGGVKPLTIRVTDFDRAAPHGTGHIKA
GLNYAMSMHAIMDAHHQGYDENMYLDAATRTKVEETGGANFLFVTKDGKVVTPKSDSILP
SITRRSLIYVAQHCLGLEAEEREVTLEEVKDFAECGLCGTAAVISPVGKIVDHGKEICFP
SGMTEMGPVTKKLYEALTGIQMGRLEAPEGWLQV
>KF627831.1_17997|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWAEARDKEGRAGAIGLNGGM
PWHCAEDMKHFKELTVSHPVIMGRKTWESLGGKYRPLPNRDNIVVSHDPMYRAPGATVVT
SLDDALDMARQEAIPDDGLDRSEIWIIGGAQLFAEGFAVRGAKPM
>KF627830.1_18001|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
VKLIAAVDKNWAIGNKGQLLVSIPQDQKMFRDETMVKVIVMGRKTLESLPGAQPLYGRTN
IVLTADPDYRVKGASVCGSVEEVMELLRAYHTDDVYIIGGESVYRQFLPYCDEAQITWID
FAYAADTHFPNLDQDAAWEMVQESDEQTYFDLCYEYRLYKKK
>KF627827.1_18008|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQLFIKMCQDIIENGVSTEGEKVRPKWEDGSSAYTIKRFGVVNRYDLSKEFPAITL
RRTALKSAMDEILWIWQKKSNNIHDLNSHVWDEWADENGSIGKAYGYQMGVKHQYKEGMM
DQVDRVLYDLKNNPYSRRIMTNIYVHQDLHEMALYPCAYSMTFNVTKEKDSEKLTLNAVL
NQRSQDILTANNWNVCQYALLLMMFAQVTDMKAGELLHVIADAHIYDRHIPVVKELIARP
TYDAPVVKLNPEVKDFYAFTTEDLIVGIM
>KF627825.1_18014|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VDLIYQNNSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDFDQMDRVLYDLK
HTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMILNQRSQDILAAN
NWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVREHIERPQFAAPKVTLNP
DVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF627824.1_18017|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MYMSRADELFIQNCKEILSHGVWDTDLEVRPRWEDGAPAHTVKRFGIVNRYDLREEFPVQ
TIRRMAFKSAVDELLWIWQKKSNNVHDLNSHIWDAWADGSGCIGKAYGCQLGVKHRYPEG
EFDQVDRVLYDLKHNPASRRILTNLYNHHDLHEMALYPCAYSMTFNVSGNTLNAILNQRS
QDMLTANGWNVTQYAILLHMIAQVSGLEAGELVHVIADAHIYDRHVPVVEKLLEAKQSPA
PKFIIDQSVTNFYAFTRDSF
>KF627821.1_18024|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHVPMIEELISREPLPAPQFWLN
PEIRDFYQFTRDDVKLIDYQTHDQIKNIPVAV
>KF627817.1_18033|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKIVVLAGGISTERDVSLSSGRGVYNALKERGHQVILLDVFLGYEGDPGNIFELDRDWVK
DVAPVSEVAPDIEKIKASRKKPSNILFGDHVIEICQMADIVFMALHGDCGENGKVQAVFD
LFGIKYTGTDSFSSALAMDKSITKQLFLQNGVPTPASHLLTGKDDPYKPEFPCVVKVSGG
GSSVGVYIVQNEKEYADAVQDAFRYDAKVLVEQYIKGREFTDCVIEGKPYPVVEIEPVSG
FYDYKNKYQAGSTIETCPAKISDELTRKIQDTALKAYQVLGIKTYARMDVLMDENGDVYC
LEANTLPGMTPTSLIPQEAAVLGISYGELCELIIEISLKRW
>KF627816.1_18036|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
VSSLSKKRIAVIFGGASSEHEVSRLSSAYIINSIDKEKFDVVTIGITKDGRWFLTTAPTA
KIANGEWENDTNNKKAFISPAPTVGGLVVLNSDGHSEVVKLDVVFPVLHGKNGEDGTVQG
LLELSKIPYVGCGVAASACCMDKVFTNIMLRDSGIDEADFTWFYTYEYKRSPEKCIEQVE
NALAYPIFVKPANAGSSVGVNKAKNREQLINAIEIAIKEDSKILFEENIIGKEVECAVFG
NEDIFASIPGEIAPAKEFYDYEAKYQSASSELYIPAKISDELIEKVRETAKKAYHLFGCA
GLTRVDFFVTEDGRVLLNELNTLPGFTSISMYPKLMANCGKEGKQLIAELIALALNKNMA
>KF627802.1_18077|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
TTEDGHIVTFRPDLNGERMEHSAARLEMPVFPKDRFVDAVVQTIKANAAYVPPYGSGATL
YVRPYMFGSDAVIGVKPASEYQFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPNGTGHIK
AGLNYAMSLHAIVDAHKNGFDENMYLDSKTRTKVEETGGANFLFVTKDGKVVTPKSDSIL
PSITRRSLIYVAKEYLGLEAEEREVYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICF
PSGMN
>KF627797.1_18088|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VNNYVDIVEKFRDKGEIMKITVLAGGTSTERDVSLVTGSMIYKSLVKSGHQVVLVDLYLG
YDGADYTDVFAIKKDWSESIQAISSQNPDIRQVRAMRKDDPYNEVGPHVIDICKQSDIVF
LALHGQNGEDGKVQAMFDLLHIKYTGTDYFSSALAMDKVISKELFIKYDIPTPKGITLTV
GQEAQWDTYPCIVKVNRGGSSVGVYKAENAQELQDALKQAFSFEKRVLIEEYIDGREFSI
GVMDGKALPIIEIAPKVGFYDYKNKYQAGSTVETCPAELPEEVTEGMQRCAEAVYRALRL
HTYVRADFRMDREYHFYCLEANTLPGMTPTSLLPQEAAAVGVDFDALCEEIIRISLEKYN
EAE
>KF627794.1_18093|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
HPRGQLNSVFTALGYYMGEAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGE
IVPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFG
YEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGC
YVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILM
TSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFS
KKQ
>KF627786.1_18107|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
VRQRKNVLKCAGIWGIIKLKNKGAGPMSIADRIFIENCRDIISNGVWDTDRPVRPRWEDG
SPAHTVKLFGVVNRYDLSLEFPIMTLRKTGFRNAIDELLWIWQKKSNNIHDLHSHIWDAW
ADENGSIGKAYGYQLGVKHHYPEGDMDQVDRILYDLKHNPGSRRIISNIYNHADLSEMRL
YPCAYSMTFNVSGNRLNAILNQRSQDMLVANNWNVCQ
>KF627785.1_18114|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGDFV
HTFGDAHIYLNHLEQVKLQLSREPRPLPQMRINPDVKSIFDFKFEDFELVNYDPHPHIAG
AVAV
>KF627776.1_18153|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VDKALWDLKHDPASRRIMTNLYNHHDLSEMALYPCAYSMTFNVSGRTLNGILNQRSQDML
TANGWNVMQYAVLLHMLAQVSGLEAGELIHVIADAHIYDRHVPVVEELLEREPYEAPRFI
LEPSVTDFYSFTPSSVRLEGYQAHALDQKIPVAV
>KF627774.1_18157|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|0
MLLPYCDTAYITRLDYEYQADTWMPNLDKEENWSMVEKSEERYCFDLIYHFTTYKNAVPE
LH
>KF627761.1_18187|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
KANSAYVPPYGSGATLYVRPYMFGSDAVIGVKPASEYQFRVFTTPVGPYFKGGAKPITIR
VSDFDRAAPNGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDSKTRTKVEETGGANFLF
VTKDGKVVTPKSDSILPSITRRSLIYVAKEYLGLEAEEREVYFDEVKDFAECGLCGTAAV
ISPVGKIVDHGKEICFPSGMNEMGPITKKLYETLTGIQMGRIQAPEGWLKVIE
>KF627760.1_18190|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKTPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKASLGGSSFGVTKVTAKEQIQP
AIAKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPITEVVSHNEYFDYEAKYNGASD
EITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAAGMEMKDVMTDIIENKFKD
>KF627749.1_18210|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VVNRYDLSKEFPALTLRRTAIKSCTDEMLWIWQQKSNNIHDLHSHVWDSWADENGSIGKA
YGYQLGVKHQYKEGMMDQVDRVIYDLKNNPYSRRIMTNMYVHQDLHEMALYPCAYSMTFN
VTKDKDSDKLTLNAVLNQRSSDVLTANNWNVCQYAVLVHMLAQVCDMKAGELVHMIADAH
IYDRHIPMVEELINREPLPAPKFWLNPEIKDFYQFTRDDVALIDYETHEQIKNIPVAV
>KF627744.1_18225|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
LYQWISIGESASKTTCSFSIREDMRFFKNTTMGGTVVMGDKTLLSLPGAKPLPGRENLVL
SLDPAFSAEGITLFSSIETLFDRLRGTDTSRVFVIGGATIYNLLMDYCETAYITKVEADG
GAEVFLRDIDAQQNWELVACSGQHRQGSLAYRFCTYRNRNVKPM
>KF627729.1_18274|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RRIMTNIYVHNDLHEMHLYPCAYSMTFNVTKEKDSEKLTLNAILNQRSQDVLAANNWNVC
QYAVLVHMLAQVCGMKAGEFVHVIADAHIYDRHVPMIEELISREPLPAPTFWLNPEITDF
YDFTPDDVRLDRYETHPQIKNIPIAV
>KF627727.1_18283|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
VKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGLFELSKIPYVGCGV
LASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEKEIPYPIFVKPSCAG
SSKGVSKAENRKELEAALYEAVKHDRNILCEETIVGREVECAVLGDRTQVKSTCVGEILA
AEEAAFYDFDAKYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVDGFGLSRVDFFLEES
GRVVFNEINTLPGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRYR
>KF627726.1_18285|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKLILATDENWAIGNKGGLLCHISGDLKYFKERTAGKTVVMGRPTLESLPGAKPLPKREN
IILTTRPDYEVPGAAVAHSEEELEQLLEGRDTDDVFIIGGGKVYRDFLDRCDTCYITKIF
DKFQADTWFVNLDER
>KF627721.1_18299|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKLIAAADKNWAIGKDGELLVRISEDMKNFSAMTTGNVIVMGRKTLERFPGGKPLPNRVN
IVLTHKKDYNGKGAIVVHSEEELWEELSKYDTESIFVTGGESIYHMLLPYCDTAYIHPS
>KF627716.1_18310|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKAIVAVDQNWGIGKEGKLLAHIPEDLKYFKEKTLGHVVVMGRRTLCSLPGGKPLPGRDT
VVLSRDEGFAPQGVTVVHSARELRELLREKHPSREVFLCGGGEVYREFLPECREVLVTKI
GREFAADTFFPDLDAQSGWEREEGELRFHGEIPFRFCVYRRTGDTE
>KF627710.1_18328|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VNSNDYNREKIMNLIAAVDNNWAIGKNNQLLVRIPMDQKFFREMTTGKVVVMGRKTLESF
PNSRPLKNRTNIVLTHNPSYEVEGAIVVHSLDELHKELEKYNSEDIYIIGGQKIYEQLVD
ECDVAHITKVDFEYDADAYFPNLDEKPEWQITGDSEEQTYFDLEFYFLRYEKVK
>KF627709.1_18332|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DLHEMNLYPCAYSMTFNVTQTPGNEKLTLNAILNQRSQDILTANNWNVCQYAILLMMIAQ
VCDMEAGELLHVVADCHIYDRHIPVVKEMIMRKPYPAPIVKLNPEVKDFYQFTTDDLIVE
NYETWPQIKNIPVAI
>KF627708.1_18333|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
SREPLPAPQFWLNPEIRDFYQFTRDDVKLIDYQTHDQIKNIPVAV
>KF627701.1_18353|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LCLIKPKHDNSIKEKRTKMNIVVLAGGLSTERDVSFKTGSMVAKALKENGHKVILLDVFM
GYSDREEDLAGIFDRADEISVQVSDIPTEAPDLAKVKASRKDQSPCFFGPNVIKMCQMAD
IVFMALHGENGENGKIQAAFDLFGVKYTGSDYLSSAIAMNKETSKQFFLANGIPTPKGIS
MTRATRQDDITKLDLTLPCVVKPCCGGSSIGVTIVRDAAEFKAALDDAFKWENELVIEEF
VQGREFSVGVIEGKALPIIEIAPKEGFYDYKNKYKAGSTVETCPAELPEQVTKDMQHYAE
EVARVIGLDTYSRSDFLLNDKNEMFCLEANTLPGMTPTSLLPQEAAVIGMSFNQLCEHLI
DISLKKYEV
>KF627698.1_18359|FEATURES|farme|multidrug|RND_transporter|antibiotic efflux|1
LYLSNYAKLNLVDQLTRVPGVGAVNVMGAGDYSMRIWLDPAAMRIRYLSPADVYQAIQSQ
NVEVSAGNVGQPIGTDNKNAYQYSLTVKGRLTSPEEFGNIILRTETGGKILRLRDVAHID
LGSASYSVVSQLDGKPTAAIAIYQQPGSNSLDVSKGVKAKMQELSQNFPAGIQYNVTLDT
TDVIHASIDEVMVTFLETTLLVVLVIFLFLQNWRAVVIPCITIPVSLIGTLAVMSLFGFS
INTLTLFGLILAVAIVVDDAIVVVENSTRLLDTGRYTSRQAVTEAMGEITGPIVGVVLVL
LAVFIPTTL
>KF627674.1_18425|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PTLEVLTHMIAQQCDLDVGDFIWTGGDCHIYNNHFEQVKLQLSREPRPYPKLIIKRRPDS
IFDYKFEDFEIVDYDPWPAIKAPIAV
>KF627666.1_18444|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
AYGYQLSVKHHYPEGDMDQVDRVLYDLKHNPASRRILTSLYNFEDLHDMHLYPCAYSMTF
NVSGKVLNAILNQRSQDMLTANNWNVVQYAILVHMFAQVSGLVPGELVHVIADAHIYDRH
IPIVERMLERAPAPAPRLIIDSSVTDFYAFTPDSFRLDGYTPAAFEEKIPIAI
>KF627651.1_18482|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VSIYILENGQDRDDRTGTGTRSVFGYQTRYDLTDGFPLLTTKKMFLRPIAEELLWFIKGD
TNIKYLVDRNVKIWNEWPYEAFKKSEDFHGETLEEFVAKIKELPADDPFVVKYGELGPVY
GRQWRNFNNEGVDQVAKLVDSLKNNPLSRRHIICAWNPSQVDNMALPPCHAFLQFYVSND
KKYLSCQLYQRSADTFLGVPFNIASYALFTAMLAQVCGYKPKEFVHTIGDAHIYKDHFDV
VKEQISRTPYPKCQLVLNPEVKSIFDFTIDDIKIENYQSHGRLVGKVSV
>KF627647.1_18496|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNLIVAADENWGIGREGQLLFHISPDLKNFKALTLHGTVIMGRKTLESLPGGRPLKNRVN
IVLSRTLEERTGGEAGAAGMTGLTASGAASPQNASAETEWLLVCRDLAQLKERLAGLEQY
PADEDVWVIGGAQVYRELLPCCRYAYVTRVAASRPADVFFADLEREPGWRLVKKGEPRQW
EGLSFRFDLFENEAPREL
>KF627646.1_18499|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGISTERDVSLSSGSEIYKALKRKGHQVILVDLFLGLPGVHGHLEELFDSEID
WAASIRGVSEKAPDLYEVKARRPGYRSILGPNVLELCSLCDIVFLGLHGEGGEDGRIQAL
FDLYGIRYTGTGHASSALCMDKSITKEMFRCYHVPTPAGITVRSEEELILPEDFTYPCMV
KTCCGGSSVGVYRVENEDELHVALKEAFTYEDHVIIEKCIIGREFSIAVVEGKALPVIEI
APLTGFYDYKNKYQAGSTIETCPADLPSEVAKRMQQHAEEACAAVSIQSYARVDFMLDTV
TMEDYALEVNTLPGMTPTSLMPQEAQALGLSFDDLCEWILAVSLKKYK
>KF627642.1_18516|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MGGKSSEHDVSLISAKTVIESIDKERYSVIMVGITKDGQWKLIDTIAHLEDGSWVNSKTS
AYICPDTGSKELLLERGGKTERISIDVVFPVLHGMNGEDGTVQGLLELAAIPYVGCGVLA
SACSMDKFYTKVIVDAIGVRQAKFVGVRRHELSNMDEVVARVEAGVPYPVFVKPSKAGSS
QGVSKAENREELVTALHLAAKHDSKILVEETIVGREIECGVLGMNEPKASGVGEVLSAEE
FYSYDAKYNNEESRTVVDPELPEGKAEEIRKDAVAIFKALDCSGLSRVDFFLTKDTNEVV
FNEINTLPGFTAISMYPMLWEARGLNKKALVQKLIDLAMNRYDV
>KF627639.1_18526|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
PVVVKPCSGGSSIGVYIVNTEEEYRQALKNSFRYENEVVVETYIKGREFACGVIDGKALP
PIEIIPKNGWFDYANKYQANATEEVCPADISEEIAERMKALTVRAFQALKLNVYSRADFI
LDADGNLYCLEMNTLPGMTSASLLPKEALADGIEYGDLCELIIQKSMEARYQ
>KF627636.1_18533|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MSKIKVAVIFGGASSEHDISLISATNVIENMPKDKYEAICIGITKKGRWLYYPGDVSNIA
SGEWEKDPDCSSAVISPDPSSQRRHNA
>KF627612.1_18597|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADKLFVNMCQDILDNGFSSEGQTVRARWEDGTPAHTIKRFGIVNRYDLQEEFPALTL
RPTAIKSAVDEMLWIWQKKSNNINDLNSHIWDEWADENGSIGKAYGYQLGVKYKFPHGEM
DQVDNVLWQLKHTPYSRRIMTNIYKFDDLMEMGLEPCAYSVTFNVTGDKLNAILNQRSQD
ILAANNWNVVQYSVLVYMMAQVSGLKPGELVHVIADAHIYDRHVDVIKELITRPQYPAPK
FSLNPEIKNFYDFTVNDMRIDDYQKNPQVKNIPIAI
>KF627612.1_18598|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNAIVVVDKNWAIGKDGGLLVHLPGDLKYYRQKTKGKVIVVGRKTLESFPGGKPLP
>KF627612.1_18599|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
LNPFLEENRCPDRECIVVTRNRDYIREDCVVCNGKEQVMELISRYDDEDVFISGGAEIYR
LFMDVCDDFYVTRIYDEFDADRYFPNLDQLGYEVTWESPMQEEKGISYRFFKYSKTL
>KF627610.1_18605|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTHAIPTPYEDLLREILEENKDAIAADAQRSDRTGTGTFGVFGRQMRFDLRESFPLITTK
RVHFKSVAIELLWFLRGSSNVRWLQERGVTIWDEWADENGDLGPVYGVQWRSWPTPDGGT
IDQIAKVIDSLKNNPSSRRHIVSAWNPAEVDNMALPPCHALFQFYVHERADGVKELSCQL
YQRSADMFLGVPFNIASYALLTYLIAQEVGMEPGEFVWTGGDCHIYSNHLEQVKKQLGYG
TDPEGNPYPPREPYPYPKLVIKTKKPSIFDYEYEDFELVDYKHHPGIAAPIAV
>KF627609.1_18606|FEATURES|farme|aminoglycoside|rmtF|antibiotic target alteration|1
VGEEFARTGGDCEKRARNRLHQVADAFMNQAQQHALWALMERRDVMGALAQHASTRERLA
NVDEYLALIARHALKGELICDAACGLNPLLLGNAGYDVLGLDIQLTCVDVINAWARSEGW
RVSARGADLVGCEALPECGLTLMLKLLPVMDAQRAGESMRLLMAARSPRVLVSFPTRTLG
GRGVGMERNYSERFESGLPDVYEISERAVIGTELFYALRRRGGIA
>KF627604.1_18619|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MYMSRADELFIQNCKEILSHGVWDTDLEVRPRWEDGAPAHTVKRFGIVNRYDLREEFPVQ
TIRRMAFKSAVDELLWIWQKKSNNVHDLNSHIWDAWADGSGCIGQAYGYQQGVKHRYPEG
EFDQVDRVLYDLKHNPASRRILTNLYNHHDLHEMALYPCAYSMTFNVSGRTLNAILNQRS
QDMLTANGWNVMQYAALVHMLAQVSGLVPGELVHVIADAHIYDRHVPVVEEIIARKPYPA
PRLRLDPAVEDFYRFTPASVKLEGYQFHPLDTPIPVAV
>KF627604.1_18620|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNLIVAADRNWAIGKDGDQLCYLPADLKRFQALTTGHTVIFGRKTLTTFPGARPLKGRRN
LVLSRQAGLEIEGAEVFQDLDALRRAAPADAFVIGGERGYRALLDACDTAFVTRIDAAWP
ADSFFPDLDRRADWYVAGAEAPLEHEGLVFRYVTYRRRP
>KF627603.1_18623|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TVGMSRADKIFIQNCKDILTNGVWDTDKEVRPKWDDGEPAHTVKKFGIVNRYNLDEEFPL
LTIRRTYWKTAVDEMLWIWQKKSNNIKDLNAHIWDSWADENGSIGKAYGYQLGIKHKYSE
GEFDQVDRVIYDLKNNPASRRIMTNIYNFADLHEMGLYPCAYSMTFNVTQKKGEEKLTLN
AVLNQRSQDVLAANNWNVVQYSVLVHMLAQVCDMQVGELVHVIADAHIYDRHIPIIQELI
ARQPYPAPKFSLNPEVKDFYQFTRNDVSVEDYITGEQIKDIPIAI
>KF627600.1_18631|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWS
LDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASEFKANA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASHHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANL
PEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEA
TGVRYTDLITKLIEGVLR
>KF627599.1_18633|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ELLWIWQKKTNDITELNSHIWDAWAGDDNTIGKAYGYQLGKKYKFRQGIMDQVDNVIWQL
KNAPASRRIMTNIYNFEDLSEMGLEPCAYSMTFNVTGNRLNAILNQRSQDVLVANNWNVV
QYAVLVHMLAQVCGYEVGELIHVIADAHIYDKHIPLVEELIGRTQYPAPKFVMNPDVKDF
YAFTLDDFKLEDYQAGPQIKNIPVAE
>KF627598.1_18635|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
KYNIHKIFIDTEGNWIYFDKPTSEISTLPAGEYDKAIISPSRGDKGLLRFKNNGDIENIK
TDVIIPVLHGKNGEDGTIQGLFEIAGIPYVGSGVLGSAVCMDKCVAKILFKEAGIPQADW
ITVRTSDISNDNWIKNVEEKLGFPCFIKPSNAGSSVGISKAHNREEL
>KF627593.1_18653|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSTSAYTVKKFGVVNRYDLSKEFPALTLRRTAIKSCTDEMLWIWQQKSNNIHDLHSHVWD
SWADENGSIGKAYGYQLGVKHQYKEGMMDQVDRVIYDLKNNPYSRRIMTNMYVHQDLHEM
ALYPCAYSMTFNVTKDKDSDKLTLNAVLNQRSSDVLTANNWNVCQYAVLVHMLAQVCDMK
AGELVHMIADAHIYDRHIPMVEELINREPLPAPKFWLNPEIKDFYQFTRDDVALIDYETH
EQIKNIPVAV
>KF627587.1_18664|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
VSKQIIAIWAEARNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMGRVTFDGMNRRCLPG
RETLILTRDKDFDCEEVTTVTSVEEALAWFEQQDKDLYIAGGAGVYKAFDGHYDALIKTT
IEADLEGDTYFPQLDMTAFKEVSRDHVVKDDKNAYDFSISRYEKEGD
>KF627578.1_18685|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VKILVLAGGLSPEREVSLSTGTMVCNALREKGQDAMLVDLFYGVEELPGDIESFFADKTP
LPPYVIESAVPDLSRLREESRNRPYGTIGKNVIELCKAADIGFMALHGEPGENGMVQAML
DMLNIKYTGAGYRGSAVAMDKALTKHILVSRGINTAEGIMLKRGEPLSDVPLPCIVKPCS
GGSSIGVRRVLDRADVLPAVEEAFKYEDDILIESFVNGREITCGVLGDTALPPAE
>KF627575.1_18693|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MLEEKRVSFRPMSEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRV
IIEYDTIPIGYAQIYRIQGELFDEYNYHETEEKIYAMDQFIGEPEYWNMGIGAEYCRVVC
QYLRTEMDANAVILDPRKNNPRAVRAYQKAGFEIIKELPEHELHEGKKEDCVLMEWRA
>KF627570.1_18710|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EMLWIWQKKSNNIKDLSSHIWDEWADENGSIGKAYGYQLGVKYKFPHGEMDQVDNVLWQL
KHTPYSRRIMTNIYKFDDLMEMGLEPCAYSMTFNVTGDRLNAILNQRSQDILTANNWNVV
QYAVLVHMLAQVSGLKAGQLVHVIADAHIYDRHVDIVREMIQRPQYPAPKFSLNPEITDF
YDFTTDDILIEDYEKNPQIRNIPVAI
>KF627565.1_18730|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MRIIVLAGGLSPERDVSLSSGSLIANALIENGHDVMLLDLFLGNDNKEILPVYRNKNSKY
RFNYIVPEHEPDLTAIKSSVISNNDFIGNGVIDLCKDADVVFLGLHGSIGENGQLQAVFD
MYGINYTGTKYIGSLLAMDKDISKKLMRENGILTADWQYIKLNEHNDFINIKYPCVVKPC
SCGSSIGVTIVENKNQLNCAIDYAKKYEEYVIIEDKIEGREFSVGILNGKTLPVIEIKPL
RGFYDYKNKYQKGLTEEICPADISDEMSQILQNNALAVHNTLRLGFYSRIDFILDDNHNA
YCLEANTLPGMTPTSLFPQEALAAGISYRELCNIIVNGNIAK
>KF627539.1_18805|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LFLWLFTERIGEDGKCQAAFDLYGIKYTGSGHLASAIGMDKGVTKQIFMSKGVPTAKSVW
IKKGESTDLKDYGMKVPVVVKACNGGSSVGVVLVHQESEYEDAVKTCFELDNQILVEDFI
KGREFSIGVINKKALPVVEIIPRDGWYDYKNKYNGATEEVCPANLNDELTKKIQKVAEDA
CNAIGCEPYARADVMMDADGNMFCLEVNTLPGMTATSLVPQEAKAVGMDFPTLCDYLVEL
SLKKNN
>KF627526.1_18836|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
EIPGCRVAHSLEEAVALFPAEEEVFVIGGAQIYAQALPLAGRFYLTRVFHAYEGDTHFPA
WNDAEWRLVSSESFASGANYPYPFAFETYERRRN
>KF627523.1|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNIPAEFNEIRPYTPEELPQIYEELIADPAFRTVVESVMPGVPFEGLAMKMRQCKTNLEF
QKAFFYGLLWDLVKKTANGLTFDCSALSDLTRNYTFISNHRDIILDSAFLSILLIDNGMT
TVEIAIGDNLLIYPWIHKLVRVNKSFIVKRGLNMRQKLEASALMSRYMHFAMKEKHENLW
IAQRQGRAKDSNDRTQDSVLKMMAMAGEGDVTERLKELNIVPLAISYEYDPCDFLKAKEL
QQKRDDEHFQKSPEDDLINMQTGLYGYKGRIHFQTSACLNHELDELKELNLPKCDLFTAI
SETIDRHIHSSYRLFAGNYVACDLLMGDNRFTAEYTEEEKEHF
>KF627518.1_18862|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
AQVNDMEVGEFIHVIADAHIYDKHVPLIEELITREQHPAPKLWINPEIKNFYDFTVDDLK
LEDYVTGPQIKNIPVAV
>KF627507.1_18896|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIVAIARNGVIGNGNALIWRIAEDLRRFKALTTGHPVIMGRKTYESIGRPLPNRTNV
VVTRRKDYRPEGCLVAGSLEQAVGLFDPSEEIFIIGGAQIYAQAMPMADRLYLTEIDSDY
EGDTRFPEWKREEWTLLSEERHERGERYDRPFAFRNYIRTKE
>KF627495.1_18929|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LLTCMMAQVCGLQPGEFIHTLGDTHLYLNHLEQVDEQLSREPRPLPKLRLNPAVKSVFDF
RYEDFTLEGYDPWPAIKAPMSF
>KF627490.1_18943|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MRGVAMIIGIWAEDEAGLIGEADKMPWSLPAEQQHFKETTMNQVILMGRKTFEGMNKRVL
PGRISIILTRDETYQSDNEKVLIMHSPKEVLDWYHKQNKDLFITGGAEILALFESELELL
YRTVVHEKFKGDTYFPSTFDFGRFKLVSEKFHDKDERNSYTFTIKKYEKVKQP
>KF627489.1_18946|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PVRPRWEDGSPAHTVKLFGVVNRYDLSLEFPIMTLRKTGFRNAIDELLWIWQKKSNNIHD
LHSHIWDAWADENGSIGKAYGYQLGVKHHYPEGDMDQVDRILYDLKHNPGSRRIISNIYN
HADLSEMRLYPCAYSMTFNVSGNRLNAILNQRSQDMLVANNWNVCQYAVLVYMMAQVSGL
EAGMLMHVIADAHIYDRHVPLVEELISREPLDAPRFIIDKSIDDFYKFTVDSFSLEGYES
HGSIGKIPVAV
>KF627479.1_18976|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLDRVLTEGIEKGDRTGTGTISVFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLKGDTNVKYLQDHGVRIWNEWADETGDLGHVYGYQWRSWPTYDGGFIDQISEAVDAIK
HNPDSRRIIVSAWNVGDLDHMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLQAGDFIHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIF
DFQFEDFELVNYDPHPHIAGKVAV
>KF627476.1_18987|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|0
VTKIDFAYEADTFFPNLDEDKEWKVTERSEEQTYFDIEYEFRTYERVKK
>KF627471.1_18997|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KEKDSDKLTLNGVLNQRSNDVLAANNWNVCQYALLLMMIAQVCDMKAGELLHVIADAHIY
DRHVDVVKELIGRETYPAPKVSLNPEVKDFYAFTTADLIVEDYQAGPQVKNIPIAV
>KF627470.1_19000|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKIIAAVDEKWGIGKGMNLLFRISEDMEFFKEKTMGKTVVMGRKTLESFPNATPLKNRKN
VVLTTDKNFKCDGTEIVHDIKTIIGKYGGDDTFVIGGGEVYRQLLPYCDSAYITKVFSDG
NADVF
>KF627467.1_19005|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YNHHDLSEMALYPCAYSMTFNVSGNTLNGILNQRSQDMLTANGWNVMQYAVLLHMMAQVS
GLEAGELIHVIADAHIYDRHVPIVEELIARTPYDAPAFWMDRSVTDFYAFTRDSFRLEGY
QAHLLEAKIPVAV
>KF627466.1_19009|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DTDKEVRPKWDDGEPAHTVKKFGIVNRYNLDEEFPLLTIRRTYWKTAVDEMLWIWQKKSN
NIKDLNAHIWDSWADENGSIGKAYGYQLGIKHKYSEGEFDQVDRVIYDLKNNPASRRIMT
NIYNFADLHEMGLYPCAYSMTFNVSGNKLNAILNQRSQDMLAANNWNVVQYSVLVHMMAQ
VAGLEVGELVHVIADSHIYDRHVPIIEKMMNSEIHEAPRFIIDKSVDDFYKFTRDSFKVE
DYKYSPFEDKIPVAI
>KF627460.1_19029|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GNRLNAILNQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHIPI
IKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF627458.1_19037|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MQAIVAADNNWGIGYQNRLLVSIPSDMKFFRQKTTGNVVVMGRKTLESFPNGLPLKNRVN
IVLTKNKNYQVKDAVIVHSEEELLEELKKYPSEKIYVIGGESIYKMMLPYCDTVYVTKID
RKFQADTYFPNLDQMEDWKMTEEGEEQTCFDLEFAFTKYERC
>KF627448.1_19070|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MALTEEQLADIRSRIPARPETDIPMPYEDLVRKILTEGTLKSDRTGTGTISLFGQQMRFD
LSKYFPLLTTKTVFFKGLAYELLWFLKGSSNINWLLEHNVHIWDEWADENGDLGPVYGVQ
WRSWPAPTPEDPNRTIDQISNVLDLIKHHPDSRRMIVSAWNPAEVEKMALPPCHALFQFY
VADDKLSCQLYQRSCDMFLGVPFNIASYSLLTMMMAQQAGLKPGEFVWTGGDCHVYDNHV
DQFLEQLGPQALPVPDHRDP
>KF627438.1_19100|FEATURES|farme|tetracycline|tet39|antibiotic efflux|0
MTVNSSRNALKRRTWALFMFFFLPGLLMASWTTRTPAIRDILSVSIAEMGGVLFGLSIGS
MSGILCSAWLVKRFGTRNVILVTMSCALIGMMILSLALWLTSPLLFAVGLGVFGASFGSA
EVAINVEGAAVEREMNKTVLPMMHGFYSLGTLAGAGVGMALTAFGVPATVHILLAALVGI
APIYIAIQAIPDGTGKNAADGTQHGEKGVPFYRDIQLLLIGVVVLAMAFAEGSANDWLPL
LMVDGHGFSPYFRPLIYAGFYPGEG
>KF627438.1_19101|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MTVGRFTGGWFIDRYSRVAVVRASALMGALGIGLIIFVDSAWVAGVSVVLWGLGASLGFP
LTISAASDTGPDAPTRVSVVATTGYLAFLVGPPLLGYLGEHYGLRSAMLVVLALVILAAI
VAKAVAKPDTKTQTAMENS
>KF627434.1_19111|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
DEPEASWPGEIVLDHQNDDQFYDFDSKYMDASASHVEVPANLPVSVLEDVRDVARRAFKA
VDGAGLSRVDTFVTPDGTVMVNEINTMPGFTPISMYPKAWDATGVSYTELITRLIEGVLR
>KF627431.1_19116|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PIIKEMIKRETYPAPKVTLNPEVKDFYGFTTDDFKIEDYQAGEQIKDIPIAI
>KF627427.1_19124|FEATURES|farme|aminoglycoside|APH(2'')-IIIa|antibiotic inactivation|1
KKIAGGMTMSHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRGINVSHTTIYRWVQ
EYGKLLYQIWKKKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLI
HGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYDYVYLLEDCGELFTRQVMAYRGEV
DLDTHIRKVSLFVTFDQVSYLLEGLRARDQDWISEGLELLEEDKANNFGANSA
>KF627424.1_19130|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QYKEGMMDQVDRVLFDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDK
LVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQACDMEAGELVHVIADCHIYDRHIPVI
KELISRKPYPAPTVKLNPEIKDFYKFTTDDLIVENYETWPQIKNIPIAV
>KF627418.1_19143|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TALKSAMDEILWIWQQKSNNIHDLHSHIWDSWADEKGSIGKAYGYQLGVKHQYKEGMMDQ
VDRVLFDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKLVLNAVLNQ
RSQDILAANNWNVCQYSLLLMMIAQACDMEAGELVHVIADCHIYDRHIPVIKELISRKPY
PAPTVKLNPEIKDFYKFTTDDLIVENYETWPQIKNIPIAV
>KF627413.1_19159|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKAILSADRKWGLGYQGRLLVSIPSDLRFFRETTMGHVVVMGRKTLATLPAGQPLKGRTN
IILSRDPEWTVRGATVVHSIKELMEVLKPYEDDDIYVAGGGEIYRQLLPYCDTAYVTRID
MTYQADTFFEDLDESPDWEMVEEGDEQTCFDIEFYFTEYRRKNEKA
>KF627409.1_19167|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
HPVIMGRRTWESLNVKYRPLPNRDNIVVSHNPQYLALGATVVTDLDAALDIARQEAIPDD
GLDRSEIWVIGGAQVFQEALPFASKAFVTKIQTSVDADTYAPDMDALVDAGLWEVADPGH
WKRTQKDDSGIKRYRFVTYRKIG
>KF627408.1_19169|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
CQLYQRSCDMFLGVPFNIASYSLLTMMMAQQAGLEPGEFVWTGGDCHVYDNHVDQFLEQL
SRDPYPYPTIEIRKADSLFDYQYEDFTIVGYQHHPTIKAPVAV
>KF627387.1_19220|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|0
NEINTMPGFTSISMYPKAWEATGVRYTDLITMLIEGVLR
>KF627384.1_19238|FEATURES|farme|beta_lactam|pbp1b|antibiotic target alteration|0
PPLVARIKPLEEAHPDLKINKQIVPGPAVGALTKASYDHDVVVVGSRGRGGFTGLLLGST
SQGLLQHAVGPVYVVPRKYVEAAETRLDTVPSSPAEVKPKALDDIKGVEEVPVSKAEPDV
VEAIETKIDPDRQ
>KF627384.1_19241|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDALDLARQEAIPDDGLDRSEIWIIGGGQLFREAMPFADKAYVTQISMHADADTYAPDV
KSLVESGAWKVLEEGVWRNTRKGSGDIAGFRFMTYAKNREE
>KF627383.1_19247|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
MNTTEFDEIRPYNDEELSGVFEELIADPAFQKVVAGVIPDVPFEMLAQKMRACRTKLEFQ
KTFCYGLLWKLAGDCTDGISLDHTAIPDKSKAYTYISNHRDIILDSGFLSVLLVDQGMDT
VEIVIGDNLLIYPWIKKFVRVNKSFIVQRALTMRQMLESSARMSRYMHYTIGEKNQSSWI
AQREGRAKDSNDRTQDSVLKMLAMGGEGDVVSRLMEMNIAPLAISYEYDPCDYLKAQEFQ
LKRDIEGYKKTMADDLKNMQTGLFGYKGRVHFQTGACLNDLLSTVDRSLPKPELFARIST
WIDQRIHSNYRLYPGNYVATVASRL
>KF627375.1_19267|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
PLGWSLDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYG
EDGTIQGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASE
FKANADAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASRHDWRI
LVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQ
>KF627370.1_19277|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MRFLWVLENRILIRRGESVTKAFFLWEKGRTFYTSNAGLKELREEICSYLERKIGVSYDP
MQETMVTVGGSEAIDVALRCMLDPGDEVLIPQPSYVSYLPCTIMADGVPVIIPLQYENEF
KLTVEDLKKAVTPKTKVLVMPFPNNPTGSIMTKADLEPVAEFIKEHDLYVLSDEIYSELS
YQGDHVSIAALPGMRERTIVINGFSKGFAMTGWRLGYCCGPKLIIEQMVKLHQYAIMCAP
TNSQYAAIEGLRHCGDEVEEMRKSYNQRRRFLMHEFKRMGLECFEPFGAFYVFPNISEFG
MTSEEFATRFLMEEKVAVVPGTAFGECGEGFLRISYAYSLEDLKVALGRLERFIEKLRNE
DKASC
>KF627367.1_19288|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QWRSWPTYDGGFIDQISEAVDAIKHNPDSRRIIVSAWNVGDLDHMNLPPCHAFFQFYVAN
GRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLQAGDFIHTLGDAHIYLNHLEQV
KLQLSREPRPLPQMKINPDVKNIFDFQFEDFELVNYDPHPHIAGKVAV
>KF627365.1_19294|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
FPKTFSVNLIWAQARDKEGRAGAIGLNGGMPWHCAEDMKHFKELTVSHPVIMGRKTWESL
GVKYRPLPNRDNIVISHDPMYRAPGATVVTGLDDALDLARQEATPDDGLDRSEIWVIGGA
QLFSEALPFADKAYVTDLDATVDADAYAPDVESLVEAGLWHEAEAGEWLTPAKDEPGIAA
YRFRILRKTK
>KF627349.1_19346|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNKRLKEILKQYEERKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQA
ADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKG
VSMLKENCTRNIHDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVE
EYIRGREFSVAVVDGKAYPIIEIAPKQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHY
AEAGAKALCIEGYARFDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEE
LIRISFKKYSK
>KF627341.1_19376|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
GRKMNLIAAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPN
RVNIVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAYIT
RLDYAYEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNERPALH
>KF627338.1_19383|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVD
RNDFSFTNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFAC
NQYLKAFGVRIAESLLLRQGQSVSDEDVLEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAEEVLVEAFMEGTELTCGCYKTKEKSVVFPPTEVVTHNEFFDYDAKYNGQVD
EITPARISDELTDRVQMLTSAIYDILGCSGIIRVG
>KF627335.1_19390|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MENIMNIVVLAGGFGKERQVSLSSGGMVARALREAGHDVILVDSYLGVKDLPEDITLAFK
NAELPTTKVERTVPDIQALAASRTGGHGEIGDGVIELCRAADIVYMALHGDDGENGKMQA
FFDILGVKYTGAGYLESALAMNKNLAKLLFAENGVLSPEGKLFRAGDDISSAAQMKFPLI
VKPCSGGSSVGLYQVENEEELRQAFESASEAYDGEVLIEQKITGRE
>KF627331.1_19400|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HPRGQHQYKEGMFDQVDRVIYDLKHNPAPRRILTNIYNFEDLHEMNLYPCAYSMTFNVTG
DTLNAILNQRSQDMLTANNWNVVQYAVLTHMMAQVAGLKVGELVHVIADCHIYDRHIPAV
KAMLELDGYPTPTFRMDESITDFYAFTKDSFSMENYQFHPFNFEIPMAI
>KF627320.1_19433|FEATURES|farme|aminoglycoside|rmtB|antibiotic target alteration|1
MSAKKVFNADEVAASILKSPKYSAIAPDAVNRIAAEECQKGGADCEKRARNRLHQIADAF
MNQKEQSMLWDMLERGDLDAALGQHASTRERMATREEYMSLIARHCPPGGIICDAACGLD
PLMLGAAGYAVRGLDIQMTCVDVINAWARRESWDVKAEGADLLGRAELPKSDLTLFMKLL
PVLDAQRAGEGMRLLSLSSSPRVIVSFPTRTLGGRGVGMERNYGERFESALPGEFEICER
MATGNELFYALRRV
>KF627317.1_19443|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MNYDELLAPAAKSMRPSGIRKFFDLAAEMPHCISLGVGEPDFKTPWTIRDAGIRSLEQGR
TRYTANAGIKELRAEICRYLARRMELNYQPSEVLVTVGGSEAIDLTIRALVKPGDEVIIP
EPCFVCYEPITSLTGGVPVHIATKVEDDFRLRADQLRAAITPRTKLLILPYPNNPTGGVM
DAADLEAIAEVLRGTNIMVLSDEIYAELTYGLDRHISIATLPDMKERTIVVNGFSKAYAM
TGWRLGYAVGPEPVIKVMTKIHQSCIMSAPTTSQYAAIAALHSCDDSIEMMRDEYNRRRR
YVVKALNDMGLTCFEPRGAFYVFPCIRCSGLTSQEFCEMLLKEQEVAIIPGDAFGASGEG
YARISYAYSVEHLETAMRRIRTFLKDHGWLAE
>KF627312.1_19459|FEATURES|farme|chloramphenicol|KS18_02010|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEI
>KF627307.1_19472|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAQGTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF627301.1_19491|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
VPVIKELISRTPYPAPTVKLNPNVKNFYDFTTDDLIVENYQTWPQIKNIPIAI
>KF627300.1_19495|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGTEKSDRTGTGTISVFGHQMRFNLEDGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISETVETIK
HNPDSRRIIVSAWNVADLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLTREPRPLPQMNINLDVKSIF
DFKFEDFELVNYDPHPHIAGAVAV
>KF627295.1_19504|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MSKISIIAAVDRRMGIGYQNKLLFWLPNDLKRFKALTTGTTIIMGRKTFESLPKGALPNR
RNIVLSTNPATNFPGAEVFPSLEAALQSCHEKEHVYIIGGETVYRQAIELADELCLTEID
NEAPQADAFFPAIDPQIWHKKSKEVHLADEKHLCSYSFVDYIKEL
>KF627293.1_19511|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWIYRKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYTEGDF
DQMDRVLYDLEHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRELIERP
QFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKSIPIAV
>KF627289.1_19519|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALKSAMDEILWIWQKKSNNIHDLHSHIWDSWADESGSIGKAYGYQLGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKKPGHDKLTLNAIL
NQRSQDILAANNWNVCQYAALVYDDGSGM
>KF627273.1_19564|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELLDRVLREGVKKEDRTGTGTYSVFGHQMRFNLEDGFPLLTTKKLHLKSIIYELL
WFLQGDTNAKYLQEHGVRIWNEWADPDGNLGHIYGFQWRSWPDYKGGNIDQISEAVETIK
HNPDSRRIIVSAWNVADLDNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLTRDPRPLPRMEINPDVKDIF
GFQYEDFNLTGYDPHPHIKGEVAV
>KF627260.1_19596|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VCAIRFVYSHILYGKRANLLVYCSFILLKILFEHSKKCLRSDFLRGKEPFIMKKTVCVIF
GGASSEYEVSLMSSASIIRNLDTEKFDILTLGITKDGRWLLYSGAVENIENNTWMNSETA
RPAFISPDKATNGLVVLNADGSYTVLKVDVLFPVLHGKNGEDGTIQGLFKLSGIPYVGCG
TLASAVCMDKAVTHTLLSAANIEQAHYLWFYADRYFADGEKIRNKIAARLNFPVFVKPAS
AGSSVGVSKVTAPEKLDAAIRLAAENDTKVVVEEGIVGQEVECAVLGNRGKSVASPVGEI
GAGAEFYDYDDKYKNGVAQLFIPARLPEDVAEEVRKTAVRAYNLLGCDGLSRVDFFVTEK
EHRVILNEINTLPGFTSISMYPKLWENAGTPYSELLEKLIDCAFTRED
>KF627253.1|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNIPAEFNEIRPYTPEELPQIYEELIADPAFRTVVESVMPGVPFEGLAMKMRQCKTNLEF
QKAFFYGLLWDLVKKTANGLTFDCSALSDLTRNYTFISNHRDIILDSAFLSILLIDNGMT
TVEIAIGDNLLIYPWIHKLVRVNKSFIVKRGLNMRQKLEASALMSRYMHFAMKEKHENLW
IAQHQGRAKDSNDRTQDSVLKMMAMAGEGDVTERLKELNIVPLAIS
>KF627250.1_19619|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKLPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNANIIARISRMVY
DAMR
>KF627248.1_19627|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PDYDGGFIDQISEAIETIKQNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSL
QLYQRSADIFLGVPFNIASYALLLQMVAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLS
REPRPLPQMKINPDVKSIFDFKFEDFELVNYDPHPHIAGVVAV
>KF627246.1_19632|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
AIADFYGLDFANVAASAGSSPLIETIGCAFLNPGDEVLMCPTFAAFIDMAQIRQAVPVVV
PLNEDKTYDLEGLYKAITKKTKIIVVCNPNNPTGTYVGREKVIEFIKKVPDDVIVLMDEA
YLEFATAEDCQSMYPLIKELPDKPIIVLKTFSKYYGMAGVRVGYALAAPELIAAIEKCPS
AMISKAGQAGAIAALADQQYYQEVKKKLVEGMTYLETEMEKLGCKVYHSQTNFILFDPHI
DAQLVRAKLMEAGIMISAPGICRVSVSTMENNRLFIETLKNIMGK
>KF627219.1_19704|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKKKILLICSGLFVLWTFWLIENSLYLKLKLATFGSGSRVGIAVLSGDKVLTVGKGAMPL
MSVFKMFVALNVLEHQEKDKVLIVTEEMINRDTYSPMLKDYPVVPFKISVAELLKYMVSA
SDNNATDILLALGGDIRATQDYVRGLGFPGIVLKVNEQEMHENIRNQYLNRAVPADVVKL
LRVVRESERLTNENKRFFEALMTETATGADKIKKYLPSNVVVGHKTGSSDRLENGIKIAD
NDVGFVRLPDGREYYLGVMIADSPMSDWDNAELIARISKIVYRHFEENRRF
>KF627210.1_19728|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYD
>KF627201.1_19746|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
LTAQPDIISFAGGMPAPELFPVEQMMEASRAVLEENGRAALQYSSTEGHPRLRQQIAERM
LAKNNIHTDADHILVTSGSQQGLDFSARVFLNPGDVVLLESPSYLGAVNAFKACEPRFIE
VPTDNGGMIMEELEKILATTERVKMIYVIPDFQNPTGRTWDLERRHQFMEIVNRYEIPVI
EDNPYGELRFEGEYLPALKSLDTKGLAIYLGTFSKILAPGYRIGWVCAEEHILAKYNFME
QAASLQASTIGQMETSKWIDMFDLDAHVATIRACYDKRRKVMLETLERELPEGCTFTHPV
GGLFAWVVLPEYMDAKELQMKCLEKKVAFVPGGSFFPNGNHENTLRLNYSCMPEEKIVQG
ITALCQTIRENLR
>KF627191.1_19772|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADQNWGIGKDNKLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRTN
IVITKNKDYDAKGAIVVHSIEEALEEIKKYPTEDVYCIGGDSIYEQMLPYCDVAHVTKI
>KF627188.1_19780|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNMNIVVLAGGISTEREVSIVSGTGVCQALRKKGHRAILVDVFCGDARVASECIEDCFPK
EYDVASAADYMRSMSEEIEEIKKSGREFFGPNVLKLCKLADIVFLALHGADGEGGTVQAA
FDLLRIPYTGSGHLGSAMAMDKNISRRLFQAYGVPTASGIALKKENPRLAAAENGVGLPC
IVKPCCGGSSVGVTIAHTEEEYQEALSAAFSYENEVIVEAYIHGREFSAGVIDGKAYPII
EIAPVEGFYDYQNKYTAGATIETCPAELSKEQTEQMQSYAVKAYEALQLSGYGRMDFMMD
EQGRMYCLEANTLPGMTPTSLLPQEAAAVGIAFPELCELLIEVSMKARGQKR
>KF627180.1_19804|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADVLFVNMCEKILEEGFSSEGMQVRARWEDGTAAHTIKTFGVVNRYDLEEEFPALTL
RPTAIKTAVDEVLWIWQKKSNNIKDLKGHIWDEWADENGSIGKAYGYQMGLKYKFAQGEM
DQVDNVLWQLKNTPYSRRILTNIYKFDDLAEMNLEPCAYSMTFNVTGDRLNAVLNQRSQD
ILAANNWNVVQYSVLLHMFAQVSGLRAGELVHVIADAHIYDRHIPVIEELISRPQYPAPK
FRLNPEIKDFYDFTVDDVMIEDYQKNPQILNIPIAI
>KF627174.1_19825|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSKIALIAAVAEKGAIGRDQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTALS
>KF627173.1_19831|FEATURES|farme|multidrug|ACR_trans|antibiotic efflux|1
LLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAK
NGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRI
ALGAAVVFGMALNTLLATVYIPNFYELMQKLQERFSKKQ
>KF627159.1_19870|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MAMSTISIVAAISDNNAIGKNLGLLWHMPADMKRFKDLTTGHAVIMGRKTFESLPKGGLP
NRKNVVLTTMPEAGFINCFACESMHDALDICGKEENIFIIGGSLVYRQGLGIADKMYLTR
IHGEFPDADAFFPVVNWDLWEEVERQEFPADEKNPYPYTFLTYVRKK
>KF627157.1_19875|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic target alteration|0
MSQADKIFIDMCKDILENGTSTEGEKVRPKWEDGSFAYTIKQFGVVNRYDLSKEFPLLTL
RRTALKSATDEMLWIWQKKSNNIH
>KF627156.1_19878|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRKSGKGIDKRRRYMSYADKVFIDMCRDIIDNGTSTEGEKVRPVWEDGTSAYTIKRFGV
VNRYDLSKEFPALTLRRTAIKSCVDELLWIWQKKSNNVNELKSHIWDSWADETGSIGKAY
GYQMGVKHQYKEGMMDQVDRVLYDLKENPYSRRIMTNIYVHEDLHEMNLYPCAYSMTFNV
TKEKGSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVCDMQVGEFVHVIADAHI
YDRHIPLVEELIKREPLPAPKFWLNPEVKDFYQFTPDDVKLIDYETGPQIKNIPIAI
>KF627153.1_19885|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
DYYLILLILYNSRMKAKFFLSCMALAILFSACNTTNRTPKQKIEQQIDSLLKDKKATVGV
AVLANDETVAVYNNQIHFPLLSVFKFHVGLAVLDKMDKGHIALDSLIEVKSSQLKSNTYS
PLRDKFPDQDITISLGELLKYSISQSDNNACDILIEYAGGIDQVNEYVKSLGIKDCNLAA
TEDLMHTSGDAYLNWSTPEEVVRLLNIADKHPLFGTQYKDFLQAIMQE
>KF627146.1_19906|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MKKRTNGASISRKAKKPKNKKNRIFDSSCADFSKIHTAADCFIFLSIGKGRSFVINYDSL
LSDQVKRMQPSGIRKFFDVAAMMEGVISLGVGEPDFQTPWVVRKEAVDILERKRIIYSAN
SGMMNLRKEIANYLNRKYDLTYDPDSEVIATVGGSEAIDLAIRAIVNPGDEVLVVEPSFV
CYKPIVELMHGVAVPIPTKEENKFKLTPEELQAHITEKTKMLILPYPNNPTGGIMTREDL
EKIAAVLRGTNILVLSDEIYSELTYGTKHCSIASIPDMWERTIYVSGFSKAFAMTGWRLG
YLCAPKPLAKQMLKIHQYAIMCAPTVSQYAAIVALQECDDEVRKMVDEYDARRRIVVDGF
NKMGLHCFNPEGAFYVFPCIRSTGMDSETFCEKLLQEEKVAVVPGSAFGESGEGFVRVSY
AYSLKHLMEALEHIAAFVQRHKQEDTP
>KF627142.1_19916|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRNPLSKKVVGIQPSGIRKFFDVVNEMKDAISLGVGEPDFDTPWRIREEGIYTLEKGRTF
YTSNAGLKELKIEICKYLDRKVSVQYDYNDEVIVTVGGSEGIDIALRAMLDPGDEVLIPQ
PSYVSYLPCTILADGVPVVIPLQHKNEFKLTAEELEAAITPKTKILVMPFPNNPTGSIMT
KEDLEPIVELVKKHDLFVISDEIYSELSYKGEHVSIASFEGMKERTILINGFSKGYAMTG
WRLGYACGPANIIEQMVKIHQFAIMCAPTNSQYAAVEALRNCDEEVKEMRESYNQRRRFL
VHEFKRMKLECFEPFGAFYIFPNIKEFGMTSEEFATRLLEEEKVAVVPGTAFGDCGEGFL
RISYAYSLEDLKEAIGRLGRFIDRLRNER
>KF627132.1|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MDLTEFNEIRPYNDEELPQIFEELIADPAFQKAATGAIPNVPFELLAQKMRACKTKLDFQ
EAFCYGILWKIAADHTAGLTLGHTAIPDKSKAYTYISNHRDIILDSGFLSILLIDQGMDT
VEIAIGDNLLIYPWIKKLVRVNKSFIVQRALTMRQMLESSARMSRYMHYTISEKNQSIWI
AQREGRAKDSNDRTQDSVLKMLAMGGEGDLIDRLVEMNIAPLAI
>KF627132.1_19941|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVD
RNDFSFTNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFTC
NQYLKAFGVRIAESLLLRQGQSVSDEEVVEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAQEVLVEAFMDGTELTCGCYKTKEKTVIFPPTEVVTHNEFFDYDAKYNGQVD
EITPARISDELTKRVQMLTSAIYDILGCSGIIRVDYIITAGEKLNLLEVNTTPGMTTTSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF627120.1_19970|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MSSLEGVDRMFSVAAPQARGKSAQDNIFAANNRAVALADKIGKDKVINGTVGSILDEDGN
LVELEVVQEAYARLTPRQIIAYAPIQGYEKFLESCIDQCFGESRPSGYINACATPGGTGA
LHHAIHNYSADGDEVLITDWHWGAYDSLIDYPNRKVASFQFLTDDGHFNVDAFREKVEDI
LSRQKNIVIILNGVANNPTGYCMSVEEWQAAVDVLKHTVEGKDKNAVLIPDVAYLDYSGE
KQECRRFFKVFGGLPKNILTIVAYTLSKGFTLYGQRQGAMIGITSDADVAKEFVDINQYA
SRATWSNCNSAAQNVMIDICSDSEKVARLDAERNTYFKLIGERAAIFMEEAKEAGVKFVP
YISGFFITIPLEGAQKVCDCLEKDNVFLVPMKKGIRLAVCSVSKAKMKGLAAKLAAAIEA
ARAKQ
>KF627120.1_19971|FEATURES|farme|multidrug|Mdr|antibiotic efflux|0
MEKGKKRTVLGPQLTRKEAMWTWKWYALWWIFFTNITCGIGLLAVVSPMAQDVIGMAPPE
AASFVGIIGVVNGGGRIFWSTVSDWIGRGVTYMIFFAFEVFAFYRLSETTDSFAFQFLVL
AVISCYGGGFSCMPAFLSDIFGVRQLAAIHGSILTAWGIAGIAGPVILALMKEATGSYSA
TLSLFSGMLALAFLISLLIHWQNETERKKWSVSAGNN
>KF627118.1_19978|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSLSIIVARAANGVIGNDNKLIWHLPDDLKMFKSRTMGRPIIMGRKTFESLPKVLPGRVH
YVLTGNKAYSVPEGVYVFHTVKELLSALPEGENFIIGGEKMYEAMFPYADKMYITEIEKE
YNGDAVFPSFCKEEWKETESVMGKGDPVHRFVTYERVRG
>KF627113.1_19990|FEATURES|farme|chloramphenicol|catD|antibiotic inactivation|1
MTLLVQDGPTFPSGIEAHLARFPPRKSGSCHFFDTLSQGRHPWLSFAERKEQMEYRIIDL
EHWKRREYFEHYRQAVPCIYSMTVQVDITNIRQKGYKLYPTMLYCLATQVNRHEEFRMNI
RPGGQLVCYDVLHPSYTVFHRESETFSSLWTLYTPDHPAFCRRYAQDQQEFGAIEKLEAK
PGQPENVFNVSMLPWAAFQGFHLQTQGFDYLLPIFTMGRFKQKEGRCWLPLAIQVHHGVC
DGFHVCRLVEELQDQLESL
>KF627099.1_20029|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
GSSFGVTKVEHEGDAAELAAAVYEASHHDWRILVEQGIDAREIECAVLCPKAGEAPQASW
PGEIVLDKRAEGDDQFYDFDSKYVNSDASHVEVPASLPEETLNRVRETAKKAFIAVDGAG
LSRVDTFVTADGEVMVNEINTMPGFTPISMYPKAWEATGVSYTNLITMLIEGVLR
>KF627096.1_20035|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MVCKALREKNHQAVLVDVFCGVDVKGNLEDVFAEEAYDIDKAAEYMHSFDAGLNEMIESR
RRFFGPNVLELCEAADVVFLALHGANGEDGRVQATFDLLGIPYTGTGYLSSALAMDKSIT
KQFFRAHHVPTPNGVTLKKGQESEPLSGFGLELPVVVKPCCGGSSVGVYIAHTNEEYWQA
MKDAFSYEPEVVVEEYIEGREFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAGSTVETCP
AVLTEEQTKEMQKHAEDGAAALGIENYCRLDFMMRKDGRMYCLEANTLPGMTPTSLLPQE
AQVLGISYPELCELLIQLSLRKRGNNA
>KF627090.1_20052|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MHKGVAKQIFLESGVDTPGGGTLYKNGSDLSYQSLGLTLPVVVKPCSGGSSIGVYIVNTD
EEYQNALEHSFHYEDEIVVEPYIKGREFACGIIDGKALPPIEIIPKTGFFDYANKYQDGA
TMEVCPADIPEEVAERMKALTVKAFNALKLNVYSRADFLLDAEGSLYCLEMNTLPGMTSA
SLMPKEAKVAGIEYSDLCELIIKKSMEARYSS
>KF627083.1_20071|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQTEEYQTNLICMSKISIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTIVMGRKT
FESLPKGALPNRRNVVLSSNPAAECPGAEVFPSLEAALQSCKEDEHVYIIGGASVYQQAL
PFADELCLTEIDNTAPEADAFFPEISPAVWQEKSREAHPADEKHLCSYAFVDYVKA
>KF627071.1_20103|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
VAVDKNWAIGMDNKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVNVVLT
SDKKYNVKGTVVVHSIDEMVEELKKYNDEDIFVIGGESIYRQLLPYCKTAYITKIDHAYQ
ADTFFPDLDQDPQWQMTKISDEQTYFDLEYVFTIYERVS
>KF627057.1_20136|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLSIIVAIAENNLIGGDNKLLWHLSEDLKRFKEITMDNTLIMGRKTFESLPGILPGRKHI
VITRDENYKVDSNQVEIVHNIQDVINEYANNSENAFVIGGGEIYNTTFPYCSKLYLTKIK
RSFSGDTYFPDIDFSKWKITYSSGEKKDPKNGIEFE
>KF627054.1_20143|FEATURES|farme|beta_lactam|ampC-EC68|antibiotic inactivation|1
TTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYAD
IAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLL
HLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSG
LSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTI
EDMARWVQSNLKPFDINE
>KF627052.1_20147|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MFLGVPFNIASYSLLTMMMAQQAGLEPGEFVWTGGDCHVYDNHVDQFLEQLSRDPYPYPT
IEIRKADSLFDYQYEDFTIVGYQHHPTIKAPVAV
>KF627044.1_20169|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
LQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRV
FQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNL
KPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPV
KPITPPTPAVRASWVHRTGAAGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILN
TLQ
>KF627043.1_20174|FEATURES|farme|bacitracin|uppP|antibiotic efflux|0
EATMEGEGFDATMKTQYVGNVASGATGSIGYAFTPTASGELNATLKVSYEDSDGQSKTKE
FPVKLSVADAAPMDDPSRVDSDMNQNASQGLPWWVWAAAAAVAVAVIVGIVLLVRRHRKK
KAKSEIDEEWDDWADGNADGKLDPQSGGDIASGKTVGDAADSATANNATASGDATSTSAI
SPSTDATDREGV
>KF627036.1_20193|FEATURES|farme|multidrug|hp1181|antibiotic efflux|0
MNLSLRRSTSALLASSLLLTIGRGATLPFMTIYLSRQYSLSVDLIGYAMTIALTIGVIFS
LGFGILADKFDKKRYMLLAITAFASGFIAIPLVNNVTLVVLFFALINCAYSVFATVLKAW
FADNLSS
>KF627025.1_20224|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
LKITLLYGGRSAEHEVSILSAFSVLNAIYYNYYQVQLVFITKEGQWVKGPLLTEKPASKD
VLHLSWDPSGQTEEGFTGKVINPGEIKEEGAIVFPVLHGPNGEDGTIQGFLETLNMPYVG
AGVLTSACAMDKIMTKYILQAAGVPQVPYVPVLKNQWKENPKKVFDQCEGSLLYPMFVKP
ANMGSSVGITKAENREELQNALATAYQYDSRAIVEQGIEAREIEVAVLGNEDVRTTLPGE
VVKDVAFYDYEAKYINNKIEMQIPAEVPEEVYQKAQEYAKLAYTMLGGSGLSRCDFFLTN
KNELFLNELNSMPGFTEFSMYPLLWENMGLKYGDLIEELIQLGMNRYHQRQSFFEKNE
>KF627014.1_20247|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPMRRLKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDSLD
DALDLARQEAIPDDGLDRSEIWIIGGGQLYREAMPFADKAYVTQISMHE
>KF627004.1_20269|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWN
VCQYSLLLMMIAQACDMEAGELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNPEIK
DFYKFTTDDLIVENYETWPQIKNIPIAV
>KF626996.1_20279|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNIPAEFNEIRPYTPEELPQIYEELIADPAFRTVVESVMPGVPFEGLAMKMRLCRTNLEF
QKAFFYGLLWDLVKKCANGLTFDCSALTDKTMNYTFISNHRDIILDSAFLCILLIDQKMN
TVEIAIGDNLLIYPWIKKLVRINKSFIVQRGLSMRQKLEASALMSRYMHFAITHKHENLW
IAQRQGRAKDSNDRTQDSVLKMMAMAGEGDAIARLKELNLVPLSISYEYDPCDFLKAKEL
QQKRDDANFRKSPEDDLINMQTGLYGYKGRIHFQTSACLNKELDEIKERNLSKTEVFTAI
SELIDKH
>KF626991.1_20291|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MKLFGKKVIYLEKLNVCVIFGGVSSEHEISKISAATVIDSLDTAKYNIHKIFIDTEGNWI
YFDKPTSEISTLPAGEYDKAIISPSRGDKGLLRFKNNGDIENIKTDVIIPVLHGKNGEDG
TIQGLFEIAGIPYVGSGVLGSAVCMDKCVAKILFKEAGIPQADWITVRTSDISNDNWIKN
VEEKLGFPCFIKPSNAGSSVGISKAHNREELSESRL
>KF626990.1_20293|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNAIVVTDKQWAIGRSGDLLFSLPGDMKHFRELTTGGTVIMGRKTLDSFPGGRPLPKRRN
IVITRSPDFHREGCETVSTPEDALALAGDEENVWLIGGGSIYTALLGRCRRASVTRVDST
VSDADTFFPDLDALPNWKIERTGEAVTENGLTYRFVDYVNTALL
>KF626986.1_20304|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPCDSDKLEEVFDRPDG
GLEISKGISTSVPNLDALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTVKTKDTRLDELGYYLP
LVVKPCSNGSSIGVYICHTEEDYYDAIHKSFDIDNTDEVVIEPFIKGREFACGILAGKAL
PLVEIVPKDGLFDYANKYQAGGASEICPPISLDAETQELIQRAGERAFEALRMDVYSRAD
FIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEYSELCEAIIQESMKARY
>KF626974.1_20336|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|0
GEKVNLLEINTTPGMTATSFIPQQVRAAGLDIKDVMTDIIENKF
>KF626973.1_20339|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MTCKLSAIVAVCDDWGIGCEGDMVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLK
NRRNIVLTRDEDFAVEGVDVVHSIDEALAAVADEPVAWVIGGGDVYRQFLPYCAEAEVTH
DHCVHPVDTYFPNLDADPAWEVVRREGVATISAGEGDEGLDYEFVTYRRVDA
>KF626972.1_20343|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YGYQMGIKYRFAQGEMDQVDNVIWQLKNTPYSRRILTNIYNFRDLSEMNLEPCAYSMTFN
VTGNKLNAILNQRSQDTLAANNWNVVQYSALLMMFAQVSGLEPGELVHVISDMHIYDRHV
PIIKELIERPQYPAPKFSLNPDVRDFYDFTADDIHIEDYQKNPQILNIPIAI
>KF626965.1_20360|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDL
HKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRA
ILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTE
VEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTP
DEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELI
>KF626964.1_20364|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IWDNDAFRYYNELCVRHGVLPVDRDTFLRAAQDGVESPVEGYRFGDLNHVYGYQWRSWPK
PDGRFIDQIAQAVELIRHNPESRRIIVSAWNVAEIGDMALPPCHVLFQFYVAGGRLSCQL
YQRSADTFLGVPFNIASYALLTLMTAQVCGLEPGEFVHTLGDAHLYLNHMEQADEQLSRE
PRPLPVMRLNPDVKSLFDFRYGDFTLEGYDPWPAIKAPMSF
>KF626953.1_20394|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIVVLAGGLSPERNVSLSSGTMIAHALRGLGHQAALVDMYFGLEAYTGPVADYFDAPLT
DQWKQVDPKAPDLAEIRAARKWQSPSQFGQGVLELCQMADIVFLALHGTCGEDGRVQAAF
DLMGIPYTGAGYLGSGLAMDKDLTKRLIAHLGVHTPQWQRVSYTEQEVEDLAAATQVPCV
VKPVASGSSIGVSIAHTRQELHGALMEGLRFGGQCVLEQYVAGREIQVAILAGQALPSIE
IIPKEGFYDYENKYQPGAAEEVCPAPIPPAWEQRVGQAALTGLPRPGAVGLFPG
>KF626951.1_20400|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTAIVCVSRSWGIGRDGALLFRISADHKRFRTLTVGKTVILGHKTLDTFPGGKPLKDRRN
IVLSHRDLDVPGAEIAHSFDEAAALGGDDAIVIGGASVYMALLSRCDRVYVTKVDADPDA
DSFFPNLDDNPDWRIESESETFEENGLKFRYVDYVRK
>KF626931.1_20448|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PDTAFEITQKFVEEYLGKSYEAVFVVHDNTAHVHSHIVFNSVSFVDGKKYRYEKGDWAKY
IQPITNRLCQEYGLSIIDVDDEKNERQHESYKEWSEYREGNFVWSDMIKRDLDACILQAK
DYEEFLRSRMSLADVTFINMCKDVIENGTSTEGEKVRPVWEDGTPAYTIKRFGVVNRYDL
RKEFPALTLRKTALKSAMDEILWIWQKKSNNIHDLHSHIWDSWADENGSIGKAYGYQLQI
KHQYKEGMMDQVDRVLYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGK
DKLTLNAVLNQRSQDILAANNWNVCQYSILLMMIAQVCGMEAGELVHVIADCHIYDRHVP
VIKELISRTPYPAPTVKLNPEIKNFYDFTTDDLIVENYQTWPQIKNIPIAV
>KF626929.1_20452|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NWNVCQYSLLLMMIAQACDMEAGELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNP
EIKDFYKFTTDDLIVENYETWPQIKNIPIAV
>KF626929.1_20453|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRIN
IVITSNKEYEVKGAIIVHSIEEALEEIKKYPAEDVYCIGGDSIYAQMLPYCDVAHVTKID
FAYEADSHFPNLDEDDEWEITGESDEQTYFDLEY
>KF626928.1_20455|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDKIAVLLGGTSAEREVSLNSGAAVLAGLREGGIDAYPVDPKEVDVTQLKSMGFQKVFI
ALHGRGGEDGTLQGMLELMGLPYTGSGVMASALSMDKLRSKLLWQGAGLPVAPWVALTRA
EFEKGLNDKQLAEISSLGLPVIVKPSREGSSVGMSKVVAENALQDALRLAFQHDEEVLIE
KWLSGPEFTVAILGEEILPSIRIQPAGTFYDYEAKYLSDETQYFCPAGLEASQEANLQAL
VLKAWTTLGCKGWGRIDVMLDSDGQFYLLEANTSPGMTSHSLVPMAARQAGMSFSQLVVR
ILELAD
>KF626926.1_20461|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>KF626925.1_20464|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MVAAIVAVDINWGIGCGGNLLVDIPEDKKFFREKTKDSIVIMGRKTWDSLPIKPLPNRIN
YIISRNSFSVGENSHVITLEEAIQIIKSTTKEEKVFIIGGGEIYKLLLPYCDTVYATKIY
SRYTADTFFTNLDKLRNEWKITEVMEMDDETYSLYDYPIYQFVTYKRRN
>KF626911.1_20499|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGTSTEREISIVTGTQVCKALREKGHESILVDIYSGDARIDLGNAFPETYDAD
AAAEYIHSFDEEIQNRFDPDRPFFGPNVLELCKAADVVFMGLHGSNGEDGKVQAVLELMK
IPYTGSGHLSSAMAMDKGISKQMFWQNQVPTPKGVILTKGEEMKPLEAYGLALPVVVKPC
CGGSSVGVSIPKTEEEYQEALKVAFSYEDVLVVEEYIKGREFSIGVVEGKAYPIIELAPI
QGFYDYHNKYAAGSTVETCPAALSEELTKKMQSYAEQAYRALRLEKYARIDFMMDEQNQM
YCLEANTLPGMTPTSLLPQEAAALGMSFADLCEKLIQVSL
>KF626897.1_20532|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
VVLAGGLSPERNVSLSSGVMVAEALRGRGHKAALVDMYFGLEDDGKTLEDRFDAPLHDAG
KHVDRDAPDLEAVKASRKGKGKSQFGPGVLELCAMADIVFLALHGQCGEDGRVQAAFDLM
GIPYTGAGYLGSALAMDKDLTKRLIAGAGVDTPRWKAVRYTERDVDRLTSQTPVPCVVKP
VDSGSSIGVSIAHDKKELRAALLDGLRFGGRSVLEQYVAGREIQVGILEDEALPSIEIIP
KSGFYDYENKYQPGAAVEVCPAEISSEAEAKLRAAALKVYRTLGLSVYSRADFILDAEGT
PWFLEINTLPGMTPTSLLPQEAAAVGVDYAALCERILLASLEARRAGR
>KF626894.1_20544|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNKRLKEILKQYEERKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQA
ADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGITKQMFLMNNVPTPRG
VSMVKEEMTTDLKALGMEFPVVVKTCCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVE
EYIKGREFSVAVVDGKAYPIIEIAPLQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHY
AEAGAKALFMEGYCRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEK
LIEVSMKKYPAQDFTL
>KF626890.1_20552|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVAADKNWAIGKDNKLLVSIPADMKMFRQETTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTGNKDYKVKDAVIVHTIEELLEEIKKYPAEQVYCIGGDSVYKQLLPYCDTAHVTKID
FGYEADSYFPNLDEMPDWKVTAESEEQTYFDLEYTFVKYERVK
>KF626889.1_20554|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MDCIVNVTQNWGIGKDGDLLVSISADLRRFRALTTGKTVIYGRKTLLTFPHARPLPNREN
WILSATPGFSVPGAAVFPSLAALQEAM
>KF626879.1_20580|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNISIIVAIARNHGIGFENKLLYWLPNDLKRFKALTTGHTIIMGRKTFESLPKGALPNRR
NIVLSRREGAVFAGAECFPALEIALSHCKEEEEIFIIGGASLYKEAMHIAQQLYITFIDD
TSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFIN
>KF626877.1_20586|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAYITRLD
YAYEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNERPALH
>KF626875.1_20592|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
CQDILENGTSTEGELVRPHWEDGTSAYTIKKFGVVNRYDLSKEFPAITLRKTYIKSATDE
LLWIWQKKSNNIHDLKSHVWDEWADEDGSIGKAYGYQLGVKHQYKEGMMDQVDRVIYDLK
HTPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGDDRLTLNGILNQRSQDVLAAN
NWNVCQYAVLMHMLAQVCDMRVGELMHVIADAHIYDRHVPIVKELIERPQYDAPKFWLNP
DIKDFYQFTTDDIKITDYVTGEQIKDIPIAV
>KF626874.1_20593|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
SFIDKERYNLYIVEMEGHRWEVILPDGTKTPIDRNDFGFMENGEKKLFDFAYITIHGTPG
ENGILQGYFDLLGIPYSSCNVLVSAITFNKFTCNQYLKGFGIRVSESLILRKGFEITDQE
VISKIGLPCFIKPNAGGSSFGVTKVKTEEEIQPAIEKAFHESDEVMIEAYMKGT
>KF626860.1_20633|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTL
DLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDL
RAILVE
>KF626858.1_20642|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DRVLYDLKHNPASRRILTNIYNFEDLHEMALYPCAYSMTFNVSGHTLNAILNQRSQDMLA
ANNWNVVQYAVLVHMMAQVSGLEAGELVHVIADAHIYDRHVPIIEKMLEKEPRPAPKFVI
DRSVTDFYRFTRDSFSLEGYDPQPFENKIPVAI
>KF626854.1_20650|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
YAMSLYPIMEAHRQGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSDSILPSIT
RRSLVAVAKDYLGLEVEEREVCFDEVKDFAECGLCGTAAVISPVGKINDHGKEICFPSGM
EKMGPVTQKLYETLTGIQMGRIQAPEGWIKVVE
>KF626853.1_20653|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYPSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKPEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF626848.1_20664|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
EMEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWAEARDKEGRAGAIGLNGG
MPWHCAEDMKHFKELTVSHPVIMGRKTWESLGGKYRPLPNRDNIVVSHDPMYRAPGATVV
TSLDDALDMARQEAIPDDGLDRSEIWIIGGAQLYAKALPFADKAYVTDLAATVDADSYAP
DMASLVEAGMWREAEVGEWHTPAKEESGIDSYRFRILAKTK
>KF626841.1_20683|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
PPRANSVFTALGYYMGEAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGEMV
PFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYE
WTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYV
MGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTS
LAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKK
Q
>KF626839.1_20690|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
LVAGELLHVIADAHIYDRHVPIVRELMKAKKFDAPKFELDDESDFYAFTVDSARLVGYEC
GPSIGRLPVAI
>KF626836.1_20698|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMILNQ
RSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRELTERPQF
AAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF626825.1_20727|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YKEGMMDQVDRVLFDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKL
VLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQACDMEAGELVHVIADCHIYDRHIPVIK
ELISRKPYPAPTVKLNPEIKDFYKFTTDDLIVENYETWPQIKNIPIAV
>KF626824.1_20728|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGTSTERDVSIVSGTGICSALRQKNHQAILVDVFCGLENVDWADPFPENYDVE
EAVSYIRSFNRHIEELKKSRKEFFGPNVLELCKKADFVFLGLHGSNGEDGRLQAVFDLMG
IPYTGTGYLSSAMAMDKGVTKAMFQMRGVPTPGGKAMKKKDRVETPQELGLDFPVVVKTC
CGGSSIGVYIVDNQADYTKALDGAFTYENEVVVEEFVEGTEYTVAVVDGKAYPVVQIVPV
QGFYDYENKYKPGAVKETCPAPISEELTRRLQEYAVEGYHALEMESYGRLDFIVTKDEKI
YCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIRVSMKKKYE
>KF626820.1_20741|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNGLPLKNR
TNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESIYRMMLPYCSKVYVTK
IDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYV
>KF626813.1_20761|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
NKIRVALLFGSCSSEHEVSCVSAAAWADALATMPDRYEVILVGITKQGRWLKYSGSTEGM
RSGSWEQDASCVPCVLSPDRSDHGLLVHSANGYELLPVDVVAPILHGKNGEDGTIQGLLE
LAAIPYVGCGVLASAACMDKAVANTIMDAYHVPHCHWCSAVRAEAETQRSALLTRVENRL
PYPIFVKPANAGSSVGITKAHNREELNTAIDTALREDDKVVFEEFIDGQEVECAAIGNPD
NPQEVRTTRPGEILAGAEFYTYDDKYKNGISKTVIPAHLPDQKLDEVKTLAARAYLALGC
AGLARCDFFVEHGTGRVLCNELNTLPGFTPISMYPKLMENEGYNFAALVDKLIGLALSKK
RGAY
>KF626810.1_20767|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
SIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRINIVITSNKEYEVKGAIIVHSIE
EALEEIKKYPAEDVYCIGGDSIYAQMLPYCDVAHVTKIDFAYEADSHFPNLDEDDEWEIT
GESDEQTYFDLEYQFVKYERKK
>KF626783.1_20831|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVAADKNWAIGKDNKLLVSIPADMKMFRQETTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTGNKDYNVKDAIIVHTVEELLEEIKKYPSEEVYCIGGDSVYKQLLPYCDTAHVTKID
FAYEADSYFPNLDEMPEWKVTAESDEQTYFDLEYTFVKYERVK
>KF626773.1_20857|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
VEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTIQGLFEMM
GVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASEFKANADAIMAQV
SEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASHHDWRILVEQGIDAREIE
CAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANLPEETLNL
VRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEATGVRYTD
LITMLIEGVLR
>KF626764.1_20882|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
PNGTIGLSKANLSINEGEFIALVGPSGSGKTTLLNTLAGFVHPTTGSVSINGQVVADESI
FVPPEHRHLGMVFQQHALWPHMSVGRNVEYPLKQTKTPQDERRRRVNWALKLVGLEGFAD
RNPSELSGGQSQRVAIARAIVAQPSMLLLDEALSALDEPLRESLRLELRHMTIDLGLTTL
HVTHDRGEAIALA
>KF626756.1_20894|FEATURES|farme|multidrug|ACR_trans|antibiotic efflux|1
DQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTT
TTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGII
LLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFAT
GAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF626751.1_20902|FEATURES|farme|multidrug|MFS|antibiotic efflux|0
EENTSSIVKTITDSLKSPGTVLAILAVFVGSIMNGQLFAGMALEFHSLSDSPVIRGLFYS
IDAISVIALQMPVSKIISRNMTKEHNATSFIVKSLGIYGISFALFACGVSSYWWICIISL
VVFSIAECIYAPLINIALVEAQPDKPLVDILNYRLIIAAIGESAGSFLGGWIVPALRPAG
LTAWYWCALALV
>KF626733.1_20940|FEATURES|farme|trimethoprim|dfrA23|antibiotic target replacement|0
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWSEARDKEGRAGAIGLNGGM
PWHCAEDMKHFQGADRLPSGDYGS
>KF626709.1_20980|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MVIAYDTGNGSDTHEPLLRVRDLCVEFPLDGGEVRHAVNDVSFDVPQGSVTCLVGESGSG
KSVTAMSTIDLVDEPGRIVGGTITFDGRDVLSLNHKNLERLRGEGISMIFQEPMHSLNPV
LRVGKQLGETIQVHSGASRESAWKRSVQWLKRVGLPNPERVMNMYPHELSGGMAQRVMIA
IALCCGPKLLIADEPTTALDVTIQAQIIHLLLKLKEEIGLSILFITHDFGVVAEVADYVV
VMYEGKVVEHGDVYGIFDHPQHPYTKALLETRPMIGARRHRLPTVRDLVPQFSALSGGNS
LAV
>KF626673.1_21046|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIV
>WP_010908954|FEATURES|argannot|aminoglycoside|AAC(2')-Ic|antibiotic inactivation|1
MDTHHVHTARLVHTADLDGETLRRLQQMVTDAFAGDFDETDWEHALGGMHALIWRHGTII
AHAAVVQRRLFYHGNALRCGYLEGVAVRKDCRGRGLVHALLDAIEQVIRGAYQFGALSSS
DRARRVYMSRGWLPWLGPTSVLAPTGVIRTPDDDGSVFVLPVGINPDTSSGLMCDWRAGN
VW
>CAA35913.1|FEATURES|argannot|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEAIRKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRNGEVAWKTASEYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGATPIVPAHEAAQRSCEPSG
>CAA25642|FEATURES|argannot|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
VQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVM
PSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLP
LPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVR
VDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFL
HPPEGGMRRMRCRSPVDWLSS
>AAA88422|FEATURES|argannot|aminoglycoside|AAC(3)-Ib|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLGGSMSIIATVKIGPDEISAMRAVLDLFGKEFEDIPTYSDRQ
PTNEYLANLLHSETFIALAAFDRGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSHRRLG
VATALISHLKRVAVELGAYVIYVQADYGDDPAVALYTKLGVREDVMHFDIDPRTAT
>CAD53575|FEATURES|argannot|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|1
MISTQTKITRLNSQDVGVMRAMLGMFGEAFEDAENYCRAQPSDSYLQDLLCGSGFIAIAA
LQGQEVIGGLAAYVLPKFEQQRKEIYIYDLGVQGAYRRRGIATALINELQRIAHDIGAYV
IFVQADYGDDPAVALYTKLGIREDVMHFDIEPQPAA
>AAA16194|FEATURES|argannot|aminoglycoside|AAC(3)-VIa|antibiotic inactivation|1
MTDPRKNGDLHEPATAPATPWSKSELVRQLRDLGVRSGDMVMPHVSLRAVGPLADGPQTL
VDALIEAVGPTGNILAFVSWRDSPYEQTLGHDAPPAAIAQSWPAFDPDHAPAYPGFGAIN
EFIRTYPGCRRTAHPDASMAAIGPDAAWLVAPHEMGAAYGPRSPIARFLAHAGKILSIGA
GPDAVTALHYAEAVARIEGKRRVTYSMPLLREGKRVWVTTSDWDSNGILDEYAAPDGPDA
VERIARDYLARTRVAQGPVGGAQSRLIDAADIVSFGIEWLEARHAAPAAAALKPKQRRD
>ACT99627|FEATURES|argannot|aminoglycoside|AAC(6')-33|antibiotic inactivation|1
MAYEFCEIGESNEYIILAARILTKSFLDIGNNSWPDMKSATKEVEECIEKPNICLGIHEN
EKLLGWIGLRPMYKLTWELHPLVISTQYQNKGIGRLLINELEKKAKQIGIIGIVLGTDDE
YFKTSLSAVDLYGENILDEIRTIKNIKNHPYEFYQKCGYSIVGVIPDANGKRKPDIWMWK
KIND
>NP_460578|FEATURES|argannot|aminoglycoside|AAC(6')-Iaa|antibiotic inactivation|1
MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>ACI28880|FEATURES|argannot|aminoglycoside|AAC(6')-Iai|antibiotic inactivation|1
MKYTIIDIKDSETYITQAAEILFDVFSEISPESWPTLQKAKEDVIECIEGENICIGIIIN
KELIGWIGLREMYKKTWELHPMVIKKTHHNMGFGKILINEIEKKARERNLEGIVLGTDDE
TYRTSLSMIELNNENILQEIKNIRNLENHPYEFYKKCGYCIIGVIPNANGKNKPDILMWK
NIMEENCG
>AAC25500|FEATURES|argannot|aminoglycoside|AAC(6')-Iq|antibiotic inactivation|1
LDYSICDIAESNELILEAAKILRKSFLDAGNESWVDIKKAIEEVEDCIEHPNLCLGICLD
DKLIGWTGLRPMYDKTWELHPMVIKTEYQCRGIGKVLIKELEKRAKGRGIIGIALGTDDE
YQKTSLSMIDINERNIFDEIGNIKNVTNHPYEFYKKCGYMIVGIIPNANGKRKPDIWMWK
DIS
>AAD03495|FEATURES|argannot|aminoglycoside|AAC(6')-Iw|antibiotic inactivation|1
MKIMPISEALLADWLQLRILLWPDHEDAHLLEMRQLLTRTDSLQLLAYSETQQPIAMLEA
SIRHEYVNGTQTSPVAFLEGIYVLPEHRRSGIATQLVQQVEQWAKQYACTEFASDAAIDN
TISHAMHQALGFHETERVVYFKKNIS
>ABV25540|FEATURES|argannot|aminoglycoside|aac(6')-ib-cr|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERTRSDA
>ABD58917|FEATURES|argannot|aminoglycoside|aadA15|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>AAD54217|FEATURES|argannot|aminoglycoside|aadA6|antibiotic inactivation|1
MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAARLDE
TVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWE
GDERNVVLTLSRIWYSAATGKIAPKDIVANWAMERLPDQHKPVLLEARQAYLGQGEDCLA
SRADQLAAFVHFVKHEATKLLSAMPVMSNNSFKPTPLRGAA
>AAK69614|FEATURES|argannot|aminoglycoside|aadA8|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSVVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKDEITKVVGK
>CAD12230.1|FEATURES|argannot|aminoglycoside|aadA9|antibiotic inactivation|1
MSNSIHTGISRQLSQARDVIKRHLASTLKAIHLYGSAIDGGLKPYSDIDLLVTVDARLDE
ATRRSLMLDFLNISAPPCESSILRPLEVTVVACNEVVPWRYPARRELQFGEWLREDILEG
VFEPAALDADLAILITKARQHSIALVGPVAQKVFMPVPEHDFLQVLSDTLKLWNTHEDWE
NEERNIVLTLARIWYSTETGGIVPKDVAAEWVLERLPAEHKPILVEARQAYLGLCKDSLA
LRADETSAFIGYAKSAVADLLEKRKSQTSHICDGAKNV
>AAF85647.1|FEATURES|argannot|aminoglycoside|AadD|antibiotic inactivation|1
MRIVNGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVM
STEEAEFSHEWTTGEWKVEVNFDSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLE
KVYQTAKSVEAQTFHDAICALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLI
GLHHRICYTTSASVLTEAVKQSDLPSGYDHLCQFVMSGQLSDSEKLLESLENFWNGIQEW
TERHGYIVDVSKRIPF
>AEI42793|FEATURES|argannot|aminoglycoside|aadK|antibiotic inactivation|1
MKPVGTEEYCLRSEHEMMSTIINFAKNDDRIRLATLEGSRTNKNIPVDTFRDYDISYFVT
DIESFKETDQWLEFFGNRLMMQKPEDMELFPSELGNWFSYIILFEDGNKLDLTLIPINEV
GDYFTKNDGLVEVLLDKDTLINNEVIADDRQYWIKKPTARAFDDCCNEFWMVSTYVVKGL
ARKEILFAIDHLNEIGRPNLLRMMAWQIGSEHGYTFSVGKNYKFINRYLPNEDWEKLLST
YSENGYQEMWQSLLTCYELFRKYSKAVSESLGYTYPDYDEAITKYTENIYSSLVI
>AAM76670|FEATURES|argannot|aminoglycoside|ANT(4')-IIb|antibiotic inactivation|1
VQHTIARWVDRLREEYADAVAILLKGSYARGDAATWSDIDFDVLVSTQDVEDYRTWIEPV
GDRLVHISAAVEWVTGWERDTVDPSSWSYGLPTQETTRLMWAINDETRRRMDRPYKTHPA
AEPEVENTVEALGKIRNAIARGDDLGVYQSAQTVAKLVPTLLIPINPPVTVSHARQAIEA
ILAFPRVPVGFAADWLTCLGLVEERSARSTAAAAERMVRGVLEMLPTDPDLLGEDIARLM
NAGLLEKYVQQ
>AAG13458|FEATURES|argannot|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKREFELY
RFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILNNAV
LFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF
>AAX38178|FEATURES|argannot|aminoglycoside|APH(2'')-Ie|antibiotic inactivation|1
MTTYTFDQVEEAIEQLYPDFTINTIEISGEGNDCIAYEINGNFIFKFPKHSRASINLLNE
VTVLKTIHNELSLPIPEVVFTGMPSEMCQMSFAGFTKIKGVPLTPLLLKNLPKQSQDQAA
KDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGHQMKKVDDFYRDI
LDNEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEY
GMEFVSKILNHYKHKDIPTVLEKYMMKEKYWSFEKIIYGKEYGYMDWYEEGLNEIRSIKI
K
>BAF93086|FEATURES|argannot|aminoglycoside|strA|antibiotic inactivation|1
LNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>CAA24789.1|FEATURES|argannot|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>AES85952|FEATURES|argannot|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>AEK25612|FEATURES|argannot|aminoglycoside|T630_4108|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDLDTELWGDHKTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>AAC32025|FEATURES|argannot|aminoglycoside|APH(3')-Vb|antibiotic inactivation|1
MESTLRRTYPHHTWHLVNEGDSGAFVYRLTGHGPELYAKIAPRTPENSAFHLDGEADRLD
WLARHGISVPRVVERGADDTTAWLVTEAVPGAAASEEWPEDERAAVVDAIAEMARTLHEL
PVSECPFDRRLDVTGEARHNVREGLVDLDDLQEEPAGWTGDQLLAELDLTRPEKEDLVVC
HGDLCPNNVLLDPETHRITGLIDVGRLRLATCHADLALAARELAIDEDPWFGPAYAERFL
ERYGAHHVDQEKMAFYQLLDEFF
>CAD91341|FEATURES|argannot|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
MTVALDEVSELKNLLSPLLDECTFEEVEYGQSDARVIRVLFPDRNTAYLKYASGSSAQEI
LQEHQRTRWLRTRALVPEVISYVSTSTVTILLTKALIGHNAADAADADPVIVVAEMARAL
RDLHSISPDDCPFDERLHLRLKLASGRLEAGLVDEEDFDHARQGMLARDVYEQLFIQMPG
AEQLVVTHGDACPENFIFQGNAFVGFIDCGRVGLADKYQDLALASRNIDAVFGPELTNQF
FIEYGEPNPNIAKIEYYRILDEFF
>AFC75738|FEATURES|argannot|aminoglycoside|rmtB|antibiotic target alteration|1
MNINDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQAVEAARTRLHGICGAYVTPE
SLKAAAAALSAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLALY
ERGVASVWGCDVHQGLGDVITPFAREKDWDFTFALQDVLCAPPAETGDLALIFKLLPLLE
REQAGSAMALLQSINTPRMAVSFPTRSLGGRGKGMEANYAAWFEGGLPTEFEIEDKKTIG
TELIYLIKKNG
>BAE48305|FEATURES|argannot|aminoglycoside|rmtC|antibiotic target alteration|1
MKTNDNYIEEVTAKVLTSGKYSTLYPPTVRRVTERLFDRYPPKQLEKEVRKKLHQAYGAY
IGGIDGKRLEKKIEKIIHEIPNPTTDEATRTEWEKEICLKILNLHTSTNERTVAYDELYQ
KIFEVTGVPTSITDAGCALNPFSFPFFTEAGMLGQYIGFDLDKGMIEAIEHSLRTLNAPE
GIVVKQGDILSDPSGESDLLLMFKLYTLLDRQEEASGLKILQEWKYKNAVISFPIKTISG
RDVGMEENYTVKFENDLVGSDLRIMQKLKLGNEMYFIVSRL
>CAA35921.1|FEATURES|argannot|streptothricin|sat-1|antibiotic inactivation|0
MKISVIPEQVAETLDAENHFIVREVFDVHLSDQGFELSTRSVSPYRKDYISDDDSDEDSA
CYGAFIDQELVGKIELNSTWNDLASIEHIVVSHTHRGKGVAHSLIEFAKKWALSRQLLGI
RLETQTNNVPACNLYAKCGFTLGGIDLFTYKTRPQVSNETAMYWYWFSGAQDDA
>CAC29201|FEATURES|argannot|aminoglycoside|sat-4|antibiotic inactivation|0
VITEMKAGHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEE
ADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINI
SIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF
>AAA26412|FEATURES|argannot|aminoglycoside|APH(3')-Ib|antibiotic inactivation|1
VNDIDREEPCAAAAVPESMAAHVMGYKWARDKVGQSGCAVYRLHSKSGGSDLFLKHGKDA
FADDVTDEMVRLRWLAGHISVPSVVSFVRTPNQAWLLTTAIHGKTAYQVLKSDFGARLVV
VDALAAFMRRLHAIPVSECSVQQWTTHAGLPERGSIEAGVVDVDDFDKEREGWTAEQVWE
AMHRLLPLAPDPVVTHGDFSLDNLLIVEGKVVGCIDVGRAGIADRYQDLAVLWNCLEEFE
PSLQERLVAQYGIADPDRRKLQFHLLLDELF
>CCJ25600|FEATURES|argannot|aminoglycoside|APH(9)-Ib|antibiotic inactivation|0
VDELEQFYQLGWTLDSAGGASGEAYMAEQDGQKLFLKRNSNPFIAALSAEGIVPKLVWTK
RIETGEVVTAQHWKNGRELSSNEMKQTRVAHLLKKIHNSRPLLSMLKRMEMEPITPEIML
NKINASLSREVLTHHIVRKSLTYLEEHIPSLDSRFFTVVHGDVNHNNWLLSDRDELFLVD
WEGAMIADPAIDIGMLLYNYVPQQQWSEWLETYGVQESLNLNKRMKWYTVIQSIGLVQWY
EEQKRYKDMNTWLKFLNEVMNSNMFI
>AKP24019.1|FEATURES|argannot|aminoglycoside|aph(3')-Ic|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKDS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>AFB78806|FEATURES|argannot|beta_lactam|blaA|antibiotic inactivation|1
MKKIITLIIGIIFITFSFATTKIDTQVTNDIQNIEKKHGGKIGVYTINRNDWSNFAVNAS
FYFPICSTYKFLVVGAILKQSMTDNKLLNQKIKISKNQIVEYSPITRRHINQIMTVKQLC
QASMQGDNTATNILIEKLGGLKNLNKFILSLADHATKVANLEPKVNHVSLTTNENKTTPK
IMARDINKLAFSDDILDKKHRLMFKQWLIASNTSNNRIAAEVPDEWEVGDKTGTCQYGTT
NDVAIIWPDDNRAVIMAIFYTQSQKNAKPNSKIVREVTKILLNRLQLNNTTKNA
>ABZ81086|FEATURES|argannot|beta_lactam|ACT-4|antibiotic inactivation|1
MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVADNASLLRFYQNWQPQWKPGTTRLYANTSIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMKPDSLQDNSLRQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILSAL
>CAJ19603|FEATURES|argannot|beta_lactam|OKP-A-6|antibiotic inactivation|1
MRYVRLCLISLIAALPLAAFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDERLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKRVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR
>CAJ19606|FEATURES|argannot|beta_lactam|OKP-A-8|antibiotic inactivation|1
MRYVRLCLISLIAALPLAAFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAJ19612|FEATURES|argannot|beta_lactam|OKP-B-4|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>CAJ19616|FEATURES|argannot|beta_lactam|OKP-B-8|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>CAJ19620|FEATURES|argannot|beta_lactam|OKP-B-11|antibiotic inactivation|1
MRYVRLCLISLITALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLATWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>CAG25831|FEATURES|argannot|beta_lactam|OKP-B-12|antibiotic inactivation|1
TALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRMLAAWRASERFPLMSTFKVLL
CGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGN
LLLKSVGGPAGLTTFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTT
PSLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAE
RIVVIYLRDTAATMAERNQQIAG
>BAM84089|FEATURES|argannot|beta_lactam|NDM-8|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMGALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AGT37351|FEATURES|argannot|beta_lactam|NDM-10|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEISPTIDQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPSFGAVTSNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDRTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AAO42602|FEATURES|argannot|beta_lactam|MIR-2|antibiotic inactivation|1
MMTKSLSCALLLSVASAAFAAPMSETQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYHILDALQ
>ACI89425|FEATURES|argannot|beta_lactam|MOX-4|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLAHAGDTSAVDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSMKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VSEQTLLAGNSAEVILEANPTAAPRESGNLMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>ACS44783|FEATURES|argannot|beta_lactam|MOX-5|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGGFELDDKASLFAPWL
KGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSRGSHRQYANPSIG
LFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLNVPEQPMGHYAYGYWKEDKPFRVTPAM
LAEEPYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYPYP
VSEQTLLAGNSPAMIYNANPAAPAPAAAGHPVLFKKTGSTNGFGAYVAFVPAKGIGVVML
ANRNYPNEGTLKAGHAILTQLAR
>AAN63647|FEATURES|argannot|beta_lactam|MUS-1|antibiotic inactivation|1
MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGV
ILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTN
EILKERNEPQAQHSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKS
AEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMTGHIENTERILSAYNQQ
HSTKND
>AAT90847|FEATURES|argannot|beta_lactam|SFB-1|antibiotic inactivation|1
MISAPSFAHENEQQTDQSNTDAVKKPQQQPTELFLSPLVPDVYLHQSYKQVSGFGLVESN
GLVVVQNKQAFIIDTPWTDSDTAKLVDWITQQGLTVTASISTHSHQDRAGGIGYLNSQGI
ATWVSDKTQRLLTANKLSTASHTFRTKQHTLQQQLIEVYDLGAGHTVDNLLVWLPKQQIL
FGGCLIKSLSSRTLGYTGEADLEQWPLTVAKVQAQFIQAKIVVPGHGKIGDTSLLSHTID
LLTQ
>WP_024531368|FEATURES|argannot|beta_lactam|Sfh-1|antibiotic inactivation|1
IILNIKYLFTAVTFLLIACESMASEKNLTLTHFKGPLYIVEDKEYVQENSMVYIGTDGIT
IIGATWTPETAETLYKEIRKVSPLPINEVINTNYHTDRAGGNAYWKTLGAKIVATQMTYD
LQKSQWGSIVNFTRQGNNKYPNLEKSLPDTVFPGDFNLQNGSIRAMYLGEAHTKDGIFVY
FPAERVLYGNCILKENLGNMSFANRTEYPKTLEKLKGLIEQGELKVDSIIAGHDTPIHDV
GLIDHYLTLLEKAPK
>ABQ10556|FEATURES|argannot|beta_lactam|PER-1|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>AAU89132|FEATURES|argannot|beta_lactam|PER-3|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSLSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>ACI95258|FEATURES|argannot|beta_lactam|KPC-8|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>AEA73284|FEATURES|argannot|beta_lactam|KPC-13|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLGTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>AIH07017|FEATURES|argannot|beta_lactam|KPC-19|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVTGQ
>BAJ05825|FEATURES|argannot|beta_lactam|IND-7|antibiotic inactivation|1
MKKSIRFFIVSILLSPFASAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSMYLVTKK
GVVLFDVPWEKVQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATAK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPKTINKLKAKYSKATLIIPGHDEWKGGGHVEHTLELLNKK
>ADK25050|FEATURES|argannot|beta_lactam|IND-11|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKTKYAHATLVIPGHDEWKGGGHVQHTLDLLDKNK
KPE
>ABC24668|FEATURES|argannot|beta_lactam|IMP-26|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAEPLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVDA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKP
YGLGNLGDANLEAWPKSAKLLISKYGKAKLVVPSHSEAGDASLLKLTLEQAVKGLNESKK
PSKLSN
>CAE48334|FEATURES|argannot|beta_lactam|IMP-16|antibiotic inactivation|1
MKKLFVLCIFLFCSITAAGESLPDLKIEKLEDGVYVHTSFEEVNGWGVVTKHGLVFLVNT
DAYLIDTPFAAKDTEKLVNWFVERGYKIKGSISSHFHSDSSGGIEWLNSQSIPTYASELT
NELLKKNGKVQAKNSFSGVSYWLLKNKIEIFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
YGLGNLDDANVEAWPHSAEILMSRYGNAKLVVPSHSDVGDASLLKLTWEQAVKGLKESKK
PSQPSN
>CAS92952|FEATURES|argannot|beta_lactam|IMP-22|antibiotic inactivation|1
MKKLFVLCVFLFCSITAAGESLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVILVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NDLLKQNGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
YGLGNLDDANVVAWPHSAEILMSRYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLKESKK
PSEPSN
>AEH41427|FEATURES|argannot|beta_lactam|IMP-27|antibiotic inactivation|1
MKKLFVLCVFVFCSITVAGETLPNLRVEKLEEGVYVHTSYEEVKGWGVVTKHGLVVLIGA
DAYLIDTPFTAKDTEKLVNWFVERGYKIKGTVSSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFDGVSYWLAKDKIEVFYPGPGHTQDNVVVWLPEKEILFGGCFVKP
HGLGNLGDANLEAWPESAKILMEKYGKAKLVVSGHSETGDATHLKRTWEQAVKGLKESKK
TLQPSN
>ADU33210|FEATURES|argannot|beta_lactam|IMP-28|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAAESLPDLKIERLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVGRGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVSYWLVKNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLMSKYGKAKLVVPSHSEVGDASLLKRTLEHAVKGLNESKK
PSKPSN
>AEN75249|FEATURES|argannot|beta_lactam|IMP-38|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAEPLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVDA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKP
YGLGNLGDANLEAWPKSAKLLISKYGKAKLVVPGHSEAGDASLLKLTLEQAVKGLNESKK
PSKLSN
>AFR33816|FEATURES|argannot|beta_lactam|IMP-32|antibiotic inactivation|1
MKKLFVLCVFFFCNIAVAEESLPDLKIEKLEEGVYVHTSFEEVKGWSVVTKHGLVVLVKN
DAYLIDTPITAKDTEKLVNWFVERGYKIKGSISTHFHGDSTAGIEWLNSQSIPTYASELT
NELLKKDNKVQAKHSFYGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGYLGDANLEAWPKSAKILMSKYGKAKLVVSSHSDIGDVSLLKRTWEQAVKGLNESKK
SSQPSD
>AFP97028|FEATURES|argannot|beta_lactam|IMP-37|antibiotic inactivation|1
MKKLFVLCVCFFCSITAAGAALPDLKIEKLEEGVFVHTSFEEVNGWGVVTKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYEIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKSGKVQAKYSFSEVSYWLVKNKIEVFYPGPGHTQDNLVVWLPESKILFGGCFIKP
HGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEKGDASLMKRTWEQALKGLKESKK
TSSQSTAS
>BAR80870|FEATURES|argannot|beta_lactam|blaIMP-52|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYIIDTPFTAKDTEKLGTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>AAA93461.1|FEATURES|argannot|beta_lactam|IMI-1|antibiotic inactivation|1
MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKDLETDFNGRIGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>CAD60972|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDPVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRAVLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANEAIPAIGKQLFAGQP
>AAF89149|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
QKLGFNYKDIKILLLTQAHYDHTGALQDLKTETAAKFYADKADADVLRTGGNSDYEMGKY
GVTFKPVTPDKTLKDQDKITLGNTILTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMP
SVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDLWVASHASQFDLHEKRKEGDPYNPQL
FMDKQSYFQNLN
>AAF89146|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
QKLGFNYKDIKILLLTQAHYDHTGALQDLKTETAAKFYADKEDADVLRTGGKSDYEMGKY
GVTFKPVTPDKTLKDQDKIKLGNTILTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMP
SVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDLWVASHASQFDLHEKRKEGDPYNPQL
FMDKQSYFQNLN
>AAT68576|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFVILFFMFICLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETGAKFYA
DKEDADVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKITLGNTILSLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLNKIKKDSQDK
>AAT68577|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFVILFFMFICLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETGAKFYA
DKEDADVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKITLGNTILTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>AAT68578|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFLSACLSLSLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAESLTIIKGNIQKLGFNYKDIKVLLLTQAHYDHTGALEDFKTETGAKF
YADKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFETKDEKRKYRVLIANMPSIIVDKKFSEVAAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>AAT68582|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFLSVCLDLNLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAESLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKF
YTDKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFDTKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQNYFQSLNNLEKSYLDKIKKDSQDK
>ADN96169|FEATURES|argannot|beta_lactam|GES-1|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>BAD08689|FEATURES|argannot|beta_lactam|GES-4|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRTAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AAK18183|FEATURES|argannot|beta_lactam|GES-8|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQL
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ACZ54536|FEATURES|argannot|beta_lactam|GES-13|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMNDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AEX59144|FEATURES|argannot|beta_lactam|GES-18|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALIFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>BAP75641|FEATURES|argannot|beta_lactam|GES-24|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRTAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AJP67510|FEATURES|argannot|beta_lactam|GES-26|antibiotic inactivation|1
MRFIHALLLAAIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>CAA54602|FEATURES|argannot|beta_lactam|FOX-1|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYARGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRHWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAIANYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLKFTEANMGYQGDAALKTRIALTHTGFYSVGDMTQGLGWESYAYPLTE
QALLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAB61645|FEATURES|argannot|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKNTLRQTTLMVATVMPLLFGSAPLWAQTANAKANIQQQLSELEKSSGGRLGVALIDTA
DNSQILYRADERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDKRDTTSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>AHL39320|FEATURES|argannot|beta_lactam|blaDHA-9|antibiotic inactivation|1
MTKSVSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSHYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>BAX00166|FEATURES|argannot|beta_lactam|bla(IMI-8)|antibiotic inactivation|1
MFFFKKSASTFIFLLCLPLNSFASQESNGVEQMRELETSFGGRIGVYILNTKNGKEFSYR
QDERFPLCSSFKAFLAASVLKRTQDKSVSLDDMMEYSGRVMEKHSPVSEKYRETGASVQT
LAKAAIQYSDNGASNLLMERYIGGPEGLTAFMRSTGDTDFRLDRWELELNSAIPGDERDT
STPKAVAISLNNIAFGSVLDAKNKSLLQDWLKGNTTGNARIRAAVPDKWVVGDKTGTCGL
YGTANDIAILWPDANSPAVMAVYTTRPNQNDKHDETVIKNAAKIAINAVYGSTK
>WP_063865149|FEATURES|argannot|beta_lactam|VCC-1|antibiotic inactivation|1
MKRIAMYVALSISTSTAFADEHNKNMADIEAAFEGRVGVYAINTGSGKAYSYRANERFPL
CSSFKAFLAAAVLKMDQDSPGVLLEKVNYHNRTMEPHSPITEKFQSQGMAVGELAAATLQ
YSDNGAANLLMEKYIKGPEGMTQFMNSIGDTKFRLDRWELDLNSAIPGDERDTSTPKAVA
ESLNKLISNTVLDNYHQEIFKKWMIGNTTGDNRIRAAVPDGWVVGDKTGTCGKYGTANDH
AFILQGNNAAPLILSIYTTRKGEHMKHDDEVIAKAARIAIENVK
>AFI56422|FEATURES|argannot|beta_lactam|blaCMH-1|antibiotic inactivation|1
MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQ
WQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGS
LAVKPSGMCFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEA
YGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPVRVETAYRILDALQ
>AKD43328|FEATURES|argannot|beta_lactam|bla|antibiotic inactivation|1
MTITFSRRQAIAGALLAVPAVSTLAASAGALLAVPAVSTLAASAGAATGGPLEKRLAELE
GRHKGRIGVAIHNLATGARIGHRADERFLMCSTFKALLAAHILARVDRKEETLDRRIVVG
KSDLVDWSPVVETRVGGEGISIAELCEAAITLSDNAAANLLLSASGGPKAVTQFLRGFGD
DVTRLDRTEPTLNYRETPDDERDTTTPAAMAETLRKLIIGDVLARGSKAQLAAWLVMNKT
GDTRLRAGFPVDWTTGDKTGTNGDRHGNANDVAIAWSPDRGAVVVTAFCEIPGISGDERN
AVIAEIGRIAAEA
>AAF23816|FEATURES|argannot|beta_lactam|vhw-1|antibiotic inactivation|1
MKKLFLLLGLLACSSATYAAKLNEDISAIEEHISGRIGVSVWDTQTDEHWDYRGDERFPM
MSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRFEHACEAAML
MSDNSAAHIVLRSIWGVHAGGTSFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMV
NTLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITA
MIWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEVQYYLALAKY
>AAP93850|FEATURES|argannot|beta_lactam|blaCMG|antibiotic inactivation|1
LSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHYFTFGK
ADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEITLGDPVTKYWPELTGKQWQGIR
MLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPKWKPGTTRLYANTSIGLFGALAVKP
SGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKT
NVQDMASWVMVNMMPDSLQDSPLKHGIALAQSRYWRVGAMYQGLGWEMLNWPVDAQTVVG
GSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGI
>CAB55427|FEATURES|argannot|beta_lactam|TLA-3|antibiotic inactivation|1
MKKIILLFILTSQLVLAQHTSILNDINAVTKDKKATVAVSVLGIENDFQFSNANGNLKMP
MLSVFKFHIALAVLNQVDKGNLTLDQKILIKKSDLLENTWSPLREKYPDGNVELPLSEII
TYTVAQSDNNGCDILLRLIGGTKTVQKLMDVNGIKNFQIKYNEEEMHKNDVKTLYANYTT
TASMVKTLKAFYKGMFLSKRSTIFLMDIMTKTNTGMSKLPGLLPKVRMARKTGSSGKMKN
GLTIAENDSGIVTLANGKHYAIAVFVKDSMESEEVNCGMIAQVSKIVWDALNKKK
>BAC76072|FEATURES|argannot|beta_lactam|CFE-1|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTTRVLQPLKLAHTWITVPQSEQKDYALGYREGKPVHVSPGQLDAEA
YGVKSSVVDMTRWVQANMDASQVQEKTLQQGIKLAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AAA21534|FEATURES|argannot|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITINNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVKQQID
>AAF61147|FEATURES|argannot|beta_lactam|KS18_02580|antibiotic inactivation|1
MWQWLGKVRWLLVVIALLGGKVMAASELDSALARLEQQHHGRLGLAYIDSGSGESYSYRG
EERFAFCSTFKAVLAGAVLQRSVSQPGLLDKRVHYAATDLLAYAPITKTHLDKGMRIGEL
AAAAVQYSDNTAANLLLQEIGGVQALNRFVQGLGDPAFRLDRIEPHLNSAEPGDVRDTTT
PLAMAHTLQAMTLGKGLPQAQQAQLVSWLKGNTTGAQRIQAGVPAGWQVGDKTGTGGYGT
TNDIAILWPEQGAPKVLAIYFTQPAADAEANRAILAEATRLVLQDKSINKIK
>CAD69003|FEATURES|argannot|beta_lactam|imiH|antibiotic inactivation|1
MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPDQLVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAAPQS
>CAC33832|FEATURES|argannot|beta_lactam|THIN-B|antibiotic inactivation|1
MTLLAKLMLATVATMSAATVQAKTPAPKPDTPVDCDSCKAWNGEVTPFNVFGNTWYVGTA
GLSAVLVTSPQGHVLLDGALPQSAPLIIANIAALGFRIEDVKFILNSHAHWDHAGGIAAL
QAASGATVVASASGALGLQSGTNGKDDPQFQAKPVVHVAKVEKVKVVGEGDAIKLGPLNL
TAHMTPGHTPGATTWTWTSCEGQRCLDVVYADSLNPYSSGDFTYTGKGDGPDISASFAAS
IAKVAALPCDIILSVHPDSTGVLDKAAKRSGEHNPFIDANACRAYAATADAMLTKRLAKE
RGVALPAAAPAAQHAH
>NP_214233.1|FEATURES|argannot|beta_lactam|cphA1|antibiotic inactivation|1
MGGFLFFFLLVLFSFSSEYPKHVKETLRKITDRIYGVFGVYEQVSYENRGFISNAYFYVA
DDGVLVVDALSTYKLGKELIESIRSVTNKPIRFLVVTHYHTDHFYGAKAFREVGAEVIAH
EWAFDYISQPSSYNFFLARKKILKEHLEGTELTPPTITLTKNLNVYLQVGKEYKRFEVLH
LCRAHTNGDIVVWIPDEKVLFSGDIVFDGRLPFLGSGNSRTWLVCLDEILKMKPRILLPG
HGEALIGEKKIKEAVSWTRKYIKDLRETIRKLYEEGCDVECVRERINEELIKIDPSYAQV
PVFFNVNPVNAYYVYFEIENEILMGE
>ACT66697|FEATURES|argannot|beta_lactam|SIM-1|antibiotic inactivation|1
MRTLLILCLFGTLNTAFAEEAQPDLKIEKIEEGIYLHTSFQEYKGFGIVKKQGLVVLDNH
KAYLIDTPASAGDTEKLVNWLEKNDFTVNGSISTHFHDDSTAGIEWLNTKSIPTYASKLT
NELLNKNGKTQAKHSFDKESFWLVKNKIEIFYPGPGHTQDNEVVWIPNKKILFGGCFIKP
NGLGNLSDANLEAWPGSAKKMISKYSKAKLVIPSHSEIGDASLLKLTWEQAIKGLNESKS
KPPLIN
>AAO33760|FEATURES|argannot|beta_lactam|TEM-7|antibiotic inactivation|1
FFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYTTGSQATMDERNR
>AAB59975.1|FEATURES|argannot|beta_lactam|TEM-10|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMD
>CAO98721.1|FEATURES|argannot|beta_lactam|TEM-15|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA74912|FEATURES|argannot|beta_lactam|TEM-17|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACB22021|FEATURES|argannot|beta_lactam|TEM-20|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAN61404.1|FEATURES|argannot|beta_lactam|TEM-21|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAD24670|FEATURES|argannot|beta_lactam|TEM-30|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD22538|FEATURES|argannot|beta_lactam|TEM-53|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF01046|FEATURES|argannot|beta_lactam|TEM-70|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASQQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF05611|FEATURES|argannot|beta_lactam|TEM-79|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
GGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAL29436|FEATURES|argannot|beta_lactam|TEM-84|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AAK71474|FEATURES|argannot|beta_lactam|TEM-89|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMGDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEI
>AAM22276|FEATURES|argannot|beta_lactam|TEM-96|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLGRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAK85245|FEATURES|argannot|beta_lactam|TEM-163|antibiotic inactivation|1
MDPQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKLW
>AAM61952|FEATURES|argannot|beta_lactam|TEM-104|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIVEIGASLIKHW
>AAS89982|FEATURES|argannot|beta_lactam|TEM-112|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAS89983|FEATURES|argannot|beta_lactam|TEM-113|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAQ98890|FEATURES|argannot|beta_lactam|TEM-122|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEQNRQIAEIGASLIKHW
>CAI29263|FEATURES|argannot|beta_lactam|TEM-130|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKPAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAR84298|FEATURES|argannot|beta_lactam|TEM-132|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAVPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ14083|FEATURES|argannot|beta_lactam|TEM-145|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLMRSALPAGWFIADKSGAGERGS
HGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABB84515|FEATURES|argannot|beta_lactam|TEM-147|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSVLPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABO64442|FEATURES|argannot|beta_lactam|TEM-162|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPKTLVKVKDAENQLGARVGYIELDLNSGKILESFRP
EKRFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQSDVVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABX71157|FEATURES|argannot|beta_lactam|TEM-164|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQVGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQTAEIGASLIKHW
>ACI25375|FEATURES|argannot|beta_lactam|TEM-166|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVGEL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADR71220|FEATURES|argannot|beta_lactam|TEM-183|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWLIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADM61585|FEATURES|argannot|beta_lactam|TEM-187|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKH
>AEL17198|FEATURES|argannot|beta_lactam|TEM-188|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AFC75525|FEATURES|argannot|beta_lactam|TEM-195|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSRNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDCWEPELNEAIPHDERDTTM
PAAVATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AFN69127|FEATURES|argannot|beta_lactam|TEM-199|antibiotic inactivation|1
QHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRPEER
FPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSA
AITMSDNTAANLLLTTIGGPKELTAFLHNIGDHVTRLDRWEPELNEAIPNDERDTTMPAA
MATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGSRGI
IAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AFS44742|FEATURES|argannot|beta_lactam|TEM-201|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETVVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGGQATMDERNRQIAEIGASLIKHW
>AGL39384|FEATURES|argannot|beta_lactam|TEM-208|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDFVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AHJ78622|FEATURES|argannot|beta_lactam|TEM-216|antibiotic inactivation|1
MSIQHFRVSLIPFFAAFCLPVFAHPETLVKVKDAEDQLGAPVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAP93849|FEATURES|argannot|beta_lactam|blaZEG|antibiotic inactivation|1
APMSDKQLADVVKRTITPLMKAQTIPGMAVAVIYQGQPHYFTFGNADVAANKPVTPQTLF
ELGSISKTFTGVLGGDAIARGEISLTDPATKYWPELSGKQWQGIRMLDLATYTAGGLPLQ
VPDEVTDSASLLRFYQNWQPQWKPSTTRLYANASIGLFGALAVKPSGMSYAQAMTERVFK
PLKLGHTWINVPKTEEEHYAWGYRDGKPVHVSPGALDAEAYGVKSNVQDMASWVMANIAP
EHVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVDAKTVVGGSDNNVALAPLPARE
VTPPVPPVKASWVHKTGSTGGFGGYVAFIPEKNLGIV
>CAB36902|FEATURES|argannot|beta_lactam|CMY-6|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYALGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABD94117|FEATURES|argannot|beta_lactam|CMY-23|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAGA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACA30421|FEATURES|argannot|beta_lactam|CMY-27|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYACGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABQ51091|FEATURES|argannot|beta_lactam|CMY-28|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDNKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABN51006|FEATURES|argannot|beta_lactam|CMY-34|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADM21467|FEATURES|argannot|beta_lactam|CMY-42|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHSSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>CBB16411|FEATURES|argannot|beta_lactam|CMY-45|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLKIPDDVRDKAALLHFYQNWQPQWTPGAKRLYSNSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTVGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACV32310|FEATURES|argannot|beta_lactam|CMY-49|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVTPGQLDAEA
YGVKSNVTDMARWIQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALHTVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADK55605|FEATURES|argannot|beta_lactam|CMY-55|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGEAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK08541|FEATURES|argannot|beta_lactam|CMY-67|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEVAWRILEKLQ
>AGE45504|FEATURES|argannot|beta_lactam|CMY-69|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALPALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACU00152|FEATURES|argannot|beta_lactam|CMY-73|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVLYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYLPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVTPGQLDAEA
YGVKSNVTDMARWIQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPTVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73437|FEATURES|argannot|beta_lactam|CMY-76|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AGZ20169|FEATURES|argannot|beta_lactam|CMY-108|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWHILEKLQ
>AHW47897|FEATURES|argannot|beta_lactam|CMY-111|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDVEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AIT76089|FEATURES|argannot|beta_lactam|CMY-113|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AKZ20821|FEATURES|argannot|beta_lactam|blaCMY-133|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGNDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AKP17985|FEATURES|argannot|beta_lactam|blaCMY-135|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHLVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>CAA82281|FEATURES|argannot|beta_lactam|SME-1|antibiotic inactivation|1
MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNT
FGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYHSPITTKYKGSGM
TLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGD
KRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTG
SCGAIGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID
>ACO07066|FEATURES|argannot|beta_lactam|SHV-66|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAD43815|FEATURES|argannot|beta_lactam|SHV-13|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAAERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAB37325|FEATURES|argannot|beta_lactam|SHV-15|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAMLARVDAGDKQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAC98092|FEATURES|argannot|beta_lactam|SHV-16|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKITHRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETDRWETELNEALPGDARD
TTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGE
RGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>BAA84973|FEATURES|argannot|beta_lactam|SHV-24|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARGTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAG49894|FEATURES|argannot|beta_lactam|SHV-29|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAAERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAK69829|FEATURES|argannot|beta_lactam|SHV-33|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLSAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAK64187|FEATURES|argannot|beta_lactam|SHV-34|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADG
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACV33211|FEATURES|argannot|beta_lactam|SHV-38|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAP82228|FEATURES|argannot|beta_lactam|SHV-44|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQLQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAP41108|FEATURES|argannot|beta_lactam|SHV-50|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRHLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAP41944|FEATURES|argannot|beta_lactam|SHV-51|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGLAGLTAFLRQIGDNVTRLDRWETELNEALPADARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAT01223|FEATURES|argannot|beta_lactam|SHV-53|antibiotic inactivation|1
IISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMST
FKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSD
NSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLR
KLLISQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGP
NN
>AAO66446|FEATURES|argannot|beta_lactam|SHV-57|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETERNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAI30649|FEATURES|argannot|beta_lactam|SHV-60|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA06587|FEATURES|argannot|beta_lactam|SHV-65|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCT
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA06588|FEATURES|argannot|beta_lactam|SHV-66|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADQ
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA06590|FEATURES|argannot|beta_lactam|SHV-69|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAY42633|FEATURES|argannot|beta_lactam|SHV-70|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGVTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47132|FEATURES|argannot|beta_lactam|SHV-77|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVALCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47137|FEATURES|argannot|beta_lactam|SHV-82|antibiotic inactivation|1
MRYVRLCIISLLATLPLAVHTSPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABC54571|FEATURES|argannot|beta_lactam|SHV-85|antibiotic inactivation|1
MRYIRLCIISLLATMPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAP58287|FEATURES|argannot|beta_lactam|SHV-98|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPAIMAERNQQIAGIGAALIEHWQR
>CAP58288|FEATURES|argannot|beta_lactam|SHV-99|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVGYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAP58289|FEATURES|argannot|beta_lactam|SHV-100|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIESESQLSGRVGMIEMDL
ASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEK
HLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNE
ALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFI
ADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAQ03506|FEATURES|argannot|beta_lactam|SHV-106|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAQ03508|FEATURES|argannot|beta_lactam|SHV-108|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLAIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACM04459|FEATURES|argannot|beta_lactam|SHV-109|antibiotic inactivation|1
MRYIRRCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDMPASMAERNQQIAGIGAALIEHWQR
>AFQ23968|FEATURES|argannot|beta_lactam|SHV-162|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMVEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23969|FEATURES|argannot|beta_lactam|SHV-163|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQQ
>AAL78281|FEATURES|argannot|beta_lactam|OXY-2-3|antibiotic inactivation|1
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQIL
YRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTL
AELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERD
TSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGGGD
YGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>CAA88908|FEATURES|argannot|beta_lactam|OXY-2-7|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>CAI43419|FEATURES|argannot|beta_lactam|OXY-5-2|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKADLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFALSIGDVTFRLDRMEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AAB97924|FEATURES|argannot|beta_lactam|OXA-16|antibiotic inactivation|1
IACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTF
KIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQITREVGE
VRMQKYLKKFSYGNQNISGGIDKFWLEDQLRISAVNQVEFLESLYLNKLSASKENQLIVK
EALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPL
RKSIPTKIMESEGIIGG
>ACQ77169|FEATURES|argannot|beta_lactam|OXA-19|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEDQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>ACR33071|FEATURES|argannot|beta_lactam|OXA-35|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>CAO91943|FEATURES|argannot|beta_lactam|OXA-45|antibiotic inactivation|1
MRGKHTVILGAALSALFAGAAGAQMLECTLVADAASGQELYRKGACDKAFAPMSTFKVPL
AVMGYDAGILVDAHNPRWDYKPEFNGYKFQQKTTDPTIWEKDSIVWYSQQLTRKMGQKRF
AAYVAGFGYGNGDISGEPGKSNGLTHSWLGSSLKISPEGQVRFVRDLLSAKLPASKDAQQ
MTVSILPHFAAGDWAVQGKTGTGSFIDARGAKAPLGWFIGWATHEERRVVFARMTAGGKK
GEQPAGPAARDAFLKALPDLAKRF
>AAN63499.1|FEATURES|argannot|beta_lactam|OXA-46|antibiotic inactivation|1
MAIRFFTILLSTFFLTSFVYAQEHVVIRSDWKKFFSDLQAEGAIVIADERQAKHTLSVFD
QERAAKRYSPASTFKIPHTLFALDADAVRDEFQVFRWDGVNRSFAGHNQDQDLRSAMRNS
TVWVYELFAKDIGEDKARRYLKQIDYGNVDPSTIKGDYWIDGNLKISAHEQILFLRKLYR
NQLPFKVEHQRLVKDLMITEAGRSWILRAKTGWEGRFGWWVGWIEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>AAP69225|FEATURES|argannot|beta_lactam|OXA-47|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASQLFEGTEGCFLLYDASTNAEIAQFNK
AKCAAQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKIPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVRNSAIENTIDNMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGSLGSNLTSSIKAKKNAITILNTLNL
>CAF74882|FEATURES|argannot|beta_lactam|oxa|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLDRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>AAW81336|FEATURES|argannot|beta_lactam|OXA-64|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKGEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF50983|FEATURES|argannot|beta_lactam|OXA-67|antibiotic inactivation|1
MNIKALLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSLKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW81340.1|FEATURES|argannot|beta_lactam|OXA-69|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAU86900|FEATURES|argannot|beta_lactam|OXA-72|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMDVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>AAW22056|FEATURES|argannot|beta_lactam|OXA-73|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALKMEMRSEMPASIRNELLMKSLKQLNII
>AEI69286|FEATURES|argannot|beta_lactam|OXA-80|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABE03012|FEATURES|argannot|beta_lactam|OXA-89|antibiotic inactivation|1
MNIKTLLLITSAIFISACSHYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FTYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF47918|FEATURES|argannot|beta_lactam|OXA-95|antibiotic inactivation|1
MNIKALFLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABO33299|FEATURES|argannot|beta_lactam|OXA-97|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISGDAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>ABQ52429|FEATURES|argannot|beta_lactam|OXA-104|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABW70410|FEATURES|argannot|beta_lactam|OXA-113|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAN41427|FEATURES|argannot|beta_lactam|OXA-119|antibiotic inactivation|1
MAIRFLTILLSTFFLTSFVHAQEHVLERSDWKKFFSDLRAEGAIVISDERQAEHALLVFG
QERAAKRYSPASTFKLPHTLFALDADAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEIGEDKARRYLKQIDYGNADPSTIKGDYWIDGNLEISAHEQISFLRKLYR
NQLPFQVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>ACD45467|FEATURES|argannot|beta_lactam|OXA-138|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACT09125|FEATURES|argannot|beta_lactam|OXA-161|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGDADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>ADI58619|FEATURES|argannot|beta_lactam|OXA-175|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIRNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADI58621|FEATURES|argannot|beta_lactam|OXA-177|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDGVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEB98921|FEATURES|argannot|beta_lactam|OXA-195|antibiotic inactivation|1
MNIKALFLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPSSQKVQDEVQSMLFIEEKNGNKMYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEI69285|FEATURES|argannot|beta_lactam|OXA-109|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIRVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEV91551|FEATURES|argannot|beta_lactam|OXA-212|antibiotic inactivation|1
MKTLQSGLIALITTFGSACTTISPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVVKDKH
SLHSYGNDLSRAQTPYIPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPTWEKDMTL
GQAMQASAVPVYQELARRIGLDLMKKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTQLAFKPDVQHAVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWAGWVETSTG
EKVYFALNMHMKTGISASVREQLVKQSLTALGII
>AEV91552|FEATURES|argannot|beta_lactam|OXA-213|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNMVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDFKRASTDYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRVGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSKDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AEV91553|FEATURES|argannot|beta_lactam|OXA-214|antibiotic inactivation|1
MKLSKLYTLTVLIGFGLSGVACQHIHTPVSFNQIENDQTKQIASLFENVQTTGVLITFDG
QAYKAYGNDLNRAKTAYIPASTFKILNALIGIEHDKTSPNEVFKWDGQKRAFESWEKDLT
LAEAMQASAVPVYQALAQRIGLDLMAKEVKRVGFGNTRIGTQVDNFWLIGPLKITPIEEA
QFAYRLAKQELPFTPKTQQQVIDMLLVDEIRGTKVYAKSGWGMDITPQVGWWTGWIEDPN
GKVIAFSLNMEMNQPAHAAARKEIVYQALTQLKLL
>AEL30572|FEATURES|argannot|beta_lactam|blaADC-30|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AFG25595|FEATURES|argannot|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKIIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>AFK24475|FEATURES|argannot|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRINSGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>CAC17622|FEATURES|argannot|beta_lactam|OCH-2|antibiotic inactivation|1
MRTSTTLLIGFLTTAAVIPNNGALAASKVNDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFKNWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLELDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVWLNKTGSTNGFGAYAAFIPAKKT
GIVLLANRNYPIDERIKAAYRILQALDNKQ
>CAC17626|FEATURES|argannot|beta_lactam|OCH-6|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMRDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVWLNKTGSTNGFGAYAAFIPAKKT
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>ABF50909|FEATURES|argannot|beta_lactam|OCH-8|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALATSKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKI
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>BAA24531|FEATURES|argannot|beta_lactam|CARB-12|antibiotic inactivation|1
MKFLLVFSLLIPSVVFASSSKFRQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGSKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNKKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGRSIFDVYTSQSR
>AAD19217|FEATURES|argannot|beta_lactam|CARB-6|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVKWSIADRSGAGGFGARSI
TAIVWSEEKKTIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR
>ACJ61335|FEATURES|argannot|beta_lactam|CARB-10|antibiotic inactivation|1
MDVRQHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAAHDLETGKRW
EHKSNERFPLTSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGM
SLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWETELNEAVPGDK
RDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGA
GGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKTVLMENSRN
>AAF89156|FEATURES|argannot|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIDKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINE
YQQKQKASN
>AAD43582|FEATURES|argannot|beta_lactam|blaB-15|antibiotic inactivation|1
MMKKMKWALVLALGLTGLNAFGQETPEVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
SKGVVVIDSPWGEEKFKNFTDEIYKRHGKKVIMNIATHSHDDRAGGLEYFKSLGAKTYST
KMTDSILAKDNKPRAQYTFDNNKSFKVGKDEFQVYYPGKGHTADHVVVWFPKDKVLVGGC
IIKSGDSKDLGFLGEAYVNDWTQSVHNIQKKFPNVQYVVAGHDDWKDQTAIQHTLDLISE
YQQKQKASN
>AAF89160|FEATURES|argannot|beta_lactam|KS04_10900|antibiotic inactivation|1
MKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGIVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEY
QQKQKASN
>AAF89161|FEATURES|argannot|beta_lactam|KS04_10900|antibiotic inactivation|1
MKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEY
QQKQKASN
>AAQ54755|FEATURES|argannot|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINE
YQQKQKASN
>ABQ84948|FEATURES|argannot|beta_lactam|blaB-15|antibiotic inactivation|1
MMKKMKWALVLALGLTGLNAFGQETPEVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
SKGVVVIDSPWGEEKFKNFTDEIYKRHGKKVIMNIATHSHDDRAGGLEYFKSLGVKTYST
KMTDSILAKDNKPRAQYTFDNNKSFKVGKDEFQVYYPGKGHTADNVVVWFPKDKVLVGGC
IIKSGDSKNLGFLGEAYVNDWTQSVHNIQKKFPNVQYVVAGHDDWKDQTAIQHTLDLISE
YQQKQKASN
>ADE18863|FEATURES|argannot|beta_lactam|VIM-1|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AEO50497|FEATURES|argannot|beta_lactam|VIM-4|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AAY44598|FEATURES|argannot|beta_lactam|VIM-5|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRKAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLALSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVTAHKNRSVAE
>AAN84550|FEATURES|argannot|beta_lactam|VIM-6|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATR
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGSEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>CAD61201|FEATURES|argannot|beta_lactam|VIM-7|antibiotic inactivation|1
MFQIRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQK
LGDTVYSSNGLIVRDADELLLIDTAWGAKNTVALLAEIEKQIGLPVTRSISTHFHDDRVG
GVDVLRAAGVATYTSPLTRQLAEAAGNEVPAHSLKALSSSGDVVRFGPVEVFYPGAAHSG
DNLVVYVPAVRVLFGGCAVHEASRESAGNVADANLAEWPATIKRIQQRYPEAEVVIPGHG
LPGGLELLQHTTNVVKTHKVRPVAE
>ABL61511|FEATURES|argannot|beta_lactam|VIM-11|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGSEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ABK63186|FEATURES|argannot|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLTEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AET05999.1|FEATURES|argannot|beta_lactam|VIM-30|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AFP99175|FEATURES|argannot|beta_lactam|VIM-33|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLFGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AFN88953|FEATURES|argannot|beta_lactam|VIM-34|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAISTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AGC50807|FEATURES|argannot|beta_lactam|VIM-37|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHISTQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AKO63212|FEATURES|argannot|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVNAHTNRSVVE
>CAA71321.1|FEATURES|argannot|beta_lactam|CTX-M-3|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAF04388|FEATURES|argannot|beta_lactam|CTX-M-8|antibiotic inactivation|1
MMRHRVKRMMLMTTACISLLLGSAPLYAQANDVQQKLAALEKSSGGRLGVALIDTADNAQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKKVLSQKVEIKSSDLINYNPITEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARAIGDNTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLRNLTLGSALGETQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLILVTYFTQPEQKAESRRDVLAAAAKIVTDGY
>AAF93177|FEATURES|argannot|beta_lactam|CTX-M-11|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAGLERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SPAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRHVLAS
>AAP43783|FEATURES|argannot|beta_lactam|CTX-M-12|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVTDGL
>AAK32961|FEATURES|argannot|beta_lactam|CTX-M-16|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTAGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>CAD08929|FEATURES|argannot|beta_lactam|CTX-M-21|antibiotic inactivation|1
MVTKRVQRMMFAGGAGIPLLLGSAPFYAQTSAGQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAN75444|FEATURES|argannot|beta_lactam|CTX-M-26|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIRAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>AAP43508|FEATURES|argannot|beta_lactam|CTX-M-30|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>BAA28282|FEATURES|argannot|beta_lactam|CTX-M-45|antibiotic inactivation|1
MVTKRVQRMMSAAAACIPLLLGSPTLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTARAGADVASLRWVMRWAKPSGAVGDVAQRQYDRAAGIRAGLPTSWTVGDKTGSGD
YGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ABA62022|FEATURES|argannot|beta_lactam|CTX-M-51|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTAGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ABQ45409|FEATURES|argannot|beta_lactam|CTX-M-66|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGNVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABY91281|FEATURES|argannot|beta_lactam|CTX-M-69|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPNAESRRDVLASAAKIVTNGL
>ACS32294|FEATURES|argannot|beta_lactam|CTX-M-75|antibiotic inactivation|1
MMTQSIRRSMLTVMATLSLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>ABW86620|FEATURES|argannot|beta_lactam|CTX-M-80|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTVDVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ACI29346|FEATURES|argannot|beta_lactam|CTX-M-84|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVAWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACP18863|FEATURES|argannot|beta_lactam|CTX-M-88|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRHDVLASAAKIVTDGL
>ACX34099|FEATURES|argannot|beta_lactam|CTX-M-91|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAVAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQSLRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>ADK11041|FEATURES|argannot|beta_lactam|CTX-M-94|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TLGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>CBL80615|FEATURES|argannot|beta_lactam|CTX-M-95|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAALLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>ADL27532|FEATURES|argannot|beta_lactam|CTX-M-99|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTESTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>ADY02545|FEATURES|argannot|beta_lactam|CTX-M-101|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELIAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ADY02546|FEATURES|argannot|beta_lactam|CTX-M-102|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQREQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AET99223|FEATURES|argannot|beta_lactam|CTX-M-117|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIQGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAM45855|FEATURES|argannot|beta_lactam|bla|antibiotic inactivation|1
MHSRSSYSRRYVLAGLCALPFASLSAGLIFNSSADAASLAAINGKTLQKKLAELEAASGG
RLGVAARSSNGGKSLSYRGDERFPMCSTFKVLAVAALLRDKPGILEQRIHFAQIDIQPWS
PVTEKHLEDGMTVAELCAAMLQHSDNTAANLVLAKLGGPQGLTSLARSFGDTTFRLDRWE
VELNTAIPGDARDTTTPLAMCNTLNGLLCGNLLKAPARERLTGWMLGCATGAGRIPAGIP
QGWRSAHKSGSGENGTANDVGVLLPPSNPGKATKPGKNKGKPLTVALYLTGSRLTGPEND
KILASATRLVCAAEGLAMPLDNMY
>CAG25836|FEATURES|argannot|beta_lactam|LEN-7|antibiotic inactivation|1
ATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVIYLRDTPASMAERNQHIAG
>CAG25834|FEATURES|argannot|beta_lactam|LEN-9|antibiotic inactivation|1
ATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVIYLRDTPASMAERNQHIAG
>CAP12346|FEATURES|argannot|beta_lactam|LEN-18|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAP12351|FEATURES|argannot|beta_lactam|LEN-23|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEHWQR
>ALK01320|FEATURES|argannot|beta_lactam|blaLEN|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMSATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>WP_000465449.1|FEATURES|argannot|beta_lactam|BL3_l|antibiotic inactivation|0
MFFKQFFEKESSTYTYMLGCEETRGAVLIDPVASDIEIYAKELEQHQFTLIYTLDTHVHA
DHITAADLLRERFHCKSVLHRNSEVSCGDILITDGCMLKVGNLSIEARYTPGHTNACTSY
LVGNMIFTGDALLIDGCGRTDFQQGNAGTLYDSIHKQLFSLPDNTIVYPGHDYKGRLSST
IGYERLNNSRLGQNRSREDFIELMNNLNLPYPKQIDKALPANQACGSISQL
>AAZ04783|FEATURES|argannot|quinolone|QnrA4|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>AAZ04784|FEATURES|argannot|quinolone|QnrA5|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>ABX72227.1|FEATURES|argannot|quinolone|QnrB15|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>CAP45903|FEATURES|argannot|quinolone|QnrB18|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AEL31271|FEATURES|argannot|quinolone|QnrB40|antibiotic target protection|1
NTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCN
FSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAY
ITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCD
LTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AEL31272|FEATURES|argannot|quinolone|QnrB41|antibiotic target protection|1
MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS
>AFA52647|FEATURES|argannot|quinolone|QnrB62|antibiotic target protection|1
MTPLLYKKTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>BAD88776.1|FEATURES|argannot|quinolone|QnrS1|antibiotic target protection|1
METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFIS
GCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>AFZ85132|FEATURES|argannot|quinolone|QnrVC1|antibiotic target protection|1
MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFS
YADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYIT
GCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLS
HSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD
>AGH56075|FEATURES|argannot|quinolone|QnrVC4|antibiotic target protection|1
MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFS
YSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYIT
GCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLS
HSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD
>BAF63419|FEATURES|argannot|multidrug|qepA|antibiotic efflux|1
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
ILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAAFFAFASVLAALADTAALLIAARALLG
LAGATIAPSTMALVRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFW
LNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASM
AALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYL
QLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQ
GLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGS
VGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDAL
QATAWAGAVLVLVAAGLVARLLRKRPALASG
>CAA83855|FEATURES|argannot|fosfomycin|FosC|antibiotic inactivation|1
MMTSIMFSMLSDITRIFVEQGLRVYPFQSSALLGVDEEGRVTLHARQLATAMASGYMPLL
TGDLLLRGEQEAQVFSSDNIAPLLAADFEVRRVLYYSDVAGVYDQGNALVPWVGNANAAC
MEACVGASSMTDLTGGMRNKFMQQRQLARLGVVSEVLSFECFDRVHLSLCGLRQFGTVFL
SE
>ACL82960.1|FEATURES|argannot|glycopeptide|vanHM|antibiotic target alteration|1
MVLVMKDIGITIYGSEQDEADVFQEISSRFGVTPTIVSSPISETNVMLAPKNKCISVGHK
SEIHKSILIALKESGVKYISTRSIGYNHIDMKAAEKMGIAVENVTYSPDSVADYTLMLIL
MAIRHTKSTLCSMEKHDFRLNSVRGKVLRDLTVGVLGTGHIGKAVIERLQGFGGHVLAYG
NNKEATANYVSFNELLQKSDILTIHVPLSDDTYHMIGHEQIKAMKQGAFLINTARGGLID
TEVLVKALEDGKLGGAALDVLEGEEGLFYFDCTQKPINNQFLLKLQRMPNVTITPHTAYY
SEKTLRDTVEKTVKNCLEFERRETHE
>ABB53368.1|FEATURES|argannot|glycopeptide|vanRB|antibiotic target alteration|0
MSIRILLVEDDDHICNTVRAFLAEAGYQVDACTDGNEAYTKFYENTYQLVILDIMLPGMN
GHELLREFRAKNDTPILMMTALSDDENQIRAFDAEADDYVTKPFKMQILLKRVEALLRRS
GALAKEIRVGRLTLLPEDFTVLCDGTELPLTRKEFEILLLLVQNKGRTLTHEIILSRIWG
YDFEGDGSTVHTHIKNLRAKLPENIIKTIRGVGYRLEES
>ABX54688.1|FEATURES|argannot|glycopeptide|vanXYL|antibiotic target alteration|1
MDNDYKYYLQLVNKQYPWQINNGSKKMVRVPYTDKEIYLDAVVVEHLIQLIETIQLQEKI
EIVDGYRTIDEQKELWEFSLKDRGKRYTHDYVAYPGCSEHHTGLALDIGLKKTAHDIIAP
KFNGEEAKKFLEHMKDYGFILRYPPNKKKVTGIAYEPWHFRYVGVPHSQIITQQAWTLEE
YIAFLHTVGEKVS
>ABX54689.1|FEATURES|argannot|glycopeptide|vanTmL|antibiotic target alteration|0
MKKQNTGVNNFRLIAAAMVVAIHCFPFQTISKELDTLVTLTVFRIAVPFFFMVSGYYLLG
PIPSSATNTYQINNYIKKQLKVYTFAIVLYLPLAFYSQSITLDMSIISFIKQLLFNGFFY
HLWFFPAWVLGLLIVQFLLKRMNIQTVLFITFVAYLIGLGGDSWWGIVKQVPFFFRFYNA
IFQLFGYTRNGLFYAPLFFALGAYLYKMNIKNFNSARNNYLLLLFSIEMILESYFLHLFN
IPKHDSMYLFLPFVMTLVFIKIYNWSPKNNLLNSSQLSLGVYLIHPYIIAVIHSISIYVS
IFTNSIINYLSVLLISYLTIRLILKRKEW
>ABX54690.1|FEATURES|argannot|glycopeptide|vanTrL|antibiotic target alteration|0
MVENKMRAYKEFYVESLLHNVQVIKKNIPKSTKIMAVVKANAYGINAVNVAIILEYIGID
FFAVATIDEAIALRKNGITSNILILGYTTPTKVDDLIHYELTQTIVSKEHAYFLNKTGKK
IMCHLKVDTGMHRLGVEPTLEEICPIFNYPFLKIKGVYSHLGSADDLSEEGKQRTIKQIS
RYNTIIAELKRKRVDVGLTHLQSSYGILNYSELAYDYVRPGIILYGLLSNNDHNVKLHLD
LQPVVAVKAQLISKKKIAPGEYIGYGTDTQLTSSKTIGVLSIGYADGIPRNLSNGEYCVV
FEDKQIPQIGRICMDMMLVDLSNCSDIPLGVMVDVLPNIEEISQIQSTITNEIISCLGSR
LGMEVK
>ABX54691.1|FEATURES|argannot|glycopeptide|vanRL|antibiotic target alteration|0
MTDRIVVVDDEQEIANLITTFLENEGFQVTTFYKGEDFLTYIARESISLAILDVMLPDID
GFRILQEIRKNFYFPVLMLTAKEENMDKIMGLTLGADDYITKPFNPIEVVARVKTQLRRV
QKYNRKVENESVIEFNKDGLTLKKDSHQVFLFDKEITVTPIEFNLLLYLFEHQGVVVSSE
ELFEAVWKEKYLENNNTIMAHIARLREKLDEQPRKPKFIKTVWGVGYIIEK
>ABB88462.1|FEATURES|argannot|glycopeptide|vanHO|antibiotic target alteration|1
MLPTMSAMTYSEPARSEASRSRSLASAPSSADEARGITIYGCGQDEAVLFKEMAPRFGIM
PTIAEAPVSEATIELASGNRCISVGHKTPISNSILLALREAGVEYISTRSIGFNHIDVKY
AESIGITVGNVAYSPDSVADFTLMLMLMVIRDAKSIIRRTEVHDYRLNAVRGKELRDLTV
GVVGTGRIGVAVMDRLKGFGCRVLAYDTIPNASADYVPLDDLLQQSDIVTLHVPLNTDTY
HLLDRRNIEEMKGGAYIINTGRGPLIETEALISALESGNLGGAALDVLEGEEGIFYADCR
DKAIDGNKPLLRLQELSNVIISPHTAYYTDHALSDTVENSIINCLEFESGK
>ABX79420|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENI
RQDTWLLDTKHTQKIKPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGLFELMK
LPYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQEQIEAFIQTHGFPVFF
KPNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIAGVEIGCGILGNDSLTVGAC
DAISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFV
TDQGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEVK
>AAK58492.1|FEATURES|argannot|glycopeptide|VanRC|antibiotic target alteration|0
MAEKIIVVDDEKEIAELVTTFLRNEGFQVEPFYDGTSALAYLEKETVDVAVLDVMLPDID
GFQLLQQIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRY
QRYNQSANPQKIEEYEKEGLLLKINSHQCFLYGKEVFLTPIEFKILLYLFEHQGSVVASE
TLFEAVWKEKYLDNNNTVMAHIARLREKLNEQPRKPKLIKTVWGVGYIIEK
>ABX79414.1|FEATURES|argannot|glycopeptide|VanXYC|antibiotic target alteration|1
MNPYLQLVSKEFPLEKNQEPPHLVLAAFSEEEVYLQPEAAKQWERLVKALKLENEICLLD
GYRTEKQQRHLWEYSLKENGLAYTKQFVALPDCSEHQLGLAIDVGLKGQQGDLICPRFRD
SVAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIIASQQWTLEEYYQ
YLEQTARQFA
>AAM09849.1|FEATURES|argannot|glycopeptide|vanD|antibiotic target alteration|1
MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWE
NYAGYPAVISPDRRIHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYV
GCDIQSSVICMDKSLAYMVVKNAGIEVPGFRVLQKGDSLEAETLSYPVFVKPARSGSSFG
VNKVCRAEELQAAVTEAGKYDSKILVEEAVSGSEVGCAILGNGNDLITGEVDQIELKHGF
FKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAKKIYRVLGCRGLARIDLFLREDGS
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIGLSLRR
>CAB61227|FEATURES|argannot|glycopeptide|vanA|antibiotic target alteration|1
MNRIKVAILFGGCSEEHDVSVKSAIEIAANIDKEKYETLYIGITKSGVWKMCEKPCVEWE
NDNCCSAVLSPDKKMHGLLVKKNHEYEIDHVDVAFSVLHGKSGEDGSIQGLFELSGIPFV
GCDIQSSAICMDKSLTYIVAENAGIATPEFWVFNKDDKPMADTFTYPVFVKPARSGSSFG
VKKVNGADELDAAIELAGQYDSKILIEQAVLGCEVGCAVLGNSSAFVVGEVDQIRLQHGI
FRIHQEAEPEKGSENAVITVPADLSAEERGRIQETAKKIYNALGCRGLARVDMFLQDNGR
IVLNEVNTLPGFTSYSRYPRMMAAVGIAFPELIDRLIVLALKG
>ACP19235|FEATURES|argannot|glycopeptide|vanHA|antibiotic target alteration|1
MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEIS
ASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVR
NVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRS
IEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYEL
VKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQA
LRDTVEKTIKNCLDFERRQEHE
>AAY67972.1|FEATURES|argannot|glycopeptide|vanSC|antibiotic target alteration|0
MKNRNPLIRKLLTQYFVTTGILLAFLVMIPLVIRFIAGTRTWYGTEPIYYILRFFADRWL
FCVAIGALLIWFGTTIYYMTKAIGYLNETIQATTQLIEEPTKRITLSSHLVDVQEEMNQL
REKSLQDQRAAKEAEQRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPQLSNAMRNRYTEI
ALQKAQRLELLISEFFEITRFNLTTIVLQTETTDLSLMLEQLTFEFLPLLEEKNLNWQLN
LQKNVLATVDTEKIARVFDNLIRNAINYSYPDSPLLLELVESDSIHIRLTNRGKTIPEEM
IGRLFEPFYRMDSSRATATGGTGLGLPIAKEILLASGGDISAESKDETIIFNVRLPKPAN
S
>AAY52011.1|FEATURES|argannot|glycopeptide|vanWB|antibiotic target alteration|1
MTQIFPFLLPVRVMQRKMCFYAGMRFDGRRYAETIDGKQLPYKLFEAGCALYNGNTGFDM
AYQENKVFNLKLAAKTLNGLLIRPGETFSFWRLVRHADKHIPYKDGLTVTNGKLTTAPGG
GLCQMSNLLFWMFLHTPLTVTERSGHEVKEFPEPNSDEIKGVDATISEGWIDLKARNGTD
CTYQISVAFDDENIIGTVFVDKRPQVLYRVANGGIEYSRESGGIYESVKVERAEIDSDTG
EITGQKPLYTNKCKICYPLPENVEIKEAKKV
>ABB88464.1|FEATURES|argannot|glycopeptide|vanXO|antibiotic target alteration|1
MKDDFVFVDEVVPGIRWDAKYATWDNFTGKPVDGYLVNRVVGTRAFCAALEKAREKAESL
GFGLLLWDVYRPQRAVDCFMRWAEQPEDGRKKLRHYPNIDRPQMFEKGYVATKSGHSRGS
TVDLTLYHLDTGELADMGGDHDVMDVVSHHGAAGITPEQEKNREHLCSIMVDSGFGSYEF
EWWHYNLKNEPYPDTYFDFPIAGS
>AAD19836.1|FEATURES|argannot|glycopeptide|vanX|antibiotic target alteration|1
MRDDFVFVDEVVSGIRWDAKYATWDNFTGKPVDGYLVNRVVGTRAFCAALEKARDKAAEL
GFGLLLWDVYRPQRAVDRFMRWAEEPEDGRKKARHYPNIERPQMFEQGYVATKSGHSRGS
TVDLTLYRLDTGELADMGGDHDLMDVVSHHGADGVPEEAAKNRAHLCAIMEGSGFSSYEC
EWWHYNLKDEPYPDTYLDFPIE
>CAB45463|FEATURES|argannot|glycopeptide|vanX|antibiotic target alteration|1
MTGDFAFVDELVSGIRWDAKYATWDNFTGKPVDGYLANRIVGTKALCAALGRAQERAEDL
GFGLLLWDGYRPQRAVDCFLRWSQQPEDGRTKARHYPNIGRAEMFDRGYVAARSGHSRGA
TVDLTLYHLTTGELAAMGGGHDLMDPISHHDARDVPRAEAANRRHLRSIMAACGFASYAC
EWWHYTLKEEPHPDTYFDFPIA
>AAF36806.1|FEATURES|argannot|glycopeptide|vanZF|antibiotic target alteration|0
MLTPLTVLYTYFCTIIFCIVFQIGFFFKALKNISIRHFLWVYVFLFYLALVYMMTGIGNV
WVVGRYETLIRVSEINLLPFSSEGVTTYILNIILFMPLGFLLPTIWPQFRTIKNTACTGF
FFSLAIELTQLLNHRITDIDDLLMNTLGAIIGYLLYRAFKMIYTRDEKKLDNKSSLVIKY
EAIFYIVCSFIGMILLYYPFLLRKII
>AAL27442|FEATURES|argannot|glycopeptide|vanE|antibiotic target alteration|1
MKTVAIIFGGVSSEYEVSLKSAVAIIKNMESIDYNVMKIGITEEGHWYLFEGTTDKIKKD
RWFLDESCEEIVVDFAKKSFVLKNSKKIIKPDILFPVLHGGYGENGAMQGVFELLDIPYV
GCGIGAAAISMNKIMLHQFAEAIGVKSTPSMIIEKGQDLQKVDAFAKIHGFPLYIKPNEA
GSSKGISKVERKSDLYKAIDEASKYDSRILIQKEVKGVEIGCGILGNEQLVVGECDQISL
VDGFFDYEEKYNLVTAEILLPAKLSIDKKEDIQMKAKKLYRLLGCKGLARIDFFLTDDGE
ILLNEINTMPGFTEHSRFPMMMNEIGMDYKEIIENLLVLAVENHEKKLSTID
>AID65165|FEATURES|argannot|macrolide-lincosamide-streptogramin|EreA2|antibiotic inactivation|1
MTWRTTRTLLQPQKLEFNEFEILNPVVEGARIVGIGEGAHFVAEFSLARASLIRYFVERH
DFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSLYGSVLIWVKSYLRESGRKL
QLVGIDLPNTLNPRDDLAQLAEIIQVIDHLMKPHVDALTQLLTSIDGQSAVISSAKWGEL
ETAQQEKAISGVTRLKLRLASLAPVLKNHVNSDFFRKASDRIESIEYTLETLRVMKAFFD
GTSLEGDTSVRDSYMAGVVDGMVRANPDVRIILLAHNNHLQKTPVSFSGELTAVPMGQHL
AEREEGDYRAIAFTHLGLTVPEMHFPSPDSPLGFSVVTTPADAIREDSVEQYVIDACGKE
DSCLTLTDDPMEAKRMRSQSASVETNLSEAFDAIVCVPSAGKDSLVAL
>CAA27626|FEATURES|argannot|macrolide-lincosamide-streptogramin|EreB|antibiotic inactivation|1
MRFEEWVKDKHIPFKLNHPDDNYDDFKPLRKIIGDTRVVALGENSHFIKEFFLLRHTLLR
FFIEDLGFTTFAFEFGFAEGQIINNWIHGQGTDDEIGRFLKHFYYPEELKTTFLWLREYN
KAAKEKITFLGIDIPRNGGSYLPNMEIVHDFFRTADKEALHIIDDAFNIAKKIDYFSTSQ
AALNLHELTDSEKCRLTSQLARVKVRLEAMAPIHIEKYGIDKYETILHYANGMIYLDYNI
QAMSGFISGGGMQGDMGAKDKYMADSVLWHLKNPQSEQKVIVVAHNAHIQKTPILYDGFL
SCLPMGQRLKNAIGDDYMSLGITSYSGHTAALYPEVDTKYGFRVDNFQLQEPNEGSVEKA
ISGCGVTNSFVFFRNIPEDLQSIPNMIRFDSIYMKAELEKAFDGIFQIEKSSVSEVVYE
>CAB37345|FEATURES|argannot|macrolide-lincosamide-streptogramin|tlrB|antibiotic target alteration|1
MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAA
RAALLDSGHYAPLTERLAGTARRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLD
MSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLL
VVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVV
AMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP
>CAC86410.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(33)|antibiotic target alteration|1
MNKKNIKDSQNFITSKRNIDKIMTNISLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYNIFGNIPYNISTDIVKRITFESQA
KYSYLIVEKGFAKRLQNLQRALGLLLMVEMDIKMLKKVPPLYFHPKPSVDSVLIVLERHQ
PLISKKDYKKYRSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYK
LFH
>AAK07612|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(35)|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIKESNINQHDTVLDIGAGKGFLTVHLLKNVDKVIA
IENDVALSQHLRKKFIHAQNVQVVSCDYRNFVVPKVPFKVVSNIPFGITSDIFSSLMFEN
VEYFLCGSIILQSEPAKKLFSSKVYNPLTVLYHTYYDLKFLYEINPESFLPPPTVKSALL
RIERKQISLDIGLKVKYLNFVSYMLQKPDLTVKTAMKSIFRKKQVRSISEKFGVDLNSKI
VCLTPNQWKNCFLEMLEVVPEKFHPS
>CAA66307|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmN|antibiotic target alteration|1
MPSRPRTDSPHRHEGPAGPARLDRDEARRVWGQNFFRSAGSARRFARQLTGAESAGNDSV
TVEVGPGAGRITKELVRDGHPIVAVEVDPHWADRLAELELPNLTVVNDDFTTWPLPDGPL
RFIGNLPFGTGTRMLRRCLALGPDRCREGVFLLQKQYTRKRTGAYGGNLFNAQWEPWYTF
RRGLGFPRQEFAPVPGSDTETLLVRSRPRPLAPWSRHAAYQRFVEDVFNTSRLTIGEAAR
ALDRRAGPGWLRGARVPPGLRVKDITAEQWADLFHACTPPPARRISPQRRR
>BAB20748|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmY|antibiotic target alteration|1
MNKKDIKFSQNFITSKRHINKIMSNLELNRNDNVFEIGSGKGHFTLELVQKCNYVTVIEI
DSNLCIQTQNKVTNYDNFRIINKDILQFKFPNNKAYKIYGNIPYYISTDIVRKIVFESEA
TVSYLIVEEGFAKRLLNTNRSLALLLMTEVDISILSKIPKEYFHPKPKINSSLIILKRHP
SKISYKDKKMYNNFVMKWVNQEYSKLFTKNQFNKALNYAKIKDLKNINFEQFLSVFNSYK
LFNN
>AAY32951|FEATURES|argannot|macrolide-lincosamide-streptogramin|lnuC|antibiotic inactivation|1
MVNITDVNQIFQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMK
ANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETLSGKGRIEE
IEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETLHIEIPNEYR
>AAO43110|FEATURES|argannot|multidrug|lsaA|antibiotic target protection|1
MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGE
ILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGG
EKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVV
DHILAIEKSQLTLYQGDFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNR
EGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPL
SMDYQPTHHKTLLTVEELRLGYEKNWLFTPISFSINAGEIVGITGKNGSGKSSLIQYLLG
DFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVF
TNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVRPAMLVIE
HDAHFMKKITDKKIALKS
>AAC44785|FEATURES|argannot|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLDPNFIREMQEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSALFADRIGVNHWFLLSGTLIICIAIVCPMINEIRKLDLK
>AEG42376.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|msrE|antibiotic target protection|1
MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEAT
LQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHG
ILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGG
YSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAG
RLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITAD
GLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYF
TQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLS
KMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKD
HKIIKTFERDC
>AAA24783|FEATURES|argannot|macrolide-lincosamide-streptogramin|vatD|antibiotic inactivation|1
MGPNPMKMYPIEGNKSVQFIKPILEKLENVEVGEYSYYDSKNGETFDKQILYHYPILNDK
LKIGKFCSIGPGVTIIMNGANHRMDGSTYPFNLFGNGWEKHMPKLDQLPIKGDTIIGNDV
WIGKDVVIMPGVKIGDGAIVAANSVVVKDIAPYMLAGGNPANEIKQRFDQDTINQLLDIK
WWNWPIDIINENIDKILDNSIIREVIWKK
>AAF63432|FEATURES|argannot|macrolide-lincosamide-streptogramin|vatF|antibiotic inactivation|1
MEDKPILGPDPQCKHPMVGFSQVCFIKNTTQNPNIIIGDYTYYDDPQDSENFERNVLYHY
PFIGDKLIIGKFCALAHGVKFIMNGANHKMSGLSTYPFNIFGNGWERVAPSRDELPYKGD
THVGNDVWIGYDVLIMPGVTIGNGAIISSRSVVTRDVPAYSVVGGNPATLIKNRFSAEVI
GKLQTIAWWDWPIDAISRNLHLIVAGDIEALARAASEIDHT
>ABH10964|FEATURES|argannot|macrolide-lincosamide-streptogramin|vgaALC|antibiotic target protection|1
MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGI
VKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQ
DLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYE
KYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGKIKVTKPYFASKQKKLRKTVKSLET
RLEKLERVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDK
MAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQN
ETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAI
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
EDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>AAF24087|FEATURES|argannot|macrolide-lincosamide-streptogramin|VgbA|antibiotic inactivation|1
MEFKLQELNLTNQDTGPYGITVSDKGKVWITQHKANMISCINLDGKITEYPLPTPDAKVM
CLTISSDGEVWFTENAANKIGRITKKGIIKEYTLPNPDSAPYGITEGPNGDIWFTEMNGN
RIGRITDDGKIREYELPNKGSYPSFITLGSDNALWFTENQNNAIGRITESGDITEFKIPT
PASGPVGITKGNDDALWFVEIIGNKIGRITPLGEITEFKIPTPNARPHAITAGAGIDLWF
TEWGANKIGRLTSNNIIEEYPIQIKSAEPHGICFDGETIWFAMECDKIGKLTLIKDNME
>CAA23899.1|FEATURES|argannot|chloramphenicol|catI|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>AAA26615|FEATURES|argannot|chloramphenicol|cat|antibiotic inactivation|1
MTFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLF
EYKDKEEMFPKKPIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSENNKIY
IPVALQLHHAVCDGYHASLFINEFQDIIKKVDDWI
>AAA22081|FEATURES|argannot|chloramphenicol|cat|antibiotic inactivation|1
MENYFESPFRGITLDKQVKSPNLVVGKYSYYSGYYHGHSFEDCARYLLPDEGADRLVIGS
FCSIGSGAAFIMAGNQGHRNEWISTFPFFFMPEVPEFENAANGYLPAGDTVIGNDVWIGS
EAIIMPGITVGDGAVIGTRALVTKDVEPYAIVGGNPAKTIRKRFDDDSIALLLEMKWWGW
PAERLKAAMPLMTSGNVAALYRFWRSDSL
>AAA23215|FEATURES|argannot|chloramphenicol|catQ|antibiotic inactivation|1
MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANIEITGLLREIKLKGLKLYPTLIYIITT
VVNRHKEFRTCFDQKGKLGYWDSMNPSYTVFHKDNETFSSIWTEYDENFPRFYYNYLEDI
RNYSDVLNFMPKTGEPANTINVSSIPWVNFTGFNLNIYNDATYLIPIFTLGKYFQQDNKI
LLPMSVQVHHAVCDGYHISRFFNEAQELASNYETWLGEK
>CAA52904|FEATURES|argannot|chloramphenicol|catS|antibiotic inactivation|1
FTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQEGELGIYDEM
IPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDIPENVFNVSM
IPWSTFDSFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQV
>EIN87433|FEATURES|argannot|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTYFVFFSTATRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>BAB43543.1|FEATURES|argannot|chloramphenicol|cmx|antibiotic efflux|1
MSIMRLFTFILSIFIVGMVEMMVAGIMNLMSQDLHVSEAVVGQLVTMYALTFAICGPILV
KLTNRFSSRPVLLWTLLIFIIGNGIIAVAPNFSILVVGRIISSAAAALIIVKVLAITAML
SAPKNRGKMIGLVYTGFSGANVFGVPIGTVIGDLVGWRYTFLFLIIVSIIVGFLMMIYLP
KDQEIQRGPVNHEAPSHENHVTSKILRPAEVAKYLIITFLVLIANSVTFVFINPLILSNG
HDMSFVSLALLVNGIAGVIGTSLGGIFSDKITSKRWLMISVSIFIVMMLLMNLILPGSGL
LLAGLFIWNIMQWSTNPAVQSGVIQHVEGDTSQVMSWNMSSLNAGIGVGGIIGGLVMTHV
SVQAITYTSAIIGALGLIVVFTLKNNHYAKTFKSS
>CAZ48628|FEATURES|argannot|rifampin|arr-7|antibiotic inactivation|1
MPNDWIPTSHENCSLVPGPFYHGTKAKLAIGDLLSPGHPSHFEQGRRLKHIYFAALMEPA
IWGAELAMSLSRQEGRGYIYIVEPLGPFEDDPNLTNKKFPGNPTKSYRTSESLRIVEVVE
DWQGHSPDVLQGMLASLEDLQRRGLAIIED
>ABZ82584.1|FEATURES|argannot|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>BAA07390|FEATURES|argannot|tetracycline|tcr3|antibiotic efflux|1
MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQ
LHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMET
LAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGA
GEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIV
AEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFT
IGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAI
VGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVAN
AASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAF
TSGFDTMFLVGGLILAVGFLLTFPLRELRDEE
>BAB59035|FEATURES|argannot|tetracycline|tet34|antibiotic target alteration|1
MSKKFIITWDAMQNYCRQLAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRHVDTICI
SSYDHDHQRDMTVLKAPEGDGEGYLIVEDLVDSGDTARKLREMYPKAKLIAVCAKPSGAT
LLDDYVVDIAQDTWIEQPWDTTVQFVEPINRKQK
>AAK37619|FEATURES|argannot|tetracycline|tet35|antibiotic efflux|1
MCVIMPASSWGAYIITIIGGILVSHGITEYSALGAYVRLIPMNFYAVFALLMVFAVAWFG
LDIGKMREHEIAASQGRGFDKDKENDSQEAHDLNEELDIRESEKGKVSDLILPIVTLIVA
TIASMLYTGGQALAADGKEFVLLGAFENTDVGTSLIYGSLLGLAVALFTVIKQGLPMVEI
ARTLWIGAKSMFGAILILVFAWTIGSVIGDMKTGSYLSTMAQGNINPHWLPVILFLLSGL
MAFSTGTSWGTFGIMLPIAGDMAGATDVALMLPMLSAVLAGAVFGDHCSPISDTTILSST
GARCNHIDHVSTQLPYALSVAFVSCIGFITLGMTASIAFSFIAASITFVIVCAILSWLSK
SKMASCQNA
>BAC67142|FEATURES|argannot|tetracycline|tetB|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLRELIASEDIANHLGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLNNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>ABI30354|FEATURES|argannot|tetracycline|tetE|antibiotic efflux|1
MNRTVMMALVIIFLDAIGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPL
LGRWSDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIAD
VTPEESRTHWFGMMGACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILH
ETHNANQVSDEIKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERF
AWDGVMVGVSLAVFGLTHALFQGLAAGFIAKHLGEQRAIVVGILADGCGLLLLAVITQSW
MVWPVVLLLACGGITLPALQGIISVRVGQVAQGQLQGLLTSLTHLTGVIGPLIFAFLYSA
THESWNGWVWIVGCGLYVVALTILRFFYPGRAVHPKNQSNSQPFL
>CBA13543.1|FEATURES|argannot|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFML
TFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITII
TVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHI
RKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIF
PGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLG
GLSFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPM
EVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRDF
>AAA73978|FEATURES|argannot|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKRIENPHPLLQITVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTECKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>AAS66087.1|FEATURES|argannot|trimethoprim|dfrA21|antibiotic target replacement|1
MNPESVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTESKVVVMGRKTFESIGKPL
PNRHTVVLSRQARYSAPGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPHANGVFL
SEVHQTFEGDAFFPVLNAAEFEVVSSETIQGTITYTHSVYARRNG
>CAF31623.1|FEATURES|argannot|trimethoprim|dfrA22|antibiotic target replacement|1
MNPELVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
PNRRTVVLSRQASYSAAGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPRADGVFL
SEVHQTFEGDAFFPVLDEAEFEVVSAETVQATITYTHSVYARRNG
>AAA25550|FEATURES|argannot|trimethoprim|dfrA3|antibiotic target replacement|1
MLISLIAALAHNNLIGKDNLIPWHLPADLRHFKAVTLGKPVVMGRRTFESIGRPLPGRRN
VVVSRNPQWQAEGVEVAPSLDAALALLTDCEEAMIIGGGQLYAEALPRADRLYLTYIDAQ
LNGDTHFPDYLSLGWQELERSTHPADDKNSYACEFVTLSRQR
>CAT00052|FEATURES|argannot|trimethoprim|dfrB3|antibiotic target replacement|1
MNEGKNEVSTSAAGRFAFPSNATFALGDRVRKKSGAAWQGRIVGWYCTTLTPEGYAVESE
SHPGSVQIYPMTALERVA
>AAX46054|FEATURES|argannot|trimethoprim|dfrB6|antibiotic target replacement|1
MDQGRSEVSNPVAGQFAFPSNAAFGMGDRVRKKSGAAWQGQIVGWYCTKLTPEGYAVESE
AHPGSVQIYPVAALERIN
>AIS67611.1|FEATURES|CARD|beta_lactam|CTX-M-155|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTAPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASGAKIVTDGL
>AAG15269.1|FEATURES|CARD|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQHQPDSDYLGNLLRSKTFIALAAFD
QEAVVGALAAYVLPRFEQPRSEIYIYDLAVSGEHRRQGIATALINLLKHEANALGAYVIY
VQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>NP_459349.1|FEATURES|CARD|multidrug|golS|antibiotic efflux|0
MNIGKAAKASKVSAKMIRYYEQIGLIPAASRTDSGYRAYTQADVNQLHFIRRARDLGFSV
AEISDLLNLWNNQSRQSADVKRLAQTHIDELDRRIQNMQHMAQTLKALIHCCAGDALPDC
PILHTLGQPDDSEPEARTGAVLRRPRRHGLAKRL
>AHN53381.1|FEATURES|CARD|beta_lactam|OXA-391|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAA90432.1|FEATURES|CARD|fusidic_acid|fusH|antibiotic inactivation|0
MLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAFTARLHIGEGDT
LRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGIVEVVPRDDRDV
AMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWAPDQLHTGEFRVDSVTGTTV
ELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRTGAVDARADGLA
DWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRVMSGGWGLFVTW
KDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWGRFIDGSDLGRL
YFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWKDLGRLYFADVD
GDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLEFGDATGDGKAD
LLVRTKDGKVALRTNHGTYWDQGKFMITL
>AAK82652.1|FEATURES|CARD|beta_lactam|TEM-102|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFVRPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAAVGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AJA32744.1|FEATURES|CARD|beta_lactam|OXA-426|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDFARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQEVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAI76927.1|FEATURES|CARD|beta_lactam|SHV-12|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAA
>AGC29882.1|FEATURES|CARD|rifampin|arr-8|antibiotic inactivation|1
MIKDWIPTTHENCKKMQGPFYHGTKAKLSVGELLTTGFNTHFEEGRTLKHVYFSAMLEPA
IWGAELAVSLSGLDGRGYIYLVEPTGPFEDDPNLTNKKFPGNPTMSYRTSEPLQIVGVVE
EWEGHSAEALKAMLDSLENLERNGLHVIYD
>AEP40500.1|FEATURES|CARD|glycopeptide|vanN|antibiotic target alteration|1
MKKIALIFGGTSAEYEVSLKSAASVLSVLENLNVEIYRIGIASNGKWYLTFSDNETIAND
LWLQDKKLNEITPSFDGRGFYDQAEKVYFKPDVLFPMLHGGTGENGTLQGVFECMQIPYV
GCGVASSAICMNKYLLHQFAKSVGVMSTPTQLISSTDEQQVIKNFTELYGFPIFIKPNEA
GSSKGISKVHTEAELTKALTEAFQFSQTVILQKAVSGVEIGCAILGNDQLLVGECDEVSL
ATDFFDYTEKYQMTTAKLTVPAKIPVATSREIKRQAQLLYQLLGCQGLARIDFFLTEAGE
ILLNEINTMPGFTNHSRFPAMMAATGITYQELISTLITLAEDK
>AAD23513.1|FEATURES|CARD|beta_lactam|CfxA2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>ADM92606.1|FEATURES|CARD|multidrug|adeS|antibiotic efflux|0
MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVD
WIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMS
ELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSL
LNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDL
TSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRD
DLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIKYSNQGSKSVFTIKISMGHEEM
G
>CAC04522.1|FEATURES|CARD|beta_lactam|OCH-1|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNSGALAASKVNDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMRDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPASQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLEGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKT
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>AGD91915.1|FEATURES|CARD|beta_lactam|OXA-232|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTSIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>AGW83446.1|FEATURES|CARD|beta_lactam|OXA-348|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNMVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTDYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWEKDMTLS
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AFC95894.1|FEATURES|CARD|beta_lactam|OXA-199|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEYKSQGVVALWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVGSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>AAP93847.1|FEATURES|CARD|beta_lactam|LEN-14|antibiotic inactivation|1
SLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFK
VLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCAAAITLSDNC
AGNLLLATVGGPAGLTAFLRQIGDNVTRLDRW
>AAA99503.1|FEATURES|CARD|bacitracin|bcrC|antibiotic target alteration|0
MSFSELNIDAFRFINDLGKEYSMLNPVVYFLAEYMMYFLALGLVVYWLTRTTKNRLMVIY
AVIAFVVAEILGKIMGSLHSNYQPFATLPNVNKLIEHEIDNSFPSDHTILFFSIGFLIFL
FHKKTGWLWLVLAFAVGISRIWSGVHYPLDVAAGALLGVLSALFVFWTAPKLSFIHQMLS
LYEKVEQRIVPSKNKSNDKSKNF
>WP_024565805.1|FEATURES|CARD|beta_lactam|BlaB|antibiotic inactivation|1
MKKIKISLILALGLTSLKAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVTD
KGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTK
MTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCI
IKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQHTLDLINEY
QQKQKASN
>AIT76086.1|FEATURES|CARD|beta_lactam|ACT-30|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMIAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYARGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQVGIVMLA
NKSYPNPARVEAAYHILDALQ
>AGH70380.1|FEATURES|CARD|beta_lactam|CMY-98|antibiotic inactivation|1
MAAQSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMGYEEAMTKRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSLVDMTRWIQANMDASQVQEKTLRQGIEIAQARYWHIGDMYQGLGWEMLNWPVNA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRI
>AGZ83154.1|FEATURES|CARD|beta_lactam|OXA-358|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSQEVKRVGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL
>AJO16038.1|FEATURES|CARD|beta_lactam|OXA-366|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTAQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ABG49324.1|FEATURES|CARD|aminoglycoside|aadA9|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLDMMSNSIHTGISRQLSQARDVIKRHLASTLKAIHLYGSAID
GGLKPYSDIDLLVTVDARLDEATRRSLMLDFLNISAPPCESSILRPLEVTVVACNEVVPW
RYPARRELQFGEWLREDILEGVFEPAALDADLAILITKARQHSIALVGPVAQKVFMPVPE
HDFLQVLSDTLKLWNTHEDWENEERNIVLTLARIWYSTETGGIVPKDVAAEWVLERLPAE
HKPILVEARQAYLGLCKDSLALRADETSAFIGYAKSAVADLLEKRKSQTSHICDGAKNV
>CCI51002.2|FEATURES|CARD|quinolone|QnrB54|antibiotic target protection|1
MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>ALX99516.1|FEATURES|CARD|multidrug|adeC|antibiotic efflux|0
MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKMIAEKSYKEFIS
DPKLLQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRVAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYKAGV
DSYFTVLDAQRSAYAAQQGLLALEQIKLNNQIEIYKVLGGGISKV
>BAJ09383.1|FEATURES|CARD|quinolone|qacA|antibiotic efflux|1
MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELDPSGTQQLWIV
DIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIA
GALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLIN
VPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIP
WVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQW
LQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFF
GHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAV
LGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFND
AFVATALVGGIIMIIISIVVYLLIPKSLDITKQK
>AGW83450.1|FEATURES|CARD|beta_lactam|OXA-352|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTDYIPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGRKIYAKSGWGWDIEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>CAB14620.1|FEATURES|CARD|aminoglycoside|aadK|antibiotic inactivation|1
MRSEQEMMDIFLDFALNDERIRLVTLEGSRTNRNIPPDNFQDYDISYFVTDVESFKENDQ
WLEIFGKRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPIREAEDYFANNDGL
VKVLLDKDSFINYKVTPNDRQYWIKRPTAREFDDCCNEFWMVSTYVVKGLARNEILFAID
HLNEIVRPNLLRMMAWHIASQKGYSFSMGKNYKFMKRYLSNKEWEELMSTYSVNGYQEMW
KSLFTCYALFRKYSKAVSEGLAYKYPDYDEGITKYTEGIYCSVK
>AHL39338.1|FEATURES|CARD|beta_lactam|ACT-25|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILKALQ
>AHA41504.1|FEATURES|CARD|glycopeptide|vanSO|antibiotic target alteration|0
MLAGVLLLAAVWVFLLRGRSTNFQFPALADFARVFDPSNFGPVVFVPAAILALGFLLVFG
LVGGWILAGRMLAPLARITRAAREAGSGSLSYRIELEGRNDEFRELADAFDAMLARLEAR
DAAQQRFAANASHELRTPLAITQTLLDVARNDPNRDGGELDERLRAVNARAIELTEALLL
LSRTDQRSFSREDVDLSLIAEEAAETLLPFAEKHGVSIETSGDIAPVIGSHALLLQLTTN
LLHNAIVHNVPEHGSVQISTAIGSESVMLTVENTGDKLSPQLVSTLTEPFQRGTARTRGD
DARVGLGLAIVKSITQAHDGSLTLSPRAAGGLSVAVRLPAAQRRP
>AAD12162.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|tlrB|antibiotic target alteration|1
MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAA
RAALLDSGHYAPLTERLAGTAGRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLD
MSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLL
VVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVV
AMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP
>AAB05623.1|FEATURES|CARD|glycopeptide|vanSB|antibiotic target alteration|0
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRAMEAQQTVKSYQPLVELIQNSD
RLDMQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNADTSNSVRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKEVP
PPLERKDELGALAHDMHSMYIRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
AVSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKTISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPKLIQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKYRLSVLNMGVHIDDTALSKLFIPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPPTSTL
>ABB59946.1|FEATURES|CARD|beta_lactam|CTX-M-82|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFPMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AIL92328.1|FEATURES|CARD|beta_lactam|CARB-19|antibiotic inactivation|1
MKKLFLLAGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>AAC76296.1|FEATURES|CARD|multidrug|acrS|antibiotic efflux|0
MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFN
EMWLQQPSLRELIQEHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFN
DEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMN
MAGYDLYKQAPALVDNVLRMFMPDENITKLIHQTNELSVM
>AFR46590.1|FEATURES|CARD|quinolone|QnrB59|antibiotic target protection|1
MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>BAA11237.1|FEATURES|CARD|multidrug|emrY|antibiotic efflux|1
MAITKSTPAPLTGGTLWCVTIALSLATFMQMLDSTISNVAIPTISGFLGASTDEGTWVIT
SFGVANAIAIPVTGRLAQRIGELRLFLLSVTFFSLSSLMCSLSTNLDVLIFFRVVQGLMA
GPLIPLSQSLLLRNYPPEKRTFALALWSMTVIIAPICGPILGGYICDNFSWGWIFLINVP
MGIIVLTLCLTLLKGRETETSPVKMNLPGLTLLVLGVGGLQIMLDKGRDLDWFNSSTIII
LTVVSVISLISLVIWESTSENPILDLSLFKSRNFTIGIVSITCAYLFYSGAIVLMPQLLQ
ETMGYNAIWAGLAYAPIGIMPLLISPLIGRYGNKIDMRLLVTFSFLMYAVCYYWRSVTFM
PTIDFTGIILPQFFQGFAVACFFLPLTTISFSGLPDNKFANASSMSNFFRTLSGSVGTSL
TMTLWGRRESLHHSQLTATIDQFNPVFNSSSQIMDKYYGSLSGVLNEINNEITQQSLSIS
ANEIFRMAAIAFILLTVLVWFAKPPFTAKGVG
>AAL68923.1|FEATURES|CARD|beta_lactam|TEM-110|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>YP_002325052.1|FEATURES|CARD|multidrug|abeS|antibiotic efflux|0
MSYLYLAIAIACEVIATSALKASQGFTVPIPSIITVVGYAVAFYLLSLTLKTIPIGIAYA
IWSGAGIILISAIGWIFYKQHLDLAACIGLALMIAGIVIINVFSKNTHL
>BAA11236.1|FEATURES|CARD|multidrug|emrK|antibiotic efflux|0
MELEDMISTDDAYVTGNADPISAQVSGSVTVVNHKDTNYVRQGDILVSLDKTDATIALNK
AKNNLANIVRQTNKLYLQDKQYSAEVASARIQYQQSLEDYNRRVPLAKQGVISKETLEHT
KDTLISSKAALNAAIQAYKANKALVMNTPLNRQPQVVEAADATKEAWLALKRTDIKSPVT
GYIAQRSVQVGETVSPGQSLMAVVPARQMWVNANFKETQLTDVRIGQSVNIISDLYGENV
VFHGRVTGINMGTGNAFSLLPAQNATGNWIKIVQRVPVEVSLDPKELMEHPLRIGLSMTA
TIDTKNEDIAEMPELASTVTSMPAYTSKALVIDTSPIEKEISNIISHNGQL
>AGW16414.1|FEATURES|CARD|beta_lactam|OXA-332|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSKDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AAO82019.1|FEATURES|CARD|glycopeptide|vanVB|antibiotic target alteration|0
MFTEKFCADGICFIMRAKNEIDHIFSELYSVPNCLQKPYFKLKVQELLLFLCMPLVICTP
ILIGFAILIPYLCFKNLEKRSIVNRLRAEQKENQQKQVVLALLIHSELFDSGFR
>ACI31326.1|FEATURES|CARD|aminoglycoside|AAC(6')-29b|antibiotic inactivation|1
VSILPVKEQDAADWLALRNLLWLADDHASEIEQYFSGGFEEPAEVLIARDATGAAVGHVE
LSIRHDLEELQGIKTGYIEGLYVAPSHRSTDLVRRFLRESEKWALEQGCSAFASDRSDRV
ITHRKFAGSAV
>ADE08533.1|FEATURES|CARD|beta_lactam|SHV-129|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAELDQQIAGIGAALIEHWQR
>NP_848167.1|FEATURES|CARD|chloramphenicol|catB2|antibiotic inactivation|1
MTNYFESPFKGKLLTEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDQLIIG
SFCSIGSGAAFIMAGNQGHRYDWVSSFPFFYMNEEPAFAKSVDAFQRAGDTVIGSDVWIG
SEAMIMPGIKIGHGAVIGSRALVTKDVEPYTIVGGNPAKSIRKRFSEEEISMLLDMAWWD
WPLEQIKEAMPFLCSSGIASLYRRWQGTSA
>AEL00450.1|FEATURES|CARD|quinolone|QnrB32|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>ABX54692.1|FEATURES|CARD|glycopeptide|vanSL|antibiotic target alteration|0
MKSKAETTTIKQILIKYLVTIGLSMLAYLVFLLTILIIMRNFVWDGTEPIYRVLHFFYRL
FNFEGILIIGVILILFVVTLFFVMKIIGYLKQIIEATKQLLEKPEQRVKLSSGLFELQEE
MNQLREKNNADNRAAKEAEKRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPEISVQTRAK
YTNIALSKAFRLEELLSEFFDVTRFNLTNLTINEELVDLSVMLEQISYEFLPILEEKKLS
WNLHVESNIKSLLDPGKMERVFDNLMRNAINYSFEDTIIDLSLEKKESQAIFKITNRTYT
IPKEKLEKIFEPFYRMDTSRSSSTGGTGLGLPIVREIIEASKGTINVSSSNNEMTFIIYL
PYID
>AAP93848.1|FEATURES|CARD|beta_lactam|LEN-6|antibiotic inactivation|1
MISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVST
FKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSD
NSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETE
>AHA41499.1|FEATURES|CARD|glycopeptide|vanHO|antibiotic target alteration|1
MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPS
ITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAA
SIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGV
IGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHL
LDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNR
LIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA
>AAB41958.1|FEATURES|CARD|multidrug|OprJ|antibiotic efflux|0
MRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSFIVD
AELRRLVDMALDNIRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADLSAG
NRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQAYL
SYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERNLRQ
KQQAFNALVLLLGSDDAAQAIPRSPGQRPKLLQDIAPGTPSELIERRPDILAAEHRLRAR
NADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSCSFLPTLTLPIFDGGRNRANLS
LAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKARYE
SGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGGRS
>AAL08441.1|FEATURES|CARD|chloramphenicol|catI|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SXDVACYGENLAYFPKXFXENMXFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>NP_052167.1|FEATURES|CARD|chloramphenicol|cat|antibiotic inactivation|1
MTFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLF
EYKDKEEMFPKKAIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSENNKIY
IPVALQLHHAVCDGYHASLFINEFQDIINKVDDWI
>AIT76103.1|FEATURES|CARD|beta_lactam|DHA-17|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAVVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>CAD70268.1|FEATURES|CARD|multidrug|fexA|antibiotic efflux|1
MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSW
IVSGIALVLAIGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQG
AGMSAIPVLSIIAISKVFPQGKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWF
TFLLAIMIVIGAYYALPTIKPAESVGSNKNFDFIGGLFLGLTVGLLLFGITQGETSGFSS
FSSLTSLIGSVVALVGFIWRIVTAENPFVPPVLFNNKDYVNTVIIAFFSMFAYFAVLVFV
PLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRFGDKRLIITGMTLMGLSTLFL
STYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIFQGALYLGAGT
GAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG
>AAG24866.1|FEATURES|CARD|beta_lactam|OXA-36|antibiotic inactivation|1
MFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFDPVRSKKRYSPA
STFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAKE
IGDDKARRYLKKIDYGNAYPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQR
LVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREA
IVRAIL
>AAC32027.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|carA|antibiotic target protection|1
MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNG
AVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQD
PELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLAL
AATLASEPELLLLDEPTNDLDDRAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEID
SGKVMRYGNGYEGYLAAKAAERQRRLLEYEQWRAELDRSRDLIASNVARLDAIPRKLPFA
VFGAGQFRMRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLTFTAEITTEAAQSRETVA
ELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSGRVGH
LRQEQTPWRPGMTVLQAFSSGRAGDIDEHTEALLSLGLFSPDDLRQRVQDLSYGQRRRIE
LARLVTEPVDLLLLDEPTNHLSPALVEELEEALTGYQGTVVVVTHDRRMRSRFNGAHLTL
QDGRVAEFTAA
>AGU69254.1|FEATURES|CARD|beta_lactam|OXA-316|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMEASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPHG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AGL43631.1|FEATURES|CARD|quinolone|QnrB70|antibiotic target protection|1
MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>NP_373280.1|FEATURES|CARD|beta_lactam|mecI|antibiotic target replacement|0
MDNKTYEISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>AIN56719.1|FEATURES|CARD|beta_lactam|OXA-418|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDRNVQQQVKNMLYIERRGDSKLYAKSGWGMDVKPQVGWYTGWVEQPNGKV
TAFALNMNMQAGDDPAERKQLTLSILDKLGLFFYLR
>AGW16415.1|FEATURES|CARD|beta_lactam|OXA-333|antibiotic inactivation|1
MKNLQLGLIVLITTFGSACTTISPSVETAKNQHQQSAQQQIQQAFNQLQTTGVIVIKDKH
GLHSYGNDLSRAQTPYVPASTFKILNALIGLEHGKATSTEVFKWDGQKRSFPTWEKDMTL
GQAIQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVL
FVEKLANIQLAFKPDVQHTVQDMLLIEQKANYELYAKSGWGMDLEPQVGWWTGWVETATG
EKVYFALNMHMKTGISASVREQLVKQSLTALGII
>AIT76104.1|FEATURES|CARD|beta_lactam|MIR-15|antibiotic inactivation|1
MMTKSLSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLINAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AAD25538.1|FEATURES|CARD|tetracycline|tet(G)|antibiotic efflux|1
MRSSAIIALLIVGLDAIGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVCAPL
LGQFSDGYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLISGITGATGAVAASTIAD
STGEGSRARWFGYMGACYGTGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLK
ETNRSHGETGKLVRIEPFVLFRLDDALRGLTALFAVFFTIQLIGQVPAALWVIYGEDRFQ
WDTTTVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFILLAFATQGWM
VFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSAT
IGAWTGWVWIVGAILYLICLPILRRPFATSL
>AAD02244.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib9|antibiotic inactivation|1
MLRSSSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARP
TLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQ
SLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVT
TPDGPAVYMVQTRQAFERTRSDA
>AAL38577.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib4|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSDA
>NP_311275.1|FEATURES|CARD|multidrug|evgA|antibiotic efflux|0
MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNG
IQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGY
CYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKS
RLMEKLECKSLMDLYTFAQRNKIG
>AHI63011.1|FEATURES|CARD|beta_lactam|OXA-365|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEMTYKSLEQLGIL
>CAL30186.1|FEATURES|CARD|chloramphenicol|cmlB1|antibiotic efflux|1
MRSKDFSWRYSLAATLLLLSPFDLLASLGMDMYLPVVPFMAGALGAGAGTIQLTLTVYLV
LLGAGQLLFGPLSDLLGRRPVLLGGGITYILASFGLAAASSPEVFLSFRILQACGASACL
VSTFATVRDIYSGSEESNVIYGLLGSMLAMVPAIGPLLGALVDAWLGWRAIFGLLGIAMI
GAVTAAWRFWPETRRQRTADLQWSQLLLPVKCLNFWLYTLCYSAGMGSFFVFFSTAPWLM
MGRQALSQLSFSLLFATVAIAMMATARIMGRLIPRWGSLNTLRVGMGCLVVGALLLAVGE
TLIPNSVLGFIAPMWLVGVGIATAASVAPNGALRGFDHIAGTATAVYFCLGGLLLGGIGT
FIIALLPSDTTWPIIAYCLILAIAVLCLSCFNPNRHHPSDDEHDSLATQDIGRSQSGHGH
D
>AGT59159.1|FEATURES|CARD|quinolone|QnrB73|antibiotic target protection|1
MSLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG
>AGN11769.1|FEATURES|CARD|beta_lactam|CTX-M-141|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQREQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>AIT76109.1|FEATURES|CARD|beta_lactam|DHA-22|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSAIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDLAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AAN86837.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|Erm(38)|antibiotic target alteration|1
MSTPHHGRHELGQNFLSDRRVIADIVEIVSRTNGPIIEIGAGDGALTIPLQRLARPLTAV
EVDARRARRLAQRTARSAPGPASRPTEVVAADFLRYPLPRSPHVVVGNLPFHLTTAILRR
LLHGPGWTTAVLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDA
GLLTITRRSRPLVDVADRARYQALVHRVFTGRGHGMAQILQRLPTPVPRTWLRANGIAPN
SLPRQLSAAQWAALFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVG
QRQPQRGRDADADPDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASF
DSSASTTLVSRKARVNGPTPPGLGDT
>NP_414995.1|FEATURES|CARD|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHTVDHH
>AHM76771.1|FEATURES|CARD|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>AAW66497.1|FEATURES|CARD|tetracycline|tet(39)|antibiotic efflux|1
MKKSLSVILITIFLDAVGIGLIMPILPELLRSLAGAEAGGVHYGALLAVYALMQFIFAPI
LGALSDRFGRRPVLIISIAGATADYLLMAAAPSLLWLYIGRIFAGITGANMAVATAYVSD
ITPAHERAKRFGLLGAVFGIGFIAGPVIGGVLGEWNLHAPFFAAAFMNGINLIMTAVLLK
ESKHSNKMTEKVQEQSILKKLSYLITQPNMAPLLGIFLIITLVSQVPATLWVIYGQDRYG
WSIFIAGVSLASYGICHSIAQAFAIAPMVKRFGEKNTLLCGIACDAIGLLLLSIAVEEWV
PFALLPLFALGGVAVPALQAMMSRGISDERQGELQGLLSSFNSLGAIIGPVLVTSLYFMT
QASAPGMVWALAAILYVITLPLLLKYRLNKYSGVP
>NP_251183.1|FEATURES|CARD|multidrug|MexE|antibiotic efflux|1
MEQSSHFSWRYPLALAAVLVLSACGKAPETTQGMAAPKVSVAEVIEQPLNEWDEFTGRLE
APESVELRPRVSGYIDRVAFHEGALVKKGDLLFQIDPRPFEAEVKRLEAQLQQARAAQAR
SVNEAQRGERLRASNAISAELADARTTAAQEAKAAVAATQAQLDAARLNLSFTRITAPID
GRVSRAEVTAGNLVNSGETLLTTLVSTDKVYAYFDADERVFLKYVELARQAGRDTRSESP
VYLGLSSEDGNPHLGRLDFLDNQVNPRTGTIRGRAVFDNAKGEFTPGLYVRLKLVGSKTY
AATLIKDEAVGTDLGKKFVLVLDGDNKTVYRTVEMGPKLEGLRIVRSGLSKGDRIVVNGL
QRVRPGMQVDPQKVEMASADTLATLARLRQSVGDSEPPKVAASKDNATRNEPRG
>AHA11126.1|FEATURES|CARD|beta_lactam|OXA-363|antibiotic inactivation|1
MKTLIFLPLLNCLSLTACTLPVSSSPSHITSTQSTQAIAQLFDQAQSSGVLVIQRGQQIQ
VYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVS
ALAREQLAFDPQVQQQVKAMLLLQERKAYRLYAKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMQNGMDPAIRLEILQQALAELGLYPKAEG
>CAG34105.1|FEATURES|CARD|beta_lactam|TEM-129|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>NP_459345.2|FEATURES|CARD|multidrug|mdsC|antibiotic efflux|0
MKITFTGYRQTATLATLAFVTTLAGCTMAPKHERPASPTAMVYPYATSTVSGAPDAADIG
WRDFFHDPLLQELIAIALRNNRDLRKAGLNVEAARALYRIQRAEMLPTLGIATAMDASRT
PADLSVMDESEINRRYEAAGATTAWELDLWGRVRSLSDQALAAYMALDETYIAARMSLVS
EVASAWLTLRADRELLRLTEDTLAAQKSSYTLTTQLARTGNATQLDLRMAEIALRSAEIN
RAAYTRQLARDRNALELLLGQPLTPELSRRLNEAVTLTEGAIPTTLPGGLPSDLLVRRPD
IRAAEYRLRGANARIGAARAAFFPTISLTGSAGTASASLSGLFEPGSGSWRFLPQITLPL
FHGGALRADLDRAHVQKQIEIARYENVIQQAFRDVADGLAGQRTLNDQVQSEQRAVEASQ
IAYELAGLRFQEGVDDYLTLLDTHRMLYGAQQRLVRTRLMQQLNIINLYKALGGGWREYS
EKKQG
>CAI10727.2|FEATURES|CARD|beta_lactam|SHV-55|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIT76108.1|FEATURES|CARD|beta_lactam|DHA-13|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AIG51284.1|FEATURES|CARD|beta_lactam|SHV-119|antibiotic inactivation|1
MRHIRLCIISLLATLPLAVQASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIT76118.1|FEATURES|CARD|beta_lactam|OXA-397|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKD
FTLGEAMQASAVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>AAA22277.1|FEATURES|CARD|multidrug|bmr|antibiotic efflux|1
MEKKNITLTILLTNLFIAFLGIGLVIPVTPTIMNELHLSGTAVGYMVACFAITQLIVSPI
AGRWVDRFGRKIMIVIGLLFFSVSEFLFGIGKTVEMLFISRMLGGISAPFIMPGVTAFIA
DITTIKTRPKALGYMSAAISTGFIIGPGIGGFLAEVHSRLPFFFAAAFALLAAILSILTL
REPERNPENQEIKGQKTGFKRIFAPMYFIAFLIILISSFGLASFESLFALFVDHKFGFTA
SDIAIMITGGAIVGAITQVVLFDRFTRWFGEIHLIRYSLILSTSLVFLLTTVHSYVAILL
VTVTVFVGFDLMRPAVTTYLSKIAGNEQGFAGGMNSMFTSIGNVFGPIIGGMLFDIDVNY
PFYFATVTLAIGIALTIAWKAPAHLKAST
>AAT46077.1|FEATURES|CARD|multidrug|lsaA|antibiotic target protection|1
MSKIELKQLSFAYDNQEVLLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGE
ILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWELERELTLLNVDPEVLWRPFSSLSGG
EKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVV
DHILAIEKSQLTLYQGNFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNR
EGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPL
SMDYQPTHHKTLLTVEELRLGYEKNWLFAPLSFSINAGEIVGITGKNGSGKSSLIQYLLD
NFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVF
TNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVKPAMLVIE
HDAHFMKKITDKKIVLKS
>AAC75137.1|FEATURES|CARD|multidrug|mdtC|antibiotic efflux|1
MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMA
SSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLP
SGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGS
SLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAE
YQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSI
RAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATI
IPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKP
LQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLT
LTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALN
IWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTG
GSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNAS
YQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDV
QAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSY
FAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAG
TAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNA
PFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLA
ALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPK
QTVTE
>YP_490321.1|FEATURES|CARD|multidrug|baeR|antibiotic efflux|0
MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILL
DLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVAR
VKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVF
SREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV
>AID67109.1|FEATURES|CARD|beta_lactam|OXA-233|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAFPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AHL30286.1|FEATURES|CARD|beta_lactam|OXA-382|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKTDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FTYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>YP_001332362.1|FEATURES|CARD|multidrug|arlR|antibiotic efflux|0
MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSING
LEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQP
QKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYN
SEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR
>NP_358565.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|mefE|antibiotic efflux|0
MKIDKKNEAFLIVSRGISRIGDIMFDFANNTFLAGLNPTSLSLVAVYQSLESVIGVLFNL
FGGVIADSFKRKKIIIVANILCGIACIILSFISQEQWMVFAIVITNIILAFMSAFSGPSY
KAFTKEIVKKDSISQLNSLLEITSTIIKVTIPMVAILLYKLLGIHGVLLLDGFSFLIAAS
LISFIVPVNDEVVTKDKMTIGGVLNDLKIGFKYIYSHKTIFMIIILSAFVNFFLAAYNLL
LPYSNQMFGEISDGLYGVFLTAEAIGGFIGAILSGVINKTLSSKRLMVFLSCSGLMLMLS
TPLYFLFQNFIILAFSPALFSLFISIFNIQFFSIVQREVDTEFLGRVFGIIFTVAILFMP
VGSGFFSVVLNPNNTFNLFIIGVSITILSLIFSTLLKRYDKNS
>AHL30284.1|FEATURES|CARD|beta_lactam|OXA-388|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKYLFNEAHTTGVLVIQQGQ
IQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>BAR45714.1|FEATURES|CARD|beta_lactam|OXA-454|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIENEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLKGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AAK52606.1|FEATURES|CARD|chloramphenicol|cmlA6|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAIVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWALQSVLGFIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR
>ACQ82811.1|FEATURES|CARD|beta_lactam|PDC-6|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>YP_002320475.1|FEATURES|CARD|multidrug|adeI|antibiotic efflux|1
MMSAKLWAPALTACALATSIALVGCSKGSDEKQQAAAAQKMPPAEVGVIVAQPQSVEQSV
ELSGRTSAYQISEVRPQTSGVILKRLFAEGSYVREGQALYELDSRTNRATLENAKASLLQ
QQANLASLRTKLNRYKQLVSSNAVSKQEYDDLLGQVNVAEAQVAAAKAQVTNANVDLGYS
TIRSPISGQSGRSSVTAGALVTANQTDPLVTIQQLDPIYVDINQSSAELLRLRQQLSKGS
LNNSNNTKVKLKLEDGSTYPIEGQLAFSDASVNQDTGTITLRAVFSNPNHLLLPGMYTTA
QIVQGVVPNAYLIPQAAITRLPTGQAVAMLVNAKGVVESRPVETSGVQGQNWIVTNGLKA
GDKVIVDGVAKVKEGQEVSAKPYQAQPANSQGAAPNAAKPAQSGKPQAEQKAASNA
>AAD01867.1|FEATURES|CARD|trimethoprim|dfrE|antibiotic target alteration|0
LANVIEMIKTNPDSRRLIVSAWNPEDVPSMALPPCHTMFQFYVNEGKLSCQLYQRSADVF
LGVPFNIASYALLTHLIAHETGLEVGEFVHTLGDAHLYQNHVEQMQEQLSREVRSFPTLV
LNPDKASVFDFDMEDIKVEGYDPHPTIKAPIAV
>CCF55073.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|Erm(43)|antibiotic target alteration|1
MNNKNPKDTQNFITSKKCINEILKNIIITADDNIVEIGTGKGHFTKALSKVVKSVIGVEI
DKSLYYNLKKDSKLQDNIQLINQDILNFQFPDNKDYKIFGSIPYNISTEIIKKILYESKA
EYNYLIVELGFAKRIQDKNKALSLLLLPKMDVEILKVIPNKYFHPKPKVESALILLKKHK
PLISAKDEKNYQFFVYKWVNKEYKKLFTKNQFKKALKNANVQNLNKISKQQFISIFYSYK
LFN
>ABL67017.1|FEATURES|CARD|beta_lactam|ACT-3|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAIHVSPGMLDAE
AYGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>AFU25656.1|FEATURES|CARD|quinolone|QnrB50|antibiotic target protection|1
MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ACK75961.1|FEATURES|CARD|quinolone|QnrC|antibiotic target protection|1
MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFI
YADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYIT
GCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLT
HSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF
>ABA71727.1|FEATURES|CARD|glycopeptide|vanRG|antibiotic target alteration|0
MNEKILIVDDEKEIADLIELYLKNDGYKVYKFYNGIDALKCVESEKMDLAILDVMLPDVD
GFHICQKIRERYFYPIIMLTAKVEDADKIMGLTIGADDYITKPFNPLEVAARVKTQLRRY
VCYNNAADIEKENVLVTEYDINGLVINKNTHKCTLYGKAVTLTPIEFSVLWYLCENRGKV
ISSEELFENVWGEKFLDNNNTVMAHIGRLREKLKEPARNPKFIKTVWGVGYTIEE
>ABO09821.1|FEATURES|CARD|beta_lactam|CTX-M-79|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AHL30275.1|FEATURES|CARD|beta_lactam|OXA-375|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLVRASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFREWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAA52372.1|FEATURES|CARD|aminoglycoside|APH(4)-Ib|antibiotic inactivation|1
MLQTSKKKSGHDESWANADAHKWRGERKRDNRKIVLSGTTKLLFVAEEQFQLIPPPSYCV
SLVPKLPSNVTQPLFEYCFAPRILFFYALKKMTQHTKLCKLSSLIWREMWAISSRLQWQC
VCAARRITMRNGGWKFIEMLSCWSDMVHKHESVLISTLPSFINFLVGPFRSAGAEPGGMH
RRVDPPRPLSPALIEAFDGVMQLSGAPSRGVTPTPRGPDALGRITDSRGGSEAGYRFNMC
NRAVPSAALPIGEVLDIGEFSGKRTYLAAVHRAREQDLPETELPAVLQPCTGMAHAIAAA
DLSHTSGFAPFGPQGMGQETPWRDKRDCYFDPQVYYWLSQMGDTLRASVAQGFEKRMLWA
EDCPEARHLRIHVKGSNAALPEPGPKTWAGDGSQAVWAGRLRPTQDSRYVVASIFPWRPW
>ABG72894.1|FEATURES|CARD|aminoglycoside|aadA24|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>AGL43628.1|FEATURES|CARD|quinolone|QnrB67|antibiotic target protection|1
MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AAR92235.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|Erm(39)|antibiotic target alteration|1
MSSVHHGRHENGQNFLRDRRVVGDIVRMVSHTAGPIVEIGAGDGALTLPLQRLGRPLTAI
EIDLHRARRLADRTTAEVIATDFLRYRLPRTPHVVVGNLPFHLTTAILRRLLHENGWTDA
ILLVQWEVARRRAGVGGATMMTAQWWPWFEFGLARKVSADAFRPRPSVDAGLLTIQRRAE
PLLPWADRRAYQALVHRVFTGRGRGLAQILRPHVHPRWLSANGIHPSALPRALTARQWVA
LFDAAG
>AAB58160.1|FEATURES|CARD|multidrug|ceoA|antibiotic efflux|1
MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVSANAPEKAAAPLPEVDVATVVPQTVTDW
QSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
AAQARNGYAQTDWQRAQRLIGDNAIAKRDYDEKQNAAREAKREPEGRRSRAGNGAHQSRL
YAHHRAGVGPRVARGNHARQRRVGRRVGRAADDAGIGVADLRVVRRRRADLPAIHQRRAQ
RPQGAGRARPRERNRLLAQRRDRFGRQPARHVVRHDPRARPLRQRGRHPGPGPLRTREGG
RQRAARGAARRRRGDQHRPGQEVRVRRRPAGPRVVSRSAARDAARQPARDRERAVGRRPR
GRERHAARASGRAGEAAHGPDDGRRCAVRAVASTAKPAAPAKADS
>AAC45805.1|FEATURES|CARD|chloramphenicol|cmrA|antibiotic efflux|1
MPFAIYVLGLAVFAQGTSEFMLSGLIPDMARDLGVSVPAAGLLTSAFAVGMIIGAPLMAI
ASMRWPRRRALLTFLITFMLVHVIGALTSSFEVLLVTRIVGALANAGFLAVALGAAMAMV
PADMKGRATSVLLGGVTIACVAGVPGGAFLGEIWGWRAAFWAVVVISAPAVVAIMFATPA
EPPAESTPNAKRELSSLRSRKLQLMLVLGALINGATFCSFTYMAPTLTDISGFDSRWIPL
LLGLFGLGSFIGVSVGGRLADTRPFQLLAVGSAALLTGWIVFALTASHPAVTLVMLFVQG
ALSFAVGSTLISQVLYAADAAPTLGGSFATAAFNVGAALGPALGGLAIGMGLSYRAPLWT
SAALVTLAIVIGAATLSLWRRPASVQETVPA
>BAA16547.1|FEATURES|CARD|multidrug|emrA|antibiotic efflux|0
MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGN
QIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMI
NSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQ
YNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIISPMTGYVSRRAVQPGAQISPT
TPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAF
SLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVR
STPVAVSTAREISLAPVNKLIDDIVKANAG
>AGW83449.1|FEATURES|CARD|beta_lactam|OXA-351|antibiotic inactivation|1
MYKKALIVAISILFLSACSSNMVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTDYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWEKDMTLS
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AAV32840.1|FEATURES|CARD|aminoglycoside|aadA11|antibiotic inactivation|1
MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDE
TVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWE
GDERNVVLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGQGEDCLA
SRADQLAAFVHFVKHEATKLLGAMPVMSNNSFKPNPLRGSA
>AGW16416.1|FEATURES|CARD|beta_lactam|OXA-334|antibiotic inactivation|1
MKTVQLCLIVLITTFGSACTTISPSVETAKNQHQQSTQQQIQQAFNQLQTTGVIVIKDKH
GLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATRTEVFKWDGQKRSFTAWEKDMTL
GQAMQASAVPVYQELARRIGVDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWAGWVETSTG
EKAYFALNMQMKTGISASVREQLVKQSLTALGII
>AAN41403.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib11|antibiotic inactivation|1
MKNTIHINSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVL
AQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDLSLANASQLGKGLGT
KLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQ
AFERTRSDA
>AAC76093.1|FEATURES|CARD|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>CAB13166.1|FEATURES|CARD|multidrug|ykkC|antibiotic efflux|0
MKWGLVVLAAVFEVVWVIGLKHADSALTWSGTAIGIIFSFYLLMKATHSLPVGTVYAVFT
GLGTAGTVLSEIVLFHEPVGWPKLLLIGVLLIGVIGLKLVTQDETEEKGGEA
>BAA32494.1|FEATURES|CARD|fosfomycin|FomB|antibiotic inactivation|1
MLENLTIRSSRVVDLNLVKVRLSTNLEDFAAYSYFSAFAEDESAPADYEVVCVDLDRDDI
PAELYADRTDRTFRGKRFKGGYYLVHYFGEPAHLITVGRTFYVFGRSLEKTVWPYFVKHI
LTVHSADHGFLHLKAAGFELPGAGATLLVGRNGAGKTVFLAQACLNGARFLSNTHTLVRD
GVAHGVPSSIRVRRDQCFGELIDKHDLTAHMESGDYVTDSSTLFESPQISTARVRNVVIV
DYDPARPQGLMPISPAAAGTFMEQFSFAVTTYGLKDDLLAHHGDFDTYVDSLARMRAQLT
ELVEGARCYRANADMLAKEVRDSTLKQLAE
>AIT76111.1|FEATURES|CARD|beta_lactam|MIR-10|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AHA80106.1|FEATURES|CARD|beta_lactam|ACT-21|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADVAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPFEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGMKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYPILDALQ
>AGW81558.1|FEATURES|CARD|aminoglycoside|spd|antibiotic inactivation|1
MEEPNKQIDNVLIELKRLFSKDLLGVYLYGSYVKGGLKKDSDVDFLVIINRDMTKEEKRI
LISKIMPISKEIGEDTSLKYIELTVLNYHENENWSYPPIEEFIYGEWLREDYLNYFIPEK
NNNIDLTILLYQAKLSSISIYGENNINNLIPDVPFIDLQKAIKESSKELIKDFYGDETNV
ILTLCRMIVTYETGKFYSKDLAGSMIIENLSENLSIEENNLISLAISSYKNGNSVDWELF
PVKSVIKKLYAYLNYKL
>YP_489794.1|FEATURES|CARD|multidrug|marA|antibiotic efflux|0
MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
RKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLH
PLNHYNS
>AHX39589.1|FEATURES|CARD|beta_lactam|CTX-M-148|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVIAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>CAC19929.1|FEATURES|CARD|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVLIFPSIKDALPNRKYAVVTRSSFTSDNENVLIFPSIKDALTNLKKI
TDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGDVYFPEIPSNFRPVFTQDFASNINYS
YQIWQKG
>YP_002002225.1|FEATURES|CARD|multidrug|mtrR|antibiotic efflux|0
MRKTKTEALKTKEHLMLAALETFYRKGIARTSLNEIAQAAGVTRGALYWHFKNKEDLFDA
LFQRICDDIENCIAQDAADAEGGSWTVFRHTLLHFFERLQSNDIYYKFHNILFLKCEHTE
QNAAVIAIARKHQAIWREKITAVLTEAVENQDLADDLDKETAVIFIKSTLDGLIWRWFSS
GESFDLGKTAPRIIGIMMDNLENHPCLRRK
>WP_020835015.1|FEATURES|CARD|beta_lactam|CARB-20|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATARIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>AIT76087.1|FEATURES|CARD|beta_lactam|ACT-33|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILDALQ
>CAX52582.1|FEATURES|CARD|peptide|mprF|antibiotic target alteration|0
MLIKKNALSILKIVFPIAVLLFVIYQSKKELTNLSFKRTLMVINGLERTDLFMLVLIGLL
AVAAMSLYDYVLKYSLRLSITNGKVFRVSWIANSFNNVLGFGGLAGVGLRMMFYKEHTKD
HKALVKGIAWLTSSMLLGLSVFSIFVAARVLPVDEVIHEKPWLWAVVIGFALILPLSLAV
SKIKDRKAGDEENADKVKNPIFAYIGASVVEWLMAGTVIYFALFAMGIHADIRYVFGVFV
IAAIGGMISLVPGGFGSFDLLFLLGMEQLGYHQEAIVTSIVLYRLAYSFIPFILGLFFAA
GDLTENTMKRLETNPRIAPAIETTNVLLVVQRAVLVRILQGSLSLIVFVAGLIVLASVSL
PIDRLTVIPHIPRPALLLFNGLSLSSALILLILPIELYKRTKRSYTMAITALVGGFVFSF
LKGLNISAIFVLPMIIVLLVLLKKQFVREQASYTLGQLIFAVALFTVALFNYNLIAGFIW
DRMKKVLRHEYFVHSTSHITHATIMAIIIVPLFFLIFTVVYHKRTKPIGEKADPERLAAF
LNEKGGNALSHLGFLGDKRFYFSSDGNALLLFGKIARRLVVLGDPSGQRESFPLVLEEFL
NEAHQKGFSVLFYQIEREDMALYHDFGYNFFKLGEEAYVDLNTFTLTGKKKAGLRAINNR
FEREEYTFHVDHPPFSDAFLEELKQISDEWLGSKKEKGFSLGFFDPSYLQKAPIAYMKNA
EGEIVAFANVMPMYQEGEISVDLMRYRGDAPNGIMDALFIRMFLWAKEEGCTSFNMGMAP
LANVGTAFTSFWSERFAAVIFNNVRYMYSFSGLRAFKEKYKPEWRGKYLAYRKNRSLSVT
MFLVTRLIGKSKKDSV
>NP_248847.1|FEATURES|CARD|triclosan|TriB|antibiotic efflux|0
MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLG
FRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQ
EELFARSVTAQARLDDARTRLKTSQASFDQAKAAVQQARDQLSYTRLVTDFDGVITTWHA
EAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIREL
GPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWV
VDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR
>NP_253661.1|FEATURES|CARD|triclosan|OpmH|antibiotic efflux|0
MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVV
PQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKE
TSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLS
DKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPND
AKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSA
ANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTR
NLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNN
SRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQ
QY
>BAE06007.1|FEATURES|CARD|multidrug|mexP|antibiotic efflux|1
MNLRHFIRITATLGVAALIAGCGESAPPGAASAPPSVPVAEVVVRPVTPYAEFTGSLTAV
EQVELRPRVAGYIQDVTVPEGRLVEKGQQLFLIDPRVFKAAQDAARARLREAEAAALLAR
TEHERAELLYARKVVARERLDSAIASRNASKAQVDAARAALDAAQLDLGFTRVTAPIGGR
VGHIQVTEGNYVTNGVTALTSIVSVDPLYVYFDVDERTYLQALAPTRGREGEQAPRVKVA
LLTDESYGRSSRLDFLANAADRGTGTVRVRAVVDNPDGQLTPGLFAKVRLETGKPRAQVL
VADHSIGTDQGRRYVLVVDEGNKTQYRPVELGPMVDGLRVVRQGLQPGERIVVKGLVRPD
MQITPRLAEIDGTPVDLSKTVGAAQ
>AAG07064.1|FEATURES|CARD|multidrug|mexK|antibiotic efflux|1
MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEE
VARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDI
RATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELI
GLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSV
EEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGK
ALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTG
LVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYD
RLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAV
VFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLA
AFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNY
VAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRIS
RLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSID
QERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVP
TENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIR
AELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLG
LIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATV
RRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKK
DEARA
>AAG07762.1|FEATURES|CARD|multidrug|mexV|antibiotic efflux|0
MLLRRMLIMLAAVIAVVAILAGYKVYSIRQQIALFSAPKPPISVTASLAEKRPWQSRLPA
IGSLKAFQGVTLTAEVSGTVRDVLFLSGDQVKLDQPLIQLESDVEEATLRTAEADLGLAR
AEYQRGRELIGSKAISKSEFDRLAAQWAKTSATVAELKAALAKKRVLAPFAGTIGIRQVD
VGDYVSPGTPIATLQDLSTLLLDFHLPEQDFPLLSRGQLVKVRVAAYPAQVFDAEIAAIN
PKVDNETRNLQVRAALENPDGKLLPGMFANLEVMLPGEEQRVVVPETAITFTLYGDSIYV
VGQKKDEQGQVSKDDKGQPQQVVERRFVRIGERREGLAVVLEGLEGGEQVVTSGQLKLDN
GAAVAIVAERDLQQEH
>AJP77080|FEATURES|CARD|beta_lactam|SPG-1|antibiotic inactivation|1
MRPLILLASALAMTAPSGALAQSAEQRAKWNGPREPFRITGNLYYVGTSGLSAYLIAGPR
GHVLIDGALPESAPLIAANIRKLGFKLSDVKYLLSNHSHVDHAGGLAELKRLTGAQMVAN
VADKPDLEAGTTIGRTDIADFPAVKVDRVIGDGDRLTLGPIALVAILTPGHTKGATSWTT
RIGSKNVIFTSSISVAGQNLINNINYPNAAADFRASFAKLRALKADIFLSFHAEAFALDE
KRARAQAGATDAFVDPNELSRQVDLAEKAFDATLAKQQAANADRR
>BAL43360|FEATURES|CARD|macrolide-lincosamide-streptogramin|mefC|antibiotic efflux|1
MENRKWFKTYMFIWAGQFASMLTSYAVQFAIVIWLSLEYKSAEVLAYAGIAAMLPQALIG
LIAGVYVDRLNRKYVMIFSDAFIALCALLLLVILQNENVNLIWIYILLGLRSVGNAFHAP
ALQAIAPLIVPQNELIKVAGINQVLHSVCRIGGPAIGTLAIAYLPISKVLYLDLIGALLA
ILSLVMVKIPNVVAKSKSSAHSIATEFSEGFQTVSKNKGLRYLFLYAMAITFVIMPAAIM
FPLLTTGHFAGGKWEIGIVEVVWGGGMLIGGVILSIFKLKGSKVVAVNVMYVLLGLTFIL
SGVLPASWFVGFVMVTAIGGISLSVFNGCFTAIVQTEVSPEKLGRVFSLYYSLAVLPSVI
GLLFTGLIAEVIGVNITFIISGCLAILVGILSFSTRNLMQLGKIKNI
>AJD73064.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|RlmA(II)|antibiotic target alteration|1
MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSA
NYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEK
TFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVL
SKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTIT
AEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF
>YP_003971446|FEATURES|CARD|mupirocin|ileS|antibiotic target alteration|0
MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQN
EFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKE
LGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESV
MWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEE
DAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGED
YEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQ
APYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAE
IPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPE
NVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPR
DKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEK
FEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRN
YPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYA
NAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFI
DVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHL
ADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLT
VVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQ
FAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPT
GGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFR
DLIAHETLATSFAVKEGAELGVEVAKA
>Q8DWT2|FEATURES|CARD|peptide|mprF|antibiotic target alteration|0
MLKKLIEKVKSLTSVIKIVFFISVLVLIIVEMIHLKRTISVEQLKSVFGQLSPMNLFLII
LVGVIAVLPTTGYDFVLNGLLRTDKSKRYILQTSWCINTFNNLSGFGGLIDIGLRMAFYG
KKGQEKSDLREVTRFLPYLISGLSFISVIALIMSHIFHAKASVDYYYLVLIGASMYFPVI
YWISGHKGSHYFGDMPSSTRIKLGVVSFFEWGCAAAAFIIIGYLMGIHLPVYKILPLFCI
GCAVGIVSLIPGGLGSFELVLFTGFAAEGLPKETVVAWLLLYRLAYYIIPFFAGIYFFIH
YLGSQINQRYENVPKELVSTVLQTMVSHLMRILGAFLIFSTAFFENITYIMWLQKLGLDP
LQEQMLWQFPGLLLGVCFILLARTIDQKVKNAFPIAIIWITLTLFYLNLGHISWRLSFWF
ILLLLGLLVIKPTLYKKQFIYSWEERIKDGIIIVSLMGVLFYIAGLLFPIRAHITGGSIE
RLHYIIAWEPIALATLILTLVYLCLVKILQGKSCQIGDVFNVDRYKKLLQAYGGSSDSGL
AFLNDKRLYWYQKNGEDCVAFQFVIVNNKCLIMGEPAGDDTYIREAIESFIDDADKLDYD
LVFYSIGQKLTLLLHEYGFDFMKVGEDALVNLETFTLKGNKYKPFRNALNRVEKDGFYFE
VVQSPHSQELLNSLEEISNTWLEGRPEKGFSLGYFNKDYFQQAPIALVKNAEHEVVAFAN
IMPNYEKSIISIDLMRHDKQKIPNGVMDFLFLSLFSYYQEKGYHYFDLGMAPLSGVGRVE
TSFAKERMAYLVYHFGSHFYSFNGLHKYKKKFTPLWSERYISCSRSSWLICAICALLMED
SKIKIVK
>WP_001033157|FEATURES|CARD|fusidic_acid|fusC|antibiotic inactivation|1
MNKIEVYKFVKVKQLVYQLIKLYRTNDMNSHKTQKDFLLNEINDIFKEKDIDISDFITSI
DDVKLTKKKAEHLLNELKVYIQDFEIPSSSQLEKIFRKVKKLKRPDINLIDTKEISYLGW
NDNSSNRKYIVYKNLDDKFEGIYGEISPNKVKGFCKICNQESDTSLFLNKTKHNKSSGTY
TKKGDYICYDSFKCNQNLDDINNLYEFIVKIK
>WP_059512353.1|FEATURES|CARD|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLIVIAFCALFASAFAAKGTDSLKNSAKGTDSLKNSIEKYLKDKKAKVGVAVLGIED
NFKLNVNEKHHYPMQSTYKFHLALAVLDKLDKENISVDKKLFVKKSDLQPNTWSPLKDKY
PNGNLELSFSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMH
KAWNVQYTNWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTV
VAHKTGSSDTNNKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSV
WDYLVKDGK
>CAL25116.3|FEATURES|CARD|beta_lactam|ADC-8|antibiotic inactivation|1
MMKDILGNLDNVPFKIMTGCIAGLLSCGTVAQSTVQQSIQQSVDRHFKPLMAQYQISGMA
IAVSINGQHYYQNYGVASKQTEQNVSEHTLFELGSVSKLFNATLTGYAQAQGQLKLSDHP
AQYFPELKNTAVNQATLLNLGTYTAGGFPLQFPEQIKTTQDMTQYFQHWQPKAAPRRIRE
YSNPSIGLMGYVTALAMKNSYSNLIENTLFPALGMHHSYINVPAAQMSNYAWGYQADQAI
RVSPGMFDAEAYGIKSNTADMLKFLDAQINPQNLKPTLRKAIQTTQMGYFRVGQMRQGLG
WEQYTYPVSLTTLLAGNSAKMALQPQPVTGISKPITAPQQALLNKTGATNGFSAYVVVIP
SQKIGLVMLANRNFPNDARVKAAYATLQQILNADIQK
>YP_006938491.1|FEATURES|CARD|aminoglycoside|ANT(4')-Ib|antibiotic inactivation|1
MNGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVMSTE
EAEFSHEWTTGEWKVEVNFDSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLEKVY
QTAKSVEAQTFHDAICALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLIGLH
HRICYTTSASVLTEAVKQSDLPSGYDHLCQFVMSGQLSDSEKLLESLENFWNGIQEWTER
HGYIVDVSKRIPF
>ANZ79476.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|Erm(47)|antibiotic target alteration|1
MNRKSVRFGQNFVTSINDINKICKKIDVNSNDVYFEIGPGKGHFTQYFVERAKEVIAIEI
DSELIPILNNKFSDLDNIKIINHDFMSYELPSTFKYKVFGNIPFNLSTSIIRKLSLEKYA
DEIYLIVELGFAKRLEDLNRKMGLMLAPFYEISILYNIPKRYFHPIPSVEVVLIKLKRTS
YNMSMKEYIKYEDFIEKWVKKDYNVLFTKNQLKQAIRYGNIDNLRILKVDQILSIFESYK
LFNGLK
>WP_015735625.1|FEATURES|CARD|multidrug|cipA|antibiotic target alteration|1
MKYLSKYEKIRKILSALNQPNYRYSQITEAIFKNKIGNFEAMNNLPKPVRNELIKELGNN
VLSITPKMEQKSNQVSKILFAIPGDEYIESVRLSYQTGWESYCISSQCGCGFGCTFCATG
TLGLKRNLTTDEITDQLLYFTLNNHPLDSVSFMGMGEALANPYVFDALHLLTDPKLFGLG
HRRITVSTIGLLPGVKKLTKEFPQINLTFSLHSPFHDQRSELMPINNHFPLEEVMTVLDE
HIQQTKRKVYIAYILLRGINDSTKHAKAVADLLRERGSWEHLYHVNLIPYNSTDATSQSF
VESDQNSINMFLRILKSKGIHVTVRTQFGSDINAACGQLYGSNGNI
>WP_014550864.1|FEATURES|CARD|multidrug|hmrM|antibiotic efflux|0
MNFRLLSQYHTDIKKLIKISLPILLAQIAQNSMGLADTIMAGRVSSTDMAAISIGASIWM
PLMFFGQGLLLALPPTISYLNGSGQHHRIAHQVRQGIWLVLGVSIPLGLLIYFCEIPLQY
MQMESKMSDLARNYLHAMLWGLPAYLMLINFRCLNDGIEKTKPAMVITFLGLLINIPLNY
IFIYGKFGMPAFGAVGCGIATAIVNWAMCLMMIFYSYTNTQERSLKVFSQLIEMPNPKTL
KKLLRLGLPIAIAICCEVALYALTSLMLSPLGATIVASHQITLNTSSFIFMFPMSIGMAT
TILVGQALGAGSPQNAKKIGYAALLLGLTVTIVTALITIFFRYEIASIFVTDEIVIAMAA
NLLLFAALYQFSDTIQMVVGGILRGYKDTKVILYITLFSYWVIGVPLGYTLGRTDWLVPH
IDAKGFWIAFVVSLTFAAFLLSLRMKKMQAMNDNAILQRLEKLK
>NP_273367.1|FEATURES|CARD|multidrug|farA|antibiotic efflux|0
MDTHTDETKLQNTQAKRKRRLTALTLLFALAAAAAGSAFFLWWQHEEETEDAYVAGRVVQ
VTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRRQNAATS
QAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESS
ARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAP
LMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSL
IPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDTSAAGAPVSKTPGAAL
PEMESTDWSEVDRTVDEILGQSAP
>NP_207972.1|FEATURES|CARD|multidrug|hp1181|antibiotic efflux|0
MFKKIFPLALVSSLRFLGLFIVLPVISLYADSFHSSSPLLVGLAVGGAYLTQIVFQTPMG
ILSDKIGRKVVVMVCLLLFLAGSLVCFIANDIVWLVIGRFIQGMGALGGVISAMVADEVK
EEERTKAMAIMGAFIFISFTISMAIGPGVVAFLGGAKWLFLLTAILTLLSLLMLLKVKDA
PKISYQIKNIKAYQPNSKALYLLYLSSFFEKAFMTLIFVLIPLALVNEFHKDESFLILVY
VPGALLGVLSMGIASVMAEKYNKPKGVMLSGVLLFIVSYLCLFLADSSFLGKYLWLFIVG
VAFFFIGFATLEPIMQSLASKFAKVHEKGKVLGQFTTFGYLGSFVGGVSGGLSYHHLGVS
NTSLIVVALGLIWGLSLFLLNNPSKQKNVYFPLDAYNEEQFETLEDKIIEWYVNISEEII
IVKYNSDHISEEEIIHLAQNFRK
>AAC43550.1|FEATURES|CARD|quinolone|lrfA|antibiotic efflux|1
MSTCIEGTPSTTRTPTRAWVALAVLALPVLLIAIDNTVLAFALPLIAEDFRPSATTQLWI
VDVYSLVLAALLVAMGSLGDRLGRRRVLLIGGAGFAVVSALAAFAPSTELLVGARALLGV
FGAMLMPSTLSLIRNIFTDASARRLAIAIWASCFTAGSALGPIVGGALLEHFHWGAVFLV
AVPILLPLLVLGPRLVPESRDPNPGPFDPVSIVLSFTTMLPIVWAVKTAAHDGLSAAAAA
AFAVGIVSGALFVRRQNRSATPMLDIGLFKVMPFTSSILANFLSIIGLIGFIFFISQHLQ
LVLGLSPLTAGLVTLPGAVVSMIAGLAVVKAAKRFAPDTLMVTGLVFVAVGFLMILLFRH
NLTVAAIIASFVVLELGVGVSQTVSNDTIVASVPAAKSGAASAVSETAYELGAVVGTATL
GTIFTAFYRSNVDVPAGLTPEQTGAAAESIGGAAAVAADLPAATATQLLDSARAAFDSGI
APTAVIAAMLVLAAAAVVGVAFRR
>CUU67654.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|erm(44)|antibiotic target alteration|1
MINKEQNIMDNRNSKNSQNFITSRKYINDILKETSIGADDNIIEIGTGKGHFTKQLSNIA
RFVTGVEIDKSLYRNLKKDIELSNNVELVNKDILKYQFPKCKKYKVFGNIPYNISTEIVK
KILYEGNAEYNYLIVEYGFAKRIMDKRRALGLLLLTKLDVEILKVIPNTYFHPKPRVESA
LILLKQHKSLIQKRDEKLYQFFVYKWVNKEYKQLFTKNQFNKALKNAKVKNINEMTNEQF
ISIFHSYKLFN
>APB03214.1|FEATURES|CARD|tetracycline|tetA(48)|antibiotic efflux|1
MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTI
RMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGL
GRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLD
PRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVG
TSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGI
GLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV
>APB03218.1|FEATURES|CARD|bacitracin|BahA|antibiotic inactivation|0
MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHG
VGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAV
FIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDA
APDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDAS
RFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLG
RLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNP
FYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQ
YKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQ
FNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGY
AKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGE
ADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINF
TITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMN
PDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS
>APB03225.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|VgbC|antibiotic inactivation|1
MQIAAQEYKTANRESGPYGITARQDRTIWFTEQKGNRIGRLTKDGDMRTFEVPTPDAGVM
SILSAHTGDLWFTEYKANKIGRMTMEGTFAEFELPEANSSPYGLAEGPDGAIWFTELSGN
RIGRITPAGIITEYDLPCEGSYPSYITAGPDGALWFTENQNNCIGRITVDGEITEYRIPT
EQSGPVGITTGADGALWFVQINGNQIGRITTAGEITEFKLPSGNARPHAITAGVSGDLWF
TEWGANQIGRITCTGDITEYPIPTPSAEPHGITVDSGGEVWFAEECDQIGRFTIQY
>APB03222.1|FEATURES|CARD|rifampin|rphB|antibiotic inactivation|0
MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQA
MLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSAT
AEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVV
VQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRI
AAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLA
QDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRT
AGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPG
KNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKN
LFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVI
RPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEK
PIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMID
LIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRT
NKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAE
AIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLM
THGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS
>WP_001211223.1|FEATURES|CARD|beta_lactam|ADC-31|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPLDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTSGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ABA28305.2|FEATURES|CARD|macrolide-lincosamide-streptogramin|mgtA|antibiotic inactivation|0
MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPPL
LADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEP
DLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYAR
FHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDW
ARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNV
EVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVAR
TLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEGGTRRAADLIEAELAAARG
>SIP52035.1|FEATURES|CARD|multidrug|cpxr|antibiotic efflux|0
MSELLLIDDDRELCELLGTWLVQEGFSVRASHDGAQARRALAEQTPDAVVLDVMLPDGSG
LELLKQLRGDHPDLPVLMLSARGEPLDRILGLELGADDYLAKPCDPRELTARLRAVLRRT
HPAQPSAQMQLGDLSLNLTRGVAQIDGQEISLTLSESRILEALLRQPGEPLDKQALAQLA
LGRKLTLYDRSLDMHVSNLRKKLGSHPDGSPRILALRGRGYYYSH
>ANZ79241.1|FEATURES|CARD|tetracycline|tetB(60)|antibiotic efflux|1
MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGG
LLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGK
VVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQ
RTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGR
KELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQ
TFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKH
LNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGI
VLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFS
SGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTI
AHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG
>AET10445.1|FEATURES|CARD|tetracycline|tetB(46)|antibiotic efflux|1
MKVLKRLLSRITLYPTVFLAGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLL
QMGGFYLLVLSLGQLISYMGNRILLHGSNQVTASLRDQAFQVMQGLPISYFDDKPAGKIA
TRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLY
KVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRIL
LADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLS
RQFPNIRRSLETGSRVLAFLDQPLEADGALELKIEKAEVVFDDVQFAYEEGKPVLKDISI
QAHPGQTLALVGHTGSGKSSIMNLLYRFYDPQEGEIRIDGQNIRHFSRESLRSHMGIVLQ
DPYLFTGTIASNVAMSQEHIDRNAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGE
RQLISFARTLYMNPQILILDEATSHIDTETEEIIQKAMAVLQKGRTTFIIAHRLSTIQDA
DQILVLSEGRIVERGQHADLVAHGGIYAQMQAIQQTVE
>AAF09244.1|FEATURES|CARD|beta_lactam|SFH-1|antibiotic inactivation|1
MASEKNLTLTHFKGPLYIVEDKEYVQENSMVYIGTDGITIIGATWTPETAETLYKEIRKV
SPLPINEVINTNYHTDRAGGNAYWKTLGAKIVATQMTYDLQKSQWGSIVNFTRQGNNKYP
NLEKSLPDTVFPGDFNLQNGSIRAMYLGEAHTKDGIFVYFPAERVLYGNCILKENLGNMS
FANRTEYPKTLEKLKGLIEQGELKVDSIIAGHDTPIHDVGLIDHYLTLLEKAPK
>NP_253677.1|FEATURES|CARD|multidrug|EmrE|antibiotic efflux|0
MTNYLYLAIAIAAEVVATTSLKAVAGFSKPLPLLLVVGGYVLAFSMLVLVMRTLPVGVVY
AIWSGLGIVLVSLVAMFVYGQRLDPAALLGIGLIIAGVLVIQLFSRASGH
>CAC41008.1|FEATURES|CARD|multidrug|AcrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFVEGSDIQAGVFLYQIDPATYQGSYDSAKGDLAKAQAAAN
MDQLTVKRYQKLLGTQYISQQDYDPAVATAQQNNAAVVAAKTAVETARINLAYTQKSPLR
SAAGSGKSPVTEGALVQNGQTTALATVQQVDPIYVDVTQSSNDFLRLKQELADARLKQEN
GKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEE
GINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRV
IVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS
>AHH86051.1|FEATURES|CARD|peptide|EdeQ|antibiotic inactivation|0
MSVTLREVTLENWEECIELEPTPEQSEFVAPNLYSIAESKFQTTFVPLAIYHDDTMVGFV
MYGLDPDDGNYWIYRLLIDAKYQRLGYGRTAISQVIEILKAKEDCQKIVIGYAPANVAAE
NLYASLGFQKNGMVLFGETIAELNF
>WP_002118772.1|FEATURES|CARD|beta_lactam|ADC-18|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKEQEVKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKAKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKTKNAIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPPLHLKNSYVNVPKTQMQNYAYGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLTFINANLNPQKYPKDIQRAISETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGSYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857795.1|FEATURES|CARD|beta_lactam|ADC-21|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKLKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANINPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857796.1|FEATURES|CARD|beta_lactam|ADC-22|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNTQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857797.1|FEATURES|CARD|beta_lactam|ADC-23|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKEQEVKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKAKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKTKNAIGEYRQYSNPSIG
LFGKIVALSMNKPFDQVLEKTIFPPLHLKNSYVNVPKTQMQNYAYGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLTFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PASLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>NP_250052.1|FEATURES|CARD|multidrug|PmpM|antibiotic efflux|0
MNSPALPLSRGLRIRAELKELLTLAAPIMIAQLATTAMGFVDAVMAGRASPHDLAAVALG
NSIWIPMFLLMTGTLLATTAKVAQRHGAGDQPGTGPLVRQALWLALLIGPLSGAVLWWLS
EPILGLMKVRPELIGPSLLYLKGIALGFPAAALYHVLRCYTNGLGRTRPSMVLGIGGLLL
NIPINYALIYGHFGMPKMGGPGCGWATGSVMWFMFLGMLFWVNKASIYRASQLFSRWEWP
DRATIGPLVAVGLPIGIAVFAESSIFSVIALLIGGLDENVVAGHQIALNFSALVFMIPYS
LGMAVTVRVGHNLGAGLPRDARFAAGVGMAAALGYACVSASLMLLLREQIAAMYSPDPAV
IAIAASLIVFSALFQFSDALQVTAAGALRGYQDTRVTMIMTLFAYWGIGLPVGYSLGLTD
WFQEPTGPRGLWQGLVVGLTGAAIMLCIRLARSARRFIRQHERLQREDAEAASVLGR
>AOT73359.1|FEATURES|CARD|beta_lactam|NDM-17|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLLVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVKPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>WP_063964000.1|FEATURES|CARD|aminoglycoside|kamB|antibiotic target alteration|1
MRRVVGKRVQEFSDAEFEQLRSQYDDVVLDVGTGDGKHPYKVARQNPSRLVVALDADKSR
MEKISAKAAAKPAKGGLPNLLYLWATAERLPPLSGVGELHVLMPWGSLLRGVLGSSPEML
RGMAAVCRPGASFLVALNLHAWRPSVPEVGEHPEPTPDSADEWLAPRYAEAGWKLADCRY
LEPEEVAGLETSWTRRLHSSRDRFDVLALTGTISP
>WP_069174570.1|FEATURES|CARD|fosfomycin|FosA6|antibiotic inactivation|1
MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPP
EESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLA
QRLAACREQQYKGMVFFDQ
>AQX82857.1|FEATURES|CARD|beta_lactam|mecD|antibiotic target replacement|1
MKNIKVKILIVCSLCLISFFLYNLLKENEIDKIFSSIENRNVDEINENITFLSRNTFSKK
QRYDRMNHIDNSLGIKKVNITDIKLLEEIVDTRKYSANMHYDSKFGKFTKKGYFEFEKNG
ESKRWELNWTPEVIIPGLTATNEVRVEELKSSRGEIVDRNGIPLAIDGEHYQVGIDPKNY
NKKDSKQIAKLLNINESTLKNKLKQSWVKDGVFVPIKSYVELSDEIKNKIPEYGLSVNKI
KGRTYPLKEASAHLLGYIGEINADELNDPKFKGYDSHSIVGKTGIEYMYDKELQNRDGLI
VYITDDDGLTDSKEILVHKKPKNGKKIVLSIDSRVQNSIYNHLKDDNGSGTAMNPKTGEL
LALVSYPSFNPYDFMFGISNKKYQALLNDKKAPLLNKFQELTSPGSTQKLLTSIIGLNNG
VINESKSYEINGKGWRKDGSWGGYKVTRFEVVNGRIDLEKAIAHSDNIFFARTTLEMGGK
KFVRGMKDLGVGEETPSDYPVRTGQIANKINLERNLNNDILLADSGYGQGEILVNPIHIL
SIYSSLVNEGNMMAPKLNMEHKSKVWKKHITSQKNIDILTSSMRKVVTGTHKLDTERNYA
NFAGKTGTAELKMTQNEGLGTQIGWFVGYDQQNPNMMLAINVKNVEDKGMSSYNAQKFAQ
VMDDLYEHGARTYEPDSE
>AFH35853.1|FEATURES|CARD|multidrug|mdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNA
YLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLC
FIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG
>ANR95875.1|FEATURES|CARD|polymyxin|MCR-1.2|antibiotic target alteration|1
MMLHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>AAF94716.1|FEATURES|CARD|beta_lactam|Vibrio|antibiotic inactivation|0
MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTV
KVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVL
LIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRV
IASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTP
DNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGG
HGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTA
LANKYGHMYGFDSGVVETHAAMILADMIDH
>YP_355256.1|FEATURES|CARD|beta_lactam|RSKD131_3983|antibiotic inactivation|1
MKHLSPLSILLMVGALTPALAQDTTPSFESAAAAAFESVIEEHDIPGLVVGVTHGGRHSF
YQTGLASREDQQPVTPDTLFELGSISKIFNVTLAALAEERGALSLDAPVADYLPSLRGSP
AGELTLIDLATHHTGGLPLQVPDEVADVDRLVDWLRSWRPPEPGTRSYSNISIGLLGHIT
AGVLGMSYADASQTVIFPALGLKSTWIDVPTDAMGRYAFGYDRKTDAPTRVTPGVLDDEA
YGVKSSARDMLTLLDLELGTGTASPEVQTAVATTQEGRFQTRLYTQAMIWEAYPWPVDPE
RLVEGNGYDFILQPQPVDEVDTTPDRRVILNKTGSTNGFGGYIAIVPSEDLGVVVLANRN
YPNEARVRATYDLITHILAE
>AAT46346.1|FEATURES|CARD|beta_lactam|ampC|antibiotic inactivation|1
MKKRITPFSRFASKGLFACSAGMLLVTVAHAANTAAAPAGMDAMVQTVMQAHQIPGMAIA
IIQPGKTTYHNYGVASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASR
YVAALRGSAFDRITLRQLGTYSAGGLPLQFPDNVTTPADVLAYYQHWQPVHPAGTTRLYS
NPSIGLMGLAASQATGESFAGLLGTTVLHPLGMNSTYLQVPPEARSRYAMGYTAAGKAVR
VSPGPLDEETYGVKSTTADMAGFLLAHMDPARSKGALQSALQQTRVPVYCAGQTRQGLGW
ESYQDWKNLDVLLAGNSNQMVFEPQPVKACPAGTMNDPDVWVNKTGSTAGFGAYAVFLPA
RQTGIVILANRNFPIADRIRLAHGILTALH
>WP_063857790.1|FEATURES|CARD|beta_lactam|ADC-15|antibiotic inactivation|1
MRFKKISCLLLSPLFIFNTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTTGKYWKEL
KNTPIDQVNLFQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQLLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKIFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857803.1|FEATURES|CARD|beta_lactam|ADC-42|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKSVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTSGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKEWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANINPQKYPKDTQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGSYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ASR73329.1|FEATURES|CARD|polymyxin|MCR-4|antibiotic target alteration|1
MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALS
FLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLA
SITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVR
NNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGE
TARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRAN
AQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKL
DKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDN
TILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVP
MLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCR
Y
>AKR18022.1|FEATURES|CARD|beta_lactam|PDC-82|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
LPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLLEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>AKR18027.1|FEATURES|CARD|beta_lactam|PDC-87|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPIAERVKIAYAILSG
LEQQAKVPLKR
>AKR18032.1|FEATURES|CARD|beta_lactam|PDC-92|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMAPHRIARL
PAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLE
QQAKVPLKR
>CAD09823.1|FEATURES|CARD|multidrug|tetR|antibiotic efflux|0
MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEM
LDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAF
LCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDH
QGAEPAFLFGLELIICGLEKQLKCESGS
>ADT64081.1|FEATURES|CARD|multidrug|MexS|antibiotic efflux|0
MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPS
GLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTP
VEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSA
EEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKL
VLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTR
DRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD
>NP_251182.1|FEATURES|CARD|sulfonamide|MexT|antibiotic efflux|0
MPVSDPMPLRHLARPRPVSHARLDGEPPRLQPLAPGNEERHEPKRPAPRRSEPADRVRDP
DARTQRDPRRRETVPRPAGQPAISAALSRLRTLFDDPLFVRTGRSMEPTARAQEIFAHLS
PALDSISTAMSRASEFDPATSTAVFRIGLSDDVEFGLLPPLLRRLRAEAPGFVLVVRRAN
YLLMPNLLASGEISVGVSYTDELPANAKRKTVRRSKPKILRADSAPGQLTLDDYCARPHA
LVSFAGDLSGFVDEELEKFGRKRKVVLAVPQFNGLGTLLAGTDIIATVPDYAAQALIAAG
GLRAEDPPFETRAFELSMAWRGAQDNDPAERWLRSRISMFIGDPDSL
>NP_250710.1|FEATURES|CARD|multidrug|mexZ|antibiotic efflux|0
MARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCL
AMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENE
PLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERL
RDDPWNRAERMFRAGLDSLRSSPYLLLADA
>NP_414997.1|FEATURES|CARD|multidrug|acrS|antibiotic efflux|0
MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFS
EIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFV
GEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLF
APQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE
>NP_253290.1|FEATURES|CARD|multidrug|Type|antibiotic efflux|0
MTLISHDERLIKALAVAIVDRPRATLKELAEAAGVSKATLHRFCGTRDNLVQMLEDHGET
VLNQIIQACDLEHAEPLEALQRLIKEHLTHRELLVFLVFQYRPDFLDPHGEGARWQSYLE
ALDAFFLRGQQKGVFRIDITAAVFTELFITLVYGMVDAERRGRAASSNSAHTLEQMFLHG
ASNPARS
>BAE77595.1|FEATURES|CARD|fosfomycin|fosB|antibiotic target alteration|0
MSNSYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGHCKEII
VTIHADNSVSVQDDGRGIPTGIHPEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGV
SVVNALSQKLELVIQREGKIHRQIYEHGVPQAPLAVTGETEKTGTMVRFWPSLETFTNVT
EFEYEILAKRLRELSFLNSGVSIRLRDKRDGKEDHFHYEGGIKAFVEYLNKNKTPIHPNI
FYFSTEKDGIGVEVALQWNDGFQENIYCFTNNIPQRDGGTHLAGFRAAMTRTLNAYMDKE
GYSKKAKVSATGDDAREGLIAVVSVKVPDPKFSSQTKDKLVSSEVKSAVEQQMNELLAEY
LLENPTDAKIVVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPALSEL
YLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLSSQEVATLITALGCGIGR
DEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIVERGHVYIAQPPLYKVKKG
KQEQYIKDDEAMDQYQISIALDGATLHTNASAPALAGEALEKLVSEYNATQKMINRMERR
YPKAMLKELIYQPTLTEADLSDEQTVTRWVNALVSELNDKEQHGSQWKFDVHTNAEQNLF
EPIVRVRTHGVDTDYPLDHEFITGGEYRRICTLGEKLRGLLEEDAFIERGERRQPVASFE
QALDWLVKESRRGLSIQRYKGLGEMNPEQLWETTMDPESRRMLRVTVKDAIAADQLFTTL
MGDAVEPRRAFIEENALKAANIDI
>YP_039997.1|FEATURES|CARD|peptide|rpoC|antibiotic target alteration|0
MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC
SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM
SPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLE
EIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRP
MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR
RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE
MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHR
LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL
NPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVH
ASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTT
LGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI
TVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGEL
MQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY
FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI
EPFIERIEGRYSKETIRHPETDEVIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARH
GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI
QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQ
PVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR
KVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSA
ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVE
SQTEVTE
>AAK44936.1|FEATURES|CARD|aminoglycoside|APH(2'')-Ig|antibiotic target alteration|0
MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQ
VEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAK
KEKG
>WP_005768149.1|FEATURES|CARD|aminocoumarin|gyrB|antibiotic target alteration|0
MSDETTSPTSGDYGAASIKVLKGLDAVRKRPGMYIGDTDDGSGLHHMVYEVVDNAIDEAL
AGYATLVNVTLHADGSCSVCDNGRGIPTDIHPTEHVSAAEVIMTQLHAGGKFDQNSYKVS
GGLHGVGVSVVNALSVWLRLRIKRDGKIHEMSFTHGVADAPLKVVGQCGTESGTEISFLP
SPETFTMVKFDFETLERRLRELAFLNSGVHILLVNQHHADVRSVELYYEGGLIEFIKYID
QSKKPLIDAPIYITSEKDGISVDVALWWNDSYHEKVLCFTNNIPQRDGGTHLAGFRSALT
RQINGYAESSGIAKKEKVNLTGDDCREGLTAILSVKVPDPKFSSQTKDKLVSSEVRPIVE
NLVNEGLSAWLEEHPNEAKILISKVVEAAAAREAARKARELTRRKGALDITSLPGKLADC
QERDPTKSEIFIVEGDSAGGSAKSGRSRQNQAILPLRGKILNVERARFDRMLSSEMIGTL
ITALGTSIGKDEFSPDKLRYHKIIIMTDADVDGAHIRTLLLTFFFRQMPELIERGHLYIA
QPPLYKVSRGKSSQYIKNEAAFEDFLIDSGLEETTLELSSGEVCAGIDLRQFVQDARLLR
QLLNGLHTRYDRNIVEQAAIAGAFNFEAFATPETAQKIADTIAKRLDLIADDMERGWSGQ
YTSDGSLCFERVLRGVKDVITLDAGFINSADARQIGHIAKNLKDIYRDPPLLRRKDKSER
IFGPTSLLESIFINGKKGITLQRYKGLGEMNADQLWETTLDPDARSLLQVKINDATDADS
LFSQLMGDEVEPRRIFIQKNALNVANLDI
>CAC29513.1|FEATURES|CARD|quinolone|gyrB|antibiotic target alteration|0
MAAQRKAQDEYGAASITILEGLEAVRKRPGMYVGSTGERGLHHLIWEVVDNSVDEAMAGY
ATQVDVRLFDDGSVEVADNGRGIPVAVHATGVPTVDVVMTQLHAGGKFGGKDSGYNVSGG
LHGVGVSVVNALSTRVEVDIKRDGYEWSQFYDKAVPGILKQGEATEATGTTIRFWADPDI
FETTKYDFGTVARRIQEVAFLNKGLTINLVDERVKQDEVVDDVVSDTAEAPVAMTVEEKS
TESSAPHKVRHRTFHYPGGLVDFVKHINRTKTPIQQSIIDFDGKGAGHEVEVAMQWNGGY
SESVHTFANTINTHEGGTHEEGFRSALTSVVNKYAKDKKLLKDKDPNLTGDDIREGLAAV
ISVKVSEPQFEGQTKTKLGNTEVKSFVQRVCNEQLIHWFEANPVDAKAVVNKAISSAQAR
IAARKARELVRRKSATDLGGLPGKLADCRSTDPRSSELYVVEGDSAGGSAKSGRDSMFQA
ILPLRGKIINVEKARIDRVLKNTEVQAIITALGTGIHDEFDISRLRYHKIVLMADADVDG
QHISTLLLTLLFRFMRPLIEHGYVFLAQPPLYKLKWQRMDPEFAYSDSERDGLLETGLKL
GKKINKEDGIQRYKGLGEMDAKELWETTMDPSVRVLRQVTLDDAAAADELFSILMGEDVD
ARRSFITRNAKDVRFLDV
>CAA55486.1|FEATURES|CARD|quinolone|gyrB|antibiotic target alteration|0
MGKNEARRSALAPDHGTVVCDPLRRLNRMHATPEESIRIVAAQKKKAQDEYGAASITILE
GLEAVRKRPGMYIGSTGERGLHHLIWEVVDNAVDEAMAGYATTVNVVLLEDGGVEVADDG
RGIPVATHASGIPTVDVVMTQLHAGGKFDSDAYAISGGLHGVGVSVVNALSTRLEVEIKR
DGYEWSQVYEKSEPLGLKQGAPTKKTGSTVRFWADPAVFETTEYDFETVARRLQEMAFLN
KGLTINLTDERVTQDEVVDEVVSDVAEAPKSASERAAESTAPHKVKSRTFHYPGGLVDFV
KHINRTKNAIHSSIVDFSGKGTGHEVEIAMQWNAGYSESVHTFANTINTHEGGTHEEGFR
SALTSVVNKYAKDRKLLKDKDPNLTGDDIREGLAAVISVKVSEPQFEGQTKTKLGNTEVK
SFVQKVCNEQLTHWFEANPTDAKVVVNKAVSSAQARIAARKARELVRRKSATDIGGLPGK
LADCRSTDPRKSELYVVEGDSAGGSAKSGRDSMFQAILPLRGKIINVEKARIDRVLKNTE
VQAIITALGTGIHDEFDIGKLRYHKIVLMADADVDGQHISTLLLTLLFRFMRPLIENGHV
FLAQPPLYKLKWQRSDPEFAYSDRERDGLLEAGLKAGKKINKEDGIQRYKGLGEMDAKEL
WETTMDPSVRVLRQVTLDDAAAADELFSILMGEDVDARRSFITRNAKDVRFLDV
>AAL97684.1|FEATURES|CARD|sulfonamide|folp|antibiotic target alteration|1
MKIGRFVIEGNAAIMGILNVTPDSFSDGGSYTTVQKALDHVEQMIADGAKIIDVGGESTR
PGCQFVSATDEIDRVVPVIKAIKENYDILISIDTYKTETARAALEAGADILNDVWAGLYD
GQMFALAAEYDAPIILMHNQDEEVYQEVTQDVCDFLGNRAQAALDAGVPKNNIWIDPGFG
FAKSVQQNTELLKGLDRVCQLGYPVLFGISRKRVVDALLGGNTKAKERDGATAALSAYAL
GKGCQIVRVHDVKANQDIVAVLSQLM
>AKJ52802.1|FEATURES|CARD|quinolone|parC|antibiotic target alteration|0
MKKDRKEEIQEVTENIIEKNMADIMSDRFGRYSKYIIQQRAIPDARDGLKPVQRRILYSM
WNLHLKNSEPFKKSARIVGDVIGRYHPHGDSSIYEALVRMAQDWKSNFPLIEMHGNKGSI
DDDPAAAMRYTESRLEKISELMLRDLDRKVVKMAPNFDDSEYEPIVLPALFPNLLVNGAK
GIAAGFATEIPPHNLGEVIDATIALIKNPTISIEELSEIVKGPDFPTGAIINGINEIKKA
LSSGQGRITISSKYHYVYDKKDESKIIGIEIIEIPFGVVKSKLVADIDAIAIDKKISGIK
EVLDQTDRNGISIFIQLEDGANADAIIAYLMNKTELSISYSYNMVAIDNNRPVILNLYSA
LIAYLSHLKEVNINGINYDLKKFKLRLEIVEGFIKVAEISDEVIHLIKESDNSKKGVILA
LMNKFKFSELQATAIAELRLYKLSRMDQIEFQEEKKNLEIQIENCNKLLNDKWEFNQYLI
KQLLEIKNQYSKPRLTEISDQKIDKEIDHKLLTKNEDFYLYITKDGYYKKISLKVYTSNE
LNTFKLKEEDNVFYFDKVNSLSKILFFTNLGNYFIIDCHLFKDCNWKDLGQHISSIVALE
SSEKIIRVIEITSFNSYANFILMSKLGYAKKVNLRDFENKSSLKTKTCMSFKDDNDELID
AQISNDEKMLFILLNNGMYHLVSENELKVGISLKARGIRLLLNLYKHPQLQVSGFITVSK
YNNIIYLTQGGYIKCWDTSKLELTTRNTPKMLFTPLKNNILGLQSLAVTLSNLKMLYTDN
NGNLAEYDWKFILKDKTKESKLLKLDYSFTNPGYFITPIKINELIEADEIEQEKIRQEYQ
GYIDKNIELTAEHALIKKSYDQDIQHLNNEEQEELFQISTEDIELPNVSNNVNDNQKDKK
NIATKESVSQKIQEIEKIDLETIMQKIKQIKKK
>NP_458564.1|FEATURES|CARD|multidrug|golS|antibiotic efflux|0
MEKKSPRLKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAII
KIAQRIGIPLATIGDAFGILPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCI
GCGCLSRSDCPLRNPGDRLGEHGTGARLLEDD
>NP_253654.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MATYNADAIEVLSGLDPVRKRPGMYTDTTRPNHLAQEVIDNSVDEALAGHAKSVQVILHQ
DNSLEVIDDGRGMPVDIHPEEGVPGVELILTKLHAGGKFSNKNYQFSGGLHGVGISVVNA
LSTRVEVRVKRDANEYRMTFADGFKDSDLEVIGTVGKRNTGTSVHFWPDPKYFDSAKFSV
SRLKHVLKAKAVLCPGLSVVFEDKNTGERVEWHFEDGLRSYLTDAVAELPRLPDEPFCGN
LEGSKEAVSWALLWLPEGGESVQESYVNLIPTAQGGTHVNGLRQGLLDAMREFCEFRNLL
PRGVKLAPEDVWERIAFVLSMKMQEPQFSGQTKERLSSREAAAFVSGVVKDAFSLWLNEH
AEIGLQLAELAISNAGRRLKAGKKVERKKITQGPALPGKLADCAGQEPMRAELFLVEGDS
AGGSAKQARDKEFQAIMPLRGKILNTWEVDGGEVLASQEVHDIAVAIGVDPGASDLAQLR
YGKICILADADSDGLHIATLLCALFVRHFRPLVEAGHVYVAMPPLYRIDLGKDIYYALDE
AERDGILERLAAEKKRGKPQVTRFKGLGEMNPLQLRETTMDPNTRRLVQLTLEDATGTLE
IMDMLLAKKRAGDRKSWLESKGNLAEVLV
>BAA37152.1|FEATURES|CARD|quinolone|parC|antibiotic target alteration|0
MSESLDLSLEGVERRSLAEFTEQAYLNYSMYVIMDRALPHIGDGLKPVQRRIVYAMSELG
LDADSKHKKSARTVGDVLGKFHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPK
SFAAMRYTEARLSRYSEVLLSELGQGTVDWVPNFDGTLDEPAVLPARLPNLLLNGTTGIA
VGMATDVPPHNLREVASACVRLLDQPGATVAELCEHVPGPDFPTEAEIITPRADLQKVYE
TGRGSVRMRAVYRFEDGDIVIHALPHQVSGSKVLEQIAGQMQAKKLPMVADLRDESDHEN
PTRIVIIPRSNRVDVEELMTHLFATTDLETSYRVNLNIIGLDGKPAVKDLRQLLSEWLQF
RIGTVRRRLQFRLDKVERRLHLLDGLLIAFLNLDEVIHIIRTEDQPKAVLMERFELSEVQ
ADYILDTRLRQLARLEEMKIRGEQEELLKEQKRLQTLLGSEAKLKKLVREELIKDAETYG
DDRRSPIVARAEARALSETELMPTEPVTVVLSEKGWVRCAKGHDIDAAGLSYKAGDGFKA
AAPGRSNQYAVFIDSTGRSYSLPAHSLPSARGQGEPLSGRLTPPPGASFECVLLPDDDAL
FVIASDAGYGFVVKGEDLQAKNKAGKALLSLPNGSAVVAPRPVRDVEQDWLAAVTTEGRL
LLFKVSDLPQLGKGKGNKIIGIPGERVASREEYLTDLAVLPAGATLVLQAGKRTLSLKGD
DLEHYKGERGRRGNKLPRGFQRVDSLLVDIPPQD
>CAL71877|FEATURES|CARD|bacitracin|uppP|antibiotic target alteration|0
MSPQQEPTAQPPRRHRVVIIGSGFGGLNAAKKLKRADVDIKLIARTTHHLFQPLLYQVAT
GIISEGEIAPPTRVVLRKQRNVQVLLGNVTHIDLAGQCVVSELLGHTYQTPYDSLIVAAG
AGQSYFGNDHFAEFAPGMKSIDDALELRGRILSAFEQAERSSDPERRAKLLTFTVVGAGP
TGVEMAGQIAELAEHTLKGAFRHIDSTKARVILLDAAPAVLPPMGAKLGQRAAARLQKLG
VEIQLGAMVTDVDRNGITVKDSDGTVRRIESACKVWSAGVSASRLGRDLAEQSRVELDRA
GRVQVLPDLSIPRYPNVFVVGDMAAVEGVPGVAQGAIQGAKYVASTIKAELAGANPAERE
PFQYFDKGSMATVSRFSAVAKIGPVEFSGFIAWLIWLVLHLAYLIGFKTKITTLLSWTVT
FLSTRRGQLTITDQQAFARTRLEQLAELAAEAQGSAASAKVAS
>AJF82744.1|FEATURES|CARD|quinolone|gyrA|antibiotic target alteration|0
MSVSEIRPIAIEDELKHSYLDYAMSVIVSRALPDVRDGLKPVHRRVLYAMHELGNDYNKA
YKKSARVVGDVIGKYHPHGDSAVYETIVRMAQDFSLRYLLVDGQGNFGSIDGDSAAAMRY
TEVRMTKLAHELLADLEKDTVDWEDNYDGSERIPEVLPTRVPNLLINGAAGIAVGMATNM
APHNMTEVVNACLAYADNPNISIEGLMEYITGPDFPTGGIIYGKSGIVDAYRTGKGRLHI
RGKYHFEEDEKTGRTTIVFTEIPYQVNKARVIERIAELVKEKKLEGISELRDESDKEGMR
IAIDLKRGENAEVVVNNLFLNTQLENSFSINMVCLDNGQPKLMNLKDIIAAFIRHRQEVV
TRRTMFELRKARERGHILEGLTVALANIDEIIETIKTSANPAEARERLLAGEWAGGGVVA
LLEKAGAISVRPDEIEGEDPNRPFGLSDSIYRLSPTQVGAILELRLHRLTGLEQDKLHAE
YTEILGQIAELTAILNDFNLLMGVIREELAQVLQQYGDARRTEIVESRVDFCREDLIPEE
QVVLTVSQTGYAKTQPLSDYQAQRRGGRGKSATSMKDDDFIQHLIVASNHATVLCFTNVG
KVYRLKVFEVPQASRGAKGRPIVNLLPLDATETVTAILPLTEFPENHYVFMATASGTVKR
VELEQFANIRSNGLRAIELNEEDTLIGVAITDGNQQIMLFSNEGKAIRFAETDVRAMGRT
AKGVRGMRVSFASSTLSEEDADVENDDSDDNDDSTDSSLVSRIVSLVVVPETGEVLCASA
NGYGKRTPVNDFPTKKRGGKGVIAIKTSERNGELVGAVSIDETKELLLISDGGTLVRTRA
AEVAMTGRNAQGVRLIRLSEEETLVGVVSIEAVEDEEELLEGEVDTTETDSEEAVSNNED
TSEE
>ALJ89624.1|FEATURES|CARD|quinolone|parC|antibiotic target alteration|0
MTSLAHHATENRSVAEFTEQAYLNYAMYVIMDRALPHISDGLKPVQRRIVYAMSELGLKS
SGKPKKSARTVGDVLGKYHPHGDLACYEAMVLMAQPFSYRYPLIEGQGNWGSPDDPKSFA
AMRYTEAKLSAYSELLLSELGQGTSEWQDNFDGSLKEPITLPARVPNILLNGTTGIAVGM
ATDIPPHNLREVVKGTIALIRNPQTSDEKLAEYIPAPDLPTKAEIITPPEELLKIQTTGR
GSYRMRAVYTIEKNEIVITELPYQVSGSKVITQIADQMQAKKLPLVVDVRDESDHENPTR
LVIVLRSNRIDAEAVMSHLFATTDLESSYRVNLNMIGEDGRPQVKSIRRILLEWIEIRKK
TVTRRLQYHLNRIEKRLHILAGLLIAYLDIDTVIRIIREEDQPKPVLMEHFNIDEIQAEA
ILELKLRHLAKLEEMEIRHEQDELSAKAAIIREQLENPESLKNLIISELKEDAKKFGDER
RSPIVARAEAVQIKEQDLMPAETVTVVLSEAGWVRAAKGADVDAENLNYRAGDQYLSHAV
GKTNQRVYFLDETGRSYALPISNLPSARGLGDPLSSKLSPASGVSFIQVYLDDDESELIA
ASSAGYGFKTQTKQLDTNAKAGKTFLTVPDKAKALPLISAQNMTHLAVLSSAGRLLILDL
AELPNLNKGKGNKLIQLEGKEQILSMTTLNLDEIIQVVAGQQHLKLKGDDLQKYMGKRAS
KGQLLPRGYQKANKLLIQR
>YP_208874.1|FEATURES|CARD|beta_lactam|rpsJ|antibiotic target protection|0
MANQKIRIRLKAYDYALIDRSAQEIVETAKRTGAVVKGPIPLPTKIERFNILRSPHVNKT
SREQLEIRTHLRLMDIVDWTDKTTDALMKLDLPAGVDVEIKVQ
>EEK14408.1|FEATURES|CARD|polymyxin|arnA|antibiotic target alteration|0
MVEGEKLIPINIEDQMKTAYIDYSMSVIVSRALPDVRDGLKPVHRRVLFGMHELGVRSNT
AHKKSARIVGEVLGKYHPHGDSSVYDTMVRMAQWWNMRYMLVDGQGNFGSIDGDSPAAMR
YTEARMRKMAEDMLIDIDKETVDHSLNFDDTLLEPTVLPTRIPNLLVNGSSGIAVGMATN
MPPHNLAEVVDGIIAYLGNQDITIDELMEYIKAPDFPTGGIIYGYDGVREAFKTGRGRVV
IRAKAHFEEVNGRDCIVVTEVPYQVNPETMREQTSNLVKEGKLEGLADIVDQTGKGGMRI
VYELKKDAIPNVVLNNLFKHTALQSSFSVNNIALVNGRPQQLNLKDLIYHFVEHRHDVVY
RRTEYELKKAKERIHILEGFMKVMATEDTMGKAIEIIRFHDKPKEDLMTEFELTEIQAEA
ILALQLRRINKLLILQTKEEYEQLLAQIIDLEDILARKERRTEIIKEELLEIKSKYGDER
RSVIEYAGGDISIEDIIPDDQVVITISNAGYIKRTSVNEYKTQARGGVGQKASATRDKDF
IEHLFIGTNHQYMLFFTEKGKCFWLRVYEIPEGGKNTKGRAIQNLINIEPDDLVKAVICT
HDLKEKDYTNSHYVIMATKKGIIKKTSLEQYSRPRQNGIVAITIKEDDELLEARLTSGNS
QIMLAVKSGKAIRFPEDKVRAVGRSGSGVRGISLDSDKDEVIGMIAIENPLEETVLVVSE
NGYGKRTFIDEPETGEAVYRITNRGGKGVKTISITEKTGNLVAIKSVLEEDDLMIINKSG
MAIRLPVSGLRVMGRATQGVRLINIKGNDSIAAVAKVMKEDEDENTTEEIENPTEE
>NP_273462.1|FEATURES|CARD|beta_lactam|pbp2b|antibiotic target alteration|1
MLIKSEYKPRMLPKEEQVKKPMTSNGRISFVLMAIAVLFAGLIARGLYLQTVTYNFLKEQ
GDNRIVRTQTLPATRGTVSDRNGAVLALSAPTESLFAVPKEMKEMPSAAQLERLSELVDV
PVDVLRNKLEQKGKSFIWIKRQLDPKVAEEVKALGLENFVFEKELKRHYPMGNLFAHVIG
FTDIDGKGQEGLELSLEDSLHGEDGAEVVLRDRQGNIVDSLDSPRNKAPKNGKDIILSLD
QRIQTLAYEELNKAVEYHQAKAGTVVVLDARTGEILALANTPAYDPNRPGRADSEQRRNR
AVTDMIEPGSAIKPFVIAKALDAGKTDLNERLNTQPYKIGPSPVRDTHVYPSLDVRGIMQ
KSSNVGTSKLSARFGAEEMYDFYHELGIGVRMHSGFPGETAGLLRNWRRWRPIEQATMSF
GYGLQLSLLQLARAYTALTHDGVLLPVSFEKQAVAPQGKRIFKESTAREVRNLMVSVTEP
GGTGTAGAVDGFDVGAKTGTARKFVNGRYADNKHIATFIGFAPAKNPRVIVAVTIDEPTA
HGYYGGVVAGPPFKKIMGGSLNILGISPTKPLTAAAVKTPS
>NP_359110.1|FEATURES|CARD|beta_lactam|pbp2|antibiotic target alteration|1
MRLICMRKFNSHSIPIRLNLLFSIVILLFMTIIGRLLYMQVLNKDFYEKKLASASQTKIT
SSSARGEIYDASGKPLVENTLKQVVSFTRSNKMTATDLKETAKKLLTYVSISSPNLTERQ
LADYYLADPEIYKKIVEALPSEKRLDSDGNRLSESELYNNAVDSVQTSQLNYTEDEKKEI
YLFSQLNAVGNFATGTIATDPLNDSQVAVIASISKEMPGISISTSWDRKVLETSLSSIVG
SVSSEKAGLPAEEAEAYLKKGYSLNDRVGTSYLEKQYEETLQGKRSVKEIHLDKYGNMES
VDTIEEGSKGNNIKLTIDLAFQDSVDALLKSYFNSELENGGAKYSEGVYAVALNPKTGAV
LSMSGIKHDLKTGELTPDSLGTVTNVFVPGSVVKAATISSGWENGVLSGNQTLTDQSIVF
QGSAPINSWYTQAYGSFPITAVQALEYSSNTYMVQTALGLMGQTYQPNMFVGTSNLESAM
EKLRSTFGEYGLGTATGIDLPDESTGFVPKEYSFANYITNAFGQFDNYTPMQLAQYVATI
ANNGVRVAPRIVEGIYGNNDKGGLGDLIQQLQPTEMNKVNISDSDMSILHQGFYQVAHGT
SGLTTGRAFSNGALVSISGKTGTAESYVADGQQATNTNAVAYAPSDNPQIAVAVVFPHNT
NLTNGVGPSIARDIINLYQKYHPMN
>YP_499533.1|FEATURES|CARD|beta_lactam|blaOXA-1|antibiotic target alteration|0
MSNQYQQYSTVKKYWHLMRPHTLTASVVPVLVGTAASKIYFLGSEDHIKISLFIAMLLAC
LLIQAATNMFNEYYDYKKGLDDHESVGIGGAIVRNGMSPELVLRLAIAFYILAAILGLFL
AANSSFWLLPVGLVCMAVGYLYTGGPFPISWTPFGELFSGVFMGMFIIVIAFFIQTGNIQ
SYVIWLSVPIVITIGLINMANNIRDRVKDKASGRKTLPILLGKNASLTFMAIMYFIAYAF
IVLTIIIKPGGSLFYLLALLSFPMPVKVIRRFKKNDTPPTMMPAMAAAGKTNTFFGLLYA
LGIYISALFAGI
>AAN62561.1|FEATURES|CARD|glycopeptide|vanL|antibiotic target alteration|1
MKIILLYGGRSAEHDVSLLSAFSVVNAVYYNYYQVQLVMITRDGQWLKGSLLTEAPTSKE
VLNLTDSAYQGTPIQPGEIKEEDAIVFPLLHGPNGEDGTIQGFLETIGMPYVGAGVLTSA
CGMDKIMTKYILQAAGIPQVPYVPVLKNYWKENPKKVFEQCEGSLLYPMFIKPANMGSSV
GITKAENREELQNALQEAYRYDTRAIVEQGIEAREIEVAVLGNEDVRTTMPGEIVKDVAF
YDYNSKYLDNKIEMQIPAQIPEETQAKAQEFAKKAYTMLGGSGLSRCDFFLTNKNELFLN
ELNTMPGFTEFSMYPLLWEKTGLPYGDLIEELIQLGVNRFKQRQAFLTDVE
>WP_002530866.1|FEATURES|CARD|beta_lactam|ACU52_03190|antibiotic target alteration|0
MADDEKPDEQNQADRQGLVTGRHVGIQPVEIRDEIQNAYLDYAMSVIVGRALPDVRDGLK
PVHRRVIYAMYDGGYRPDRGWNKCSRVVGDVMGKYHPHGDSAIYDTLVRLAQPWAMRYKL
VQGQGNFGSQGNDGAAAMRYTECKMAPLAMEMVRDIDQDTVDFQPNYDNKETEPVVLPSR
FPNLLVNGSSGIAVGMATNIPTHNLREVNEAVQWSLAHPNASHEELLEACMERIKGPDFP
GGALIVGRQGIEDAYRTGRGSVTMRAVIDMEEDKKGRQCLVVTELPYMCNPDNLATKIAD
LVNSGRINGIADIRDDSSARTGQRLVIVLKRDAQPRVVMNNLYKHTALQDTFGCNMLALV
DNVPRTLRLDQFISYWIDHQMEVIRRRTEYRLAQAEKDAHIQRALVKALDMLDEVIALIR
RSPNTEAASTGLQELLDIDEIQARAILDMQLRRLAALERQKIIDRLEELERLIADYKAIL
ASEDRQREIISTELAEIVDKYGDERRTRIIAADGDFSEEDFIPDDDVVVTITRGGYAKRT
RTDLYRVQKRGGKGVRGASLRADDEMAQLFTTTNHQWILFFTNMGRVYRTKVWQLPEAGR
DARGGHVAGLLSFLPDEKIAQVMTLRSYDGAEYLLLATRKGMVKKTALKAYDSSRQAGVI
AVNFRTEDDELIGAEQCSAADDVLLISRKGQAIRFSAGDDQLRPMGRATSGVTGMKFRGD
DELLSMSIIHSDMPEDDRFVFTATGGGYAKRTAVSEYRQQGRGGVGIKAMALSEERGSLV
GGLVVSEADEIIAIKTSGQITRSAVSEVPAKGRSTMGVKFVSVRGGDAVSIIAVNPEHTV
EEEVADESVETVEGDATQAQSGGVVRRSDTVDDDRAVDTAGNDMKPEDNGE
>NP_415804.1|FEATURES|CARD|isoniazid|fabI|antibiotic target alteration|0
MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIV
LQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDIS
SYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPE
GVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGI
SGEVVHVDGGFSIAAMNELELK
>YP_006374661.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|1
MGMWCTLCTSYTYQTNKKYIVFLGGHFKMAKEKFDRSKPHVNIGTIGHVDHGKTTLTAAI
TTVLSKKNGGQAMAYDQIDGAPEERERGITISTAHVEYETDTRHYAHVDCPGHADYVKNM
ITGAAQMDGAILVVSAADGPMPQTREHILLSRQVGVPYIVVFLNKVDMVDDEELLELVEM
EVRDLLTEYEFPGDDVPVVAGSALKALEGDASYEEKILELMAAVDEYIPTPERDNDKPFM
MPVEDVFSITGRGTVATGRVERGQVRVGDEVEVVGIAEETSKTTVTGVEMFRKLLDYAEA
GDNIGALLRGVAREDIQRGQVLAKPGTITPHTKFSAEVYVLTKEEGGRHTPFFTNYRPQF
YFRTTDVTGVVELPEGTEMVMPGDNVTMEVELIHPIAIENGTKFSIREGGRTVGAGVVTE
IKA
>NP_249870.1|FEATURES|CARD|polymyxin|basR|antibiotic efflux|0
MKLLVVEDEALLRHHLYTRLGEQGHVVDAVPDAEEALYRVSEYHHDLAVIDLGLPGMSGL
DLIRELRSQGKSFPILILTARGNWQDKVEGLAAGADDYVVKPFQFEELEARLNALLRRSS
GFVQSTIEAGPLVLDLNRKQALVEEQPVALTAYEYRILEYLMRHHQQVVAKERLMEQLYP
DDEERDANVIEVLVGRLRRKLEACGGFKPIDTVRGQGYLFTERCR
>NP_217280.1|FEATURES|CARD|trimethoprim|dfrE|antibiotic target alteration|0
MTPYEDLLRFVLETGTPKSDRTGTGTRSLFGQQMRYDLSAGFPLLTTKKVHFKSVAYELL
WFLRGDSNIGWLHEHGVTIWDEWASDTGELGPIYGVQWRSWPAPSGEHIDQISAALDLLR
TDPDSRRIIVSAWNVGEIERMALPPCHAFFQFYVADGRLSCQLYQRSADLFLGVPFNIAS
YALLTHMMAAQAGLSVGEFIWTGGDCHIYDNHVEQVRLQLSREPRPYPKLLLADRDSIFE
YTYEDIVVKNYDPHPAIKAPVAV
>N8R5I6|FEATURES|UNIPROT_deepARG|beta_lactam|F991_03391|antibiotic inactivation|1
MLKSKPCSLSAKKVLVLTGLLSCSLPLWAQQLSEQQVKQVLDQQFKPLLEQYKIPGMAVA
VTLNGQHYFINYGVASKQSKQAVSSDTLFELGSVSKTFNATLAGYAQAQGRLSFSDHPAK
YFPALKNTAVNRATILDLGTYSAGDFPLQFPDSVVKQQDMLKYYQTWQPKSKVGTTRQYS
NPSIGLMGYVTALAMKKPYAELVEKTLFPQLGMTQSFINVPEQHMSKYAWGYKADQAMRV
SAGMLDAEAYGVKSSSSDMLKFLDTQINVQQLQQPIRKAIENTHVGYFKVGSMTQGLGWE
QYAYPVKLETLLDGNSSKMALESHAVTPIKQPKIASPATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYRSIEQLLQLQQVR
>A0A126VEX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVAHEGHTPGHLKLTHILLAMAPAVVLGLLFHEVIKSLFEP
KNVMYALVVGGVLLLTAEWLKPKKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATI
SGGMLVGVSRYAASEFSFILAVPMMIGASGLDLYKSLHFLTLADLPMFVVGFVTAFLVAL
VAIKTFLTLIKRISFVPFAIYRFIVAAAVYVVFM
>A0A0U1YUW8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIGQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>I0QVK9|FEATURES|UNIPROT_deepARG|beta_lactam|SPM24T3_07834|antibiotic inactivation|1
MKLQAVTATLIGLILASTAQAKSSEQEKVDQIIKPLMQQYQIPGMAIAVSIDGETTFYNY
GVASRQSRQPITNSTLFEIGSLSKTFTATLASWAQQQGKISFNDAASQYLPQLKHSAFDN
VSLLNLATHTSGLPLFEPEGVNTPQQLMDWYKQWKPTQPVGSVRVYSNMGIGLLGIIAAK
SLHQPFIDVMQQQLLPKLGMHNTFIKVPADKMAEYAQGYNKQDKPVRVGPGPVDAEAYGL
KSSSADLIRYLDINLHEQPIDASWQVAVDATHRGYYRVAGFTQDLMWENYAYPSPLELLL
KNNGSQIITDAQPTKAINPPQPPLEQAIYNKTGSTNGFSTYAMFVPVKKMAIIILANKSY
PNEARVKAAYQILATQKEGF
>U2FF67|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MISLKNITKSFKLGENEIEILHGINLEIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSGG
QYLLDGKDISKFDSDALAKLRRDKFGFIFQRYNLLSTMNALENVALPSIYAGANKSEREK
RANELLGSLGLSEKAKNLPNKLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGLRV
MEILVDLYKKGHTIIIVTHDPKIAEYASRVIEIKDGNIVSDNVKNGEIYEATKQTQPEKS
KFTYYKDQLIESFKMSVNAMLAHKLRSLLTMLGIIIGITAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMLSGKVKTLSISDANMLSKQSFLDSVTPNTSTSGVLTYENISL
SASLKGGGVGSFDVNGLKLEEGRIYDDDEVLNSASVALIDQNTKNSIFKNENPIGKIILF
NKKPLRIIGVLQKDDFKMGDSSTLKIYAPYTTVLNKVTGDKFISSVTAKVNEGVNAQIAE
KTLTELLEIKHGKKDFFTRNSDSIKQTIEETISTMRLLISSIAVVSLVVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIVLSYAIGYIFNNFLNGFS
MIFSNGSIVLALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>AAB47993|FEATURES|ARDB_deepARG|qa_compound|Qac|antibiotic efflux|0
MPYIYLLIAIITEIIGTSFLKSAEGFTKLWPTLGTLISFGICFYFLSTAMKYLPLNISYA
TWAGLGLVLTTLVSVIIFKENINLISIFSITLIIIGVVLLNVFGSGH
>A0A0K6LIM3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIKGINHLLFSVSDLEKSIEFYEKVFHAQLLVKGQKTAYFDLNGLWLALNLEADIPRNE
IHKSYTHTAFTIDPKDFDAILQRLKNLNVNILNGRPRDKQDQKSIYFTDPDGHKFEFRTG
TLQDRLSYYKKDKPHMKFYI
>E8KX99|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQTAQYIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLG
AILAVMVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNF
FVVAIMLVVYGIAFIWIEDRNRRVEPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGAT
ILGGIIVGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFIDGNTLTGGQAAILLVASVTAF
LVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLFYGAVKLIFG
>J2SE75|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTTFTVLILGMVEGLTEFLPISSTGHQIIVADLLDFDGERAMAFNIIIQLGAILAVV
WEFRRKILEIVSGLPTQRNAQRFTLNLLIGFIPAVVLGVLFADKIHEYLFNPITVAMALV
VGGIIMLWAERREHVVYVDHVDDMRWTDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQASDLPVFALGFVTAFVFAMIAVRGLLKF
IASHSYAVFAWYRIAFGLLILATWVFGWVNWTEAAAV
>A0A078LJ69|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEEQVEVLKGISLQIHAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRIAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKR
RLERAEELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
DEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPSQKTQAGQGIAEPV
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLNAIQKQPWVTSATPAVSQNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGNTFNREQLNGRAQVVVLDSNTRRQLFPNKAKVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGIGLSMLIAFTLQM
FLPGWEIGFSPVALLTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0Q5E8E1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAMGIAKAVVLAVVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAILA
VYFRRLLGITLALPNDPKARRFVLGILVAFLPAAIIGGLFSKYIKYYLFNPWIVCATLVA
GGIVLLVLDETDLEVKKRDVFDFTLPMDFRIGLFQCLAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAIPTMAGAFAKDLLDNYKNLSRDDTGLIVIGFIVAFISAFIVVRTVLDYV
ASHGFRLFAWWRIIVGSLGFAGLIIFG
>A0A0A0QAX5|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>D6I449|FEATURES|UNIPROT_deepARG|beta_lactam|ECCG_02785|antibiotic inactivation|1
MGFLRSGCYPDSCHADWYRYNLTYRQCKSGPPMAGRFVWKPDLMFKTTLCALLITASCST
FAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQP
LKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNMNPR
DINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>R8KQR9|FEATURES|UNIPROT_deepARG|beta_lactam|ICS_02473|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRNLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALDALKTTNK
>YP_002638786|FEATURES|ARDB_deepARG|multidrug|tolc|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDV
TYQTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEA
ENRNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNSAQYDDSNM
GQNKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASIS
SINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLN
IKYALGTLNEQDLLALNSTLGKPIPTSPESVAPETPDQDAAADGYNAHSAAPAVQPTAAR
ANSNNGNPFRH
>A0A0F3UL57|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0M3BKH5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTAALLSFTVAAFGSSGHALAASEADRIAAIVDKAIEPAMKEHGVPGMAVAVTIDGRRYF
RNYGLASKEGNMPVTEDTLFELGSVSKTFTATLGAYAQVTGKLSLEDHAGKYIPELEGSA
IDKATLLHLATYTAGGLPLQFPDEVGTDKQMRAYFKRWKPAAAPGEQRRYSNPSIGFFGH
ITGIAMGRDFREAMEGELFPKLGLSHSYITVPSAAMKDYAWGHNKAGKPVRVNPGMFAAE
AYGVKSSTSDMVRFVEANIEPGKLDGAVAQAVEGTHVGYFRVGEMVQGLGWEQYPYPVTL
ERLLAGNAQTMAMDAHAAKALTPPQQPVPATLYNKTGSTGGFGAYVAFVPEEKIGIVMLA
NRNLPIPARIKAAHAILEQLAGQTE
>A0A127STN6|FEATURES|UNIPROT_deepARG|beta_lactam|CfxA6|antibiotic inactivation|1
MLNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSIS
QIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVK
INREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFI
AKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNAL
KECKTGIDRIVAPLLDKEGVVIAHKTGSGDVNENGILAAQNDVAYICLPNKVCYTLAVFV
KDFKGNESQASQFVAHISAVVYSLLINTALN
>A0A105KRF0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILIFKTLILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRRRIASVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILLAEARQRERGDAPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>A0A011ELX9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKNQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVGIMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNGIKK
>A0A0Q9UPW9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MGIKMDEYELLDKDSGPYGITAGKDGALWFTQHKANQIGRMTVNGEVTPFVVPTPNAGVL
SITSTTQGDIWFTENRANKIGKLTGTGEIIEYTLPSPNSAPFGITEGHNGDIWFTEMNGN
RIGRILSSGEIIQYDLPSPGSYPSFIVAGTDGAIWFTENQSNQIGRITMLGEVTNYTLPT
KNAGPVGITSGPDGALWFVEINGNKIGRITTSGTLCEYTIPTAGARPHAIGTGPDCALWF
TEWGSNQIGRITMQGEITEYPIPTQNAEPHGIASGPDGAIWFTEECNKIGRLSIL
>A0A0L0K4Q7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPLHITEFPVPDPESGPYGITLGPDGALWFTMVHSGHIGRLTPDGDVTTYPLDTPGTGPT
VITPGPDGALWFTEFRGHRVGRITVTGEVTSFPLPTPDAGPFGIVTGADGAVWCTEANVG
RIARITPDGTVTEFPLPDAGAFPSGIAAGGDGRLWFTLNQANAIGAMSYEGEVTVYPLPT
PNAGPVGITAGLDDAMWFVEIGAGQIGRIELTGDIREFSLPDPTARPHAITAGPDDAYWF
TEWSSNGIGRITPKGEITSSPLPTPSSEPHGITLGPDGALWTALETGTIARLTPTTKGS
>S4MS04|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MADRDAGPYGITAGPDGALWLTFVHSGRIGRLTLDGELTEYALDSPSCRPMVIAPGPDGA
LWFTRSADHRIGRVTVAGETESFALPTPDCGPYGITAGPDGALWFTQMNTDRIGRLTTGG
EITEFALPVTGAFPSAITPGPDGALWFTLNQANAIGRITVTGDIRLHPLPTPDAAPVGIT
SDGTDLWFVEIAAGQVGKAATDGRIEEFPLPDRTSRPHAITATSPGDCWFTEWGTNRIGH
LTPKGKLLEHPLPSPHSEPHGITTTPDGTVWAALETGAVARVAP
>A0A097R812|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNKSTDNTIKKVSVVIPVFNEQESLPILIKRTHAACELLNKPYEIILIDDGSHDASAEIL
TQAAEIPENHIVAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVETAE
QGYDVVGTVRAKRKDTWFRKTASKMINMMIQKATGKSMGDYGCMLRAYRRPIIEAMLHCH
ERSTFIPILANTFARRTIEIDVRHDEREFGESKYSFLKLINLMYDLVTCLTTTPLRLLSI
VGSVIALSGFTLAVLLIAMRLIFGPTWAAEGVFTLFAVLFTFIGAQFVGLGLLGEYIGRI
YNDVRARPRYFVQKIVSADALKTHESVEQQEEE
>A0A0V8JKB8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQGINHCCFSVSNLAQSIGFYKQVLGANLLVTGTATAYLDLNGLWIALNEEKHIQRNEI
HDSYTHFAFSIKAGDLKCFEAKLAAYHVPILKGRTRDERDRESIYFTDPDGHKFEVRTGT
LEDRLRYYKETEPHMVFVEEGKGK
>A8MN40|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNMNVELSAPLAVANGNGEPLLRLQGVSRSFLAGDREFLALKGIDLQIHSGELVAIIGAS
GSGKSTLMNILGCLDNASSGSYQVGGQETRTLGDDALAALRRDHFGFIFQRYHLLPHLDA
LHNVEIPAVYAGTPQAQRHARARELLTRLGLVGHLGHRPSQLSGGQQQRVSICRALMNGG
QVILADEPTGALDTASGKEVMNILLELHAAGHTVILVTHDPKVAAHAERIIEVSDGQIVS
DRRTGTAAVPTPAAEPPRAAEPARRLVASLGMFREAFKMAWIALISHRMRTLLTMLGIVI
GITSVVSISAIGEGAKGYVLKDIQAIGSNTIDIYSGSNFGDSRAKTIETLVPADVTALNA
LYYVDSATPVIGQSTLVRYRNLDVDVQLNGVSEHYFQVRNIPLAAGIVFSADDARRQAQV
VVIDHNTRKRLFGPHVDPLGQVILVGNLPCTVIGVTAENKNLFVASNQLNIWVPYETAAG
RVLGQRHLDSISVRIKDGVPSKRVEEEVTKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSL
TLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCL
FGGVVGIGLSYGIGYLFELFVKQWEMVFSPASIVMAFACSTLIGVLFGFVPARNAARLDP
IEALARD
>A0A084IXL3|FEATURES|UNIPROT_deepARG|beta_lactam|er45_18715|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQTNQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>F0JWD5|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVVFAYHDMGCLGVQALLDAGYEISAIFTHADNPAEKVFYGSVSRLAALAGIPVYAPD
DINHPLWVERIAQLAPDVIFSFYYRNLLNNEILKLAPHGAFNLHGSLLPKYRGRAPLNWV
LENGENETGVTLHRMVAKADAGAIIAQQRVAIDPEDAALTLHKKLCQSASQMLEYALPAI
KQGQTQETAQNESEATYFGRRKPEDSFLDWNKPATVLHNMVRAVADPWPGAFSYVGTQKF
TIWSSRVHPRVNAAQPGSVISVAPFLIACGDGALEIITGQSVDGITMQGSQLAQTLGLVE
GSRLNSQPVCTVQRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLTHP
NFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VQYHKRIIFPSTSEVYGMCTDKFFDEDHSNLIVGPINKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENTGNRCDGEIINIGNPDNEASIEELGKMLLASFDKHPLRQHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPTIDMQETIDETLDFFLRTVDIVEKSS
>ABN48512|FEATURES|ARDB_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFN
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>A0A0W0AKG9|FEATURES|UNIPROT_deepARG|beta_lactam|VO68_15095|antibiotic inactivation|1
MKGWIKCGLAGAVVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFV
YFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPELI
DHYEALIKAAPQA
>D6I818|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGRTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGILKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A109BKN4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPIWEVILLGLIEGLTEFLPVSSTGHLLLTEHFLDICNPGKSFEVLIQLGAILAILSVYS
VKLTRVALAMPHDARARRFVASVLLAFLPAAFIGALAHDFIKTVLFETPMLIASMLVIGG
VVLLVVDRMKLNVRYNDAMDFPPSLAFKIGVMQCFAMIPGVSRSGATIVGAMLLGTDKRS
AAEFSFFLAMPTMAGAFAFDLYKNSAILSTADVTNIVIGFITAFIAAVFVVKHLLDYVSR
HGFALFGWWRIIVGSAAIIAMLAMGDTSGSCVVH
>A0A089KXD9|FEATURES|UNIPROT_deepARG|aminoglycoside|R70331_17715|antibiotic inactivation|1
MNTRALLDQIAALFKEELKENLTGIYLHGSLAMGCFNPLKSDVDFLVVVKDKLTAVNHSN
IAKIALSLHDEMSDASNERGVEFTIILETYLNAFVYPTPFEFHYSDYHREKYRADENYLC
GGFEDKDLASQIVVAYERGIALYGEPLSELYEPVDSQYYLDSILNDVEGCAAEIVDNPPA
YLTPTYLTLNLCRVLYYVKEGKIASKREGGKWGITYLPQRFLPLVRHCLTSYNSEAADGE
NSNSAPDVQSLLAFVEYMIQEIKQGLALDDLLNSH
>CAD13485|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISRKKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>D0W3H5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFMIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLVGFHSNHKVFEIAIQLGAVLAVVF
EYRQRFAGVLHGLGKDKKANRFVLNLAVAFMPAAVMGLLFSKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSYTVPKKIDVDALRPVDALMIGIAQVFALIPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYQFFTLHDIGLILIGFVAAFVSGLVAVKALLR
FVSKKNYIPFAYYRIVFGIAIIILWLSGWISWE
>A0A103T3F3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MRSQPLLKLAAVTRRFPAGDKDVVVLNNVNLSIDAGEIVAIVGASGSGKSTLMNILGCLD
HPSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPR
AERHARARALLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTK
SGQDVIRILHELNALGHTIVIVTHDKAVARHARRIIEISDGEIIADRPNRHYAEALAEAL
AEAPAEALVEVGADAAASTPSAPAADDARPPVGADPVANADPAPPARRFAAGTGRFAEAC
RMAWIALVSHRLRTLLTMLGIIIGITSVVSIVAVGEGAKRYMLEEIGSIGTNTINVYPGT
DWGDSRADTIQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNIDVNALVSGVGDRYFQ
ARGMRSALGVAFDDDAVRRQAQVAVIDQNTRRKLFGATRNPVGEVILVDNVPCVVIGVTA
DKKSAFGSVKSLNVWVPYTTASGRLFGQRYLDSITVRVRDGQPSAAAEKSLEKLMIQRHG
RKDFFTYNMDSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIR
MAVGARQSDILQQFLVEAVLVCLLGGTIGIALSFGLGALFSMFVTQWKMVFSAGAIVTAF
VCSTLTGVIFGFMPARNASRLDPIDALARD
>P80545|FEATURES|ARDB_deepARG|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
QPANAKANIQQQLSELEKNSGGRLGVALIDTADNSQILYRGDERFPMCSTSKVMAVSALL
KQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTAMNKILEH
LGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPQAMAISLQNLTLGKALAE
PQRAQLVEWMKGNTTGGASIRAGLPTTWVVGDKTGSGDYGTTNDIAVIWPANHAPLVLVT
YFTQPQQNAEARKDVLAAAAKIVTAGL
>N9AJJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWTRLWGAATGIVSGEPQGRRLGIGLILASIPIILIGLTFGQTVKELLFNNIAIAIG
LIVGGLIIIWIEKNPPQVRAQEVEDLTIKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIVGAGLLDLYQSYDVFSGTQDWVVLTVGLLVSFISALLLIRAL
VAYVAKRDFMIFAWYRIVSGLLILLFAYTGWTLW
>A0A0N0CMI1|FEATURES|UNIPROT_deepARG|beta_lactam|AM629_10065|antibiotic inactivation|1
MKHSPLRRSLLLAGITLPLVNFAFPAWAGAIPSSLHKQLAELENSAKGRLGVTLINTVNG
QAIQYRGDERFPFCSTFKLIVAAAVLHKSMSQSDLLAKHINYSEVDLLSYAPIARKHLDQ
GMSITQLCAATLQYSDNTAANLLIKELGGVAAINHFTQSLGDHTFRLDRWEPDLNSAIPD
DPRDTTTPAAMAASVNKIAFGAVLAASQRDQLIDWLKGNTTGDASIRAGAPAGWVVGDKT
GGGDYGTTNDVAILWPPKGAPVILAVYFTQFQQDAESRRDVLASATRLVMEHLA
>A0A084J6H3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRIGRINATGEINSFPIPTANAGAM
SIISDQTGDLWFTEYNSSKIGKMSMNGLFEEYVLPTTNAAPFGITEGPDGAIWFTEMNNG
RIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPT
PNSGPVGIASGPDGAIWFVQIIGNKIGRITFEGEIKEFVIPTPNARPHAIIPGKNRDLWF
TEWGGNQISRITVEGVITEYTIPTNNAEPHGITFCPDGDLWFAEECNQIGRLTIIT
>A0A0S2FIQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGIIEGITEFLPISSTGHLLIAQHWLGARSDLFNISIQAGAILAVVVIYWK
RLWGLATGFTQRDNLDYLLKLGLAFGLTAVLGIAVKKAGFTLPDHVTPIAWALVLGGVWM
VAAEHFAAKRAAALGERAEITWTVAALVGIAQVVAGVFPGTSRSAATIFIALLAGTTSRA
AATEFAFLVGIPTMFAASGYELMHVLGTPAAANEDWSALAVAFIASAVTAFIAVKWLLRY
IQSHRFTAFAVYRVAFGAALLLLMPSGS
>A0A0V9E1W6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGDGPVEVLKGISLSVEAGEMVAIVGASGSGKSTLMNILGCLDKS
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRESRAAAPKEALP
ASTGWAQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWANSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
AMAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQMFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>YP_002937728|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEIFDIIKSVIFGIVEGITEWLPISSTGHMILLNEILPLRIGKNPDDFYSMFEVVIQLGA
ILAVVVLFWSQIWPFGRKNNKAPLAKTGIGAWVKTDIFVLWFHILVSTIPAAIIGILFDD
VFERLFYNFQTVAIMLILFGIAFIVIETRHNGKSAKINSLVDISYTTALMIGFFQLIAAV
FPGTSRSGATIVGALLIGVSRTVAAEYTFFLAIPVMFGASLLKLVKFGFHFTGEEAAILI
IGMIVAFVVSLIVIKFLMGYIKKHNFIVFGWYRIVLGAIVLLCGIAGLL
>D3J1E5|FEATURES|UNIPROT_deepARG|beta_lactam|blaTem|antibiotic inactivation|1
LPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPXMSTFKVLLCGAV
LSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLT
TIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLT
LASRQQLIDWMEADKVAGPLLRSALPAGWFIA
>A0A0A0CTA2|FEATURES|UNIPROT_deepARG|chloramphenicol|KS18_02010|antibiotic inactivation|1
MNYLKIEIDRWDRKEHFLHYRNIVQCGFSLTTKIDITHLLSSLVEKRYKFYPTMIYLISK
VVNSYSEFRMSIKDEELIVWDDVNPAYTIFHKETETFSAIWTEFNSDLEEFMKNYSADYE
TYKDNLCFFSKPELPENHFHISSVPWVSFDGFNLDIANFTDYFPPIFTMGKFYQDGNQTR
LPLAIQVHHAACDGFHVGRVINKLQELCNDFV
>A0A0L7AKK3|FEATURES|UNIPROT_deepARG|beta_lactam|AC067_05550|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPEWARGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLNPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A063U6S2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNQVKMTEFPVGKPEEALYGVASTPDGALWFTLAKGNAIGRLSPDGEVSRFPLPHADGQP
TTITCGPDGRPWFTLSSANAVGRLSPDGALRMFELPRPASRPFGIAAGHDGCLWFAEMAG
DRIGRITIDGDIEEYDLPVKGGYPSCIAAGRDGLMWFTLNQAGAIGSISATAAPRIFPLG
AADAAPVGIASDAQGALWIAQAGNGAIARFDAGGRITEFPLHSRAARPHAIAADAAGNLW
FTEWGANRIGRISEAGDPAGYELAAPGSEPHGIAIDPHGCVWAALETGSLVRLQALPRD
>YP_622885|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MNNLHNTNGLMRFAKVAAASTLLATLLAACAVGPDYKRPDAAAPAAFKEAPTLAAGEQAG
TWKTAEPADGEHRGEWWKVFGDPVLDSLETQALAANQNLKAAAARVEEARAATRSARSQW
FPQVGAGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVGRNVEASRAD
QAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELREQALKLVQRRFNEGDIS
ELDVSRAKNELASAQADAVGVARRRAASEHALAILLGKAPADFAFKETPIVPVAVKIPPG
LPSALLERRPDVSAAERAMAAANARIGLAKSAYFPKLDITGSFGYEASTLGNLFLWSSRT
FLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLADLRLL
DDQIRAQDAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVST
VNLIRALGGGWGNAPAPTAVGDAASGKADVAAR
>A0A0K1QU26|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCTGIETLLDSGYEIAAVFTHADDPKENAFYASVAQLCARRGIAVHA
PEDVNHPLWIERISQLTPDYLFSFYYRQLLSEPLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAILAQKNVGIERSDTALSLHGKLRGAATDLLRDTLP
ALLAGKVSETPQDESQATTFGRRTPADGKLIWQKPAEELFNLVRAVTQPYPGAFCAVGEH
KLVVWSAEVVKGNEGQMPGRVISVDPLRIACGEDSLVISAGQRNDNGLYLSGPQLAGELG
LVDGSVLRGAESARTPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAISRLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYHKRVIFPSTSEVYGMCQDDKFDEDTSSLVVGPINKQRWIYSTSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNRNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGAGYQDVSHRKPSIDNAKRLLDWTPTVEMSETIGNTLDFFLREALLEIA
DNA
>ZP_03028356|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYATD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>C6E5W3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIFEAIILGIVEGLSEFLPISSTGHLILASALMKLQQSEAHKVFEVTIQLGAMLAVVQI
YRKQLLARPELLKKVCFAFLPTGVLGYLLYKAVKSFFLPSLVSYTLIAGGIAFILIELWM
KNRPASTASLDHMSYRQAFAIGTIQSLSMVPGVSRSGATIMGGLIIGMNRKDAAEFSFLL
ALPTMLAATCYDIYKNYSAFHAGDWQNIAVGFVTSFVFAVIGIKALLKIITSHTFIPFGI
YRIAVGIVFLVFLT
>ZP_04279826|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNTKVETFYPGKGHT
EDNIVVWLPQYKILAGGCLVKSAEAKNLGNVADAYVNEWSTSIENMLKRYGNINSVVPGH
GEVGDKGLLLHTLDLLK
>A0A0B4ZW49|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
AFLFLLHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGA
VLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLL
TTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELL
TLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIV
VIYTTGSQATMDET
>J6HCV7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARIAAEQGIPVWAPE
DVNHPLWIERIREIKPDVLFSFYYRNLLCDDIVNIAPQGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGNIVAQKSVAIGADDAALALHRKLCSAASELLAKALPAI
RDGKTQERAQDESQATYVGRRTPEDGRLDWERSAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLAAAKAGTVISVAPLVVACQEGALEIVTGQTERGVYMQGTQLAQALGLVA
GAVLSSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDNNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVVWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWVPTVEMEETVEHTLDFFLRTVELTDSGK
S
>ABU97164|FEATURES|ARDB_deepARG|beta_lactam|CMY-2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFHQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>H2JIM1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLFVLKSIVLGIVEGVTEFLPISSTGHLIIFENIMGFKSASPNYVEMYTYVIQLGAI
LAVVLLYWKKIKETIINFFPQKVGYEKSGFKFWFMIFIACIPGAAVKLLLDKPVETYLMT
PVTVAIVLILGGLWMIYAEKKFRNNNLGKQKLSVTPKQALIIGAFQCLAIIPGMSRSAST
IIGGWVAGLSTVVGAEFSFFLAIPVMFGYSLLEIIKIGGLTSLPAAELISLVVGFVVAFL
VSVAVISQFISYLKRKPLKSFAIYRMIFAVIVLIAGFMGFFK
>A0A0C5JU56|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLALKAVILGVVEGLTEFLPISSTGHLILVGSLLNFNDEKGKIFDIVIQFGAILAVC
WEFRAKIAQVVLGLGNDSKARRFAVNVIIACLPAIVLGLLFGKHIKAVLFNPIVVATAFI
VGGVIILIVERHNRRNAAAGNLPRVTSLDDLSALDALKVGFAQCLALVPGTSRSGATIIG
GMMFGLERRVATEFSFFLAIPILFGATIYELYKSRSMLAVEDFGLFGIGFVFAFISAFIC
VRWLLRYIASHDFTAFAWYRIVFGLIVLASAYSGLVVWAD
>A0A0D5C9H1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
KAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVA
MNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLT
LGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGFGS
>A0A0S1RIW9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILVQQGTRQDCTQRYTPASTFKLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQ
PTDPARWIKYSVVWYSQLTARALGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPFEQVDFLRKFVNRQLPVKAAAYDLAENLFEVGEADGW
>A0A0C5G322|FEATURES|UNIPROT_deepARG|aminoglycoside|TU94_25875|antibiotic inactivation|1
MSDHAGPRTVSPALLGAGGGGDWLPVTAGESGAFVFRSADAARYAKCVPAADAAGLEAER
DRVEWLSGRGVPGPRVLDWSSGDAGACLVTSAVSGVPADQVSAEELRLSWGRVTDAVRRL
HEVPVPECPFRRGLDAMVALARDVVARGAVNPEFLPVEQQHLPPAELLARLTGQVPRRRE
QEVADTVVCHGDLCLPNIILDPRTLDVSGFIDLGRLGLADRHADLALLLANARETWPDEQ
WARAADAAFAERYGIAVDHDRLRFYLHLDPLTWG
>A0A0R0A2T7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKSVRTLFSRVGLTAVVAALLISGQVQAADSDSHLKSTVDAQAKSLMKAHDIPGMAFGI
IVDGKSSFYNYGLADKQSGKAVSENTIFELGSISKTFAATLASYSELNGTLDLEDTADKY
IPYLQDSAIGNTKLINLATYSAGGLPLQVPNDVKNNKELFRYYKSWQPAFPINSKRLYSN
ASIGLFGHISALSMGADYTQVMEDKILPLLNMPSTFVNVPNDKMDDYAFGYNAAGEPIRV
NPGILDAEAYGIKSTSADMTHYMAANMGLIPLDKNIQQSLQNTRKGYYQASTVTQGLAWE
MYPFPTQLDTLLEGNSTDVVLKPQPIIANNQPTPVLNDVWVNKTGATNGFGGYIAYIPAK
KSGIVILANKNYPNAERVKAAYTILQSAMAN
>X2JVF6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPRLSSKVRWVSTMNIIEIKQLNRYFGEGENRVHVLKDISLSIERGDFVAIMGQSGSGKS
TLMNIIGCLDTATGGSSKIDGKETIELTNDQLSDLRSQKFGFIFQRYNLLSSLTAAENVA
LPAIYAGMPQSQRLERAKQLLEKLGLGDKWQNKPNQLSGGQQQRVSIARALMNGGEIILA
DEPTGALDSHSGENVMEILRQLHEEGHTIIMVTHDKHIAASANRIIEIKDGEIISDTQKR
QVKSAVKNPSVFKGRFGFSKDQLMEAFRMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVA
LGNGSQQKILENIRGIGTNTMTIFNGNGFGDRRSRHIQNLKISDANTLSKQSYIQSVTPN
TSSSGILVVGNKSFTSANLYGIGEQYFDVEGLKLKQGRLLTEDDVDQSNQVVVLDESAKK
AIFANENPLGKTVIFNKRPFRVIGVVSDQQLGGFPGNSLNLYSPYSTVLNKITGGSRIGS
ITVKISDDVNSTVAEKSLTELLKSLHGKKDFFIMNSDTIKQTIENTTGTMKLLISSIAFI
SLIVGGIGVMNIMLVSVTERTKEIGVRMAIGARQINILQQFLIEAVLICLIGGVAGILLS
VLIGVLFNSFITDFSMDFSTASIVTAVLFSTLIGVLFGYMPAKKAAELNPITALAQE
>J3D5H8|FEATURES|UNIPROT_deepARG|beta_lactam|PMI16_03612|antibiotic inactivation|1
MYRQVINTLCAVSAFTLFTGCSSYADNTATQPDIQGTVDAAIRPLMEKYAIPGMAVAVTI
DGRNYFYNYGVASRASGQAVTNATLFEIGSLSKTLTATLASYAQVNGRLSLSDSVSRHLP
YLSGTPFDNISLMNLGTHTAGDFPLQLPDEVTNDEQLMDYYKNWKPTHAAGTYRTYSNPG
IGLLGVVTAKSMRMSFADAMEKTLFPRLGMTHSYIHVPAEQMKNYAQGYNKFDAPVRVNP
GMLADEAYGVKTNTLDLIRFINANMGLVGLDGKLQQAVTDTHTGYFKAGEITQDLIWEQY
PDTSPLERLLAGNADQMVYQGVAATAISPPLPPQAAVFLNKTGSTGGFGAYALYAPAKKI
GIVMLANRNYPNAQRVTAAYRILSELDKQNAPRR
>A0A077DH69|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIELQGINKYFGSDNNRTHVLKNIHLSIKKGDFVAIVGTSGSGKSTLMNIIGCLDTAD
SGSYTIDGKEISHFNADELSDLRQKKFGFIFQRYNLLSTLNAADNVALPAIYSGMDQKSR
HERAISLLDKLGLKDKIYNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSASGQ
TVMEIIQQLHAEGHTIILVTHDKQIAEYANRVIEIKDGTIIRDESKSTDIVDKPVEIQQA
KRTWRFYKDQLFESFKMSIQAIIAHKLRSLLTMLGIIIGITSVVSVVALGNGSQQKILSN
ISALGTNTMDIMNGKGFGDRRADRVRNLTVADSDILARQSYIVSSTPNSSVSGTLTYGSN
SYTAYIKGVGVQFFDVKGIQSIEGQFFTQEQVKHSEQVAVIDQNTFQQVFHSVSPIGKVI
MVNKKPLRIIGVAKTQNNMGMQSNYLNIWIPYTTAMNKISGDRHIDSITVKVKDDINSQV
AEKNLTELLTMRHGKKDFFVMNTDTIKQTIENTTNTMKILISSIALISLIVGGIGVMNIM
LVSVTERTKEIGVRMAIGARQSSILQQFLMEAVLICLIGGITGIILSFIVGGIFNASSSE
FVMIFSTFSIVAAVLCSTLIGVIFGYMPARNAARLNPITALARE
>A0A0T0PT47|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDLLTAVILGIVEGVTEFLPVSSTGHLVLATELLGYDPQRWAVFNIAIQPGAILAIVVL
YWRTFLAVLTGLTKREPQSIAFVRNLLIAFVPAVALGLAFNDEIEALLENAVVVAWALIA
GGIAILVIERLAKTHPVGGIAGVSAMQSAKIGIVQCIAMIPGVSRSGATIMGAMALGIDR
RTAAEFSFFLALPTLTGATVLQMLKHRDAITGGDLQLIAVGFVVSFVVALAVVKAFLAVV
TKHGFAPFAWYRIVAGVAALAFLTLK
>ABH08225|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVLSLELPEVKGMGRFGYVPYVGYKCINYVSVSSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHSINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>A0A0F4T8L8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLTTVKVLILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILEIITGLPTQRNAQRFTLNLLIGFLPAVVLGVLFADKIHEYLFNPITVAVALV
VGGIIMLWAERREHVVYVDHVDDMRWTDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQAGDLPVFALGFVTAFFFAMIAVRGLLKF
IASHSYAVFAWYRIAFGLLILATWVFGWVNWTEAAAL
>S3IUZ0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MMTPAPIKKVSIVIPVYNEQDSLPELLRRTSEACQKLNRDYEILLVDDGSSDDSAAMLTR
AAEAPDSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIVTLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSWFRKRASKMINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRAIEIPVHHDERQFGDSKYSFMRLINLMYDLITCLTTTPLRLLSVVG
SIIALSGFGLAVLLVVLRLALGPQWAADGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVSSETALSSEENQ
>Q6UIU7|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGK
>A0A069BA71|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIIDVVTGLPAQREARRFTMNVVIATVPAVALALLFEKTIKSVLFAPVPVAVALV
VGGAAILWVEGRQRERSEPARVQSIDALTPFDALKVGLAQCCALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPVIFGATLYETAKDWRAFNVDSVGLFAIGLVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIAFGLFVLLVGYSGWIEWT
>AAG34690|FEATURES|ARDB_deepARG|glycopeptide|vanHB|antibiotic target alteration|1
MRKSVGITVFGCEQDEANAFRALSPDFHIIPTLISDAISADNAKLAAGNQCVSVGHKSEV
SEATILALRKVGVKYISTRSIGCDHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAI
RGAKPTMHAVAQQDFRLDRIRGKELGDMTVGVIGTGHIGQAVVKRLRGFGCHVLAYDNSR
KMDADYVQLDELLKNSDIVTLHVPLCADTRHLIGQKQIGEMKQGAFLINTGRGALVDTGA
LVEALESGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTER
VLQDTTEKTIRNCLNFERSLQHE
>A0A084IRZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKAEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIAIPVMAGATGLDLLKSWKYLSVDDIPMFAVGFITSFLVATLAVVTFLKLL
EKIGLKPFAYYRILLAIVFTLFVLL
>Q689F3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA23b|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWDSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVIGK
>ZP_03065389|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYVGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLCLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0C2V4Z7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILQAIIIGIIEGFTEFLPISSTGHMIVASEFLGIEQSTVFKAYEVIIQFAAILAVMLL
YREKINLKEIDLWQKIMVAFLPLAIIGFLLKDWVKEIFVTSTVAWMFIIGGIIFIIVEYF
HKDEACEAKEVESVTWKQALIIGFGQVLSLIPGTSRAGSTIIAGMLAGVNRKASTEFSFL
LAIPVMMAVSGYDLLKHYHEFMGADLTAFVVGFVVAFVVAYVTIKLFIVFLQRFTFVAFG
IYRILFGIILLMIL
>J9SSY2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA243|antibiotic inactivation|1
MTVRLSSCALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPDYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
LKAAAYDLAENLFEVGEASGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>YP_002225954|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAEEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0X8QA24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGEKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGTGRLSLIHILLGMVPAVVVGLVLHDQIKTLFNPIN
VMYALVVGGVLLLAAEYLKPKQPKAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDMYKSIGFLTMADFPMFAVGFVTAFIVALIA
IKAFLELIKRISFVSFAIYRFIVAAAVYMVFM
>A6MFP0|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
VIALVLSACNSNSSHTQELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAI
NSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNK
IIKEIGGIKKVKQHLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANG
KLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSE
PIVLVIFTNKDNKSDKPNDK
>A0A0F3FSN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDLILIFKAIIISIVEGLTEFVPVSSTGHMILVGELIDFKGEFANMFTVVIQLGAILA
VVVLYWKKISSSVVQFFQYIFTGGKEGKTGFRFGINVIVGSIPAMIIGLLLHDAIKGLFT
PVAVIYGFIVGGILLIVIENIFRKRRPKATNIDDITPKESLVVGVAQCFAMWPGMSRSAS
TIMGGWIGGLSTPVAAEFSFFLAIPAMFGSTLLDMIKFDYSIMDTTNWVALAVGFVVAFI
VALVVMNKFVSYLKKKPMRVFAVYRVIVGVLLAVLVFTNIISLPPL
>C9Y042|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELRDIRRSYPSGETEVEVLKGVTLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVATLGDDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAIYAGTGRAA
RQARARELLARLGLEARVEYQPSQLSGGQQQRVCIARALMNGGQVILADEPTGALDSHSG
EEVIATLKQLRDRGHTVIIVTHDPDVAAQAERIIEIRDGEIISNPPPVGKRDVAGLSAQP
HDAPALGQFINSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
EDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQAIQRQPWVSSATPTVSQSLRLRYG
NVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRAQVVVIDSNARRQLFPNKANVVG
EVVLVGNMPATVIGVAEEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSITVRVKEGYD
SGEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARKSDVLQQFLIEAVLVCLVGGALGIGLSLLIAFALQLI
LPGWEIGFSPVALLTAFLCSSATGVLFGWLPARNAARLNPVDALARE
>A0A0D6SVU8|FEATURES|UNIPROT_deepARG|beta_lactam|SZ39_2442|antibiotic inactivation|1
MNLLLVFSIENLKGMMILKNKRMLKVGLCVGILGLSLTSLEAFTGGALQVEAKEKTGPVK
HKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQN
STEKLNEVITYTKDDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPK
GYEKALRQMGDRVTMADRFETELNEAIPGDIRDTSTAKAIATNLKDFTVGNALPADKRKI
LTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKD
EKEATYDNKLIADAAEVVINALK
>YP_001178170|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPQHEGEGKGRLTLIHILLGMVPAVVLGLIFHDAIKSLFNPI
NVMYALVVGGVLLIAAELLKPKEPKAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSYHFLTAADFPMFAVGFVTAFLVALV
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A103PY10|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHGIKRIMAAALFSTCATATIGYAANDRQDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPN
LQGSPFGNVSLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWRPTYSPGAYRTYSNVSI
GTLGLITAISMGQQDFAVPLSRHLLSPLGMKSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVVLKTLTEGNSLSMALNAMPVNEIKPPRAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>A0A060KZX0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQHSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0R1XMA2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKKIAMIVFVTKQIAYIFNARKDQFLLDIIKSIILGIVEGITEFLPISSTGHLVLVDEFI
KMQQPKQFTDMFNVVIQLGAIMAVVVLYFHKLNPLSPKKTGREKKSTWNLWLKVIVAVLP
SAIIGLPLNDWMDEHLMNWAVVSATLIIYGILFIIVENRNEKKKSDLHARYSDLDSLPYS
IALFIGMFQVLSLIPGTSRSGATILGAILIGASRYVGTEFSFFLAIPTMFGASLLKIVKF
FAKGGSLGGEQGVILLVGMVVSFVVAYLSIRFLMNYIKNNDFKAFGWYRIILGALVIGVN
LFLL
>A0A103ED48|FEATURES|UNIPROT_deepARG|beta_lactam|WS68_16125|antibiotic inactivation|1
MKHSLSRRSVLIAAVSAPLIGACAPLAGHSDNVGTADAQRSLRELEASFDGRIGVAALDT
ATNAKIAHRADERFAFCSTFKMMLSAAVLARSAAEPDLLPRRIAYAKRDLVEYSPITGKH
VGAGMTAAELCAAALQYSDNTAANLLISLLGGPQAVTAYARSIGDAVFRLDRWETELNTA
IPGDLRDTTTPSAMAASLHRLLLGDALGQVQREQLNGWMLDNTTGNERIRAGVPTAWRVA
DKTGTGDYGTANDIGVLYPPGRAPIVLAIYTTGRVQQARARNDVIASAARIVARAFS
>A0A0A8BWH5|FEATURES|UNIPROT_deepARG|aminoglycoside|RO07_02130|antibiotic inactivation|1
MTPISVTIRPIELHDIASWGSLRHQLWPHASPAEHEREITEILSEPNRYAAFIAISQEGR
ALGFAEAAIRQDYVNGCDTSPVLFLEGVYVAPDARRRGVAKALFGRVEQWGALRGCEEFA
SDTDVANIDVQTLHRALGFEETERVVFFRKRTLKGTSD
>S6FQZ7|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKNKARIQVGICIGLLCLSFTGFNPLFGSAHAEAKSIENTKMTSCILNQKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTY
SPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTADKRTILTDWMRGNATGDELIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAETAKVAL
NALK
>YP_002414662|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITISATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTNSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>NP_455659|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFILCALF
NAWLLPAWKLSTARTPVREGMRRVMSNKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMLPIGMVGNLQQL
FTLICAFYIGSVIAEPARETLSASPADARARGSYMGFSRLGLAIGGAISYIGGGWLFDMG
KALAQPELPWMMLGIIGFITFLALGWQFSHKRTPRRMLEPGA
>W7P231|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MKKTAPAYTPVDLSRWPRKEHFEVFQSFAECTINQTVLIDITALRKHIKAVGWKFYPTII
FLLSNIMNRHPEFRMAMKDNELVVWNEIHPSYTIFHPETETFSSLWSHYDGNIHHFQNTY
AEDTARYGNNLSYWPKEESRENVFFVSSIPWVTFTNFNMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPMAVQVHHSVCDGFHVARMFNELQEMCDGLLGLKEE
>A0A060L009|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>R9RAS1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DKATSGKYYIDGEDISDFTADELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVD
HDNRIERAKKLLEKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDS
KSGIMVMKILNQLHEEGHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQREIKKELQED
KKSINNLKKNKFQVAKDQFFESFNMSVSAIIAHKMRSLLTMLGIIIGIASIVCVVAIGNG
SQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTDVDILEKQSYVDSVTPNSTSS
GTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALIDENTQKSLFGE
NENPIGKVILFNKKPLKIIGTVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
VKNDIDSQVAQKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTRRY
>A0A0P0GRE4|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-71|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
CDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A060KTS2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAVNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAVAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>H6SW48|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>C2SKW4|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0014_24730|antibiotic inactivation|1
MLPVVLLSCVTLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEYDAKLGIYALDTGTNQ
TVTYRSNERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLVNYNPITEKYVDTGMT
LKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVQPGDTR
DTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRAGVPGEWEVADKTGSG
SYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKIVLDSLKVTNK
>E0XCT5|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
STSKAINSAILLEQIPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSD
NTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLN
KLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKS
>G5GJU8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIQLLKVIVLGIVEGLTEWLPISSTTHIKLVDDIIKFNATESFKEVFIVFIQLGPMLA
VAITYFQKLNPFDPAKNSPKKKASFVLWLKIIIAALPAAILGVLLDDWIDAHFSSTLINS
LMLIIYGLIFIVYENINRNKQPEITKTGQIGYQTALYIGMCQVLALIPGTSRSGVTILGA
MMLGCSRSISVEFSFLIGIPILFGAGVLKLLKYALSIQFHFDLLEIVYLLTGCLVSFIVA
AYTISYFLNWIKKHNFKPFGYYRIALGIVTLIWFGLRALVK
>Q2FC80|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
FK
>F7NRS8|FEATURES|UNIPROT_deepARG|beta_lactam|Rhein_0458|antibiotic inactivation|1
MNLIAKSVLKATAVLVLTLSSFVISAQSPLLKEQIETIVTGKKATVGVAVWGPDDLEPLL
VNPFEKFPMQSVFKLHLALLVLHQVDQGKLELSLSVAVKRAEVLQNTWAPMMKDYQGDEF
TVTIEQLLQYSVSHSDNVACDLLFELIGGPAALHAYIQFVGIAETDVVANEAQMHADDQV
QYQNWTSMKAAARILKKFEQKELLSETSQALLWKWMVETTTGPERLKGLLPADAVVAHKT
GTSGIRGGKTAATNDIGVIMLPDGRPLLVAVFVKDSAESNKTNEAIIAQVAQAAYQFELK
KLSAVSPN
>B6XBM4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MATLLELHNITRRYPAGEQEITVLKKVSLKIHSGEMVAIIGASGSGKSTLMNILGCLDKP
SSGEYYVAGQNIAELDNDQLAQLRREHFGFIFQRYHLLSHLSAEQNVEIPAIYAGAGKAQ
RQERAEKLLQRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMKILKDLCAQGHTVIIVTHDPKVAQQAERIVEIKDGEIINDSGALAVKVAEFPAKAV
IRKNPLGQWVSRFSEALLMAWRAMVVNKMRTLLTMLGIVIGIASVVSIMVIGDAAKGMVL
NDIKSIGTNTISVYPGKDFGSDDPENRQVLKASDISAIAQQPYVQSVTGSIETSARLRKG
NLDAVARVSGVGTDYFQVYGSHFSEGMGFTQDMLTRRAPVVVIDRNTKRRFFPNKQNVVG
ETLLIGNMPATIIGVLGEQKSIFGSSKSLEVFLPDTTINSKLINRSYYDSIVVRVNEGVD
AKVAEQQLVRLLTLRHGKKDIFTYNIDTLVKTAEKTTQTMQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAVLVCLIGGLMGIGLSYGVSLIAQMA
LPGWTFEFDPIALISAFACSTAIGVIFGFLPAKNAAKLNPIDALARE
>A0A127T5I3|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-29|antibiotic inactivation|1
MIKKSLCCALLLGVSCSSIAASMTEKQLADVVEKNITPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTQYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDSASLLRFYQTWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGFEQAMTKRVFKPLGLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVVANMAPDNVQDASLKQGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVDAAYRILDALQ
>A0A127SAY8|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-46|antibiotic inactivation|1
MGIKGNLMAIRFFTILLSTFFLTSFVYAQEHVVIRSDWKKFFSDLQAEGAIVIADERQAK
HTLSVFDQERAAKRYSPASTFKIPHTLFALDADAVRDEFQVFRWDGVNRSFAGHNQDQDL
RSAMRNSTVWVYELFAKEIGDDKARR
>I8TD97|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDAILLGLIEGLTEFLPISSTGHLLIAEHWLGRRSDLFNVIVQAGAILAVTLVYRERLR
ELATGWNKPELRDYSIKLFVAFLVTAVLGLLAKKLGAELPETTRPIAAALIVGGLIIFIV
EGWAKRQPIRDLVTWKLAFAVGAAQVIAGSFPGTSRSAAAIFVAMLAGLTNRKLAAEFAF
MVGIPTMFAASAYELLKLAMHGQLQSEAWGELAAGFAVAAVTGFVAVKWLLRYVAGHSFI
LFAWYRIALGAVLLILLG
>S3KEB2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQMPSFFEIVKILVIALVEGVTEWLPVSSSGHMLLVDAFLPLKASAEFKSLFFIVIQLAA
VCAVIVLFWEDMFPFRFGKENIKEKTVVQKDIFVLWFKTLIACIPGAAAVFLFGDFIEAH
LQTPAVISCALIFYGILFIVVERINEKRSARIEQLSAIDYKTAFIIGLFQVLSIIPGTSR
SGATIIGALLIGVSRQAAASFTFFLAVPVMLGSSLLKLLKYGGSLSAHEAILLLTGCAVS
FAVSLAAVKFLMSYIKKHDFKAFGLYRIALGLIVLFALKIV
>A0A0E1MK66|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKRMLKIGICVGILGISLTSLEVFKGGTLQVEAKEKTGQVKHKNQATHKECSKLEQKF
DARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKEDLV
DYSPVTEKHVDTGMKLGEIAEAAVRYSDNTAGNILFHKIGGPKGFEKALRKMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIARNLKDFTIGNALPHQKRNILTDWMKGNATGDKLIRA
GVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAEV
VIDAIK
>AAK69613|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|EreA2|antibiotic inactivation|1
MTWRTTRTLLQPQKLEFNEFEILNPVVEGARIVGIGEGAHFVAEFSLARASLIRYFVERH
DFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSLYGSVLIWVKSYLRESGRKL
QLVGIDLPNTLNPRDDLAQLAEIIQVIDHLMKPHVDALTQLLTSIDGQSAVISSAKWGEL
ETAQQEKAISGVTRLKLRLASLAPVLKNHVNSDFFRKASDRIESIEYTLETLRVMKAFFD
GTSLEGDTSVRDSYMAGVVDGMVRANPDVRIILLAHNNHLQKTPVSFSGELTAVPMGQHL
AEREEGDYRAIAFTHLGLTVPKMHFPSPDSPLGFSVVTTPADAIREDSVEQYVIDACGKE
DSCLTLTDDPMEAKRMRSQSASVETNLSEAFDAIVCVPSAGKDSLVAL
>W0LCB9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGGKPVEHDGQSTGHLKLGHILLAMIPAVVLGLLFHDVIKSLFEP
KNVMYALVAGGVLLLVAEWLKPKNPPAVGLDDITYRQAFAIGCFQCLALWPGFSRSGSTI
SGGMLVGVSRYAASEFSFILAVPMMMGASGLDLYKSLHFLTLGDLPMFAVGFLTAFVVAL
IAIKTFLQLIKRISFVPFAIYRFIVAAVVYMVFM
>NP_389667|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MEIKGINHLLFSVSHLDTSIDFYQKVFGAKLLVKGRTTAYFDMNGIWLALNEEPDIPRND
IKLSYTHIAFTIEDHEFEEMSAKLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLRYYKQEKTHMHFYDETAF
>U6A769|FEATURES|UNIPROT_deepARG|beta_lactam|blafona-5|antibiotic inactivation|1
MAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTA
MNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPQAMAKSLQNLT
LGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
>ABY55282|FEATURES|ARDB_deepARG|beta_lactam|OXA-1|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLSDLGYSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>A0A0Q4J6E7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWITYVVLGIIEGLTEFLPVSSTGHLILAGELFGYTDESSIVFKIAIQLGAILAVLVAY
RARFTGVALGLTRMDRQAIAFTRNILIGFLPAMVAGALFYDAIRAVMQKPVIVAVALIVG
GMLILLIERMVKRVRIHAVEDMSVGNAISVGAMQCIAMLPGVSRSGATIMGALLLGVERR
TAAEFSFFLAVPTMIGATAYSLYKDRALLTLDDLTGIAIGFGAAFVVALLVVKGFVRIVG
RFGFAPFAWYRIVAGSMALIWLLAR
>YP_002332890|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALVQFACA
PVLGALSDRFGRRPILLVSLAGATVDYAIMATVPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFL
LPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDR
FHWDATTIGISLAAFGILHSLAQAMITAPVAARLGERRALMLGMIADGTGYILLAFATRG
WMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>Q104Y6|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampc-EC14)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPLKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>P80298|FEATURES|ARDB_deepARG|beta_lactam|BL2e_fpm|antibiotic inactivation|1
NTNNTIEEQLSTLEKYSQGRLGVALINTEDNSQITYRGEERFAMASTSKVMAVAAILKES
EKQAGLLDKNIIITKSDLVAYSPITEKHLATGMSLAQLSAATLQYSDNTAMNKILDYLGG
PSKVTQFARSINDVTYRLDRKEPELNTAIHGDPRDTTSPIAMAKSLQALTLGDALGQSQR
QQLVTWLKGNTTGDHSIKAGLPKHWIVGDKTGSGDYGTTNDIAVIWPKNHAPLILVVYFT
QQEQDAKYRKDIIVKATEIVTKEFSNTSQKK
>A0A0P8ZN79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAAVMGIVEGLTEFLPISSTGHLILAGSLLGGFDDERGKVFEIAIQTGAIFAV
IMVYWQKIRSTVVALPRQAKAQRFALNVLIGFLPAVVLGLLFGKVIKEHLFTPAVVASTF
IIGGFIILWAEKRPPGSVRVENVDDMTPWDALKVGLVQCFAMVPGTSRSGSTIIGGMLLG
LSRQAATDFSFFLAIPTLIGAGVYSLYKVRSLLSVADIPLFAVGLLFSFLSAWLCVRWLL
RYISSHSFVPFAWYRIAFGILILVTAWQGWIVWAE
>A0A0A1I3E0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIETLLSSGFDIAAVFTHADDPKENAFYGSVAQQCARNGIPVHA
PEDVNHPLWIERIAKLNPDYLFSFYYRHLLSEPLLATAGKGAFNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAILAQKKVAIECSDTALSLHDKLRVAATDLLRDTLP
ALLAGKVSEIPQDESKATTFGRRTPADGKLIWQKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISVDPLRLACGEDSLVISAGQRNDNGLYLSGPQLAGELG
LVDGSLLRGAESGRTPRHTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDDKFDEDTSNLVVGPINKQRWIYSTSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A0W0U8V5|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1_1|antibiotic inactivation|1
MTNTYNHEMQQQLKESLELLKMILGPDLLAVYLYGSSLVGGLQRYSDIDLFVITNRQTTM
EERRRLVNGLLQISGIYMQGTKRPIEMTLVEKTAINPWNYPAQFDFQYGEWLRTSFEAGQ
ITPWTTHEMPDLALIITQILLKSHTLSGLEPKQLLPDVPWRDYIKALLCDQSRLIADLEH
DTRNVLLTYARTWSTLKTNAFRSKQDAADWVIHHLPKEHQPVMQRAKLICMGVENEHWDD
IHSLVKPCAEYMIDQIHQASLLVNLNDPGNVIRLAE
>A0A0P8IA83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLVFHDTIKSLFNPIN
VMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLSASDIPMFAVGFVTAFIVALVA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0L0H3T7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|GM31_23085|antibiotic efflux|1
MEPIIALRHVYREFTAGTQTIPVLSDISLSIAAGEMVAIVGASGSGKSTLMNIIGCLDKP
TAGEVIINGTAVHNADSLRLAELRSRYLGFIFQRYHLMPYLTAEENIAIPALYTAMPEAQ
RVARTRALAQKLGLEDRLQHRPAQLSGGQQQRVSICRALINGAHVILADEPTGALDSVNG
KALMAVLHQLHASGHTVIIVTHDRDIAHQAQRIVEIRDGRIVADIRQTGAVDPVPALPEQ
DNGRASLGRSVHESVRMAWRSLLGHRMRAFLSMLGIIIGISSVVSSMAVGEGARQAIMSE
IGKLGNTTLEIRPGTGWGTKRPDMERALSMEDVSSLQKLPWISGVSPMVSSMTLAVRKGL
DSSMMLSGVSQDYFSLQGLRFVQGNGFTARDVADGEPVLILDETGRDTLFPGGEDPLGQI
VQIAGAPWRVIGVATKPGPKVVGGFMAAWVPHTSLQHRITGEKPLEAITLRFQETLTPQA
ATQKAERHLIREHGKKDFFTQTDDQLANALQKTSDSMSLLITTIAAISLLVGGVGVMNIM
LVSVTERTHEIGIRLSVGARPLDIMNQFLIEAVMICALGGLIGVIGSWVAGNLFSFFTDA
FSMVFTAFPVVMACGFSALIGLTFGYFPARRAARLNPTEALARE
>V7I9S9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGSLQDYNVRSEIPEVFMDIYFIFKAVVIAIVEGITEFLPVSSTGHMIIVGDLIGFPETE
FTKMFNVVIQLGAILAIVVLYFNKLMGLLISLLRGERRGIAFTKALVIGVIPAGILGVLF
EDIIDKYLFKPIPVIIGLFVGAVLLIVVENRFRRKAKTHDVEDITPMQALKVGLFQCLAM
WPGMSRSSSTIMGGWISGLSSSVAAEFSFFLAIPIMLGASLLKLVKFQMEFGLGSLQSTE
LVSFGLGFVVAFVVALICVKGFVGFVKRRPMRVFAVYRIAISIILVLLAAFKVVSF
>A0A0M0M7T7|FEATURES|UNIPROT_deepARG|beta_lactam|WH43_04590|antibiotic inactivation|1
MNVIINAVVTASTLLMVAFSPFKISAQSPLLKEQIESIVIEKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNAWAPIMKAYQGDEF
SVPVQQLLQYSVSHSDNVACDLLFELIGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSASSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GYSGIKAGKTAATNDIGIILLPDGRSLLVAVFVKDSAESTRTNEAIIAQVAQAAYQFELK
KLSALSPN
>A0A0E0TVN5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVDSATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>V1I7D4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLVAAQAERIIEIHDGKIVHNPPAQEKKREQDVAAAA
VSTASGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQVLKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNASGVSGDYFNVYGISFSEGNTFNAVQQRDRAQVVVLDANTRRQLFPNKANVI
GEVVLVGNMPVIVIGVAEEKQSMYGNSNLLQIWLPYSTMSDRIMGQSWLNSITVRVKDGV
NSNQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>R9KPL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEIFKAIMFGIVEGITEWLPVSSTGHMIILDEFIKLDCTPEFLEMFLVVIQLGAIMAVV
LLFWGKIFPFQFKDKSKPVIEMDKIMLWLKIAVACVPAAIVGLLFDDLCEELFYHAISVA
IALIVFGVAFIIVERKNKGKGAKIKALDDITFRTALIIGLFQLIAAIFPGTSRSGATIVG
ALLIGVSRSVAAEFTFFLAIPVMFGASLLKIVKFGFSFTGEEVCILLVGMVVAFAVSVFV
IKFLMDYIKKHDFQVFGWYRIALGIVVIALGVGGVITV
>YP_002029849|FEATURES|ARDB_deepARG|multidrug|smeE|antibiotic efflux|1
MARFFIDRPIFAWVIAIIIMLAGGLALFKLPISMYPNVAPPAVEISASYPGASAKVVEDS
VTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQ
EVQRQGINVAKSSSGFLNVIAFVSEDGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGG
KYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRL
QTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANAL
DTAAGVDATLKELEGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLLEAIVLVFVVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLSVLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIM
SEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMAL
SVLVAIVLTPALCATMLKPLKKGEHHVAHKGWSGRFFNGFNRGFDRTSESYQRGVRGILH
RPWRFMGIVAALFLLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALEK
HFMENEKDAVESVFSVQGFSFAGMGQNAGMAFVKLKDWKDRDADNGVMPITGRAMAALGQ
IKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAQSSKLANVRP
NGQEDTPQFRIDIDVAKATSLGLSIDQINTTLATAWGSSYIDDFVDRGRVKRVFVQADQA
FRMVPEDFDLWSVKNDKGEMVPFSAFASKRWDYGSPRLERYNGVSATEIQGEPAPGVASG
DAMAEIEQLAKQLPQGFGVEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAALYESWSVP
TSVLLVAPLGILGAVLANTFRGMERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGAS
LIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGV
FFVPLFFVVVQRVFKRKSTT
>ABC60094|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPSIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLDPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSALFADRIGVNHWFLLSGILIICIAIVCPMINEIRKLDLK
>H0BRV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIRATLVALPTERQAQRFVLNVVIGFVPAVLLGLLLGKAIKAHLFTPVVVASTFI
IGGFIILWAERRSPAATRIHSVDDMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSMADLPMFMTGLVFSFLSAWLCVRWLLR
YISTHSFVPFAYYRIVFGIIVLVTAWTGWVQWAD
>S3K6H6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLPTLAIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGKTAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPQHEGTGTGRLSLIHILLGMVPAVVLGLIFHDMIKSLFNPI
NVMYALVVGGVLLIAAECLKPKKPRAEGVDDITYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSIGFLTMGDLPMFAVGFVTAFIVALI
AIKTFLQLIKRISFIPFAIYRFVVAAVVFFIFT
>G5GCS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWFEAIVLSIVEGLTEFLPVSSTGHMIITEGLFHMESTPFVKAFTVIIQFGAILSVVCL
YWRRFFNPPVEAGKNTSWWGRIWPFYLKLIVGVLPAVVVGLKLGDFIDENLGSVNTVAAM
LIIGGVFMLYCDKLFNKGSEQTPLTYKRALMVGLYQCIAALLPGTSRSMATIVGGMQQKL
TRKAAAEFSFFLAVPTMFGATCKKVYDLLKDGTGDALLQGNHLTLLLAGNIIAFLVAILA
IKFFLNYVTKYGFKAFGWYRIIVGLLIFGMALCGYPLTMAD
>T0HCE2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVVIQLGAILAVVV
LYWRTFWAVAMGLLRREPVSWRFLRNLVVAFIPAAIIGLALHDYIEILLGAPQVVAWALI
AGGVAILLIERMVKQDLFHGIADIPLARVIGIGFIQCLAMVPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGATALELLKKGDQIISAAVGWDSIALGFVVSFLVAIVVIKAFV
GLVSKHGFAPFAWYRIIAGASALVWLALR
>F4SVT9|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVISLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQISN
>A0A0K9MCD6|FEATURES|UNIPROT_deepARG|chloramphenicol|AC624_14110|antibiotic inactivation|1
MKFQRIDLDNWSRKPYFEHYLNRVNCTFSMTVNIDITELLPALKQKGMKLYPAFLYMVTN
VVNAHREFRTSFHTDGELGYWESMIPSYTFFHQDDQTFSTMWTEFADEFHLYYQNYVTDM
KKYGDNKGLVAKELEPPYTFPVSCIPWVSFSGFNLNISGDGRYLLPIITSGKYFEQEGKT
LLPVSLQVHHAVCDGYHASLFINDLQNWATNYKEWLGVE
>Q2FC30|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
L
>A0A0A0M9Q6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDFLAALLLGILEGLTEFLPVSSTGHLLIAQHWLGARSDLFNIVIQAGAILAITLVFRQ
RLWSLATGLDQRDNRDYLAKLAVAFLVTAAVGLPVRLAGWELPETVSPIAWALILGGVWM
ILAERIARRRPGSAHITWTIAVLVGLAQVVAGVFPGTSRSASAIFLAMILGSNRSASTEF
VFLVGIPTMFAASGFALVEHLLASGTGGEAWGELALAFAAASATGFIAVRWLLGYIKKHD
YTPFAIYRIVLGVVLLAWLPIGE
>A0A0R5RPH1|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCAFLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>CAI46978|FEATURES|ARDB_deepARG|beta_lactam|BL2c_pse3|antibiotic inactivation|1
MKFQCHFLSVPVAILGCVGLICTSAYAMDTGILDLAVTQEETTLQARVGVAVIDTDSGLT
WQHRGDERFPLNSTHKAFSCAAVLAQADRHKLNLEQAIPIERTALVTYSPVTERVPPGGT
LTLRELCRAAVSISDNTAANLALDAIGGARTFTAFMRSIGDDKTRLDRREPELNEATPGD
ARDTTTPIAAARSLQTLLLDGVLSAPARNELTQWMLGDQVADALLRAGLPRDWQIADKSG
AGGHGSRSIIAVVWPPKRSAVIVAIYITQTAASMSASNQAVSRIGSALAKALQ
>A0A093SFZ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGEVPHEGKTAGRLKLTHILLAMIPAVVLGLIFHDFIKSLFYPQN
VMYALVIGGFLLLAAEWFKPKEPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFAVGFVTAFLVALIA
IKTFLKIIKRISFIPFAIYRFIVAGVVYMVFM
>A0A009KLL0|FEATURES|UNIPROT_deepARG|aminoglycoside|J522_3133|antibiotic inactivation|1
MKIMPVTEPLLADWLQLRRLLWPDHEDAHLLEMRQLLEQPQTLQLLSYNDQQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPECRRLGVASTLVQQVEHWAKQFACTEFASDAALDN
TISHAMHRALGFQETERVVYFKKNIS
>A0A0Q3AXI2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
KGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>CAJ77845|FEATURES|ARDB_deepARG|multidrug|adeA|antibiotic efflux|1
MDSMQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHA
FRTAEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARL
KVQLERYEQLLPSNAVSKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISG
RIGQSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKT
VRITNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIP
QALLVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGHQYEQFYIANKGLKVGDKVVVEG
IERIKPNQKLALAVWKAPAVANHASSVETKTSIAEGAQP
>E8SJX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFELIKAIILGIVEGMTEFAPVSSTGHMILVDDMWLKSTEFLGPESAFTFKIVIQLGS
IFAAAWIFRHKYFEMLHIGKYAPAQQPGRRSKPRRLNLLHIIIGMIPAGVLGLLFDDLIE
KYLFSVPTVLIGLFLGAIYMIIADKFSLNVKNPKTLNEITYFQAFVIGLSQAVAMWPGFS
RSGSTISTGVLMKLDHKSASDFTFIMAVPVMLAASGLSIIKHLDYIELTHIPFYILGFLA
AFTFGFISIKLFLKLIQNVKLLPFAIYRIVLVVVIAVVYFGIIK
>G5FCX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIEVIKAVILGIIQGITEWLPISSTGHLILFDNIWPMASSPEFFEVFKVVIQFGSILA
VLVLFFDKLNPFSPKKGYRDKKETFDLWKKVVAGCIPIVIVGLPLDMILEDYLSGVYVIA
ATLILYGIAFIVIESRASVPSMNTLQDLTYKTAFFIGCFQVLAAIPGTSRSGATILGAVL
LGCSRYVASEFSFFLAVPVMAGASGLKLLKYFLKEGMFSGPEWFLLIIGTLVSFIVSIFA
IRLLLGYIRNHDFKVFGVYRIILGIVVIIYFTFLA
>D4XKS6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKPNDFSRTFKKLLMVAGLISFSSALWAENLTEQQVKAVIDQQFKPLLAQYKVPGMAVA
VTLNGKHYFVNYGLASKQSQQAVSNKTLFELGSVSKVFNATLAGYAQAQGQLSFSDHPAK
YFPELKNTAVNRATILNLGTYNAGGFPLQFPDHVVKQQDMIRYFQEWQSKTKIGAARQYS
NPSIGLMGYVTALAMKKPYVELIEQTLFPQLGMTQSFINVPKPYMSQYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINVQQLQQPIRKAIEHTHVGYFEVGAMTQGLGWE
QYAYPVKLETLLEGNSSKMALESHAITPIKQPKIASPATYFNKTGATNGFGAYAAFIPQQ
KIGMVMLANTNFPNEARITATYQAMQQILKQNAAQ
>ZP_04109362|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEKMKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKN
VWVHTELGYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVII
THAHADRIGGIKTLKERGIKTHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFY
PGKGHTEDNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENIN
FVVPGHGEVGDKGLLLHTLDLLK
>A0A0T6V5E4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWVAVQALILGVVEGVTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRSKILSVVVGLPRESQAQKFTLNLLIAFMPAVVLGVAFADLIHEYLFNPITVAAALV
LGGIVMLWAERRDHVIRAETVDDMNWALALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFAVFAIGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRICFGLLILATWQFGLIDWTSAQG
>A0A0G3K6Z7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ybjZ|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAVEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLLLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>M7NWW4|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDWFDLLKAIILGFVEGMTEFAPVSSTGHLIIVDDMWLKTEEFLGKYPANTFKIVIQLGS
ILAVVIVFWKRLFSLIGLYQVETREGGSTRFNLMHVIIGMLPAVVLGFAFKDLIDDYLFG
VETVIWALVAGAILMITADKFGPKTPSVTSLDQLTYKQAFSIGLVQCLSLWPGFSRSGAT
ISGGVLFGLNHKTAADFTFIMAVPIMAGASLVSVVKNMDMMSMDYLSFYVVGFVSAFLFS
LLSIKFFLKLIDRIKLTPFAIYRIVIAAVLAWIVWM
>B0G4X1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDVLKVILLGIVEGITEWLPVSSTGHLILVGNVLKPGLSDAFMEMFNVVIQLGAIMAVV
VLYFHKLNPFSPKKTQKQKLLTWQMWIKVLIACVPAAVVGLLFDDILDKIFYKPLPVAVM
LIVYGVLFIIVENRNEGRKPAVRRISELDIKMLLWIGAFQMLALIPGTSRSGATIVGALI
IGVSREVAAEFTFFLAIPVMFGASALKLIKFGFHFTAAEFGFLMLGCVVSFGMSVIAIKF
LMNYIKKNDFKVFGYYRIILGALIILVALFKMLLG
>W7ZR08|FEATURES|UNIPROT_deepARG|beta_lactam|JCM19047_3672|antibiotic inactivation|1
MEVEEETMEQGFSQLEDRYHAILGVYALHTETGETIASNEEDRFAYASTHKALSVGVLLQ
QHSLEELDKRVHYNEKDLVTYSPITEQHVETGMTLKELSDASIRFSDNPAANFIFNEIGG
PEGFKHALQDMGDQVTEPKRWETELNHWAPGEVSDTSTAKALVETLHGVALGDELDEEKQ
DLFTDWLVHNTTGDTLIRAGVPKGWQAGDKTGSAVYGTRNDIGIIWPPDHAPVVLAVLSH
TDEEDGEVDDHLIADATKEVLILLGLE
>ZP_04252176|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEKMKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKN
VWVHTELGYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVMDVII
THAHADRIGGIKTLKERGIKTHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFY
PGKGHTEDNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENIN
FVVPGHGEVGDKGLLLHTLDLLK
>A0A0K2ATT0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNEFIEPGAEPVQEFTVSGPDAGPYALAEGPDGALWFTLVHQDAVARRDPRDGSVTVHPV
GAGPTVIAPGPDGAMWFTEYRAHRIGRIAPDGSYSSHAPLTPEGGPFGIVAGPDGAMWFT
LSSVDRVGRITVDGDVTEHPAPGAFPSAVAAGPDGALWCTLNRQNAVGRLTTDGRGTAHP
LPTEGAAPVGMAAGPDGALWFTEIGAGRIGRITVDGEITEYPLPDPAARPHAVTAGPDGA
LWFTEWGSGRVGRITVDGGITSYALSRPDSEPHGIAVHDGALWCALETGSLARIEVPA
>X2JLX5|FEATURES|UNIPROT_deepARG|beta_lactam|bla-OXA2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLARSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>L2EKP4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAQYDVPGMAVAVTVRGKSQVFNFGLASKADATPVTEHTLFEIGSVSKTFTATLASYAAQ
RGAISLSDKASQYLPGLAGSSLDAISLLELGTYTAGGLPLQFPDAVTTSAQMLAYFKDWK
PTYAAGTHRQYSNPSIGLFGYLAARSLGEPFDNLMEHRIFPGLGLKHSFIRVPQSRMGDY
AYGYKDGKPIRVNPGVFDSEAYGVKTTAADMIRFVEANMDGARLEPTLQRAVTGTHTGYF
RVGPMTQGLGWEMYAWPTSLEDLLTGNAAGMLEPKEVARLAQPQPPRADVLINKTGSTNG
FGAYVVFVPARQIGVVMLANRNLPIPERVRAAYQILKALDAQ
>A4XTY3|FEATURES|UNIPROT_deepARG|beta_lactam|Pmen_2038|antibiotic inactivation|1
MRPSLRPLLLALGLCLGSQSAFAELRQAVDAAVEPMMQTYAIPGMAIAISHKGQQHFFEY
GVASRESGQAVDRHTLFELGSISKLFTATLGAYAEARGTLNLSDNASQYLPGLQGSAFDH
ISLLDLATYTPGGLPLQFPDAVGNERQMLDYYRNWQAVYPPGTQRLYSNPSIGLFGHLAA
ASLAKPFQELMEQDLLPQLGMQESYVQIPAAQMTRYAWGYRDDKAVRVSPGALDAEAYGL
KSTAADMLRFIDANLHPDKLPAPLHQAVSSTHRGYYQVGDMTQGLGWERYAYPISLAKLQ
AGNSAEMALHPQAVERFSAPTPAEGDLLLNKTGSTNGFGAYILLLPARDTGLVILANRNY
PNAERVRLALQLLEAIDH
>L3BZY9|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSSLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>AAL75564|FEATURES|ARDB_deepARG|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAIGGLXGDISPHLPFVIAAILNACTFLMVFFIFK
PAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQ
SADGTVWLIGTALYGLLLAICLLIRKPAPVAATC
>A0A0H5LZY7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_5|antibiotic efflux|1
MTALLELKGIRRSYQSGGETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYSVAGQDVATLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKQE
RRERAKMLLTRLGLEERVDYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKTVAAVATSEVTS
LTPPAPSWQQLTGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQM
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVYDDMAALKEQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITREQVERQAQVAVIDRNTQRRLFPHINDV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRSYFDSITVRIKEG
YNSKEAEQQLIRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLIVE
MFLPNWQITFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>W8F5D2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAIIAILL
VYFQKLVSIAMAMPTSAKARRFVLAVAVAFLPAALIGALAHDFIKTVLFETPILICIVLV
IGGVILLAVDRMPLKPRYTDIMDYPPSLAFKIGLFQCLAMVPGTSRSGATIVGALLMGTD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRDALSFDDSALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGSLGLAALLLYR
>A0A0T9KR44|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MSECEKIKKVSIVIPVYNEQESLPALIERTLAACKLLTQPYEIILVDDGSSDRSAELLTA
AASEPESHIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVSAEQTENNQEVEK
>A0A0K9FH33|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQNINHLLFSVSNLEESIAFYEKVFDAKLLVKGRSTAYFDVNGLWLALNVEKDIPRND
IHQSYTHIAFSIHEDDFDDMYEKLVHLNVNILDGRQRDVRDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYKKEKVHMEFFDV
>N8RGF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGAFTGQEQGRRLSLNLIIASIPIVIIGLSFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAVLAVGIVVAFISALIVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>A0A096YVR7|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MNHSPLRRSLLIAAVSAPLVGACAPLRDNARNVAAEQQLRELESTFDGRLGFVALDTATG
ARIAHRADERFPFCSTFKTMLSAAVLARSAGDAALLQRRIPYAKRDLVRYSPITEKHVGA
GMTVAELCAATLQYSDNTAANLLIALLGGPQAVTAYARSIGDATFRLDRRETELNTAIPG
DERDTTTPAAMAASVRRLLVGDALGTAQRAQLNAWMLGNKTGDARIRAGVPAGWRVADKT
GTGDYGTGNDIGVAYPPDRAPIVFVVYTTMRSRNAQARDDVIASAARIAARAFV
>A0A0W0H2L9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDADYEIAAVFTHADDPKEKTFFGSVAQLCAQHDIPVHA
PEDANHPLWVERIGKLAPDFIFSFYYRKLLSEPLLACATRGAFNMHGSLLPRYRGRAPAN
WVLVNGETETGVTLHQMVKRADAGPVFAQQRVSISATDSALTLHGKLREAAIDLLSDTLP
LLAEGRLSGTPQDEAQASCFGRRTPADGLIDWSLPATRLYNLVRAVTQPYPGAFCPVGDH
KLIIWAARVEPSNNGAAPGTVISHDPLRIACGDGSLIINAGQRGDEGLYLSGAQLAREFG
LVDGSQLLDTKKQRPVRRTRVLILGVNGFIGNHLSERLLQDERYEIYGMDIGSDAVERLR
AKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPNIELSETIGKTLDFFLREAMAEKA
DQC
>A0A0C5WEQ0|FEATURES|UNIPROT_deepARG|beta_lactam|F652_3146|antibiotic inactivation|1
MRKKMQNTLKLLSVITCLAATAQGALAANIDESKIKDTVDGLIQPLMQKNNIPGMSVAVT
IRGRNYVYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQASGKLSLEQSVSHYV
PELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIG
TGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNM
EILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWE
QLPYPVSLPNLLTGNDMAMTKNVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSSLEGNK
>A0A0T9P632|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGAVPHEGKTSGHLTLGHILLAMIPAVGLGLVFHDTIKSLFNPQS
VMYALVAGGILLLVAEWFKPKNPKAVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASALDLYKSLHFLTLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>A0A099G502|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSYLNDVILGVIEGITEFLPISSTGHLLLAQHWLGARSDTYNIVIQAGAILAVTLIYRRR
LADLATGWRDPGSRDYLAKLLTAFVITAVLGVVVKKAGFQLPETVTPIAWALVIGGVWMI
LAERFAARLPDSAAITWRVAVAVGVAQVVAGVFPGTSRSAATIFAAMLLGTSNRAAATEF
AFLVGIPTMYAASAYELLDRLRGGGAAAPEDWTALGIAFVVSTVTAFVSVKWLLGYIQTN
RFTIFAVYRIIFGGLLLALGWYGVVS
>Q4L200|FEATURES|UNIPROT_deepARG|beta_lactam|blaORN-2A|antibiotic inactivation|1
MRQYRLALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYRAGE
RFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPE
AMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP
>A0A0Q1VQV3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTLDATKITFKQAFLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMVNIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>G8EI98|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQLDCLLPGLWG
>A0A136C6T7|FEATURES|UNIPROT_deepARG|beta_lactam|ACS95_02835|antibiotic inactivation|1
MILKNKRMLKIGICVGILGISLTSLEVFKGETLQVEAKEKTGKVKHKNQATHKEFSQLEK
KFDAQLGVYAIDTGTNETIAYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKED
LVDYSPITEKHIDPGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIATNLKDFTVGNALPDDKRKVLTDWMKGNATGDKLI
RAGVPTDWEVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIKEAA
EVVIDAIK
>B9W1Z5|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-10|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGVIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESSPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>V6G2H1|FEATURES|UNIPROT_deepARG|beta_lactam|EC970259_5036|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAKTYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>G8LXE6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEILKAIIIGIIEGITEWLPISSTGHMILADEFIKLNMSDEFKEMFLVVIQLGAILAVVL
LYWKKLFPVSFDKKLEIKQDTVSLWMKVLVAVLPAAIIGVPFEDKIDELFYNYKVVIATL
IIYGVLFILIENRNKNKKSLINNFGQLSYKTALIIGIFQVLSLIPGTSRSGATILGAILI
GCSREIAAEFSFFLALPVMFGASFVKILKFGFVFSGQEIAVLATGMIVAFVVSILAIKFL
VGYIKRNDFKAFGYYRIVLGLILAFYFAVLR
>A0A081V9E5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLFVAACATATAGRAAAATLEDLHDTVTRHIAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEVGSVSKTLTATLAADAQEGGELSLADPAGKYLPA
LQGKPFGVVTLRDLGTHTSGGMPVQVPDSIRDDAGLIRYLDAWRPAHAPGTYRTYSNVSV
GMLGWLTAKAMHKDFAVLMEQRLFPALGMTHTYINVPDARQDDYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLIETAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNSMKMLRGGLPATAIKPPLAPSADTWINKTGSTNGFSTYVAFVPSKRIA
IVMLANRSYPNEDRVKAAYGILGALDGRR
>Q104Z8|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampc-EC26)|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>K7QCV3|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYW
KSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPDYPDLPLVLPNVVHDGDFTLQEGKLRA
FYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTV
VGGHDSPLHGPEL
>A0A0N7AFF0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCphA|antibiotic inactivation|1
AGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKP
VLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPL
VLPNVVHDGDFTLQGGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADV
KAYPQTLERLKAMKLPIKTVIGGHDSPLHGPE
>T0WD81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMDIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVSAEFTFFLGIPVMFGASFIKILHFFKNGNSLNLEQFGVLLVACLVAF
GVSMIAIKFLTDYVKKHDFTFFGKYRIVLGIVLLIYAAFKAFLG
>W1FSZ7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRVAISPDDVALTLHHKLCQAARQLLEEALPAI
KTGDYAEHPQQEAEATCFGRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCKNDRAAQPGTVISVSPLLIACADGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTAKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAISRFSAAS
TIPFRRRRYQHSLRMD
>A0A0V8C7A0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNSADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFKAFLG
>A0A0D5ANU7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVVKGLPNDPRQQRFAINVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
VGGFVILWAEWRERHRGETHDPRANALLEAAKAGAPRIETLDDLRISDAIKVGFAQCFAL
IPGTSRSGATIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYEMYKSRALLSADDLSVFA
VGFVAAFISAFFCVRWLLKFIATHDFRGFAWYRIVFGIIVLVTAYTHLIAWQP
>Q9LAR6|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-22|antibiotic inactivation|1
LLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDKVTRLDRWETELNEALPGDARDTTTPASMAATLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>A0A061MPW9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRNLFLPTFGMIAVASLFHGSSACAADGGEQARLERAVNEAIRPVMKENDIPGMAVAVTV
NGKRYVFNYGVASRENGQKVTEDTIFELGSISKTFTATLASYAQLRGTLSFSDKASKYLP
ALAGSSFDTINLLDLGTYTAGGLPLQFPDDVTGQDKMIAYYKNWRPDHAPGTRRLYSNPS
IGLFGYLAAASMGEPFDALMEQKIFPGLGLTHTYIRVPQDQMGNYAYGYSKSNKPIRVGP
GALDSEAYGVKTTAADMIHFLEANMDSSKLDETLQSAIATTHTGYYRIGDMTQGLGWEMY
AYPTSLERLQAGNSNEMSRNPNKANKLVPPQPPRRDVLINKTGSTNGFGAYVAFAPAKGI
GIVMLANRNYPIPARIKAAYRILTALDKESGMR
>W0J3N8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFFRSRLRLATAFLATSCAALATPDDAAASDPATPARTEIVRASDPPDALDAIVLGIVE
GVTEYLPVSSTGHLVIANHFLDLESTVPLYDGEGQMLWAKKPSPRHPEGEPLTIKAAADA
YAVIIQAGAIAAVGLIYWRRLLQIARGLFGNSPDGVRLLRNIVLACIPPGLAGLLLGDFI
DSHLFSIRTVAWALVAGSVLMVAAEWWRKRQPRRIVEYTGEDLKAGQALFIGFAQCLALW
PGMSRSMVTMVAGYFTGMRPARSAEFSFLAGFALLSAAALYKSWKAGPAVIEVFGWSNTL
LGMLVATIAAVIAIKGFVGYLSRHGLGIFAIYRLALAAVLFVWFV
>A7KEG3|FEATURES|UNIPROT_deepARG|beta_lactam|blaGES-7|antibiotic inactivation|1
LLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRFAMCSTFK
FPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQAAVQLSDN
GATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIAMARTVAK
VLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRNDIGFFKAQ
ERDYAVAVYTTAPKLSAVERDELVPLLGQVL
>A0A101Y593|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFDEQSPIMKTYEIVIQLGAILAIAL
VYRKRVLDLLGIGRSNRGRGGVMPASRLNLIHVILGIAPALAVAFFARDFIKGLFGATTV
LWALVAGGILMIVAEWWNKRKSRVTAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKYFTKDTIWDFAIGFVIAFVVAY
VVVVLFMKLIQKIRPTHFAIYRFILAAVFWLFIMR
>K8A885|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGQPPHEGVGKGRLSLIHILLGMVPAVVLGLLFHDFIKSLFNPIN
VMYALVVGGVLLIIAEVLKPKEPKAPGLDDMSYRQAFLIGCFQCLALCPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSMGFLTMADLPMFAVGFVTAFIVALVA
IKTFLHIIKRISFIPFAIYRFIVAAAVYAVFM
>CAR69107|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAQLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>AAY92384|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPKAQRFTINLLIAFLPAVVLGVIFADLIHAYLFNPITVATALV
VGGLIMLWAERRQHQVHAETVDDITWKDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDFPVFAIGFVTAFVFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWVDWTAAKP
>A0A0E0VRK8|FEATURES|UNIPROT_deepARG|beta_lactam|ST398NM01_2020|antibiotic inactivation|1
MLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNKIINE
IGGITKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSK
KNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFIYPKNQSEPIIL
VIFTNKDNKSDKPNDKLISETAKNVINKF
>I0JX12|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDIWQTILLGIIEGISEFLPISSTGHLLIAEHWMGEKSETFNIFIQLGAVLAVCLIYKE
RVSSFFFLWKNKEKIPYFLKLGLAFFITALLGLWVKKMGWELPKDLGPVIIAIFGGAFWI
YFVEKVSCRNQSFVEDISWLTAIAVGVSQVVAGVLPGFSRSAATILMAVLFGVSRPAATE
FAFLLGIPTMFAASLFSWVEQTNFLKVPPTDPPLTLFLGFFVSAIVAFIAVKWLLSFIQT
HTFIPFVWYRVGLGLILLMIFAIEWKSH
>NP_761383|FEATURES|ARDB_deepARG|multidrug|norM|antibiotic efflux|0
MHRYKKEASNLIKLATPVLIASVAQTGMGFVDTVMAGGVSATDMAAVSVAASIWLPSILF
GIGLLMALVPVVAQLNGAGKREQVPFEIQQGAVMALLISIPIIGVLFQTQWILGYMNVDA
VMATKTIGYIHAVMFAVPAFLLFQTLRSLTDGLSLTKPAMVIGFIGLLLNIPLNWMFVYG
KLGAPALGGVGCGVATAIVYWIMFLLLLFYVTTSHRLRQVQLFTTFHPPQLNAQVKLFKL
GFPVAAALFFEVTLFAVVALLVAPLGSTVVAAHQVAINFSSLVFMLPMSIGAATSIRVGH
MLGEKSTEGARIASHVGILVGLSTAVFTALLTVILREQIALLYTDNRVVITLAMQLLIFT
AIYQCTDAIQVIAAGALRGYKDMRAIFNRTFIAYWLLGLPTGYVLGLTDWIVEPMGAQGF
WIGFIVGLSSAAAMLGVRLHWLHRQNDEIQLNYEAR
>A0A0N9SC43|FEATURES|UNIPROT_deepARG|beta_lactam|BL2d_oxa1|antibiotic inactivation|1
MIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNKAKCATQMAPDSTFKIAL
SLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWM
>A0A0F6HAZ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGENVEFDDLFDIFIQSGAILSV
LFLYREKFKSQIVSSFRYILKQNSDSEGFHFLIQICIGAFPILIAGFIAKKFLDTIKARP
DLLDILSGAWIFGGVLILVAEWYFHQRPEEKKSIGFKDSILIGIFQCMALIPGMSRSAAT
IITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGNTIPVLMFGFLVSFLLC
TLVIRWFLRYIQKHSFSVFGVYRILLGVGVLVLTKLI
>A0A0D2WMJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDESTLISALVMGVVEGLTEFIPVSSTGHLILLGDLIGFQGPPGRLFEVVIQLGAILAVC
VVYFQRLLHIAVTLPSSRESRRFVLAILLAFLPAAVIGVFAHGFIKSVLFNPHVVSVALI
VGGIAILWIERNLPDPRHFAVEDFSPRLALGIGFVQTLAMIPGVSRSGATILGALLMGVE
RRTAAEFSFFLAIPTMLGAVVYDTYKNYSTLTSDGSLVIAIGFVAAFVAGLLVVRSLVAF
VGRYGFTPFGWYRIALGVVMLAILSLR
>A0A0Q4MSV1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEQAITKVSVVIPVWNEQESLPELIRRTDAACATLALDYEILLVDDGSSDRSAEMMVAA
AEAPGSHVVAVLLNRNYGQHSAIMAGFSHVSGDLVITLDADLQNPPEEIPRLVAAAQEGY
DVVGTVRQNRQDSGFRRHASKLINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERS
TFIPILANTFARRAIEIPVLHAEREFGDSKYSLMRLINLMYDLITCLTTTPLRLLSVFGS
VIALCGFVLSLVLILMRLFLGPEWSAEGVFMLFAVLFIFVGAQFIGMGLLGEYIGRIYND
VRARPRYFIQRVVSRDDASSSQDKSL
>Q8L2S4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
HRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGV
LGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATY
>F0L8Y6|FEATURES|UNIPROT_deepARG|aminoglycoside|aac|antibiotic inactivation|1
MRGRRLSLQFSIRDAAAFLDDWSLLRHRLWPDASVAEHRAELQNLSDNDAGFIAYDLVGM
AIGFADVSLRRDYVNGCDTSPVAFLEGVYVEEEFRGQGVAAALIAEVTRWAISKGVSELA
SDADIANVDSHRMHAALGFEETERVVYFRKLLPSHS
>A0A0W0SUS7|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1|antibiotic inactivation|1
MINTFSSEMQQQLKESINLLKVIFGAELLGVYLYGSSLIGGLQKYSDIDLFVVTSRATTL
EERRRLIINLLQISGLYMKSTKLPIEMTFVEKAEINPWHYPPQFDFQYGEWLRTSFEMGH
IEPWATHEMPDLALIITQILLKSHTLYGLEPKQLLSHVPYSDFIKAMLHDLGRLTEDLEY
DTRNVLLTYARIWSTLKTNAIRSKPSAADWVMHHVPKSYQPVIQRAKLICIGVENEYWDD
IKSLVKPCADFMIDKIHKATSLVDLNDPNNFIKLAE
>A0A0U3DH97|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTVLLIKAAIMGIVEGLTEFLPISSTGHLILTGSLLGFDDAKSKVFDIAIQTGAIFAVI
LVYWQRLRDTVAGLGSDARARRFTKNVAIGFFPAVVLGLLFGKAIKAHLFTPTVVASTFI
IGGFIILWAERRQSAVVRVENVDDMSPLDALKVGMLQCLAMVPGTSRSGATIIGGMLIGL
SRKAATDFSFFLAIPTLIGAGAYSLYKERALLSTADLPMFSVGLLFSFLSAWVCVRWLLR
YISSHSFVPFAYYRIVFGVIVLATAWSGLVVWAD
>A0A095EQE7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIVSVVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVLSVDALTPLDAFKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>J3HEI5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFKVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKISQIVKGLPTQRNAQRFTLNLLIGFLPAVVLGVLFADQIHHYLFNPITVAVALV
VGGIVMLWAEQRDHVVHVDHVDDMRWSDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEYSFFLAMPTMVGAAVYSGYKYRELFQTGDLPVFALGFVTAFFFAMIAVRGLLKF
IANHSYAAFAWYRILFGLLILATWAFGWVNWTAAAAS
>H4F2C8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEDQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFESPGNTFAVLIQLGAILAILS
VYFTKLLGIALSLPSSPESRRFVMAVLIGFLPAAVIGALAHDFIKTVLFETPMLICVVLI
LGGFVLLWIDRQPLTPKYTDVTQYPLSLALKIGFCQCVAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMAGAFALDLYKNRDALSFDDGTIIAIGFVAAFVTALLVVRSLLDF
VSKRGYAPFAWWRIVIGSIGLVALLVGR
>U1THP4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADVLDFTGDRFNAFNIIIQLGAILAVV
WEFRGKIFEVVSGLPTQRKAQRFTVNLLIAFLPAVVLGVIFADLIHHYLFNPITVATALV
VGGIIMLWAERREHEVHAETVDDITWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>A1EGT9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIDGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDAI
>A0A158C2S8|FEATURES|UNIPROT_deepARG|beta_lactam|AWB81_03660|antibiotic inactivation|1
MTHSPARRALLAAAASVPFASACTSWPADQSAASQLKALEAASNGRLGVAALNTGDGAIV
NYRADERFPFCSTFKVLLASAILTRSAHEDGLLDQRIRYTQSDLVNYSPVSEKHVADGMT
VAELCAAAIQYSDNSAANLLIRLLGGPPAVTAFARSIGDDEFRLDRMETELNTAIPGDLR
DTTTPAAMARSLQRLALGNALGARERDQLQAWMRGNTTGDARIRAGVPRDWQVADKTGTG
DYGTSNDVAVLWPPSKPPIVVVIYFTQREQDAKARSDVLASAAKIVARKFG
>ZP_00742722|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MIQSINHICFSVINLEKAIEFYQNILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEI
QYSYTHIAFTVTNNEFDSLKEILIQNHVNILPGRERDDRDKRSIYFTDPDGHKFEFHTGT
LQDRLQYYKEDKKHMTFY
>A9L1V7|FEATURES|UNIPROT_deepARG|beta_lactam|Sbal195_0845|antibiotic inactivation|1
MRSFAISTVLVMSSLLASSIFAAPAFASTAAKTEWQETRSWDAIFTQHQVEPQQAKQQQA
KPQKTKSQQASGVVVLWNENKQQGYTNNLKRANQGFLPASTFKIPNSLIALELGVVKDEH
QVFKWDGKSRDIATWNRDHNLITGMKYSVVPVYQEFARQIGEARMSKMIASFDYGNEDIS
GNLDSFWLDGGIRISATEQIDFLRRLYHNKIHASERSQRIVKQAMLTEANSDYIIRAKTG
YAVRAEPSIGWWVGWVELDDNVWFFAMNMDIPNAAGLPLRQAITKEVLKLEHVIP
>A0A0K6HHR7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFTDALEALVLGLIEGLTEFIPVSSTGHLLLVGHFIGFESNGKTFEVLIQLGAILAILS
VYFSKLLTVARGLPTDPGMRRFVLGVLIGFLPAAIIGAILHGFIKEVLFDPTIVCISLIL
GGIVLLAVDGLALKVEHRDAMHYPLPMYLKIGICQCLAMIPGVSRSGATIVSAMLMGADK
RSAAEFSFFLAMPTMAGAFAYDLLKNYKNLSFNDGALIVIGFVSAFVAGLFVVRSLLNFV
SRHGFALFGWWRIVIGAAGLAGILVYG
>A0A0E3Z3R5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDLLAALLLGIIEGLTEFLPISSTGHLLIAQHWLGPRSDFFNIVIQAGAILAVTLVFRQ
RLWELATQLHVPAHRDYVAKIAVAFLVTAVVGLPVRLAGWELPETVTPIAWALVIGGLWM
LLAEHYAEKRGDIATVSWKVAVLVGLAQVVAGVFPGTSRSAAAIFVAMLAGTSRRSSATE
FVFLVGIPTMFAASGFAFVELVLDDALGGEDWTAVALAFTAAAATGFVVVRWLMGYIKAH
RFTGFALYRIVLGLLLLTLMPAGS
>I6TUC8|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC-64|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLXKYDVPGMAVGVIQNN
KKYEMYYGXQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANFNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>A0A0F0TSG3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRLPQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>CAA57985.1|FEATURES|CARD_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVKRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIYGNIPYNISTDIIRKIVFDSIA
NEIYLIVEYGFAKRLLNTKRSLALLLMAEVDISILSMVPREYFHPKPKVNSSLIRLSRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>A0A0P9UZG6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPKEKTFFGSVAQMCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAVDLLCETLP
LLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGD
NKLIVWAASVDTSSNGEAPGTVISHEPLRIACGDGSLVITAGQRGDNGLYLSGAQLAREF
GLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>U6ZC39|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADLHSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFEGDTAKTFEVIIQLGSILAV
VVVFWRRMFGLIGIHFGQPPQHEGRGKGHLTLVHIVLAMIPAVVLGLVLHDFIKSLFNPV
TVTYALVAGGVLLLLAEWFKPKKPQAEGLDDISYVQAFLIGCFQCLALWPGFSRSGATIS
GGMLVGVNRYAASEFSFILAVPIMLGASGLDLYKSWHFLSLSDLPMFAIGFVTAFVVAMI
AIKTFLQLIKRISFVPFAIYRFIVAAVVWLVMM
>A0A0J6BPT4|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKLTSKYETIRRILSEFKQPEYRYAQIMDAIFKQNIGEYGRMTMLPKFLRDELNRILGPN
VCSIVPVKELTSKQVSKVLFAIPGDERVEAVRLTYERGWKSYCISTQCGCGFGCKFCATG
TIGLKRNLTADEITDQLLYFRLNGHTLDSISFMGMGEALANPHIFDAMTILTDPYLFGLG
HRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVGDVLMALDR
HIRQTGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGSWEHLYHVNLIPFNSTEVTPDSY
RQSDPTRIRAFARILKSKGISITVRTQFGSDINAACGQLYRSE
>A0A0F0DFU1|FEATURES|UNIPROT_deepARG|beta_lactam|UB44_19355|antibiotic inactivation|1
MFSRWSKTFAFALTACAVAMSSATAHAELVVRNDLKRVFDAAGVSGTFVLMDISADRTYV
VDPARAARRIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYKQWEHDMALPEAIR
LSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGRVIDQFWLRGPLEISAFEEARFTSRM
ALKQLPVKPRTWDMVHRMLLIEQQGDAALYAKTGVATEYQPQIGWWVGWVERAGSVYAFA
LNIDMPREGDMAKRIPLGKQLMQALEVWPAP
>A5ZWF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKNKTERKRNMSVLEFIKVVILGIVEGITEWLPISSTGHMILVDEFIKMDMTTEFKDFFL
VVIQLGAILAVVVLYWSKLWPFYIRQIPKKKKAQIARKNPFSRIVLTFVEKFCDKDKWIL
WFKIIVACIPTIVIALPFNDFIEEKFNNYVVVAIALIVYGVIFIIVENYNKRRKPICTSL
EDLSFATAFKIGIFQVLSVIPGTSRSGSTIIGGILVGTSRTVAAEFTFFLAIPVMFGASL
LKLVKFGFTFTPAEVLTLVTGVVVAFFVSIIAIKFLMGYIKKHDFKAFGWYRIVLGVLVM
GYFVGKISLDN
>A0A024KQZ1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNIDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0J1G1H7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKERIMDIVEILKAILFGIVEGITEWLPISSTGHMIILDEVVKLNVSKEFLSMFLVVIQL
GAILAVVVLFWNKIWPFSTKEQYFIKKDTFSMWFKILVACVPAAVIGLLFEEQFDEWFYN
YQTVAIALIVFGILFIVIENRNKHIRPKINSLAEITYTTAIWIGIFQLIAAVFPGTSRSG
ATILGGILVGLSRTVAAEFTFFLAIPVMAGASLLKIVKFGFDFTGAELAILLIGMAVAFV
SSIIVIKFLLSYIKKNDFKVFGWYRIVLGIIVLLFFMLR
>CAD20591|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-95|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESNKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>A0A084EPS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASVWAMFNVMIQLGAILAVVV
LYWRTFWAVAMGLLRLDPVSIRFVRNLLVAFIPAVVIGLALHDYIDTLLGSPRVVAVALV
VGGVAILVIERLIREQRFHGIADIPLVRVIGIGFIQCLAMVPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGASTLELLKKGDQLTSAQVGWDSIALGFIVSFIVALLVIKWFV
GLVSRHGFAPFAWYRIIAGIGALVWLSLR
>YP_523088|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIVLLIKAAIMGLVEGLTEFLPISSTGHLILAGTLLGFDNEVGKVFDIAIQTGAIFAVI
LVYWQKIRDTLVALPTEKQAQRFSLNVLIAFVPAVVLGLLFGKAIKAHLFTPVVVASTFI
IGGFIILWAERRQEKNPAAVRIHDVESMTPMDALKVGLAQCLAMIPGTSRSGATIIGGML
LGLSRKAATDFSFYLAIPTLIGAGVYSLFKERALLSMADLPTFAVGLVVSFFSAWLCIRW
LLRYIASHSFVGFAYYRIVFGVVVLATAWSGAVTWAA
>A0A0R1XHX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNIFKAVLLGIIEGITEFLPISSTGHLYLANEFIKLDETPAFITMFMVVIQLGAILAVV
VLYFHRLNPFSPKKSHQEKNDTWKLWFKVILAVIPSMIIGLLLNDWMDAHLNTWPVISAT
LIIYGVLFIVIERWNAHRTPRETDLNAISPKTGLEIGFFQLLSLVPGTSRSGATILGGIT
IGASRYVATEFSFFLAIPTMVGASGLKLAKYILKGNTFTGDQLMVLLVGTVVSFLVAYVA
IRFLLNFIKKNDFQGFGWYRIVLGLLVIAWFGLHG
>E0SD05|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSDMEAINKVSVVIPVFNEQESLPELIRRTTAACDQMNRDYEILLVDDGSSDNSAALLTE
AAQAPGSHVVAVILNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVDTADQG
YDVVGTIRENRQDSWFRKSASRMINHLIQRTTGKAMNDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRATEIMVHHSEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSVVG
SVIALSGFTLALLLILLRLFFGAAWAADGVFTLFAVLFSFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRIVGNDPRSSEQDNEE
>A0A0G4JF36|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKPYLTLCATLAAATAIGWMAFNARSYAAGPDADATADPRQAEIKLLVDNTITPLMARQ
NVPGMAVGIVFDGHTYVFDYGVADKAAKRPVTPDTLFEIGSVSKTFTATLAAYAQATGAL
SLNDKTRRFVPELAGTPFGDVTLVNLGTHTTGGMPLQAPDDIRDTDQMLQYLKTWKPAQP
TGTVRTYSNVSIGALGWITARAMHGDFSTLVTEHVFKPLDLTHTFIRVPKDQQANYAWGY
GKDGKPIRVSPGVFEQEAYGVKTTASDLLRFVQANLGTPARDNALQQAILATHTGYFFDK
PMTQDLIWEQYPYPVSVDALLEGNSNHMAYEPTPAHELSPPMAPASVVWINKTGSTNGFG
AYVAFVPSKQMGIVLLANKNYPMDERIRAAHHILTTLDGGTRATGASRE
>Q8D281|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKEILIIIILGIVEGITEFFPISSNGHLILINYIFNIDKENIQNIIKIIQIGPIFSIILL
FKEKIKKSITFFYFNINNIKKKLILILFNLVLSCIPISILGFMFYKKLEEFYSPKYISYF
LILGSIFFILSEFISLKKIKIDNFKKISFLKYFIIGSSQCFSLLPGVSRLGITISIGLIL
NIDRYVLFKFSMILFSSIMPAVLILEVYKNFFYLKENIFFVIIGVMSSFLTSLIFGRTAI
KIMKNTSLIIFAIYRIFIACIILFTCN
>Q7N3Q6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFEQIKKVSVVIPIYNEEESLPLLLERTLAACKQLTQEYELILVDDGSSDKSAEILIQA
AEQPENHIIAILLNRNYGQHSAIMAGFNQVNGDLIITLDADLQNPPEEIPRLVKTAEQGY
DVVGTRRANRQDSLFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIVEAMLQCHERS
TFIPILANTFARKTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGS
VIAVSGFLLAVLLMVLRLIFGAIWAAEGVFTLFALLFIFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGDNKTNDNQEEY
>A0A0K9YQX7|FEATURES|UNIPROT_deepARG|aminoglycoside|ADS79_16900|antibiotic inactivation|1
MSDLNNEKIPTEAIQARKVVEELLGSTIVGVYLFGSAVTSGLRIHSDVDVLVVVNQCLTE
ENRRKLTDRLMPISGKIGNSDSVRPLEVTVINHGDVVPWRFPPKNEFIYGEWLRDEFENG
QIQEPTYDPDLAIVLAQVRKNSVSLFGPDASEVLEPVPMTHIRRAIMDCLPGLIAGIKGD
ERNVILTLARMWLTIAVGEISSKDIAAEWVIPQLPKEHATLLNVAKKAYRGEVVDKWEGL
DSEVLALVNHMKSSIESYVSI
>A0A0A0Q9K0|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-2|antibiotic inactivation|1
MMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKMALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILSAL
>A0A0E2QC34|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSLADEFDEIKKVSVVIPVYNEEQSLPQLLERTIKSCKQLTQSYELILVDDGSSDRSAKM
LVEAAENPDNHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVQTA
SQGYDVVGTRRANRQDSWFRKTASKMINAMITKATGRSMGDYGCMLRAYRRHIIEAMLQC
HERSTFIPILANTFARRTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLS
VVGSIIAAGGFVLAVLLIVLRLLFGASWAADGVFTLFAILFMFIGAQFVAMGLLGEYIGR
IYNDVRARPRYFIQKVVGADLKSDKNQEEN
>A0A087F9T9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWVAFQALILGIVEGLTEFLPISSTGHLIVVGDLLGFNGEKATAFKIIIQLGAILAVI
WEFRAKVLGVVVGLPSDPNAQRFTFNLLLAFIPAVIFGLAFADLIEHWLFNPITVAMALI
IGGIIMLWAEKREHAIKAETVDDMTWKLALKVGFAQCLALIPGTSRSGATIIGGLVFGLS
RKAATEFSFFLAMPTMVAATVYSLVKYRDILQMSDLPIFAIGFVSTFIVAMITVRALLKF
ITSHSYAVFAWYRIAFGLVILATWQLHLIDWSTAQP
>A0A0C2VGZ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVIDAVILGTLEGLTEFLPISSTGHLILASKLLGLKQTDAHKAFEVSIQLGSILAVLFI
YAKKLLVDKSIWIKVIVAFLPTAIFGFLFYKTIKSLFGIETVSIMLIVGGVLFLLVEFFR
RNKKGNEGKSIDDLTINESFVIGLFQSLSMVPGTSRSGMTMLGGIFSGLNRKSAAEFSFL
LAVPTMVAATFYDLYKNRSSMAVDDYTLLAIGFGFAFIVAFFTVKAMIRFLENHTFVAFG
IYRIIVGLAFWFLVV
>YP_001454231|FEATURES|ARDB_deepARG|multidrug|AcrA|antibiotic efflux|1
MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPEVGVVTLKTEPLQITTELPGRT
NAYRIAEVRPQVSGIILKRNFTEGGDIEAGVSLYQIDPATYQAAYESAKGDLAKAQAAAN
IAQLTVKRYQKLLGTKYISQQDYDSALADAQQANASVVAAKAAVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELASGKLKQENG
KAKVELVTSDGITYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
TNPDALLVPQQGVTRTPRGDASALVVGADDKVETRQIVANQAIGDKWLVTDGLKSGDRVI
VTGLQKVRPGAQVKAQEVTADNEQQAASANPSEQSKS
>V0VBA2|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLNFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0M4G457|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAATKIVTEGL
>A0A090YUB2|FEATURES|UNIPROT_deepARG|beta_lactam|blm|antibiotic inactivation|1
MKKNTLLKVGLCVSLLGVSQFASAISPVQAVEKIEQKVIKNAEGTISISQLNSKVWVHTE
VGYFNGEAVPANGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKEKGIQAHSTALTAELAKENGYEEPLGDLKTITNMKFGNMKVETFYPGKGHT
EDNIVVWLPQYKILAGGCLVKSADAKDLGNVADAYVNEWSASIGNVMNRYKNMKSVVPGH
GDVGDKGLLIHTLDLLK
>J2P759|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSVKAVVFAYHDIGCAGIESLLTAGFEIAAVFTHADDPKENAFYGSVAQLCAQKGIPVHA
PEDANHPLWIERIAKLNPDYLFSFYYRHLLSVPLLATARQGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQTVAIERSDTALTLHGKLRVAATDLLRDTLP
ALLQGKVTETVQDESKATVFGRRTAADGKLLWKKPAEELFNLVRAVTQPYPGAFCDVGEH
KLIVWTAEVAKGNEGLAPGRVISVDPLRIACGEDSLVITAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDQYEVYGLDIGSDAIDRLR
SHPHFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLVVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNENDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGAGYQDVSHRKPSIANAKRLLDWAPTVEMSETIGNTLDFFLREAMLEIA
DHSTEKAR
>YP_001834888|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVIT
NKFYSSTHRGPSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKP
QQREMLLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKE
PTVIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAQLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYTDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0A1YDC9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVVIQLGAILAVVV
LYWRTFWAVGMGLLRREPTSWRFLRNLLVAVIPAAVIGLALHNYIEELLGAPRVVAWALI
AGGIAILGIERMVKENRFHGIADIPFVRVVGIGFIQCLAMIPGISRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGATTLELLKNGDKLTSATVGWGSIVLGFIVSFIVALLVIRWFV
GLVSRHGFAPFAWYRIVAGIAALAWLSLR
>V9HNW7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKVVILSLVEGITEFIPVSSTGHLILVNEFIKLKPESFANMFSIIIQLGAILSVIL
IYFNKLNPFSYKKSASKKRETIEIWKRVIIGVLPAAVLGLKFDDFIDEKLMNPYVVMTTL
FVWGIVIIFIEARHKKAKIKSIADMSYKTALLIGLAQCIALVPGTSRSAATIIGAMLLGC
SRTVSAEFSFFLAIPTMFGATSLKIVKAILRGTPMSMWQVFLILLGTVLSFIFALIVIRK
FMKYVKEHNFIAFGLYRVVLSVVMAIYFLIIAK
>CAR61679|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARAL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMA
RWMPETRPAGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSALMWQSVICCLLAGLMMWIPGWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGALVGGLQNIGSGVLAWLSAMLPQTGQGSLGLLMTLMG
LLILACWLPLASRISHQGQTV
>Q83QT8|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERDIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEIFQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFLPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYHIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSCYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0H3F4Y6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIVESHSLLVAAILGVVEGLTEFLPVSSTGHLIIVGNLLGFTGDTSKSFEVVIQLGSILA
VVVMFWRRLFNMIGLHFGKPPVHEGSGSRRLNLLHIILGMIPATVLGLLLHSQIKALFEP
KYVMYALVVGGILLIAAELLKPKKPRAEGLDDITYVQAFMIGVFQCLALWPGFSRSGATI
SGGMLMGISRFAASEFSFLLAVPMMMGATALDLYKSYSFLNMADLPMFATGFVSAFIVAL
IAIKTFLAVIKRISFIPFAIYRFFVAIAVYFVFIA
>A0A031J7A6|FEATURES|UNIPROT_deepARG|aminoglycoside|BES08_20160|antibiotic inactivation|1
MIVRITVGSNADLLEWSALRTSLWPDGSEAEHQEDVVQLMAEPQPFIGFLARDKHGALVG
FAEAAMRVDYVNGCETSPVAFLEGLYVVEECRRQGIGRGLVDAVEAWARSMGCAELASDA
MLDNTVSHAMHAALKFEETERVVYFRKVLTPMPLLS
>E0TYV1|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKNKATLKLGLCIGLLCLSLTGFKPFYGSTHAEAKAIGDTKMTSCIANKKFVQLEKKFDA
RLGVYAIDTGTNKTIAYRPNERFAYASTYKVLAAAAVLKKNPIEKLNEVMHYSKDDLVTY
SPITEKHVDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKANRF
ETDLNSAIPGDIRDTSTAKALASDLKAFTVDNTLTTDQRTILTDWMRGNATGDELIRAGA
PTGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSKRFTKDANYDNALIAEAAKVVL
NDLK
>AAQ62546|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLDPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSALFADRIGVNHWFLLSGILIICIAIVCPMINEIRKLDLK
>A0A0J9BHW1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGEKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKEPHEGTGTGKLTLIHILLGMVPAVVIGLLLHDQIKTLFNPVN
VMYALVVGGVLLIAAELLKPKQPKAVGVDDITYRQAFVIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSMGFLTMADFPMFAVGFVTAFIVALIA
IKTFLHIIKRISFIPFAIYRFIIAAAVYAVFVL
>A0A086G9U2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTSGQLKLGHILLAMIPAVVLGLVFHDVIKSLFAP
KNVMYALVVGGLLLLAAEWLKPKTPRAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTI
AGGMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTWGDLPMFAVGFVTAFVVAL
IAIKTFLSLIKRISFVPFAIYRFIVAAVVYMVFL
>YP_608682|FEATURES|ARDB_deepARG|multidrug|MexD|antibiotic efflux|1
MSKFFINRPNFAWVMALFISLAGLLVIPALPVAQYPSVAPPQISITASYPGASAKVLVES
VTSIIEESLNGAKGLLYYESTNNSNGVAEVLVTFEPGTEADMAQVDVQNRLKQAEARMPQ
AVLTQGLKVEQASAGFLLIYALTSKASDSGDTTALADYAARNINNELRRVPGVGKLQFFA
SEAAMRVWVDPQKLVGYGLSIDDINNAIRGQNVQVPAGSFGSTPGASEQELTATLAVQGT
LDTPEAFAGIVLRANPDGSRVLLGDVARLAIGSENYNLSSRLDGHPAVAGAVQLAPGANA
IQTATLVKERLAELSQFFPEGVEYAVPYDTSRFVDVAIEKVLHTLAEAMVLVFLVMFLFL
QNVRYTLIPSIVVPVCLLGTLMVMKLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERL
MAEEGLSPVAATVKAMGQVSGAIIGITLVLAAVFLPLAFMSGSVGVIYQQFSVSLAVSIL
FSGFLALTFTPALCATLLKPVPHGHHEKGGFFGAFNRAFARVTERYSVMNSALVARAGRW
MLAYVGILVVLGYSYLRLPEAFVPSEDLGYSIVDVQLPPGASRVRTDHTAEALEQFLMSR
EAVASSFIVSGFSFSGQGDNAALAFPTYKDWSVRGQEQSAEAETAAINAQFAANGDGTIT
AVMPPPIDGLGNSGGFALRLMDRGGLGREALLAARDQLLARANGNPVILYAMMEGLAEAP
QLRVQIDREKARALGVSFETINSTLATAFGSAVINDFTNAGRQQRVVVQAEQGERMTPES
VMRLYAPNASGEQVPFSAFATTKWEEGPVQLVRYNGYPSIRIAGDAAPGASTGQAMAEME
RLVSELPPGIGYAWTGLSYQEKVSSGQAAGLFALAILVVFLLLVALYESWAIPLTVMLIV
PIGALGAVWAVMLTGMPNDVYFKVGLITIIGLAAKNAILIVEFAKELWEKGYSLRDAAIE
AARLRFRPIVMTSMAFILGVVPLAIATGAGAASQRAIGTGVIGGMLSATLLGVVFVPICF
VFVLTLLKRKPAPVKQAIEAVE
>AAZ93366|FEATURES|ARDB_deepARG|beta_lactam|CMY-2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGXPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A0G3VQK8|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
CGAVLSRVDAGQEQLDRRIHYSQNDLFEYSPVTEKHLTDGMTVRELCSAAITMSDNTAAN
LLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTG
ELLTLASRQQLIDWMEADKVAGPLLRS
>AAA48273|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVLSLELPEVKGMGRFGYVPYVGYKCINHVSISSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTIFAHISHSINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>A0A073JWR5|FEATURES|UNIPROT_deepARG|beta_lactam|BAMA_03925|antibiotic inactivation|1
MKGMMILKSSRMIKIGICVGVLSLSLASVKSFASKPLQVEAKEETNKTQHIDFAIHQGFV
QLERKFDARLGVYAIDTGTNQTVTYRPNERFAYASTYKALAAGAILQQNSIEKLNEVITY
TEEDLVTYSPVTEKHVDTGMTLGEICEAAIRYSDNTAGNILFEELDGPKGFERTLRQIGD
KVTIADRFETELNEAIPGDIRDTSTPKTLATNLKAFTVGSALSADKRKILIDWMSGNATG
DKLIRAGVPENWEVADKSGAGSYGTRNDIAIIWPPNRAPIIIAILSSRDKKDATYDNELI
AQATKVTVNVLK
>N8XK94|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDAEARHFAFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESKNFDHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIAVGFVAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>F4HDX0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAAHFLGFEGQKAATFEVIIQLGSILAVIFV
YWRKMFGLIGIHFGEKVDQNKAHLNLIHIILGMIPAVVLGLLFHSTIKSWFNIHNVIGAL
VAGGILLILAEKFRPQPAYAEELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMG
VGKKAAAEYSFILAVPMMMGATALDLYKSLPFLSWDDLPLFAVGFVTAFIVAMIAIRTFL
HLIGKISFVSFAIYRFILAILLAWIVLA
>I6YE68|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDEAFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>D8GY68|FEATURES|UNIPROT_deepARG|beta_lactam|bla2|antibiotic inactivation|1
MKNKRLLKIGICVGILGLSLTSLEAFTGGSLQVEAKEKKGQIKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLVEVITYTKEDLV
DYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATGDKLIRA
GVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAEV
IVNAFR
>A0A0J6BSX3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDSTLYLLKAFFLGIIEGLTEFIPVSSTGHLILFGDWIQFESSSGKVFEVVIQLGSILA
VMWIFRARLWQLIRGTLAGERQELMFTRNLLLAFLPAAVIGAVFIKVIKQTFYHPGVVAV
TLVLGGLIMLWVERRAPHTPGDAPGASDDTASDERATARRLEDISWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYRNLDVLTQHDLSGIA
VGFVAAFLSALVVVRAVLRFVANHTYRGFAWYRIALGLVVAVWLFAR
>A0A0B5X661|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEAISYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWTYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTVFVLL
>G1V7D6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKIIEAEGINKFFGTGQNRVHVLKDMSFAIEEGDFVAIIGQSGSGKSTLMNILGCLDTQS
SGVCRIGGVDIGTLDSDELAELRGKRIGFIFQRYNLLSTLSATENVALPAVYSGVDKKAR
LDRAKSLLADLGLPDKLENKPNELSGGQQQRVSIARALMNGGSIILADEPTGALDSKSGE
NVMDILTELNRRGHTIIVVTHDHHIAGFASRVIEIKDGSIISDTRSRELVPAPERELPRS
PRASFLFRKDQFVEAFKMSVQAILAHKMRSVLTMLGIIIGIASVVSVVALGRGSQEKIIA
NISSMGTNTINVYPGQGFGDRKSDKVKTLTVADSDVLGKQSYIDSATPNTTAAGTLVYRN
ITVNAQLSGVGEQYFDVKGLKPAEGRFFNRDDVRANHSYVVIDDNTRKKLFPNGGDPVGQ
VLLFNRQPLEIIAVAEKQDSVFGPTDTLNLWAPYTTVMNKITGQRHISSVIVKVKDNVMP
LMAEKNLTALLTARHGKTDFFTVNTDSIKKTIESTTGTMALLISGIALISLVVGGIGVMN
IMLVSVTERTREIGLRMAIGAKQGNIMEQFLIEAVLICVIGGVLGIVVSYLIGVVFDLLV
SNFAMSYSAGSMLLALVCSSAIGIVFGFMPARNASRLNPIDALSRE
>A0A0M0X581|FEATURES|UNIPROT_deepARG|chloramphenicol|AMS60_00965|antibiotic inactivation|1
MKFNRIDRKNWHRKEYFEHYLQQQTTFSITNEINITILMENLKKKNVKLYPAFIFIITKI
VNAHREFRTSFNSEGKLGYWTEVLPSYTIFDKKTCTFSSIWSSNVTTFSEFYSQYEKDVE
RYNGTGRMFPKTPIPENNIPISMIPWSSFTGFNLNINNGGDYLLPITTGGKYSQVNGELF
LPVSLQIHHAVCDGYHASVFMNEFQRLADESVEWL
>A0A090U5T9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCLGVQAVLDAGYDIAAIFTHADNPGENAFFGSVSRLAADAGIPVYAPD
DVNHPIWAERISQLAPDVIFSFYYRHLLCDAILALAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGAIVAQQRVAISSDDTAFTLHHKLCQTARRVLEQALPAI
ERKETHDVQQNESEATYFGRRTPEDSFLTWNRPATTLHNMVRAVAAPWPGAFSYSGTQKF
TIWSSRVHAQNQTAQPGTVISVSPLLIACSEGALEVVTGQAGNGITVQGAQLAQILGLVA
GSRLNTPSLAASKRRTRVLILGVNGFIGNHLTERLLREDHYEIYGLDIGSDAIGRFLNHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDNVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNSARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENAGGRCDGEIINIGNPENEASIKELAEMLLESFDKHPLRNHFPPFAGL
RVVESSSYYGKGYQDVEHRKPNIRNAKRCLDWEPTIDMRETVDETLDFFLRSVDLTEHSS
>A0A0T8KVP9|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MDLWVAIQALILGVVEGITEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRRKIIDVVVGLPKERQAQKFTVNLLIAFMPAVVLGVAFADLIHEYLFNPITVAAALV
IGGIVMLWAERRDHAIRAETVDDMTWTLALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFAVFAIGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIGFGLLILATWQLGMIDWSTAVG
>J7I3K6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMGSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0Q6QYG5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDRLKTLAVCVAVLATGQCVAQDQIETVVNAAVRPVMQAQAVPGIAVAVTVNGKPHYFNY
GVASKESAQPVTENTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASSVLPDLRGSAFDN
ISVLQLGTYSAGGLPLQFPDDADAPDKMLGYFKQWKPTYAAGTHRLYSNPSLGLFGYLAA
QSMGAPFDDVMEKTLLPKLGLKHTYLTVPQAQMGLYAQGYNKEDKPVRVGPGALDSEAYG
VKTSAADMIRYVEANMKLASLEDPMQRAITTTHTGYYKVGEMTQGLGWEFYHYPVTLDTL
LAGNSTQMTMEAHEVQWLTPPQPQPKNVLINKTGSTSGFGAYVAYVPSKDIGIVILANKN
YPNPERVKIAHTILSALAK
>W2CQD2|FEATURES|UNIPROT_deepARG|beta_lactam|T230_04875|antibiotic inactivation|1
MAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>B4U7H4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIIHAIILGIVEGALEFLPVSAAGHLTLVGKLLGINTENPAFKIYEIFMQIGAVIAVII
LYSKRLIIDKEIWLKIIAGFVPTGAIGFLFYKPIKHYLLGNPLITASMVFIGGVIIIIVE
SLSKKPKIASLKDVTIKDAITVGFIQALALIPGVSRSGATIIGAMLIGFERKTAADFSFL
IAIPTILSAGFYSLLKDHSQIHHQDILPMSISFITALIFAIVSVKTFLNFISFNNLKIFG
YYRIITGLAYLAYLLR
>A0A0Q8SV31|FEATURES|UNIPROT_deepARG|bacitracin|ASE31_19850|antibiotic target alteration|0
MDLVLLAKAALMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIRSTLVALPRERSAQRLVLNVLIGFLPAVVLGLLLGKAIKAHLFIPVVVASTFI
LGGFVILWAEKRPPGATRIHEVDDMGPLDALKVGLVQCMAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAMPTLIGAGVYSLYKERALLSVADIPMFAVGLVFSFFSAWLCVRWLLR
YISSH
>E1T6Z6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLACKALILGIVEGLTEFLPVSSTGHLIVAGSLLNFNDAHAKTFDVVIQLGAILAVC
WEFRRRIVTVVTGLPSRPEARRFTLNVIIATIPAIVLGLLLEKSIKAALFSPVPVAFALV
VGGVVILWVEARQRGQAGESKVARVHDVDDMTPMDALKVGLAQCFALIPGTSRSGSTIIG
GMLFGLDRRVATEFSFFLAIPIMFGATAYELHKDWHTLSADALGVFALGFVAAFVSAFLC
VRWLLRYVAGHDFTAFAWYRIGFGLLILLVGYSGALSWAD
>YP_001176066|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MLNRSSSSGHRLGRQALLFPLCLVLYEFSTYIANDMIQPGMLTVVAQYNAGIEWVPTSMT
AYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLAILLAQTIEQFMVLRFLQGVSL
CFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFILFAL
LAAISYFGLHRAMPETATRLGEKLSLKELGRDYKEVLKNVRFVAGALATGFVSLPLLAWI
AQSPVIIISGEKLSSYEYGLLQVPIFGALIIGNLVLARLTSRRSVRSLIILGGWPIAGGL
ILAAVATVASSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQML
IFTVGIEVSKHAYIIGGNGLFSLFNLANGVLWVGLMVIFLKNKRVGNALQP
>N9CG48|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLFKAAIMGLVEGITEFLPISSTGHLILSGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGAMKGQEQGRRLSLNLIIASTPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRKHLVVSSEVDDLTFKQATLIGLIQCFALIPGTSRSGSTIIGSLFLG
ISRKAAAEFSFFLGIPVLMGAGLLDMYKMRNDLHSNDLAVLAVGIVVAFISALIVIRALI
RYVSKHDFTAFAYYRIGFGVFILATWWTGWVHW
>N0B0B8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMHYITAIILGMVEGLTEFLPVSSTGHLILSGEILNFKGDNAKTFEIFIQLGSILAVVVV
FWKRFLNILGLIGDHKNKLNILHIIFAMIPAVILGLLLHDAIKTYLFSSNTVVIGLVAGG
ILMIYAEKKKAPNLITSLDTLTYAQAFKIGLFQCLALWPGFSRSGSTISGGLLVGADRKV
SADFSFIVAVPMMVAASGLDLLKSYDSLSMSDVPFFAVGFVTAFIMALLAIKIFLKVVAK
VKLTPFAYYRFILAIVVYLFLNK
>K0PBW6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEYMNSIILGIIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYRHR
LLDLVLGWRDPRNRSYAAKLIVAFLITAVLGLVVKKLGFQLPETATPIAWALIIGGVWMI
FAEWAAARRPPYKEITWLVAILVGIAQVVAGVFPGTSRSGATIFVAMLAGTGDRAAATEF
AFLVGIPTMYAASAYELLKTFKDGGAANEDWTSLGIAFVVSTVVAFIAVKWLLSYIRSNR
FTMFAIYRIILGGILLGMAATGAIA
>A0A127SPH0|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
DILLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPPK
AYSNWSTPSEMVRLLKMADEKNLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGVVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEMK
>YP_002047829|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQLFYGPLSD
RVGRRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTLPRDLYEGT
QLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMARWMPETRP
AGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMVVSIL
FILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVWTLLIPAAL
FFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQTGQGSLGLL
MTLMGLLILACWLPLASRISHQGQTV
>L2VIM6|FEATURES|UNIPROT_deepARG|beta_lactam|WCO_03797|antibiotic inactivation|1
MLKMTLCALLITASCSALAAPQQLNDIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPVTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPDWTPGTQRLYANSSIGLFGSLAVK
PSGLSFEQAMDTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWLQSNIDPRNINDKTLQQGIQLAQSRYWKIGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPVRVAAAWQILNALQ
>A0A0G3X2P5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLFVAACATATAGRAAAVTQDDIHDTVTRHVAPLMKQFAIPGMAIGVVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLASDAQEGGELSLADPAAKYLPA
LQGKPFGGVTLLELGTHTPGGMPLQVPDSIRDDAGLIRYLDAWQPAYAPGTRRTYSNVAI
GMLGWLTAKAMNRDFSVLMEQRLFPALGMTHTYINVPDARTADYAQGYTQDGKPIRMTGG
MLWQQAYGVRTTAADLLRFVQANMGLVDTAPRLQRAIERTHTGYFRAGPMTQDLIWEQYP
YPVALPTLLEGNAPKMLFNATPASAIKPPLAPNPDTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRNFPIEDRVKAAYGILESLGGGR
>CAB96926|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MphC|antibiotic inactivation|1
MTRHNEIIKCAEKYQLHIQPQTISLNESGLDFQVAFGKDKHGVEWVLRLPRRPDVYKRTK
PEKQTVDFLQKNVSFEIPKWKVHAKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPLPEN
FINTLAETLVDLHNIPEENINVQHINIKTIQEIKNDFQRRMNKVKETYGVSDELWNRWKQ
WLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSEPSMDFIGHHRVFDDE
GLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMESGESAYETMALKELGMKE
>A0A0T6XQW5|FEATURES|UNIPROT_deepARG|aminoglycoside|N185_34800|antibiotic inactivation|1
MRVLLMDGETIGRWVEMRLALWPDTPAADHRAEVESCLAEGDRYASFLCEDEAGVAAGFA
EASIRHDYVNGCETSPVGFLEGIYVLPAYRRRGVARALITAVERWATSRGCQELASDTAT
DNLRSQSLHMALGFEETERVVYFRKELAPAVADN
>Q4KES7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB1|antibiotic efflux|0
MSEPLLHLTGISRSFTAGDREFLALKHIDLSIQAGEMVAITGASGSGKSTLMNILGCLDY
ATAGSYKVNGRETRDLDDQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGTPQV
RRHGRARELLARLGLSGHLGHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTAS
GKEVMNILQELHGLGHTVIIVTHDPKVAANAQRIIEVRDGEIVSDRANPRPADEAPSEPP
VSVRPAGARRLVASLGLFKEAFVMAWVALVSHRMRTLLTMLGIVIGITSVVSIVAIGEGA
KRYVLKDIQAIGSNTIDIFPGASFGDSRAAAIQTLMPADVTALNQLYYVDSATPMVGRSL
LLRYGNIDLNATVNGVSHLYFQVRDIKLASGISFSENDARRQAQVVVIDHNTRNRLFGPD
VDPLGQVILVGNLPCTVIGVTRENKNMFAASNLLNVWLPYETAAGRVLGQRHLDSISVRI
KDGQPSKVVEEHVKKLMEQRHGTKDFFTNNLDSIMQTVQRTSRSLALLLSLIAVISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGAIGISLSFAIGY
LFTLFIKEWEMVFSMGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>A0A0G9HZG4|FEATURES|UNIPROT_deepARG|aminoglycoside|Y886_30125|antibiotic inactivation|1
MTDGFSVRAAAAADLRAWAALRVALWPDESDAFGGVAEALQREDAANFLAFAGDGQAIGF
ADVTLRQDYVNGTDSSPVGFLEGWYVAPEWRGRGVGRALLREVQDWTRAQGCSELASDAL
LDDAAAQAAHHACGFEETERVVYFRMPVAD
>E4SXD5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPTSFINMFMVVIQLGAILSVI
VIYFNKLNPFAPSKSKREKGQTWQIWFKVIAAVLPSIIIGLPLNDWLEENMTSWQVISAT
LIIYGILFIVLENYYAKRQPSLTDLNKMSYKTALLIGCFQVLSMIPGTSRSGATILGAML
IGSSRYVATEFSFFLAIPTMFGASLLKLFKFFKAGHVFVGSQLAILLVGMVVSFIVAYLS
IKFLLKYVQTHDFKPFGWYRIVLGIIVIICGLVFA
>S3MUN3|FEATURES|UNIPROT_deepARG|beta_lactam|F945_03287|antibiotic inactivation|1
MKKNLFACLVLSTALTQVACSTLQTTADPSTQASTAQQSIKSYFDEVQTKGVIVIKQDGQ
LQTYGNDLSRANTEYVPASTFKILNALIGLENHKVTLNEVFKWDGQKRSFPTWEKDMNLA
EAMKLSAVPVYQELARRIGVDLMAQEVKRLNFGNAQIGTQVDNFWLVGPLKVTPVQEVEF
VEQLAHKQLPFKPEVQETVQQMILLQEVKGNKIYAKSGWGMDLDPQVGWLTGWVEQPNGK
KVAFSLNMEMKPKMSGSIRNEITLKALENLGVI
>Q5XLF8|FEATURES|UNIPROT_deepARG|beta_lactam|cfxA2|antibiotic inactivation|1
ANPPLTNVLTVSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCN
DFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLM
FKDMVNVAQTDSFIATFIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEG
LIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYI
CLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQ
>YP_002086937|FEATURES|ARDB_deepARG|multidrug|mexE|antibiotic efflux|1
MEQSSHFSWRYPLALAAVLVLSACGKAPETTQGMAAPKVSVAEVIEQPLNEWDEFTGRLE
APESVELRPRVSGYIDRVAFHEGALVKKGDLLFQIDPRPFEAEVKRLEAQLQQARAAQAR
SVNEAQRGERLRASNAISAELADARTTAAQEAKAAVAATQAQLDAARLNLSFTRITAPID
GRVSRAEVTAGNLVNSGETLLTTLVSTDKVYAYFDADERVFLKYVELARQAGRDTRSESP
VYLGLSSEDGNPHLGRLDFLDNQVNPRTGTIRGRAVFDNAKGEFTPGLYVRLKLVGSKTY
AATLIKDEAVGTDLGKKFVLVLDGDNKTVYRTVEMGPKLEGLRIVRSGLSKGDRIVVNGL
QRVRPGMQVDPQKVEMASADTLGTLARLRQSVGDSEPPKVAASKDNATRNEPRG
>R8GNX0|FEATURES|UNIPROT_deepARG|beta_lactam|IKE_05732|antibiotic inactivation|1
MVQKNKKELDWLKPVNVVTTAAILATTLFTPIVDVLPGKYNIVHAAETQSPAKYGVIDTS
NNWKGIYSDHIWPHVTENMGTYNRYRLGTPTNGMTTNMVNFKIDYPLVAVEAKLRSNADR
YIEFHWARYDFVKGTWCLQDSTAFISPDAPKPKVGEWGIWKVTYDQTTKKNTYYLNGKMV
GYRNYQDGTLGNANYLFRAEGFEKSYVDVESIYTSNSATNFVLAPKVNGVTDAQTKLTGS
GSPGAAVTIESNVMPGKYTGTVDGNGNFSIDIPKQKAGTELTVTQALDGSTSEKTVVTVK
DGTAPDAPKVNPVTSQDTKITGTGEKGAKATVKIGNGEYEGTVDEKGNYAIDIPEQPVGT
ELSVTLTDAAGNTSQPTKINVGEKDTTAPDAPKVNKVTDQDTKVTGTGEKGSKVSVVVDG
KEIGTGKVDDQGNYTVDIPKQAGGKEIVVTLTDAAGNTSQPTKTKVETKDVTAPDAPKVN
PVTDQDTKVTGMGEKGATVKVVVDGKEIGTGKVDDQGNYTVDIPKQPVGKEVVVTLIDTA
GNTSQPTVTKVKIDSATQEKAVKEAKYAIDHLFTNSSRSKFNHDFTTVKKGAIQIHVTEQ
HIAEAMEKLRKIPDDYKEKPAFQKEIERAQSLVEDREKMQEGNLVQNGLFDSGLNKWKPW
LGTGATTPTVKTDDDKSKNVIKLDPNSSVEQVLTGLEPNTTYELTAYARAEDNEKFSVGT
KKTGTANVTVPIYSKEYSQAHLTFKTGPNSTTATIYLYKNGGTKSGYADFVITKKVMGET
EQTHQKFSQLEKEFDAKLGIYALDTSTNQTVIYNPNERFAYASTHKALAVGVLLQKKSIE
DLDQRIMYTDKDLVNYNPITEKHIDRGMTLKELADASLRYSDNTAQNLIFKQIGGPDGFK
KALQEIGDTVTNPQRIEPELNDVNPGETPDTSTPKALAASLQTFILGDVLPTEKRNLLID
WMKRNTTGDKLIRAGVPKGWEVADKTGAASYGTRNDIAVIWPPNKKPIVLAILSNRDKKE
AKYNDQLIAEATKIALDSLKINNK
>A0A081LGF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNVWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKDIITPEAANTFKVVIQLGS
ILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPAVILGFLFEDYIDKYL
FDVRTVAVGLILGAVLMLVADWINKRKTETSSVDNMTYRQALYIGLFQCLALWPGFSRSG
STIAGGVILGLNHRAAADFTFIMAMPIMAGASLLTLVKNAEYLTTDMLPFFIVGFVSAFI
VALFVVRFFLKLINKIKLVPFAIYRIILGLILFILFM
>Q6QIU5|FEATURES|UNIPROT_deepARG|beta_lactam|blaampC|antibiotic inactivation|1
MNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVAS
KQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGVSLL
NLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPVGSYRVYSNLGIGMLGMIAAKSLDQ
PFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIKSNA
RDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLVEGNN
AGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDD
RVEAAYHIIQA
>A0A024P8V8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIHGINHLLFSVSDLETSIRFYQDIFGAELVVKGRTTAYFDWNGLWLALNEEKDIPRNE
ISASYTHMAFTVDERDFDEVYQKLTDHHVNILPGRKRDKRDKPSVYFTDPDGHKFEFHTG
TLQERLDYYKEAKPHMEFFR
>B1LLK9|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLIHDKILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KDGNILEIAQCENEATCFGRRTPEDSFLEWHKSAAVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGGGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>D0WWU8|FEATURES|UNIPROT_deepARG|beta_lactam|VMC_16480|antibiotic inactivation|1
MKKLFLLAGLMVCSTLSYASQLNEDISLLEQQTSSRIGVSVWDTQADERWDYRGDERFPL
MSTFKTLACAKMLSDMDSGKLSKNATAKVDERSIVVWSPVMDKLAGQNTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTMFLRTIGDKATRLDRIEPRLNEATPGDSRDTTTPNAMLN
TLRTLVEGETLSYESRVQLKIWMQDNKVSDSLMRSVLPTGWSIADRSGAGGHGSRGINAI
IWKENHRPVYISIYVTETELSLQARDQLVAQISQLILQKYKDN
>A0A0K9M761|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKLTSKYETIRRILSEGKQPEYRYAQIMEAIFKQNIGEYERMTLLPKFLRDELNRVLGPN
VCSIAPVKELTSKQVSKVLFAIPGEEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATG
TIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDSNLFGLG
HRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLMALDR
HIRETGRKVYIAYILLREVNDSTAHAEAVADLLRGRGAWEHLYHVNLIPFNSTEVTPDSY
RQSDPSRIKAFVRILKSKGISVTVRTQFGSDINAACGQLYRSE
>B1HZM2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTVQSINHLLFSVSDLEKSIAFYENVFGAKLLVKGNSTAYFDVNGLWLALNVEKDIPRND
IQYSYTHIAFTISEDEFDKMYDKLVQLKVLILDGRQRDERDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYKKEKLHMEFFNH
>AAM11670|FEATURES|ARDB_deepARG|beta_lactam|CFE-1|antibiotic inactivation|1
MMKKSLCCALLLTASVSTFAAEKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIAKNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAAGAKRLYANSSIGLFGA
LAVKPSGMRYEEAMTKRVLQPLKLTHTWITVPQSEQKDYAWGYREGRPVHVSPGQLDAEA
YGVKSSLVDMTRWVQANMDASQVQEKTLRQGIEIAQARYWRIGDMYQGLGWEMLNWPVNA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVDAAWRILEKLQ
>ZP_02007607|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFAINVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
IGGFVILWAEWRERHRGETHDPRANALLEAAKAGAPRIETLDDLRISDAIKVGFAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKSRALLSADDLSIFA
VGFVAAFISAFFCVRWLLKFIATHDFRGFAWYRIIFGIIVLVTAYTHLIAWQA
>C0CNW4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIIEFFKVVILGIIEGITEWLPISSTGHLILADEFIKLNVSDAFMQMFLVVIQLGAILA
VVVLYFKKLWPFCTWEGNGEVLKSKDKWILWGKIVLACLPAICISPFNDFIEEKFNNYVV
VAMMLIVYGILFIIIENYNKKRTPTCTSLKEMSVKTALLIGLFQVLAVVPGTSRSGSTII
GGILIGVSRTVVAEFTFFLGIPVMFGASLLKVVKFGFDFTGTEITILLLGMAVAFFVSIL
AIKFLIGYIKKHDFKAFGWYRIVLGIVVLGYFVGKTYI
>B7N5M0|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>W8TWP4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGQVPHEGKTSGHLTLGHILLAMIPAVGLGLVFHDVIKSLFNPQS
VMYALVAGGILLLAAEWFKPKNPKSIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASGLDLYKSLHFLSWGDLPMFAVGFITAFVVALIA
IKTFLSLIKRISFVPFAIYRFIVAAAVYWVFMS
>YP_001102017|FEATURES|ARDB_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
QQGSRPKTKLDIMRVAVTIEISNQLSEVLSVIERHLEPTLLAVHLYGSAVDGGLKPHSDI
DLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQ
FGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNE
TLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEAR
QAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>A0A0S6V5T4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELSGISRSYQSGDQTVAVLKNVSLSIEAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLDSDALARLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAVALLQRLGLSERVGYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLREQGHTVIIVTHDPAVAQQAERIIEIRDGEIIADSRPDGQSNPNAKPLEM
VTPAPSWQQTIGRFREALVMAWRAMAASKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTFRQALKYDDLAALREQPYVSALSPSIASSMRLRL
GNVDVAANVNGVSEQFFRVYGMTFTEGAGIDQLQVQSQSQTVVIDANTQRRLFPNQKEVV
GRVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNAYFDSITVRIRDGY
NSQEAEQQLTRLLTLRHGKKDVFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLLVQV
VLPGWQISFPPAALLSAFVCSTAIGVVFGYLPARSAARLNPIDALARE
>CAS11957|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTMQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATMLEIGSLFLIYKWSYGEPLIRLIIAGPILMGGMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVTTVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHSITEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMALRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQVQGATQ
>A0A0K6MCP2|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKLKNKASIKFGICVGLLCLSITGFTPFFNSTHAEAKSIEDTNMASCITNKKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAK
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVVAILSNRFTKDANYDNALIAEAAKV
VLNDLK
>I6D8H2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLEKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSRFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>YP_001058926|FEATURES|ARDB_deepARG|multidrug|OprA|antibiotic efflux|0
MKAMMKPRARRRGARAARRPNGLRAWPLAVAAALVAGCTLAPRYERPAAPVPAHYWSTAA
GAPREAGPAAAGGPRAMPDARGGDAGRDARDARLDDWRAYFTDPALRALIDAALANNRDL
RIATLRIQEARGLYGVARADRLPSIDGSLGYERTRLYDPVLRESATSSLYRASVGVSAFE
IDLFGRVKSLSDAALAEYFATAEAQRAARISLIAEVASAYVTERALVDQLGLAERTLAAR
DAAYALTQRRYAAGTSTAIELRTAEMLVASARASKAALEREHTQAASALKLLAGDFMTAL
PADAPALDALAVARVSPGLPSDLLEQRPDIRQAEQRLVAANANIGAARAAFFPRIALTTD
VGSVSDAFAGLFSAGSSVWTFAPRLTLPIFAGGRNRANLDVADARKHIAVAEYEKTIQTA
FREVADALAARDQIDAQLAAQQAVYGVDAERLRLAQRRYDSGVASYLELLDAQRSTFESG
QELIRLKQLRLTNAITLYRALGGGWSRAGCGGDGCA
>A0A0F6XAB9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSIKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPREKTFFGSVAQMCARHGITVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGD
NKLIIWAASVDTSSNGKAPGTVISHEPLRIACGEGSLVITAGQRGDNGLYLSGAQLAREF
GLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSEHLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>A0A1M5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKTTLCALLITASCSTLAASFSEQQINDIVHRTITPLVEQQKIPGIAVAVIYQGKPYYF
TWGYADVTQKRPVTQQTLFELGSVSKTFTGVLSGDAIARGEINLSDHVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDEVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
AVKPSGLSFEQAMQTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGMLDAEAY
GVKSTIEDMARWVRSNINPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVDPD
SIINGSDSKIALAARPVKAMMPPTPAVRSSWVHKTGATGGFGSYIAFIPEKELGIVMLAN
KNYPNPARVTAAWQILNALQ
>A0A132HKC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHRIGVVISGLTSDAKSQRFAINVIVATLPAIVLALVFGKWIKAHLFNPITVAMAFI
VGGVVILLTEWREARRGTVSRPQGNALLEAAKAGAPRIESVDDLNWHDALKVGLAQCFAL
VPGTSRSGATIIGGMLFGLSRKVATEFSFFLAIPVIFGATVYELYKARALLSADDLGIFA
VGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIIVLVTAWTGFISWQA
>A0A0E3MRW2|FEATURES|UNIPROT_deepARG|beta_lactam|FOX-5|antibiotic inactivation|1
MTAAVDGIIQPMLKAYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSK
TLTATLGAYAAVKGGFELDDKVSQHAPWLKGSALDGVTMAELATYSAGGLPLQFPDEVDS
NDKMRTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHT
YIQVPESAMVNYAYGYSKEDKPVRVTPGVLAAEAYGIKTGSADLLKFAEANMGYQGDAAV
KSAIALTHTGFYSVGDMTQGLGWESYAYPVTEQTLLAGNAPAVSFQANPVTRFAVPKAMG
EQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE
>A0A010KZ29|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTLDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>Q3JJI9|FEATURES|UNIPROT_deepARG|beta_lactam|oxa|antibiotic inactivation|1
MPAAGAGRTRADRLLADPFCFSGLARGAATIVLVARVLVRKLSVCHNASPITRARAMPFS
DRPAFQAHAFDPDRANAVCRAVAFVGRKRSRAASWLDDPSRFAMFKSQQFIAAMWLSPGC
CIVFAARVAQFAAAAETGRMGQQDGLDERLLGVCGVRAVEEDRRRDSGEQNRIRRANEWR
PAIESSLRSFGPNDEPFPTLCGTTMKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTG
KLLLQDGDCGRRASPASTFKIAISLMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTD
PTRWLKYSVVWYSQQVAHHLGAQRFAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQI
SPLEQLEFLGKMLDRKLPVSPTAVDMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDW
ARGSGWFVGWIVRGKQTLVFARLTQDERKQPVSAGIRTREAFLRDLPRLLAAR
>A0A127SUF5|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
DRYLIDPRHIGYTTHLWTAFHISVMPCLGSSLPTSPGFRHQPFGLRLPEYQGRRFRALPR
HSTFWIISSPKKHIFPFGLESAIIKNTNQKIYWRTTIMGFKLIDRDNWTRDVYFQQYFSN
IPCTYSMSVKLDITSLRKSGQKLYPTMLYFLTTIVNRHSEFRTALNNEGQLGIFDSMHPC
YTVFHNDSQTFSNLWTEYHENYEQFCSAYEIDRANYASNMAFSAKPNQPENIFTVSMLPW
VSFEGFNLNLQKGYAYLLPIFTLGRYYDEGTKTLLPLAIQVHHAVCDGFHVCRFVDELQT
LINQFFENND
>K6GVI0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESLAAVVLGIVEGATEFLPVSSTGHLILVGHLIGFTGDKADSFDVIIQLGAILAVVCL
YWRRFWWLVSPKPHHAFSGIRGLWMLFLTSLPAGLVGLAARKSIKAHLFNPWSVALALAV
GAIMIFVVERRKKRDRYYSLDEMTPGLAFGIGCFQCLSLWPGFSRSAATIMGGMLLGAKR
SLAAEYSFIGAVPLMFAATLYDFYKSAALFSADDLGVLGIGFVVSFVSALVAVKAFIVLV
QRITLRPFAWYRLALAGAVFFFWPK
>A0A085FFY8|FEATURES|UNIPROT_deepARG|beta_lactam|FG93_02833|antibiotic inactivation|1
MPKRLYAGLAASVLAGTLGSLSSAHGAGPDQDARVRQAVDESVKPVMEQHGIPGLAVAVT
IDGKRYFIEYGLASKEPRVSVTRDTLFELGSISKTFTATLATYAEVEGKLSLSDSVSQHM
PELRGSALDDVRLLDLGTHTAGGFPLQVPDDVKDQKQLMAYYRAWKPRFTPGTYRNYANP
SIGLLGVVTAKAMGASFETLMERRLFPDLGLRRTYITVPAAEMKSYAWGYSRDDKPTRVS
PGLLATEAYGIKSNAVDMIRFLEVNMGIGTVPGKVAVAASATHTGYFRAGELIQDLIWEQ
YPYPVELDRIVAGNSAKMIMNGTPAVAIEPPMAPRSDVILNKTGSTNGFGGYVAYVPAKK
IGIVMLANKNYPNDARVKAAHQVLSRLAE
>A0A0Q7P3A1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALILGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQRLLSIALALPSSEKARRFVLSVLVAFLPAAVIGAIAHDFIKTVLFETPALICIVLI
VGGVILYAIDRMPLKPIYRDVMDYPPSLAFKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRAALDFNDVTVIAVGFIAAFVSALIVVRSLLNF
VSNRGFAPFAIWRILVGTAGLIGLWLFG
>F4Y5N6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
SESNPEVGNKRLEIKKADLVVWSPITEKHLQSGMTLAELSAAALQYSDNTAMNKIIGYLG
GPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKRDTTTPLAMAESLRKLTLGNALGEQQ
RAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGTTNDIGVIWPENHAPLVLVTYF
TQH
>AAT02170|FEATURES|ARDB_deepARG|tetracycline|tetS|antibiotic target protection|1
MEEIKLKIINIGILAHVDAGKTTLTESLLYSSGAIKELGSVDSGTTKTDTMFLERQRGIT
IQTAITSFQRENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHA
LRKMNIPIIFFINKIDQNGINLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQW
ETVIVGNDYLLEKYTIGKTLNIAELEKEENERIQSCSLYPVYHGSAKNNIGIKQLIEVIT
SKLFSPTQLNSDKLCGNVFKVEYSDDGQRLVYVRLYSGTLHLRDSVNISEKEKIKVTEMY
TSINGELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPHREILENPLPMLQTTIEPCKS
VQREKLLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQEKYHIEIETRK
PTVIYMERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTEL
LEPYLSFEIYVPQEYLSRAYNDASKYCANILNTKLKGNEVILIGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0F5XWF3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTLVFAYHDMGCVGITALLNAGYEIAAIFTHNDEATENHFFGSVARLAAEHGIPVYAPD
EANHPIWLDRIRTLAPDMIFSFYYRHLLSDEILQCARHGAFNLHGSLLPKYRGRAPLNWA
LINGERETGVTLHRMVKRADAGNILAQQRVAIEDQDTALTLHRKLSAAAEQLLNDLLPDL
RHGQISEWPQEESQASRVGRRTAEDGRIDWHQPAQAIHNLVRAVTDPWPGAFAFAGSVKF
IVWKSRVHPQQHHARPGTVLSKHPFLIACGDGALEIQTGQSEHGVYMNGSQLAQSLGMVP
GALLYSQPQSVLQRRTRVLILGVNGFIGNHLTERLLQDDHFEVYGLDISSDAISRFLDHP
HFHFVEGDIAIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCTDASFDEDCSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGRQKRCFTDI
QDGVEALFRIIENKQQNCDGQIINIGNPDNEASIKELAEQLLASFERHPLRHQFPPFAGF
REVESSSYYGKGYQDVEHRKPAIRNARRLLGWTPTVTMDTTIDNTLDFFLRTLEQQADHR
>A0A125UIL0|FEATURES|UNIPROT_deepARG|beta_lactam|BsLM_2003|antibiotic inactivation|1
MKLKNKASIKFGICVGLLCLSITGFTPFYSSTHAEAKSIEDTNMASCITNKKLVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKNDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKSFEKSLKQIGDHVTKAK
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVVAILSNRFTKDANYDNALIAEAAKV
VLNDLK
>YP_001401993|FEATURES|ARDB_deepARG|fosmidomycin|rosa|antibiotic efflux|0
MTDRSDTGCQQPVNVSVKRTSFSILGAISVSHLLNDMIQSLILAIYPLLQAEFSLSFAQI
GLITLSYQLTASLLQPLIGLYTDKHPQPYSLPIGMGFTLSGILLLAVATTFPVVLLAAAL
VGTGSSVFHPESSRVARMASGGRHGLAQSVFQVGGNFGSALGPLLAAIIIAPYGKGNVGW
FSLAALLAIVVLLQVSKWYKLQQRASYGKVLKTSSAKTLPKNKIISTLAILMVLIFSKYF
YLTSISSYYTFYLIHKFGVSVQSAQIHLFVFLFAVAAGTIIGGPLGDKIGRKYVIWGSIL
GVAPFTLALPYASLYWTGILTVFIGVILASAFSAILVYAQELIPGKVGMVSGLFFGFAFG
MGGIGAAVLGYVADLTSIELVYQICAFLPLLGIFTALLPNLDDK
>YP_001308137|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGLDILFIIKAIIIAIVEGLTEFIPVSSTGHMILASSIINFKGDFVKMYEVVIQLGAILA
VVVLYWKKIKNSVIEFFRYIFTKGKEGKTGFNFGINVIVGCIPMLIIGLLFYKKIKSLFN
PEAVVIGFIVGGILLIIIENMFRKSNKHATKSLDSITPMQALKVGVFQVLSVWPGMSRSA
STIMGGWIAGLSTPIAAEFSFFLAIPAMIGASAKDLMEFDYSGMNLTSWISLVVGFIVAF
VVSVVVMDKFVSYLKKRPMRVFAVYRIGAGIVFGILMFFGFLNFTL
>X8HU22|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSIELLKSALFGLVEGITEWLPVSSTGHMLLLNEFVRLGSSTDFWDMFLVVIQLGAILA
VCVMFFGELNPLSRRKEPAARRSTWALWAKIVVACLPAAAIGIPLDNWMEEHLGSPFVVA
AALIAYGVLFILIETRREHKAELASSMGEGSPSVRGKHFAAPSPEGDGSHAKASPADRDA
RIQDTEDIDWPTAIGIGCFQVLSMVPGTSRSGSTIIGGLLLGCSRTVAAEFTFYLAIPVM
FGASALRLAKYFLKGNVFTMEEAAVLLVGCAVAFLVSLLVIRFLMGYIRRHDFKPFGWYR
IALGIATIAYFGLRLVA
>A0NRK0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGQTIVNALILGIVEGLTEFIPVSSTGHILLLGHFLGFDSTGKTFEVLIQLGAILAILS
VYFGRLWTLLITLPSDPSSRRFVAGILIAFLPAAVIGVLLHSFIKEVLFETPALICTTLL
LGGIVLLWIDRLPLKPRYTNVMDYPLSLCLKIGFCQCLAMVPGVSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMAGAFAYDLYKNRDVLSMDDAMLIGIGFVASFISGVFVVKGLLDF
VSKHGFAPFAWWRIFVGIAGFAGLYFLG
>A0A0S1RS79|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTQQACAERYTPASTFKLAIALMGPDADILQGPHEPVWNYQPAYPDWGGDVWGQ
PTDPARRIQYSVVWYSQLIAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLPRLVNRQLPVKAAAYELADNLFEVG
>A0A0D7KHT8|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKSISKYETIGQILSDFKQPAYRYGQIIDAIFKQKIAEYERITILPTFLREALARTLGPN
VSSVNPIKELTSQQVSKVLFAIGGGERVEAVRLSYKRGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFYLNGHTLDSVSFMGMGEALANPHLFDALAILTNPNLFGLG
HRRITISTIGLLPGIDRLTREFPQVNLTFSMHSPFDEQRSELMPINKRFPLRDVLNSLDR
HIRHTGRKVYIAYILLRGFNDSAEHAKAVAALLRGRGAWEHLYHVNLIPYNSTEVTPQSY
LPSDPERIETFVRTLKMYGVNVTVRTQFGADIKAACGQLYRADSKMNG
>AAA24777|FEATURES|ARDB_deepARG|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A127SQ15|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-22|antibiotic inactivation|1
ASGQLLSGYRAGERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEK
HL
>ACJ39691|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MEVANVPRRHCCLFARPIPIVEVAAEADAMVTVFGILNLTEDSFFDESRRLDPAGAVTAA
IEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRY
ALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVR
FFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSR
KSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDA
RDRGLDHA
>R7H5W9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIIKSIILGIVEGVTEWLPVSSTGHMILVDSFLHLNVDSDPAANEKFKEMFLVVIQLG
AILAVVLLFWHKIWPFGKKNNRVPLSKTGFGAYLKMDIVRMWCKVIVACVPAAIVGLLFD
EKIDELFYNHWVVSITLIVFGVAFLLVERWNKDRTPRISHIDRLPYRTAMLIGVFQLIAA
VFPGTSRSGATIVGALLLGVSRVVAAEFTFYLAIPVMFGASLLKLVKHGFAFTGLETAVL
LVGMLVAFLVSVFVIRFLMDYIKKHDFTVFGWYRIVLGILVIICGLTGVIQV
>G4MEH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMFKALILGVVEGLTEFLPVSSTGHLIVAGSLLDFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSVVTGLPARTDARRFALNVIIATIPAIVLGLLFEKSIKSVLFSPVPVSVALI
LGSIVILWAESRQRDRDATPRVTYVDDLSYGDAFKVGLAQCFALIPGTSRSGSTIIGGML
FGLERRVATEFSFFLAIPIIFGATFYEMAKYWRTLTVDDLGLFVIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAE
>I9WK98|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLTLTAILLGIVEGLTEFLPVSSTGHLILATSLFGFDPEQWKTFNIVIQLGAILAVIVQ
FWRTFMAVGLGLIKFNPTSIRFVRNVLLAFLPSAVLGLLLKHWIEGLLGQPSVVAWALIV
GGIAILAIEKVSKPGPLTGVAELPAIQCIGVGLAQCLAMVPGVSRSGATIMGALAMGIER
RTAAEFSFFLAVPTMMGASTLELWGARAQLAAGTGPVGWGEIGIGFVVSFVVALVVIKAF
MAFVSRSGFAPFAWYRIVAGVVALVLLSRVS
>CAA70208.1|FEATURES|CARD_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNKKNIKDSQNFITSKRNVDKIMTNISLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVNHDNFQVLNKDILQFKFPKNQSYKIFGSIPYNISTDIIRKVVFESIA
DESYLIVEYGFAKRLLNTKRSLALLLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISYKDKQKYNYFVMKWVNKEYKKIFTKNQFNKSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>H0G0V6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLLAIALALPTSVKARRFVFSVLLAFLPAALIGAAAHGFIKSVLFETPMLICVVLI
VGGIILYAIDRLPLTPRYTDVFDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMVGAFALDLYKNRDALSFDDVGLIAAGFIAAFIAGIFVVRSLLDF
VAHRGFTPFAIWRILVGTAGLVGLWLLG
>A0A0R0B6P4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFNQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLEMAKAGQLGSENWTDVGVAFLAAAVTGFVVVKWLMGYIKSH
KFTAFAIYRIALGAALLLWLPSGS
>H1AFJ3|FEATURES|UNIPROT_deepARG|beta_lactam|AmpC|antibiotic inactivation|1
RLIFALLSPRQCQKNSWRRWSANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAAN
KPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLAT
YTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYE
QAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMA
NWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQVWAGRCSTGPWRPTRWVEGSDSKV
ALAPLPVAEVNPPAPPVKASWVHKTGSTGRVWAATWPLIPEKAESVFVMLANTAIRTRTR
SVVVIKKKKKH
>A0A0J6IQE6|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic efflux|0
MQAGLRIDVDTYRGTREGVPQLLELLDEAQIKATFFFSVGPDNMGRHLWRLIKPRFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGKDLGHLMRQTLAAGHEVGLHAWDHHGWQANTGRW
SEAQLIEHIRLGVDTLSDITGQAVECSAAAGWRADERVVEAKQRFGFRYNSDCRGHSLFR
PRLADGSLGAPQIPVDLPTFDEVVGPHLSAADFNSYILDRFSPQRLNAYTIHAEVEGILM
ANDFRQLLAQARARDIQFQPLRNMLPADLESVPAGQLSRGVLQGREGWLGVQQP
>A0A136FS57|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTAIVFAYHDIGCAGLAALIQAGYPIAAVFTHPDDPSENRFFGSVAQLCARHGIPVHAP
EDVNHPIWVERIRALEPDFIFSFYYRNLLSNDVLACAKRGAYNLHGSLLPRYRGRAPANW
VLVNGETETGVTLHRMVQRADAGAIVAQQRVAIAADDTALTLHAKLREASQTLLRDSLPA
LAEGRLTEREQDESQATTFGRRSAADGELEWSRPAVELNNLVRAVTQPYPGAFGWIGDRK
LIVWSAQARQESHGQAPGSVLSLEPLRIACGEGVLEIQAGQLGDNGLYLSGPQLAREAGL
VAGARLHRQDRRAKRRTRVLILGVNGFIGNHLSERLLADGEYEVYGLDIGSDAIERLKAD
PNFHYVEGDISIHTEWLEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRH
CVKYGKRVIFPSTSEVYGMCQDERFDEDRSNLVVGPIKKQRWIYSVSKQLLDRVIWAYGA
KGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIKLVDGGAQKRCFTDV
DDGIEALFRIIENQGGRCDGQIINIGNPDNEASIRELAEELLAQFEAHPLRHEFPPFAGF
REVESKSFYGDGYQDVAHRKPSVENARRLIDWQPSTAMAATVGKTLDFFLREAMAQREA
>A0A0F7F7F9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTSRLLQFNEQSDLMKTFEIVIQLGAILAIAL
VYRRRILDLLGIGRKRDGGGVMPRSRLNLIHVILGIVPALAVAFFARDFIKSLFGASTVL
WALVAGGILMIIAEWVNKRKIRVTAEEMDDISYGQALAIGLYQIISVLWPGFSRSGSTIS
GGMLTGVSYKASADFSFLIAIPIMCAASGYELLDSYKEITGDMIGIFAIGFLVSFVVAYV
VVILFMRLIQKIRLTHFAIYRFVLAACFWLFVMR
>T1YCN5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKQMLKSINHICFSVRNLNDSIHFYRDILLGKLLLTGKKTAYFELAGLWIALNEEKDIPR
NEIHFSYTHIAFTIDDSEFKYWHQRLKDNNVNILEGRVRDIRDRQSIYFTDPDGHKLELH
TGTLEDRLNYYKEAKPHMTFYK
>F0GXX2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILDLLKVFILSIVEGVTEFLPVSSTGHLILVNEFVKLEPEKFANAFNVIIQLGAILSVV
VLYFRKLNPWDLEKTKKYFPKNYDKLNGQSKIYYRLSHPHKETMDLWKRVIIGVIPAGVL
GLLLDDIIDAYLFNPMVVALMLFVWGIGIILLEKKNKNENRQRVDNLSLISYKTAFLIGC
FQVLAMIPGTSRSAATIIGAMILGLSRSASAEFSFFLAIPTMLGATLLKVVKNVSGFSGY
EWILILIGMILSFIVAYIVIKKFISYVQKNDFIIFGKYRIILSIIVFLYFLIIK
>A0A0C5E8R4|FEATURES|UNIPROT_deepARG|aminoglycoside|TO66_29130|antibiotic inactivation|1
MIRIEPCQSAHQPGWLPLRQALWPHCPAQEHLDEANDLLNHPQRYINLLAYTTDDQPVGL
AEASLRHDYVNGTEHSPVVFLEGLYVSPEWRRQGIAERLIEAVAQWGRQHGCVEMASDTG
LDNLLGQNVHKALGFEETERVVYFRKGL
>M1SLA2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILLGKALILGVVEGLTEFLPISSTGHLILVGDLLDFNDERGKAFEVIIQFGAILAVC
WEFREKLWKVASTVKSSAISRRFILNLLIASIPAMGLAFIFGKHIKAVLFAPIPVASAFI
LGALVIFWAERRQTKLMHSPGKAHIQSVDDLTSLDALKVGLAQCAALIPGTSRSGATIIG
GMLFGLPRAVATEFSFFLAIPVIGGATAYELLKLWKNPVSLSSDFTLAIVVGFIAAFISA
FICVRWLIHYVAGHNFIPFAWYRIVFGVLVLVSAYTGLVAWSH
>W7KVK5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIMILKAIILGFVEGMTEFAPVSSTGHMIIVDDMWLNTKEFLSKYEANTFKVVIQLGS
ILAVVIIFRDRFIEMLGLGGRGKSSEETQSRLKLSQVIVGLIPAGILGVLFEDYIDEHLF
STETVLIGLVIGAFLMIFADIFGGKNPKTVSVDQITYKQALSIGLIQCFSLWPGFSRSGS
TISGGVLLGLSHRAAADFTFIMAVPIMAGASFLSLIKNLEYFSVEALPFFIAGFISAFVF
ALISIRFFLKIIGKIKLIPFAIYRIVLAGVIYFVFL
>A0A0U1YUH2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQESKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYPTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>R9VI07|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLDLNNIRRSYPSGDGPVEVLKGITLRINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSLLSSDQLAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKA
RLERAKALLTRLGLGERADYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIISNPPAKTEAAAPANHDAI
MTHAGGWRQFVSRFQEALTMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRSIGTNTIDVYPGKDFGDDEPQYQQALKYDDLQAIQKQPWVKSATPAVSQNLRLRY
GNIDVAASANGVSGQYFNVYGMTFSEGASFNEEQLKGRAQVVVLDSNTRRQLFPNKASVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVNEGY
SSEQAEQQLTRLLSLRHGKKDFFVWNMDGVLKTAEKTTRTLQLFLTLVAVISLLVGGIGV
MNIMLVSVTERTREIGIRMAVGARAGDVLSQFLIEAVFVCLVGGALGVTLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTFTGVLFGWLPARNAARLDPVDALARE
>B2CD59|FEATURES|UNIPROT_deepARG|beta_lactam|blaMOX-2|antibiotic inactivation|1
GCCSKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAY
AVVKGAMQLDDKASRHAPWLKGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYR
QWTPAYSPGSHRQYSNPSIGLFGHLAASSMKQPLPSACYQSACAQPPDG
>L9PF67|FEATURES|UNIPROT_deepARG|beta_lactam|ampC2|antibiotic inactivation|1
MNFRHIILGALASLVPTSAAHATEVCTALADSNGPTLFQRGDCQRQVTPASTFKIAISLM
GYDAGILKDQRTPKLPFRAGYVDWRDDWRQDTDPTMWMTNSVVWYSQQVTQQLGMQRFAG
YARQFKYGNANVAGDAEHDGLTLSWISSSLKISPLEQLTFLNKVVNRQLGVSARAYDMTA
RLTQRDQPLAGWRVHGKTGAASGYGWYVGWATKGKRSFSFAHLMQRDDTQPKDVPTGVLA
REALLKELPLLLGSVEQEALLRESVDQTILPLMKKYDVPGMALALTDHGKNYVFNYGLAS
RETRQPVDRDTLFEVGSVSKTLVATLATYAQAQGRLALSDKVSQHMPALRGSSFDHVNLI
HLGTHTAGEFPMQVPDNIKNYDQLMDYYRRWQQPAGAAGASRTYSNLTIGLLGMISAQSM
GLPIADAMEKQLLPALDMRQTYIKVPAEQMTHYAQGYNDANAPVRVHPAVLEPEAYGIKT
TAADLIRFVDANLGQAALDEPLRQAVEATHIGYFKLGKMTQDLIWEQYPAAAGLPGLLVS
ASEQVTWKSNPVTPLTPPLAPQADTLLHKTGSTGGFGAYVLFSPGRKTGIVMLANKFYPG
AARIEAAYSILSQLEQRRQ
>CAA70206.1|FEATURES|CARD_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQKFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGDFTLELVQRCNFVTAIEI
DHKLCKTTEKKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>A0A0X8D6P2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDLLIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEDERSKTFEIVIQLGAILAISIL
YRKRLVSLFNIKPILKKEKKFNAIHIILGVFPAVIAGLLLHDVIKNYLFRPNTVVIGLVA
GAILMIIAEKKKLKPASYSLDDLTYRQALTIGLFQCLSVYPGFSRAGATISGGLLARASY
KTASEFSFLIAIPIMIGATGLDLLKSWNYLSTSDIPMFAVGFVTSFVVAMLAVVTFLRIL
EKLGLTPFAYYRMVLAIVFTIFVLL
>A0A0T9M4T5|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MFQNEEIKKVSIVIPVYNEQESLPALIERTSAACKLLTQAYEIILVDDGSSDSSAEMLTA
AANAPESCIIAVLLNRNYGQHSAIMAGFNQASGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRLINLMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGAEQTDNNQEVEK
>A0A0G3FB19|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
PETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDA
GQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPK
ELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQ
LIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGS
QATRDER
>A0A0P9N4M4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPKEKTFFGSVAQMCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGD
NKLIVWAASVDTSSNGEAPGTVISHEPLRIACGEGSLVITAGQRGDSGLYLSGAQLAREF
GLVAGSQLLDKTKRRSVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>R7H8C1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEILELLKAVLFGIVEGITEWLPISSTGHMILFNQFVKLNVSEDFWKLFEVVIQFGAILA
VVLLFWNKLWPFTTKTVKVHRSKNETGSRFQTKKKVCWKRGALDMWLKIIVACIPAAIVG
ILFDDLIDELFYHPIPVAVALIVVGVIFIIVETVRGKKRPTTTSIDAITYKEAVIIGLFQ
LAAAVFPGTSRSGATIVGALMIGVSRATAAEFTFFLAVPVMFGASLLKAAKYILAGIAMT
GGEALILLVGTVVAFIVSVFVIKFLMGYIKKHDFKVFGWYRIILGILVILILR
>C3MAK3|FEATURES|UNIPROT_deepARG|beta_lactam|NGR_c32650|antibiotic inactivation|1
MRYIRLRKLGVFAAVCLFIGHGTEALASDSRGHFESVVDEAIRPLMKEYDVPGMAVAVTI
EGKRYVFNYGVASKESGRKVGDETLFEIGSISKTFTATLAAYAEARETLSLSDKASQHLP
ALVGSSFDRISLLELATYTAGGLPLQFPASVTDQETMVAYFKGWQPGYAAGTHRLYSNPS
IGLFGYLAAKSMGEPFDELMEKTLFPELGLTRTHISVPEERMGDYAHGYSKAGKPVRVSP
GVLDSEAYGVKTTASDLIGFVEANMDGAELEDTLQRAIAATHTGYFKVGDMTQGLGWEMY
PYPVDLKQLLEGNSPEVSFKPNRVTRLDPPLPPRDDVLINKTGSTSGFGAYAAFVPAEKI
GVVILANRNYPIPARVKAAHQILAELQRAP
>CAS07945|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTNYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHTVDHH
>A0A099DZX8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MANGNGEPLLRLQGVSRSFLAGDREFLALKGIDLQIHSGELVAIIGASGSGKSTLMNILG
CLDNASSGSYQVGGQETRTLGDDALAALRRDHFGFIFQRYHLLPHLDALHNVEIPAVYAG
TPQAQRHARARELLTRLGLVGHLGHRPSQLSGGQQQRVSICRALMNGGQVILADEPTGAL
DTASGKEVMNILLELHAAGHTVILVTHDPKVAAHAERIIEVSDGQIVSDRRTGTAAVPTP
AAEPPRAAEPARRLVASLGMFREAFKMAWIALISHRMRTLLTMLGIVIGITSVVSISAIG
EGAKGYVLKDIQAIGSNTIDIYSGSNFGDSRAKTIETLVPADVTALNALYYVDSATPVIG
QSTLVRYRNLDVDVQLNGVSEHYFQVRNIPLAAGIVFSADDARRQAQVVVIDHNTRKRLF
GPHVDPLGQVILVGNLPCTVIGVTAENKNLFVASNQLNIWVPYETAAGRVLGQRHLDSIS
VRIKDGVPSKRVEEEVTKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLTLLLSLIAVISL
VVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLFGGVVGIGLSYG
IGYLFELFVKQWEMVFSPASIVMAFACSTLIGVLFGFVPARNAARLDPIEALARD
>YP_001176128|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELNNIRRSYPSGDGAVEVLKGITLQVEPGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDISTLDSDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGVERKK
RLERAQALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPAKKNHAGVHKEVLP
PPTGWGQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDIYPGKDFGDDEPQNQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRKQLFPTKSSVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
TQAEQQIERLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQMFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGIALSMLIAFTLQLFL
PGWEIGFSPFALLTAFLCSTATGVLFGWLPARNAARLDPVDALARE
>A0A0I9RJ70|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-21|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATARINERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>ABB53352|FEATURES|ARDB_deepARG|glycopeptide|vanHB|antibiotic target alteration|1
MRKSVGITVFGCEQDEANAFRALSPDFHIIPTLISDAISADNAKLAAGNQCVSVGHKSEV
SEATILALRKVGVKYISTRSIGCDHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAI
RGAKPTMHAVAQQDFRLDRIRGKELGDMTVGVIGTGHIGQAVVKRLRGFGCHVLAYDNSR
KMDADYVQLDELLKNSDIVTLHVPLCADTRHLIGQKQIGEMKQGAFLINTARGALVDTGA
LVEALESGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTER
VLQDTTEKTIRNCLNFERSLQHE
>A0A0H5RP73|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLCDIRDSTKAAALLIVAVLLCASTGTTASASPDTLAAIVDRAFRPLMAQYDIPGMAVAV
TVDGEQRYFDFGVADKQSGTPVTRDTIFEIGSVSKTFTATLASYAHALGRVSLADHPSTY
MPELAGSAIDRADLLNLGTFTAGGLPLQFPPDITDDAQMPPYFQHWTPDAPPGQQRRYSN
PSIGLLGHLTALAMNRDFSDLIEQQVFPKLRLHRSYIRVPQTEMDGYAWGYNADNEPVRV
NPGVFDAEAYGVKSSAADLLRFVETNIAPDDLEAPMREAVEGTHIGYFKVGEMTQGLGWE
QYPYPVTLERLLAGNSSTMAMQPNPATSLTPRPNGSPALFNKTGSTDGFGAYAVFVPDKR
IGLVVLANKNYPIAARVTAAHAVIQELSNA
>YP_002228414|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMVQALNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFRMA
RWMPETRPAAAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSALMWQSVICCLLAGLMMWIPGWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQN
GQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>A0A0K1K5F3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRRKTLAIMAACLLPASSWADDRAAQIRAIVDSAIRPVMAEFDVPGMAVAVTIGGEPVFV
NYGVASREQNTPVTENTLFELGSISKTFTATLASYAQAQGKLSFDDHPGKYIPALKGSAV
DKASLLHLATYTAGGFPLQFPEKFDSKGQELAYFKQWKPDAAPGVQRRYSNPSIGLFGHA
AAAALKTDFDNALEKQLLPKLGLNSTYVHVPEAAKANYAWGYNKDNKPVRVSGGAFDWEA
YGVKSTAADMIRYLQLNIDPSQLDAVARRAVDGTHVGYFEVGVMVQGLGWEQHPYPVSLE
RLQDGNSRAMTWEANPVTRIASPVAAPAMTLFNKTGSTGGFGAYALFVPGKKIGIVMLAN
KAYPNPARLKAAHAILEQLAPMAK
>A0A0C1GM57|FEATURES|UNIPROT_deepARG|beta_lactam|RA19_23950|antibiotic inactivation|1
MRFTASVLSRAAAGLALGLSLATMSAAETRLEALAETVSQVEQRLGGRVGLSIKEVDGPT
SWSHREDERFLMNSTVKTPVCGAVLAQRDAGALTLSDALPVREADLQSYAPVTKSRVGEE
MTIGALCLAALDMSDNTATNILIDHLGGPQAVTQFFLSIGDPISRLDRPEPDLNTFAPGD
PRDTTTPAAMAATLEKLLLGHALTAASRDLLTDWMSHGGVTGNLLRADAPAGWQVFDKSG
SGSHTRNIIAMVTTDKGAPWITTIFLSDVDADFDTRNAALQELGSAVMAVIRD
>AAQ75378|FEATURES|ARDB_deepARG|beta_lactam|OXY-2-7|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGSG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>A0A086Y3M5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHDTIVAAVLGLLEGLTEFIPVSSTGHLLLAGHFLGFNSTGKTFEVVIQLGSILAILGVY
ARRLVQIFTSAPHDPKSRRFIAAVLLAFLPAVVIGVLAHDFIKTVLFESPALIAWMLVLG
GIVLLVVDRLPLRPVVHDVMDLPLSKALAIGFCQCLAMIPGVSRSGSSIVGAMLMGVDKR
AAAEFSFFLSMPTMAGAFAYDLYKNRDALSSGDLHLIAIGFVFAFLSAVVVVKGLLDYVS
RHGYALFGWWRIIVGGLALLGLTLGH
>ZP_02884769|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDWLLACKALILGIVEGLTEFLPVSSTGHLIVAGSLLNFTDEHAKTFDVVIQLGAILAVC
WEFRRRIASVVTGLPSRPEARRFTLNVIIATIPAIVLGLLLEKSIKAALFSPVPVAFALV
VGGVVILWAEARQRGQGGEGKAARVHDVDNMTPMDALKVGLAQCFALIPGTSRSGSTIIG
GMLFGLDRRVATEFSFFLAIPIMFGATAYELYKDWHLLSVDALGIFALGFVAAFVSAFLC
VRWLLRYIAGHDFTAFAWYRIGFGLLILLVGYSGALSWTD
>ZP_03466816|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTSLFTAAILGIVEGLTEFLPVSSTGHLIITGHLLGFTGEKAASFEVAIQLGAILAVVVL
YWSRFWGLLFPKPGQQFSGIRGLYLLFLTSLPASVLGLLAHDFIKQHLFNPYTVAWALGV
GAIMILIVEKKETTPSCFTLDEVTPKLALGIGCFQCLALWPGFSRSAATIMGGMLLGAKR
KIAAEYSFIAAVPIMFAATGYDMLKSYKLFTMADMPFLAVGFIVSFLSAWAAVKGFIYLL
GKLTLRPFAYYRLALAPLVLFFWS
>J0W539|FEATURES|UNIPROT_deepARG|beta_lactam|Rleg4DRAFT_2512|antibiotic inactivation|1
MKSVGIRILSAALLSACASASGFASDEAKLKAITDAAIKPIIEKYAIPGVAVAITADGQN
HVFNYGVESEDTGRPVAPTTLFELGSISKTFTVTLASYAEASGQLSLSDKVGKFLPAMKG
KPFGDVALMSLGTHTAGGFPLQLPDEVKTEKQLLGYFEAWQPSYAAGTQRSYANPSIGAL
GYVVAKAMHGDFAALMEGKLFAALGMKSTYIDVPKARLADYAQGYKRSGEPARMTPAMLS
AEAYGVKSTAGDMIRFVGANMGLIKLDEKLQQAITNTHIGYFKAGAMTQDLIWEQYAYPP
SLNELLEGNSPAMLKTMPVSELQPAMQPGDDVWINKTGSTNGFGAYVAFIPKQRLGIVIL
ANKNYPNEDRVAAAYQILTALSAD
>ZP_03221593|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGCVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>R6VUV6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKSLLFGIVEGITEWLPVSSTGHMILFDEFVQLNMSAAFKEMYLVVIQLGAILAVV
LLFWDQIWPFQSGAKYDGSNKVLPGWIKENIFVMWLKIVVACVPAVIIELAAGDYLEALF
YNYKTVSIMLIVVGILFIIVEDWNKKRTAKITSIADITYQTAFLIGVFQLIAAVFPGTSR
SGATIIGGLILGLSRQIAAEFTFYLAIPVMFGASLIKLLKFGFHFTALEVGVLAVGMIAA
FLVSVVVIRFLMGYIKKHDFKVFGWYRIVLGVVVLASFAFFL
>D1LFF0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
NLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLV
TWLKGNTTGAASIRAGLPTSWAVGD
>A0A127SM14|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIIN
RHEEFRTALDKNGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTKFLQNYQKDIDAY
GERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGEKYYIP
LSIQVHHAVCDGFHVCRFLDELQDLLNK
>AAB34257|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MGKEKTHVSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGSVA
NDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVD
ALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM
HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPS
LQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>S1MBT5|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWMLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPVREGMARVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
APSAVKWMYAIEACLSLTLLYPIARWSERRFRLEHRLMAGLLVMSLSMIPVGMVSNLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYVGGGWLFDLG
KSAQQPELPWIMLGIIGIITFVAMGWQFSQKRATRRLLERDA
>M5D5T2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPAEVQQRPCQLLVTCKSLISKRPPRIGAEQRAPNGCTKDQTHPFGAAWIVYSFDLLSPP
APALSMSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIIIQAGAILAVV
LVFRQRLLQLATGFGQRENRDYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALII
GGIWMLLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRR
AAAAEFVFLVGIPTMFAASAYTFLELAKEGNLASENWTEVGVAFVAAAITGFVVVKWLMG
YIKSHTFTAFALYRIALGAALLLWLPSGS
>F8N9P6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIIAIVEGLTEFLPVSSTGHMLIVENLLGVEDSDFVKAFTIIIQFGAILSVVVL
YWSRFFRLDHTPAPAGSNTWQKIKHKWYFYWLLLVAFIPTGVIGLIVKKSGMLDFMLTPS
NAIWIVPVMLVVGGIFMLFCDRIFNKGTEANKVTERRAFWIGVIQCFSLIPGTSRSMTTI
VGGMSQKLTRRRAAEFSFFLAVPTMAVATGLDVHELFVGHDVVGTGWDISHNLIMLLVGC
VVAFIVALLAMKWFVSFLSKYGFKWFGWYRILVGAFILAWMLSGHSMVMFD
>A0A154X4H1|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MTKITPEYTVVDLSRWARKEHFEVFQGFAQSTFNQTVQLDITVLLKHIKEVGWKFYPAII
SLISHVVNRHPEFRMAMKDDELVIWNEVHPSYTLFHKETETFSSLWSHYDGNIHHFQRVY
AEDVARYGNILAYWPKEESRENIFFISDIPWVSFSSFNVNVANMRNFFAPMFTFGKYYNQ
DGKVLLPFAVQVHHSVCDGFHVARLINELQELCDNLPHHSEALNV
>A0A0V8JG30|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLVEGLTEFLPVSSTGHLIIAGHFLGFTGDKAKTFEIVIQLGSILAVVVLYWKRLWSLL
GVGKIESEDGQKGHLNLIHIFCGMLPAVVIGLLVHDAVKKYLFSTSTVVFSLIVGGLLMI
YAEKKKKKITAATLDQITYKQAFIIGLFQCLALWPGFSRSGATISGGVLMGLSHRTAADF
TFILAVPIMIAASGLDLYKSWDYLSASDLPFFVTGFVTAFIVAVVAILFFIRLIAKVKLT
PFAYYRFILAAVLAAIIWL
>A0A0R2Z6M8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDDSAQLLEDA
AAEEGSHVVAVILNRNYGQHAAIMAGFEQCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGVLFAFALIIMRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSPSDQVQS
>D0SHT5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHLIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFNLLKGFFSGDAEARHFAFSVLIAFFPAVIIGVFAVDFIKSVLFSPLVVAIAL
IVGGLIIFWVEAKNFDHKTTEATKITYKQALLVGCAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIRNADVLTQDNMLNIGVGFVAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGVILLFVFL
>M1K0S5|FEATURES|UNIPROT_deepARG|beta_lactam|F384_08595|antibiotic inactivation|1
MLKIRFHQTLLIAGLLAFFVGSSPLSAREQATTTQIQQKLAALEKQSGGRLGVALINTAD
RSQILYRGDERFAMCSTSKAMVAAAVLKQSETQHDILQQKMAIKKADLTNWNPVTEKYVD
KEMTLAELSAAALQYSDNTAMNKLLEHLGGTGNVTAFARSIGDTTFRLDRTEPELNTAIP
GDERDTTTPLAMAKSLHKLTLGDALADTQRAQLVAWLKGNTTGGQSIRAGLPENWVVGDK
TGGGDYGTTNDIAVIWPEGRAPLILVTYFTQPQQDAKGRKDVLAAAAKIVTQGL
>T2L514|FEATURES|UNIPROT_deepARG|aminoglycoside|ant|antibiotic inactivation|1
MIPYEAQQAQSIAEDVLGESIVGIYLFGSAVAGGLQRNSDVDVLVAVSDSPTCKQREALV
AQLMKVSGTIGNAQATRPVELTVITISDVVPWRFPPRAELIYGEWLRDEFEAGHIPKPAC
DPDLAIVLKKVIDNSLPLYGVNAAEVFGPVPMADVQRAIRDSLPTLLAETAGDERNVLLT
LSRMWLTVATGDIASKDVAAEWAKEQLAKEDAALLDYAKQGYLGKVDDQWQGKQGEFQAL
ICSMRKSIETCLATPR
>A0A0I3RH09|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPAEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTFPAI
KHGNILEIAQRENEATCFGHRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A076LH69|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMNTRLSCTLALSALLLSPVTQASTPPSAAMRVTEAVRQTIPALMQQQQIPGMAVAVIYQ
GTPYYFSYGVADKATRREVTPQTLFELGSVSKTFTGVLGGYALQRGDIRLQDTVASQWPA
LNGPQWRAITLQQLATYTAGGLPLQVPDAVTDTAQLLDFYQRWQPRWAPGTMRSYSNASI
GLFGMLAVRPSGMDFSQAMTRWVLQPLGLKHTYFRVPPVAEGEYAWGYREGRALRVSPGM
LEQEAYGIKSSAQDMAVWLQANLDPAAVPQATLRQALLRAQSRYYQSGEMYQGLGWEMLS
WPLKAQTLIDGSDNRVALQPQQVHPLVPPTPPQAASWVHKTGSTNGFGAYIAFIPGSRLG
IVMLANKNYPNPARVQAAYTILQQLQ
>AAS20534|FEATURES|ARDB_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MAIRIFAILSSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>M6UUA8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSTGHLFLFSSFFPFSGESFEFDDLFDIFIQSGAILSVLFLYREKFRSQMFSSFQYLTK
RNSDPQGFYFLIQIVIGAFPILVVGFIAKKFLDTIKARSDFLDILAGAWIFGGILILVAE
WFFQKRQGAEENPPVGFRDAILIGIFQCVALIPGVSRSAATIVTARFLRKDTKSSAEFSF
FLAVPVLFAAGIYKLIKHRSILNETTIPVLAFGFLISFLLCTLVIRLFLRYLQKHSFGVF
GIYRILLGVGVLVFTKFIR
>A0A0E2LUZ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTYSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VAVFWRRLFGLIGIHFGQKPSRDHATLSLIHVILGMMPAIVVGLAIHSWIKANLFGPQTV
MYALVAGGILLIIAEKFRPAVTAETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRHAAAEFSFIMAVPMMVAASGLDLYKSRDFLSMADFPMFAVGFITAFVVAMFAIK
TFLTLIRRIDFIPFAIYRFIVAFAVYLVFVA
>E9TJB4|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MLIFYFPGGEMSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGI
ALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSG
LGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATG
AVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLM
LPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMP
VGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGCSRLGLAIGGAIGY
IGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>AAB23456|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmU|antibiotic target alteration|1
MPSRYGSRQDLGQNFLVDPDIIKLIRRAPNERKVPSLIWRRRGHVTLPLSRLGRPVTAVE
LDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWVS
AVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERRP
EPLVRERREYQDFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLTA
EQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG
>A0A0N0C1X1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVG
LYFKKLWDVVIGFFTGDTYSRRFVIGVLVAFLPAVVVGLVAGKYIKSVLFNPWVVCFTLI
VGGAILLWVDKLDLKPREHDATRFPLLMYLYIGIAQCVAMIPGVSRSGASIVAAMLLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKNRSEMTMDHMGIVAIGFVVSFITAVIVVKTFLTY
VTRHGFVVFAWWRVIVGTLGLIALALGR
>R6SKJ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIKAILFGIVEGITEWLPISSTGHMILLNEFINLNVSKDFYSLFEVVIQLGAIMAVVV
MYFKTIWPFGFGKTKKETKETFNLWGKILVACVPAAIIGILLDDWLDAHLYNSIVVSLML
IIYGIIFIVVESKNMGKGKTENLNDITYKQALGVGVFQLLSLIPGTSRSGATIIGGLILG
LKRSVAAQFTFFLAIPVMFGASLLKLLKYIMKVGVAFQAGELALLGIGCLVAFIVSILVI
KFLMNYIRKHDFKVFGYYRIVLGIIVLLYFFIIK
>A0A0F6Z2Z3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFQAIIIGIIEGFTEFLPISSTGHMIVASKFLGVAETDLTKAYEVIIQFAAILAVMLI
YREKITFKKIDLWMKLLFAFLPLAIVGFIFKDQIKTLFNVQTVAWMFIIGGIVFLIVEYF
YTEQEYHVKDVEKVSWIQAWWVGFAQIFSLVPGTSRAGATIIGGLLSGMDRKTSAEFSFL
LAIPVMAAVSGYDLLKHYQDFANANWGAFMIGFIVAFAVAYATIKLFLAFLQRFTFVAFG
IYRIIFGIILLMIL
>A0A0U1YWZ0|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVLKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>H3MZT1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MALSNLLILAIIQGLAELLPVSSSAHVIMAEKILGLDPSAPDMTLLLVMLHSGTMFAVIV
HFWKSWRSTYFSSVAAFKHYALRIFTATMMTGIVGLTLQHIIKVYFAGNTSNFEIESLFS
NSKLIASGLFVSGILIIVSSRIKESHTENLSLIQSVLVGMVQGLCLPFRGLSRSGATISA
ALSIGVARKTAEEFSFALAVVLTPVVIFKEMVRAFHNSAALSVSSIVFPSLLGMVFSFIA
GLVALRWLAGWLEHDKWHLFGGYCLLAACVILWIG
>YP_002240036|FEATURES|ARDB_deepARG|multidrug|AcrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQAAAN
MDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSAVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLKQENG
KAKVELVTNDGLKYPQAGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
VNPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKTGDRVI
VTGLQKIKPGVQVKAQEVASDDKQQATGNAPSEQTKS
>A0A0K6MBC4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEIKGINHLLFSVSHLDTSIDFYQKVSDAKLLVKGRTTAYFDMNGIWLALNEEPDIPRND
IKLSYTHIAFTIEDHEFEEVSAKLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLRYYKQEKTHMHFYDETAF
>BAH02339|FEATURES|ARDB_deepARG|glycopeptide|vanSB|antibiotic target alteration|0
MERKGIFIKVFSYTIIVLLLLVGVTATLLAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QNKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPLTSTL
>U6B905|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MISENSIICLLILGVVEGLTEFIPVSSTAHLLIISKMMGIKSPGDSFIILVQLGAVAALL
YVYFSRIITIIKSIPYDPYARHFSICLCIGVIPSAILGFLAHDFIKSVLFKENTTMCISL
IMGGIILLIVDRVNLKAKYFDAQKYPISLAFRIGLFQCLSMIPGTSRSGATIVGSLILGA
DKRSAIDFSFFLAMPTIIGACLLDFYRNSTIIINDIGVGIIIGCFASFISGLIVVRFLLN
FMSKQGYTLFAIWRIVVGSIGLLLG
>A0A0M0EPJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNMWEIFVAVILGLVEGLTEFAPVSSTGHMIIVDDIWLKSNELFGSEVANAFKVVIQLGS
ILAVVVLFWGRFMDLLGLRKMKNPSAPGGQKLNLLQIIVGLLPAAVLGLLFEDYIDENLF
TMKTVIVGLILGAFLMIAADKFRPKVTAETVDQITYKQALGVGLIQCLSLWPGFSRSGST
ISGGVLLGMSYRAASDFTFIMAVPIMAGASLLKIIKYWDIFTPEVLPFFIAGFISAFIFA
LFCIRFFLVLINKVKLTPFAIYRIVVAVVLMFIFW
>B7NF27|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPTNSDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0J1LVE6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFESTPIKKVSVVIPVFNEQESLPELIKRTCAACEKLGKEYEILLIDDGSSDNSAQLMME
ASQAQNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFTLSVLLVILRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTHSTEEHHA
>D1AGG7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILDIIKVFILSLVEGLTEFIPVSSTGHMIIVDHFIKLSSNKEFTDSFLIIIQLGAILSV
LVYYFPRLWPFSNDKEKNKDIWNMWIKIAVAVLPAVVLGQLFDDILEEKFFNPFTVSLML
IIYGVILIIIESSKKVKVKTKTIQELSFKTAVGIGFFQCLAMIPGTSRSAATIIGGVLLG
LERVLATEFSFFLAIPTMFGASFYKIMKSGFNLSGYEVFLIALGFVLSFIISYIVIKLFL
DYIKKHDFKVFGYYRIILGIVMLAFMFMTK
>J8ZPI6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRIKIEEFELPHMDSGPYGITRGKDGALWFTQHKANQIGRMTVDGKVTHIDLPTINAGVL
SITSTDQGDIWFTENRTNKIGKLSVTGGITEYTLPNSDSGPFGITQGHNGDIWFTEMNGN
RIGRILSSGDIIEYSLPVPDSYPSFIVAGSDHALWFTQNQSNQIGRITIGGEVTTYKLPT
KQAGPVGITNGPDGALWFVEINGNKIGRITTSGIISEFTIPTPNARPHAIVTGPDRALWF
TEWGSNQIGRITINGEITEYPIPTKNAEPHGMVVGPDKALWFAEECNKLGRLSFV
>U3N6P2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-114p|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADADILQGPHEPVWNYQPAYPDWGGDVWRQPTDPARWIQYSVVWYSQLIAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRRLVNRQLP
VKAAAYELADNLFEVGQADGWRLYGKTGTGSPGSDGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>A0A120EEM8|FEATURES|UNIPROT_deepARG|beta_lactam|aww70_18715|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGEPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A0H5B5K6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVQQGNPFVHAFTFIIQFGAILSVVC
LYWKKFFSFKPEMWKLYGLLIIGVLPAVVVGLAAKKSGLLDWLLDSIWVVAITLVLGGIF
MLFCDNIFNKGREENEVTPKRAFLIGLFQCLSVIPGMSRSMSTIVGGMANKLTRKKAAEF
SFFLAVPTMAGATILDVYDMMKGDVKWATSDNLFLLGVGCVVSFAVAIFAMKWFVSFLTK
YGFKAFGWYRIIVGVILLAMLLSGMSLNMVD
>A0A0A4A0Q3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRLSLTALALLASTSVLAQTPSPDAIIKPLMQQYQIPGMAVAILHGGKTEFYNYGVASKE
TQQPITAQTLFEIGSLSKTFTATLASYAAQQKKMQFSDKASTWLPELKGSAFDQVSLLNL
ATHTTGTPLFVPDDVTNQQQLMNWYKNWQPPAQPGTQRVYSNLGIGMLGMIAAKSLHQPF
ISAMEQQLLPAMGMKHTYIQVPQSEMDQYAQGYNKQDKPVRVTPGPLDAESYGLKSTSAD
LIRWLAIQLDEQKVATEWQQAIATTHQGYYKTEAFTQAMMWEYYPLPVSSKQLVEGNSGQ
RIMKGMSATLITPPQAAPQQAWYNKTGSTNGFSTYAVFIPSQKIAVIMLANKWFPNDDRV
IAADKIIQTLAH
>A0A0W0B118|FEATURES|UNIPROT_deepARG|beta_lactam|VO70_17680|antibiotic inactivation|1
MSRILLPGLLAAGLLFSLPASAASGCMLFADGSGKPISSQGDCSSQLPPASTFKIPLALM
GYDSGFLVDEKLPALPFKPGDDDWLPAWRETTTPSRWLTYSVVWYSQRLTEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKLVSGKLPVSAQTLQHT
ANILRQPDIDGWQIHGKTGMGYPKLLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASIKAKEDVFAALPEQLKKL
>E6WP51|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MRSRILSSRLTTPIAHVSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNI
VIQAGAILAVTLVFRRRLWELATGLGDAANRDYVFKLAAAFLVTAVVGLPVRLAGWELPE
TVTPIAWALVLGGVWMLVAEHYAEKRGDVATITWKVAILVGLAQVVAGVFPGTSRSAAAI
FMAMLAGTSRRSSAAEFVFLVGIPTMFAASGYAFMELAMEGGLGNEDWAGVAIAFAAASV
TGFAVVRWLMGYIKAHRFTGFAVYRILLGIGLLALMPAQ
>H1ACB8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MWFASQSIPQRATYKLPLNLALDIMRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGS
AVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDI
IPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDP
VPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRL
PAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK
>J3AY86|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MQPLTGINHFLFSVSDLERSFCFYRDVLGAKPLVRGRKLAYFDWNGYWLALNEERDIPRN
EIALSYTHIAFSVAEEAFADWKRHLEQHGVHILPGRERDERDKRSLYFTDPDGHKFELHT
GNLQDRLAYYREAKPHMTFFD
>A0A072EGR8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIELLKAIFFGVIEGVTEWLPISSTGHLILVQEFISLHQDKAFMEMFNIVIQLGAIIA
VIVIYFERLNPFQPGKSPQQIRLTWQLWLKVAIACIPSIIIAVPLDDWFDAHFNHMLPIA
IALIVYGIAFLWIEKRNQTLEPRVIKLSRMSYKTAFFIGCFQVLSIIPGTSRSGATILGA
IILGASRTVAADFTFFLAIPTMFGYSGLKALKFFIDGNHLTLSQLLVLLVASLTAFAVSL
YVIKLLTDYVKKHDFTVFGRYRIVLGSLLIVYSVFKSLF
>G2FL59|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDFISAIILGIVEGITEFLPISSTGHLIIVNQFIGFTGQFAKMFDVVIQLGAILSVVVY
FWKRLIPLGHNNSSKNHKIFELWKKTIVGVIPALGIGFLLDKYIEEHLFNTTVVAISLIV
GGLILVYIESRRSTARINSIQHLDYKTAFLIGLIQCLAMVPGTSRSAATIIGAMLLGASR
VVAAEFSFFLAIPTMVAASGYTFLKNGMFLSGHEILVIAVGFLVSFIVAWMVISAFMNYV
SKKNFKPFAYYRIVLGIFVLTYFGFFHS
>A0A090HZK0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLKVIIYGIVEGITEFLPISSTGHLILLSKFLPLSPQSFENAFSVIIQLGAILSVVVL
YFDELNPFSLKKGRLSNISSDKKLSFKEFWKYRDLKTMRLIAKIIVGFLPAAVLGFLLDD
LIDKYLFNNVTVAIALVFYGIVIIIMESRKSEDVKFETIDEIDMRTIVLIGFFQCLAMVP
GTSRSAATIIGAMLLGCSRKSAAEFSFFLAIPTMLGATALKIIKLGFSFSSTQWMQIILG
MVVSFAVAYAVIVKFMGYIKKHDFKVFGVYRIILGIIVLTVTYVMR
>A0A0H5LUL8|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKSGLKRTLFMSVAALPLCLSTSIAQANTPVEHAKIQQKLMALEKESGGRLGVTLINTAD
NSQIHYRADERFPMCSTSKVMAAAALLKKSETQQALMDERIHFKKSDLVTWSPITEKKLQ
EGMTWAELSAATLQYSDNTAMNLILTQLGGPAKLTEFARSIGDKSFRLDRPEPELNTAIP
GDERDTSTPQAMAESLQNLTLGDALAKSQRAQLVGWLKGNTTGAASIRAGLPATWQVGDK
TGAGEYGTTNDIAVIWPDNHAPLILVTYFTQPVKDAQSRREILAEAAKIAVSPFADGIQ
>J3YSB8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCVGITALIKAGFTIEAIITHLDSPSEKNFFGSVARMAAEHCIPVFAMP
DVNHPLWIERLKVLAPDVMFSFYYRQLLCQEILSLPTVGSFNLHGSLLPRYRGRSPLNWV
LVNGETHTGVTLHRMTSQADAGNILMQRSVAITPEDDALSLHRKLCEAAATMLESILPAI
HQKNFSETPQKDYPDSYMTARTAEDGRLNWEQPATTLVNLVRAVTDPWPGAFSYARGEKF
IVWKARVRPNSDSVQPGTVLCIDPLVIAAGSDALEIQAGQRQQGVYMRGCQLAYDLGLVD
GALLNAYPSVRHQRRTHVLILGVNGFIGNHLTERLLHDGRYEIYGLDISTDAIRRFLVNP
FFHFIEGDINIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYQKRIIFPSTSEVYGMCTDRVFDEDESSLIVGPIKKQRWIYSVSKQLLDRVLWAYGEQ
ECLRFTLFRPFNWMGPRLDTLNAARIGSSRAITQLILNLVEGSPIKLVDGGAQKRCFTDI
SDGIEALFRIIENKNHNCDGQIINIGNPGNEASIRQLAELLLASFNRHPLRQHFPPFAGF
RNVESSSYYGKGYQDVEHRKPSIRNAKHLLDWNPKVPMAQTIDETLDFFLKTVDFSDAKC
>A0A060KQ27|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHIGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0A6ZWL2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLHREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIDKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNIRRQLFPHKADVV
GEVILVGNMPARVIGVAEENSRCLVAVKCCVSGYLTARCPGELWASRG
>Q4HNK8|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MENLYALILGIIEGLTEFLPISSTGHMILGTTILGIKMDDFWRSFLIIIQLGSILAVLFV
FWRKLLQSFVLWLKLVFAFLPTGLIGLFVAKHLELLFNGYVVVFMLILGGVVFIVIELLH
KGKNYAVNALEEVSFKQAFCIGLIQSLAMIPGTSRSGASIIGGLLLGLNRKVAAEFSFLL
AVPTMMIATAYSIYKEPSILSSASSFMPLFIGFVVAFVVAVLVIKFFLKFIAKFDFIPFG
IYRIVLGILFFYLYASGILDAGSEFEL
>A0A0M3G9V2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNHYLNAFLRSIIEAVTEFLPVSSTGHLFLFSSFFPFSGESFGIQFDDLFDIFIQSGAIL
SVLFLYREKFGSQIRSSLRYVTKQNSDPQGFYFLVRIAIGALPILVAGFIAKNFLDTIKT
RSDLLSILAGAWIFGGVLILVAEWFFQKRRGVEEKTPVGFRDAILIGIFQCAALIPGVSR
SAATIVTARFLGKDTKSSAEFSFFLAVPVLFAAGIYKLIKYRSILNEVTIPVLTFGFLIS
FLFCTLVIRLFLRYLQKHSFGVFGIYRILLGVGVLVFTKFIR
>W1H7Q9|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MTRFLLCSFALVLLYPSGIDMYLVGLPRIAQDLGASEAQLHIAFSVYLAGMASAMLFAGR
IADRSGRKPVAIVGAAIFVIASLLCAQAHTSSHFLIGRFIQGIGAGSCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKYPWQSLFYTMTGMGVMVAVLSVFILRE
TRPTAPPQAASPQHDAGESLLNRFFLSRLLITTLSVTVILTYVNVSPVLMMEEMGFDRGT
YSMAMALMAMISMAVSFSTPFALSLFNPRTLMLTSQVLFLAAGVTLSLATRQAVTLIGLG
MICAGFSVGFGVAMSQALGPFTLRAGVASSVLGIAQVCGSSLWIWLAAIIGLSAMNMLIG
ILIACSIVSLVLLLVVTPPRVAQYDEEAAVES
>R0VXF0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKDINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARAEKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>ZP_00742443|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGAVEGLTEFLPVSSTGHMILTGHLIGFEDERAKVFEVVIQLGSILAVVVIFWKRLWSLV
GIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSTIKEVLFGPGPVVISLVAGGILMIVAEK
FSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFIL
AVPMMVAASGLDLIKSWDVLSSADITLFVTGFVTAFVVAMLAIVSFLKLLSRVKLTPFAY
YRFILAAVFYFFIM
>M8D6T7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MQLQGINHLLFSVSDLERSIRFYQDALGAKLLVRGRKLAYFDLNGLWLALNEETDIPRNE
IHQSYTHIAFSVEEKQFEEWKDHLIASGAAILPGRERDERDKLSIYFTDPDGHKFELHTG
TREDRLAYYRETKPHMTFFD
>ABX75558|FEATURES|ARDB_deepARG|multidrug|EmeA|antibiotic efflux|1
MKNKKSMMNLAIPYLFLVFLGAGLVIPVLPTLKEQMHFSGTTMGMMISIFAIAQLVASPV
AGALSDKIGRKKLIAIGMIIFSFSELLFGLAQAKTGFYISRALGGVAAAMLMPSVTAYVA
DMTTIAERPKAMGLVSAAISGGFIIGPGVGGFIAHFGIRVPFYVAAILAFLGFILTITIL
REPERTIESHQEIEKVSFLDILKNPLFGSLFIIILISSFGLQAFESIYSIMASINFGFSM
SEIALVITVSGILALFFQLFLFDAIVNKIGELGLIQLTFFASAIFIAVIAFTKSNLVVAL
STFVVFLAFDLFRPAVTTYLSKHAGNRQGVINGLNSAFTSFGNILGPMAAGYMFDLNHLF
PYYISAIILLGTGFLSLFLNRKNFSKI
>YP_001374431|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTEGPSLNLLHIIIGMIPAGVLGVLFHSTIKEVLFGPGPVVISLIAG
GILMIVAEKFSKPSTARTLDEITYKQAFAIGMFQCLALWPGFSRSGSTISGGLIARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSVADLPLFASGFITAFIVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFLM
>A0A0D0JDN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLFSALLLGILEGVTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAILAITLVFRQ
RLWTLATGLHQRENRDYVMKLGTAFLVTAVVGLPVRLAGWELPETVSPVAWALIIGGIWM
LLVEAYTARLPDRDQVTWTVAIGVGIAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAATE
FVFLVGIPTMFAASAYAFLELAKEGKLASENWTDVSVAFLAAVVTGFVVVKWLLGYIKSH
RFTAFAVYRILLGAGLLLWLPAGN
>CAA06639|FEATURES|ARDB_deepARG|beta_lactam|ACT-20|antibiotic inactivation|1
MMIKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPEAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEALQ
>A0A0B1YFE9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQSINHLLFSVSNLEQSIAFYENVFDAKLLVKGNSTAYFDVNGLWLALNVEKNIPRND
IQYSYTHIAFTISEDEFDKMYDKLVQLKVHILDGRQRDERDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYMKEKLHMEFFNH
>F8XIJ5|FEATURES|UNIPROT_deepARG|aminoglycoside|HMPREF9349_04665|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLDIMRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVD
GGLKPYSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPW
RYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPE
QDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQ
YQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>J2YH09|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELWTAVQALILGIVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTINLLIAFMPAVVLGVIFADLIHEYLFNPITVATALV
VGGLVMLWAERRQHEIHANTVDEISWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRNLFQPDDLPVFAIGFITSFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLVILATWQFGWVDWTAVHS
>A0A139SSD1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MRRNLPILSFPTLALACLFTLTTRAHARAETPEHSEVAAPLAPLTPGQAIVLGLVEGVTE
FLPVSSTGHLILTNQFLALDSEEALRDAAGSPLWHKPPNPDAPEGEPLTIKVAADTYTVV
IQVGAILAVLSLYWPSCLKLLRGLLGRDREGLLLLRNLVLAFVPVALVGLLASDFIEAYL
FSVAAVIGGLVGGAVLMLAVEAWRRKKTPSAAHPTDADKQPAQLTPTESLKVGLIQCLAL
WPGASRSMLTIVGGYWAGLSPARAAEFSFLVGLPVLAGAAILKGWRSGPEMIAVFGAPSV
LLGMAVAAISAALAVKFLIKILTRSGLAPFALYRLVLAAAVAVVVYL
>E2PAV6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIENLNKYFGLGQTQAHILKNINLSIERGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGICRIDGKETQTMSADELSDLRQRKLGFIFQRYNLLSALNANENVALPAIYAGMDSSSR
KKRADTLLTKLGLSDKTQHKPNELSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILRDLHHEGHTIIMVTHDPNIAAQASRVVEIKDGQIIRDEHQRADVQETALNKTTT
QKTRFWAQLFESFKMATSAIMAHKMRAILTMLGIIIGITSVISVVALGRGSQQQILSNIN
NLGTNTMDIMNGTGFGDRRANLTKNLTISDALMLGRQSYVESTTPSSNVSATLIYGNTAV
TGSVRGVGEQFIDVKGLKLISGRFFSAEEVKNVAQIIVIDPNTQKDLGLTEPVEGKTILV
DKKPLQIIGVAQQSNNMNQSSLTLWAPYTTIMQRISGAKQIDSLTVKIKDDIESQTAEKS
ITELLVAKHGKKDFFIMNSDTIKQTITSTTNTMTLLISSIALISLIVGGIGVMNIMLVSV
TERTREIGVRMAIGAKQRNILQQFLIEAVVICLIGGVIGILLASAIIWAFNTLGSNFKMM
LSPESVVIAVLCSTLIGVVFGYIPARNASQLNPITALAQE
>YP_788913|FEATURES|ARDB_deepARG|multidrug|mexh|antibiotic efflux|0
MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGV
GELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEI
LHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAISAPFSGQLGIRRVHL
GQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDP
LIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAH
QDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSS
AAPPVPVAGR
>B1FFV2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIVSIVTGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVQSIDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRFVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>P58777|FEATURES|ARDB_deepARG|chloramphenicol|catI|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVAAMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>A0A0F5F8M2|FEATURES|UNIPROT_deepARG|beta_lactam|TN98_10925|antibiotic inactivation|1
MKKSLFCFVLFSLSVRCVAADLSSQQVTSLVKAAIEPLMEQQAIPGMSVAVLYKGRTQFV
NAGVADTNSGRRVTENTLFELGSVSKTFTGTLAGILIRNGELRLNEPVQKVWPQLTGAQW
RPVRMLHLATYTAGGLPLQLPEAVTDQASLLRFYQEWQPQASPGTVRQYSNASIGLFGAL
MVKGDFEAAMVKSLFQPLRLTRTFITVPPSMMINYAWGYKNGQPVRVSPGMLDAEAYGVK
STARDMLTFMQANSDPNGLSAGNAVLRNAIRTAQSRYFRTASFYQGLGWEIYDWPVSADT
LIADSENGVALKPQPVTRVEPVGPSRRASWVHKTGSTNGFGAYIAFIPEKNTGIVMLANK
SYPNPLRIRAAWQIMHALEQGAAE
>YP_001453760|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELSNIRRSYPSGEEQVEVLKGISLQIHAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRIAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKR
RLERAEELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
DEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPSQKTQAGQGIAEPV
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLNVIQKQPWVTSATPAVSQNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGNTFNREQLNGRAQVVVLDSNTRRQLFPNKAKVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGIGLSMLIAFTLQM
FLPGWEIGFSPVALLTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A081RZF6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFEQIKKVSVVIPVYNEEESLPLLLERTLAACKQLTQEYELILVDDGSSDKSAEILIQA
AEQPENNIIAILLNRNYGQHSAIMAGFNQVNGDLVITLDADLQNPPEEIPRLVKTAEQGY
DVVGTRRANRQDSLFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIIEAMLQCHERS
TFIPILANTFARKTIEIDVAHAEREFGDSKYNFMKLINLMYDLLTCLTTAPLRLLSVVGS
VIAVSGFLLAVLLITLRLIFGSIWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGNKKTNDNSENQEEY
>A7ZW03|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGIDPAMRAENISVAQYCQMANYLAENAPLQES
>G2RTX6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIIVAIILGIVEGLTEFAPVSSTGHMIIVDDLWLNSKELFSSPVANTFKIVIQLGSIL
AVVVIFKDRFINLLGLGKKPAAPIGPTNRLNLMQVIVGLLPAGVLGLLFDDYIDEHLFSL
NTVLIGLVVGAVLMILADLFGPKRPRVETVDQMSYGQALGIGLFQCIALWPGFSRSGSTI
SGGVLLGMSHKAAADFTFIMAVPIMAGASGLSLIKNWQYFTSDALPFFIAGFISAFIFAL
VSIRFFLKLINRIKLVPFAIYRIVLAAILYFVFL
>A0A0M3BXB9|FEATURES|UNIPROT_deepARG|beta_lactam|YA64_09330|antibiotic inactivation|1
MRFKKISYLLLPPLIIFSTSIYAGNTSKEQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKNSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQCAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFMPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0G4Q0T4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPALLELNEVSRIYNNGEEETVVLNKISLTINAGEMVAIIGASGSGKSTLMNILGCLDKP
NSGEYKVAGQSVAKMDGDQLAALRREHFGFIFQRYHLMSHLSAEQNVEIPAIYADKNATQ
RKERARELLTRLGLGERIDYRPNQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
KEVMAILKQLNEQGHTVIIVTHDPLIAAQAERIIEIKDGEIINDNCHQITVNKVKKETTA
VLPSPYFGQIFGRFTQALDMAWRAMVVNKVRTLLTMLGIIIGIASVVTIIVIGDAAKSMV
LADIKAIGSNTIDIYPGKDFGSDSPEDRQSLTLQDVFALKQQSYVQAVTPQVQFSTRLRR
GNQDSPASVAGVSDDYFTVYAMTFSQGRSFTPDMIQRQAQVVVIDENTCQRFFPHKKEVI
GEQIIIRNIPSTIVGVIAEKKSAFGNGQSLRVWVPYSTVTTPRPVGRGFPLLRPQPSV
>A0A085GAK8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MAQFEPIRKVSVVIPVYNEEESLPALLSRTQAACRQLTQKYEIILIDDGSSDRSAEMLTE
AAEVPENCIVAVLLNRNYGQHSAIMAGFNHVSGDLVITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRANRRDSWFRKSASKLINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARKTVEIPVQHSEREFGDSKYSLMKLINLMYDLITCLTTTPLRMLSVVG
SAIALFGFVLAVFLILMRLIHGPVWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGMRSDENSQEEE
>YP_001974111|FEATURES|ARDB_deepARG|multidrug|smeC|antibiotic efflux|0
MKPMLLRALAAATMTAVLGGCVSMAPHYQRPEAPVPAQFGNAGTGEAEPALAMPAWRDVF
LEPRLQQVIALALQNNRDLRVAVLQVEKERAQYRIQRAALLPSVDASGSVTRSRVSDANS
ETGVTQQTESDAVQVGISSWELDLFGRIRSLKNEALQNWLASAENQRAARTSLVAEVATA
WLALAADEQSLAFTQQTLDSQQQTLQRTEARHAQGLASGLDLSQVQTSVEAARGALAKLQ
TQQAQDRDALQLLVGAPLDPALLPTAQALDGSVALAPLPANLPSSVLLQRPDVLSAEHAL
QAANADIGAARAAFFPTLALTANYGHSSTALSTLFSAGTRGWSFAPSITAPIFHAGALKA
SLDASKIGKDIGIAQYEKAIQQAFSEVADALATRDHLTAQLDAQRALVADSQRSYTLAEA
RYRTGLDGYLQSLDAQRSLYAAQQDLIALQQQEAGNRVTLFKVLGGGADAR
>A0A0J1KHY4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEATPISKVSVVIPVFNEQESLPELIRRTSAACEKLDTAYEILLIDDGSSDNSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATAKEG
FDVVGTVRQNRQDSRFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>A0A0F4VWV4|FEATURES|UNIPROT_deepARG|chloramphenicol|ClosIBUN13A_CONTIG66g00733|antibiotic inactivation|1
MGLNIIDMNTWDRRECFNHFFNNAKCTYSITVNIDITNLYKYIKNNKLRFYPTFTWVVSK
VINKYKEFKMSFDEEGRLGFFDEIGPSYSVLNDKTKVMSDLYTSFDNVFIKFYKDMENSL
NSYKKDNKFTTTFQNNFFIVSCLPWFNYTSFNVNNEGSNPFLFPMVTWGKFFEENNKIIM
PLTIQVHHAVADGYHCSLFFSDVEEISRNPEQYLK
>AAL51021.1|FEATURES|ARDB_deepARG|aminoglycoside|ANT(3'')-Ii-AAC(6')-IId|antibiotic inactivation|1
MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDE
TVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWE
GDERNVVLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGRGEDCLA
SRADQLAAFVHFVKHEATKLLGAMPVMSKTKLGITKYSIVTNSNDSVTLRLMTEHDLAML
YEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVAL
GSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPS
NLRAIRCYEKAGFEKQGTVTTPDGPAVYMVQTRQAFERTRSDA
>A0A0U1HQI1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKKSIVNILVFAAIATSPFYTSAQTRLTDQQVATIVNKNLNPLIEQQDIPGMAVAVFYD
GKPQFFNYGVADIKAGIPVTENTLFELGSVSKTFTGIAGEYAMQTGIMNLNDPVTKYAPE
LTGQQWQGVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQHWQPQWAPGVMRNYSNASI
GLFGALAVKKSPLTFENYMKEYVFQPLKLTRTFITVPESMLPDYAWGYKDGQPVRVTLGM
LGEEAYGVKSTTKDMVRYMQANMDPDQLSAKNDKLKKAIIAAQSRYFQAGDLFQGLGWEM
YNWPIDPQKVIADSGNDIALKPRKAEELLPPQLATPASWVHKTGATNGFGAYIVFIPEEK
IGIVMLANKNYPNPVRVQAAYNILQALH
>V0SDC7|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1595_03072|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>M9UY78|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX|antibiotic inactivation|1
RNPMVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTAD
NSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVN
GTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIP
GDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKAYTVH
>A0A060KTL3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>YP_001605795|FEATURES|ARDB_deepARG|polymyxin|RosB|antibiotic efflux|0
MHHSTPLITTIVGGLVLAFLFGTLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPEL
AEIGVILLMFGVGLHFSLKDLLAVKSIAIPGAIAQIAVATLLGMGLSHFLGWDLITGLVF
GLCLSTASTVVLLRALEERQLIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETT
NLNQLFTELAITIGKVIAFITLMIVVGRLVPWILAKTASTGSRELFTLAVLVLALGIAYG
AVELFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILVNE
PLAVIASLAIIIFGKSAIAFALVRLFGHSKRTALTISVSLAQIGEFAFILAGLGISLGLL
SGHGRNLVLASAILSIMLNPLLFTLLDRYLAKTETMEDLILEEAVEEEKQIPVDLCNHVL
LVGYGRVGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVFGNAANADVMALGRLDC
ARWLLLTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIAN
SMLNMLKIETLTEEDKMPVCPI
>CAR61098|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDV
TYQTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEA
ENRNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNAAQYDDSNM
GQNKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASIS
SINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLN
IKYALGTLNEQDLLALNSTLGKPIPTSPESVAPETPEQDAAADGYNVHSAAPAVQPTAAR
ANSNNGNPFRH
>A0A127SAJ7|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENQIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>A0A0T6VPJ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWIAFQALILGVVEGITEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVV
WEYRRKIIDIVVGLPKEQQAQKFTVNLLVAFMPAVVLGVAFADLIHEYLFNPITVATALV
IGGGVMLWAEKRQHRIQAETVDDMRWTQALKVGFAQCLALVPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDFMVFAIGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIAFGIIILATWQFGVIDWSTAAG
>YP_002415221|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDTGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
ASPVVEKK
>A0A101DGA9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLQATILGIVEGLTEFLPISSTGHLILSGHLLQFTGEKANTFDIVIQLGAILAVVVL
YKDFFLNLFFDFTPNKKEFKGIRGIYLLFLTTLPASILGLLTHSYIKKYLFTPFTVSLSL
LVGAIFILVVENKKQNNTTYFKLDQINPKLALGIGLFQCLALWPGFSRSAATIIGGMLLG
LERKLAAKYSFLAAVPIMFAATGYDLLKNFQLFNPQDLTILGLGFIISFFSALVAIKTFI
YLLGKITLKPFAIYRIILALIVLFYYI
>YP_001527590|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MRPPETTGCRRAGCGAFPVPFCGTKAPMTLGTLMEALVLGLLEGLTEFIPVSSTAHLLLA
AHFIGFESTGKTFEVLIQLGAVLAILVVYFQRFLRVAVQLPTSPGARRFVIGIVLAFLPA
AIIGVALHGFIKEVLFESPKVVCAALIFGGIVLVLLDRIPFKPRFNNAMGFPLTTALGIG
FFQCLALIPGMSRSGSTIVGAMVLGADKRSAAEFSFFLALPTMLGAFVYDFWKNRNALSM
DDGLLIAVGFVAAFCAALLVIRTLLDFVSRHGYAVFGWWRILIGGVSLIALYLGH
>A0A0N0K8T3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTTITAILLGIVEGLTEFIPVSSTGHLILASELFGYDAKTWEVFNVVIQLPAVMAVVVL
YWRTFMDVAMGALRGSRESIAFVRNVLAAFIPAAIVGVLFKSKIDLLLENPVVVCIALIV
GGFAIIAVERLVSHQTYRPVGQMPLAQAIRIGMMQCIAVIPGVSRSGATIMGALVMGENR
KTAAEFSFFLAVPTMLGATVKQLWDHRHELSAGAGPVGIKEIAIGSVVSFLVSLIVIKFF
IGYVSKRGFTPFAAYRIVLGALGLAWLLWV
>A0A0R3AC69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTVNLLIAFLPAVVLGVIFADLIHHYLFNPITVATALV
VGGIVMLWAERREHEVHAESVDEISWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWIDWSAAKA
>A0A081VBZ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVVSVDALTPLDALKVGIAQCCALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0M2KGJ0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCIGLNALVKAGYKIEAIFTHPDSAAENPFFASVARTAADLDIPVFAPE
DVNHPLWIDRIRAMAPEAIFSFYYRNLLCEKILNCAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMTASADAGDILVQEKVQISADDNALTLHRKLNATAETLLADALPAL
KAGQLTASPQDHSQATVVGRRRPEDGRIDWSLSASVVNNLVRAVTEPWPGAFGYVGSAKF
IVWKGKVRQDQPAAKAGTVLSVSPLIVACGEGALEIVTGQSENGVYMQGTQLAQTLGLVC
GALLSNQPVTTVKRRTRVLILGVNGFIGNHLTERLLKDDDFDIYGLDIGSDAISRFIGHP
RFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRVIFPSTSEVYGMCDDPDFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGRQKRCFTDI
SDGVEALFRIIENKNNNCDGQIINIGNPENEASIKELAEQLLESFERHPLRNQFPPFAGF
RDVESSSYYGKGYQDVEHRKPAVRNARRLLGWTPTVTMDKTIDNTLDFFLRTADGVEENQ
>1815179A|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmO|antibiotic target alteration|1
MARPTQRARTLSQNFIADRATAERVARLAVPDRGRPPLLLEVGAGNGALTEPLARRSREL
HAYEIDPRLVPGLRARFARSPHVHVVAGDFLTARPPRTPFAVAGNVPFSRTADIVDWCLT
APGLTDATLLTQLEYARKRTGDYGRWTLLTVLTWPRHEWRLVGRVGRSRFCPAPRVDAGI
LRIERRPTALLTGAAARRDWADLVELGFSGVGGSLHASLRRAHSRRRVDAAFRAARLDPG
VLVGEVAPDRWLRLHEELTA
>C2VBS1|FEATURES|UNIPROT_deepARG|chloramphenicol|bcere0020_21450|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMLLEKIHQKEIKFYPTFIYIISRM
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKGDKSFSSIWTDYSSDFHIFYKNYEEDMK
CFANVHGLFPKENIPPNVYPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNDGSKVM
LPFSLQVHHAVCDGYHASRFIEDLQELVNTCNEWL
>A0A0X8DA31|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGRVSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPVEEDPFLKTFLVAIQLGAIL
AVLLLYGRRLAADRALWLRIAVAFVPTGVIGFLFYPLIKGVILGNDAVVAFFLFFVGAVL
LFADRLAERAQYQDVKALPLARVAWIGVFQGLAALFPGTSRSGATILGGLLLGLDRRAAA
EFSFLLALPTMFAAVGYDLWKSAPEVPEGGWSLLLLGFLAALATALVTVRWMLAFVARYG
FRPFALYRMALAAVYAFFFLR
>B7LM77|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPIKKVSVVIPVYNEQESLPELINRTTAACESLGKEYEILLIDDGSSDASAQMLVE
ASQAPDSHIVSILLNRNYGQHSAIMAGFSYVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARQAVEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIATSGFSLAILLVVLRLAFGSQWSGEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQKVIRPASSIDIEENH
>A0A0F6SVU1|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLAFHDVIKSLFNPQS
VMYALVAGGLLLLAAEWFKPKNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASGLDLYKSLHFLSWGDLPMFAVGFITAFVVALIA
IKTFLSLIKRISFVPFAIYRFIVAAAVYWVFM
>Q2FC33|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYE
>A0A0C2ZT23|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFDAIIIGTIEGFTEFLPISSTGHMIVASDFLGIEQSKLIKAYEVIIQLAAILAVMIL
YRDKLKPSQILLWQKIMVAFLPLAIIGYLFKDPIKALFSIEIVAWMFIVGGVIFLIVEYF
YKEEKAHITNVDELSYKQALWIGIAQLFSFIPGTSRAGATIIGGMLLKMDRKSSAEFSFL
LAIPVMGAVSGYDLLKHYQDFIGIDYTPFVVGFVVAFVVAYITIKLFLAFLARFSFVAFG
IYRILFGIVLLAFYL
>EDK10390|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVETLKTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDSRFYDHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTSEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKSLNELTLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIGIAKG
GADILLASGEKMTLSTNAMRWTGRSNPVKVGEQIWIRQRANGEWQLGQIPAANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKPGQKMWQPKNSPDRYDGPMRLRVGLGQSKNMIAIRAIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIE
CNDIPVIYGETKDKINGFANIPLGENALKPTDDSTNGEELDQQPETVPELPELQSNFTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYM
KTALSDKPERKLSLPPKIVEKNIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYY
VPTELQQRLNNEGNTPATQPQELF
>NP_759331|FEATURES|ARDB_deepARG|tetracycline|tet34|antibiotic target alteration|1
MSNKFVITWDAMQTYCRQLAEKQMPADQWKGIWAVSRGGLVPGAILARELGIRYVDTICI
SSYDHDHQRDMTVLKAPEGDGEGYLIVEDLVDSGDTARKLREMYPKAKLIAVCAKPSGKE
LLDDYVVDIAQDTWIEQPWDMALAYAEPVNRKQK
>C6RFF6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MKNLIELKNLSKKFKLGDNVFDALKDVNLTIKKGEFIAIIGQSGSGKSTLMNILGCLDNP
SGGQYLLEERDISKFEGDELARLRREKFGFIFQRYNLLSTLTTLQNVALPSVYAGVSKKE
REKKAGELLEGLGLGEKLQNLPNKLSGGQQQRVSIARALINGGEIILADEPTGALDSKSG
LMVMEILTNLHKQGHTIIIVTHDPNIAAYANRVIEIKDGKILSDTVKSGEIFASEKPAPK
QKNIFSFYKDQFIESFKMSINAILSHKLRSALTMLGIIIGITSVICVVALGQGSQEQILS
DIRGIGTNTIDILNGKGFGDMRSERVRNLTVSDATMLSKQDYLDSVTPNASASGTLTYGN
KSASATIKGGSEESLNVMGYKVEAGRVFTAQEVAESASVIVIDQPTREQFFADEDPLGKT
VLFNKRPFKIIGVVAKNDNMFADSSTLRTFSTYTAVINKLTGDRHLSSITVKVKDNVNAQ
IAEQSLTEILTAKHGKKDFFTRNSDTIKKTIEETTKTMTLLISCIAFISLLVGGIGVMNI
MLVSVTERTKEIGIRMAIGARQGNILEQFLIEAVLLCLIGGLIGVGSAFGIGYLAENLAP
DIKMIFSQTSIVVALVVSSAIGVIFGYMPARSASKLNPIDALSRE
>A0A0J6GUC9|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic inactivation|0
MQAGLRIDVDTYRGTREGVPRLLELLDEAQIKATFFFSVGPDNMGRHLWRLAKPRFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGQDLGHLMRQTLAAGHEVGLHAWDHHGWQANAGRW
SEAQLIEQIRKGVDTLSDITGQAVECSAAAGWRADERVVQAKQTFGFRYNSDCRGHSLFR
PRLTDGSPGTAQIPVDLPTFDEVVGPALSAADFNAYILDRFSPQKLNAYTIHAEVEGILM
ANDFRQLLAEAHSRGIHFGPLRDLLPPDLDSLPVGQLSRGVLDGREGWLGVQQP
>C4TTC0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKGIRRSYQYGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKTTSNVGTSDAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVYDDMTALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITREQVERQSQVVVIDRNTQRRLFPHLKEV
VGQVILIGNMPATIVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLKTAEQTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPVALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>K1UV23|FEATURES|UNIPROT_deepARG|beta_lactam|SM8_01675|antibiotic inactivation|1
MHPSTSRPSRRTLLTATAGAALAAATLVPGTAHASSGGRGHGSGSVSDAERRLAGLERAS
GARLGVYAYDTGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRIFYTQDD
VDRADGAPETGKPENLANGMTVEELCEVSITASDNCAANLMLRELGGPDAVTRFVRSLGD
RVTRLDRWEPELNSAEPGRVTDTTSPRAMTRTYGRLVLGDALNPRDRRLLTSWLLANTTS
GDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTTKTEQDAARDDGLV
ADAARVLAETLG
>B2VGJ3|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDIHQLWIAAILGLVEGLTEFLPVSSTGHMILVGHLLGFEGNKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVPHEGSGQGRLTLIHILLGMVPAVVIGLLLHDQIKTLFNPVN
VMYALVVGGVLLIAAELLKPKRPKSPGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMIGATGLDLYKSMGFLSMADFPMFAVGFVTAFIVALIA
IKSFLHIIKRISFIPFAIYRFIVAAAVYALFVL
>A0A0M9FNY8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNRGIEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGAILLVYAFIAFLF
>A0A031G8J9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSFINPSKVISCSAFGVIFAANACMAATPSDEQLQALVNKAVTPVMQQQQVPGLAVAITI
NGQPHYFNYGVAAKDTGQKVSENTLFEIGSVSKTFAATLAGYAQATGKLDLSTKASQLWP
ELKGSAFDNISVLQLGTYSAGGLPLQFPDQWDSADKMLGYYQQWKPSFPAGSQRLYSNPS
LGLFGYLAAKTLGQPYDQAMSETLLPKLGLQHTYLQVPKAQMSLYAQGYDKNNQPVRVTP
GAMDSPAYGVKTSAADMLRYVQANLKPASLETPLQQAIANTHTGYYSVGDMTQGLGWEMY
RYPISLERLLAGNSTEMAMQPHKVQWLNSPLPQADNVLLNKTGSTGGFGSYVAFVPSKDV
GVVILANKNFPIPERVKIAHTILSVLTD
>U1TW70|FEATURES|UNIPROT_deepARG|beta_lactam|N173_04160|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFKDTPGKYWKEL
KNTPINQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGHYQVNTMYQALGWEEFSY
PAMLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYTVLNAIKK
>F2LPE0|FEATURES|UNIPROT_deepARG|beta_lactam|bgla_2g26610|antibiotic inactivation|1
MKFRKMMSAMIQAVLFCAAGAMLGIADTAFAAADRVQAVVDETIRPLMTEKQIPGMAVGV
VVDGKAHVFNYGVASKESGRPVTNATLFELGSVSKTFTATLASLAEVDKQLSLSDKVETY
LPPLRGSDFGKVRLLDLGAHTVGGLPLQVPDDVHDEAELISYLKHWHAAHAPGTFRTYSN
ISIGTLGILTANRLQQDSTSLMEGRLFPGLGLKNTFIDVPAAREADYAQGYTAAGKPIRM
KMEVVGREAYGVKSTAGDLLHFMQGNMKLIPLEASLQRAVTQTHTGYFQAGPMTQDLIWE
QYPYPVALKTLLTGNGPAMLFKGMKVTEIRPPEAPRDDVWINKTGSTNGFSSYVAFVPAK
RMGIVILANRSYPIEDRVAAAYRILTALDGAGQ
>D1CZM6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFFNLLEAAFLGLIEGLTEFILVSSTGHLLLIGHFLGFESTGKTFEVLIQLGAILAILS
VYSAKLARIATDFPRDARTRRFVLGVLVAFLPAAFIGALAHGFIKGVLFETPMLVCIMLI
VGGFILLWVDQLNLRPRYHNVMDYPLPICLAIGFIQCLAMIPGVSRSGSTIVGSLLLGAD
KRSAAEFSFFLAMPTMAGAFAYDLFKSRNILSFNDGALIVVGFIMAFISGVFVVRHLLDY
VSRHGFALFGWWRLIVGSAGMAALIIWG
>YP_001572363|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MIRTSSRLLLCCLLGSATALSGCALIREDTAAHQQLQPENSQLANDIHLASSGWPQAQWW
RQFNDPQLNALIQQTLSGSHTLAEAKLREKKSQSQAELLEAGSQLQVAALGMLNRQRASA
NGFLGPYALDAPKLGMDGPYYTEATIGLFAGIDLDFWGVHRSAVAAAIGAQNAALAETAA
VELSLTTGVAQLYYSMQASYQMLDLLQQTRDVVDYAIQAHQSKVAHGLEAKVPYHGARAQ
MLAVDKQIAAVKGQIKETRESLRALMGVEAMPDIKSASLPQVNTGIPSTLSYELLARRPD
LQAMRWYVQASLNQVDAARALFYPSFDIKAFFGLDSIHLDSLFKNTSKQINFIPGLRLPL
FDGGRLNANLASTRAASNILIERYNQSVLNAVRDVAINGARLQTLNDERDMQVQRVDATR
YTQASAEAALKQGLGSRLQATEARLPVLSEQVSLLMLDTQRIIQSIQLIKSLGGGYQAA
>A0A0W0NDN0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVTIERTDTGLSLHAKLREAATALLRDALP
QLAQGKLIETAQDDSKATYFGRRTAADGKLDWKKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQADVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCDGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIDNAKRLLNWEPSVEMSETIGNTLDFFLREAMLEIA
DKK
>NP_831165|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSTIKEGLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFVTGFVTAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>S1EGL0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSHPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>ZP_03836027|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLSSGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYNAGLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVLWFIVTCLATLLAQNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHILPWEGMFILFAAL
ASISFFGLQRAMPETATRLGEKLSIKELGKDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIISGEHLSSYEYGLLQVPIFGALIAGNLALARLTSRKTVRSLIIMGGWPIAVGLV
IAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIELSKHAYLLGGNGLFSLFNLASGVLWLILMVIFLKDKRVGNSRKI
>ABR13271|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGS
QYAMRIWMDPNKLNNFQLTPVDVISAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDIIAKFNGKPASGLGIKLATGANAL
DTATAIRAELKKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAIFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFSGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIQKGGHGEHKGFFGWFNRMFDKSTHHYTDSVGNILRSTGRY
LLLYIIIVVGMAFLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTDYFLTK
EKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGAENKVEAITGRAMGTFSHIKDA
MVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNGL
EDTPQYKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAQYRM
LPNDINNWYVRGSNGQMVPFSASSTSRWEYGSPRLERYNGLPSMEILGQAAPGRSTGEAM
NLMEELASKLPAGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFF
VPVFFVVVRRRFSRKNEDVEHNHPVDHH
>B1KZ37|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYGKMKQMVSNLKLPDYRYEQLTKAIFHQRIDNFDDIHILPKALRMSLVNEFGK
NVSSVIPVFSQDSKQARKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNNHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTKKFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVVGLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCSTLKKAGISATVRTQFGSEISAACGQLCYENEL
>YP_274443|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MMDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAV
VWEFRRKILDVVTGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATAL
VVGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLK
FIATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A0U1NX91|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGINHLLFSVSNLEKSIEFYQNVLDAKLLVKGRSTAYFDLNGIWLALNEEKDIPRTE
ISYSYTHIAFSIADEDFSKMQEKLLLWNVNILPGRERDEKDKKSIYFTDPDGHKFEFHTG
TLLDRLDYYRKEKPHMEFYI
>A0A0G1N3Y8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIEGLTEFLPVSSTAHLMIASKLLGVPDSDFLKTFEIVIQLGAIFAVLFLYFKKIFDF
KLIKNLFFGFLPAAVLGFVFYPLFRSLLERIDLALLALFFGGIVLIVFEEFFPARGGSVS
GGKEKDGSTSLTTSESLDEKKSFVIGLWQSLAMIPGVSRSLATIFGGLAQGLSKKNAVEF
SFLLALPTMFFASGYDLFKNYSSMDFSNWQNLALGFFVSFLSAVLSVKLFLKFLEKNNFQ
AFGWYRIIFSLAVFGLLFI
>A0A0M6WVU0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIELIEVLKAVLFGIVEGVTEWLPISSTGHLILLNEVVKLKVSDEFYSMFEVVIQLGAIL
AVVVLFWSQIWPFGRKNNVAPLTKRGPGAWIKTDIFKLWFHILVSTIPAAVIGVLADDWV
EEHFYNYQMVSVMLILFGIAFILIENSHKGKNSRINSLADIGYDTALFIGLFQLIAAIFP
GTSRSGATIVGALLIGVSRTVAAEYTFFLAIPVMFGASILKIAKFGLDFSTSEVVILFVG
CVIAFAVSLIVIRFLMGYIKKHDFKVFGYYRIILGIFVLACGFLGALHA
>A0A0D5CA60|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
KAPAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVA
MNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLT
LGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
>F5L7W1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIKGINHLTFSVSDLEKSVQFYQEVFGAKLLVKGRRSAYFDLNGLWIALNLEEDIPRNEI
HHSYTHIAFSVDEKDFACLEDKLKRLGIRILPGRSRSEKDKKSIYFTDPDGHKFEFHTGT
LQDRLNYYRAEKPHMTFYD
>A0A0K9GZF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIFVAIVLGLVEGLTEFAPVSSTGHMIIVDDLLFKSNELFGSEIANAFKVVIQLGSIL
AVAIIFWKRILDLLGLRKMKSVERKSGNRLSLLKIFVGLVPAGIFGVLFEGYIDEHLFSV
KTVAIGLLIGAFLMIAADKVKPRIKTATVDDITYKQAIGVGLIQCLSLWPGFSRSGSTIS
GGVLLGMSYRAAADFTFIMAIPIMAGATLLKIIKYWSFFTPDVLPFFIAGFISAFIFALI
CIRFFLKLIEKIKLTPFAIYRIVLAAIILFIYL
>G7ZTT4|FEATURES|UNIPROT_deepARG|aminoglycoside|ANT(9)-Ia|antibiotic inactivation|1
MLIGVYLYGSAVMGGLRMNSDVDILVITNQSLSEKTRRNLTNRLMLISGKIGNIKDMRPL
EVTVINQKDIVPWHFPPKYEFMYGEWLREQFEKGEIPESTYDPDLAILLAQLRKNSINLL
GPKATEVIEPVPMTDIRKAIKESLPGLITSIKGDERNVILTLARMWVTASTGEIRSKDLA
AEWAIPQLPDEHATLLNKAREAYLGECVDKWEGMESEVAELVNHMKKSIESSLNIQLPFR
IV
>A0A0X8SED4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKINRLAAALFAALILPAGHAADKADIDAIIQPLMQKYAVPGMAIAVSVEGKQQFYHYG
VASRQTGKPITNQTLFEIGSLSKTFTATLATYAVSEGKMSFADPASRYLPALRGSAFDHV
TLLNLATHTSGLPLFVPDDVTNDAQLMAYYQQWQPPHAVGSYRVYSNLGIGMLGIITAKS
LNQPFTQAMEKQLLPALGMNHTYIKVPAEEMANYAQGYNKKDQPVRVTPGPLDAEAYGIK
SNAQDLIRYLDANMQVVKVGDPWRKALAATHTGYYRTGVFTQDLMWESYAYPEKLATLTE
GNNAGMIMNGAPATAITPPKQDQGAAWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFP
NDDRVAATYRIVQALDKR
>A0A158FUC9|FEATURES|UNIPROT_deepARG|beta_lactam|AWB73_01647|antibiotic inactivation|1
MKFRALSLLATAIFSFGAMSGAALAADRDTAKIRQTVDRTIRPLMALHGIAGMAVGVVVD
GRPYVFDYGVASKATKQPVTHDTLFELGSVSKTFTATLASYAQIEGDLSLNDAVSRHLPS
LDGTAFGKVTLLNLGTHTPGGLPLQVPDEVHNDAQLMQYFRTWRPAGPPGTIRTYANPGI
GTLGLIAAKSMNENFDTLMQTRLFPALGLKHSYIDVPASKQRDYAQGYAKDETPIRMKGG
VLSSEAYGVRSTAADMTRFLQINMKMVRIDPAFQRAVDATHTGYFQAGPMTQDLIWEQYP
YPAALQSLLDGNASAMILNATPVTRIDPPQAPRDDVWINKTGSTNGFGTYIAFVPKERIG
IVMLANRNIPNEDRVKAAYAIITSLAGAQ
>R8TK21|FEATURES|UNIPROT_deepARG|beta_lactam|IKC_04835|antibiotic inactivation|1
MKKNTLLKVGLCVCLLGTIQFVSTISSVQASQKVEKTVIKNETGAISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTAKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTVLTAELAKKSGYEEPLGDLQTVTNLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGH
GEVGGKGLLLHTLDLLK
>ZP_03282047|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARSLGKYFLLVDNMLVVLGFFVVFPLISIRFVDQMGWAALMVGIALGLRQLVQQ
GLGVFGGAIADRFGAKPMIVTGMLLRAAGFATMAIAHEPWVLWFSCFLSGIGGTLFDPPR
TALVVKLIRPQHRGRFFSILMMQDSAGAVVGALLGSWLLQYDFRLVCATGAVLFILCALF
NGLYLPAWKLSTVKAPVREGLGRVLSDKRFVTYVLTLTGYYMLAVQVMLMLPIMVNDIAG
TPTAVKWMYAIEACLSLTLLYPIARWSERRFRLEHRLMAGLLIMTLSMMPIGLVSSLQQL
FTLICTFYIGSVIAEPARETLSASLADARARGSYMGFSRLGLALGGALGYAGGGWLFDAG
KAMSQPELPWVMLGVVGFITFIALWWQFSQKRSASGMLEPGA
>R8CJA2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKAYLFQPYTVVIGLVA
GAFLMIFAEAKKAEVTAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMVGATGLDLLKSWKYLSADDIPMFAIGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0J6IKL5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQPQARRFTVNLIIAVLPAVVLGVIFADTIHEYLFNPITVATALV
IGGIIMLWAERRQHVIHAETVDDMTWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVRALLKF
ISSHSYAAFAWYRIVFGLLILATWQFGWIDWSAASA
>A0A150DTH3|FEATURES|UNIPROT_deepARG|beta_lactam|AT258_18160|antibiotic inactivation|1
MKGMMILKNKRMLKIGICVGILGLSISSLQAFTGGASQVEAKEKTEPVKHNNHATYKDFS
QLEKKFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQKNSTEKLNEVVTY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQIGD
RVTMSDRLETELNEAIPGDNRDTSTAKAIATNLKDFTVGNALPDKKRNILTDWMRGNATG
DKLIRAGVPKDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVNAIR
>A0A0A7LME7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYWHALLLAVVEGLTEFLPVSSTGHMVIVANLLGIGQLPYTETYITGIQLGAILSVVVL
YWRRFLQSTGFYMKLAVAFLPFGFLGFLLKDVIEQLLKSVAVVAWALVLGGIVLLFVDRM
FKNKKPHYVSMPKYKQAFRIGLYQCIALIPGVSRSAATIVGGLAQGFDRRSAADFSFLLA
VPTMVVITGYQLLKGYKSNPLSLDELKMLLFGNAVAFAVAMLAVRSFVNFLTRYGFRAFG
FYRILVGAIILIMLGLGINLQLI
>G9EAI4|FEATURES|UNIPROT_deepARG|beta_lactam|KUC_0987|antibiotic inactivation|1
MGKILSAKSGLIMTGSLLVGSYAWASDTAENADIEALVNDTIAPLMAEHRIPGMAVAVSI
GGQQHYFNYGEADQEAGIPVTDETLFELGSISKIFTAALTGYAQTSGALSLSDPASQYLP
ALEGSVFDEITLLELGTYTAGELPLQFPDAVQSEAQMLDYYRQWQPESAPGSQRLYSNPS
LGLMGYLTAQRLGKPFETLMQEALFAPLGLEHSYYQVPESQQAHYAYGYSKEDKPIRVNP
GMLDAQAYGLKSTAADVLTFVEAHMEVPGLDDESLSQALAATRTGYFEFGDMTQGLGWES
YAYPVALEQLLAGNSLEMILQPNPANRLTPPLAPRQEALYNKTGATNGFGGYVAFVPSEQ
IGIVLLANRNYPTPARIEAAHHILTSLTEAP
>A0A0C5J248|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFYPHLQALILGLVEGLTEFLPISSTGHLILAGSLLDFNDERGKLFEIVIQSGAILAVC
WEYRQRLAQIGRGVWQGNDPASRRFVLNIAIAFLPLAVLGLAFGKVIKAHLFTAPVVASL
LIGGGLVILWAERRTHTVRIETIEALTPRDALVMGLFQALALFPGTSRSGATIIGGLLYG
LSRRAATEFSFFLAMPTLILASMYELYRDRALLRWQDLDLWIIGFVTAAVSAFVCVRWLL
RFIAHHDFTPFAWYRIGFGLLILASWHWGWVTWAA
>ABG68909|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAVEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGNDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>H5XH09|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTRTFITEYPVVAEPGSGTGPYGVTSGPDGALWFTMARSGRIGRFVPGEEPTIHRLDPDC
QPTVIVSGPDGALWFTEYQGHRIGRITTEGEVTEFSPPTAEAGPYGLTVGPDGALWFTEL
GADRIGRVTTDGELTEYPLPLRGAFPSIIDTGSDGALWFTLNQANAIGRMALDGTVTVHE
LPTEAAGPVGLTAGADGALWFVEIMAGQVGRITTDGEITEYPLPDRAAKPHAITAGDDGR
HWFTEWGAGRVGSITSDGVVEVHELPSPGSEPHGITVGPDGAVWTALENGALARVDVDPG
RKH
>K4N2F3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDTDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATVDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>YP_001476958|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNKVHQGHFARKRFGQNFLTDQFVIDSIVSAIHPMPGEAVVEIGPGLGALTEPVGARMD
RMTVIELDRDLAARLANHPQLKDKLTIHQQDAMTVNFAEMAEQAGQPLRVFGNLPYNIST
PLMFHLFSYTQAIRDMHFMLQKEVVNRLVAGPNSKAYGRLTVMAQYYCNVIPVLEVPPTS
FTPAPKVDSAVVRLVPHLVNPNPVGDVRMLSRITTQAFNQRRKTVRNSLGDLFTPEQLTE
LGIDPILRAENISVAQYCKLANWLSANPAPQQ
>A0A060KZB6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRRFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A127SE08|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANIEITGLLREIKLKGLKLYPTLIYIITT
VVNRHKEFRTCFDQKGKLGYWDSMNPSYTVFHKDNETFSSIWTEYDENFPRFYYNYLEDI
RNYSDVLNFMPKTGEPANTINVSSIPWVNFTGFNLNIYNDATYLIPIFTLGKYFQQDNKI
LLPMSVQVHHAVCDGYHTSRFFNEAQELASNYETWLGEK
>A0A0M1JAQ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIILLKAAILGIVEGLTEFLPISSTGHLIIVGDLLNFNDARGKVFEIAIQLAAILAVV
WEYRLTIFDIIVLLPTERKAQRFAINIILAFLPAAVLGLLFAKTIKTYLFNPLSVATAFV
IGGILILIIENNPRRARIQDIDEITWTGAIKIGFAQALSMIPGTSRSGATIIGGMFLGLE
RRVATEFSFFLAIPTMFAATLYDVYKHKDLLHFSDFPVFLVGGLTSFISAFIAVRGLLRY
ISKNNFIIFAWYRIAFGLLLIIVYSAFIPWQGGD
>CAU08343|FEATURES|ARDB_deepARG|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFGIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>Q8KT56|FEATURES|UNIPROT_deepARG|beta_lactam|cfxa2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQVLALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>ZP_02367088|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSIYATYPGASAQVIEES
VTAVIEREMNGVPGLLYTSATSSAGQASLYLTFKQGVSADLAAVDVQNRLKTVEARLPEP
VRRDGISVEKAADNIQLVVSLTSEDGRMSAVQLGEYASANVVQALRRVEGVGKVQFWGAE
YAMRIWPDPVKLAALNLTASDIATAVRAHNARVTIGDIGRSAVPDSAPIAATVLADAPLS
TPDAFGAIALRARADGSTLYLRDVAKIEFGGNDYNYPSFVNGKTATGMGIKLAAGSNAVA
TEKRVRATMDELSKFFPPGVTYQIPYETSSFVRVSMQKVVTTLIEAGVLVFAVMFLFMQN
FRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALALAVSIGFS
AFLALSLTPALCATLLKPVADDHHEKRGFFGWFNRFVARATNRYTRRVGQVLKRPLRWLV
VYGALTAGAALLLTKLPTAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRKKEP
SAYTFALGGFNLYGEGPNGGMIFVTLKDWKERKRAHDQVQAIVARINEHFAGTPNTTVFA
MNSPALPDLGSTGGFDFRLQDRGGLGYAALVAAREKLLAEGHANAVLTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINATLAVMFGSDYIGDFMHGAQVRRVIVQADGLHRLDPGDV
TKLRVRNAKGEMVPLSAFATLHWTMGPPQLTRYNGFPSFTINGSAAAGHSSGEAMAAIER
IASTLPAGVGYAWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEA
ARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQVAIGTGVLGGVVSATLFAIFLVPLFFV
CVGRVFDVGPRRRGGAHAALEIK
>A0A0A2G474|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIVLAIVEGLTEFLPISSTGHLMLTQAFLGMESTPYVRAFTVFIQLGAILSVVTL
YWKRFFLLPKSQMLQTEESSCNKHRWQALFYFYLKLVVACLPAAIAGFFFEEHIDALLSN
VYVFATMLLLGGVLMLFVDRIFATSKREKVSFSNAFMIGLYQCIAMIPGVSRSMATIVGG
QQQGLSRKIAAEFSFFLAVPVMFGATLLKAYKLFKQFGVDIFVDNAVSLIVGNVVAFVVA
IFAMRFFINFLTKFGFKYFGYYRIVVGLLILCLLWSGFPLDLK
>J7JZQ3|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRRLSCALGAALSLCALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>W4B1E4|FEATURES|UNIPROT_deepARG|chloramphenicol|C161_10563|antibiotic inactivation|1
MFNSIVLDQWDRKPYFDHYLNQVRCTYSITANLDITLLINELKLKGLKFYPALIHMISTV
VNAHREFRTCFDAEGRLGYWDEMSPSYTIFHEDNKSFSTIWTAFHEDFETFHNRHLEDMK
NYKDHKQFVAKPNEPPNTFPVSSIPWVNFTGFNLNIYNEGTYLLPIFTMGKYVQQNDKVY
LPLSVQLHHAVCDGYHAGVVFNELQSLADRCQDWC
>A0A0E1JG76|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACETLGKAYEILLVDDGSSDDSARMQTD
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SVIALAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHLASQEENHP
>C3I2Z2|FEATURES|UNIPROT_deepARG|beta_lactam|bthur0013_31230|antibiotic inactivation|1
MVPVVFLSCATLIGCSDGNTQSELPKQTNQTKQETTGNDSFAKLEKEFDAKLGIYALDTD
TNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNPITEKYVDS
GMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVHPG
DVNDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVADKT
GSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKIALGVLKAKNK
>BAA06245|FEATURES|ARDB_deepARG|aminoglycoside|AadD|antibiotic inactivation|1
MNGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVMSTE
EAEFSHEWTTGEWKVEVNFYSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLEKVY
QTAKSVEAQKFHDAICALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLIGLH
HRICYTTSASVLTEAVKQSDLPSGYDHLCQFVMSGQLSDSEKLLESLENFWNGIQEWTER
HGYIVDVSKRIPF
>Q1IPW7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAYLLAALLGVVEGLTEFLPVSSTAHLRICEALLHIDLGDGFWKMFSIVIQLGAILCLP
IYFRARISEFFATFPKGKSGNHTALTHPLTLTIIAFLCTAIPAFLFTKIIGKHLESVIIM
GSALLIGGIVMWIVDVMFADKGATDDMDKMSVGQAIWIGLCQVLSAVFPGTSRSMSTIAA
GQLSGMTRAAALEFSFFLSIPTMVVATCYDLLKTLRHKDEAGAALGVVHMDAHAWITLAI
GFIVSFIVAYFVVAWFMKWVRTRGFVPFAVYRIVVGIAVLAWALKR
>YP_309460|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTSLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHTVDHH
>A0A0K2BGK9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTILALKALIMGIVEGLTEFLPISSTGHLILAGSLLNFAGPGFSKEKVDVFEIVIQAGA
ILAVCWEYRVRIASVLGGLFTDRKAQRLVINLIIAFLPAAILGFLFSKKIKAVLFAPVPV
AIAFIVGGLVILWVERRNKGRMGYSSSRIDSVDDMTPLDAFKVGCAQAFALIPGTSRSGA
TIIGGMLFGLSRKAATEFSFFLAIPTLFAATIYSLYKERALLSAADVPLFTVGTVAAFVS
AFLCVRWLLRYISSHDFTVFAWYRILFGLVILGTAYTGVVAWVE
>A0A059XTM5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLDLNNIRRSYPSGDGQVEVLKGITLRINAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGTYRVAGTDVSLLSSDQLAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKA
RLERAKALLTRLGLGERADYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIIRNPPAKTEAAAPANHDAV
MTHAGGWRQFASRFQEALTMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRSIGTNTIDVYPGKDFGDDEPQYQQALKYDDLQAIQKQPWVKSATPAVSQNLRLRY
GNIDVAASANGVSGQYFNVYGMTFSEGASFNDEQLKGRAQVVVLDSNTRRQLFPNKASVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVNEGY
SSEQAEQQLTRLLSLRHGKKDFFVWNMDGVLKTAEKTTRTLQLFLTLVAVISLLVGGIGV
MNIMLVSVTERTREIGIRMAVGARAGDVLSQFLIEAVFVCLVGGALGVTLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTFTGVLFGWLPARNAARLDPVDALARE
>A0A0E9FPI2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGFIADVIKTIFLGIIQGITEWLPISSTGHLLIFNSIWPMLPNEFFDVFKVVIQFGSILA
VIFLYWHRLNPWDGRKNEKQKKRTFNLWLKVLIGCIPAGVFGLILNDLIDSVLSANFVIA
VTLIAYGIIFIVVEKHPKKATIKNIESMDYLTALKIGFFQCLALIPGTSRSGATILGGLY
SGCTRTLSSEYSFFIAIPTMAGASLLKIVKYVHVNGMFPMSQLFLLLLGTFISFVVSLFA
IRSLINYVKKHDFTVFGYYRIVLGILVLLLFYVLR
>F0KJS2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYADNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQLLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>U3AV18|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRLTITALALLLIGQTALAQPNKLRATVDAAVQPAIEQYRIPGLAVAIVHKGERHFFNYG
VASRESSQAVNEHSLFELGSVSKLFTATLGAYAQAEGKLSLDDPASQHLPALRGSAFDRI
SLLDLATYTPGGLPLQFPDAVRSERQMLDYYRAWQPAYAAGSQRLYSNPSIGLFGHLAAA
SLGKPFDQLLEGQLFPQLGMTESHVHVPQSKMARYAWGYRDDQAIRVQPGPLDAEAYGVK
STATDMLRFVEANLDPSQLPVPLRQAIATTHQGYYRVGDMTQGLGWERYAYPITLQRLQA
DNSSQMALEPHAVERFATPQPAEGDLLLNKTGSTNGFGAYVALVPARDTGLVILANRNYP
NAERVRIALEILATLEP
>YP_002030220|FEATURES|ARDB_deepARG|multidrug|smeA|antibiotic efflux|1
MSLPRPLSRSPHPLLLPLLMSLAACSAGRSETPATPEVGVITASAQPLALQQTLPGRAVP
FEVSEVRPQIGGLIRQRLFTEGQQVKAGQLLYQVDPAPYQAAFDTARGQLAQAEATVLSA
QPKAERTRTLLGLDAASKQDADDATSALKQAQANVIAARAALQAARINLDYTRISAPIDG
RIGTSSVTAGALVAAGQDAALATIQRLDPVYLDVTQSSTQMLALRKQLDAGLVKAIDGKA
QVKVLLEDGSTYAHEGTLEFVGSAVDPGTGNVVLRAVIPNPDGLLLPGMYLKAVLPMATD
ARALLVPQKAVLRNERGEPLLRLLDARDHVVERRVGIGQVVGNQWQITQGLKAGERVIVS
NGSAVSLGQQVKAIAATTAQLAAMPAIDPNGNTDETSH
>A0A127SL66|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MTVKLDVTRVIASKRKIYPIMLYAISHVVNQHEEFRTAISKEGNLGIYDELIPCYTIFHK
DTETFSNLWTPYHSDVSAFAEAYHRDVEEYGSIHSMNPKPNEPDNTFPVSMIPWESFEGF
NLNLKNGYDYLLPIFTIGKFFSEADRTVIPIAIQVHHAVCDGFHLCRFIGELRKLLLDL
>A0A127SD48|FEATURES|UNIPROT_deepARG|beta_lactam|GES-20|antibiotic inactivation|1
AQRFAMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLE
AAQAAVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTT
TPIAMARTVAKVLYGGALTSTSPHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANG
GRNDIGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>YP_001694718|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESKRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>Q6HIX0|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDVR
CYASVHGLFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEENKIM
LPVSLQVHHSICDGYHASRFIEDLQELSNSCNEWLK
>C4XT96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESLAAVVLGIVEGATEFLPVSSTGHLILVGHLIGFTGEKADSFDVIIQLGAILAVVCL
YWRRFWWLVSPKPHHAFSGIRGLWMLFLTSLPAGLIGLVARKSIKAYLFNPWSVALALSV
GAVMIFLVEQRKTRDRYYSLDEMTPGLALGIGCFQCLSLWPGFSRSAATIMGGMLLGAKR
SLAAEYSFIGAVPLMFAATLYDFYKSAHLFSADDLGVLGIGFVVSFVSALIAVKAFIVLV
QRITLRPFAWYRLALAAAVFFFWPK
>ABB82608|FEATURES|ARDB_deepARG|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSXSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHIXKDDIVAYSPILEKYVGKDITLKELIEASMAY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>D8MHV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDILKSIIIGIVEGITEFLPVSSTGHIILAEALMRIPSGNVWTNSFTAVFDYAIQLGAI
FAVIQLYFNRLNPFSQKKTSKERFQTWRLWIKVVVGVIPAVIFGFLFNDFMDAHLLNFRV
VSATLIIYGIAFIWIENRQKNIAPKITSLNKITFKLALFIGLFQVLSLVPGTSRSGATIL
GAVILGASRFVAAEFSFFLSIPVMFGVTILKVGTFLLHGGRFTGMQSIVMLVGFVVSWIV
ALFAIKVMMRYIQNNDFKIFGWYRIAIGAIFLLLGFAGFVK
>A0A0Q8IWW4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDRLKNIAACMAIFAAGQCVAQDQIETVVNAAVQPVMQAEGIHGMAVAITVNGQAHYFNY
GVASKEAGNPVTQDTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASQVLPALRGSAFDQ
ISVLQLGTYSAGGLPLQFPAEYDSADKMLSYYKQWKPLYVPGSHRLYSNPSLGLFGYLAA
QSMGQPFDDLMEKTLLPKLGLKHTYVHVPQAQMALYAQGYNKDGQPVRVTPGALDSEAYG
VKTSAADLLAYVGANMKPTSLEKPLQQAIALTHSGYYTVGGMTQGLGWEMYRYPITLDRL
LDGNSTPMAMQAHEVQWLNPPQAQPQDALINKTGSTGGFGAYVAYVPSKDIGIVMLANKN
YPNAERVRIAHQILSALTR
>A0A0J6BPI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLWEAFVAIVLGLVEGLTEFAPVSSTGHMIIVDDFLFQTKEMFSPEVANTFKIVIQLGS
ILAVVVLMWDRFMSLLGLNRLAGKREVQAGPRLNLATVIVGLIPAGILGVLFDDYIDEYL
FSTKTVVIGLVLGALLMLAADWFRPKRAKIESVDQITYKQAFLVGLIQCFSLWPGFSRSG
STISGGVLLGMSHRAAADFTFIMAVPIMAGASFLSLLKRWDAITMDSIPFFVVGFISAFV
FALLSIRFFLKLINRIKLTPFAIYRLVLAAVIYFVFM
>A0A0V8CAQ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLVAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFKAFLG
>A0A0G3EI75|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIEVRDIVKTYRMGDVEVRALRGCSLRIDRGEFVAITGPSGSGKSTLMHILGLLDTPDSG
SYRLEGHEVSRLTDDQLAIRRARSIGFVFQQFNLLARVSALENTALPLIYRDHPSPADPE
DLLKRVGLGDRKEHTPGELSGGQQQRVAIARALVNRPSVMMADEPTGNLDSASSGEILTI
LRKLNETGLTVIVVTHDPEVTAVASRVISIRDGRVTEDRGRVPADSASGSVAKDTDFDFR
VGGEHDARTHPLGWIGRKLDEAGAMFRQAVRALMANKTRTALSMLGVLIGVAALIAVMAL
GTGAREAVEERISRLGANLLVLRPGARQRGAVRMAAGATSRLTLEDAEALPRRLPSVDAA
APVVNGMAQLTWEGHNWRTSITGTTPAYLRIHDYELLYGRNFTAAEVENRARVALVGTTL
VRELFDGSNPIGRTLRMNRVRFEVIGILPEMGASFGRDPNDMVIIPVTTAMKRLFGKTYI
NTVEIRVVDRDHMEYTEKAVIRLMKERHRIDPEREAFSVFNMGDLREAITATSKTMALLL
AGIGGVSLFVGGIGIMNIMLVSVTERTREIGIRKAVGAKRSDVLAQFLIEAAVIGIFGGF
LGILTGWGASLAMTRYAGWNTIITPLTVGLAFTFSAVVGVIFGLWPARKASRLNPIDALR
YE
>J9BF03|FEATURES|UNIPROT_deepARG|beta_lactam|IEM_00219|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSESPKQTKQEHISNQSFVKLEKDY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDLRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKTLREIGDTVTNPE
RFEPELNEVQPGDTHDTSTPKALAISLQTYALGDILSTEKQNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHAKKDAKYDDKLIADATKI
VLDALKVTNK
>S0UDS5|FEATURES|UNIPROT_deepARG|beta_lactam|WC5_00871|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRAINPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSGDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYHEGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPIDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVDPDSII
NGSDSKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYIAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>R7BXJ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLLKTVLLGIVEGITEWLPISSTGHLILADEFIKLNMTGAFKEMFDVVIQLGAIMA
VVVLYFHKLNPFSPKKNHREKMDTIVLWTKVILAVFPAAIIGILFDDWLNAHFYNPPVVA
AMLIIYGILFIIIENRNKRIRRRPMNDLTRLSYGMALGIGVFQVLALIPGTSRSGATILG
GILLGCSRTVAAEFSFFLGIPVMFGASLLKIVKFGLAFTTTQLIVLIVGMVVSFLVSIVA
IKFLLGYIKKNDFKAFGVYRIILGLLVIVYFAFIK
>Q7M176|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-12|antibiotic inactivation|1
IDXXSQSSSKFRQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQRFPLTSTFKTIA
CAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAAN
IILSAVGGSKGVTDFLRQIGDKTRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGS
ALSEMNKKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPI
IVSIYLAQTQASMAERNDAIVKIGRSIFDVYTSQSR
>A0A0J5QQ86|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MRIQGLNHLLFSVSDLDASIEFYQQVFGAELLVKGNSTAYFDLNGMWLALNEEKEIPREE
ITLSYTHLAFSIAEEEFNDIYEQLVDLKVNILQGRERDVRDKKSIYFTDLDGHMFEFHTG
TLEDRMNYYKQEKTHMTFYR
>ZP_02684554|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MANFFIRRPIFAWVLAIILMMAGALAIMQLPVAQYPTIAPPAVSISATYPGADAQTVQDT
VTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQ
EVQQQGISVEKSSSSFLMVAGFVSDNPNTTQDDISDYVASNIKDSISRLNGVGDVQLFGA
QYAMRIWLDANLLNKYQLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRL
KDPEEFGKVTLRVNTDGSVVHLKDVARIELGGENYNVVARINGKPASGLGIKLATGANAL
DTATAIKAKLAELQPFFPQGMKVVYPYDTTPFVKISIHEVVKTLFEAIILVFLVMYLFLQ
NIRATLIPTIAVPVVLLGTFAVLAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
MEDNLSPREATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATLLKPVSAEHHEKKSGFFGWFNTRFDHSVNHYTNSVSGIVRNTGRY
LIIYLLIVVGMAVLFLRLPTSFLPEEDQGVFLTMIQLPSGATQERTQKVLDQVTHYYLNN
EKANVESVFTVNGFSFSGQGQNSGMAFVSLKPWEERNGEENSVEAVIARATRAFSQIRDG
LVFPFNMPAIVELGTATGFDFELIDQGGLGHDALTKARNQLLGMVAKHPDLLVRVRPNGL
EDTPQFKLDVDQEKAQALGVSLSDINETISAALGGYYVNDFIDRGRVKKVYVQADAQFRM
LPGDINNLYVRSANGEMVPFSTFSSARWIYGSPRLERYNGMPSMELLGEAAPGRSTGEAM
SLMENLASQLPNGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAASLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGRGLI
EATLEASRMRLRPILMTSLAFILGVMPLVISRGAGSGAQNAVGTGVMGGMLTATLLAIFF
VPVFFVVVKRRFNRHHD
>A0A060L041|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSRVQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTSDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A0N0LJM0|FEATURES|UNIPROT_deepARG|beta_lactam|AMQ68_09385|antibiotic inactivation|1
MICLLLNLYSCKATKKEASTDIKILVDSLAQSLMSENKIPGMSIAVTVEGKHSFFNYGIL
SKESNQPVTNQSLFELGSISKTFTVTLASLSQINGNLDMQAPVSNYLPHLKNTVFDSVKL
YYLGTHIAGGLPLQLPDNITTDEQLMNYYKTWVPLYAPGTKRVYSNPSIGLLGVIAGKTM
NEPFTKAMTDHVFSKIGMSNTFYDVPQNKMGDYAQGYNKEDQPVRLNPAVLANEAYGIKS
CTQDMLKFVDRNMGIGNLDATLSKALQATHTGYFTTGVMTQDLIWEQYNYPASLSQLLEG
NAAEMAYKASDTKPLVPPMKPQPNVVINKTGSTNGFASYVIYIPSKKIGIVILANKNYPI
KPRVETAYKILSYLDNPKNKL
>V3E3G7|FEATURES|UNIPROT_deepARG|chloramphenicol|L423_01726|antibiotic inactivation|1
MKKTAPEYTPVDLSRWPRKEHFEVFQSFAECTINQTVLIDITALRKHIKAVGWKFYPTII
FLLSNIMNRYPEFRMAMKDNELVIWNEVHPSYTIFHPETETFSSLWSHYDGNIHHFQNTY
AEDTARYGNSLSYWPKEESRENVFFVSSIPWVTFTNFTMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPMAVQVHHSVCDGFHVARMFNELQEMCDGLSEL
>A0A0E1NJZ8|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGNVPHEGKTNGHLTLGHILLAMIPAVGLGLAFHDVIKSLFNPQS
VMYALAAGGLLLLAAEWFKPKNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASGLELYKSLHFLSRGDLPMFAVGFITAFVVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>CAC81916|FEATURES|ARDB_deepARG|tetracycline|tetE|antibiotic efflux|1
MNRTVMMALVIIFLDAIGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPL
LGRWSDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATVAVAASTIAD
VTPEESRTHWFGMMSACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILH
ETHNANQVSDEIKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERF
AWDGVMVGVSLAVFGLTHALFQGLAAGFIAKHLGEQRAIVVGILADGCGLLLLAVITQSW
MVWPVVLLLACGGITLPALQGIISVRVGQVAQGQLQGLLTSLTHLTGVIGPLIFAFLYSA
THESWNGWVWIVGCGLYVVALTILRFFYPGRAVHPKNQSNSQPFL
>A0A0G8L688|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
KLWTLATGLGERDNRDYVLKIGVAFLVTAVVGLIVRKAGWQLPETVHPVAWALLIGGLWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGSENWADVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRIVLGAALLLWLPAAA
>G3KE69|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNNGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGAS
>AAR29970|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILGHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A096C0K2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIVEGLTEFLPVSSTGHMIITQNLMGVQQGDAFVHAFTFIIQFGAILSVVC
LYWRRFFHIDHTPAPADCKSPFLRMIHPVRFYWLLFVGVLPAVVIGMAAKKSGLLDWLLD
SVWVVAVMLVVGGVFMLFCDRIFNKGKEANRVNEKRAFNIGLFQCLSVIPGTSRSMATIV
GGMANGLTRRRAAEFSFFLAVPTMAGATLLDLLDLLKEDGSWATAHNLTMLAVGCIVSFV
VALLAMKWFVNFLAKYGFRWFGWYRIIVGVAILVMLLSGMSLNMVD
>A0A0T9Q3Q6|FEATURES|UNIPROT_deepARG|aminoglycoside|ERS008531_02079|antibiotic inactivation|1
MLIQKIDQTTLSGWVKLRTQLWPNHGSDAHHHDGENIIFCSDKLISFVAIADSGDIVGFA
DASLRHDYVNGCDNTPVVFLEGIFVVDTYRRKGIAAQLVTAIQAWGRVKGCNELASDTDI
DNIASQKMHQSLGFQETERVVFFKKQISDLR
>Q84GI4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDTEA
YGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVPA
EVVINGSDNKVALAATPVTAVNPPAPSVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHILEALQ
>A0A0F3GDI2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRPSLRPLLVTLSLCLGSQSAFAELNQAVDAAVKPMMQAYAIPGMAIAISHKGQQHFFEY
GVASRESGQAVDRHTLFELGSISKLFTATLGAYAEARGTLNLSDNASQYLPELRGSAFDH
ISLLDLATYTPGGLPLQFPDAVSSERQMLDYYRNWQAVYAPGMQRLYSNPSIGLFGHLAA
ASMAKPFQQLMEKDLLPQLGMQESYVQIPAEQMTRYAWGYRDDKAVRVGPGALDAEAYGL
KSTAADMLRFIDANLHPDKLPAPLLQAVSSTHRGYYQVGDMTQALGWERYAYPISLAKLQ
AGNSAEMALQPQPVERFSVPKPAEGDLLLNKTGSTNGFGAYILLLPARDIGLVILANRNY
PNAERVRLALQLLESLEP
>B7LK52|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENRESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAISLFGITL
ICAGFSIGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVTPGRPVAAHEEIHHHA
>A0A143ML95|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHWIELLKAVILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGVRGRHPGGKPRLTLLHVIIGLLPAGVLGVLFEDYIDEHLFSTQ
TVLIGLVLGALLMIAADQFAKKAARAQTVDQITYKQAFLVGLVQCLSLWPGFSRSGSTIA
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVSAADIPFFIAGFLSAFVFALL
AIRFFLRLINRIRLVPFAVYRIVLAVVIYFLYF
>A0A0N7AFG6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCphA|antibiotic inactivation|1
YYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNA
YWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKV
RAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIK
TVMGGHDSPLHGPELIDHYE
>W9BMV1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARLAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLGDEILNLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGDIVAQQAVAIGADDAALTLHRKLCAAATELLSRALPAI
LAGTTDERPQDHSQATYVGRRTPEDGRLDWELPAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLPAAKPGTVLSIAPLIVACQDGALEIVTGQTERGVYMQGAQLAQALGLVS
GAVISSKPVEAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAINRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWEPKVEMEETVEHTLDFFLRTVELVDDKN
P
>D9PSM1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEILKVILLGIIEGVTEWLPVSSTGHILLLDEFIKLNMSDAFKSMFTVVIQLGAILAV
VVIYWNKVWPFKKGQSHLISISKSKMIMWAKIIVACIPAAIIGIKFDDYIEEHFYNYFVI
SLALIIFGILFIIIENRNKESHKKLVDSIDKITYKQAFIVGLFQVIAAVFPGTSRSGATI
LGGIAIGLSRTIAAEFTFFLAIPTMFGASLLKLLKFGFSFTAMEAFVLLLGTAVSFVVSV
ITIKFLMNYIKNNDFKVFGYYRIALGVLVLIYFGLIR
>A0A0C2I8P3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNPKVVVFAYHDIGCTGIESLLAAGYDIAAVFTHADDPKENAFYGSVAQLCARKGITVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEELLATAKNGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGGILAQNRVAIERADTALSLHTKLRESAAALLNEALP
QLAAGKLSETAQDESKATYFGRRTPADGKLVWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIIWSAEVVKGNEGQAPGRVISVDPLRIACGEDSLVINAGQRNDNGLFLSGPQLANELG
LVDGSFLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDENFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGQLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCF
TDIADGIEALARIVDNENDCCNGQVINIGSPNNEASIRQLGEELLRQFEAHPLRSNFPPF
AGFREVESKAFYGTGYQDVSHRKPSVENAKRLLNWEPTVEMSETIGNTLDFFLKEAMLEI
ADKR
>B6D9D2|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA13|antibiotic inactivation|1
MTAEISTQLSKVLSVIEHHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVTARLDDTTRR
ALFNDLLEVSAFPGESEILRAIEVTIVVHEDIMPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLIKALNETLKLWNSQPDWAGDER
NVVLTLSRIWYSAATGKIAPKDVAANWAMEHLPAQHQSVLLEARQAYLGQEEDRSVLRAD
KLEEFIHFMKSEITKVLGNDV
>A0A0A8UK20|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMTMMGIAVLMLSLFILKE
TRPASPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>NP_814810|FEATURES|ARDB_deepARG|multidrug|EmeA|antibiotic efflux|1
MTKKNSMMYLAISNLFLVFLGVGLVIPVIPQLKEEMHFSGTTMGMMISIFAIAQLITSPI
AGVLSDKIGRKKMIATGMLVFSISELLFGLAQAKSGFYISRGLGGIAAALLMPSVTAFVA
DMTTISERPKAMGLVSAAISGGFIIGPGVGGFIAYLGIRAPFFAAAFLAFIGFILTLTVL
KEPEKRILAAVEAKKGSFMDILRNPMFTSLFVIILISSFGLQAFESIYSIMATINFGFTT
SEIAIVITVSGILALICQLFFFDAIVQKIGEMGLIQLTFFASAIFIAVIAFTKNNLVVVF
STFIVFLAFDLFRPAVTTYLSKHAGDQQGTINGLNSTFTSFGNILGPMAAGALFDINHFF
PYYVSAVILLGTGFLSLFLNRNKM
>A0A0R2MUL6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAVILGIVEGITEFLPISSTGHLVLVDEFIKMQQSTQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPRKDRTEKRDTWVLWSKVILAVIPSVIVGLPLNDWMDEHLMNWGVVSAA
LIVYGILFIVIENHNKALTPRFADLKTLPYTTALFIGCFQLLSLVPGTSRSGATILGAIL
IGTSRYVATEFSFFMAIPTMFGASLLKLVKFFAHGGSLAGLQGVVLAVGVIVSFVVAYLA
IRFLLDYIKKNDFKIFGWYRIVLGVVVIAYFAVKTLM
>A0A060KZC0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFPLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVIWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>P9WFV2|FEATURES|UNIPROT_deepARG|mupirocin|ileS|antibiotic target alteration|0
MTDNAYPKLAGGAPDLPALELEVLDYWSRDDTFRASIARRDGAPEYVFYDGPPFANGLPH
YGHLLTGYVKDIVPRYRTMRGYKVERRFGWDTHGLPAELEVERQLGITDKSQIEAMGIAA
FNDACRASVLRYTDEWQAYVTRQARWVDFDNDYKTLDLAYMESVIWAFKQLWDKGLAYEG
YRVLPYCWRDETPLSNHELRMDDDVYQSRQDPAVTVGFKVVGGQPDNGLDGAYLLVWTTT
PWTLPSNLAVAVSPDITYVQVQAGDRRFVLAEARLAAYARELGEEPVVLGTYRGAELLGT
RYLPPFAYFMDWPNAFQVLAGDFVTTDDGTGIVHMAPAYGEDDMVVAEAVGIAPVTPVDS
KGRFDVTVADYQGQHVFDANAQIVRDLKTQSGPAAVNGPVLIRHETYEHPYPHCWRCRNP
LIYRSVSSWFVRVTDFRDRMVELNQQITWYPEHVKDGQFGKWLQGARDWSISRNRYWGTP
IPVWKSDDPAYPRIDVYGSLDELERDFGVRPANLHRPYIDELTRPNPDDPTGRSTMRRIP
DVLDVWFDSGSMPYAQVHYPFENLDWFQGHYPGDFIVEYIGQTRGWFYTLHVLATALFDR
PAFKTCVAHGIVLGFDGQKMSKSLRNYPDVTEVFDRDGSDAMRWFLMASPILRGGNLIVT
EQGIRDGVRQVLLPLWNTYSFLALYAPKVGTWRVDSVHVLDRYILAKLAVLRDDLSESME
VYDIPGACEHLRQFTEALTNWYVRRSRSRFWAEDADAIDTLHTVLEVTTRLAAPLLPLIT
EIIWRGLTRERSVHLTDWPAPDLLPSDADLVAAMDQVRDVCSAASSLRKAKKLRVRLPLP
KLIVAVENPQLLRPFVDLIGDELNVKQVELTDAIDTYGRFELTVNARVAGPRLGKDVQAA
IKAVKAGDGVINPDGTLLAGPAVLTPDEYNSRLVAADPESTAALPDGAGLVVLDGTVTAE
LEAEGWAKDRIRELQELRKSTGLDVSDRIRVVMSVPAEREDWARTHRDLIAGEILATDFE
FADLADGVAIGDGVRVSIEKT
>A0A0U5KD98|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPTSFINMFMVVIQLGAILSVI
VIYFNKLNPFAPSKSKREKGQTWQIWFKVIAAVLPSIIIGLPLNDWLEENMTSWQVISAT
LIIYGILFIVLENYYAKRQPSLTDLNKMSNKTALLIGCFQVLSMIPGTSRSGATILGAML
IGSSRYVATEFSFFLAIPTMFGASLLKLVKFFKAGHVFVGNQLAILLVGMVVSFIVAYLS
IKFLLKYVQTHDFKPFGWYRIVLGIIVIICGLVFA
>A0A127T0B4|FEATURES|UNIPROT_deepARG|beta_lactam|CfxA6|antibiotic inactivation|1
MLNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSIS
QIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVK
INREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFI
AKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNAL
KECKTGIDRIVAPLLDKEGVVIAHKTGSGHVNENGILAAQNDVAYICLPNKVCYTLAVFV
KDFKGNESQASQFVAHISAVVYSLLINTALN
>A0A084GIY5|FEATURES|UNIPROT_deepARG|beta_lactam|GS18_0220900|antibiotic inactivation|1
MKSLSNVYRPSSFKKMVPVLLLSCATLIGCSTNNAHTDSTKTKEQENVANHDFAELEEKF
DAKLGVFALDTGTNQTVTYNPDERFAYASTHKALAVGALLQQISIEDLNQRITYTREDLV
NYNPVTEKYIDKGMTLRELADASLRYSDNTAGNLILNQLGGPAGFKKALEAIGDDITSPE
RMEPDLNEVNPGETHDTSTPRALAASLQDFILGDALPTEKRELLIDWMKRNTTGDALIRA
GVPEGWEVADKTGSGSYGTRNDIAIIWPSKGDPIVLAVLSSREKKDADYDDKLIAEATEM
VMNDLKVKEN
>A0A136D7B4|FEATURES|UNIPROT_deepARG|beta_lactam|ACS92_11515|antibiotic inactivation|1
MILKNKRLLKIGICVGILGLSITSLEAFTGGPLQVEAKEKKGKIKHKNQATHKEFSQLEK
KYDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKED
LVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTDWMKGNATGDKLI
RAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAA
EVVIDAIK
>A0A077PKV1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKFVINTLVFATIGTSSFYASAQKTLTAQQVAEIVNNTLTPLLEKQDIPGMAVAVIYD
GKPQFFNYGVADIKTRRPITENTLFELGSVSKTFTGIAGGYAMQTDTLDLNDPVTAYSSE
LTGSQWRGVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPLWAPGMMRNYSNASI
GLFGALTANKSQLTFETYMTKYVFRPLKLTHTFITVPESMQSDYAWGYKNGQPVRVTPGM
LSAEAYGVKSTTQDMVKYMQVNMAPDSLSADNDKLKKAILAAQSRYYRAGNMFQGLGWEM
HNWPINPQRVIADSSNDIALQPHKVEALIPPRSAVSASWVHKTGSTDGFGAYIAFIPEEK
IGIVMLANKNYPNPVRVEAAYHILKALL
>ZP_03284557|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFSLIGIHFGRLPQREGEGKGRLTLIHILLGMIPAVVLGLIFHDTIKSLFNPI
NVMYALVVGGVLLIAAELLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0U3R306|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTVPPGVDVPSPRTPSVSTFRITDDKAGPYGIAAGPDGALWLTLVHRGSVARLALDGAFE
EYALDAAGCRPTVVAAGPDGALWFTRHQDHRIGRVTTDGEVTSFALPTADGGPYGITAGP
DGALWFTETTGDRIGRITPGGEVTEFALPVAGGFPSAITTGPDGALWFTLNGANAIGRIT
VDGDTAVHPLPTEAAGPVGIAADGRAVWFAEILAGQIGRILPDGRITEFPLPDRSAKPHA
VVAAADGECWFTEWGAGRIGRVTETGEITEHALPDPSSEPHGITVGPDGALWTALETGGV
ARVERLP
>A0A0G3VS34|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
CGAVLSRVDAGQEQLGRRIHYSQNDLFEYSPVTEKHLTDGMTVRELCSAAITMSDNTAAN
LLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTG
ELLTLASRQQLIDWMEADKVAGPLLRS
>ZP_03048876|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDAIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
ATPVVEKK
>A0A087NXY8|FEATURES|UNIPROT_deepARG|beta_lactam|JM78_10775|antibiotic inactivation|1
MTYSSKRRTLLLAAATAPLALTVAACASSQAAAPNEAATPDVAAAAAAAALAHLERDAGG
RLGVCAIDTASGRRVAHRAAERFPFCSTFKAMLSAAVLAQSVARPGLLQQRVTYGKADLV
NYSPVTEKHVGAGMTVAELCEATIQYSDNSAANLLMKLIGGPSAVTAYARSIGDDTFRLD
RWETELNTALPGDLRDTTTPAAMAASMRVLTLGDALPAAQRAQLVTWLRGNKVGDKRIRA
GVPAGWTVGDKTGTGDYGTTNDAGVVWAPSRAPIVLAVYYTQARADARAKDDVIADVARV
VVAAFG
>R2PHY3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIANIFKAIILGIVEGITEWLPISSTGHLILADEFIKINMSPAFIEMFNVVIQLGAILA
VVVLYFTKLNPFAPSKSHKERQDTWTLWFKVIIACLPAAVIGLPLDDFLEAHFHKFLPVA
IMLIVYGIAFIVVERHNKTKTPKCTNLNDFTYKAALIVGAFQLLSLIPGTSRSGATILGA
IIIGSSRFVATEFSFFLGIPVMFGASGLKIVKFLMNGNTFGASEIIVLLVGMVTAFVVSI
VAIKFLLDYIKRNDFTAFGWYRIVLGIILIGYWLIAM
>A0A158GUB2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRGKIGSVVTGLPVRADARRFTLNLIIATIPAIVLGLLFEKGIKSVLFSPVPVSVALI
VGGIVILWAESRQRERAVTPRVQSVDDLSYTDAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVNDFGLFAVGLVAAFISAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A132THZ2|FEATURES|UNIPROT_deepARG|chloramphenicol|AMQ84_28155|antibiotic inactivation|1
MNFNMINRENWQRKEYFEHYLQQRTSFSITHNINISVLMENLKKKNYKLYPAFIYMVTQI
VNSHIEFRTCFNAEGKLGYWSDVVPSYTIFDKSTSLFSSIWTLQLNSFNDFHAQYEKDVE
KYSGTGKLFPKTPVPDNVLPISMLPWSSFTAFHLNINNNGDFLLPIITAGKYSKVTNEWL
LPVSLQVHHAVSDGYHASVFIDALQRLAEESEMWL
>U5VF53|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRRKILDVVFGLTRQPAARRFTGNLLLAFLPAVVLGVLFADLIHEYLFNPITVAAALV
VGGFIMLWAERRDHRVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLIFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFVTSFIFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWQFGWVDWSTAHG
>V4IQG0|FEATURES|UNIPROT_deepARG|chloramphenicol|B590_25524|antibiotic inactivation|1
MDAPTPTPIPVDLDTWPRRQHFAHYRRRVPCTYAMTVEVDVTTFAAELRRSPRKSYLAQV
WALATVVNRHDEFRMCLTASGDPAVWPVVHPAFTVFNPRRETFACVWAPYDPDFGTFHDT
AAPLLAEHSRATDFFPQGDPLPNTFDVSSLPWASFTGFTLDIRDSWDHLAPIFTLGRYTR
RDARLLLPLSVQIHHAAADGFHTARLTGELQTLLATPTWL
>ZP_02465589|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVVILLAGMIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPNDSYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GAGDYAMRVWLDPQKVAQRNLTADDVVRAIREQNVQVAAGVIGASPTLPGTPLQLSVNAR
GRLQNEEEFGDIVVKTAPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLAISDEVRKTMAELKQDFPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASIIPLIAVPVSIVGTFSLLLLFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGLTAQAATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRAMNRVLGGFFRGFNKVFHRGAENYGRGVR
GVLSRKAVMLGVYLVLVGATVMVSRIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGAIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFDQRHGKALSAGAIAGALN
QQYAAIKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYARLADATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVNVTDVFDTMQIYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNAAGEMVPLSSLVTVSPTFGPEMVVRYNAYTAADVNGGPAP
GFSSGQAQAAVERIAAQTLPRGVKFEWTDLTYQQILAGDSAFWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGKTPFEAAVEASRLRLRPILMTSIAFIMGVVPLVLSTGAGAEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAQKDSAGYGVPAPDA
>A0A059WBY5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPTQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>ACH85850|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLV
WRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLP
SALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMF
SSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLL
DQAYANGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY
>A0A0D0T9I5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSAGYEIAAVFTHADDPRENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEALLATARKGAFNLHGSLLPKYRGRAPVN
WVLVNGETETGVTLHRMVKRADAGAILAQQSVSIDRTDTGLSLHAKLRDAAATLLRDALP
QLAQGKLAETAQDESQATYFGRRTAADGKLDWKQPAETLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVSPLRIACGEDSLVIKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVQMSETIGNTLDFFLREAMLEIA
DKK
>A0A0Q7ALT8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQIARSILAGTFFLVCGTPAGFAQERIEDTVNAVIQPLMKQQDIAGMAVAVTYNGQRHYF
NYGVASKDTKKPVNDQTLFEIGSVSKTFTATLGAYAQAQGKLSLADPASRFAPELRGSAF
DGISLLNLATYTAGGLPLQFPAEADQQDRMFSYYTTWKPLYPVGTQRLYSNPSIGLFGYL
AARSLGQPFDEVMEGTLMPGLGLKQSYVRVPQDQLSRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSSSDLMRFLEANLRPEKLDADLKQAIATTHTGFYKAGGMNQGLGWEFYPAPFTLD
DLLAGNTPQMALTPQKVEPLNPPRPAPDGAWVNKTGSTNGFGAYAAFVPGKDMGIVMLAN
RNYPIEERVKAAHRILMALDSQ
>A0A0Q9ZJ97|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLFVQAVIMGIVEGITEFLPISSTGYLILSADVMGFWTKEKVDLFVVVVQLGAILAV
IYDYWGRLWQALMGLLTGKAEGMTNPRQLGLSLIVSTIPVMIVGFTFADEIKAYLFNPIV
VAIMLIIGGLLIFYVEKRPKTVIAEEAEDVSIKTALMIGLFQCLALIPGTSRSGATIIGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLLKHGDVLKSSEDWLVLGIGTIVSFVIALLC
IRLLVAWVSRRDFTIFAWLRIITGVIVLVAAWGFGYQMAG
>A0A0D9AXA7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHIAKTTLAGIFFLFCETSVGFAQERIEETVNAVIQPLMKQQDIAGMAVAITHNGQRQFF
NYGVASKDTRKTVTDQTLFEVGSVSKTFTATLGAYAQAQGKLQLSDSVGGHAPELRGSAL
ENVRLLDLATYSAGGLPLQFPDDADHPDRMFSYYQAWKPLYPASTQRLYSNPSIGLFGYL
AARSLGQPFDDVMQQTLMPGLGLKRSYVRVPQDQLGRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSSADLIRFVEANLRPQTLDEPLKQAIATTHTGFYRVGKMNQGLGWEFYPAPFTLE
DLLAGNTPQMALTPQKVEALSPPRPAPDGSWINKTGSTNGFGAYAAFVSGKDLGIVILAN
KNYPIEERIKAAHKILAALEQQ
>YP_001187667|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIWMAFQALILGIVEGLTEFLPISSTGHLIVVGDLLGFNGETATAFKIIIQLGAILAVM
WEFRARVLGVVLGLRSEPRAQRFTFNLLLAFIPAVVFGLAFADLIEHWLFNPITVATALI
VGGIIMLWAEKREHAIQAESVDDMTWKLALKVGFAQCLALIPGTSRSGATIIGGLVFGLS
RKAATEFSFFLAMPTMIAATVYSLFKYRDILQWSDLPIFAIGFVSTFIVAMITVRALLKF
IANHSYAVFAWYRIAFGLVILATWQLHLIDWSTAQP
>A6VRL7|FEATURES|UNIPROT_deepARG|aminoglycoside|Mmwyl1_0154|antibiotic inactivation|1
MTVKIRTIQATDAAAWSALRIEFLPEIKDISQAEVNAFFLGSYPNVQEVLVALDDNQHMI
GFIELNLRDNVPGSSQQTTPYIEAWFVSPDCQGQGIGKALIEAAEQWAKQQGFQELGSDA
PISNKKSVNLHKQLGFNEIERVVCLLKPLT
>BAH65231|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKPPAHEGQGSGRLSLIHILLGMIPAVVMGLIFHDTIKSLFNPV
NVMYALIVGGVLLIAAEVLKPKQPRAVGIDDMTYRQAFVIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSIGFLNMGDVPMFAVGFVMAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>R7M264|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSENLIAVLLGIVEGLTEFIPVSSTGHMIIVGHMIGFEGNLAKIFDVVIQLGAILAVLVL
YKERFARFLTKEGWQLGNGLTGWHIAAGCVPTMAFAFLVHSFIKKYLFSPATVAIGLVLG
ALLMIYAEHRIKGHEKELVQDVDHISIRQALYIGFFQFLSLWPGFSRSGSTMGGALLVGV
NRKAGADFTFIMALPIMVAACLFELLKNLAGLSAGDLTVLAIGFVTAFVVGYLSIVWFMK
FLQRSTLTAFGIYRILLALVTVWYFYL
>A0A0A0Q9J6|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-5|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPRRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A1HTG6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHENWIAVIIGIVEGLTEFLPISSTGHMILAGSLLGFEGEKASVFEVFIQLGAILSVFIL
YRDKFLQMLDIRRLRITGGLSAAHVAAGILPVMAVGYLLHKPIKTYLFSPFTVIVGLVAG
GVLMLVAEKLARRPVTRDVEDITLQQAFLVGLFQILSLWPGFSRSGSTIAGGLFFGLSRK
AAAEFSFIIAVPLMLVACLYDLLKIWDKLNMGDIQLFAIGFVTAFVVAYLSIVWFLGFLN
KSSLAAFAYYRFILAGLSYYYFFLR
>J8GWV0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSTTDIPLFATGFITAFVVAMFAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFFIM
>A0A0M9HII9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGLQALLDAGYEIAAVYTHADDPDENTFFGSVARLCARHGITVHA
PEDPNHPLWVERVAKLAPDFIFSFYYRQLLGEPLLACAKKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHQMVKRADAGPVFAQQRVPISTTDTALTLHGKLREAATDLLSETLP
LLAQDRLSGTPQDESRATCFGKRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCTVGDN
KLIIWAADLELRNDGEAPGTVISHDPLRIACGEGSLVIRAGQRGDAGLYLSGAQLAREFG
LVEGSQLLDTQKRRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TQPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDESFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGKGYQDVSHRKPSIANARQLIGWTPGIELSTTIGKTLDFFLREAMIEKA
DQR
>J4TUQ2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIEKLNKYFGTGENQAHILKDINLSIDQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGVCRIDGKETIAMNADELSNLRQRKFGFIFQRYNLLAALNANENVALPAVYAGMPSRER
KAHADALLDKLGLKEKTQNRPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSGE
TVLEILQDLHREGHTIIMVTHDPNIAATASRVIEIKDGRIIKDERQQPYQHQQKLTKGEY
RAPRFWDQLVESFKMATSAIMAHKLRALLTMLGIVIGIASVISVVALGRGTQQQVLSNIN
SLGTNTMTIMNGTGFGDRRANLTKNLTVSDAELLNKQGFVDSTTPLSNLSATVIYGNTNV
TGSVNGVGEQYLNVKGMKMVSGRFFNDSEVKEAAQVVVIDANTQKDLGIIAPVEGKVILV
DKKPLKIIGLAEESNNMHQTSLKLWTPYTTLMQRISGEKHIDSLTVKVKDEVESQTAEKS
VISLLSAKHGKKDFFIMNSDTIKQTITSTTNTLTLLISSIALISLVVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQRNILQQFLIEAILICLLGGVIGILLAGTIITLFNTLGSNFKML
LSLESVVLAVFFSTLIGVVFGYMPAKNASKLNPIVALSQE
>B3E171|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHDLWPTILLGIIEGLSEFLPISSTGHLLVAEHWLGERSETFNIFIQLGAVLAVCLIYKE
RLSSFLFLWKDREKLPYFLKLSVAFIITSILGLWVKKMGWELPKDLGPVIIAIFGGAFWI
YFTEKVSSQRQSFVEEISWPTAIAVGASQVVAGVLPGFSRSAATILMAVLLGVSRPAATE
FAFLLGIPTMFAASLFAWIEETHFLKNPSLDSPLTLATGFCVSAVVAFISVKWLLSYIQT
HTFIPFVWYRVGLGFFLIALVALGWKTQ
>I3Y8Q4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDWPLLLKALILGIVEGLTEFLPVSSTGHLIIVGSLLDYTDEQSKVFKIVIQLAAILAV
CWFYRKRIVQVTLGMWNREPERRFAINILIAFLPALVLGVFFHHAIKTYLFNPLTVAGAL
IVGGLIILYVERRPRKVRFESVDDITWREALKVGFAQTLAMFPGVSRAGATIMGGLVFGL
SRRAATELSFFLAIPTMLAATVYDVYKARDLLVMDDLSVFAVGFAAAFVAAALTVKTLLR
YVSNHSFEVFAWYRIGFGLLVLITAYTGLVEW
>A0A0M3G2R6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|AAX16_03865|antibiotic efflux|1
MNIIEIKDLNRYFGEGENRVHILKNVSLNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
NGSYKINGKETIELSKDQLSDLRSQKFGFIFQRYNLLSSLTAAENVALPAIYAGMSQEKR
LSRAKQLLEKLGLGDKWQNKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGQ
NVMEILRQLHAEGHTIIMVTHDREIAASANRVIEIKDGEIIGDTQKEAVKSAVENPTKSK
PHFGFSKDQFVEAFRMSVSAIIAHKMRSLLTMLGIIIGITSVVSVV
>M3DBP6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPSPHTPSVREFRLTDDRAGPYGITAGPDGALWLTLVHRGGVARLGLDGAYEEYALDPAD
CRPTVIAPGPDGALWFTRLQDHRIGRVTVGGLVTSFALPTPDGGPYGITAGPDGALWFTE
TAGDRIGRITVDGEVTEFALPVEGGFPSAITTGPDGALWFTLNGANAIGRLTPDGGTAVR
PLPTDAAGPVGIAADGRAVWFTEIAAGRIGRITPDGRITEYPLPDRAATPHAVVAAADGE
CWFTEWGTGRVGRVTEAGEITEHALPDPSCEPHGITVGPDGALWTALETGGVARVERPLP
>A0A0N0JDF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLIKAAIMGVVEGLTEFLPISSTGHLILTGSLLNFTGETVKVFDVAIQTGAMFAVI
WEYRVRLLGTVRGITHDPIAQRFARNVIVAFIPAAVFGLLLGSMVKAHLFKPVPVAMAFI
VGGLIILWVERWHRQKYGDRDLEGARRARVETVDDMNTLDALKIGLIQCLALIPGTSRSG
ATIIGGMVLGFSRKCATEFSFYLGIPTLMAAGAYSVLKQRHLLSMADLPMFAVGLVMAFF
SALLCIRWLIRYVSTHDFTLFAWYRIVFGLIVLATAYTGVVTWAA
>S9TFS2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSAYFDALILGLVEGLTEFLPISSTAHLLLVGDMLGFQGPPGKTFEIVIQLGSILAICVV
YWGKLWSVASSLNQPGSRAFVRNIVIAFLPAGIAGAFLYKYIRQLLDTPVVAAVALIVGG
FIILLIEKMVHKPLVHTVEDISPRRALAIGACQVLAMVPGVSRAGATIMGSLLLGVDRRT
ATEFSFFLAIPTMIGASVYSIYKNWADLSFDNGALIAFGFVAAFLAALLVVRSLVVFVGR
HGFAPFAWYRIVFGGTMLVLLLSR
>G5IUJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANFIKAILFGIIEGITEWLPISSTGHLILADEFIGLKVSPEFMAMFNVVIQLGAILA
VVYLYFHKLNPFSPTKNALEKRDTWTLWSKVIIAVLPSVIIGLPLDDWLDAHFYNFLSVS
IVLIIYGIGFIVVEKRNKNKEPKCTDLNKFTYKAALIVGMFQVLALIPGTSRSGATILGG
IMIGASRFVATEFSFFLGIPTMFGASALKIFKFLKDGNAFDLQGTVILLTGTIVSFIVSV
LAIRFLMNYIKRNDFTFFGWYRIVLGAVLIVYWLVSL
>A0A132EVX7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNVTRFVATLLVAGCAAATAGRAAAFTPDDVRQAVDRTVAPLMKQYEIPGMAIGVIAD
GRPHVFDYGVMSTQTGQPVAADTLFEIGSVSKTLTATLAADAQERGELSLTDPVSRYVPA
LQRRPFGRVTLVELGTHTAGGLPLQVPDTIRDEARLMRYLEAWQPAYAPGTRRTYSNVSV
GMLGWITAKAAGGDFSTLMTQRLFAPLGMTHTYIDLPDARMANYAQGYAKDGKPVRMTGG
ALWREAYGVRTTAADLLRFVQANLGRADTPPQLRRAIERTHAGYVRAAPLTQDLIWEQYP
YPVALPTLLEGNGMKMIVDATPASELKPPQPPRQDVWINKTGSTNGFSTYVAFIPAKRVG
IVMLANRSFPNDARVEAAYRILASLVDGR
>A0A0C1Z8C8|FEATURES|UNIPROT_deepARG|beta_lactam|H735_14730|antibiotic inactivation|1
MKKLFLLLGLLVCSSATYAAKLNEDLSAIEDHITGRIGVSVWDTQTDEKWDYRGDERFPM
MSTFKTLACATMLKDMDSEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRIEHACEAAML
MSDNTAANIVLRSIGGPHGVTRFLRSIGDKATRLDRFEPRLNEAKPGDKQDTTTPNAMVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAM
IWKENHKPVYISIYITETDLSLQARDQVIAQISQLVLDEYKNI
>A0A0J6HMB7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVATALV
VGGIVMLWAERRQHEVHAESVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRNLFVPADFPVFAIGFITAFIFAMIAVRALLIF
IASHSYATFAWYRIAFGLVILATWQFGWVDWTAVKP
>F4C7Z4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLIEAIILAIVEGLTEFLPVSSTGHLIIATALMGIEPSAFVKLFTVAIQLGTILSVVIL
YFKRFFRSWSFYLKLFVAFIPAAIFGLLFSDEIDNMLESPMTVAITLVLGGIVLLFVDKW
FNAPRIDNSDNISYATALKIGFFQCLAMIPGTSRSGATIVGGMAQKLSRKAAAEFSFFLA
VPTMFGATAKKLLDFYKDGNQFTADQYNILFIGNLVGFIVAIIAIKSFIGYVTKYGFKAF
GWYRIIVGGIIIVMLLSGHSLSVL
>P0C071|FEATURES|UNIPROT_deepARG|multidrug|mepC|antibiotic efflux|0
MTKSLLSLAVTAFILGGCSLIPDYQTPEAPVAAQWPQGPAYSPTQSADVAAAEQGWRQFF
HDPALQQLIQTSLVNNRDLRVAALNLDAYRAQYRIQRADLFPAVSATGSGSRQRVPANMS
QTGESGITSQYSATLGVSAYELDLFGRVRSLTEQALETYLSSEQARRSTQIALVASVANA
YYTWQADQALFKLTEETLKTYEESYNLTRRSNEVGVASALDVSQARTAVEGARVKYSQYQ
RLVAQDVNSLTVLLGTGIPADLAKPLELDADQLAEVPAGLPSDILQRRPDIQEAEHLLKA
ANANIGAARAAFFPSISLTANAGSLSPDMGHLFSGGQGTWLFQPQINLPIFNAGSLKASL
DYSKIQKDINVAKYEKTIQTAFQEVSDGLAARKTFEEQLQAQRDLVQANQDYYRLAERRY
RIGIDSNLTFLDAQRNLFSAQQALIGDRLSQLTSEVNLYKALGGGWYEQTGQANQQASVE
TPKG
>D3AIH3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIIETLKVIVLGIVEGFTEWLPISSTGHMILVDEIIHLKQPEDFKNMFMVVIQLGAILA
VVVMYFHKLNPFSPTKKPAQKRATLELWSKIILACIPAAVIGLLIDDIMEKYLMNGYVVA
ATLIIYGVLFIVIENANRNRNFEMQRVGDISYQTALYIGLFQLLSLVPGTSRSGSTILGA
MILGCSRGAAAEFSFFLGIPVMFGASFLKIVKYGLHFTGPQVFYLLLGMVVAFIVSVYAI
RFLMGYIRKHDFKFFGYYRIVLGVIVLVYFGITALIG
>A0A0R3AG42|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDNSAQLLEDA
AAEEGSHVVAVILNRNYGQHAAIMAGFEQCRGEVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGVLFAFALIVMRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPTPVVVVDGLVSSHTSTSPSDQVQS
>A0A127PZZ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLVEGFTEFLPISSTGHLILAGSLLDFTADIGREKAEVFEIAIQAGAIFAVCWEYRARI
AAVLRGLPSDPKARKLVLNLVIAFIPAAILGLLFSKMIKEKLFAPLPVAIALIVGGFVIL
WVERRNKTHGSVARVDSVDDMTALDALKIGFAQAFALIPGTSRSGATIIGGMMFGLSRKA
ATEFSFFLAIPTLFAATIYSLYKDRALLSASDIPLFSIGTVAAFVSAFLCVRWLLRYISS
HDFTAFAWYRIVFGLVVIVTGYAGWVSWVH
>A0A0V8JP04|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIIVAIILGIVEGLTEFAPVSSTGHMIIVDDLWLNSKELFSPEVANTFKIVIQLGSIL
AVVVLFRNRFINLLGLNRKNEKYEQVTNRLKLSQVIVGLLPAAVLGFLFEDFIDKHLFSL
NTVLVSLIAGAILMIIADRFASRIPKTETVDQMTYRQAIGVGLFQCIALWPGFSRSGATI
SGGVLLGMSHRAASDFTFIMAVPIMAGASGLSLIKNWQYFTIDALPFFIAGFISAFIVAL
VSIRFFLKLINRIKLVPFAIYRIVLAVAIYLVFF
>A0A120HUS1|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDXLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLI
>A0A0E1APP2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRDTRFSCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTTTLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>U2TFP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFADIIKVFILSLVEGLTEFIPVSSTGHMIIVDQFLQLSQNEEFANAFKIIIQLGAILSV
VVYYWKRIVPFAKGLSKSQRADIIQMWIKIVIAVLPAVVLGLLFDDIIDKVLFNSVVVAI
MLVIYGVILIWLESRKKKEGGIASITQMSVKTAIGVGLFQCLAMIPGTSRSAATIIGGVL
LGLNRVLATEFSFFLAIPTMLGATLLKLVKLGTALSGYEWFLIALGFVLSFVFAYAVIKV
FMDYIKKHDFKVFGYYRIILGIIVLVLYFMGAIK
>AAK28907|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmX|antibiotic target alteration|1
MSAYGHGRHEHGQNFFTNHKIIKSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAV
EVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAW
TDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRR
VGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLP
PRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR
>A0A127SH64|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMAQLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAQTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVY
DAMR
>R5NPH0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNIIKAIVFGIIEGITEWLPISSTGHLILAERFLGFEGLSAGFWDMFEVVIQLGAILAV
VVLYFKNIWPLKYRESKHGGRELKFDKDILNLWGKIIVACVPAILIVVLKLDEWADVHFY
NPTCIAIMLIVVGIAFLVIESTKRKEPRVNSIKDLTYKDAIIIGIFQIIAGLFPGTSRSG
ATIIGALLIGISREVAAEYTFYLAIPAMAGASLLKVLKFGLAFTSQELIALIVGTFISFI
VSIVVIKFFMNYIRKHDFKVFGWYRITLGIIVLILVATNIMC
>E7SK77|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYRQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0F3KKY5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLLLKAAILGIVEGLTEFLPISSTGHLILAGELLKFNDERGKLFEIVIQSGAILAVI
WEYRARIAAVVGGARHDAAARRLILNLAIAFCPAAALGFLFSKAIKAHLFNAPVVASMFI
IGALVIMWAERRQHSIRVQTVEEMSPLDALKVGCAQAFALVPGTSRSGATIIGGMLFGLS
RKAATEFSFFLAIPTLIIASLYSLYKDRALLAADDLGIWAVGLLFSFVSAFFCVRWLLRF
ISSHSFMVFAWYRIVFGIIVLLTWQYGWVNWVDS
>A0A024EIF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP2|antibiotic target alteration|0
MVEGLTEFLPISSTGHQIIVADLLGFGGERAMAFNIIIQLGAILAVVWEFRRKILEIVTG
LPTQRNAQRFTLNLLISFMPAVVLGVLFADKIHEYLFNPITVAVALVVGGIVMLWAERRE
HRVYVDHVDDMRWTDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAM
PTMVGAAVYSGYKYRDLFQAGDLPVFTLGFVTAFFFAMIAVRGLLKFIASHSYAAFACYR
IAFGLVILATWAFGWVNWTEAAAF
>A0A031JKF4|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVVIQLGAILAVVV
LYWRTFWAVALGLLRKEPASWRFLRNLLIAFLPSAVIGLALHDFIETLLGAPKVVAWALI
IGGVAILLIERMVKENRFHGIADIPMARVVGIGFIQCISMIPGVSRSGATIMGALALGVE
RRTAAEFSFFLAIPTMLGASTLELLKKGDQITSATVGWGSIGLGFLVSFIVALLVIRWFV
GLVSRHGFAPFAWYRIVAGAAALLWLTMR
>F3DX96|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQWNGTLFCTGLLLVSSVTFAEDNAAALDTLVQTEARKVMQENNIAGLSIAITLHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTQNIDTYLPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPENVQNTRQLMDYFKAWQPDYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQRRLFPALGLNSTYVSVPDEKQALYAQGYNKLDEPVRVSPGILAAE
AYGVKSSSRDLIRFVEANIGLGQHDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPIRL
DMLLAGNASAMLNTQKAEAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAERQIGIVILAN
KNYPNEERVKLAYRILQHAAPFN
>H7E610|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTAACESLDKAWEILLIDDGSSDSSAELMVK
ASQEAGSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLCCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSVMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPYTEESHQ
>J8B6V1|FEATURES|UNIPROT_deepARG|beta_lactam|IEI_02596|antibiotic inactivation|1
MNLLLVFSIENLKGMMILKNKRMLKIGICVGILGLSVTSLEAFTGGSLQVEAKEKTGQVK
HKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQN
SIDTLNEVIKFTKEDLVEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFNKIGGPK
GYEKALRQMGDRITMADRLETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNI
LTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKD
EKEATYDNQLIAEATEVIVKSLK
>A0A145AGJ8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGISCSALAAPVSEK
QLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSIS
KTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVT
DNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYEQAMTTRVLKPLKLDH
TWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADA
SLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPVAEVNPPAP
PVEASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ
>Q3LG63|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKEPLKR
>V8KEK8|FEATURES|UNIPROT_deepARG|beta_lactam|V415_06780|antibiotic inactivation|1
MGFLRSGCYPDSCHADWCRYNLTHRQCKSGPPMAGRFVWKPDPMFKMTLCALLITASCST
FAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQP
LKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPL
DITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKAI
TPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>A0A009Q434|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESKQFEHKTDDATKITFKQALLVGLVQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMVNIGVGFVAAFIAALLVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>A0A0X1T7Z3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSAAQALILGIVEGLTEFLPISSTGHQIIVADLLNFGGERAIAFNIIIQLAAILAVV
WEFREKIFTVIRDLPTQRTAQRFTVNLLVAFMPAVILGVLFKDLIATYLFNPITVATALV
VGGLVILWAERREHVVRAESVDEINWKDALKVGFAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGYGFRHQFQMADLPVFAVGFVTSFVFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLVILATWQFGWIDWSSEG
>CAD11594|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFSEIPSNFRPVFTQDFASNINYSYQIWQKG
>G3ESU4|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-25|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVSGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>R8ESV7|FEATURES|UNIPROT_deepARG|beta_lactam|IKK_02337|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNKS
>A0A062G317|FEATURES|UNIPROT_deepARG|beta_lactam|J530_3011|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNRGP
LDAAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFS
YPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVM
LTNKRIPNEERIKAAYAVLNAIKK
>A0A0H0DBG6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGTLALLEAGYDIAAIFTHPDTAGENHFFSSVARIAAERGIPVYAPD
DVNHPLWVERIRALAPDVIFSFYYRNLICDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVHRADAGAIVAQHRVAIDADETALQLHQKLCTVAQSLLRDALPAI
LNGTFSETAQDESKASTFGRRTPEDGRLDWNQPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEEALEIITGQTDSGLYVQGMQLAQSLGLVA
GALITSAPVVAVKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGQIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQVS
>A0A0X8F8Z1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMLAIIKIIIMGIVEGITEWLPISSTGHLILVEEFLAMDLRPEFWNIFVYVIQLGAILA
VVWIYFDRLNPFSSHKDAHQKRTTWETWFKVVIGCVPAGVIGLSLNDYVESHFQNWLVVA
LALILYGITFILVENRNQGRTAPIQNIQDLTYTKAFQIGLFQALSVIPGTSRSGSSILGA
TILGTSRPLAADFSFFMSIPIMFGMTVLKLGKAFLKGFHFTGAELSLLILGVVVAYVVSI
LTIRFLLHYIQKNDFKVFGWYRIGLGLVVVLYFAFFAA
>A0A142NDP7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIVKGLPTERNAQRFTLNLLIAFFPAVILGVLFADAIHEYLFNPITVAVALV
VGGIVMLWAEQRSHVVSVQHVDDMRWSHALKVGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPNDLPVFALGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIGFGLLILATWLFGWVNWTAAAAA
>CAO82964|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSQIDKVRYMFNKIT
>A0A0N0C5G1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIEGLTEFLPVSSTGHMILTAHLLGLSEDNESVKTFEVVVQLGAVLAVVVLYWNKFID
MFRFTGGKRSYTSRLNLIHIFLAMVPAVVIGLVFRDWIKAHLFGAQTVLYSLVIGGILMI
VAERWSHRSERITTHDVDDITYKQAFVVGLFQILALWPGFSRSGSTISGGLFAGVSRVAA
AEFTFLVSVPIMIGATGYDLYKSIDHLNTSDLPIFAIGFIAAFIVAMLAIKTFLSILKKL
SLTVFAVYRFVLAAVFFFILMM
>J8INA8|FEATURES|UNIPROT_deepARG|chloramphenicol|III_03076|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMMLEEIHQKEIKFYPTFIYVISRV
INKHTEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGFFTKENIPPNFFSISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDGSRVM
LPVSLQVHHAVCDGYHASRFIEDLQELANTCNEWLK
>S0RV74|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIANIFKAIILGIVEGITEWLPISSTGHLILADEFIKMNMSAAFTEMFNVVIQLGAILA
VVVLYFNKLNPFSSSKSHQERNDTWTLWFKVIIACLPAAVIGLPLDDFLEAHFHKFLPVA
IMLIVYGIAFIVVERHNKTKTPKCTNLNDFTYKAALIVGAFQLLSLIPGTSRSGATILGA
IIIGSSRFVATEFSFFLGIPVMFGASGLKIVKFLLNGNSFGISEIVVLLVGMVTAFVVSI
IAIKFLLDYIKRNDFTVFGWYRIVLGIILIGYWLIAM
>YP_316450|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADLTQILHALILGFVEGFTEFLPISSTGHLILAGQLLGFNGEKAKVFMIAIQLAAILAV
VWEYRVRLRHVVSTVHTEPASRRLVVNLMAGFLPAAVLGFLFYKEIKGYLFNPIVVASAL
VIGGVLILWAERRKHVVSTPTVDDLGWRRALAVGFAQALAMVPGTSRSGATIIGGLFLGL
SRKAAAEFSFLLAIPTMFAATAYDLYKNWQLFDAGDIPLFAIGGVASFASALFAVRTLIK
FVSRHDYTVFAWYRIVFGGVVLATAYSGLVDWGVTH
>A0A127SUW3|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYVVTTILN
RHEEFRTSLDKNGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAY
GERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYHIP
LSIQVHHAVCDGFHICRFVNELQELINS
>W0LIX9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELSGIRRSYLSGEQTVDVLKDVSLSIEAGEMVAIMGASGSGKSTLMNLLGCLDKP
SAGIYRVAGQDVATLNNDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKSA
RRERAIALLQRLGLGDRIAYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLCEQGHTVIIVTHDPAVARQAERIIEIRDGEIIADSHSATQGHAPAKTLEL
ASPAASWRQMFGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPIYRQALKYSDLEALREQPYVSALSPKISSSMRLRF
GNIDVAANVTGASEQFFRVYGMTFTQGTGLDPLQVQSHAQVVVIDANTQRRLFPYQNNVV
GEVILVGNMPATVVGVAKEKQSMFGSSQTLNVWVPYTTMANRLVGKDSFDSITVRILDGY
NSQEAEQQLTRFLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGIALSFAIGLLVQS
VLPGWQISFPPAALLSAFLCSTGIGVVFGYLPARNAARLNPIDALARE
>A0A0R2F9V9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDLLKSLVIGIVEGLTEFLPVSSTGHIIIAESLMNIPGGSVWTKSFTAMFDYAIQLGAI
FAVIQLYFHKLNPFAPSKSTIEKKQTWTLWFKVIVGVLPAVVAGLALNDYMDAHWLNAWV
VASMLIIYGILFIVVERYLANKDAWLTDLNTMTFKMALFIGLFQVLSIVPGTSRSGATIL
GALILGASRFVAAEFSFFMSIPVMFGVTILKVGKYLLDGGSFTGAQAGVMAVGFIVSWIV
AYFAIKVMMNYIKNNDFKVFGYYRIVVGIVVLALGTAGMLTMH
>A1AFX9|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A127SLR9|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTVNEMPE
FRTALTEKGLGYFSEMHPAYTIFNQEQKTFSGIWTAHKSNYTAFLSSYEADVAKYSSSEK
YDPKPERPVNSFDVSMIPWFSFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKMLPLAIQV
HHAVCDGYHVGRFIELLQKKIIGFDSGFNSTPSDTSATVKDE
>A0A0E3CGA8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
SSGSYQIAGKETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKAQ
RLQRAAQLLEKLGLGNKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMQILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDQRQSLQITAHKMTQTA
TNQGWQFYRDQFFEALNMSINAIIAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
NAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
AAEKNVTALLLSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGIRMAIGAKQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMS
EFTMLFSTFSIVVAVLCSTLIGIIFGYVPAKNAAKLNPITALSQE
>M5PX05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSWISAALLGVVEGLTEFLPISSTGHLILANSLLGLSGQKIATFDVIIQLGAILAVVVL
YRRRFLGLVAPSLVQTDQDQSGLNGFAPPSSSQFAGIRGLFLLFLTSLPAALLGLASHDL
IKSNLFGPISVAWALGAGAIIILVIETVRPKSRYASLDDITPLLALGIGCFQCLALWPGF
SRSAATIMGGMILGARRTMAAEYSFIAAVPIMIAASGLELVKNLGLFTSSDMMFLATGFV
VSFFSAWAAIKFFIALLGKTTLRPFAYYRLALAPLVLLFWSTGLN
>G0PUG4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MAVSEMSVADKDAGPYGIAAGPDSALWLTFARSGRVARLTLDGELDEYSLEAPECRPAVI
APGPDGAMWFTRSQDHRIGRVTADGETESFAVPTSGSGPFGITAGPDGAMWFTEMNTDRI
GRITSTGEITEFVLPRTGACPSAITGGPDGALWFTLNQANAIGRVTVRGDIAIYRLPTPN
AAPVGITSDGAALWFVEIAAGQIGRITVDGAIEEFPLPDRTAKPHAIVAASTGDCWFTEW
GANSIGHITGSGEITEYGLPSPSSEPHGITLGPDGALWAALETGGVARLEP
>O54281|FEATURES|UNIPROT_deepARG|beta_lactam|mecI|antibiotic target replacement|0
MDNKTYEISSAEWEVMNIIWMKKYASANNIIEEIQMQRDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>A0A066P3G6|FEATURES|UNIPROT_deepARG|chloramphenicol|AF34_02999|antibiotic inactivation|1
MTKITPEYTAVDLSSWARKEHFEVFQSFAQCTINQTVQLDITALLKHIKQVGWKFYPSII
SLISTVVNRHSEFRMAMKNNELVIWNEVHPSYTLFHKETETFSSLWSHFDGNIHHFQNVY
AEDVSLYGDNLAYWPKEEYRENIFFISDIPWVSFTSFNINVANMQNFFAPMFTFGKYFNQ
DGKVLLPFAVQVHHSVCDGFHVARLINELQELCDNLPHY
>D1PRP4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEILFDLLRSVVYGVIEGITEWLPISSTGHMILAEQVLKFSFDEEFMSMFRVVIQLGAIL
AVVVLYFKKLWPFCADNGRDSGLAKHLRWPVVRLWLKIIVACLPAAVLGFLLDDWLDAHL
YNSVVVAIMLIVYGVAFILIERRPRVPSTTKLSRITYKQAILVGAWQVLAMIPGTSRSGA
TIVGGLLCGMSRPCASQFTFFLAIPVMAGASGLKVVKYVLGGSSFTMPEVLALIVGCVVA
FLVSMAAIRFLMNYVKKHTFTAFGWYRIALGIVVLGIWIAQTALAA
>A0A0M0VZC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFITSIILGIVEGLTEFIPVSSTGHMILTTKVLGYDDQTPMMKTFEIVIQLGAILAIAI
VYWNRILNLLGWSRSEPLNKKESRKRLNLIHILLGIAPALLVAYFARDFIKSLFHVQTVL
FALVAGGIFMIFAEWFNKHKVQVTSQELDDMTYKQALQIGIYQIISVLWPGFSRSGSTIS
GGMLSGVSYKASADFSFIIAIPIMCAASGYELLDSYRYFTSETVGVFLTGFIVSFVVAYF
VVLAFRKLIQKIRLTHFAIYRFVLAAIFWLFIMQ
>A0A0Q4J1U4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTELLTVILLGIVEGITEFLPVSSTGHLILATRLLGYDAGRWEVFNVVIQLGAILAIVVL
YWRTFWAVGMGLFRREPKSWLFLRNLVVAFIPAAVIGLALHKYIEALLGNAEVVAIALVV
GGFAILAVERFAPRSDISGVADIPLKTVIGIGFLQCLAMIPGVSRSGATILGALALGVER
RTAAEFSFFLAIPTMLGASALELLKNRDAIASGGGVGLGAIAIGAAVSFIVALLVVKWFV
GIVTKHGFVPFALYRVVAGSAALIWLLSK
>A0A0K6IRK0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPERGHSWGILPVSGISWWEAAVLGMVEGATEFLPISSTGHLIIVQDLLGHTDEASKVFN
VAIQLGAILAVCWYYRDRLWRVTQGLGHDPAARRFVLNLFVAFLPAALIGLVAHKAIKTY
LFSPLTVALALALGAVLIFVVERWRPALRIQSVDDMRPADALKVGFAQSLALIPGTSRSG
ATIIGGMAFGLSRQAATEFSFFLAIPTMFAAVLYDLAKSWSALSRDDLTAIALGFAVAFV
SALAAVRFLLGFVARHSFVGFAWYRLALALVVWAYFAV
>A0A029LD78|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVM
YALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDTPMFAVGFITAFVVALIAIK
TFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>C7D1L0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLDLSKDFMEMFNVVIQLGAIMA
VVILYFHKLNPFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDYLDAHFYNFLTVS
IMLIVYGIAFIIIEKRNKNIAPKCTNLKDFTYKAALIVGAFQVLALIPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASFLKIFKFLAKGNTFGSEEIIILLTGSIVAFVVSI
IAIKFLLNYLKKNDFTVFGWYRVILGAILIGYWLFS
>A0A0Q9EE32|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVVIL
YFKRFFQTFDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAISLLIGGIILLKVDEW
FNKPNDPEVSTEITYAKAFKIGLFQCLAMIPGVSRSGASIVGGMSQKLTRTSAAEFSFFL
AVPTMLGATAKKCYDYYKAGFELSHDQINMLVIGNIVAFIVALLAIKTFIGFLTKNGFKV
FGYYRILAGIILLLIHFFIHPLTII
>H0RYG5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSDTLRAVLLGIVEGVTEFLPVSSTGHLLLAERFFGLGEDGFWKSFAILIQLGAILAIV
ALYFFKLTRVAIGALTNPDDRRFIIGVLIAFLPAVIIGLIAGKYIKALLFDPWVVCFSLI
VGGAILLWVDQIDLKPREHDATRYPLLMYLWIGVAQCLAMIPGVSRSGSTIVAAMLLGGD
KRSAAEFSFFLAIPTMVGAFVYDFYKSRAEMTTDHLGLIAIGFVVSFITAMIVVKAFLGY
VTRHGFVLFAWWRVIVGTLGLIALALGK
>A0A0D7LJQ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLVFHDTIKSLFNPIN
VMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLSASDLPMFAVGFVTAFIVALVA
IKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>A0A0A3HTZ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFFDLMKAIILGFVEGMTEFAPVSSTGHMIIVDDLWLNTKEFLGSGSANTFKIVIQLGS
ILAVVFVMWKRMLSLVGLYKIKGQTASRKFNLGHVIAGIIPAGVLGVLFEDFIDENLFST
NTVIIGLIIGAIWMIIADRFGERKTMITSLDDISYGKAFKIGLIQCLSLWPGFSRSGATI
SGGVMLGLDHKTAADFTFIMAVPIMAGASGLSLIKNWSDLEPSHTGFYILGFISAFVFAL
IAIKFFLRLISKVKLVPFAIYRIVLAVVLIVVLYL
>D2T3V0|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MTERAIEKVSVVIPVYNEQQSLPELMRRTDAACAQLALDYEILLVDDGSSDDSAALLTAA
AEAPGSPVVAVLLNRNYGQHSAIMAGFSHASGDLVITLDADLQNPPEEIPRLVATAQQGY
DVVGTVRQNRQDSRFRKFASRIINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERS
TFIPILANTFARRTTEIPVLHAEREFGDSKYSLMRLINLMYDLMTSLTTSPLRLLSVFGS
IIALSGFAFSLLLIALRLFLGAQWAGDGVFVLFAVLFIFVGAQFIAMGLLGEYIGRIYND
ARARPRYFIQRVVSRNADSIKEQKS
>A0A100JD76|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb_2|antibiotic inactivation|1
MPLHITEFPVPDPESGPYGITLGPDGALWFTMVHSGHIGRLTPDGDVTTYPLDTPGTGPT
VITPGPDGALWFTEFRGHRVGRITVTGEVTSFPLPTPDAGPFGIVTGADGAVWCTEANAG
RIARITPDGTVTEFPLPDAGAFPSGIAAGGDGRLWFTLNQANAIGAMTYEGEVTVHPLPT
PNAGPVGITAGLDDAMWFVEIGAGQIGRIELTGDIREFPLPDPTARPHAITAGPDDAYWF
TEWSSNGIGRITPKGEITSSPLPTASSEPHGITLGPDGALWTALETGTIARLTPTTKGS
>H3SMI3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVYIWIAVILGIVEGLTEFIPVSSTGHMILTTRLMGIAEQEDFLKTFEIVIQLGAILAIT
VVYWQRILAMLGLRSRTVAQGHVRTKQLNLLHVALGIGPALIVAFFARDYIKSQFDNTAT
ILWALVAGGVFMWIAEWFGSRRKPAAETMDDITYLQALLIGLYQILSVVFPGFSRSGSTM
SGGMLSGVSYRAAADFSFLMAIPIMFLASGYELIDGYRMLTLDIIGFFALGFIVSFIVAY
LVVVTFLKHIQRIRLRHFAIYRFVLAGLFWFFIIR
>A0A0A8HJ86|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MILLKNISKKINGVAILDNVSLRICKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGEYFL
DNYDVNKASKDEKARLRREKIGFIFQRYNLLNLLNAKENVALPAVYAGKNKNERLKKAKE
LLSFLELDHKEFSKPNQLSGGQQQRVSIARALINGGELILADEPTGALDSKSGKIVLEIL
TKLNEQGHTIVLVTHDPCIAAMAKRVIEIKDGKIIKDSNPKELINPDKKIMSKERKSFSL
LKNQIIESFKMSIAAIIAHKLRSLLTMLGIIIGIASVVCVVALGLGAQQSILASISSIGT
NTIEVVSGRGLGDIRSGKTRLNLSDLKTLSSLPYLEAVEADVGKVGVVTYKSNSLQARIY
GVGPNHLKLRGLVMVDGRFINYEDINDNTNICIVDENALRILFENANARSVLGKSIIFNK
QPLTIVGVLKRERDNKGFRADENTIKIYTPYTTLMNKITGDKQIRAIVTKVKDEVNPSLA
EEAMIKILEIKRGQKDFFTINSDAIKNAVEENTATLTLLVSSIAVVSLIVGGIGVMNIML
VSVSERTREIGVRMAIGARKEDILMQFLIEAVLICSFGAIFGVLLSFVIVEVFNSLGMGF
TMILSLNSIFLGLLSSVLIGLVFGFFPAKNAANLNPINALSKE
>A0A077JMT3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-159|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAKLSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>L0MBE5|FEATURES|UNIPROT_deepARG|beta_lactam|D782_4108|antibiotic inactivation|1
MFKTSLCALLLGASCTALAAPHTEQQITEIVNRVITPLIKEQTIPGMAVAVIYQGKPYYF
TWGDADVAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEISLNDPATKYWPELTGKQW
QGITLLHLATYTAGGLPLQVPDDVTTDAELRRYYLNWQPEWAPGTHRLYANASIGLFGAM
AVKPSGLSFEKAMTERVLQPLKLTQTWVTVPPAEQKHYAWGYRDGKAVHVSPGQLHAEAY
GVKSSIQDMAHWVLFNMNASKIKEKTLQQGILLAQSRYWQIGEMYQGLGWEMLNWPVNPD
TIVNGSDSKIALAALPAKAIMPPAPAVSASWVHKTGATGGFGSYVAFVPQQELGIVMLAN
KNYPNPARVAAAYQILNSLK
>G8GMB8|FEATURES|UNIPROT_deepARG|beta_lactam|IMP|antibiotic inactivation|1
TAAESLPDLKIERLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNTEAYLIDTPFTAKDTEK
LVTWFVGRGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSF
GGVSYWLVKNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPK
SAKLLMSKYGKAKL
>A0A011RP42|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKSIILGVVQGITEWLPVSSTGHMILVDEFLMLNASEAFMEMFLVVIQLASIMAV
VLLYFKRLNPFDSDKDEHQKKETWHIWSKVVVGILPAGVFGLLFEDVINDLFFNWITVAV
ALIVYGVAFILIEKRNEGKIPQIATWEQLTYKVALLIGFFQVLALIPGTSRSGATIVGAI
LIGTARPIAAEYSFFLSIPVMMGASLLKIIGFGLTFTFEEMMILLVGCIVSFVVSIFAIK
FLMNYIRKNDFSSFGWYRIAVGLLVIGYFGLIG
>A0A0Q9XU61|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MIVKIEEYELLDIDSGPYGITTGKDGALWFTQHKANQIGRMTVNGEVTHFVIPTSDAGVL
SITSTTQGEVWFTENKANKIGKLTATGEMIEYVLPCPDSAPFGITEGNNGDIWFTEMNGN
RIGRILSSGEMVEYDLPNPGSYPSFIVVGPDGAIWFTENQSNQIGRITISGEITNYLLPT
KHAGPVGITCGPDNALWFVEINGNKIGRITPSGKISEYTIPTANARPHAIVEGPDHALWF
TEWGSNQIGRISMKGEVTEYSIPTRNAEPHGITLGFDGAIWFAEECNKIGRLSLLLKS
>A0A0N9ZR54|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-62|antibiotic inactivation|1
VTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSK
VMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNV
GINK
>ZP_03917649|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmX|antibiotic target alteration|1
MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAV
EVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAW
TDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRTAFRPQPNVDGGILVIRR
VGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLP
PRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR
>Q2W724|FEATURES|UNIPROT_deepARG|bacitracin|uppP2|antibiotic target alteration|0
MLEALLLGVVEGLTEFLPISSTAHLMLIGDMLGFEGPPGKTYEIVVQLGAILAVCVVFRQ
RLWGVATTITQPRSFAFARNVMVAFLPAAVIGATLYKYIKQMLESPLVAAIALVVGGVAI
LVIERLVKRARIHDIEDMSPALALGVGFCQVLAMVPGVSRAGATIMGSMLLGLDRRAAAE
FSFFLAIPTMCGASAYSLYKNWATLSFDGAGLIALGFVAAFLSALVVVKGFIGFVGRHGF
APFAWYRIAFGSLMAVLILMR
>M8D8L4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPLSLWEAFVALILGLVEGLTEFAPVSSTGHMIIVDDFLFQTKELYSPEVANTFKIVIQ
LGSILAVVVLMWDRFMNLLGLKKMPGQSTSGPRLNLLTVLIGLIPAGIFGVLFDDYIDEY
LFSTKTVVIGLVIGALLMIAADWFRPGRPKVVTVDQITYKQALMVGLIQCLSLWPGFSRS
GSTISGGVLLGMSHRAAADFTFIMAVPIMAGASFLSLLKRWEYITFDAVPFFIVGFISAF
VFALISIRFFLKLINRVKLVPFAIYRLVLAAVIYFVFL
>A0A0J0GP88|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNNIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVARKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRESRAAAPKEALP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKASVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>CAA52967|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLRTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYTPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0L0M840|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMFKALILGVVEGLTEFLPVSSTGHLIVAGSLLDFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSVVTGLPARTDARRFALNVIIATIPAIVLGLLFEKSIKSVLFSPVPVSVALI
LGGIVILWAESRQRDRGATARVTSVDDLSYGDAFKVGLAQCFALIPGTSRSGSTIIGGML
FGFERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVDDLGLFVIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAE
>D7PIJ4|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLTKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKS
>ZP_02631430|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGIDFLFILKALIIAIVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
ILAVVVLYWRKISSSVVEFLCYIFSFIGLKASNDKRKYEKRLAESETGFRFGINVIIGTI
PAAILGLLFHDEIKEYLFSTKTVAIGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYG
QSLLVGCFQCLSLWPGMSRSASTIMGGWISGLSTTVATEFTFFLAIPAMVGASGLDLFKF
DYSQMNATNWISLILGFIVTFIVSLVVIDKFINYLKKKPMRVFAIYRVFAGIVLAILILT
KVIS
>ZP_02846059|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MIYERSSYSVMQNILTAVVQGIIEGLTEFLPVSSTGHLILSGKLLNFTGDKADTFEIIIQ
LGAILAVAVIYWRRIFNLLGIKGLSPEMAGAQQDKLPGRLNLLHIILACLPAMVLGLVLH
SFITSYLFSAYTVLVGLVFGGIFMLFGESSSKSSVQSDGVDQITYKQAVYIGLFQCLALW
PGFSRSGATIAGGLLAGVGYRAATNFSFLIAIPMMVAASGFELLKSYNTLTASDAVFFIT
GFLVAFVVALVAVITFLKLLERFKLAPFAYYRFALAAVFLVYLLVTGN
>A8HNS6|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-28|antibiotic inactivation|1
PLYALPADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVL
KKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAH
VGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGD
SQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAP
>G5D8T4|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-193|antibiotic inactivation|1
FLGHFALPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQINKTGWRRIKLLEDFCSRRFR
>ACI72896|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRKPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLALLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEEQ
>W8A5M6|FEATURES|UNIPROT_deepARG|chloramphenicol|JCM19047_1264|antibiotic inactivation|1
MTFTVINRRRWKREEMFAHYIKQKTTFSITTELQVDVLYKRVKQKGYKFYPAFLYMVTSV
VNNHVAFRMSFNQEGELGYWSHLEPVYTIFHEKTKLISGIWTSMNKHFGHFHTSYLQDAM
TYQGSQALFPKKQVPENAVSISMIPWTSFTGFNLMIHQDINHLLPIVTAGKLIEKNQSLY
LPVSLQVHHAVCDGYHASVFMNDCQRMANQAHEWLK
>ABP89888|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTEPEQW
DVVIEGNDDLLEKYMSGKSLEALELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVIT
NKFYSSTYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKP
QQREMLLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A084J0M7|FEATURES|UNIPROT_deepARG|beta_lactam|ER45_13820|antibiotic inactivation|1
MKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNTNSVVPGH
GDIGDKGLLLHTLNLLK
>AAB05627|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNKIKVAIIFGGCSEEHDVSVKSAIEIAANINTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAIFSPDRKTHGLLVMKEREYETRRIDVAFPVLHGKCGEDGAIQGLFELSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQMIEKGDKPEARTLTYPVFVKPARSGSSFGV
TKVNSTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMIIVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTLPGFTSYSRYPRMAAAAGITLPALIDSLITLAIER
>A0A086C2H6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRHATILNLCGLAASTLFFATTSAFATAAPAERLKALVDAAVQPVMKANDIPGLAVAITL
KGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWP
ALQGSRFDGISLLDLGTYSAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNP
SIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDRPLRVG
PGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPIDLKRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRD
VGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR
>A0A118E228|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLESTQFVIKMWLALSCCIASVAHAARGVEPADVERIVDAVARPLQDKYGIPGLAIAVTV
DGRHYFYNYGVASKATRQPVTDRTLFEIGSLSKTFTATLAAYAQQGGELSFADSVSRYLP
ALQGSSFDRISLLNMGTQTSGLPLFVPDRITNTAELLDYLKNWRPAHTPGTHRVYSNLGI
GTLGVIAAASMNERFETLIEKNLFPELRMTHSYIDVPAEQSGNYAQGYTKQDAPIRLKAG
MLASEAYGVRSCTSDLIKFIDANMGLVPLSDKWARALDATHVGYYDAGGMIQSLIWEQYP
YPVSLGELLAGNDLIGKDVVAKPFNPPLPPKQDAWINKTGSTNGFSTYAAFVPSRKVGVV
ILANKSYPLSERVTAGYKIVDSIVRAER
>A0A0J1LG61|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSHIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDSQVAAQAERVIEIRDGEIVRNPPPQKPSGGRDIAEPT
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPNKAKVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGILKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGVLFGWLPARNAARLDPVDALARE
>A0A0R2LHQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIKSIILGIVEGITEFLPISSTGHLVLVDEFIKMQQPKQFTDMFNVVIQLGAILAVVV
LYFHKLNPVSPKKSSQEKKNTWSLWFKVIVAILPSAIIGLPLNDWMDEHLMNWAVVSATL
IIYGILFIVVENRNEKKKSDLQAKYANLDSLPYSIALFIGMFQVLSLIPGTSRSGATILG
AILIGTSRYVGTEFSFFLAIPTMFGASLLKIVKFFGQGGSLGGEQGIILLVGMVVSFVVA
YLSIRFLMNYIQNNDFKAFGWYRIILGALVIGVNLFLL
>A0A0A8BM90|FEATURES|UNIPROT_deepARG|beta_lactam|NA29_04535|antibiotic inactivation|1
MAFSARSYAAEAGAQVQTNPRQDEIKSLVDKTIAPLMARQDIPGMAVGIVFDGQSYVFDY
GVADKATNKPVTDDTLFEIGSVSKTFTATLATYAQAAGALSLTDKVSRRAPEFAGTPFGD
VKLLNLGTHTTGGMPQQVPDNVTNIDEMTQYLKAWKPAKPTGTARTYSNISIGALGWITA
RAMHGDFATLMSDHVFKPLDLKHTFIKVPEDQQANYAWGYKNGKPIRVSPGVFEQEAYGV
KTTASDLLRFVNANLGEAVHDRRLRHAIYATRTSYFFDAPMTQDLAWEQYPYPVTVETLI
EGNSTRMSMESTPARELTPPMAPAPVSWVNKTGSTSGFGTYVAFVPSKQMAIVLLANKNY
PMEERLRAAHRILTTLDGSRPAPTAPAK
>V8M0E0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQTAQYIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLG
AILAVMVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNF
FVVAIMLVVYGIAFIWIEDRNRRVDPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGAT
ILGGIIVGTSRSVAADFTFFLAIPTMFGYSGLKAVKYFIDGNTLTGGQAAILLVASVTAF
LVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLFYGAVKLIFG
>A0A0H0SH36|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MPQLQGLNHLLFSVSDLEKSFCFYRDVLHAKPLVRGRKLAYFDLNGYWLALNEEPDIPRN
EIAHSYTHMAFTITEESFDEWYAHLEKHDVTILHGRDRAERDKRSIYFTDPDGHKFELHT
GTLQDRLAYYRDEKHHMTFFE
>ZP_02903251|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYINEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMQNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMLSYIKHARSMRDIRNETGTARPDPAVMKRLVQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTSDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFIAYWVLGLPSGYILALTDLVVKPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSATILQRAAR
>A0A0M9AV03|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTNKTNMARLTVLGACVALLGAGPCLAQAQTDQQIQSTVDAAIKPILQTQGVPGMAVAVT
VNGKPHYFNYGVASKESVQAVTENTLFEIGSLSKTFTATLGAYAIATGKLSLSDKASQVL
PDLRGSAFDNVSVLQLGTYTAGGLPLQFPDEADHADKMLGYFKQWKPVYAAGTHRQYSNP
SIGLFGYLAAHNLGVPFDEAMTNTLLPKLGLTHTFLRVPPDQMSVYAQGYDKNDKPVRVD
PGALDSEAYGVKTSTADMIRYVQANLKPASLEKPLQQAIATTHTGYYTVGDMTQGLGWER
YSYPISLDKLLGGNSTPMAMEAHKVQWLNPPQPEPESVLINKTGSTGGFGAYVAFVPAKD
IGIVILANKNYPIPERIKAAHQILSALAK
>A0A0F4VNW4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDFLFILKAIIIAIVEGLTEFIPVSSTGHMILASSIIGFNDPKVFVDMFEVVIQLGAI
LAVVVLYWKKIKDSVIEFFTYIFTKGKKGKTGFQFGINVLIGCIPMGVIGIVFYRQIKML
FNPKIVVAGLIVGGILLIIIENKFRKNRKYSTKNIDSITPLQSLKVGVFQVLAVWPGMSR
SASTIMGGWVAGLSTPIAAEFSFFLAVPAMIGSTAKDLFEFDFSMMNMTLWITLIVGFIV
AFIVSLVVMEKFVAYLKKRPMRVFAVYRVGIGIIFAILMMLGMNLNM
>ZP_03993170|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYHPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A117VL82|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIVSIVTGLPSRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERGEPPRVQSVDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDALGLFALGLVAAFVSAFVCVRW
LLRFVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>R6SBS9|FEATURES|UNIPROT_deepARG|chloramphenicol|BN612_00522|antibiotic inactivation|1
MFKLIEKNTWKRKPYFDHYFGQIRCTYSITVNIDISVVMSFKNKNRTKLYPLLIYVLTKA
VNNHEEFRTAINDKGELGVWDTLLPCYTVFHEENETFSNIWTVWNDDLMTFLSNYERDME
MFGGNYGIDAKPDTPANTFPVSSLPWTTFTGFNLNIFADGSYLLPIFTYGKYFQQDDKYL
IPLSIQVHHAVCDGFHVSILIDEIQQICNSLGA
>YP_041771|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLKSINHICFSVRNLNDSIHFYRDILLGKLLLTGKKTAYFKLAGLWIALNEEKDIPRNEI
HFSYTHIAFTIDDSEFKYWHQRLKDNNVNILEGRVRDIRDRQSIYFTDPDGHKLELHTGT
LENRLNYYKEAKPHMTFYK
>A0A0B5ILT3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKPPVHEGQGSGRLSLIHILLGMIPAVVLGLIFHDTIKSLFNPI
NVMYALIVGGVLLIAAEVLKPKEPRAVAVDDMTYRQAFVIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSIGFLNASDIPMFAVGFIMAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAVVYVVFF
>R8QZI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAFLMIFAEVKKAEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVDDISMFAIGFITSFIVAMLAVVTFLKLL
EKIGLKPFAHYRILLAILFTLFVLL
>D6S600|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLINIIKAIILGIIEGITEFLPISSTGHLYLANYVVKLQENQSFIDMFMVVIQLGAILSI
IVIYFNKLNPFSLSKTKLQRENTWSLWLKVIVAVLPSVIIGLPLNDWLDEHMTNWQVISA
TLIIYGILFILLENYYRNRNAKLTDLNKISFRMAFLIGCFQVLSLIPGTSRSGATILGAM
LLGASRYVSAEFSFFLAIPTMFGASLLKIVKYVHAGHTFVGDQLAVLLVGMVVSFVVAYL
AVKFLLKFIQTHDFKSFGWYRIALGIIVIIIGVFVK
>A6UFC2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFRSPGNTFAVLIQLGAILAILL
VYFQKLLSIALALPTSVRARRFVLSVLLAFLPAALIGAAAHGFIKSVLFETPMLICVVLI
VGGIILYVIDRLPLTPRYTDVFDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMVGAFALDLYKNREALSIDDIGLIAAGFIAAFIAGIFVVRSLLDF
VSHRGFTPFAIWRILVGTAGLVGLWLLG
>G5I980|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIIEVVEILKAIIFGFIQGVTEWLPVSSTGHMILLNEFLPLRQSNEFMELFFVVIQFGS
ILAVPLLYWKRMVPWALKGGFRLKPDILLLWGKIVVACIPAGVAALLWNDEINNLFYHPY
VVVIMLIVVGILFLVVEARKREPVVHTAVELTWRAALWIGFFQMIAAVLPGTSRSGATII
GALMIGVSRIAAAEFTFIMAVPVMVGASLFKILQFGWELTWVEAVILLTGMIVAFLVSLL
VIQGLMNFIKKHSFKIFGWYRIGLGIVMAMYLLT
>M4WS35|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTQQTIVFAYHDIGCTGIEALLAAGYRIDAVFTHADDPQENRFYGSVAQLCARHGIPVHA
PEDVNHPLWIARIRELQPQYIFSFYYRHLLSEELLACAAKGAYNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVTRPDAGAILAQQRVAIAEDDTALILHGKLRQASRELLDDALA
KLARGELSEVAQDESRASYFGRRTPADGAIDWQRPARELHNLVRAVTQPYPGAFAPVGER
KLIVWSSRVASGNGGQAPGSVLSVDPLRIACGEDALEIRSGQQGDAGLFLAGPQLAREMG
LVEGSRLHGAARKAKRKTRVLILGVNGFIGNHLSERLLRDGDYEVYGLDIGSDAIERLRT
NPDFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLVR
YCVKYGKRVIFPSTSEVYGMCSDANFDEDKSNLIVGPINKQRWIYSVSKQLLDRVIWAYG
QKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTD
VDDGIEALARIIDNEGSRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRDQFPPFAG
FREVESRSFYGDGYQDVSHRKPSIRNARRLLDWEPTVELSETIGKTLDFFLREALAERSG
GAPHAVPLKSIA
>YP_402564|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIFGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAM
IFFLIKETLPLERRQLFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>E3VVM6|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANFNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0G4JB37|FEATURES|UNIPROT_deepARG|aminoglycoside|LMG16407_00540|antibiotic inactivation|1
MTSTKYFVQPIGPDDIPSWRMLRHCLWPQASADEHDREMAETLSSPERYATFIAFSTAKA
ALGFAEASIRHDYVNGCDTSPVLFLEGIYVAPEARRQGVAKALFEYVEQWGALHACEEFA
SDTDVRNDGVQALHRALGFEETERVVFFRKRTSKAALR
>A0A0A7HF61|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
EDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIR
YSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMG
DHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKV
AGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQ
IAE
>A0A127SPI0|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELKNRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYICRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>A0A0S3ETK4|FEATURES|UNIPROT_deepARG|beta_lactam|PN96_22825|antibiotic inactivation|1
MKKLFFLLALMVASPLSHASKLHEDVSLLEQQISGRIGIAVWDTQTDKHWAYRGDERFPL
VGTFKTLACATMLSEMDTGILKKNATAIVEKRDMVMWSPIMDKLAGQNVRIEHACEAAML
MNDNTATNLVLSEIGGPKSVMLFLRTIGDKATRLDSAEPSVNEAMPGDKHDTTTPNAMVN
TLETLIDGDALSYESRIQLKIWMQDNKVSDPLMRSVLPSGWSIADRSGAGGNGSLGFNAI
IWKENHKPVYISIYLAETELSLQAREQLIAQISQLILYKYRNI
>A0A0S1RS46|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRILFQQGTRQDCTQRYTPASTF
KLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARA
LGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPFEQVDFLRKFVNRQLPV
KAAAYDLAENLFEVGEADGWRLYGKTGTGSPGSHGVYTPANAYGWFVGWARKDDRQLVFA
RLLQDEGTTQPNAGLRARDGLMRDWAAMVAAPRK
>A0A0A0Q8J6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_pao|antibiotic inactivation|1
MRDTRFSCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDRAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>B0BL07|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGRIAPKDVAADWAMEHLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>A0A0D0WPL5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPQPTIRETALPDPDCGPYGIAAGPDGALWATLVRSGGIARVSADGTVRVHPGDPASRPL
VVTAGPDGALWFTRSGDDRLGRITTAGAATSVALPAGTGPGGIAAGPDGALWYAGMSNDT
VGRVDVDGTHTAYPLPVAGGFPSMITAGPDEALWFTLNQANAVGRIACDGEAALHPLPTA
AAGPVGITLGVDGALWFVEIAAGQLCRITTDGRIEEFPLPDRAARPHAIVADPAGGCWFT
EWAANRIGHVTAAGRIDAYDLPTPGSEPHGLAVLPDGTVHAALESGAIAHLTPA
>W1W6T5|FEATURES|UNIPROT_deepARG|beta_lactam|Q614_SASC00125G0001|antibiotic inactivation|1
NITIVILLIYRNYNCNIGGYILKKLILLIAIALVLSACNSNSSHAKELNDLEKKYNAHIG
VYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPI
LEKYVGKDITLKELIEASMTYSDNTANNKIINEIGGIKKIKKRLKKLXXXXANNKIIKEI
GGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKE
NKKFLLDLMLNNKNGDTLIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVLV
IFTNKDNKSDKPNDKLISETAKSVMKEF
>U1MZK6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWYELFIGFLLGVVEGLTEFAPVSSTGHMILVDDLWLNSSSFLGQEVANTFKIVIQLGS
ILAVIVVFRNRFKELLNPKELLAIRSSGPTKKLNLLHIFIGLLPAGVLGLLFEDYIDENL
FSIKTVLIGLVIGAFFMIAADLSGVKRQTTATLDEISYKQALGVGLIQCFSLWPGFSRSG
STISGGVLLGMSHRAAADFTFIMAVPIMFGASALSLYSKWEYFTMATLPVFVVGFISAFL
FALLSIKFFLKLINKVKLTPFAIYRIVLAAVIYFLYF
>ZP_02621059|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MENLWFIIKAIIIGIVEGITEFLPVSSTGHMIIVEDLINFKEGVMPASLYTKQYIDAFTM
IIQLGAILAIVVLYWGKIKSSFENFALSKPKSGFKFWLNIAVAAVPAGILGLKFHSKINE
KLFNPGSVTAALIVGAIWMIFAEKRYRGKFTTRDIDNVTIKQAFIIGCFQCLALWPGMSR
SASTIIGAWIVGLSTVAAAEFSFFLALPVMFGLTLKSLIFDINIFTLGSMHIIGLTIGFI
VSFIVALIVVDKFITFLKKRPMRVFAIYRILLGIVLIILSLFNVISM
>V6A918|FEATURES|UNIPROT_deepARG|aminoglycoside|neo|antibiotic inactivation|1
MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAERRPTLFVKQEVLSAHAE
LPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAVPGDTLSALAQRGELEPERLVRL
VAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLL
DRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAA
WAEAFLVEYGGDIDGERLAYFRLLDEFF
>A0A0D6BL88|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRQITLTGRGLFGACALLLGASQALAETTPDSALKATVDATIRPLMQQQGIPGMAVAIIV
DGKRHYFNYGVASKDNQRPVDHDTLFEVGSVSKTFTATLAAYAQASGKLALNDNASQYLP
ALRGSAFDGISLLQLGTYTAGGLPLQFPDDVKGEDKTLDYYNTWKPTFSPGTQRLYSNPS
LGLFGYLAARSLGQPFDQLMEQTLFPKLGLKHSYVRVPQDQRSHYAQGYDKQNKPSRVGP
GAMDSEAYGVKTSAADLLQFVAGNLQPGQLDATVQRAIASTQSGYYRVGDMTQGLGWERY
AYPVPLARLLAGNSSAMALEPHPVQWLTPAQAPQADALYNKTGSTNGFGAYVLFVPGKQI
GIVLLANKNYPNEERVKAAHGILSALEAAR
>B4U4X0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIELLKAIFFGVIEGVTEWLPISSTGHLILVQEFIRLHQDKAFMEMFNIVIQLGAIIA
VIVIYFERLNPFQPGKSPQQIRLTWQLWLKVAIACIPSIIIAVPLDDWFDVHFNHMLPIA
IALIVYGIAFLWIEKRNQTLEPRVVKLSRMSYKTAFFIGCFQVLSIIPGTSRSGATILGA
IILGASRTVAADFTFFLAIPTMFGYSGLKALKFFIDGNHLTLSQLLVLLVASLTAFAVSL
YVIKLLTDYVKKHDFTVFGRYRIVLGSLLIVYSVFKSLF
>G2LNV1|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MLNLYQVITSIIIGIIEGITEFLPISSTGHMIIASHYLQIENNKIKILEIFIQFGSTLST
LYFFRHTIFNIIKHTKTKKKTKNIHIILSILPTILFGLIFYHQIKQLFYLENVIFSLILG
GIFLIFSEIFQPKKHTIDHIKNISLRQAIIIGLFQIFSLYPGFSRSGSTIATAILLGIKK
SVAIEFSFIISIPLLIGASFFELLNNIANIKISDIPILFIGCLISFLVSFLCIRCLLKIL
NKTSLIFFGIYRLIISGLIYFVIKN
>AAB05246|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDPVRISEKEKIKVTEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>J2VJ79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLWCLHYEVFTALRVKEAVSINMETQTIVEALFLGLLEGLTEFIPVSSTGHLLLAGHFLG
FESNGKTFEVLIQLGAILAILTVYFGRLLKIARDLPSDPKTRRFVTGVLIAFLPAVVIGV
LAHGLIKAILFESPMLICTMLILGGLILLWVDRLDLKPRYHDAMDFPLPLYFKIGLFQCF
AMIPGTSRSGSTIVGALLLGADKRSAAEFSFFLAMPTMAGAFALDLFKNRNVLTFDDLTL
IGVGFLAAFISAVLVVRYLLDYVSRHGYGLFAWWRLVVGTVGLVALILMR
>Q60250|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKKLNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQIPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>X8GQG8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIKDNKNIIEIQNINKYFGEGENRVHILKNISLTIEKGDFVSIIGQSGSGKSTLMNIIGC
LDKATSGKYYIAGEEISQFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGA
DHDTRMARAEKLLDKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALD
SKSGIMVMKILNQLHEEGHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQREIKKEALE
EKSEINNLKKNKFQVAKDQFFESFNMSIAAIVAHKMCSLLTMLGIIIDIASIVCVVAIGN
GSQQKVLENISSLGTNTMDIFNGEGMGNRFADRIKSLSTTDVDILEKQSYIDSVTPNSSS
SGTIVYQNQSYSGSLKGVGADYFDVRGVKVTSGRAFSKEDEEELSSVALIDENT
>C6DAW6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACRQIGKPWEIILVDDGSSDRSAELLTEAA
SDPEKHIIAVLLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYAAQGYD
VVGTVRANRQDSLFRKLASKTINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLHCHERST
FIPILANTFARKTIEIDVMHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFLGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLTTSLRDEEE
>A0A0D0H2P9|FEATURES|UNIPROT_deepARG|beta_lactam|KY49_1937|antibiotic inactivation|1
MKHGIKRIMAAALFSTCATATIGYAANDRRDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPN
LQGSPFGNVSLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWRPTYSPGAYRTYSNVSI
GTLGLITATSMGQQDFAVPLSRHLLSPLGMKSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSMALNAMPVEEIKPPQAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>A0A0A1FP78|FEATURES|UNIPROT_deepARG|beta_lactam|G155_12500|antibiotic inactivation|1
MTGLSRRNVLIGSLVAAAAVGAGVGGAAPAFAAPIDDQLAELERRDNVLIGLYAANLQSG
RRITHRPDEMFAMCSTFKGYVAARVLQMAEHGEISLDNRVFVDADALVPNSPVTETRAGA
EMTLAELCQAALQRSDNTAANLLLKTIGGPAAVTAFARSVGDERTRLDRWEVELNSAIPG
DPRDTSTPAALAVGYRAILAGDALSPPQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGS
GDYGSTNDAGIAFGPDGQRLLLVMMTRSQAHDPKAENLRPLIGELTGLVLPSLL
>A0A140PTD0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DKATSGKYYIDGEDISDFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVD
HDNRMERAKKLLEKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDS
KSGIMVMKILNQLHEEGHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQREIKKELQED
KKSINNLKKNKFQVAKDQFFESFNMSVSAIIAHKMRSLLTMLGIIIGIASIVCVVAIGNG
SQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTDVDILEKQSYVDSVTPNSTSS
GTIVYQNQSYSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALIDENTQKSLFGE
NENPIGKVILFNKKPLKIIGTVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
VKDDIDSQVAQKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVV
GGIGVMNIMLVSVTERTKEIGIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIG
WGFNSISKSFSMIFSVFSIVMAVLFSTLVGIVFGYMPAKNAAKLDPIEALSRE
>I3XEC9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRNVRLQTLGVLAAASLFCGASSQATASDSPGHIKRVVDEAIRPIMEEYDVPGMAVAATV
QGRRYVLNYGVASKESGQKVGDETLFEIGSISKTFTATLASYGEARGVLSLSDSASKHLP
ALSGSSFDRISLLDLATYTAGGLPLQFPASVTDQKEMIGYFKGWRPSYAAGGHRLYSNPS
IGLFGYLAAKSMGEPFDALMEKTLFPALGLTQTHISVPEDRMGDYAHGYSKAGKPVRVSP
GVLDSEAYGVKTTAADLIRFVEANIEGAELDDTLQRAIAATHSGYFRVGDMTQGLGWEMY
AYPTDLKRLLAGNSPEVSFKPNKVTRLDPPLPPRDDVLINKTGSTSGFGAYAAFVPAEQI
GIVILANRNYPIPARVKAAYQILTALQRLPAEDR
>B3R270|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MIDWIHLGKAFFLGLLEGLTEFLPISSTGHLILVGDWIDFTSHEARVFDVVIQLGAILAV
CWLYRAKIANLCDGVVRRDPDALRFATAVLVAFLPAAVIGALLIGPIKHYLFDPAVVAAA
LIAGGLVILWVERRSAVPRIHAIEDFGWKQAIGIGLAQCVAMIPGTSRSGATIIGGMLSG
VSRQAATEFSFFLAIPTMLGAATYDAMRHYHLLSMQDFWSIAAGFTAAFLSALVVVNALV
RLVARHSLRAFAWYRIGLGVVIGVVSLGWSV
>X4ZZA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHDYFIAIIQGIVEGLTEFLPVSSTGHLILSGALLGFTGEKADTFEIIIQLGAILAVAVI
YWRRILGLLGLMKIPSGHEAGKERPKLNLLHIILACIPAMLLGCILHSFIKTYLFSPYTV
LAGLVLGGIFMLVGQMRQAPVRAESIDQLSYRQAFTIGLFQCLSLWPGFSRSGATIAGGL
LTGASYEAATNFSFLVAIPMMIAASGYELLKSYQTLTAADAGFFITGFLVAFVVALLAVI
TFLKLLEKLKLAPFAYYRFALAAIFLIYLLAQ
>C8CE51|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-214|antibiotic inactivation|1
ESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGM
TVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDE
RDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGA
GERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEICASLIKHW
>AAD25095|FEATURES|ARDB_deepARG|tetracycline|tetG|antibiotic efflux|1
MRSSAIIALLIVGLDAMGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVFAPM
LGQLSDSYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLVSGVTGATGAVAASTIAD
STGEGSRARWFGYMGACYGAGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLK
ETHHSHGGTGKPVRIKPFVLLRLDDALRGLGALFAVFFIIQLIGQVPAALWVIYGEDRFQ
WNTATVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFVLLAFATQGWM
VFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSAT
AGAWNGWVWIVGAILYLICLPILRRPFATSL
>T1EBQ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLIQAVIMGIVEGITEFLPISSTGYLILSADLMGFWTKEKVDLFVVVVQFGAILAV
IYDYWGRLWQALMGLLTGKAEGMSNPRQLGLSLIVATIPVMIVGFTFADEIKAYLFNPIV
VAIMLIIGGLLIFYVENRPKAIIAEEAEDVSLKTALMIGLLQCLALIPGTSRSGATIIGA
LWLGVSRKASAEFSFFLGIPVIIGAALLDFIKHRDVLTSSEDWLVLGIGTVVSFIVALLC
IRLLVAWVSRRDFKIFAWLRIVTGVLVLIAAWGFGYQMAG
>X8DL26|FEATURES|UNIPROT_deepARG|chloramphenicol|cat3|antibiotic inactivation|1
MPAEHALLVVMATFEPLDLQQWPRREWFEHYLDRCPTYYSMTVDLDITNLRAAVDASGRK
TYPTQIWALATVVNRHPEFRMALDDQGNPGVWDVVDPAFTVFNPDRETFAGISARYTPDF
DAFHSEAAELLSEYRNASILFPQGAPRPRNVFDISSIPWTRFTGFTLTIAPGWAHLAPIF
TIGKFYEQEGRTMMPLALQIHHAAADGYHSTRLVEELRQIIADPDWVRD
>CAI57693|FEATURES|ARDB_deepARG|trimethoprim|dfrA7|antibiotic target replacement|1
MKISLISATSENGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFDSMGVLPNRKYA
VVSRKGISSSNENVLVFPSIEIALQELSKITDHLYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDINFPKIPENFNLVFEQFFLSNINYTYQIWKKG
>A0A0W7TXI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTYTLLVAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VAVFWRRLFGLIGIHFGQKPSQDHATLSLVHIILGMLPAVVIGLMIHSWLKANLFGPVTV
MYALVAGGILLIIAEKARPAVRAETLDDISYKQAFGIGCFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMVAASALDLYKSRDFLSLADFPMFAVGFVTAFVVAMFAIK
TFLALIRRLDFIPFALYRFVVAFAVYLVFVA
>A0A0J5X269|FEATURES|UNIPROT_deepARG|beta_lactam|VL15_12295|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLVLTVTACASPRAGAPDVSSTTSFDALERAAGGRLGVCAIDT
ASGRRALYRADERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVTYGKADLVKYSPVSEKH
VDTGMTVADLCAAAIQYSDNSAANLLMKLLGGPSAVTAYARSIGDDAFRLDRWETELNTA
LPGDLRDTTTPAAMAASLRVLTLGDALPAAQRAQLVAWLRGNKVGDKRIRAGVPAGWTVG
DKTGTGDYGTTNDAGVVWPPSRAPIVLTVYYTQTRADARAKEDVIAAATRIAVATFG
>A0A0D6TLI3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIILAIIEGITEFLPVSSTGHMIIASSFFGIAGDDFTKLFTIVIQLGTILSVVVL
YFKRFFQSIDFYFKLFVAFIPAVFFGLLLNDFIDDLLESPIVVAISLIIGGFLLLKVDDW
FGNAENTEISYLTALKIGLFQCLAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFLAIPT
MLGATVKKLYDYSKLGVEITDHQLNLLIIGNIVGFIVALIAIKSFIGYLTKHGFKIFGYY
RIIAGVAILIIHFFVQKLTII
>A0A060KZ85|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDCGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABB80128|FEATURES|ARDB_deepARG|bacitracin|bcrA|antibiotic efflux|1
MNTIIKTTDLTKMYGPQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQ
IEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIV
GLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAK
ERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVV
LMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKIAMSEDSLEDYFVKLI
GGGTIG
>A0A0I9PBM9|FEATURES|UNIPROT_deepARG|beta_lactam|BN1200_380071|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGIEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>YP_001453560|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAALMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVTGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVKIPVREGMGRVMADKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPSAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLLMSLSMLPVGLVGNLQQL
FTLICTFYIGSVIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KALQQPELPWMMLGVIGIMTFLALGWQFSHKRTPRGMLEPGA
>A0A060KTU2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTASPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0T7NTK8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSIITTLVLAAIATSPLCTSAQTILTEQQVAAIVNNTLTPLLKEQDIPGMAVAVFYD
GKPQFFNYGVADIKTGRRVTENTLFELGSVSKTFTGVAGEYAVQTGMVNLNDPVTEYASE
LTGNQWKKVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKKSQLTFENYMMKNVFQPLKLKHTFITVPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTSQDMVRFMQANMSPDSLPAENDKLKRALIAAQSRYFQAGEMFQGLGWEM
YNWPINPQRVIADSGNDIALKPRKAEELQPPHPAIRASWVHKTGATNGFGAYIVFIPEEN
IGIVMLANKNYPNPVRVQAAYNILQALR
>ZP_02031678|FEATURES|ARDB_deepARG|chloramphenicol|catI|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HFLARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>A0A158RKM7|FEATURES|UNIPROT_deepARG|chloramphenicol|BCA_2477|antibiotic inactivation|1
MRFHIIDRENWNREQYFEHYLKLKCTFSMTVNVDITRLLKELHQKGIKFYPVFIYLISKV
VNNHKEFRTSFNDEGALGYWEEMIPSYTLFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
LYTNVHGLFTKENIPPNVFPISSIPWASFTGFNLNINNDGDFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFIEDLQKLSNRCNEWLK
>A0A0P9N756|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMVFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
IGGVIMLWAERREHTVRTETVDDMSWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>J2ZFD8|FEATURES|UNIPROT_deepARG|beta_lactam|PMI29_06013|antibiotic inactivation|1
MDRLKTIAACMAIFAAGQCVAQDQIETVVNAAVQPVMQAEGIHGMAVAVTVNGQAHYFNY
GVASTETGSPVTQDTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASHVLPALRGSAFDH
ISVLQLGTYSAGGLPLQFPAESDSADKMLGYYKQWKPLYAPGSHRLYSNPSLGLFGYLAA
QSMGQPFDDLMEKTLLPKLGLKHTYVHVPQDQMALYAQGYNKDDKPVRVSPGALDSEAYG
VKTGAADLLAYVGANMKPASLEKPLQQAIALTHSAYYAVGDMTQGLGWEMYRYPITLDRL
LDGNSTPMAMEAHKVQWLNPPQAQPQNVLVNKTGSTGGFGAYVVYVPSKGIGIVMLANKN
YPNAERVKIAHQILSALPQ
>I6ZM40|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYARTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWLKDRAPLILVTYFTQPQPKAESRRDVLAS
>A0A062XLT1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDLIKSIIIGIVEGLTEFLPVSSTGHIILAETLMKIPGGAVWTKSFTPFFDYAIQLGAI
FAVIQLYFNKLNPFSPQKTDREKFQTWRLWIRVAVGVLPAVVFGLLLNDFMDAHLLNFWV
VSAMLIIYGVIFIVIENRQKGIAPLITDVNQITFKLALYIGLFQVLSLVPGTSRSGATIL
GAIILGASRFVAAEFSFFLSIPVMFGVTLLKMFKFFHEGGSFTGMQGLVMLFGFVVSWIV
ALFAIKFMMNYIKNNDFKAFGYYRIIVGVIFLLLGMTGVITTMH
>A0A0P9LE92|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDTAGLHDTRLDSDRPLPHLQGVSRSFMAGEREFQVLKNIDLAINAGELVAIIGAS
GSGKSTLMNILGCLDHASTGSYQVNAQETRDLDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAVYAGTPQSQRHQRAQALLTRLGLGGHLEHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRILLELHAAGHTVILVTHDPKVAAHAERIIEVSDGEIIS
DRRTALQTLNAAEPQEATQKSLAPRRLVAGFGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGSNFGDSRAKSIETLLPADVAALN
QLYYIDSATPVVGRSMLVRYRNIDVDAQLNGVSNRYFQVRNIQLAAGITFSEQDARRQAQ
VVVLDHNTAQRLFGAGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNIWMPYETAA
GRLLGQRHLDSISVRVKDGMPSKAVEEQIKTLMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LIGGVIGIGLSYGIGYLFTLFVKQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>W7ZJT7|FEATURES|UNIPROT_deepARG|beta_lactam|JCM19046_4801|antibiotic inactivation|1
MVLGACSTPETAEQGKQQQNQEDDLTAPFSELEDQYDARLGVYALNTGNGQTIAFNEDER
FAYASTHKALAVGVMLQQLSIEDLDKQVTFSEAELVTYSPITEQHVETGMSLREISDAQI
RYSDNTAANLVFNEINGPAGFKEALRAIGDDVTEPERMETELNDVNPGETRDTSTPKALA
ESLYAFSFGDALDKEKQTLLNDWLIHNTTGDDVIRAGVPDDWVVGDKTGSASYGTRNDIG
IIWPPNDEPIVIAVLSSKDEQDGKSDDALIAEATEAALRLLIDDFE
>A0A150Q8Z8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHESEAAKTLDIVIQLGAVLAVVVYF
RERLAVTVRGIVRRDPDSLRLALALAVGFFPAALVGLLFHKAIKAYLFGPGPVAVALIVG
GILMVAVEARRRRQPDQGAPRLEDVTLPRAAAIGFAQCFALWPGASRSMTTIVGGQLSGL
STAAAAEFSFLLAIPTLGAATLFDLARNGRALLEAPGGPAALGVGLAVSFAVALLVIAVF
LRYLKRYGLAPFGWYRIALGAVVLWLWLASRSAPAEAGAAAEGPGTQSDTAAANQENAPK
AR
>A0A0Q7X1D0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILALKALIMGLVEGFTEFLPISSTGHLVLAGSLLNFTGEKAKVFEIAIQGGAMIAVI
WEYHKKICDVLFGMFRDERARRFAINVVVAFIPAAALGFLFSKKIKAVLFAPVPVALAFI
IGGLIILWVERRARNNPVAVRVQSVDDMTTMDALKVGIAQVFALIPGTSRSGATIIGGMM
FGLSRKVATEFSFFLAIPTLLAATFYSLWKERALLSAADLPLFSIGAVVAFVSAFACIRW
LLRYISTHTFTVFAWYRIAFGIVVIASAYSGMIVWAE
>CAJ51087|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTRHNEIIKIAEKHQLHIKPQTISLNESGLDFQVAFGEDEHGIEWVLRLPRRPDVYKRTK
PEKQMVDFLQKNVSFEVPNWKVHTKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPVTKN
FINTLAETLVDLHNIPKENITAQHINIKTIQEIKNDFQRRMNKVKETYGVADGLWNRWKQ
WLENDELWPRRATMIHGDLHPGHIMVDNQANVTGLIDWTEATYSDPSMDFMGYHRVFDDE
GLEQLITAYGKAGGETWPRMKEHIIELNAVFPMFIAEFAMESGEPAYEKMALQELGMKE
>I0F850|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWELFVAAILGIVEGLTEYAPVSSTGHMIIVDDIWLKSSNLMSEEAANSFKVVIQLGS
ILAVAIVFKDRILNLLGLKKNITSDQKQGHKLSIAQIAVGLVPAAVLGFLFEDYIDEYLF
SVKTVAFGLIAGAILMLFADWVNKRKAATDTLDRISYKQAIAVGLFQCLALWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAMPIMMGASFLSLVKHWDSLSSDLMPFFIVGFICAFVV
ALFVVRFFLRLINKIKLVPFAIYRIILGVILLLIMM
>ACI85051|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MLIFYFPGGEMSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGI
ALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSG
LGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATG
AVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLM
LPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMP
VGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGY
IGGGWLFDLGKSVHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>A0A0E0WYW6|FEATURES|UNIPROT_deepARG|chloramphenicol|A225_1960|antibiotic inactivation|1
MACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKV
LMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>D7PIH0|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-1|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVALKKSDLVNYNPITEKHLN
EGMTIGELAAAALQYSDNTAMNKLIEHLGGPNKVTDYARTLGDNTFRLDRTEPTLNTAIP
GDERDTTSPRAMALSLQHATLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWIVGDK
TGSGDYGTTNDIAVIWPENKAPLVLVTYFTQPEKDAKS
>V4NH70|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLIAVFLGFVEGLTEYIPVSSTGHLLLLSHFLGFDSQGKAFEVLIQLGAVLALLSLYF
NRLWNVLITLPSSPQSRGFVVSILVAFFPALVLGVVLHDFIKTVLFESPYLICVSLIVGG
IILWAVDKYAPTPTHDDAMRLSWKTSLIIGLFQCLAMVPGMSRSGSTLIGAMLCKVEKKA
AAEFSFFLAMPTMAGAFAYDVYKTHDQMSFNDAGLVAVGFITAFVTALFVVRAVLNFVSR
HGYGVFALWRIAVGGIGLILLSLGH
>A0A0M8VNM1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTHVSIEEFAVADSAAGPYALATGPDGALWFTLVHSGRIGRLVPGEEPTSHPLDPTCGPT
IITSGPDGALWFTEYGAGRIGRITTDGVIDEFDVPTPGCGPFGIAAGPDGALWFTETAAD
RIGRITVDGGVTEFPLPVTGAFPSAITAGGDGGMWFTLNQANAVGRIGMDGAVTLHSLPT
EEAAPVGIAAGRDGVLWFVEIGAGQIGRITPDGQITEFPLPNRAARPHAVTVNGQGTVWF
TEWGDNRVGTITPDGCVTVHDLPTPRSEPHGITVGPDGALWTALEIGALARIAPADSTT
>YP_002529178|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVIFWKRLWSLV
GIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKKVLFGPGPVVISLVAGGILMIVAEK
FSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFIL
AVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLSRVKLTPFAY
YRFILAAVFYFFIM
>A0A157WTZ6|FEATURES|UNIPROT_deepARG|chloramphenicol|cat_3|antibiotic inactivation|1
MLLKHIKEVGWKFYPAIISLISDVVNRHPEFRMAMKDDELVIWNEVHPSYTLFHKETETF
SSLWSHYDGNIHHFQRVYAEDVARYGNILAYWPKEESRENIFFISDIPWVSFSSFNVNVA
NMRNFFAPMFTFGKYYNQDGKVLLPFAVQVHHSVCDGFHVARLINELQELCDNLPHHSEA
LNV
>R8N2P9|FEATURES|UNIPROT_deepARG|beta_lactam|IK1_01787|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGDWEVADKTGSGSYGTRNDIAIIWPPNKKPLILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNK
>A0A0L7T1U5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKVVVFAYHDMGCVGINALVNAGYDIAAIYTHADAAGENQFFASVARTAAELGIPVFAPE
EINHPLWIDRIKSSEPDAIFSFYYRNMLCDEIIHCAKQGAFNLHGSLLPDYRGRAPLNWA
LVNGETETGVTLHRMVARADAGAIIAQQRVTITAEDNARSLHGKLNETAAGLLSGILPEI
KTGEFTELPQDHSKARYFGRRTPEDGRIHWDQPAAVIHNLVRAVTDPWPGAFSYVGASKF
TVWKTRVHSDRPAAKAGTVLSTQPLIIACGSEALEVLTGQSENGVYMQGSQLAQTLGLVP
GALLNSLPNAAVKRRTRVLILGVNGFIGNHLTERLLRDDNFEIFGLDISSDAISRFIANP
RFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCSDPVFDEDHSNLIVGPINKQRWIYSVSKQLLDRVLWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGQQKRCFTDI
ADGVEALFRIIENKNNNCDGQIINIGNPDNEASIKQLAEQLLASFERHPLRDQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNARRLLNWTPEVGMDKTIDDTLDFFLKTVEPVEGSR
>F8GN48|FEATURES|UNIPROT_deepARG|beta_lactam|ampC1|antibiotic inactivation|1
MKRIPVARIATFAMACSLFAANASAADSVSQRQVERAVNDAIRPLMAAHGVPGMAVAVTA
GGKRYVFNYGVASKAGGRKVDGDTLFEIGSVSKTFTATLASYGQARGALSLADPAGKYLP
ALAGSSLGATSLLDLGTYAAGGLPLQFPDAVTDTRSMVDYFRGWRPRYAAGTHRQYSNPS
IGLFGYLAASSMGQPFDDLMEKTLFPALGLAHTYIRVPKARMGDYAYGYSKDGKPVRVAP
GVLDAEAYGVKTTAADMIRFVEANIDSAGLDDKLRRAIAGTHTGYFKVGDMVQGLGWEMY
AWPTRVDSVLAGSSPQVVLEANPVSRLEPPLSSPADVLVNKTGSTNGFGAYVVFVPAKRI
GIVMLANKNFPVPERVKAAFRILAVLDGVPAGAGSR
>B2CD77|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
GLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQ
LLQWMVDDRVAGPLIRSVLSACWFIADKTGAGERGARGIVALLGPNNKAERIVVIYDC
>U6A4F7|FEATURES|UNIPROT_deepARG|beta_lactam|6|antibiotic inactivation|1
MAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTA
MNKILEHLDGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPLAMAKSLQNLT
LGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
>A0A0D8DUU8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNAIRIAATLFVAACAAATAGRAAAATQDEIHDTVTRHVAPLMKQFAIPGMAIGIVAD
GKPYVFDYGVMSTQTGQPVTGDTLFEIGSVSKTLTATLASDAQESGELSLTDPAGKYLPA
LRGKPFGRVTLLELGTHTPGGMPLQVPDSIRDDAGLMRYLDAWRPAYAPGTRRTYSNVAI
GMLGQLTAKAMNRDFAGLMEQRLFPALGMTHTYINVPAARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLVETAPRLQRALERTHTGYFRAGPFTQDLIWEQYP
YPVALPTLLAGNAPPMLHDATPATELKPPLAPRPDAWINKTGSTNGFSTYVAFVPAKRLA
IVMLANRSFPIEDRVKTAYRIVESLGGKP
>Q9KRU4|FEATURES|UNIPROT_deepARG|multidrug|norM|antibiotic efflux|0
MHRYKKEASNLIKLATPVLIASVAQTGMGFVDTIMAGGVSAIDMAAVSIAASIWLPSILF
GVGLLMALVPVVAQLNGAGRQHKIPFEVHQGLILALLVSVPIIAVLFQTQFIIRFMDVEE
AMATKTVGYMHAVIFAVPAYLLFQALRSFTDGMSLTKPAMVIGFIGLLLNIPLNWIFVYG
KFGAPELGGVGCGVATAIVYWIMLLLLLFYIVTSKRLAHVKVFETFHKPQPKELIRLFRL
GFPVAAALFFEVTLFAVVALLVAPLGSTVVAAHQVALNFSSLVFMFPMSIGAAVSIRVGH
KLGEQDTKGAAIAANVGLMTGLATACITALLTVLFREQIALLYTENQVVVALAMQLLLFA
AIYQCMDAVQVVAAGSLRGYKDMTAIFHRTFISYWVLGLPTGYILGMTNWLTEQPLGAKG
FWLGFIIGLSAAALMLGQRLYWLQKQSDDVQLHLAAK
>A0A0F0ZVX8|FEATURES|UNIPROT_deepARG|beta_lactam|SS37_25035|antibiotic inactivation|1
MFIFLNTFKYVSAHETITLINASIILKNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
TAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRK
LLTGELLTLASRQQLIDWMEADKVTGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPD
GKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>YP_002384189|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFMHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATIALSYIPMMSWVAVSPV
ILIDAGGLTTTQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLALLIV
GNLLSPHVWLWSVLGTSLYAFGIGLIFPSLYRFTLFSNNLPKGTVSASLNIVVLTVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELVEEQ
>A0A0F7H761|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELSNIRRSYQSGDQTLEVLKSVSLRIDAGEMVAIIGASGSGKSTLMNILGCLDKP
NSGIYRVAGQDVATLNGDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGMNNSA
RHARAAALLQRLGLGERIAYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
KEVMTILKQLCEQGHTVIIVTHDPAVAQQAERIIEIHDGEIIGDSRPQAQGKPQAKSLEL
ATPAPSWQQMADRFREALSMAWWAMAANKMRTLLTMLGIVIGIASVISILVIGDAVQQQV
LAEIKSIGTNTVDVYPGKDFGDDDPTLRQALKYDDLSALDAQPYISALSPMTRSSMRLRF
GNIDVAANVAGVSEQFFRVYGMEFSQGTAIDVRQVESQTQTVVIDTNTQRRLFPQQKNVL
GEVILIGNMPATVVGVAKEKQTMFGSSKMLSVWVPYTTMANRLMGNDYFDSITVRIRDGY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLILVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGILGIVLSFTIGLLVQL
AMPGWQINFPPVALLSAFLCSTGIGVVFGYLPARSAARLDPIDALARE
>A0A0F3ZWB8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDMAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDVIFSFYYRNLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQKVAIDADETALQLHQKLNATAQTLLRDALPGI
LNGTFSETVQDESKASCFGRRAPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAISRFLNNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>D6MTC9|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampC)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPARVAAAWQILNALQ
>L0MU30|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDVRRLVFSLVLGIVEGLTEFLPISSTGHMILVENILNCMDDSVIAFTVIIQLGAILSI
TKIFWSQLYGMSMICIKKIFFKQHDDHNHLCIRHIFLGTFPGIMLGMIFYEKIGLIFELT
YIMYGLIIGGIFLLVGELCASKEPRVSRINNITYLQAFLIGCFQCLAFWPGFSRAGATIG
GGLVVGLDRRISSEFSFFLAVPIIFGSAVLTLYHYRSCIGLMDALLLIAGSATAFFIALF
TVRYFLKIVQNVSLIPFAIYRFLLAGGIYWGLMT
>A0A0E0UN93|FEATURES|UNIPROT_deepARG|beta_lactam|SinmeB_3627|antibiotic inactivation|1
MTHFSATKFVMAAAALLCCGAGAHAADRGEEGELARLVDETIRPLMREHGVPGMAIAVTV
RGKKYIFNYGLASRESGQKVTDETMFEIGSVSKTFTAMLASYAEARGDLALSDPAGKYLP
ALAGTRFDDISLLNLGTYTAGGLPLQFPDSVTDQESMIDYYRDWRPTYAAGTHRLYSNPS
IGLFGYLAAKSMGEPFADLMEKSIFPAFGLTSTFIAVPQDRADDYAYGYSKAGKPIRVTR
GVLDSEAYGVKTTAADLIRFVEANIDGTGLDEPIRRAIAATHTGYFKVGAMTQGLGWEMY
PYPTKLDDLLAGNSSRMALEPHKVSKLVPPAAPQENLWINKTGSTNGFGAYAAFVPAERI
GIVMLANRNYPIPARVKAAYQILSTLESGPGSADAR
>CAR58719|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAL
GQLIYGPMADSLGRKPVILGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAIAAILASVM
IFALIKETLPVERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVPPQDFGYYFALNIVFLFVMTIINSRFVRRVGALNMFRAGLWIQFAMAVWMVFSA
LMGIGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIALCAACSILFYLYASRPKKR
>YP_416126|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFIIELIKGIILGVVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVEGQNDQQRRSKPRRLNLLHVLVGMVPAGILGLLFDD
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSVKVKNPQTVDQINYFQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILG
FLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIVLVIFIAILYFGFGIGKGI
>D8DVR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIQTIIISIVEGLTEFLPVSSTGHMIITQNLLGVQSGDPFVHAFTFIIQFGAILSVVC
LYWKHFFQMRNKHEFNEKMKFYGLLIIGVLPAVIVGLVAKKSGLLDWLLDSVHVVAITLV
LGGIFMLFCDRIFDKGKDDNEITTKRAFFIGCFQCLSVIPGMSRSMSTIVGGMQQKLTRK
NAAEFSFFLAVPTMAGATLLDLIEMFGEDTQWATSENIMLLIVGCVVAFFVALFAMKWFV
SFLAKYGFKWFGWYRILVGSIILLLLATGHSLVMVD
>A0A125WUK4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQDLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>U2ARW8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MKLEQQEINILHSDSGPYGIAISPEGKVWFTQHKANKISCLDKAGQIQEYIVPTPDAGVM
CLTVSSEGDIWFTENRANKIGKLTAKRQFIEYPLPHQHSAPYGITEGPDGDIWFTEMNGN
RIGKLTSEGKIHEYELPNEGSYPSFITLGSDHSLWFTENQNNAIGKITESGELTEFPIPT
PAAGPVSITKGHDDALWFVEIVGNKIGKITVSGDITEYNIPTPNARPHAIAAGVKSDLWF
TEWGGNKIGRLTSDQTIEEYTINTPHAEPHGIGCDNDGTVWFALECNKIGKLKLTK
>A0A0V8ER33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPTDKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWSDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFKAFLG
>A0A0H0YK68|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVIIGIVEGLTEFLPISSTGHIDLVDQVVKLSQGREFMNMFEYVIQFGAILAVI
LLYFNKLNPFSKPTVKEQNATWQLWAKVIIAVLPSVVVGLPLNDWMDKHLHTPLVVATTL
IVYGVLFIIVENYLKNKPSHITTLADITYQTALLIGLFQVLSIVPGTSRSGATILGALLI
GTSRYVATEFSFFLAIPTMVGVSILKIGKYLLQGNGFTGEQWMVLLTGSVVSFLVAIVAI
KWLLKFVQTHDFKPFGWYRIALGAIVLLVMFL
>L7GJQ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMFSALLLGILEGLTEFLPVSSTGHLLIAEQWLGRRSDFFNIVIQAGAILATTLVFRQ
RLWTLATGLGDRANRDYVLKLGTAFLVTAVVGLVVRKAGWQLPESVQPVAWALVIGGVWM
LVAEHFAARMPERERVTWKVAIAVGLAQVVAGVFPGTSRSAATIFLAMLLGLSKRSAAAD
FAFLVGIPTMFAASGYSFLELYKNGVVGSEDWGDVAIAFAAAVVTGFIVVKWLLGYIKSH
RFTAFAVYRIVLGAALLLWLPAA
>A0A078M1U5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELVKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKSEEFLGKYSANTFKIVVQLGS
ILAVVVVMWKRLFSLIGLYKIDGKPMMQRFNLAHVIIGMLPATVIGFALKDFIDDNLFSV
ETVVYALVAGAILMLVADKFGPKKPKITSLDQMSYGLAFKVGLVQCLSLWPGFSRSGATI
SGGVLFGMNHKTAADFTFIMAVPIMAGASLVSVLKNWDQISMDHMSFYIVGFISSFVFAL
ISIKFFLALIDKVKLTPFAIYRLVLAAVLAFVLFF
>A0A127T6J8|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-34|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNRPITQNTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTRYWPELTGKQ
WQNISLLHLATYTAGGLPLQIPDEVTNKTALLRFYQNWQPQWAPGAKRLYANSSIGLFGV
LAVKPSGMSYEEAMIRRVLQPLKLTHTWITVPQNEQRDYAWGYRDGKPVHVSPGQLDAEA
YGVKSSIMDMARWVQANMDASHVQEKTLQQGIGLAQSRYWRIGEMYQGLGWEMLNWPVKA
DTIINGSDSKIALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVDAAWRILEKLQ
>V9ZX37|FEATURES|UNIPROT_deepARG|beta_lactam|AH4AK4_1197|antibiotic inactivation|1
MTMQQQVRMTLLTAGTLLWAGLTQAAADDPLRPLVDASIRPVLKEYRIPGMAVAVLKDGK
AHYFNYGVANRESGAPVSEQTLFEIGSVSKTLTATLGAYAVVKGGFQPDDRVSQHAPWLK
GSAFDGITMAELATYSAGGLPLQFPDEVDSTDKMRAYYRQWTPAYPAGTHRQYSNPSIGL
FGHLAAHSLGQPFEQLMSQTLLPGLGLAHTYLKVPAAAMGNYAYGYSKEDKPIRVNPGIL
ADEAYGIKTSSADLLAFVGANMADGGDEPLQQAIAMTHKGIYSVGTMTQGLGWESYPYPV
SEAALLAGNSPAVTYNANPVSPVAGSQKAGEARLYNKTGATNGFGAYVVFVPAKGVGIVM
LANRNYPNEARVKAAHAILSKLAE
>CAA40357|FEATURES|ARDB_deepARG|beta_lactam|y56|antibiotic inactivation|1
MKHSSLRRSLLLAGITLPLVSFALPAWANALPASVDKQLAELERNANGRLGVAMINTGNG
TKILYRAAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLIKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTARPN
DPRDTTTPAAMAASMNKLVLGDALRPAQRSQLAVWLKGNTTGDATIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASVTKIILSQIS
>A0A127SZ40|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0L8C2V5|FEATURES|UNIPROT_deepARG|aminoglycoside|AC244_07670|antibiotic inactivation|1
MRVLLMNADMVGRWLDMRLALWSDTPAGIHRGEIDACLAAGERQAAFLCEDDAGVAAGFA
EVSLRTDYVNGCETSPVAFLEGIYVLPRYRRHGVARALITAAERWAVSHGCRELASDTDT
DNLESQSLHTALGFEETERVVYFRKELSASFTDN
>A0A0F5PBI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEMSLLSIVLLGIVEGLTEFIPVSSTGHLILAGEVMRVPQGTETFDIVIQLGAILAVVVL
YRQRFLDVIAGLFRRDPQAIRFTRNVLIGFLPSAVIGAVAYGAIKAMLNAPIIVAVALIL
GGVAILVIERTVRTPTCDSVEGMSVKTTLGIGMIQCLSMIPGVSRSGATIMGALTLGVER
RTAAEYSFFLAIPTMMGATALALWKARNELGDAQATAIAIGFVISFIVAMLVIRWFLNVV
TRHGFAPFAWYRIIVGSIALIWLMI
>M4S5U4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLPALIVVILLGIVEGVTEFLPVSSTGHLILAGELLGFNSAAAGTFEIVIQLGAILAVIV
LYWRRFWDVLAGLVRGDARAIAFARNIALGFLPSAVIGLMVYKVVKAMLETPVIVAVALI
VGGVAILVIERLVRAPSTHSVEEMGWKTALGIGFVQCLSMIPGVSRSGATIMGALGLGVE
RRTAAEFSFFLAVPTMLAASGYDLYKSGGALGSDDWLAIAVGFVVSFIVALVVIRWFIGI
VSKYGFAPFAWYRIVAGGIALVWLLVR
>A0A0A8I9A8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIRLENIQKKINNTTILENINLYIQKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGKYFL
DAYEVTNLSKDEKARIRREKIGFIFQRYNLLSLLNAKDNVALPAVYAGKNKHERSQKAKE
LLSFLELDHKELSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGKIVLEIL
NKLNDQGHTVVLVTHDREIAARAKRVIEIKDGKIISDNGVKKADEIKAKLMPKEKKSFNL
LKNQLFESLKMSVASIVAHKLRSLLTMLGIIIGIASVVCVVALGLGAQQNILASISSIGT
NTIEVVSGRGLGDIRSGRTRLNLSDLKTLSSLPYLEAVEADVGKVGVVTYKNNSLQARIY
GVGPNHLRLRGFVMVDGRFINNEDIKDNTNICIIDENALRILFDNISAKDVLGKSVIFNK
QPLTIVGVLKKERDNKGFRADENTIKIYTPYSTLMNKITGDKQIRAIVTKVKDEVNPALA
EEAMVKILEIKRGKKDFFTINSDAIKNAIEENTATLTLLISSIAVVSLIVGGIGVMNIML
VSVSERTREIGVRMAIGARKEDILMQFLIEAVLICSLGAIFGVVLSFIIIEVFNSLNFGF
TMILSLNSVFLGLLSSVLIGVVFGFFPAKNAANLNPISALSKE
>B0NFD9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDVLKVIILGIVEGITEWLPVSSTGHLILVGDVLKPSMSDAFMEMFNVVIQLGAIMAVV
VLYFHKLNPFSPRKTSKQKMLTWQMWIKVLIASVPAGIVGLLFNDILDKLFYKPFPVAVM
LIVYGVLFIIVENRNVGRKPSVRRISELSVSMLIWIGIFQMLALIPGTSRSGATIVGALI
IGVSREVAAEFTFFLAIPAMFGASLLKLVKFGFHFTGAEFGLLILGCLVSFGLSVVAIKF
LMGYIKKHDFKIFGYYRIILGGIIIVVTLVQTFLA
>A0A0S3MWL6|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDNDTSINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADNYGLRPVFFITAS
VLILCFFVTLFCIKEKFKPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGSVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTASVVLFNAIYSWNSLRRRRLPQVSN
>A0A101HH54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTFKIIILSILQGITEVLPISSTGHLILIGRLLNSEISGDFFLLSVLHLGTTLAVIVFY
RKDLFKNFFTKEKWTFFLKLLLASLPAAVAGVFLQDYIASTFHGSTIIAISLIVVGLLFI
LFENIDLPTKKISPEKVDLKSMLIIGLGQTLALIPGTSRSGITTLTGMMVGLEKYSAFKF
SFILGIPILLGTTLYEILKEYLAVTSPTFFTASVVVAKTAPYILITFVVGYLALFLVSKF
KKSKWLTLFGIYRIVVGILILILAI
>F0EZV1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKKCRLLLHCPKPQKAACTPTPLLTTPLFRQPETALHPCRLLFPPKGQNVMSLIQCKDIN
RYFGTGENRVHVLKNINLTIEKGDFVAIIGQSGSGKSTLMNILGLLDTPTSGTYAIAGTE
TSKMSADELAALRRKRFGFIFQRYNLLSSISARDNVALPSVYAGIGHAERSRRADMLLDK
LGLKGKEKNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDSGSGENVMEIIRQLY
ADGHTIIMVTHDPKIAAQANRVIEIKDGEIISDHSKTAELPESNVQAIQEKRGFGFYKDQ
FAEAFKMSVQAIVAHKMRSMLTMLGIIIGIAAVVSVVALGRGTQEKILSDINSMGTNTIS
VFPGKGFGDRRSGKVKTLTVADSDAIAKLSYVESTTPSVSTSGTVTYRNIDLTAAANGAG
PQFFDVRGLKLDQGRLYDDEDVRSNAQVAVIDSNAVAQLFPDGSDPLGKVIMMDKRPLTI
IGTLKKEDNSFGDSSSVNIYVPYTTLMHQISGSKHINGIAVKVKDNVDSQTAEKGVKELL
LARHGTEDFFTRNSDSIKQTIESTMGSMTLLISCIAVISLVVGGIGVMNIMLVSVTERTK
EIGVRMAIGARQGNILQQFLIESILLCVIGGLSGVLISFGLAALFNSFVSDFAMSFSTAS
IIGAVLCSTAIGVVFGYMPAKNASKLNPIDALAHD
>A0A127SDB4|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-10|antibiotic inactivation|1
SHQEGAMKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCASN
DLARASKEYLPASTFKIPNAIIGLETGVIKNEHQLFKWDGKPRAMKQWERDLTLRGAIQV
SAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLY
LNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYF
FAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
>A0A0M4FC59|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-458|antibiotic inactivation|1
MTVRLSSTALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
LKAAAYDLAENLFEVGEAGGWRMHGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>ZP_03412557|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFMTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>D2AUZ0|FEATURES|UNIPROT_deepARG|aminoglycoside|Sros_3941|antibiotic inactivation|1
MSDHSGPQAISPVLLSVGGGDWLPVTAGESGAAVFRNADATRYAKCVPAADAADLKAERD
RVAWLNDQGVPGPRVLDWHSGDVGACLMTSAVSGISADQVPAEKLRVAWERIADAVRRLH
EVPVPQCPFRRDLDAMVAVARGVVARDAVNPEFLPVEQQHTPPGELLDRLTRQVPRRREQ
EAADTVVCHGDLCLPNIILDPRTLDVSGFIDLGRLGQADRYADLALLLANARETWKDEER
GRAADMAFAERYGIALDHERLRFYRHLDPLTWG
>N8QLU1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWARLWGAATGIFSGEPQGRRLGIGLILASIPIVLIGLTFGQTVKELLFNDIAIAIG
LIVGGLIIIWIEKHPPQERVHEVEDLSVKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSAHVFDGQQDWIVLATGIIVSFVSALLLIRAL
VAYVAKRDFMIFAWYRIASGLVILLFAFTGWKLW
>R5YBG2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEALKVIFLGIVEGITEWLPISSTGHLILVEEFVKLSLRHEFVEMFNVVIQFGAILAVI
LIYFNKLNPFSAKKSEKQKMMTIQLWIKVIIATLPAMVIGLLFDDFVDEHFMNAYVVAAM
LIIYGILFIVIEKKHEGVTPQATKLSQLTIPMALAIGGFQVLAMIPGTSRSGATILGGLI
IGASRSVAAEFTFFLAIPVMFGWSLLKMLKFGFAFTGQEFLLLLLGCVVSFVVSIFVIKF
LMQYIKKHDFKVFGYYRIVLGVIVFLYFTVSALLA
>C5TL54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILILFKTLILGIIEGLTEFLPISSTGHLIVLGDLMNFQSNGKVFEIAIQLGAVLAVVF
EYRQRFTHIIKGLGKERTANRFVLNLFIAFIPAAIVGLLFSKQIKLHLFNPITVATMLVL
GGFFILWVEKRQAKTKPKVNHVDDMRPIDAFVVGCAQICALIPGTSRSGSTIMGGMLWGL
ERKTATEFSFFLAVPMMIAATGYDILKNYKLFTLQDVGQIAIGFIAAFIAGLLAVKALLK
FVSSKNYVPFAYYRIVFGGLILLTWMLGWVSWSE
>YP_001746870|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKLALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>ZP_02848503|FEATURES|ARDB_deepARG|glycopeptide|VanRB|antibiotic target alteration|0
MDIRILLVEDDEHIGNTVKTFLIEAGYKVDVCINGIEAYTNFYNHTYQLVILDIMLPGMS
GHELLREFRKRNNTPILMMTALSDDENQIKAFDAEADDYVTKPFKIQLLLKRVGALLRRS
GALAKEIRCSNLTILPDDFRALYDGVELPLTLKEFEILMLLVQNKGRTLSHEIILSRVWG
YDFDGDGSTVHTHIKNLRAKLPENMIKTARGVGYRLEEDTL
>A0A0H0SHB8|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPN
VCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFGCKFCATG
TIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFDAMTILTDPSLFALG
HRRITISTIGLLPGIEKLTQEFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLMALDR
HIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGSWEHLYHVNLIPFNSTEVTPDSY
RQSDHSRIKAFVRILKSKGISVTVRTQFGSDINAACGQLYRSE
>T5KSP4|FEATURES|UNIPROT_deepARG|aminoglycoside|L681_07815|antibiotic inactivation|1
MGAPDPFTDGLPLPRAWQEALADAHIERQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGDEIARLRWLQEQGQPAPTVIATAEEAGRRWLLMSALPGRDLASSPELAPQQLVELLA
DALRRLHVLPVAACPFDQRLASRLQAAAARVDAGLVDADDFDDERLGQSAQQVFAELCST
RPDHEDLVVSHGDACLPNLMAVEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGAVADERRLAFYRLLDEFF
>A0A0A0Q9J9|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-18|antibiotic inactivation|1
MMKKSLCCALLLGVSCSALAAPVSDKQLAQVVADTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADVAANKPVTPDTLFELGSISKTFTGVLGGDAVARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDAVTDNASLLRFYQRWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMRYEQAMTERVFKPLALHHTWINVPEAEEKNYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMADWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
KTVVEGSDGKVALAALPAVEVVPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQVGIVMLA
NKSYPNPARVDAGYRILSALK
>Q6QV00|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PLERRLSRMFGRAVDVVSRNAVNPDFIPDEDKSTPQLDLLARVKRELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGMEAPDRERLAFYLRLDPLTWG
>A0A081S062|FEATURES|UNIPROT_deepARG|aminoglycoside|MEG1DRAFT_00859|antibiotic inactivation|1
MNNKYQQSSYIQSENDLYRIVVSSNPNFNDWLYLRSALWPVTSEEKHRDEMNSILDSDNK
VAFLIQSDTDDFYGFAEASLRFEYVNGCSSSPVAYLEGIYISPELRRKGLATRLINQIKS
WANDHGCTEIVSDAAINNEESQALHLSLGFVETERMVFFRKLIK
>YP_981592|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIALLIKAAIMGIVEGLTEFLPISSTGHLILAGALLGFDDDKAKVFDIAIQTGAIFAVI
LVYWQKIRSTLIALPNEKQAQQFALNVLVAFVPAVVLGLLFGKAIKAHLFTPVVVASAFI
VGGFIILWAEKRQQRNPATIRIHDVESMSTMDALKVGLVQCLAMIPGTSRSGSTIIGGML
LGLSRKAATDFSFYLAIPTLIGAGAYSLFKDRALLSMADAPMFGVGLLFSFLSAWLCIRW
LLRYIASHDFVPFAWYRIAFGIVVLATAWSGVVTWAE
>A0A0E1APA3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
PEDVNHPLWLERIRQLRPDYLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQ
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELG
LVEGARLRGAASGPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKA
DPHFHFVEGDIGIHSEWLEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIVR
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
QQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTD
VDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAG
FREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREA
QA
>Q2FC70|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHTKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
FK
>F5LGC0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSYTFEEFALPDKDSGPYGLTAGKDGAIWFTEQKGNRIGRIAPDGTITEYPVTAEDAGLS
VILSAADGALWFSGYKAGIIGRIRLTGEITEFSLPTADSGPFGLAEGPDGAVWFTEMTGN
KIGRITEDGTITEYGLPLPGAFPSFIARGSDGAMWFTENQGNRIGRITSAGEITGYRLPS
EQAGPVGITAGPDGALWFAEINGNRIGRISTTGGITEYPLPEPGARPHAITAGTQGDLWF
TEWGGNKIGRINTAGELSEYAIPREKAEPHGLVVGPDGAVWFAQESGQIGRLTVRSF
>R5PBP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLSIVEILKVVFLGIVEGVTEWLPISSTGHMLLVDEFIQIQASKEFKEMFFVVIQLGAIL
AVILLFWKKMWPFQMKDKSKPVCVKETFSLWFKVVVACIPGAIVTLLFDDYITAHFETPY
VIAGALIFYGIVFIIVERWNKTRTPKVEKLEDITYKTAFLIGLFQVLSIVPGTSRSGSTI
IGALLIGVSRVAAAEFTFFLAVPVMFGYSLLKVIKMSVAITSSELVILIVGCAVAFAVSL
VVIKFLMSYIKKHDFQVFGVYRIILGIAVIAYFALAA
>A0A029HTN1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFMNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLNWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0G3QEC2|FEATURES|UNIPROT_deepARG|chloramphenicol|AB182_14595|antibiotic inactivation|1
MKNTTPEYTTVDLSRWARKEHYEAFQGFAQCTFSQTVQIDITALLKHIQGVGWKFYPTII
FLLAKIVNRHAEFRMAIKNNELVIWNDSHPAYTIFHDETETFSSLWSHYDGNIQHFLKVF
SEDVAQYRHNLSYLPKEESRENIFFVSANPWVSFTSFNINIAHMDNFFAPMFTLGKYDKQ
GEKVLLPLAVQVHHAVCDGFHVARLINELQELCDDISQYSERLKN
>A0A0E3B2L9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNHYLNAFLRSIIEAVTEFLPVSSTGHLFLFSSFFPFSGESLEFDDLFDIFIQSGAILSV
LFLYREKFGSQMLSSFQYLTKRNSDSQGFYFLVQIVIGAFPILVVGFIAKKFLDTIKARP
DLLDILAIAWIFGGVLILIAEWFFQKRQGTEEKKTVGFRDAILIGIFQCVALIPGVSRSA
ATIVTARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKHRSILNEVTIPILAFGFLISFL
LCTLVIRLFLRYLQKHSFGVFGIYRILLGVGVLVFTKFIR
>YP_001457641|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGQFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>A0A0M0FUC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLPLLVIALILGIVEGLTEFLPISSTGHLIIIGDLLGYNDATSKVFKIVIQFAAILAVC
WDYRERLVRVAAGVGTEPAAQRFIGLLFIGFLPAAVLGLMFHSTIKGLLFNPLTVATALV
VGGLLILWIERRAYHPRINTIDEMRWPDALKVGFAQAAAMIPGTSRSGATILGGLVFGLS
RKAAAEFSFFLSIPTMFAATVYDLYKNRELLDMADLPVFAVGFVASFFAAMFAVKAFIHF
ISNHTFVAFAWYRIAFGLVVLATWQLGLVEWSEF
>AAN73274|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-8|antibiotic inactivation|1
MMRHRVKRVMLMTTTCISLLLGSAPLYAQANDVQQKLAALEKSSGGRLGVALIDTADNAQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKKVLSQKVEIKSSDLINYNPITEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARAIGDNTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLRNLTLGSALGETQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLILVTYFTQPEQKAESRRDVLAAAAKIVTDGN
>C8C179|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-206|antibiotic inactivation|1
MMSTFKVLLCGAVLSRVDPGQEQLGRRIHYSHNDLVEYSPVTEKHLTDGMTVRELCSAAI
TMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMA
TTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIA
ALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACD88490|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLEPNFIREMQEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNFQKRILLITASIFMMGISLT
ISGLLPQSGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGLFADRIGVNHWFLLSGILIICIAIVCPMINEIRKLDLK
>W0BJB7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGTLALLEAGYEIAAIFTHPDTAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDAIFSFYYRNLICDEILSLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVHRADAGAIIAQQRVVIDADETALQLHQKLCTVAQSLLRDVLPAI
LNGTFSETAQDESQSSCFGRRRPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSASPLIVSCGEQALEIVTGQTDNGVYVQGAQLAQSLGLVT
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
AGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKEGRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMDQTIDETLDFFLRTVELSEQVS
>A0A0T9TEX9|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSPLRRSLLLAGITLPLVNFSLPAWAAAPSDLLGNQLAELERKSNGRLGVTMINTANG
RKIQYRGTQRFPFCSTFKFMLAAAVLGKSQTQPDLLNKHIKYRESDLLSYAPITRKNLAH
GMTVSQLCAATMQYSDNTAANLLIKELGGVESVNAFARSIGDQAFRLDRLEPDLNTALPN
DPRDTTTPAAMAASMNKLVLGDALPATQREQLTLWLKGNTTGAETIQAGAPADWIVGDKT
GSGDYGTTNDIAVLWPTQGAPIVMVVYFTQREKDAKPRRDVLAAATKIVLSSLSPAKS
>A0A0C7CW29|FEATURES|UNIPROT_deepARG|aminoglycoside|neo_2|antibiotic inactivation|1
MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEVARRPTLFVKQEVLSAHAE
LPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAVPGDTLSALAQRGELEPERLVRL
VAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLL
DRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAA
WAEAFLVEYGGDIDGERLAYFRLLDEFF
>K4EJN1|FEATURES|UNIPROT_deepARG|beta_lactam|blaPER-1|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSLSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQAAQTAYQFELK
KLSALSPN
>F7QH36|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLADLLKAVVLGVVEGVTEFLPVSSTGHLLLVERFMDLDRENFWKTFAVMIQLGAILAIL
VIYFGRLWRIAVGMFSDPAARRFVIGVLLAFFPAVILGLLFGGFIKSVLFNPWVVCFTLI
AGGAVLLWVDQQDLNPRYHDATTFSLPMYLGIGIAQCAAMIPGVSRSGASIVAAMLFGAD
KRAAAEFSFFLAIPTMVGAFAYDFYKSRGEMTMDHGLVIAVGFVVSFITAIIVVKTFLDF
VTKRGFALFAWWRVIVGTLGLIALALGK
>C6SKZ0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIGFHSNHKVFEIAIQLGAVLAVVF
EYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIADVDALRPIDALMIGVAQVFALIPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFVAAFVSGLVAVKALLR
FVSKKNYIPFAYYRIVFGIAIIILWLSGWISWE
>S9T1C0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKVQGLNHLCFSVSDLERSISFYEHILEAKLVVKGRKLAYFDLHGLWISLNEEQDVPRDE
IHPTYTHIAFTVSEHDIDEIKTKLVQYGARILPGRERDERDKRSIYFTDPDGHRFEFHSG
QLADRLDYYKDTMPHMTFLE
>A0A0F4XXR5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQIARSILAGTFFLVCGTPAGFAQERIEDTVNAVIQPLMKQQDIAGMAVAVTYNGQRHYF
NYGVASKDTKKPVNDRTLFEIGSVSKTFTATLGAYAQAQGKLSLADPASRFAPELRGSAF
EGISLLNLATYTAGGLPLQFPDEADHPDRMFGYYTTWKPLYPVGTQRLYSNPSIGLYGYL
AARSLGRSFDEVMERTLMPGLGLKHSYVRVPQDQLGRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSSSDLISFLEANLRPEKLDADMKQAIATTHTGFYKVGGMNQGLGWEFYPAPFTLD
DLLAGNTPQMALTPQKAEALNPPRPPPDGTWINKTGSTNGFGAYAAFVPGKDMGIVMLAN
RNYPIEERVKAAHRILMALDGQ
>A0A0W0LKG0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGDRAAAFNIIIQLGAILAVV
WEFRRKILHVVVGLPKQQQAQRFTLNLLIAFMPAVILGVIFADLIHHYLFNPITVATALV
IGGVIMLWAERREHVVRAETVDDMKWTDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDVAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>A0A0N1BZ73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLAQYLDAVLLGLLEGLTEFIPVSSTGHLILLGEMLGFKGQAEDLFKVVIQLGAILAI
LLVYFQKLWGVVRGLVQGNGESYRFTAAILLAFLPAAVIGVFAHSYIKSVLFNPTVVSVA
LITGGIAILAAERLVPRPQHFAVEAFPPKLSLSIGFAQCLAMIPGVSRSGATIIGALLMG
VERKAAAEFSFFVAIPTMLGAATYDLYKNREVLAVDSVGMIAVGFIVAFLSALLVVRWLV
AFVGRHGFAPFAWYRIVIGSIMLAWLTFFAG
>R8N2F7|FEATURES|UNIPROT_deepARG|beta_lactam|IK1_01687|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNIVFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNKLIADAAEVIVKALK
>W0Q7Z2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MRKTTACMNLIEIENLNKYFGLGENQAHILKNINLIIEQGDFVAIIGASGSGKSTLMNII
GCLDTASSGICRISGKETQQMTADELSDLRQRKFGFIFQRYNLLPALTANENVALPAIYA
GMDTTSRKQRADNLLAKLGLDDKTRNRPNELSGGQQQRVSIARALMNGGEIILADEPTGA
LDSKSGETVLEILRDLHQEGHTIIMVTHDPNIAAQASRVVEIKDGEIIRDERPKPYSTEL
KLNKTPHKQPRFFDQLIESFKMASSAILAHKMRALLTMLGIIIGIASVISVVALGQGSQQ
QILANINSLGTNTMDILNGTGFGDRRANLTKNLTISDALTLSRQNYVESTTPSSNVNATL
IYGNTAVTGSVRGVGEEFMDVKGLKLISGRFFTAEEVKNVAQVIVIDPNTQKDLGLPNPV
EGEIILVDKKPLQIIGVAQQANAMNQTSLTLWSPYSTIMQRVSGAKQIDSLTVKIKDNVE
SQTAEKSITELLIARHGKKDFFIINSDSIKQTITDTTNTMTLLISSIALISLIVGGIGVM
NIMLVSVTERTREIGVRMAIGAKQRNILQQFLIEAVVICLIGGVIGILLASGIIWAFNSL
GSNFKMILSPESVIIAVLCSTLIGIVFGYIPARNASRLNPITALAQE
>Q9WWZ9|FEATURES|UNIPROT_deepARG|multidrug|ttgA|antibiotic efflux|1
MQFKPAVTALVSAVALATLLSGCKKEEAAPAAQAPQVGVVTIQPQAFTLTSELPGRTSAY
RVAEVRPQVNGIILKRLFKEGSEVKEGQQLYQIDPAVYEATLANAKANLLATRSLAERYK
QLIDEQAVSKQEYDDANAKRLQAEASLKSAQIDLRYTKVLAPISGRIGRSSFTEGALVSN
GQTDAMATIQQLDPIYVDVTQSTAELLKLRRDLESGQLQKAGNNAASVQLVLEDGSLFKQ
EGRLEFSEVAVDETTGSVTLRALFPNPDHTLLPGMFVHARLKAGVNANAILAPQQGVTRD
LKGAPTALVVNQENKVELRQLKASRTLGSDWLIEEGLNPGDRLITEGLQYVRPGVEVKVS
DATNVKKPAGPDQANAAKADAKAE
>R6GVH5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEILKAILFGIVEGITEWLPISSTGHMILLNNFIHLNVTSEFYKLFEVVIQLGAILAVVI
LYFKSIWPFKKEKEERKETFSLWGKILVACVPAAIIGLLFDDWFDARFYNSIVVSIMLIL
YGIIFIIFEKKNIGSKTTKSLKDITYKQAFVVGVFQVLALIPGTSRSGATIVGGLLIGLE
RKTIADFTFLLAIPVMAGASLLKLVKYIKDVGLVFATGELMILGVGSLVAFIVSIIVIKF
LLSYIKKHDFQAFGWYRIVLGIIVLLYFFLLK
>A0A0G3FCZ3|FEATURES|UNIPROT_deepARG|beta_lactam|blaB-15|antibiotic inactivation|1
MLKRIKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVT
DKGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYST
KMTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGC
IVKSGDSKDLGYIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISD
YQQKQKASN
>A0A086C1G9|FEATURES|UNIPROT_deepARG|polymyxin|G039_0306900|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIALHA
PEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMVERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTAADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQ
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGSLRGPASG
PQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGI
HSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPS
TSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFN
WMGPRLDRLESARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIID
NRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDG
YQDVAHRKPSIENARRLLDWQPAIELRETIGKTLDFFLHEALREREAQA
>A0A099TU97|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELFHAIILGIVEGLTEFLPISSTGHLILTSKLLGIPQDIFHKTFEVVIQLGSILAVIFV
FYEKLFKNSLYLWIKLALGFLPAGILGFLFYPYIKELFSPIIVSIALILGGIVFIILEIF
YKEKEHHTTEINTISYKQALLIGFFQALAMIPGISRSGATIVGGLLLGCNRKVATEFSFL
LALPTMIIASAYSLYRNHEVLNADNTLILGVGFVAAFFSALLAIKLFLSFVSRFNFIPFG
IYRIVLGVAFLYYLDII
>R9B454|FEATURES|UNIPROT_deepARG|aminoglycoside|F896_01059|antibiotic inactivation|1
MNIMPISESQLSDWLALRSLLWPDHEDAHLLEMRQLLKQTDTLQLLVYSETQLAIAMLEA
SIRHEYVNGTQTSPVAFLEGIYVLPEYRRSGIATQLVQCVEEWAKQFACTEFASDAALEN
TISHAMHRALGFHETERVVYFKKNIG
>C4I9L7|FEATURES|UNIPROT_deepARG|beta_lactam|GBP346_B2158|antibiotic inactivation|1
MPAAGAGRTRADRLLADPFCFSGLARGAATIVLVARVLVRKLSVCHNASPITRARAMPFP
DRPAFQAHAFDPDRANAVCRAVAFVGRKRSRTASWLDDPSRFAMFKSQQFIAAIWLSPGC
CIVFAARVAQFAAAAETGRMGEQDGLDERLLGVCGVRAVEEDRRRDSGEQNRIRRANEWR
PAIESSLRSFGPNDEPFPTLCGTTMKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTG
KLLLQDGDCGRRASPASTFKIAISLMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTD
PTRWLKYSVVWYSQQVAHHLGAQRFAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQI
SPLEQLEFLGKMLNRKLPVSPTAVDMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDW
ARGSGWFVGWIVRGKQTLVFARLTQDERKQPVSAGIRTREAFLRDLPRLLAAR
>E7SJB1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKSITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>ABG70292|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKSASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLCEDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPL
>Q63GU6|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMILAEVKKQEATACSLDDLTYRQALTIGFFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATSLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0P8WI24|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MVKGINHLCFSVSNLEKSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEQEEFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>A0A0V9EE96|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGTLALLEACYDIAAIFTHPDAAGENHFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDVIFSFYYRNLICDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQRVSIDADETALELHHKLCTAAQSLLRDALPAI
LNGTFSETEQDESKASCFGRRAPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAISRFLNNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDASSLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGSQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPENEASIRELAEMLLASFERHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>M5NW16|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIWDIIVAVILGIVEGLTEYAPVSSTGHMIIVDDLWLKSKELLTPEAANTFKVVIQLGS
ILAVAIVFKDRILNLLGLKKNITEAQKEGSRLSLAQIAVGLVPAAVLGFLFEDYIDEYLF
SVRTVAVGLIAGAVLMLVADWINKRKTATDSVDRITYKQALGIGLFQCLALWPGFSRSGS
TISGGVMLGLNHRAAADFTFIMAMPIMAGASLLSLIKNWESLSVDLLPFFIAGFISAFIV
ALFVVRFFLKLINKIKLVPFAIYRIILGILLFVLFL
>R6KYF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSVLEFIKVVILGIVEGITEWLPISSTGHMILVDEFIKMDMATEFKDFFLVVIQLGAILA
VVVLYWGKLWPFYIRQIPKKKKAQLARKNPVSRIALTFVEKFCDKDKWILWFKIVVACIP
TIVIALPFNDFIEEKFNNYVVVAIALIVYGVIFILVENYNKRRKPTCTSLEDLSFATAFK
IGIFQVLSVVPGTSRSGSTIIGGILVGTSRTVAAEFTFFLAIPVMFGASLLKLVKFGFAF
TPAEILTLVTGVVVAFFVSVIAIKFLMGYIKKHDFKAFGWYRIVLGILVLGYFIGRNFLG
>ABG68552|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTNYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKNWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHTVDHH
>F3H502|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSIKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPREKTFFGSVAQMCARHGITVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGENETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAEGQLPATLQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGE
NKLIVWAANAEAGNNGEAPGTVISHDPLRIACGEGSLIITAGQRGDSGLYLSGAQLAREF
GLVAGSQLLDKAQRRSIRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDERCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>A0A059IN92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTYMNDVWLGVIEGITEFLPISSTGHLLVAEHWLGARSDTYNIVIQAGAILAVTLIYWRR
LVELLTNWSDPDNRDYLFKLLIAFGITAALGLIVKKLGFELPTTITPIAWALLIGGFWII
AAEHFAAKLPDSTRITLRVAVAVGLAQIVAGVFPGTSRSGATIFVAMLLGTSNRAAATEF
AFLVGIPTMYAASGYELLKQFTHGAHHQVENWTSLGIAFVVSTITAFIAVKWLLGYIQVH
RFTIFAVYRILFGGLLLALTATGTLG
>E1KP18|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVEQGNPFVHAFTFIIQFGAILSVVC
LYWKKFFSFTKEMWKLYGLLIIGVLPAVVVGLAAKKSGLLDWLLDSIWVVAITLVLGGIF
MLFCDKLFNQGKEENEVTPKRAFFIGMFQCLSVIPGMSRSMSTIVGGMANKLTRKKAAEF
SFFLAVPTMAGATILDVYDMMKENVNWATSDNLLLLGIGCVISFFVAILAMKWFVSFLTK
YGFKAFGWYRIIVGGILLAMLLSGVSLNMVD
>AAQ16271|FEATURES|ARDB_deepARG|glycopeptide|vanWG|antibiotic target alteration|1
MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETS
SLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLN
LVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINE
GWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIA
SVCRTEKDKMTGSQTEKELYVNQCKIAYKLPDDVKIEERGV
>A0A0W0N4A2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPKARRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVRAETVDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADFPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAVFAWYRIAFGLVILATWQFGWIDWTAVKP
>ZP_04233366|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MSEFSLIFYLFKEERGVLKGINHLCFSVSNLENAILFYERVLEGELLVKGRKLAYFNICG
VWIALNEEAHIPRKEIHQSYTHLAFSVEQKDFERLLHRLEENNVHILQGRERNVRDCESI
YFVDPDGHKFEFHSGTLQDRLNYYREEKPHMTFY
>A0A0I9RXB2|FEATURES|UNIPROT_deepARG|beta_lactam|EC81_0210815|antibiotic inactivation|1
MKKSRRKRLVILCIALVCIIVLVFLLFSKSTSNNSTNPPLTDVLTDSISRIVSACPGEIG
VAIIINNTDTVKVNDKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVKIDRNRLDSKTW
SPMMKDYSELVISLTVRDLLRYTIAQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHDRAYFNYTSPLGAAMLMNRLFTESIVSGEKQSFIKNTLKECVTGTDRIV
APLLDKERVSIAHKTGSGNVNENGILAAHNDVAYICLPNNVCYTLAIFVKDFKGNESQAS
QYVAHISEVVYSLLIQNSAIP
>A0A0L6K2T1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLVSIALALPTSAKARRFVLAVALAFLPAAVIGALAHDFIKTVLFETPMLICVVLI
IGGVILLAVDRMPLKPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDGALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGSLGLIALLVFG
>N8V1X7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILSGQLLDFWTIEKRDMFAVAVQIGAIAAV
IYEYRGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTKEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMMVLAVGIIVAFISALVVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>A0A0P0QE16|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLSQPYEIILVDDGSSDNSADMLTA
AAEKPDSHVIAVLLNRNYGQHSAIMAGFNQVTGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVVALSGFVLALVLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGAQHDHNTQEEE
>H1C1X1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A069ZKH0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQSIILALVEGLTEFLPVSSTGHMILTEGILGMESTAYLKAFTVMIQFGAILSVVVY
YFRRFLPFPIFGLKPDPTTSLGGWRLYGLMIIGCIPAAILGALFNDTIDDLLGNTWVVLT
MLFLGGILMIYFDRIFTNKTERKVTTQNAFIIGLFQCLAMVPGVSRSMATIFGGMQQGLT
RRQAAEFSFFLAVPTMFGATLLKGYKLYKELGMGVFEENWQTLLIGNVVAFLVALLAIKF
FISFVTKYGFRAFGYYRIILSVGIAIALLLGANISLG
>H1HI26|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DKATSGKYYIDGEDISDFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVD
HDNRMERAKKLLEKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDS
KSGIMVMKILNQLHEEGHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQKEIKKELQED
KKSINNLKKNKFQVAKDQFFESFNMSVSAIIAHKMRSLLTMLGIIIGIASIVCVVAIGNG
SQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTDVDILEKQSYVDSVTPNSTSS
GTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALIDENTQKSLFGE
NENPIGKVILFNKKPLKIIGTVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
VKDDIDSQVAQKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVV
GGIGVMNIMLVSVTERTKEIGIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIG
WGFNSISKNFSMIFSVFSIVMAVLFSTLVGIVFGYMPAKNAAKLDPIEALSRE
>Q9X5C0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIVLAAHPVKAITPPTPAVRASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A069CMH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTAGRLKLGHILLAMIPAVVLGLLFHDFIKSLFAP
KNVMYALVVGGFLLLAAEWLKPKKPSAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTI
AGGMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTMGDLPMFAVGFATAFVVAL
IAIKTFLSLIKRISFVPFAIYRFIVAAVVYMVFM
>A0A029L7J9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDIARWVQINLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A090UKU1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEATPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSSDRSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>A0A125X9Z8|FEATURES|UNIPROT_deepARG|beta_lactam|AB34_4949|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>ZP_03030551|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVHKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDAIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AAPVVEKK
>A0A0M4JL69|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYYTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>A0A064DN59|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEAAPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSSDNSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFTLSVVLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSNEENRA
>W8PVB3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHIAKSLLAGTFLLACGTTPGFAQERIEETVNATIGPLMKQQGVAGMAVAITHNGQRHFF
NYGVASKDTKKPVTDQTLFEIGSVSKTFTATLGAYAEAQGKLSLSDPASRFAPELRGSAF
DGISLLNLATYTPGGLPLQFPDEADHPDRMFDYYKTWKPLYPTGTQRVYSNPSIGLFGFL
AARSLGQPFDEVMEHTLMPGLGLKHSYVRVPQDQLGRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSSSDLIRFIEANLQPEKLDADLRKAIATTHTGFYSVGGMTQGLGWEFYPYPISLD
ELLAGNAPQMAMTPNKVEPLDPPRPAPDDAWINKTGSTNGFGAYAAFVPGKNMGIVLLAN
KNYPIEERVKAAHRILTALQAQ
>A0A0W0PH22|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDIEALHETSINSDQPLLHLQQVSRSFMAGDREFQVLKHIDLAIHTGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVNGQETREQDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAIYAGTAQVKRHERAQALLTHLGLGGHLQHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDHKVAANAERIIEISDGEIIS
DRRTAQATQPVPEAQPAKQPGMAPRRLMASLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLLPTDVAALN
QLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSDQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNLWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>A0A0A0Q7Z6|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-6|antibiotic inactivation|1
MMTKTLCCALLLSTSCSVLAAPLSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAKNKPVTPQTLFELGSISKTFTGVLGGDAVARGEISLGDPVTKYWPALTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDSASLLRFYQNWQPQWKSGTTRLYANASIGLFGA
LAVKPSGMSYEQAITTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMKPDAIQDTSLRQGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVDGSDNKVALAPLPASEVNPPAPPVKASWVHKTGSTGGFGSYAAFIPEKSLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A0E2LL05|FEATURES|UNIPROT_deepARG|beta_lactam|M001_07410|antibiotic inactivation|1
MKGWMKCTLAGAMVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELI
DHYEALIKAVPQS
>A0A0H5RR67|FEATURES|UNIPROT_deepARG|aminoglycoside|BN2156_03163|antibiotic inactivation|1
MTDWQPVVHGESGAGVFRSADGSRYAKVVGPAAVADLAAERDRVSWAHDHALPVPAVVDW
GSTADGGAFLITSAVTGVGADRLPESALRQAWPSIVAAVRDLHGIAVGDCPYRRDLDDML
ARAGSVVAAGAVNPEFLSDADRGVAPAALLARVEVEADLRRRQESADQVVCHGDLCLPNI
LIDPERLTVEGFIDLGRLGLADRHADLALLVANTADTFPGFADDAAAGLAAGYPAAVDPE
RLRFYLALDPLTWG
>A0A038GNZ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMLLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLDFTSEKAKVFDIAIQTGAIFAVI
LFYWRRLVDTAAALGDSARARRFVLNVLIAFLPAVVIGLLVGKAVKAHLFTPTVVATSFI
AGALVILWAERRPKSTVRVFTVDDMSPFDALKVGLLQCLALVPGVSRSGSTIIGGMLVGL
SRNAATEFSFFLAIPTLIGAGAYSLFKERHLLAATDAPLFAVGLIFSFLSAWVCVRWLLR
YVATHDFVPFAWYRIAFGVAVLVTAHFGWVNWAD
>A0A0Q6I169|FEATURES|UNIPROT_deepARG|beta_lactam|ASG61_24945|antibiotic inactivation|1
MKSWNTVFRPLKFKKIVPALLLTCVTLAGCSEGNDQSVQAKQKNQESVIKHHFVKLEDKF
DARLGVFALDTSTNQTVTYRADERFIYASTSKALAVGALLQQKTIDDLNQRITYTQDDLV
NYNPITEKHVDTGMTLKELCDAALRYSDNTAMNLILKQIGGPNGLEKSLRDVGDNVTMPE
QFEPELNDVKPGETHDTSTPRALATSLQSFTLGDALPVEKRGLLIDWMKRNTTGDSLIRA
GVPKGWVVADKTGAGSYGTRNDIAIIWPPKGDPIMLAILSSRDKKDANYNDKLIAEATKE
VINAYQANHK
>A0A069ARV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSLDVIFILKSVIIAIVEGLTEFIPVSSTGHMILVGNLIDFKGQFAEMFEVVIQLGAIL
AVVVLYWKKIKDSVIEFFKFIFTGGKEGKIGFRFGMNVIIGCIPFAIIGVLFYDNIKSLF
NLQSVIIGFIVGGILLLVVETLFRKKNPSTDNIDKITPIQALKVGTLQVLSAWPGMSRSA
STIMGGWIAGLNSPTAAEFSFFLAVPAMVASSGKDLFEFDYSIMTPTLWIALVVGFIVAF
IVSIIVMEKFVNFLKKKSMRVFAVYRIIMGVVLAVLAFTNIISV
>A4STN9|FEATURES|UNIPROT_deepARG|beta_lactam|ampS|antibiotic inactivation|1
MLPPPGPLSHSPRRPHVPDPVTRPARSRPDILTASQLPPASTFKIPLALMGYDSGFLVDE
NLPALPFKPGDDDWLPAWRETTTPSRWLTYSVVWYSQRLTEWLGMERFQQYVDRFDYGNR
DLAGNPGKHDGLTQAWLSSSLAISPQEQARFLGKMVSGKLPVSTQTLQHTANILRQPDID
GWQIHGKTGMGYPKLLDGTLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASLKAK
EEVFAALPDQLKKL
>J3HIN4|FEATURES|UNIPROT_deepARG|beta_lactam|PMI39_02504|antibiotic inactivation|1
MTFAATPDVDAIVDQAIKPLMQQQAIPGIAVAVVVKGQPHYFTWGMADEKQQRPVTQETL
FELGSVSKTFTGVLSGVAVNKGEIALSDRASKYWPALNTPQWRDITLLQLATYTAGGLPL
QVPDAVTDEKALANFYQQWQPQWAPGNTRQYANSSIGLFGWLATKPSGLTFEQAMQQRVF
TPLQLKHTFITVPDSEKDAYAWGYREGKPVRVSPGLLDAEAYGVKSSIKDMARWMQANMD
PQQVKDKTLQQALNFAQTRFYRTDALYQGLGWEMLDWPSQADMAVKGADNKVALGPQPVR
DAKAHPRVTASWVHKTGATGGFGAYVAFIPEKQVGIVILANKNYPNTERVKAAMQILKAL
Q
>E8PKS8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPIQEDPFLKTFLIAIQLGAILAIL
LLYGRRFAVDRALWLRIGAAFLPTAAMGFLLYPLIKGKILGNDGIVVFFLFSVGLVLLLA
DRLAERARYGDVLELPLARVALIGLFQGLAALFPGTSRSGATILGGLLLGLRRKAAAEFS
FLLALPTMLAAVGYDLLKSAPAVPEGGWNLLGMGFLAALVTALLTVRWMLSFVERHGFRP
FAYYRMALALVYAYFFLR
>NP_756491|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLNFPWQSLFWTMAIMGVAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>YP_001346370|FEATURES|ARDB_deepARG|beta_lactam|BL1_pao|antibiotic inactivation|1
MRHATILNLCGLAASTLFFATTSAFATEAPAERLKALVDAAVQPVMKANDIPGLAVAITL
KGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWP
ALQGSRFDGISLLDLGTYSAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNP
SIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDRPLRVG
PGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPIDLKRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRD
VGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR
>A0A0X5FPP5|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAALAASDKPRENCESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>M4KTJ2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEIKGINHLLFSVSHLDTSIDFYQKVFGAKLLVKGRTTAYFDMNGIWLALNEEPDIPRND
IKLSYTHIAFTIEDHEFEEVSAKLKRQHVNILPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLRYYKQEKTHMHFYDETAF
>D2JBV1|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSNAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A0E1E7S6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHNKKLALSGFFAVSLLLSGASACLAASQPDSALKPLVDAAIRPLMQQQDIAGMAVAITI
KGQPHYFNYGLASKEEQKAVDADTLFEVGSVSKLFTATLGAYAQASGKLSLDDPASRYLP
AFKGSPFEHISLLQLGTYSAGGLPLQFPEQWDSQDKMLGYYQGWKPAFAPGAQRLYSNPS
IGLFGYLAAQSLGQPFEQLIEQKLFPQLGLQHSYIQVPKSQMGNYSQGYGKDGKPVRLGP
GALDAEAYGVKTTAADLLRFVQANLKPESLPQPWPQAIAITHTGYYQVEGMTQGLGWELY
PYPLSLDALLAGNSSQMAFEPHPTRWFTPPQAPRANTLLNKTGSTNGFGAYVLFVPGKDI
GLVLLANKNYPNAERVKVAHALLKALDDQAGAAKQP
>A5WCV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLILKAVIMGIVEGITEFLPISSTGYLILSADLMSFWTKEKADLFIVVIQLGAILAV
IYEYWGRLWHALMGLITGKSEGPNALKNPRQLGLSLIVATIPVMLVGFTLADQIKEYLFN
PYTVAIMLILGGLLIFYVERKQIPVIAEEAEDVSLKTALLIGLMQCLALIPGTSRSGSTI
IGALWLGVSRKAAAEFSFFLGIPVIIGAGLLDLLKHKDVLSSGQDWLILGVGVLVSFVVG
LLCIRWLVDWVSRRDFTIFAWLRIITGIIVLLVAWIFGYTIQG
>A0A0E2QE21|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MATLLELHNITRRYPAGEQEITVLKKVSLKIHSGEMVAIIGASGSGKSTLMNILGCLDKP
SSGEYYVAGQNIAELDNDQLAQLRREHFGFIFQRYHLLSHLSAEQNVEIPAIYAGAGKAQ
RQERAEKLLQRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMKILKDLCAQGHTVIIVTHDPKVAQQAERIVEIKDGEIINDSGALAVKVAEFPAKAV
IRKNPLGQWVSRFSEALLMAWRAMVVNKMRTLLTMLGIVIGIASVVSIMVIGDAAKGMVL
NDIKSIGTNTISVYPGKDFGSDDPENRQVLKASDISAIAQQPYVQSVTGSIETSARLRKG
NLDAVARVSGVGTDYFQVYGSHFSEGMGFTQDMLTRRAPVVVIDRNTKRRFFPNKQNVVG
DTLLIGNMPATIIGVLGEQKSIFGSSKSLEVFLPDTTINSKLINRSYYDSIVVRVNEGVD
AKVAEQQLVRLLTLRHGKKDIFTYNIDTLVKTAEKTTQTMQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAVLVCLIGGLMGIGLSYGVSLIAQMA
LPGWTFEFDPIALISAFACSTAIGVIFGFLPAKNAAKLNPIDALARE
>M5QGI6|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic efflux|0
MQAGLRIDVDTYRGTREGVPRLLELLDEAQIKATFFFSVGPDNMGRHLWRLIKPQFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGKDLGHLMRQTLAAGHEVGLHAWDHHGWQANTGRW
SEAQLIEQIRRGVDTLSDITGQAVECSAAAGWRADERVVQAKETFGFRYNSDCRGHSLFR
PRLADGSLGAPQIPVDLPTFDEVVGPELSAADFNSYILDRFSPQKLNAYTIHAEVEGILM
ANDFRQLLAQARTRDIHFQPLRDLLPADPDSIAAGQLSRGVLDGREGWLGVQKP
>A0A0U2M1D0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFELLKAIFLGVVEGITEWLPVSSTGHLILVQEFIKLNQDKAFLDMFNIVIQLGAILA
VIVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSILIAVPFDDWFEAHFNYMIPIA
IALIVYGIAFIWIEKRNANIEPEVTDLAHMPYLTAFWIGCFQVLSIVPGTSRSGATILGA
IIVGTSRSVAADFTFFLAIPTMFGYSGLKAVKFFLDGNVLNFSQFLILMVASVTAFLVSL
YVIRFLTDYVKKHDFTIFGKYRIVLGTILILYSIAKNIF
>A0A0J7EQB6|FEATURES|UNIPROT_deepARG|beta_lactam|TU65_13465|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGITQFVSTVSSVQAEQKLEQKVIKNEAGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSASIENVLKRYGNINSVVPGH
GEVGDKGLLLHTLDLLK
>A0A060KQ49|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A7I298|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIDLININKNFPLGDSQINVLKNINLHIDKGEFVAIIGQSGSGKSTLMNIIGCLDTPSSG
EYKIENRDVAHFTSDDLANLRSKKFGFVFQRYNLISSMNALENVALPAVYAGASTEFRTK
RAKEILNELDLKDKMQNLPNKLSGGQQQRVSIARALINGGEIILADEPTGALDSKSGETV
MQIFTDLYKKGHTIIMVTHDKHVASYASRIIEIKDGEILSDTKKNDEIFELKSEEIVQKN
IFSSYKDRFIESFKMSVSAIFSHKLRSVLTMLGIIIGISSVICVVALGKGSQEKIISSIR
AIGTNTINIMPGKSAADARLNKIKTLTIEDSNVLANQPYIDYSTPNTSANGLIAYANLSS
NGILSGGGANSLAIRSVELQSGRNFTDDDIKNSASVVIIDQNTVDTFFTNTDPIGKILLF
KNRPLLIIGMAENEKFSSQDRLKIYAPYTTVMNKISGNRDISSITVKISDNVSTKTAEDS
ITAILTKRHIIKDFHTRNSDTIKETIESTMGTMRLLISSIAVISLIVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKESNILEQFLIEAILLCSIGGVLGIIIALGFGAAFNSVSSDFVMK
FSLMPAITALIASCAIGIVFGYLPARNASRLNPIDALSQE
>E6GKQ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYFAFISERNGDMLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLDLSKDFMEM
FNVVIQLGAIMAVVILYFHKLNPFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDY
LDAHFYNFLTVSIMLIVYGIAFIIIEKRNKNIAPKCTNLKDFTYKAALIVGAFQVLALIP
GTSRSGATILGAILIGASRFVATEFSFFLGIPVMFGASFLKIFKFLAKGNTFGSEEIIIL
LTGSIVAFVVSIIAIKFLLNYLKKNDFTVFGWYRVILGAILIGYWLFS
>N8R0V8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAFSVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESKQFEHKTLDATKITFKQAFLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>A0A0Q7HDK9|FEATURES|UNIPROT_deepARG|beta_lactam|ASD05_04445|antibiotic inactivation|1
MNPPVQRRSLLLAASVLPLASACTAWSRTGSPSSAEAQLAELERASGGRLGVAGFHTGSG
ARIQHRAHERFPLCSTFKLMLAAAVLERSAKDVSLLARHIGYGKADLVSWSPITEKHVAD
GMTVAELCAATVQYSDNGAANLLLKMLGGPATVTAFARGIGDQAFRLDRTEPELNTAIPG
DLRDTTTPAAMSDSVQRLALGDALGTAQREQLKDWLLGNTTSTERFLAGVPAGWKVGDKT
GSGSYGSTNDVGVLWPPAGAPVVLSVYLTFPQKDAKGRNDVIASATRIVVAALAG
>W4CTB0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIVKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANSFKVVIQLGS
ILAVVIIFRNRFIDLLGLGKLSRKDLAVVPEGQRQAPAEGRLKLTHILVGLLPAGIFGFL
LEDYIDEHLFSTFTVLIGLVVGALFMICADRFAPANARTESVDQITYRQALSVGLIQCIS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLLKNWQYFTLDALPFF
IAGFISAFIFALVSMRFFLKLINRIKLLPFAIYRIVLAGVVYLIWF
>R7CSF0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYEYFCAVVVGIVEGLTEYIPVSSTGHMIIVGHMLGFEGTLADLFDVFIQLGAILSVLVV
YREKFKFILNTHHWFRRRGPSVLNVAISMFPASLMGLIFHDFIKHKLFSPYTVIIGLVLG
GVFMIFAEKKRKKFTVTDVDRITSRQALKIGFFQCLSLWPGFSRSGSTIAGSLLLGISRK
AAADFTFIMAVPLMFLACTFDLIKVIPYLQTSDFGILAVGFFTAFIVAYASILWFLKFLN
NSTLTGFAVYRFFVAIVAFIYFW
>C3VJU8|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
ELNDLEKKYNAHIGVYALDAKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKK
VHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTATNKIIKEIGGIKKVKQRLKE
LGDKVTNPGRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNN
KSGDTLIKDGVSKDCKVADKSGQAITYAS
>A0A069P772|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMLKALVLGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQAKTFDVVIQFGAILAIC
WEYRAKIGSIVSGLPTRPDARRFAVNVIIATIPAIVLGLLLEKKIKAVLFSPVPVSVALI
IGGIVILWAEARQRDRAVPPRVHSVDDLTYADAFKVGLAQCFALIPGTSRSGATIIGGML
FGLDRRAATEFSFFLAIPIIFGATLYEMAKYWRTLTVDDLGLFAIGLVSAFVSAFICVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A0H3ELJ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGMLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>NP_250709.1|FEATURES|CARD_deepARG|multidrug|amrA|antibiotic efflux|1
MHIQWTGSLRGLLAALVALFLLGCEEAADAGKTAEAPAEVGVIVARPAPIGITSELPGRL
EAYRQAEVRARVAGIVTRRLYEEGQDVRAGTVLFQIDPAPLKAALDISRGALARAEASHA
AAADKLKRYADLIKDRAISEREYTEAQTDARQALAQIASAKAELEQARLRLGYATVTAPI
DGRARRALVTEGALVGEDSPTPLTRVEQIDPIYVNFSQPAGEVAAMQRAIREGQVKGVAD
KDIAVRLVLADGSEYPLAGELLFSDLAVDPGTDTIAMRALFRNPHRELLPGGYVQVRLQR
AVNPQAITVPRDALIRTAQSAVVKVVNPKGLVEDVEVRADTLQGRDWIISRGLKGGEWVI
VENAAQHAAGSSVQAVVRQPASADAPSPLAASPAGQ
>A0A0W8EE82|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSYWHALLLAIVEGLTEFLPVSSTGHMVIVANLLGIGQLPFTETFITSIQLGAILSVVAL
YWRRFLQSFDFYLKLAVAFLPFGILGFLLKDVIAELLKSVTVVATSLVVGGIVLLFIDRI
FKEPGKQITTPSYAKALKVGLFQCLALVPGVSRSAATIVGGLAQGFDRRSAADFSFLLAV
PTMTVITAYELYKTYKLNPLQAADIKVLLFGNAVAFVVALLAVRSFVTFVSRYGFRAFGI
YRIIVGVIILTMIGLGINLQLV
>ZP_03284540|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLTGFSSMSQAENLLQVYQQARLGNPDLRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYGNGYRDNNGVNSNATSASLQLTQTLFDMSKWRALTLQEKSAGIQDV
TYQTDQQTLILNTATAYFNVLSAIDSLSYTEAQKQAIYRQLDQTTQRFNVGLVAITDVQN
ARSQYDSVLANEVTARNNLDNALESLRQVTGNYYPELASLNVDSFKTDKPQAVNALLKEA
ENRNLALLQARLSQDLAREQIRQAQDGHLPTLSLSASTSVSDTTYSGSKTNTQAYDDKNI
GQNQVGLSFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRNVVQTVRSSFNNVNASIS
SINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQQLSSARYQYLINQLN
IKQALGTLNEQDLLALNNALGKPVSTSPESVAPENPQQDAAVDNFNGNGNAPVAQPASAR
TTAPAGNGNNPFRQ
>YP_001974113|FEATURES|ARDB_deepARG|multidrug|smeA|antibiotic efflux|1
MSFLRPLSRSPRPLLLPLLLALAACSAGRTDAPAMPEVGVIIASAQPLALQQTLPGRAVP
FEISEVRPQVGGLIRQRLFTEGQQVKAGQLLYQVDPAPYQAAFNTARGQLAQAEATVLSA
QPKAERTRALVSMDAASKQDADDATSALKQAQANVIAARAALQAARINLDYTRVTAPIDG
RIGTSSVTAGALVAAGQDTALTTIQRLDPVYLDVTQSSTQMLALRKQLDAGLVKAIDGKA
QVKVLLEDGSTYAHEGTLEFVGSAVDPSTGNVKLRAVIPNPDGLLLPGMYLKAVLPMATD
ARALLVPQKAVVRNERGEPLLRLLDAKDHVVERRVSTGQVVGNQWQITSGLKAGERVIVS
NGSAVSLGQQVKAVAATTAQLAAMPAVDPNGNTDEKSH
>A0A0D0QC74|FEATURES|UNIPROT_deepARG|beta_lactam|RW25_29605|antibiotic inactivation|1
MEGMMVLKNKRMLKIGICVGILGLSLTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGD
RITMSDRFETELNEAIPGDIRDTSTARAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALK
>A0A117LRV3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGVVEGITEFLPISSTGHLLLVNRLVGFTGSFANMFDVIIQLGAILSVVVYFWHRINPFS
SRKTDKEKKQTWDLWRTTLVGVIPALLVGGTIGKLVEDALFNPLTVAAALVIGGIVLIIV
EKGARFSTINSISALNYKTAFFIGLIQCLAMIPGTSRSAATIIGAMLLGASRSVAAEFSF
FLAIPTMVAASAYSFLKADASLSAAEWQILSIGFVVSFLVAWLVIAAFMNYIKKKDFKPF
GYYRIIVGLAVFYIAFMK
>A0A127SHD5|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-12|antibiotic inactivation|1
CFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGYLVDEEHPALPYKPSYDGWL
PAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQA
WLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYTANILKVSEIDGWQIHGKTGMGYPKK
LDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASIKAKEEVQAALPAQLKKQ
>A0A0U5IM19|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-55|antibiotic inactivation|1
MNKGLHRKRLSKRLLLPMLLCLLAQQTQAVAAEQTKVSDVGSEVTAEGWQEVRRWDKLFE
SAGVKGSLLLWDQKRSLGLSNNLSRAAEGFIPASTFKIPSSLIALETGAVRDETSRFSWD
GKVREIAAWNRDQSFRTAMKYSVVPVYQQLAGEIGPKVMAAMVRQLEYGNQDIGGQADSF
WLDGQLRITAFQQVDFLRQLHDNKLPVSERSQRIVKQMMLTEASTDYIIRAKTGYGVRRT
PAIGWWVGWLELDDNTVYFAINLDLASAGQLPLRQQLVKQVLKQELLLP
>YP_002114152|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDKIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>A0A0P0GGT1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTXM-15|antibiotic inactivation|1
CSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQ
YSDNVAMNKLIAHVGGPASVTAFARQLRDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQ
TLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTN
>F4MZW6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSESKKIKKVSIVIPVYNEQESLPILIERTSAACKLLTQPYEIILVDDGSSDNSAELLTA
AANEPESHIIAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRAHRQDSVFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGAEQTENNQEVEK
>A0A097SRS7|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
PIFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEER
FPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSA
AITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVA
MATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGI
IAALGPDGKPSRIVVIYTTGSQG
>G5H1P3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIAFMELVKVAVLGIVEGVTEWLPVSSTGHMILVDEFIRLDVSTAFMDMFLVVIQLGAI
LAVVVLNVGKLNPFLTSKSRQERRETFDLWGKVIVACLPAAVIGLAFNKYMEEHFMNAPV
VAAMLILYGILFIIVERWNKRRVPRVESLAQLDYRTAFIIGIFQVLSLVPGTSRSGATIL
GGIIFGASRYVATEFTFFLAIPVMFGASFLKLVKFGWNYSGTELVILGVGMATAFIVSIL
SIRFLLRYIKRNDFTVFGWYRIALGIVVLAYLFIIGDPTKG
>ZP_03903435|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDNLLVAAVLGIVEGLTEFLPVSSTGHLIITGHWLGFTGTKAATFEVVIQLGAILAVVVL
YRRRFWGLLRPRAEEAFSGVRGLWLLFLTSLPASLLGLAVHDAIKTHLFGPVTVAWALGV
GALAILLVEALPRRPRVDSLDSLTPWLALGIGCFQCLALWPGFSRSAATIMGGMLLGARR
KVAAEYSFIAAVPIMVAATGFDMLGNYGLFSAEDFLFLGVGFVVSFLAAWAAVKVFIRLL
AVTTLRPFAWYRLVIAPLVLVLLS
>A0A0C2I2K4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQAVILGIVEGLTEFLPISSTGHQIIVADLLNFGGERAVAFNIIIQLGAILAVV
WEFRHKVFSVVRDLPTQRNAQRFTLNLLVAFLPAVVLGVLFKEIIATYLFNPITVAAALV
VGGLIILWAERRQHVVHADTVDEITWKDALKVGFAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGYGFRHQFQMADLPVIALGFVTSFVFAMIAVRGLLKF
IASHTYVAFAWYRIAFGLVILATWQFGWVDWSTKG
>A0A0G0ELH2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIYQALVLGIVEGLTEFLPISSTAHLIFASNLLKIAQSDFIKLFEVFIQAGAILSVIIL
YAKYIFQHAKIAKKVIVSFIPTAIIGFLLYKIIKVYFFENYFLITCMFILVGLVFIAIEF
LIKKKKLKLDKQLSKTTFFHALIIGLAQSLAVIPGVSRSGIVMVAMMSLGYVRKESAIYS
FLLAIPTIIAASFYDLYKSRDIISLDYENIMLLTIGFISAFITAYISMKWFISFLQNNTL
MKFAWYRILLGIILFVVNR
>A0A0D0PUE6|FEATURES|UNIPROT_deepARG|beta_lactam|RT27_27150|antibiotic inactivation|1
MFVLNKFYNILHYKKIVTVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>CAP72501|FEATURES|ARDB_deepARG|trimethoprim|dfrA17|antibiotic target replacement|1
MLWSSNDVTQQGSRPKTKLAIKGVKLKISLISAVSENGVIGSGPDIPWSVKGEQLLFKAL
TYNQWLLVGRKTFDSMGVLPNRKYAVVSKNGISSSNENVLVFPSIENALKELSKVTDHVY
VSGGGQIYNSLIEKADIIHLSTVHVEVEMISNSL
>YP_408416|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLPIMVNDVAGAP
SAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFT
LICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKS
AHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>BAG80136|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLALLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNKLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEER
>A0A0P0QCM8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MAALLQLSGIRRSYRSGEQTVEVLKGISLSIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLSDDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAEALLRRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCAQGHTVILVTHDPAVARQAERIIEIRDGEIIADSRPAPQENAQAKPLAL
AAAAPSWRQMGGRFREALSMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTYRQSLKYGDLDALREQPYISALSPSISSSMRLRL
GNVDAAANVNGVSEQFFRVYGMSFTQGVGIDPMQVQSQAQTVVIDANTQRRLFPHQKNVV
GEVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNSYFDSITVRIRDGY
DSKEAEQQLSRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLAVQL
VLPGWQISFPPAALLSAFLCSTGIGVVFGYLPARNAARLNPIDALARE
>A0A0A8P2R8|FEATURES|UNIPROT_deepARG|polymyxin|pbgP|antibiotic target alteration|0
MTFEKIKKVSVVIPVYNEEESLPQLLARTVTVCQKLEQEYEIILVDDGSRDSSADILTRA
AEIPENHVIAIFLNRNYGQHSAIMAGFHQADGDLVITLDADLQNPPEEIPRLVDAANEGY
DVVGTRRANRQDSWFRKSASRLINAMITRVTGRSMGDYGCMLRAYRRHIIRAMLQCHERS
TFIPILANTFARKTIEIDVTHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGS
IIAVTGFLLAVLLITLRLIFGSMWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGVKKTSENDNQEKS
>A0A0B1Z690|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIVVADLLGFGGERAMAFNIIIQLGAILAVV
WEFRRKIFEVVLGLPTQPGARRFTANLLIAFFPAVILGVLLADWIHHYLFNAITVATALV
VGGLVMLWAEKRQHRVHAESVDDMTWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAIGFITAFIFAMIAVKGLLRF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKP
>A0A0P7KUH5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFLTFIQVLVLGAVEGLTEFLPISSTGHQIIVADLLGFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIVKGLPTQLKAQRFTLNLLIGFLPAVILGVLFADNIHEYLFNPITVAVALV
VGGVVMLWAEQREHVVHVEHVDDMRWPDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEYSFFLAMPTMVGAAVYSGYKYRDLFQASDLPVFALGFVTAFIFAMIAVRGLLKF
IASHSYAVFAWYRIGFGLLILATWLFGWVNWTAATAA
>D6IFV3|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQMLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVTAHEEIHHHA
>A0A0P9ASA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTTITALILGVVEGLTEFLPISSTGHQIVVADLLSFGGERAMAFNIIIQLGAILAVV
WEFRRKILEIVTGLPTQRNAQRFTLNLLIGFLPAVVLGVLFADKIHEYLFNPITVAVALV
VGGVIMLWAEQREHVVYVDHVDDMRWSDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQAGDLPVFALGFVTAFIFAMIAVRGLLKF
IASHSYAVFAWYRIGFGLLILATWVFGWVDWNGAAAL
>K1J4P3|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1171_03569|antibiotic inactivation|1
MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSASLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAKLKTL
>A0A0A5SCX6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSIVIPVYNEQESLPALLERTTAACKQLSQPYEIILVDDGSSDNSADMLTA
AAEKPDSHVIAVLLNRNYGQHSAIMAGFNQVTGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SIVALSGFVLALVLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGVQQDHNTQEEE
>F9DGV6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLFQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVEQGNPFVHAFTFIIQFGAILSVVC
LYWKKFFSFKPEMWKLYGLLIIGVLPVVVVGLAAKRSGLLDWLLDSIWVVAITLVVGGIF
MLFCDNIFNKGKEENEVTPKRAFLIGLFQCLSVIPGMSRSMSTIVGGMANKLTRKKAAEF
SFFLAVPTMAGATILDVHDMMSEKVEWATSNNLFLLGIGCVVSFVVAIFAMKWFVNVLAK
YGFKAFGWYRIIVGIILLVMLLSRVSLNMVD
>A0A0N1KIJ5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFKDEFEEIKKVSVVIPVYNEEQSLPILLERTIAACKQLSQTYELILVDDGSSDRSAKL
LTEAAENPDNHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVKTA
EQGYDVVGTRRANRQDSWFRKTASKMINSMITRATGRSMGDYGCMLRAYRRHIIQAMLQC
HERSTFIPILANTFARRTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLS
VVGSVIAVSGFLLAVLLIVLRLIFGAMWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGR
IYNDVRARPRYFIQKVVGTDVKADKNQEEN
>A0A0R2CNR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGVTEFLPISSTGHLVLVDEFIQMEQSKAFVDMFNVVIQLGAIMAVV
VIYFNKLNPWATQKSSLEKKQTWTLWKKVIVAVIPSVIVGLPLNDWMDAHLMNWLVVSIA
LIFYGVLFIVIENRNAQTQPKFSDLNTLSYKTAITIGLFQVLSLIPGTSRSGSTILGGIM
VGTSRYVAAEFSFFLAIPTMFGASLLKLYKFFKHGGSLAGLQGVILAVGVLVSFVIAYIS
IRFLLNYIKTKDFKIFGWYRIILGIIVIGYFLIFH
>A0A0M3AA06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFHVLILAIIQGLAELLPVSSSAHVILAEKLMGFDPSAPDMTFLLVMLHTGTMFAVIV
YFWASWRKTYFSSITNFKKQAGFIILATAITGILGLTLQALIKHVFFAGAKHFEIEQLFS
NSKLMAAALVSAGILIILSAQLDRGQTGEISLKSAAWIGAIQALCLPFRGFSRSGATIST
GLFLGVARQKAEEFSFALAVVLTPAVIVKEFYRLMHAENFQHMHLSQLLFPSVLGMVFSF
IAGLAALKWLSSWLEHGRWQLFGFYCIGFAGVVLALG
>A0A089LVU1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAVILAIVEGITEFIPVSSTGHMILTSKLLGFSEQDNLMKTYEIVIQLGAILAIAV
VYRQRILNLLGIGRSRDRGGVMPRSRLNLIHVLLGIVPALAVAFFARDFIKSLFSASTVV
WALVAGGILMIVAEWVNKRKVRITAQEMDDISYGQALAIGLYQIISVLWPGFSRSGSTIS
GGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKEITGDTFVMFAIGFVVSFVVAYV
VVMLFMHFIQKIRLTHFAIYRFILAAFFWLFIMR
>R5FNS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSPDMLIEALKALLLGVVEGITEWLPISSTGHMILVDEFVQLNVSPGFLELFLVVIQIGS
IMAVIITFRHKLNPVSRTKDEVERHKTWRMWGMVVIGSIPAAFFGLLLDDWAHDNFYSAF
TVAAMLILYGIIFIVIERYNRRRKERVLGTVEKPIGKHGRVEAIDPSDPEAVDKALFKIV
DPYEMDWKTAIKIGCFEVLAIIPGTSRSGATIIGGMLCGCSRTAAAEFTFFLAIPVMFGW
GLVKAVKFFLDGIAMTQTEIVVLVVGILSAFIMGMIAIRFLMGYIKQNDFTVFGVYRIII
GLIVLGYFGTKALGLM
>YP_002932544|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVLAIIMMLAGALAIMSLPVAQYPTVAPPAVTISASYPGADAATVQNS
VTQVIEQNMNGIDNLMYMSSTSDSAGNASITLTFEAGTDPDIAQVQVQNKLQLAMPSLPQ
EVQQQGVSVDKASSSILLVAGFISEDGSLSQDDIADYVASNIKDPLSRTQGVGSVQLFGS
QYAMRIWLDPNKLNKYNLTPVDVVSQIKVQNNQIAGGQLGGTPPVPGQQLNASIIVQTRL
KDPTEFGKILLKVQQDGSRVLLRDVARVELGAENYGTIARYNGKPAAGIAVKLATGANAL
DTAKAVKTELARLAPYFPASLKTVYPYDTTPFVQLSIDEVVKTLLEAIVLVFVVMYLFLQ
NIRATLIPTIAVPVVLLGTFAVLEIVGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
SEEGLPPKEATKKSMEQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSSMVL
SVLVAMILTPALCATMLKPIAKGDHGVQTGFFGWFNRLFEKSTHHYTDSIGRILRGTGRY
LVIYLLIVVGMGLLFIRLPTSFLPEEDQGVLLTMAQLPPGATQERTNNVLKQVSHYYLTK
EKDNVESVFTVSGFGFSGQGQNNGLAFVSLKPWDERKGDQNKVTAIIQRAAVAFSKINDA
MVYPFNLPAIVELGTASGFDFELIDQANLGHEKLTEARNQLLGMAAQHPDLLVGVRPNGL
EDTPQFKLDIDQEKAQSLGVSLADVNQTISAALGGAYVNDFIDRGRVKRVYVQADAPFRM
LPSDIDNWYVRSSNGQMVPLSAFSSSRWEYGSPRLERYNGLPSMEILGEAAPGKSTGEAM
ALMETLVAKLPAGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLATSLRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAVDLMHKEGKGLV
EATLEAVRMRLRPILMTSLAFILGVMPLVISNGAGSGAQNAVGTGVMGGMVSATILAIFF
VPVFFVVVRRRFGRRSEDLEHSRPVEPHNK
>J7GS97|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGFQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>YP_215847|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALISPLLGPLVGAAWVHVLPWEGMFILFAAL
AAIAFFGLQRAMPETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIA
QSPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLI
ITAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNLQTV
>A0A0M3RS84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVYIYKFIISIITGAIEGITEFLPISSTGHIIIISHWLGISHKNTDVLKIFVQLGSAIAI
LIFFFKKIINIVTFKRRKKRTKNIHILISLIPTASLGMIFYNDIKLLFNIKNIMYALIFG
GFFLIISEIFKPKKNKINSINDISVLQSFIIGCFETLCLYPGFSRSGATIGSAILLGIKR
SVAINFSFIISIPLTIGASILDLIKNINNMSTNHIPYYLSAFFISLIISLISINKLIKIL
NKFSLKIFGFYRVILASVIYFIN
>P85302|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
ATDIRQVVDSTVEPLMQQQDIAGLSVAVIQNGKAQYFNYGVANKDSKQPITENTLFEIGS
VSKTFTATLAGYALANGKLKLSDPASQYLPALRGDKFDHISLLNLGTYTAGGLPLQFPEE
SDNTGKMISYYQHWKPAFAPGTQRLYSNPSIGLFGHLAAQSLGQPFEKLMEQTVLPKLGL
KHTFISVPETQMSLYAQGYDKAGKPVRVSPGALDAEAYGIKTSTSDLIHYVEVNMHPAKL
EKPLQQAIAATHTGYYTVDGMTQGLGWEMYPYPIKVDALVEGNSTQMAMEPHKVNWLTPP
QAAPLDTLVNKTGSTGGFGAYVAYVPSKGLGVVILANKNYPNAERVKAAHAILSAMDQ
>ABN11268|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0U1EMB4|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MSLNEPIKKVSIVIPVYNEQESLPALIDRTTAACKLLTQAYEIILVDDGSSDNSTELLTA
AANDPDSHIIAILLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVHVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGNSKYSLMRLINLMYDLITCLTTTPLRLLSLVG
SAIALLGFTFSVLLVALRLIFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGAEQTENNQDVEK
>B8ZI24|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDXAVIWPENHAPLVLVTYFTQPQQDAKN
>A0A0Q6L4I1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIIDALLLGLLEGLTEFIPVSSTGHILLAGHFLGFNSTGKTFEILIQLGAILAILS
VYWARLWRMLVDLPRDPQTQRFVAGILIAFLPAALIGAFAHGFIKTVLFESPRLICVMLI
LGGFVLLLLDKLDLKPRYGDVTNFPFSVYLKIGLFQCLAMIPGTSRSGATIVGSLLMGVE
KRAAAEFSFFLAMPTMAGAFAYDLYKNRDILSVADLPVIGVGFIAAFVMALLVVRHLLDY
VSRNGYSLFGWWRLIVGGIGLIALTVWG
>AAT45022|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-14|antibiotic inactivation|1
MVTKKVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLATLEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIRPTDLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>A4BCD2|FEATURES|UNIPROT_deepARG|aminoglycoside|MED297_13282|antibiotic inactivation|1
MNIRTMTLKDREVWAEMRSSLWPEFDEDHTPELDKYFAGQSRDVTEAFIAEVDGQAAGFI
ELNIRNYAEGSHEPAVPYVEAWYVASEFRGQGLGKQLMARAEQWALERGYIELASDTDEW
NAYSIEQHTKLGFKETGRVVCFLKTLTKKP
>A0A0Q8BEN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQSQTIIEALLLGLLEGSTEFIPVSSTGHILLAGHFLGFKSTGKAFEVLIQLGAILAILS
VYAGRFWTFLKRPDRIWLLGETIVGVLASLVWLGGCAFELVASAVRRRKPNLFLPPELPN
DPAVRMMVSLAIGFLPAAIIGVLAHDFIKTVLFETPKLICIMLILGGIVLLWIDRLDLKP
KYASVADFPLSLYLKIGLFQCLAMIPGTSRSGATIVGGLLMGADKRAAAEFSFFLAIPTM
LGAFTLDLVKNWGALSAADFPIIAAGFIAAFVMAVIVVRSLLGYVSRHGYALFGWWRLIV
GGVGLAALFIWG
>A4ZZ91|FEATURES|UNIPROT_deepARG|beta_lactam|blaACT|antibiotic inactivation|1
LCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGK
ADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIR
MLDLATYTAGGLPLQVPDGVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKP
SGMSYEQAITTRVFKPLRLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKT
NVQDMASWVMVNMKPDSLQDNSLRQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVIE
GSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYP
NPARVEAA
>A0A010T6Z8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAVQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGEREKAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTVNLLIAFMPAVVLGVIFANMIHKYLFNPITVATALV
VGGIIMLWAERRVHTVHAETVDEINWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQAADLPVFAIGFVTAFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWVDWSAATS
>AAV80410|FEATURES|ARDB_deepARG|tetracycline|tetT|antibiotic target protection|1
MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRAST
VSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLN
IPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQ
IIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFA
ITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIK
SLESVMNGEIVKVDQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPC
DLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILKLFGNIQMEVIESLLKSRYKIDARF
CELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSF
QNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGT
EILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSEL
LSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN
>ZP_04146665|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MEKMKKNILLKLGVCVSLLGTTQFVSTISSVQASQKVEQKVMKNEAGTISISQLNKNVWV
HTELGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHA
HADRIGGMKTLKERGIKAHSTALTAALAKENGYEEPLGDLQTVTNLKFGNMKIETFYPGK
GHTEDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYRNITSVV
PGHGEVGDRGLLLHTLDLLK
>R8DUN6|FEATURES|UNIPROT_deepARG|beta_lactam|ICC_03068|antibiotic inactivation|1
MVLKNKRMLKIGICVGILGLSLTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRITM
SDRFETELNEAIPGDIRDTSTARAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
EVIVKALK
>B7TCL6|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA3|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0H0ZVW7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNEQSIVGAALLGILEGLTEFIPVSSTGHILLAGHFLGFRSTGRAFEVLIQLGAILAILS
VYSARLRDLFVRMPPAPGARHFLFGVLLAFLPAAVIGALAHGIIKTVLFETPMLICVMLI
LGGFVLLWVDRWAIKPKYEDASKYPMSMYFKIGLFQCFAMIPGTSRSGSTIVGALLLGAD
KRSAAEFSFFLAMPTMVGAFAYDLFKNRDILTVADLPIIVTGFVMAFFSAVIVVRRLLDF
VSRRGYALFAWWRLVVGTVGMIALLIWG
>A0A0S3NFF9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLLAISYSTFAASHSEQQINEIVHRTMTPLIEQQQIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQQTLFELGSVSKTFTGVLSGDAIAREEITLSDPVTKYWPELTAKQW
NRITLLHLATYTAGGLPLQVPDDIKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAVAWQILNALQ
>A0A0X1S0M1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSEILKAIILGLVEGLTEFAPVSSTGHMIIVDDMWLKTKDFLGSSSANTFKIVIQLGSIL
AVVVVMWKRLLSLIGLYHIEGQTKHHRFNLLHVIVGIIPAGVLGVLVEDYIDAHLFSIKT
VIIGLFIGAIFMMIADRFAWKKPRVMSLDDLTYKQAFQVGLVQCLSLWPGFSRSGATISG
GVLLGLDYRVAADFTFIMAVPIMAGASGLSLFKHYQDINPDDLNFYIVGFISAFIFALLS
IKFFLKLISRIKLMPFAIYRIVLAAVLAWIVFF
>A0A0Q0X208|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFYALIYGIVEGITEFLPISSTGHLILTGNLMGVPWSKEVKDAFEVVIQGGAILSVLV
FYWRDFLKIRHVNTDPQQRTLWLGVLVACIPAVILGLLFGDAIKANLFRPSVVAWALIVG
GVLMWLIESRRVTPSVSAIESIGVRRSFLIGALQCLALLWPGFSRSASSILGGMALGLDR
ATATKFSFYLGVPTLGGAALLNLIQERELIFGEIGLLNVVIGAGVSFVTAYLAIGWLLKF
VSTNTFKGFAVYRVIVGILILILLATGVMSNGSLA
>A0A0Q9HCV9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQGINHMCFSVSNLEQSITFYQKVLGAELLVQGKSTAYFSLNGLWLALNEEKNIPRSDI
QYSYTHLALSISIENFDEARELLKQHNVTVLPGRNRDERDKKSIYFMDPDGHKFEFHTGT
LQDRLAYYQEEKPHMIFYPLKE
>A0A0S8Z5L1|FEATURES|UNIPROT_deepARG|aminoglycoside|ASE98_04520|antibiotic inactivation|1
MIKRCTLLDHDGWLPLRVALWPDSASDNDHVKNTILSAPERYLVLIFVDEQGNASGFAEA
SLRADYVNGTHSSPVAFLEGLYVQPASRGQGIARQLVAGIQQWAEEMGCTELASDALLNN
QGSHAMHEALGFTETERVVYFLKSLGANKA
>L8B0T0|FEATURES|UNIPROT_deepARG|beta_lactam|AQU-1|antibiotic inactivation|1
TSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPHYFN
YGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFD
GITMAELATYSAGGLPLQFPDKVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLA
ASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVNPGMLADEAY
GIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGRYSVGGMTQGLGWESYPYPVSEQAL
LAGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTSGFGAYVAFVPAKGVGIVMLANRSYP
IQE
>M5APG0|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIVMALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSSILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A0L0QTJ1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTLKGINHILFSVSDLERSITFYQHVFAAKLLVKGRSTAYFDVNGIWLALNEEKDIPRQE
IHHSYTHIAFSIDEADFDRMYQKLQRLNVNILEGRSRDERDKKSVYFTDPDGHKFEFHTG
TLADRLAYYKEEKQHMEFFLD
>K6D6L7|FEATURES|UNIPROT_deepARG|aminoglycoside|BAZO_16289|antibiotic inactivation|1
MMRDLSNEKIPKQAMQALKIVEELLGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLP
EVTRKKLTDRLMLISGKIGNTDFVRPLEVTVINHNDVVPWLYPPRNEFTYGEWLRSEFEK
GQIQEPTYDPDLAIVLAQARKNSISLFGPDASYILDPVPMTDIRRAIKDSLPGLIEGIKG
DERNVILTLARMWQTVSIGEISPKDVAAKWALPRLPKEYSTLLDLARKAYRGEHFDKWEG
LDSELTALVNHMKNSIESCLSQTQEKQ
>YP_002240485|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLEVPPSA
FTPPPKVDSAVVRLVPHRTMPYPVKEVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTE
LGVDPAVRAENISVEQYCKMANWLSNNLPSKES
>CAI59792|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>Q2J2D8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLSDIIRAVILGVVEGVTEFLPVSSTGHLLLVGRFFNLGEGDFWKTFDVLIQLGAILAIL
ALYFAKLWRIALGMFSDPAAQRFIIGVLVAFLPAAVIGAAAGSYIKLFLFNPWVVCFSLI
VGGAVLLWVDQLDLKPRHHDATTFPVLMYFYIGCAQCVAMIPGVSRSGASIVAAMLFGAD
KRAAAEFSFFLAIPTMVGAFVYDLYKSRADLTTDHMTIVAVGFVVSFITAIIVVKTFLGY
VTRHGFQLFAWWRVVVGTLGLIALAMGR
>AAX19284|FEATURES|ARDB_deepARG|glycopeptide|vanA|antibiotic target alteration|1
MNRVKVAILFGGCSEEHDVSVKSAREIAANIDNEKYEPLYIGITKSGVWKMCEKPCAEWE
NSNCYSAVLSPDKKMHGLLVKKNHEYEIHHVDVAFSGMHSKSGEDGSIQGLFELSGIPYV
GCDIQSSAICMDKSLTYTIAKNAGIAIPEFWVINKDDKPAADTFTYPVFVKPARSGSSYG
VKKVNVADELDAAIESARQYDSKILIEQAVLGCEVGCAVLGNSSELIVGEVDQIRLQHGI
FRIHQEAEPEKGSENAVITIPADLSAEERGRIQETAKKIYKALGCRGLSRVDMFLQDNGR
IVLNEVNTLPGFTSYSRYPRMMAAAGITLPELIDRLIVFALQG
>A0A0M8XQB3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTQAVIREVALTGPGSGPYSITVGPDGALWLTLAGSGGVARLGLDGEVRTYRDDPPDSRP
LIIVAGPDDALWYTRSGDDRLGRITVDGNVDSVALPPGSAPCGLAAGADGALWYAGMGDD
TVGRVTVDGVVTTYPLPVAKGFPSMLAAGSDDALWLTLNQGNAIARVDLDGAVTVHPLPT
EAAGPVGITAGGDGALWFVEIVAGQLGRITPDGRIDEFPLPDRAARPHAIVADPGGGCWF
TEWGANRIGHIDAQGRITGHDLPTPASEPHGLTVTSDGAVWAALEIGAVAHLGVTR
>W3VD31|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLSTLFHAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFTGDKAETFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGEAPHEGKTNGKLKLSHILLAMLPAVTLGLLFHDTIKSLFNPQS
VMYALIIGGVLLIIAEILKPKTPKAEGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVNRYTASEFSFILAVPMMMGASGLDLYKSLHFLTASDIPMFAVGFITAFIVALIA
IKTFLALIKRMSFIPFAIYRFIVAAAVYWVFM
>T3DFZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEVFKAVILGIVQGITEWLPVSSTGHMILVDEFIKLNFSDTFISTFLVVIQFGSILAVL
VIFFKKLNPFDSSKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDIDRLFFNSTVVAIA
LIVYGIIMIGLEKRNKRPKYKDFSQVTYKLALCIGLFQCLALIPGTSRSGSTIIGAVLLG
ASRYVAAEFSFFLAIPTMLGASALKLLKAGFGFSGFEWLILGVGSVVAFIVSIVVIKFFM
DYIKKHDFKVFGYYRIVLGIIVLAYFFLF
>A0A060P1L6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|BRPE67_ACDS28220|antibiotic efflux|1
MSGPIVELSNVSLHYAAGDERVLVLNEISLTINAGEFVAIVGASGSGKTSLLNIIGCLAR
PSAGKYRLAGESVLEADRGTLARLRREYFGFIFQRYNLLPQLNATENVEVPAVYAGLPAV
RRRYRAQELLTSLGLGNRVEHRPNQLSGGQQQRVSIARALMNGGKVLLGDEPTGALDSKS
AREVMESFISLHRQGHTVILVTHDEKVAAHAHRIIKIEDGIIVGDKPTCKAKVRSTGSSS
LGGSDHVNVAKKAEEVDSAACGAVGESERLQSLIPCLRTSVEIALRSLANSRLRSVLTML
GIVIGVAAVVSIVALSAGAKERMLDTIRSLGTNTVTFWPNVYSDAEKQSSRSSLTLSDLS
LMSTQDEVDSATAEIEQSVLLKYQDAHGLGTLDGVNKDYFRVRGLRFVGGRSFDDDDIEK
RSQVAVISQQTQRKLFGPHGDAIGKIISLNDVPVRVVGVAEEKRGMFSDPRALDVWMPLV
AATTRVTGSRPPDRIIVRVKEGYRSDDAEAHLGRALRKRHGRRDFESFNANSFARALNKT
ERIMSVLMVVIAITTLGVGGIGVMNMMLVSINERTREIGIRVAVGARHRDITQQFLTEAV
FLCVTGGLFGLILSCGLSVVVSHVAPDWQMLHSPITAVTAFASATLVGIVFGLMPARRAA
GLDPIDALAHE
>A0A0B2JK06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEELSLFQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVPSSDFVKAFTVIIQFGAILSV
VVLYWKRFFKLNKCKIFDTDIVNNNDRSARWIEYGKRFLYKYDFYWKLLIAFIPAAFFGL
LFSDKIDEMLESVTVVAVMLVIGGIVMLFVDKWFAKSSPNQEMTPKKAFCIGLFQCIAMI
PGVSRSMATIVGGMAQKMTRKNAAEFSFFLAVPTMFAATAYKLLKLVTSENGLQILQDNI
IPLIVGNVVAFIVAFLAIKFFISFVTKYGFKAFGYYRIIVGGIIIVFMLLGYNLEID
>C7F8X9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTXM-15|antibiotic inactivation|1
PCGSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAA
LQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAM
AQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQA
>A0A089IXN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLAIIKAIVLGLVEGLTEFAPVSSTGHMIIVDDIWLKSQEFLGKYTANTFKVVTQLGS
ILAVVVIFRKRFIDLLGLKRFSKESLEPVPDGQLQVQTGGRLKLGQVIVGLIPAGLLGML
FEDYIDEYLFSTSTVLIGLVIGALFMICADLFAPKRARKQSVDQITYRQALAVGLIQCVS
LWPGFSRSGSTISGGVLLGLSHRAAADFTFIMAVPIMAGASLISLYKNWQYFTLDALPFF
IAGFISAFVFALLSMRFFLKLINRIKLLPFAIYRIVLATVVYIIFF
>A0A127SCB6|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-29|antibiotic inactivation|1
MIKKSLCCALLLGVSCSSIAASMTEKQLADVVEKSITPLMKAQSIPGMAIAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDSASLQRFYQTWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGFEQAMTTRVFKPLGLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVVANMAPDNVQDASLKQGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVRASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A0E9BV84|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGINALLKAGFTISAIYTHADTASENHFFGSVARIAAENSIPVYAPD
EVNHPLWIDRIKSAEPDVIFSFYYRNLLCDQILNSAKQGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVKKADAGEIIAQQRVAIADEDNALTLHRKLVDCASALLESALPAM
KQGNIVGTPQNEADATVVGRRTPEDGRINWALPASQINNLVRAVTDPWPGAFAFAGTTKF
VVWKAKVLSTPHNVRPGTVLSAEPFVVACGEGALEIQTGQTANSVYMNGVQLAQHLGMVN
GALLYSQAVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVFGLDIGSDAISRFVGHP
RFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYGKRIIFPSTSEVYGMCTDANFDEDHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLFDGGRQKRCFTDI
SDGVEALFKIIENKNNNCDGQIINIGNPDNEASIKELAERLLESFERHPLRASFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLGWTPTVEMNTTIDNTLDFFLRTVELQDDKE
>D6SA31|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEILKVILLGIIEGITEWLPVSSTGHILLLDEFIKLNMSDAFKSMFTVVIQLGAILAV
VVIYWKKVWPFKKGQTHLISISKSKMIMWAKIIVACIPAAIIGIKFDDFIEVHFYNYFVI
SLALIIFGILFIIIENKNKESHKKLVDSIDKITYKQAFIVGLFQVIAAIFPGTSRSGATI
LGGIAIGLSRTVAAEFTFFLAIPTMFGASLLKLVKFGFSFTAMEAFVLLLGTAVSFIVSV
ITIKFLMNYIKNNDFKVFGYYRIALGVLVLIYFGLIR
>YP_001587036|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAL
GQLIYGPMADSLGRKPVILGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAIAAILASVM
IFALIKETLPVERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVPPQDFGYYFALNIVFLFVMTIINSRFVRRVGALNMFRAGLWIQFAMAVWMVFSA
LMGIGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFTSAWPMIWSIALCAACSILFYLYASRPKKR
>A0A108CUI1|FEATURES|UNIPROT_deepARG|beta_lactam|WM16_03815|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLALTLNACASPRANASSVGAATSLAELERAAGGRLGVYALDT
ATGRRVQHRADERFPFCSTFKAVLIAAVLAQSAARPALLARHVMYRQADLVGWSPVTEKH
VDAGMTVGELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWETELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQYVQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTINDIGVLWPPARGPIVLTVYYTQARADAKGRDDVIAAATRIAIAALG
>D7RF79|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDSLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYPGQEDRLASRADQ
LEEFVHYVKGEITKVVGK
>A9L2W2|FEATURES|UNIPROT_deepARG|beta_lactam|Sbal195_2383|antibiotic inactivation|1
MQRHTLLATMPLLSGVLLTATLFSNVTTAETLNTKDIQSLVDSAVKPLMAEYGIPGAVIG
ITIEGKQYFYQYGVSSKTTGQSVTEHTLFEIGSISKTFTATLANYAQIEGKLSLTDMTSD
YVPALKGSHFDEISLINLATHTAGDLPMQVPDKVTNNAELMDYLKHWQPSFAAGTNRNYA
NPSIGLLGMIAAQSLNKTFQQALEQTLFPQLGMTSSYIQVPSSKMADYAQGYNKQDMPVR
VNPGVLADEAYGVKTTATDLLHFVEANMQIHPLAKPLQTALDETHTGYFDVGMMTQDMIW
EHYSYPIDLDKILEGHTQEVVFGSTPVKPIVPPLAPQQNVWINKTGSTGGFAAYAAFIPA
QKLGIVLLSNKNYPVPPRVTVGYQILTGIEKLQK
>A0A0C5VH06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWTLATGLGERDNRDYVLKVSVAFLVTAVVGVIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHVAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSRRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWADVAVAFVAATITGFVVVKWLLSYIKKH
RFTVFAVYRIVLGAALLLWLPAAAG
>A0A060KZ34|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIRPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A127T6C3|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-34|antibiotic inactivation|1
MLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIAN
NRPITQNTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTRYWPELTGKQWQNISLLHLA
TYTAGGLPLQIPDEVTNKTALLRFYQNWQPQWAPGAKRLYANSSIGLFGVLAVKPSGMSY
EEAMIRRVLQPLKLTHTWITVPQNEQRDYAWGYRDGKPVHVSPGQLDAEAYGVKSSIMDM
ARWVQANMDASHVQEKTLQQGIGLAQSRYWRIGEMYQGLGWEMLNWPVKADTIINGSDSK
IALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLANKSYPNPARV
DAAWRILEKLQ
>E9RZN7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEMLKVILLGIVEGITEWLPISSTGHLILVDEFIKLQASAAFKEMFNVVIQLGAIMAVV
VLYFHKLNPFSPKKTQKQKAWTIQLWMKVIVACIPAGVIGILFDDWMEAHLHKPEIISAM
LILYGILFIVVENWNKGKTPKVTKLSQLSYQTALLIGGWQVLSLIPGTSRSGATIVGALL
LGTSRYVAAEFTFFLAIPVMFGASFVKILKFGLSFTAMEAAMLLVGCLVAFVVSVIAIKF
LMGYIKKNDFKVFGYYRIILGALVLLYFTVFA
>A0A0N0BLK8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAPMSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPIEQDAFLKTFLIAIQLGAIL
AILLLYGRRFLADRALWLRIGVAFVPTGLMGFLFYPLIKGVILGDDRIVVFFLFFVGLVL
LLADRLAERARYGDVRELPLFRAAWIGFFQGLSALFPGTSRSGATILGGLLLGLKRKAAA
EFSFLLALPTMLAATGYDLLKSSHQVPEGGWGLLLLGFLAALLTALLTVRWMLGFVERFG
FRPFAYYRMVLALVYAYFFLR
>P36555|FEATURES|UNIPROT_deepARG|polymyxin|eptA|antibiotic target alteration|1
MLKRFLKRPVLGQIAWLLLFSFYIAVCLNIAFYKQVLQDLPLNSLRNVLVFISMPVVAFS
VVNSVLTLASFIWLNRLLACVFILVGAAAQYFILTYGIIIDRSMIANMMDTTPAETFALM
TPQMVLTLGLSGVLAAVIAFWVKIRPATPRLRSGLYRLASVLISILLVILVAAFFYKDYA
SLFRNNKQLIKALSPSNSIVASWSWYSHQRLANLPLVRIGEDAHRNPLMLKGDRKNLTIL
IVGETSRGDDFSLGGYPRDTNPRLAKDDVIYFPHTTSCGTATAISVPCMFSDMPRKHYDE
ELAHHQEGLLDIIQRAGINVLWNDNDGGCKGACDRVPHQNVTELNLPGQCIDGECYDEVL
FHGLEDYIDHLKGDGVIVLHTIGSHGPTYYNRYPPQFKKFTPTCDTNEIQNCSQEQLINT
YDNTVLYVDYIVDKAINLLKSHQDKFTTSLVYLSDHGESLGENGVYLHGLPYSIAPDTQK
HVPMLIWLSKDYQQRYQVDQACLQKRASTLDYSQDNLFSTMLGLTGVQTTYYQAADDILQ
PCRRLSE
>F1AW48|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
FSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWET
ELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPA
GWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLR
>CAK55562|FEATURES|ARDB_deepARG|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVEPGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVLVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>J8F9A6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNQIGRINATGEINSFPIPTANAGAM
SIISDQNGDLWFTEYNSSKIGKMSMNGLFEEYVLPTTNAAPFGITEGPDGAIWFTEMNNG
RIGRITKSGEITEFELPNSKSSPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPT
PNSGPVGIASGPDGAIWFVQIMGNKIGRITFEGEVKEFVIPTSNARPHAIIPGKNRDLWF
TEWGGNQISRITVEGFITEYTIPTNNAEPHGITICPDGDLWFAEECNQIGRLTIIT
>A0A0M2ZY89|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFELLKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRQKIIELVRGFFSGDIHARRFTINVLVAFIPAVVIGVLAVDFIKQVLFSPLVVAFAL
IIGGLIIFAVEARKFEPKTIEATDITLKQAILVGFAQCVAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLIRNADVLTSDNLMNISVGFVAAFIAAILVVKALVK
FVEKHTLRVFAWYRVVLGIILLIVFL
>YP_236040|FEATURES|ARDB_deepARG|multidrug|MexF|antibiotic efflux|1
MNFSKFFISRPIFAAVLSLLILIAGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVASPLEQAITGVEGMLYMSSQATADGKLTLTITFALGTDLDNAQVQVQNRVTRSEPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDKRYDMLYLSNYAVLNIKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTATDVVNAIREQNRQVAAGQLGSPPSPNATSFQMSINTQ
GRLVSEEEFENVVVRAGADGEITRLKDIARIELGSSQYALRSLLNNQPAVAIPIFQRPGS
NAIDISNDVRARMAELKQSFPEGMDYSIVYDPTIFVRGSIEAVIHTLFEALILVVLVVIL
FLQTWRASIIPLVAVPVSLIGTFAVMHMFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIELGLEPVAATHKAMAEVTGPIIATALVLCAVFVPAAFISGLSGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLKGHDAPKDRFSRFLDKMLGSWLFRPFNRFFEKASHGYVGTV
ARVIRSSGIALLVYAGLMVLTWMGFASTPTGFVPSQDKQYLVAFAQLPDAASLDRTEDVI
KRMSELALKQPGVQDAIAFPGLSINGFTNSPNNGVVFVTLKPFDERKDPSLSANAIAGAL
NGQFASIQEAYMAIFPPPPVQGLGTIGGFRLQIEDRGNLGYDELYKETQNIIAKSRSVPE
LAGLFTSYTVNVPQVDAAIDREKAKTHGVAVSDIFDTLQVYLGSLYANDFNRFGRTYQVN
VQAEQQFRQDADQIGQLKVRNNLGEMIPLATFVKVSDTAGPDRVMHYNGFITAEINGAAA
PGYSSGQAQAAVEKLLREELPTGMIYEWTDLTYQQILSGNTALFVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAIAGVMIAGSDNNIFTQIGLIVLVGLACKNAILIVEFAKD
KQAEGMSPLDAVLEACRLRLRPILMTSFAFIMGVVPLVLSSGAGAEMRHAMGVAVFSGML
GVTFFGLLLTPVFYVLIRNYVERQEARKAARVNSQQNLPAEMH
>D7NB90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIQTLIIAIVEGLTEFLPVSSTGHMIITQNLLGVPQGDPFVHAFTFIIQFGAILSVVC
LYWKRFFLMRTKEEFFSKMKFYGLLIVGVIPAVIVGLLAKKSGLLDRLLDSVEVVAVTLV
LGGVFMLFCDRLFNKGTEENKVDWKRALKIGCFQCLSVIPGMSRSMSTIVGGMQQKLTRR
RAAEFSFFLAVPTMAGATLLDLLDMFKEGTDWATTHNIEMLVLGCVVAFIVAIFAMKWFV
SFLTRYGFKAFGWYRIIIGTVILLLLATGHSLVMVD
>A0A124K8M5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNAIRIAATLFVAACAAAMAGRSAAATQDEIHDTVTRHVAPLMKQFAIPGMAIGVVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLTDPAGKYLPA
LQGKPFGVVTLLNLGTHTPGGMPLQVPDSIRDDADLMRYLDAWRPAYAPGTRRTYSNVAI
GMLGFLTAKAMHEDFAVLMEQRLFPALGMTHTYIDVPAARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLVETSTRLQRALERTHTGYFRAGPFTQDLIWEQYP
YPVALPTLLAGNAPPMLHNATPVTKIEPPLKPRPDTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRSFPIEDRVKTAYRIVESLQGKP
>A0A0U5Q9L2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTSGQLKLGHILLAMIPAVVLGLAFHDFIKSLFAP
KNVMYALVVGGLLLLAAEWLKPKKTSAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTI
AGGMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTWGDLPMFAVGFITAFVVAL
IAIKTFLSLIKRISFVPFAIYRFIVAAVVYMVFL
>YP_002227903|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDV
TYQTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEA
ENRNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNAAQYDDSNM
GQNKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASIS
SINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLN
IKYALGTLNEQDLLALNSTLGKPIPTSPESVAPETPDQDAAADGYNAHSAAPAVQPTAAR
ANSNNGNPFRH
>CAA37982|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDV
TYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANELTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEA
EKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDD
SNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINA
SISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLIN
QLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQT
SARTTTSNGHNPFRN
>H0FYH7|FEATURES|UNIPROT_deepARG|beta_lactam|SM0020_11305|antibiotic inactivation|1
MTKFSATKFAMAAAVLLCCGAGAHAADRGEQGELARVVDETIRPLMKEHGVPGMAIAVTV
RGKKYIFNYGLASRESGQKVTDETMFEIGSISKTFTATLASYAAARGDLALSDPAGKYLP
ALAGTRFDDISLLDLGTYTAGGLPLQFPDSVTDQESMIDYYRDWRPTYAAGTHRLYSNPS
IGLFGYLAAKSMGEPFADLMEKSIFPAFGLTSTFIAVPQDRADDYAYGYSKAGKPIRVTR
GVLDSEAYGVKTTAADLIRFVEANIDGTGLDERIRRAIAATHTGYFEVGAMTQGLGWEMY
PYPTKLDDLLGGNSSRMALEPHKVSKLVPPAAPQENVWINKTGSTNGFGAYVAFVPAERI
GVVMLANRNYPIPARVKAAYQILSTLESDPGSADAR
>L9P3W9|FEATURES|UNIPROT_deepARG|beta_lactam|ACINNAV57_2787|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLERTIFPELGLKYSYVNVPKTQIQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>J2W1I5|FEATURES|UNIPROT_deepARG|aminoglycoside|PMI20_02731|antibiotic inactivation|1
MIRIEPCQPAHQADWLPLRQALWPDCPAEEHRDEIASLLDDPQRYINLLAYTADGRPVGL
AEASLRHDYVNGTEHSPVVFLEGLYVSAEQRRQGIAERLIDAVAQWGRDQGCVEMASDTG
LENLVSQTVHKALGFEETERVVYFRKSL
>K9N4F2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-2|antibiotic inactivation|1
MTIRIFAIFFSTLIFATFAHAQEGTLERSDWKKFFDDYQAKGTIVVADERQADRILSVFD
QARATKRYSPASTFKIPHTLFALDVGAVRDEFQVFRWDGIKRSFAGHNQDQNLRSAMRNS
TVWVYELFAREIGEEKAKRYLKQIGYGNADPSTSKGDYWIDGTLEISAYEQISFLRKLYR
NELPFRVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGAVFFALNIDTP
NRMDDLFKREAIVRAILHSIDALPPN
>D2D0D6|FEATURES|UNIPROT_deepARG|beta_lactam|blaTER-1|antibiotic inactivation|1
MRHSLFAPILLLALFALPAWAHEATVNQVKAAERQLEARVGYAELDLASGRLLASYRPDE
RFPMMSTFKVPLCAAVLARVDAGEEKLDRRVRYRQQDLVEYSPVTEKHLADGMTVAELCA
AAITLSDNTAANLLLASVGGTQGLTAFLRRSGDQTSRLDRWETELNEALPGDARDTTTPQ
AMAKTLHNLLTGSVLSAASRQQLRSWMVDDKVAGPLLRSTLPHGWFIADKTGAGNRGSRG
IIAALGPDGQPARIVIIYLTGTEASMDERNRQIAEIGETLVKHW
>CAR61116|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRQLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>R8Z3W6|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRATGFATMGIAQEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPVREGMARVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLFYPIARWSEKRFRLEHRLMAGLLVMSLSMMPVGMVSSLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAQQPELPWMMLGIIGIITFLALGWQFSQKRAARRLLERDA
>A0A142I9K0|FEATURES|UNIPROT_deepARG|beta_lactam|blaPDC|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNL
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>NP_414618.4|FEATURES|CARD_deepARG|sulfonamide|leuO|antibiotic efflux|0
MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHVLGMSQPAVSNAVARL
KVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCS
PLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVP
LFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQPWYDTVDKQASIAYQG
MAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKG
HQWMEEQLVSICKR
>A0A127T7C8|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTILN
RHEEFRTALDKNGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAY
GERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYHIP
LSIQVHHAVCDGFHVCRFLDELQDLLNK
>R8DAZ4|FEATURES|UNIPROT_deepARG|beta_lactam|IG9_00087|antibiotic inactivation|1
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQIKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGVLLQKKSIEDLDQKIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIMLAILSNHAKEDAKYDDKLIADATKI
VLDALKVTNKS
>BAC53825|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNQKNPKDTQNFITSKKHVKEILNHTNISKQDNVIEIGSGKGHFTKELVKMSRSVIAIEI
DGGLCQVTKEAVNPSENIKVIQTDILKFSFPKHINYKIYGNIPYNISTDIVKRITFESQA
KYSYLIVEKGFAKRLQNLQRALGLLLMVEMDIKMLKKVPPLYFHPKPSVDSVLIVLERHQ
PLISKKDYKKYRSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYK
LFH
>A0A127SBP5|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLDKLDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLIKGG
K
>A0A0L0BAQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAMQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAVV
WEFRRKILEVITGLPTQRNAQRFTLNLFIGFLPAVVLGVIFADKIHEYLFNPITVAVALV
LGGFIMLWAEKREHAVRVHHVDDMRWTDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKFHHLFQPADFPVFALGFVVSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLIILATWQFGWIDWSSAQG
>A0A0G3EKP2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKRKAACLATTIFMTLTATSPASHATGEPPARIRQTVDAVVRPIMTKNRIAGMAVGVVAD
GKPYVFNYGVASRATGRPVTANTLFELGSVSKTLTATLVSYAQASGRLSLSDKTGQYLPA
LRGHPFGEVPLVDLGTHTPGGLPLQVPDDIHDNAQLMRYLGAWRPTHAPGTYRTYSNISI
GTLGLITAKSFGQDFATLMQGRLFPALGMTHTYINVPQAKMADYAQGYTKAGAPIRMAPG
VLAAEAYGVKSTASDMLRFVRANMAMVPLEGKLQRAVLATHTGYFKAGPMTQDLIWEQYP
YPVPLQSLLDGNSAAMVLHGAPVAPITPPQAPSAHAWINKTGSTNGFGAYVAFIPQKRMG
IVILANKNFPMEERVSAAYRILTALAGDAR
>ZP_03232649|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVSILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTEWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALK
>A0A0D5AK02|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLLQILVLAVIQGAAELLPVSSSAHVIAAEKLMGLDPTAPQMTLLLVMLHTGTMFAVIA
YFWKSWRTTYFSSGQAFRTNALCILVATLATGIVGVALLQFIKHVVVADSSNFEIEHLFG
NSRLIAAALAAAGLLIIVSSRLQDRGIDNLTLRQSAWIGAVQGLCLPFRGFSRSGATIST
GLALGVTRRRAEEFSFALAVVLTPAVIAKEAYRLYKEYAATTTAMHSDGLLHLMGPSMIG
MALSFLAGLVALRWLSRWLEQGRWHFFGCYCLLASLLVLWIG
>A0A029LHN6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVTRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEVAQRENEATCFGRRTPDDSFLEWYKPASVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>E2GGY0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQHVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPV
>U4VCK6|FEATURES|UNIPROT_deepARG|aminoglycoside|Q644_14880|antibiotic inactivation|1
MGTLVARREHAEAWAQLRHALWPDTSLEQHLQEIYETLDQDDPPDAVTFIAESAGGQIAG
FAEAALRRDYVNGCETSPVLFLEGIYVSPEYRQRGTARLLCEAIANWGREKGCTEFASDV
LLENRDSQSFHTALGFDETERVIFYRKLL
>YP_001687825|FEATURES|ARDB_deepARG|tetracycline|tetC|antibiotic efflux|1
MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCA
PVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAAAGAYI
ADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFL
MQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDR
FRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRG
WMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIVTAIYA
ASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST
>A0A0Q4WRE6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLVLIAKALVLAVVEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
VYFGRLWSIATALPNDPRARRFVLAILIAFLPAAIVGGLFSKYIKLYLFNPWIVCATLVA
GGIVLLIIDDTVGEPKVAPNDGTHDGPTEHPRKTDVFEFSLPMALKIGLFQCVAMIPGVS
RSGATIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSNDALLIVIGFVA
AFISALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAGLILFG
>A0A0D5CE58|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-154|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>Q2FC56|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHSKELNNLEKKYNANIGVYALDTKSGKEVKYNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIIKEIGGIKTIKKRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
FK
>A0A0X8P410|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTTLYLIKAFILGIVEGLTEFIPVSSTGHLILIGDWINFESSQGKVFEVVIQLGSILA
VMWIFRARLLQLIRGTLTGVASEVAFTRNLLIAFLPAAVIGAIFIKSIKQVFYHPGVVVV
TLVLGGLIMLYVERRTRHTPGDAPGAADDTASDERATARTLEQITWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYKNMDLLTQHDLSGIA
VGFVAAFLSAIVVVRAVLRFVANHTYRVFAWYRIVFGAVVAAWIFTR
>A0A0L0WCC1|FEATURES|UNIPROT_deepARG|multidrug|rlmN|antibiotic target alteration|1
MKQTKTKYGKMKQIVSNLKLPDYRYEQLTKAIFHQKIDNFDDMHILPKALRIALVNEFGN
NVSSVIPVFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVIGLLKNRGSWEHLYHIDLIPYNSTDKTTFE
FQSSIAIKQFCSTLKKAGISVTVRTQFGSEISAACGQLCYENE
>A0A089MB69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
ILAVVIIFYKRFIDLLGLKRFSRKEMTAVPDGVQQVETEGRLKLGQVLVGLIPAGVFGLL
FEDYIDEHLFSTSTVLIGLVVGAVFMIIADRFAPKKVKTETVDQITYRQALSVGLIQCVS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLIKNWQYFTLDALPFF
IAGFISAFVFALLSMRFFLKLINRIKLLPFAIYRIVLAAVVYLVWF
>A0A0Q7TBT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLIAIVLGLVEGLTEFIPVSSTGHLLLTKIALGLTDPTWDTFIVLIQLGAVLAVVAV
YFQRLWQVVVGLPTKPEARRFALSVIIGCIPAFAAGLLLHGVIKHFFENPYLPQVICVSL
IIGGFLLLIVDKKAPAPREMDGMALSLKTAFFIGLFQCLSLLPGVSRSGSTIVGSMLIGV
ERKAAAEFSFFMAIPIMVGAFALDLLKSYKDIDTSHASTIAVGFVVSFLSGLLVVKTMIA
FIGKRGFAPFAWWRIVVGVIGLGLIYIPR
>G3ESI2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-1|antibiotic inactivation|1
ACASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNKAKCATQMAPDSTFKIALSLMAF
DAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSHEITQKIGLNKIKNYLKDF
DYGNQDFSGDKERNNGLTEAWLESSLEISPEQQIQFLRKIINHNLPVKNSPIEHTIENMY
LQDLDNSTKLYGKTGAGFTAYRTLQNGWFEGFIISKSGHRYVFVSALTGNLGSNLTSSIK
AKKNAIT
>A0A0B5R6A3|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSESLKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALGVLKAKNK
>ACI73806|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVTAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGSGYQ
AAPVVEKK
>D6E535|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIFDIIKSVIFGIVEGITEWLPISSTGHMILLNEILPLRIGKNPDDFYSMFEVVIQLGA
ILAVVVLFWSQIWPFGRKNNKAPLAKTGIGAWVKTDIFVLWFHILVSTVPAAIIGILFDD
VFERLFYNFQTVAIMLILFGIAFIVIETRHNGKSAKINSLVDISYTTALMIGFFQLIAAV
FPGTSRSGATIVGALLIGVSRTVAAEYTFFLAIPVMFGASLLKLVKFGFHFTGEEAAILI
IGMIVAFVVSLIVIKFLMGYIKKHNFIVFGWYRIVLGAIVLLCGIAGLL
>A0A0Q9M879|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKIGSINHLLFSVNDLDESIAFYKDVFDARLLVKGRKLAYFDLNGLWLALNVEDDIPRNE
INYSYTHIAFSVESEDFDTVVKKLEDLGVNILSSRTRDERDKKSVYFTDPDGHKFEFHTG
TLQDRLSYYKDDKSHMMFYDE
>A0A0N9WJ97|FEATURES|UNIPROT_deepARG|beta_lactam|AO353_20470|antibiotic inactivation|1
MKYSPSRRSLLKAGLTLPLITLVVPAWANASAADKPLAELYKKLAELENSAKGRLGVALI
NTANGHEIQYRGGERFPFCSTFKLMLAAAVLHKSMAEPGLLEKHIAYAEADLLSYAPIAK
QNLEQGMSIAQLCAATLQYSDNTAANLLIKELGGVAAVNLFAKGLGDPAFRLDRQEPELN
TAIPEDQRDTTTPAAMAASVQKVVLGDALATPQREQLVTWLKGNTTGDASIRAGTPTGWI
VGDKTGSGDYGTTNDVAVLWPQTGAPVVLAVYFTQHQKDAEARRDVLASATRLVMAHVS
>V5Z6B2|FEATURES|UNIPROT_deepARG|polymyxin|yfbE3|antibiotic target alteration|0
MTEQLIKKVSIVIPVYNEQQSLPELMRRTDAACAQLALDYEILLVDDGSSDDSAAMLVAA
AEAPDSHIVAVLLNRNYGQHSAIMAGFSHVSGDLVITLDADLQNPPEEIPRLVATAQQGY
DVVGTVRQNRQDSGFRKLASRMINHLIQRATGKAMGDYGCMLRAYRRHIIDAMLNCHERS
TFIPILANTFARQATEIPVLHAEREFGDSKYSLMSLINLMYDLITCLTTTPLRLLSVFGS
VIALMGFAFSLLLIALRLFLGAEWAGDGVFVLFAVLFIFIGAQFVGMGLLGEYIGRIYND
VRARPRYFIQRVVSRDADCTKDKKL
>E6VF19|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLTDIIRAVILGIIEGVTEFLPVSSTGHLLLAGRFFNLGEGDFWKSFAVLIQLGAILAIL
ALYFVKLWRIALGMFSDPAARRFVIGVLLAFLPAAVIGAAAGGYIKHFLFNPWVVCFSLI
VGGAILLWVDQLELKPRYHDATAFPLRTYFYIGCAQCTAMIPGVSRSGASIVAAMLLGTD
KRSAAEFSFFLAIPTMLGAFVYDLYKSRGEMTFDNLTIVAIGFVVSFITAIIVVKTFLTY
VTRHGFELFAWWRVIVGTLGLIALALGM
>T0GKV0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVVIQLGAILAVVV
LYWRTFWAVGMGLLRREPTSWRFLRNLLVAFIPAAVIGLALHNYIEELLGAPRVVAWALI
AGGIAILGIERMVKENRFHGIADIPFVRVVGIGFIQCLAMIPGISRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGATTLELLKNGDKLTSATVGWGSIVLGFIVSFIVALLVIRWFV
GLVSRHGFAPFAWYRIVAGIAALAWLSLR
>YP_002089536|FEATURES|ARDB_deepARG|multidrug|mexB|antibiotic efflux|1
MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDT
VVQVIEQQMNGIDNLRYISSESNSDGSMTITVTFEQGTDPDIAQVQVQNKLQLATPLLPQ
EVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGS
QYSMRIWLDPAKLNSYQLTPGDVSSAIQAQIVQISSGQLGGLPAVKGQQLNATIIGKTRL
QTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANAL
DTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQ
NFRATLISTIAVPVVLLGTFGVLAAFGLLDHTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMAL
SVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAP
YLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLE
KESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKD
AMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGM
SDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARM
NPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAM
AAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVE
AAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWV
PLFYVAVSTLFKDEASKQQASVEKGQ
>B7JNM8|FEATURES|UNIPROT_deepARG|chloramphenicol|BCAH820_2426|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEENKIM
LPVSLQVHHSVCDGYHVSRFIEDLQELSNSCNGWLK
>A0A127SGS2|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MKLYPAMLYYLATIVNHHPEFRTAINQAGELGIYDEMIPSYTIFHEDTETFSDLWTEYVP
NIEEFSRAYENDIQLYGSNHGMIGKPDVPENVFTVSMIPWSTFESFNLNLQKGYSYLIPI
FTLGKYYEEDGRIVLPLAVQVHHAVCDGFHICRFVNELQELINS
>ZP_03000572|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVEVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSVIILQRASR
>A0A0U2BMY0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MATPILSLKNIKKSFAFGDDSLEVLKGIDLDIYRGEMVAIVGQSGSGKSTLMNIMACLDA
PTSGEYRIDGLCTQEMDGEQLASLRRDKFGFIFQRYQLLSSLNATANVAMPAIYAGVSQK
TREQKAQALLAKLGLEQRLDHYPNQLSGGQQQRVSIARALMNGGQIIFADEPTGALDSQS
SRDVMAILTELNREGHTIILVTHDPKIAQSASRIITIADGQIISDDNNSNDTVNTTQDFQ
QNTHRTLNFQAIGRIKEAFHMAVLTMLASKMRTLLTMLGIIIGIASVVLIVALGNGSKQQ
ILNQINSMGSSTISVFMGGDNEDDTTPPNDLTFDDMYALETLPSVASTSPDLSMSMTAQV
GNHSKGVQVDGVGLNHHRLQNVQFVTGSMFRQSDLDNFSQNVIISEKTKQNFFKQNNALG
QILILNGVPTKVVGVFKYNGIEGNFDRNLKVWLPYRTFQARFAGESPRLNSITVLLKPNE
SSALASESINQLLTQRHGKKDFTLFNSDSLAKTVEKTAQSLTLLIGAIAVISLLVGGIGV
MNIMLVSVTERTGEIGVRMAVGATYGDIVWQFLIEAMVVCALGGVLGVLLAFGLGGLLQL
FDIKVIFSATSIALAVGCASLIGLVFGLMPAHKGAKLNPIEALNKG
>G0JXY6|FEATURES|UNIPROT_deepARG|aminoglycoside|BurJV3_1756|antibiotic inactivation|1
MEATHARMDGMPLPHAWQEALADARIERQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGDEIERLRWLQAQGQPAPMVIATAEEAGRRWLLMSALPGHDLASSPRLAPHHLVELLA
DALRGLHALPVASCPFDQRLASRLQAAQARVEAGRVDADDFDDERLGQSAQQVFAELRTT
RPDHEDLVVSHGDACLPNLLAAEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFRRYGVVADERRLAFYRLLDEFF
>A0A081NU27|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRFIIHEYAVNGYDSGPYGITAGKDGAMWFTEQKGNRIGRIHAEGEIHSFPVPTANAGVM
SIVSDGTGGLWFTEYRANKIGRMSMDGHFAEYELPAANSAPFGITEGPDGAMWFTEMNSG
RIGRITKSGEITEFELPHPRAFPSFITPGPDGALWFTQNQNNTIGRITTRGEVKEYSIPT
PNSGPVGITTGPDGALWFVQIMGNKIGKMTSSGEVSEFVIPTPNARPHAIICGKNGDLWF
TEWGGNQIGRITVEGVITEYAIPAKNAEPHGITMGPNGDIWFVEECNQIGRLTLN
>F7R3F0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPKHFLNFTAHAFQTLVSHIFIDYNKEVNQSRYIQKGLLIIMIIELIKAFLFGIVEGITE
WLPISSTGHMILLDQFVKLDVSKSFYSMFEVVIQVGAIMAVVVIYWNKIWPFHKSKQTGP
LAPTGIWRYVDKDIIIMWIKIVIACLPAGIIGVAFNDTFEKLFYNPVSVAIALIVFGIAF
IWIETVHKNKRAKINSLAELSYYTVILIGFFQLIAAVFPGTSRSGATIVGALILGVSRTV
AAEFTFFLAIPVMFGASLFKLLKFGFVFSSAELLILIVGLITAFVSSIIIIKFLMQYIKK
HDFKVFGWYRIVLGLLVLLYFLVIK
>AAS61093|FEATURES|ARDB_deepARG|fosmidomycin|RosA|antibiotic efflux|0
MTDRSDTGCQQPVNVSVKRTSFSILGAISVSHLLNDMIQSLILAIYPLLQAEFSLSFAQI
GLITLTYQLTASLLQPLIGLYTDKHPQPYSLPIGMGFTLSGILLLAVATTFPVVLLAAAL
VGTGSSVFHPESSRVARMASGGRHGLAQSVFQVGGNFGSALGPLLAAIIIAPYGKGNVGW
FSLAALLAIVVLLQVSKWYKLQQRASYGKVLKISSAKTLPKNKIISTLAILMVLIFSKYF
YLTSISSYYTFYLIHKFGVSVQSAQIHLFVFLFAVAAGTIIGGPLGDKIGRKYVIWGSIL
GVAPFTLALPYASLYWTGILTVFIGVILASAFSAILVYAQELIPGKVGMVSGLFFGFAFG
MGGIGAAVLGYVADLTSIELVYQICAFLPLLGIFTALLPNLDDK
>AAO24820|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGSTCRHASLLYTSGAIAESGSVDTGTTRTDTTFLERQRGITIQTAV
TSFQWKDIKVNIIHTPGHMDFLAKVYRSLSVLDGAILLISAKDGVQAQTRILFHALNKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTEPEQWDVVIE
GNDYLLEKYTLGKSLEILELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYS
STYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQKERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKKPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRNDLTFFTNGR
SVCLTELKGYYVTTGESVCQPRRPNSRIDKVRYMFNKIT
>J3E6W5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGIQTLLDSGYDIAAVFTHADDPKENAFYGSVAQLCANKGIPVHA
PEDVNHPLWIERIAKLAPEYIFSFYYRNLLIESLLAVAKKGAFNLHGSLLPSYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAIVAQQRVAIERSDTALSLHGKLRTAAADLLRDALP
AMLQGKTSETAQDESKATVFGRRTAADGKLVWAKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIAWSAEVVKGNDGQAPGRVISVDPLRIACGEDSLVILSGQRNDNGLFLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIDRLR
SHPHFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKHFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLDWTPTVEMRETIGNTLDFFLREAMLEQA
DKR
>A0A132C7X6|FEATURES|UNIPROT_deepARG|aminoglycoside|WS62_05630|antibiotic inactivation|1
MTHPTSLFTIRAAAASDALAWRQLRRALWPHADDAEHARDVAQQLDAPNRHACFIAWTPD
GAPLGFAEVAVRRDYVNGCDTSPVLFLEGIFVDPAARRRGVARALCSAAAVWGATCGCAE
FASDAPLDNAASHALHRALGFDETERVVFFRKTLAR
>A0A0U3AZA5|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKESDLVNYNPIAEKHVNGTMSLAELSAAAL
QYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMA
QTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNHIA
>ZP_03059695|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALANTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILALAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCASSSILFCLYASRPKKR
>A0A127T310|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-28|antibiotic inactivation|1
MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGATRLYANASIGLFGA
LAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDISSWVKANMNPAALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVM
>T5P1B5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLMIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0V8GF85|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIIELLKALLLGFVEGMTEFAPVSSTGHMIIVDDMWLQTTDFLGKYSANTFKIVIQLGS
ILAVVVVFWKRLFSLIGLYKIEGEHDAAGTHKLKLRHVLIGLLPAAVLGLLFEDFIDENL
FSIETVIIGLAVGALLMIAADKFGPKEPKTTSLDQITYRQAALVGLFQCISLWPGFSRSG
STISGGVFLGMNHRTAADFTFIMAVPIMFGASFLSLVKNWENIQPNHFAFYAVGFVASFV
FALLSIRFFLKLINKIKLVPFAIYRLVLAAVLAVIVYM
>J7YI37|FEATURES|UNIPROT_deepARG|beta_lactam|IE3_02148|antibiotic inactivation|1
MNSLLKVGVCVSLLGATQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTELG
YFNGVAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRI
GGTKTLTERGIKAHSTALTAELAKKNGYEEPIGDLQTITNLKFGNMKVETFYPGKGHTED
NIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINININSVVP
GHGEVGDRGLLLHTLDLLK
>R6JS89|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAIIFGIVEGITEWLPISSTGHMILLNEIMPLKVSDAFYSMFEVVIQLGAIMAVV
ILFWHQLWPFGKKNNKEPLAESGAGAYVKWDIFKLWFHILVSCVPAAIVGILFDEQLEAM
FYNYTTVAIMLIIFGIAFIIVETMHHGKKPKVRHLTGITYKLAFYIGLFQLIAAIFPGTS
RSGATIVGALILGISRTVAAEYTFFLAVPVMFGASLLKGVKFLIHNSMTSMEAMILLIGM
LVAFIVSLVVIKFLMGYIKKHDFKVFGWYRIVLGIIVLICGFAGVIGA
>A0A127QT06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLVEGFTEFLPISSTGHLILAGSLLDFTADIGREKAEVFEIAIQAGAIFAVCWEYRARI
AAVLRGLPSDPKARKLVLNLVIAFIPAAILGLLFSKMIKEKLFAPLPVAIALIVGGFVIL
WVERRHKTHGSVARVDSVDDMTALDALKIGFAQAFALIPGTSRSGATIIGGMMFGLSRKA
ATEFSFFLAIPTLFAATIYSLYKDRALLSASDIPLFSIGTVAAFVSAFLCVRWLLRYISS
HDFTAFAWYRIVFGLVVIVTGYAGWVSWVH
>YP_002225584|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMNPTELTKYQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTDEFGKILLKVNQDGSQVRLRDVAKIELGGENYDVIAKFNGQPASGLGIKLATGANAL
DTATAIRAELKKMEPFFPPGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
TEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPVAKGDHGEGKKGFFGWFNRLFDKSTHHYTDSVGNILRSTGR
YLLLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLTMVQLPAGATQERTQKVLDEVTDYYLN
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEKNKVEAITQRATAAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLFGEVAKYPDLLVGVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDINDWYVRGSDGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MAMMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
VEATLEAVRMRLRPILMTSLAFMLGVMPLVSSSGAGSGAQNAVGTGVLGGMVTATVLAIF
FVPVFFVVVRRRFSRKSEDIEHSHSTEHR
>ZP_04060511|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MIIIEFIKALILGIVEGLTEFAPVSSTGHMILVDDMWLQSSQFLGSHSAFTFKIVIQLGS
VFAAAWVFRERYFEMLHIGKYKHVAHSEGMRSKPRRLNLLHVLVGMIPAGILGVLFDDFI
EAHLFSVPTVMIGLFIGAIYMIIADKYSTKVKHPQTVDQINYFQAFVIGISQAVAMWPGF
SRSGSTISTGVLMKLNHKSASDFTFIMAVPIMLAASTLSLLKNYQYIDLAHVPFYIIGFL
AAFIVGLIAIKTFLHLINKVKLVPFAIYRIVLVIFIAILYFGFGIGKGI
>A0A0Z9D5Z7|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1_1|antibiotic inactivation|1
MSIDLSNKKIPKEAIQALKTIAELLDNMLIGVYLYGSAVMGGLRMNSDVDILVITNQSLS
EKTRRNLTNRLMLISGKIGNIKDMRPLEVTVINQKDIVPWHFPPKYEFMYGEWLREQFEK
GEIPESTYDPDLAILLAQLRKNSINLLGPKATEVIEPVPMTDIRKAIKESLPGLITSIKG
DERNVILTLARMWVTASTGEIRSKDLAAEWAIPQLPYEHAILLDKARKAYLGGYIDKWKG
MDSEVTELVNNMKKSIESSLNL
>NP_460867|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDISDFRRALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQPDQAP
>A0A0E3YYP7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLPNATDSVILGLVEGITEFLPISSTGHLIITTHLLGLDGDTVVGNDRKGRPMTLKDAAD
TYTVIIQVGAIAAVALIYWSQLSRILAGLAGKDPAGIRLLRNIILACIPPVITALAFKSF
IKAKLFSVPTVAGALLAGALLMLFAEWWRRRSEAQAPATASAPEFTGADLTPLQALTIGF
VQCLALWPGMSRSMTAMVAGYFVGLRPVRAAEFSFLLGLPLLGAAAVKDSLDGGSAVINA
FGWFNIIIGLIIAFASAAVAVRFLISFLNKHGLTSFAWYRMALAVVLGFLFIF
>A0A069CVH7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MYYFYINEGLFIMIIEFIRSIIIGIVEGITEFLPVSSTGHIIIAESLMKIPGGVVWTKAF
TDMFDYVIQLGAIMAVIQLYFTKLNPFTSKKSYRERVATWRLWFKVIIGVLPAVVFGFLL
NDWMDAHLMNPWVVAGTLIFYGILFILLETRNEHTKPWLTDLDKMSWKLALAIGFFQVLS
IVPGTSRSGATILGAMFLGTSRFVAAEFSFFMSIPVMFGVSILKVGKYLANGGAFTGTQA
VVMTIGFLVSWAVAYFAIKFMMRYIQNHDFKIFGWYRIALGILVILLGMFGLLHV
>R8P0F6|FEATURES|UNIPROT_deepARG|beta_lactam|IKQ_02969|antibiotic inactivation|1
MKMHSLLKVGVCVSLLGATQFVSTISSVQAERTVEQKVIKNETGTISLSQLNKNVWVHTE
LGYFNGVAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITKLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNININLVVP
GHGEVGNRGLLLHTLDLLK
>YP_002705657|FEATURES|ARDB_deepARG|multidrug|smeC|antibiotic efflux|0
MKPMLLRALAAATMTTVLGGCVSMAPRYQRPEAPVPVQFGNAATSETDSALAMPAWREVF
VEPRLQQAIALALQNNRDLRVAVLQVEKERAQYRIQRAALLPSVDASGSVTRSRVSDANS
ETGTTQITEADAVQVGISSWELDLFGRIRSLNNEALQNWLASAENQRAARTSLVAEVATA
WLALAADGQSLAFTQQTLDSQQQTLQRTEARHAQGLASGLDLSQVQTSVEAARGALARLQ
TQQAQDRDALQLLVGAPLDAALLPSAHVLDGSVALAPLPADLPSSVLLQRPDVLSAEHAL
QAANADIGAARAAFFPTLTLTANYGHSSTALSTLFSAGTRGWSFAPSITAPIFHAGALKA
SLDASKIGKDIGIAQYEKAIQQAFSEVADALATRDHLATQMDAQRALVAASQRSYTLADA
RYRTGLDGYLQALDAQRSLYTAQQDLIALQQQEAGNRVTLFKVLGGGADAR
>A0A0R1R9D1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAALLGIIEGITEFLPVSSTGHLILADQFIKLHQSTAFINMFNVTIQLGAILAVV
IIYFHKLNPFSPRKTLAERQATWQIWGKVIFAVFPSVVVGLLLNDWMDAHLMNWVVVAIT
LILYGILFILVENHNATLTPTISTVPQISYRIAFLIGCFQLLSLVPGTSRSGATILGGIF
LGASRLASTEFSFFLAIPTMFGATLLKLLKFFMHGGTLAGEEGLILLTGVVVSFVTAYIA
IKALLDYVKTNSFKPFGWYRIILGIVVILYFLIA
>A0A023E9E2|FEATURES|UNIPROT_deepARG|beta_lactam|ASA01S_103_00100|antibiotic inactivation|1
MEKATTRSLLVLSTLLLSPLSHAKEAEPLTALVDGAIQPLLKEHRVPGMAVAVLKEGKAH
YFNYGVADRESGARVSEQTLFEIGSVSKTLTATLGAYAAVKGGFQLEDKASQHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVDSTDKMRAYYRQWTPAYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPVRVNPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAVVKSAIALTHTGFYYVGEMTQGLGWESYAYPVTE
QTLLAGNSSAVIYNANPVKSVATSQEMGGARLYNKTGSTGGFGAYVAFVPAKGIGIVMLA
NRNYPNEARVKAAHAILSQLAE
>A0A0M1LST9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDFLFIFKAIIVAIVEGLTEFVPVSSTGHMILASDLINFQGEFVKMFEIVIQLGAILA
VVVLYWKKIKDSVIEFFTYIFTGGKKGEVGFRFGINVLIGSIPAGVVGILFYSKIKTLLN
PQAVVVGFIVGGILLLVIENIFRKKRHSVKSIDRITPMQSIKVGLFQVLSMWPGMSRSAS
TIMGGWVAGLSTPIAAEFSFFLAIPAMVGSSAKDLFEFDFALMNATNWVALIVGFIVAFI
VSLIVMEGFVAYLKKKPMRVFAIYRVVAGIVFAILMYKGIVTPHL
>A0A0P0AJK5|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-157|antibiotic inactivation|1
RHAVVRSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSK
VMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNV
AAIS
>AAL33886.1|FEATURES|CARD_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYASRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFFGWRAIFVTLAALAL
PALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>A0A0U1YV19|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVGLDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A060KTM4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETLRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0J1G9E3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLDFIEILKIIFLGIIEGITEWLPISSTGHMLLVDEFISLNMSESFKEMFFVVIQLGAI
LAVVMVFWKKMFPFQFKNKKQPIIIKDTFSMWFKVVVACIPGAVVTILFDDYIDAHLHTP
IVIAAALIFYGITFILVENWNKKRLPKVVHLSDITYQTALLIGLFQVLSIIPGTSRSGAT
IVGALLIGVSRIAAAEFTFFLAVPVMFGLSALKMLKFGFHFGENEILALIVGMVVAFFVS
LAVIKFLMSYIKKHDFKVFGWYRIGLGIVVLASLI
>A0A0N2A7G6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MAALLQLSGIRRSYRSGEQTVEVLKGISLSIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLSDDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAEALLRRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCAQGHTVILVTHDPAVARQAERIIEIRDGEIIADSRPAPPEDTQAKPLAL
AAAAPSWRQMGGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTYRQSLKYGDLDALREQPYISALSPSISSSMRLRL
GNVDAAANVNGVSEQFFRVYGMSFTQGVGIDPMQVQSQAQTVVIDANTQRRLFPHQKNVV
GEVILVGNMPATVVGVAKEKQSMFGSNKTLNVWVPYSTMANRLMGNNYFDSITVRIRDGY
DSKEAEQQLSRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLAVQL
VLPGWQISFPPAALLSAFLCSTGIGVVFGYLPARNAARLNPIDALARE
>A0A0E1WUY4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFFNLLEAAFLGLIEGLTEFIPVSSTGHLLLIGHFLGFESTGKTFEVLIQLGAILAILS
VYSAKLARIATDFPRDARTRRFVLGVLVAFLPAAVIGALAHGFIKGVLFETPMLVCIMLI
VGGFILLWVDQLNLRPRYHNVMDYPLPICLAIGFIQCLAMIPGVSRSGSTIVGSLLLGAD
KRSAAEFSFFLAMPTMAGAFAYDLFKSRNILSFNDGALIVVGFIMAFISGVFVVRHLLDY
VSRHGFALFGWWRLIVGSAGMAALIIWG
>E9CKL1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSCVEPIKKVSVVILVYNEQESLPALLERTTAACKQLTQPYEIILVDDGNSDGSAEILTA
AAQQPESQVIAVLLNRNYGQHSAIMAGFNQVTSDLIITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMDDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLVTCLTTTPLRLLSVVG
SVVALSGFVLALVLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGEQQIHKIQEEE
>D1LFH2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
NLLNQRVEIKKSELVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASV
TAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLV
TWMKGNTTGAASIQAGLPASWV
>A0A0F3LWV1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MVGAIGLLTSSSVFAQTPSPDAIIKPLMEQYQIPGMAVAILHDGKTEFYNYGVASKETRQ
PITAQTLFEIGSLSKTFTATLASYAAQQKKLQFSDKASTWLPELKGSAFDQVSLLNLATH
TSGTPLFVPDDVTNQQQLMNWYKNWQPPAQPGTQRVYSNLGIGMLGMIAAKSLHQPFIRA
MEQQLLPAMGMHHTYIQVPASAMGQYAQGYNKQDKPVRVTPGPLDAESYGLKSTSADLIR
WLAIQLDEQKVATEWQQAIDATHQGYYKTDAFTQAMMWEYYPLPVSAQQLVDGNSGQRIM
KGMSATLITPPQAAPQQAWYNKTGSTNGFSTYAVFIPSQKIAVIMLANKWFPNDDRVMAA
DNIIQALSH
>AAC76071|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEAEK
RNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>A0A0R2YAG9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNYQPKYLVSALLLLSGSCMAATDMRQVVDSNVKPLMQQQDIPGLSVAVINQGKVQYFNY
GVAAKDTQAAVSQNTLFEIGSVSKTFTATLGGYAQAIGKLKLSDKASLYLPSLAGSAFDR
ISLLQLATYTAGGLPLQFPQASDSATTMLGYFQHWKPTYAAGEQRLYSNPSIGLFGYLTA
QSLGQPFNVAMEKTLLPKLGLTNTYVSVRTDKASQYAQGYDKQQKPVHVGPGALDSEAYG
IKTSSQDLARYVIANMHPQTLEQPLQQAIAATHAGYYTVNGMTQGLGWERYPYPITLQAL
LDGNSTPMAMEPHKVNWLSPAQAQPANVLYNKTGSTGGFGAYVAYVPSKDMGVVILANRN
YPNAERVKVAHAILSALGQ
>A0A0N0XMB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
VGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A0A1R5R9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEASPISKVSVVIPVFNEQESLPELIRRTSAACEKLDTEYEILLIDDGSSDNSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATAKEG
FDVVGTVRQNRQDSRFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>CAA43220|FEATURES|ARDB_deepARG|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFML
TFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPIITII
TVPFLMKLLKKEVRIKGHFGSKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHI
RKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIF
PGTMSVIIFGYIGGILVDRRVPLYALNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLG
GLSFTKTVISTIVSSSLKQQEAGAGMSLLNFTSLLSEGTGIAIVGGLLSIPLLDPRLLPM
EVDQSTYLYSNLLLLFSGIIVISWLVTLNLYKHSQRDF
>A0A0Q4MZZ0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDIGCAGVRALNDAGFTIEAIFTHADQPGENHFFASVARTASRMGIPVYAPD
DVNHPLWIDRIQGMQPEVIFSFHYRDMLGEALLACAPQGAFNLHASLLPKYRGRAPLNWV
LVNGEQETGVTLHRMVQRADAGAIVAQRQVAIAPEDDALNLHHKVCQAAEQLLTDALPGI
LRGDYPQREQDEREATVVGRRTPEDGRLDWQWPATRNHNLVRAVSDPWPGAFSWVGSSKF
IVWQSKVRSDLPAAKPGTVLSVNPLTIACGEGALEVVTGQSESGIYMQGSQLAQTLGLVA
GALLHNQPVSVIKRRTRVLILGVNGFIGNHLTERLLADDNFEIFGLDIGSDAISRFVGHP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDDTFDEDRSSLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGRQKRCFTDI
RDGIEALFLIIENKQGNCDGQIINIGNPENEASIAELAEQLLASFERHPLRGQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLGWQPTVEMGLTIDATLDFFLRTVEPGVTEE
>A0A0Q4PWR6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLVIKAIIMGVVEGLTEFLPISSTGHLILTEHLLGFAGMEDKMKVFEIVIQAGAMMA
VIWEFRARIGLVLSGIFSDPVQQRFALNVLIAFLPAAILGLIFASSIKKHLFAPTPVAAA
FIIGGFIILWVEKRAKDNPAVERITSLDQITPVDALKIGIAQAFALIPGTSRSGATIMGS
MIFGFSRKVATEFSFFLAIPTLVGATVYSLYKDRALLSMDDVSFFTIGTVSAFISAFLCI
RWLLRYIMTHTFVIFAWYRIVFGLIVLITGYYGVIVWADK
>YP_002640141|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MTVLSFAIPSWGSPTWSAFFMQRIIQFFSQRATTLFFPMALILYDFAAYLTTDLIQPGII
NVVRDFNADVSLAPASVSLYLAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLL
TTSMTQFLVARFVQGTSICFIATVGYVTVQEAFGRTKAIKLMAIITSIVLVAPVIGPLSG
AALMHFVHWKVLFGIIAVMGLLALCGLLLAMPETVQRGAVPFSAVSVLRDFRNVFRNPIF
LTGAATLSLSYIPMMSWVAVSPVILIDAGGMSTSQFAWAQVPVFGAVIVANMIVVRLVKD
PTRPRFIWRAVPIQLSGLATLLLGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFS
NNLPKGTVSASLNMVILTVMAVSVEVGRWLWFHGGRLPFHLLAAVAGVIVVFTLATLLQR
VRQHEAAELAAEK
>A0A0Q7FPI6|FEATURES|UNIPROT_deepARG|aminoglycoside|ASC84_02630|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSDKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTEQELLAIYKETLNQLNAVA
IIDCPFISSIDHRLKESKFFIDNQLLDEIDQDDFEAELWGDHKTYLSLWNELNETRVEER
LVFSHGDITDSNIFIDKSGEIYFLDLGRAGLADEFVDISFVERCLREDVSEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>A0A0H4SJY6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
LCCALLLSTSCSVLAAPMSEKQLAEMVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGK
ADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIR
MLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKP
SGMSYEQAITTRVFKRLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKT
NVKDMANWVMVNMKPDSLEDSSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVE
GSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYP
NPARVEAA
>YP_594556|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MNIINIGILAHVDAGKTTLTESLLYASGTISEPGSVEKGTTRTDTMFLERQRGITIQTAV
TSFQWHSCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVLSAKDGVQAQTRVLFHALRKLN
IPTIIFINKIDQVGIDLESVYQSVRDKLSADIIIKQTVSLSSKITLTENTSAEVWDSVIE
NNDELLAKYIAGESISQKELAQEEQRRVQDASLLPVYHGSAKNGLGIQQLMDAVIGLFQS
TKEQGSAALCGRVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSDVPFPMLRTTITPKTAEQRDR
LLDALTQIADTDPLLHYEVDSTTHEIILSFLGRMQLEVVSALLTEKYKIETAVKEPTVIY
LERPLKVASHTIHIEVPPNPFWASIGLSVTPLPLGSGVKYESRVSLGYLNQSFQNAVMDG
IRYGLGQGLCGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKKSGTQLLEPYL
SFTLYAPQEYLSRAYHDAPKYCATIETAQIKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQATVGEPIIQPRRPNSRLDKVRHMFSKIP
>A0A0Q9AB19|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNQILVVDLPSGPYALAAGPDGAMWVTLVHSGQIARVTAAGDVTVYDVAPDSRPSIITAG
PDGALWFTRNGDDRIGRITTAGVLSEVELPSGSAPFGIASGPGGALWFTAMNSGVIGRVD
VDGTVTEVATPGGMPSMITAGPDGALWFTLNEANAVGRLEPSGSLRVREVPTPRSGPVGI
AATHDDAIWFTEILADKVGRIPTDEAIQELDLPGKPHAVVADPSGGVWVSLWGSDQIARI
TADGEVSTVDLIENGEPHGLAIARDGALWVAMEAGYLWRLPVG
>A0A0M9DQ00|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLLEAILLAIVEGLTEFLPISSTGHMIITASFAQMKADNFFKMFIVAIQLGAILSVVVL
YWKRFFQSIDFYFKLIVAFIPAAIVGLLLKKHIDTLLERVDVVAVALLLGGIILLFVDKW
FSKNELNQNQTTQDINYKTAFIIGCFQCISMIPGVSRSASTIIGGLTQRLNRKVAAEFSF
FLAVPTMFAATVKSIWDVKEDFLNQTQEQWTLFFVGNIVAFVVALIAIKFFIGVLTKYGF
KAFGWYRIIVGLILLTLIIRGYSLEML
>A0A0F2SFN4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFSEIIKAIMLGVVEGITEWLPISSTGHMILVDEFLQLNMSEAFKEMFFVVIQLGAIMA
VVVLYWNKLIPFSLKRKLTIRNDTILLWLKILAACVPAAIIGLLWDDEIDALFYNYQTVA
VMLILYGILFILIESRNGKIKPKINNLSQISYQTAIMIGLFQLLALVPGTSRSGATILGA
ILIGTSRTVAAEFTFFLAIPVMFGASLLKIYKFGLNFTNDELTILFTGMIVAFVVSILAI
KFLVGYIKKHDFKAFGWYRIVLGIIVVLYFW
>J7J471|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIVSIVSGLPSRPDARRFTLNVVIATIPAIALGLLLEKKIKAVLFAPVPVAFALV
VGGAIILWAEARQRERSEPPRVQSVDELTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFISAFVCVRW
LLRFVATHDFTVFAWYRIVFGLFVLLVGYSGWLNWA
>A0A0X3RJC6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDTLKVILFGIVEGITEWLPISSTGHMILLEEFITLNVRREFWDIFLVVIQLGAILAVV
WINFNQLNPFAPSKSQAEKEETWMTWFKVVVGCLPAAIAGLILDSWMEANLMNWFVVAVM
LIVYGIWFIWIENRNKNRQAKINSMAEMTYMDAFKIGLFQVLSLVPGTSRSGSTILGATI
VGTSRPLAANFSFFMSIPIMFGASALKLVKAFLDGFVFTGTEIWLLLVGMVVAFVISVLT
IKLFLKYIKTNDFKVFGWYRIVLGIVVILYFLLFNS
>YP_001972437|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRFTLLAFALAVALPAVHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAVGSKASAEALTCNAYADAAEKKFDAQLARETAGTR
>S7UDV1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSLASAAVLGVVEGLTEFLPVSSTGHLILTSSLLGLSGQKIDAFNVIIQLGAILAVVVI
YRDRFLGLIRPEEGRRFSGLYGIKLLIITSLPASALGLIANDFIEQALFNPRTVAIALAV
GALLILFMESRNKAPRVRSIDEMTPGLALGVGLFQCLALWPGFSRSAATIMGGMFCGAGR
TVAAEYSFIAAVPIMCAATGYKLLSTWSLYTSDDLLFLAVGFVVSFLAAWAAVKTFIALL
QRFTLRPFAWYRLALAPFVLFFWPAWAS
>D7RFM8|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-114a|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATQPNAGLRARDELVRDWPAMAGAWRP
>A0A0U1YUN4|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVALWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGLTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>YP_002445444|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEQEDFEYLIQRLEENDVHILKGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>J8NTG1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRIGRINATGEINSFPIPTASAGAM
SIISDQTGDLWFTEYNSSKIGKMSMNGLFEEYVLPTTNAAPFGITEGPDGAIWFTEMNNG
RIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPT
PNSGPVGIASGPDGAIWFVQIIGNKIGRITFEGEIKEFVIPTPNARPHAIIPGKNRDLWF
TEWGGNQISRITVEGVITEYTIPTNNAEPHGITFCPDGDLWFAEECNQIGRLTIIT
>CAA33715|FEATURES|ARDB_deepARG|aminoglycoside|AadD|antibiotic inactivation|1
MRIVNGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVM
STEEAEFSHEWTTGEWKVEVNFDSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLE
KVYQTAKSVEAQKFHDAICALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLI
GLHHRICYTTSASVLTEAVKQSDLPSGYDHLCQFVMSGQLSDSEKLLESLENFWNGIQEW
TERHGYIVDVSKRIPF
>ZP_02909221|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIALFIMLGGAFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLLYTSATSSAGAASLYLTFKQGVNADLAAVEVQNRLKTVEARLPEP
VRRDGIQVEKAADNIQLVVSLTSEDGRMTAVQLGEYASANVVQALRRVDGVGKVQFWGAE
YAMRIWPDPVKLAGHGLTASDIASAVRAHNARVTVGDIGRSAVPDSAPIAATVFADAPLK
TPADFGAIALRTQPDGSALHLRDVARIEFGGNDYNYPSYVNGKVATGMGIKLAPGSNAVA
TEKRVRATMDELSAYFPPGVKYQIPYETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGVMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEGLAPYDATVKAMRQISGAIIGITVVLTSVFVPMAFFGGAVGNIYRQFALSLAVSIGFS
AFLALSLTPALCATLLKPVSGDHHEKRGFFGWFNGFVARSTQRYATRVGAMLKKPLRWLV
VYGALTAAAAFMLTQLPSAFLPDEDQGNFMVMVIRPQGTPLAETMQSVREVESYIRRDEP
AAYTFALGGFNLYGEGPNGGMIFVTLKNWKERKAERDQVQAIVARINARFAGTANTTVFA
MNSPALPDLGSTSGFDFRLQNRSGLDYAAFSAAREQLLAAGGKDPALTDVMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVIVQADGLHRLDPADV
KKLRVRNASGEMVPLAAFATLHWTLGPPQLTRYNGYPSFTINGSAAPGHSSGEAMAAIER
LAAKLPAGIGHAWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVLGVTLRAMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLVDAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQMAIGTGVLGGVITATVLAVFLVPLFFV
IVGRLFEVGPRRRGGSQPATMEGSQ
>A0A0K9TJI0|FEATURES|UNIPROT_deepARG|beta_lactam|ERYG_00252|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>J5H242|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDIIRVVVLSFVEGLTEFIPVSSTGHLIIVNEFIKLKPENFANIFNIIIQLGAIMAVVV
LYFHKLNPFSKDEMHKKETLNIWKKVIIGALPAAVLGLLFDDIIDAHLMNAKVVATMLFL
WGVVIILIEKRNMKNENNIAGMTYMTAFMIGIFQCFAMIPGTSRSAATIIGAMLLGLSRV
ESAEFSFFLAIPTMLGATSLKVVKLFIKHTPITSFQVILILLGVVLSFVFALIVIRKFMD
YVKNHDFIVFGIYRMILSMVVLTYFLLK
>ABX28186|FEATURES|ARDB_deepARG|tetracycline|tet38|antibiotic efflux|1
MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGI
GAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFPLLLVGRIIQTAGLAAAETLY
VIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPF
LFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNA
QRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYI
VAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFAL
MYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSH
FGIILIILGLMSIVGLVLFVSLNRWTQSEK
>A0QSY0|FEATURES|UNIPROT_deepARG|quinolone|mfpA|antibiotic target protection|1
MRIGANGDETVWADEEFAGRDFRDEDLSRIRTERVVFTECDFSGVDLSESEHHGSAFRNC
TFRRSTIWHSTFTNCSLLGSVFTECRIRPVTFVECDFTLAVLGGCDLRAVDLSDCRLREV
SLVGADLRKAVLRRADLTGSRVQDARLEEADLRGTRVDPTFWTTAKVRGAKIDIEQALAY
AAAHGLAVHGG
>A0A0M8R9N7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPSRPEVTLQEYVVAGPEAGPYALTAGPDGALWCTLVHQGRVARVTTAGDVTTYPLRTAT
GGPTMIATGTDGALWCTEFKEHRVTRLVPGRAVDGGAQVESFTLPTADAAPLGIAAGPDG
AVWFTESAADRIGRITPDGTVTEYPLPVRGAFASVIATGPDGALWFTANQANAIGRITPD
GDTVLHDLPTPGAGPVGLTAGPDGALWFVEIAAGQVGRITTDGTVEEFPLPDPACRPHAI
AAGPDGALWFTEWGAGRIGRITTSGRVDGYDLPDPASEPHGIALGPDGALWAALETGSVV
RIAVTAEGAQPGR
>M9UYD2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX|antibiotic inactivation|1
AQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAGLKKS
ESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGG
PASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQR
A
>YP_001348629|FEATURES|ARDB_deepARG|multidrug|amrA|antibiotic efflux|1
MHIQWTGSLRGLLATLVALFLLGCDKAPEAEKATDAPAEVGVIVAKPAPIGITSELPGRL
EAYRQAEVRARVAGIVTRRLYEEGQDVRAGTVLFQIDPAPLKAALDISRGALARAEASHA
AAADKLKRYADLVKDRAISEREYTEAQTDARQSLAQIASARAELEQARLRLGYATVTAPI
DGRARRALVTEGALVGEDSPTPLTRVEQIDPIYVNFSQPAGEVAAMQRAIREGQVQGVAD
KDIAVRLVLADGSEYPLAGELLFSDLAVDPGTDTIAMRALFRNPHRELLPGGYVQVRLQR
AVNPQAITVPRDALIRTAQSAVVKVVNPQGVVEDVEVHADTLQGRDWIVSRGLKGGERVI
VENAAQHAAGSSVQAVVRQPASAGAPSPLAASPAGQ
>I3I623|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFQLQAKGVFVDFVLVIKAIVMGIVEGVTELLPISSTGHLILAADMMNFLENEKRTVFE
IFIQMGAMLAIVWEYRRKIFGSLGGVVRPGIERNLYVNVALAFFPAALIGFLLSDFIMTY
LFSPYVVASGFIVGGLAIIWVEKFAYAPRIQEMDDLSYRDALKVGLCQCLALIPGTSRSG
ATIIGGMYFGLSRKASTEFSFFLAIPMISAASLYSLWGAREQLEWSDAGILAVGFITAFI
ATFVVMRALLIFISKHTYIAFAWYRIAFGILILITAYTGAISWSH
>R7ECC3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKVIFLGIVEGITEWLPVSSTGHMILVDQFMKLKVSEEFWQMFLVVIQLGAVLA
VVVLDFKKLWPFHKNDPSRESNWNYISTNERIGKLQKFADKYINMNKIVLWLKILVSCVP
AIIVALPFNKWIEKTFMNYWVVSVMLIVYGVLFIVIENYNKSRKPSRTKLSDISFKDALF
IGIFQLLALIPGTSRSGATIIGGILLGMSRKLAAEYTFFLAIPVMFGASFLKLIKFGLHF
TGTEVVYLLLGMVVAFGVSIAAIKFLMGYIKKHDFKVFGWYRIVLGVVVLAYFLLA
>ZP_04197552|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGICVGILGL
SLTSLEAFTGGALQVEAKEKTRPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKDDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPAHKRNILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVIVKALR
>T1YZQ0|FEATURES|UNIPROT_deepARG|beta_lactam|bla(CTX-M)|antibiotic inactivation|1
NQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAF
ARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWM
KGNTTGAASIQAGLPASWVLGDKTGSGGYGTTNDIAVIWPKDRAPLILV
>X5PZ73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTVVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWKMLLELPYDRLTRHFVLGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVILLLVDRMKPKPYYHDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAVGFVAAFVTALIVVRFLLDY
VSRHGYALFGWWRLVVGIVGLAGLAIWG
>G3JVG9|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGELDLAVSCSTGPDV
>R4WAM0|FEATURES|UNIPROT_deepARG|beta_lactam|AQU-1|antibiotic inactivation|1
TSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPHYFN
YGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFD
GITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLA
ASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLADEAY
GIKTSSADLLAFVKANIKGVDDKGLQQAIALTHQGRYSVGEMTQGLGWESYPYPVSEQTL
LAGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANRNYP
IQE
>YP_001220629|FEATURES|ARDB_deepARG|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALNTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>K2TXA4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPKEKTFFGSVAQMCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQIVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGD
NKLIVWAASVDTSSNGEAPGTVISHEPLRIACGEGSLVITAGQRGDSGLYLSGAQLAREF
GLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>A0A0M8TBT8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSEIPVADEDAGPYGITTGPDGALWLTFVHSGRIARLTLDGELDTFPLESAECGPTVIAP
GPDGALWFTRFQDHRIGRITTAGETESFPLPTPDSGPFGITAGPDGAMWFTEMNTDRIGR
ITGTGEITEYALPGTGSYPSAITAGPDGALWFTLNQANAIGRITVHGDIAVHPLPTPGAA
PVGIASDGVALWFVEIAAGQIGRISVDGAIEEFPLPDRTAKPHAIVAAAPGDCWFTEWGA
NAIGHITRSGQITEYGLPSPSSEPHGITVGPDAAVWAALETGAVARLARQPGR
>H0SGI9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSDTLRAVLLGIVEGVTEFLPVSSTGHLLLAERFFGLGEDGFWKSFAILIQLGAILAIV
ALYFFKLTRVAVGALTNPDDRRFIIGVLIAFLPAVIIGLIAGKYIKALLFDPWVVCFSLI
VGGAILLWVDQIDLKPREHDATRYPLMMYLWIGVAQCLAMIPGVSRSGATIVAAMLLGGD
KRSAAEFSFFLAIPTMVGAFVYDFYKSRAEMTSDHLGLIAIGFVVSLITAMIVVKAFLGY
VTRHGFVLFAWWRVIVGTLGLIALALGK
>ZP_04120479|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMVILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYNNQLI
AEATKVIVKALR
>YP_001726874|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHSIAEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>A0A0N1AQA1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MALIELHGVSRRYTLGEIEVRALDGITLAIEAGEFVAIMGQSGSGKSTLMNVLGCLDNPT
EGRFLIDGQDAGQLGPDELAALRRERFGFIFQRYHLLPHLDARGNAALPAVYAGVGASAR
GARAQALLERLGLGERLHHKPNELSGGQQQRVSIARALMNGGQIILADEPTGALDSNSGA
EMLRLLKELNAAGHTIILVTHDPTVAAHAQRVIELRDGHVVKDDGTPAGHQAPGPQPTAA
AHDAPAEPAPSSPHAAPAGWLRRLQVQWREALSTAWLSLQGNRLRTFLSMLGISIGIASV
VSIVALTSAARTTFEGEFQGVMSGKIWLWRGNSDLPPGAQPPSFRLSELDALRSLPGVAS
VQGERQLNAQLRQGARDSSVQVRGADSGTLFERKLKVDSGRFFSPYELSVGAQVLVLDEQ
SRKALFKDSESPVGKTVLVSSSGLAGGLGGGGETASTASAEGLPGGARATPPAPLPFTVI
GTVKADTQLGFDFGNGRAYVPERTFIQRLDSRPAVDAFSVQMDFTQPPEEVLRHIKHRLV
ALRGAENFSSWSGDSEFRKMQNFSAGFAALFAGVGAIALLVGGVGVMNIMLVSVSERTRE
IGIRMAVGARQGDVRLQFLIEAVVLCCLGGLVGVAFSWLGAQALNAAQDKLFVSVSWAAL
GVAFAVSSAVGLVFGTVPARRAAALSPVDALARE
>AAV80411|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDIACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGKVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>YP_542447|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MIALNTASPQGMQMKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRD
AAFEKINEARSPLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALT
LQEKAAGIQDVTYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFN
VGLVAITDVQNARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDK
PQPVNTLLKEAEKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSK
TRGAAGTQYDDSNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQ
TVRSSFNNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQE
LANARYNYLINQLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYA
PDSPAPVVQQTSARTTTSNGHNPFRN
>A0A089IZI9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFDEQDSIMKTYEIVIQLGAILAIAI
VYRQRILNLLGIGRSGRSRGGVMPASRLNLIHVLLGIVPALAVAFFARDFIKSLFGASTV
LWALVAGGILMIIAEWVNKRKIRVTAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYRNFTNDTIWYFAIGFVISFVVSY
VVVVLFMRMIQKIRPTHFAIYRFILAAVFWLFIMR
>A0A0Q4KQ43|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLTVILLGIVEGITEFLPVSSTGHLILATRLLGYDAGRWEVFNVVIQLGAILAIVVL
YWRTFWAVGMGLIKREPKSWLFLRNLVVAFIPAAVIGLAFHKYIEALLGNAEVVAIALVV
GGFAILAVERFAPRSDISGVADIPLKTVVGIGFLQCLAMVPGVSRSGATILGALALGVER
RTAAEFSFFLAIPTMLGASALEILKNRDAIASGGGVGLGAIAIGAAVSFIVALLVVKWFV
GIVTKHGFVPFALYRVVAGSAALIWLLTK
>K7SCS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLFDALILGALEGVTEFLPISSTGHLILASQLLGLEQTNAHKAFEVSIQLGSILAVLFL
YAKRLLQDKTLWLKIGVAFLPAGALGFLFYKQIKALFGVETVSIMLIAGGIVFLAFEYLR
RDKPIDSGKDITELTFKEAFTIGVFQSLSMIPGTSRSGATLIGGLIMGLSRKSAAEFSFL
LAIPTMIIATAYDLIKHRNEMVVDDYFMLSIAFITAFVFALATVKLFVAFVSRHTFTPFA
IYRIVVGIIFFYFVAVLPA
>AAO38251|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|EreA2|antibiotic inactivation|1
MTWRTTRTLLQPQKLEFNEFEILNPVVEGARIVGIGEGAHFVAEFSLARASLIRYFVERH
DFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSSYGSVLIWVKSYLRESGRKL
QLVGIDLPNTLNPRDDLAQLAEIIQVIDHLMKPHVDALTQLLTSIDGQSAVISSAKWGEL
ETAQQEKAISGVTRLKLRLASLAPVLKNHVNSDFFRKASDRIESIEYTLETLRVMKAFFD
GTSLEGDTSVRDSYMAGVVDGMVRANPDVRIILLAHNNHLQKTPVSFSGELTAVPMGQHL
AEREEGDYRAIAFTHLGLTVPEMHFPSPDSPLGFSVVTTPADAIREDSVEQYVIDACGKE
DSCLTLTDDPMEAKRMRSQSASVETNLSEAFDAIVCVPSAGKDSLVAL
>U7TU81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFINSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFMDSTLIIAIT
LIVYGVIFIGIEVVYKLKKIKPKVKRFGGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLLKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVIVLLY
>YP_277581|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MSMIYITLNIIAYVIDVRSLILDVRRLVFSLILGIVEGLTEFLPISSTGHMILVENILNC
MDDSVIAFTVIIQLGAILSITKIFWSQLYGMSMICIKKIFFKQHDDHNHLCIRHIFLGTF
PGIMLGMIFYEKIGLIFELTYIMYGLIIGGIFLLVGELCASKEPRVSRINNITYLQAFLI
GCFQCLAFWPGFSRAGATIGGGLVVGLDRRISSEFSFFLAVPIIFGSAVLTLYHYRSCIG
LMDVLLLIAGSATAFFIALFTVRYFLKIVKNVSLIPFAIYRFLLAGGIYWGLMT
>E9LZM4|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQSSAVRQKLAALEKSSGGRQGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>A0A0L0LHE9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTPLDAIVLGLLEGAAEFLPVSSTGHLILASDLLAIPESAFLTSFIIAIQFGAIGAVLLT
YWRSFLNIAVLKRLFVAFLPTAIIGFTLYPLIKGVLLKSELTVVIALFVGGVLLILFELL
HKEEAREVETDTFATIPYKKAFLIGLFQSIAVIPGVSRSAATIMGGLLLGIRRAAIVEFS
FLLAVPTMGAATSYDLLKNYELFADADIGILLIGMATAFITALIVLRIFLAFIKRYTFIP
FGVYRIILAITFFFLVLY
>S3BQE8|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1486_01041|antibiotic inactivation|1
MTMRTTTARRAVLGALGLTLVVPLTACGQEAPGASSKPASSGASASPAAVKRAQTAERFA
KIEQKFDARIGVQAVDTGTGRQVAYHADERFAYASTHKAFTVAAVLDKYSVDGLDKKKIA
VKASDPVGHAPVTEANVGKKLTLRELCEAAVRQSDNGADNLLVRDLGGPKKLEAFLEGLG
DHVTEVSRYEPDLTEATPGDTRDTTTPRAFTKDLRAVILEKGLGKQERKLLDSWMLNSPT
GTKLIRAGVPDDWKVSDKSGAGRYASRSDIAVVRPPGKAPIVVSVMSKRTEEDASYDDRL
VSEAATVVADTLG
>A0A127STE9|FEATURES|UNIPROT_deepARG|chloramphenicol|catA16|antibiotic inactivation|1
KLYPVILYAITKVVNNHIEFRMSLDENDNLGYYINVNPSYTIFHKDNNTFSNIWTKYDSS
FEKFYNNYEKDIQEYGNEKGFITKKCEENNLINISSIPWVTFTEFNLNLPRGEKYLLPIF
TVGKFYEQSNKILLPLAVQVHHAVCDGFHTSRFINDLQEFVNNFENIV
>CAO72212|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmX|antibiotic target alteration|1
MSAYGHGRHENGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAV
EVDAKLAAKLTQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAW
TDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRTAFRPQPNVDGGILVIRR
VGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLP
PRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR
>A0A0G0YF57|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLFQTIFLGIIEGLTEFLPVSSTAHLMIVSRLFGVADSEFLKTFEIAIQLGAICAVLVL
YFKKIFSDFSLIKNVAVGFVPTATTGFLFYGIFKSLLGNIYIALATLFFGGIVLILFEKF
SKPKNDSTSLTTSEQLDLKKSFTVGLWQTLAMIPGVSRSMATILGGMMTGLSKQAAVEFS
FLLALPTMFSATVYDIYKSYSLFSFSEWQTLGIGFLIAFLSALVSVKWFLGFISKNSFAN
FGWYRITFTILIFAILF
>R5LH28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLTELVKIVVLGIVEGITEWLPVSSTGHLILFGQFLNLKSSQEFINMFNVVIQLGAILA
VVVIYFKKLWPVSKNNGTAKLCWDKDKLWLWLKIIVACIPSAVIGLLFEDKIDAIMTSPY
IVAATLIIYGIIFIVVENINKNKEFKITSLKEITFKTALIIGLFQVLALIPGTSRSGVTI
IGAMLIGTARTEAAEFTFFLGIPTMFGASLLKIFSFLKDGGGFSGPEAIYLLAGMVVSFA
VSIIVIRFLMSFIKKHDFKPFGIYRIVLGLAVIAFLVFA
>E2GM25|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-114a|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGRHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLP
VKAAAYELADNLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATQPNAGLRARDELVRDWPAMAGAWRP
>B0LQH6|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERK
>NP_755678|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MMSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILA
VVVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNP
INVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATI
SGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVAL
IAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>J3F5L7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSEPLLQLTDISRSFTAGDREFLALKNINLTIHAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYKINGRETRDLDNQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGTPEP
QRHARARELLARLGLEGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTTS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRRNERDTTALSNEDA
VPKSTAARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGAK
RYVLKDIQAIGSNTIDIYSGTSFGDSRSAAIETLVPADVTALNQLYYVDSATPVVGRNLL
LRYRNIDLDAQVNGVSDLYFQVRGIKMESGIAFSESDARRQAQVVVIDHNTRHRLFGEGV
DPLGQVILIGNLPCTVIGVAAENKNIFSSSKSLNVWVPYETAAGRLLGQRYLDSISVRIK
DGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSVMQTVQKTSRSLALLLSLIAVISLVVGG
IGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGHL
FSLFIKEWEMVFSLASVLTAVICSTLIGIVFGFVPARNASRLDPIEALARD
>ACK77685|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIVMLAGVLAIMKLPIAQYPTIAPPAVSISANYPGADAKTVQDT
VTQIIEQNMNGIDNLMYMSSTSDSSGSVTITLTFDSGTDPDIAQVQVQNKLSLATPLLPQ
EVQQQGLKVEKSSSSFLMVAGFVSDDPNMTQDDIADYVASNIKDPISRSSGVGEVQLFGA
QYAMRIWLDPNKLNNYQLTTTDVTSAITEQNNQIAAGQLGGLPPVPGQQLNASIIAQTRL
TSPEEFGKILLKVNTDGSQVRLRDVAHIERGAESYAVTARYNGKPAAGLGIKLATGANAL
NTAKGVKDELAKMAPFFPQGMKVVYPYDTTPFVKISINEVVKTLIEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
SEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIPKGDHGVKTGFFGWFNRMFEKSTHHYTDSVGNILRSTGRY
LIIYLLIVVGMGLLFLRLPSSFLPDEDQGILLTMVQLPAGATESRTNKVLEEVSDYFLNK
EKDNVVSVFTVAGFGFNGNGQNNGLAFVSLKDWGERPGAGNKVEAIAGRAMGAFSQIKEG
LVFPFNLPAIIELGTATGFDFELIDQGGLGHEKLTEARNQLLGMVAQHPDVLVGVRPNGL
EDTPQFKLIVDQEKAKALGVSITTINSTLSTALGGSYVNDFIDRGRVKKVYVQAEAPFRM
LPEDINKWYVRGTSGQMVPFSAFSSAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
NLMEQLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISILVVFLCLAALYESWSVPFSV
MLVLPLGVIGALLAATMRGMNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPVFFVVVRRRFSKKNEDLEHSHPVEHH
>AAM11666|FEATURES|ARDB_deepARG|beta_lactam|BL1_ampc|antibiotic inactivation|1
MKKKLVFCALLLGVSCSALASSLSEKELAKVVKRTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTPQTLFELGSVSKTFTGVLGGDAIARGEISLNDPVTRYWPELTGKQ
WQGIRLLDLATYTAGGLPLQVPDNVTDPAALLNFYQTWQPQWKPGTTRLYANSSIGLFGA
LAVKPSGMGFEQAMTTRVLKPLKLDHTWIQVPKSEEQHYAWGYRDGKAVHVSPGMLDGEA
YGVKSNAEDMASWVMVNMAPERVQATSLKQGIALAQSRYWRVGSMYQGLGWEMLNWPVDG
KTIIDGSDNKIALAALPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYQILNALQ
>YP_001588592|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>R6KMX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILIFKAIILGIVEGITEWLPVSSTGHMILVDEFIKLNVSPAFKEMFFVVIQLGAVMA
VVVLYWKKLFPFSTSEKFLVKKDTFQMWFKIVVACIPAAIVGILFDDKIDELFYNYQTVA
LALIIVGIAFIIVEKKNKGRVFMKTKLSDITYKDAVIIGLFQLIAAIFPGTSRSGATIVG
AIIFGVSRGLATEFTFFLAIPVMFGASLLKILKFGLTFTGTEISVLLIGMIVAFIVSMIS
IKFLTDYVKKHDFTVFGWYRIILGIIVILYFLGKTFIF
>AAF68936|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVAFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>R6D652|FEATURES|UNIPROT_deepARG|chloramphenicol|BN558_00761|antibiotic inactivation|1
MSKIPFDLTTWNRKEHFHHYLNTVSCRYGMTVNLDITLLRAALKKRNYKLYPAVIHLLSR
CVNQHKEFRMTLDQDDQLYYFDLLNPSYTIFHTDDETFSSTWTQYDPSFPAFYQNYLDDM
QQYGNNHGMLARSPREDCFDISCLPWATFTEFHLDLPDARRFLLPIFTFGKYFKQDGKIL
LPLSVQVHHAVCDGFHLCRFVNECQQLADQCEAWL
>A0A0A2R5Z2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDITSLLHALILGVVEGLTEFLPVSSTGHMIIVAELIGFTGDKAKTFEVVIQLGSILAV
VFLFWRRMFALIGIHFGRVPHEGQTQGKLNLLHIIIAMLPAVVLGLLLRDQIKSLFNPVN
VMYALVAGGILLIVAEVFKPKKVQATGLDDISYRQAFAIGCFQCLALWPGFSRSGATISG
GMLMGINRYTASEFSFILAVPMMMGATALDLYKSWHFLSSSDIPMFAVGFLAAFIVALIA
MKTFLSLIKRISFIPFAIYRFIVAAAVYVVFVH
>A0A0H3HBI4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGNVEVLKGITLNIAAGEMVAIVGASGSGKSTLMNILGCLDKP
TGGTYRVAGTDVARLNGDELARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGAERKA
RLARAHELLVRLGLGDRAEYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSRSG
EEVMGILHQLKAQGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPALSPAQGGVLRQRT
AAEPSAWRQFSSGFREALIMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAIGTNTIDVYPGKDFGDDDPRYQQSLKYDDLLAIQKQPWVSSATPAVSKSLRLRA
DNIDVAASAEGVGAQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNARRQLFPHKARVV
GEVILVGNMPATVIGVADEKQTMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVNEGY
DSAVAEQQLLRLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLLIAFVLQL
FLPGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0W0NT75|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPRFIPSVTALALFIGASHCLAATDLRAVVDASVKSLMQQQAIPGLVVGVLQDGKAQYFS
YGVADKQSGQSVSENTLFEVGSVSKTFTATLAGYAVATGKLTLDQPASHYLPALKGGRFD
HISVLNLGTYTAGGLPLQFPQEADASQRMIGYFQQWQPAFAPGTQRLYSNPSLGLFGYLA
AQSLGQPFDQLMEKTLLPRLGLKHTFLKVPLNKMSLYAQGYDSKGKPVRVGAGAMDSEAY
GIKTSAADLLHYVDVNMNPAGQAKLVQQAIALTHTGYYTVNGMTQGLGWEMYPYPIALDA
LIDGNSTQMAVEPHKVEWLTPARAPHADTLVNKTGSTNGFGAYVAYVPSKRLGVVILANR
NYPNGERVKVAHGILKALAP
>ZP_03105209|FEATURES|ARDB_deepARG|glycopeptide|VanRB|antibiotic target alteration|0
MDIRILLVEDDEHICNAVKVFLSGAGYKVDACFNGDEAHTKFYDNTYQLVILDILLPGMN
GHELLREFRKLNNTPVLMMTALSDDENQIRAFDAEADDYVTKPFKIQLLLKRVEALLRRS
GAVAKELHYGKLTILPEDFNVFYDDEELLLTLKEFEILMLLVQNNGRTLSHEVILSRVWG
YDFDGDGSTVHTHIKNLRAKLPDNIIKTVRGVGYRLEETS
>A0A0T9U413|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_2|antibiotic efflux|1
MTALLELKGIRRSYQSGGETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYSVAGQDVATLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKQE
RRERAKMLLTRLGLEERVDYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKTVAAVATSEVTS
LTPPAPSWQQLTGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQM
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVYEDMAALKEQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITREQVERQAQVAVIDRNTQRRLFPHINDV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRSYFDSITVRIKEG
YNSKEAEQQLIRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLIVE
MFLPNWQITFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>AAT35601|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-3|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCCTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGKTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDTAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABG71850|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MIMKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMAR
TLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLALCAGVTFS
MARWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMN
VWTLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>A0A0G4JBK5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_2|antibiotic efflux|0
MTRTAAPLLRLTGISRTFGEGVGAVTVLRDVELEIGRGEMVAIMGPSGSGKSTLMNVLGC
LDRASSGRYEIDGHDVASLSDDALAARRREHFGFIFQRYHLMGHLTAQGNVEVPAVYAGS
PKERRAARSAALLERLGLGKHLSHRPSQMSGGQQQRVSIARALMNGGDIILADEPTGALD
SRSGHEVMQILRELHARGHTIILVTHDPGVAAWAQRIIEIADGRIVRDRLNDPIAPSAQD
EPDNPGDTRHRPPSDPVDTKRYETSRKSARERDPAAAASRPRAGSLTGWLRGWPTFSESL
SMAWHALASHRLRTGLTMLGIVIGITSVVSLSAIGEGTKQRVLNDIGNIAPNTITVIRGK
DFNDDKAAEIRTLLPRDAALLAAQPYTDSVTPQVGPRTARMRFGRLDTDAQVHGEGADFL
RANGLKLARGRSFDAAEVERQAQVALLGENTLRKLMPNGGDPIGQTVLAGSLPLRIIGVV
RDRSSMFVSRSLNVYVPWTTVASRLAGQQHLESITVRILDGHPPAAAEVGIIRALTRAHG
QKDFFTFNMDTIVKSISRTSQMLTLLLSFVALISLVVGGIGVMNIMLVSVTERTREIGIR
RAIGARRQDILRQFLIEAVLVCLMGGAVGVALSCAIGWLVAALVPQVAVVFSVRTVTAAV
MCSCAIGVVSGWWPARSAARLDPVDALARE
>A0A140CXX8|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
VGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGD
SQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGRGGYGTTIDIA
>A0A059I2E9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLYALILGIIEGLTEFLPISSTGHMILGTTILGIDIDEFWKSFLIIIQLGSILAVIFV
FWRKLFQGLDIWLKLAVGFFPTGVIGLFVAKYLNALFNGWVVVGMLIFGGVVFILIELAH
KNKQYRINSLEEISFKQAFCIGIFQSLAMIPGTSRSGASIIGGLLLGFNRKVAAEFSFLL
AIPTTIIATAYSIYKEPELLSNANSLIPLGIGFITAFIVAVLVIKFFLKFISKFDFIPFG
IYRIILGFVFFYLYYSGILNAGSEFKL
>YP_001348630|FEATURES|ARDB_deepARG|multidrug|amrB|antibiotic efflux|1
MARFFIDRPVFAWVVSLLIVLAGILAIRFLPVAQYPDIAPPVVNVSASYPGASAKVVEEA
LTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNADLAAVEVQNRLKIVESRLPES
VRRDGIYVEKAADSIQLIVTLTSASGRYGAMELGEIASSNVLQALRRVEGVGKVETWGAE
YAMRIWPDPARLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLV
TPEQFGEIPLRIRADGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVA
TAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQN
FRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMA
EEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFS
AFLALSLTPALCATLLRPLDAGHHEKRGFFGWFNRTFLRLTGRYQKAVGGILARPIRWML
VYALVIGVVALLFARLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVADVERYLAEHEP
VAYAYAVGGFSLYGDGTSSAMIFATLKDWSERQDASQHVGAIVERINQRFAGLPNRTVYA
MNSPPLPDLGSTSGFDFRLQDRGGVGYDALVKARDQLLARAAEDPRLANVMFAGQGEAPQ
IRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADGARRLSIDDI
GKLHVRNEQGEMVPLATFARAAWTLGPPQLTRYNGYPSFNLEGQAAPGYSSGEAMAAMEQ
LMQGLPEGVAHEWSGQSYEERLSGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVP
LGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMDLLQATLEA
ARLRLRPIVMTSLAFGFGVIPLALSSGAGSGAQIAIGTGVLGGIVTATVLAVFLVPLFFL
VVGRLFRLRKAPRADASANTPTELT
>A0A0F0F4I3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTGLQAVILGIVEGLTEFLPISSTGHQIVVADLINFGGERAMAFNIIIQLGAILAVV
WEFRRKIFEVVVGLPRQREAQRFTVNLLIAFMPAVVLGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERREHVIRVDQVDDMRWSDALKIGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPDDFPVFAIGFVVSFIFAMIAVRGLLKF
IANHSYAAFAWYRIGFGLIILGTWLFGWVDWTTAHG
>B9J839|FEATURES|UNIPROT_deepARG|aminoglycoside|Arad_3392|antibiotic inactivation|1
MQIKEASFEHLDAWLRLRAELWPGSSMEHHRAELTQILTKENAIAFIACDQTGHAVGFAE
ATLRHDYVNGCKTSPVLFLEGIYVRREYRRRGVAQSLCRTVADWGRAAECREFASDALLD
NVESHAFHDALGFEETQRVVYFRKLL
>S1CK10|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFFTAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A097SRQ6|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
PFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFK
VLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNT
AANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKL
LTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDG
KPSRIV
>A0A0R2ZFV2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSAGYEIAAVFTHADDPRENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEALLATAGKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKISIERTDTGLSLHAKLRDAAATLLRDALP
QLAQGKLAETAQDESQATYFGRRTAADGKLDWKQPAETLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVSPLRIACGEDSLVIQFGQRNENGLYLAGPALADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVQMSETIGNTLDFFLREAMLEIA
QSIDEAK
>A0A0H3KQ39|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRITVTRVVATLLVATAAIATTGRAAELTQAHIRQIVTQQVAPAMKQYAIPGVAIGVIVD
GKRYVFDYGVMSKDTGKPVTADTLFEIGSVSKTLTATLAADAQEGGELSLSDPVARYVPA
LNGKPAGALTLLELGTHTAGGLPQQVPDAIHDDATLIGYFDAWRPASVPGTQRVYSNVGI
GTLGWITAKAMKRDFAELMERRLFPALGMTHTYIDVPDARRADYAQGYTTDGTPIRMKPG
GLWQPAYGVRTTATDLLRFVQANMGGIDIAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNASKMLSDAVPAVALTPPLAPQRNVWINKTGSTNGFSTYVAFVPAKRIG
FVMLANRRVPNEVRVEIAYRILASLGGAR
>A0A0Q0B2R4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPKEKTFFGSVAQMCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCTVGD
NKLIIWAASVDTSSNGEAPGTVISHEPLRIACGEGSLVITAGQRGDNGLYLSGAQLAREF
GLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>A0A0W7Y7R0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVIVVMWKRMLSLVGLYNIDGQSKSINGRFNLLHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVVYALVAGAILMIAADKLAPRKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYAVGFISSFIF
ALLSIKFFLALISKVKLMPFAIYRLVLAAVLCVIIFM
>I3VNW5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-24|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSEAQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVDDKTGS
GDYGTTNDIAVIWPQGRAPLALVTYFTQPQQNAERRRDVLASAARIIAEGL
>S6F2B6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPETSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFKAFLG
>G8EXA1|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
CGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGAT
WTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSD
WAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFMLQEGKLRAFYAGPAHTPDGIFVYFPDEQ
VLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEAL
>A0A0J2ECT1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIVITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFMNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPL
>A0A068R7A1|FEATURES|UNIPROT_deepARG|aminoglycoside|ant|antibiotic inactivation|1
MLLIPSEAAEVLLIVQKRLVESLVAVYLHGSAVVGGLRPRSDVDLLVVIDQPITSEIRES
LAADLMMISGRYPADPDGRRPVEVIVFLRTDLIASPYPARSEFIYGEWLRDEYEEGKTPK
PVCDPELTLVLAQSRQEAIPLLGPDASRLIPVIPRSDIRRAIKEVLPVLLETLQGDERNV
LLTLARMWRTVVTGEFVAKDVAAGWAAARLPVVQAIVLIDVRESYLSGCEEDWQNRQQEL
QLTVNALHDCVLTNL
>B7LQD5|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDAIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALV
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A145NDP6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLMGPDTPLTRYYGRLLMMKKSLCCALLLGLSCSALAAPVSEK
QLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHYYTFGKADIAANKPVTPQTLFELGSIS
KTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVT
DNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDH
TWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADA
SLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPAAEVNPPAP
PVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILEALQ
>YP_001480516|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTTGHLKLGHILLAMIPAVVLGLLFHDVIKSLFAP
KNVMYALVVGGFLLLAAEWLKPKKPSAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTI
AGGMLVGVNRYAAAEFSFILAVPMMIGASGLDLYKSLHFLTMGDLPMFAVGFATAFVVAL
IAIKTFLTLIKRISFVPFAIYRFIVAGVVYMVFM
>L1NBU5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILESIILAIVEGLTEFLPVSSTGHMILTEGILGMESTAYLKAFTVMIQFGAILSVVIF
YFRRFLPFPILGFRPDETTSLGGWRLYALMIVGCIPAAVLGGLLNDQIDALLGNTWVVLA
MLFLGGILMIYFDRIFGAKGEKRVTVTNAFIIGLFQCLAMIPGVSRSMATIFGGMQQGLT
RRQAAEFSFFLAVPTMFGATLLKGYKLYKELGMQVFQENWQTLLIGNVVAFLVALLAIKF
FIDFVTRYGFRAFGYYRILLSVGVAIALLLGANISLS
>A0A0F0T2J1|FEATURES|UNIPROT_deepARG|beta_lactam|SS44_20885|antibiotic inactivation|1
MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQ
WQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGS
LAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPNYAWGYREGKAVHVSPGMLDAEA
YGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPVRVETAYRILETLQ
>N8WBL8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDAEARHFAFSVLLAFIPAVVIGVFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESIKFDHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIAVGFVAAFISALFVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>A0A0N6ZNG9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNEFNERYDTDSVREFTVSDADAGPYALTEGPDGALWFTLVHRGAVARRDPDDGHVTVHP
VGDGPTVITAGPDGALWFTEYRAHRIGRLTPEGAYSSFAPRTPEGGPFGITAGPDGALWF
TLSSADRVGRVTVDGEVTEYPAPGAFPSALTTGPDGALWCTLNQGNAVGRLTTDGHGTAY
PLPTEGAGPVGIAAGPDGALWFTEIGAGRIGRITVDGAVTEYPLPDPAARPHAVTAGPDG
ALWFTEWGGGRVGRITVDGHVSSYPLSRTDCEPHGITAHDGALWCALETGSLARIEVRP
>K7QCS7|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VQENSMVYFGAKGVTVVGATWTPDTARELHKLIKLVSRKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRA
FYAGPAHTPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTV
VGGHDSPLHGPE
>J8ASL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLG
RVKLTPFAYYRFILAAVFYFFIM
>AAK17952|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>X5LBG4|FEATURES|UNIPROT_deepARG|aminoglycoside|BN979_01272|antibiotic inactivation|1
MTDWRPVSDGESGAGVFRSADGSRYAKVVGPAAVADLAAERDRVSWAHAHGLSVPSVIDW
EITEDGGAVLVTSAVGGIGADRLTETALRSAWPAVVEAVRALHGVVADDCPYRRDLDEML
SRARSVVAAGAVNPDFLRDEDRDVPQAELLARVEREAERRRRQEVVDQVVCHGDLCLPNI
LIDPDRLTVEGFIDLGRLGIADRHADLALLLANTADSFPGFAEDAAAGLAAGYPAEVDPE
RLHFYLALDPLTWG
>A0A0G0R0E2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIHALILSVVEGITEFLPISSTGHLILASQLLKIEQTEFVKSFEIYIQLGAIMSVLFL
YLKQIRRKEVLLPTIIAFLPTALVGLLLYGSIKNVLLGNSLVTVAALFWGGILIIIVELF
FKEKDHHVNDIGKISLKSALVIGLFQSISVVPGVSRAAATIIGARLMGVKRKTAAEFSFI
LALPTMLAATGLDLLKSDFSFGTSEVILLVVGFLGSFLVASLAIKFLLSYIQNHSFIAFG
VYRIILAILFYLLILRNA
>A0A0F2QN88|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWVAIQALILGVVEGVTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRRKILDVVIGLPKESQAQKFTLNLLIAFMPAVVLGVAFADLIHEYLFNPITVATALV
IGGAVMLWAERRDHTIRAETVDDMNWALALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDFAVFAVGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIGFGLLILATWQFGLIDWASAQG
>ZP_04631836|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIIMLAGALAIMKLPVAQYPTIAPPAITISANYPGADATTVQNT
VTQVIEQNMNGIDNLLYMSSSSDSSGNVQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVAGFISEDGTMLQEDIADYVGSNIKDPISRTTGVGDVQLFGS
QYAMRIWMDPHKLNNFGLTPVDVISAIRVQNNQVAAGQLGGTPPVPGQELNSSIIAQTRL
TTAEEFSQILLKVNTDGSQVRLKDVAIVKLGAESYNIIARYNGKPAAGIGIKLATGANAL
NTSAAVKAELAKLQPFFPAGLKVVYPYDTTPFVKISINEVVKTLIEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
QEEGLPPKEATKKSMEQIQGALVGIALVLSAVFIPMAFFGGATGAIYRQFSITIVSAMVL
SVLVALILTPALCATMLKPIAKGEHGPKTGFFGWFNRMFEKSTHHYTDSVANILRSTGRY
LVIYLALVIVMGLLFIRLPSSFLPEEDQGVFLTMVQMPAGATQERTQNVLNQVTDYYLDK
EKDVVNSVFTVNGFGFSGQGQNTGLAFVSLKNWDERPGDQNKVPAIVGRASAAFSQIKDG
LVFAFNLPAIVELGTATGFDFQLIDQGNLGHQKLTEARNQLLGMAAQHPDMLVGMRPNGL
EDTPQFKVEVDQEKAQALGVSISDINTTLGSAMGGSYVNDFIDRGRVKKVYVQADAPFRM
LPGDIDKWYVRNSAGQMVSFATFSSAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
DLMQELAAKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALMAASLRGLENDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLV
ESTLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPVFFVVVRRRFSRKNEDVEHAHAVDHKVP
>S5Z0Z2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHWIELLKAVMLGMVEGLTEFAPVSSTGHMIIVDDLWLRSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGFRGRHPGGKPRLTLIHVIIGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADKFAKRVARAQTVDHITYKQAFLVGLVQCLSLWPGFSRSGSTIA
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIVGFLSAFVFALL
AIRFFLQLINRIRLVPFAVYRIVLAVVIYFLYF
>R5BNR6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDQNLIAFILGIVEGATEFLPVSSTGHMILVGDFLGFTGQRASVFEVFIQLGAILSVFFY
YREKFMSMLRRENWIRNDRLSLAHIFFGMLPAMAIGFLGHSFIKNYLFSAGTVIIGLIIG
GLFMLWAEKRHKPITVETVDQLSMYQCLQIGLFQVLALWPGFSRSGSTIAGGLMLGVSRK
AAADFSFIMAVPIMLIACIYDLLKIIDQLQWSDFVMFAIGFVTAFVFAYLSIVWFLKFLN
KSSLAGFAYYRFVIAVIAFAYFFIF
>A0A0S8KZM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELMLLVQAVILGIVEGLTEFLPVSSTGHLIIVGDTLGFTGERAKAFEIFIQLGSILGVM
WYYRARVWALASGMHRAPERRFILNLLIAFLPAAVIGLLTHKYIKAYLFSPITVAVALIV
GGFLIFVIERWHKHRGARIHSVDEVTPLDAFKVGIAQTFSLFPGTSRAGATIMGGLLTGL
SRTTATEFSFFLAMPTMFAATLYDLFKSREYLQASDTLLFAVGFVVAFITAVFVVKGFLK
YVARHTFRPFAWYRIGFGILVLFYFW
>A0A0C3M7V6|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYGKMKQIVSNLKLPDYRYEQLTKAIFHQRIDNFDDMHILPKALRMSLVNEFGK
NVFSVIPIFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTKKFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRMFIAYIMLEGINDSKEHAEAVIDLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSSIKQFCSTLKKAGISATVRTQFGSEISAACGQLCYENEL
>A0A109WFX3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGSLMNPEAANSFKVVIQLGS
ILAVAIVFKDRILNLLGLKKNVTRDQQKGYRLTIAQIAVGLVPAAVLGFLFEDFIDRYLF
SVRTVAYGLIAGAVLMLIADWVNKRKDTINTVDRITYKQAFCVGLFQCLALWPGFSRSGS
TIAGGVILGLNHRAAADFTFIMAIPIMAGASLLKLVKYWSSLSPDMIPFFLVGFICAFVV
ALLVVKFFLRLINRIKLVPFAIYRVILGIILIMLVR
>A0A127T0Y0|FEATURES|UNIPROT_deepARG|chloramphenicol|catB|antibiotic inactivation|1
MIDLATWKRRVYFEHYMHTVRCTYSVTLNIEVDELIKKIKSLGIKAYPVQIYMLSTIVNT
FPEFRMAINRQGVLGCWDTVNPSYTIFNKTAETFSSLYTPFNHDFVPFYENCIKNIEVYS
NSETLFPQSDMPENLFTISSLPWLSFSGFNLNISGEGTYLPPIFTIGRYLEQNDKKQMPL
AIQVHHAVCDGYHVSRFAEALQDMAMDFDNWL
>A0A101RD81|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MKRGEPTLMPVFIEEFTLAGSDSGPYALTTGPDGALWFTLVHSGGIGRLVPGGVLTHHQL
DPDCGPMIIAVGPDDALWFTEHRAHRIGRIALDGKVEEFTVPTAECGPFGIAAGPDGALW
FTETAADRIGRITTDGRVTEFPLPATGTYPSAITAGADDGMWFTLNQADAIGRIGMDGAV
TLHPLPTRSAGPVGITAGHDGAVWFVEIGAGQIGRITPDGQITEFPLPDRTSRPHAITAG
SDGTLWFTEWAGNRVGSLTPDGTVTVHDLPTPGSEPHGIALGPDGALWTALEIGALARVS
VRVRTQ
>K7QCS9|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYW
KSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRA
FYAGPAHTPDGIFVYFPDQLVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTV
VGGHDSPLHGPE
>R9JPI3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDALKVIILGIVEGITEWLPISSTGHLILVEEFIKLELSEAFIEMFNVVIQLGAILAVV
VIYFHKLNPFSPTKTQKQKMLTIQLWVKVAIAAVPAAVIGLLFDDMIEAKFMNAYVVAAT
LIIYGILFIIVEESHKNKQPKVTKLSRLTIPMVLVIGVFQVLALIPGTSRSGSTIIGALL
IGTARGVAAEFTFFLGIPVMFGASFLKIIKFLKDGAGIAGNEIFLLLLGCGVSFAVSIFA
IKFLMQYIKNHDFKAFGYYRIVLGVVVLIYFGVSGLLAA
>BAF47404|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRSTLLAFALAVALPSAHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAVGSKASAEALTCNAYADAAEKKFDAQLAKETAGAR
>U7H085|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNLKKLLIVAGVFSVSSTLWAKDLTEQQVKAVIDQQFKPLLAQYNIPGLAVAVTLNGQHY
FVNYGVASKQSQQPVRNDTLFELGSVSKTFNATLAGYAQAQGKLSFSDHPAKYFPELNNT
AVNRATILNLGTYTAGGFPLQFPDEVVTQQDMVKYFYKWQPKTKISVARQYSNPSIGLMG
YVTALVMKKPYSELIEKTLFPQLGLKQSFIHVPESQMKNYAWGYKNDQAMRVSAGMFDAE
AYGVKSSSADMLKFIDAQLNPQQLKQPMRKTIENTHVGYFKVGAMTQGLGWEQYTYPVSL
ATLLQGNSSKMALESHTVTPIKQPKLASAATLFNKTGATNGFGAYVAFIPQQKIGIVMLA
NTNFPNEARITASYQTIQQLLKQQ
>YP_402153|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPI
SGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGMLKQENG
KAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
LNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVV
ISGLLKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>A0A009I9X2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-10|antibiotic inactivation|1
MRFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLIDQNFKPLLEKYNVPGMAVGIIQNN
KKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETHQGHYQVNTMYQALGWEEFSY
PAMLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYTVLNAIKK
>A0A0S9K3K8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLVLIAKALVLAVVEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
VYFGRLWSIATALPNDPRARRFVLAILIAFLPAAIVGGLFSKYIKLYLFNPWIVCATLVA
GGIVLLIIDDTVGEPKAAPNDGTHEGPTEHPRKTDVFEFSLPMALKIGLFQCVAMIPGVS
RSGATIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSNDALLIVIGFVA
AFISALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAGLILFG
>A0A0A8P2Z6|FEATURES|UNIPROT_deepARG|beta_lactam|blaKPC-21|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPRSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>E3DFK4|FEATURES|UNIPROT_deepARG|beta_lactam|EJP617_16750|antibiotic inactivation|1
MENDPMKKKTRNRLLLCTTLAVTPWLTAAAPMTQQQLTRLVDNTIKPLLEKQHIPGMAVA
VLYKGQPQFFNYGVAETEHQRAVTQHTLFELGSVSKTFTGVAAGAAMQTGLINLNDRVAQ
HCPELNGAQWQKITLLNLATYTAGGLPLQLPDEVTDTASLQHYFQQWQPQWPAGTMRHYS
NASIGLFGALAVKNSGLSFADYLNKSVFQPLKLTQTFITVPPSAQADYAWGYQDGQPVRV
TPGMLGAEAYGVKSSTGDMVKYMQANINPASLSSDNKGLAMAIASAQRRYYRVGNMYQGL
GWEMVNWPISPAGVIADSSNDIALKARPATALKAPQSAVASSWVHKTGSTNGFGAYVAFI
PEKQLGIVMLANKNYPNPQRIAAAWQILQALDESK
>K8RAY1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSVVTGLPARSDARRFTLNVIIATIPAIALGLLLEKHIKAVLFSPVPVSVALI
VGGIVILWAESRQRERGVITRVHSVDDLSYGDAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVNDIGLFVIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A0W0P4F9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
GMAVAIMSNGQRHYFNYGVASKDNQQPVDNDTLFEVGSVSKTFTATLGAYAQASGKLALQ
DIASQYLPALRGSVFDGVSLLQLATYTAGGLPLQFPDEVQGEAKTQDYYSTWKPRFEPGT
QRQYSNPSIGLFGYLAARSLGQPFDQLMEGTLFPKLALKHSYIHVPKDQLKHYALGYDKQ
DKPIRLGSGPLDAQAYGVKTSAPDLLQFVADNLQPGELDDTLQKALASTQSGYYQVGDMT
QGLGWERYAYPVPLARLMAGNSSQMALEPHPVQWLNPAQPPKTDALYNKTGSTNGFGAYV
LFVPSKQIGIVLLANKNYPNEERIRAAHAILGALDSAR
>A0A0G0NLA9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILQSIIFGIVEGITEFLPISSTGHLILLSKLLHIPQNDFTKSFEIIIQLGAISAVIFL
YFKTLWNIETIKKLIVAFIPTGVIGLLLYKVVKTYLLGNESIVLWSLFLGGIALVIFEYF
HKEERAVVEKNISSISYREAFLIGLFQSIAIIPGVSRSAATIVGGLSLGLRRTTIVEFSF
LLAVPTMLAASGLDLIKNYNSFSVDQLGVLSIGFTSSFVVAMGSIVFLLRYIQKHNFIMF
GLYRILLPILLWLIIF
>A0A0R2A4P6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVLGIVEGITEFLPISSTGHLYLVDEFVRLNESTAFINMFMVVIQLGAILAVVALYFNKL
NPWARNKQVIERNQTWSLWFKVIVAVLPSIVIGLPANDWLEANLTSWQVIATTLIVYGIL
FIVIENYNRTRTAKLTNLNQLSYKTAILIGIFQILSMVPGTSRSGATILGAILIGASRYV
ATEFSFFLAIPTMFGASLLKVAKYFVNGNTFTGGQLVVLLTGVVVSFIVAYLSIKFLLAY
IRNNNFKAFGWYRIVIGIVVVIYFGLIR
>A0A091B8B5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLFDALILGALEGVTEFLPISSTGHLILASQLLGLEQTNAHKAFEVSIQLGSILAVLFL
YAQRLLQDKMLWLKIGVAFLPAGALGFLFYKQIKALFGVETVSIMLIAGGIVFLIFEYLR
RNKPIDAGKDVSELTFKEAFTIGVFQSLSMIPGTSRSGATLIGGLVMGLSRKSAAEFSFL
LAIPTMIITTAYDLLKHRNEMVVDDYFMLTVAFITAFVFALATVKLFVAFVSRHTFTPFA
IYRIVVGLIFFYFVAALPA
>CAM88415|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MFMPPVFPAHWHVSQPVLIADTFSSLVWKVFLPDGTPAIVKGLKPIEDIADELRGADYLV
WRSGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLP
SALLPIRERFAALFQRARDDQNAGRQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMF
SSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLL
DQAYAYGCLSAAWNADGEEEQRDLAIAAAIKHVRQTSY
>A0A0H4R524|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MWEIIVAIILGIVEGLTEFAPVSSTGHMIIVDDLWLNSKELFSSPVANTFKIVIQLGSIL
AVVVIFKDRFINLLGLGKKPAAAIGPTNRLNLMQVIVGLLPAGVLGLLFDDYIDEHLFSL
NTVLIGLVVGAVLMILADLFGPKRPRVETVDQMSYGQALGIGLFQCIALWPGFSRSGSTI
SGGVLLGMSHKAAADFTFIMAVPIMAGASGLSLVKNWQYFTSDALPFFIAGFISAFIFAL
ISIRFFLKLINRIKLVPFAIYRIVLAAILYFVFL
>A0A127SZJ8|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRTQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMAQLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAQTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVY
DAMR
>B2TLN1|FEATURES|UNIPROT_deepARG|chloramphenicol|CLL_A2128|antibiotic inactivation|1
MNFKLIDIENWERKECFNHFMNIAKSTYSLTVNVDISKLLSLTKEKGYRFYPTFTWIVSR
AINKHKEFKMGFDQNGNLGYFEEISPDYSVLNEKTKIMNSLCTSYNDNFKWFYEEMVSDM
NNYKVRGILTEPQDNFFLISCLPWLSYTSFDVTNQSERQFLFPMVTWGKYFEHDGKVLMP
LTLQVHHAVADGYHCSLFYSDVQQVLENPQNYIE
>A0A0Q6S6C2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSKWSLPLSFLATVLASNVSIAMADDFSSKAGAFFEPVVKQYDIPGLVVGVTKNGVHEFY
TLGLASRADNRPVTADTLFELGSMSKVFNVTLAALAEERGKLSLNDTVAHHVCADACSIG
DDLTLMDLATHHSGGLPLQVPDNISDVNGLVTWLRNWHPPQPGARSYSNISIGMLGYISG
KAMGSNYKQAVQDVLFPAFGLQHTWIDVPKDEMSQYAFGYDRKTNAPIRVNPGVLDAEAY
GVKSSARDMLKVLDVELGRGQASDELRKAVDRTHEGQYRTAFFTQDMIWEQYPWPAELQT
MMSGNGYDFIMKPQPVDGIIPPLSSQKDVILNKTGSTNGFGGYIAMVPGEGLGIVVLANR
NYPNEARVKATYSLIKALGSQ
>W9AY91|FEATURES|UNIPROT_deepARG|beta_lactam|BN977_05631|antibiotic inactivation|1
MRLSRRSALIGGLTFAAAVCTSAPVHADPGTPLDQRIAALERRHGAKIGLSAVDLDGPGA
VSHRADESFAMCSTFKAYAAGRILRGVERGEFPLDATEYVDPAAVVANSPRTGPRAGTEM
TLADLCQAALQVSDNTAANLLLKRLGGPPAITAFARSIGDERSRLDRWETELNSAVPGDP
RDTSTPAALAGGYRALLTGDALAPPQRSLLEQWMRANETSSMRAGLPQGWTTADKTGSGD
YGSTNDVGVAYGPDGRRVLLAIMTRSAADDPKAAGLRPLIGELVGLVLPYLLDPNHP
>R7E2G7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLLEIIILGIVEGLTEYLPVSSTGHLLLTESLLNMSQSKEALDALAVCIQGGAILAVLS
LYFPRVKAMAQGVRGNNPAGLKLLVNLILAFLPAAVVGLCCASLIKEYLFNTYTVAYSWI
VGGGVILAYCAWRAREGRSNEGNSGASIESLTPARALTVGALQCVAMIPGTSRSLMTMLG
GMFVGLSVEAAVEFSFLLGLITLGAATVHDAYKDGALMLESFGWEALAVGTVVSWLSAWL
AVKWMVSYLQKHSFAVFGWYRIAIGIVTLVLLSMGLMH
>AAV74568|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSXDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQIIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTMPGFTSYSRYPRMVAAAGITLPALIDSLITLALKR
>YP_906603|FEATURES|ARDB_deepARG|quinolone|MfpA|antibiotic target protection|0
MEHWVDCEFTGRDFRDEDLSRLRTERVVFSECNFGGVNLTESEHRGSAFRNCSFERTTLW
HSTFAQCSMLGSVFVSCRMRPLVLDEVDFTLAVLGGNDLRGVDLSGCRLREASLVETDLR
KSVLRGADLRGARTNGTKLDDADLRGANPDPSLWRSASLAGARIDVPQALSFALAHGLRL
DS
>A0A0N0HCF5|FEATURES|UNIPROT_deepARG|beta_lactam|ADL27_50800|antibiotic inactivation|1
AALAAATLVPGTAHASSGGRGHGHGSGSVSDAERRLAGLERASGARLGVYAYDTGSGRTV
AYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRIFYTQDDVEP
>A0A0J6FYW6|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic inactivation|0
MQAGLRIDVDTYRGTREGVPRLLELLDEAQIKATFFFSVGPDNMGRHLWRLIKPQFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGKDLGHLMRQTLAAGHEVGLHAWDHHGWQANTGRW
SEAQLIEQIRRGVETLSDITGQAVECSAAAGWRADERVVQAKETFGFRYNSDCRGHSLFR
PRLVDGSLGAPQIPVDLPTFDEVVGPQISAADFNSYILDRFSPQKLNAYTIHAEVEGILM
ANDFRQLLAQARARDIHFQPLRDLLPVDLNSLPAGQLSRGVLEGREGWLGVQQP
>A0A127SUC6|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVY
DTIENQ
>A0A0D7XQK2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB2|antibiotic inactivation|1
MLNEVGKINIKGINHLLFSVSNLEKSIEFYEKVFHAQLLVKGQKTAYFDLNGLWLALNLE
ADIPRNEIHKSYTHMAFTIDPKDFDAIHQRLKNLNVNILNGRPRDKQDQKSIYFTDPDGH
KFEFHTGTLQDRLSYYKKDKPHMKFYI
>G2T1B2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAWQRLMHSSYEKNGVFMAEILKAIIFGIVEGITEWLPISSTGHMILLNEFLTLDVSAEF
WDMFLVVIQLGAILAVVVLFWNLIWPFARSSSEAVVAAEQNEKSGSLAKREYWVLGPVTV
RMPVIINWCKIVVSCLPAIVFVVLGLDETCDRLFYNPVCVAVALIVFGVAFILVENHNAA
KQAPVEQMRDITFQMAILIGLFQLLAAAFPGTSRSGATIIGALLIGVSRKAASEFTFILA
IPVMLGASLLKLMDFGLHLTGTEWAVLLSGMVSAFLVSVVVIKFLLGYIRKHDFKVFGWY
RIGLGVVVLLYFFLLK
>A0A073K1R6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEGEKAKTFEVFVQLGSILAVVVL
FWKRLWSLVGIGKVTEGPSLNLLHIIIGMIPASILGFLFHDQIKEILFGPGPVVISLVAG
GILMIIAEKFSKPSTAQTLDDITYKQAFAIGMFQCLALWPGFSRSGSTISGGLLARVSHK
AAAEYTFILAVPMMLGATGLDLIKNWDILSSADIPLFATGFITAFVVAMLAIVSFLKLLA
RVKLTPFAYYRFALAALFYFFVMN
>BAE96116|FEATURES|ARDB_deepARG|glycopeptide|vanHD|antibiotic target alteration|1
MQEKIDITVFGCERDEAAVFRKLSSEYGVTVSLIEDVVSEHNAKLADGCQCVSVSHKAEL
SEQLLLALKHAGVKYISTRSIGFNHIDIQAAGQLGMAVGTVAYSPGSVADYTVMLMLMLL
RGTKSVLRGTQKQNYCLNDCRGKELQDLTVGVLGTGRIGQAVMERLEGFGCKVLAYDRTH
KAGANYVSFCELLKSSDIVTLHVPLAEDTRHMIGREQLEMMKREALLINTARGALVDTAA
LVAALKEQKIGGAALDVLEGEEGIFYHECTQKTIGHPYLSVLQKMPNVIVTPHTAYHTDR
VLVDTVSNTIRNCLNFERSLGNV
>A0A0A3YX48|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYFDVSILAVIQGLAELLPVSSSAHVIMTEKLLGLDPAAPDMTLLLVMLHTGTMFAVIV
YFWNNWRETYFSSGRAFKKNVFLIILATAVTGVVGLALMKLIKYFFAANADTFEIESLFS
NSKIIASGLAAAGLLIILSSRLKEKDRGELSPLSAAGIGFVQGLCLPFRGFSRSGATIST
GLSLGVARKRAEEFSFALAVVLTPAVIVKEGLRAFSSGSAGTVAVSSGVLLPSLVGMLLS
FVAGLLALRWLSRWLEHDRWHLFGGYCLCAAALIGWLG
>G8PYQ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQPSARRFTANLLIAFLPAVVLGVLFADWIHHYLFNPITVAAALV
VGGLVMLWAEKRQHQVHAETVDEISWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAIGFVTAFIFAMIAVKGLLRF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKS
>A0A059WHE0|FEATURES|UNIPROT_deepARG|beta_lactam|blaP1b|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVXAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>L0NNI0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPEQSIISALVLGIIEGLTEFIPVSSTAHVLLAGHFLGFESPGNTFAVLIQLGAILAILL
VYFRKLWEIAMALPTSGKARRFVLTVLLAFLPAAVIGALAHDFIKTILFETPMLICIVLI
LGGFVLLAVDRMAIRPKYTDIMDYPPSLAFKIGLFQCLAMVPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDLIRFDDGIVIAIGFIAAFVMALVVVRSLLDF
VSSRGYAPFAWWRIAVGTAGLVGLLIFG
>U1H2V5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAAHFLGFEGQKAATFEVIIQLGSILAVIFV
YWRKMFGLIGIHFGEKVDQNKAHLNLIHIILGMIPAVVLGLLFHSTIKSWFNIHNVIGAL
VAGGILLILAEKFRPQPAYAEELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMG
VGKKAAAEYSFILAVPMMIGATALDLYKSLPFLSWDDLPLFAVGFVTAFIVAMIAIRTFL
HLIGKISFVSFAIYRFILAILLAWLVLA
>A0A0W0NX82|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTVNLLIAFLPAVVLGVIFADLIHHYLFNPITVATALV
IGGIIMLWAERREHQVHAETVDDITWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFITSFIFAMIAVKGLLKF
IASHSYAAFAWYRIGFGLLILATWQFGWIDWAAAKA
>A0A0K6JX64|FEATURES|UNIPROT_deepARG|fosfomycin|fosB_7|antibiotic inactivation|1
MKVKGINHLLFSVSHLYTSIDFYQKVFDAKLLVKGKTTAYFDLNGIWLALNEEPDIPRND
IKESYTHIAFTIEDQEFEEMSAKLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLRYYKQEKTHMDFYD
>A0A127SII8|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITAPCSTFAAPQQINDILHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPSTKYWPELTAKQWNGI
TLLHLATYTPLAACHCRCRMTLNPQATCCASIKTGNLHGLQEHNVCMPTPVSVCSAHWL
>A0A125WEM9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPKIPTSKVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLADLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>D0EJY6|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-15|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRLWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>W4VPH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKDILIAFILGIVEGLAEFLPVSSTGHLILVGHLLGFEDERAKTFEIVIQLGAILAITIL
YRERLVSLFNIKPILNKEKKFNAIHIVLGVFPPAIIAGLLLHDVIKTYLFRPNTVVIGLI
AGAILMIIAERKKSEPTSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLSKAS
YKASSEFSFLIALPVMVGATGLDLLKNWNHLSVSDIPMFLVGFITSFVVAMLAVVTFLKW
LEILGLTPFAYYRIVIAILFTIFVLL
>A0A109G0V0|FEATURES|UNIPROT_deepARG|beta_lactam|AWW70_20720|antibiotic inactivation|1
MLVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSEPPKQTKQENTGNHSFVKLEKEY
DAKIGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIMLAILSNHAKEDAKYDDKLIADATKI
VLDDLKVTNK
>G2Z4Z9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLLQALILAIIEGLTEFLPISSTGHMVIASSFMGIAEDDFTKLFEIVIQLAAILSVVVI
YWRKFFDFTRIQFYIKLVIAVIPALLIGGLLKKHIEAMLETPVFIATILLLGGFILLFVD
NWFQNPSINDEKEISNKKAFAIGCYQTLAVIFPGLSRSAATIIGGMQQGLTRKSAAEFSF
FLAVPTMLAATIKSIYDVYKDSPEVLNTDNLGILAIGNIVAFLVAYASIKFFIGFLTRNG
FKMFGYYRIVLGVLLLIIHYFHPLTVS
>A0A120JTS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIEILKVIFLGIVEGITEWLPISSTGHMLLVDEFLQLNASQEFKNVFFVVIQLGAILA
VVLIFWHKMWPFQFKDKSKPTLKMDIFTMWIKVVIACIPGAIVTILFDDYIEAHFQTPLV
IALALIIYGIAFIVIERWNKTRDPKIATLGDITYQTAIMIGLFQVLSIVPGTSRSGATII
GALIIGVSRVAAAEFTFFLAVPVMFGLSFLKILSFGLNFTGYELMLLFVGSFVAFIVSIV
VIKFLMSYIKKHDFQVFGWYRIVVGILVILLLVI
>A0A0D5NN54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLKAVILGIIEGLTEFLPVSSTGHMILVADLLNFVGERETVFEVVVQFGAVMAVFVLY
FKRFISFLRFDFSKGSGLNIIHLILGMIPASIIGYLLHGFIKERLFSTTTVLIALVAGGL
LMIAADRWKERTRVTAETIDDITYKQAFGIGCFQILALWSGFSRSGSTISGGIFLGTSQK
AAADFTFILSVPMMLGASGVDLIQSRDVLSASDAPLFITGLIASFVVALIAVTTFINVIK
RVKLTWFAYYRFVIAALFLAYYFI
>A2W3Q6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MRQPLLKLAAVTRRFPAGDKDVVVLNNVNLSIGAGEIVAIVGASGSGKSTLMNILGCLDH
PNEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
ERHARARALLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDKAVARHARRIIEISDGEIVADRPNRHYAEALAEVGI
GAAATTETAADTPSAPPAPASGDAPPPTDNDTATDPTPHARRFAAGTGRFAEACRMAWIA
LVSHRLRTLLTMLGIIIGITSVVSIVAVGEGAKRYMLEEIGSIGTNTISFYPGSDWGDSR
ADTIQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNVDVHALVSGVGDSYFQTRGMRF
ALGVPFDDDAVRRQAQVAVIDQNTRRKLFGATRNPVGEAILVDNVPCVVIGVTADKKSAF
GSVKSLNVWVPYTTASGRLFGQRYLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFFT
YNMDSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGAR
QSDILQQFLVEAVLVCLLGGTIGIALSFGLGALFSVFVAQWKMVFSAGAIVTAFVCSTLT
GVIFGFMPARNASRLDPIDALARD
>A0A0U1H8R9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSIINTLIFTAIATFPLYSLAQTKLTEQQVATIVNNTLTPLLEKQGIPGMAVAIFYD
GKPQFFNYGMADIKTGRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPE
LTGSQWKDVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKRSQLTFENYMKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTSQDMVRFMQANMDPESLPAGNDKLKAAIIASQSRYFQAGDMFQGLGWEM
YNWPINPQRVIADSGNDIALKPRKVEALVPAQPAVRASWVHKTGATNGFGAYIVFIPEEK
VGIVMLANKNYPNPVRVQAAYDILQALR
>A0A0B6FI11|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VDVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKTAASIAASDVIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVYDDMTALKEQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITREQVERQSQVVVIDRNTQRRLFPHLKEV
VGQVILIGNMPATIVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YNSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLKTAEQTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A0D7NV67|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFGLGEGAFWDSFTVLIQLGAILAIVV
LYFKKLWDVAIGMFTGDAYARRFVIGVLVAFLPAVVVGLVAGKYIKSMLFNPWVVCFSLI
VGGAILLWVDRLDLKAREHDATKFPLLMYLYIGIAQCIAMIPGVSRSGASIVAAMFLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKNRSEMTMDHMGIVAIGFVVSFITAIIVVKAFLGY
VTRHGFVVFAWWRVIVGTLGLIALALGH
>I0XN59|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNSYLNAIFRSVIEAITEFLPVSSTGHLFLFSSFYPFSEGADFDDLFDIFIQSGAILSVL
VLYRAKFLEQGKSALCYLLRKEESREGFLFLTRVTIGFLPIMVAGFLFRGFLDKIKSRGD
ILAILGWAWFVGGLLILLSEFWFQRREKIKTSEPIGIKDAIIIGIFQCLALIPGVSRSGA
TIVTARFLGKDTKSSAEFSFFVAVPVLFLAGGYKLFKHRAVLNWENLPILSLGFVLSFLL
CFFVIKWFLRYLRTHSFTGFGWYRILLGISVLLFYKLVMQG
>G8RLV6|FEATURES|UNIPROT_deepARG|beta_lactam|MycrhN_5650|antibiotic inactivation|1
MTELSRRHVLLGGLTLAAVAATSEKPALADPAEPPSLSVEALIQGLEQKHNASIGVFATN
LASGKTVAHRAQEPFAMCSTFKAYASGRILQMAQHGELSLDDPMFVDPAGILPNSPVTAP
RAGGEMTLAELCQAVLQQSDNAGANILLNRIGGPQAITAFARSIGDHQTRLDRWETELNS
AIPGDLRDTSTPEALGAGFRALLDGDVLAPPQRGLLDDWMRANQTSSMRPGLPAGWTSAD
KTGSGDYGSTNDVGIAYGPEGQRVLLAIMTRTQANDPKAENLRPLIGEVTTLVMPTLLA
>YP_002394085|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQASDTLRRTEPLLREGFVSAEEVDRARTAQRAAEADLNAVLLQAQSAAS
SVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTLATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>A0A0B0KSP7|FEATURES|UNIPROT_deepARG|aminoglycoside|PJ15_2890|antibiotic inactivation|1
MKIMPVTEPLLADWLQLRILLWPDHEDAHLLEMRQLLEQPHTLQLLSYNDQQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGVATTLVQQVEDWAKQFSCTEFASDAAIDN
TISHAMHRALGFQETERVVYFKKKIS
>A0A124QFE1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNAIRIAATLLVAACAATMAGRAAAATQDEIHDTVTRNVAPLMKQFAIPGMAIGVVVD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAANAQEGGELSLTDPAGKYLPA
LQGKPFGVVTLLNLGTHTPGGMPLQVPDSIRNDADLMRYLDAWRPAYTPGTRRTYSNVAI
GMLGLLTAKAMHEDFTVLMERRLFPALGMTHTYIDVPAARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLVETSPRLQRALERTHTGYFRAGPFTQDLIWEQYP
YPVALPTLLEGNGPPMLHDATPVTKLEPPLAPRANTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRSFPIEDRVKAAYRIVESLDGTP
>BAD77822|FEATURES|ARDB_deepARG|trimethoprim|dfrA17|antibiotic target replacement|1
MKISLISAVSENGVIGSGPDIPWSVKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSKNGISSSNENVLVFPSIENALKELSKVTDHVYVSDGGQIYNSLIEKADIIHLSTVHV
EVEGDIKFPIMPENFNLVFEQFFMSNINYTYQIWKKG
>V0TP86|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1598_02173|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>YP_002638128|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFIDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFILCALF
NAWLLPAWKLSTVRTPVREGMRRVMSDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMIPIGMVGNLQQL
FTLICAFYIGSVIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KALTQPELPWMMLGIIGFITFLALGWQFSHKRTPRRMLEPGA
>B6HZ32|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGIDPAMRAENISVAQYCQMANYLAENATLQES
>A0A133X183|FEATURES|UNIPROT_deepARG|beta_lactam|PtVF89_11505|antibiotic inactivation|1
MKKIIMFLCMGLLFCVSAWAQRTCFLATEKQTVLKREGNDCNQRYSPASTFKIALSLMGF
DSGILKDELHPEWPYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQALTRQLGMKRFKGYI
DAFHYGNQDASGDKGQNNGLTHAWLSSSLAISPIEQIQFLQKIIHKKLPVSQKAYTMTKN
IMYIQELPGGWKLYGKTGTGRQLTKDKSQKLPLQHGWFVGWIEKDDRVITFAKHIADSKE
NNTFASFRAKNDALIQLFNLINELEK
>YP_001268143|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRSKIFEVVFGLTHQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPVTVAAALV
VGGVIMLWAERRKHRVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFALGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLFILATWQFGWVDWSTAHG
>N3NF65|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDSDALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERGIEIRDGEIVRNPPAIEKVNVTGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAGGIGVMNIMLV
SVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWE
IGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A157P855|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_2|antibiotic inactivation|1
MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHY
FTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANSSIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEETHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVTANMAPDALQDTSLKQGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVSPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A0A6FF41|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTEPLLQLTGITRSFTAGDREFLALNNINLTINAGEMVAIIGASGSGKSTLMNILGCLDY
TTAGSYKINGQETRDLDNQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGTPQL
QRHARARELLARLGLEGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTAS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRANERDTTHLLSEEP
VAPKAAASRRLVASLGLFKEAFAMAWVALISHRMRTLLTMLGIVIGITSVVSISAVGEGA
KNYVLKDIAAIGSNTIDVYPGSSYGDKRAAAIETLTPADVTALNQLYYVDSATPMIGRSL
LLRYRNIDLDAQVNGVSDQYFKVRGIKMAAGIPFSENDARRQAQVVVIDHNTRQRLFGQD
VDPLGQVILIGNLPCTVIGVAAQDKSLFASGKTLNVWVPYETAAGRVLGQRYLDSISVRM
KDGQPSKVVEEHVTQLLLQRHGTKDFFTNNLDSVLQTVQKTSRSLALLLSLIAVISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGH
LFSVFIKEWQMVFSLASVLTAVVCSTLIGIVFGFVPARNASRLDPIEALARD
>A0A0M3GZ12|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRCFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRV
AEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A0U2ZUP5|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
QYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMA
QTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNHI
>A0A0U1KEK2|FEATURES|UNIPROT_deepARG|polymyxin|pmrF_2|antibiotic target alteration|0
MSQNEKIKKVSVVIPVYNEQESLPALIERTSAACKLLTQPYEIILVDDGSSDSSADILTA
AANEPDSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVAVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGGEQTENNQEIEK
>A0A0A0Q8Q0|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFKRLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKRAREGDGA
>G8EX96|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
KCGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVKENSMVYFGTKGVTVVGA
TWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKS
DWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDE
QVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEE
>K8NZN5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLADLLKALVLGIVEGVTEFLPVSSTGHLLLVERFMDLDRDNFWKTFAVMIQLGAILAIL
VIYFGRLWRVALGMFSDPAARRFVIGVLLAFFPAVVLGLIFGSFIKSVLFNPWVVCFTLI
AGGAVLLWVDQQDFKPRYHDAMAFSLPMYLGIGVAQCAAMIPGVSRSGASIVAAMLFGAD
KRSAAEFSFFLAIPTMVGAFVYDFYKNRADMTMDHGLIIAVGFVVSFITAIIVVKTFLDY
VTRHGFALFAWWRVIVGSLGLIALALGK
>ACA35067|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQALEEYPDSRENI
VDALAAFLRRLHSIPLCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGCPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFHKYGIDNPDMNKLQFHLMLDEFF
>E5LCR5|FEATURES|UNIPROT_deepARG|aminoglycoside|aac(6')-Iz|antibiotic inactivation|1
MIASAPTIRQATPADAGAWAQLRLGLWTDADDPLEELTQSLADAEGAVFLACAADGEAVG
FAEVRLRHDYVNGTESSPVGFLEGWCVQPQWQGRGVGRALLTAVQAWTRDAGCRELASDS
RVEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>A0A0A1Z6N6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNSSVRNFLFSALFFGSGTCMAATDLRPVVDGSIEPLMQQQGIAGLSVAVVNKGKVQYFN
YGVANKDNQQSVTQDTLFEIGSVSKTFTATLGGYAQASGKLKLSDMASQHLAALKGSAFD
RISLLQLATYTPGGLPLQFPDAADSADTMLGYFQHWKPAYAPGAQRLYSNPSIGLFGYLS
ARSLGQPFNVVMENTLLPKLGLKNTHVSVPADKADTYAQGYDKDQKPVRVGPGALDSEAY
GIKTSTQDLAHYVMVNMHPQTLEKPLQQAIATVQTGYYTVNGTTQGLGWEYYPYPIKLQA
LIDGNSTPMAMEPHTVKWLAPAQVQPANVLYNKTGSTRGFGAYVAYVPSKDIGVVILANK
NYPNAERVKVAHAILSALDH
>A0A023C968|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTLNLLIAFLPAVVLGVIFADLIHHYLFNPITVATALV
VGGVIMLWAERRQHEVHAESVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWIDWAAAKA
>A0A0V9JPZ8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEEQVEVLKGITLQINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRLDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPSQSPRQGKGIQEPT
VKTASGWSQFVSGFREALTMSWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQSLKYDDLSAIQKQPWVTSATPAVSQNLRLRY
GNTDVAASANGVSGDYFNVYGMTFSEGNTFNREQLNGRAQVVVLDSNTRRQLFPHKASVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSMLIAFTLQL
FLPGWEIGFSPVALLTAFMCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0Q6HBB1|FEATURES|UNIPROT_deepARG|chloramphenicol|ASG46_09935|antibiotic inactivation|1
MTVTRCTYSLVIDLDITKLYAILKEKRLKVYPVQIYLLARAVQNIPEFRMDQVDDALGYW
EILHPSYTILNKETQTFSSIWTPYDENFARFYKSCVADMDTYSKSNNLFPKPHMPENMFN
ISSLPWIDFTSFNLNVSTDEAYLLPIFTLGKFKVEEGKIILPVAIQVHHAVCDGYHAGQY
VEYLRWLIEHCEEWLNDSMQIT
>P0C069|FEATURES|UNIPROT_deepARG|multidrug|mepA|antibiotic efflux|1
MQFKPAVTALVSAVALATLLSGCKKEEAAPAAQAPQVGVVTIQPQAFTLTSELPGRTSAY
RVAEVRPQVNGIILKRLFKEGSEVKEGQQLYQIDPAVYEATLANAKANLLATRSLAERYK
QLIDEQAVSKQEYDDANAKRLQAEASLKSAQIDLRYTKVLAPISGRIGRSSFTEGALVSN
GQTDAMATIQQLDPIYVDVTQSTAELLKLRRDLESGQLQKAGDNAASVQLVLEDGSLFKQ
EGRLEFSEVAVDETTGSVTLRALFPNPDHTLLPGMFVHARLKAGVNANAILAPQQGVTRD
LKGAPTALVVNQENKVELRQLKASRTLGSDWLIEEGLNPGDRLITEGLQYVRPGVEVKVS
DATNVKKPAGPDQANAAKADAKAE
>A3SYD1|FEATURES|UNIPROT_deepARG|beta_lactam|NAS141_18974|antibiotic inactivation|1
MKSPNLALAVVLSVPFALPASLFAQSATSEQIVEIAGASFAPVIEQYRIPGLVVGITWQG
QHSFYATGVAARKGNLAATPDTIFELGSISKIFTATLAALAEDRGMLDLNAPVSDSIPQL
EGAAFGAIRLVDLSTHVTGGLPLQVPGEVGNVPELIRWLESWQPPQPGTRSYSNVSIGLL
GHITAQTMGMSFAQAAEDVLFPAMGLGSTYVDVPDDAMDRYAFGYDRKTDAPIRVNPGVL
ADEAYGVKSTARDMLRLLDLELGRGGADPALTAALERTRQGQAETAYYTQDMIWEQYPWP
VDVARMEAGNGYDFILSPQPATRLTPPLPPQRDVILNKTGATNGFGGYVALLPGQDLGIV
VLANRNYPNEARVRATYALITDLLATQD
>D3PMQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFEALILGILEGLTEFLPISSTGHLTLAAHLLQLDIENDPFIKSFIVVIQLGAILAVL
ALYFQRFLRDIEVWKRIIVAFIPTGILGFLLADVIENVFLGNDLIVVINLVGVGILLLFV
DRWLQHHKRYDDVNQMPVPHAVLIGLSQALAMMPGVSRSGATIVGGMALGLSRRAAAEFS
FILAVPTMLSATGFSLVRHMDQFRADSWGLLVVGFLAAFISALLTVRWLLDFVSRNSFVP
FAIYRILIGVVYGVFFLR
>A0A127SHD7|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
PYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELT
AKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGL
FGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALD
AETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWP
VNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIV
MLANKNYPNPARVAAAWQILNALQ
>BAG77975|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCASSSILFCLYASRPKKR
>A0A0A8LE36|FEATURES|UNIPROT_deepARG|beta_lactam|blaFOX-12|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYARGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRHWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAIANYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLKFTEANMGYQGDAALKSAIALTHTGFYSVGDMTQGLGWESYAYPLTE
QALLAGNSSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRN
YPIEARVKAAHAILSQLAE
>A0A014PRU6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCIGINALVKAGYQIEAIFTHADSAAENPFFASVARTAAELGIPVFAPE
DVNHPLWIDRIKAMAPEAIFSFYYRNLLCEEILSCASSGAYNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMTARADAGDIMAQERVAITAEDNALTLHRKLNATAEQLLADSLPAL
KAGQLSGKAQDHSQATVVGRRKPEDGRIDWSQPAEVVNNLVRAVTEPWPGAFGYVCSAKF
LVWKGKVRHDQPAAKAGTVLSVSPLIVACGQGALEVVTGQSENGVYMQGSQLAQTLGLVS
GALLRNQPVTAVKRRTRVLILGVNGFIGNHLTERLLKDDNFDIYGLDIGSDAISRFVGHP
RFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDPNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGKQKRCFTDI
SDGVEALFRIIENKNNNCDGQIINIGNPDNEASIKELAEQLLASFERHPLRNQFPPFAGF
RDVESSSYYGKGYQDVEHRKPAIRNARRLLNWTPEVTMDKTIDATLDFFLRTVDGVEESK
>YP_002203876|FEATURES|ARDB_deepARG|tetracenomycin|tcmA|antibiotic efflux|1
MTSQTTIDTTGPGDKAPQSPSDQPPLSGLRGHPWLTLLTVAVGVMMVALDGTIVAIANPA
IQADLKASFADVQWITNGYFLALAVALITAGKLGDRFGHRQTFLIGVVGFGAASGAIGLS
SSIAAVVTFRVLQGLFGALLMPAALGLLRATFPAEKLNMAIGIWGMVIGASTAGGPILGG
VLVEHVNWQSVFFINVPVGALALVLGVLILLDHRAENAPRSFDLLGIALLSAAMFCLVWA
LIKAPTWGWGDGLTWTFIVASVVGFGLFAFWETKVKEPLIPLGLFRSVALSAGVVLMVLM
AIAFMGGLFFVTFYLQNVHGMRPIDAGLHLLPLTGMMIVGSPLAGVLITKLGPRIPLAGG
MAATAIAMYGMSTLQADTGSALMSLWFALLGLGLAPVMVGATEVIVGNAPMELSGVAGGL
QQAAMQIGGSLGTAVLGAVMASKVDGDLAGNWKDAGLPALTPAQLDQASEAVQVGVAPVA
KGTPPEIVAKITDVAHDTFISGMSLASLVAAGVAAFAILVALLTKRGENAEAGAGVGHI
>V5RXJ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLLEVIVLGLVQGLTEFIPISSSGHLVVAQTLFGSGSDHLFLEAINIGTFLALVVYFFP
KIMTIVRLLIEKREGRLVRNILITSVPAGLVGYVAADFISGSAFFGSIIVVMGTLLVVGI
LMIILEKLPRLSEARDGEALSAGRAFLVGIAQMLALIPGVSRSGSTIIAGRLLGLNPKEA
AEYSFLASLPIMAGVTLKVFLTDGDYLAAHATDLVIGNIVAFLSGLMAVSFLMRYLAYHD
LRLFGWYRVALAAIIGVTLLVQL
>A0A0D4C4C1|FEATURES|UNIPROT_deepARG|beta_lactam|UM93_16900|antibiotic inactivation|1
MATFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAIT
MSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMAT
TLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAA
LGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>E6L8T0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIKLENISKKIGQNTILKQINLQIEKGEFVAIIGQSGSGKTSLLNIIGTLDEPSGGRFFF
ENYEVTNLNKDEKARLRREKIGFIFQRYNLLPLLSAKENVALPSVYAGKKSEERNQRATN
LLENLELSHKMNSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGVMVLEIL
QKLNTQGHTIILVTHDPKIAAKAGRVIEIKDGEILSDTKQNSKMREFEIKTMLKEKKSFN
LLKNQVFECFKIAYSSIIAHKLRSLLTMLGIIIGIASVVCVVALGLGSQAKVLQTTSSLG
TNTIEIRPGRGFGDLRSGRTRLNFSDLETLRSLEYLEAVEASEGTSGVLTYTNKSLNARA
EGVGVNSFNMDGLKLEVGRILDEKDLSESANVAVLDFNAKKNIFPSVKSEELLGKIVIFN
STPFKIIGILQKDTRRPISDNIVRLYIPYTTLMNKLTGDRKLREIIVKVKDNVSSSLAEN
AIIRVLELKRGQRDFFTFNIDSFKEAITANKRTTTILTICVALIALVVGGIGVMNIMLVS
VSERTREIGIRMAVGARREDILMQFLIEAVMICVIGAFMGVALSFGVIFVFNLFASDFLM
IFSGSAVLTGLLSSVLIGLIFGFFPAKNAANLNPINALSKE
>S2XME1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKINHLLFSVSDLESSIRFYEEVFGAKLMMKGRKTAYFDLEGLWLALNEETDIPRNEIKE
SYTHMAFTITEEEYEETLVRLNQLNVSILPGRERDERDKKSIYFEDLDGHKFEFHTGTLQ
DRLEYYKNEKEHIEFYG
>A0A069DC23|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIQGINHLCFSVSNLSQSIRFYETVFGAKILLEGRTLAYFDLNGIWIALNQENVPRNYT
TPTYTHIAFTVDEQDLNELRERLAEVNAKVLPGRERDARDQQSIYFLDPDGHMFEFHTGT
LQDRMNYYREDKPHIKFF
>M5CTC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFNQRENRDYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLEMAKDGKLGSENWTDVGVAFLAAAVTGFVVVKWLMGYIKSH
RFTAFAVYRIALGAALLLWLPSGS
>A0A0L3K1A4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPIWIDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>J0PI82|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTMAACKQLAYEYEIILVDDGSRDNSAQLLEDA
AALEGSNVVAVILNRNYGQHAAIMAGFEHCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVHHAEREHGESKYSPMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGMLFAFALIVLRLAFGSGWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAETFTVDGLTSSHTSTSPSDQVSS
>AAD51056|FEATURES|ARDB_deepARG|glycopeptide|vanRD|antibiotic target alteration|0
MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGKDALKCIESVELDLAILDIMLPDVD
GFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLELVARVKAQLRQYM
RYKQPGIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVST
EELFEAVWGERFFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK
>J8CUJ7|FEATURES|UNIPROT_deepARG|beta_lactam|IG7_02420|antibiotic inactivation|1
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQKIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKLLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKNPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNKS
>R8YPL7|FEATURES|UNIPROT_deepARG|beta_lactam|F931_00293|antibiotic inactivation|1
MQFKKISCLLLPPLFIFSSSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTEQQVLTFFKEWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFTDLGLKHSYVNVPKTQMQNYAFGYSQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>B2MWW3|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFRKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0D0F2A4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTIQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAVSLLIGGIILLKVDEW
FNTPNIAESAQEITYLQAFKIGLFQCLAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATAKKCYDYYKAGFELSHDQVNLLVIGNVVAFIVALLAIKTFIGFLTKNGFKV
FGYYRIIAGIILLLIHFLIHPLTII
>A0A0E0U187|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KYGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>D4DSK7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGANRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDSAT
SGSYQIDGIETAKMEPDELAALRRERFGFIFQRYNLLGSLTARDNVALPAVYMGMGGKER
STRAEKLLQDLGLEGKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVIEIIQKLHKEGHTVIMVTHDPGIAAIANRIIEIRDGEIISDSSKNPEIPESKIERIKE
KSSWLFYYDQFVEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSEKKILAD
ISAMGTNTISIFPGRGFGDRRSGRIKTLTIDDAKVIAKQSYVASATPQTTSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLESGRLFDESDVKEDAQVVVIDQNTKNKLFGTDTDPLGKT
VLFRKRPLTVIGVMKKEENSFGNADVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQ
VAEKGLTELLKTRHGTEDFFMNNSDSIKQMVETTTGTMKLLISSIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLVGVGLSTAISLVFNHFVT
EFPMEISIGSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALAQD
>CAF31839|FEATURES|ARDB_deepARG|aminoglycoside|APH(7'')-Ia|antibiotic inactivation|1
MTQESLLLLDRIDSDDSYASLRNDQEFWEPLARRALEELGLPVPPVLRVPGESTNPVLVG
EPGPVIKLFGEHWCGPESLASESEAYAVLADAPVPVPRLLGRGELRPGTGAWPWPYLVMS
RMTGTTWRSAMDGTTDRNALLALARELGRVLGRLHRVPLTGNTVLTPHSEVFPELLRERR
AATVEDHRGWGYLSPRLLDRLEDWLPDVDTLLAGREPRFVHGDLHGTNIFVDLAATEVTG
IVDFTDVYAGDSRYSLVQLHLNAFRGDREILAALLDGAQWKRTEDFARELLAFTFLHDFE
VFEETPLDLSGFTDPEELAQFLWGPPDTAPGA
>R8Y658|FEATURES|UNIPROT_deepARG|beta_lactam|F935_00535|antibiotic inactivation|1
MRFNKISCLLLPPLFIFNTSIYAGNSPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KNYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTPGKYWKEL
KNTPIDQINLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFVKANLNPQKYPADIQHAINETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTALSKEPSVKIYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>J2V6J3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLEEKAIRKVSVVIPVYNEEESLPELVRRTDAACAELGLEYEILLVDDGSSDRSGEMIAD
AADMPGSHVVGVLLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPNLVKAAQQG
YDVVGTVRQNRQDSWFRRRASRTINHLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARRTIELPVAHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIVG
SLIALAGFAFSLILIVLRLFLGAAWAGDGVFLLFAVLFIFVGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVIHPQQKASSVQEIEQ
>A0A0N0K081|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIELYLIPILLGIVEGLTEFLPVSSTGHLILATELLGFDAQAWAVFNIAIQPGAILAIVV
LYWRTFMDVLKGLMTWEPSAVAFTRNLLIAFFPAVVLGLAFGDQIDKLLENAVVVAWALI
IGGVAILVVEKLAKTSDAGGVAGVPFKTAIGIGLVQCIAMIPGVSRSGATILGAMAMGVD
RKTAAEFSFFLALPTLTGATALQLFKNRELLTPDDFGAIAIGFVVSFVVALVVVKAFLKI
ITRFGFVPFAWYRIIAGVAALVWLANR
>A0A096CMJ4|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF0661_08100|antibiotic inactivation|1
MTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGIS
LDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVA
QTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQS
FIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISY
TLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS
>A0A0H3FEC2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MAQYEPIRKVSVVIPVYNEEESLPALLSRTQAACQQLTQQYEIILVDDGSSDSSGDMLAA
AAEQPDSHVIAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVATADEG
YDVVGTVRANRRDSWFRKTASKMINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTIEIPVQHSEREFGDSKYSLMKLINLMYDLITCLTTTPLRMLSVVG
SVIAIFGFLLAVFLILMRLINGPEWSAEGVFTLFALLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGVRSEDHSQEEE
>AAQ12895|FEATURES|ARDB_deepARG|glycopeptide|vanXB|antibiotic target alteration|1
MENGFLFLDEMLHGVRWDAKYATWDNFTGKPVDGYEVNRIIGTKAVAFALREAQIHAARL
GYGLLLWDGYRPKSAVDCFLRWAAQPEDNLTKEKYYPNIERAELITKGYVASQSSHSRGS
TIDLTLYHLDTGELVSMGSNFDFMDERSHHTAKGIGNAEAQNRRCLRKIMESSGFQSYRF
EWWHYKLIDEPYPDTYFNFAVS
>CAD04960|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMNPTELTKYQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTDEFGKILLKVNQDGSQVRLRDVAKIELGGENYDVIAKFNGQPASGLGIKLATGANAL
DTATAIRAELKKMEPFFPPGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
TEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPVAKGDHGEGKKGFFGWFNRLFDKSTHHYTDSVGNILRSTGR
YLLLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLTMVQLPAGATQERTQKVLDEVTDYYLN
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEKNKVEAITQRATAAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLFGEVAKYPDLLVGVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDINDWYVRGSDGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MAMMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
VEAMLEAVRMRLRPILMTSLAFMLGVMPLVISSGAGSGAQNAVGTGVLGGMVTATVLAIF
FVPVFFVVVRRRFSRKSEDIEHSHSTEHR
>J3EPZ3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLASGFEIAAVFTHPDDPKENAFYGSVAQLCARKGIPVHA
PEDANHPLWIERISKLNPEYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAITAQQRVAIERTDTALTLHGKLRQAASDLLRDTLP
ALLQGKISETPQDESKATVFGRRTPADGKLVWSKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSADVVKGNEGQAPGRVISVDPLRIACGEDSLVVNAGQRNDSGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDANFDEDSSNLVVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWAPTVEMKETIGNTLDFFLREAMLEIA
DKKR
>A0A0U5PDZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MNIIEILKVIVLGIVEGFTEWLPISSTGHMILVDEIIHLNQPSAFKNMFLVVIQLGAILA
VLVLYFDKLNPFSVRKKPAQKQAALVLWSKIILACIPAAVIGFLVDDILDEYLMNGYVVA
ATLILYGVLFIFIENRNQYRSFEVQKVGDISYQTALWIGLFQLLALIPGTSRSGATILGA
MILGCSRAASAEFSFFLGIPVMFGASLLKVVKYGMNFTGSQIFYLILGMVVAFVVSVYSI
KFLMGYIRQHDFKFFGYYRIVLGAVVLLYFIITAFIG
>A0A127SRH3|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-2|antibiotic inactivation|1
MMKKSLCCALLPTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVE
>W1R8E7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQAIVLAIVEGLTEFLPVSSTGHMIIAEGIMGVESTSFVRAFTVMIQFGAILSVLVL
YRKRFFCFPVAPRALGQGKGKEFMSRFDLYWKLLIALVPAVILGFLFEDWVDRMLGSVWV
VAVVLFLGGIFMLFVDKLFASSDREEITYPKAFVIGLFQCLAIFLPGLSRSMATIVGGQQ
QKLSRKAAAEFSFFLAVPTMLGATLLKAYKLYKEGGIEIFREHMTVLLVGNIVAFIVALA
AIKFFIGFLTRYGFKAFGYYRILVGGLLIVLMLSGVSLAV
>YP_001716198|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmT|antibiotic target alteration|1
MNKKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFTFELAKRCNYVTAIEI
DPKLCRITKNKLIENFQVINKDILQFKFPKNKSYKIYGNIPYNISTDIIRKIVFESTATE
SYLIVEYGFAKRLLNTNRSLALFLMTEVDISILSKIPREYFHPKPRVNSSLIVLKRHPSK
ISLKDRKQYENFVMKWVNKEYIKLFSKNQFYQALKYARIDDLNNISFEQFLSLFNSYKLF
NR
>B8ZI21|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQIL
YRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTL
AELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERD
TSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVXDKTGAGD
YGTTNXIAVIWPEDHAPLVLVTYFTQPHA
>I0QW04|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MAQFEEINKVSVVIPVFNEEESLPVLLSRTIAACRQLTMPFEIVLIDDGSTDNSAELLTQ
AAEQPENCVVAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVAKAQEG
YDVVGTVRSNRQDSWFRKNASKIINMMIQRATGKSMGDYGCMLRAYRRHIVQAMLNCHER
STFIPILANTFARKTAEIPVLHAEREFGDSKYSLMKLINLMFDLITCLTTTPLRMLSVVG
SFIALFGFLLALVLILMRLILGPEWAAEGVFTLFALLFMFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVIGAIAVDNDKDQEIK
>A0A080VIX8|FEATURES|UNIPROT_deepARG|aminoglycoside|neo|antibiotic inactivation|1
MHDAATSMPPQAPATWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAE
LPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAVPGDTLSALAQRGELEPERLVRL
VAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLL
DRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAA
WAEAFLVEYGGDIDGERLAYFRLLDEFF
>G5QLU6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADSPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLDWEPSIAMRDTVEETLDFFLRSVDIAERAS
>NP_390993|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTLWELFVAAILGIVEGLTEYAPVSSTGHMIIVDDIWLKSSNLMSEEAANSFKVVIQLGS
ILAVAIVFKDRILNLLGLKKNITSDQEQGHKLSIAQIAVGLVPAAVLGFLFEDYIDEYLF
SVKTVAIGLIAGAILMLFADWVNKRKTATDTLDRISYKQAIAVGLFQCLSLWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAMPIMMGASFLSLVKHWDSLSSDLMPFFIVGFICAFVV
ALFVVRFFLRLINKIKLVPFAIYRIILGVILLLIMM
>I6C8L1|FEATURES|UNIPROT_deepARG|beta_lactam|SFK315_4868|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQMPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVLFRQGR
>G3JXZ1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
MAAAAVLKKCESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVA
MNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLT
LGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTKRYR
>A0A0D6UWQ6|FEATURES|UNIPROT_deepARG|aminoglycoside|SY87_28445|antibiotic inactivation|1
MRAAQASDAAAWRQLRRALWPHADDIEHARDIARQLDAPARHACFIASPPGILAPVGFAE
VAVRHDDVNGCGASPVLFLEGVFVEPAARRRGVARALCAAAAAWGTARGCAAFASDAPLE
NAASHALHRALGFDKTERVVFFRKPLAR
>BAC10599|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIVGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>I7AC74|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-11|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNXKAERIVVIYLRDTPASMAERNQQI
>A0A0N1DC88|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAIAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFMPAVVLGVIFSDLIHHYLFNPITVAAALV
VGGIIMLWAEQRQHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGFKYRHLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IASHSYAAFAWYRIAFGLVILATWQFGWVDWAAAKP
>N9TCR6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILTGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIIGGFIILWAERRPHQIVTQEVDDLSFKQAILIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAVLGVGIIVAFVSALVVIRALI
RYVSKHDFTAFAYYRIIFGLFILATWWTGWVHW
>A0A091AY54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPELLQALLLGIIEGITEFLPISSTGHLLIAEHWLGARSELFNIVIQAGAILAVTLIYRQ
RLWQLASGLHLRENREYALKLALAFGITAVLGLVVKKLGFELDDAVQPIAWALILGAIWM
LAAEQLAERRAARPGISWTAAALVGLAQVVAGIFPGTSRSAATIFVAMLAGTRDRGEATE
FAFLVGIPTMFAASGYSLLKQMHGGAAEDWTALAVAFAASTVTAFIAVKWLLGYIQTHRF
TAFSIYRIALGALLLTFL
>G0AYX4|FEATURES|UNIPROT_deepARG|beta_lactam|Sbal175_2141|antibiotic inactivation|1
MQRHTLLATMPLLSGVLLTATLFSNVTTAQTLNSKDIQSLVDSAVKPLMAEYGIPGAVIG
ITIEGKQYFYQYGVSSKTTGQSVTEDTLFEIGSISKTFTATLANYAQGKGKLTLTDMASD
YVPALKGSHFDKISLINLATHTAGDLPMQVPDKVTNNAELMDYLKHWQPSFAPGTHRNYA
NPTIGLLGMIAAQSLNKTFQQALEQTLFPQLGMTSSYINVPSSKMADYAQGYDKQDMPVR
VNPGVLADEAYGVKTTATDLLHFVEANMQMHPLAKPLQTALDETHTGYFDVGMMTQDMIW
EHYSYPIDLDKILMGHTQEVVFGSTPVKPIVPPLAPQQNVWINKTGSTGGFAAYAAFIPA
QKLGIVLLSNKNYPVPPRVTVGYQILTDIEKLQK
>F0F231|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIAVLLKALILGIVEGLTEFLPISSTGHLIVLGDLLNFSSQGKVFEIAIQLGAVLAVVV
EYRQRFANVVSGFGRDAAVNRFVLNLAVAFVPAAAVGFVFRKAIKEYLFNPITVAIALVV
GGFVILWIEKRMQKQPARVQGVDNMRPKDALMVGVAQCFALIPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATVYDVYKSWSLFQLHDLGLIAVGFVAAFVSGLFAVRSLLK
FVSTRNYVPFAYYRIVFGLLILATWKLGWVAW
>F4DVJ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAFQALILGIVEGLTEFLPISSTGHLIVVGDLLGFNGETATAFKIIIQLGAILAVIWEFR
AKVLGVILGLPSDPKAQRFSFNLLLAFIPAVVFGLAFADLIEHWLFNPITVAMALIIGGI
IMLWAEKRAHTIQVETVDEMNWKLALKVGFAQCLALIPGTSRSGATIIGGLVFGLSRKAA
TEFSFFLAMPTMVAATVYSLFKYRDILQVSDLPIFAIGFVSTFIVAMITVRALLKFITSH
SYAVFAWYRIAFGLVILATWQLHLIDWSTAQP
>A0A0U1QEV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDNALYLIKAFILGILEGLTEFIPVSSTGHLILVGDWINFQSGDGKVFEVVIQLGSILA
VMWVFRARLMQLIRGTLTGVASEVAFTRNLIIAFLPAAVIGAIFIKTIKSVFYHPGVVVV
TLVVGGLIMLYVERRTHHTPGDAPGAADDTASDERASAHTLEQITWKQALGVGVAQCFAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVFDMYKNFGLLTQHDLSGIA
VGFIAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGAVVAAWIFTR
>A0A0R1S5H1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVIINIIKAIILGIIEGITEFLPISSTGHLYLADYLVKLNEPKYFIDMFMVVIQLGAILS
IIVIYFSKLNPFSLKKTALQRKNTWILWFKVVVAVIPAMIVGLPLNSWLEENMTNWQVIS
ATLIIYGILFIILENYYKNRQAKFTDLNKISFQMAFLIGCFQVLSLIPGTSRSGATILGA
MLIGASRYVSAEFSFFLAIPTMFGASLLKIVKYIKAGHTFAGDQLMVLLVGMVVSFVVAY
IAVKFLLRFIQTHDFKSFGWYRIVLGIIVILAGVLNFIH
>A0A127T6T7|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
YYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTA
KQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLF
GALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDA
ETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPV
NPDSIFNGSDNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVM
LANKNYPNPARVAAAWQILNALQ
>A0A009KAQ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILSGQLLDFWSIEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTKEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMLVLAVGIIVAFISALVVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>ZP_03282035|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MRNVMSPSDAPINWKRNLAVAWFGCFLTGAAFSLVMPFLPLYVEQLGVTGHSELNMWSGL
VFSITFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIIMLLMGVAQNVWQFLILRALLG
LLGGFVPNANALIATQIPRHKSGWALGTLSTGGVSGALLGPLAGGLLADTYGLRPVFFIT
ASVLFLCFIVTLACIRENFTPVPKKEMLHARDVLGSLKNPRLVLSLFVTTMIIQVATGSI
APILTLYVRELAGNVNNIAFISGLIASVPGVAALLSAPRLGKLGDRVGPEKILICALVIS
VLLLIPMSMVQSPWQLGVLRFLLGAADGALLPAVQTLLVYNSTNQISGRIFSYNQSFRDI
GNVTGPLVGAGVSATFGFRTVFIVTACVVLFNAVYSWFSLSRALRTPVKKSEA
>Q4U0T7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQRIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>Q0PM60|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA3c|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0G0P2N2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLIHVLILSAVEGITEFLPISSTGHLILVSRILNLESSDFLKTFQIVIQLGAIIAVVVL
YSKKLLTGGALIKKLAVAFIPTAIVGFTLYPLIKGALLGSSSITLNALFWGGVAIIFIEK
FLKNPKSEIRNPKSNELTYKQALVIGTFQSLSVIPGVSRAAATIVGGLLTGLDREKATEF
SFLLAIPTMFAATTLDIYRSRQMIAQGGFLTLFMGSVLAFFFATLAVKFLIVYIKKHDFT
VFGIYRIVLAILFWIFAK
>F4Y5N4|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATL
QYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMA
ESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIA
VIWPENHAPLILVTYFTQ
>Q1IZI4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFYAIIYGIVEGITEFLPISSTGHLIVAGNLMGVPWSKEIRDTFEVVIQGGAILAVLA
YYWRDFAGQARVIGHDRPTQRLWLGVIVGVIPAVVLGVLFGDVIKAHLFRPSVVAWALIV
GGVLMWVIENRKAPPVVHDLKQIGLGRAFLIGAAQCLALLWPGFSRSASSILGGMVMGLD
RPTATRFSFYLGIPTLGGAALLDFIKSRHLLAEIGLLNVFLGAAVSFVVAYLAIGWLLRF
VSQHNFKGFAVYRVIFGLLILLLVASGRLANGGL
>A0A125A894|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNAIRIAAALVVAACAAATAGRAAAATQEEIHDTVTRHVAPLMKRFAIPGMAIGVVAD
GKPYVFDYGVMSTQTRAPVTGDTLFEIGSVSKTLTATLAADAQEGGELLLTDRAGKYLPA
LQGKPFGAVTLLNLGTHTPGGMPLQVPDSIRDDADLMRYLDAWRPAYAPGTRRTYSNVAI
GMLGILTAKAMHEDFTVLMEQRLFPALGMTHTYIDVPAARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLVETSPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLAGNAPPMLYDATPATQLEPPLAPRPDTWINKTGSTNGFSTYVACVPAKRIA
IVMLANRSFPIEDRVKAAYRIVESLRGKP
>A0A0P0HZ66|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-170|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGNSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A127SD56|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-205|antibiotic inactivation|1
MAIRFFTILLSTFFLTSFVHAQEHVVVRSDWKKFFSDLQAEGAIVIADERQAEHALLVFG
QERAAKRYSPASTFKLPHTLFALDAGAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEIGEDNARRYLKQIDYGNADPSTIKGNYWIDGNLKISAHEQILFLRKLYR
NQLPFKVEHQRLVKDLMITEAGRSWILRAKTGWEGRFGWWIGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>A0A0X8L5B7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGILFCKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTNAQAKTFDVVIQFGAILAIV
WEYRRKIGSIVAGLPTQPKARRFTLNVIIATIPAIVLGLLLEKHIKAVLFAPVPVSVALI
VGGLVILWAEARNRDKNVAPRVTSVDDLSYSDALKVGLAQCFALIPGTSRSGSTIIGGML
FGLERKVATEFSFFLAIPIIFGATLYELARDWKSLTVDSLGLFMVGLVAAFISAFVCIRW
LLRYVATHDFTAFAWYRIGFGLLILIVGYSGGLSWAE
>A0A0K2ZSP4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFSALLLGILEGLTEFLPVSSTGHLLIAEQWLGRRSDFFNIVIQAGAILATTLVFRQRLW
TLATGLGDRANRDYVFKLGTAFLVTAVVGLAVRKAGWQLPESVQPVAWALVIGGVWMLVA
EHFAARMPERERVTWKVAIAVGLAQVVAGVFPGTSRSAATIFLAMLLGLSKRSAAADFAF
LVGIPTMFAASGYSFLELYKNGAVGSEDWGDVAIAFAAAVVTGFIVVKWLLGYIKSHRFT
AFAVYRIVLGAALLLWLPAA
>R9KUS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMFIEILKAFFIGVVEGITEWLPISSTGHMILVDEFVKLNVSPEFLELFLVVIQLGAIM
AVLILYFHKLNPFSPRKTAPEKRGTWRLWGMVAIGCIPAAAIGLTLDDFFNEYFYNAWTV
AVALIVYGVVFILLERRNRKREAAWLASRGPRASRGAHARPLPVGPGDDGDDAEAALFRV
RTVDEIDWKTALKIGCFQMLAIIPGTSRSGSTIIGGMLCGCSRTAAAEFTFFLAIPVMFG
WGVLKLIKYILAVGLAMTATEIAVLVVGIVTAFVVSVISIKFLMGYIKKNDFTAFGVYRI
IVGIVVLAYFGVKVLL
>NP_416340.1|FEATURES|CARD_deepARG|multidrug|mgrB|antibiotic efflux|0
MKKFRWVVLVVVVLACLLLWAQVFNMMCDQDVQFFSGICAINQFIPW
>P00808|FEATURES|ARDB_deepARG|beta_lactam|BL2a_III2|antibiotic inactivation|1
MKLWFSTLKLKKAAAVLLFSCVALAGCANNQTNASQPAEKNEKTEMKDDFAKLEEQFDAK
LGIFALDTGTNRTVAYRPDERFAFASTIKALTVGVLLQQKSIEDLNQRITYTRDDLVNYN
PITEKHVDTGMTLKELADASLRYSDNAAQNLILKQIGGPESLKKELRKIGDEVTNPERFE
PELNEVNPGETQDTSTARALVTSLRAFALEDKLPSEKRELLIDWMKRNTTGDALIRAGVP
DGWEVADKTGAASYGTRNDIAIIWPPKGDPVVLAVLSSRDKKDAKYDDKLIAEATKVVMK
ALNMNGK
>G8AT12|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIDQYLDAALLGLIEGLTEFLPVSSTGHLIIFDTLLGFEGPPGKVFEVVIQLGAILAIC
TVYFARLWKVVTGLKDDPGARHFAMAVILAFLPAMVLGAALHGVIKAVLFNPTVVSIALI
LGGVAILMAERLVPAPRYHQIERFPAPLALKIGLCQCLALVPGVSRSGATILGSLLMGVD
RRTAAEFSFFLAIPTMAGATVYDLYKNWSLMTVDSALLIGVGFVTAFIRGGAGGQGAGGL
RRALRLRALRLVPHRHRVGDAGVPLSVKSRP
>A0A0F5RVX6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB1|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVRGRKLVYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGI
LQDRLNYYREDKPHMTFY
>A0A0X3RIL5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTLQEYVVAGPEAGPYALTAGPDGALWCTLVHQGRVARVTTAGDVTTYPLRTATGGPTMI
ATGTDGALWCTEFKEHRVTRLVPGRAADGGAQVESFTLPTADAAPLGIAAGPDGAVWFTE
SAADRIGRITPDGTVTEYPLPVRGAFASVIATGPDGALWFTANQANAIGRITPDGDTVLH
DLPTPGAGPVGLTAGPDGALWFVEIAAGQIGRITTDGTVEEFPLPDPACRPHAIAAGPDG
ALWFTEWGAGRIGRITTSGRVDGYDLPDPASEPHGIALGPDGALWAALETGSVVRIAVTA
EGAQPGR
>ABG72269|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGIDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>A0A0A8UZT1|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKKLSVFLCMTLVYCSTTLAQSTCFLVQENQTVLKHEGKDCNQRFAPESTFKIALSLMGF
DSGILKDELHPEWQYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQVLTQKLGMLRFKNYV
DAFHYGNQDVSGDKGKTNGLTNAWLSSSLAISPSEQIQFLQKIVNKKLPVSPKARTMTKN
ILYIQELAGGWKLYGKTGNGRQLTKNKSQKSPLQHGWFVGWIEKDGRVITFTKHIADSKK
HVTFASFRAKNEALNQLFYLINELEK
>A0A0N1DFP4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTTITVLILGMVEGLTEFLPISSTGHQIIVADLLSFGGERAMAFNIIIQLGAILAVV
WEFRRKILEIVTGLPTQRNAQRFTLNLLIGFLPAVVLGVLFADKIHEYLFNPITVAVALV
VGGIIMLWAEKREHVVCVDHVDDMRWTDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQAGDLPVFALGFVTAFFFAMIAVRGLLKF
IASHSYAVFAWYRIGFGLLILATWVFGWVNWTEAAAL
>G7LMH7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADDKAKTFEVIIQLGSILAV
VAMFWRRLFGLIGIHFGQVPHEGQTAGRLKLTHILLGMIPAVVLGLVFHDVIKSLFDPKN
VMYALVVGGFLLLAAEWLKPKQPRAMGLDDITHRQAFIIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADLPMFAVGFVTAFVVALIA
IKTFLQIIKRISFVPFAIYRFFVAAVVYVVFL
>H8FX98|FEATURES|UNIPROT_deepARG|beta_lactam|PHAMO_510100|antibiotic target replacement|1
MYHDNDRAKLFSRRAMMLAGGKATLIVGLAARMYYLQVMEADKYAMQAEDNRITTRLLAP
PRGLILDRNGIAMAINQQNYRVMVVAEQTPSLDYTLDALGKIIPIGESERARIHKEARRR
RRFVPVSVRENLTWEEVARVEVNAPDLPGIMIDVGQSRYYPMESLGAHILGYVAAVSEND
LTDDPLEELPGFRIGKGGVERVYDMALRGRAGTLSLEVNSVGRIHRELERKEGEPGIDLN
LTLDTRLQQYAAQRLGDESAAVVVMDILTGDIVVMASTPSFDPNSFNRGLSNDEWKELTS
NPRSPLTNKVIAGQFAPGSTFKLVSAIAALESRDITPDMRVLCTGHMQLGSIKFHCWKKE
GHGAQDMISGLKNSCDVYFYEVARRVGFEKIAEMARRFGLGSPTGVDLPSERSGLIPDRA
WKRKALKQPWHPGETLINAIGQGYVTATPIQLAVMTARIANGGYAVVPHVARDQVVEKSV
HPRPPPEWPSLEVSRQSLAIVRKGMFAVSNEPGGTAYKARITQEGMWLSGKTGSAQVRRI
TMRERETGVKKNEQLPWKERDHALFVAYAPEENPRYSIAVVVEHGGGGSAVAAPIARDIM
LEVQKRDLARGTAEADGAPEPPPDFRRF
>A0A0H3VE81|FEATURES|UNIPROT_deepARG|aminoglycoside|Aph3VIa|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSDKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTEQELLAIYKETLNQLNAVA
IIDCPFISSIDHRLKESKFFIDNQLLDEIDQDDLDAELWGDHKTYISLWNELNETRVEER
LVFSHGDITDSNIFIDKSGEIYFLDLGRAGLADEFVDISFVERCLREDVSEETAKIFLKH
LKNDMPDKRNYFLKLDELN
>A0A0A3ARH0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
SSGSYQIAGKETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKPQ
RLQRAAQLLEKLGLGNKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMQILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDQRQSLQITARKMTQTT
TNRGWQFYRDQFFEALNMSINAIIAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
NAFTAQVRGVSEQYFNVKGIQTITGYLFNAEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
AAEKNVTALLLSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGVRMAIGAKQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMS
EFTMLFSTFSIVVAVLCSTLIGIIFGYVPAKNAAKLNPITALSQE
>N9E9K1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDLFVVAIQMGAIAAV
IYEYWGKLWGAAIGLFSGEPKGRHLGVSIIAASIPIMIVGLTCGDIVKELLFNDISVAIG
LIVGGLIIWWVEKNPPKVNAVEVDNITIKEAIYIGLIQVLALIPGTSRSGATIIGGMMLG
VSRKASTEFSFFLGIPVIVGAGLLDLFKNYHIYETTQDWTVFFVGLMVSFVSALILIRVL
VAYVSKRDFMVFAWYRIASGLIILLFALTGWKLW
>A0A0H3FMQ0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGIQSLLGAGYDIAAIFTHPDNPGENQFFGSVARIAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLCDEILNIAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNHADAGDIVAQQAVAIGPDDAALALHRKLCAAASDLLGQALPAI
REGKTEERAQDHSQATYVGRRTPEDGRLDWDKPAQTLHNLVRAVSDPWPGAFAYAGANKF
IVWKSRVRADLPAAKPGTVISVAPLVVACQQGALEIVTGQTERGVYMQGAQLAQALGLVS
SAVLSSKPVVAVKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPENEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWEPTVEMEETVEHTLDFFLRTVELTDDKN
S
>L4JDY1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKL
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAVEKVNVAGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>B8ZI08|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKN
>E5ULG2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRFFGSGENRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAT
SGSYQIDGIETSQMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMDSKER
AERAEKLLGDLGLQNKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEDGHTVIMVTHDPGIAANANRVIEIRDGQIISDTSKNPDIPPSKVERIKE
KASWSFYYDQFMEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSQQKILED
INSMGTNTISIFPGRGFGDRRSGRIKTLTINDAKAISQQSYVASATPQTNSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLEEGRLFDDDDVKTDAQVVVIDQNTKTKLFGEGVNPLGKT
ILFKKRPLTVIGIMKKDDNSFGNSDSLMLWSPYTTVMHQITGESYTNSIVVKIKDDANTQ
VAEKSLTELLKARHGTEDFFMNNSDSIKEMVESTTGTMTLLISSIAVISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLSGVLLSASISLVFNYFVT
DFPMSISMASVIGAVVCSTAIGVAFGFMPANKASKLNPIDALAQD
>A0A0P9FNG7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MANEQRVRSPASYEEAPVGDWFNVVLLGIVEGLTEFLPISSTAHLLIVAKMLGFRNDAGG
TFEIFIQSGAILAVLGFYARDLLAQARTLPHDAMTRRFWTGALVAFLPAALVGMVMRTWI
KAVLFGSPMVIAGALIVGGVILIIIELLPRRLATTSNLTHVSLRQAFGIGVAQVFALVPG
ISRSGASIVGGLLAGLDRATATRFSFYLAIPTLGAATLLDLVSSLDQLVPGDLGRLVLGA
LVSLVVAWMSIGWLLRYVAHNGFVAFGVYRIVVGAVVLALVALGRL
>A0A061CQJ9|FEATURES|UNIPROT_deepARG|bacitracin|upk|antibiotic target alteration|0
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPTSFINMFMVVIQLGAILSVI
VIYFNKLNPFAPSKSKREKGQTWQIWFKVIAAVLPSIIIGLPLNDWLEENMTSWQVISAT
LIIYGILFIVLENYYAKRQPSLTDLNKMSYKTALLIGCFQILSMIPGTSRSGATILGAML
IGSSRYVATEFSFFLAIPTMFGASLLKLFKFFKAGHVFVGNQLAILLVGMVVSFIVAYLS
IKFLLKYVQTHDFKPFGWYRIVLGIIVIICGLVFA
>A0A081NVF2|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MRLTSKYETIRRMLSDFKQPEYRYAQIMDAIFKQNVGEYGRMTVLPKFLRDELTRMLGPN
VCSIVPVKELTSNQVSKVLFAIAGDEHVEAVRLTYEQGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFRLNGHALDSVSFMGMGEALANPHIFDAVTILTDPHLFGLG
HRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLKALDR
HIRHTGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGSGEHLYHVNLIPFNSTEVTPDSY
QQSDPNRIQAFVRILKSKGISITVRTQFGSDINAACGQLYRSE
>R2P954|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIANIFKAIILGIVEGITEWLPISSTGHLILADEFIKLNMSPAFIEMFNVVIQLGAILA
VVVLYFSKLNPFAPSKTHEEKQDTWTLWFKVIIACLPAAVIGLPLDDFLEEHFHKFLPVA
IMLIVYGIAFIVVERHNKTKTPKCTNLNDFTYKAALIVGAFQLLSLIPGTSRSGATILGA
IIIGSSRFVATEFSFFLGIPVMFGASGLKIVKFLMNGNTFGGSEIIVLLVGMVTAFIVSI
IAIKFLLDYIKRNDFTVFGWYRIVLGIILIGYWLIAM
>CAC42503|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACA
PVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHGPFFAAAALNGLNFLTGCFL
LPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDR
FHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRG
WMAFPIMVLLASGGIGMPALQAILSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>ZP_02700942|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKREMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>A0A0F5BFR4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGEGKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>A0A076VE11|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-115|antibiotic inactivation|1
MLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQILYRADERF
AMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAA
LQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAM
AQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGSGDYGTTNDI
AVIWPENHAPLDLLNFFTQPPSRAESRP
>A0A109YLL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAVFNIAIQPGAILAIVVL
YRRLFREMIVGFFRRDPVAIAFVRNLLLAFLPAVVLGLAFGDYIEALLENAVVVAWALVI
GGFAILLVERFAKPVDSGGVAALTTRQSIIVGLVQCIAMIPGVSRSGATIMGAMALGIDR
KTAAEFSFFLALPTLTGATVLQLAKHHDAITRNDLGLIALGAFVSFIVAWAVIKAFLAVV
TRYGFGPFAWYRIIVGAAALVWLALR
>I1ZAJ4|FEATURES|UNIPROT_deepARG|beta_lactam|oxa-58|antibiotic inactivation|1
EMRLEQTGTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLDRAKTAYIPA
STFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELARRI
GPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQQQ
VKEMLYVERRG
>D4HYR0|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVVFAYHDIGCTGLRALAQAGYQIAAIFTHTDDAAENHFFASVARTAAQLGVPVYAPE
DVNHPLWIDRIRSMAPDVIFSFHYRHMLNDAIISSASRGAFNLHASLLPKYRGRAPLNWV
LANGERETGVTLHHMVKRADAGAIIAQSKVPIADHDDALTLHHKMCAAAGELLANTLPDI
RTGSDVAHPQDESQASYVGRRTPEDGRIDWQLPAQRIHNLVRAVTDPWPGAFSFVGSGKF
IVWQSKVRHDYPANRPGTILSVAPLVVACAEGALEIVTGQSDSGVYMQGSQLAQTLGLVA
GAWLHNQPAAVLQRRTRVLILGVNGFIGNHLTERLLLDDNFDVYGLDIGSDAISRFIGHE
RFHFVEGDISIHSEWIKYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDATFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGGQKRCFTDI
HDGIEALFRIIENRQHNCDGQIINIGNADNEASIRQLAEQLLASFERHPLRNRFPPFAGF
REVESSSYYGKGYQDVEHRKPSISNAKRLLNWQPKVTMDKTIDDTLDFFLQNVEPGDAAQ
>A0A097SRT5|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
AHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRI
DAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGG
PKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASR
QQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVIIYTT
GSQAT
>J2SVX6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHKYLFNPITVATALV
VGGFIMLWAERRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAVGFVTAFVFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLFILATWQFGWVDWSAAKP
>A0A0D5BUE1|FEATURES|UNIPROT_deepARG|beta_lactam|blaB1|antibiotic inactivation|1
MKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYVVTD
KGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAQYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGYIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISDY
QQKQKASN
>A0A0U1YUI7|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDCGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>YP_001460869|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQIVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRIT
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRAMGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQA
LDNALQPDRAAQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>A4G2R9|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MPHFSSRRSLLLAAIATPFAGMAIPAFASDQRISRSAIQQEFSRLEASARGRLGLSAFNT
GNGMRVQYRAYERFPVCSTFKTIVAAAILQKSTTDKRLLNKRIRYNKDEVEQSGYAPITQ
KHIADGMSIAELCAATLQYSDNAAANFLMQELGGPAAVTAYARTIGDDTFRLDRWEPELN
TAIPGDLRDTSTPAAMGKSVQRLTLGDALALPQREQLVNWLKGNTTGGKRMQAGVPQDWI
VGDKTGTGYYGTTNDAGVIWPATGAPIVAAIYFTQNEKEARPRDDIIASATRIVVAALG
>A0A0D1RCI3|FEATURES|UNIPROT_deepARG|beta_lactam|C797_14977|antibiotic inactivation|1
MKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKEDLV
DYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITMSD
RFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRA
GVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYNNQLIAEATKV
IVKALR
>A0A0S4XNW5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILILQAAIMGIVEGLTEFLPVSSTGHLILTGSLLGLKGKFWESFDMAIQFGSIIAVI
WEFREKISYIIKGMINKDSTAWRFAINVIIASMPAGLLALAFEHQIKSVLFNPISVAIAL
VIGGFIILWAEHMQEEGPARVQSMDDLSILDALKVGIAQIAALIPGTSRSGSTIIGGMLF
GLSRKTATEFSFFLAIPILFAASIKELFGIREYLDQTHITLFLVGFVFSFISAFICVRWL
LKFVSTNNFKGFAWYRIIFGIVILLTWMTGSIEWGKVS
>A0A094S6M8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGEVPHEGKTSGRLKLTHILLAMIPAVVLGLIFHDFIKSLFYPQN
VMYALVIGGFLLLAAEWFKPKQPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYTASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFAVGFVTAFIVALIA
IKTFLKVIKRISFVPFAIYRFIVAGVVYMVFM
>A0A0X4EV50|FEATURES|UNIPROT_deepARG|chloramphenicol|AWI28_10900|antibiotic inactivation|1
MKKTIPEYTPVDLSRWPRKEHFEVFQSFAECTINQTVLIDITALRKHIKEVGWKFYPTII
FLLSKIMNRHSEFRMAMKDNELVIWNEIHPSYTIFHPETETFSSLWSHYDGNIHHFQNTY
AEDVARYGNILSYWPKEESRENVFFVSSIPWVTFTNFTMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPMAVQVHHSVCDGFHVARMFNELQEMCDGLPELSGERNG
>U2Z2S8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQVVILGVVEGLTEFLPISSTGHQIVVADLLGFGGERAMAFNIIIQLGAILAVM
WEYRRKILITVFNVPRQREAQRFTANLLIAFLPAVVIGVAFADLIHEYLFNAITVAAALI
IGGLVMLWAERRQHEVTVEEVDDMTWKEALKIGFAQCLAMIPGTSRSASTIIGGLLFGLS
RRAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFALGFVVSFIFAMIAVRALLKF
IANHSYAVFAWYRIGFGLLILATWQFHLIDWSSAQG
>S3AMN9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEQYVIALILGVIEGITECIPVSSTGHMIIIGHMLNFEGTHADVFEVFIQIGAILAIYTH
YRRTFNGFLKRKNWIKTRGVSLLHISAGMLPVLMAGYLLQYIIKEYLFGPIPVIVGLIIG
AIFMIYAEKRTVSGRLVDSVNNLTIYQCFQIGLYQMLCLWPGFSRSGATIAGGMLIGCTR
RAAADFSFIMAVPVMIIVCVYDLVRVIHVLELNDIIMFIIGTVVSYIVGYITVKGFLWYL
NRSSLASFGYYRIIVAILAIIYLYM
>I6ZFW7|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-14like|antibiotic inactivation|1
GSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAA
AVLKQSETQKXLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAINKL
IAQLGGPGGVTAFARAIGDETFXLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHA
LGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLV
LVTYFTQPQQNAESRRD
>YP_001726662|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKAIKLMAIITSIVLLAPIIGPLSGAALMHFVHWKVLFAIIAAMGLVS
FVGLLLAMPETVKRGAVPFSAVSVLRDFRNVFCNRLFLFGAATIALSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANTIVARFIKDPTEPRFIWRAVPIQLVGLALLIV
GNLLSPHVWLWSVLGTSLYAFGIGLIFPSLYRFTLFSNNLPKGTVSASLNIVVLTVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGLFVVLTLAGLLKRVQLHQASELAV
>A0A142BX76|FEATURES|UNIPROT_deepARG|beta_lactam|blaACT|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGILDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>J2MNY8|FEATURES|UNIPROT_deepARG|beta_lactam|PMI20_03723|antibiotic inactivation|1
MECQPIMHNKNLALSGFFTISLLLSGASTCLAASQPDSALKPLVDAAIRPLMQQQDIAGM
AVAITLKGQPHYFNYGLASKEGKKAVDADTLFEVGSVSKLFTATLGAYAQASGKLSLNDP
ASRYLPALKGSAFEHISLLQLGTYSAGGLPLQFPEQWDSQDKMLGYYQGWKPAFAPGAQR
LYSNPSIGLFGYLAAQSLGQPFEQLMEQRLFPQLGLQHSYVQVPKSQMDNYAQGYGKDGK
PVRVSPGALDAEAYGVKTSAADLLRFVQANLKPESLAQPWPQAIALTHTGYYQVEGMTQG
LGWELYPYPLSLDALLAGNSSQMAFEPHPTRWFTPPQAPRADTLLNKTGSTGGFGAYVLF
VPGKDIGLVLLANKNYPNAERVKVAHALLKALDDAQP
>A0A0H0T4T4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSKALKVQLDGGPYALAAGSDGAMWVTLVHGGAVARVSVTGDVRTYPVGEGSRPSIISAG
PDGALWFTRAGDDRIGRITTAGELTSFELPSGSAPFGIATGPDGALWFTMMSSGEIGRID
TDGEITAAATVGGMPSMITRGPDDALWFTLNEAGAVGRLAVDGTLKLRELPTAAAGPVGI
AATHDDAVWFTEVRADKIGRIPVDDAIQELDLPGKPHAVVADPTDGVWVSLWGSDQIARI
SGDGDVVTIDLPSGSEPHGLAIGPDGACWVALECGFVLKMPT
>A0A034T8S4|FEATURES|UNIPROT_deepARG|beta_lactam|MA13_contig00011-0001|antibiotic inactivation|1
MMNTRLSCTLALSALLLSPVTQASTPPSAAMRVTEAVRQTIPALMQQQQIPGMAVAVIYQ
GTPYYFSYGVADKATRREVTPQTLFELGSVSKTFTGVLGGYALQRGDIRLQDTVASQWPA
LNGPQWRAITLQQLATYTAGGLPLQVPDAVTDTAQLLDFYQRWQPRWAPGTMRSYSNASI
GLFGMLAVRPSGMDFSQAMTRWVLQPLGLKYTYFRVPPVAEGEYAWGYREGRALRVSPGM
LEQEAYGIKSSAQDMAVWLQANLDPAAVPQATLRQALLRAQSRYYQSGEMYQGLGWEMLS
WPLKAQTLIDGSDNRVALQPQQVHPLVPPTPPQAASWVHKTGSTNGFGAYIAFIPGSRLG
IVMLANKNYPNPARVQAAYTILQQLQ
>N9RDH2|FEATURES|UNIPROT_deepARG|aminoglycoside|F888_03237|antibiotic inactivation|1
MKIMPVSEPFLADWLQLRRLLWPDHEDAHLLEMRQLLEQPHTLQLLSYNDQQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGVASALVQQVEHWAKQFACSEFASDAALDN
TISHAMHRALGFQETERVVYFKKNIS
>A0A0K0WRK7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-172|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKPIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>C8C169|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIDDKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>W6J5Y2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKQPHEGTGTGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPLN
VTYALVVGGFLLIAAEVLKPKVPRAQGVDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSMGFLTVSDIPMFAVGFITAFIVALIA
IKTFLELIKHISFIPFAIYRFVVAAAVYLVFF
>A0A0Q9SDL5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHTIFEAIIIGIVEGLTEFLPVSSTGHMILAQSLLNTQNDEVMKTFDFVIQLGAIMAVVL
IYWKRILSLFGLVKRKSESRSGKKLNLLHILIGIIPAGVIGVLFNDFVDEKLFNSTTVLI
GLVLGGILLIIAEKKKEQPSSVVLDDLTYRQAFFIGLWQLVSIWPGFSRSGSTIAGGMLS
GVSRAASADFTFIMAIPIMFGASGVYFLKNYHALSSNDFGFFAVGFVVAFIVALLAVVTF
IKLVQNMKLTYFAYYRFAVAIIFALYMFLK
>A0A0K1N3M5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEMKNINRYFGTGDNRVHILKNISLNVEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
SGSYKINNNETLELSKDQLSDLRSQTFGFIFQRYNLLSSLTAAENVALPAIYAGMPQTQR
LTRAKQLLEKLGLGDKWQNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGE
NVMEILRQLHSEGHTIIMVTHDRDIAASANRVIEIKDGEIIGDSQKEAVQSAIKNTGKSK
SRFGFSKDQLIEAFKMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
KGIGTNTITIFNGTGFGDRRAEQMQNLTVNDANALSNQSYVQSVTPNSTSSGTLIYGNQT
FSSTSLKGVSEQSFDVEGLTLKLGNTFTPEDIRNNQSVALIDESAKKSIFPLENPLGKIV
MFNKRPLRIIGVVSDRQMGGASSSLNIYAPYSTVMNKISGSKKIASITVKVSDSVNSAVA
EKGITELLQMRHGKKDFFIMNSDTIKQTIESTTSTMKLLISSIAFISLIVGGIGVMNIML
VSVTERTKEIGVRMAIGARQSNILQQFLIEAVLICLIGGVTGILLSGVIGLLFNTFMSDF
AMAFSTASIIAAVAFSTLIGVVFGYMPAKRAAQLDPITALARE
>A0A0U1YUL1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKGWNAHFTEHKSQGVVALWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0H4VIP8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWQAIILAIIEGLTEFLPVSSTGHMVIASSLMGISAFEFTKMFTVTIQFGAILSVVVL
YWKRFINSVDFYQKLLVAVIPALAIGFVLKDYVDAMLERVEVVAISLLLGGVILIFVDKW
FKEKENPVTTPSYKNALIIGLFQCIAMIPGVSRSASSIIGGLTQNMTRKAAAEFSFFMAV
PTMLAAATYSVLKDLLHLEISDVVKLDFPKIEKALSSITPQEWQVLAIGNVVAFLVAMAA
IRFFVGFLTKYGFKLFGYYRIVVGLVILLLLGLGIEIKIV
>A0A158ANJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNYTDAQSKTFDVVIQFGAILAIC
WEFRAKIASVVTGLPARADARRFTINVIIATIPAVVLGLLLEKHIKAVLFSPVPVSVALI
VGGIVILWAEARQRDRGAMTRVHGVDDLSYADAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRMLTVDDLGLFAIGLIAAFVSAFVCVRW
LLRYVATHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>J8G1T0|FEATURES|UNIPROT_deepARG|chloramphenicol|II9_03113|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCTFSMTVNVDITMLLEEVYQKGVKFYPVFIYLISKV
VNNHKEFRTSFNDEGALGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMR
YYASVHGLFTKENTPPNVFPISSIPLTSFTGFNLNISNDADYLLPIITCGRYFNEKNKVM
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>R5L5G3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIEIIKALVLGIVEGITEWLPISSTGHMILVDEFLKLNVSEEFKSMFLVVIQLGAILA
VVVLYFKKLIPLDVQNKKLHWKKDTLVMWLKIIVSCIPAAIVGVFFDDELEAVFYNWQTV
SAALILFGILFIIIEKRNRGREPKINSINDISYKTAVIIGIFQLIAAVFPGTSRSGATIV
GALLIGVSRSVAAEYTFFLAVPVMFGASALKLVKFGFDFTSQELVILFVGLVSAFVVSIL
AIKFLMSYIKKHDFTAFGWYRIVLGAAVILYFALAS
>A0A0S4XQC3|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MQKINLTTYPRKSTYEAFLHHEIPVLSTTCEIDITELYKFRQQYALRLFPLLAFMIDKTI
NEIEAMKHRIIDGELYAYDVIHPSFTTLLPNNTISFCDAIHMDDAKMFYEHIVTLSDVAT
QTADVEMREKHGRYFISNIPWIRFSSFVHPYLSQYASIPIVTTGKFQQNGMNITIPIALQ
VHHSLADGYHLGRFYTLLEQNIKNTPEILSGIV
>A0A127SDD5|FEATURES|UNIPROT_deepARG|beta_lactam|GES-5|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERGLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>A0A0A2EPY3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSVVEAIILAIVEGLTEFLPISSTGHMVIAQSLMGMESTEYVKSFTVMIQFGAILSVVVL
YFKRFVNFSLPSDMWHGNVPGWRRTLARFRFYFKLVVGVVPAVIFGLLLNDWIDRMLGSV
WVIAVNLILGGFVMLFIDGLIRRNERSEVTYLNAFVIGLFQCIAILLPGMSRSMSTIVGG
MTQGLTRKAAAEFSFFLAVPTMFGATLLTAYKMWKEGGMEVFSQNMDTLIIGNVVSFIVG
LMAIRFFVAYLSKHDFKAFGVYRIIVGGIIIAMLLLGIDLAVI
>ZP_04615616|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKYFIERPIFAWVIAIIIMLAGGLAIMKLPVAQYPTIAPPAISISANYPGADATTVQNT
VTQVIEQNMNGIDGLMYMSSSSDSSGSVQLTLTFNSGIDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVQKSSSSFLMVAGFISDDGTMKQEDIADYVGSNIKDPISRTSGVGDVQLFGS
QYAMRIWMDPHKLNNFKLTPVDVITAIKVQNNQVAAGQLGGTPPVPGQQLNSSIIAQTRL
TSAEEFSKILLKVNTDGSQVRLKDVATVQLGAESYNVIARFNGKPAAGIGIKLATGANAL
NTSAAVKAELAKLQPFFPASLKVVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
QEEGLPPKEATKKSMEQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMVL
SVLVALILTPALCATMLKPIAKGSHGPKTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRY
LVIYLAIVIGMGLLFLRLPSSFLPEEDQGVFLTMVQLPAGATQERTQKVLDHVTDYYLDK
EKDVVNSVFTVNGFGFSGQGQNTGLAFISLKNWDERQGAENKVPAIVGRASQAFSRIKDG
LVFAFNLPAIVELGTATGFDFQLIDQANLGHAKLTAARNQLLGMAAQHSDVLVGMRPNGL
EDTPQFKVEVDQEKAQALGVAISDINTTLGSAMGGSYVNDFIDRGRVKKVYVQADAPFRM
LPSDIDKWYVRNNEGQMVSFATFSTAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
DLMQELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAASLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLV
ESTLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFF
VPVFFVVVRRRFSKKSEDIEHAHPVDHQAK
>Q0YS18|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSVQHLLELVDVHRTYQIGESTVQALRGVSVTIEQGEFVAIMGASGSGKSSLMQILGLLD
TPDKGDYLLLGQNVNTLSEDELSGLRNNVAGFVFQQFHLLKRMSIVENVRLPHIYSGIKG
DFRKEALERLRQVGLAERVDHTPNQLSGGEQQRVAIARALVRDPLIIFADEPTGNLDTKN
SAEIMKIFKGLHEEGKTIVMVTHEKEIADYAGRVITMRDGVIISDEQRTGSVPARSAEPL
AGFEIHGPAKVSLWQDGRFIGFMAQAFQAILANKMRSFLSVLGIFVGVASVIAMMALGEG
AKAAMQEQLKSMGSNMLSIRGGSAKIRGAAQGAGAVARFTAIDVEDIAELTTLVKNATGV
VNGSARMVYGNKNWSSSLTGVGYDYGTMRASTPTVGRWFTREEIQKRDKVAIIGVTVVKE
LFGNTNPIGGTIKINRINFTVIGIAPAKGFSGPQDEDDVVLIPVTTAMYRVLGKDYLSGI
FVEVTSPALIEQAKSTISELIRKRHRLQADDDSFNIRDMTEIQKMLSSTTQTMSVLLGSI
AAISLVVGGIGIMNIMLVSVTERTREIGLRKAIGARKGDIMLQFLVESVGLTISGGLIGI
IAGIGVSFMLAIFAGWAVKTSVVSVVVATVFSALIGIFFGLWPARKAAELKPLEALRYE
>I1V582|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
AMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNV
AMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNL
TLGKALGDSQRAQLVTWMKGNTTGAASIQAGPPASWVV
>A0A105SP05|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHGIKRIMAAALFSTCATATIGYAADDRQDTVKRVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPN
LQGSPFGNVTLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWRPTYSPGTYRTYSNVSI
GTLGLITATSMGQQDFAVPLSRHLLSPLGMKSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSMALNAMPVEEIKPPRAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>H5Y6H4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVV
LYFKKLWDVAIGMFTGDAYARRFVIGVLVAFLPAVVVGLVAGKYIKSMLFNPWVVCFSLI
VGGAILLWVDKLDLKAREHDATRFPLLMYLYIGIAQCLAMIPGVSRSGATIVSAMLLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKNRSEMTMDHMGIVAIGFVVSFVTAIIVVKTFLEY
VTRHGFVVFAWWRVIVGTLGLIALALGR
>A0A090ZAE1|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSELPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIATTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADATKVVLNTLKATE
>YP_002639394|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATLIAMTTHSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMA
RWMPETRPAGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQN
GQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>A0A0W7XVS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDERAKVFEVVIQLGSILAVVVV
FWKRLWSLVGIGKVKEGPSLNLLHIIIGMIPAGVLGVLFHSAIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAATGLDLIKSWDVLSSADVTLFATGFVTAFVVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFIM
>A0A0T6VNR3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWIAFQALILGVVEGITEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVV
WEYRRKIIDIVVGLPKEQQAQKFTVNLLVAFMPAVVLGVAFADLIHEYLFNPITVATALV
IGGVVMLWAEKRQHRIQAETVDDMRWTHALKVGFAQCLALVPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDFMVFAIGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIAFGIIILATWQFGVIDWSTAAG
>NP_462699|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGSLLDTLWNWRACYAFLLVLCAGVTFSMA
RWMPETRPAGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQT
GQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>F4A139|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLLFKAFIMGIVEGITEFLPVSSTGHLIIVGDLIGFNDERFSVMFEIVIQLGAILAVIF
YYRKKIADSFRHMKPGQWGFNLWLKIIIAFIPAAVIGLAVNDFVEAHLFSSFTVAIALVV
GAVLMLLVERVFWNYRADDMDEINGRQALLIGAVQCLSLFPGMSRSASTIMGGMMAGMSV
KAAAEFSFFLAMPTMIAATGYSFLKGFSAMSGLEWAALAVGFIMSFVVALIVVDRFLTYL
GKHPLKPFAYYRLVVGILMIVLTLTGIVS
>YP_002410376|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATMLEIASLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAITQMHQVLNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAIAEGQCWQSDWRIT
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMALRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENIFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>W7ZPJ7|FEATURES|UNIPROT_deepARG|beta_lactam|JCM19047_2965|antibiotic inactivation|1
MKRYGAIFTLTVLAACGTPETTEQQQPDDENSAATFSVLEDHYDARLGVYALDTGNGQTI
AYNEDERFAYASTHKALAVGVLLQQLSLDELDTQILFSEADLVTYSPITEQHVETGMSLH
EISDARFATATIQRLILFSMKLAVHQGLKRHSEKLEDEVTEPERIETELNDVKPGETRDT
STAKALAESLYAFSLGDALDEEKQTLLNDWLIHNTTGDALIRSGVPEGWLVGDKTGSASY
GTRNDIGIIWPPDEDPIVIAVLSSKEQADAESDDALIAEATEAALRMLMDDFEYGASQTP
>A0A0A6XXS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHLWNMFVAAILGLVEGLTEFAPVSSTGHMIIVDDLLLKSNKLYGEEAANVFKVVIQLGS
ILAACVVFKDRFLNLLGLKKDITSDQVHGNRLKLTQVIIGLLPAAILGFLFEDYIDKKLF
SVNTVLVALIVGAILMIVSDLVRPRKPKVETVDQMTYTQAFIIGLFQCLALWPGFSRSGS
TISGGVLLGLSHRAASDFTFIMAVPVMFGASILSLAKHWDAVTAETIPFFIVGFISAFIF
ALIAIRFFLRLINKVKLVPFAIYRIILAIILYIAVM
>A0A143I180|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTTGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVERIRALAPDVIFSFYYRSLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQKVAIDADETALQLHQKLNATAQTLLRDALPGI
LNGTFSETAQDESKASCFGRRAPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>B5BCP7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTAACESLGKAWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTSFTEESHQ
>A0A0W8H2Z5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWARLWGAATGIFSGEPQGRRLGIGLILASIPIVLIGLTFGQTVKELLFNDIAIAIG
LIVGGLIIIWIEKHPPQERVHEVEDLSVKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSAHVFDGQQDWIVLATGIIVSFISALLLIRAL
VAYVAKRDFMIFAWYRIASGLVILLFAFTGWKLW
>A0A119HGA0|FEATURES|UNIPROT_deepARG|beta_lactam|WL29_16505|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLALTLSACASPLANASSVGAASSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALFTQRVTYRQADLLEWSPVTEKH
VDTGMTVSELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQFAQWLRGNKTGDKRIRASVPTGWQVG
DKTGTGDYGTTNDIGVLWPPARGPIVLTVYYTQARADAKRKDDVIAAATRIAVAALG
>A0A0K3A085|FEATURES|UNIPROT_deepARG|aminoglycoside|XTPLMG730_3131|antibiotic inactivation|1
MSDGYSIRAAAAADLRAWAALRVALWPDESDAFGGVAEALQREDAANFLAFAGDGHAIGF
ADVTLRQDYVNGTDSSPVGFLEGWYVVPEWRGRGVGRALLRQVQDWTRAQGCSELASDAL
LDDAAAQAAHRACGFEESERVVYFRMPVAD
>S3TN27|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWKDTYFSSWESFKRQAWYVVLATLITGVLGLALQALIKHVFFGGASSFEIEHLFS
NSKLMAAALAAAGILIILSSRLDRGQQGNINLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQRAEEFSFALAVVLTPAVILKELYRLVHAQGGQAVASGQLSHVITPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCLGFAVVVLCIH
>E0SD04|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVVFAYHDFGCVGLRALVAAGYTVEAVFTHADNPAENQFFGSVARTAAELGIPVFAPE
DVNHPLWVERIAAMSPDVIFSFYYRHLLSDAILQSAVHGAYNLHGSLLPRYRGRAPLNWA
LVNGETETGVTLHRMVARADAGNIVAQQRVAIDESDTALSLHRKLRDVAEQLLKDTLPAI
AAGKANDIPQDESQATYVGRRTPEDGRIEWQKPARTLYNLVRAVTEPWPGAFSFVGTTKF
IIWQAKVRTDFAAAKPGTVLSTSPLVVACGSDALEIVTGQGDNGIYLQGAQLAQSLGLVT
GAILNNSPVVSVKRRTRVLILGVNGFIGNHLTERLLQEDNYEVFGLDISSDAIERFLGNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKTIRDC
VKYKKRIIFPSTSEVYGMCTDPVFDEDNSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KDGIEALFRIIENKDGVCDGQIINIGNPDNEASIRQLAEQLLESFEKHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLHWQPTIEMEKTVAETLDFFLQTVETGRFSQ
DSE
>CAB61228|FEATURES|ARDB_deepARG|glycopeptide|VanHA|antibiotic target alteration|1
MKNIGITVYGCNQDEADAFRALSPQFGIMPSIINADVSEANAISAPLNQCISVGHKSEIS
ASILVALKRGGVKYISTRSIGCNHIDTIAAKRIGITVGNVAYSPDSVADFTMMLMLMAVR
NTKSIVRSVEKHDFRLDSVRGKVLSEMTVGVVGTGQIGKAVIERLRGFGCKVLAYSHSKS
IEVYYVPFDELLQNSDIVTLHVPLHTDTHYIIGHEQIQRMKKGAFIINTSRGPLVDTYAL
VKALENGKLGGAALDVLEGEEEFFYSDCTQRPIDNQFLLKLQKMPNVIITPHTAYYTEQA
LRDTVEKTITNCLDFERRLEHE
>C3KCH4|FEATURES|UNIPROT_deepARG|beta_lactam|PFLU_3467|antibiotic inactivation|1
MNFSVRNFLFSALFFVSGTSMAATDLRKVVDSHVGPLMQQQGIAGLSVAVVNKGKVQYFN
YGVANKDKQQPVTQDTLFEIGSVSKTFTATLGGYAEASGKLQLSDKASQHLAALKGSAFD
RISLLQLATYTPGGLPLQFPDAADNADAMIGYFQHWKPAYAPGAQRLYSNPSIGLFGYLS
AQSLGQPFNTAMEKTLLPKLGLKNTYVSVPADKADAYAQGYDKQDKPVRVGPGALDGEAY
GIKTSTQDLAHYVMVNMRPQTLEKPLQQAIATTHTGYYTVNGMTQGLGWESYPYPITLQA
LMDGNSTPMAMEPHNVKWLNPAQAQPANVLYNKTGSTGGFGAYVAYVPSRDIGVVILANK
NYPNAERVKVAHAILSALDH
>A0A087M7Z0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFQSIIMGIVEGFTEFLPVSSTGHMIIVGDWLGVKQDSMVKAYEVIIQFAAILAVVLN
YKEKFSPKKIDLWMKLAVAFVPLGLVGFMFAKQVKAMFSVEIVALMFIIGGIVFLVVEKF
YTPKEHFIDDVEKVSYTQAFWIGIAQVFALIPGTSRAGSTIIGAMLVGLTRKASAEFSFL
LAFPVMCATTAYDLVKHRSELFTDANFIILAVGFVVSFLVAYATIKLFLKFLETFTFVSF
GIYRIIFGVALLAFY
>A0A0K9YJA2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MPQLTGINHLLFSVSDLERSFCFYRDVMGAKPLVRGRKLAYFDWNGYWLALNEEQDIPRN
EIAHSYTHLAFSIDEASFDDWKSHLEKHDVIILPGRERDERDKRSLYFTDPDGHKFELHT
GTLQDRLSYYRSEKGHMTFFD
>A0A0T6YT16|FEATURES|UNIPROT_deepARG|beta_lactam|N182_02225|antibiotic inactivation|1
MATIKLGLSTAILATLASSAFAEGGERAQIAAAVDKAIRPIMREHKVPGMAVAVTVEGRH
YFLNYGVASKETNAPVTENTLFELGSISKAFAATLASYAQVTGKLSFDDHPGKYIPAFAG
TPIDKATLLHLATYTAGGLPLQFPDAVKSDADMVGYFSTWKPEAKPGKTRRYSNPSIGLF
GHTAALAMGGSFSAVLESEIFPKLGLKHSYVRVPDSQMGSYAWGYGKADKPIRVTAGTFD
AEAYGVKSSAIDMIRFVETNIQPELLDGAIRKAVEGTHVGYFDSGKMVQGLGWEQYPYPV
SLERLLDGNSRDMALKSNPVKALDPPKRPDGSTLYNKTGSTNGFGGYVAFVPEKKIGIVL
LANRNYPNPERIKAAHAILKSLEAAAK
>B3Q5X8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIDIIRAVILGIVEGVTEFLPVSSTGHLLLAERFFNLGEGNFWKSFAVLIQLGAILAIL
ALYFVKLWRIALGMFTDANARRFVIGVLVAFLPAAVIGAAFGGYIKHYLFNPWVVCFSLI
VGGAILLWVDQLDLKPRYHDATAFPLLTYFYIGCAQCTAMIPGVSRSGASIVAAMLLGTD
KRSAAEFSFFLAIPTMLGAFVYDLYKNHADMTADNLIIVAIGFVVSFITAIIVVKTFLTY
VTRHGFELFAWWRVIVGTLGLIALALGL
>G0CM08|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
KLWTLATGLGERANRDYVLKIGVAFMVTAVVGLIVRKAGWQLPETIQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGSENWTDVSVAFIAATLTGFVVVKWLLGYIKKH
RFTVFAVYRILLGAALLLWLPAA
>Q2J7L5|FEATURES|UNIPROT_deepARG|aminoglycoside|Krm|antibiotic target alteration|1
MAVRDGGGSAPVGSQEQAVDRVRETVARSRRYGAVAPETVRRLAERALVASRGDEPEAVK
RTKRSLHEIYGAYLPERAPGYPGLLRDIGAAVGGGDPDAVAAAVSRAMRVHASTRERLPY
LREFYAAVFGAVPTPAVVQDLACGLNPLAFGSMGLPAQTTYLASDIDSQQMEFLDRALDL
LEVEHRVEVVDLVSGAVPAQHADVTLVLKTLPLLERQRAGAGWELVDALRSPFVVVSFPT
RSLGQRSKGMFQTYSAAFEAQAAERGWTFDQAEIANELIYIVRR
>X4ZJE5|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKSTSKYERIQHLLSDLKQPAYRFQQIADAIFKQRIGEYDRMTIIPKAIRNELIKNFGEN
VLNLTPVMQKTSNQVNKVLFAIEGNEHVEAVQLSYERGWKSYCISSQCGCGYGCRFCATG
TIGLKRNLTADDITDQLLYFHLNGQALDSVSFMGMGEALANPYIFDTLKILTDSRTFGLG
HRRITVSTIGIIPGIDRLSKEFPQVNLTFSLHSPFVEQRSELMPINNRFPLNEVLNKLDQ
HISDTGRKVYIAYILLRGENDSNEHAEAIAALLKNRGPWEHLYHVNLIPYNSTDVTPDNF
HQSDKERVQRFAHILKSKGIKVTVRTQFGTDIDAACGQLYGHNK
>A0A136CW86|FEATURES|UNIPROT_deepARG|beta_lactam|ACS92_18865|antibiotic inactivation|1
MKKNILLKLGVCVSLLGTTQFVSTISSVQASQKVEQKVMKNEAGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLILTTSRGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAALAKKNGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
GDNIVVWLPQYNILAGGCLVKSADAKDLGNVADAYVNEWSTSIENVLKRYGNINLVVPGH
GEVGDRGLLLHTLDLLK
>W6VP37|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAIAFNIIIQLGAILAVV
WEFRRKIIDVVTGLPTQPGARRFTANLLIAFMPAVVLGVIFSDLIHEYLFNPITVATALV
VGGIIMLWAEKRQHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGYKYRHLFVPSDFPVFAIGFITAFIFAMIAVRALLVF
IGSHSYAAFAWYRIAFGLVILATWQFGWVDWNAVKP
>C5IKV7|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2a|antibiotic inactivation|1
MREAVTIEIPNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>B5ABX9|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC-25|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIP
>E4T3U6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLIQTIILAIVEGITEFLPVSSTGHMIIAQKLLSIESTEFVKAFTVNIQFGAILSVVVL
YWKRFFQSLDFYWKLIVAVIPALVLGFLFSDKIDSLLENVEVVAIMLVLGGILMLFVDKW
FNKPNDDQTMDWKRALKVGFFQCIAMIPGVSRSMASIVGGMTTKLTRKNAAEFSFFLAVP
TMAAASGYKLLKLFMDPAGKSMLSENLVTLLVGNLVAFVVAMIAIKFFIGFLTKYGFKAF
GYYRIIVGVAILVLLFLGVDLNIL
>A0A0J1LXP4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNICRSYPSGEGQVEVLKNVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TNGTYQVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPSQKPSAGRGIAEPT
VTTASGWRQFASGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLVAIQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGNTFNAEQLNGRAQVVVLDSNTRRQLFPNKAQVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLSLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPFALLTAFLCSTATGVLFGWLPARNAARLDPVDALARE
>A0A0U1BFW8|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MISRRALLVGGVSAAGVVAAGCSRNGNRRPAPDELASLEKDFGGRIGVYALDTGSGDTVG
HRADERFLMCSTVKTFIVSAILRRRLSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTV
SELCDATLRYSDNTGANLLITQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTS
TPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKG
ETNDIAVIWPPGRAPIVMAVLTVPEDPTSTKGKPTIAAATRIVLRAFGA
>A0A0J8VNM0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPVHEGAGKGRLSLIHILLGMVPAVVLGLVFHDAIKSLFNPIN
VMYALVVGGLLLIAAECLKPKEPRALGIDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTMHDLPMFAVGFITAFIVALIA
IKTFLHIIKRISFIPFAIYRFIVAGAVYLVFM
>G4HC14|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKHLSKYEKIRKILSALKQPNYRYSQITEAIFKNKIRTFEAMNNLPKPLRNELIKELGNN
VLSITPKMEQKSNQVSKILFAISGNEYIESVRLSYKTGWESYCISSQCGCGFGCTFCATG
TLGLKRNLTTDEITDQLLYFTLNKYPLDSVSFMGMGEALANPYVFDALHVLTVPKLFGLG
HRRITVSTIGLIPGIKKLTKEFPQINLTFSLHSPFNDQRSELMPINNHFPLEEVLTVLDE
HIQQTKRKVYIAYILLRGINDSTKHAEAVADLLRSRGSWEHLYHVNLIPYNSTDATSQSF
AESDQNSINMFLKVLKSKGIHVTVRTQFGSDINAACGQLHGSNGKIE
>A0A076Q258|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-161|antibiotic inactivation|1
KQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGG
VTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQL
VTWLKGNTTGAASIRAGLPTSWTVGDKTGSGGYGTTNDIAVIWPQGRAPLILVTYF
>J3IDE6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGIQALLDSGYDIAAVFTHADDPKETAFYASVAQLCAQKGIPVHA
PEDVNHPLWIERIAKLDPEYIFSFYYRNLLSEQLLTTAKKGAFNLHGSLLPSYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQRVAIERSDTALSLHGKLRIAATDLLRDILP
AMLQGKISETPQNESKATVFGRRSAADGKLLWAKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVKGNDGQAPGRVISVDPLRIACGEDSLLILSGQRNDNGLFLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPHFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKHFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDGDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLDWTPTVEMRETIGNTLDFFLREAMLEQA
DMR
>A0A127T1S5|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-129|antibiotic inactivation|1
MKTIAAYLVLVFFSSTALSESISENVAWNKEFTTESVHGVFVLCKNSTNSCTTNNAARAS
TAYIPASTFKIPNALIGLETGAIKNERQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIARDVGEIRMQKYLNLFSYGNANIGGGIDKFWLEGQLRISAVNQVKFLESLYLNNLPA
SKANQLIVKEAIVTEATPEYIVHSKTGYSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNESKLPSRKSIPAKIMAGEGIIIGG
>M6KAI2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPVSSTGHLFLFSSFFPFYGESLEFDDLFDIFIQSGAILSVLFLYREKFRSQIVSSFRYV
LKQNSDSEGFNFLIQICIGAFPILIAGFMAKKFLDTIKARPDLLEILSGAWIFGGVLILI
AEWYFHQKGTEEKKPIHFKDSILIGIFQCMALVPGMSRSAATIITARFLGKDTKSSAEFS
FFLAVPVLLAAGIYKLIKYRSILNGNTIPVLMFGFLVSFLLCTLVIRWFLRYLQKHSFSV
FGVYRILLGVGVLVLTKLI
>A0A109FPG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLIGFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQRNAQRFTVNLMIAVLPAVVLGVIFADLIKHYLFNPITVATALV
IGGVIMLWAERRQHAVHAHSVDDITWKEALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWSAVKP
>V5LEG1|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-212|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVENSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A101LHN4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTAIVFAYHDIGCAGLAALIQAGYPIAAVFTHPDDPGENRFFGSVAQLCARHGIPVHAP
EDVNHPIWVERIRALEPDFIFSFYYRHLLSEEVLACATRGAYNLHGSLLPRYRGRAPANW
VLVNGETETGVTLHRMVKRADAGAIVAQQRVAIAPEDTALTLHGKLREASQELLRDALPA
LAAGTLQEREQDESQASTYGRRSAADGELQWSRPATTLANLVRAVTQPYPGAFGWIGERK
LIVWSAQARQERHDQAPGTVLSLEPLRIACGEGVLEVQAGQLGDAGLYLSGPQLAREAGL
VAGARLHRQDRRAKRRTRVLILGVNGFIGNHLSERLLADGEYEVYGLDIGSDAIERLKAN
PNFHYVEGDISIHTEWLEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRH
CVKYGKRVIFPSTSEVYGMCQDERFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGS
KGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIKLVDGGAQKRCFTDV
DDGIEALFRIIENRGGRCDGQIVNIGNPDNEASIRELAEELLAQFEAHPLRHEFPPFAGF
REVESKSFYGDGYQDVAHRKPSVENARRLIDWQPTTAMAATVGKTLDFFLREALAQREA
>W0APH6|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMATAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMTIMGVAVLMLSLFILKE
TRPAAPATSNKPQENTESLLNRFFLSRVLITTLSVSVILTFVNTSPVLLMEIMGFKRGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMIASQLLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGVGAWNMLIGI
LIACSIVSLLLIMLVASGRTVAAHEEIHHHA
>A0A066T2Y7|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHNA
>A0A099DEP5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWYELLIGFLLGVVEGMTEFAPVSSTGHMILVDDLWLNSSSFLGQEVANTFKIVIQLGS
ILAVIVVFRSRFKELLNPKELLAIRNSGPTNKLNVLHILIGLLPAAVLGLMFEDYIDTHL
FSIKTVLIGLVIGAFFMIAADLSGVKRQTTATLDEISYKQALGVGLIQCFSLWPGFSRSG
STISGGVLLGMSHRAAADFTFIMAVPIMFGASALSLYSKWEYFTMATLPVFVVGFISAFL
FALLSIKFFLKLINKVKLTPFAIYRIVLAAIIYFLYF
>A0A0Q6THQ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILALKAIIMGLVEGFTEFLPISSTGHLILAGSLINFTGEVAQVFEIAIQAGAIFAVM
WEYRVRIGAALGGVTSDPRQQKLVINLIVAFLPAAVLGVLFSKAIKAHLFAPVPVAAAFI
VGAFVILWAERRHKVLPGAHRIQTVDDMTVLDAFKVGCAQCFALIPGTSRSGATIIGGML
FGLSRTAATEFSFFLAIPTLLAATVYSVFKARHDLHATDLPLFLIGGVAAFVSAFLCVRW
LLRFISTHDFTGFAWYRIVFGVVILVTAHFGWVVWAE
>F5TDA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWLLDIIKVIILGIVEGITEWLPVSSTGHMILVDEFLQLNQSAEFKEMFLVVIQLGAILA
VVMMYFNKLNPFSKKKTKEQQKDTINMWLKVIVGVIPAGVLGVLFDKTLEKYFYNFPTVA
FTLVLYGILFIVVENNPKFKKQNIRRFEDLSYSLAFYVGCFQVLSLIPGTSRSGATIIGA
LILGLSRSLAAEFSFFMSIPVMFGASLLKLRKFGFAFSFFQFFILILGMFVAFVVSVMAI
KMLMRYIKKHDFKVFGYYRIVLGVILILYYIIR
>A0A117MVL2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLVAAILGVVEGLTEFLPVSSTGHLLLLGHFLGFESKGKSFEILVQLGAILAILLVY
FRRLLDIALRLRTDPAARRFVIGVLLAFLPAAAIGALAHGFIKGVLFNPFLVCTTLIAGG
LVLLVVDELELEVKHHDATAFPLAMYFKIGLIQCLAMIPGVSRSGSTIVGAMLLGADKRA
AAEFSFFLAMPTMAGAFAYDLMKNYKDLTASDTLLIGIGFVTAFISALIVVRSFLDFVSK
RGFTPFAWWRIVVGSAGLAGLWVFG
>V6F9E9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVM
YALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALIAIK
TFLQLIKRISFIPFAIYRFILAAAVYVVFF
>ZP_02405550|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLAGMIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPNDSYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GAGDYAMRVWLDPQKVAQRNLTADDVVRAIREQNVQVAAGVIGASPTLPGTPLQLSVNAR
GRLQNEDEFGDIVVKTAPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLAISDEVRKTMAELKQDFPAGVDYRIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASIIPLIAVPVSIVGTFSLLLLFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGLTARAATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVR
GVLSRKAVMLGLYLVLVGATLLVSKIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGAIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFDQRHGKALSAGAIAGALN
QKYAALKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYARLADATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVNVTDVFDTMQIYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNAAGEMVPLSSLVTVSPTFGPEMVVRYNAYTAADVNGGPAP
GYSSGQAQAAVERIAAQTLPRGVKFEWTDLTYQQILAGDSAFWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGKTPFEAAVEASRLRLRPILMTSIAFIMGVVPLVLSTGAGAEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAQKDSAGYGVPAPDA
>A0A0J6NY18|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQSLKFRTLAGMLGCLTFLPLAAQAANDAGKSDLDAAVEATIPPLMKAKDIPGMAVAVLA
DGKAHYFNYGVASRETGQPVTQDTLFELGSISKTFTGILGGYALAQGKLSLADKASRYQP
ELKGSVFDRVSLLQLATYSAGGLPLQFPDAVAGQASMLAYYRGWKPDYAPGERRLYSNPS
IGLFGHLAARSLGQPFDQAMERGLLPKLGLSHTFIHVPEAEQSRYAWGYAKAGKPIRVGA
GVLDAEAYGIKSSAADLLKYLAINMSPPADPALQRALDASHAAYYRVGDMRQGLGWEGYR
YPISLERLLAGNSNEIAFQPQKVEWLNPPRLAEGDVLLNKTGSTSGFGAYVLFVPARKVG
IVMLANRNYPNAERVRAAYRILSAVDPSLARRRGD
>A0A150DQS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLFNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKEATAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWEYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIDLKPFAYYRILLAILFTLFVLL
>AAX84025|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmT|antibiotic target alteration|1
MNKKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFTFELAKRCNYVTAIEI
DPKLCRITKNKLIEYENFQVINKDILQFKFPKNKSYKIYGNIPYNISTDIIRKIVFESTA
TESYLIVEYGFAKRLLNTNRSLALFLMTEVDISILSKIPREYFHPKPRVNSSLIVLKRHP
SKISLKDRKQYENFVMKWVNKEYIKLFSKNQFYQALKYARIDDLNNISFEQFLSLFNSYK
LFNR
>A0A0U2XLX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIEILKALVLGIVEGLTEFAPISSTGHMIIFDDLWLNTEGFLGAPSANTFKIVIQLGS
ILAVVFVFWKRMLSLVGLYKIEQDTPAKFNILHVVIGIIPAGVFGLLFEDFIDENLFSIE
TVLVGLVVGAFFMIIADKFGPKKPSINSLDEISYLKALSVGAVQCFSLWPGFSRSGSTIS
GGVLLGLDHRTAADFTFIMAVPIMLGASIVSLVKNWEAISFDHLSFYAAGFVTAFIFALI
SIKFFLKLISRIKLVPFAIYRIVLASVLAFIVFL
>A0A0N9WAG3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLNAGFEIAAVFTHADDPKENTFYGSVAQLCARKGIPVHA
PEDVNHPLWIERIAKLNPDYLFSFYYRNLLGEQLLATARKGAFNLHGSLLPTYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQRVAIERADTALTLHGKLREAASNLLRDTLP
LLAQGKITETAQDESKASVYGRRTAADGKLVWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVKGNEGLAPGRVISVDPLRIACGEDSLVVTSGQRNENGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDKYDVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNENDSCNGQVINIGNPDNEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A0A7DPP0|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFEPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>Q0F190|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDTGKSEDKLTMDILQATILGLIEGATEFLPISSTGHMIVASHWLGISQNEENKAFEVI
IQLAAILAVVANYRDKFTIAHLELWKKVCLAFIPVGIVGLLLHKQIKAMFTVETVAVMFI
VGGIIFLVVEYLHRGKSYPVQRVEEISYRQALWIGLAQVCALIPGTSRAGASIIGALLVG
LNRKASAEFSFLLALPVMMAASGFDLLKHYQDFIGADVIALATGFVVAFVSAWLVMRLFI
HFLERFTFVAFGVYRILFGALLLWGLS
>S0XBN1|FEATURES|UNIPROT_deepARG|beta_lactam|WG5_05196|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYCPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>A0A0A1MTN8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB_2|antibiotic inactivation|1
MQLFIVVLRKNETNHIEVIKLFIKGVNHFLFSVSDLEKSIRFYQNVFDAKLLVKGRSTAY
FDLNGMWLALNLEKDIPRNEISQSYTHIAFSIEEADFDSIYNKLEELDVNMLTGRPRDEK
DKKSIYFTDPDGHKFEFHTGTLQDRMNYYKQEKPHMEFYI
>A0A0E9BPC7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMADLHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILA
VVVMFWRRLFGLIGIHFGEVKHEGVGTGRLTLIHILLGMIPAVVVGLALHDQIKTLFNPI
NVMYALVVGGLLLLAAEFLKPKQPKSPGIDDITYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFILAVPMMIGATGLDIYKSLGFLTMADFPMFAVGFITAFVVALL
AIKVFLELIKRISFVSFAIYRFIVAGAVYMIFM
>YP_294981|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRRRIANVLSGLTTDPKAQRFAINVIVATVPAIVLALVFGKWIKAHLFNPITVALAFI
IGGVVILLAERRDARRGMVTNPRGNALLQAAKAGAPRIESVDDLNWRDALKVGLAQCFAL
VPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKARALLSVDDLGIFG
IGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIIVLATAYSGLIAWHA
>A0A157ZJ06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLVLLTKAAIMGIVEGLTEFLPISSTGHLILAGSLLGFTSEKAKVFDIAIQTGAIFAII
LYYWRRLMDAAAGLAGDGRSRRFVANVLIAFIPAVILGLLFGKAVKAHLFTPTVVATSFI
VGAFVILWAERRPASTARIHSVDDMSPVDAFKVGLIQCLALIPGVSRSGSTIIGGMLIGL
SRSTATEFSFFLAIPTLIGAGAYSLYKERALLTIADAPLFAVGLAFSFISAWLCIRWLLR
YVATHNFVPFAWYRIAFGIAVLITAHMGLVNWAD
>J3DXV3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIETLLNSGYEIAAVFTHPDDPNENAFYASVAQLCARKGIPVHA
PEDANHPLWIERISKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQRVAIARTDTALTLHGKLRLAATDLLRDTLP
ALLEGKVSETPQDESNATVFGRRTPADGKLLWNKPAQELFNLVRAVTQPYPGAFCAVGEH
KLIVWSADVVKGNEGQAPGRVISVDPLRIACGEDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGGAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDGNFDEDSSNLVVGPINKQRWIYSTSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNENDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRNNFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWIPTVEMSETIGNTLDFFLREAMLEVA
ERESTEESC
>G5LRD1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPIYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPNIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>A0A158CI86|FEATURES|UNIPROT_deepARG|beta_lactam|AWB82_05438|antibiotic inactivation|1
MKFRALSLLAASIFSFGAMSGAAHASDVASIRATVDQTIKPLMALHGIHGMAVGVVVDGK
PYVFDYGVASKATNQPVTRDTLFEVGSISKTLTATLASYAQVEGDLSLTDPVSKYLPSLD
GTEFGKVTLLNLGTHTPGGLPLQVPDDIHDNDQLMQYFRTWRPAQPPGTIRTYANPGIGT
LGLIAAKSMKQDFTPLMQTRLFPALGLKHSYIDVPASKQRDYAQGYTKDDTPIRMKGGVL
SAEAFGVRSTAADMTRYLQINMNMVRIDPAVQRAVDATHTAYFQAGPLTQDLIWEQYPYP
VALQPLLEGNAASMITNAMSVTRIDPPQAPRDDVWINKTGSTNGFGAYIAFVPKARVGIV
MLANRNIPNEERVKAAYAIIASLAGGR
>AAM11668|FEATURES|ARDB_deepARG|beta_lactam|CMY-82|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTKRVLRPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQAHMNASKVQEKTLQQAIELAQSRYWRVGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A0H5BQ21|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQALLDAGYDIAAIFTHPDNPGENHFFGSVARLAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLGDEILNLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGDIVAQQAVAIGADDAALTLHRKLCAAATELLSRALPAI
LAGTTDERPQDHSQATYVGRRTPEDGRLDWELPAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLPAAKPGTVLSIAPLIVACQDGALEIVTGQTERGVYMQGAQLAQALGLVS
GAVISSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWEPKVEMEETVEHTLDFFLRTVELVDDKN
P
>F9D7X7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVEQGNPFVHAFTFIIQFGAILSVVC
LYWKKFFSFTSDMWRLYKLLVIGVLPAVVVGLAAKKSGLLDWLLDSIWVVAITLVLGGIF
MLFCDKIFNKGREENEVTPKRALSIGLFQCLSVIPGMSRSMSTIVGGMANKLTRKKAAEF
SFFLAVPTMAGATILDVYDMMKGDVKWATSDNLFLLGVGCVVSFAVAIFAMKWFVSFLTK
YGFKAFGWYRVIVGVILLAMLLSGMSLNMVD
>NP_979752|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNEAGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGMKTLKERGIKAHSTVLTAELAKKSGYEEPLGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSASSKDLGNVADAYVNEWSISIENVLKRYGNINSVVPGH
GGVGDRDLLLHTLDLLK
>A0A0M1UPM4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILDSILLGIIEGLTEFLPISSTGHLIVLSEILGLEQDNVNKAFEIIIQFAAIMALVFV
YPSKFTFSHIELWKKIVVAFLPIGTIGFLFSTQIKNLFSIEIIAWMFIIGGIVFLIIEKF
YDENKTHTLDVENISYKQAIFIGMMQVFALIPGTSRAGASIIGAMMAGLNRKTSAEFSFL
LAVPVMCATTGYDLVKHHDELLLVGANLLNLAIGFVVSFIVALIVIKLFLKFLERFTFVA
FGIYRIIFGILILLIF
>A0A098Q3P8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWGLATGLGERTNRDYVLKVGVAFLVTAVVGLVVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWTDVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRMLLGTALLLWLPAAAG
>A0A0C2RI10|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRSVSIVIPVYNEQESLPELLRRTEAACRQLHHDFEIVLVDDGSRDESANMLEEA
AGRENSPFVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAEAEKGY
DVVGTVRGNRQDSALRRYPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIIDAMLACRERS
TFIPILANSFARHTTEIVVAHAEREHGDSKYSPMRLINLMFDLVTCMTTTPLRLLSIVGF
AMAGLGVLFAVALIVLRLAFGAGWAGDGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRSQPADPAPAVTVDGLSSTATSSTSDQVLS
>A0A0H3X1M7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MGFSARAYAAETGAQVPANPRQEAVRSLVDKTIVPLMARQDIPGMAVGIVFDGQSYVFDY
GLADKAANTPVTNDTLFEIGSVSKTFTATLAAYAQAAGMLSLTDKTSRIAPEFAGTPFGD
VKLLNLATHTTGGMPLQVPDNAGNLDEITQYLKAWKPAKPTGTVRTYSNVSIGALGWLTA
RAMHGEFATLMSDHVFKPLGLKHTFLRVPEDQQANYAWGYKDGQPVRVNPGVFEQEAYGV
KTTASDLLRFVRANLGETVYERRLRHAIYATRTSYFFDTPMTQDLIWEQYPFPVSVDTLL
DGNSSRMAYEPTPARELTPPMAPSPVSWVNKTGSTNGFGAYVAFVPSKQMGIVLLANKNY
AMDERIRAAHVILTTLDGTRPAPAPAK
>D7XAT4|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9552_03771|antibiotic inactivation|1
PRFVWKPDPMFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQ
GKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPE
LTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSI
GLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGA
LDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLD
WPVNPDIIINGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELG
IVMLANKNYPNPARVTAAWQILNALQ
>A0A0X8Q738|FEATURES|UNIPROT_deepARG|beta_lactam|AL522_14075|antibiotic inactivation|1
MKKSLFYLALFSLSASCVAADLSSQQVTSLVKAAIEPLMEQQAIPGMSVAVLYKGRAQFV
NLGVADLESRRRVTENTLFELGSVSKTFTGTLAGIMIRNGEIRLNDPVQKRWPQLTGEQW
RPVRMLHLATYTAGGLPLQLPDEVTDQASLLRFYQNWQPTSAPGLQRQYSNASIGLFGSL
MVKGDYEQAMERHVFQPLRLTRTYITVPPSMMLNYAWGYKNGQPVRVSPGMLDAEAYGIK
STARDMLTFMQANIDPNRLSAGNAVLRNAIRTAQSRYFKVGSLYQGLGWEMYDWPVDAET
LLRDNDNAVALKPRPATQVNPVGPSQSASWVHKTGATNGFGAYIAFIPEQNSGIVLLANK
NYPNPLRIRVAWQILQALQQGTPE
>A0A097SRP9|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
LIPFFAAFCLPCFAHPETLVKVKDAEGQLGARVGYIELDLNSGKILESFRPEERFPMMST
FKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSD
NTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLR
KLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGP
DGKPSRIVVIYTTGSQATM
>A0A0A2Y1H5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAGHFLGFEGQKAATFEVIIQLGSILAVIFV
YWRKMFGLIGIHFGEKVDRNKAHLNLIHIILGMIPAVVLGLLFHSTIKSWFNIHNVIGAL
VAGGILLILAEKFRPQPAYAEELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMG
VGKKAAAEYSFILAVPMMIGATALDLYKSLPFLSWDDLPLFVVGFVTAFVVAMIAIRTFL
HLIGKISFVSFAIYRFILAILLAWIVLA
>M6A5J5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGENVEFDDLFDIFIQSGAILSV
LFLYREKFKSQIVSSFRYILKQNSDSEGFHFLIQICIGAFPILIAGFIAKEFLDTIKARP
DLLEILSGAWIFGGVLILVAEWYFHQRPEEKKPIGFKDSILIGIFQCMALIPGMSRSAAT
IITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGNTIPVLMFGFLVSFLLC
TLVIRWFLRYIQKHSFSVFGVYRILLGVGVLVLTKLI
>A0A0Q5LBX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLLKAAAMGVVEGLTEFLPVSSTGHLILAGALLGFDDEKAKVFDIAIQTGAIFAVI
LVYWQKIRATLVALPTQRQAQRFALNVLIGFLPAVVLALLVGKAIKAHLFIPTVVASTFI
IGGFIILWAEKRPRTAIRVESVDDMTMLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGVYSLVKERHLLAWADLPLFLTGLVFAFLSALVCVRWLLR
YISTHSFVPFAYYRIVFGVIVLWTAWSGAVAWVD
>Q8KA52|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFFHKIVIPIIIGIIQGITEFFPVSSTGHMIIFIDWLDIKNKDTKILEIFVQLGSTISV
FLFFYKKIIQILQLPMQKESNEKKNIHVLISILPTMFLGLIFYNKIKSLFNPTNVMYALI
LGGFFLIIAEKFKPKKPKTNSIKEINLVQSLIIGCFQTLCLYPGFSRSGASIAIATLLGF
KRSVAVNFSFIISIPLIAGASVLDLIKNIQNVNMLNIPYLFSGFTISFIISFLLIKKFIT
ILNKVSLTFFGIYRFLIAGIIYFI
>NP_709855|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDAIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAEHVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AAPVVEKK
>A0A0M9CX31|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNALLELKNIERSYPAGEEQVKVLDNVTLSIYAGEMVAIIGASGSGKSTLMNILGCLDKP
SHGEYRVAGQNIAELNNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAVYAGAVKTE
RRQRAIELLSRLGLEERINYRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMVILKQLCEQGHTVIIVTHDPKIAAQAQRVIEIKDGLIMSDSGPQLRKKVTEVPSVT
SKISSIRQIFGRFNEALLMAWRAMVANKMRTLLTMLGIIIGIASVVTILVIGDAAKALVL
SNIKEIATNTISVYPGEDFGSDDPVSKQALKIADVDAIKVQPYILAVSPVIEGGMRLRKG
NIDVAARVSGIGDEYFQVYALRFAQGMSFTSDMVRRQGQVVVIDKNTQRKLFPHQKNVIG
EVILMGNMPATIVGVIAERKSAFGSDSSLHVWLPYSTMTSRLMNRNYLDSITVRIKDGHN
SKDAEQKIVQLLTLRHGKKDIFTYNTDMLIKTVEKTTRTLQLFLTMVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAILVCLVGGVLGIALSYTIAFIAQLA
LPGWHFVFQPIALLSAFACSTAIGVIFGFLPARNAARLDPIEALARE
>A0A0Q8II49|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGLTQPATFVVLIQLGAILAVVT
VYFAKLGMLIRDALTGKAYAWQFALTVVIACVPAVIAGVLLRDFIQGDLWESAALICWSL
LIGGFVLLVVDRLKLQPKYDDIYTFPWHLAAIIGLFQMISLIPGVSRSGSTVVGGMLFGA
SKRAAAEFTFFVALPIMVGAFGYDLYKSRDLIDASIALNVAVGFAAAFVVGAIVVRYLLN
FVSRYGFAPFAWWRIAVGIFGLVGIYFFGR
>D4KR14|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLSFIEILKVIFLGIVEGITEWLPISSTGHMLLVDEFLQLNASDSFKEMFFIIIQLGAI
LAVVVLYWNRMFPFQFKDKAKPVIRKDIFSLWFKVVVACIPGAAVTILFDDYIEAHLHTP
VVIAIALIFYGVAFILIENWNKTREPKIKTLADISYQTAFMIGLFQVLSIIPGTSRSGAT
IIGGLIIGVSRVAVAEFTFYLAVPVMLGMSLLKLLKFGFAFTGAELVILGVGTVVAFLVS
IVVIRFLMSYIRKHDFKVFGWYRIVLGALVLVYFAFR
>A0A023CTC0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVEIIKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLQSQEFLGKYAANTFKVVIQLGS
ILAVVVVFKDRFIDLLGLRGRHRDGQPRLKLMQVIVGLIPAGVLGVLFEDYIDEHLFSTA
TVLIGLVLGALLMIAADVFAKKAPKAQTVDQITYKQALIVGLVQCLSLWPGFSRSGSTIS
GGVLAGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIAGFISAFLFALL
AIRFFLKLINQIRLVPFAVYRIVLALVIYVLYF
>YP_001177494|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRPHSSISIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAV
GQLLYGPMADSIGRKPVILGGTLVFAAAAVACALAQTIEQLIMMRFLHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLLAPMIGGAVLVWLSWHVIFWILAIAALLASAM
IFFFIDETLPVERRQKFHIRTTIGNFASLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVSPQHFGYYFALNIVFLFVMTIINSRFVRRAGALNMFRAGLWIQFVMAIWMVFTA
FFDVGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSMATFNTAWPMIWSIAFCATCSILFYLYASRPRKSAH
>L0LHQ5|FEATURES|UNIPROT_deepARG|aminoglycoside|RTCIAT899_CH00745|antibiotic inactivation|1
MEFVEALLAKASRDWTRVKTGESGDLVYRREDGRAYAKIAASARSADLAGERDRLLWLQG
KGIAVPEVIDWRETEDGACLIMTAIAGVPATDLDGETLLKAWSSMAQQLKVLHELPADQC
PFDRSLSLMFAKAADVVARDVVNPDFLPPEDQDRPARDLLDRVERDLPVRLDQEAIDRVL
CHGDACMPNFMVDPHSLQCTGLIDLGRVGKADRYVDFTLMIANAEENWTAPEQGERAFSI
LFETMEIKKPDRERLAFYLRLDPLTWG
>A0A0Q9V8V2|FEATURES|UNIPROT_deepARG|beta_lactam|ASG98_06885|antibiotic inactivation|1
MKTWKEMFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEEKY
DANLGVFALDTGTNKTVTYHPDERFAYASTHKALAVGALLEQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALEKIGDDVTLPE
RFEPDLNEVNPGETHDTSTARALATSLQKYVLGQALPEDKRELLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKDAEYNDKLIAEAAKQ
AVKTLKVTRK
>A0A060RJR0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSIKIKEYTLPMKKSGPYGITVGPDGALWFTENAGNRIGRISTNGEITEYIVPTSDAGLS
IIANGTDGHLWFTEYKANKIGKITIEGKITEYDIPTANAGPYGIVLGPDGAMWFTEITGN
KIGRITTSGVISEYDLPVQGSFPSMIVSGPDEALWFTENQGNKIGRITRTGDIDEFDIPT
ADSAPVGICKGTDNCLWFVEIMGNKIGRISTSGEFFEYPLPTKNAKPHAITSGKDGDLWF
TEWGSNKIGRITLCGEIIEYPIPTPEAEPHGLVLGPDGAIWFAEEANKIGQLIY
>A0ESF8|FEATURES|UNIPROT_deepARG|beta_lactam|len-1-like|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQQFARRSAPADRALTNA
>A0A096HMQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLMGFVGGKAKVFEIAIQTGAIFAVM
LVYWQKIRDTLVELPSSRQAQKFALNVLIGFLPAVVLALLFGKYVQEHLFTPVIVATTFI
LGGFVILWAEKRPAAATRVQSVDDMTALDALKVGLVQCFALVPGTSRSGSTIIGGMLMGL
SRKAATDFSFFLAMPTLIGAGVYSLYKERALLSMADVPLFAVGLIFSFISAWLCVRWLLR
FISTNSFVPFAWYRIVFGIIVLVTAYTGIVDWHH
>R7FE20|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVIELLKALVFGIVEGITEWLPISSTGHLILLDEFLSLKASENFKEMFDVVIQLGAILAV
VVIYWKKLWPFGRENNPKPLTTSGFGACVKKDVLQMWCKVIVATVPAAVIGLLLDDWSQA
HLYNAWTVAIMLILFGVAFIWIEKWHKNQKPKMNSIGALRYSTVLMIGVFQLIAAIFPGT
SRSGATIVGALLLGVSRTAAAEFTFFLAVPAMFGASLLKLVKCGLPSTGMETAMLLIGMI
SAFVVSIVVIRFLMSYIKKHDFTVFGWYRIVLGVLVLICGITGVIG
>B8XLK1|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERIRQIAEIGASLIKHW
>CAJ00297|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELHPNMRVMNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYS
STYRKKSELCGIVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKKPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A031G1I6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTFIQVLILGAVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRPKIFDIVKGLPTQRNAQRFTLNLLIAFLPAVVLGVLFADKIHQYLFNPITVAMALV
VGGIVMLWAEQRSHVVSVDHVDDMRWSDALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQASDLPVFALGFVIAFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWVFGWVNWTEAAA
>C9MRA3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLIQTIIISIVEGLTEFLPVSSTGHMIITQHLLGVSQGSPFVHAFTFIIQFGAILSVVC
LYWKRFFHIDRTPVPADVENPFLRFIHPLRFYWLLFVGVLPAVVIGLAAKKSGLLDWLLD
SIWAVAIMLVVGGIFMLFCDKIFNKGREENKVNEKRAFNIGLWQCLSVIPGTSRSMATIV
GGMANGLTRKRAAEYSFFLAVPTMAGATLLDLLDILKEDATWVNTHDLIMLAVGCVVSFV
VALLAMKWFVSFLTKYGFKVFGWYRIIIGIIIIVMLLSGISLNMVD
>G4CF98|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVMLALKALLLGILEGLTEFLPISSTGHLIVAGNLIGFDSEYTAFKIAIQLGAVLAVVF
EYRRRFAHVLTHIGKDRQVNRFVGNLMIAFVPAAVVGLLFDDFIEQVLFNPISVAAALVV
GGFLILWIEKRQQNRAPKVATVDDMRPRDALVVGLAQILALIPGTSRSGSTIMGGMMWGL
ERKAATEFSFFLAVPVMIAATGYSMVKNLHVFTWQDIGLIAIGFVAAFAAGLLAVKALLR
FVSSKNYVPFAYYRIIFGGIILLTWQLGWVDWTVK
>A0A0D1CKR8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLTFTAILLGIVEGLTEFLPVSSTGHLILATRLFGYDSSQWATFNIVIQLGAILAVIVQ
FWRTFWAVGMGLLKLNPTSIRFVRNVLLAFIPSAILGLLLKHYIDALLGEPAVVAWALII
GGFAILGVEKIAKPGPLTGVAELPAKQCLGVGLAQCLAMVPGVSRSGATIMGALAMGVER
RTAAEFSFFLAVPTMVGATTLELLGAREELMAGTGIVGWNEIAIGFFVSFVVALVVIKAF
MAFVSKSGFAPFAWYRIVAGALALFLLSRV
>A0A0G0N0J1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLYLYSIVAGLIQAVTEFLPVSSSGHLVILHDFVNFNIGNTLAFDVALHLGTALALIIF
FRKDIWKYILAVLNVFIPKRQVNQRDLKDAMLIVYGSIPAVIFGFLLKKFAPTMFRQTEV
VVITLVVVAILFFVVEKTAKHTRDYTGMSIGKALYIGCAQVLALIPGVSRSGITIIAGMS
ADLKRSEAAKFSFLLSIPAVLGAGLLEMFDIAWTKLPNQEIIGIIVGFVVSAVIGFVVIK
FFLKYVEHHKLNVFAWYRICLALILLLWLYLK
>A0A0R1MCU3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGITEFLPISSTGHLVLVDEFIQLEQSKQFVDMFNVVIQLGAIMAVV
VIYFHKLNPWSPRKSTVEKKKTWTLWKKVIVAVIPSILIGLPLNDWMDEHLMNWFVVSMA
LIIYGILFIVIENRNKKLTPTYDDLDALTYKTAITIGLFQILSLVPGTSRSGATILGGIM
IGTSRFVAAEFSFFLAIPTMFGASLLKLYKYFTHGGTLIGSQGIVLAVGVIVSFVIAYLS
IRFLLNYVKKNDFKVFGWYRIVLGVIVIGYFTLFH
>B3RA77|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNKIFQKAMPAIAAAAALLYGAGAHAAERVDAAALKRVVDAAIQPVMQAHDVPGMAVAVT
AGGKQYAFHYGVAAKAGGRKVDADTLFEIGSVSKTFTATLAAYAQARGDLSLADNAAKYL
PQLAGSSVGATSLLDLGTYAAGGLPLQFPEAVTDTGKMVDYFRNWRPRFAAGTHRQYSNP
SIGLFGYLAARSMGQPFDALMEKMLFPALGLRNTYITVPKARMGDYAYGYAKDGKPVRVT
PGVLDAEAYGVKTTASDMMRFVMANIDSSGLDDTLQRALATTRTGYFKVGDMVQGLAWEM
YAWPAQRDSVLAGSSPQVVFEANPVARLDPPQAARSGMLVNKTGSTNGFGTYVAYVPSQR
IGIVMLANKNYPVAERVKAAFKVLQYLDGQPVGEGKP
>A0A102LJI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILIFKTLILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRRRIVSVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGVIILLAEARQRERGDAPRVQSVDALTRLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLGASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>C2JVN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVIIGIVEGLTEFLPISSTGHIDLVDQVVKLSQGRQFMNMFEYVIQFGAILAVI
LLYFNKLNPFSKPTVQAQKDTWQLWAKVIIAVLPSVVVGLPLNDWMDKHLHTPLVVATTL
ILYGVLFIVLENYLKNKQAHITSLADITYQTALLIGLFQVLSIVPGTSRSGATILGALLI
GTSRYVATEFSFFLAIPTMVGVSILKIGKYLLQGNGFTGEQWVVLLTGSVVSFLVAIVAI
KWLLKFVQTHDFKPFGWYRIILGAIVLLVMFL
>W7CN05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLWIVAVILGIVEGLTEFLPVSSTGHMILAAELMGVQDTWKQINTFEVVIQLGSIMAVV
VVFWRRLWAVVGVRTGEYKNKQGQLNLMHVIVGCIPAIIAGLLFDDLIDEHLFSYQTVIV
ALIAGGILMLIAEKVAAKNNHLSESLDKLSYRQAFYIGCFQLIALWPGFSRSGSTMSGGL
IVGVGRKTAAEFSFIIAVPMMIGATGLKVFKALDTMSMSDVPVFIVGAIVAFIVAMIAIV
FFLKLISKVTLKGFAYYRFAIALVFIAYMIWR
>A0A072YNM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIIKVIIIGIVEGITEFLPVSSTGHMIIIEDLIKFKEGVEPISLYTKQYKDAFTMIIQ
LGAILAIVVLYWDKIKKSFQNFSPSHPKSGFKFWLNIAVAAVPAGVIGLKYHSKINEKLF
NPESVTAALIVGAVWMIFAEKRYRGKFKTRDIDSVTIKQAFIIGCFQCLALWPGMSRSAS
TIIGAWIVGVSTVAAAEFSFFLALPVMFGVTLKSLKDINVFDLSSMHIIGLTVGFIVSFV
VALIVVDKFINFLKKKPMRVFAIYRILLGIVLIVLFLFNVIQL
>YP_001374841|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLIKGINHICFSVSNLETSIAFYEKVLEGELLVKGRKLAYFRICGTWVALNEETDIPRKE
IHQSYTHIAFSIEKEDFERLLQRLKENDVHILQGRKRDVRDCKSIYFTDPDGHKFECHTG
TLEERLQYYKEAKPHMTFY
>F4T0A0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYSSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLNWEPKIDMQETIDETLDFFLRTVDLTDKPS
>B0K909|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGKFIHFTGNFATMFEIVIQLGAILAVVFH
YRKKIFASLKNLKPGSWGFNLWFKIFIAFIPAAVIGLLTHKYIEEHLFSPFTVAIALIAG
AIMMIVIEDTFGKRYKIDNMDKVDTKKSLLIGIAQVMSLFPGMSRSASTIMGGMLAGLSV
KAAAEFSFFLAIPTMFAATTLSLLKGFSAMSLLEWQALAVGFITSFLTALFVVDKFLSYL
TRHSLKPFAYYRLAVGVLMILLVAEKIVK
>ABY42552|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDDRAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASALDLIKSWDILSVADIPLFATGFITAFVVAMLAIVSFLKLLG
RVKLTPFAYYRFILAAVFYFFIM
>A0A0W2I6A1|FEATURES|UNIPROT_deepARG|chloramphenicol|ASV07_12980|antibiotic inactivation|1
MKKTAPEYTPVDLSRWPRKEHFEVFQSFAECTINQTVLIDITALRKHIKAVGWKFYPTII
FLLSNIMNRHPEFRMAMKDNELVIWNEVHPSYTIFHPETETFSSLWSHYDGNIHHFQNTY
AEDTARYGNSLSYWPKEESRENVFFVSSIPWVTFTNFNMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPLAVQVHHSVCDGFHVARMFNELQEMCDGLSALSEERNG
>A0A0Q9A6S7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTFDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAVSLLIGGIILLKVDDW
FNNPNAAETSQEITYLQALKIGLFQCIAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATAKKCYDYYKAGFDLSHDQINILIIGNIVAFIVALLAIKTFIGFLTKNGFKV
FGYYRILAGIILLLIHFFIHPLTII
>A0A0U5LBU9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKVISQVLATTALIAACSLSQAATTDINAIVSPPITRLMAQQDIPGMAVAVYVKGQSYYY
VWGMADKAQRRPVTTDTLFELGSVSKTFTGVLGGVAVAKGEIALNDRASKYWQRLALPHW
QHITLLQLATYTAGGLPLQVPDNVTSEAQLALFYQQWQPQWAPGEKRLYANSSIGLFGLL
AVKPSGMTFEKAMQQRVFTPLNLKNTFINVPQNKQDVYAWGYRDGKAVHVSPGMLDAEAY
GVKSTIKDMARWMQANMNPQQVTDPTLQQAIKLAQTRFYRTDALYQGLGWEMLNWPEQSS
IIATGADSNVALAPQQLVKIDAVTPHQATWVHKTGATGGFGAYVAFIPQKQVGIVILANK
NYPNPERVKAAMEILSQLQ
>R8P7B2|FEATURES|UNIPROT_deepARG|beta_lactam|IKQ_02047|antibiotic inactivation|1
MNLPLVFSIKSLKGMRILKNKRILKIGICVGILGLSLTSLETITGGTLQVEAKEKTGQVK
HKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIAYRPNERFAYASTYKALAAGVLLQQN
SIDKLNEVITYTKEDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNIVFNKIGGPK
GYEKALRQMGDRVTMADRFEPELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNI
FTEWMKGNTTGDKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKD
EKEATYDNQLIAEAAEVVINALR
>G8P355|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMDIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLNLEQFGVLLVACLVAF
GVSMIAIKFLTDYVKKHDFTFFGKYRIVLGIVLLIYAAFKAFLG
>A0A060KTY4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFATCITSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A0B7DEZ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDFWTFFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIIEIVKGLPTERNAQRFTLNLLIAFLPAVVLGVLFADAIHHYLFNPITVAVALV
VGGIVMLWAEQRSHVIRVEHVDDMHWSDALKVGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQQSDLPVFALGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWMFGWVNWTAAAAG
>A0A0G3K600|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYELLLIDDGSSDNSAHMLVE
ASQAGNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0S1Z1Y3|FEATURES|UNIPROT_deepARG|beta_lactam|blaGES|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEAEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>A8SBZ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLQEGFITFFEIIKAILMGIVEGITEWLPISSTGHMILVEQVVKFNASEEFMSMFRVVIQ
LGAILAVVVLFWNKLWPFGLRQGKVISKPSVWNLWFKVVAATLPVLVISPLDDWMEEHFY
NYITVAAMLILYGVLFLVVENRRTTPRVTKLEQISYRDALLIGVWQCLAIIPGTSRSGAT
IVGGLLLGLSRACVAEFTFYLAIPVMAGASLLKVVKFAVSGVSITGTEIAVLLVGCVVAF
VVSLAAIRFLMDYVKRHDFKFFGIYRIVLGAIVLAVAAITALA
>A0A074VD28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLFLKALILGIVEGLTEFLPVSSTGHLIVVGNLLKFETTGEVFDITIQLGAILAIVF
EYKHRFAHIITHIGKEPATNRFVLNLAIAFIPAAIMGLLFSEQIKHYLFNPITVATALVI
GGLLILWIEKRQSRTEPKVKTVEDMRPRDALIVGLAQILALIPGTSRSGSTIMGGMLWGI
ERKAATEFSFFLAVPVMIAATGYDMLKHLHEFTRDDLLLIAIGFVAAFLSALVAVKALLR
FVAHKNYIPFAWYRIVFGGIILVTWATGWVKW
>A0A022PEU0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNALLELKGIERSYPAGEQQVKVLDDVTLSIYAGEMVAIIGASGSGKSTLMNILGCLDQP
SNGEYRVAGQNVAELSNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAIYAGAAKAA
RRQRAIELLGRLGLEERIDYQPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCEQGHTVIIVTHDPKIAAQAQRIIEIKDGRIMSDSGTQVSRKVTKAPSLT
SKISSIRQTLGRFNEALFMAWRAMVANKMRTLLTMLGIIIGIASVVTILVIGDAARASVL
SDIKEIATNTIDIYPGEDFGLDDPVNMQALKIEDADAIKAQPYILAVSPEIEGQMRLRKG
NIDVASRVTGVGDEFFQVYALRFSQGMGFSLDMIRRQGQVVVIDKNTQRKLFPHQKNVIG
DVILVGNMPATIVGVVSDKRATFGSSKSLHVWLPHSTMTSRLVNRNYLDSITVRIKDGYN
SKDIEKKIVQLLTLRHGKKDIFTYNVDMMVKTAEKTAHTLQLFLTMVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAILVCLVGGVLGIALSYTIALIAQLA
LPGWHFVFQPIALLSAFACSTAIGVIFGFLPARNAARLDPIEALARE
>J8BJK1|FEATURES|UNIPROT_deepARG|beta_lactam|II3_05048|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGVQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGICVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIEKLNEVITYTKDDLVEYSPVTEKHVDTGMALGE
IAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMADRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGGYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATEVIVKALR
>A0A024LWQ3|FEATURES|UNIPROT_deepARG|beta_lactam|BN975_00919|antibiotic inactivation|1
MTGLSRRNVLIGSLVAAAAVGAGVGGVAPAFAAPIDDQLAELERRDNVLIGLYASNLDSG
RTLTHRADQIFAMCSTFKGYAAARVLQLAERGEISLDNRVFVDADALVPNSPVTETRAGA
EMTLAELCQAALQRSDNTAANLLLKTIGGPAAVTAFARSVGDERTRLDRWEVELNSAIPG
DPRDTSTPAALAVGYRAILAGDALSPSQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGS
GDYGSTNDAGIAFGPDGQRLLLVMMTRSQAHDPKAENLRPLIGELTALVLPSLL
>D7PIH1|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARKLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKS
>Q2I724|FEATURES|UNIPROT_deepARG|beta_lactam|bla-PSE1|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLSKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>A0A0S3JAB1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTTLLELKDIRRSYPSGDGSVEVLKGITLSVNAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVEGVDIATLDGDALARLRRDHFGFIFQRYHLLPHLTAAQNVEVPAVYAGSGRQQ
RLARARELLGRLGLHERVDYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSASG
EEVMAILHQLREQGHTVIVVTHDPEVAAQAERIVEIRDGELISNPPAKPAAAARVGAEKT
LPASGWRQFSGGFREALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVIVGDAAKQRVL
ADIRAMGTNTIDVYPGKDFGDDDPQYQQALKYDDLLAIQKQPWVSSATPAVSKNLRLRMN
NTDVAASANGVGPQYFNVYGMTFSEGSTFNDVQLRGRAQVVVLDGNTRRQLFPHKASVVG
EIILVGNMPATVVGVADEKQSMFGSSKILRVWLPYTTMAGRVIGQSWLNSITVRVKEGYD
STLAEQHLARLLNLRHGKKDIFTWNMDSILKTAERTTHTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARAADVLQQFLIEAVLVCLVGGALGVGLSLMIAFTLQLL
LPGWEIGFSPLALLMAFVCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0A2YDS8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
SSGSYQIAGKETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKAQ
RLQRAAQLLEKLGLGNKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMQILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDQRQSLQITARKMTQTA
TNRGWQFYRDQFFEALNMSINAIIAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
NAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
AAEKNVTALLLSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGVRMAIGAKQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMS
EFTMLFSTFSIVVAVLCSTLIGIIFGYVPAKNAAKLNPITALSQE
>AAM22221|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MSTNLSVIKNPRVQSDQRRLVRRPDVKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDL
VHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPF
LWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMG
GFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAAL
MAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLG
ERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQ
LQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWRNSSN
SRCT
>R6MUZ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFTLEIIKAIVLGIVEGLTEWLPVSSTGHMILVDEFMSLNVSKAFMDMFLVVIQLGAILA
VVALNFDRLNPFSKRKTYLKKRQTISLWGKVIVGCIPAAVIGLAFNDYMEEHFMNAQVVA
FTLILYGVLFIIVENYNKHRTPSIKDIDYLDYKTALIIGFFQVLSLVPGTSRSGSTILGG
ILFGTSRVVATEYTFFLAIPVMFGASALKLFKFGFNYTFEEVILLLVGMVVAFIVSIISI
KFLLCYVRTNDFKAFGWYRIILGLIVFVYFYFQG
>Q0HV28|FEATURES|UNIPROT_deepARG|beta_lactam|Shewmr7_2039|antibiotic inactivation|1
MSTFSQSLLRHPHNARFSGQLSSNRLGPTVLGLLLLSTTPLLAYAASDARNAEHIQTEQI
QALVDSAINPLMTEYGIPGAIVGISLNGQRYFFPYGVSSKTSNQRVSTNTLFEIGSISKT
FTATLATYAQVQGKLTLTDKVSEYVPELRGSAFDQISLINLATHTAGDLPMQVPDKVTNN
VELMRYFKEWQPAYAAGTHRNYANPSIGLLGLIAAKQLGQSFPEAMEQTVFPQLGMTSSY
LKVPTNKMVDYAQGYNKQDQPVRLNPGVLADEAYGIKTSAVDLLRFVETNMQQHTISNTL
QQAIDATHMGYFDVGMMTQEMIWEHYPYPITLDKLLAGHTQDVVFGSMPVKAIEPPQVQQ
PDQWVNKTGSTGGFAAYVAYLPAKKLAMVLLSNKNYPVHPRVTVGYQILTSLETLPN
>A0A0A0QAW9|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-12|antibiotic inactivation|1
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKSEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDTSLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>A0A0U1DTP3|FEATURES|UNIPROT_deepARG|beta_lactam|A5726_00470|antibiotic inactivation|1
MTGLSRRNVLIGSLVAAAAVGAGVGGAAPALAAPIDDQLAELERRDNVLIGLYASNLDSG
RRITHRADQMFAMCSTFKGYAAARVLQMAERGEISLDNRVFVDADALVPNSPVTETRAGA
EMTLAELCQAALQRSDNTAANLLLKTIGGPAAVTAFARSVGDERTRLDRWEVELNSAIPG
DPRDTSTPAALAVGYRAILAGDALSPSQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGS
GDYGSTNDAGIAFGPDGQRLLLVMMTRSQAHDPKAENLRPLIGELTALVLPSLL
>W3V324|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNALLELRGIERSYSAGEQQIKVLDDVTLSIHSGEMVAIIGASGSGKSTLMNILGCLDKP
SRGEYRVAGQNVAELNNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAIYAGAAKTV
RRQRAIALLGRLGLDERVNYRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCEQGHTVIIVTHDPKIAAQAQRIIEIKDGHIMNDSGSQLSKTVTEAPLIT
SKISSIRQIFGRFNEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVTILVIGDAAKALVL
SDIKEIATNTISIYPGADFGSDDPVSKQALKIADVDAIRAQPYILAVSPDIEGGTRLRKG
NIDVAARVSGIGDEYFQVYALYFAQGMSFTSDMVRRQGQVVVIDKNTQRKLFPHQKNVIG
EVILMGNMPATIVGVIAERKSALGSDSSLHVWLPYSTMTSRLLNRNYLDSIVVRIKDGHS
SKEVEQKIVRLLTLRHGKKDIFTYNTDMLIKTVEKTTRTLQLFLTMVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAILVCLVGGVLGIALSYTIAFIAQLA
LPGWSFVFQPVALLSAFACSTAIGVIFGFLPARNAARLDPIDALARE
>D2KNX6|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>S00464|FEATURES|ARDB_deepARG|beta_lactam|SHV-187|antibiotic inactivation|1
SPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVD
AGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLTAVGGP
AGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQR
QLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRD
TPASMAERNQQIAGIGAALIEHWQR
>G5NFN2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRYHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>A0A0D6HY69|FEATURES|UNIPROT_deepARG|beta_lactam|blaF|antibiotic inactivation|1
MMNLSRRSVLIGSLAVMAAAGVRMPTASAAPVDDRIADLERRNNASIGIYAVDLDSNRTV
AHRADDSFAMCSTFKAYLAARILRGAERGELSLDDRVFVDPAALLSNSPITETHAGGEMT
LAELCQAALQRSDNAAANLLLKQIGGPAEITAFARSIGDQRTRLDRWETELNSAVPGDPR
DTSTPAALAGGFRAVLTGDVLAPPQRQLLDEWMRANETSSLRAGLPDGWTSADKTGSGDY
GSTNDVGIAYGPQGQRILLALMVRTRGDDPNADGFRPLIGELTALVLPELGVH
>A0A076FBL8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFFSAIILGIVEGLTEFLPVSSTGHMILVADLLGLEQNNVLKCFEVVIQLGSILAVVFM
FFDRLKEDFLLWIKLLIGFVPTAIIGLLLYKHIKALFEPTTVAYALIIGGIVFIIVELWH
KKINYDGDTKTLHEVSFKQAFIIGLSQCLAMIPGTSRSGSTIITGLLCGLSREVAARFSF
LLAIPTMFAATTYDTYKNREIFAQNLDALWMFLVGGVVAFVVAFVVIKLFLKFVSKFSYI
SFGIYRIILGAIFLIWVL
>A0RP01|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIKLENIKKSFITGGVSSEVLKGINLEIKKGEFVAIIGQSGSGKSTLMNILGCLDTPTSG
KYLLDSLDISKFKKDELSNLRLKKFGFIFQRYNLLSSNDTKSNVALPGIYAGMSKADRIN
RAKDILVKLGLETKFDTMPNHLSGGQQQRVSIARALMNGGEILLCDEPTGALDSSSGVMV
MQILDSLHKDGHTIIVVTHDKDIAAWADRIIEIKDGNIISDTRKNSQIYELKQNLKEIKP
SLKAIRDQFFESFVMSLGAIKSHKLRSFLTMLGIIIGIASVICVVALAKGSQQKILSDIN
NMGTNTITIFPGKGFGDMHSGRVRSLSIDDSNLLGKLDFVDFSTPRMNTSGLLTYANQSF
SGSLRSGSEYSLAISGLKIEKGRDFTKDDIINSRSNIIIDQFTKDAFFKDVDPIGKVILF
NKQPFTIVGLVKRDETSFSGDNLTVYAPYTTTMNKLTGDRDIRSIMLKLKDGVNAQVAEQ
SIIEVLKIRRGSKDFFTRNSDTIRQTIESTMNTMSLLISGIALISLMVGGIGVMNIMLVS
VFERTKEIGIRMAIGAKSKDIMTQFLIEAILLCAIGGSIGIGLAYAIGYGFNVFGGDFKM
IFSTASIFIALGVSSLIGIVFGYIPARNASKLNPIDALLRE
>B8L3F5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQQGSSILSTFFLPPRVHAPSMSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARS
DFFNIVIQAGAIVAVVLVFRQRLLQLATGFNQRENRDYVFKLGAAFLVTAVVGLVVRKAG
WSLPETVTPVAWALIIGGVWMLLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSR
SASAIFLAMLLGLSRRAAAAEFVFLVGIPTMFAASAYTFLEMAKDGKLGSENWTDVGVAF
LAAAVTGFVVVKWLMGYIKSHRFTAFAIYRIALGAALLLWLPSGS
>A0A0Q4C2T2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLNFTAILLGIVEGLTEFLPVSSTGHLILATRLFGYDASQWATFNIVIQLGAILAVIVQ
FWRTFWAVGMGLLKFNPTSVRFVRNVLLAFIPSVILGLILKSHIEALLGNAEVVAWALIV
GGIAILGIEKIARPGPLTGVAELPVMQCLGIGFAQCLAMVPGVSRSGATIMSALAMGIER
RTAAEFSFFLAVPTMIGATTLELVSHRHELAAGLGPVGWTQIGIGFSVAFVVALVVIKAF
MAIVTRSGFAPFAWYRIIAGALALFLLSRV
>A0A0H3EUC9|FEATURES|UNIPROT_deepARG|beta_lactam|NRG857_30085|antibiotic inactivation|1
MSIQHFRVALIPFFSAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>R6DR64|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYILDVLKSILFGIIEGITEWLPISSTGHMILLEKICKFKEVSPNFFEMYLVVIQLGAII
AVVVMFWNKLWPFKKKQLENGKSKLAVKPRIIELWFKVIVGSIPAGIIGILFNDLLDKYL
YNYITVAITLIVYGVLFVAVEIINRKRRPKVTKLTEVSFKNAFFIGCFQALSLIPGTSRS
GSTILGGIMLGNSRRVASEFTFFLAVPAMLGASLIKIIKFGFGFTVTEFVILFVGMITAF
AVSLVVIRFLMNYIKNHTFTVFGIYRIVLGAIVLITYFATK
>W0EPL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLETIIIAIVEGLTEFLPVSSTGHMIITQSILGVESTPFVRAFTVIIQFGAILSVVCL
YWKRFFRLNRTPLPGNPSALRRFLHTYDFYWKLLVAFIPAAVFGLALGDWIDTLLENVVV
VAVMLVIGGIFMLFCDRIFNKGSDQTELTEKRAFYIGLFQCIAMIPGVSRSMATIVGGMT
QKLLRKAAAEFSFFLAVPTMFAAMGYKILKLFSEPEGADLIMSNMGTLLLGNVVAFVVAL
LAIKFFIGFVTRYGFKAFGWYRIIVGGVILVMLLMGHNLTIV
>E1VPA5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLLKTIVMALVEGITEFLPVSSTGHLIIAGDLLNFLDKEKRDVFEVAIQLAAILAI
CWEYRARLWNVARGVTHERSAQRFVGNLLIAFLPAAFLGLIFIKAIKEHLFSPVPVAIAL
IIGGFLILWAEKRKHTIRVLEVEDMTPLDALKIGCAQCLALIPGTSRSGATIIGGLFFGL
SRKAATEFSFFLAIPTMFAATLYDLIKHRALFSADDLGVLAVGSIFTFISSLFVVRGLIR
YVSNHDFTVFAWYRIGFGLLLIALTFSGAVTWAE
>A0A0M9C4C0|FEATURES|UNIPROT_deepARG|beta_lactam|ACX03_24505|antibiotic inactivation|1
MKKLFLLAGLMVCSTLSYASQLNEDISLIEQQTSSRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLSKNATAKVDERSIVVWSPVMDKLAGQNTRVEHACEAAML
MSDNTAANLVLNEIGGPKAVTMFLRSIGDKATRLDRLEPRLNEATPGDNRDTTTPNAMVN
TLRTLIEGETLSYESRVQLKIWMQDNKVSDSLMRSVLPTGWSIADRSGAGGHGSRGINAI
IWKENHRPVYISIYVTETELSLQARDQLIAQISQLILQKYKDN
>A0A0Q5P055|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDWLVAIILGIVEGITEFLPVSSTGHLVLATELLGFDAARWSVFNIAIQPGAILAIVVL
YWRTFLAVLQGLFRREPNSVAFVRNLLIAFLPAAVLGFAFNDRIEALLENATVIAWALIV
GGVAILIVERLAKTYKTGGIAGVSWFDSLRIGLVQCIAMIPGVSRSGATIMGAMTLGIER
RTAAEFSFFLALPTLTGATVLQMVKHRDAITADSLQLIGVGFVVSFIVALVVVKGFMALV
TRHGFAPFAWYRIVAGGVALIALNIH
>A0A0H1RD36|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLHSRLSPSLAAALLAYALGSLSTAFGAGSDQDAKVRQVVDDAMKPVIQQYGIPGLAVA
VTVGGTRHFIEYGLASNDPRVSVTRDTLFELGSISKTFTATLATYAEGEGKLSLNDPVSK
HMPELKGSALDDVRLLDLATHTAGGFPLQLPDNVKDQQQLIAYYRAWKPRFSPGTHRSYA
NPSIGLLGVIAAKTMEASFETLAERLFSELGLRRTYVNVPAAEMKSYAWGYNRDGRPVRV
SRALLANEAYGVKSNAVDMIRFLEVNMGIGTVPTRVARALKATHTGYFRSGELIQDLVWE
QYPYPVELEKIVAGNSMNMKAMPATAIDPPMAPREDMILNKTGSTNGFGAYVAFVPEKKV
GIVMLANKAYPNEARVEAALQVLSRLRE
>A0A0D8KN94|FEATURES|UNIPROT_deepARG|aminoglycoside|RP75_23205|antibiotic inactivation|1
MSGRFVIKDAAVSLDDWSLLRHRLWPDASFVEHRAELQNLSDNEVGFMAYDLAGVAIGFA
DVSLRHDYVNGCDTSPVAFLEGVYVEEAFRGQGVAAALIDEVTRWAISKGVSELASDADI
SNVDSHRMHAALGFEETERVVYFRKFLSSDS
>A0SKI7|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA7|antibiotic inactivation|1
MSEKVPAEISVQLSQALNVIGRHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAASLND
AVRQALLVDLLEVSASPGQNKALRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAG
IFEPATTDSDLAILLTKAKQHSVVLAGSAAKDLFSSVPESDLFKALADTLKLWNSPPDWA
GDERNVVLTLSRIWYTAATGKIAPKDVAATWAMARLPAQHQPILLNAKRAYLGQEEDYLP
ARADQVAALIKFVKYEAVKLLGASQ
>A0A0E3GXH3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSAGYEIAAVFTHADDPRENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEALLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVSIDRTDTGLSLHAKLRDAAATLLRDALP
QLAQGKLTETAQDESQATYFGRRTAADGKLDWKQPAATLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVIRFGQRNENGLYLAGPALADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVQMSETIGNTLDFFLREAMVEIA
QSIDEAK
>AAV58814|FEATURES|ARDB_deepARG|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPSTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYAQVKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>A0A0B0D6P8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIKGVNHFLFSVSDLERSIHFYQQVFGAKLLAKGKTTAYFDLNGLWLALNEEKEIPRNE
ISQSYTHIAFSIDEKDFDHAYKELVALNVNVLSGRKRDRRDKKSIYFTDPDGHKFEFHSG
TLQDRIDYYKEAKPYMDFYE
>A9W2S5|FEATURES|UNIPROT_deepARG|beta_lactam|Mext_1480|antibiotic inactivation|1
MRKRALAALVLSGLPLLPTPALATDPSGRVAAAVEQAYRPLLKAYDVPGIAVAVTREGHS
TVFTFGLADRERQRPVTRDTLFEIGSVSKTFTATLVSYAQGLGRLSLDDAPSRFLPSLRG
SALDRVSLLDLGTYSAGGLPLQFPDAVADEAAMIAYFRRWQPSAPPGTQRLYSNPSLGLF
GAAAAAAMGGDFAELMETRLFPGLGLKHSFIRVPASESERYAWGYGRDGAPIRVNPGVLD
GEAYGVKSSAADMILFVEAHLDPTRLDPPMRQAVQGTQIGYFRVGAMVQGLGWEQFPYPI
SLERLQAGNAEPMRFEAQPAARLDPPQRPTGVTLFDKTGSTNGFGAYVAFVPAKRIGLVM
LANRAFPMPARIAAAHAVLEALAAEEP
>A0A0W0ATB8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MELIYADARIDCASHGVGVTYIHHETHKMEKATTRSLLVLSTLLLSPLSHAKEAEPLTAV
VDGAIQPLLKEHRVPGMAVAVLKEGKAYYFNYGVADRESGARVSEQTLFEIGSVSKTLTA
TLGAYAAVKGGFQLEDKASQHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVDSTDKM
RAYYRQWTPAYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQV
PESAMANYAYGYSKEDKPVRVNPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAVVKSAI
ALTHTGFYSVGEMTQGLGWESYAYPVTEQTLLAGNSSAVIYNANPVKSVAKSQEMGGARL
YNKTGSTGGFGAYVAFVPAKGIGIVMLANRNYPNEARVKAAHAILSQLAE
>A0A099WW60|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQAIVLAIVEGLTEFLPVSSTGHMIIAEGIMGIESTSFVKAFTVMIQFGAILSVLVL
YRKRFFCFPVAPRALGQGKGVEFLSRFDLYWKLLIALVPAVILGFLFEDWVDRMLGSVWV
VAVVLFLGGIFMLFVDKLFASSDRELVTYPKALVIGLFQCLAIFLPGLSRSMATIVGGQQ
QKLSRKAAAEFSFFLAVPTMLGATLLKAYKLYKEGGIEIFREHMTVLLVGNIVAFIVALA
AIKFFIGFLTRYGFKAFGYYRILVGGLLIVLMLSGVSLAV
>A0A0K1M862|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
KLWTLATGLGQRDNRDYVLKIGVAFLVTALVGLIVRKAGWQLPETVQPVAWALLIGGLWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGSENWADVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRIVLGAALLLWLPALA
>A0A072SF63|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPSPRTPSVSTFRITDDKAGPYGIAAGPDGALWLTLVHRGSVARLALDGAFEEYALDAAG
CRPTVVAAGPDGALWFTRHQDHRIGRVTTDGEVTSFALPTADGGPYGITAGPDGALWFTE
TTGDRIGRITPGGEVTEFALPVAGGFPSAITTGPDGALWFTLNGANAIGRITVDGDTAVH
PLPTEAAGPVGIAADGRAVWFAEILAGQIGRILPDGRITEFPLPDRSAKPHAVVAAADGE
CWFTEWGAGRIGRVTETGEITEHALPDPSSEPHGITVGPDGALWTALETGGVARVERLP
>A0A0W0M8D7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLIGFGGERFEAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQRNAQRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
IGGVIMLWAERREHAVHAHSVDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWTAVKP
>J2NY32|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVIEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHKYLFNPITVASALV
VGGIIMLWAERRQHVVHAESVDDITWKEALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLVILATWQFGWVDWTAAKP
>ZP_02423658|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A0R1ICK5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFVKLNEPTAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNNVEKKQTWSIWFKVIVAILPSVIIGLPLNDWMDKHLTSWQVISA
TLLIYGILFIVVENWLKNKDPQTADLDSLSYKTAFQIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIFKYFKHGNTFTGDQTIILLVGTLVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIILAIIVIAYFGSKALMA
>A0A0R0DN07|FEATURES|UNIPROT_deepARG|aminoglycoside|ABB31_12140|antibiotic inactivation|1
MEAPRARMEGMPLPRAWQEALADARIEQQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGDEIARLRWLQAQGQPAPTVIATAEEEGRRWLLMSALPGHDLASSPALAPQHRVQLLA
DALRGLHALPVAACPFDQRLASRIEAAQARVEAGRVDADDFDDERLGQSAQQVFAELRAT
RPDHEDLVVSHGDACLPNLLAVEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDSRW
VAPLFRSYGVVPDERRLAFYRLLDEFF
>A0A0C1TUZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METIIFIIKSIILGIVEGITEFLPVSSTGHLVIFQNLIGFKGTSTNYVEMYTYVIQLGAI
LAVVILYWKKIKDTLVNFFPQKVGYEKSGFKFWFMIFIACIPGGFFGILLDDLAEQYLFT
PISVAITLFLGGIWMIYAEKKFRNNNAKNHELNVTPKQAILVGLFQCLAIIPGMSRSAST
IIGGWVAGLSTVAAAEFSFFLAIPVMVGMSFLKILKIGGISILTSPEIISLAVGFVVSFI
VALAVINKFISYLKKKPMKIFAIYRMIFAVVVLAAGFMGIF
>A0A0L6XWZ0|FEATURES|UNIPROT_deepARG|beta_lactam|AKG99_18240|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQLAQSRYWQISDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Q8RB29|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKMELLIKAFIMGIVEGLTEFLPISSTGHLIIVGSFIKFTGKFATMFEIVIQLGAILAVV
YYFKDKILSSLKALKPGEWGFNLWYKTFIAFLPAAIIGILTHHYIEEHLFSPFTVAIALI
VGAIMMIVIEDIFGKKYKIDNMDKVSTSKAFWIGVAQVMSLFPGMSRSASTIMGGMLVGL
SVRAAAEFSFFLAIPTMLAATGFELVKNITSMSLLEWEALAVGFIMSFITALIVVDKFLA
YLKRHVLKPFAYYRLLVGVLMLFLIAQKIVK
>V9WUV1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRLAALAAAITLTLGHSAAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARNHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGDASVLELGAYSADCLPLQFPDAVQTPQQVVDFFRHWQPRANPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLKQMGLGNTYLQVPASAQGLYAQGYDSADKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPEGLPPALAQATAITQRGYFQVGAMTQGLGWERYPYPVTL
GTLVDGNGPQLIREPQATTRLQPALPPLPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNYPNEARVRAAFDILSGL
>A0A127STZ5|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
VSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICRF
VNELQELINS
>J4JN58|FEATURES|UNIPROT_deepARG|beta_lactam|BURMUCF2_A0294|antibiotic inactivation|1
MTHSSQRRILLLAAATAPLALSLGACAARDAAVSDAASPVGASPASFAALERAAGGRLGV
CAIDAATGRRALYRADERFPFCSTFKAMLAAAVLAQSVAHPGLLQQRVTYGRSDLVNYSP
VTERHVDTGMTVAELCAATIQYSDNTAANELMKRIGGPAAVTAYARSIGDDTFRLDRWET
ELNTALPGDLRDTTTPAAMAASLRVLVLGDALPPAQRAQLIEWLRGNKVGDKRIRAGVPT
GWRVGDKTGTGDYGTTNDAGVLWPPSRAPIVLAVYYTQARADAKAKDEVIAAATRIAIAT
LA
>A0A059HPB7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLNNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGSYIF
DDYEVTQLNSDEKARLRREKIGFIFQRYNLLNLLSANDNVALPAVYAGKKVQERNFRAQE
LLGNLELEHKIESKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGIMVLEIL
KKLNTQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDSKKDKIVYQGQVKSMPKEKKTLT
LLKNQAFECLKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLDYLEAVDAHSNTSGVATYTNISLSARA
EGVGVNNFAIEGLKLQVGRILNNEDIETNANVAVLDFNAKKNLFPRQKSEDVLGRVVIFN
SQPFKIIGVLQKDTEKPIEDNVVRLYMPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AVIRILEIKRGQRDFFTFNSDTFKQAITANKRTTTILTASVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICSMGAILGVLLSVFVIFGFNTLSTDFPM
ILNAYSVLLGLLSSVLIGVIFGFFPARNAANLNPISALSKE
>W0A0I6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGQKPAPGHATLSLVHIILGMLPAVLIGLAIHSWIKAHLFGPETV
MYALVAGGILLIIAEKCRPAVTAETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRHAAAEFSFIMAVPMMMAASGLDLYKSRDFLSMADFPMFAVGFVTAFVVAMIAIK
TFLALIRRLDFIPFAIYRFVVAFAVYLVFVA
>ZP_02904358|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINHQLSRLLLCGILGSATLMSGCALIRKDSAPHQQLKPEQIKLANDIHLASSGWPQAQW
WKQFNDPQLDALIKRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSSVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSIQASDQMLDLLEQTHDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVEKQIAAVKGQITETREALRALTGAGASDMPEIKSTALPQVQTGIPATLPYDLLAR
RPDLQAMRWYVQASLNQVDAARALFYPSFDIKAFFGLDSIHLDTLFKNTSRQINFIPGLK
LPLFDGGRLNANLEGTRATSNMMIERYNQSVLNAVRDVAVNGTRLQTLNEEREMQAERVE
ATRFTQRAADAAYKRGLTSRLQATEAQLPVLSEEMALLMLDSRRVIQSIQLMKSLGGGYQ
AAPIVEKK
>ACB18769|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQ
LFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMA
RWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVLGL
SSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQT
GQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>B9KP84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVALVLGLLEGLTEFIPVSSTGHLLLAGHFLGFESAGRSFEVVIQLGAVLAVLTVYAAKL
VSVIRAAPHDPRAFRFLVAVLVAFLPAVVIGVLAHGFIKAVLFETPILIATMLILGGIVL
LFVDRMAPEPRYDDAMDLPLNVALKIGFIQCLAMVPGVSRSGATIVGGLMLGAGKRAAAE
FSFFLSMPTMAGAFAFDLFKNRDVLDASALGEIAVGFVAAFVAAVLVVRWLLGYVSRHGY
ALFGWWRIAVGSVALAALLAGY
>A0A0B3SJF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLQVLVLAIVQGVAELLPVSSSAHVIMAEKLMGLDPSAPEMTLLLVMLHTGTMLAVIV
YFWKSWRERYFSSKYDFIHNAKQVIIATAFTGVIGLALMFFIEKVLMRGTQHSEIEHLFG
NLYIISAGLAMAGILILISGTRRPPMGDRPMRAADSAWIGAVQGICLPFRGFSRSGSTIS
TGMMRGLDKVRVEEFSFALAVVLTPPVIVKEAYRLYKSGGAQSFSGHYMTVLTPSLVGMV
FSFLAGLVALRWLSRWLEHGRWYLFGIYCLVASAVVLAASQFL
>P86889|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MGSAMVLSMSLLGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMEL
PVWMVMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAAL
LYSVWELNAIIAIDVLGAVIASITVLIVRIPKLGDRVQSLDPNFIREMQEGMAVLRQNKG
LFALLLVGTLYMFVYMPINALFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGN
YQKRILLITASIFMMGISLTISGLLPQSGFFIFVVCSAIMGLSVPFYSGVQTALFQEKIK
PEYLGRVFSLTGSIMSLAMPIGL
>A0A157ZVI7|FEATURES|UNIPROT_deepARG|beta_lactam|AWB77_01135|antibiotic inactivation|1
MKLCAPRLLAAAIFSLSAMSGTAHASDASSIEATVDRTIEPLMTRNGIAGMAVGVVVDGK
PYVFDYGVASKATKQPVTRDTLFELGSISKTFTATLASYAQIEGDLSLNDPVSKYLPSLD
GAEFGKVTLLNLGTHTPGGLPLQVPDEVSDNDKLMQYFRTWRPSKPPGTIRTYANPGIGT
LGLITASSMKQDFDALMQTRLFPALGLKHSYMHVPATKERDYAQGYAKDDTPIRMKGGVL
SSEAYGVRTTASDMTRFLQINMNMVRIDPAFQRAVDATHTGYFQAGPMTQDLIWEQYPYP
VQLQSLLDGNAASMILNATPVTRIDPPEAPRDDVWINKTGSTNGFGAYIAFVPKARVGIV
MLANRNIPNEERVKAAYAIITSLTSAQ
>J3BZA2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYAEMGCAGISALLNAGYEISAIFTHSDTGTESHFFDSVARLAAEQGIPVYAPE
DVNHPLWVDRIKTMAPDYIFSFYYRALLNDSILSCAKLGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGDIVAQQRVAIDEQDNALTLHRKLVACATEVLNNALPGV
KRGDIVTTPQNESEATVVGRRTPEDGRIKWEAPAQTVNNLVRAVTYPWPGAFAFAGTVKF
VVWKSRVHNVDHHAKPGTVLSVEPFLIACGEGALEVMTGQSDNGVFMNGSQLAQNLGMVK
GALLYSQPVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVYGLDIGSDAISRFLDQP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDKHFDEDHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDI
QDGIEALFRIIENKQNNCDGQIVNIGNPDNEASIKELAERLLASFERHPLRSNFPPFAGF
REVESSSYYGKGYQDVEHRKPSIKNARRLLDWTPTVEMDTTIDNTLDFFLRTVELQDKP
>Q7N8A4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKRFSVLTGGLLLTASLGAQASNTADQTRLTNTVDKTIHSLMQEYDIPGMAIAVTFHGQ
HFFYQYGDASKESNTPVTKETIFELGSVSKTFTGSLISWAQVTGAISFSDKASQHFQPLA
GSAFDNINLLNIATYTAGGLPLQFPDEIDSNNKMVDWFQHWQPTYTPGTYRQYSNPSIGL
AGYIVAQRLEKPYSKLMENQILSPLGLHHTWFNVPAQEMKNYALGYSKENKPIRINPGVL
DEEAYGLKTSAQELISFVDANIDPSRVGDSKLAQAIRATHTGYYRVGEMTQGLGWELYHW
PVTLEQVLSGNSAQIAYQANKTTELALPEPPTDALFINKTGSTNGFGTYVAFVPQEQMGI
VLLANKNYPNEARIKAAWQILNALK
>A0A0W0RNQ5|FEATURES|UNIPROT_deepARG|beta_lactam|Lani_0856|antibiotic inactivation|1
MKKIIVFLFTGLLFCTTTYAQDRCFLAKENETVLKHEGGGCNQRYAPASTFKIALSLMGF
DSGILKDEKHPEWPYKKEYERSTVNVCSHSHTPRTWLRDSCVWYSQVLTKQLGMKRFKNY
VDAFHYGNQDVSGDKGQNNGLTHAWLSSSLAISPVEQIQFLQKIIDKKLPVRQKALNMTK
DILYIQELAGGWKLYGKTGTGLQLTTDKSQKLPLQHGWFLGWIEKNGRAISFVSHVTDSK
EKVSFASLRAKNDALIKLFYLINELEK
>A0A077PCP2|FEATURES|UNIPROT_deepARG|polymyxin|pbgP|antibiotic target alteration|0
MQSLKFFRSIEIVTFEKIKKVSVVIPVYNEEESLPQLLERTIAACQQLEQKYELILVDDG
SRDSSADILTQAAETPENHVIAILLNRNYGQHSAIMAGFHQADGDLVITLDADLQNPPEE
IPRLVKTAEEGYDVVGTRRANRQDSWFRKTASKIINAMITKATGRSMGDYGCMLRAYRRH
IVHAMLQCHERSTFIPILANTFARRTTEIDVTHAEREFGDSKYSFMKLINLMYDLLTCLT
TAPLRLLSVVGSIIAVTGFLLAVLLIALRLIFGSIWAAEGVFTLFAILFMFIGAQFVAMG
LLGEYVGRIYNDVRARPRYFIQKVVGVRKINDNQEKS
>A0A0M3E8B9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCLGVQAVLDAGYDIAAIFTHADNPGENTFFGSVSRLAAEAGIPVYAPD
DVNHPIWAERISQLAPDVIFSFYYRHLLSDAILEQAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGAIIGQQRVAISPDDTALTLHHKLCQTARQVLEQALPAI
KRRETRDVLQNESDATYFGRRTPEDSFLTWNRPATTLHNMVRAVAAPWPGAFSYSGTQKF
TIWSSRVHPQPQTAQPGTVISVVPLLIACSEGALEVVTGQAGNGITMQGAQLAQVLGLVA
GSRLNSPSLAASKRRTRVLILGVNGFIGNHLTERLLREDHYEIYGLDIGSDAIGRFLNHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
DGLRFTLFRPFNWMGPRLDSLNSARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENAGGRCDGEIINIGNPENEASIKELAEMLLESFDKHPLRHHFPPFAGL
RVVESSSYYGKGYQDVEHRKPNIRNAKRCLDWEPTIDMRETVDETLDFFLRSVDLTEHSS
>B9JZB6|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MEDQSIVSALLLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILA
VYIQKLLGIALSLPSNPKSRHFVLAVLVAFLPAAIIGALAHDFIKAVLFETPMLICVMLI
LGGVILLWVDRMTFKPRYTDVMDYPLSLALKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRNALSMDDGLLIGVGFLAAFISALFVVRGLLDF
VSRRGYAPFAWWRIAVGVVGLIGLLVWG
>A0A094ULT8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLQNEQIKKVSIVIPVYNEQESLPALIQRTSAACKLLSQPYEIILVDDGSSDNSAELLTA
AANEPDSGIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRVINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGAEQTENNQEVEK
>Q9RB37|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAVIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAVSLLIGGLILLKVDEW
FNNPNAAETSQKITYLQALKIGLFQCIAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATVKKCYDYYKAGFELSHDQVNILIIGNVVAFIVALLAIKTFISFLTKNGFKV
FGYYRIIAGIILLLIHFFIHPLTII
>U5F5T5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEILKAALYGILEGITEWLPVSSTGHMILFEEILPMKVSENFWNVFLVVIQLGAILAV
VLLYWNKIFPFNFKNKNRPFIRHDIMNLWGKILVACIPAAIVGIAFDDILEKYLYTSVVV
ATMLVLVGIAFLIIENRNRHKRARVTSLQELSYVDALKIGVFQLIAAIFPGTSRSGATIL
GGLMIGVSRTIAAEFTFFLAIPVMFGASLLKLLKFGLSFTGAELAILCTGMIVAFLVSVI
VIRFLMSYIKKHDFKIFGYYRIVLGVVVLACFFMGIIKM
>ABP35557|FEATURES|ARDB_deepARG|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAATPMLCSSNIVGLHKYWLEFAV
>N9PPK4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSRDAESRHFTFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVAFAL
IIGGLIIFWVESKNFDHKTTEATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIGVGFVAAFFSALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>A0A0L0H2U7|FEATURES|UNIPROT_deepARG|beta_lactam|GM31_01230|antibiotic inactivation|1
MQKMLNTALAVTALTLTTATFAAENTLTSAQIGKTVDTTIAPLLKAQAIPGMAVAVIYKG
QPYYYTYGKADIKQDRPVTRETLFELGSVSKTFAGVLGGDALSRGEISLSDPATKYWPEL
TGSQWKGITMLHLATYTAGGLPLQVPADAKDMASLLNFYQHWQPQWAPGTRRLYANSSIG
LFAALAVKPSGLSYEQALTERVLQPLKLTHTWVNVPQQDAKNYAWGYRDGQPVRLTPGML
NAEAVGLKSSVVDIASWLQANMNPQQLEDRTLSNAISLAQSRYWRIGSMYQGLGWEMLNW
PVKADTVINGSDNKVALAPLPAVAIEPPAPRVAASWVHKTGSTNGFGAYVAFIPEKQLGI
VMLANKAYPNTERVKAGYAILKALQ
>R5VR46|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MALSFIEILKVVFLGIVEGITEWLPISSTGHMLLVDEFITLDASDSFKDMFFVIIQLGAI
LAVVTIFWNKMWPFQMKDKTQSVFKKDTWSMWFKTVVACIPGAVVTLLFDDFIEDHLHTA
VVISIALIFYGIAFIVIENWNKTRTPKVETLNDITYKTAFFIGMFQVLSIIPGTSRSGAT
IIGALLLGVSRVAAAEFTFFLAVPVMFGLSALKLIKFGLSFTGAELAILIIGCVVAYLVS
IVVIKFLMGYIKKHDFKIFGWYRIVLGVIVLLYFAFFA
>G4CR43|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLFKALILGIIEGLTEFLPISSTGHLIVFGNLMDFKSNGKVFEIAIQLGAVLAVIF
EYRIRFKHVVNYVGKDRTVNRFVVNLIIAFIPAAIVGFLFSKQIKAVLFNPISVATMLVL
GGFFILWVEKRAKSHPPKVTSVDDMSPKDALIVGLAQICALVPGTSRSGSTIMGGMLWGL
DRKVATEFSFFLAVPVMIMATTYDILKNYKLFSLQDIGLIVVGFVAAFVAGLLAVKALLK
FVSAKNYVPFAYYRIIFGGLILLTWQMGWVHWTLD
>A0A127SRG6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>E6WIX3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLEETPIRKVSVVIPVYNEEESLPELVRRTHTACDLLNLEYEILLVDDGSSDRSGEMIAD
AADMPGSHVVGVLLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPNLVAAAQQG
YDVVGTVRQNRQDSWFRRRASRLINKLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARRTIELPVKHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVVG
SVIALAGFAFSLILIVLRLFLGAAWAGDGVFVLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVIHPHKNASVQEIEQ
>A0A066TG69|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLLEIKNINRWFGHGENRVQVLKDINLSIEKGDFVAIIGQSGSGKSTLMNIIGCLDVPS
SGSYRIDGVETAAMTADEQAALRRRSFGFIFQRYNLLSSLTARENVALPAVYAGMEHGER
LKRADELLAQLGLAGKEANRPSELSGGQQQRVSIARALMNGGEIILADEPTGALDTGSGQ
NVMEILHKLHDAGHTIVMVTHDPTIAANANRVIEIRDGRIIADHSKNTSMRPSKIESIAE
HNSWHFYRDQLFESFRMSIQAIMAHKMRSFLTMLGIIIGIASVVSVVALGRGSQAKILEN
INAMGTNTVSVYPGYGFGDRRSSRIKTLTVGDAEVLRQQDYVDSVTPGVSSSGTLTYANQ
SLSAQMYGVGDQYFDVRGIKIAVGRLFNEDDVTQNSQVVVIDDNTKNKLFADGTNPLGQV
ILFNKRPLRVIGVTAPNNNGFMDSDSLQLYTPYTTLMNRISGSKYITSVTVKVKDNVNSQ
TAEIGIIELLKARHGAEDFFTRNSDTIKQTIESTTGTMTLLISSIALISLVVGGIGVMNI
MLVSVTERVKEIGIRMAIGARQHNILEQFLIEAVLICLIGGVVGVLFSFSISMLFNLVAN
DFAMSFSPLSIVMAVLCSSVIGVLFGFMPAKRASQLNPIDALSRD
>ABR13270|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKEAQQGAQQVPEVGVVTLKSEPLQMTTELPGRT
SAYRIAEVRPQVSGIILKRNFTEGGDVKAGESLYQIDPATYQASYESAKGDLAKAEAAAK
ISQLTLNRYKKLLGTQYISQQDYDSALADAQQANAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSAVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVELVTNDGIKFSQTGTLEFSDVTVDQTTGSITIRAIFPNPDKTLLPGMFVRARLEEG
TNPSAILVPQQGVTRTPRGDASALVVGADNKVETRNITATQAIGDKWLVTEGLKDGDRVI
ITGLQKVRPGAQVKAQEVKSDDKQQASAAGQSEQTKS
>A0A0M4FF82|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTALEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>E5AZX0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRAEIKK
>A0A0Q8JJQ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENTLYLIKAFILGILEGLTEFIPVSSTGHLILVGDWLNFDSGDGKVFEVVIQLGSILA
VMWVFRARLLQLIRGTLTGVPSEVAFTRNLILAFLPAAVIGAIFIKTIKSVFYHPAVVVV
TLVLGGLIMLYVERRTRHTPGDAPGAADDTASDERASAHTLEQITWKQALGVGVAQCFAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAAYDMYKNFGLLTQHDLSGIA
VGFVAAFLSAMVVVRAVLRFVANHTYRVFAWYRIIFGGVVAAWIFTR
>I6YPP4|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLSLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>S7HGJ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDYIIAVILGIVEGVTEYLPVSSTGHMILVGDMLGFTGPRASVFEVFIQLGAILSVIVI
YKEKFIRMLHQYRCWDLFRRENWFRTDTGLTLAHVAAGIVPVMGIGYLAHHAIKTYLFSA
GTVIIGLIIGGIFMLVAEKSHTKTVCNDVEKMTIAQAFLTGMFQILALWPGFSRSGSTIA
GGLFLGLSRKAAADFSFIIAVPVMIVACFYDLLKSLSDLSGNDLVMIVIGFITAFIVAYI
SVLWFLKFMNKSTLASFAYYRFVVAVISFVYFFIL
>A0A083ZNT1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLVSIAVAMPTSAKARRFVLAVLVAFLPAAVIGALAHDFIKTVLFETPMLICVVLI
IGGFILLAVDRMPLKPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGALLMGTD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRDALSFDDSALIAVGFVAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGALGLVALLVIG
>A0A0G8BZK7|FEATURES|UNIPROT_deepARG|beta_lactam|B4147_2161|antibiotic inactivation|1
MKGMMILKNKRMLKIGVCVGILGLSLTSLEAFKGGTLQVEAKEKTGPVKHNNHAMYKDFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPVHKRNILTGWMKGNATG
DKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVCPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALR
>A0A0E2N5C5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVLGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
VGGVVLLVVDRMKLQPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFIAAFVTALIVVRFLLDY
VSRNGYSLFGWWRLVVGTVGLVALMIWG
>A0A0E2UD77|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFVELLKAIFYGIVEGITEWLPISSTGHLILVEEFVKLNQSAAFMEMFNVVIQLGAILA
VIVIYFNRLNPFQPGKSKQEVQLTWQLWAKVIVAILPVVIIGLPFDNWFNAHFYNFITVA
LMLIVYGVAFIWVEKQHKNVEPEVTSLAKMSYKTALFIGLFQVLSIIPGTSRSGATILGG
IIMGTSRTVATEFTFFLGIPVMFGASLLKVLKFFLKGNVLGFGSILILLVASLTAFLVSL
LAIKFLTDYVKKHDFTAFGKYRIGLGIILVIYFIFTLIF
>A0A124PV48|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRERIVSVVCGLPSRPDARRFTLNVVIATIPAIALGLLLEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVQSVDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRFVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0Q7CI15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAAVMGIVEGLTEFLPISSTGHLILAGSLLGFDDDKAKVFDIAIQTGAIFAVI
LVYWHKIKSTVVALPRQPKAQRLALNIFIGFLPAVVLGLLFGKAIKAHLFIPIVVASTFI
IGGFIILWAEKRPPGSVRVEHVDDMSPWDALKVGLVQCFAMIPGTSRSGSTIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGVYSLYKERALLSMADLPLFAVGLVFSFISAWLCVRWLLK
YISTHNFIPFAWYRIAFGVVVLATAWSGAVVWAE
>NP_459843|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAAL
AAIAFFGLQRAMTETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIA
QSPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLI
IAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNLQTV
>A0A158EVM2|FEATURES|UNIPROT_deepARG|beta_lactam|AWB71_00260|antibiotic inactivation|1
MKFCTLSFLATAIFSFGAMPAAAHAADIDDAKIKATVDDTIKPLMALHGIAGMAVGVVVQ
GKPYVFDYGVASKETKQPVTRDTLFELGSVSKTFTATLASYAQLEGDLSLNDPVSKHLPS
LAGSEFGKVTLLNLGTHTPGGLPLQVPDDVHDNAQLMQYFKTWRPAQPPGTIRTYANPGI
GTLGLITAQSMRQDFDALMQTRLFPALGLKHSYMDVPTARARDYAQGYAKNDAPIRMKGG
VLSSEAYGVRSTAADMTRYLQINMNMVRIDPTFQRAVDATHTGYFHAGPMTQDLIWEQYP
YPVALQSLIDGNAQSMIMNATPVTAIDPPQAPRDDVWINKTGSTNGFGTYIAFVPKERVG
IVMLANRNIPNEERVKAAYAIITSLIGGR
>A0A023E1Z7|FEATURES|UNIPROT_deepARG|beta_lactam|ASA01S_002_00950|antibiotic inactivation|1
MSRILLPGLLAAGLIFSLPASAASGCMLFADGTGKPISSQGDCSSQLPPASTFKIPLALM
GYDSGFLVDENLPALPFKPGDDDWLPAWRETTTPSRWLTYSVVWYSQRLTEWLGMERFQQ
YVDRFDYGNRDLAGNPGKHDGLTQAWLSSSLAISPQEQARFLGKMVSGKLPVSTQTLQHT
ANILRQPDIDGWQIHGKTGMGYPKLLDGTLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVFAALPDQLKKL
>C4I6V9|FEATURES|UNIPROT_deepARG|aminoglycoside|GBP346_B3039|antibiotic inactivation|1
MTHPAALFKIRAAQASDAAAWRQLRRALWPHADDIEHARDIARQLDAPARHACFIASPPG
ILAPVGFAEVAVRHDHVNGCGASPVLFLEGVFVEPAARRRGVARALCAAAAAWGTARGCA
AFASDAPLENAASHALHRALGFDGTERVVFFRKPLAR
>A0A0B1U8D9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESLAAVVLGLVEGVTEFLPVSSTGHLILVGHLIGFTGEKADSFDIIIQLGAILAVVCL
YWRRFWWLVSPKPLHAFSGLRGLWMLFLTSLPAGIVGLLARKTIKTHLFGPTTVALALAV
GALMIFWVERRKKRDRFYSLDEMTPRLALGIGCFQCLSLWPGFSRSAATIMGGMLLGAKR
GLAAEYSFIAAVPLMFAATLYDFYKSADLFSADDLGILAIGFVVSFVAALAAVKGFIVLV
KRVSLRPFAWYRLALAAAVFFLWPK
>B6IW85|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDTVPYLEALLLGIVEGLTEFLPVSSTGHLILVAEFLGFQGQEQDVFKVVIQLGAILAI
LVVYFAKLWRVLLGVLARDPAAWRFAGAILLAFLPAAVIGAAAHGFIKSVLFSPLVVSVA
LIVGGFAIIAVERLVPASRWHAVEEFPPLLALKIGLVQCLALVPGVSRSGATILGALMMG
VDRRTAAEFSFFVAIPTMLGASVYDVYKNMDVMTLDGVGLIAVGFAAAFVSALLVVRTLV
DFVARYGFTPFAWYRIAVGSAMLVWFGLLAG
>A0A0M2N221|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHLLINAFILGVVEGVTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
VMFWRRLFGLIGIHFGQPPVHEGKTQGHLTLGHILLAMIPAVVLGLVFHDAIKTLFAPRT
VVYALVVGGFLLLAAEWLKPKQPRAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRFAASEFSFILAVPMMMGATALELYKSLPFLSMADLPMFAVGFGTAFIVALIA
IKTFLSVIKRISFVPFAIYRFIVAAVVYMVFL
>A0A094SB23|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKKSIINTLVFTTIAISPLYTSAQTILTQQQVATIVNKTLKPLLEQQNIPGMAVAVFYD
GKPQFFNYGVADIKAGIPVTENTLFELGSVSKTFTGIAGEYAVQTGIMDLNDPVTKYAPE
LTGRQWQGVKMRHLATYTAGGLPLQLPDSVTDQESLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKKSPLTFENYMKEHVFQPLKLTHTFITVPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTSKDMVRFMQANMDPDHLSAENDTLKKAIIAAQSRYFQAEDLFQGLGWEM
YNWPIDPQKVIADSGNDIALKPRKVVELLPPQPATPASWVHKTGATNGFGAYIVFIPEQK
IGIVMLANKNYPNPVRVQAAYNILQALR
>A0A0M3GYR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIGFHSNHKVFEIAIQLGAVLAVVF
EYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLFDKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIADVDALRPIDALMIGVAQVFALVPGTSRSGSTVMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFIAAFVSGLVAVKALLK
FVSKKNYIPFAYYRIVFGIVIIILWLSGWISWE
>A0A0B0IGG9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSITGLNHFLFSVSNLEKSIKFYQEVFDAKLLVKGKSTAYFDLNGIWLALNEEPDIPRNE
ISESYTHVAFSIKEEQFDEIFSKLKQLNVTILSGRQRDIKDKKSIYFTDLDGHKFEFHTG
TLQDRIDYYKAEKHHMEFFDI
>D2QH85|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELIHAIALAIIEGLTEFLPVSSTGHMIIYSSLAGIAGNEFTKLYTVDVQFGCILSVLVM
YHRRFMTDTRTGTFVVPSYLKSLPVRLQPMADFYSKILIAFLPAAIIGFLLNDFIDSLLE
SITTVAISLLVGGIVLVFIDRIINRQPKDGEVTVPDAIRIGFFQCIAMIPGVSRSAATII
GGMYQGLSRTQAAEFSFFLAVPTMAAASGYKLLKTYKLIQPADYQTLLIGNAIAFVVGLL
AIRGFVGFLNKYGFKVFGYYRIALGLLLLGLMAAGVKLDVL
>C7BHM1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFEQIKKVSIVIPVYNEEESLPLLLERTLSACKQLTQDYELILVDDGSSDKSAEILVQA
AEQPENHIIAILLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVETAEQGY
DVVGTRRANRQDSLFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIIEAMLQCHERS
TFIPILANTFARKTIEIDVAHAEREFGDSKYNFMKLINLMYDLLTCLTTAPLRLLSVIGS
VIAVSGFLLAVLLVVLRLIFGAIWAADGVFTLFAILFMFIGAQFIAMGLLGEYIGRIYND
VRARPRYFIQKVVGNKKTNDNQEEY
>U2EVJ3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MISLKNITKSFKLGDNEIEILHGINLEIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSGG
QYLLDGKDISKFDSDALAKLRRDKFGFIFQRYNLLSTMNALENVALPSIYAGANKSEREK
RANELLGSLGLSEKAKNLPNKLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGLRV
MEILVDLYKNGHTIIIVTHDPKIAEYASRVIEIKDGNIVSDNVKNSEIYEASKQTQPEKS
KFTYYKDQLIESFKMSVNAMLAHKLRSLLTMLGIIIGITAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMLSGKVKTLSISDANMLAKQSFLDSVTPNTSTSGVLTYENISL
SASLKGGGVGSFDVNGLKLEEGRIYDDDEVLNSASVALIDQNTKNSIFKNDDPIGKIILF
NKKPLRIIGVLQKDDFKMGDSSTLKIYAPYTTVLNKVTGDKFISSVTAKVNEGVNAQIAE
KTLTELLEIKHGKKDFFTRNSDSIKQTIEETISTMRLLISSIAVVSLVVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIVLSYAIGYIFNNFLNGFS
MIFSNGSIVLALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>A0A0R1UNZ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAAILGIIEGITEFLPISSTGHLYLADEFIKLHESTAFINMFMVVIQLGAILAVV
VLYFGKLNPWAPHKNQLERHQTWTLWFKVILAVLPSVIVGLPLNDWMEAHLTSWQVIATT
LIVYGILFIVIETYNRRTTARFTDLNQLPFKIAILIGLFQILSMVPGTSRSGATILGGIL
IGTSRFVATEFSFFLAIPTMFGASLLKLLKYFLHGNTFTGSQTLVLLTGTVVSFAVAYLA
IKFLLNYIRHNDFKGFGWYRIGLGVIVIAYFGLIHA
>A0A0P9S0W1|FEATURES|UNIPROT_deepARG|polymyxin|ALO68_05557|antibiotic target alteration|0
MVGGAHRQAGPGFHFFLLLPPASRRCVTGLRKKSALNLHGSLLPRYRGRAPANWVLVNGE
SETGVTLHQMVKRADAGPILAQQRVSISATDTALTLHGKLREAAADLLGETLPLLAHGQL
SGTPQDEALATCFGRRTPADGLIDWALPATQLYNLIRAATQPYPGAFYPVGENRLIVWAA
RVEARSAGDRPGTVISQDPLRIACGEGSLVIDAGQRGDNGLYLSGAQLAREFGLVQGSQL
IDTEKRHPARRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLRTKPNFHF
IEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRYCVKYN
KRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQKGLQF
TLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVADGIE
ALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFAGFREVES
QSFYGKGYQDVSHRKPSVDNARHLIGWTPGIDLGETIGKTLDFFLREAMAEKAGQR
>ZP_04631861|FEATURES|ARDB_deepARG|polymyxin|rosB|antibiotic efflux|0
MGTLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKD
LLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMAGFVFGLCLSTASTVVLLRALEERQ
LIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFI
TLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMV
LNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILVHEPLAVVASLAIIIIGKSAAA
FILVRLFGHSKRTALTISVSLAQIGEFAFILAGLGISLGLMSEHSRNLVLAGAILSIMLN
PLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPVDLCNHALLVGYGRVGSLLGAKLHAEG
IPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCARWLLLTIPNGYEAGEIVA
SARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIANSMLNMLKIETLTEEDKRPL
CPI
>A0A0G2NPP2|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTAACESLGKAWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEESHQ
>D6EH62|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNEINESYDTDSVREFTVSDADAGPYALAEGPDGALWFTLVHRGAVARRDPDDGRVTVHP
VGDGPTVIAPGPDGALWFTEYRAHRIGRITPEGHYASFAPLTPEGGPFGITAGPDGAMWF
TLSSADRVGRVTMDGEVTEHPAPGAFPSALTAGPDGALWCTLNQGNAIGRLTPEGHGTAY
PLPTPGAAPVGIAAGPDGALWFTEIGAGRIGRITVTGDLTEYPLSDPAARPHAVTAGPDG
ALWFTEWGSGRVGRITVDGRVTSYPLSRTDCEPHGIAVHDGALWCALETGSLARIQVPA
>A0A023YZW6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADKG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREYGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A127SWZ0|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMACWVRSNMNPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>A0A022PIW0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVAEFIPCYLFRIFINGRLLYMTDLSTLFHAAILGVVEGLTEFLPVSSTGHMIIVGHMLG
FTGDKAETFEVIIQLGSILAVVVVFWRRLFGLIGIHFGDVPHEGKTNGKLKLSHIILAML
PAVTLGLLFHDVIKSLFNPQSVMYALVIGGVLLITAEILKPKTPRAEGLDDITYRQAFMI
GCFQCLALWPGFSRSGATISGGMLMGVNRYTASEFSFILAVPMMMGASGLDLYKSLHFLS
ASDIPMFAVGFITAFVVALVAIKTFLALIKRISFIPFAIYRFIVAAAVYWVFM
>YP_312412|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MIMKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMAR
TLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFS
MARWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMN
VWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>ZP_03044758|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVFRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTESRFIWRAVPIQLVGLALLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEER
>G2DKH5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MDLIECKHINRYFGSGENRVHVLKDVSLSIKKGDFVAIIGQSGSGKSTLMNILGCLDAAS
SGSYRIDGIETAQMQPDELAGLRRQRFGFIFQRYNLLNSLNARDNVALPAVYAGMPPSRR
VERAEKLLHDFGLAGKENNRPNELSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
NVMEVIHGLHRQGHTVIMVTHDPKIAAHANRVIEISDGRIIADNSKADVEKMGVRHGLNE
EPSWSFYYDQFVEALKMSVQAVVAHKMRSLLTMLGIIIGIAAVVSVVALGKGSQEKILSD
INAMGTNTISIYPGRGFGDRRSMRIKTLTIEDAQVLAQQAYVENVTPQTSSGGTLTYRNT
DLSARLYGVGSEYFDVRGLKLESGRLFDADNVKEDAQVVVIDQNTKNKLFGEGEDPLGKV
VLFRKRPLLVVGVLQPENNMFGGGSDTLQLFAPYTTVMHQITGESHTNTIIVRIKDDADS
AAAESGLTELLTARHGTKDFFMQSSDSIKQTVESTTGTMTLLISSIALISLVVGGIGVMN
IMLVSVTERTKEIGVRMAIGARRSNILQQFLIEAVLICLIGGLAGILLSAGISVLFNQFV
TDFAMRLSVWSVLGAVACSTLIGVVFGFMPADRASRLNPIEALAHD
>N2B1Y2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEALKVIILGIVEGITEWLPISSTGHLILVEEFIKLEQSEAFIEMFNVVIQLGAILAVV
VIYFHKLNPFSPKKTEKQKMLTIQLWVKVAIAAVPAAVIGLLFDDMIEAKFMNAYVVAAT
LIIYGILFIVVEESHKNKQPAVTKLSKLTIPMVLVIGGFQVLALIPGTSRSGATIIGALL
IGTARGVAAEFTFFLGIPVMFGASFLKILKFFKEGGGIMGSEVLLLLLGCGISFGVSVFA
IKFLMQYIKNHDFKVFGYYRIALGVIVLAYFGIAGLLAA
>ZP_04091529|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEKMKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKN
VWVHTELGYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVII
THAHADRIGGIKTLKERGIKAHSTTLTAELAKENGYEEPLGDLQAITKLKFGNMKVETFY
PGKGHTEDNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENIN
FVVPGHGEVGDKGLLLHTLDLLK
>NP_836133|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWLNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSTPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHTVDHH
>A0A0H4SHU7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
LCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHYYTFGK
ADIAANKPVTPQTLFELGSISKTFTGVLGGDALARGEISLDDPVTKYWPELTGKQWQGIR
MLDLATYTAGGLPLQVPDEVTDDASLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKP
SGMRYEQAMTERVFKPLALHHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAQAYGVKT
NVQDMANWVMANMAPENVADASLKQGITLAQSRYWRIGSMYQGLGWEMLNWPVEAKTVVE
GSDSKVALAALPAVEINPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYP
NPARVEAA
>A0A136D006|FEATURES|UNIPROT_deepARG|chloramphenicol|ACS92_14845|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCTFSMTVNVDITMLLEEVYQKGVKFYPVFIYLISKV
VNNHKEFRTSFNDEGALGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMR
YYASVHGLFTKENTPPNVFPISSIPWTSFTGFNLNISNDADYLLPIITCGKYFNEKNKVM
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>YP_002236547|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLTGFSAMSQAENLLQVYQQARISNPDLRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYNNGYRDSNGINSNVTSGSLQLTQVLFDMSKWRALTLQEKTAGIQDV
TYQTDQQTLILNTATAYFKVLAAIDTLSYTEAQKQAIYRQLDQTTQRFNVGLVAITDVQN
ARSQYDAVLANEVTARNDLDNAVEGLRQVTGNYYPELASLNVNGFKTNKPQAVNALLKEA
ENRNLSLLQARLSQDLAREQIRQAQDGHLPTLNLSASTGVSNTRYNGSKTNTPLAYNDSD
VGQNQIGLNFSLPLYQGGAVTSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNVNASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQQLSNARYNYLINEL
NIKSALGTLNEQDLVALNNTLGKPIPTSADSVAPENPQQDATADGYGNTTAAVKPASART
TQSSGSNPFRQ
>CAG34250|FEATURES|ARDB_deepARG|multidrug|smeE|antibiotic efflux|1
MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDS
VTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQ
EVQRQGINVAKSSSGFLNVIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGG
KYAMRIWLDPNKLHTYGLSVAEVTAAIKAQNAQVAIGQLGGAPSIKGQQLNATINAQSRL
QTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANAL
DTAAGVDAALQDMKSFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIM
SEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMAL
SVLVAIVLTPALCATMLKPLKKGEHHVAHKGWSGRFFNGFNRGFDRTSESYQRGVRGIIH
RPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALEN
HFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDANNGVMPITGRAMAALGQ
IKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRP
NGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQP
FRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASG
DAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVP
TAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGAS
LIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGV
FFVPLFFVVVQRVFKRKSTT
>AAC64521|FEATURES|ARDB_deepARG|multidrug|amrA|antibiotic efflux|1
MHIQWTGSLRGLLAALVALFLLGCEEAADAGKTAEAPAEVGVIVARPAPIGITSELPGRL
EAYRQAEVRARVAGIVTRRLYEEGQDVRAGTVLFQMDPCALKAALDISRGALARAEGNQP
AAAEKFKRYAELIQDRAISEREYTEAQTDARQPLAQIASGQGRTGAGPPAPWYATVTAPI
DGRARRALVTEGALVGEDSPTPLTRVEQIDPIYVNFSQPAGEVAAMQRAIREGQVKGVAD
KDIAVRLVLADGSEYPLAGELLFSRLAVDPGTDTIAMRALFRNPHRELLPGGYVQVRLQR
AVNPQAITVPRDALIRTAQSAVVKVVNPKGLVEDVEVRADTLQGRDWIISRGLKGGEWVI
VENAAQHAAGSSVQAVVRQPASADAPSPLAASPAGQ
>A0A0W0V3L1|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1|antibiotic inactivation|1
MNNEMQQQIQQCFDLIKAILNNDLLGVYLFGSSIAGGLQKYSDIDLLVISNRSTTHDEKA
KFVKNLLEISGIYMKGERFPIEMTIIEKSQVSPWHYPPIFDFQYGEWLRSQFNDGIIEPW
GSNEMPDLAIMITQVLLASKTLYGANPHEILCKVPYTDYMLATLDALPSLMADIDTDTRN
VLLTLARIWRTVETDTISSKPAAASWSIKQLPQEYILVMHRAKAICIGEEKEYWDDIKAL
IKPCADFISDKINFKLARINLSENTYKSINMLNE
>A0A0T9T6M3|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MVFNIAVFLVSIIWHWVSLMTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFT
GDKAKTFEVIIQLGSILAVVVVFWRRLFGLIGIHFGATPHEGKSSGHLTLGHILLAMLPA
VGLGLVFHNAIKSLFNPHSVMYALVAGGLLLLAAEWFKPKNPKAVGLDDITYRQAFAIGC
FQCLALWPGFSRSGATISGGMLVGVNRYAASEFSFILAVPMMMGASGLDLYKSLHFLTLG
DLPMFAVGFTTAFIVALIAIKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>A0A0B1R3B0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGITALLNAGFEISAIFTHADSSGENNFFGSVARLAAEQGIPVYAPE
DANHPLWVDRIKTMAPDYIFSFYYRNLLNDNILSSARLGAFNLHGSLLPKYRGRAPLNWA
LVNGEKETGVTLHRMVKRADAGDIVAQQRVAIEEQDNALTLHRKLVTCASQVLEQALPAM
KRGEIAATPQDHSQATVVGRRTPEDGRIKWEQPAQTINNLVRAVTDPWPGAFAFAGTVKF
VVWKGRVHADAPAAKPGTVLSVEPFLIACGEGALEVVTGQSENGVYMNGTQLAQSLGMVP
GALLYSQPVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVYGLDIGSDAISRFLDQP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDKHFDEDHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDI
RDGIEALFRIIENKGNNCDGQIVNIGNPDNEASIKELAERLLASFERHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPAIKNARRLLDWTPTVEMDTTIDNTLDFFLRTVELQDKP
>A0A117M1S3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIWQAMILGFTQGITELLPISSSGHLVILQNWLQIYPTPIIFDLYLHLISIVVIVYYFR
HTLLSIDRDLIIKLSIATVPLVLLGFLLRNSIDTLFNSSLVAGVGLLISSLFNFWAAKNF
LKENTSQDITNAKAGYIGVFQAVALFPGISRSGSTLFGSSLTRLDKKKAFEFSFLMAILA
IFAASAGQLILDGTNNLPQISATHWSAYLLGGLVCFITSLASLKLLKLTLQKTKYHLFGW
YCLLMGLLTLALYFA
>A0A0C3EDB5|FEATURES|UNIPROT_deepARG|beta_lactam|SU60_01350|antibiotic inactivation|1
MKKLFLLMGLLVYSSASLATHLNENISNIEQQISGRIGVSIWDTQNDSHWDYRGDERFPL
TGTAKTLACATMLESMDTGQLDKNATSKLVKENMVMWSPVMEKMTGESVRVEHACEAAML
MSDNTAANLVLSSVGGPDAVNLFLRRVGDNTTRLDRQEPEINEAKPGDVRDTTTPNAMVN
TLESLLEGKVLAYESRLQLRIWMQDNKVSNALIRSVLPQGWSIADRSGQGGHGSRSVNAV
IWKEDHKPIYITIYVTDTELSLQARDQLVAQISQLILEPYKNI
>A0A0H3FJU3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
VVVFWRRLFGLIGIHFGRPPMHEGEGSGRLSLIHILLGMIPAVVLGLVFHDLIKSLFNPV
NVMYALIVGGFLLIAAELFKPKEPRAVGIDDMTYGQAFAIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSIGFLNTGDIPMFAVGFIMAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>B3QPP3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIEVVDITKSYTIGESSVHALQGVSLTIAQGEFVAIMGASGSGKSTLMHILGMLDVPDSG
QYRLMGKDVGKLNGDELATLRNNVAGFVFQQFHLLGRMSTIDNVMLPCIYSDERRDFRSD
ALARLEMVGLGHRADHRPNQMSGGEQQRVAIARALIRDPMLIFADEPTGNLDTKNSHEIM
RILTELHQQGKTIIMVTHEHDIAAYADRVITMQDGKIIDDRKKEDAGRRSEVSGEPMKLD
HQPLFKPSRMLGFVKQAFRSIAANKIRTLLSVLGILVGVASVIAMMALGSGARASMEERL
KSMGSNLLSVRGGSAKIRGSAQGSGTFTRFTRQDVEAIAEFSPLVRYASGYVTGTAQMVY
LNRNWSSTVEGVGIEYGKMRSTIPTIGRWFTSDEIRSRRKVAIIGTTVASELFGNDDPVG
QTIKINRINFRVIGILPPKGFAGHRDQDDAVLVPVTTAMHRLLGRDYLNSIYVEVTSADR
LDAAKEAIDALVRKRHKLQPNDEDSFYIRDMTEFQQMLSATTETMSMLLGSIAAISLVVG
GIGIMNIMLVSVTERTREIGLRKAIGARRGDIMLQFLIESVGMTLTGGLIGIAVGVGVSV
MLSTFAGWAVQTSIFSVVLATGFSVLIGLFFGLWPAKKAAGLKPVEALRYE
>A0A0U2ZT72|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
MCSTSKVMAAAAVLKKSESEPNLLNRRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
QYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMA
QTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNHIA
>U1WVJ9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHNHEVYSSVMRKYTTLLIGFLAGSAIIPAGGALAAGTINDDELRRIVDETVRPLMAGQK
IPGMGVAISIDGKSRFFGYGVASKESGQKVDEDTIFEIGSISKTFTATLGGYGLATGAFS
PSDPATRWAPELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFRKWKPDYRA
GTQRRYSNPSIGLFGYLAARSMGQPFDVLMEQKLLPAFGLKNTFVHVPESRMKDYAYGYA
KADKPTRVASGTRDAEAYGIKTTAPDLLRFVELNIDSASLAPDFQKAVAATHTGYYRVGA
NNQGLGWEIYTYPVTLKTLLAGNSSDMALKSHKIEKFDPPHAPSADMFINKTGSTKGFGA
YAAFVPAKKTGIVLLANRNYPNDERIKAAYRILQAIDKSE
>A0A0L2R4H7|FEATURES|UNIPROT_deepARG|aminoglycoside|AEV26_02385|antibiotic inactivation|1
MDIRQMNKTNLEHWRGLRKQLWPGHPDDAHLADGEEILQADYLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGANKGCREMASDTTPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A0Q4ENQ7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNSKAVVFAYHDIGCAGIEALLTAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDFIFSFYYRNLLSEALLATAKKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVIIDRTDTGLTLHAKLRDAATHLLRDALP
QLAQGKLAETAQNESQATYFGRRTVADGKLDWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEIYGLDIGSDAIERLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLKEAMLEIA
DKK
>W6M7I5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLILKALILGLVEAASEFLPISSTGHLIIVGDFLDFTGPRAEAFEIFIQLGAILSVV
WIYRQRIRTTLLNYTSDTQARRLVANLAIAFIPAAILGFLFHKYITHYLFNPVTVAGALV
AGGIAILLIERYAPSGRVQSVDHMTWKDALTVGVAQSVALFPGVSRSGATIMGGMLGGMS
RFAATEFSFFLAIPTMFAATGYSLLKEWSNLSLADVPMFAVGFVAAFLGGLAVVRFLLHY
VSQNNFAPFAYYRIIFGGLLLLYFHWHPWVGKGA
>A0A0M0GKJ7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MEFKLQEINLASKDTGPYGIAVTDKGEVWFTQHKANKISCIHLDGEITEYSVPTPDAKVM
CIIVSSEGEVWFTENAANKIGRITKEGTILEYPLPNPDSAPYGITEGLNGDIWFTEMNGD
RIGRIQDDGTIHEYELPAQGSYPSFIALGSDHALWFTENQNNAIGRMTENGEVTEFKIPT
PASGPVGITKGNDGALWFVEIIGNKIGRITTSGEITEFEIPTPNARPHAITAGAGNDIWF
TEWGANKIGRITDNTIIEEYPIETPNAEPHGISRSDGKTIWFALECDKIGKITIID
>D7RNT4|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-114a|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPGST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATQPNAGLRARDELVRDWPAMAGAWRP
>A0A0M9GU87|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGLNHFLFSVSDIEVSITFYQEVFDAKLLVKGRNTAYFDLNGMWLALNVEEAIPRNE
IHQSYTHIAFSIEEEEFDEIYEKLRRLNVNILSGRPRDDRDKKSIYFTDPDGHKFEFHTG
TLQDRLDFYAKEKTYMEFF
>YP_002452159|FEATURES|ARDB_deepARG|glycopeptide|VanRB|antibiotic target alteration|0
MDIRILLVEDDEHICNAVKVFLSGAGYKVDACFNGDEAHTKFYDNTYQLVILDILLPGMN
GHELLREFRKLNNTPVLMMTALSDDENQIRAFDAEADDYVTKPFKIQLLLKRVEALLRRS
GAVAKELHYGKLTILPEDFKVFYDDEELLLTLKEFEILMLLVQNNGRTLSHEVILSRVWG
YDFDGDGSTVHTHIKNLRAKLPDNIIKTVRGVGYRLEETS
>A0A0K9H9B5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWELFVAFILGLVEGATEFAPVSSTGHMIIVDDILLKSKELFSEPVANTFKVVIQLGS
ILAVVVVFKDRILNLLGLQKGSRSAYRSGPRLTLVHIFIGLVPAAALGFLFEDYIDEHLF
SINTVLIGLVAGAFLMLAADWLAPGRIKAETVDDITYKQAFLIGLFQCIALWPGFSRSGS
TISGGVLLGMSHRAAADFTFIMAMPIMAGASAISLIKNWEYFSIDVLPFFIVGFISAFVF
ALLSIRFFLELINRIKLTPFAIYRIVIAAVIYFVFL
>A0A127SUA0|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLWYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNADIIARISRMVY
DAMRRQGGYW
>U1ZBC7|FEATURES|UNIPROT_deepARG|beta_lactam|N878_07675|antibiotic inactivation|1
MLLGAGDALAGSTAKQQIETAVNAIIEPLMAEHAIAGMAVALSVEGRRYTFNYGLASRET
GQAVDDATLFEIGSVSKLLSATLGAYAAASGKLDLHDSASQHLSELRGGPFEQISLLELA
TYSAGGLPLQFPEQVLDRASMLAYYRSWQPSYAAGTQRLYSNPSIGLFAHLAAASLGEPF
AESMERRLFPAFALTQSYIQVPPSRLPAYAQGYDKADQPVRVNPGMLDAEAYGVKASAAD
LLRFVEANLHPEALPEPWPRAVAMTQTGYYRVGDMSQGLGWERYAYPIDLARLQAGNSAD
MALQPQAIERFDAPIPATGDLLLNKTGSTNGFGAYVLLLPARDIGLVLLANRNYPNTERV
RVALQILEALPR
>A0A0U2CJA3|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKEMNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLIN
NFGETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCK
FCATGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPN
LFALSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVM
NILDEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLFKSRYKSGKLYHVNLIRYNPTIS
APEMYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQLYGNYQNSQ
>I1V572|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAALQYSDNT
AMNKLIAHLGGPDKVAAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLKNL
TLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVV
>C0EWY7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIEMLKVILLGIVEGITEWLPISSTGHMILVDEFIKLNVPKDFMEMFLVVIQLGAILAV
CVIYFHKLNPFSPKKSAKEKRETVDIWGKVIVGCLPAAVIGLAFNDKIDALFYNAPTVAF
TLILYGILFIIVENYNKHREPQVGELSDLTYKIAVIIGCFQVLALIPGTSRSGATIIGAM
ILGTSRFVAAEYSFFLSIPVMFGASFLKLVKYGFHYTGMEVTILVVGMLVAFIVSIVAIK
FLLGYIKKNDFKAFGVYRIVLGIVVAAYFLFVK
>A0A127ST01|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGAQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>A0A150EID6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWFIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTEGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSTADIPLFATGFITAFIVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFFIM
>YP_309461|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPI
SGRIGKSNVTEGALVQNGQATALATVQQLDPIYLDVTQSSNDFLRLKQELANGTLKQENG
KAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
LNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVV
ISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>ZP_03585936|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIALFIMLGGAFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLLYTSATSSAGMASLYLTFRQGVNADLAAVEVQNRLKTVEARLPEP
VRRDGIQVEKAADNIQLVVSLTSDDGRMTGVQLGEYASANVVQALRRVDGVGRVQFWGAE
YAMRIWPDPVKLAGHGLTASDIAAAVRAHNARVTVGDIGRSAVPDSAPIAATVFADAPLK
TPADFGAIALRSQADGAALYLRDVARIEFGGSDYNYPSYVNGKVAVGMGIKLAPGSNAVA
TEKRIRAAMDELSAYFPPGVKYQIPYETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGAMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EERLAPYDATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALSLAVSIAFS
AFLALSLTPALCATLLKPVDDGHHDKRGFFGWFNRFVARSTQRYATRVGAMLNKPLRWLV
VYGVLTAVAALMLTRLPSAFLPDEDQGNFMVMVIRPQGTPLAETMQSVREVESYLRREEP
AAYTFALGGFNLYGEGPNGGMIFVTLKNWNARQAARDHVQAIVARVNERFAGTPNTTVFA
MNSPALPDLGSTGGFDFRMQNRGGLDYAAFSAAREQLLAAGAKDAALTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVIVQADGQHRLDPDDV
KKLRVRNARGEMVPLAAFATLHWTLGPPQLTRYNGYPSFTINGSAAPGHSSGEAMAAIER
IAATLPAGIGHAWSGQSFEERLSGAQAPLLFALSVLVVFLALAALYESWSIPLAVMLVVP
LGVIGAVLGVTLRAMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLLAQRMSLAEAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQTAIGTGVLGGVIAATVLAVFLVPLFFV
VVGRLFGFGTRRRGSAPAVNVEGSR
>ABC35282|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIAAATFAVVVIAGLGAFGAIRVNASAPEKSAAPLPEVDVATVLSKTITDW
QSYSGRLEAVEKVDVRPLVSGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
AAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAQAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLRYIGGAKD
GRKVPVELGLANESGYSRQGVIDSVDNRLDTSSGTIRVRARFDNADGSLVPGLYARVKVG
GSAPHPALLIDDAAINTDQDKKFVFVVDQQGRVSYREVQLGAQHGNQRVIAGGLAAGDRI
VVNGTQRVRPGEQVKPHLVPMTGGDDAAATPVAGGVQRPQGAPGNARA
>R6J142|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELIKVIIIGIVEGITEWLPISSTGHMLLVDEFIHMNVTPEFREMFLYVIQLGAILA
VIILFWNKMWPFQSKKKNGSVIKKETFVLWFKVVIACIPGFVAYLLLDFVDNCYVVAAAL
IVYGVLFIVIENWNRGREPRVKTLEEISYKDAFIIGLFQALSIIPGTSRSGSTIIGGLVI
GVSRVTAAEFTFFLAVPVMVGVSLLKIIAFGFSFTSAELITLIVGCVVAFLVSVVVIKFL
MSYIKRKDFKVFGWYRIVLGVVVIAYFLLK
>A0A127T792|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-66|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEETPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>A0A088DHN5|FEATURES|UNIPROT_deepARG|beta_lactam|adc-72|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKSVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKEWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANINPQKYPKDTQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGSYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>R9VXF1|FEATURES|UNIPROT_deepARG|chloramphenicol|H650_24125|antibiotic inactivation|1
MKKTTPEYTTVDLSRWARKEHFEAFQTFAQCTFSQTVQLDITALLKHIKAVGWKIYPTLI
FLIAKIVNKHTEFRMAIKDNELVIWNDIHPCYTIFHDETETFSSLWSHYDGNIHHFLDIY
SEDVARYGNNLSYLPKEESRENVFFVSANPWVSFTGFNINIANMQNFFAPMFTIGKYYQQ
GEKVLLPLAVQVHHAVCDGFHVSRLINDLQTMCDDLLRHSGEPEA
>A0A118KKJ5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLFVAACATATAGRAAAATQDDLHDTVTRHIAPLMKQYAIPGMAVGIVAD
GKPYVFDYGVMSTQTGKPVNGDTLFEIGSVSKTLTATLAADAQEGGELSLADPAGKYLPA
LQGKPFGVVTLLDLGAHTSGGMPVQVPDSIRDDAGLIRYLDAWRPAHAPGTYRTYSNVSV
GMLGWLTAKAMHKDFAVLMEQRLFPALGMTHTYINVPEARQADYAQGYTPDGKPIRMTGG
MLWQPAYGVRTTASDLLRFVQANMGLIETAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNSMKMLRDGLPASAIEPPLAPSADTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRSFPNEARVKAAYGILGALDGRR
>T0FMK3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYEENFEFDDLFDIFIQSGAILSV
LFLYREKFRSQIVSSFRYILKQNSDSEGFNFLIQIGMGAVPILIAGFVAKKFLDTIKTSP
DLLDILSGAWIFGGVLILIAEWYFHKKQENVEKKPINFKDSILIGIFQCMALVPGMSRSA
ATIITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGHTIPVLIFGFLVSFL
LCTLVIRWFLRYLQKHSFSVFGVYRILLGVGVLVLTKLI
>A0A0Q0ATH4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRALLELKGVTRRFVAGEKDFIALNDINLTINAGDLIAITGASGSGKSTLMNVLGCLDH
ANSGSYKVDGRETGTLTDDELAELRRDHFGFIFQRYHLLPHLAAIQNVEMPAIYAGTGKS
MRVERAQKLLERLGLSGHLEHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNTDRPIINEKATE
RLPSKPRQGNRLMANIGLFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIEAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVAALSSQYYIDSATPNIGRN
MLLRYRNIDVSATVSGVSPSYFQVRGTKMGSGVGFNKDDARRQAQVVVIDYNTRIRLFGP
KVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNVWMPYETASGRLLGQSYLDSITVR
VKDGQPSKVVEDNVNKLMQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSFVIG
YVFSLLVKEWQMVFSVGSIVTAFICSTLIGIVFGFVPARNAAQLDPIEALARD
>A5V412|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEMSLLSIVLLGIVEGVTEFLPVSSTGHLILAGEVMKVPQGTETFDIVIQLGAILAVVVL
YRERFAAVLAGLGRRDPAAIRFTRNVLVGFLPSAVIGAVAYGAIKAMLNTPIIVAVALIL
GGIAILVIERLVRSPTCDSVEGMSLRTSFGVGLVQCLSMIPGVSRSGATIMGALTLGVER
RTAAEYSFFLAIPTMLGATTLALWKARHELGDAQATAIAIGFVVSFIVAMLVIRWFLGVV
TRHGFAPFAWYRIIAGTAALIWLLAR
>A0A0J0N3K6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAIVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIIAQQRVAISPDDVALTLHHKLCQAARHLLEQALPAI
KTGDYAERPQQEADATCFGRRTPEDSFLDWNTPAVELHNQVRAVSDPWPGAYSYVGTQKF
TVWSSRVCVNNSAAQPGTVISVSPLLIACRDGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTTKRRTRVLILGVNGFIGNHLTERLLQEDHYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPQNEASIQELAEMLLTCFEKHPLRNHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVNITEHTS
>NP_290094|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIIXVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VIYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>NP_752857|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MRDYYWRRNCMQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAG
IDWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTL
LRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPW
EGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGF
VSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIM
GGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVS
AAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>A0A0M1NEQ7|FEATURES|UNIPROT_deepARG|beta_lactam|AM232_20245|antibiotic inactivation|1
MNKRWFYQILAPMGLVLMVAGCSDEEKQVVQQSETEQTGGTNQTSENITAKETTIKKFEQ
LEKEYDARLGVYAIDTGTKETVEFHENERFAFTSTHKALAVGALLQQKSIEDLNQRITYT
SEDLVNYNPITEKHVDTGMTLKELADASLRYSDNTAGNLILEQLGGPAGFKKVLEGIGDN
VTNPERIEPDLNVVNPGETHDTSTPIALATSLQAFTLGDALPTEKRELLIDWMKRNTTGD
ALIRAGVPKGWVVADKTGAGSYGTRNDIAIIWPSKGNPIVLAVLSSRDEKEADYNDELIA
EATEEVIKALKVKDK
>A0A104EY39|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHGIKRIMAAALFSTCATATIGYAANDRQDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPN
LQGSPFGNVTLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWRPTYSPGTYRTYSNVSI
GTLGLITATSMGQQDFAVPLSRHLLSPLGMKSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSMALNAMPVNEIKPPRAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAHRILTSLGLDGR
>A0A0L8IIX4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRALLELNGVTRRFVAGEKDFIALNDINLTINAGELVAITGASGSGKSTLMNVLGCLDH
PNSGSYKVDGRETGTLTDDELAELRRDHFGFIFQRYHLLPHLAAIQNVEMPAIYAGTGKG
MRVERAQKLLERLGLSGHLEHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNTDRPIINEKTTE
RLPTKPRQGNRLMANIGLFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIQAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVAALSSEYYIDSATPNIGRN
LLVRYRNIDVSATVSGVSPSYFQVRGTKMGLGVGFNKDDARRQAQVVVIDHNTRIRLFGP
KVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLLGQTYLDGITVR
VKDGQPSKVVEDNVNKLLQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGISLSFVIG
YVFSLLVKEWQMVFSLGSIVTAFICSTLIGIVFGFVPARNAAQLDPIEALARD
>A0A102KVQ2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHGIKCIMAAALLSTCAAATIGYAADDRQDTVKSISDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMADKTGKYLPN
LQGSPFGNVTLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWQPTYSPGTYRTYSNVSI
GTLGLIAATSMGQRDFAVPLSRHLLSPLGMKSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALTTLTEGNALSMALNAMPVKEIKPPQAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>A0A0T6XT24|FEATURES|UNIPROT_deepARG|beta_lactam|N183_06515|antibiotic inactivation|1
MTTIKLGLTTAILFSLTATVFAADGEQARIAAAVDKAIRPIMGEYKVPGMAIAVTVDGQH
YFVNYGVASKETKAPVTENTLFELGSISKTFAGTLASYAQVLGKLSFDDHPGKYMPDLSG
SAIDKATLLNLATYTAGGLPLQFPDEVKSNADMLTYFSNWKPGAEPGKERRYSNPSIGLF
GHAAGLAMGSNFATALETELFPKLGLKHSYVTVPRSAMGSYAWGYGKADKPIRVNPGMFD
AEAYGVKSSAADMIRFVEANIQPEQFDGPVRKALEGTHIGYFDTGKMIQSLGWEQYPYPV
SLERLLDGNSGTMAMEANPATALNPPKRPDGATLYNKTGSTSGFGGYVAFVPEKKIGVVM
LANRNFPNPERIKAVHAILKTLATAAE
>D0SZ27|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIISVLKALFLGFIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRKKIINLLHGFISGDYHARRFAINVFIAFIPAVVIGVIAVDFIKQVLFSPSVVASAL
IIGALLIFAVEAKNFKVQTIEATNIGFKQAIVIGLVQCLAMIPGTSRSGATIIGGMLAGL
SRKAATEFSFFLAIPTMLGAATYDIFRNVDVLTSENLLNISVGFVTAFIAALLVVKAMVK
FVEKHTLKVFAWYRLVLGSIILFIF
>AAV58812|FEATURES|ARDB_deepARG|glycopeptide|vanSB|antibiotic target alteration|0
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QGKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPLTSTL
>I7ACB5|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
AFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLC
GAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANL
LLTTIGGPKELTAFLXNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGE
LLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSR
IVVIYTTGSQATMDERNRQI
>YP_001444376|FEATURES|ARDB_deepARG|tetracycline|tet34|antibiotic target alteration|1
MSKKFIITWDAMQSYCRELAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRHVDTICI
SSYDHDHQRDMTVVKAPEGDGEGFLIVEDLVDSGDTARKLREMYPKAKLIAVCAKPAGVE
LLDDYVVDIAQDTWIEQPWDMSIQFVEPVNRKQK
>A0A0D0QU15|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNHNDIKRVSVIIPVYNEEESLPELLRRVTESCEQLSQDYEVILIDDGSRDRSATIISEA
AAREGSKLVAVLLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVATAMEGY
DVVGTIRRNRQDSWFRKTASRFINKSVQRATGVQMSDYGCMLRAYRRHIIDAMLCCQERS
TFIPILANSFARRTTELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTAPLRLLSIVGS
VVAGIGFTFSILLILLRLLMGADWAADGVFTLFAILFTFVGVQLIGMGLLGEYIGRMYTD
VRARPRYFIHQIVRSTPDASQQETQS
>F8IAK2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSWLSALSLGALQGFAELFPFSSLGLLIIVPHVLGWPVPVGRVYLPFVVALHLGTALGLF
VVFGHVWWQILRGLVRDRHRRRQLLLILTAALPAGVAGLLAKHWVAGFFSSPRLAAVMLM
VNGVLLVRAPLAARPSLRWWDDLGWLAALRIGLYQILALIPGFSRSGLALWGSARQGLDY
ESAAHFSFLVAFPLIFGAALVELPKLAHGSPGMVSRALGGGFLAFVVAAWAARYLLGYFR
QHGLRRLGWASLMLGAVSLAALTWGW
>R5W397|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIFDVFVAVVWGIVEGITEWLPISSTGHMILVNQFLSFSDNNFKDMFLVVVQLGAILAV
VLLFWDRIWPFNFKTKKNNEPFVKMDIMQLWFKIIISCVPAAIVGLLFDEVIEDMFYNGV
VVAGALIIYGVLFIVVENWNKGRRPVITTVAEIGYNSAIIIGLFQLLAAIVPGTSRSGAT
ILGALLIGISRGVAAEYTFYLAIPVMLGASLLKIIKGGFGFGVMGTVTLTVGMVVAFVVS
LFVIKFLLGYIRKHDFKAFGYYRIVLGVIVLLYFFISGAQAV
>F5RMW7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDISLMELVKVVILGIVEGLTEWLPVSSTGHMILVDEFIRLDVSTAFMDMFLVVIQLGAI
LAVVVLNLEKLNPFLKSKSKAERRETLDLWGKVIVACLPAAVIGLAFNKYMEEHFMNAPV
VAAMLILYGILFIVVERWNKRRTPRVDDLAALDYRTAFIIGMFQVLSLVPGTSRSGATIL
GGIIFGASRYVATEFTFFLAIPVMFGASFLKLVKFGWNYTGTELVILGVGMVTAFIVSIL
SIQFLLRYIKRNDFTAFGWYRIALGIVVLAYLFMVGDPTKE
>R4FCD2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHIIELIKALILGLVEGATEFAPVSSTGHMIIVDDMWLKSSEFLGKYGANTFKVVIQLGS
VLAAVVVFKDKFFELLYLRKGEVRKGPRLTLMHIFVGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADRFGKRTVAQTVDDITYKQAFIVGLVQCLSLWPGFSRSGSTISG
GVLVGMSHRAAADFTFIMAVPIMAGASAISLLKNWEYITFDALPFFVVGFISAFVFALLA
IRFFLRLINRVRLVPFALYRIVLAAVIYVVYFA
>N9NTN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLIKGFFSGDAEARHFAFSVLLAFIPAVVIGVFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESIKFDHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIAVGFVAAFISALFVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>F6KHM3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
KKSGSEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAH
VGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGD
SQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVT
SFT
>J0W058|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLPTLAIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGQTAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPEHEGVGTGRLSLIHILLAMIPAVVLGLVLHDAIKSLFNPV
NVMYALVVGGVLLIVAECFKPKVPRAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTMGDLPMFAVGFVTAFIVALV
AIKTFLQLIKRISFIPFAIYRFIVAAVVFFIFT
>W4BC06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTEAIKAIILGIIEGLTEFLPVSSTGHLILAGDLLDFEGEGAVTFKIVIQLGAVMAVLLL
YWKKYVNIGMNMLKLDFSKSKGLNAIHMILAMVPALVVYLLFKDTIKSQLFGPKPVLIGL
IAGGLLMIFAARSRRSVTSETVDGLNYTQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDALNSDDLVLMLIGFVTSFLVAMIAVVTFIK
LIKRLRLEWFALYRFVLAGLFYVIVIL
>A0A0P9PHR7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSMNQKVDIEALHETSINGDQPLLHLQQVSRSFMAGDREFQVLKDIDLAIHIGELVAIIG
ASGSGKSTLMNILGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRYHLLPHL
DAVRNVEIPAIYAGTAQVKRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSIARALMN
GGQVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIEVSDGEI
ISDRRTAQATQPVPEAQPATPPGPAPRRLMASLGLFREAFNMAWIALISHRMRTLLTMLG
IIIGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLLPTDVAA
LNQLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSDQDARRQ
AQVVVLDHNTAQRLFGPGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNLWMPYET
AAGRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTS
RSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVM
VCLMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAAR
LDPIEALARD
>A0A0L7AMR2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHSDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQMSPEVIFSFYYRHLIHDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPAAVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQSLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>ACD76089|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTALPGKTAFQVLEEYPDSGENI
VDALAAFLRRLHSIPVSNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>A0A060KTV9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILATYFTQPQPKAESRRDVLASAAKIVTDGL
>U6A4G9|FEATURES|UNIPROT_deepARG|beta_lactam|blaFONA-5|antibiotic inactivation|1
MAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPVAEKHLDTGMTLAEFSAATIQYSDNTA
MNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPQAMAKSLQNLT
LGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
>N1MSZ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVVIQLGAILAVVVL
YWRTFWAVGMGLLRREPVSWRFLRNLLIAFIPSAIIGLALHDYIEILLGAPQVVAWALIV
GGVAILLIERAVKEQRFHGIADIPAMRVLGIGLVQCISMIPGVSRSGATIMGALMLGVER
RTAAEFSFFLAIPTMLGATALELIKKGDQITSAAVGWDSIALGFVVSFIVALLVIRWFVG
LVSKHGFAPFAWYRIVAGIAALVWLGTR
>A9CV81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGTTLVGAALLGLLEGLTEFIPVSSTAHLLLAGHFLGFNSPGNSFEVLIQLGAILAILS
VYFARLWKLAMDLPTSAEARRFVGAILLAFLPAAVIGVMAHGFIKTVLFESTALICWVLI
GGGIVLLIIDRMPLRPKYTNVMDYPLSLAFKIGLVQCLAMIPGTSRSGATIAGALLLGAD
KRSAAEFSFFLAMPTMAGAFAYDLYKNYDKLGMDDVTAIIIGFVMAFIAGVIVVRSLLDF
VSKHGFAPFAWWRIAVGTLGLIGLWLF
>U2BI35|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MCKGEKEKRRKELMDFIEVIKAVILGIIQGITEWLPISSTGHLILFDNIWPMASSPEFFE
VFKVVIQFGSILAVLVLFFDKLNPFSPKKGYRDKKETFDLWKKVVAGCIPIVIVGLPLDM
ILEDYLSGVYVIAATLILYGIAFIVIESRASVPSMNTLQDLTYKTAFFIGCFQVLAAIPG
TSRSGATILGAVLLGCSRYVASEFSFFLAVPVMAGASGLKLLKYFLKEGMFSGPEWFLLI
IGTLVSFIVSIFAIRLLLGYIRNHDFKVFGVYRIILGIVVIIYFTFLA
>A4W932|FEATURES|UNIPROT_deepARG|chloramphenicol|Ent638_1533|antibiotic inactivation|1
MKTTTLEYTPVDLSRWARKEHFEVFQSFAQSTINQTVLVDITVLLKYIKESGWKFYPTII
FLLSKIVNSHAEFRMAIKNNELVIWNEIHPSYTIFHNETETFSSLWSHYDGNIHHFQDVY
SEDVACYGNNLSYWPKEESRENVFFVSAIPWVSFTSFNINVANMQNFFAPMFTIGKYYQQ
DGKVLLPLAVQVHHSVCDGFHVARLFNELQEMCDDILRLSEEFNA
>H5UY49|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEETKLTKVSVVIPVFNEQDSLPALIARTCNACASLGLDYEILLVDDGSLDQSAQLIAD
AAATSAGHIVGVMLNRNYGQHSAIMAGFSHVSGDVIITLDADLQNPPEEIPRLVAAAQEG
YDVVGTVRQNRQDSWFRKKASRTINGLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARKTIELPVTHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRLLSVLG
SVIALAGFAFSLTLVVLRLFLGAAWAGDGVFMLFAVLFMFVGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQCVIRTPQAPSSQEIK
>A0A098LF44|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNFIEAIILAIVEGLTEFLPVSSTGHMIITSALMGINEQEFTKIFTVQIQFGAILSVVIL
YWKRFFTSLDFYYKLFVAFLPAAAIGFLLGDFIDSLLENVIVVAASLLLGGIFLLFVDRI
FNPLKGKSLDELSYKNSLIIGFFQCIAMIPGVSRSAATIIGGMAQNLNRKAAAEFSFFLA
VPTMFAASGYKLLKDYKAIDASNLNVLIVGNVVAFIVALLAIKFFIGFVTKYGFKVFGYY
RIALGLILLILLALGVDLKIQ
>ABW24731|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYS
STYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKKPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVNTQLKNNEVILSGEIPARCIQEYRNDLTFFTNGR
SVCLTELKGYYVTTGESVCQPRRPNSRIDKVRYMFNKIT
>Q9KJC2|FEATURES|UNIPROT_deepARG|multidrug|arpB|antibiotic efflux|1
MSKFFIDRPIFAWVIALVIMLVGALSILKLPINQYPSIAPPAIAIAVTYPGASAQTVQDT
VVQVIEQQLNGIDNLRYVSSESNSDGSMTITATFEQGTNPDTAQVQVQNKLNLATPLLPQ
EVQQQGIRVTKAVKNFLLVIGLVSEDGSMTKDDLANYIVSNMQDPISRTAGVGDFQVFGA
QYAMRIWLDPAKLNKFQLTPVDVKTAVAAQNVQVSSGQLGGLPALPGTQLNATIIGKTRL
QTAEQFESILLKVNKDGSQVRLGDVAQVGLGGENYAVSAQFNGKPASGLAVKLATGANAL
DTAKALRETIKGLEPFFPPGVKAVFPYDTTPVVTESISGVIHTLIEAVVLVFLVMYLFLQ
NFRATIITTMTVPVVLLGTFGILAAAGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVM
SEEGLPPKEATKRSMEQIQGALVGIALVLSAVLLPMAFFGGSTGVIYRQFSITIVSAMGL
SVLVALIFTPALCATMLKPLKKGEHHTAKGGFFGWFNRNFDRSVNGYERSVGTILRNKVP
FLLGYALIVVGMIWLFARIPTAFLPEEDQGVLFAQVQTPAGSSAERTQVVVDQMREYLLK
DEADTVSSVFTVNGFNFAGRGQSSGMAFIMLKPWDERSKENSVFALAQRAQQHFFTFRDA
MVFAFAPPAVLELGNATGFDVFLQDRGGVGHAKLMEARNQFLAKAAQSKILSAVRPNGLN
DEPQYQLTIDDERASALGVTIADINNTLSIALGASYVNDFIDRGRVKKVYIQGEPSARMS
PEDLQKWYVRNGAGEMVPFSSFAKGEWTYGSPKLSRYNGVEAMEILGAPAPGYSTGEAMA
EVERIAGELPSGIGFSWTGMSYEEKLSGSQMPALFALSVLFVFLCLAALYESWSIPIAVV
LVVPLGIIGALIATSLRGLSNDVYFLVGLLTTIGLAAKNAILIVEFAKELHEQGRSLYDA
AIEACRMRLRPIIMTSLAFILGVVPLTIASGAGAGSQHAIGTGVIGGMISATVLAIFWVP
LFFVAVSSLFGSKEPEKDVTPENPRYEAGQ
>A0A0J6G8V0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSLKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPKENNFYGSVAQLCARKGIPVHA
PEDANHPLWIERIRKLNADYIFSFYYRNLLGEELLASVSKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGDILAQQRISIERSDTALSLHAKLRETAAQLLAEALP
LLPEGKLKETPQDESKATYVGRRTAADGLLQWSRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWGAEVVAGNQGHAPGQVISCDPLRIACGQDSLIVTAGQRNDNGLYLSGPQLARELG
LVEGSRLRGSESGRPARRTRVLILGVNGFIGNHLSERLLQDDRYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GTKGLKFTLFRPFNWMGPRLDRLDSARVGSSRAITQLILHLVEGTPIRLVDGGEQKRCFT
DVADGIEALARIIDNKGGKCDGQIINIGNPDNEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDVESQSFYGTGYQDVSHRKPSVENARRLIDWTPTTELSETIGKTLDFFLREAMVEIA
EKR
>U7SL96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPISSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNVFVVAIT
LITYGVIFIGIEVVYKLKNIKPKVKRFAGLKYKTAFLIGLFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIIVIILLN
>A1KSF8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARAEKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHKAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A0D7X855|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIQGWNHICFSVSDLEKSVHFYQNVLDGKLLVKGRKLAYLDCLGMWLALNVEEDIPRNE
IHHSYSHIAFSVAEADFEDMLNKLRAFNVTILPGRERNEQDKRSVYFTDPDGHKFEFHTG
QLQDRLEYYKNEKKHMTFYD
>V5Z4F7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MADIHQLWIAAILGLVEGLTEFLPVSSTGHMILVGHLLGFEGNKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGQGRLTLIHILLGMVPAVVIGLLLHDQIKTLFNPVN
VMYALVVGGVLLIAAELLKPKQPKSEGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMIGATGLDLYKSMGFLTRADLPMFAVGFVTAFIVALVA
IKSFLHIIKRISFIPFAIYRFIVAAAVYALFVL
>A0A0N1HNG9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METFSLLEIFKAVILGIVQGITEWLPVSSTGHMILVDEFIKLNFSDTFISTFLVVIQFGS
ILAVLVIFFRKLNPFDSSKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDIDRLFFNST
VVAIALIVYGIIMIGLEKRNKRPKYKDFSQVTYKLALCIGLFQCLALIPGTSRSGSTIIG
AVLLGTSRYVAAEFSFFLAIPTMLGASALKLLKAGFGFTGFEWLILGVGSVVAFIVSIIV
IKFFMDYIKKHDFKVFGYYRIVLGIVVLAYFFLF
>AAW34142|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSALDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREI
LLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>R4YIG6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVA
VLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNR
QDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTF
ARRAVEIPVMHAEREFGDSKYSFMRLINLMYYLVTCLTTTPLRLLSIFGSVIALLGFAFG
LLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQ
RVVRQPETASKEEDRS
>A0A024KIC2|FEATURES|UNIPROT_deepARG|aminoglycoside|AAC(6')-Iaa|antibiotic inactivation|1
MVEIRRLKETDRDAWRRQRLLLWPGHVEAEFDTDITQMLANPDTPTFGGFEGGELVGFAE
ASVRPYGAGCETSPVAWLEGIYVAPSHRRQGLGRGLVDAIASWARERGFSEMGSDAAIYN
TTSHLSHAGWGFEETERIVLFRRKLT
>A0A0J5Y0Y1|FEATURES|UNIPROT_deepARG|beta_lactam|ABV89_11680|antibiotic inactivation|1
MKRWKEMFYTSKLKKMMPALALSCAAVVGFSSSGVQAETVKCQKQETKSDREFAKLEEKY
DANLGVFALDTGTNKTVTYHPDERFAYTSTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLKELADASLRYSDNTAGNLILQQLGGPDGFKEALENIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALAASLQTYVLGQALPEDKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPNGDPIVLAILSDRTEKDAEYHDKLIAEAAKQ
AVKALKATYK
>A0A125X0Q0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEETPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>B6FV98|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDMLKVIILGIVEGITEWLPISSTGHLILVDEFIKLGASRAFKEMFNVVIQLGAILAVV
VLYFHKLNPFSPKKSRKQKVYTIQLWMKVIVACLPAAVLGILLDDWMEAHLHNYVVVSIT
LILYGILFIVIENWNKDKTPQVTKLHQLSYQTALLIGVFQVLSLVPGTSRSGATIIGALL
LGTSRYVAAEFTFFLAIPVMFGASGIKLLKFIKVGGGFTGMEAAMLIVGCLVAFVVSIIA
IKFLMGYIKKNDFKVFGYYRIILGVIVLGYFAASGFLK
>A0A098FPG3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWVAIQALILGVVEGVTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRSKILDVVIGLPKESQAQKFTLNLLIAFMPAVVLGVAFADLIHEYLFNPITVATALV
IGGVVMLWAERRDHTIRAETVDDMNWALALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDFAVFAVGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIGFGLLILATWQFGLIDWASAQG
>R5HS29|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKVILLGIVEGITEWLPISSTGHMILVDEFIHLNVSQDFMDVFLVVIQLGAIFA
VVVLYWNKLWPFYIKKLPRRTQMAIAKKPKWAQVILNFVERYCDKDKWILWFKIVVACLP
TIIIALPFNDFIEAHFNNYVVVAIALIVYGVLFIIVENYNKGREPQCTSLEDLTFKTAFL
IGCFQVLSVVPGTSRSGSTIIGGILVGTSRTVAAEFTFFLGIPVMFGASLLKLLKFGFGF
TGTEVLILVIGMVVAFVVSILAIKFLMGYIKKHDFKAFGWYRIVLGVLVLVYFIGKTLLA
>X2KNN5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
VLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQ
TLFELGSISKTFTGVLGGDAIARGEISLGDPVAKYWPELTGKQWQGIRMLDLATYTAGGL
PLQVPDEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKPSGMSFEQAMTKR
VFKPLKLDHTWINVPKEEEAYYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVKAN
MNPAALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLP
VAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVM
>H3RA15|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGTGTGRLTLIHILLGMIPAVVIGLVLHDQIKTLFNPIN
VMYALVVGGLLLLAAEFLKPKQPKSVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATGLDLYKSLGFLSMADFPMFAVGFITAFVVAMIA
IKVFLELIKRISFVSFAVYRFIVATAVYMLFT
>C9R4F0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKQLNRYFGEGENRVHVLKDISLSIERGDFVAIMGQSGSGKSTLMNIIGCLDTAT
GGSYKIDGKETIELTNDQLSDLRSQKFGFIFQRYNLLSSLTAAENVALPAIYAGMPQSQR
LERAKQLLEKLGLGDKWQNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSHSGE
NVMEILRQLHEEGHTIIMVTHDKHIAASANRIIEIKDGEIISDTQKRQVKSAVKNPSVFK
GRFGFSKDQLMEAFRMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
RGIGTNTMTIFNGNGFGDRRSRHIQNLKISDANTLSKQSYIQSVTPNTSSSGILVVGNKS
FTSANLYGIGEQYFDVEGLKLKQGRLLTEDDVDQSNQVVVLDESAKKAIFANENPLGKTV
IFNKRPFRVIGVVSDQQLGGFPGNSLNLYSPYSTVLNKITGGSRIGSITVKISDDVNSTV
AEKSLTELLKSLHGKKDFFIMNSDTIKQTIENTTGTMKLLISSIAFISLIVGGIGVMNIM
LVSVTERTKEIGVRMAIGARQINILQQFLIEAVLICLIGGVAGILLSVLIGVLFNSFITD
FSMDFSTASIVTAVLFSTLIGVLFGYMPAKKAAELNPITALAQE
>Q1W758|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
LLAGITLPLVNFSLPTWAAGIPGSLDKQLAALEHSANGRLGIAMINTGNGTKILYRGARR
FPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAHGMTVSELCAA
TIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPNDPRDTTTPAA
MAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKTGSGDYGTTND
IAVLWPTKGAPIVLVVYFTQREKDANPVPDVLALCQPKYFGRKF
>A0A0A0Q8L0|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-36|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADTAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVEASWVHKMGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>A0A0B6X686|FEATURES|UNIPROT_deepARG|beta_lactam|XBW1_2050|antibiotic inactivation|1
MPFSSLRLTRISATIFPLLGALIPFPTHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
HSIITYRGHERFPLCSTSKMMTVSALLKKSETDKDLLNQRIHYQQSDIVEYSPITEKHLK
DGMTLAELSAATIQYSDNTAMNLLLDQLGGAHSVTRFARSIGDNAFRLDRKEPELNMVTP
GDERDTTTPQAMADSLYKLALGNTLAATQRTQLVEWLKGNTTGGTSISAGVPDNWIVGDK
TGRCDYGSTNDIAVIWPDKDKAPLILVTYFTQPSDKDAKAHNDVLAAAARIMTQER
>A0A139QGG2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIVEMLKSIIFGIVEGITEWLPISSTGHLILVQEFLKYKDQNAAFMEMFNVVIQLGAIL
AVVVIYFDKLNPFKPGKTAREVQKTWQLWAKVVIAAAPAAIIGLPLDDWFDAHFYNFISV
ACMLIIYGVAFILLEKRNKTVEPAITNLDRLPYKTALYIGLFQVLSLFPGTSRSGATIVG
GLLNGTSRSVVTEFTFFLGIPVMFGASGWKILKFIIKGNTLGFGQFFLLLVAMGVAFGVS
LYVIRFLTDYVKKHDFTIFGKYRIGLGVLLIVYGIFKAIF
>A0A0H3W0X1|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
AIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFAYASTSKAI
NSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNK
IINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANG
KLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFIYPKNQSE
PIILVIFTNKDNKSDKPNDK
>YP_543187|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MIMKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLMVLIAASAMQGMGTGVGGVMAR
TLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFS
MARWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMN
VWTLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>ZP_02213597|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEKMKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKN
VWVHTELGYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVII
THAHADRIGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFY
PGKGHTEDNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENIN
FVVPGHGEVGDKGLLLHTLDLLK
>B6JCL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFDLFKALVLGIVEGVTEFLPVSSTGHILLAERIFDLDQDNFWKTFAVLIQLGAILAIL
AIYFQRLWRVATHMFTDPAARRFVIGVLVAFLPAVILGLIFGTFIKEVLFNPWVVCFSLI
AGGAVLLWVDQQDVNPRHHDAMAFPLPMYLGIGIAQCAAMVPGVSRSGASIVAAMLFGAD
KRAAAEFSFFLAIPTMLGAFVYDVYKSRGDMTMDHAFIIIVGFVVSFITAIVVVKTFLDF
VTKNGFTFFAWWRVIVGTLGLIALALGA
>A0A0L7TFF4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGQKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGSGTGHLTLIHILLGMAPAVVIGLLLHDQIKSLFNPIN
VMYALVVGGVLLLAAEFLKPKTPKAEGIDDITYRQAFVIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSMGFLSMADFPMFAVGFVTAFIVALVA
IKTFLHIIKRISFVPFAIYRFIVAAAVYMVFV
>A0A102EKZ5|FEATURES|UNIPROT_deepARG|beta_lactam|WS45_22090|antibiotic inactivation|1
MTIRLSSFAVGTALSLFALAAAPARATVLCTVVADAADGRIVFQQGTQQACAERYTPAST
FKLPIALMGADAGILQSPHEPVWNYRPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLAAK
ALGQERFQRYTSAFHYGNEDVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLP
VKAAAYELAESLFDVGEAGGWRLYGKTGTGSPGSNGVYNAANAYGWFVGWARKDGRQLVF
ARLVQDERATKPNAGLRARDDLMHDWPAMVGTPRK
>YP_002384075|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSALSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDV
TYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNIDNFKTDKPQPVNALLKEA
EKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGANSAQYDD
SNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINA
SISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQQLANARYNYLIN
QLNIKSALGTLNEQDLIALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQT
SVRTSNGNNPFRN
>Q8RMP1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A0B6AGL9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNVKIKEYELPHADSGPYGITSGRDGALWFTQHKTNRIGRMTIKGKVEHFNIPTINAGAL
SIISTTQGDIWFTENKANKIGKLTITGEIMEYVLPNPDSAPFGITEGHHGDIWFTEMNGN
RIGRILPSGETIEYDLPHPASYPSFIVAGSDHALWFTLNQSNQIGRITLEGEVTTYQLPT
AQAGPVGITNGPDEALWFVEINGNKIGRITTSGVINEYAIPTPNARPHAIVTGPDGALWF
TEWGSNQIGRITVNGKITEYPIPTKNAEPHGIAVGSDHALWFAEECNKLGRLSFVQNP
>Q2MEY3|FEATURES|UNIPROT_deepARG|aminoglycoside|kamB|antibiotic target alteration|1
MRRVVGKRVLEFSEAEFDQLRSQYDEVVLDVGTGDGKHPYKVARQHPNQLVVALDADKTR
MERMSAKAAAKPAKGGLPNLLYLWATAEKLPPLTGVGELHVLMPWGSLLRGILGSSPEML
RGLAAVCRPDAAFLVALNLHAWRPPVPEVGEHPEPTPETVDEGLAARYAQAGWQLTDCRY
LAAEEVAALETSWTRRLNSSRDRFDVLALTGKINP
>C3AGN1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDTIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGEKAKTFEIVIQLGAILAIAVL
YHKRLVSLCNIKPLLQKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAFLMIFAEVKKTEATAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTMSGGLLAKVNY
NAASEFSFLIALPVMVGATGLDLLKSWEYLSIDDLPMFAVGFITSFVVAMLAVVTFLKLL
AKIGLKPFAYYRILLAIVFTIFVLL
>A0A0U1YWT7|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWRVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0F6TZE0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLTVADIPMFAVGFVTAFVVALV
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>AAN41440|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQHQPDSDYLGNLLRSKTFIALAAFD
QEAVVGALAAYVLPKFEQARSEIYIYDLAVSGEHRRQGIATALINPLKHEANALGAYVIY
VQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>YP_001334730|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSSAETPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMMLMGMAQNIWQFLLLRALLGLLGG
FIPNANALIATQIPRHKSGWALGTLSTGAVSGALLGPLAGGFLADHWGLRTVFFMTAAVL
FICFLFTLFLIRENFVPIARKEMLSAREVFSSLQNPKLVLSLFVTSLIIQVATGSIAPIL
TLYVRDLAGNVSNIAFISGMIASVPGIAALMSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSTSQISGRIFSYNQSFRDIGNVT
GPLIGASVSANYGFRAVFLVTAGVVLFNAIYSTLSLRRPAADTSHSVN
>A0A0P9VIH9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MGCGGGLNMNQKVDIEALHETSINSDQPLLRLQQVSRSFMAGDREFQVLKHIDLAIHTGE
LVAIIGASGSGKSTLMNILGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRY
HLLPHLDAVRNVEIPAIYAGTAQTTRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSI
ARALMNGGQVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIE
VSDGEIISDRRTAQTTQPAPEAQPATPPGPAPRRLLASLGLFCEAFNMAWIALISHRMRT
LLTMLGIIIGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLL
PSDVAALNQLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSD
QDARRQAQVVVLDHNTAQRLFGPGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNL
WMPYETAAGRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQ
TVQKTSRSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQF
LVEAVMVCLMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVP
ARNAARLDPIEALARD
>ZP_04145743|FEATURES|ARDB_deepARG|beta_lactam|BLA1|antibiotic inactivation|1
MEQIYFGDCLLYVSKKSVKNLKGMMILKNKRLLKIGICVGILGLSLTSLEAFTGGSLQVE
AKEKNGQIKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKAL
AAGVLLQQNSTKKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNI
LFHKIGGPKGYENALRKMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIAKNLKDLTVGN
ALPHQKRNILTDWMKGNATGDKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPI
IIAILSNKDEKGATYDNQLIAEAAEVVVNAFK
>ZP_03064513|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQIVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPLLMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAITEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAAAKPPSMAADAFTNPDYMR
YAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILA
LLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGP
VYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEV
TALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWD
ATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQ
EQHVCQLFARLPDWTAPALTPATEQAQGATQ
>C6Z4K6|FEATURES|UNIPROT_deepARG|beta_lactam|BSFG_01962|antibiotic inactivation|1
MKKSRRKRLVILCIALVCIIVLVFLLFSKSTSNNSTNPPLTDVLTDSISRIVSACPGEIG
VAIIINNTDTVKVNDKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVKIDRNRLDSKTW
SPMMKDYSELVISLTVRDLLRYTIAQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHDRAYFNYTSPLGAAMLMNRLFTESIVSGEKQSFIKNTLKECVTGTDRIV
APLLDKERVSIAHKTGSGYVNENGILAAHNDVAYICLPNNVCYTLAIFVKDFKGNESQAS
QYVAHISEVVYSLLIQNSAIP
>A0A089J8L0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIVKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
ILAVVIIFRNRFIDLLGLKKFSRKELTVVPEGQPQAPAEGRLKLAQVIVGLIPAGIFGFL
FEDYIDEHLFSTSTVLIGLVVGAIFMICADRFAPKTIKTESVDQITYRQALSVGLIQCVS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLLKNWQYFTLDALPFF
IAGFISAFLFALLSMRFFLKLINRIKLLPFAIYRIILAGVVYLIWF
>A0A0Z8CFJ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAL
ALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGAILLVYAFITFLF
>ABB70049|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTEPEQWDVVIE
GNDDLLEKYMSGKSLEALELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYS
STYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0H3QQ28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWWTAFQAFILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAKAFNIIIQLAAILAVV
WEFRGKIFQVVRDLPSQRQAQRFTANLLIAFFPAVVLGVLFADLIHEWLFNPITVALALV
VGGVVMLWAERRKHVIRAEHVDDMNWKDALKIGCAQCLAMIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYVYRDLFRPEDLPVFAVGFVTSFVFAMLAVRALLKF
IGNHSYAAFAWYRIAFGLLILATWQFHLIDWSTAGEV
>A0A127STC5|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
FSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMMPWSTFDGFNLNLQKGYDYLIPIFTMG
KYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELING
>B8ZHY6|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGEVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKS
>A0A150MQL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPLRPYVWKQTISAQKGWTKMQWMELWKAVILGMVEGLTEFAPVSSTGHMIIVDDLWLKS
TEFLGQYAANTFKVVIQLGSILAAVVVFKDRFLDLLGVRGRHPGGKPRLTLLHVIIGLFP
AGVLGVLFENYIDEHLFSTKTVLIGLVFGALLMIVADQFAKKAARVRTVDEITYKQAFFV
GLVQCLSLWPGFSRSGSTIAGGVLAGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVS
AADIPFFIAGFLSAFVFALLAIRFFLQLINRIRLVPFAVYRIVLAAVIYFLYF
>Q65TH4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKELNRYFGEGENTVHVLKNISVNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
SGSYKIDGKETNELTSDQLSDLRSQKFGFIFQRYNLLSALTAAENVALPAIYAGKSQSER
LARAEELLKKLGLDGKEKNKPSELSGGQQQRVSIARALMNGGEIILADEPTGALDSHSGE
NVLEILRQLHSEGHTIIMVTHDKNIAASANRIIEIKDGEIIDDTQKHPVQNTVNNQSKAK
SRFGFSKDQLMEAFQMSVSAIIAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILSNI
SGLGTNTMTIFNGTGFGDRRAEQMQNLTVNDANALAKQSYVQNVTPNSSSSGLLIYGNQS
FTSTNLKGIGEQYFDVEGMTLKQGRSITAQEVRDNAQVALLDESSKKSIFPNDNPIDKIV
MFAKRPFRIIGVVADRQMGAASSSLNIYAPYTTVMNKVTGGTKIDSITVKIADNVNTAVA
EKSLTEYLTVRHGKKDFFIMNSDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIML
VSVTERTKEIGVRMAIGARKSNILQQFLIEAILICMIGGISGIMLSLIIGGIFNVFMTDF
TMVFSTFSIVAAVLCSTLIGVIFGYMPAKNAAQLDPITALARE
>A0A080UJ41|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKNKATIKFGICIGLLCLSFTGFKPLYGSMHAEAKSIEDTKMTSCITNKKFVQLEKKFHA
KLGVYAIDTGSNKTIAYRSNERFAYASTYKILAAAAVLKNNSIEKLNEVIHYSKDDLVTY
SPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPNGFEKSLKQIGDHVTKSNRF
ETDLNSAIPGGIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRAGA
PIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSNRFTKDANYDNALIAEAAKVAL
NDLK
>F6D9T0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFHAVILGIIEGLTEFLPISSTGHLIVAAELMGLNQDDHNTAFKIIIQLAAILAVFAT
YAERFHPSQYRLWIKVFIAFLPIASIGFLLADSIEALFNVATVAWMFIIGGVIFLVVEHF
YKESQHTVRNLDQLTYKQTLWVGFAQIFALIPGTSRAGATIIGGMLTGLDRKTSAEFSFL
LALPVLTATSGYSLLKHYDAFAQTSFTPLIIGFIVSFLVAWLSIKLFLKFLQHFTFRAFG
IYRILLGSALLIWFV
>Q2FC64|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNK
>A0A0M8UDC7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MAIERVVVSDGAAGPYGVTVGADGGVWFTLVHAGEIGRLAADGTVTRHPLDSKDCGPAVI
AAGPDGALWFTRMRDHRIGRIAVDGQESSFALPTADCGPYGLAAGPDGALWFTEMNADRI
GRITVDGEVTEYPLPVAGGFPSMIAAGSDGALWFTLNQGNAIGRITVDGRTSLHPLPTEG
AAPVGITAGPDGALWFVEIGAGQVGRITVDGEVTEYPLPDRAARPHAVTAGPDGRLWFTE
WAAGRIGSLTPDGAYAGYELDGGEGGAAAEPHGIAVTPDGTVHAALELGAIARLTT
>E1KWF6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEILKVILLGIIEGVTEWLPVSSTGHILLLDEFIKLNMSDAFKSMFTVVIQLGAILAV
VVIYWNKVWPFKKGQSHLISISKSKMIMWAKIIVACIPAAIIGIKFDDYIEEHFYNYFVI
SLALIIFGILFIIIENKNKESHKKLVDSIDKITYKQAFIVGLFQVIAAIFPGTSRSGATI
LGGIAIGLSRTIAAEFTFFLAIPTMFGASLLKLVKFGFSFTAMEAFVLLLGTAVSFVVSV
ITIKFLMNYIKNNDFKVFGYYRIALGVLVLIYFGLIR
>A0A085U9T4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELNSIRRSYQSGEQTVDVLQDVSLEINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGIYRVAGQDVGQMDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGVGKNE
RRERAKMLLTRLGLGDRVSYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQADRIIEIKDGHIMADSGSKAPEKPIVSEPLS
LSPPAPSWQQLGGRFREALLMAWRAMASNKMRTALTMLGIIIGIASVVSILVVGDAAKQM
VLADIRAIGTNTIDIYPGKDFGDDDPSNRQALVYGDMAALKAQSYVNAVSPVISGSMRLR
FGNTDVAGSVSGVSSQYFRVYGIKIDQGTAITPDQVERQVQVVVIDRNTQRRLFPHMNDV
IGQVMLIGNMPATIIGVVEEKQSMFGSSKALRVWIPYTTMANRLMGKSYFDSITVRINDG
YNSKEAEQQLVRLLTLRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAVLVCLVGGALGITLSFAIGMAVQ
LVLPSWEVTFSTTALISAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>ZP_04174269|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLRGINHLCFSVSDLEKSIVFYEKILEGELLVKGRKLAYFNICGVWVALNEEVHIPRNEI
HQSYTHISFTVEQEDFNCLLKRLEENEVHILKGRERDVRDCESIYFQDPDGHKFEFHSGT
LQDRLNYYREEKPHMTFY
>N9S3C0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWKKTYFSSWESFKKQAFYIILATLITGVLGLALQSLIKHVFFGGASSFEIEHLFS
NSKLMAAALISAGVLIILSSRLDRGQQGEISLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQKAEEFSFALAVVLTPAVILKELYRLIHAQGLQTVAHGQMFHSMVPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGMYCIGFAVVVLCVN
>E4LJ75|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEITLMELLKTVILGIVEGLTEWLPISSTGHMILVDEFIQLNVTKAFMDMFLVVIQLGAI
LAVVVLNAGKLNPFLRRKSNAERRETFDLWGKVIFSCIPAGAIGLALNKYMEEHFMNAPV
VASMLILYGVLFILVERWNRVRTPRIENLSQLDYRTAFIIGVFQVLSLVPGTSRSGATIL
GGILFGASRYVATEFTFFLAIPVMFGASFLKLVKFGFHYTGAELVILAVGMVTAFIVSIL
SIRFLLRYIKRNDFTAFGWYRIALGVVVLAYLFAVGDPT
>ZP_02346647|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MANFFIRRPIFAWVLAIILMMAGALAIMQLPVAQYPTIAPPAVSISATYPGADAQTVQDT
VTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQ
EVQQQGISVEKSSSSFLMVAGFVSDNPNTTQDDISDYVASNIKDSISRLNGVGDVQLFGA
QYAMRIWLDANLLNKYQLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRL
KDPEEFGKVTLRVNTDGSVVHLKDVARIELGGENYNVVARINGKPASGLGIKLATGANAL
DTATAIKAKLAELQPFFPQGMKVVYPYDTTPFVKISIHEVVKTLFEAIILVFLVMYLFLQ
NIRATLIPTIAVPVVLLGTFAVLAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
MEDNLSPREATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATLLKPVSAEHHEKKSGFFGWFNTKFDHSVNHYTNSVSGIVRNTGRY
LIIYLLIVVGMAVLFLRLPTSFLPEEDQGVFLTMIQLPSGATQERTQKVLDQVTHYYLNN
EKANVESVFTVNGFSFSGQGQNSGMAFVSLKPWEERNGEENSVEAVIARATRAFSQIRDG
LVFPFNMPAIVELGTATGFDFELIDQGGLGHDALTKARNQLLGMVAKHPDLLVRVRPNGL
EDTPQFKLDVDQEKAQALGVSLSDINETISAALGGYYVNDFIDRGRVKKVYVQADAQFRM
LPGDINNLYVRSANGEMVPFSTFSSARWIYGSPRLERYNGMPSMELLGEAAPGRSTGEAM
SLMENLASQLPNGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAASLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGRGLI
EATLEASRMRLRPILMTSLAFILGVMPLVISRGAGSGAQNAVGTGVMGGMLTATLLAIFF
VPVFFVVVKRRFNRHHD
>D5DH82|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKTWKKMFRASKLQKMLPVFALSCAAVVGFSSSEVHAETVKCQRQETKSDREFAKLEDKY
DANLGVFALDTGTNKTVTYHPDERFAYASTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLDGPDGFKEALEKIGDNVTLPE
RFEPDLNEVNPGETHDTSTPRALAASLQKYVLGQALPEDKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPNGDPIVLAILSNRTEKDAEYNDKLIAEAAKQ
AVKTLKITRK
>AAC44147|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGGAGAADSLVCRCWRGS
PQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGL
LVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQML
IFTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>A0A090EVT3|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFSKLWHMLVKLPSDPQTRRFVIGILIAFLPAAVIGALAHDFIKTILFESPRLICIMLI
IGGVVLLVVDRINFKPVHHDVERFPLSVYLKIGLFQCLSLIPGTSRSGSTIVGALLMGVD
KRAAAEFSFFLAMPTMVGAFAFDLFKNRNVLTSADLPIIAVGFIAAFVAALIVVRFLLDY
VSRKGYALFGWWRLLVGTVGLLALMVWG
>A0A060KTF3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDEMFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ZP_02993449|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLILKAIIIGIVEGITEFLPVSSTGHMIIAGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIMSTLKNFLPSDRVPVKKCGLKFWINIGIASIPAAAIGIPFNDKIEEKLFY
PWPVTIALIVGAIWMIYAENRYRNNSKTTSIDDINAKQAIIIGLFQCLALWPGMSRSAST
IIGAWIVGLSTVAAAEFSFFLAIPAMIGASGMSLIKHNVFSTCSSIELIALAAGFIVSFI
VALVVIDKFIAFLKKKPMKVFAIYRIALGIILIILLYSNIIKWH
>A0A0S1ULF5|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MHPSTSRPSRRTLLTATAGAALAAATLVPGTAHASSGGRGHGHGSGSVSDAERRLAGLER
ASGARLGVYAYDTGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRIFYTQ
DDVDRADGAPETGKPENLANGMTVEELCEVSITASDNCAANLMLRELGGPAAVTRFVRSL
GDRVTRLDRWEPELNSAEPGRVTDTTSPRAITRTYGRLVLGDALNPRDRRLLTSWLLANT
TSGDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTAKTEQDAARDDG
LVADAARVLAETLG
>A0A0K9F523|FEATURES|UNIPROT_deepARG|beta_lactam|ACZ11_19375|antibiotic inactivation|1
MVNKKRFFQILAPIGLMLMVVGCSNDNKQVIQQSETEPNQTSENIVENTTIDKFEQLEKK
YDARLGVYAIDTGTKKTVEFREDERFAYTSTFKALAAGAVLQQNSIEELNKIVTYTSDDL
VTYSPITEKYVDTGMTLKDISEAAIRYSDNTAGNLLFKELGGPEGFETSLKKLGDQVTNA
ERIETGLNEAVPGETRDTSTPKALANDLQAYALGEVLTHEKQTMLVDWLKRNTTGDNLIR
AGVPKGWEVGDKTGGGGYGTRNDIAIVWPPNREPIVIAILSSRDKQDATYNDELIAQASE
VVMNVFNSTPNNK
>A0A0B7D7P9|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIIDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALV
VGGVIMLWAEKRQHEVHAETVDEIRWSDALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IGSHSYAAFAWYRIVFGLVILATWQFGWVDWSAAKA
>U1FS69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVILELIKGIILGIVEGLTEFAPVSSTGHMILIDDMWLKSTEFLGSESAFTFKVVIQLGS
VFAAAWVFRERYFEMLHIGKYKAEPLDGVDQKPKRLNLIHIVVGMIPAGILGLLFDDVIE
KYLFSVPTVMIGLFVGAIYMIVADMYSKKVKNPKTVDQISYVQAFIIGLSQAIAMWPGFS
RSGSTISTGVLMKMNHKAASDFTFMMAVPVMLGASGLSLVKNIEFIHANQIPFYILGFLA
AFIFGLISIKLFLHLISKVKLLPFAIYRIILVIIIAILYFGFGIGHNITGA
>A0A118TKF7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHGIKRIMAAALFSTCATATIGYAANDRRDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDNAGKYLPN
LQGSPFGNVSLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWRPTYSPGAYRTYSNVSI
GTLGLITATSMGQQDFAVPLSRHLLSPLGMKSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSMALNAMPVNEIKPPQAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>C6IWE4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKINGINHFCFSVSDLDRSMAFYEQVFGATPLVKGHKLAYFDLNGLWIALNQEDIPRDKQ
HRTYTHIAFSIDEGDFEAFQNRLRELNVEVLPGRERDQRDKKSIYFLDPDGHMFEFHTGT
LQDRLDYYKADKDHMIFY
>A0A0M2UH65|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRLAALAAAITLTLSHSAAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEDKLNLDAPAKRYHPALAGAP
IGDASVLELGAYSADCLPLQFPDAVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLKQMGLENTYLQVPASAQGLYAQGYDSADKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPEELPPALAQATAITQRGYFQVGTMTQGLGWERYPYPVTL
ATLVDGNGPQLIREPQATKRLQPALPPLPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNYPNEARVRAAFDILSGL
>S6AW64|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRLTAKFLLLALACGHGGVTLADDQDAAVQRAARDLMQEYRIPGLAIAITAHGEQRFYNF
GVASKESGQQVTQDTLFEVGSVSKTLTATLAGYAQANGRLDLGANPVRYLPELAGTALDK
VSLINLATHTAGGFPLQLPETVRNQRQLIDYYRAWRPSSAPGTQRTYANPSIGLLGVVAA
KSLELPYAKAMETLLLPKLGMPNTYIEVPASAMPRYAQGYDKADAPVRVNPAPLAAEAYG
VKTSSKDLLRFVEAQLGQGGLDGKVEQAIAATRTGYFKVGDMTQALIWEQYSYPVALDTL
LRGNGSQMVLESHPVSAIVPPLAPQKEVWVNKTGSTNGFGAYVAFVPSRGVGIVLLANRN
YPNEERVRLAYRILAELD
>A0A0Q9XLK8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLILELIKGLILGIVEGLTEFAPVSSTGHMILIDDMWLKSSEFLGSESAFTFKIVIQLGS
VFAGAWVFRERYFEMLHIGKYRASSVDGVGQKPNRLNLLHIIVGMIPAGILGLLFDDVIQ
KYLFSVPTVMIGLFIGAIYMIIADIYSKKVTNPQSVDQINYVQAFVIGLSQAIAMWPGFS
RSGSTISTGVLMKMDHKSASDFTFIMAVPVMLAASGLSLVKNFEYIHLDHIGFYALGFIA
AFVVGLIAIKTFLYLISKVKLIPFAIYRIVLVIIIAILYFGFGIGQGITGE
>A0A0B6RPL9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLDFDADQAKTFDVVIQFGAILAVC
WEYRRRIGAVVAGLPSRPEARRFALNVVIATLPAIVLALLLEKAIKRVLFSPVPVAFALV
AGGAVILWAEARQRERREPARVTSIDALTPLDALKVGLAQCCALIPGVSRSGATIIGGML
AGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFSADSIGLFAIGLAAAFVSAFACVRW
LLRYVASHDFTVFAWYRIVFGLVVLLVGYSGWLNWS
>A0A088T2N3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKFIEIIKTIIIGIVEGITEWLPISSTGHMILVDEWIKLDVSPEFMEMFLVVIQLGAILA
VVVLFFNKLNPLAFKKTKEERNDIWQIWFKVLIGVIPAAIIGLLLDEWLYNTLYNYITVA
IMLVVYGVLFIVIENKNKGKKATITSFNDLSYKTAFLIGMFQVLALIPGTSRSGATILGA
VILGTSRFIAAEFSFFLSIPVMFGASFIKILDFGFNFTGSELIILITGMVTAFIISIITI
KFLLGYIKKHDFKVFGWYRIILGVIVIVYFLVPYLVSIYI
>C6M509|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGANRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDSAT
SGSYQIDGIETAKMEPDELAALRRERFGFIFQRYNLLGSLTARDNVALPAVYMGMGGKER
STRAEKLLQDLGLEGKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVIEIIQKLHKEGHTVIMVTHDPGIAAIANRIIEIRDGEIISDSSKNPEIPESKIERIKE
KSSWLFYYDQFVEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSEKKILAD
ISAMGTNTISIFPGRGFGDRRSGRIKTLTIDDAKVIAKQSYVASATPQTTSGGTLTYRNT
DLSASLYGVGEQYFDVRGLKLESGRLFDEGDVKEDAQVVVIDQNTKEKLFGTDVNPLGKT
VLFNKRPLTVIGVMQKEENSFGNADVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQ
VAEKGLTELLKTRHGTEDFFMNNSDSIKQMVESTTGTMKLLISSIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLVGVGLSTAISLVFNQFVT
EFPMEISIGSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALSKD
>A0A0P8HSL1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEAAPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSSDNSAQLMMN
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAAKGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>CAS10898|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGENKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>D4KXF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLSFIEILKVIFLGIVEGITEWLPISSTGHMLLVDEFLQLNASDSFKEMFFIIIQLGAI
LAVVVLYWNRMFPFQFKDKAKPVIRKDIFSLWFKVVVACIPGAAVTILFDDYIEAHLHTP
VVIAIALIFYGVAFILIENWNKTREPKIKTLADISYQTAFMIGLFQVLSIIPGTSRSGAT
IIGGLIIGVSRVAVAEFTFYLAVPVMLGMSLLKLLKFGFAFTGAELVILGVGTVVAFLVS
IVVIRFLMSYIRKHDFKVFGWYRIVLGALMLVYFAFR
>YP_405557|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MIMKRHRNVNLLLILVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMAR
TLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFS
MARWMPETRPVDAPRTRLLTSYKTLFGNGGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMN
VWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>A0A119UZC5|FEATURES|UNIPROT_deepARG|beta_lactam|WM15_18725|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLALTLSACASPLANASSVGAATSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALFTQRVTYRQADLLEWSPVTEKH
VDTGMTVSELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQFAQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTTNDIGVLWPPARGPIVLTVYYTQARADAKRKDDVIAAATRIAIAALG
>R0DD00|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPVWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVATVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPSAASGKRRIRVLILGVNGFIGNHLTERLLNEENYDVYGMDIGNNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILDLVEGSPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIEELATLLLDSFDKHPLRGHFPPFAGF
QIVESRSYYGKGYQDVAHRKPNIDNARRCLDWEPSIAMRDTVEETLDFFLRSVDITERAS
>A0A0R3N045|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSDVVKAVVLGIIEGVTEFLPVSSTGHMLVAQRFFGLGEGAFWQSFVVLIQLGAILAIV
MLYFVKLSRVALGMFTNPDDRRFVIGVLLAFLPAVVIGLVAGKYIKEFLFNPWVVCFTLI
VGGAILLWVDQLYLKPTQHDATRYPLLMYLWIGIAQCVAMIPGVSRSGASIVAAMLLGGD
KRSAAEFSFFLAIPTMIGAFAYDFYKNRAEMTTDHIGIVAIGFVVSFITAAIVVKTFLTY
VTRHGFTFFAWWRVVIGMLGLIALALGK
>AAA62025|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MIMKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMAR
TLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFS
MARWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMN
VWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>A0A0K6KXM0|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKLKNKASIKFGICVGLLCLSITGFTPFFNSTHAEAKSIEDTNMASCITNKKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAK
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVVAILSNCFTKDANYDNALIAEAAKV
VLNDLK
>A0A0A8EDG1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNQVSIEEHAVADSAAGPYALTTGPDGALWFTLVHSGRIGRLVPGEEPTSHRLDPTCGPT
LITPGPDRALWFTEYRADRIGRITTDGVIDEFAVPTPGCGPFGIATGPDGALWFTETAAD
RIGRITVDGHITEFPLPVTGAFPSAITAGDDGMWFTLNQANAIGRIDMNGAVTLHPLPTE
AAAPVGIAAGRDGTLWFVEIAAGQIGRITPDGQITEFPLPDRTARPHAVTVDGDGTAWFT
EWGGNRVGAITPDGSLTVHGLPTPHSEPHGITVGPDGALWTALEIGALARIAPAGSTA
>A0A0K0HB05|FEATURES|UNIPROT_deepARG|aminoglycoside|aac|antibiotic inactivation|1
MEIRKMNKTDLEHWRELRKQLWPGHPDDAHLADGEEILQADHLTSFIALDGGVVIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSCRQRGVAKQLIAAVEQWGAANGCLEMASDTSPEN
TVSQSVHQALGFEETERVIFYRRRC
>I6Z9G4|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
RMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDE
RFPMCSTSKVMAAAAVLKQSETQKQLPNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSA
AALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPR
AMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTN
DIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAA
>A0A0R1KWN1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSQSTQFTDMFNVVIQLGAIMAVV
VIYFHKLNPLSPKKTHVEQHDTWILWFKVVVAVLPSVVIGLLFNDWMDAHLMNWQVVSAM
LLLYGILFIVIENRNANRQPQFTDLGRLSYKTAFIIGMFQLLSLVPGTSRSGATILGGIL
IGTSRYVATEFSFFLAIPTMFGASLLKVYKYFSNGGAFTGLQTAILLTGMFVSFVVAYFA
IRFLLNYIQHNNFKVFGWYRIVLSIIVIVYFGFLAH
>F1CKJ3|FEATURES|UNIPROT_deepARG|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
FAMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPVAEKHLDTGMTLAEFSAA
TIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPQA
MAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGDKTGSGE
>S6HM19|FEATURES|UNIPROT_deepARG|aminoglycoside|CFII64_02016|antibiotic inactivation|1
MIKRCTLLDHNSWLPLRTALWPDSAADSDHDKQTILREPERYLVLVFTDENDNALGFAEA
SIRTDYVNGTHSSPVAFLEGLYVQPASRGQSIARQLVAGVEQWALEMGCTELASDALVEN
RVSHSMHEALGFEETERVVYFLKSLGVDREQ
>A0A127SZE9|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRTQQMSELENRIDSLLNGKKATVCIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMAQLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAQTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVY
DAMR
>A0A0F6VSN5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPPHEGVGKGRLSLIHILLGMVPAVVLGLVFHDFIKSLFNPIN
VMYALVVGGVLLIIAEVLKPKEPKAPGLDDMTYRQAFFIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSMGFLTMADLPMFAVGFVTAFVVALVA
IKTFLHIIKRISFIPFAIYRFIVAAAVYAVFM
>N9KZ67|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSNVFVIAIQMGAIAAV
IYEYWTRLWGAATGMFTGEETGRRLGFGLILASLPIILIGLTFGQTVKAMLFNDIAVAIG
LIIGGLIIIWIEKHPPQVRAQEVEDLTYKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYDVFQTTQDWTVLSVGIIVSFISALILIRAL
VAYVAKRDFMIFAWYRIVSGLLILLFAYTGWTLW
>A0A080FPF0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTFPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>B9BS30|FEATURES|UNIPROT_deepARG|beta_lactam|BURMUCGD2_4198|antibiotic inactivation|1
MTHSSQRRILLLAAAAAPLALSVGACAARDAAVSDAASPVGAAPASFAALERAAGGRLGV
CAIDTATGRRTLHRADERFPFCSTFKAMLGAAVLAQSVAHPGLLQQRVTYGRSDLVSYSP
VTERHVDTGMTVAELCAATIQYSDNTAANELMKLIGGPAAVTAYARSIGDDTFRLDRWET
ELNTALPGDLRDTTTPAAMAASLRVLVLGDALPAAQRAQLIEWLRGNKVGDKRIRAGVPA
GWRVGDKTGTGDYGTTNDVGVMWPPSRAPIVLAVYYTQTRADAKAKDDVIATATRIAIAT
LG
>NP_792892|FEATURES|ARDB_deepARG|multidrug|MexF|antibiotic efflux|1
MNFSKFFISRPIFAAVLSLLILIAGAISLFQLPISEYPEVVPPTVVVRASFPGANPKVIG
ETVASPLEQAITGVEGMLYMSSQATADGKLTLTITFALGTELDNAQVQVQNRVTRTEPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDQRYDMLYLSNYAVLNIKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTATDVVNAIREQNRQVAAGQLGSPPSPNATSFQMSINTQ
GRLVSEEEFENVVVRAGPDGEITRLKDVARIELGSSQYALRSLLNNQPAVAMPIFQRPGS
NAIDISNDVRARMAELKKGFPEGMDYSIVYDPTIFVRGSIEAVIHTLFEALILVVLVVVL
FLQTWRASIIPLVAVPVSLIGTFAVMHMFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIELGLEPVEATHKAMAEVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLKAHDAPKDRFSRFLDKILGGWLFRPFNRFFEKASHGYVGTV
ARVIRSSGIALLVYAGLMVLTWLGFASTPTGFVPSQDKQYLVAFAQLPDAASLDRTEDVI
KRMSELALKQPGVENAIAFPGLSINGFTNSPNNGVVFVALKPFDERKDPSLSANAIAGAL
NGQFASIQEAYMAIFPPPPVQGLGTIGGFRLQIEDRGNLGYDELYKETQNIITKSRSVPE
LAGLFTSYTVNVPQVDAAIDREKAKTHGVAVSDIFDTLQVYLGSLYANDFNRFGRTYQVN
VQAEQQFRQDADQIGQLKVRNNLGEMIPLATFVKVSDTAGPDRVMHYNGFITAEINGAAA
PGFSSGQAQTAVEKLLREELPNGMVYEWTDLTYQQILSGNTALFVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAIAGVIIAGSDNNIFTQIGLIVLVGLACKNAILIVEFAKD
KQAEGMSPLDAVLEACRLRLRPILMTSFAFIMGVVPLVLSSGAGAEMRHAMGVAVFSGML
GVTFFGLLLTPVFYVLIRNYVGRQEARKAAKAQKLQNLPAEMH
>YP_002039320|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDRFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMNFGELSAQLGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPYPVKDIRVLSRITTEAFNQRRKTIRNSLDNLFSVETLTE
MGIDPAMRAENISVAQYCQMANYLSENAPLKES
>R5YD54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIEILKAVLFGIVEGITEWLPISSTGHMILLNEIMPLKVSDEFYSMFEVVIQLGAIMA
VVILFWDQIWPFGKKNNNEPLTKKWIGAWIKTDIFKLWFHILVSMVPAAIIGILFDKTFE
RLFYNYTTVAIMLILFGIAFIIVETRHKGKNAKINTLADIGYDTAILIGVFQVIAAIFPG
TSRSGATIVGALLIGVSRTVAAEYTFFLAIPVMFGASLLKIWGFGLHFSLDEAVILIVGM
VVAFVVSLIVIQFLMGYIKKHDFKVFGWYRIVLGAIVLICGILGAIHG
>A0A0U5QI49|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEITSVNHICFSVSDLNTSIQFYKDILQGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNE
ISHSYTHVAFSIDEEDFQKWIQWLKENQVNILKGRPRDIKDKKSIYFTDPDGHKIELHTG
TLKDRMEYYKCEKTHMQFYDEF
>A0A0J1L692|FEATURES|UNIPROT_deepARG|chloramphenicol|ABW03_04210|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMTVTRCTYSLVIDLDITKLYAILKEKRLKVYPVQIYLLARAV
QKIPEFRMDQVNDALGYWEILHPSYTILNKETKTFSSIWTPYDENFGRFYKSCVTDMDTY
SKSSSLFPTPHMPENMFNISSLPWIDFTSFNLNVSTDITYLLPIFTLGQFKMKEEKITLP
VAIQVHHAVCDGYHVGQYVEYLRWLIEHCEEWLND
>R9LDI7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKINGINHFCFSVSDLDRSMAFYEQVFGASPLVKGRKLAYFDLNGLWIALNQEDLPRDRQ
HRTYTHIAFSIDEGDFEAFQNRLREFNVEVLPGRERDARDQKSIYFLDPDGHMFEFHTGT
LQDRLDYYKVDKDHMIFY
>A0A0Q1G353|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFKVIVLGLVEGLTEFIPVSSTGHLILVGNVLKFTDQFADSFSVIIQLGAILAVVILYR
RIFLGLFNFKQPGFYGKREILLLFLTSVPALMFGALLHGWIKNYLFSVLTVSIALILGGV
GMILAEKFSRKDKDTLDQITYKHALLIGLFQSISLFPGMSRAASTISGGLVLGYDRKIAA
QYSFIAAVPIMFAACGYDALQNWEVLTAKGNLLLLGVGFAVSFVVALAAVKVFIEILKRW
SLTSFAIYRIILGFLMIFLLLGGYVSIN
>A0A0J5VK03|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLLVAACVTATAGRAGAATPDDLHDTVTRHIAPLMKQYAIPGMAVGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVGKYLPA
LQGKPFGVVTLLDLGTHTSGGMPVQVPDSIRDDAGLIRYLDAWRPAHAPGTYRTYSNVSV
GMLGWLTAKAMHKDFAVLMEQRLFPALGMTHTYINVPEARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLIETAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNSMKMLRDGLPASAIKPPLAPSANTWINKTGSTNGFSTYVAFVPSKRIA
IVMLANRSFPNEDRVKAAYGILGALDGRR
>A0A150DEJ4|FEATURES|UNIPROT_deepARG|beta_lactam|AT261_08945|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTNQTKQETTGNDSFAKLE
KEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTRE
DLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVT
NPERFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTGDNL
IRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEA
TKIALGVLKAKNK
>A0A060KZ67|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGAM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>B8D6X4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDLHQIIVSIIIGVIEGITEFLPISSTGHMIIASHWLKIDNENTKILEIFIEFGSALSI
LYFFHKKILRILKFNINVKKTNTKNLHIILAILPTIFFGLLFYKKIKLLFNTYNVMYALI
LGGIFLLISEIFKPKKYKTCSINDISLLQSAIIGFFQIFCLYPGFSRSGATIGTAILLGI
KRSVAIEFSFIISIPLIMGASFYDFINNMHNFKILDLPIFFIGFMISFIVSILCIKKLLK
IINRTSLIFFGIYRFIISGLIYFIN
>A0A0T9KS05|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEDVLTMKTSIISSLIFATLATSPLYASEQKILTQQQIATIVNNTLAPLIEKQDIPGMAV
AVFYDGKPLFFNYGVADIQNRRPVTENTLFELGSVSKTFTGVVGGYAEQTGILNLSDSVT
KYSPELTGRQWKDISMLNLATYTAGGLPLQIPDSVTSMKLLWQYYQQWQPQWAPGVMRNY
SNASIGLFGTLAVKKSNLSFEDYMAQHVFQPLKLTHTFITIPDSMQSDYAWGYKDGQPVR
VTPGVLAAEAYGVKSTAQDMVKFMQANIEPEKLLADNDKLKKAIISAQSRYYRSGNMFQG
LGWEMYDWPINPQEVIDSSSNEIALQPHKINALMPPYSAVPASWVHKTGSTNGFGAYIAF
IPEKKIGIVMLANKNYPNPVRIEAANHILQSLY
>A0A0U4JR88|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGGKPVPHEGQTAGQLKLGHILLAMIPAVALGLLLHDMIKSLFEP
KNVMYALVVGGLLLLAAEWLKPKKPSAVGLDDITYRQAFLIGCFQCLALWPGFSRSGSTI
SGGMLVGVSRFAASEFSFILAVPMMIGASGLDLYKSLHFLTLNDLPMFAVGFATAFVVAL
IAIKTFLQLIKRISFVPFAIYRFIVAAAVYMVFIH
>A0A0U5L8V7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCTGITALLRAGYSIAAIFTHADATSENHFFGSVARLAAENGIPVYAPD
NVNHPLWIDRIRAMAPDMLFSFYYRHLLGEEILACAAQGAFNLHGSLLPQYRGRAPLNWV
LVNGETQTGVTLHRMVKRADAGDIIAQATQEIDAEDTALTLHHKLVRCADNLLNDALPVM
LQGKIAGRPQREEQATVMRARTPDDGRLIWSQAATQLHNLVRAVTDPWPGALAWAGTTKF
TVWKSRVVAVAGDAAGKPGTVISTAPFVIACGEGALEIVTGQADNGVYMNGSQLAQSLGV
VPGALLGSQPVATAKRRTRVLILGVNGFIGNHLTERLLQDDNFEVFGLDISADAISRFIG
HPRFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIR
DCVKYDKRIIFPSTSEVYGMCDDDSFDEDHSRLVVGPINKQRWIYSVSKQLLDRVIWAYG
DKQGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGSQKRCFT
DISDGVEALFRIIENRAGNCDGQIINIGNPHNEASIRDLAEQLLASFERHPLRAQFPPFA
GFREVESSSYYGKGYQDVEHRKPSIRNARRLLEWTPQVAMETTIDNTLDFFLRTVEVQGD
AS
>G3E3I9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSSI
INGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKN
YPNPARVAAAWQILNALQ
>Q9XAK7|FEATURES|UNIPROT_deepARG|glycopeptide|SCO3595|antibiotic target alteration|1
MARLKVGIVFGGSSEEHAVSVKSAQEVARNLDTEKYQPFFVGITKDGAWRLCDGPGQDWE
NGDCRPVVLSPDRSVHGLLVLEQGQYRSVRLDVVLPVLHGTLGEDGATQGLLELSGIPYV
GCDVQSSALCMDKSLAYVVARSAGIATPDFWTVTGDETIDPGRLTYPVFVKPARSGSSFG
VSKVCRPEDLATAVESARRYDTKVLIEAAVVGSEVGCAILGNDPDLIVGEVDRIALSHGF
FRIHQEEQPENGSENSTPVVPADIPTEKRSLVQETAKAVYRALGCRGLSRVDMFLKEDGE
VVLNEVNTLPGMTSYSRYPRMMAAAGLPLSEVIDRTLSLALTGKLR
>A0A0U2CIP0|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGNKKVKQRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPPAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>YP_002633439|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MSKQLITLYFNIFLVFLGIGLVVPVLPVYLKDLGLNGSDLGILVAAFALAQMVISPFGGN
LADKLGKKLIICIGLVLFSVSEFIFAMSSSYTLLIISRIIGGFSAGMVMPGVTGMIADIS
PAKDKAKNFGYMSAIINSGFILGPGLGGFMAEFSHRLPFYFAGTLGIAAFICSIFFIHGA
KRQTTDGFTQIEPQELAKINIKAFITPVIITFVLAFGLSAFETLFPLYTADKAHYTPKDI
SISITGGGILGAVFQIFLFDKFMKYFKELTFIQFALFYSALVLFFLIIAHSYWSIMLISF
IVFIGFDMIRPAVTNYFSNIAGDRQGLAGGLNSTFTSMGNFIGPLVAGVLYDFDFEFPLY
MSIAVMLLGIFIIFVEKTIRSKKQTQEG
>A0A103FMX8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIIEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIVDVVTGLPAQREARRFVMNVVIATLPAISLALLFEKTIKSVLFAPVPVAVALV
VGGVVILWVEGRQRERGAPARVQSIDALTPLDALKVGLAQCFALIPGMSRSGSTIIGGIL
FGLDRRVATEFSFFLAIPVIFGATLYETAKDWRAFDADSIGLFSIGLVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIAFGLFVLLVGYSGWIEWT
>A0A084JQK8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILNFIEILKVIFLGIVEGVTEWLPISSTGHMLLVDEFITLDMSGVFKEMFFVVIQLGAI
LAVVLMFWDKMFPFQFSDKSQSIIRKDIFSIWFKVVIACIPGAIITILFDDYIETHLHTP
MVIGAALIFYGIAFIVIEEWNKKRLPTTQQIEDITYYTAFLIGLFQVLSIIPGTSRSGAT
IIGALLIGVSRVAAAEFTFFLAVPVMFGLSAIKILKFGFTFTSAELFVLTLGMAIAFAMS
VLVISFFMGYIKKHDFKVFGCYRIILGVIVCLYFVFK
>A0A0V9REN6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNSPAVEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0I9NAJ4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGSVEVLKGITLSINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDIAQLNGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSERRA
RLARAHDLLVRLGLGDRADYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAGQAERIIEIRDGEIVRNPPGSRQGGGLRARQQP
EPSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
ETAEKQLLRLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAFILQLFL
PGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0B4DVE4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDWLAAIILGLVEGLTEFIPVSSTGHMLLLGHFMGFESAGKTFEIVIQLGALLAIISVY
FKKLWTLATRWPFDAEARRFLIGLLIAFAPAVVIGFLAYDFIKTVLFETPQVVCIALIVG
GVILLLLDRMDKTPRWLDAEAYPMRIYFLIGLFQCLAMIPGVSRSGATIAGGLLLKTDKR
SAAEFSFFLALPTMGAAVAYDLLKNHKTLDFSDIGLIVVGFVVAFISALAVVRFLLDFVS
KRGFGVFAWWRIVVGVVGLALLQAGF
>A0A089LCT4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIVKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
ILAVVIIFRNRFIDLLGLKKFSRKELTVVPEGQPQAPAEGRLKLAQVIVGLIPAGIFGFL
FEDYIDEHLFSTSTVLIGLVVGAVFMICADRFAPKTITTESVDQITYRQALSVGLIQCVS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLLKNWQYFTLDALPFF
IAGFISAFLFALLSMRFFLKLINRIKLLPFAIYRIILAGVVYLIWF
>A0A0J6LLC7|FEATURES|UNIPROT_deepARG|aminoglycoside|VL04_15770|antibiotic inactivation|1
MTIAPACSRPHAWLALRAALWPDCPSDEHRREIDAQTAEPARYAAFVATDASCGAIGLIE
VALRHDYVNGTRHSPVGFIEGLYVAPAHRRSGVAGRLLGAAKDWSRDRGCAELASDTGLD
NLVSQQAHQALGFEETERVVFYRMAL
>W8RUK8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWVVFQALLLGVVEGITEFLPISSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVV
WEYRRRIIDVVVGLPKERKAQKFTANLLVAFLPAVVLGVTFADLIHEYLFNPITVATALV
IGGVVMLWAEKRSHRIQAETVDDMHWTHALKVGCAQCLALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQSGDVPVFAVGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIIFGIAILATWQFSLIDWSTATG
>D9RAF8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGFDFMEILKAVFLGIVEGITEWLPISSTGHMLIVDEFLQLNASAAFKEMFFVVIQLGAI
LAVVLLFWDKMFPFQFNNRNKAMIKKETFSIWFKVVIACIPGAVVTILFDDYIEEYFHTP
AMIAAALIFYGIAFLVVELWNKKRTPITNDLSDITYQTALMIGLFQVLSIIPGTSRSGAT
IIGALLIGVSRVAAAEFTFFLAVPVMFGLSAIKILKFGLAFTREELLILGIGTVVAFAVS
ILVIKFLMSFIKKHDFAVFGWYRIVLGAILLLYFKFH
>A0A0G3SIF7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_2|antibiotic efflux|1
MAALLQLSGIRRSYRSGEQTVEVLKGISLSIEAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLSDDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAVALLRRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCAQGHTVILVTHDPAVARQAERIIEIRDGEIIADSRPAPQENAQAKPLAL
AAAAASWRQVGGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTYRQSLKYGDLDALREQPYISALSPSISSSMRLRL
GNVDAAANVNGVSEQFFRVYGMSFTQGVGIDPLQVQSQAQTVVIDANTQRRLFPHQKNVV
GEVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNNYFDSITVRIRDGY
DSKEAEQQLSRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLAVQL
VLPGWQISFPPAALLSAFLCSTGIGVVFGYLPARNAARLNPIDALARE
>A0A081RZ01|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNALLELRGIERSYSAGEQQIKVLDDVTLSIHSGEMVAIIGASGSGKSTLMNILGCLDKP
SRGEYRVAGQNVAELNNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAIYAGAAKTV
RRQRAIELLGRLGLDKRVNYRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCEQGHTVIIVTHDPKIAVQAQRIIEIKDGHIMNDSGSQLSKTVTEAPPIT
AKISSIRQIFGRFNEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVTILVIGDAAKALVL
SDIKEIATNTISVYPGEDFGSDDPASKQALKIADVNAIRAQPYILAVSPDIEGGARLRKG
NIDVAARVSGIGDEYFQVYALRFAQGMGFTSDMVRRQGQVVVIDKNTQRKLFPHQKNVIG
EVILMGNMPATIVGVIAERKSALGSDSSLHVWLPYSTMTSRLLNRNYLDSITVRIKDGHN
SKEAEQKIVRLLTLLHGKKDIFTYNTDMLIKTVEKTTRTLQLFLTMVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAILVCLVGGILGIALSYTIAFIAQLA
LPGWSFVFQPVALLSAFACSTAIGVIFGFLPARNAARLDPIDALARE
>A0A071LQF6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCVGLSALLEAGYEVSAIFTHQDNAGENPFFGSVARIGAERGIPVYAPD
DVNHPLWVDRIRALAPDVIFSFYYRNLICQDILECAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHKMVSRADAGDIIAQAAVAIAPEDNALSLHHKLTAQARTLLSDILPKI
RNGNAPGRAQDNSQASYVGRRTPEDGRLDWNRNASDLHNLVRAVAHPWPGAFSYAGITRF
VVWSSRLVDGYPAARAGTVVSTSPLVVACGSGALEIVTGQADNGVYMQGGQLAQTLGLVE
GAILSHAPVVAAKRRTRVLILGVNGFIGNHLTERLLQDENYEIFGLDIGSDAISRFLGNP
HFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDPVFDEDHSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGRQKRCFTDI
SDGIEALFRVIQNKDGKCDGQIINIGNPENEASIKELAEMLLASFERNPLRKHFPPFAGF
REVESSTYYGKGYQDVEHRKPSIRNAQRLLGWTPTVEMERTIDETLDFFLRTVELPEDNA
>BAH62608|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGSVEVLKGITLSIHAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDIAQLDGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSERRA
RLARAHELLVRLGLGERADYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIVEIRDGEIVRNPPASRQGGGLRARPQA
EPSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
ETAEKQLLRLLELRHGKKDVFTWNMDSVLKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVALSLMIAFILQLFL
PGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>R4KKX1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIWVMFVALVLGMVEGLTEFAPISSTGHMIIVDDILLHSKELFSASTANTFKVVIQLGS
ILAVVVVFKARFMDLLGLRKGVSDDQLHTKKLSLKHVFVGLIPAALLGFLFEDYIDKYLF
SIQTVIIGLVLGAILMLIADWYRPKASKIETVDQITYKQALGMGLFQCIGLWPGFSRSGS
TISGGVLLGMNHRAAADFTFIMAVPVMLGASGLSLIKNWQYFTIDALPFFILGFISAFLF
ALLSIRFFLKLINRIKLVPFAIYRILLATLIYVLY
>R4WED9|FEATURES|UNIPROT_deepARG|beta_lactam|A9196_14360|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFVKANIKGVDDKGLQQAIALTHQGRYSVGEMTQGLGWESYPYPVSE
QTLLAGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHAILSKLAP
>C8C0G3|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-48|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A010L303|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-10|antibiotic inactivation|1
MRFNKISCLLLSPLFIFNTSIYAGNTSKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKKL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PALLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>N8XF94|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFELVKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRQKIIELVRGFFSGDIHARRFTINVLVAFIPAVVIGVLAVDFIKQVLFSPLVVAFAL
IIGGLIIFAVEARKFEPKTIEATDITLKQAILVGFAQCVAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLIRNADVLTADNLMNISVGFVAAFIAAILVVKALVK
FVEKHTLRVFAWYRVVLGIILLIVFL
>D1LFC7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
AAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMN
KLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLG
HALGETQRAQLVTWLKGTTT
>A0A0C2RXN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWLAVQALILGVVEGITEFLPISSTGHQIIVADLIGFGGERAIAFNIIIQLAAILAVV
WQYRDRVLGVIVGLPKERPAQNFTLNLLVAFIPAAVLGVAFADLIHEYLFNPITVATALV
IGGVIMLWAERRDHSVQAETVDDMNWKLALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQSSDLPVFAIGFVTSFVFAMLAVRALLKF
IGNHSYATFAWYRIVFGIVILATWQFGIIDWSTAQG
>Q58PW4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKKTRTTLLLCTALAVTPWFSAVAAPMTQQQVTRLVDDTIKPLLEKQHIPGMAVTVLYQ
GQPQFFNYGVAETEHQRAVTQHTLFELGSVSKTFTGVAAGVAIQTGLINLNDRVALHCPE
LNGAQWQKITLLNLATYTAGGLPLQLPDEVTDTASLQHYFQQWQPQWPAGTMRNYSNASI
GLFGALAVKNSGLSFADYLNTSVFQPLKLTRTFITVPPSAQADYAWGYKDGQPVRVTPGM
LAAEAYGVKSSTGDLVKYMQANINPASLSSDNKELAKAIVSAQTRYYRVGNMYQGLGWEM
VNWPISPDEVIAGSGNDIALHAWPATALKAPQSAVASSWVHKTGSTNGFGAYIAFIPEKQ
LGIVMLANKNYPNPQRVAAAWQILQALDESKQEDAGDKTAFCHPH
>A0A0F0YAQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRLPQREGEGSGRLTLIHILLGMIPAVVLGLVFHDAIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>J8CMK1|FEATURES|UNIPROT_deepARG|beta_lactam|II5_01808|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSESLKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALGVLNAKNK
>YP_002238177|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYFVEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVVAQLNGSGRRDRIAQQVRQGFWLAGFVSVLIMVVLWNAGYIISSMHNID
PLLAEKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATASVYWVMFASMLWWVRRARSMRDIRCAERFSRPDVAVLLRLVQ
LGLPIALALFFEVTLFAVVALLVSPLGIIDVAGHQIALNFSSLMFVLPLSLAAAVTIRVG
FRLGQGSTIDAQVSARTGVGVGVCLAVFTAIFTVLMREQIALLYNDNPEVVLLASHLMLL
AAIYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYLLALTDMVVPRMGPAG
FWCGFIIGLTSAAIMMMLRMRFLQRQPSSIILQRAAR
>Q9RNI5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEVSNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADCAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>A0A0P0AF17|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-139|antibiotic inactivation|1
VSLLLGSVPHFAQTADVQQKLAFFERQSGGRLGVAKINTADNSQILYRADERFAMCSTSK
VMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAEL
>A0A0G8BAP8|FEATURES|UNIPROT_deepARG|aminoglycoside|AAY84_08625|antibiotic inactivation|1
MIVICDHDNLDAWLALRAALWPSSSPEEHRAEMREILASPHHTAFMARGVDGAFIGFAEV
ALRYDYVNGCESSPVAFLEGIYAVERARRQGWATRLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>J7K6F5|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDCFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLP
VKAAAYELADNLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATQPNAGLRARDELVRDWPAMAGAWRP
>YP_001583349|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIATAAVATLAVVGLGTFGAMRVNANAPEKAAAPLTEVDVATVVPQTVTDW
QSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
AAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREAAANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAPPLTTLVSVSPIYASFDADEQTYLQYINGARN
GRKVPVELGLANETGYSRSGEIDSVDNRLDTSSGTIRVRARFDNADGTLVPGLYARVKVG
GSAPHAALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQPGMQHGNQRVIVSGLAAGDRV
IVNGTQRVRPGEQVKPHMVPMTGGDAPSAPIASTAKPAAPAKADS
>A0A062Y960|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0E4H934|FEATURES|UNIPROT_deepARG|aminoglycoside|PRIO_2416|antibiotic inactivation|1
MNIQVEPILDRFTAIFKEELKADLAGIYLHGSLAMGCFNPVGSDIDILVVIRTPLPHYRA
ARIAQKLLSLRDEIANGLEISVIREAVLASVTCPTPCELHFSDYHRERYRVDADYLCGGY
EDADLASQIAVAYYRGRTLYGEPLARQYPPVNPSAYLSSILHDIADAAAEIMDNPMYITL
NLCRVLYYLQEGKIASKREGGEWGTASLPPEFKELVQVCLNQYNGVPEDRQVQPGQWTAF
AGYMLGVIDKKAAGDA
>A0A107KA39|FEATURES|UNIPROT_deepARG|beta_lactam|WL80_09825|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLALTLSACASPLANASSVGAATSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALFTQRVTYRQADLLEWSPVTEKH
VDTGMTVSELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQFAQWLLGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTTNDIGVLWPPARGPIVLTVYYTQARADAKRKDDVIAAATRIAIAALG
>A0A009L9T2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLIKGFFSGDAEARHFAFSVLLAFIPAVVIGVFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESIKFEHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIAVGFVAAFISALFVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>A0A0W2ZE37|FEATURES|UNIPROT_deepARG|beta_lactam|ASU65_19610|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILKALQ
>J2DH47|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARLAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLGDEILNLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGDIVAQQAVAIGADDAALTLHRKLCAAATELLSRALPAI
LAGTTDERPQDHSQATYVGRRTPEDGRLDWEQPAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLPAAKPGTVISIAPLIVACQDGALEIVTGQTERGVYMQGAQLAQALGLVS
GAVISSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPENEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWEPTVEMEETVEHTLDFFLRTVELTDDKN
S
>A0A0A0CVC8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKQFSVLTGGLLLAASLGAQASNTPDQARLTNTVDKTIHSLMQEYDIPGMAIAVTFRGQ
HFFYQYGDASKENNTPVTKETIFELGSVSKTFTGSLISWAQVTGAISLSDKASHHFQPLA
GSAFDNINLLNIATYTAGGLPLQFPDEIDSNSKMVDWFQHWQPKYTPGTYRQYSNPSIGL
AGYIAAQSLEKPYSMLVKNQILSPLGLHHTWFNVPAQEMKNYALGYSKENKPIRINPGVL
AEEAYGLKTSAQELIGFVDANIDPSRVGDSKLAQAIRATHTGYYRVGEMTQGLGWELYHW
PVTLEQVLSGNSAQLAFQANKTTELSPPEPPTDALFINKTGSTNGFGAYVAFVPQEQMGI
VLLANKNYPNEARIKAAWQILKALK
>AAC27754|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEES
VTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEP
VRRDGISIEKAADNAQIIVSLTSEDGRISGVELGEYASANVLQALRRVEGVGKVQFWGAE
YAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLT
TPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVA
TEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQN
FRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFS
AFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLV
VYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSP
SAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFA
INMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADV
TKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIER
IASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEA
ARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFV
CVGRVFDVVPRRPGGAQAALEAK
>I4KK95|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHMAKSILAGTFFLVCGAAPGFAQDRIEDAVNATIQPLMKQQDIAGMAVAITYNGQRHYF
NYGVASKDTKKPVTDQTLFEIGSISKTFTATLGAYAQAQGKLSLADPASRFAPELRGSAF
EGISLLNLATYTAGGLPLQFPAEADHPDRMFSYYTTWKPLYPAGTQRLYSNPSIGLFGYL
AARSLERPFDEVMERTLMPGLGLQHSYVRVPQDQLGRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSSSDLMRFLEANLRPEKLDADLKQAIATTHTGFYRVGGMNQGLGWEFYPAPFTLD
DLLAGNTPQMALTPQKVEPLNPPRPAPDGAWINKTGSTNGFGAYAAFVPGKDMGIVMLAN
RNYPIEERVKAAHRILAALDVK
>CAR59960|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAAL
AAIAFFGLQCAMPETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIA
QSPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLI
IAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNLQTV
>V8BNK3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVLQTIILAIVEGLTEFLPVSSTGHMIITQGLLGIESTPFVKAFTIIIQFGAILSVVCL
YWRRFFRLDHTPVPPNSSVFKAFIHKWNFYWKLLVAFVPAMVIGFVGKMSGLIDRFLESV
EVVAIMLVVGGIFMIFCDKLFNKGKEETVLTERRAFNIGLFQCIAMIPGVSRSMATIVGG
MSQRLTRRAAAEFSFFLAVPTMAAATALDVWEVFFGSDANTSWATPDNLAMLALGCVVAF
VVALLAMKWFVAFLTKYGFKAFGVYRIIVGGFILLWLLLGHNLSMVS
>E3CK52|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLVIELIKAVFLGIVEGITEWLPISSTGHLILVQEFVKLNQGHAFNELFNIVIQLGAILA
VMVIYFERLNPFQKGKTTKEVRLTWQLWMKVVIACIPSAIIGLLLDDWMDAHFSNFTSVA
TMLIVYGIAFIWIERRNRNVEPQVTDLARMHYKTALYIGLFQVLSIIPGTSRSGATILGA
ILVGTSRSVAADFTFFLGIPTMFGYSGLKFVKFLLEGHHLTFAQWLVLLVASMVAFAVSM
VVIKFLTNFVKKHDFTVFGWYRIVLGIVLLLYAAARVLPA
>AAK91782|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYPNLAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>A0A126VLL6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELTGICRSYQSGEQTVDVLKNVTLSIDAGEMVAIIGASGSGKSTLMNILGCLDKP
SAGTYRVAGQDVATLNGDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGVGKAA
RRERATALLQRLGLGERVSYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLREQGHTVIIVTHDPTVAQQAERIIEIRDGEIVNDSRPVSAPNPQAKPLEL
AAPAPSWQQVGGRFREALVMAWRAMAANKMRTMLTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPAYRQSLKYDDLEALREQPYVGALSPNISSSMRLRM
GNVDAAANVSGVSEQFFRVYGMAFSQGSGIDPLQVQSQAQVVVIDANTKRRLFPHQKEVV
GEVILVGNMPATVVGVAQEKQSMFGSSKTLSVWVPYSTMANRLMGNAYFDSITVRIRDGY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGIGLSLAIGLLVQL
VLPGWQISFPPVALLSAFICSTAIGVVFGYLPARNAARLNPIDALARE
>A0A0R0DPT6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDPISALLLGILEGLTEFLPVSSTGHLLIAERWLGHRSDFFNIVIQAGAILSVALVFRQ
RLWSLATGLHEPGNRDYVLKLATAFLVTAAVGLPVRMAGWQLPETVTPIAWALVFGGVWM
LLAERFAARLPDRDTVTWKVAVGVGLAQVVAGVFPGTSRSAAAIFLAMLLGLSRRSSAAE
FVFLVGIPTMFAASGYAFFELARRGQLAHEAWSDVGIAFAAAVVTGFVVVKWLLGYIKHH
RFTGFAVYRMALGAALLLFLPAGH
>A0A090MVL6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLADLLKALFLGIVEGVTEFLPVSSTGHLLLAERIFNLDQENFWKTFAVLIQLGAILAIL
VIYFQRLWHVATHMFTDPAARRFVIGVLVAFLPAVVLGLIFGHFIKAVLFNPWVVCFSLI
AGGAVLLWVDQQDVNPRHHNAMTFPLPMYLGIGIAQCAAMVPGVSRSGASIVAAMLFGAD
KRSAAEFSFFLAIPTMIGAFAYDVYKDRADMTMDHALIIVVGFVVSFITAIIVVKTFLDF
VTRNGFTFFAWWRVIVGTLGLVALALGA
>A0A0X9JLY0|FEATURES|UNIPROT_deepARG|chloramphenicol|cat_2|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMTVTRCSYSLVIDLDITKLYAILKEKRLKVYPVQIYLLARAV
QKLPEFRMDQVNDELGYWEILHPSYTILNKETKTFSSIWTPYDENFARFYKSCVADMDTY
SKSSSLFPKPHMPENMFNISSLPWIDFTSFNLNVSTDITYLLPIFTIGKFKVEEGKIILP
VAIQVHHAVCDGYHVGQYVEYLRWLIEHCEEWLDSLDMS
>A0A0B3WYW0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACQKIGKPWEIILVDDGSSDRSADLLTEAA
SDPEKHIIAVLLNRNYGQHSAIMAGFQQAVGDVIITLDADLQNPPEEIPRLVEYAAQGYD
VVGTVRANRKDSLFRKLASKTINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVMHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFFGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLSTTLRDEEE
>A0A0B0KNH9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILSGQLLDFWTIEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTKEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMMVLAVGIIVAFISALVVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>E6LGF5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIENFIKAIIFGIVEGITEWLPISSTGHLILADELLKMQESEAFMTMFNVVIQLGAILA
VVVLYFHKLNPFALSKSKAEKNDTWSLWFKVIVAILPSVIIGLPLDDWLDAHFYNFISVA
IMLIVYGVAFIVVEKRNRSITPKITEFHQITYKLALFIGMFQVLALIPGTSRSGATILGG
ILLGASRFISAEFSFFLGIPTMFGASLLKIVKFFAEGHSFTTENTIILLTGTVVSFFVSI
LAIKFLISYIKKNDFTAFGWYRIVLGIILIGYWVVAR
>ABA71359|FEATURES|ARDB_deepARG|tetracycline|tet(B)|antibiotic efflux|1
MNSSTKIALVITLFDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKTDKIQE
>CAJ15581|FEATURES|ARDB_deepARG|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYKSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWNHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEDLSDFAKKFHLTTNETES
RNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>A0A0S4HPK3|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDFWTTVSVLILGVVEGLTEFLPISSTGHQIIVADLLDFGGQRAMAFNIIIQLGAILAVV
WEFRRKILEIITGLPTQRNAQRFTLNLLIGFMPAVVLGVLFADKIHEYLFNPITVAVALV
VGGFIMLWAERREHVVYVDHVDDMRWTDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQAADLPVFALGFVTAFLFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWAFGWVNWTEAAAL
>E3PX75|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIRVLILSIVEGVTEFLPVSSTGHLILVNEFVSLKPQSFSNSFNVIIQLGAILSVVV
LYFEKLNPFSSNKSKQQKKNTIDLWLKVIVGVIPAGILGFLFDDFIDEYLFGPVTVTIAL
FVWGIIIVWIENKNKKISIDSVYKITYKTALLIGLVQCLAMIPGTSRSAATIIGAMLLGC
SRGAAAEFSFFLAIPTMFGATLLKLAKMFLGGTIFTAWQWFLLFLGCVFSFIVALLVIKL
FLNYVQKHNFKVFGYYRIALSSILLVYFFFIK
>J1IFP3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAVQALILGVVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQRNAQRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVAAALV
VGGVIMLWAERRQHEVHAETVDDITWKDAIKVGFAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWSAVKP
>A0A0A5FRP1|FEATURES|UNIPROT_deepARG|beta_lactam|CSF007_10040|antibiotic inactivation|1
MMHKTLSCALLLVASGSTFATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYY
FTWGMADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSKYWPALSGKQ
WEGISLLNLATYTAGGLPLQVPDNITDETSLQNYYETWQPQWAPGTKRFYSNASIGMFGK
LAVKPSGMSFEQAMNKRVFQPLNLTHTWIHVPEREEKHYAWGYRDGKAVHVSPGMLDAEA
YGVKSSIKDMASWVRANMTPSEVKDASLQKGILLAQSRYLQVGDMYQGLGWEMLNWPMKA
TIAVGGSDNKVALAPLSAVEINPPAPALNSSWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVEAAYRILEALQ
>A0A104LWP5|FEATURES|UNIPROT_deepARG|beta_lactam|WT08_17490|antibiotic inactivation|1
MKIRHALSSALVLLGCAAAPAYAKTLCTAIADATTGKFLLKDGDCSRRATPASTFKIAMS
LMGYDAGFLRNEHEPVLPYRDGYVDWGGAAWKQPTDPTRWLKYSVVWYSQQITHHLGAQR
VAQYAKAFGYGNADLSGDPGKNNGLDRAWIGSSLQISPLEQIGFLRRMLNRDLPVSANAI
DMTERIVDTTTLADGTIVHGKTGMAYPLLADGTRDKAHGFGWFVGWIKRGKETLVFASLT
QDERKEPGSTGVRTRDAFLRELPQRLAAH
>A0A095FE60|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFSKMMPAMTQAVLFCAAGAMLGIADTAFAAADRVQAVVDETIRPLMTEKQIPGMAVGV
VVDGKAHVFNYGVASKESGRPVTNATLFELGSVSKTFTATLASLAEVDKQLSLSDKVETY
LPPLRGSDFGKVRLLDLGAHTVGGLPLQVPDDVRDEAELISYLKHWHAAHAPGTFRTYSN
ISIGTLGILTANRLQQDSTSLMEGRLFPGLGLKNTFIDVPAAREADYAQGYTAAGKPIRM
KMEVVGREAYGVKSTAGDLLHFMQGNMKLIPLEASLQRAVTQTHTGYFQAGPMTQDLIWE
QYPYPVALKTLLIGNGPAMLFKGMKVTEIRPPEAPRDDVWINKTGSTNGFSSYVAFVPAK
RMGIVILANRSYPIEDRVAAAYRILTALDGAGQ
>A0A0H1AS43|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRPSDTPAVTVIPVADHQDGPYGITAGPDGALWLTFVHSGRIARLALDGGLSTYALDSPG
CRPTVITPGPDGALWFTRSGDHRIGRVTIDGEISSFPVPTPDSGPFGITAGPDGALWFTQ
MQTDRIGRVTVEGEVTEYRLPGAGPGAVPSAITAGPDGALWFTLNQANAVGRITTSGDVT
TYPLPTPGAAPVGITSDGAALWFVEIAAGRIGRISVDGAIEEFALSDPAAKPHAIVAGTA
GECWFTEWGANRVGRVTAGGEITEYGLPTPSSEPHGIAVGPDGALWTALETGAVARVRP
>A0A0U0YQ63|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MPAEHALLVVMATFEPLALQQWPRREWFEHYLDRCPTYYSMTVDLDITNLRAAVDASGRK
TYPTQIWALATVVNRHPEFRMALDDQGNPGVWDVVDPAFTVFNPDRETFAGISARYTPDF
DAFHSEAAELLSEYRNASTLFPQGAPRPRNVFDISSIPWTRFTGFTLTIAPGWAHLAPIF
TIGKFYEQEGRTMMPLALQIHHAAADGYHSARLVEELRQIIADPDWVRD
>ABO61000|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTPLALAATLVFDVAAADAPLPQLRAYTVNASWLQPMAPLQIADHTWQIGTEDLTA
LLVQTTEGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRRT
GATVVANAETAVLLARGGSNDLHFGDDITYPPASADRTIMDGERVTVGGMAFTAHFMPGH
TPGSTAWTWTDSRDGKPVRIAYADSLSAPGYQLQHNARYPRLVEDYWRSFTTVRGLPCDL
LLTPHPGASRWNYAAGAEAGANVLTCKAYADAAEKAFDAQLAKEAAGAR
>ZP_04070977|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFVTGFVTAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>B7IX68|FEATURES|UNIPROT_deepARG|beta_lactam|BCG9842_B2862|antibiotic inactivation|1
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSEPPKQTKQIKQIKQENTGHDSFAKLE
KEYNAKLGIYALDTGTNQTVAYHPNDRFAFASTSKSLAAGALLRQNSIEALDERITYTRE
DLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYNDKLIADA
TKVVLDTLKVTNKN
>A0A127SHV7|FEATURES|UNIPROT_deepARG|chloramphenicol|catA16|antibiotic inactivation|1
MTDAPRLTLIDFENWERKEHYAHFMNEVRCSYSVCVNLDITPLNGQRLYPAMLWLLTRTV
NEMPEFRTALTEDGLGYFSEMHPAYTVFNRDVKTFSAIWTEYQPDYPSFLRVYEADVEKY
SSTTRYEPKPGRPANSFDVSMVPWLSFTAFNLNIFGDGTYLLPIFTIGKTFDENGETMLP
LAIQVHHAVCDGYHVGRFVELLQENTNRFGCDSCAAYSDITKEMRG
>YP_002394431|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFMWRAVPLQLVGLALLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEER
>E5KCK0|FEATURES|UNIPROT_deepARG|beta_lactam|BL2b_tem1|antibiotic inactivation|1
KAFCAKFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTF
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
TAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRK
LLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPD
GKPSRIVVIYTTGSQATMDERNRQIAEIVP
>F9DS51|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MVVLYLIENRIGEGRPSRKESQMELFDLIKALILGFVEGMTEFAPVSSTGHLIIVDDMWL
KTEEFLGKYPAITFKIVIQLGSILAVVVVFWKRLFSLVGLYNVENGVKMSERFNLLHVIV
GMLPAVILGFAFKDLIDDYLFGVETVIIALVAGALLMIAADRFGPKHPRVQTLDQITYKQ
AFTVGLVQCLSLWPGFSRSGATISGGVLFGMNHRTAADFTFIMAVPIMAGASLVSVLKNW
EYMSMDHIWFYVVGFLSAFIFSLISIRFFLKLISRIKLVPFAIYRIVLAIILAVIVFL
>A0A0D0NYI3|FEATURES|UNIPROT_deepARG|beta_lactam|RW26_17670|antibiotic inactivation|1
MSRLLLSGLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASIKAKEEVLAALPAQLKKL
>A0A0Q0U6T2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDFIKSVIIGIVEGMTEFLPVSSTGHIILAESLMKIPGGALWTKSFTAVFDYAIQLGAI
FAVIQLYFHKLNPFSAQKTPRERFQTWRLWMKVIVGVLPAVVFGLLLNDFMDAHLLNPWV
VSATLIIYGIAFIVIENRQKGIAPRVTDVSKVTYQMALFIGLFQLLSLVPGTSRSGATIL
GAILLGASRFVAAEFSFFLSIPVMFGVTLLKVGMYLLHGGSFTGGQLGVLFVGFVVSWLV
ALFAIKFMLRYIQNNDFKAFGWYRIVIGIVFLILGAAGLLHMA
>A0A0F6G895|FEATURES|UNIPROT_deepARG|beta_lactam|BG16_6038|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLLQDGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>J3BGZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYVNSIILGIIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWRDPRNRSYAAKLIVAFLITSILGLIVKKLGFQLPENATPIAWALIIGGVWMI
FAEWAAARRPPHKEITWLVAILVGIAQVVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASAYELVKTFKDGGAANEDWTSLGIAFVVSTIVAFVAVKWLLSYIRSNR
FTVFAIYRMILGGILLAMAATGMIA
>A0A0Q6LD49|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MAIQGLNHFLFSVSDLDRSIAFYQEVFHADLLVKGRSTAYFDLNGMWLALNEEKDIPRQD
IRHSYTHIAFSVKEEDMDTMYDRLVKSGACILGGRERDPRDKESIYFTDPDGHKFEFHTG
TLEERLSYYREEKKHMEFYDDRKKP
>A0A0Y5PH77|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A0K2G9W9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAEWGAALAVILGIVEGLTEFLPVSSTGHLILVGHALGFTGDVAANAEISIQLGAILAVI
VFEREKIGRLLSGTWQEQGDLRRLVTESRGESWRSLLNTSMKAHPSLWFMIGLGVAFLPA
AAVGLLAHGWITSHLFTPRTVAATSILGGFIILLVEARPRPGRTMTLDQVSLAEAVWIGV
AQCASLIPGMSRSGSTIIGGLLAGLDRKVATEYSFFLALPTIIAATVYETYKARATFSDQ
DFLALGIGMVVSFLVAWAVIAAFLAYVQRHTLRVFAYYRIALGLMVFFVFR
>A0A090UYY9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEALPITKVSVVIPVYNEQESLPELLRRTTAACESLGKDYEILLIDDGSSDSSAQLLID
ASEAQGSHVVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKTASKMINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAVTGFTLSILLVILRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIHPESLHSTKENQQ
>A0A068YSE8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYKKRPADPRHWPDFLLRQGGQCQLPHRRIAVKSPGGAAQHVADELDGQEHQRWFRSSDR
QSSAQPSPGHQSRTPQASAGCDAGGARCGVMVLRAWQRPARADMALANGLLATAIISPIL
NGASVDIALLIKAAIMGIVEGLTEFLPISSTGHLILAGALLGFDDDKAKVFDIAIQTGAI
FAVILVYWQKIRSTLIALPNEKQAQQFALNVLVAFIPAVVLGLLFGKAIKANLFTPVVVA
SAFIVGGFIILWAEKRQKRNPSAIRIHDVESMTTMDALKVGLVQCLAMIPGTSRSGSTII
GGMLLGLSRKAATDFSFYLAIPTLIGAGAYSLFKERALLSVADVPLFGVGLLFSFLSAWL
CIRWLLRYIATHDFVPFAWYRIAFGIVVLGTAWSGLVTWAA
>A0A124EDH7|FEATURES|UNIPROT_deepARG|chloramphenicol|M2E15_5831|antibiotic inactivation|1
MLPVSLQVHHAVCDGYHASRFIEDLQELANTCNEWLK
>L7HDA7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKDITRSFMAGEREFIALKGIDLTIQAGEMVAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPQT
QRHSRAQELLTRLGLAGHTSHRPSQLSGGQQQRVSIARALMNGGDVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIVSDKANASVGLELPGETP
IESRRSGARRLVASLGLFKEAFNMAWVALVSHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDLDAQVNGVSERYFKVKGLKLEAGIAFSENDARRQAQVVVIDRNTRQRLFGAH
VDPLGQVILVGNLPCTVIGVTAENKNMFAASKSLNVWVPYETAAGRVLGQRHLDSITVRI
KDGQPSKVVEENVNKLMLQRHGTKDFFTNNLDSIMQTVQNTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGIIGISLSYAIGY
LFSLFVKEWEMVFSVGSVVTAFACSTLIGIVFGFVPARNAARLDPIEALARD
>A0A0J8AV74|FEATURES|UNIPROT_deepARG|aminoglycoside|V473_07990|antibiotic inactivation|1
MSGPAARIARVAAVHAPSWVRMRAALWPDASVADHHDHIADMMANGGDLVAFVALDDRGD
AIAFVEASLRRDYVNGCDTSPVVFVEGLYVTPAMRHEGIAKALIDAVEGWGLAMGCTEMA
SDSDIAHLASHAFHHAAGFIETERVVYFRKVIG
>A0A0B3BNH7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALLLGIVEGLTEFLPISSTGHQIIVADLIGFGGERARAFNIIIQLGAILAVV
WEYRRKILDVVVGLPRQRSAQSFTFNLLLAFLPAAVIGVIFSDLIHEFLFNPITVAAALV
VGGVVMLWAERRPHAVQAETVDDMRWSQALKVGCAQCLALIPGTSRSASTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFALGFVVSFIFAMLAVRALLRF
IGNHSYAAFAWYRIAFGLLILATWQFGWIDWSTAQG
>Q13ES7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFDIFRAVILGVVEGVTEFLPVSSTGHLLLVGRFFNLGEDSFWKSFAVLIQLGAILAIL
SIYFAKLWRIALGMFSDPAARRFVIGVLVAFLPAAMIGAVAGSYIKLYLFNPWVVCFSLI
VGGAILLWVDQLDLNPQQHDATAFPLPMYFYIGCAQCLAMIPGVSRSGASIVAAMLFGAD
KRSAAEFSFFLAIPTMVGAFVYDFYKNRGEMTTDHLTIVAIGFVVSFITAVIVVKTFLGY
VTRHGFELFAWWRVIVGTLGLIALAMGR
>A0A0N8QSD0|FEATURES|UNIPROT_deepARG|beta_lactam|ALO86_01849|antibiotic inactivation|1
MQRNGTLLCTGLLLVSSVAFAEDNSAALDTLVQTEARKVMQENNITGLSIAITRHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGRLSLTQIIDSYMPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPEKVQNTRQLMDYFKAWQPEYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYVNVPDDKQALYAQGYNTLDEPVRVNPGILAAE
AYGVKSSSRDLIRFVEANIGLGQYDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPIHL
DVLLAGNASAMLNTQKADAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAQKQLGIVILAN
KNYPNEERVKLAYRILQHAEPLN
>A0A0M2ARY7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLDLSKDFMEMFNVVIQLGAIMA
VVILYFHKLNPFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDYLDAHFYNFLTVS
IMLIVYGIAFIIIEKRNKNVAPKCTNLKDFTYKAALIVGAFQVLALIPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASFLKIFKFLAKGNTFGSEEIIILLIGSIVAFVVSI
IAIKFLLNYLKKNDFTVFGWYRVILGAILIGYWLFS
>A0A0X2PD75|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTTGHLKLGHILLAMIPAVVLGLLLHDFIKSLFAP
KNVMYALVVGGFLLLAAEWFKPKKPSAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTI
AGGMLVGVNRYAAAEFSFILAVPMMIGASALDLYKSLHFLTMGDLPMFAVGFATAFVVAL
IAIKTFLSLIKRISFVPFAIYRFIVAGVVYMVFM
>A0A0V3TXP0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIALHA
PEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMVERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTAADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQ
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELG
LVEGARLRGPASGPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKA
DPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVR
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
QQGLRFTLFRPFNWMGPRLDRLESARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTD
VDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAG
FREVESRSFYGDGYQDVAHRKPSIENARRLLDWQPAIELRETIGKTLDFFLHEALREREA
QA
>A0A073KCK1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MINGVNHLCFSVSNLEKSIQFYKTVLEGSLLVRGRKLAYFDICGMWVALNEEVDIPRDEI
HQSYTHLAFSVAREDFEKLLQRLEDNKVHILQGRERDVRDCQSIYFIDPDGHKFEFHSGT
LQNRLNYYKEAKPHMEFYE
>A0A0E2BFY9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGESLEFDDLFDIFIQSGAILSV
LFLYREKFRSQIVSSFRYVLKQNSDSEGFNFLIQICIGAFPILIAGFMAKKFLDTIKARP
DLLEILSGAWIFGGVLILIAEWYFHQKGTEKKKPIHFKDSILIGIFQCMALVPGMSRSAA
TIITARFLGKDTKSSAEFSFFLAVPVLLVAGIYKLIKYRSILNGNTIPVLMFGFLVSFLL
CTLVIRWFLRYLQKHSFSVFGVYRILLGVGVLVLTKLI
>D4K8S9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIVEGITEWLPISSTGHMILVEQVVKFNASEEFMSMFRVVIQLGAILAVVVLFWNKLWP
FGLRQGKVISKPSVWNLWFKVVAATLPVLVISPLDDWMEEHFYNYITVAAMLILYGVLFL
VVENRRTTPRVTKLEQISYRDALLIGVWQCLAIIPGTSRSGATIVGGLLLGLSRACVAEF
TFYLAIPVMAGASLLKVVKFAFSGTAITGTEVAVLLVGCVVAFVVSLAAIRFLMDYVKRH
DFKFFGIYRIVLGAIVLAVAAITALA
>A0A0F4KS24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNIIKAVILGIIEGITEFLPISSTGHLYLANEFVKLQESQAFINMFMVVIQLGAILAVV
VIYFHKLNPFSPQKNPSEKKATWILWLKVIVACLPSVIIGLPLNDFMDAHFNNWQVISAT
LLIYGILFIVVENYNHHRHPHLTDLNTLPYSIALAIGAFQVLSLVPGTSRSGATILGAML
IGSSRFVATEFSFFLAIPTMFGASGLKLFKYFIHGHSFTGAQSIVLIVGTLVSFIVAYAA
IKFLLDYIKKNDFKAFGWYRIILAIIVIGYFGFLK
>A0A0D6T8Z0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDHNTIVAAALGVLEGLTEFIPVSSTGHLLLAGHFLGFDSPARSFEVLIQLGALLAILGL
YAARLVQVVRDAPHDPVARRFIGAVLLAFAPAAVIGAMAHGFIKTVLFETPMLVAVMLIL
GGFVLLWVDRRAATPRYTRAEDIPLSMAFRIGLFQCLAMIPGVSRSGATIVGALLMGADK
RSAAEFSFFLAMPTMLGAFSLDLWQNRAVLDAGAINDIAVGFITAFLAAVVVVRWLLGYV
SQHGYGLFAWWRIIVGSLALLALVLGM
>ZP_03949543|FEATURES|ARDB_deepARG|multidrug|lsaA|antibiotic target protection|1
MSKIELKQLSFAYDNQEVLLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGE
ILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGG
EKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVV
DHILAIEKSQLTLYQGNFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNR
EGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIEPL
SMDYQPTHHKTLLTVEELRLGYEKNWLFAPISFSINAGEIVGITGKNGSGKSSLIQYLLD
NFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVF
TNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVKPAMLVIE
HDAHFMKKITDKKIALKS
>V5RLB4|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-26|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVACLARITKQSALW
>A0A0K0TQJ3|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-164|antibiotic inactivation|1
MVKKSLRKFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>J9B8B5|FEATURES|UNIPROT_deepARG|beta_lactam|IEM_00965|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNETGTISLSQLNKNVWVHTE
LGYFNGEAVPSSGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLNRYGNINSVVPGH
GEVGDRELLLHTLDLLK
>A0A0K6H7Z0|FEATURES|UNIPROT_deepARG|beta_lactam|Ga0061061_103121|antibiotic inactivation|1
MKRKYIVSIYIMCSSIFLATAGACAAELDRGLLKAIVDVAIEPVMREHAVPGMAVGLTVD
GKHYFFNYGVASKESGHPVTETTLFEVGSVSKLFAGLVGAWGAVEGEVSLTAPASSYMPA
LRGSSFDRITLLQLATYTAGGLPLQFPPEVRDEASMVSYFRSWKPAYPAGAQRVYSNPSI
GLFGHLAAAGMGRSYEDILEAKILPSLGMASTHVRVPPERMADYAFGYTREGKPRRISLD
VLGAAAYGVRTSAADLLKFLDANIAPPQDARLRRAIAATQTGYVRVGEMTQGLGWERYDY
PVSLETLVAGNTPQASGKGKAATWLVPPALPRPDVLLNKTGSTNGFGAYVAVVPGRRLGI
VLLANRFYPNPDRVRAAHAILSAVADGAAR
>A0A069BDK2|FEATURES|UNIPROT_deepARG|aminoglycoside|DP46_5212|antibiotic inactivation|1
MTHPAALFKIRAAQASDAAAWRQLRRALWPHADDIEHARDIARQLDAPARHACFIASPPG
ILAPVGFAEVAVRHDDVNGCGASPVLFLEGVFVEPAARRRGAARALCAAAAAWGTARGCA
AFASDAPLENAASHALHRALGFDGTERVVFFRKPLAR
>I1DSB1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MISLKNITKSFKLGENEIEILHGINLEIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSGG
QYLLDGKDISKFDSDALAKLRRDKFGFIFQRYNLLSTMNALENVALPSIYAGANKSEREK
RANELLGSLGLSEKARNLPNKLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGLRV
MEILVDLYKKGHTIIIVTHDPKIAEYASRVIEIKDGNIVSDNVKDSEIYEASKQIQPEKS
KFTYYKDQLIESFKMSVNAMLAHKLRSLLTMLGIIIGITAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMLSGKVKTLSISDANMLAKQSFLDSVTPNTSTSGVLTYENISL
SASLKGGGVGSFDVNGLKLEEGRIYDDDEVLNSASVALIDQNTKNRIFKNDDPIGKIILF
NKKPLRIIGVLQKDDFKMGDSSTLKIYAPYTTVLNKVTGDKFISSVTAKVNEGVNAQIAE
KTLTELLEIKHGKKDFFTRNSDSIKQTIEETISTMRLLISSIAVVSLVVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIVLSYAIGYIFNNFLNGFS
MIFSNGSIVLALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>A0A0W0MHR3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNSKAVVFAYHDIGCAGIEALLTAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVVIERSDTGLTLHAKLREAAVNLLRDALP
QLAQGKLTETAQDESQASYFGRRTAADGKLDWNQPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACAEDSLVIKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLKEAMLEIA
DKK
>ABB99435|FEATURES|ARDB_deepARG|beta_lactam|OXA-1|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASAPTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>AAC73966|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVTGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0T5XF37|FEATURES|UNIPROT_deepARG|beta_lactam|AOX65_14345|antibiotic inactivation|1
MKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYY
TFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQW
QGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGAL
AVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGTLDAQAY
GVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEAN
TVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLAN
KSYPNPARVEAAYHILKALQ
>A0A0T6ELH8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIMFILKAIIIAIVEGLTEFIPVSSTGHMILVGSAINFNGEFAKMFEVVIQLGAILA
VVVLYWEKIKESIIEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGIIGVLFYHKIKALFR
PEAVIIGFIVGGILLLIIENIFRKKEHAVQDIDSITSAQALKVGLLQILAVWPGMSRSSS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTPTLWSALILGFVVAFI
VSIIVMNKFVSYLKKKPMKVFAIYRVLAGLLLAVLVFTKIIVLTV
>A0A0R1P2L4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFNLMIIELIKSFFFGLVEGITEWLPISSTGHMILLDQFVKLDVSKSFYSMFEVVIQLGA
IMAVVVIYWKRIWPFHHSQAVGVAAPKGIWRYVDKDIMIMWLKIFISCLPAGIIGVAFND
TFERLFYNPVSVAIALIVFGVAFIWIETAHKGKKAKVNSIAEISYNMAVMIGFFQLIAAV
FPGTSRSGATIVGALLLGVSRTVAAEYTFFLAIPVMFGAALFKLLKFGLAFTSMEFWIMM
VGLLTAFVSSIIVIKFLMRYIKKHDFKVFGWYRIALGLLVLLYFLVLK
>J8CQR4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEAKKAEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIAIPVMAGATGLDLLKSWKYLSIDDIPMFAVGFITSFLVAMLAVVTFLKLL
EKIGLKPFAYYRILLAIVFTLFVLL
>J9SPE6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA114|antibiotic inactivation|1
PASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQ
LTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKVVN
RQLPVKAAAYELADNLFEVGQADGWRL
>E5WV58|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1016_00481|antibiotic inactivation|1
MTDVLTDSISRIVSACPGEIGVAIIINNTDTVKVNDKSVYPMMSVFKVHQALALCNDFDN
KGISLDTLVKIDRNRLDSKTWSPMMKDYSELVISLTVRDLLRYTIAQSDNNASNLMFKDM
VNVAQTDSFIATLIPRSSFQIAYTEEEMSADHDRAYFNYTSPLGAAMLMNRLFTESIVSG
EKQSFIKNTLKECVTGTDRIVAPLLDKERVSIAHKTGSGYVNENGILAAHNDVAYICLPN
NVCYTLAIFVKDFKGNESQASQYVAHISEVVYSLLIQNSAIP
>A0A0F1A7S8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTQALLDAGYDIAAIFTHPDTAGENTFFGSVARIAAEHGIPVYAPD
DVNHPLWVERIRALAPDMIFSFYYRNLLCDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQKVAIDADDTALQLHHKLNATAQTLLRDVLPTI
LNGTFSETAQDESKASCFGRRTPEDGRLDWSKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAARPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVALKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLNNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>L7C7C1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIQLHGLRKDYRVGDHDLPVLKGITLNIEAGEYVALMGSSGSGKTTLMNLLGSLDHPTDG
DYHLAGIDVSSLTPLELAAFRSQHIGFVFQNFNLLPRATALDNVMLPTIYASDGRSRREC
IEDATKLLESVGLGGRLDHMPNQLSGGERQRIAIARALMNRPKLLLADEPTGNLDTVTEQ
EILALFRQLNQEHGITLVVVTHDAEVAHEADRVVRMKDGLVAEDVRQRASTVDQSRLANS
RAEPLREPASAWSLPATWNAIVVAVLALRRNALRTVLTMLGVIIGVASVISTMELSAGAS
TAIEETVASMGASMLTISPGKASSTSGRQRSIQIIPDDVVAVAEQCSAVKVAAPLVYSQV
QLVRQNRRWSPNLALGTTSQYLAARNWDQLELGTPFTQEQVLDAAKVCILGKTVAHELFD
TEYPIGEEIRVNGVPLRVVGVLTEKGGDVIGNDQDDIIIGPWTTFKLRVNSSTGATAQFS
TFADQMPPMQLASTRRSTQREEIHQIYVEAESPDHVELARQQITQVLSRRHNVEPAGAYR
INDITEVSKVVGQVVGGVSALGLVIAGVSLMVGGVGIMNIMLVSVTERTREIGLRMAVGA
NRSAILRQFLIEATVLCVVGGFIGIFAGHMWSVLVGRVIGWPTAMSIWAPIVAVTVAATV
GIVFGYYPARTASRLNPIDALRYE
>V7UKU8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQENKREQGVDAAV
ANTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>D3V5Q4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKDFPMMKKFVINTLAFATIATSPFYASAQKTLTAQQVEKIVNDTLTPLLEKQDIPGMAV
AVIYDGKPQFFNYGVADIKTQRPITENTLFELGSVSKTFTGIAGGYAMQTDILNLNDPVT
AYSPELTGSQWRDVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWKPLSAPGMIRNY
SNASIGLFGALAVNKSQLTFETYMTKYVFLPLKLTHTFITVPESMQSDYAWGYKNGQPVR
VTPGMLSAEAYGVKSTTQDMVKYMQANMAPDSLPADNDKLKKAILAAQSRYYQVGNMFQG
LGWEMHNWPINPQRVIADSNNDIALQPREVEALIPPRSAVPASWVHKTGGTDGFGAYIAF
IPEEKIGIVMLANKNYPNPVRVEAAYHILKALR
>A0A096BNP3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIVETIILAIVEGLTEFLPVSSTGHMIITRDLLGMKADDLFINAFIVIIQFGAILSVVT
LYWKRFFRLDHTPAPAGSTAVRAFLHKWDFYWKLLVAFIPAAVIGLLANHLIEKMLGSVV
VVAVMLVIGGVFMLFCDRLFNHRSEMTPLTEKRALRVGLFQCIAMIPGVSRSMATIVGGM
AQGLTRKRAAEFSFFLAVPTMFAATCLDVFKLIKNGGVEALSAHVPTLLLGSGVAFVVAL
LAMKWFVAFLTKYGFKAFGVYRIIVGGAILIWLMMGHQLAMVD
>A0A143ZGQ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPEHSIFSALILGLIEGLTEFIPVSSTAHILLAGHFLGFESKGKTFEIIIQFGAILAILT
VYFQRLWSILIALPSDPRARRFVLLILLAFLPAAVIGFLAHDFIKNVLFETPKLICIMLI
VGGIILYAIDRMPMEPRYRDMMDYTPALALKIGLFQCLAMIPGTSRSGATIAGSLLMGTD
KRSAAEFSFFLAIPTMLGATVLDLYKNRDVLDFNDASLIAVGFIAAFVSALLVVRSLLAF
VSSRGFTPFAIWRIVVGTAGLIGLTVFG
>ZP_02889082|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MDNMYNSNGLMRFAKVAAASTLLATLLAACAVGPDYKRPDVSTPAAFKEAPTLAAGEQAG
TWKTAEPADGEHRGEWWKVFGDPVLDSLESQALAANQNLKAAAARVEEARAATRTARSQW
FPQVGAGFGPTRQGLSSASQLQPQGTGPTNATLWRAQGTVSYEADLFGRVSRNVEASRAD
QAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELRDQALKLVQRRFNEGDIS
ELDVSRAKNELATAQADAVGVARRRAASEHALAILLGKAPADFAFKETPIVPVAVKVPAG
LPSALLERRPDVSAAERAMAAANARIGLAKSAYFPKLDITGAFGYEASTLGNLFLWSSRT
FLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLADLRLL
DDQIRAQDAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVST
VNLIRALGGGWGAAPAPAAVGDAATGKADVAAR
>V8QL33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDQVWYLFKAIVLGVVEGVTEFLPISSTAHLLILGDWIGFDSGQFKVYEIVIQLGSILAV
MWLYRQRLREVIVGTFTGNRTEQRFTLNLIIAFLPAAIIGLLLINQINRLLDGKFMIYAF
TLVVGGIIMLWVERRPTMAKHTTLQDHELAHQVQRLEDITWKQALVVGFAQCLAMIPGTS
RSGATIISGMMAGIHRKTATEFSFFLAMPTMIAATVLSLYKHGGELTQSNLLAVVLGFIA
AYVSALLVVRALMRFLSSASYRPFGWYRIVFGLIVAMWAWNQMA
>D2XSF4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-1|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAEXXXXXXXXXXXXXXXXXXXXXXXXXXVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILV
>A0A0B3BCQ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGSFINFTGKFATMFEIVIQLGAILAVVYY
YRGKILASLKNLKPGDWGFNLWFKIFIAFIPAAVIGLFTHKYIEEYLFSPFTVAIALIVG
AIMMIVIEDTFGKRYKIDNMDKVDTKKSFWIGIAQVMSLFPGMSRSASTIMGGMLVGLSV
KAAAEFSFFLAIPTMLAATGFELVKSFTAMSLLEWEALAVGFIMSFITALFVVDKFLSYL
TKHPLKPFAYYRLIVGLLMLLLISEKIVK
>N1ZGC7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFELLKAFLFGVVEGITEWLPISSTGHMILLDQFVQLDVSKDFYSMFEVVIQLGAILAV
VVIYWHKIWPFHQADKNAHAQGIWRYVDKNIMIMWLKIFIACLPAGLIGVAFNDTFERLF
YNPTCVAIALIVFGIAFILIEDIHKNKQPKITSIAELSYYTVVLIGFFQLIAAVFPGTSR
SGATIVGALILGVSRTVATEFTFFLAIPVMFGAALFKLVKFGFSFTPLEIWILVVGLVTA
FITSIIAIKFLMQYIKKHTFKAFGWYRIILGLLVIAYFWFVK
>A0A0R2FUX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGITEFLPISSTGHLVLVDEFIKMEQSKAFVDMFNVVIQLGAIMAVV
VIYFTKLNPWASKKSPLEKKQTWTLWKKVIIAVIPSIIIGLPLNDWMDSHLMNWLVVSIA
LIFYGILFIIIENHNAHTQPKFSDLNTLSYKTAIIIGLFQVLSLIPGTSRSGSTILGGIM
VGTSRYVAAEFSFFLAIPTMFGASLLKLYKFFSHGGSLAGLQGVILAVGVIVSFVVAYIS
IRFLLNYIKNKDFKVFGWYRIVLGVIVIGYFLIFH
>A0A0Q9VIG4|FEATURES|UNIPROT_deepARG|beta_lactam|ASG99_21105|antibiotic inactivation|1
MKSLSNIFSTSTFRKIVPVLFLSCATLVGCSNNNDHAELTKPKKQETANNHDFAKLEEKF
DAKLGVFALDTGTNQTVTYHPDERFAYASTHKALAVGALLQQKSIEDLNQRITYTREDLV
NYNPITEKHVDTGMTLKELSDASLRYSDNTAGNLILKQLGGPTGFKKALEEIGDNVTNPE
RFEPDLNEVNPGETHDTSTPRALATSLQAFTLGDTLPTEKRELLIDWMKRNTTGDALIRA
GVPKGWXVADKTGAGSYGTRNDIAIIWPSKGDPIVLAVLSSRDKKDADYNDKLIAEATEE
VIKALKVKNK
>ZP_03452771|FEATURES|ARDB_deepARG|multidrug|OprA|antibiotic efflux|0
MKAMMKPRARRRGARAARRPNGPRAWPLAVAAALVAGCTLAPRYERPAAPVPAHYWSTAT
GAPREAGPAAAGGPRAMPDARRGDAGRDARDARLDDWRAYFTDPALRALIDAALANNRDL
RIATLRIQEARGLYGVARADRLPSIDGSLGYERTRLYDPVLRESATSSLYRASVGVSAFE
IDLFGRVKSLSDAALAEYFATAEAQRAARISLIAEVASAYVTERALVDQLGLAERTLAAR
DAAYALTQRRYAAGTSTAIELRTAEMLVASARASKAALEREHTQAASALKLLAGDFMTAL
PADAPALDALAVARVSPGLSSDLLEQRPDIRQAEQRLVAANANIGAARAAFFPRIALTTD
VGSVSDAFSGLFSAGSSVWTFAPRLTLPIFAGGRNRANLDVADARKHIAVAEYEKTIQTA
FREVADALAARDQIDAQLAAQQTVYGADAERLRLAQRRYDSGVASYLELLDAQRSTFESG
QELIRLKQLRLTNAITLYRALGGGWSRAGCGGDECA
>A0A124NU13|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIVSVVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVMSVDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVSAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>P60936|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSYLHAIILGIVEGITEFLPISSTGHMIIASSMMGIEDSSFTKAFEVIIQFGAIMSVLVL
YWKRFLPHWGFYRKLFVAFLPTAIIGFVVKDVVEHLMGSVQVVAWSLIIGGVILIWADKA
FAHLTMMGRKTDDLTYKDSVKLGLFQAIAMIPGVSRSGATIMGGLTLGMNKKEAAEFSFF
LAVPTMAAATLYKLLKIYKTIEPAQINLLLVGCAVAFVVAMIAIKFFIGIVSRYGFRGFG
YYRIVLGLVILILLYTGHDLQMV
>A0A034TVN2|FEATURES|UNIPROT_deepARG|beta_lactam|JCM18905_2314|antibiotic inactivation|1
MVCSTLSYASQLNEDISLIEQQTSSRIGVSVWDTQTDERWDYRGDERFPLMSTFKTLACA
TMLSDMDSGKLSKNATAKVDERSIVVWSPVMDKLAGQNTRVEHACEAAMLMSDNTAANLV
LNEIGGPKAVTMFLRTIGDKATRLDRLEPRLNEATPGDNRDTTTPNAMVNTLRTLIEGET
LSYESRVQLKIWMQDNKVSDSLMRSVLPTGWSIADRSGAGGHGSRGINAIIWKENHRPVY
ISIYVTETELSLQARDQVIAQISQLILQKYKDN
>G8QQM1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMELLKALLLGIVQGITEWLPISSTGHLLLLDELIQLQISPACKELFMVIIQLASILAVI
ILYFSTLNPFSTKKGQLEKKQTWNLWGKVLVATLPAGVAGVLLNDFMDTYLYIWPVIVVA
LASYGLVYILLEKKGRGTRKPRITTLSEISYADAAKMGAFQMLALVPGTSRSGSTILGGI
IIGIDRPIAAQFSFFMAIPIMAGASLLKLLKIGFSFTNSEYLILAVGFITSFVVSLFCIK
ALVAYVRKHDFSIFGFYRIALALVVTIFFLTTGR
>A0A0G3Z5G4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLFVAACATATAGRAAAATQDDLHDTVTRHIAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPAGKYLPA
VQGKPFGVVTLLNLGTHTPGGMPLQVPDSIRDDAGLIRYLAAWRPAYAPGTYRTYSNVAI
GMLGWLTAKAMHKDFAVLMEQRLFPALGMTHTYINVPEARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLVETAPRLQRALERTHAGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNSMKMLRDGVQATAIKPPLAPSADTWINKTGSTNGFSTYVAFVPSKRIA
IVMLANRSYPNEDRVKAAYGILGALDGRR
>Q1GVD5|FEATURES|UNIPROT_deepARG|aminoglycoside|Sala_0666|antibiotic inactivation|1
MKVREAQSRDIAAWAAMRARLWPDADAAELADELPSMLTDTTLWNFILTSTGDRAVGFAE
VQLRTMFDGCVVAPYPHIEGLWVDAELWRMGGARALLAAIEERARRRGHDRIGSDVELDN
ETSQAWHEKCGFNEEVRTILYSKPLRAR
>A0A0E1VGJ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLLELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSTNFLGSQSAFTFKVVIQLGS
VFAAAWVFRERFLEILHIGQHKPEPSTAGDRRSKPRRLNLIHVLVGMVPAGILGFLFDDL
IEKYLFSVPTVLIGLFIGAIYMIIADKYSKTVQHPQTVDQINYFQAFVIGISQAIAMWPG
FSRSGSTISTGVLMKLNHKAASDFTFIMSVPIMLAASGLSLLKHYEYIHLAHIPFYILGF
LAAFIVGLIAIKTFLHLINKVKLVPFAIYRIVLVIFIAILYFGFGIGKGI
>S3IMW1|FEATURES|UNIPROT_deepARG|aminoglycoside|RGCCGE502_01971|antibiotic inactivation|1
MNQQAGNTIRIERASRDDIDAWAKLRTALWSDQSMQEHSRDLRRLLDDDVADFRGFLAFR
PDGEAVGFAEACLRHDYVNGCRSSPVLFLEGIHVEPAFRRGGVGRALLEAVRAFGKASGC
TEFASDALLDNVDSHRFHAALGFEETQRVVYFRQPL
>A0A0H3UWU2|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVLGK
>AAT60435|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIDMAEKKFKNRVTDVIITHAHADR
IGGIKTLKERGIKTHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>J8I158|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLQGINHICFSVSNLEKSIEFYQKILQAKLLVTGRKLAYFDLNGLWIALNVEEDIPRNEI
KQSYTHIAFTVTNEKLDHLKEILIQNEVNILHGRERDERDQRSLYFTDPDGHKFEFHTGT
LQNRLEYYKEDKKHMTFYK
>A0A0G4JCA6|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MDLLLAFKAVILGVVEGLTEFLPISSTGHLILAGSLLDFNDDKGKVFEIVIQFGAILAVC
WEFRVKIAQVVAGLGSDAKARRFAVNVIVACLPAIVLGLLFGKHIKAVLFNPTVVATAFI
IGGVIILLVERHNRRNAEAGKLPRVNAIDDLSVADALKVGVAQCLALVPGTSRSGATIIG
GMMLGLERKVATEFSFFLAIPILFGATIYELYKARSTLSVDDFSLFGIGFVAAFISAFVC
VRWLLRYIASHDFTAFAWYRIVFGLVVLATGYSGLVVWAD
>A0A127SXK4|FEATURES|UNIPROT_deepARG|chloramphenicol|catA16|antibiotic inactivation|1
MFTLIDFENWERKEHYAHFMNEVRCSYSVCVNLDITPLNGQRLYPAMLWLLTRTVNEMPE
FRTALTEDGLGYFSEMHPAYTVFNRDVKTFSAIWTEYQPDYPSFLRVYEADVEKYSSTTR
YEPKPGRPANSFDVSMVPWLSFTAFNLNIFGDGTYLLPIFTIGKTFDENGETMLPLAIQV
HHAVCDGYHVGRFVELLQENTNRFGCDSCAAYSDITKEMRG
>A0A0R1VTD2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIIKAIILGIIEGITEFLPISSTGHLYLADEFVKLNEDKAFINMFMVVIQLGAILAVVL
LYFHKLNPFSPKKTQRERGRTWQLWFKVIVAVIPSIIVGLPLNDWMDAHLNTWQVISATL
IIYGVLFIVIERFNKTRQSTLNDLNRLPYRTALLIGVFQLLSLIPGTSRSGATILGAILI
GTSRYVATEFSFFMAIPTMFGASLLKIVKFLKNGQFVGDQVIVLLVGMIVSFVVAYLSIR
FLLNYIKKNDFQAFGWYRIALGVIVVAFFGLRALLA
>H7EFX3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|SEHO0A_04458|antibiotic efflux|1
MSNDLPAAICLKSIRKEYVINNVSNTVLADINLTIHQGEMVAIVGPSGSGKSTLMNIIGC
LDKPDAGRLTLFDRDTAEISHDRLAECRQKYIGFIFQRYQLLPWLSVIDNVMMPARYTTQ
THQQALIRARMLMARLGMADKLSYLPNQLSGGQQQRTGIARALMNGAPIILADEPTGALD
RQNGQEVMALLKELHREGHTIVVVTHDAEIAAQTQRQIHLEDGKIVCQHTTDMPDVSLPA
LLTQVQCARFRLRDAIFTAWLALMGHRVRAFLSMLGIIIGIMSVVNTVAIGEGARQKVLN
DIARLGAHKIEIQPGVDTRGNPLYGILSADDLRYLKSLPFVTEVSAFVSQHMAVASLKKA
GVMGVRGVGREWFALNNQHILSGNLFSLFEQSSAAQAVIIDEIARQKLFPDASGDVIGQL
INIGGSLWRVTGLVSNGLVTGEGQLYVPFTSFMERISPSATVSQIDVHVAENVDETDASR
QIAVAMKARHGAGNIQVKTNQQVLKAVSNASQSLNLLITAIACISLFVGGIGVMNVMLVS
VSERTREIGIRLAVGATRHDILRQFLTESVVICLLGGALGVLLSLLTSLAIGMFATTIVM
KIGLLPVLGAFAISTLTGLVFGFFPARNAAKLNPVEAIARE
>A0A0J5FWD3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNTLLELKGVSRSYLAGEEQVNVLDNISLSVHAGEMVAIIGASGSGKSTLMNILGCLDKP
SSGEYWVAGRDTAGLDSNQLAELRREYFGFIFQRYHLMAHLTAEQNVEIPAIYSGVPKMQ
RRERAIELLKSLGLGNRISYRANQLSGGQQQRVSIARALMNGGQVILADEPTGALDSVSG
QEMMDILKQLCRQGHTVIIVTHDPNIAAQAQRVIEIKDGRIMSDSRPSECRTQTSSPFSS
SVSVKNSSVQQIWGRFNEALLMAWRAMIVNKLRTLLTMLGIIIGIASVVTILVIGDAAKS
MVLSHIKSIATNSIKIYPGGDFGDDDSDLDSQALKLTDIPIIKSQHYVQAVSPEFRVNGR
LRRGNIDVNASVLGVGGDFFQVYAMKFVQGMPFTSEMLQHQAQVAIIDNYTRKKLFPYQN
NVIGEELILENIPLTVIGVIGDGQEFYSGNILQIWLPYSTMNGRLINKSYLDSIDVRVKD
GYSANKAEEKLKQLLAFHHGKKDVSTYNVNRTIEAIDKTTRTLQMFLTLVAVISLVVGGI
GVMNIMLVSVTERTREIGIRMAVGARTSDIMQQFLIESVLVCLMGGILGITLSYSLSLTA
QWMLPKWNFVYNPAAFIVAFGCSTVIGIIFGFLPARNAAHLDPIEALARE
>A0A0B0Q9Q1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKDIITPEAANTFKVVIQLGS
ILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPAVILGFLFEDYIDKYL
FDVRTVAVGLILGAVLMLVADWINKRKTETSSVDNMTYRQALYIGLFQCLALWPGFSRSG
STIAGGVILGLNHRAAADFTFIMAMPIMAGASLLTLVKNAEYLTTDMLPFFIVGFVSAFI
VALFVVRFFLKLINKIKLVPFAIYRIILGLILFILFM
>CAA08843|FEATURES|ARDB_deepARG|beta_lactam|OXA-1|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIRLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>D3I0I3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSILETLIIAIVEGLTEFLPVSSTGHMIIAQGLLGVESTPFVKAFTIIIQFGAILSVVCL
YWNRFFRLDHSPAPQGSSAWARLIHKWDFYWKLLVAFMPAVVIGLIGKKTGLIDRFLESV
EVVAVMLVVGGVFMLFCDSIFNKGSEDTKITEKRAFRIGLFQCIAMIPGVSRSMATIVGG
MAQKLTRRRAAEFSFFLAVPTMAAATVLDVWEVFFSDSADTNWATADNLAMLALGSVVAF
VVALLAMKWFVDFLAKYGFKAFGIYRIIVGGFILIWLMTGHTLSMVG
>J8GWP6|FEATURES|UNIPROT_deepARG|beta_lactam|II9_02182|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNEAGTISISQLNKNVWVHTEL
GYFSGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADR
IGGMKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQSVTNLKFGNMKVETFYPGKGHTE
DNIVVWLPQYQILAGGCLVKSASSKDLGNVADAYVNEWSTSIENVLKRYGNINLVVPGHG
EVGDRGLLLHTLDLLK
>YP_001371127|FEATURES|ARDB_deepARG|beta_lactam|OCH-3|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFTLSDPATKWAP
ELADSSFDKITMLDLGTYTPGGLPLQFPDAVSDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYRVDANNQGLGWEFY
NYPTALKTLLEGNSSDMALKSHKIEKFDTPSQPSADVWLNKTGSTNGFGAYAAFIPAKKI
GIVLLANRNYPIDERVKAAYRILQALDKKQ
>W4ECV6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRKEI
HQSYTHLAFSVEQKDFERLLHRLEENNVHILQGRERNVRDCRSIYFVDPDGHKFEFHSGT
LQDRLNYYREEKPHMTFY
>L1M6P3|FEATURES|UNIPROT_deepARG|bacitracin|CSV86_02372|antibiotic target alteration|0
FLPISSTGHQIVVADLIDFGGERAMAFNIIIQLGAILAVVWEFRRKILDVVVGLPRQRQA
QRFTANLLIAFFPAVILGVAFADLIHHYLFNPITVAVALVVGGVIMLWAERREHVIRVQE
VDDMRWTDALKIGCAQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
VYSGYKYRHLFQPDDFMVFAIGFVVSFIFAMIAVRGLLKFIASHSYAAFAWYRIGFGLLI
LATWVFGWVDWSVAQG
>W8KWW9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MALWIAVLLGIIQGVFMFLPVSSTAHMVLAEHWLIGRGESLPPPDSPEMILFALVVHVGT
LVSIIVVFWTSLWRFTLGALGGAWQWAGQGGRGPAPLYWRLFWLGMFSVLCTGLLGLAFK
AAFEQIFAHPWMIAITLTLTGILLWWTDRLSPRKRGLKGINWRVAGVIGLAQGLALMPGL
SRSAMTIMFSLFAGLKRRWAAEYSFFLAIPTICAATLVQAIQVHRADEPVVIGLAPLAVG
FVVAAVVGIISLKLVIYFLYRAQLKVFSFYVWFLALAVAMGWLGV
>A0A0D5CA69|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
VMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNV
AMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNL
TLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGAGG
>E0IY58|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAHLAPEVIFSFYYRHLICDAILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPTI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYHKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>I3VFR3|FEATURES|UNIPROT_deepARG|beta_lactam|GES-11|antibiotic inactivation|1
MRFHHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSGEKK
>A0A0U1YUE9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWDRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRVEPKIGWWVGWVELDDNVWLFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0M0GR56|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWLTLLKALILGMVEGLTEFAPVSSTGHLIVVDDLMIKSQEILGKYPANTFKVVVQLGS
ILAVVIVFRDRFIEMLGLRRKKEKTHTLKLSHIIVGLLPAMVLGLLFDDFIDEHLFSLKT
VLIGLAAGSILMIAADMFRPKVPVIETVDQLTYKKAILVGLMQCIALWPGFSRSGSTISA
GVLFGLSYRAASDFTFIMAVPIMAGASGISLLKNWMYMTPEFAPFLITGFISAFIFAYLS
IRFFLTVISRIKLIPFAIYRLVLVAVIVIFFM
>A0A023VDV8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYQVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDSQVAAQAERVIEIRDGEIVRNPPPHKSSGGREISGST
VKTVSGWSQFISGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPNKAKVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLSLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A0R2ZBJ8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDNSAQMLEDA
ANEQGSNIVAVILNRNYGQHAAIMAGFEQCRGEVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLVSLMFDLLTCMTTTPLRLLSIVGF
SLAALGVLFAFALVILRLAFGAQWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSSDQVQS
>A0A010L5L0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAFSVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESKQFEHKTLDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>A0A0F7HDZ8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRAEPISKVSVVIPVFNEQESLPALLERTTAACKQLLQPYEIILIDDGSSDNSAAMLTA
AAEQPGSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTTEIEVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVIALSGFVLAVLLIVLRLVLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGAKPTQNTQEEE
>N8Y217|FEATURES|UNIPROT_deepARG|beta_lactam|F961_00589|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGAYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQLLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGHYQVNTMYQALGWEEFSY
PAMLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYTVLNAIKK
>AAK61182|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGD
VYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>A0A0B6TR48|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DEYEVTKLNNDEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKK
LLNDLELAHKLDSKPNELSGGQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEIL
QKLNEQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDTKKEKAQEKLILKTMPKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAHSNTSGVATYTNISLSARA
EGVGVNNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSENILGRVVLFN
SQPFKIIGVLQKDTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPM
ILNAYSVLLGLLSSMLIGVIFGFFPARNAANLNPISALSKE
>N9EX72|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFHVLILAIIQGLAELLPVSSSAHVILAEKLMGFDPSAPDMTFLLVMLHTGTMFAVIV
YFWASWRKTYFSSITNFKKQAGFIILATAITGILGLTLQALIKHVFFAGANHFEIEQLFS
NSKLMAAALVSAGILIILSARLDRGQTGEISLKSAAWIGAIQALCLPFRGFSRSGATIST
GLFLGVARQKAEEFSFALAVVLTPAVIVKEFYRLMHAENFQHMHLSQLLFPSVLGMVFSF
IAGLAALKWLSSWLEHGRWQLFGFYCIGFAGVVLALS
>A0A0J9C4S7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLVEVLKIIVLGIVEGFTEWLPISSTGHMILVDEIIRLNQPDAFKDVFLVVIQLGAILA
VVVMYFHKLNPFSPTKSSRQKDATWALWIKIVIACVPAAVLGLLLDDWMEAHLFNAYVVA
AALIIYGVLFIVLENSSVCSNPQINKVGQISAKTAFMIGMIQLLALIPGTSRSGSTILGA
MVLGCSRGAAAEFSFFLGIPVMFGASLLKLVKYFVAGNVFTGPQIFYTVLGMLIAFVVSI
YSIQFLMSYVRKHDFKFFGYYRIILGVIVLAYFGITALAS
>EEQ96502|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MRVFSRWPAIPFRLFNPSPCPLSQGTDFMDIFNLLEAAFLGLIEGLTEFIPVSSTGHLLL
VGHFLGFESTGKTFEVLIQLGAILAILTVYSAKLLKILTDFPRDARTRRFVFGILVAFLP
AAVIGALAHGFIKSVLFETPMLVCAMLIIGGFVLLWVDQLNLRPRYHDVMDYPLPMCLAI
GFIQCLAMIPGVSRSGSTIVGSLLLGADKRSAAEFSFFLAMPTMAGAFAYDLYKSRDILS
FNDGALIGVGFVMAFISGVFVVRYLLDYVSRHGFKLFAWWRLIVGALGMAALMIWG
>A0A150LIQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAVFLCEEISVQIYYFQLSLSPWSRLIAKKTPLPFLKIGSTIKRISRILIKAALIFAEKR
RYCEGKGMLAMDIITILKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYAAN
TFKVVIQLGSILAVVVVFKERFIDLLGLRGRHRDGQPRLKLMQVIVGLIPAGVLGVLFED
YIDEHLFSTATVLIGLVLGALLMIAADVFAKKAPKAQTVDQITYKQAFIVGLIQCLSLWP
GFSRSGSTISGGVLAGMSHRAAADFTFIMAVPIMLGASVLSLLKNWQYFTMDALPFFIAG
FISAFVFALVSIRFFLRLINQIRLVPFAVYRIVLALVIYVLYF
>A0A081XW60|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTDVSIEEHPVAGSGPYAITTGPDGALWYTLVHSGQIGRLVPGDEPESWRLDPGCGPTII
TTGPDGALWFTEYQAHRIGRITVDGAVAEFALPTPESGPFGIAAGSDGALWFTETTGDRI
GRITTNGEVTEFPLPATGAFPSAITAGADGAMWFTMNQANAIGRIGTDGTVTVHPLPTAA
AAPVGITLGPDDAVWYVAIAAGHIGRVTTEGEITEFPLPDRTGRPHAIAPGADGALWFTE
WGGNRVGSITTDGVIKVHDLPTSGSEPHGIALGPDGALWTALETGARINREPLP
>I3I9R0|FEATURES|UNIPROT_deepARG|aminoglycoside|O59_002518|antibiotic inactivation|1
MLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASA
FPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILL
TKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWY
SAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKG
EIIKSVGK
>A0A060KZ38|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIEKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A0K2WA23|FEATURES|UNIPROT_deepARG|chloramphenicol|BN1090_A2_00516|antibiotic inactivation|1
MNFYRIDMDRWSRKPYFEHYMKESKCSYSITANLNVTTLLDRLQNKKVKLYPAFIYMVSR
VVNSHTEFRTTFNDKGQLGYWDHMIPNYTIFHKEDKTFSAMWTEYSNDFSLFYKNYQCDM
EQFGDKKGLWAKENVPVNTFSISSLPWVSFTGFNLNLYNEEYLLPIITGGKYFSDGKEIL
LPVSLQVHHAVCDGYHVSTFINDLQKLADSCEEWVV
>A0A150F587|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGNLMNPEAANSFKVVIQLGS
ILAVAIVFKDRILNLLGLKKNVTRDQEKGHRLTIAQIAVGLVPAAILGFLFEDYIDRYLF
SVRTVAFGLIAGAILMLAADWINKRKETTDTVDRISCKQALCVGLFQCLALWPGFSRSGS
TIAGGVILGLNHRAAADFTFIMAIPIMAGASLLKLVKYWDSLSPGMIPFFLVGFISAFIV
ALLVVKFFLRLINKIKLVPFAIYRIILGVILLMLAV
>A0A0J7GT95|FEATURES|UNIPROT_deepARG|beta_lactam|TU58_17720|antibiotic inactivation|1
MILKKKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITYTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPVEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
KVIVKALR
>A0A0A8HVL7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MICLENIQKKINNTTILENINLYIQKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGKYFL
DAHEVTNLSKDEKARIRREKIGFIFQRYNLLSLLNAKDNVALPAVYAGKNKHERSQKAKE
LLSFLELDHKELSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGKIVLEIL
NKLNEQGHTVVLVTHDREIAARAKRVIEIKDGKIISDNGVKKSDEIKTKLMPKEKKSFNL
LKNQLFESLKMSIASIVAHKLRSLLTMLGIIIGIASVVCVVALGLGAQQNILASISSIGT
NTIEVVSGRGLGDIRSGRTRLNLSDLKTLSSLPYLEAVEADVGKVGVVTYKNNSLQARIH
GVGPNHLRLRGFVMVDGRFINNEDIKDNTNICIIDENALRILFDSISAKDVLGKSVIFNK
QPLTIVGVLKKERDNKGFRADENTIKIYTPYSTLMNKITGDKQIRAIVTKVKDEINPALA
EEAMVKILEIKRGKKDFFTINSDAIKNAIEENTATLTLLISSIAVVSLIVGGIGVMNIML
VSVSERTREIGVRMAIGARKEDILMQFLIEAVLICSLGAIFGVMLSFIIIEVFNSLNFGF
TMILSLNSVFLGLLSSVLIGVVFGFFPAKNAANLNPISALSKE
>AAB41436|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>S0U555|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAQEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPVREGMARVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
ASSAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMMPVGMVSSLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAQQPELPWMMLGIIGIITFLALGWQFSQKRAARRLLERDA
>A0A0V2D6T8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLEAGYEIAAIFTHADNPAENAFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEDILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPSATSGKRRIRVLILGVNGFIGNHLTERLLNEENYDVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIANDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QIVESRSYYGKGYQDVAHRKPNIDNARRCLDWEPSIAMRDTVEETLDFFLRSVDIAERAS
>V0AKS9|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1620_00207|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0A1A7J7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLIHDKILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KDGNILEIAQCENEATCFGRRTPEDSFLEWHKSAAVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHTSAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPVCAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGQMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVELTDKPS
>Q79DX3|FEATURES|UNIPROT_deepARG|beta_lactam|BL2a_pc|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKKLNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQIPYNKLNKKIHINKDDIVAYSPILEKYVGKDITL
>A0A072CT55|FEATURES|UNIPROT_deepARG|aminoglycoside|DT74_22125|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNEAFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTNQELLAIYKEAFNLLNSVA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDAELWGDHKTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>Q1H8Q3|FEATURES|UNIPROT_deepARG|beta_lactam|oxa|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIGDAGTGKLLVQDGDCGRRASPESTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLT
QDERKQPVSAGIRTREAFLPDLPRLLAAR
>T9ARE0|FEATURES|UNIPROT_deepARG|beta_lactam|G938_04594|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGAQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPFAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKMLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0J5H183|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIKGINHLLFSVSDLERSITFYQNVFDAKLLVKGRNTAYFDLNGMWLALNVEKDIPRTEI
NHSYTHIAFTIDEAEYHQMLDKLRSLKVNILPSRPRNDKDKKSIYFTDPDQHKFEFHTGT
LEDRLEYYRQDKDYMEFFD
>A0A0M9XUR9|FEATURES|UNIPROT_deepARG|beta_lactam|ADK86_10240|antibiotic inactivation|1
MRKPTTSLTRRSVLGVGLGLGGALALGSTTASAASAGAVPSGTTRPGTTSSGSPAAVRRL
RALEREHQARIGVFALNLATGASLLHRAHELFPMCSVFKTLAAAAVLRDLDHDGSQLSRV
IHYTEAEVTKSGHAPVTKDHIDTGMTIRDLCDATIRYSDNCAGNLLLRELGGPTAITRFC
RSLGDPVTRLDRWEPELNSAEPDRRTDTTSPYAIARTYQRLVLGNALDRPDRALLTDWLL
RNTTTLTTFRTGLPKGWTVADKSGGGDTYGTRNEAAIAWTPDGAPVLLTALTHKPTLPTA
PGDTPLIIKLATVLSEAVAPA
>A0A0C9Q951|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVIIGIVEGLTEFLPISSTGHIDLVNHVIKLSQSQDFINMFEYVIQFGAILAVI
LLYFNKLNPFSKPTAKARNATWQLWAKVIIAVLPSVVVGLPLNNWMDEHLHTPLVVATTL
IIYGVLFIILENYLKNKNAHITTLADITYQTALLIGLFQVLSIVPGTSRSGATILGALLI
GTSRYVATEFSFFLAIPTMVGVSILKIGKYLWQGNGFSGEQWAVLMTGSIVSFLVAIVAI
KWLLKFVQTHDFKPFGWYRIALGAIVLLVMFI
>AAG37597|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGLDNQAIASFEIRD
QYITALNHLVLSLELPEVKGMGRFGYVPYIGYKCINHVSVSSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHSINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>A0A0U1YUF5|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANADYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSNGLGLR
QAITKEVL
>A0A0E9ZQC7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLPRLAALATAITLTLGHTAAHADDQLQAKVDRIIRPLMQEHGIAGMAVAIYARDHAHY
FSYGVASKAEGVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGEATVLELGAYSADCLPLQFPDTVQTPQQVVAFFRSWQPHAKPGTQRCYSNPSLGLFGD
LAARAQQQPFATLMTQGLLAKMGLEHTYLNVPASAQGLYAQGYDATNQPVRVGPGPYADE
AYGIKTSASDLLHYVRLHMQPQGLPPALVQATALTQQGYFQVGAMTQGLGWERYPYPVPL
DTLVDGNSPRLIREPQATTRLQPALPALPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNFPNEARVRAAFGILSGL
>A0A089KVG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFDEQNSIMKTYEIVIQLGAILAIAL
VYRKRVLDLLGIGRSNRGRGGVMPAPRLNLIHVILGIAPALAVAFFARDFIKGLFGATTV
LWALVAGGILMIVAEWWNKHKSRVTAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKYFTKDTIMDFAIGFVIAFVVAY
FVVVLFMKLIQKIRPTHFAIYRFILAAVFWLFIMR
>E4TXT2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLFDALILGALEGVTEFLPISSTGHLILASQLLGLEQTNAHKAFEVSIQLGSILAVLFL
YAKRLLQDKMLWLKIGVAFLPAGALGFLFYKQIKALFGVETVSIMLIAGGIVFLLFEFLR
RNKPIDSGKDISELSFKEAFTIGVFQSLSMIPGTSRSGATLIGGLIMGLSRKSAAEFSFL
LAIPTMIIATAYDLLKHRSEMVVDDYFMLSVAFITAFVFALATVKLFVAFVSRHTFTPFA
IYRIIVGIIFFYFVAALPA
>A0A061JJN6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVIWEYRRKIIDVVVGLPRERQAQKF
TVNLLVAFMPAVVLGVAFADLIHEYLFNPITVAAALVVGGIVMLWAEKRDHAIRAETVDD
MNWVLALKVGFAQCLALVPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAAVYS
GYKYRDLFQPGDFAVFAIGFVTSFIFAMLAVRALLKFIGNHSYAAFAWYRIGFGLLILAT
WQLGMIDWSTAAG
>A0A0T9U723|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_6|antibiotic efflux|1
MTVLLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAELDSDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPNVAAQAERIIEIKDGRIMADSGSKTVPNIVISEPMS
LTPPAPSWQQLVGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVYDDMAALQAQPYVSAVSPSITSTIRLR
RGNIDVAGSVSGVSEQYFKVYGMKLEQGTAITREQVERQSQTVVVDRNTQRRLFPNMQDV
VGQVILIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITVRIKEG
YSSKEAEQQLIRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPLALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>S6WH72|FEATURES|UNIPROT_deepARG|bacitracin|A245_07939|antibiotic target alteration|0
MMDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAV
VWEFRRKILDVVVGLPKQQEAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATAL
VVGGVIMLWAERRVHTVRTETVDDMTWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAV
>A0A085PBT2|FEATURES|UNIPROT_deepARG|beta_lactam|carB6|antibiotic inactivation|1
MSANQYYGVTYMKSLLVFALLMPSVVFANSSKFQSVEQEIKGIESSLSARIGVAILDTQN
GESWDYNGDQRFPLTSTFKTIACAKLLYDAEHGKVNLNSTVEVKKADLVTYSPVLEKQVG
KPITLSDACFATMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKL
GDLRDTTTPNAITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVKWSIADR
SGAGGFGTRSITAIVWSEEKKPIIVSIYLAQTEASMAERNDVIVKIGRSIFEVYTSQSR
>I6ZI96|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKRSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>A0A124RPE0|FEATURES|UNIPROT_deepARG|aminoglycoside|WS86_18550|antibiotic inactivation|1
MTHSLAHFTIRAAEASDDDAWRRLRRALWPHADDAAHARDIARQLGAPDRHACFIASAAD
GAALGFAEVAVRRDYVNGCDTSPVLFLEGIFVAPAARRRGVARALCSAAAAWGEARGCAE
FASDAPLENAASHALHRALGFAETERAVFFRKALQRRRGGLSG
>R6E3S6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLFQTIIIAIVEGLTEFLPVSSTGHMIIAQNLLGVGKGDPFVHAFTFIIQFGAILSVVC
LYWKRFFRLDHSPAPEGAGTWGRLKHKFYFYWLLVVGVLPAVVIGLLAKKSGLLGWLLDS
VEVVAVMLVVGGVFMLFCDKIFNKGTEENRMTERRAFIVGLFQCISVIPGVSRSMATIVG
GMQQGLTRRRAAEFSFFLAVPTMAGATLLDVLEMMSGDATWVNAHNITMLLVGCAVAFVV
ALLAMKWFVNFLAKYGFKLFGWYRIVVGLVLIILLATGHSLQMVD
>Q11CA6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAEQTIAQALMLGVLEGFTEFIPVSSTGHILLAGHFLGFQSTGKAFEILIQLGAILAVLS
VYAGRLWKMLIELPHEPATRRFVLGILIAFLPAAIIGVVAYQIIKTVLFETPLLICTMLI
LGGIVLLWVDRWAKKPLYRDITQFPLSVYLKIGLFQCLSMIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAMPTMAGAFAYDLYKNYHLLTAADLQIIGVGFIAAFVAAVLVVRSLLDF
VSRRGYALFGWWRIFIGVLGLIGVLVLG
>YP_001025938|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLAGMIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPNDSYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GAGDYAMRVWLDPQKVAQRNLTADDVVRAIREQNVQVAAGVIGASPTLPGTPLQLSVNAR
GRLQNEDEFGDIVVKTAPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLAISDEVRKTMAELKQDFPAGVDYRIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASIIPLIAVPVSIVGTFSLLLLFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGLTARAATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVR
GVLSRKAVMLGLYLVLVGATLMVSKIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGAIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFDQRHGKALSAGAIAGALN
QKYAALKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYARLADATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVNVTDVFDTMQIYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNAAGEMVPLSSLVTVSPTFGPEMVVRYNAYTAADVNGGPAP
GYSSGQAQAAVERIAAQTLPRGVKFEWTDLTYQQILAGDSAFWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGKTPFEAAVEASRLRLRPILMTSIAFIMGVVPLVLSTGAGAEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAQKDSAGYGVPAPDA
>H2IJ18|FEATURES|UNIPROT_deepARG|beta_lactam|VEJY3_22156|antibiotic inactivation|1
MKKLFFLLALMVASPLSHASKLHEDVSLLEQQISGRIGIAVWDTQTDKHWAYRGDERFPL
VGTFKTLACATMLSEMDTGILKKNATAIVEKRDMVMWSPIMDKLAGQNVRIEHACEAAML
MNDNTATNLVLSEIGGPKSVMLFLRTIGDKATRLDSAEPSVNEAMPGDKHDTTTPNAMVN
TLETLIDGDALSYESRIQLKIWMQDSKVSDPLMRSVLPSGWSIADRSGAGGNGSLGFNAI
IWKENHKPVYISIYLAETELSLQAREQLIAQISQLILYKYRNI
>Q6UIV7|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSQKDTSTPAAFGR
>YP_002807373|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MIALNTASPQGMQMKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRD
AAFEKINEARSPLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALT
LQEKAAGIQDVTYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFN
VGLVAITDVQNARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDK
PQPVNALLKEAEKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSK
TRGAAGTQYDDSNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQ
TVRSSFNNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQE
LANARYNYLINQLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYA
PDSPAPVVQQTSARTTTSNGHNPFRN
>A0A0S8ETT1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|AMS22_10315|antibiotic efflux|1
FIAIMRPSGSGKSTLLHVLGLLDVPDHGSHRLLGREVAQLSDDELAVRRRETIGFIFQQF
NLLPRLTALENTAMPLLYSQGRLSFERAQTLLGEVGLSDRASHRPNELSGGQQQRVAIAR
ALINRPQLILADEPTGNLDSKSQAEILALLQSLNAQGITVIIVTHEEEIARMASRVIRMR
DGVIQADERHRPALGQAAAAAGSATGTTHAAVAGFFEHLRQGLKTLAANKVRTGLSMLGI
LIGVAAVVAMLALGQGAKTEIEARLASLGSNLLMLRPGAPRIGGVAMETGSVLRLTLDDV
AAIRERLPAVRDASATVNGRAQAGFLNRNWSTQVLGTGVSYASMRAAQPDVGRFFTEEEV
RRRARVAVIGRTVVEKLFADQDPIGETIRLNKVSFQVIGILPEKGASAWRDQDDLVVIPV
LTAMHRLLGKEYVDYIDVEVASAEEIQPTQKALEALMFSRHRIPISQQQDAVNIRNLADI
QAALSETSRTMAYLLSAIAAISLLVGGIGIMNIMLVSVTERTREIGLRKAVGAQRRDILM
QFLLESLVVSAVGGLLGILLGALATLVLSIAAGWTTSITLASVLLAFIFSAGIGMVFGLY
PARKAAQLNPIDALRYE
>I4D9K6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLIIKAIILGIVEGITEFLPVSSTGHLIIVNEFINFTGNFAKMFDVIIQLGAILSVVVY
FWHKLFPFGKHKSRLEKAEIWDIWKKTIVGVLPALFIGAIFGKRIEDKLFTPIVVALALL
IGGIILIIIESKNKGGKINSIKQLSFKTALSIGFIQCLAMIPGTSRSAATIIGAMLLGST
RLVAAEFSFFLAIPTMVAASGYSLLKIGFGLTSNEMLLLAIGFVVSFIVALFVISGFMNY
ISKRDFKLFGYYRIILGILVLVYFSFLK
>G0VRA8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDYIIAVILGIVEGVTEYLPVSSTGHMILVGDMLGFTGPRASVFEVFIQLGAILSVIII
YKEKFIRMLHQYRCWDLFRRENWFRTDTGLTLAHIAAGIVPVMGIGYLAHHAIKTYLFSA
GTVIIGLIIGGIFMLVAEKSHTKTVCNDVERMTIAQAFLTGMFQVLALWPGFSRSGSTIA
GGLFLGLSRKAAADFSFIIAVPVMIVACFYDLLKSLSDLSGNDLVMIIIGFITAFIVAYI
SVLWFLKFMNKSTLASFAYYRFVVAVISFVYFFIL
>A0A0T6UDE6|FEATURES|UNIPROT_deepARG|beta_lactam|AO724_19535|antibiotic inactivation|1
MKGWMKCTLAGAMVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELI
DHYEELIKAVPQS
>A0A0M1IUV0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLILKAIIIGIIEGITEFLPVSSTGHMIIAGSIIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIMSTLKNFLPSDRVPVKKCGLKFWINIGIASIPAAAIGIPFNDKIEEKLFY
PWPVTIALIVGAIWMIYAENRYRKNSKSITIDDINAKQAIIIGLFQCLALWPGMSRSAST
IIGAWIAGLSTVAAAEFSFFLAIPAMIGASGISLIKHNVFSTCSSIELIALAIGFIVSFV
VALVVIDKFIAFLKKKPMKVFAIYRIALGIILIVLLYSHVIKWS
>A0A127SW64|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLSGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVY
DTIENQ
>YP_402154|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVATNMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVIYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHSDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGNWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALHESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRHRFSRKNEDIEHSHTVDHH
>ABC69169|FEATURES|ARDB_deepARG|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDCDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAAMPMLCSSNIVGLHKYWLEFAV
>P04190|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINAVVPGH
GEVGDKGLLLHTLDLLK
>A0A108U9X6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGIIEGITEFLPISSTGHLLIAQHWLGARSDLFNISIQAGAILAVVVIYWK
RLWGLATGFTQRDNLDYLLKLGLAFGLTAVLGIAVKKAGFTLPDHVTPIAWALVLGGVWM
VAAEHFAAKRAAALGERAEITWTVAALVGIAQVVAGVFPGTSRSAATIFIALLAGTTSRA
AATEFAFLVGIPTMFAASGYELMHVLGTPAAANEDWSALAVAFVASAVTAFIAVKWLLRY
IQSHRFTAFAVYRVAFGAALLLLMPSGS
>A0A072YRD5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIIKVIIIGIVEGITEFLPVSSTGHMIIIEDLIKFKEGVEPISLYTKQYKDAFTMIIQ
LGAILAIVVLYWDKIKKSFRNFSPSHPKSGFKFWLNIAVAAVPAGVIGLKYHSKINEKLF
NPESVTAALIVGAVWMIFAEKRYRGKFKTRDIDSVTIKQAFIIGCFQCLALWPGMSRSAS
TIIGAWIVGVSTVAAAEFSFFLALPVMFGVTLKSLKDINVFDLSSMHIIGLTVGFIVSFV
VALIVVDKFINFLKKKPMRVFAIYRILLGIILIVLFLFNVIQL
>A0A0W3F1I7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIVEMLKSIIFGIVEGITEWLPISSTGHLILVQEFLKYKDQNAAFMEMFNVVIQLGAIL
AVVVIYFDKLNPFKPGKTAREVQKTWQLWAKVVIAAAPAAIIGLPLDDWFDAHFYNFISV
ACMLIIYGVAFILLEKRNKSVEPAITNLDRLPYKTALYIGLFQVLSLFPGTSRSGATIVG
GLLNGTSRSVVTEFTFFLGIPVMFGASGWKILKFIIKGNTLGFGQFFLLLVAMGVAFGVS
LYVIRFLTDYVKKHDFTIFGKYRIGLGVLLIVYGIFKAIF
>L0DP10|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTSLKLENIRKTYSRGKVSVPVLKGLSLTIERGDMVALMGSSGSGKTTLVNLLGSLDQPT
SGRYWLDGIEVSSLSEKERAQLRNEKIGFVFQNFNLLPRLTALENVMMPLAYSASGLSDR
ECRERATALLERVGLGSRLDHEPAQLSGGEQQRVAIARSLVNRCTILIADEPTGNLDSKT
GQEILDIFRELNEEDGLTIVLVTHDPGVAEHADRIIHMRDGNIVDDPRPAFDSGSVPAPS
PNLGVGEATATRKKKPGILSEVRFFRRTTEMALRSLRRNVMRSVLTTLGIIIGVGSLISI
AEIGKGSSTAIKQVLVTTGANSLLVQAGAASNNGVSLGSGTIKTLTPEDAEAITNECPAV
DSLAPIVVARRQVVNGNRNWVPIYIYGTTPGFLRVREWERLAEGEAFTTDDVRDVSMVCV
LGQTLVDELFSGESPLGKEVFVNDVPLRVIGVLSRKGTNIIGVDQDDILLAPWTTIKFRV
SAASSPNVMPQASAPGGSDLVNQFSLLTRRYPRSQASLYPAQSESQKAATPKLERFANVD
SILVRAQSTEEIPAAMAQITELIRERHQIGPGMEDDFDVRDFTEVIRAVQATVNLVAGLL
VCAALTSLAVGGVGIMNIMLVSVTERFKEIGLRMAVGAAPRDILRQFLVEAVVLCVLGGT
VGILAGRTGSFLIRVLAQWPTEPSLLAVIGSVSVSVTVGIIFGYYPAWKASRLNPIEALR
YE
>A0A071KV37|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_pao|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDRAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A127SHR1|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
NVFTVSMVPWSTFESFNLNLQKGYSYLIPIFTLGKYYEEDGKILLPLAVQVHHAVCDGFH
ICRFVNELQELING
>B1KUC3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIDIIFILKAIIIAVVEGLTEFIPVSSTGHMILVGSAINFNGDFAKMFEVVIQLGAILA
VVVRYWEKIKESIVEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGIMGLLFYHKIKSLFR
PEAVIIGFIVGGILLLIIENMFRKKEHAVQDIDSITFTQALKVGLLQILSVWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTPTLWSALILGFVVAFI
VSIIVMNKFVSYLKKKPMKVFAIYRVLAGLLLAALVFTKIIVLTV
>K0I3U2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWAKIRSTLVALPTERQAQRFALNVFIAFVPAVVLGLLFGKAIKAHLFTPVVVASTFI
IGGFIILWAERRPPSATRIHSVDAMTPLDAIKVGLVQCLAMIPGTSRSGATIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGVYSLYKERALLSAADIPLFATGLVFSFLSAWLCVRWLLR
YISTHSFVPFAYYRIVFGVIVLVTAWTGWVQWAD
>A0A157WMV1|FEATURES|UNIPROT_deepARG|polymyxin|arnA_2|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
PEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQ
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELG
LVEGARLRGAASGPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKA
DPHFHFVEGDIGIHSEWLEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIVR
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
QQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTD
VDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAG
FREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREA
QA
>G4CEP2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECRNINRSFGEGDSRVHVLKDVGLTIEKGDFIAIIGQSGSGKSTLMNILGCLDSAS
SGSYTIDGVETAQMSADELAALRRRKFGFIFQRYNLLGALSARDNVALPAVYAGMAQKER
EARATQLLADLGLAGKEHNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSASGV
MVMEILQELHQKGHTIILVTHDPNIAAFANRVIEIHDGRIVADTSKQPHQAVHRIESRGE
QSSWRFYQDQFAEAFRMSVQAIMSHKMRSLLTMLGIIIGIASVISVVALGRGTQDKILAD
ISAIGTNTIAVYPGKGFGDRTRHRIRTLSVADAEAIAKQGYVDSATPMMSGNGTATYRNI
NVNAQIIGAGEQFFGVRGIKLAEGRFFDQSDVDHRTQVVVIDPNTRQQLFPDGRNPLGQT
ILFNKRPLRVIGLTKEDPNGFGAGENLQMWSPYTTVMQRITGARHIQSITVKIQDQVSSA
VAEQGLKELLISRHGKEDFFTSNSDSIKKTVESTTGAMTLLISSIALISLVVGGIGVMNI
MLVSVTERTREIGIRMAIGARQANILQQFLIESVLICLIGGLIGISLSYLIGLLFNALAA
EFAMSFSTLSIIAAVLCSSAIGILFGFIPAKNASKLNPIAALSRD
>ABW06431|FEATURES|ARDB_deepARG|trimethoprim|dfrA16|antibiotic target replacement|1
MKLSLMAAKSKNGIIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSNFSTNDEGVMVFSSIQDALINLEEITGHVIVSGGGEIYKSLISKVDTLHISTVDI
ERDGDIVFPEIPDTFKLVFEQDFESNINYCYQIWQKS
>ZP_03720331|FEATURES|ARDB_deepARG|beta_lactam|pbp2b|antibiotic target alteration|1
MLIKNEYKPQMLSGTTKTKKPLTSNGRIGLVLGAVALAFTGLLVRGVYLQTSQHEFLKNQ
GDQRFVRTLPLLASRGMITDRNGATLALSAPTESLYAMPSGMEEMPTAEQLEKLSAIADV
PVEVLKNKLSKKDKGFIYLKRQLSYEKAEEIKALGIKGIAFQKELKRHYPMGNLFAHVIG
FTNIDGKGQEGLELSREDSLRGEDGAKVVLRDNKGNIVDSLDSPRNSVPKNGQDMILSLD
QRIQTLAYDELNKAVAYHKAKAGAVVVLDAQTGEILALVNSPAYDPNQPGQANSEQRRNR
AVTDMIEPGSAMKPFTIAKALDSGKVDPTDTFNTLPYKIGPATVQDTHVYPTLDVRGIMQ
KSSNVGTSKLSAMFTPKEMYDFYHDLGVGVRMHSGFPGETAGLLRSWRRWQKIEQATMSF
GYGLQLSLLQLARAYTVLTHDGELLPVSFEKQAVAPKGKRVIKASTAKKVRELMVSVTEA
GGTGIAGAVDGFDVGAKTGTARKLVNGRYVDNKHVGTFIGFAPAKNPRVIVAVTIDEPTA
NGYYGGVVAGPVFKEVMSGSLNILGVSPTKPLSNTATVKVPS
>A0A126VMJ0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSQVEPINKVSVVIPVYNEQESLPALLERTTAACHQLTQAYEIILVDDGSSDASADMLTA
AAERPDSHVIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEQG
YDVVGTVRANRQDSWFRKSASKVINLMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLLTCLTTTPLRLLSVVG
SVVALCGFVLALLLFTLRLVLGPEWAEGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGKRSDPKTQEEER
>R5M9H4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFFEILKVLVLGIVEGFTEWLPISSTGHMILVDEIIHLDVSQAFREVFMVVIQLGAILA
VVVLYFHRLNPLSPRKTENQKRATIRLWMKIVVACIPAAIIGIPFDNLLDKLMNGYVVSA
MLILYGVFFILLENRNRGVQFRIQRVTQISFRTAACIGLFQVLAMVPGTSRSGATILGAM
LLGCSRGAAAEFSFFLGIPVMFGASFLKIIKFIFVDGMTFQAYEVFYLLFGMAVAFGVSV
YSIKFLMEYVKQHDFKFFGYYRIVLGIIVLSYFGISALVAA
>NP_518822|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFALNVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
IGGLVILWAEWRERHRGQTHDPRGNALLEAAKAGAPRVETLDDLRLSDAFKVGLAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSTDDLSIFG
IGFVAAFISAFFCVRWLLRFIASHDFRGFAWYRIVFGVIVLVTAYTHLIAWQA
>A0A0Q4HRN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELLTVILLGIVEGITEFLPVSSTGHLILATRLLGYDAGRWEVFNVVIQLGAILAIVVL
YWRTFWAVGMGLIRREPKSWLFLRNLVVAFIPAAVIGLALHHYIEALLGNAEVVAIALVV
GGFAILAVERFAPRSDISGVADIPLRTVVGIGLLQCLAMIPGVSRSGATILGALALGVER
RTAAEFSFFLAIPTMLGASGLELMKNHAALTSGDGVGLLSIAIGALVSFVVALLVVKWFV
GIVTKHGFVPFAWYRIAAGSAALVWLLSK
>A0A127SB10|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-205|antibiotic inactivation|1
DAAPRRGLIQALGVKGNLMAIRFLTILLSTFFLTSFVHAQEHVVVRSDWKKFFSDLQAEG
AIVIADERQAEHALLVFGQERAAKRYSPASTFKLPHTLFALDAGAVRDEFQVFRWDGVKR
SFAGHNQDQDLRSAMRNSAVWVYELFAKEIGEDNARRYLKQIDYGNADPSTIKGNYWIDG
NLEISAHEQISFLRKLYRNQLPFQVEHQRLVKDLMITEAGRSWILRAKTGWEGRFGWWVG
WIEWPTGPVFFALNIDTPNRTDDLFKREAIARAILRSIDALPPN
>YP_001811889|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MDNMYNSNGLMRFAKVAAASTLLATLLAACAVGPDYKRPDVSTPAAFKEAPTLAAGEQAG
TWKTAEPADGEHRGEWWKVFGDPVLDSLEAQALAANQNLKAAAARVEEARAATRTARSQW
FPQVGAGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVSRNVEASRAD
QAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELRDQALKLVQRRFNEGDIS
ELDVSRAKNELATAQADAVGVARRRAASEHALAILLGKAPADFAFKETPIVPVAVKVPAG
LPSALLERRPDVSAAERAMAAANARIGLAKSAYFPKLDITGAFGYEASTLGNLFLWSSRT
FLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLADLRLL
DDQIRAQDAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVST
VNLIRALGGGWGAAPAPAAVGDAATGKAEVAAR
>A0A0N9YFN9|FEATURES|UNIPROT_deepARG|beta_lactam|XA26_25690|antibiotic inactivation|1
MTGLSRRNVLIGSLVAAAAVGAGVGGAAPAFAAPIDDQLAELERRDNVLIGLYAANLQSG
RRITHRPDEMFAMCSTFKGYVAARVLQMAEHGEISLDNRVFVDADALVPNSPVTETRAGA
EMTLAELCQAALQRSDNTAANLLLKTIGGPAAVTAFARSVGDERTRLDRWEVELNSAVPG
DPRDTSTPAALAVGYRAILAGDALSPPQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGS
GDYGSTNDAGIAFGPGGQRLLLVMMTRSQGLDPKAENLRPLIGELTALVLPSLL
>YP_002850060|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELSHIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGMYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDSQVAAQAERVIEIRDGEIVRNPPPQKPSGGRDIAEPT
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPNKAKVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGILKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGVLFGWLPARNAARLDPVDALARE
>A0A0M2N0P3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSNSEVNKSTDNTIKKVSVVIPVFNEQESLPILIKRTHAACELLNKPYEIILIDDGSHDA
SAEILTQAAEIPENHIVAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRL
VETAEQGYDVVGTVRAKRKDTWFRKTASKMINMMIQKATGKSMGDYGCMLRAYRRPIIEA
MLHCHERSTFIPILANTFARRTIEIDVRHDEREFGESKYSFLKLINLMYDLVTCLTTTPL
RLLSIVGSVIALSGFTLAVLLIAMRLIFGPTWAAEGVFTLFAVLFTFIGAQFVGLGLLGE
YIGRIYNDVRARPRYFVQKIVSADALKTHESVDQQEEE
>L0M062|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTQPALLRHSINWQDVEMFDVTQIKKVSVVIPVYNEQESLPELIRRTDAACALLHRDYE
ILLVDDGSSDNSARMLCDAADMPGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDAD
LQNPPEEIPRLVEKAEEGYDVVGTVRQNRQDTLFRKTASKMINRLIQRTTGKAMGDYGCM
LRAYRRHIVDAMLNCHERSTFIPILANTFARRAIEIPVHHAEREFGDSKYSFMRLINLMY
DLVTCLTTTPLRLLSVVGSVIALLGFGFSVLLVLLRLMFGPQWAAEGVFMLFAVLFMFIG
AQFVGMGLLGEYIGRIYNDVRARPRYFIQRVIRQPETAAEEENQQ
>A0A158DYS6|FEATURES|UNIPROT_deepARG|beta_lactam|AWB80_07683|antibiotic inactivation|1
MKFRALSLLAAAIFSFGAISRAAYAGDADGIQSTVDETIKPLMALHGITGMAVGVVVQGK
PYVFDYGLASKTTKQPVTRDTLFELGSISKTFTATLASYAQIEGDLSLSDPVSRHLPSLA
GSEFGKVTLLNLGTHTPGGLPLQVPDQVHDNDQLMQYFRTWRPAQPPGTIRTYANPGIGT
LGLITAKSMRQDFDVLMQTRLFPALGLKHSYIDVPAAKQRDYAQGYAKDDTPIRMKGGVL
SSEAYGVRSTAADMTRFLQINMNMVRIDPAFQRAVDATHTGYFQAGAMTQDLIWEQYPYP
VALQALLDGNSAAMIMNATPVTRIDPPQVPRDDVWINKTGSTNGFGAYIAFVPKERVGIV
MLANRNIPNEERVKAAYAIITSLVQHQ
>CAB54703|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMQQYISLSGVMTNNGPDNQTIASFEIRD
QYITALNHLVLSLELPEVKGMGRFGYVPYVGYKCINHVSVSSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHSINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>A0A059L8R7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFSDLIHQYLFNPITVATALV
VGGIIMLWAEKRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPSDFPVFAIGFVTAFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLVILATWQFGWVDWTAVKP
>X5LGS8|FEATURES|UNIPROT_deepARG|beta_lactam|BN979_03200|antibiotic inactivation|1
MTGLSRRNVLIGSLVTAAAVGAGVGNAAPALATPLDDQIADLERRHNALIGLYASNLDSG
RTLAHRPDEMFAMCSTFKGYAAARVLQMVGRRQISLDNRVFVDREAIVPNSPITETHVGA
EMTLAELCQAALQRSDNTAGNLLLKTIDGPAGITAFARSIGDERTRLDRWEVELNSAIPG
DPRDTSTPAALAAGYRQVLAGDALSPPQRRQLEDWMRANQTSSVRAGLPEGWTTADKTGS
GDYGSTNDVGIAYGPDGQRLLLAVMTRSQADDPKADNLRPLIGELTAAVLPSLL
>B9VQ98|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
DDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEDRLAS
RADQLEEFVHYVKGEITKVVGK
>A0A0H3CET2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQ
WQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGS
LAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEA
YGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPVRVETAYRILDALQ
>A0A070KJ65|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDITITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQSLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVELTDKPS
>A0A084GP10|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWEIFVAVVLGIVEGLTEFAPVSSTGHMIIFDDLLFQSKELYGQQVANTFKIVIQLGS
ILAVVIIFRERFLSLLGLKKETTKEKQTKLKLSQVFVGLLPAGIFGLMFEDYIDEHLFSI
NTVLIGLVVGAFLMIAADFVQKKRTVTTETVDKITYKQALMVGLIQCLSLWPGFSRSGST
ISGGVMLGMNHRTASDFTFIMAVPIMAGASGLSLLKNWEYFTLDALPFFIAGFISAFVVA
LISIKFFLALINKVKLVPFAIYRIVLAAVIYFVFL
>Q2FC28|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASXKY
SDNTANNKIINZIGGIKKIKKRLKKLGDKVTNPVRYE
>AAA83416|FEATURES|ARDB_deepARG|beta_lactam|BL1_asba|antibiotic inactivation|1
MKQPTTLSLLTLGSLLISSFASAAQDAPLTAIVDGAIQPVLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTYTSTLGAYAVVKGGFKLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESVEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLGQPFEQLMSQTLLPGLALLPTPTSRCLRGMGDYAYGCAKEEKPIRVNPGVLAD
EAYGIKTSSADLLAFVKANISGVDDKALQQAISLTHQGRYSVGEMTQGLGWESYAYPVSE
QTLLAGNSSAVIYNANPVKPVAASQETGGARLYNKTGSTNGFGAYVAFVPAKGIGIVMLA
NRNYPNDARVKAAYAILSKLAD
>A0A031HLD9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVV
LVYWQKIRSTVVDLPTSRQAQRLTLNVIIGFLPAVVLALIFGKFIKAHLFTPTVVATTFI
LGGFVILWAERRPASAMRVQTVDEMTPLDALKVGLVQCLAMIPGTSRSGATIIGGMLMGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSAADIPMFAVGLVFSFISAWLCVRWLLR
YISTNSFVPFAWYRIAFGIIVLVTAFTGVVSWSEV
>A0A0L1NR81|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIETLLNSGYEIAAVFTHPDDPKENAFYSSVAQLCARKGIPVHA
PEDANHPLWIERISKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQRVAIERSDTALILHGKLRVSATDLLRDTLS
ALLQGKVSETPQDESQATVFGRRTPADGKLLWNKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWSADVAKGNEGLAPGRVISVDPLRIACGEDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRGPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDGNFDEDSSNLVVGPINKQRWIYSTSKQLLDRVIWAY
GQRGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNENDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRNNFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWIPTVQMSETIGNTLDFFLREAMLERA
EQSTEESC
>A0A155VJ91|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSHIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDSQVAAQAERVIEIRDGEIVRNPPPQKPSGGRDIAEPT
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALRYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPNKAKVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGILKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGVLFGWLPARNAARLDPVDALARE
>D5VPN8|FEATURES|UNIPROT_deepARG|aminoglycoside|Cseg_4049|antibiotic inactivation|1
MLIRPAAPRDLDAWAALRAALWPGDTIGDHRAELAEALASEGDSAAFVAEASDRLIVGFI
EASLRHDYVNGCETSPVAFVEGLYVRPEFRKTGVGLALCDAVADWGRGRGCSELASDALA
DNLESHAFHQAIGFEETERVVYFRKPL
>A0A128RUR5|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKKIIIFLCTGLLFCVSTWAQGTCFLAKENQTVLKREGNDCDQRYSPASTFKIALSLMGF
DSGILKDELHPEWPYKKEYELYLNVWKYPQNPHTWIRDSCVWYSQALTRQLGMKRFKGYV
DAFHYGNQDVSGDKGQNNGLTHAWLSSSLSISPTEQIQFLQKIIYKKLPVSQKAYTMTKN
IMYIQELPGGWKLYGKTGTGQQLTKDKSQKLPLQHGWFVGWIEKDERVITFAKHIADSKE
NTTFASFRAKNDTLIQLFNLINELEK
>A0A0F4J4T8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MAIERVVVSDRAAGPYGVTVGADGGVWFTLVHAGEIGRLSADGTVTRHPLDSKDCGPAVI
AAGPDGALWFTRMRDHRIGRITVDGAESSFALPTADCGPYGLAAGPDGALWFTEMNADRI
GRITVDGEVTEYPLPVAGGFPSMIAAGSDGALWFTLNQGNAIGRITVDGRTSLHPLPTED
AAPVGITAGPDGGLWFVEIGAGQVGRITVDGEVTEYPLPDRAARPHAVTAGPDSRLWFTE
WAAGRIGSLTPDGTYAGYELDGGEGAAAAEPHGIAVTPDGTVHVALELGAIARLTT
>A0A0F2SBB0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDFLSALILGIVEGITEFLPISSTGHLIIFNQFVGFTEQFANMFDVVIQLGAILSVVVY
FRKRLIPFGNYKSSTNQKIFDLWKKTLVGVIPALGIGFLVADYIEERLFNTTVVAIALIV
GGLILLYIENKRPSLRIKSMEQLTYRTAFFIGIIQCLAMIPGTSRSASTIIGAMLLGASR
VVAAEFSFFLAIPTMVAASGYTLLKNGFILTPHEFLVVGFGFVVSFIVAWAVIAGFMSYV
SKKDFKPFGYYRIVLGIIVLAYFSFL
>R5N3X3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFIELLKVILLGIVEGITEWLPISSTGHMILVDEFIKLNVSDAFMEFFLVVIQLGAIMA
VVVLYWSKLWPFYIRKIPKKTQMALRKQPAVSRAILTFVEKYCDKEKWILWVKILVACLP
TIIIALPFNDIIEEKFYNYVVVAITLIVYGVLFIVIENYNKRRRPACTSLEDLTFKTALI
IGCFQVLSVVPGTSRSGSTIIGGILAGTSRTVAAEFTFFLAIPVMFGASLLKLVKFGFAF
SSTELIILIVGVLVSFVVSILAIKFLMGYIKKHDFKAFGWYRIILGILVLGYFIGKTLLA
>A0A0D8LBV0|FEATURES|UNIPROT_deepARG|beta_lactam|UA45_07625|antibiotic inactivation|1
MPWLAFSAPGFSAADNVAVVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVEAK
QPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAAKYWPELTQPQWKGITLLDLAT
YTAGGLPLQVPDAVKSRADLLHFYQQWQPSWQPGDMRLYANSSIGLFGALTANAAGMPYE
QLLTARILAPLGLSHTFITVPESAQSRYAYGYKNKKPVRVSPGQLDAESYGVKSASKDML
RWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEV
ALQPHPVTDNRVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKA
AQAILSALE
>R0EBD0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLNAIILGLVEGLTEFIPVSSTGHLLLTKELMGLKDPSWDTFIVLIQLGAILAVVAL
YFHRLWNVLIGLPTRPEARRFALSVLIAVIPAFIAGLLLHDIIKSFLFESPLIICWSLLV
GGIILLVVDKTAPPAVDHDAMALPLHKVLIVGLFQCLSLVPGVSRSGSTIVGSMLFGIER
RAAAEFSFFMAIPIMVGAFALDVYKNRHAFDAGHISLVAIGFVVSFLSGLVVVKYMLDFV
SKRGFGPFAWWRIAVGVAGLALMYTHHWPV
>YP_002237398|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTVKQNSSLGIVFILGLLAMLMPLSIDMYLPALPVIAAQYNVPDGSAQMTLSTYILGFAL
GQLLYGPMADSLGRKPVILGGTLVFAAAAVACALSQTIDMLIVMRFFHGLAAAAASVVIN
ALMRDIYPKDEFSRMMSFVMLVTTIAPLVAPMVGGAVLVWFSWHAIFWILALVALLASLM
IGLFIRETLPADRRQPFHLRTTLGNFATLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
ININHVAPQHFGYYFALNIVFLFLMTMFNSRFVRRVGALRMFRAGLWIQFAMAVWMVVCA
LLDVGFWSLVIGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIIGAL
LSMATFTTAWPMLISIAFCATCSIFFSLYASRRRKIAH
>YP_688010|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MTNLKSDTRGLHMNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTE
PLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSA
KGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQGYDQALADAQQANAAVTAAKAAVETAR
INLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQ
ELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLL
PGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWL
VTEGLKAGDRVVISGQQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>F0ETL7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKDLNRYFGEGENRVHILKNISLNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
SGSYKINGKETIELSKDQLSDLRSQKFGFIFQRYNLLSSLTAAENVALPAIYAGMSQEKR
LSRAKQLLEKLGLGDKWQNKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGQ
NVMEILHQLHAEGHTIIMVTHDREIAASANRVIEIKDGEIIGDTQKKAVKSAVENQTKSK
PNFGFSKDQFVEAFRMSVSAIIAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
KGIGTSTMTIFNGTGFGDRRAEQMQNLTINDATALNQQSYVQSVTPNSSSSGTLIYGNQT
FSSTSLKGVGEQYFDVDGLKLKSGNLFSAQDVADNNQVALIDESAKKSIFPDENPIGKIV
MFNKRPLRIIGVVSDKQMGGASSSLNLYAPYTTVMNRISGSKKIGSITVKVDDSVNTTVA
EKGITELLTMRHGKKDFFIMNSDTIKQTVESTTGTMKLLISSIAFISLIVGGIGVMNIML
VSVTERTKEIGVRMAIGARQFNILQQFLIEAVLICLIGGVTGILLSGLIGLLFNVFMTDF
TMAFSTGSIVAAVVFSTLIGVIFGYMPAKRAAQLDPITALARE
>A0A0H3FNF0|FEATURES|UNIPROT_deepARG|beta_lactam|Rahaq_4870|antibiotic inactivation|1
MMKNTLRKTVLMAAAVVPMLAFSAVSWAQTATKMTSVQQQLAALEKDSGGRLGVMLINTE
DNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHL
DTGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAI
PGDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKSRRDVLASAAKIVTQGY
>A0A0M3R7E1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-455|antibiotic inactivation|1
MTVRRFSCALGAALSLSALAGAPARAAVLCTVVADAADGRIVFQQGTQAACAERYTPAST
FKLPIALMGADAGILQGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
LKPAAYDLAETLFDAGEAGGWRLYGKTGTGSPGGNGVYTPDNAYGWFVGWARKDGRQLVF
ARLLQDEKATRPNAGLRARDDLMRDWPAMADAPRQ
>E8WZQ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPILQVIILAIVQGLAELLPVSSSAHVVVAEKLMGLDPTSPQMTLLLVMLHTGTMFAVIV
YFWRRWVHTYFRSSAAFTSVVVRIAVATILTGVIGYPIQKVIEKVMFHGAPKAEIEQLFG
RLDLIAIALFFVGLLILFAGLAERRSMTGRTTGASDEDMSLGQAGIIGATQGLSLPFRGF
SRSGSTISAGMLAGVARESAETFSFALAVVLTPAVLAREGMRLVKFSHEAAAAGTPLDLH
GAIGSSVLGMILAFVAGLAGLKWLSSWLEAGRWYLFGIYCLVMSAVVFFLHTRGY
>A0A084J9T2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDLIIIIKAIIIAIVEGLTEFIPVSSTGHMILVGNAINFRGEFADMFQVVIQLGAILA
VVVLYWKKISDSVIEFFKCIFTLGKKGQTGFKFGINVLIGCIPMGIVGVVFYKQIKSLFN
LQSVIVGLLVGGFLLLIVENFFRKRKNKAVKNIDDITPMQALKVGVFQVLAVWPGMSRSA
STIMGGWVAGLSTPVAAEFSFFLAVPAMVGSSAKDLFEFNYSIMTPTLWVALIVGFIVAF
VVSIIVMDKFVTFLKKKPMRVFAIYRVAVGVLLAVLVFTKVITLVA
>A0A0Q5B2N6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKRALAALVLSGLPLVPAPAPAADPSARVAAAVEQAYRPLLKAYDVPGIAVAVTRAGHS
TVFTFGLADREQQRPVTRDTLFEIGSVSKTFTATLVAYAQGLGQLSLDDAPSRFLPSLRG
SALDRVSLRDLGTYSAGGLPLQFPDSVTDEAAMIAYFRRWHPSAPPGRQRLYSNPSLGLF
GAAAAAAMGGDFAGLMETRLFPGLGLTHSFIRVPASESERYAWGSGKDGTPIRVNPGVFA
GEAYGVKSSAADMIRFVEANLDPARLDPPMRQAVHGTQLGYLRVGEMVQGLGWEQFPYPI
SLERLQAGNGEPMRFEAQPATRLDPPQRPTGAMLFNKTGSTNGFGAYVAYVAFVPAQRIG
LVMLANRAFPMPARIAAAHAVLEALAAEAP
>A0A0M3A642|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MALLKKTKTIFYVLISSMGLTTYVNANQQITTAKVENAMTQAFQPLMQKYAVPGMAIGVL
YQGKSYEKYYGVQSLADKKSVNKSTLFELGSVSKLFTATAGSYAQSVSKLSLQDHPGKYL
PALKNSEINQVTLLQLATYTTGNLPLQFPDPIKTDAQTLKYFQDWKVNQPVGQFRQYSNP
SIGLFGEATAKAMNMPFSTLLEQVIFPQLQLQHSYVNVPKAQQAQYAFGYDQNNRPIRVN
PGPFDAQAYGVKSNLPDLLQFLKLNLNPDQAKASIRPAIEGTHIGYFKMGGMTQALGWET
FDYPARLETLLESNSDRVVMQSNPVEKTLVKSGARVFHKTGSTNGFGTYLIYIPAEKFGL
VMLMNKRIANAERIQAAYEVLNTLKQTSHP
>A0A0A1I193|FEATURES|UNIPROT_deepARG|beta_lactam|BN844_1770|antibiotic inactivation|1
MRMTRSILAGTFLLGYGMMPGFAQDRLEDTVNAVIEPLMKRQDIAGMAVAITLDGQPHYF
NYGVASRETKQPVTDQTLFEIGSISKTFTATLGAYAQARGKLSLSDPAGRYAPELHGGAL
ESISLLNLATYTAGGLPLQFPDAADHPDRMFGYYKTWKPLYPAGTQRLYSNPSIGLFGYL
AARSLDRPFDEAMEQTLMPGLGIKHSYLRVPASESSRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSASDLIRFVEANLRPEKLDPALQQAIATTHTGFYQVGGMTQGLGWEFYPYPVTVS
ELLAGNSAEVAMKPNKVEPLDPPQPAPDSAWINKTGSTGGFGAYAAFVPGKNMGIVLLAN
KNYPIEERVKAAHRILTALEER
>G2GWW8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSQIESIQKVSIVIPVYNEQESLPILIARTSAACQLLTQPYEIILVDDGSTDDSAAILTR
AADAADSAIIAVILNRNYGQHAAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVKVAEEG
YDVVGTIRENRQDSWFRKTGSRLVNMMIQHATGKSMGDYGCMLRAYRRHIVEAMLSCHER
STFIPILANTFARRTKEITVRHAERSFGDSKYSLMKLINLMYDLVTCLTTTPLRLLSALG
SMIAVSGFMLAFLLVILRLIFGSVWAGGGVFTLFAILFMFIGAQFIGMGLLGEYIGRIYH
DVRARPRYFIEKIVRAKSAKNIQEKEQ
>A0A0Q9HGT1|FEATURES|UNIPROT_deepARG|beta_lactam|ASE46_13595|antibiotic inactivation|1
MKTWKEMFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCHRQETKSDREFAKLEEKY
DANLGVFALDTGTNKTVTYHPDERFAYASTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALENIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALATSLQKYVLGQSLPEDKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKDAEYNDKLIAEAAKQ
AVKTLKVTRK
>A0A0M9D1C5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLYKKFFRSADLVSFEQIKKVSVVIPVYNEEESLPLLLERTLAACKQLTQNYELILIDDG
SSDKSAEILIQAAEQPENHIIAILLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEE
IPRLVKTAEQGYDVVGTRRANRQDSLFRKTASKIINAMITKATGRSMGDYGCMLRAYRRH
IIEAMLQCHERSTFIPILANTFARKTIEIDVAHAEREFGDSKYNFMKLINLMYDLLTCLT
TAPLRLLSVIGSVIAVSGFLLAVLLVVLRLIFGAIWAADGVFTLFAILFMFIGAQFVAMG
LLGEYIGRIYNDVRARPRYFIQKVVGDRKTNDN
>J8XEI2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEKSIIFYEKVLEGELLVKGRKLAYFNICGVWVALNEETHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCKSIYFVDPDGHKFEFHSGT
LQDRLNYYREDKSHMTFY
>S9TF11|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFYVIVAIVLGIVEGLTEFIPVSSTGHMILTAKLMGIEEQANWLKTFEIVIQLGATLAMT
VVYWNRILEMLGLRKRTVQQGHVICPRLNLLHVIIAIAPALAVAYVAKDHIKQLFDSTEA
VLWALVVGGAFMWFAEWYGSRRQPSADTIDEISYKQAFSIGLFQILSVLWPGFSRSGSTM
SGGMLSGVSYRASADFSFLIAIPIMCAASGYELLQNYKMFTLDIFAFFVLGFLVSFVVAY
VIVVAFLKHIQRIKLRHFAIYRFVLAALFWYFMM
>A0A0J6NCY9|FEATURES|UNIPROT_deepARG|aminoglycoside|VK98_17900|antibiotic inactivation|1
MHIRALKLATLPAWQGLRQQLWPHHSPAAHRADGERILSSRQLASFLALDDAGQALGFAD
AAIRQDYVNGCDGSPVVFLEGIFVLPAHRQRGIARQLVAAVQAWGLERGCAELASDAPLD
NLASQRMHAALGFEETERVVFFRMALT
>A0A081L6D2|FEATURES|UNIPROT_deepARG|chloramphenicol|BA70_16450|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMTLTRCSYSLVINLDITKLHAILKEKKLKVYPVQIYLLARAV
QKIPEFRMDQVNDELGYWDILHPSYTVFNKETKTFLSIWTPYEESFVKFYKSCLADIETY
NKSSKLFPKPNMPENMFNISSLPWVDFTSFNLNISTDETYLLPIFTLGKFKMKEEKIILP
VAIQVHHAVCDGYHVGQYIQYLRWLIEHCEEWLNG
>A0A0N7HK18|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-107|antibiotic inactivation|1
VSLLLGSVPLYAQTADVQQKLADKERQSGGRLGVAYFNTADNSQILYRADERFAMCSTSK
VMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNV
EKKNNL
>A0A080K4I9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLLEIKAINRWFGTGENRVQVLKDINLSIEKGDFVAIIGQSGSGKSTLMNIIGCLDVPS
SGSYKIDGVETAAMTADEQAALRRRSFGFIFQRYNLLGTLTARENVALPAVYAGMEYDER
MKRADELLAQLGLAGKEENRPSELSGGQQQRVSIARALMNGGEIILADEPTGALDTGSGK
NVMEILHKLHDAGHTIVMVTHDPTIAANANRVIEISDGRIIADHSKNADIPPSNIESIEE
HNSWHFYRDQFFESFLMSIQAIMAHKMRSFLTMLGIIIGIASVVSVVALGRGSQEKILEN
INAMGTNTVSVYPGYGYGDRRSSRIKTLTVGDAEVLKQQDYVDSVTPGVNTSGTLTYDNQ
SLSAQLYGVGDQYFDVRGIKLAFGRLFNEDDVTQNSQVVVIDDNTKNKLFADGTNPLGKV
ILFNKRPLRIIGVTEPNNNGFSDSDSLQMFTPYTTLMNRISGSKYITSVTVKVKDNVNSQ
TAEKGIIELLKVRHGTEDFFTRNSDTIKQTIESTTGTMTLLISSIALISLVVGGIGVMNI
MLVSVTERVKEIGIRMAIGARQHNILEQFLIEAVLICLIGGLVGVLFSFAISMLFNLLAT
DFAMSFSTISIVMAVLCSSVIGVLFGFMPAKRASQLNPIDALSRD
>A0A0T8J1L3|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
KVIVKALRQ
>YP_401803|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLHVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKVYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGIDPAMRAENISVAQYCQMANYLAENAPLQES
>A0A0W0ALM7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQMGSILAV
VAVFWRRLFGLIGIHFGQKPPQDHATLSLVHIILGMLPAVIIGLGIHSWIKANLFGPETV
MYALVAGGILLIIAEKFRPTVRSETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMVAASGLDLYKSRDLLSMADFPMFAVGFITAFVVAMIAIK
TFLAMIRRLDFIPFAIYRFIVAFAVYLVFVA
>A0A132CWQ3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNAIRIAATLFVAACAAAMAGRAAAATQDEIHDTVTRHVAPLMKQFAIPGMAIGVVVD
GKPYVFDYGVMSTQTGKPVTGETLFEIGSVSKTLTATLAANAQEGGELSLSDPAGKYLPA
LQGKPFGVVTLLNLGTHTPGGMPLQVPDSIRDDADLMRYLDAWRPAYAPGTRRTYSNVAI
GMLGFLTAKAMHEDFTVLMEQRLFPALGMTHTYIDVPAARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLVETSPRLQRALERTHTGYFRTGPFTQDLIWEQYP
YPVALPTLLAGNAPPMLHNATPASELEPPLAPRADTWINKTGSTNGFSAYVAFVPAKRIA
IVMLANRSFPIEDRVKTAYRIVESLHGKP
>A0A0D6EXP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFSLYFSSLILGLIEGATEFLPVSSTGHLIIASELLNFNHASANVFEIFIQLGAILAIV
VEYRKTLFTVASGALHDRTSQDFVLRLFIAFLPAAILGLLFHKAIKAYLFSPLYVSLALI
LGGVVMIAIEKRPLKVNTKSTNDINMMQAFKIGCAQCLSLIPGVSRAAATIMGGMLTGLN
RKTATEFSFYLAIPIITAASLFDLLKNFHDLTPQDLPIFAIGFVTAFLSAYAVIKLFIRF
VATHTFISFAWYRIILGIIVFTYFNGQV
>A0A0J5Z1D4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIRGINHFLFSVSDLERSIQFYKNVFNAKLLVKGKTTAYFELAGIWIALNEERNIPRNE
IAHSYTHVAFKVDDSDFENMCNKLEKLKVHILPGRARDMRDKKSIYFTDPDGHKFEFHTG
TLRDRLEYYRSEKGHMEFFG
>D2JD74|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>M9TDF1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
ADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGIT
LLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKP
SGLSFEQAMQTRVFHPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
>A0A060L004|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTAGNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0A1RZG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGKTPHEGTGKGRLTLGHILLGMIPAVVLGLIFHDTIKSLFNPINVMY
ALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGML
MGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLTAADIPMFAVGFVTAFVVALVAIKT
FLQLIKRISFIPFAIYRFIVAAAVYVVFF
>C9N1K9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFADIIKVFILSLVEGLTEFIPVSSTGHMIIVDQFLQLSQNEEFANAFKIIIQLGAILSV
VVYYWKRIFPFAKGLSKSQRADIIQMWIKIVIAVLPAVVLGLLFDNIIDKVLFNSVVVAI
MLVIYGVILIWLESREKKEGGIASITQMSVKTAIGVGLFQCLAMIPGTSRSAATIIGGVL
LGLNRVLATEFSFFLAIPTMLGATLLKLVKLGTALSGYEWFLIALGFVLSFVFAYAVIKV
FMDYIKKHDFKVFGYYRIILGIIVLVLYFMGAIK
>A0A060L043|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGATNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A1UJW6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSLIREIAGGPYALAAGPDGAMWVTLVHDGAIARVGADGAVDRFPVADGSRPSLISAGPD
GALWFTRNGDDRIGRLTTAGELTEFPLSEGSAPFGICAGADGALWFTEMGSGGIGRITVD
GQTSGWASVGGTPSMITRGPDDAVWFTLNQGNAIGRLHPRDGVTMRELPTRGAGPVGITA
THDDAIWFTEILADKLGRIPLDGALQEIDLPGKPHAVVADPSGGVWVSLWGADRLARVSA
DGDIETFDLPPGSEPHGLAFGPDGGLWVALESGFVLRMPD
>B0T669|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLIAIVLGLVEGLTEFIPVSSTGHLLLTKIALGLTDPAWDTFIVLIQLGAVLGVVAL
YFQRLWAVVVGLPTQPEARRFALTVLIGCIPAFAAGLALHGVIKHFFENPYLPQVICVSL
ILGGVILLVVDKKAPPPREMDGMALSLKTAALIGLFQCLSLLPGVSRSGSTIVGSMLIGV
DRKAAAEFSFFMAIPIMVGAFALDLLKSYKDIDASHAGAIAIGFVVSFLSGLVVVKFLID
FVGKRGFTPFAWWRIVVGVIGLGLIYIPR
>ZP_04653995|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQLFYGPLSDRVG
RRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTLPRDLYEGTQLR
HANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMARWMPETRPAGA
PRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMVVSILFIL
PIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVWTLLIPAALFFF
GAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQTGQGSLGLLMTL
MGLLILACWLPLASRISHQGQTV
>F0V6U5|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDRAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPITLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>ZP_01788419|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVETLRTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDSRFYDHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTSEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKSLNELTLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIGIVKG
GAEILLASGEKMTLSTNAMRWTGRSNPVKVGEQIWIRQRANGEWQLGQIPSANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKPGQKMWQPKNSPDRYDGPMRLRVGLGQSKNMIAIRAIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIE
CNDIPVIYGETKDKINGFANIPLGESALKPTDDSTNGEELDQQPETVPELPELQSNFTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYM
KTALSDKPERKLPLPPKIVEKSIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYY
VPTELQQRLNNEGNTPATQPQELF
>A0A0L0AC39|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MVAFATAWTGTSVQAAPSAVETLVKARAESLMSQYNIAGMAIAVTDGRQQMFFNYGLASR
EARTPVTADTLFELGSISKTFTAALAAYAQANGKLSLSDHPGQYLPALRGTPLDQVTLAD
LGTHSAGGFPLQLPDDIQNDAQLMTYFRNWRPSYAPGTQRSYANPSIGLLGLIAAKSMDV
SFAQAVHDTLLPALGLAHTYLDVPADQLPLYAQGYDKQDQPVRLNPAVLADEAYGFKSSA
RDMLHYLQAQMGTVTVPAKLREALKATQQGYFRVGGMTQGLIWEQYGYPVALDTLVQGNS
NAVALTTQPTSPLQPLDEVWINKTGATNGFGGYVAFVPSKKIGVVVLANKNYPNEARVRF
AHELVQALDK
>B1J846|FEATURES|UNIPROT_deepARG|beta_lactam|PputW619_2381|antibiotic inactivation|1
MHFASLTAATALALIATSANAADPLQAQVDDIIRPLMHDQDIAGMAVGLYVNGKAHYFSY
GVASKTDNSPVTADTLFEIGSLSKTYTATLAALASAEGKLDLDAPAQRYQPALAGTSLGK
TSVLELGAYSADCLPLQFPDSVQTDEQALEFFRTWKPRAEHGTQRCYSNPSLGLFGDLAA
RAQQQPFAELMTKSLLPQMGLKHTYLQVPASAQGLYAQGYDAQNRPVHVSPGPYADEAYG
IKTSASDLLRYVRLHMQPAELSPALRKAAAITQAGYFQVGAMIQGLGWERYPYPAALDTL
VDGNSSRIVREPQATQRLNPTRPALPQAWYNKTGATSGFGAYAAFIPAEGKAIVLLANRN
YPNEERVRAAYRILSSIDR
>K7QD67|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVSTSQTRDLMKSNWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRA
FYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTIERLKAMKLPIKTV
VGGHDSPLHGPE
>Q84H50|FEATURES|UNIPROT_deepARG|beta_lactam|BL2b_tem1|antibiotic inactivation|1
FFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYTTGSQAT
>N8QXC4|FEATURES|UNIPROT_deepARG|beta_lactam|F992_00626|antibiotic inactivation|1
MIASRMLFLLAGLLSCNSSIWAKPLSEQQVKEIVDQQFKPLLDQYKIPGLAVGVTLDGKH
YFINYGLASKSNEQAVSNNTLFELGSVSKTFNATLAGYAQAKGQLLLSDHPAKYFPELKN
TAVNKATILNLGTYTAGGFPLQFPDEVVTQQDMLQYFQTWQPKTNVGTARQYSNPSIGLM
GYITALALKRPYSELLEKTLFPQLGLSQSFVQVPEQQMSQYAWGYKNDQPIRVSAGMLDA
EAYGVKSSSSDMLKFLDIQIHPQKLKQPLRAAVETTHVGYFKVGAMTQGLGWEQYAYPVK
LETLLEGNSSKMALESHIVTPIKQPKRAPAATLFNKTGSSNGFGAYAAFIPQQKIGIVML
ANTNFPNEARITASYHVMQQLLQKNTAQ
>R7ET08|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFELLRALLYGIIEGITEWLPVSSTGHLIIINAIPALELGSSLPGEFRAEFCEMFEVVI
QLGAIMAVVVFFFDRLYPFGRKSHPKTAAESRASLMLLAKIAVASLPAAAAGLAADRLLE
HFTGCGLHALLYTPPVVASALIIYGIFFIAVERLRRGKAPAVESVNDITFANALLIGAFQ
ALAIIPGTSRSGSTVLGACCLGISRTAAAEFSFFMAIPAMLGASLIKGAKFCRFLAASGE
TLPAAETAALAAAFVTAFAVSVATVRFLLDFVKRHTFSAFGVYRILLGIAVIAWFGLKK
>A0A031G709|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHQYLFNPITVATALV
VGGVIMLWAERRQHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAIGFITAFIFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLVILATWQFGWVDWSAVKP
>A0P564|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLYLLWAAFVLGVIEGVTEFLPVSSTGHLIIAADVLKFSNGSSDVFEIFIQLGAIMAVI
TEYRRKLINTVSNIPHDPAAQKFAASIAIAFIPAAILGFFFHSTIKFYLFNPVSVAVALI
VGGLAMILIEKLMPPRQIGSQPDVNFKQALLIGMAQCLSLVPGVSRAASTIMGGVLCGLD
RKSATEFSFFLAIPIIIAASFYDLFKNFDLLNKDDFLILFFGSVTAYISALLIIKIFIRY
VAHNNFIGFGWYRIMIGIITLFYFY
>A0A098U5H7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSTKSIAIACLSLLPLTADAVDAAAVRAAVDRAIQPLMAQHDVPGMAVAVTVDGQVLFFN
YGEASKQEHKPVTENTLFELGSVSKTITATLACYAQGLGKLSFGDHPGQYVPQLKGSAID
RASVLELGTYTAGGLPLQFPDDVETEAQTIAYFRAWQPDAAPGTLRRYSNPSLGLFGHVT
ARALGVGLADAVEGQLFPALGLKHSHIRVPAGATGDYAWGYDKANRPARVSPGPFDAEAY
GVKASAADVIRFVQLNIDASSLPDPMRRAIDCTHTGYFRIGDTVQGLGWEQYRAPLTLAA
LQAGNSAKMSAEPNPAVRLEPPQAPPPGTLFNKTGATRGFGAYVLFVPERRVGIVMLANK
NYPNAARVGAAYSILGTLAP
>I3XFL5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLLSIALALPTSVKARRFVLSVLLAFLPAALIGAAAHGFIKAVLFETPMLICVVLI
VGGVILYMIDRLPLKPRYTDVFDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMVGAFTLDLYKNRDALSFDDISVIAVGFIAAFVAGIFVVRSLLDF
VSHRGFTPFAIWRIVVGTAGLIGLWLLG
>A0A0R2AZE1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIIIGIVEGLTEFLPISSTGHIDLVNSVIKMNQSAAFTAMFEYVIQFGAILAVI
LLYFNKLNPLTTKKTPQERSDTWVLWFKVLVACLPSIVIGLPLNSWMDEHLHTPVVVASM
LILYGILFIIIENHFKNTPAKVTGLGQISYRLAFFIGIFQALSIIPGTSRSGATILGAII
LGASRFVATEFSFFMAIPTMVGVSLLKIWKFFREGNSFGSEQVLILAAGMIVSFIVAWAT
IKWLLKFVQTHDFKPFGWYRIALGIIVLLVMFFH
>W0V2K2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKIIKLISLLACAFPLAGHAAGDAQPPLKDQVDSAVAALMKQYNIPGMAVGISVDGKRYF
YNYGVASRDSKLPVDQDTLFEIGSISKTFTATLAAYAEVDGKLALSDKASKYLPALRGSS
LDQVSLLNLATHTPGGMPLQFPDEVQSDEQVMNYFRQWKPAYAPDTYRTYANPGIGLLGW
IAARSMDIPFEDALEKKLFPALGLKHSYIKVPASQFKHYAQGYNSKDAPVRVSPGPLAAE
AYGVKTGTGDLLQFLEANMQLAKVDDQWQRAIKHTQTGYFRSGTLTQDLIWEQYAYPVEL
KPLLAGNSGDMAYHPNPATRIEPALPPQANVLINKTGSTNGFGGYVVFIPAKKTGIVILA
NKNYPVDARVTTAYQLLQALDGRQASKQ
>C6C762|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDLGCVGLRALAAAGYTIEAVFTHADNPSENQFFGSVARTAAELGIPVFAPE
DVNHPLWVERIAAMAPDMIFSFYYRNLLSDDILRCAPHGAFNLHGSLLPRYRGRAPLNWA
LVNGETETGVTLHRMVSRADAGNIVAQQQVAIDDADTALSLHHKLRESAAQLLAQALPAI
AAGRVEEHAQDESLATYVGRRTPEDGRLEWQKPARTLYNLVRAVTEPWPGAFSFVGTTKF
IVWQAKVRTDFAAAKPGTVLSTSPLVVACGSDALEIVTGQGDSGIYLQGSQLAQSLGLVT
GAILNNAPVVSVKRPTRVLILGVNGFIGNHLTERLLSEDNYEIFGLDISSDAISRFLGNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDPMFDEDRSNLIVGPINKPRWIYSVSKQLLDRVIWAYGEK
EGLSFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KDGVEALFRIIENRDGVCDGQIINIGNPDNEASIRQLAEMLLESFEKHPLRHQFPPFAGF
RDVESSSYYGKGYQDVEHRKPSIRNAKRLLHWQPTIEMEKTVAETLDFFLKTVDQPGSAE
>A0A060KT75|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAATVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGW
>B2CD50|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
PEGSFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRE
LCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTT
MPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVQDHYSSP
>A0A118FSQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVTGLPSRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVMSVDALTPLDAFKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0A3YTF6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKEPHEGTGTGKLTLIHILLGMVPAVVIGLLLHDQIKSLFNPIN
VMYALVVGGVLLLAAEFFKPKQPKAVGIDDITYLQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMIGATGLDLYKSMGFLTMQDFPMFAVGFVTAFIVALLA
IKVFLELIKRISFVSFAIYRFIVAAAVYAIFM
>C7RK47|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKALILGIVEGVTEFLPVSSTGHLILAGDLLNFNDDRGKLFEIVIQSGAILAVC
WEFRAKIVQVLLGLPSDRAAQRFALNVLVAFLPLAIIGLLFGKAIKASLFNAPVVATAFI
VGGLVILWAERREHRIRIESIDDLTLLDALKLGLAQALALIPGTSRSGATIIGGLFFGLS
RRAATEFSFFLAIPTLIGATIYQLYKERALLSFDDLGMWVVGFVAAFVSAFWAVRGLLRY
ISTHDFSAFAWYRIAFGVVVLVTWHYDIVAWTSG
>ZP_03164918|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRHALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTASQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQSGQAP
>A0A0D9AGQ8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTMALSRPAAADVDFAGIDATVTDAAQAVMAQHAIPGLAIAITAQGEQRFYEFGVASKAT
QQAVTRDTLFEIGSVSKTLTATLAAYAETQGKLSLTDSPSRYLPALQGSQLDRITLIDLA
THTAGDFPLQLPDAIRNDQQLTDYFRSWQPRYAPGTRRVYANPGMGLLGMAVASGLGIPY
VEALQSRLLPTLGMNSTYIDLPSGERMRYAQGYNKNGDPVRLNPALLANEAYGVKTTSQD
LLRFVEAQLGTIKTDRSVRQAITATQTRHYRVGAMTQALVWEQYDYPVALDDLLVGNGSK
MVLDSQPVEPISPPSPPQADVWINKTGSTNGFGAYLAFIPAEQLGIVILANRYYPNEDRV
KLAYRILGQLAQ
>A0A0T9UAY8|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLVFHDVIKSLFNPQS
VMYALVAGGLLLLAAEWFKPKNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASGLDLYKSLHFLSWGDLPMFAVGFITAFVVALIA
IKTFLSLIKRISFVPFAIYRFIVAAAVYWVFM
>Q8VN24|FEATURES|UNIPROT_deepARG|beta_lactam|kluA-8|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAIIWPENQTPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>W0MWK7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MRPYPINRVSIVIPVYNEQQSLPELLRRTETACAQLNHAFEIVLVDDGSRDDSAEILQQA
AARDGSPFVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVALAEQGY
DVIGTVRSNRQDSAWRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEVLVEHAEREHGDSKYSPMRLINLMFDLITCMTTTPLRLLSIIGF
SMAFLGGLFAVLLIVLRLIFGATWAGDGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKIVRSSSVTANDSVVPPYINKVAP
>A0A104TUA0|FEATURES|UNIPROT_deepARG|beta_lactam|WJ75_07370|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLALTLSACASPLANASSVGAASSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALFTQRVTYRQADLLEWSPVTEKH
VDTGMTVGELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQFAQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTTNDIGVLWPPARGPIVLTVYYTQARADAKRKDDVIAAATRIAIAALG
>A0A0A0WMG9|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ2|antibiotic inactivation|1
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSNERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDSLKVTNK
>YP_410000|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MIMKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMAR
TLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCVGVTFS
MARWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMN
VWTLLVPAALFFFGAGMLFPLATSGAMEPFLFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>Q8GLT3|FEATURES|UNIPROT_deepARG|aminoglycoside|aada2C|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPATEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0E2N2W0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEITSVNHICFSVSDLNTSIQFYKDILQGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNE
INHSYTHVAFSIDEEDFQKWIQWLKENQVNILKGRPRDIKDKKSIYFTDPDGHKIELHTG
TLKDRMEYYKSEKARMQFYDEF
>ZP_03984378|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVIT
NKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMY
TSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>YP_001436507|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLTGFSAMSQAENLLQVYQQARLSNPDLRSSAADRDAAFEKINEARS
PLLPQLGLGADYTYNSGFRDNDGVDSTAKSASLQLTQTIFDMSKWRALTLQEKTAGIQDV
TYQTDQQTLMLNTATAYFQVLSAIDALSYTEAQKQAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDNVLANEVTARNNLDNALEQLRQVTGNYYPQLASLNVDNFKTTKPAAVNALLKEA
EQRNLTLLQARLSQDLAREQIRYAETGHMPTLGLTASSSVSDTDYSGSKTSGAAASRYAD
SKIGQNSIGLSFNLPLYSGGSVTSQVKQAQYSFVGASEKLESAHRNVVQTVRSSYNNVNA
SISSIKAYEQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQQLSSARYNYLIN
QLNIKSALGTLNEQDLVALNNSLGKPVSTAPESVAPENPEQDAAVNNMANGGGNAPAMQP
AAATRSSNSNSGNPFRQ
>R9HTF7|FEATURES|UNIPROT_deepARG|beta_lactam|C801_02901|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNW
STPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGTLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNADIIARISRMVYDAMR
>A0A0W7Y973|FEATURES|UNIPROT_deepARG|beta_lactam|AMR94_10155|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINAVVLGH
GEVGDKGLFLHTLDLLK
>ZP_04320832|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSNRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGIPTDWVVGDKSGAGSYGTRNDIAVVWPPNRAPIIIAILSSKDEKEAIYDNQLI
AEATKVIVKALR
>A0A0U5PCR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MLEALKVIILGIVEGITEWLPISSTGHLILVEEFVKLKMSDDFMSMFNVVIQLGAILAVV
VIYFHKLNPFSRTKTDKQKKLTLQLWVKVIAAAVPAAVIGLLFDDLLDAYLMNYVVVAIM
LILYGVIFIVVEKRNEHVRPSVRRLSDLTIPMALMIGGFQVLALIPGTSRSGATIIGGLL
IGASRAVAAEFTFFLAIPVMFGASLLKIVKFGFHFTGMESFLLLLGCAVSFAVAIFAIKF
LMQYIKGHDFKAFGYYRIVMGIIVLLYFGMSALFA
>X8HW03|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLKFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNVLVVAIT
LIAYGVIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVIVLLY
>W3YJI5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSLADEFDEIKKVSVVIPVYNEEQSLPQLLERTIKSCKQLTQAYELILVDDGSSDRSAKM
LVEAAENPDNHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVQTA
AQGYDVVGTRRANRQDSWFRKTASKMINAMITKATGRSMGDYGCMLRAYRRHIIEAMLQC
HERSTFIPILANTFARRTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLS
VVGSIIAAGGFVLAVLLIVLRLLFGASWAADGVFTLFAILFMFIGAQFVAMGLLGEYIGR
IYNDVRARPRYFIQKVVGADLKTDKNQEEN
>A0A0M0T701|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MDTLLELKGVSRNYPAGEGQLTVLDNISLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGEYWVAGRNIADLDSDQLAELRREYFGFIFQRYHLLTHLTAEQNVEIPAIYSGVSKIQ
RRERAIELLKSLGLENRIDYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSTSG
QEMMDILKKLCQRGHTVVIVTHDPNIAAQVQRVIEIKDGRIMSEVRSSERPKLPLPSSVE
TKTVNVKTSSVQQIWGRFNEALLMAWRAMNVNKLRTLLTMLGIIIGIASVVTIVVIGDAA
KSMVLSHIKSIATNSISIYPGKDFGSDNALDMQALKLTDIPAIKSQPYVQAVSPEFMNEG
RLRQGNMDAKAQISGVGSDFFQVYAMKFSQGIPFTSDMIERQSQVVIIDDNTRKKFFPYQ
GNVVGKELLLINMPLTVIGVIANGQSLYSSNTLQVWVPYSTMNSRLMNQNYLNSIAVRLK
DDHASNEAEEKINQLLIFRHGKKDFHTYNMNKTIKIMDKTTRTMQIFLTLVAVISLVVGG
IGVMNIMLVSVTERTREIGIRMAVGARTSDIMQQFLIEAVLVCLIGGILGIILSCSISFM
VQLMLPNWDFVYNFTAFIIAFGCSTAIGIIFGFLPAKNAAHLDPIEALARE
>A0A0A4A9W7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDKADTFEVVIQLGSILAV
VVMFWRRLFSLIGIHFGKVPHEGTGSGHLSLIHILLGMVPAVVIGLIFHDKIKELFNPIN
VMYALVVGGVLLLAAEYLKPKQPKAVGVDDMTYRQALIIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFILAVPMMMGATVLDLYKSIGFLTMADFPMFAVGFIVAFIVALIA
IKVFLKLIQRISFVPFAIYRFIVAAAVYMIFV
>A0A0S2F818|FEATURES|UNIPROT_deepARG|aminoglycoside|LA76x_1534|antibiotic inactivation|1
MRAASAADVGAWSRLRQVLWPQADPAQHAGDIEQMLARPESAVVFLVVNADGDVCGFAEA
SLRNDYVNGTESSPVGFLEGWYVQAQWRGRGAGRALIVAVEQWTLQRGASELASDALLDN
HASHRAHAACGFDETERVVYFRKRLREPG
>A0A0U1YWZ8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNTHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGDVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0G4WBH8|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1_2|antibiotic inactivation|1
MLIPAEAKRALPVIQQSLADSLVAVYLHGSAVAGGLRPKSDVDVLVVIDRATTHAIRARL
VTELMKISGRPGGDTLRPLELIVFHRADLAESVYPARSEFVYGEWLRDAYETGEVPRPEA
DPELTLVLAQARQEASPLFGPEPAELLPAIPQADVHRAIKDALPSLLDSLEGDERNVLLT
LARMWRTLRTGEFVPKDVAAEWAIPLLPAESAALVSCARNAYLGMMDIDWEARQREVRRV
ASDLSERVAGML
>G7LZR4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIVGIDILFIIKAIIMGIVEGLTEFIPVSSTGHLILTGSIINFKGDFADMFEVVIQLG
AILAVVVLYWQKISDSVVDFFAYLFSKGRKGEVGFRFGINIIIGSIPAMIFGFILHDKIK
SLLFGAGPVVIAFFVGGILLIVIENKFRKNKHAVRDIDQITPIESLKIGFFQCLAMWPGM
SRSASTIMGGWVAGLSTTVAAEYSFFLAIPAMVGSSALDLIKFDYSEMNMTNAIALAVGF
IVAFVVALIVMRKFIDYLKKRPMRVFAVYRIGAGIVFSILIFFNFISM
>Q5WE80|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MVNGINHMTFSVSNMDKAVSFYKHVFMEAPLVLGEKTAYFTIGGTWLALNLQPDIDRKEI
RQSYTHIAFSIEESQLDAFYTRLLEAGADILPGRKRQVETEGKSIYFRDPDGHLLEVHTG
TLAERLAHYEKTAPDMLVNIDEQNKK
>N6YFY2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKAISAVVLPAMEKNQIPGMAVALVLGEKTYVFNYGVSDVEKQTPVTDETIFEIGSISKT
FTATLAMHAEATGKLKLTDTAARYLPELAGTDFGNLQLFHLGTHTLGGIPLQVPDEVQTR
EQLLEYFRTWKPAFRAGTMRTYANPSIGALGWITAKSLGQDFSTAMTQAIFQPLGLTSTY
LSVPAQKMSSYAWGYNKDKKPVRVNPGMLDSEAYGIKTTASDLSAFLKANMGMLPLDSML
QAALNNTRKRYFSVGQMTQGLIWEEYAMPVDLPTLQEGNAPKIILNPTPVSAKVPAATPD
SNVWVNKTGATNGFGAYVAFVPEERFGVVLLANKNYPNAERVEIAHKIYSNLTGKQ
>A0A0Q9ECU6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGIIEGVTEFLPISSTGHLLIAQHWLGSRSDLFNISIQAGAILAVVLIYRR
RLWQLATGFMQPDNRDYLLKLIVAFGVTAVLGLTVKKLGFVLPHKVLPIAWALVLGGIWM
LVAEHYAAKHAQTLGERTTISWTVAILVGVAQVIAGVFPGTSRSAATIFVALLAGTTSRA
AATEFAFLVGIPTMFAATAYELLGVIGTPAATSENWTALAVAFAASAATAFVAVKWLLHY
IQKHRFTVFAYYRFALGAALLLLMPSGS
>YP_002382152|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLQTGARLGRSALLFPLCLVLYEFSTYIANDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRVGRRPVMLVGVVWFIVTCLATLLAQNIEQFTVLRFLQGISLC
FIGAVGYAAIQESFEESVCIKITALMANVALIAPLLGPLVGAAWVHMLPWEGMFILFAVL
AAISFVGLQRAMPETATRIGEKLSLKELGRDYKQVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEKLSSYEYGLLQVPVFGALIAGNLVLARLTARRTVRSLIIMGGWPIVIGLV
VAAIATAFSSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMVQMLI
FTVGIEVSKHAWLGGGNGMFNLFNLANGVIWLLLMVIFLRDKSVGNSQKA
>NP_462120|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MMSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILA
VVVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNP
INVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATI
SGGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVAL
IAIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>A0A126NS35|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAILAVVLAFRQ
RLWTLATGLNQAENRDYVMKLGVAFLVTAIVGLPVRLAGWELPETVTPVAWALVIGGVWM
LLAERFAGRLPDSTTITWKVAVAVGLAQVVAGVFPGSSRSAAAIFVAMLLGLTRRAAAAE
FVFLVGIPTMFAASGYALLEMAKKGQLGSENWTDVSVAFVAAAITGFIVVKWLLSYIKRR
PFTGFALYRIALGFGLLLFLPAGN
>K7Q950|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVSTRQTQDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRA
FYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKVMKLPIKTV
IGGHDSPLHGPE
>A0A098G740|FEATURES|UNIPROT_deepARG|aminoglycoside|LFA_2422|antibiotic inactivation|1
MNSSNEQLENNPDAQQINACLDVVTKILGDNILGVYLYGSALVGGLQKYSDIDLFVVINH
ATTLSEKNELTKHLLHISGLYMKSAKRPLEMTIVEKGAVNPWHYPPRFDFQYGEWLRASF
EMGEIEPPNLEMPDLALIITQVLLISQTLFGEQPEKILAPVPYADFIKAMLQDLDRLAAD
IKDDTRNVLLTLARIWCTLETNTICSKPDAADWVIERLPKTYQAVMNRAKSICIGVENEY
WEDIKASLEPCADWILQKINTIKLFINPNKIAYKVSE
>C2W385|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAVL
YHKRLVSLCNIKPLLQKEKKFNALHVFLGVFPAVIAGLLLHDVIKTYLFQPYTVVIGLVV
GAILMIFAENKKTEATAHSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTMSGGLLAKVNY
KAASEFSFLIALPVMVGATGLDLLKSWEHLSIDDLPMFAVGFITSFIVAMLAVVTFLKLL
AQIGLKPFAYYRILLALVFTIFILL
>A0A0F3XKJ6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYEILLVDDGSSDNSALMLTE
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIAVAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEEIHP
>V8ME64|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLMGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>A0A0B2AVF6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLLQILVLAVVQGAAELLPVSSSAHVIVAEKLMGLDPTAPQMTLLLVMLHTGTMFAVIA
YFWKSWRATYFSSGQAFRTNALCILVATLATGIVGVTLLQFIKHVVVADSANFEIEHLFG
NSRLIAAALAAAGLLIILSSRLQDRGIDNLSLRQSAWIGAVQGLCLPFRGFSRSGATISA
GLALGVARRRAEEFSFALAVVLTPAVIVKEAYRLYKEYAATTTAMHSDGFLHLMGPSMIG
MAMSFLAGWVALRWLSRWLEQGRWHFFGFYCLLASLLVLWIG
>A0A0C9NBM3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGTHVNDLLAAIILGIVEGVTEFLPVSSTGHLILAGALLGYDDARWQMFNIVIQLGAILA
VVVLYWRTFWTVMVGLAKRDPGSIRFVRNLLIAFIPAAVIGVLAKKHIEALLLQPKVVAI
ALIVGGIAILVIERLVKPGTTRGIAAVPAKTALGVGFLQCLAMIPGVSRSGATILGALTL
GVERRTAAEFSFFLAIPTMLGASVVETAGHLDAMRAGSSIGPLEIGVGFVVSFIVALLVV
RWFVGIVGKHGFGPFAWYRIVAGSIALALLTLH
>Q5BM18|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-20|antibiotic inactivation|1
IADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSK
TFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTD
KAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHT
WITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKT
LQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDNKVALAALSAVEVKPPAPA
VK
>A0A0M2C5B8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRQSRAAAAKEALP
AATGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTNVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
GLAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>D8GXV5|FEATURES|UNIPROT_deepARG|chloramphenicol|BACI_c23590|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMISSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMR
CYANVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEENKVI
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>YP_002848372|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFQSGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGS
QYAMRIWMDPNKLNNFQLTPVDVISAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDIIAKFNGKPASGLGIKLATGANAL
DTANAIRDELKKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLAEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAIFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFDKSTHHYTDSVGGILRSTGR
YLALYLIIVVGMAYLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTDYYLT
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGKENKVEAITQRAMGAFSQIKD
AMVFAFNLPAIVELGTATGFDFQLIDQAGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPEDIGNWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MAMMEQLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHSVEHH
>NP_289632|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEXESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0D7XKJ4|FEATURES|UNIPROT_deepARG|beta_lactam|UZ38_19085|antibiotic inactivation|1
MKLWFSTLKLKKAAAVLLFSCVALAGCANNQTNASQPAEKNEKTEMKDDFAKLEEQFDAK
LGIFALDTGTNRTVAYRPDERFAFASTIKALTVGVLLQQKSIEDLNQRITYTRDDLVNYN
PITEKHVDTGMTLKELADASLRYSDNAAQNLILKQIGGPESLKKELRKIGDEVTNPERFE
PELNEVNPGETQDTSTARALVTSLRAFALEDKLPSEKRELLIDWMKRNTTGDALIRASVP
DGWEVADKTGAASYGTRNDIAIIWPPKGDPVVLAVLSSRDKKDAKYDDKLIAEATKVVMK
ALNMNGK
>ZP_01974653|FEATURES|ARDB_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
QQGSRPKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDI
DLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQ
FGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNE
TLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEAR
QAYLGQEEDRLASRADQLEEFVHYVKGEITKSVGK
>R0EDL5|FEATURES|UNIPROT_deepARG|beta_lactam|OR214_01020|antibiotic inactivation|1
MFSRWSKTFAFALTACAVAMSTTTAHAELVVRNDLKRVFDDAGVSGTFVLMDIGADRTYV
VDPARAARRIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYQQWEHDMALPEAIR
LSAVPIYQEVARRVGLERMQAYVDAFEYGNRQLGSVIDQFWLRGPLEISAFEEARFTSRM
ALKQLPVKPRTWDMVQRMLLIERQGDAALYAKTGVATEYQPEIGWWVGWVERAGHVYAFA
LNIDMPREGDMAKRVPLGKQLMQALAVWPAP
>A0A091C207|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDLFNIAIQAGAILAVTTVYRR
RIWGLSTGLFSDPVARDYAFKIAGAFLVTAFVGLPVRLLGWELPETVTPIAWALVIGGVA
MLVAERFADRSTPSEDITWKIAIAVGLAQVVAGVFPGTSRSAAAIFAALAFGLNRKPAAA
EFVFLVGIPTMFAATGYAVLEAVLDGNAAGEDWAGLLLAFVAAAITGVITVRWLLKWIST
HSFAPFAWYRIGLGAALLFGLPAGA
>A0A143GH84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAVQALILGVVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVVGLPTQRNAQRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVAAALV
VGGVIMLWAERRQHEVHAETVDDITWKDAIKVGFAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWSAVKP
>S4YW71|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKQPFQTFLNQVGFTALVTASLLSGTVQAADNNDHLKSTVDQQAKLLMNEHNISGMAFGI
IIDGKSHFYHYGLADKKAKIPVSENTIFELGSISKTFAATLASYSELNGTLKLEDTTDKY
IPYLKNSAIGNTKLINLATYSAGGLPLQVPDDVKNNKELLRYYKSWQPVFPINSKRLYSN
ASIGLFGYISALSMDADYTQLMEEKILPSLNMPNTFINVPSDKMADYAFGYNAAGDAIRV
NPGMLDAEAYGIKSTITDMTHFMAANMGLVPLDKNIQQALNNNRKGYYQASTFTQGLGWE
MYPYPTQLDTLLEGNSMDVVLKPQAIKTDNHPTPTLNNVWVNKTGATNGFGGYIAYIPAE
KSGIVILANKNYPNADRVKAAYTILESAMTR
>B7A5W2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAPMSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPIEQDAFLKTFLIAIQLGAIL
AILLLYGRRFLADRALWLHIGVAFVPTGLVGFLFYPLIKGVILGDDRIVVFFLFFVGLVL
LLADRLAERARYGDVRELPLFRAAWIGFFQGLSALFPGTSRSGATILGGLLLGLKRKAAA
EFSFLLALPTMLAATGYDLLKSSHQVPEGGWGLLLLGFLAALLTALLTVRWMLGFVERFG
FRPFAYYRMVLALVYAYFFLR
>A0A0R2S5F5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNFWEAIILAIIEGLTEFLPVSSTGHMIIASSFMGIAHEEFTKLFTIAIQLGTILSVVVL
YVKRFFQSIDFYVKLLVAFIPAVVLGLLFNDLIDELLESPVTVAVSLIIGGIILLRVDQW
FGQGEDTEISYSTALKIGFFQCLAMIPGVSRSGASIVGGMSQKMSRTAAAEFSFFLAVPT
MLGATAKKSFDYYQAGFELTTEHIQLLAIGNIIGFFVALLAIKTFINFLSKSGFKVFGYY
RIIIGVCILWIHFFIHPLTLI
>A0A0M7G8A4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_2|antibiotic inactivation|1
MRLNSMLRTGLFALMAAGCALAQAGQAETDRKVDEAVQAVMREHGIAGMSIAVTRNGTQH
FYNYGVASRQTGRPAGSDTLYEIGSISKTYTATLAAYAQVRGRLALSDSPAKYLPELAGS
DFAKLSLINLGTHTTGGFPLQVPDAIKNQAQLMAYLKAWKPEHAAGTYRTYANPSIGMLG
MVAAKSLNRPFKAAMERDLFPKLGLTSTYIDVPAARMADYAQGYNKQNAPVRVNPGVLAD
EAYGVKTSARDLIRFVDANMGLNLADAGLRGAIAQTHVGYYQLGDMTQDLAWEQLRYPAT
LDALLTANAGNYNSQSQPVAALNPPLPPQETVWINKTGSTNGFGGYVAFVPSKKLGIVIL
ANRNYPNEARVRLAYRILGELEQ
>I1W5J4|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-169|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRGEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTDGESGNYG
>W8RL04|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKDIITPEAANTFKVVVQLGS
ILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPAVILGFLFEDYIDKYL
FDVRTVAVGLILGAVLMLVADWINKRKTETSSVDNMTYRQALYIGLFQCLALWPGFSRSG
STIAGGVILGLNHRAAADFTFIMAMPIMAGASLLTLVKNAEYLTTDMLPFFIVGFVSAFI
VALFVVRFFLKLINKIKLVPFAIYRIILGLILFIMFM
>A0A0R1NYU5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSETTQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPKKTHVEQHETWVLWFKVVVAVLPSVVIGLLLNDWMDAHLMNWEIVSAM
LLLYGILFIAIENRNANRQPQFSDLNRLSYKTAFIIGMFQLLSLIPGTSRSGATILGGIL
IGTSRYVATEFSFFLAIPTMFGASLLKVYKYFHHGGTFDGMQTAVLLTGMLVSFVVAYIA
IRFLLNYIQHNNFKVFGWYRIILSIVVIGYFGIRTLI
>I0BMP6|FEATURES|UNIPROT_deepARG|aminoglycoside|B2K_23630|antibiotic inactivation|1
MNIHVELDTLAALLENELKEQLTGIYLHGSLAMGGFHPEHSDIDVLVVVKRKLTQEEKKR
IARGLLAFEERLHGGGVELSVITVSSMEHWKHPASFEFHYSAAHRDRYRADENYICGGGT
DPDLAAHLTVTYHRGIALYGPPVRSVVPEIPREHYMDSIFSDIENAPEQIAAKPVYYTLN
LCRALYYLREGVVSSKVEGGAWGLSVLPPEYRPLIRQCLDEYSGLKQQPSAHNSRLAEEF
AGYMCTAIHREAGASGSSKI
>YP_254220|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MsrA|antibiotic target protection|1
MEQYTIKFNQINHKLTDLRSLNIGHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESG
TVETVGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNY
SPILLLDEPTNHLDKIGKDYLKNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRV
FKGNYTQYQNQYEQEQLEQQRQYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIA
PDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPII
AQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMA
YYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALDRSCNVLSGGERTKLSL
AVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELT
GQSIHDIT
>A0A0K2LDF5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFIKLNESKAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNHREKSQTWSIWFKVLVAILPSVIIGLPLNDWMDAHLTSWQVISA
TLLIYGILFIVVENWLKGKRPQTADLESLSYKTAFQIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIGKYFMKGNAFTSSQTIILLVGTLVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIVLAIVVIAYFGIKAMVA
>ACC95408|FEATURES|ARDB_deepARG|chloramphenicol|cmlA4|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTVQLTLATYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLAFTSLAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVTGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLI
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFIAPMWLVGIGVATAVSVAPNGALQGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRAKGSRGQGEHDVVALQSAESTSNPNR
>E1QWU0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSIELLKSALFGLVEGITEWLPVSSTGHMLLLNEFVRLGSSTDFWDMFLVVIQLGAILA
VCVMFFGELNPLSRRKEPAARRSTWALWAKIVVACLPAAAIGIPLDNWMEEHLGSPFVVA
AALIAYGVLFILIETRREHKAELASSMGEGSPSVRGKHLAAPSPEGDGSHAKASPADRDA
RIQDTEDIDWPTAIGIGCFQVLSMVPGTSRSGSTIIGGLLLGCSRTVAAEFTFYLAIPVM
FGASALRLAKYFLKGNVFTMEEAAVLLVGCAVAFLVSLLVIRFLMGYIRRHDFKPFGWYR
IALGIATIAYFGLRLVA
>A0A0Q4EFH2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNHSLQKFLFSALLISSGSCVAATDLRTVVDAGVKPLMQQQGIPGLSIAVVNQGKVQYFN
YGVASKETKQAVNQDTLFEIGSISKTFTATLGGYAQATGKLKLSDTASQHLPALAGGVFD
HISLLQLATYTPGGLPLQFPDAADNAGAMLGYFQHWKPAYAPGEQRLYSNPSIGLFGYLA
AQSLGQPFNLAMEKTLLPKLGLTNTHVSVPASKTAQYAQGYDKNLKPIRVSPGALDSEAY
GIKTSTQDLARYVIANLHPETLEKPLQQAIASTHAGYYTVNGMTQGLGWERYPYPITLQA
LLDGNSTEMAMQPHKVNWLTPTQPQPANVLYNKTGSTGGFGGYVAYVPSKDMGVVILANR
NYPNAERVKLAYAILSAMDH
>ZP_02901431|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MIMKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLIAVTTSSLTVLIAASAMQGMGTGVGGVMAR
TLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFS
MARWMPETRPADAPRTRLLTSYKTLFGNGGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGIMN
VWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRISHQGQAV
>A0A0K1JGG7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MAAHGHQTTAQELVVTEGDAGPYAITTGPDGALWFTVVHHGLIGRLVPGETPTFHRLDPE
CGPTVIVPGPDGALWFTEYQAHRIGRITVAGEVAEFTIPTPESGPFGIAAGPDGALWFTQ
TTTDRIGRITVDGQVSEFPLPTTGAFASAITAGSDGAMWFTLNQANAIGRISMDGAVDLH
PLPTEAAAPVGVASAPDGALWFVEIGAGQVGRMTPDGQITEFPLPDRAARPHAITVDDEG
VAWFTEWQGNRIGSITRDGAVTLYDLPTPASEPHGITCGPDRALWAALEIGALARVPRKA
D
>Q99QF3|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-12|antibiotic inactivation|1
PRFMSIQRRNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASM
AATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIV
ALLGPNNKAERIVVIYIGX
>B4RCI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWVLAIILGVVEGLTEFIPVSSTGHILLLGHFLGFHSTGKVFEVMIQLGAILAVISVY
FGRLWSVATHLHTDPAARRFVASIVLAFLPAGFAGFLLHDYIKAVLFETPAVICVSLILG
GFALLAVDRIQREPVYTDAGAFPLKTAFIIGLFQCLALIPGVSRSGATVAGALLMRCDKR
SAAEFSFFLAMPTMAGAFTVDLAKNYKLLSADDAGIIALGFVCALVAAIITVRKVVDFVG
RHGFAPFAWWRIAVGALGLLGLAFIG
>F2NB93|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLELIKSAFLGLVEGVTEWLPISSTGHLILVDEFVKLDVTPQFWNMFEVVIQLGAILA
VCVLFFHDLNPFSARKGARGRRQTWVLWGKIIVGCIPAAVIGLAVNDFMEEHLNNSYVVA
AALIVYGIAFIIIENRRAARDLGPGCEAVPGRSIREGGTHFASSAEATSICGSDSETGDF
GEIATLQDITWKTALGIGLFQVLAIVPGTSRSGSTIIGGLLLGCTRSVAARFTFFLAVPV
MFGASLLKLVKYFIKGGSFGASETAIMAVGCIVAFLVSLAAIRWLMDFVRCHDFKGFGVY
RIVLGIIVLAYFVGVRPALGL
>A0A142EC40|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-214|antibiotic inactivation|1
MFIFLNTFKYVSAHETITLVNASIILKKEEYEYSTFSCRPYSLFAAFCLPVFAHPETLVK
VKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLG
RRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFL
HNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWME
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
RNRQIAEIGASLIKHW
>G0AY19|FEATURES|UNIPROT_deepARG|beta_lactam|Sbal175_0847|antibiotic inactivation|1
MRSFAISTVLVMSSMLASSIFAAPTFASTAAKTEWQETRSWDAIFTQQQVEPQQAKQQQA
KPQKTKSQQASGVVVLWNENKQQGYTNNLKRANQGFLPASTFKIPNSLIALELGVVKDEH
QVFKWDDKSRDIATWNRDHTLITGMKYSVVPVYQEFARQIGEARMSKMIASFDYGNEDIS
GNLDSFWLDGGIRISATEQIDFLRRLYHNKIHASERSQRIVKQAMLTEANSDYIIRAKTG
YAVRAEPSIGWWVGWVELDDNVWFFAMNMDIPDAAGLPLRQAITKEVLKLEHVIP
>A0A0Q0BBK1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPREKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDALLACAKKSALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPILAQQRVSISATDTALTLHGKLREAAADLLGETLP
LLAHGQLSGTPQDEALATCFGRRTPADGLIDWALPATQLYNLIRAVTQPYPGAFYPVGEN
RLIVWAARVEARSAGDRPGTVISQDPLRIACGEGSLVIDAGQRGDNGLYLSGAQLAREFG
LVQGSQLMETEKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARVIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSVDNARHLIGWTPGIELGETIGKTLDFFLREAMAEKA
GQR
>D9WUI9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MVTGSENELPAPAIREIPVADQDAGPYGITAGPDGALWLTFVHSGRIARLTLDGQLQEYA
LDSPTCRPTVIAPGPDGALWFTRYQDHRIGRVTVDGETESFSVPTSDSGPYGITAGPDGA
VWFTEMNTDRIGRITGSGEITEFPLPVEGGFPSAITAGPDGALWFTLNQANAIGRITTDG
DTAVYPLPTPSAGPVGITSDGTAVWCVEIAAGQIGRIAMDGAIEEFPLPDRAAKPHAIVA
VSTGECWFTEWGANRVGRVTASGEIAAYDLPSPSSEPHGITLGPDGALWTALETGSVARV
AP
>B7LT82|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSESDDAINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEELGVTGHSALNLWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMILMGMAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITAS
VLMLCFVVTLLCIKEKFQPVSKKEMLHVREVVFSLKNPRLVLSLFVTTMIIQIASGSIAP
ILTLYVRELAGNVGNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPDKILIAALIFSVL
LLIPMSFVQTPWQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTACVVLFNIIYSWNSLRRRREPQVLG
>A0A0Q9GHD7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQGINHMCFSVSNLEQSITFYQKVLGAELLVKGKSTAYFSLNGLWLALNEEKNIPRSDI
QYSYTHLAFSISIENFDEARELLKQHNVTILPGRNRDERDKKSIYFTDPDGHKFEFHTGT
LQDRLAYYQEEKPHMTFYSLKE
>A0A0J6K8B5|FEATURES|UNIPROT_deepARG|beta_lactam|VI26_15845|antibiotic inactivation|1
MFKHLILFASLATPLSQALAADPLAVAADKLAKLERDFGGSIGVYAIDTGSGATVANRPN
ERFPMCSSFKGFLAAGVLAQSQAKPGLLDKRIRYSKTTLPNWSPLTTQHQANGMTVAELS
AATVQYSDNGAANLLLKEINGPAALTAFMRSIGDTTFRLDRLEPELNSAIPGDPRDTSTP
KAVAESMQKLALGKALAAPQRQQLADWLKGNTTGKARIRAAVPDGWEVGDKTGTCGVYGT
ANDYAVIWPPKRAPIVLAVYTKHAKKEAKHSDEVIAAAARAALEALNVKS
>A0A0L0R563|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDNALYLIKAFILGILEGLTEFIPVSSTGHLILVGDWINFQSSDGKVFEVVIQLGSILA
VMWVFRARLLQLIRGTLTGVASEVAFTRNLIIAFLPAAVIGAIFIKTIKSVFYHPGVVVV
TLVVGGLIMLYVERKTHHTPGDAPGAADDTASDERASAHTLEQITWKQALGVGVAQCFAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVFDMYKNFGVLTQHDLSGIA
VGFIAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGGIVAAWIFTR
>E1SED2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGEKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGTGRLSLIHILLGMVPAVVVGLVLHDQIKTLFNPIN
VMYALVVGGVLLLAAEYLKPKQPKAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDMYKSIGFLTMADFPMFAVGFVTAFIVALIA
IKAFLELIKRISFVSFAIYRFIVAAAVYMIFM
>A0A0C3HT06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWELFVAAILGIVEGLTEYAPVSSTGHMIIVDDIWLKSSNLMSEEAANSFKVVIQLGS
ILAVAIVFKDRILNLLGLKKNITSDQEQGHKLSIAQIAVGLVPAAVLGFLFEDYIDEYLF
SVKTVAIGLIAGAILMLFADWVNKRKTATDTLDRISYKQAIAVGLFQCLALWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAMPIMMGASFLSLVKHWDSLSSDLMPFFIVGFICAFVV
ALFVVRFFLRLINKIKLVPFAIYRIILGVILLLIMM
>D3Q8G8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTATITEHVVTDAAGGPYALTSGPDGALWITLVHGGRIARFVPGTEATAHELAPGSGPMI
IAPGPDNALWFTQNRAHSIGRLTTDGDLTEYPLPTPDCGPFGIAAGPDGALWFTEMTGDR
VGRISVDGKVTEYPLPMTGGMASAITAGRDDGMWFTLNQANAIGRVGMDGDITVHALPTE
AAGPVGICAGPDGALWFVEIGAGQIGRITVDGTITEFPLPDRAARPHAITAHDGALWFTE
WGANRVGTIDPSGAVTVHDLPTPGSEPHGIATGPDGALWTALETGALARIG
>A0A0G1I8J6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFQAIILSIIEGLTEFLPISSTGHLILAQKYLSVTTSEFTKSFDIVIQFAAILAVVWI
FRHRLFKSPENWKSTIIAFIPTGIIGFTLYKLIRHVLLGNPLIVVYSLFFGGLILLLVDR
ISKMNHGLKTQNDLSTPQLLGIGLFQSLSIIPGISRSAAAIVGGLSFGLTRAQAVEFSFF
LAIPTMLAASGYDLLKSGLGFSPEEYLLLALGCLISFFSALVAVRLFIDYVKKHDFTLFA
VYRILLSIVAFLTISS
>A0A158BQK9|FEATURES|UNIPROT_deepARG|beta_lactam|AWB75_03765|antibiotic inactivation|1
MKFRALSFLATAIFSFAAMSGAAWARDAASIKTTVDETIKPLMALHGIAGMAVGVVVDGK
PYVFDYGLASKATKQPVTRDTLFELGSISKTFTATLASYAQINGDLSLNDPVSTYLPTLG
ASEFGKVTLLNLGTHTPGGLPLQVPDEIHDNAQLMQYFRAWRPAQPPGTIRTYANPGIGT
LGLITAKSMRQDFDALMQMRLFPALGLTHSYMNVPASRQSDYAQGYAKNDAPIRMKGGVL
SSEAYGVRTTAADMTRFMQINMNMVRIDPVFQRAVDATHIGYFQAGPMTQDLIWEQYPYP
VALQALLDGNAASMILNATPVTRIDPPQPPRDDVWINKTGSTNGFGAYVAFVPKERVGIV
MLANRNIPNEERVKAAYAIITSLTGSR
>AAP83161|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSVSFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>A0A0X8JX91|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYFFEILKAIFFGIVEGITEWLPISSTGHLILAQEFIQFKDQNETFMSMFNVVIQLGAIL
AVMVIYFNKLNPFKPGKDKVQVRRTWQLWSKVFVATLPLLAVFKFDDWFETHFYNKVSVA
IMLIVYGVAFIYLEKRNKAQAIEPTVTELDKLPYKTALYIGLFQVLALLPGTSRSGATIV
GGLLNGTSRSVVTEFTFYLGIPVMFGASALKIFKFIKAGEVLSFGQFFLLLVAMVVAFAV
SMVAIRFLTNYVKKHDFTMFGKYRIVLGSVLLLYSFVRLFV
>A0A017IJD5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKENVAGGTEPV
VKTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQRFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTITGILFGWLPARNAARLDPVDALARE
>A0A0U5J5A0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MEWLADINPIGAFVELDAILLLKALILGIVEGLTEFLPISSTGHLIIVGSLLGYTDEQSK
VFKIVIQFGAILAVCWLYRERIVRVVRRMWSPTPERRFALNILIAFLPAMVLGVLFHDTI
KTYLFNPLTVAGALIVGGLVILYIERRPPRVRFTEVDDIGWREALKVGFAQTIAMFPGVS
RAGATIMGGLVFGLSRKAATELSFFLAIPTMLAATLYDIFKSRDLLAMHDLPVFGVGFFA
AFLAAMLSIKVLLRYVSNHSFEVFAWYRIAFGLLVLATAYTGLVQW
>A0A147H1W6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTAIVFAYHDIGCAGLAALIQAGYPIAAVFTHPDDPGENRFFASVAQLCARHGIPVHAP
EDVNHPIWVERIRALEPDFIFSFYYRNLLSEEVLACASRGAYNLHGSLLPRYRGRAPANW
VLVNGETETGVTLHRMVKRADAGAIVAQQRVAIAPDDTALTLHGKLREASQELLRDALPG
LAAGTLEEREQDESQASTYGRRSAADGELEWSRSATELANLVRAVTQPYPGAFGWIGERK
LIVWNAQAQAEHHGQAPGTVLSLEPLRIACGEGALEVRAGQLGDAGLYLSGPQLAREAGL
VAGARLHRQDRRAKRRTRVLILGVNGFIGNHLSERLLADGNYDVYGLDIGSDAIERLKTN
PHFHYVEGDISIHTEWLEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIVRH
CVKYGKRVIFPSTSEVYGMCQDERFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGS
KGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIKLVDGGAQKRCFTDV
DDGIEALFRIIENQGGRCDGQIVNIGNPDNEASIRELAEELLAQFEAHPLRHEFPPFAGF
REVESKSFYGDGYQDVAHRKPSVENARRLIDWQPTTAMAATVGKTLDFFLREALAQREA
>W4BB43|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLTILKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSEEFLTKYVANTFKVVIQLGS
ILAVIVVFKDRFLDLLGLKRKKPEAGAPADTGRLKLSQVIVGLIPAGILGVLFEDFIDEH
LFSTETVLIGLVIGAIFMIVADKVSSKKEPKVVSVDQITYRQAFSVGLIQCLSLWPGFSR
SGSTISGGVMVGMSHRAAADFTFIMAVPIMFGASFLSLLKNWEYFTLEALPFFIAGFVAA
FVFALISIRFFLKLINRIKLVPFAIYRIVLAAVIALVLYL
>Q307S8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAGTIEISDPISEVLSVIERHLKSTLLTVHLYGSAVDGVLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPVENETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSHPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVASDWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLQEFIRYEEGEIIKSVGK
>YP_254125|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MIIIEFIKGLILGIVEGLTEFAPVSSTGHMILVDDMWLKSTEFLGPHSAFTFKVVIQLGS
VFAAAWVFRERYFEMLHIGKYRNSSINEEFRSKPRRLNLLHVLVGMIPAGILGVLFDDFI
EAHLFSVPTVMIGLFLGAIYMIIADKYSKKVQNPKSVDQINYVQAFVIGISQAVAMWPGF
SRSGSTISTGVLMKLDHKSASDFTFIMAVPIMLAASALSLVKNYQYIELAHIPFYLIGFL
AAFIVGLIAIKTFLHLINKVKLVPFAIYRIVLVIIIAILYFGFGIGQGISG
>L0BD43|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-97|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTEKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>J8ZVZ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLINAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKVEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMVGATGLDLLKSWKYLSVDDIPMFAIGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0U2WDM4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDILKAVMLGIVEGLTEFAPVSSTGHMIIFDDMWLKSEQFLTQQGANTFKVVIQLGSIL
AVVILFWQRFIDMLGLGRRVSEPRAKRLKLTHVIVGLLPAAILGLLFEDYIDEYLFSTRT
VLIGLVLGAILMIAADRFRKKRPETETVDQITYKQALTVGLIQCLSLWPGFSRSGSTISG
GVLLGMSHRAASDFTFIMAVPIMAGASALSLFKNWEYLSADALPFFIAGFISAFVVAYFS
IRFFLKLINRIKLVPFAVYRLLLAAVIYVLFF
>K8ZMQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIMNIIKATILGIVEGITEWLPISSTGHLILVDQFIKMRESAAFMEMFNVVIQLGAILA
VVLLYFHKLNPFSPQKNEIEKKDTWTLWGKVIVACIPSAVIGLLFDDWLEAHFYHFVPVA
VMLIVYGVLFIIIENRNKNVTPKVTTLPGLTWKTAFFIGMFQVLALIPGTSRSGATILGA
ILIGCSRYVSAEFSFFLGIPTMLGASALKMVKFFLKGNTITFGNGMVLLVGCVVSFVVSV
LAIKFLMKYIQKHDFKAFGWYRIILGILLLGYWFIAMR
>X5ZXE4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAEVAMDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGA
ILAILSVYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRL
ICIMLIIGGVVLLAVDRMKLQPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGA
LLLGVDKRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPVIAIGFIAAFVTALIVV
RFLLDYVSRNGYSLFGWWRLVVGAVGLVALFIWG
>U2MXZ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVLQTIILAIVEGLTEFLPVSSTGHMIITQSLLGIPSDEFVKAFTVIIQFGAILSVVVL
YWRRFFRLDHSPALERASNVQRFLHKWNFYYKLLVAFLPAMVIGGLLNSVIDRLLGSVMV
VAVMLVLGGVFMLFCDRLFNKGRENTVLTTRRALYIGLFQCIAMIPGVSRSMATIVGGMA
QKLTRKDAAEFSFFLAVPTMFAATCLDVLKMVLRMHETGDTGVFVDHLGTLLLGSVVAFF
VALLAIKGFVAFLTKYGFRAFGVYRIIVGGFIIVWLLLGHSLAMVD
>A0A0N9W9H7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFIAKPCAALLLLASTVSFGNLAMANAQRSDIDSIVQDAAQAVMQQYNIPGLAIAVTAN
GKQQFYNFGVASKETQQKVTSDTLFEIGSISKTFTVTLATYAEVNGQLSLTDHPGKYLPE
LAGSPFDKATLINLATHTAGGFPLQVPDQVQNNQQLMDYFKAWQPTYAPGAQRTYANPSI
GALGMITAISMKMPFAVALEQRLFPALGMPNSFINIPASKLSLYAQGYNKQDVPVRLNPG
VLGDEAYSVKTSSTDLIRFVEANLGVAKVEAKLGRALMETHKGYFQLGPMTQDLIWEQYD
YPVQLSALVEGNADKMIYDSHVVTALNPPLAPREAVWINKTGATGGFSAYVAFVPEKKFG
IVVLANKSYPNEPRVRLAHRILSELD
>A0A0A0YZY5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVTERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>C0FNG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKAILFGIVEGITEWLPISSTGHMILLNEIVSLDVSDEFYSMFEVVIQLGAILAVV
ILFWNQIWPFGKKDNKEPLAKTGAGAYIKWDIFKLWFHILVSCVPAAIVGVLFDEQLEAL
FYNYQTVAIMLILFGVAFIVIENYHKGKKAKVNTLVGIDYKLAFWIGMFQLIAAIFPGTS
RSGATIVGALLLGISRTVAAEYTFFLAIPVMFGASLLKGAKFLMNATMTSQEGVILVVGM
VVAFAVSLVVIKFLMEYIKKHDFKVFGWYRIILGVIVLLCGFAGFIG
>I0DH95|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSEGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKLSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>E5B1I1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEDHPMKKKTLTTLLLCTALAVTPWFSAVAAPMTQQQVTRLVDDTIKPLLEKQHIPGMAV
AVLYQGQPQFFNYGVAETEHQRAVTQHTLFELGSVSKTFTGVAAGVAIQTGLINLNDRVA
QHCPELNGAQWQKITLLNLATYTAGGLPLQLPDEVTDTSSLQHYFQQWQPQWPAGTMRNY
SNASIGLFGALAVKNSGLSFADYLNTSVFQPLKLTRTFITVPPSAQADYAWGYKDGQPVR
VTPGMLAAEAYGVKSSTGDLVKYMQANINPASISSDNKELAKAIVSAQTRYYRVGNMYQG
LGWEMVNWPISPDEVIAGSGNDIALHAWPATALKAPQSAVASSWVHKTGSTNGFGAYIAF
IPEKQLGIVMLANKNYPNPQRVAAAWQILQGLDESKQEDAGDKTAFCHPH
>R8CHU3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MGQSINHICFSVSNLEKAIEFYQNILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEI
QYSYTHIAFTVTDNEFDSLKEILIQNHANILPGRERDERDKRSIYFTDPDGHKFEFHTGT
LQERLQYYKEDKKHMTFY
>YP_001569731|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISEQFGVPAGSAQLTLSTYILGFAL
GQLIYGPMADSLGRKPVILGGTLVFAAAAVACALAQTNDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIIGGWVLVWLSWHYIFWILAIAAILASVM
IFALIKETLPVERRQSFHIRTIIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVPPQDFGYYFALNIIFLFVMTFINSRFVRRVGAQNMFRAGLWIQFAMAAWMVFSA
LMGIGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFTSAWPMIWSIALCATCSILFYLHASRPKKR
>L7V6E6|FEATURES|UNIPROT_deepARG|beta_lactam|MULP_01828|antibiotic inactivation|1
MPGKGIRAGEGTPLGIITRAATPLILAIASLCALVATPAVAAPDALSAAVDSAFRPLLVQ
YDIPGMAVAVTVNGQQRYFNYGVAAKQSGAPVTADTIFEIGSVSKTFTATLACYAQELGR
ISLAGHPSAYMPQLAGSAIDKATLLNLGTYTAGGLPLQFPPEITDDAQMQAYFQQWTPDD
APGQQRRYSNPSIGLLGHLTALAMNSDFADLVQTQVFPKLGLSHSFIRVPQAQMDDYAWG
YNASNEPVRVNPGVFAAEAYGVKSSAPDMLRFVEANISPEGLPASMRRAVQATHLGYFNV
ADMVQGLGWEQYSYPVTLDQLLAGNSNTIAMQPNPVTLVAGVPPSGPRLFNKTGSTDGFG
AYAAFVPDKRIGIVMLANKNFPNAARITAAHAVLEKLAAESR
>ZP_04677702|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLLELIKGLILGIVEGLTEFAPVSSTGHMILVDDMWLKSTKFLGEQSAFTFKVVIQLGS
VFAAAWVFRERFFELLHIGKHKPEQHATAGRRSKPQRLNLLHVLVGMIPAGILGFLFDDV
IEKYLFSVPTVMIGLFLGAIYMIIADKYSEKVTNPQTVDQINYFQAFVIGISQAIAMWPG
FSRSGSTISTGVLMKMNHKAASDFTFIMSVPIMLAASGLSLLKHYEYIHLAHIPFYLLGF
LAAFIVGLIAIKTFLHLINKVKLVPFAIYRIILVVIIAILYFGFGIGKGI
>A0A0S2AWM7|FEATURES|UNIPROT_deepARG|beta_lactam|blaGES16-like|antibiotic inactivation|1
HALLLAGIAHSAYASEKLTFKTDLEKLEREKAAEIGVAIVDPQGEIVAGHRMAQRFAMCS
TFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQAAVQL
SDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIAMART
VAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRNDIGFF
KAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILST
>A0A0F7XY02|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB1|antibiotic efflux|0
MNVELSPARAVSALEDQPLLRLDGVSRSFMAGDREFLALKGIDLEIHAGELVAIIGASGS
GKSTLMNILGCLDHASAGSYQVSGQETRDLDDDALAALRRDHFGFIFQRYHLLPHLDALR
NVEIPAVYAGVAQAGRHARARELLGRLGLGGHLAHRPSQLSGGQQQRVSICRALMNGGEV
ILADEPTGALDTASGKEVMNILLELHGAGHTVILVTHDPKVAAHAERIIEVSDGQIVSDR
RTRAEAPAPTAEAAPAREQAPRRLVASLGLFREAFKMAWIALVSHRMRTLLTMLGIIIGI
TSVVSISAIGEGAKGYVLKDIQAIGSNTIDIYSGTSFGDSRAKAIETLVPADVTALNELY
YVDSATPVIGQSSLVRYRNIDADVQLNGVSEQYFQVRNIPLAAGIVFSADDARRQAQVVV
IDHNTRKRLFGDGVNPLGQVILVGNLPCTVIGVTAENKNLFVAGNTLNVWMPYETAAGRV
LGQRHLDSISVRIKDGMPSKRVEEEVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLTL
LLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIG
GVIGIGLSYGIGYLFALFVKQWEMVFSLGSVVTAFVCSTLIGIVFGFVPARNAARLDPIE
ALARD
>A0A0L8ARZ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILLLKAAVMGVVEGLTEFLPISSTGHLILAGALLGFDDDKAKVFDIAIQTGAILAVV
IVYWQKISSTVRALPRSADAQRFALNVFIAFVPAVILGLLFGKAIKANLFTPEVVATTFI
IGGFIILWAERRQAVAVRIGEVEDMRWQDALKVGLVQCLAMIPGTSRSGATIIGGMLLGM
SRKAATDFSFYLAIPTLIGAGAYSLYKERALLSMADAPMFAVGLVFSFFSAWVCVRWLLK
FISTNSFEVFAWYRIVFGLVVLGTSYSGLVKWAA
>AAK58493.1|FEATURES|ARDB_deepARG|glycopeptide|VanSC3|antibiotic target alteration|0
MLIIIPFAVRFVAGMRVWYGYEPIYQILRLFADYWLLCLAIGALLIWVSTTIYYMSKAIS
YLNETIQATNQLIAEPTKRIVLSSNMIDVQEEMNQLREKNLQDQRAAKEAEQRKNDLIVY
LAHDLRTPLTSVIGYLTLLEEEPQLSTELRARYTKIALQKAQRLELLISEFFEITRFNLT
TIALQTETTDLSLMLEQLTFEFLPLLEEKNLHWQLQLQKKVFATVDTEKMERVFDNLIRN
AINYSYPNSPLRLAISESDDILIRLTNQGKTIPAEKIGLIFEPFYRMDASRATATGGTGL
GLPIAKEIVEALGGKIWAESRDETIVFSIRLPKAAMEKNEQLSKPHPSEPTA
>J7VX11|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFNQRGNREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRTAAAE
FVFLVGIPTMFAASAYTFLEMAKAGQLGSENWTDVGVAFLAAAVTGFVVVKWLMGYIKSH
RFTAFAIYRIALGAALLLWLPSGS
>CAB63489|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRSTLLAFALAVALPIAHASGAETPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTQDLT
ALLVQTADGAVLLDGGMPQMAGHLISNMKVRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAKVAANAESAVLLARGGSDDLHFGDGITYPPASADRIVMDGEMITVGGIAFTAHFMPG
HTPGSTAWTWTDTREGKPVRIAYADSLSAPGYQLQGNPRYPHLIEDYRHSLATVRALPCD
VLLTPHPGASNWDYAAGSKASAKALTCKAYADAAEQKFDAQLAKETAGAR
>A0A119MV15|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHGIKCIMAAALFSTCATATIGYAANDRQDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRQPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKTGKYLPN
LQGSPFGNVTLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWQPTYSPGAYRTYSNVSI
GTLGLITATSMGQQDFAVPLSRHLLSPLGMKSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVELDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSMALNAIPVNEIKPPQAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRRYPNEERVTAAYRILTSLGLDGR
>ACB19530|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>A0A0J6I6M0|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic efflux|0
MQAGLRIDVDTYRGTREGVPRLLELLDEADVKATFFFSVGPDNMGRHLWRLIKPQFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGKDLGHLMRQTLAAGHEVGLHAWDHHGWQANTGRW
SEAQLIEQIRRGVDTLSDITGQAVECSAAAGWRADERVVQAKETFGFRYNSDCRGHSLFR
PRLADGRLGAPQIPVDLPTFDEVVGPELSAADFNSYILDRFSPQKLNAYTIHAEVEGILM
ANDFRQLLTQARARDIHFQPLKDLLPADIDSLPAGQLSRGVLEGREGWLGVQKP
>CAC44638|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQGIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVAFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLFVSLTNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>A0A0M0XDV3|FEATURES|UNIPROT_deepARG|aminoglycoside|aphA6|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDTELWGDHKTYLSLWNELNETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>B2RI95|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQAIVLAIVEGLTEFLPVSSTGHMIIAEGIMGVESTSFVRAFTVMIQFGAILSVLVL
YRKRFFCFPVAPRALGQGKGKEFMSRFDLYWKLLIALVPAVILGFLFEDWVDRMLGSVWV
VAVVLFLGGIFMLFVDKLFASSDRGEITYPKAFVIGLFQCLAIFLPGLSRSMATIVGGQQ
QKLSRKAAAEFSFFLAVPTMLGATLLKAYKLYKEGGIEIFREHMIVLLVGNIVAFIVALA
AIKFFIGFLTRYGFKAFGYYRILVGGLLIVLMLSGVSLAV
>A0A0S2EIS9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSIHIFEALILGLIEGLTEFIPVSSTGHLILASELMGFKSTANTFEVLIQLGAVLAVLS
VYFGKLWHLAVTLPSSPRSRHFVLGILVAFLPAAVIGAFAHGFIKGVLFETPMVICVALL
VGGVLLLVIDRIPRQPRYTDIESYPLSLCLKIGFFQCLAMIPGTSRSGSTIAGALLLGTD
KRSAAEFSFFLAMPTMAGAFAFDLLKNYQYLNADDAVTITIGFVMAFLSGLVVVRSLLSF
VSRYGFAPFAWWRIVVGAIGIGVLLALR
>A0A0G1RYX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWWQTGILAIVEGITEFLPISSTAHLLITSRILGLPVTEFVKSFEIAIQLGAILAVAAM
YRKQIMDPKLWGRLLAGWVPTAAAGAALYPFIKGELLENLGVTIAALFAGGIILILLEKS
SIFKVQYSMKKTADLPLWKYLIIGVFQAMSIVPGVSRAAATIIGGMMVGLSRREAVEYSF
ILAVPTMAAAVGWDLFKSGGNFGRGEWVIMAVGFAGAFVSAAAAVKWLISYVRTRDLSYF
GWYRIILGAVIYLIFIFR
>A0A0N8QTP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADLIHHYLFNAITVATALV
IGGVIMLWAERREHAVRTETVDDMTWTDALKIGLVQCLAMVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>BAD07295|FEATURES|ARDB_deepARG|trimethoprim|dfrA17|antibiotic target replacement|1
MLWSSNDVTQQGSRPKTKLAIKGVKLKISLISAVSENGVIGSGPDIPWSVKGEQLLFKAL
TYNQWLLVGRKTFDSMGVLPNRKYAVVSKNGISSSNENVLVFPSIENALKELSKVTDHVY
VSGGGQIYNSLIEKADIIHLSTVHVEVEGDIKFPIMPENFNLVFEQFFMSNINYTYQIWK
KG
>A0A066P2V5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRLPQREGEGKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTVGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A084IZT9|FEATURES|UNIPROT_deepARG|chloramphenicol|ER45_14990|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMMLKEIHQKEIKFYPTSIYVISRV
INKHTEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGFFPKENIPPNIFPISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDGSRVM
LPVSLQVHHAVCDGYHASRFIEDLQELANTCNEWLK
>A0A0H1RGS8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MANIIEALFLGLIEGLTEFLPVSSTGHLLLVGHFLGFESTGKTFEVLIQLGAILAILSVY
FNKLWTIAKALPYDPDARRFVIGVVVAFLPAALIGAVLHGFIKEVLFNPWIVCMTLIAGG
FVLLLVDRMPFEATQDDATRFPLSMYLKIGLLQCLAMIPGVSRSGATIVGAMLMGASKRA
AAEFSFFLALPTMAGAFTYDLLKNYKILSADDAVIIVAGFIAAFIAAVVVVRTLLAYVSR
HGFTPFAYWRIIVGAVGLAGLIAFG
>ZP_01363656|FEATURES|ARDB_deepARG|multidrug|mexD|antibiotic efflux|1
MSEFFIKRPNFAWVVALFISLAGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDS
VTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQ
AVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFF
SSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKG
TLDDPQEFGQVVLRANEDGSLVRLADVARLELGKESYNISSRLNGTPTVGGAIQLSPGAN
AIQTATLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLF
LQNVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSI
LFSGFLALTFTPALCATLLKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGR
FMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKS
REAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSAAAEIAALNEHFALPDDGTV
MAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEA
PQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPE
SVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEM
ERLAAQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLI
VPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAI
EAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPIC
FVWLLSLLRSKPAPIEQAASAGE
>A0A0S1RTM3|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RYTPASTFKLAIALMGSDAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVW
YSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRK
LVNRQLPVKAAAYELAENLFEAGQADGWHLYGKTGT
>YP_002385298|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKNATRNKLPALILTVAAVVALVYVIWRVDSAPATNDAYASADTVDVVPEVSGRIV
ELAVKDNQLVKQGDLLFRIDPRPYEASLAKAQASLTALDKQIMLTQRSVEAQQLGAAAVK
TSVEKALAIVHQTSKTFQRTESLLAEGYVSDEDVDRARTAHRSAQVDYAALLLQAQSAVS
GVGGVDALVAQREAVLADIALTKLHLEMATVRAPFDGRVVSLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETELNNIRAGTPATVRLMSDSGKTFEGKVDSIGYGVLPDDGGMVLGGL
PRVSRSINWVRVAQRFPVKIMVDNPDPEMFRIGASAVANLEPQ
>P20074.1|FEATURES|ARDB_deepARG|chloramphenicol|catA5|antibiotic inactivation|1
MDAPIPTPAPIDLDTWPRRQHFDHYRRRVPCTYAMTVEVDVTAFAAALRRSPRKSYLAQV
WALATVVNRHEEFRMCLNSSGDPAVWPVVHPAFTVFNPERETFACLWAPYDPDFGTFHDT
AAPLLAEHSRATDFFPQGNPPPNAFDVSSLPWVSFTGFTLDIRDGWDHLAPIFTLGRYTE
RDTRLLLPLSVQIHHAAADGFHTARLTNELQTLLADPAWL
>N9Y5J1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGINFILILKAIVIGIVEGMTEFVPVSSTGHMILAGSLIDFRGEFADMFTVVIQLGAILA
VVVLYWKKISSSIVEFFKYIFTKGREGKTGFRFGINVIVGSIPAAFVGFLLHDAIKGLFN
PQSVIVGFIVGGILLLIIENIYRKKKPEARDIDEITPKQALIVGIAQCFAMWPGMSRSAS
TIMGGWIAKLSTPIAAEFSFFLAIPAMVGSTGLDLFKFDFSIMNTSMWIALAVGFVVAFI
VALVVMDKFVSYLKKKPMQVFAIYRIIVGILLAALVFAKIITLPAL
>A0A144KT05|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYEILLVDDGSSDNSALMLTE
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIAVAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEEIHP
>ZP_02902278|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MTNLKSDTRGLHMNKNRGFTPLAVVLMLSGSLALTGCDDKPAQQGGQQMPAVGVVTVKTE
PLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIDAGVSLYQIDPATYQAAYDSA
KGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALANAQQANAAVTAAKAAVETAR
INLAYTKVTSPISGRIGKSAVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQ
ELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLL
PGMFVRARLEEGLNPNAILVPQQGVTRTPRGEATVLVVGADDKVETRPIVASQAIGDKWL
VTEGLKAGERVVISGLQKVRPGVQVKAQEITADNNQQATSGAQSEQSKS
>A0A0T6LB47|FEATURES|UNIPROT_deepARG|chloramphenicol|AS196_09195|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMTVTRCTYSLVIDLDITKLYAILKEKRLKVYPVQIYLLARAV
QQIPEFRMDQVNDALGYWEILHPSYTILNKETKTFSSIWTPYDENFGRFYKSCVADMDTY
SKSSSLFPTPHMPENMFNISSLPWIDFTSFNLNVSTDITYSLPIFTLGQFKMKEEKITLP
VAIQVHHAVCDGYHVGQYVEYLRWLIEHCEEWLNDSMQIT
>A0A0G4QFT7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSTFDKIKKVSVVIPVYNEEESLPQLLERTIKSCKQLKQEYELILVDDGSSDNSAKMLEE
AAAIEENHVIAIVLNRNYGQHSAIMAGFNQADGDLIITLDADLQNPPEEIPRLVTTAEEG
YDVVGTRRRNRQDSWFRKTASKMINSMITKATGRSMGDYGCMLRAYRRHIVEAMLQCHER
STFIPILANTFARRTIEIDVAHAEREYGDSKYSFLKLINLMYDLLTCLTTAPLRLLSIVG
SVIAVSGFVLALLLIVLRIIFGAMWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYN
DVRARPRYFIQKVVGVNKPNEDQEKD
>A0A0L6JVM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIEIIKAIILGIVEGITEWLPISSTGHMILADEFIKLNVNDAFKEMFLVVIQLGAIMA
VVLLYFNKLNPFSTKKTIKEKKDTVSIWLKVLIGVIPAGVLGVVFDDWLDEHFYNYGTVS
ITLIIYGILFILIENRNKNKTTTVTDFSDLSYKASFGIGVFQVLSLIPGTSRSGATILGG
ILLGSSRHIAAEYSFFMSIPIMFGASTLKIIKFGFNFTGMEVAVLLSGMIVAFVVSIIAI
KFLMRYIRNNDFKAFGWYRIVLGILILLYFLIIK
>G8EX97|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
KCGLAGALVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGA
TWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKS
DWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDQ
QVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYE
>J3E2U1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WQFRRKIFDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVATALV
VGGVVMLWAERRQHEVHAESVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFITAFVCAMIAVRGLLIF
IASHSYATFAWYRIAFGLLILATWQFGWVDWTAVKP
>I3DIE1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEINKLNRYFGEGKNQVHVLKNISINIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAS
NGSYKIDGKETNELSSDQLADLRSQKFGFIFQRYNLLASLTAAENVALPAIYAGKPQSER
LAYAQQLLNKLGLSDKAYNKPSELSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGQ
NVMAILRQLHSEGHTIIMVTHDREIAATANRIIEIKDGEIISDTQKAPIVESDSQPIIPS
PRFTFSKDQLIEAFKMSVSAIIAHKLRSLLTMLGIIIGITSVVSVVALGNGSQQKILSNI
NGLGTNTMTIFNGTGFGDRRAEQMQNLTVNDANALAKQSYVQSVTPNSAASGLLIYGNQA
FTSTNLRGIGEQYFNVEGMKLLQGRTIQTQDIIESAQVALLDQSAKKALFPNDDPIDKIV
IFSKRPFRIIGVVSDRQMGAASSSLTLYAPYTTVMNKVTGGVKIGSITVKVADNVNTTVA
EKSLTEYLLVRHGKKDFFIMNNDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIML
VSVTERTKEIGIRMAIGARKNNILQQFLIEAVLICMIGGLSGILLSLIIGEVFNVFMHDF
TMSFSTFSIVAAVLCSTLIGVIFGYMPAKNAAELNPITALTRE
>A0A0M9DN05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVIVVMWKRILSLVGLYNIDGQSKSMTNRFNLAHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVVYALVAGAILMIAADKLAPRKPKIDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYAVGFISSFVF
ALLSIKFFLALISKVKLMPFAIYRLVLAAVLCVIIFM
>A0A085EYM7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MNVDQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGLSQPATFIVLIQLGAILAVIT
VYFAKLGLLIRDALMGKAYAWRFAIAVILACLPAIIVGVLGREYIQQVIYESPLVICISL
LIGGIVLLIVDRMPKQEKYDDIYQFPWHLALVVGLFQMLSLIPGVSRSGSTVVGAMLFGA
TKRSAAEFTFFIALPIMVGAFGYDLYKSRELIDMSLGLNIAIGFAASFVVGTIVVKYLLG
FVSKHGFAPFAWWRIVVGAAGLVAILAFGR
>A0A0E9C1H4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKIYFTALLVALSASSSATDLSSQEIASRVKDVITPLMAEQGIPGMSVAVLYKGRPQYLN
FGVADTATDRRVTENTLFELGSVSKTFTGVLAGVMIRNSELRLNDPVQKYWPALKGPQWQ
AIRMVHLATYSAGGMPLQLPASVVDQDSLLRYAQQWQPGVAPGIQRQYSNVSLGLLGYLM
VKGEFEEAMQKNVFTPLRLTRTFYTVPASMMFDYAWGYKDGQPVRVSPGMLSAETYGVKS
TARDMMTFMQANANPNGLSSGNTVLRNGILTAQSHYLTAGQLSQGLGWEIYPWPVKEQTL
IDASDTKTALEAQPATLVNPVKAADRASWIHKTGSTNGFGAYIAFVPQLNSGIVMLANKN
YPNPERIKAAVAILDALQ
>YP_264987|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIILLIQAVIMGIVEGITEFLPISSTGYLILSADLMGFWTKEKVDLFVVVVQFGAILAV
IYDYWDRLWQALMGLLTGKAEGMSNPRQLGLSLIVATIPVMIVGFTFADEIKAYLFDPIV
VAIMLIIGGLLIFYVENRPKPIIAQEAEDVGLKTALMIGLFQCLALIPGTSRSGATIVGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLLKHKDVLTSSEDWLVLGIGTVVSFIVALLC
IRLLVAWVSRRDFKIFAWLRIITGVLVLIAAWGFGYQMAG
>A0A0C1WZ69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALV
IGGIIMLWAEQRQHEVHAETVDEIRWTDALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFVTAFVFAMIAVRGLLKF
IGNHSYAAFAWYRIAFGLFILATWQFGWVDWSAAKP
>NP_816352|FEATURES|ARDB_deepARG|multidrug|lsaA|antibiotic target protection|1
MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGE
ILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGG
EKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVV
DHILAIEKSQLTLYQGNFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNR
EGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDSL
SMDYQPTHHKTLLTVEELRLGYEKNWLFAPISFSINAGEIVGITGKNGSGKSSLIQYLLD
NFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVF
TNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVKPAMLVIE
HDAHFMKKITDKKIVLKS
>A0A0J6D8F1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTTACESLGKAWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRMALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTSFTEESHQ
>A0A0Q6H3T7|FEATURES|UNIPROT_deepARG|chloramphenicol|ASG65_12470|antibiotic inactivation|1
MKFNIIDRENWYRKEYFEHYLQQQTTFSITNEINITVLMKNLKKKNYKLYPAFIFMVTKI
VNSHREFRTSFNPEGNLGYWSEILPSYTIFDKKTYTFSSIWSPNVSRFSEFHSQYEKDVE
EYNGTGSLFPKTPIPDNNIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQIKHELF
LPVSLQIHHAVCDGYHASVFMNDLQRFADESADWL
>YP_254114|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MKKQLFTLYFNIFLIFVGIGLVIPVLPVYLKDLGLKGSDLGILVAVFALSQMIISPFGGT
MADKLGKKLIICIGLVLFAISEFLFAIGHHFPVLIASRILGGFSAGMVMPGVTGMIADIS
PAKDKAKNFGYMSAIINSGFILGPGIGGFLAEFSHRAPFYFAGTLGVLAFIMSLLLIHNP
RKETTEGFHSLEPEVFTKINWKVFITPIILTLVLAFGLSAFETLFSLYTAEKANYTPRDI
SIAIVGGGVAGAVFQVFFFDKFMKYMTELTFIIWSLLYSAIVLGLLILSHSYWTIMFISF
IVFIGFDLIRPALTNYYSNIAGNRQGFAGGLNSTFTSMGNFVGPLVAGALFDVNVEFPLY
MAIIVMLFGIVIIFVEKALQATRRRKHTTK
>N9DX56|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAMMGLVEGITEFLPISSTGHLILTGQLLDFWSIEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIIGGFIILWAERRQHQVVSHEVEDLTFKQATFIGLIQCFALIPGTSRSGSTIIGSLFLG
ISRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMMVLGVGIVVAFISALIVIRALI
RYVSKHDFTAFAYYRIGFGVFILATWWTGWVHW
>ZP_04283753|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVRGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMMFY
>A0A0A6W6P8|FEATURES|UNIPROT_deepARG|beta_lactam|OI73_13275|antibiotic inactivation|1
MRICAAATLLALAVPFVAEAHFNDALLAQPVRQLEHAAGGRLGVAAIDTGDGSVFTYRGN
ERFPLCSTSKVFTVAAILKKAETAQGLLNENIAIRHADLVNYNPVTEKQVGGTMTVAELS
AAALQYSDNAAMNKLLTHLGGPHAVTAFARSIGDNTFRLDRTEPTLNTAIPGDTRDTTSP
TAMAQSLQKLVLGTALAPAQRQQLADWMKGNTTGTYSIRAGLPADWVVADKTGSGDYGTT
NDIAVIWPPHHAPLVLVTYYTQTDKHAASRKDVLASAAKIIASGYEN
>A0A0R5RPK9|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MMQFTKIDINNWSRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTILN
RHEEFRTALDKNGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAY
GERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYYIP
LSIQVHHAVCDGFHVCRFLDELQDLLNK
>A0A064T3F2|FEATURES|UNIPROT_deepARG|beta_lactam|AE24_04439|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>S5P3T0|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MEYKKFDINSWNRKEHFEHYRNLQCSFSLTSEIEITTFLQYLKENKYKFYSSIIYFISKL
VNSTFEFKISIKNNEIVTWDVLHPSYTIFHKKEETFSSIWSEYSDDKTIFFNEFEKDCIN
YENNKSLFPKFNIPENHFNISCLPWIKYSGFNLNLPHLNDYFQPIITIGKYDKNENKIVL
PITIQIHHAVCDGFHVAKFINKLQEWCNEPEKHL
>A0A0Q4MRT8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKFMGAAMLCITAVSAAQAAALEKTRVDQVIEPLMKEYQIPGMAVAVSIDGKTTFYNYG
VASKETRLPINQNTLFEIGSLSKTFTATLASWAQLQGKIAFDDPASRYISELKGTAFDKV
SLLNLATHTSGLPLFEPDGVKTHAQLMSWFKEWQPAQPAGTQRIYSNMGIGLLGLATANS
LKQPFTEAMQKRLLPAFGMHNSFVQVPANKMANYAMGYNKQDKPVRVNPGVLDAEAYGLK
SSSADLIRYLDINMNVQSVEAQWHKAVEATHTGYYHVSGFTQDMMWESYPYPTPLNTLLE
NNSSKIIYDGHPASAILPPQAPMQNAIYNKTGSTSGFSTYALFVPARKMAIIILANKSYP
NEARVKAAYDVLNAQKGGF
>A0A0G2ASF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTSLQAFILGVLQGLTELLPVSSSGHLILAESFFDMEIDPLSMLGFNVLLHAGTLLALVL
CYFTEWRKLLLSPFTGDATYRRLLILLIIATVPGALAGLAFEDVIAQKLSSPLAVVLAFL
VTAAVLLLGERSEQSRQAEHLTGSRALVIGLAQACALVPGLSRSGCTISAARLFHTTRRD
ALDFSFLLAVPIIAGATGVSLWHLLAGTVALPAAGIIVVGFVSSFVASILAIRFLRSFVT
QHSLAWFSWYLVVISVLLLARGL
>A0A0E2UMH9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQEAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
VGGVIMLWAERRVHTVRTETVDDMTWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFVFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>NP_630197|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmO|antibiotic target alteration|1
MARPTQRARTLSQNFLADRATAERVAHLAVPDRGRRPLLLEVGAGNGALTEPLARRSREL
HAYEIDPRLVPGLRARFARSPHVHVVAGDFLTARPPRTPFAVAGNVPFSRTADIVDWCLT
APGLTDATLLTQLEYARKRTGDYGRWTLLTVLTWPRHEWRLVGRVGRSRFCPAPRVDAGI
LRIERRPTALLTGAAARRDWADLVELGFSGVGGSLHASLRRAHSRRRVDAAFRAARLDPG
VLVGEVAPDRWLRLHEELTA
>G7SG10|FEATURES|UNIPROT_deepARG|aminoglycoside|SSUD12_1342|antibiotic inactivation|1
MSIDLSNKKIPKEAIQALKTIAELLDNMLIGVYLYGSAVMGGLRMNSDVDILVITNQSLS
EKTRRNLTNRLMLISGKIGNIKDMRPLEVTVINQKDIVPWHFPPKYEFMYGEWLREQFEK
GEIPESTYDPDLAILLAQLRKNSINLLGPKATEVIEPVPMTDIRKAIKESLPGLITSIKG
DERNVILTLARMWVTASTGEIRSKDLAAEWAIPQLPYEHAILLDKARKAYLGVYIDKWKG
MDSEVTELVNNMKKSIESSLNL
>A0A0Q3KFF6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQNFIEAFVLGIVEGLTEFLPVSSTGHLLLLGHFLGFESNGKTFEVLIQLGAILAILLVY
FRRLLDIALRLPTDPSARRFVLGVLIAFLPAAVIGAILHGFIKTVLFNPFIVCCTLIAGG
LILLVVDELELQEKHADATTFPLPMYFKIGLIQCLAMIPGVSRSGSTIVGAMLLGASKRA
AAEFSFFLAMPTMAGAFAYDLLKNYKTLTFDDGVLIVIGFVAAFFAALIVVRSFLDFVSK
RGFAPFAWWRIIVGMVGLAGLWIVG
>YP_410370|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDVLVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPNDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>J1IL06|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNSNAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEALLATAKKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVVIERTDTGLTLHAKLRDAATNLLRDALP
QLAQGKLTETAQDESKATYFGRRTAADGKLDWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWNAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEIYGLDIGSDAIERLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDNCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIDNAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A7GYF8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIELKNIVKKFKVGDSDIEILHSINLSIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSSG
QYLLDGADISNFDSDALAKLRRNKFGFIFQRYNLLATMNALQNVALPSVYAGVDKKNREQ
RAHEILASLELDDKAQSLPNKLSGGQQQRVSIARALINGGEIILADEPTGALDSKSGLKV
MEILVNLHKLGHTIIIVTHDPKIAEYANRVIEIKDGNIISDTTKKDEIFTAKKHDAPQKS
AFVYYKDQLIESFKMSISAMLSHKLRSLLTMLGIIIGIAAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMRSGRVKTLVISDAQMLEKQPFLESVTPNTSTSGTLTYENISL
SASLRGGGSGSFDVNGLKLASGRLYDDDEVASSASVAVIDHTTKISVFPNIDPIGKIILF
NKKPLRVIGVLQKDDFTFGDASTLKIYAPYTTVINKITGDKYISSITVRVKESVNAQVAE
KSLTELLTIKHGKQDFFTRNSDSIKQTIEETISTMRLLISSIALISLIVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIAFSYVIGYVFNNFLEGFS
MIFSNASIVVALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>H6R4S4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTDYIQAIEVPGAPYGVTTTPDGTIWFSMATTGAIGRYHDGTVTTYALEPADGQPTVIVP
GPDGAVWFTEFRGNRIGRITADGERISIAADAPYGLCVGPDGALWFTELQSGHIARLGAD
GVITRFPVAGMPSMIVPGSDGALWFTLNQANAIGRSTTDGEITVYPLPTEAANPVGITAG
PDGALWFVEIGAGQIGRIDTDGTIDEFPLPDRAARPHAIIAGPDQALWFTEWGAGRLGRV
TTDGTITNLDLPGTEPHGLTAGSDGIITVAMESGILARVPVAIPS
>A0A0N1RVL2|FEATURES|UNIPROT_deepARG|beta_lactam|PAGR_g2149|antibiotic inactivation|1
MLMKIYFTTLLFALSASSSATDLSSQEIASRVKDVITPLMAEQGIPGMSVAVLYKGRPQY
LNFGVADTATDRRVTENTLFELGSVSKTFTGVLAGVMIRNSELRLNDPVQKYWPALKGPQ
WQAIRMVHLATYSAGGMPLQLPASVVDQDSLLRYAQQWQPGVAPGIQRQYSNVSLGLLGY
LMVKGEFEEAMQKNVFTPLRLTRTFYTVPASMMFDYAWGYKDGQPVRVSPGMLSAETYGV
KSTARDMMTFMQANANPNGLSSGNTVLRNGILTAQSHYLTAGQLSQGLGWEIYPWPVKEQ
TLIDASDTKTALEAQPATLVNPVKAADRASWIHKTGSTNGFGAYIAFVPQLNSGIVMLAN
KNYPNPERIKAAVAILDALQ
>D2ZIZ1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDAVGENTFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRKIAPEMIFSFYYRSLLCDEILSVATNGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVNRADAGAIVAQQRVAIGPDDTALELHHKLCAAAQTLLRDTLPTL
LNGSFSEIAQDESKASCFGRRTPEDGRLDWHKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAARPGTVVSASPLVISCGEQALEIVTGQTDSGLYVQGAQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLRDDNYEIYGLDIGSDAIGRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDNNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
AGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTIQMEQTIDETLDFFLRTVELSEQAS
>S3NJZ2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLNAGYEIAAVFTHADDPKEKTFFGSVAQMCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGD
NKLIIWAASVDTSSNGEAPGTVISHEPLRIACGDGSLVITAGQRGDNGLYLSGAQLAREF
GLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGEGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>AAL38578|FEATURES|ARDB_deepARG|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRCDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAAMPMLCSSNIVGLHKYWLEFAV
>D2TRQ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLLFHDMIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTVADIPMFAVGFVTAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0T7NPD8|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MLQNKAIKKVSVVIPVYNEQESLPVLIERTSAACKLLTQPYEIILVDDGSSDNSADILTV
AANEPDSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVTVAEEG
YDVVGTVRANRQDSLFRKTASRMINMLIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARHTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGGEQTENNQEIEK
>A0A0A2U4I8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIEGLTEFLPVSSTGHMILTAHLLGLSEGNESVKTFEVVVQLGAVLAVVVLYWNKFID
MFRFTGGKRSYTSRLNLIHIFLAMVPAVVIGLVFRDWIKAHLFGAQTVLYSLVIGGILMI
VAERWSHRSERITTHDVDDITYKQAFVVGLFQILALWPGFSRSGSTISGGLFAGVSRVAA
AEFTFLVSVPIMIGATGYDLYKSIDHLNSSDLPIFAIGFIAAFIVAMLAIKTFLSILKKL
SLTVFAVYRFVLAAVFFIILMM
>YP_002393667|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQ
LFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLMVLIAASAMQGMGTGVGGVMARTL
PRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMA
RWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVLGL
SSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQT
GQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>A0A0D0GYQ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHIIELMKALILGLVEGVTEFAPVSSTGHMIIVDDMWLKSSDFLGKYGANTFKVVIQLGS
VLAAVVVFKDKFFELLYLRKSEVRKGPRLTLMHIFIGLLPAGVLGVLFEDYIDEHLFSTE
TVLIGLMLGALLMIAADRFGKRTKVAQTVDDITYKQAFIVGLVQCLSLWPGFSRSGSTIS
GGVLVGMSHRAAADFTFIMAVPIMAGASAISLLKNWQYITMDALPFFIVGFISAFVFALL
AIRFFLRLINRVRLVPFAIYRIVLAAVIYIVYFA
>A0A0M0NMC7|FEATURES|UNIPROT_deepARG|aminoglycoside|VL23_16705|antibiotic inactivation|1
MEAPRARMEGMPLPHAWQEALADARIERQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGDEIARLRWLQAQGQPAPTVIATAEEEGRRWLLMSALPGHDLASSPALAPQHRVQLLA
DALRGLHALPVATCPFDQRLASRLQAAQARVEAGRVDADDFDDERLGQSAQQVFAELRAT
RPDHEDLVVSHGDACLPNLLAVEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VARLFRSYGIVPDERRLAFYRLLDEFF
>A0A137RRX8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFTEVKKQEATACSLDDLTYHQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAVLFTLFVLL
>YP_001573360|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQTLFDMSKWRALTLQEKAAGIQDV
TYQTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEA
ENRNLSLLQARLSQDLAREQIRQAQDGHLPKLNLTASTGISDTSYNGSGTHGPGSQYDDS
NMGQNKVGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINAS
ISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQ
LNIKYALGTLNEQDLLALNSTLGKPIPTSPESVAPETPEQDAAVDNFNGNAPAAQPVSAH
TTSTRGNGNPFRH
>F0V6U4|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLLATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A0E9ZQV9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKIFEVVFGLTSQPTARRFTGNLLLAFLPAVVLGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERREHCVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLLILATWQFGWVDWATAHG
>I2QKC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVV
LYFKKLWDVAIGMFTGDAYARRFVLGVLVAFLPAVVVGLVAGKYIKSMLFNPWVVCFSLI
VGGAILLWVDKLDLKAREHDATRFPLLMYLYIGIAQCIAMIPGVSRSGASIVAAMFLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKNRSEMTMDHMGIVAIGFVVSFVTAIIVVKTFLEY
VTRHGFVVFAWWRVIVGTLGLIALALGR
>A0A0W8K065|FEATURES|UNIPROT_deepARG|chloramphenicol|LI7559_09935|antibiotic inactivation|1
MNFQTIDLDTWYRKSYFDHYMKEAKCSFSITTNVNVTNLLAVLKKKKIKLYPVFIYIVSR
AIHSRPEFRTTFNDKGQLGYWEQMHPCYTIFHQDDQTFSALWTEYSNDFSRFYRQYLQDA
ERFGDKKGLWAKPDIPPNAFSVSSIPWVRFTNFNLNLDNSEHLLPIITNGKYFSEGGETF
LPVSLQVHHAVCDGYHAGAFMNELERLAADCEEWLM
>A0A109QWB3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYCDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWHYPAKRELQFGEWQCNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPRDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>A0A0U4IW52|FEATURES|UNIPROT_deepARG|beta_lactam|AV650_16940|antibiotic inactivation|1
MVRNTLRQTTLMVATVMPLLFGSAPLWAQPANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDKRDTTSPQAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTAGL
>A0A0J1LSC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKTPHEGTGKGRLTLGHILLGMIPAVVLGLVFHDMIKSLFNPIN
VMYALVVGGLLLIAAEYLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLTTADIPMFAVGFVTAFVVALVA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>D2WSB2|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-12|antibiotic inactivation|1
SVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWE
TELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLP
AGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRE
>V5Z4K6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKKSLNTLLLGATLAVTTPWICFAAAPMTQQQVTELVDSTIKPLLEKQHIPGMAVAVLY
HGQPQFFNYGVAETEHPRAVTQHTLFELGSVSKTFTGLASGVAMQSGLINLNDRVAQHSP
ELKGAQWQKITLLNLATYTAGGLPLQLPDAVTDSPGLWHYFQQWQPQWPAGTMRNYSNAS
IGLFGALAVKNSGLSYADYLTKSVLQPLKLTRTFITIPPSAQADYAWGYNNGKPVRVTPG
MLDAEAYGVKSSTGDLAKYLQANIAPADLSSDNKVLAQAIASTQTRYYRVGNMFQGLGWE
MYDWPISPAEVIAASGNDIALQARPVTALKAPQSAVASSWVHKTGSTSGFGAYIAFIPEK
QLGIVMLANKNYPNPDRVTAAWQILKTLADRK
>A0A142BQ21|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-214|antibiotic inactivation|1
MTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPND
ERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVTGPLLRSALPAGWFIADKSG
AGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A101C0I7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MALLKKTKTIFYVLISSMGLTTYVNANQQITTAKVENAMTQAFQPLMQKYAVPGMAIGVL
YQGKSYEKYYGVQSLADKKSVNKSTLFELGSVSKLFTATAGSYAQSLSKLSLQDHPGKYL
PALKNSEINQVTLLQLATYTTGNLPLQFPDPIKTDAQTLKYFQDWKVNQPVGQFRQYSNP
SIGLFGEATAKAMNMPFSTLLEQVIFPQLQLQHSYVNVPKAQQAQYAFGYDQNNRPIRVN
PGPFDAQAYGVKSNLPDLLQFLKLNLNPDQAKASIRPAIEGTHIGYFKMGGMTQALGWET
FDYPASLETLLESNSDRVVMQSNPVEKTLVKSGARVFHKTGSTNGFGTYLIYIPAEKFGL
VMLMNKRIANAERIQAAYEVLNTLKQTSHP
>A0A0J6AJ04|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACRKIGKPWEIILVDDGSSDRSAELLTEAA
SDPDSHIIAVLLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYASQGYD
VVGTVRANRQDSLFRKLASKTINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVLHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFLGAEWAAEGVFTLFAVLFMFIGAQFIGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLTTSLRDEEE
>A0A0S2SQE7|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPDELASLEKDFGGRIGVYALDTGSGDTVG
HRADERFLMCSTVKTFIVSAILRRRLSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTV
SELCDATLRYSDNTGANLLIAQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTS
TPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKG
ETNDIAVIWPPGRAPIVMAVLTVPEDPTSTKGKPTIAAATRIVLRAFGA
>V5ARQ7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKEIRRSYPSGDGMVEVLKGITLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
TRGTYRVAGTDVSTLSGDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKA
RLARAKELLTRLGLGDRSEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERIIEIRDGEIIANPPAKTTSASAAKHEGV
VTSVGGWRQFTSRFQEALTMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRSIGTNTIDVYPGKDFGDDEPQNQQALKYDDLLAIQKQPWVRSATPSVSQNLRLRY
GNIDVAASANGVSGQYFNVYGMTFSEGTAFNAEQQGRRAQVVVLDSNTRRQLFPDKASVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTIAGRIMGQSWLNSITVRVNEGY
SSEQAEQQLTQLLNLRHGKKDFFVWNMDGVLKTAEKTTRTLQLFLTLVAVISLLVGGIGV
MNIMLVSVTERTREIGIRMAVGARAGDVLSQFLIEAVFVCLVGGALGVMLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTFTGVLFGWLPARNAARLDPVDALARE
>T0PAZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIFEILKAILFGIVEGITEWLPISSTGHMILLDEFVKLNVSEAFMEMFLVVIQLGAILA
VVVTYWKKLFPFSLGRGKLLIKKDIMIMWVKIVAACIPAALVGVLWDDKIEALFYNYKTV
AIMLILFGILFIVVENRNKGKKSKINTISQITFKAALMVGFFQLIAAVFPGTSRSGATIL
GGIFIGMSRTIAAEFTFFMAVPVMFGASLLKLVKFGLAFSGSEVIILLVGMVTAYVVSVV
IIKFLMQYIKNRDFKIFGWYRIVLGVIVLLYFWLV
>YP_001966537|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTALPGKTAFQVLEEYPDSGENI
VDALAAFLRRLHSIPVSNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDRAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>YP_002633428|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLLELLKALILGIVEGLTEFAPVSSTGHMILVDDMWLKSPEFLGSQSAFTFKIVIQLGS
VFAAAWVFRKRYFEMLYIGKYQPAATETESADGKIGKRVKPKRLTLWHVLVGMIPAGILG
LLFDDVIEKYLFSVPTVMIGLLLGAFYMIFAQKFSERYAHRENIDQITFFQAFVIGLSQA
VAMWPGFSRSGSTISTGVLMKMNYKAASDFTFIMAVPIMLAASLLSLVKHIGYIHLSHIP
FYIIGFLAAFIFGLLSIRLFLNLINRIKLIPFAIYRIILVIFIAILYFGFGIGKGI
>J2ST42|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLLKVLILGAVEGLTEFLPISSTGHQIIVADLLAFGGERAMAFNIIIQLGAILAVV
WEFRPKIVEIVKGLPTQRNAQRFTLNLLIGFLPAVVLGVLFADQIHHYLFNPITVAVALV
VGGIVMLWAEQRDHVVHVDHVDDMRWPDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEYSFFLAMPTMVGAAVYSGYKYRGLFQTSDLPVFALGFVTAFFFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLLILATWAFGWVNWTAAAAG
>F3MJD3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFITSIILGIVEGLTEFIPVSSTGHMILTAKVLGYDDQTPIMKTFEVVIQLGAILAIAI
VYWNRILNLLGWSRSEPLTRKVPRRRLNLMHIFLGIAPALLVAFFARDFIKSLFHAQTVL
FALVAGGIFMIFAEWYNKHKVQVTAHDMDDLTYKQAFLIGIYQIISVLWPGFSRSGSTIS
GGMLSGVSYKASADFSFIIAIPIMCAASGYELLDSYRYFTLDTIGVFLAGFIVSFVVAYF
VVLAFMKLIQKIRLTHFAIYRFGLAAVFWLFIMH
>C6JDT6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWVFCITYYLAETCLIRLKIVVNKNNNKKENRKGKIMDFIELLKVIFLGIVEGITEWLPI
SSTGHMILVDEFLKLNVTEDFKNLFFVVIQLGAILAVVVLYWNKLWPFYIRPISKKQQAV
LNRHGAVSRGILTFVEKFCDKEKWVLWFKIIVACIPTIVIALPFNDVIEEKFNNYVVVAI
ALIVYGILFIVIENYNKRRRPTCTNLENLSFKTALIIGLFQVLSVVPGTSRSGSTIIGGI
LAGTSRTVAAEFTFFLGIPVMFGASLLKILKFGFSFTGTEVMILIVGMVVAFVVSIIAIK
FLMGYIKKHDFKAFGWYRIALGILVLGYFIGKTLLGCK
>A0A0H3KVV5|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MPLFSEAGIHQWRLTMTHLFRRRASTAVTLLALAMPLAAQAGFDEAALQRGIQQLEKNAG
GRLGVAVTDTTDGTVFTYRGDARFPLCSTSKVFAVAAILKKSESADGLMSEKIAIHKADL
VNYNPITEKHVGATMTVAELSAAALQYSDNTAMNALLTRLGGPQQVNAFARSIGDSTFRL
DRKEPELNTAIPGDKRDTTSPDAMMQSLKKLVLGKALAPAQRQQLTDWMKGNTTGANSIR
AGLPASWTVADKTGSGDYGTTNDIAVIWPPHHAPLVLVTYYTQPDKHAAARKDVLAGAAK
IVASGYNK
>A1AZA9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDHNTIVAAALGLLEGLTEFIPVSSTGHVLLAGHFLGFDSPGRAFEVLIQLGAIMAILGV
YAGRLWRIFSSAPQDPRARRFILAVLLAFLPAVVIGVLAHRIIKEVLFETPTLIAVMLIV
GGVVLLFVDRMANRPRHFSAEDFPLPMALKIGFIQCLAMIPGVSRSGATIVGALLLGADK
RSAAEFSFFLSMPTMLGAFVYDLYKNRDILDAAATGNIVIGFVCAFLAAVVVVRGLLNYV
STYGYGLFAWWRIAVGVAVLLALQAGW
>D0X6B6|FEATURES|UNIPROT_deepARG|beta_lactam|VME_06290|antibiotic inactivation|1
MKKLLLLFGLVVCSSATYAAKLNEDLASIEEHISGRLGVSVWDTQTDEKWDYRGDERFPM
MSTFKTLACATMLKDMDSEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRIEHACEAAML
MSDNTAANIVLRSIGGPHGVTRFLRSIGDKATRLDRFEPRLNEAKPGDKQDTTTPNTMVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAM
IWKENHKPVYISIYITETDLSLQARDQVIAQISQLVLDEYKNI
>W7W5S1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTQPAIREIPLTGPGSGPYSITVGSDGALWLALAGSGGVARLGPDGEVRTYRDDPPGSRP
LIIVGGPDGALWYTRSGDDRLGRIAVDGETGSVALPPGCGPCGLAVGPDGAFWYAGMNDD
TVGRVSVDGEVTSFPLPVEKGFPSMLAAGPDDALWLTLNQANAIARIDLDGSVTLHPLPT
EAAGPVGITRGVDGALWFVEIAAGQVGRITPDGRIDEFPLPDRAARPHAIVADPAGGCWF
TEWGANRIAHLDPDGHITAHTLPTPASEPHGLTVTPDGAVWAALEIGAVAHLTPPAPRAP
R
>A0A127SUY3|FEATURES|UNIPROT_deepARG|chloramphenicol|catA16|antibiotic inactivation|1
MRKMTLTLIDFDNWERREHYLHFINEVRCSYSVCINLDISNLNGQRLYPAMLWLLTRTVN
EMPEFRTSLTEDGLGYYSEMHPAYTVFNKDAKTFSGIWTAYQPDYPSFLRGYEEDVGKYS
STTQYEPKPGRPANSFDVSMVPWFSFSAFNLNIFGDGTYLLPIFTMGKTFEENEKTMLPL
AIQVHHAVCDGYHLGKFIETLQANINKFDA
>L5MMU9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MQPLTGINHFLFSVSDLERSFCFYRDVLGAKPLVRGRKLAYFDWNGYWLALNEERDIPRN
EIALSYTHIAFSVAEEAFADWKRHLEQHGVHILPGRERDERDKRSLYFTDPDGHKFELHT
GSLQDRLAYYRKAKPHMTFFD
>A0A0Q7LRS7|FEATURES|UNIPROT_deepARG|beta_lactam|ASD34_02750|antibiotic inactivation|1
MNTLIQRRTLLLAVAVTPLAGACSAWPKKGAQAGAQAQLAELERACGGRLGVAGFHTRSG
ARLQHRAHERFPLCSTFKLMLAAAVLERSTTDASLLGRRISVGKGDLVSHSPVAEKHLAT
GMTVREMCAATMQYSDNAAANLLLKVLGGPAVVTAFARRIGDTTFRLDRTEPELNTAIPG
DPRDTTTPTAMSDSVQRLALGDALGAPQREQMCEWLLGNTTSTERFLAGVPAGWRVGDKT
GAGSYGTTNDVGVLWPPSGAPLVLSVYLTFPDKDAKGRNDVVASATRIAVQALAS
>YP_002467958|FEATURES|ARDB_deepARG|beta_lactam|pbp1b|antibiotic target alteration|0
MFFNFKKYFLIKVFFFVLILTLCYGLYLYVKINRFINGKVWNFPTSIYGRIVNLEPGNSY
SQKEVLHLLKSTMYRKVDLVMLPGEYSIKNNTIEFIRRAFDFPDIREDEFHARLYFNKDT
LVKIKNIDNNHDFSFFRLEPKLIAMLKSPEAKKRMFIPRNQYPEMLVKTLLAIEDKYFYE
HDGIHLSSIGRAFLVNLMAGRTIQGGSTLTQQLIKNLFLTNTRSILRKINEIYMALILDR
FYTKDRILELYLNEVYLGQDGDEQIRGFPLASIYYFGRPINELNLEQYALLVGMVKGASL
YSPWTNPNLALKRRNLVLFLLYKQKYITRKIYKDLCKRSLNVQPKGNIISSHPSFIQLVC
EEFHKKIHNPIKNFPGTKIFTTLDYTSQNAVEQAVKIEIPILKRKKRLKDLEVAMIVIDR
FTGEVQALIGSSKPEFNGYNRALKTRRSIGSLSKPITYLTALSQPEKYHLNTWISNYPLS
IKLDSGQYWTPKNNNFSFSKKVLLLDALIHSINIPTVNLSINIGLKKLVDSWLLLGISKK
YITPLPSISLGAINLTPFEIAQVFQIIGSGGYKSSLSSVRSIISDDGKVLYQNLPQSIHI
ESSEASYLTLYGMQQVVKSGTAKSLGTIFKEFSLAGKTGTTNNLVDNWFVGIDGKQIVIT
WIGRDNNHTTRLYSSSGAMQIYKRYLQYQRPVPLVLKAPNNINMFYINNLGELFCKKNNQ
HNRMLPIWSIKNKKICNDKLSERFSIKKKKNFLFWLKNLF
>A0A0U2B9Y5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MATPILSLKNIKKSFAFGDDSLEVLKGIDLDIYRGEMVAIVGQSGSGKSTLMNIMACLDT
PTSGEYRIDGLCTQDMNGEQLASLRRDKFGFIFQRYQLLSSLNATANVAMPAIYAGVSQK
TREQKAQALLAKLGLEQRLDHYPNQLSGGQQQRVSIARALMNGGQIIFADEPTGALDSQS
SRDVMAILTELNREGHTIILVTHDPKIAQSAKRVIEIFDGQILSDNNSDNTPNTAQYFQQ
NTHRTLNFQAIGRIKEAFHMAVLTMLASKMRTLLTMLGIIIGIASVVLIVALGNGSKQQI
LNQINSMGSSTISVFMGSDNEDDTTPPNDLTFDDMYALETLPFVASTSPDLSMSMQAQVG
NHSKGVQVDGVGLNHHRLQNVQFVAGGMFRQSDLDNFSQNVIISEKTKQAFFKQNNALGQ
ILILNGVPTKVVGVFKYNGIEGNFDRNLKVWLPYRTYQARFAGESPRLNSITVLLKPNES
SALASESISQLLTQRHSKKDFTLFNSDSLAKTVEKTAQSLTLLIGAIAVISLLVGGIGVM
NIMLVSVTERTGEIGVRMAVGATYGDIVWQFLIEAMVVCALGGVLGVLLAFGLGGLLQLF
DIKVIFSATSIALAVGCASLIGLVFGLMPAHKGAKLNPIEALNKG
>J3ZVN2|FEATURES|UNIPROT_deepARG|beta_lactam|BTG_03330|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSESLKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALGVLKTKNK
>A0A060KQF0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVSYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>L8PU39|FEATURES|UNIPROT_deepARG|beta_lactam|BSI_39800|antibiotic inactivation|1
MKNKATLKLGICIGLLCLSLTGFKPFDGSTHAEAKAIEDTKMTSRITIKKFVQLEKKFDA
RLGVYAIDTGTNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLVTY
SPITEKHVDTGMSLKEISEAAIHYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTRANRF
ETDLNSAVPGDIRDTSTAKALATDLKAFTVDNTLTTDKRTILTDWMRGNATGDELIRAGA
PIGWEVGDKSGAGNYGTRNDIAIVWPPNRAPIILAILSNRFTKDAHYDNALIAEAAKVVL
NDLK
>NP_644926|FEATURES|ARDB_deepARG|tetracycline|tet38|antibiotic efflux|1
MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGI
GAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFALLLVGRIIQTAGLAAAETLY
VIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPF
LFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNA
QRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYI
VAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFAL
MYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSH
FGIILIILGLMSIVGLVLFVSLNRWTQSEK
>A0A0C5VJB2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSNNEVIKNEVDEIKKVSIVIPVFNEQESLPILIKRTHAACELLNKPYEIILIDDGSHDN
SAEILTRAAEIPENHIVAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRL
VATAEQGYDVVGTVRAKRKDTWFRKTASKMINMMIQKATGKSMGDYGCMLRAYRRPIIEA
MLHCHERSTFIPILANTFARRTIEIDVRHDEREFGESKYSFLKLINLMYDLVTCLTTTPL
RLLSIVGSVIALSGFTLAVLLIAMRLIFGPTWAAEGVFTLFAVLFTFIGAQFVGLGLLGE
YIGRIYNDVRARPRYFVQKIVSADALKTHVSVEQQEEE
>Q3KD12|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHHYLFNPITVAAALV
VGGIVMLWAEQRQHEVHAETVDEIRWTDALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IGSHSYAAFAWYRIVFGLVILATWQFGWVDWTAAQP
>N8XSM0|FEATURES|UNIPROT_deepARG|beta_lactam|F966_01227|antibiotic inactivation|1
MNQPKAFSMTLKKLCLLTGLLSCSSALWAGNLTEQQVQTIVDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQAVSNSTLFELGSVSKTFNATLAAYAQAQGQLSLSDHPAK
YFPELKNTAVNRATILNLGTYNAGGFPLQFPDEVVQQQDMIKYFQAWQPKTTIGAARQYS
NPSIGLMGYVTALAMKKPYSELIEKTLLPQLGMTQSFIRVPEQHMSQYAWGYKADQAMRV
SPGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRQAIENTHMGYFKVGAMTQGLGWE
QYAYPVSLETLLQGNSSKMALESHAITAIKQPKLATPATFFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQNNSAQ
>A0A0Q5E699|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLVIKAIIMGVVEGLTEFLPISSTGHLILTEHLLGFAGMEDKMKVFEIVIQAGAMMA
VIWEFRARIGLVLSGLFSDPVQQRFAMNVLIAFLPAAILGLLFSSAIKAHLFAPIPVAAA
FIIGGIIILWVEKRAKTNPAVERITSLDQITPVDALKIGIAQAFALIPGTSRSGATIMGS
MIFGFSRQVATEFSFFLAIPTLIGATVYSLYKDRALLSMDDLSFFTIGTVAAFISAFLCI
RWLLRYIMTHTFVIFAWYRIVFGLIVLITGYYGVIVWAD
>A0A127SWF4|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
GLAAKSCIFACELPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKA
TVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLP
NTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSF
NLSETEDDMHSSFEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGAN
KLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDN
ADIIARISRMVYDTIENQ
>F5S585|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLFKALILGIVEGLTEFLPISSTGHLIVLGDLMNFNSNGKVFEIAIQLGAILAIVV
EYRQRFANVITGIGRNDQANRFVLNLAIAFIPAAVVGLLFRKHIKEYLFNSITVAIALIV
GGLLILWIEKRTQHRPPKVKNVDDMSGKDALVVGLAQCLALIPGTSRSGSTIMGGMLWGI
ERKAATEFSFFLAVPMMVAATGYDIYKSWQEFTWGDVGLIAVGFVAAFVSGLFAVKALLK
FVSTKNYVPFAYYRIVFGSFILITSQTGWITWSQM
>A0A0D8WBK3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMLWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFILAAAVYVVFF
>A0A0M2G217|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVIIGIVEGLTEFLPISSTGHIDLVDQVVKLSQGRQFMNMFEYVIQFGAILAVI
LLYFNKLNPFSKPTVQAQKDTWQLWAKVIIAVLPSVVVGLPLNDWMDKHLHTPLVVATTL
ILYGVLFIVLENYLKNKQAHITSLADITYQTALLIGLFQVLSIVPGTSRSGATILGALLI
GTSRYVATEFSFFLAIPTMVGVSILKIGKYLLQGNGFTGEQWVVLLTGSIVSFLVAIVAI
KWLLKFVQTHDFKPFGWYRIILGAIVLLVMFL
>P30897|FEATURES|ARDB_deepARG|beta_lactam|CARB-10|antibiotic inactivation|1
MNVRQHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAAHDLETGKRW
EHKSNERFPLSSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGM
SLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWEPELNEAVPGDK
RDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGA
GGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKTVLMENSRN
>A0A127T844|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
ALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKK
QPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLAT
YTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFE
QAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMA
CWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKI
ALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVA
AAWQILNALQ
>B8DYR6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIWVIILGIVQGITEFLPISSTAHLILIPYLVKIPDFGLSFDVGLHLGTFWAVLIYFLK
DWWEFLVSIFKGGEKRRILGLIVLATLPAGILGVFLDPFVEKISQPQVYSFAIWIILIGV
ISFGIIFLLLEKYSKKNLEIKDLNLKRGLIIGFWQVLSLFPGVSRSGSTISGGMFTGLKR
DEATKFSFYLSLPIIGGAVFFKLFHVIKSGDLGSLSLILWGAIVAFIVGILTIHLLLNYV
KKASLKVFSYYRFILALAILLAYFNLQVLSLIVFGVAIVYLIFRMVRGEKERN
>V3TMQ5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNTVVFAYHDIGCVGIRALVAAGYTIKAIFTHPDSPAENHFFGSVARTAAEFGIPVFAPD
DVNHPLWVERVAAMSPDVIFSFYYRNLLSDDILQCAHQGAFNLHGSLLPRYRGRAPLNWV
LVNGETETGVTLHRMVSRADAGNIVAQQRIAIDEKDTALSLHGKVRDAAGQLLAAALPGI
ASGHFSETPQNEHEATTVGRRTPEDGRIRWEQPAKTTYNLIRAVTEPWPGAFSYVGTTKF
IIWQAAVRADFPAANPGTVLSTSPLVIACGNDALEVITGQGDNGIYLQGSQLAESLGLVT
GAILNNAPVISMKRRTRVLILGVNGFIGNHLTERLLQEDGYEIFGLDISSDAIARFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDPMFDEDNSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EALRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGKQKRCFTDI
KDGVEALFRIIENRDGVCDGQIINIGNPDNEASIRQLAEMLLKCFEAHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLQWEPTIDMELTVADTLDFFLNTVEQAGTAE
>C0QU08|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIESIILGIVEGLTEFLPVSSTGHLILVSKLLGLEQTDAHKAFEVAIQSGAILAVVFL
YREKLTHSIDLWKRLIIAFIPTGILGFLLYKIIKGLFSPYIVSIMLIVGGLVFIAVEFFY
KKSEHQIDDILKIPYYKAFFIGVFQSIAMIPGTSRSGATIIGGLLLGLDRKTAAEFSFLL
AVPTMFAATSYDIMKNYHHFHIENWIALLTGFVTAFVFAVLAIKLFIGFVSRYNFVPFGI
YRIILGFIFLLFVL
>A0A127SUM3|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNCKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNADIIARISRMVY
DAMRRQGGYW
>A0A060KT65|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRANERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0K3Z9H2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNTLQ
>L0HP91|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
GRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDL
VNYNPIAEKHVNGTMSLAELSEAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRL
DRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKAVGDSQRAQLVTWMKGNTTGAASIQ
AGLPASWVVGDKTGSGGY
>Q5TLE0|FEATURES|UNIPROT_deepARG|aminoglycoside|addA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLRLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>F4XB10|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIVELLKSFFLGVVEGITEWLPISSTGHLILVDEFIKLNVTTEFMDMYRYVIQLGAILA
VLVLFFHKLNPFSPRKSSHQKRQTWTLWGLVVLACIPSAVIGLPLNDWMDEHLMNPWVVA
AALIVYGVGFLIIEDRSRTPAIRRTSDLTWQIALCIGLFQALSIIPGTSRSGATILGAII
LGCARPVAAEFSFFLAIPTMVGVSVLKLGKFFAEKIAAGEALFTGPEAAILAVGFIVSFV
VSLLCIRFLMDFVKKHDFKPFGWYRIVLGILVLLFFGIRALVA
>A0A0J8PTG5|FEATURES|UNIPROT_deepARG|aminoglycoside|STRNTR1_2718|antibiotic inactivation|1
MEATHARMDGMPLPHAWQEALADARIERQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGDEIARLRWLQVQGQPAPTVIATAEEGGRRWLLMSALPGHDLASSPALAPQHLVELLA
DALRGLHALPVASCPFDQRLASRLQAAQTRVEAGLVDADDFDDERLGQSAQQVFAELRAT
RPDHEDLVVSHGDACLPNLLAAEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFRRYGVVADERRLAFYRLLDEFF
>V3TNZ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLLVAFILGIVEGLTEFLPVSSTGHLIIVGQWLGFEGATAKTFEIIIQLGSILAV
VAVFWRRMFGLIGIHFGEVPHEGQHNGHLALGHILLAMIPAVILGLVFHDFIKSLFNPRT
VAYALVVGGFLLLAAEWLKPKHPRSVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLTGVSRYAASEFSFILAVPMMLGASALDLYESWHFLTKADLPLFIVGFLTAFVVAMIA
IKTFLQLIKRMSFIPFAIYRFIIAAVVYLVFM
>A0A0F3ZPK0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNNIRRSYPSGDGPVEVLKGLSLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLGGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRESRAAAPKEALP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0C1U857|FEATURES|UNIPROT_deepARG|multidrug|rlmN|antibiotic target alteration|1
MKQTKTKYEKIKQIISNLKLPDYRYEQLTKAIFHQRIDNFDDMHILPKVLRIALVNEFGN
NVSSVIPVFSQDSKQAQKLLFELADGERIEAIGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVIGLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCSTLKKAGISVTVRTQFGSEISAACGQLCYEDELSC
>ZP_04612532|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIILMLAGALAIMKLPIAQYPTIAPPAISISANYPGADATTVQNT
VTQVIEQNMNGIDNLLYMSSSSDSSGNVQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVAGFISEDGTMLQEDIADYVGSNVKDPISRTAGVGDVQLFGS
QYAMRIWMDPHKLNNFGLTPVDVINAIKVQNNQVAAGQLGGTPPVPGQELNSSIIAQTRL
TNAEEFSQIMLKVNTDGSQVRLKDVAIVQLGAENYNIIARYNGKPAAGIGIKLATGANAL
NTSAAVKAELAKLQPFFPAGLKVVYPYDTTPFVKISINEVVKTLIEAIILVFIVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSALGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
QEEGLPPKEATKKSMEQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSVTIVSAMVL
SVLVALILTPALCATMLKPIAKGEHGPKTGFFGWFNRMFEKSTDHYTDSVGNILRSTGRY
LVIYLAIVIGMGVLFLRLPTSFLPEEDQGVFLTMVQLPAGATQERTQKVLNQVTDYYLDK
EKDVVNSVFTVNGFGFSGQGQNTGLAFVSLKNWDERPGDQNKVPAIVGRASAAFSKIKDG
LVYAFNLPAIVELGTASGFDFQLIDQGNLGHQKLTEARNQLLGMAAQHPDLLVGLRPNGL
EDTPQFKVEVDQEKAQALGVAISDINTTLGSAMGGSYVNDFIDRGRVKKVYVQADAPFRM
LPDDIDKWYVRNSSGQMVSFATFSTAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
DMMQELVSKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAASLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLV
ESTLEAVRMRLRPILMTSLAFILGVLPLVVSSGAGSGAQNAVGTGVMGGMVTATVLAIFF
VPVFFVVVRRRFSSKSEDLEHPHAVDPKVK
>A0A0R3CB77|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHTLKKYAVSALLLGAGSCMAATDMRQVVDSHVTPLMKQQGIPGLTVAVVQQGKVQYFN
YGVAAKDTQAPVTENTLFEIGSVSKTFNATLGGYAQAIGKLKLSDMTSQHLPVLAGSAFD
RISLLQLATYTAGGLTLQFPDAADSATTMMDYFQHWKPTYAPGEQRLYSNPSIGLFGYVT
AKSLGQPFTVAMEKTLLPKLGLTNTYTRVPADKAGQYAQGYDSQQKPVRVNPGALDFEAY
GLKSSSQDLARYVIANMHPQTLEQPVQQAIATTHAGYYTVNGMTQGLGWERYPYPIGLQA
LLDGNSTPMAMEPHKVTWLTPAQAEPANVLYNKTGSTGGFGAYVAYVPSKDMGVVILANR
NYPNAERVKVAHAILSAMDQ
>ZP_02902942|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHTTMPYPVKDIRVLSRITTEAFNQRRKTIRNSLGNLFSAEVLTE
MGIDPAMRAENISVAQYCQMANYLAENAPLQES
>R7AC04|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNFFEILKVLVLGIVEGFTEWLPISSTGHMILVDEIIHLNVSEAFREVFMVVIQLGAILA
VVVLYFHKLNPFSPRKTQNQKRATIRLWMKIVVACIPAAVIGLPFDNLLDKLMNGYVVSA
MLILYGVFFILLENRNRGVKFRIQRVTQISFQTAAAIGLFQVLAMVPGTSRSGATILGAM
LLGCSRGAAAEFSFFLGIPVMFGASLLKIVKFMLEGASFQMYEIFYLIFGMAVAFGVSVY
SIKFLMEYVKQHDFKFFGYYRIVLGIIVLSYFGISALVGA
>G1WR63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDVLKVILLGIVEGITEWLPVSSTGHLILVGDVLKPGLSDAFMEMFNVVIQLGAIMAVV
VLYFHKLNPFSPKKTQKQKLLTWQMWIKVLIACVPAAVVGLLFDDILDKIFYKPLPVAVM
LIVYGVLFIIVENRNEGRKPAVHRISELDIKMLLWIGAFQMLALIPGTSRSGATIVGALI
IGVSREVAAEFTFFLAIPVMFGASALKLIKFGFHFTAAEFGFLMLGCVVSFGMSVIAIKF
LMNYIKKNDFKVFGYYRIILGALIILVALFKMLLG
>B1T4V9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIVSIVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVQSVDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRFVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A101GKQ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTWLQALIISIVEGITEFLPISSTGHMIITEAVLGMEPTEFSKAFIVNIQFGAILSVIVL
YWKKFFTSLDFYYKLFVAFIPAAVVGYLAGNLIDRMLGSVLVVAISLVAGGIILLFIDKW
FNNTAEQGENEVTYSSALKIGFFQCIAMIPGISRSAATIIGGMTQKLNRKAAAEFSFFLA
VPTMFAASAYKLIENYKSINTQNIPLLVFGNIIAFIIALLAIRTFINYLTRHGFRLFGWY
RIVLGGLILILLALGIDLNITG
>A0A0U1MQT8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKSINHICFSVRNLNDSIHFYEDVLLGKLLLTGKKTAYFKLAGLWIALNEEKDIPRNEI
HFSYTHIAFTIDDSEFNYWHQRLKDNNVNILEGRVRDIRDRQSIYFTDPDGHKLELHTGT
LENRLNYYKEAKPHMTFYK
>A0A060NWP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAICWEYRA
KIGSVVTGLPVRADARRFTINVIIATIPAIVLGLLFEKHIKSVLFSPVPVSVALIIGGIV
ILWAEARQRERGALTRVHSVDDLTYGDAFKVGLAQCFALIPGTSRSGATIIGGMLFGLER
RVATEFSFFLAIPIIFGATIYEMAKYWRTLTVDDLGLFAIGLIAAFISAFVCVRWLLRYV
ASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A127SB27|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQEKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>R2P249|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAVILGIIEGITEWLPISSTGHLILADEFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKSTVEKKDTWTLWFKVIVACIPAVIIGLPLDDWLEANFHKFLPVA
IVLIVYGIAFIIVEKRNKNKTPRWTSLNDFTYQAALLVGLFQVLALVPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLAEGNSFKMEETVVLLVGTFVSFVVSV
LAIKFLLSYLKKNDFTAFGWYRIILGIILIGYWFIAM
>Q57P40|FEATURES|UNIPROT_deepARG|aminoglycoside|aac6|antibiotic inactivation|1
MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFVAMADGGAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGLAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A0R3AEP3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPKARRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVRAETVDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADFPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAVFAWYRIAFGLVILATWQFGWIDWTAVKP
>D1LU77|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-4|antibiotic inactivation|1
QTQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGS
VSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDD
VRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKL
AHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQ
EKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPP
APAVKASWVHKTGSTGGFGSYVAFVPEKNLGIV
>A0A064TG34|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTKACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A147G540|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFSWARLSALALLVSGSALATTSPDSIIKPLMQQYQIPGMAVAILHDGKTEFYNYGVASK
ESGQPINEQTLFEIGSLSKTFTATLASYAAQQNKLKFSDAASQWLPELKGSAFDRVSLLN
LATHTSGTPLFVPDDVTNTRELMRWYKQWQPEAQPGTVRVYSNLGIGMLGMIAAKSLHQP
FISAMEKQLLPAMGMTHSYVQVPASQMGRYAQGYNKQDRPVRVTPGPLDAESYGLKSTSA
DLIRWLAIQLQQQPVAPAWQQAVAATHQGYYHTEAAFTQAMMWEYYPLPVTTQQLVDGNS
GARIMKGMKATLITPPQAAPQQAWYNKTGSTNGFATYAVFIPSQRVALIMLANKWFPNDD
RVVAAEKIISNIGKGE
>A0A0E1DQL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIELLKAIFFGVIEGVTEWLPISSTGHLILVQEFIRLHQDKAFMEMFNIVIQLGAIIA
VIVIYFERLNPFQPGKSPQQIRLTWQLWLKVAIACIPSIIIAVPLDDWFDAHFNHMLPIA
IALIVYGIAFLWIEKRNQTLEPRVVKLSRMSYKTAFFIGCFQVLSIIPGTSRSGATILGA
IILGASRTVAADFTFFLAIPTMFGYSGLKALKFFIDGNHLTLSQLLVLLVASLTAFAVSL
YVIKLLTDYVKKHDFTVFGRYRIVLGSLLIVYSLFKSLF
>A0A0R1QF35|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFVKLNEPTAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKTHIEKRQTWSIWFKVILAIIPSVVIGLPLSDWMDAHLTSWQVISA
TLLIYGILFIVVENWLKNKQPQTADLDSLSYKTAFQIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIGKYFAHGNTFTGDQTIILLVGTLVSFIVAYA
SIKFLLNYIKRNDFKAFGWYRIILAIIVIAYFGFKSFA
>D7A228|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFGTLLEAFLLGLLEGFTEFLPVSSTGHILLAGHFLGFESQGKVFEVVIQLGAILAIVV
AYFQRFLHVLVTLPTSERSRNFVIGILIAFLPAAVIGAFAHGFIKNVLFETPALICIMLI
LGGGVLLWVDTLKLRPIHDDAMAFPKALALKIGFIQCLAMIPGVSRSGSTIVGGLLLGAS
KPAAAEFSFFLALPTMAGAFAYDLYKNRDALNADDATLIAVGFVAAFIAALAVVRGLIAF
VSRHGYTPFGWWRIAVGGVGLVALALVG
>A0ESG2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITMRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVMVNMKPDSLEDSSLRKGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A085FDS5|FEATURES|UNIPROT_deepARG|aminoglycoside|FG93_03207|antibiotic inactivation|1
MAAPMLIETCTDGMLEDWVRLRLALWPDSTAQEHRDEAVGILESPSDTAFIARNDAGAAI
GLAEAALRHDYVNGCETSPVGFLEGIHVEPGWRRHGVARALCAAVETWAKRHGCVELASD
TDLSNAVSQQTHDALGFEETERVVFYRKLLQSR
>A0A076WDR9|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MIVLNKFFNISHYKKVVPVLFLSCVTLIGCSNSNTQSKPPKQTKQENTVNHSFTKLEKEF
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGVLLQKKSIEDLDERIVYTSEDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLRAIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFALGDVLSTEKRELLIDWMKRNTTGGNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VIDALKATNK
>N8YA55|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLLHVLILAIVQGLAELLPVSSSAHVILAEKLMGFDPSAPEMTFLLVMLHTGTMFAVIV
YFWKSWKKTYFSTWQDFKRQAFYVILATGITGVLGLALQAIIKHVFFGGASSFEIEHLFS
NSKLMAAALATVGIIIIIASRFDGKQTGEINFKRASIIGAVQAFCLPFRGFSRSGATIST
SLFLGISRQKAEEFSFALAVVLTPAVIVKEFYRLIHSQGLQSSQIGHLMMPSLFGMVFSF
FAGLAALKWLSSWLEHGRWYLFGIYCLAFSVVVLLVS
>A0A142JN48|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRARIGKVVRGLRDDPLSQRFAANVVIASVPAIVLAFIFGKWIKAHLFNPISVALAFI
VGGVVILLAEWRDARRGTVSHPQGNALLEAAKAGAPRIESVDDLNWRDALKVGLAQCFAL
VPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKARALLNGDDLGIFA
VGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIVVLLTAYTGLVSWHA
>J0H6V6|FEATURES|UNIPROT_deepARG|beta_lactam|Rleg9DRAFT_4806|antibiotic inactivation|1
MKSIRIRILSAVLLSAGAATSAFAADETKLKAITDAAIKPIIEKYAIPGVAVAITADGQD
HIFNYGVESKDTGRPVAPTTLFELGSISKTFTVTLASYAEASGQLSLSDKVGKFLPGMKG
KPFGDIALMNLGTHTAGGFPLQLPDEIKTEKQLLGYFETWQPSYAAGAQRSYANPSIGML
GYIVAKAMHADFAALMQGKLFAGLGLKSTYITVPKARLADYAQGYKRSGEPARMTPAVFS
SEAYGVKSTAGDMIRFVAANMGLVKLDEKLQQAITSTHIGYFKAGAMTQDLIWEQYAYPA
ALNDLLAGNSPAMLKTMPVSELRPPMKPRDDVWINKTGSTNGFGAYVAFIPKQRLGIVIL
ANKNYPNDDRVAAAYQILTALSAD
>ACQ66104|FEATURES|ARDB_deepARG|glycopeptide|vanHB|antibiotic target alteration|1
MRKSVGITVFGCEQDEANAFRALSPDFHIIPTLISDAISADNAKLAAGNQCVSVSHKSEV
SEATILALRKVGVKYISTRSIGCDHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAI
RGAKPTMHAVAQQDFRLDRIRGKELGDMTVGVIGTGHIGQAVVKRLRGFGCHVLAYDNSR
KMDADYVQLDELLKNSDIVTLHVPLCADTRHLIGQKQIGEMKQGAFLINTGRGALVDTGA
LVEALESGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTER
VLQDTTEKTIRNCLNFERSLQHE
>U1J9Q0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIINAIILGIIEGITEFLPISSTGHLIVASKWLGIESTDANLAFEVIIQLAAILAVLAN
YKDKFSPKHFNLWVKVAIAFIPLGIIGFIFSDVIKTLFSVPVVGVMFIVGGVIFLLLERS
YKETHCTTTDVTQVTYKQALWIGVAQVFALIPGTSRAGSSIVGAMLCGLNRKASAEFSFL
LGLPVLAAASGYDLLKHYQLFSLDDLTALAVGFLTSFIVAYFTIKLFIRFLENFTFVSFG
LYRIVFGVILLTIAYT
>ZP_03614478|FEATURES|ARDB_deepARG|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A0W0PSJ7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLNTGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEPLLATASQGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVTIELSDTGLSLHAKLRDAASNLLRDVLP
QLAQGKLTETVQDESQATYFGRRTAADGKLDWKQPAQTLFNLVRAVTQPYPGAFCAVGEH
KLIVWQADVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCDGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVAMSETIGNTLDFFLREAMLEIA
DKK
>A0A031H8Q2|FEATURES|UNIPROT_deepARG|aminoglycoside|BW38_01803|antibiotic inactivation|1
MEAGSSDGGVMPLPSQWRSALRDADIEMQGIGVSRADVARVRRQGLPDAFLKSEVIDAFS
ELEGEILRLRWLRAQGQPVPTVLDTAEEGGRRWLLMSALPGHDLASSPTLAPAQVVVLLA
DALRALHVLPVAGCPFDHRLASRLPEVAARVAAGLIDADDFDDERLGQSAEQVHAELIAT
CPADEDLVVAHGDACLPNLMAVDGRFSGFIDCGRLGVADRCQDLALAARSLVHNYDDTRW
VAPLLARYGMGADERRLAFYRLLDEFF
>A0A127SER9|FEATURES|UNIPROT_deepARG|beta_lactam|AER-1|antibiotic inactivation|1
EQTRLDRKEPELNEATPGDVRDTTTPNAIVSSLRKILLGDVLSDPSRSELTQWMLDDQVA
GALLRASLPSDWKIADKTGAGGYGSRSIVAVIWPPSKQPLVVGIYITQTKASMQASNQAI
ARIGAVLKDAVGP
>E2NQ82|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLYLKTILFGIVEGITEWLPISSTGHMILLNEFVKLDVSKDFYSMFQVVIQLGAILAVV
VIYWNQIWPFKKNTNPMVKGFFKYVDRDIFDLWLKIIFACIPAAVVGLLFDDVFEALFYN
PPCVALALIVFGVGFIVIENRNAKLRPKINSLRAINGKTAFLIGMFQLIAAIFPGTSRSG
ATILGGLMLGVSRTVAAEFTFFLAIPVMFGASLLKLVKFGLAFTASQLAVLGLGMLVAFV
SSILIIKFLMSYIKKHDFKVFGWYRIVLGLLVLAYFFIIK
>A6DDM3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIIDSIILGIVEGITEFLPISSTAHMIIVSTLLGLKQTMQNVAFEVIIQLGATLAIVFI
YLDKINFKEIDLWKKVILAFLPLAIVGFLFRHQIKEFFTITTVAWMFIIGGIIFFIVEKM
YKEENRINEVEKVSLKQAFIIGIFQVFALIPGTSRSGATIVGGMLSGLNRKTAADFSFLL
ALPTMFAASGYEMVKNLDTFKDSNLIVLAVGFIVSFISCYIAVKWFLNFVKKYTLIPFGI
YRIIFGIILLYLVNQGIINA
>CAH94334|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Ia|antibiotic inactivation|1
MNHCITQGRRGFADGLRGARRRSRGGRPIPCVRKFPMSSSDHIHVPDGLAESYSRSGGEE
GRAWIAGLPALVARCVDRWELKRDGGVRSGEASLVVPVLRADGTRAALKLQMPREETTAA
LIGLRAWGGDGMVRLLDHDEESSTMLLERLDGSRTLASVEDDDEAMGVLAGLLNRLHSVP
APPGLRGLGEIAGAMVEEVPSAVDSLADPEDRSRLRGWASAVAELVGEPGDRVLHWDLHY
ENVLAAEREPWLAIDPEPLVGDPGFDLWPALDTGWERIEATGDARRVVRRRFDLLTEALE
LDRGRAAGWTLARLLQNTLWDIEDGLTAIAPSQIAVAEALAKP
>D4KH41|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFTLEIIKAIVLGIVEGLTEWLPVSSTGHMILVDEFMSLNVSKAFMDMFLVVIQLGAILA
VVALNFDRLNPFSKRKTYLKKRQTISLWGKVIVGCIPAAVIGLAFNDYMEEHFMNAQVVA
FTLILYGVLFIIVENYNKHRTPSIKDIDYLDYKTALIIGFFQVLSLVPGTSRSGSTILGG
ILFGTSRVVATEYTFFLAIPVMFGASALKLFKFGFNYTFEEVILLLVGMVVAFIVSIISI
KFLLRYVRTNDFKAFGWYRIILGLIVFVYFYFQG
>Q8VLP3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPASISPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0A1DZU3|FEATURES|UNIPROT_deepARG|aminoglycoside|Aph3Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAAFLRRLHSIPVCNCPFNSDRAFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>E9LZM3|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVRQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>A0A0F5Y2Y5|FEATURES|UNIPROT_deepARG|beta_lactam|EP46_05115|antibiotic inactivation|1
MKKSLSYLVLWSLSASCVAADLSSQQVTSLVKAAIEPLMEQQEIPGMSVAILYKGRAQFI
NAGVADLASGRRVTENTLFELGSVSKTFTGVLAGVMIRNGDIALNDPVQKYWPQLTGTQW
HHIRMLHLATYTAGGLPLQLPVEVTDQASLLNYYQQWQPQAAPGTLRQYSNASIGLFGAL
MVKGDYQQAMEKNVFQPLRLTRTYITVPPSMMLDYAWGYKNGQPVRVSPGMLDAEAYGVK
STARDMLTFMQANADPNRLSSGNTVLRNAIRTAQSRYFKVRDFYQGLGWEIYDWPASAAA
IIADSESSVALKPQPATLLNPAVPSQRASWVHKTGATNGFGAYVAFIPEQNTGIVMLANK
NYPNPLRIKTAWKILETLQ
>A0A0K0TQH6|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-439|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVHQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYDTKIGWWVGWVELDDNVWFFAMNMDMPTS
DGLGLRQAITKEVLKQEKIIP
>ACI75321|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGISAWNMLIGI
LIACSIVSLLLIMFVAPGRPVTAHEEIHHHA
>J2TNQ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLGFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPGARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVASALV
VGGFIMLWAERRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPSDFPVFAVGFVTAFVFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLIILATWQFGWVDWSAVKP
>A0A0H0CSB5|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MEKIIPEYTAVNLSRWARKEHFEVFQGFAQSTFNQTVLVDITVLLSHIKNVGWKFYPTII
FLVAKIVNRHPEFRMAMKDNELVIWNEIHPNYTIFHNETETFSSLWSHYDGDIQHFQKTY
SEDMARYGDKLAYWPKEESRENIFFISGIPWVSFTSFSVSVANMKNFFAPMFTLGKYYEQ
EGRVLLPLAVQVHHSVCDGFHVARFFNELQEVCDALPQQTGQQE
>B8IMS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIAGIGKAVVLALVEGATEFIPVSSTGHQLLIGHFIGFQSPNNTFEVLIQLGAILAIVG
VYFGTLLDLLRRAPSDPKARRFILAVLIAFLPAAIIGGIFSKAIKLYLFNPWIVCSTLVA
GGLVLLVIDETELEQKYDDVHQFSLRMALKIGLFQCLAMIPGVSRSGATIVGAMLMGSGK
RAATEFSFYLAMPTMAGAFAKDLLDNYKNLSRDDFGLIAVGFVVAFLSALFVVRKLLNYV
SRHGFALFAWWRIIVGAAGFAGLIVFG
>A0A0J7AFQ9|FEATURES|UNIPROT_deepARG|chloramphenicol|TU52_21310|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYCNEENKVM
LPVSLQVHHSVCDGYHVSRFIEDLQKLSNSCNEWLK
>A0A126PQQ7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLVERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIRDGELVSNPPPREARTAAAKEALP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>G7DIU4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVV
LYFKKLWDVAIGMFTGDAYARRFVIGVLVAFLPAVIVGLVAGKYIKTLLFNPWVVCFSLI
VGGAILLWVDRLNLKPREHDATRFPLLMYLYIGIAQCIAMIPGVSRSGASIVAAMFLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKSRSEMTMDHMGVVAIGFVVSFITAIIVVKTFLSY
VTRHGFVLFAWWRVIVGTLGLIALALGH
>YP_001292390|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVETLKTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDSRFYDHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTSEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKSLNELTLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIGIAKG
GADILLASGEKMTLSTNAMRWTGRSNPVKVGEQIWIRQRANGEWQLGQIPAANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKPGQKMWQPKNSPDRYDGPMRLRVGLGQSKNMIAIRAIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIE
CNDIPVIYGETKDKINGFANIPLGESALKPTDDSTNGEELDQQPETVPELPELQSNFTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYM
KTALSDKPERKLPLPPKIVEKSIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYY
VPTELQQRLNNEGNTPATQPQELF
>A0A0F3IX28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLFWQAAFLGLVEGLTEFLPVSSTGHLILLGDLIGFQGPPGKVFEIVIQLGAILAIVV
LYWRKLFGVLLAAPNDKAAQRFILVILLAFLPAMVIGAGAHGFIKSVLFSPWVVSIALIL
GGIAILVIEGRGTEERYHDIAEMPPKTALTIGFIQCLAMIPGVSRSGATILGARLMGLDR
KTAAEFSFFLAVPTMAAATVYDLYKNWSQLSFEGGAVIGVGFAVAFLTALLVVRVAVGFI
ARHGFTPFAWYRIALGALMLGLLIAR
>E0XCT9|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
STSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSD
NTANNKIIKEIGGIKKVKQRLKELGDKVTNTVRYEIELNYYSPKSKKDTSTPAAFGKTLN
KLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKS
>B2UHL6|FEATURES|UNIPROT_deepARG|beta_lactam|Rpic_3962|antibiotic inactivation|1
MFSRWSKTFASALTACAVAMSTTTAHAELVVRNDLKRAFDDAGVSGTFVLMDIGADRTYV
VDPARAARRIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYQQWEHDMALPEAIR
LSAVPIYQEVARRVGLERMQAYVDAFEYGNRQLGSVIDQFWLRGPLEISAFEEARFTSRM
ALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWVGWVERAGHVYAFA
LNIDMPREGDMAKRVPLGKQLMQALAVWPAP
>A0A0J7DCB6|FEATURES|UNIPROT_deepARG|beta_lactam|TU62_14055|antibiotic inactivation|1
MFVLNKFCNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHGKEDAEYDDKLI
ADATKVVLNTLKATG
>A0A060KTU5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGRVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRALLILVTYFTQPQPRAESRRDVLASAAKIVTDGL
>A0A127SMP8|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MTVKLDISKLKKDGKKLYPTLLYGVTTILNRHEEFRTALDKNGQVGVFSEMLPCYTIFHK
ETETFSSIWTEFTADYTEFLQNYQKDIDAYGERKGMFAKPNPPENTFPVSMIPWTSFEGF
NLNLKKGYDYLLPIFTFGKYYEDGGKYHIPLSIQVHHAVCDGFHICRFVNELQELINS
>H0FBQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENSLYLFKAFILGILEGLTEFIPVSSTGHLILVGDWINFQSSDAKVFEVVIQLGSILA
VMWVFRARLLRLVRGTLTGVPSEVAFTRNLLLAFLPAAVIGAIFIKTIKSVFYHPAVVVV
TLVLGGLIMLYVERRTRHTPGDAPGAADDTASDERASAHTLEQITWKQALGVGVAQCFAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAAYDMYKNFGVLTQHDLSGIA
VGFVAAFLSAMVVVRAVLRFVANHTYRVFAWYRIIFGGVVAAWIFTR
>A0A060KZ75|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0A1I124|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSKKAVVFAYHDIGCVGIETLLNSGFDIVAVFTHADDPKENTFYGSVAQLCARKGIPVHA
PEDVNHPLWIERIGKLDPDYLFSFYYRHLLSEPLLAIAPKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVAIERSDTALSLHGKLRQAAIDLLRDTLP
SLLAGEVREREQDESRATVFGRRTAADGKLVWQRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVEGNEGQDPGRVISVDPLRIACGVDSLVITSGQRNENGLYLGGPQLANELG
LVDGSVLRGTESRRGPRRTRVLILGVNGFIGNHLSERLLRDDKYDVYGLDIGSDAIERLR
SHPHFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDNNFDEDTSNLIVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNENDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVQMSETIGNTLDFFLREAMLELA
DKR
>A0A0M9WZ90|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQSINHFLFSVSNLDASIAFYQNVLGAKLLVKGKSTAYLDLNGVWLALNVEVGIPRNE
IHQSYTHIAFSINEDDVDTMFDKLQRNNVNILEGRKRDVGDKSSIYFTDPDGHKFEFHTG
TLTDRLNYYKKEKTYMEFFD
>A0A0A2R9P0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALLELRNIYRRYPSGDSSVTVLDDVSLTISAGEMVAIIGQSGSGKSTLMNILGCLDTP
SDGHYFVAGKNTAELSGDELAALRREHFGFIFQRYHLLSHLSAEQNVEMPAIYAGLSARE
RRERAAALLQRLGLGERLIYRPGQLSGGQQQRVSIARALMNGGEVILADEPTGALDSQSG
KEVMAILRQLCDAGHTVIIVTHDPSIAAQAARIIEIKDGHILSDSGSVINPQAKALAAKP
PLKSSAFSRFLGRFNEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVTILVIGDAAKALV
LSDIKSIGTNTIFVYPGKDFGSDPGQDQQSLKPGDVDVIRQQPYVYAASAEIENGARLRR
GNLDSAARVTGIGPDFFTVYDMRFGEGRAFSPEMYERRSQVVIIDMNTKRKLFPHQNNVI
GEMLLVGNMPATVVGVIADRKSMFGNSKTLQVWMPYTTLTGRLMKRNYLDMISVRIRDGY
NTKNAEEQLVRLMTLRHGKKDTFTYNLDSIVKTVDKTTTTMQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARAGDVMQQFLIEAVLVCLMGGAIGLGLSYSIAFAAKM
ALPDWEFVFRPAAIVSAVLCSTAIGIIFGFLPARNAAKLDPIDALARE
>A0LM36|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MDLIELQDIRKTYRLGEIDVPVLRGISLKVSPGDFVALMGTSGSGKTTLMNILGCLDRPT
SGHYRFDGQDVVDLTPDQRAALRNRKIGFVFQNFNLLPRMSAVENVMMPLSYAGGGVSDQ
NGRERAGALLTRMGLGEHLDNEPSQLSGGQQQRVAIARALINNPSLLFADEPTGNLDSAT
SEEVLRVFQRLNEEEGVTIILVTHDPSVAQCARRIVRIRDGVIEPESGAVGDMPQVSKAA
PAQSKPVHSAMRRGDLDKFRRSLHTALSSLRRNVLRAALTTLGIIIGVAAVIAMMEIGRG
SSTAIQRTIASMGAHTLALLPGTAASGGVSFGGGSVMTMTPQDSEAIVNECPAVLAAAPI
VRARTQVVHGSRNWVPAGIYGTTPTFLEIREWPLAEGDVFTERDVRNASKVCVLGQRLVD
ELFQGENPIGLEVRIKNVAFKVIGVLSPKGANMMGMDQDDLLLAPWTAIKYRVTGSSLAN
VNQSAASTSSASITDQVNSLSNLYPTEKVVLYPEISTTQAFDTPLPVRFTNVDQILVGIR
STSGTRAAIRQIGEVLRERHRLRPGEPDDFSVRDMTEMTKTLASTATMMTKLLLAVALIS
LIVGGVGIMNIMMVSVTERTREIGLRMAVGARAKNILQQFLFEAVLLCFLGGAVGILVGR
GISHLVTVLLNWPTELSLDAILAAVGVSATVGIVFGYYPAWKASRLDPIVALRYE
>M5EJA2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MESQTIVQALLLGLLEGLTEFLPVSSTGHILLAGHFLGFRSTGKAFEILIQLGAILAILS
VYFRRLWKMLLELPYDRLTRHFALGILIAFLPAAVIGALAHDFIKTILFESPRLICIMLI
IGGVVLLLVDRMKLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLYKNRNVLSSADLPIIAVGFIAAFITALIVVRFLLEY
VSRHGYSLFGWWRLVVGGVGLVALMIWG
>A0A127I2G4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLLDFTGDRFNAFNIIIQLGAILAVV
WEFRGKIFEVVSGLPTQRKAQRFTVNLLIAFLPAVVLGVIFADLIHHYLFNPITVATALV
IGGVIMLWAERREHEVHAETVDDITWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKGLLRF
IASHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>A0A0A8H7H4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLDYYYALILGIIEGLTEFLPVSSTGHMILGAEILGLNIDDFWRSFFIIIQLGSILAVI
FIFKDKLTQKLDIWLKLAVGFLPAGGVGFIAYKFLKEIFNGYTVAIMLIIGGIVFIIIEL
KHRKKDYTIHSLDEVSCKQAFVIGLTQALAIIPGTSRSGASIIGGLLLGLDRKVASEFSF
LLAIPTMIIATAYSIYKEPQVLSNMSNFIPLAIGFVTAFVVAFVVIKIFLKLISKINFIP
FGIYRIILGFVFLYLFMSGMLDISRTGV
>A0A0U3GVG0|FEATURES|UNIPROT_deepARG|beta_lactam|AS202_10895|antibiotic inactivation|1
MRKIIILLNIIILVNFTANCQTKKLNTKEVVKTEFGNILDSLEVNGSILIYDVKNKIYYS
NDFSWAKTGVIPASTFKIPNSIIALETGIIKNDSAIFKWNGEKRRFKIWEEDLTFKKAFQ
VSCVPCYQEIARKVGVKRMKKYLRKLDYKGMVFDTLTIDNFWLEGNSKISQKQQIDFLRK
FYFSKFPISDRTIKIVKNIMEIERTENYILSGKTGLSSIEEKYNGWFVGYVETKSNVYFF
ATNVIPTDGLNVDDFISSRINVTKNALKQMNIMK
>A0A0E4CY84|FEATURES|UNIPROT_deepARG|bacitracin|uppP5|antibiotic target alteration|0
MELLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYAANTFKVVIQLGS
ILAVVVIFRNRFIDLLGLKRFSRKELTAVPEGQPAVETTGRLKLAQVIVGLIPAGVLGFL
FEDYIDEHLFSTSTVLIGLVVGAILMICADLLAPKKIKTESVDQITYRQALSVGLIQCLS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLLKNWQYFTLDDLPFF
IAGFISAFLFALLSMRFFLKLINRIKLMPFAIYRIILAAVVYFVWFYIS
>N9FIY1|FEATURES|UNIPROT_deepARG|beta_lactam|F933_01738|antibiotic inactivation|1
MIQLKYQTLFSKKTFMLIGLLSCSSSLWAQPLTDLQVKKIVDQQFKPLLERYKIPGLAVA
VTLNGKHYFVNYGVASQQSKQAVSNSTLFELGSVSKTFNATLAGYAQAQGQLSFSDHPAK
YFPELKNTAVNQATILNLGTYSAGGFPLQFPDEVVQQQQMIQYFQNWRAKTKVGAARQYS
NPSIGLMGYVTALAMKKPYAELVEKTLFPQLDMTQSFINVPTQQLPHYAWGYKNNQPMRV
TSGMFDAEAYGIKSSSSDMLKFLDAQINPSKLKQPLRKAIENTHVGYFKVAAMTQGLGWE
QYTYPVKLETLLQGNSSKMALESHTAIAVKQPRIASAATFFNKTGSTNGFGVYAAFIPQK
KIGIVMLANTNFPNEERIKASYGVMQQLIQVNSTQ
>A0A0A0QAX0|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-20|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDALARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEALQ
>Q3IDA4|FEATURES|UNIPROT_deepARG|bacitracin|uppP2|antibiotic target alteration|0
MDIFNAIILGIIEGITEFLPISSTGHIIVAAQWLGIEATATNQAFGVIIQLAAILAVLAN
YKDKFTPKHLNLWIKVAIAFIPLGIIAFIFSDVIKALFNVPVVGVMFIVGGVIFLLLERN
YKEQNCTTTDVTQVTYKQAIWIGIAQVFALIPGTSRAGSSIVGAMLCGLNRKASAEFSFL
LGLPVLAAASGYDLLKHYDLFTFDDLTALAVGFVTSFIVAYFTIKLFIRFLENFTFVSFG
IYRIVFGVILLTIAYV
>YP_416138|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MNKQILVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGT
LADKLGKKLIIYIGLILFSVSEFMFAIGQNFLILMLSRVIGGMSAGMVMPGVTGLIADIS
PSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDP
KKVSTNGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDI
SIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISF
VVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIY
MAIGVSLAGVIIVLIEKQHRSKLKEQNM
>A0A157S6I2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDSHIYLLKAFLLGILEGLTEFIPVSSTGHLILFGDWIEFDSGTGKVFEVVIQLGSILA
VMWIFRARLWQLIRGTLTGDRQEVLFTRNLLLAFLPAAVIGAIFIKHIKQVFYHPAVVAV
MLVVGGLIMLWVERRAPKTPGDLPGAADDTASEERATARRLEDISWKQALGVGVAQCLAM
VPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYRNASLLSSHDLSGIA
VGFVAAFLSALVVVRAVLRFVANHTYRGFAWYRIALGLVVGGWLMMRA
>BAC77725|FEATURES|ARDB_deepARG|tetracycline|tetX|antibiotic inactivation|1
MTLLKYKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEA
MKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQN
DTVIWDRKLVTLEPDKEKWILTFGDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTQ
VDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQTESII
NETEMFSLDFSFQKLMNL
>A0A147I935|FEATURES|UNIPROT_deepARG|aminoglycoside|NS319_00625|antibiotic inactivation|1
MIVTPAAPEHSQGWLALRAMLWSEEAGDPAEIAGRLAQGGGFVALENAQVIGFAEAAIRH
DYVNGCDTSPVLFLEGLCVDPAHRRQGVAGALVAAVADWGRAQGCTEFASDAELDNIDSH
AMHRALGFVETERVVYFRRML
>A0A0U4WRS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSALQALILGIVEGITEFLPVSSTGHQIVVADLIGFRGDTVIAFNIVIQLAAILAVV
WEYRFKVFEIVTDLPRKSYAQRFTGNLIVAFLPAAVLGVILGDLIHEYLFNPINVAFALV
IGGVIMIWAEKRKHRIRVEEVDDMRWHDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGATVYSVYKYRHMFVPSDAMIFAVGFVTSFIFAMLAVKALLKF
IGNHSYVVFGWYRIVFGLLILATWQFGWIDWHAAKAAG
>W0AGI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIITAILLGIVEGITEFLPVSSTGHLILATELLGFRAEDWAVFNIAIQPGAILAIVVL
YWRTFIAVLTGLLKGEKNSIAFVRNLLIAFIPAVALGLIFADQIDALLENAVVVAWSLII
GGVAILIIERLAKTHEVGGISAVTAGQSIKIGLVQCIAMIPGVSRSGATIMGAMAFGIDR
RTAAEFSFFLALPTLTGATALQLFKHRDAVTSDMMGLIGIGFVVSFIVAVVVVKAFMAVV
TRYGFAPFAWYRIIAGTAALIWLLAK
>A0A101LPQ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSALQALILGIVEGITEFLPISSTGHQIVVADLIGFGGERAIAFNIIIQLAAILAVV
WEYRFKVLEIVTDLPRKSYAQRFTGNLIIAFLPAAVLGVILGDLIHEYLFNPITVAFALV
IGGVIMIWAEKRTHRIRVEEVDDMRWHDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGATVYSVYKYRHLFTASDVLVFGVGFVTSFIFAMLAVKALLKF
IGNHSYEVFGWYRIVFGLLILATWQFGWIDWHAAKAAG
>A0A0U5HGA1|FEATURES|UNIPROT_deepARG|aminoglycoside|neo|antibiotic inactivation|1
MEAPNPFTDGMPLPWAWQEALADARIERQSIGVSRADVARVQRPGQADAFVKSEVIDAFS
ELGDEIARLRWLQEQGQPAPTVIATAEEAGRRWLLMSALPGRDLASSPELAPQQLVELLA
DALRGLHALPVAACPFDQRLVSRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELCSP
RPDHEDLVVSHGDACLPNLMVVEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGAVADERRLAFYRLLDEFF
>A0A0N8RUF2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVAMALV
IGGVIMLWAERREHTVRTETVDDMSWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>I3E727|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIKNEGDLVGVINGLNHLLFSVSDLEKSIQFYQDVFDAKLLVKGRSTAYFDLNGMWIALN
LEKDIARNEIHQSYTHIAFTIEEKDFDMMYEKLKKLNVNIFPGRPRDERDKKSIYFTDPD
GHKFEFHTGTLQDRMAYYKQEKTHMKFY
>ZP_02700344|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQACLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAAL
AAIAFFGLQRAMPETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIA
QSPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLI
IAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNLQTV
>E9XKY7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHSDNPCEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQMSPEVIFSFYYRHLIHDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPAAVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQSLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVELTDKPS
>F2J6U6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTNDTIVSAFILGIVEGLTEFIPVSSTGHILLLGHFLGFESTGKTFEVLIQLGAILAILT
VYFGRLWSIALALPSDARSRRFVAGIVVAFLPAAVIGVFAHGFIKTVLFESPELICSTLL
IGGVVLLYIDRLPLKPRYTNAMDYPLGLCLAIGLCQTVAMIPGVSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMAGAFAYDLYKNRDVLSADDAMIISIGFVTSFVAGVFVVKGLLDF
VSRHGFAPFAYWRIFVGVAGFVGLYFAG
>A0A0J0YUF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLFKALILGIVEGLTEFLPISSTGHLIVFGSLLDFHSNGKVFEIAIQLGAVLAVIF
EYRQRFTHVLTNIGRDNKVNRFVLNLIVAFIPAAVVGFLFSKQIKEVLFNPISVATMLVL
GGLVILWVEKRAVKQTAKVTSVDDMRVRDALVVGLAQILALVPGTSRSGSTIMGGMIWGL
ERKVATEFSFFLAVPVMIAATVYDVLKHYKLFSAQDIGLISVGFVAAFVSGLLAVKALLK
FLATKNYVPFAYYRIIFGGLILLTWAMGWVNWN
>U6EVW9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLILKAIILAIVEGLTEFVPVSSTGHLILVSDVINFKGDYANLFNVVIQLGAILAVVVV
YWDKLLNSVKDIFVPDRRGLRFWINIVVACIPAVIFGFSLDDYIDKYLFNPVTVAIGLVI
GGILMIIVENKYRRRSKTKNIYDMKLRQSIFVGMFQCLALWPGMSRSASTIMGGWIAGLS
PVVAAEFSFFLAIPVMVGASGLKLVKSGFYMTNIEFIALIVGFVGAFLVSLVVIEKFIKF
LQKKPMRIFAIYRIFIGVILLVLAIFRVVTI
>C9WXE8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKLVGK
>A4FRA8|FEATURES|UNIPROT_deepARG|beta_lactam|ampA|antibiotic inactivation|1
MLKNAFRHTALIAAATVPLLFGSASLWANTAPNADALQQKLADLEKSTGGRLGVALINTA
DNSQIVYRGDERFAMCSTSKVMAAAAVLKQSETDSRVLSKKRCDYKSRSDQLEPNCQEAL
GAGMTLAEMSAATLQYSDNTAMNKILTHLGGPEKVTAFARSIGDTTYRLDRTEPALNSAL
PGDPRDTTTPLAMAKSLRSLTLDNALGETQRAQLVEWMKGNTTGDASIRAGLPKNWIVGD
KTGSGDYGTTNDIAVIWPENRAPLILVTYFTQPQQNAKARRDVLASAAKIVTEGL
>D6MTD0|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampC)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIVLAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAY90134|FEATURES|ARDB_deepARG|beta_lactam|BL1_sm|antibiotic inactivation|1
MTKINRLATALFAALILPAGHAADKADIDAIIQPLMQKYAVPGMAIAVSVEGKQQFYHYG
VASRQTGKPITNQTLFEIGSLSKTFTATLATYAVSEGKMSFADPASRYLPALRGSAFDHV
TLLNLATHTSGLPLFVPDDVTNDAQLMAYYRQWQPPHAVGSYRVYSNLGIGMLGMITAKS
LNQPFTQAMEKQLLPALGMNHTYIKVPAEEMANYAQGYNKKDQPVRVTPGPLDAEAYGIK
SNAQDLIRYLDANMQVVKVGDPWRKALAATHTGYYRTGVFTQDLMWESYAYPEKLATLTE
GNNAGMIMNGAPATAITPPKQDQGAAWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFP
NDDRVAATYRIVQALDKR
>YP_001572361|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESLPKKIPHNKVPALVLVLLALAVMVFVIWRVDSAPSTSDAYASADTIDVVPEVSGRIV
ELAVVDNQQVKKGDLLFRIDPRPYEASLAKAEASLAALDKQIMLTQRSVDAQKYAASSVE
ATVAKARAAAKQASDTLRRTEPLLSEGFVSAEDVNRARTAQRAAEADLNAVLLQAQQAAS
AVSGVDALVAQRVAVQADIALTKLHLEMATVRAPFDGRVVSLKTSIGQFASAMKPIFTLI
DTDHWYIIANFRETELKAIQAGTPAAIRLMSDSSKTFQGKVDSIGFGVLPDDGGMVIGGL
PRVSRSINWVRVAQRFPVKIMVEKPDASLFRIGASAVATLEPQ
>J2XX51|FEATURES|UNIPROT_deepARG|beta_lactam|PMI37_00545|antibiotic inactivation|1
MSSIHPIKVISCSAFGLLFGAASCMAAAPGDAQLQALVNAAVTPIMQQQDIPGLTVALTV
KGQAHYFNYGVAAKDTGQKVSENTLFEIGSVSKTFTATLAGYAQATGKLDLSSKASQLWP
DLKGSAFDHISVLQLGTYSAGGLPLQFPESADSADKMLGYFQRWKPIYPAGSHRQYSNPS
LGLFGYLAAKSLGQPFDQAMMQTLLPKLGLQHTYLSVPAAQMSLYAQGYNKDGKPLRVTP
GALDSQAYGVKTSAVDMLRYVQANLRPETLEPLLQQTIANTHTGYYSVGDMTQGLGWEMY
RYPISLDRLLAGNSTEMAMEAHKVQWLNPPQPQPEDVLINKTGSTGGFGTYVAFVPSKDV
GIVIMANKNFPIPERVKMAHEILSAVAE
>I4KW71|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLGAGYDIAAVFTHADDPKENNFYGSVAQLCARHGIPVHA
PEDANHPLWVERIAKLNPEYIFSFYYRNLLSEPLLAIARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVSIDRTDTGLSLHAKLRDAATALLRDALP
QLALGKLTETAQDENQATYFGRRTAADGKLDWKKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQADVVKGNDGLAPGRVISVNPLRIACGEDSLVIKFGQRNENGLYLAGPALADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCDSQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPSVQMSETIGNTLDFFLHEAMLEIA
DKK
>D7GKY1|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDTLAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQCQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>ABK86352|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEKMKNTLLKLGVCVSLLGITPIVSTISSVQAERTVEHKVIKNETGTISISQLNKN
VWVHTELGYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKRVTDVII
THAHADRIGGIKTLKEKGIKAHSTALTAELAKKNGYEEPIGDLQAITKLKFGNMKIETFY
PGKGHTEDNIVVWLSQYNILAGGCLVKSASAKDLGNVADAYVNEWSTSIENVLTRYRNIN
AVVPGHGEVGDRGLLLHTLELLK
>A0A151YMH5|FEATURES|UNIPROT_deepARG|beta_lactam|AWW73_04470|antibiotic inactivation|1
MRFQKISCLLLSPLFIFSTSIYAGNTLKEQEIKKLVDQNFKPLLEKYNVPGMAVGIVQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTLSFEDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGKYRQYSNPSIG
LFGKVVALSMNQSFDQVLEKTIFPDLGLKHSYVNVPKLQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPADIQRTINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>NP_862291|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVRPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0P6RLD2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIIKVLPTQRNAQRFTLNLLIAFLPAVVLGVLFADAIHEYLFNPITVAVALV
VGGIIMLWAEQRSHVISVEHVDDMRWSHALKVGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPNDLPVFALGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWLFGWVNWTAAAAA
>W4AFJ7|FEATURES|UNIPROT_deepARG|chloramphenicol|C162_33553|antibiotic inactivation|1
MIFNLIDRDNWKRQEIFNHYLNQGTTFSLTAEIEISVLYRIIKQQEYKLYPALLFLMTRV
VNSNIAFRMGYNCTGELGYWDKVDPLYTIADSVSESFSAIWTAGTNDFKAFHVAYVSDVE
NYKDSGRLFPKTPIPEHTFSVSMIPWTSFTGFNLNISNNGNYLLPIITAGKFTTTGDSIY
LPLSLQVHHAVCDGYHAGWFMNEVQAMADRAEEWIDGGC
>A0A0N1KYZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEDQSIVSALILGVIEGLTEFIPVSSTAHVLLAGHFLGFESPGNTFAVLIQLGAILAILS
VYFTKLWQIAMSLPSSEKSRRFVGVVLLGFLPAAVIGALAHDFIKTVLFETPLLICIVLI
LGGFVLLWIDRKPLTPRYHDVTEYPLSLALKIGFFQCLAMVPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMVGAFALDLYKNRDALSVDDGLIIGIGFVAAFVSALFVVRSLLNF
VSKRGYAPFAYWRIAVGTVGLLALIVLG
>A0A0N0W4B4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIDKLAPDFIFSFYYRQLLGDPLLACAKKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDETRASCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGCCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>ZP_04049838|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MIIDFIKVLILSIVEGVTEFLPVSSTGHLILVNQFVKLEPEGFSNAFNIIIQLGAILSVV
VIYFKRLNPWDREKTERYFPRNYDKLNGQSRFYFRLTHPDKKTIELWKRVIVGILPAMVL
GLLFDDFIDEHLFNPMVVATMLLVWGLIIIFVEKRNKGNKGFRHDNIAMVSYKTVLAIGL
FQTLAMIPGTSRSAATIMGAMILGLSRSAAAEFSFFLAIPTMLGATFLKVIKNFGGFTAY
QWILILLGMVLSFLVAYFVIKKFMAYIRNNDFIPFGIYRIILAIIVFIYFLFV
>A0A070CSE5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>ZP_03612813|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MRKQLFTLYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGVLVAAFALSQMVISPFGGT
LADKLGKKLIICIGLVLFSISEFMFAAGQTFTILMISRVLGGFSAGMVMPGVTGMIADIS
KGADKAKNFGYMSAIINSGFILGPGFGGFLAEISHRLPFYFAGSLGAIAFTMSLVLIHNP
KKETTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTSEKANYSPKDI
SIAITGGGIFGAVFQVFFFDKFMKYMTELNFIASSLLYSAIVLVMLILANGYWTIMVISF
IVFIGFDMIRPALTNYFSNIAGDRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLY
MAIAVSLSGIVIIFIEKWLRTRRKQSQSS
>A0A0H5LSU0|FEATURES|UNIPROT_deepARG|polymyxin|pmrF_1|antibiotic target alteration|0
MLIGWLMHSQRLWGHTVSQNEAIKKVSIVIPVYNEQESLPALIARTSAACQQLTQPYEII
LVDDGSNDSSGDILTAAANEPDSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQ
NPPEEIPRLVTVAEEGYDVVGTVRSNRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLR
AYRRHIVEAMLHCHERSTFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDL
ITCLTTTPLRLLSLVGSVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQ
FVGMGLLGEYIGRIYNDVRARPRYFIQKVVGGEQTENNQEVEK
>A0A0J0UXR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTNKIQTAAVSRKAVAATLGALAVLAILQPATAAALTVQVASTTETAMTAWRAALLGII
EGVTEYLPISSTGHLLVASDLLGLGTTKADQGAADTYAIAIQFGAILAVAGLFWKRFRDM
ILGVFGKSAGGRHLLILLIVAFAPAAVLGFLLDDKIKEVLFSSWTIVFAWFVGGLLILGL
ERAGKIPHRGEPAEPGRDRLLEMTVRQAFIIGLVQCIALWPGTSRSLAAILGALLVGVSM
SAAVEFSFLLGFVTLSAASGYSVLKDGGELFTQFGLLDPLIGLVFAFLAAVISIKWLITY
LQQHSLAIFGWYRIVIAGITAGLLITGALNA
>A0A0F1MFR1|FEATURES|UNIPROT_deepARG|beta_lactam|SG66_20380|antibiotic inactivation|1
MRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFDPV
RSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTV
WVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNE
LPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTPNR
MDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>K0E098|FEATURES|UNIPROT_deepARG|beta_lactam|BUPH_00023|antibiotic inactivation|1
MKLKAMSLMASAVVALSVITPVSRAADDAANDATAAMKSLVDPAIEPLMERHHVPGMAVG
VIANGKTYLFDYGVASAETRQPVTQRTLFEIGSISKTFTATLAAYAQLNGQLNLTDDTQH
YLPSLRGSAFGKVSLLNLGTHTPGGLPLQVPDNIHDNAQLLQYFRAWKPAYAPGTYRTYA
NPGIGTLGLITAKSMGQDFASLIEQRMFPALGMTSSYIHVPAANISDYAQGYTKDGAPIR
MKGGVLADEAYGVRTTAADMVRFVQANMNLIGVDSQLQRAITATHTGYYKAGALTQDLIW
EQYPYPVTLSTLHEGNAPSMAVTPTPATAIEPPLPPQQNVWINKTGSTNGFGAYVAFIPG
KRVGVVLLANENFPIEDRVSAAYRIMSALVAGGQ
>A0A0J0UK45|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLLLKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQRIRATLVALPTERQARRFALNVLIGFLPAVLLGLLLGKAIKAHLFTPVVVASTFI
LGGFVILWAERRQQAAVRIHSVDDMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDYSFFLAIPTLIGAGVYSLYKERALLSAADIPLFAVGLVFSFISAWLCVRWLLR
YISLHSFVPFAWYRIAFGLVVLATAWSGLVTWAE
>A0A089LL00|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIIKAVILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
ILAVVIIFRNRFIDLLGLKKFSRKELTVVPEGQPQAPAEGRLKLAQVIVGLIPAGIFGFL
FEDYIDEHLFSTSTVLIGLVVGAVFMICADRFAPKTIKTESVDQITYRQALSVGLIQCVS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLLKNWQYFTLDALPFF
IAGFISAFLFALLSMRFFLKLINRIKLLPFAIYRIILAGVVYLVWF
>A0A074JHT9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MQTAQFIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLG
AILAVMVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNF
FVVAIMLVVYGIAFIWIEDRNRRVEPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGAT
ILGGIIVGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFIDGNTLTGGQVAILLVASVTAF
VVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLLYGAVKLIFG
>W1G2N9|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-115|antibiotic inactivation|1
MQEQAIPGMAVAIIYKGKPYYFTWGKADIANNHPVTQHTLFELGSVSKTFNGVLGGDAIA
RGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQ
PQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNY
AWGYREGKPVHVSPGQLDAEAYGVKSSVIDMAHWVQANMDASHVQEKTLQQGIELAQSRY
WRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGST
GGFGSYVAFVPEKTLAS
>A0A070D9Y6|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPASPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGLPVAAHEEIHHHA
>YP_002100653|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVSANAPDKAAAPLTEVDVATVVPQTVTDW
QTYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
AAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAPPLTTLVSVSPIYASFDADEQTYLQYINGARN
GRNVPVELGLANETGYSRSGVIDSVDNRLDTSSGTIRVRARFDNADGTLVPGLYARVKVG
GSAPHQALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQPGMQHGNRRVIVSGLAAGDRV
IVNGTQRVRPGEQVKPHMVPMTGGDDPAAPLASTAKPAAPAKADS
>V3D0Z0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPSQHEGMSKGRLSLIHILLGMIPAVVLGLVFHDAIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>AFO09969.1|FEATURES|megares|beta_lactam|OXA-184|antibiotic inactivation|1
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNIKIREELL
EKYIYSLN
>CAA31895.1|FEATURES|megares|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|1
MHTQKAITEALQKLGVQSGDLLMVHASLKSIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDNARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPNERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMPGRDGEVAWKTASDYDSNGILDCFAIEGKQDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPAHEAIERSCEPSG
>AAK44921.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MSLSFSDPRFDDVKAPVDECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTE
KGTFIINGTERVVVSQLVRSPGVYFDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTV
GVRIDRKRRQPVTVLLKALGWTSEQIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLR
PGEPPTKESAQTLLENLFFKEKRYDLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATI
EYLVRLHEGQTTMTVPGGVEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRE
RMTTQDVEAITPQTLINIRPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGG
LSRERAGLEVRDVHPSHYGRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDG
VVSDEIVYLTADEEDRHVVAQANSPIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVS
PRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVV
VAEESGVIEEVSADYITVMHDNGTRRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVI
ADGPCTDDGEMALGKNLLVAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDT
KLGAEEITRDIPNISDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLR
AIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDG
DKLAGRHGNKGVIGKILPVEDMPFLADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHS
GWKVDAAKGVPDWAARLPDELLEAQPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLV
DADGKAMLFDGRSGEPFPYPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQ
FGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFK
VLLKELQSLCLNVEVLSSDGAAIELREGEDEDLERAAANLGINLSRNESASVEDLA
>BAB47622.1|FEATURES|megares|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQKWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETES
RNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>WP_000918667.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG
NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT
DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV
YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL
RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG
EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT
TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT
HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG
FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT
VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG
MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG
TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL
VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT
LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL
GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG
RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL
DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>CAH17152.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MKKIPNMNEVTEKKPLTEFTEKAYLDYSMYVILDRALPSIADGLKPVQRRIVYAMSELGL
KATAKYKKSARTVGDVLGKFHPHGDSACYEAMVLMAQPFSYRYPFVDGQGNWGSPDDPKS
FAAMRYTEARLSHYADVLLGELLQGTVDWVDNFDGTLQEPALLPARLPNILLNGATGIAV
GMASDILPHNLTEVANACIHLLDNPQADIKTICEYIKGPDFPTEAEIISPSETIRAMYES
GNGSIKMRAIYTQEKQNIVITALPYQVSGARVMEQIALQMQQKKLPMVEDLRDESDHEHP
TRLVIIPRSNRVDIESLMSHLFATTDLERSYRVNFNMIGLDGKPRVKGLLAILTEWLEFR
LATVKRRLQFRLEKVLERIHILEGLLIAYLNIDEVIAIIREHEQPKQGLISRFNLTERQA
EAILEMKLRHLAKLEEIKLRGELDELSDERDTLQKTLASHFLLKELVKEEITKDRDEFGD
PRRSPIITREDSQALKEEDILPNEPITVVLSKNGWVRAAKGHDVDGKELSYKAGDEFKAQ
TLARTNQQVLFFDGEGKVYSLPGHVLPSARGQGEPLTGKLNPAEGVLFEAIVGGEPEQKV
LLATDSGYGFIAKIEDLYVKNRNGKACIKLSEKSHILPPRLIPNREQLFVACATNVGRLL
IFSLEELPELSRGKGNKLISIPAAKAVSREEYIVDIQVLTTNDSLTVHAGKRHFTLKGED
LTHYKGERGRRGNRLPRGLQNVSQLHVTQSE
>ABX45063.1|FEATURES|megares|beta_lactam|OXA-208|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNAHIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>WP_011764849.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTSKTYDESSFRVLKGLEPVRERPGMYTRTDSPAHIIQEVIDNAADEALGGFAKKIHVTL
HLDGSVTVADDGRGIPVGLHPEEGVPVVVLAYTRLHAGGKFDKREGNGAYAFSGGLHGVG
VAVTNALSTRVEVEVKRDGKIHRIDFSDGGENIGAVRIEGDCGRQTGTRVRVWPDPKYFE
APRVPMNELERLLRSKAVLLSGVSVRLDIEQAAGPALTKTWSYPEGLAGYLKELAGDVEP
VAPIFTAEKYAGKDDASFAPGEGAAWALAWFESAVPSESYVNLIPTVNGGTHESGLRAGV
FEAVKSFIEHHTLLPRGVKLQQEDVCGRMSFLLSARLLDPQFQGQVKEKLNSREAVKLVS
TQLRDPFEIWLNNHVEAGKAIAELSIKQALARQKNAQKVEKKKTSGVAVLPGKLSDCESE
DIAENELFLVEGDSAGGSAKMARNKETQAILPLRGKVQNAWEIDPDRLLANAEIHDIAVA
LGVDAHRADSSPDLSGLRYGKIVIMSDADVDGSHIQTLLLTLFFRHFPKLIENGHIYVAQ
PPLYRVDVPAQGKKRPARRLYALDDGELAAIRDRLAQEGFKPDAIEIGRFKGLGEMNPDQ
LRETTMDPATRRVLPVQVRAEAIEQTLKMFTLLMGKGEASGRRAWMEEKGDTVEADV
>CAG39069.1|FEATURES|megares|aminoglycoside|aac3|antibiotic inactivation|0
MRTLNKDEHNYIKQIANIHETLLSQAESNYKCTKLSIALRYEMICSRLEHTNDKIYIYEN
EGQLIAFIWGHFSNEKSMVNIELLYVEPQFRKLGIATQLKIALEKWAKTMNAKRISSTIH
KSNLPMISLNKDLGYQVSHVKMYKDID
>AAW66496.1|FEATURES|megares|tetracycline|tet39|antibiotic efflux|1
MPILPELLRSLAGAEAGGVHYGALLAVYALMQFIFAPILGALSDRFGRRPVLIISIAGAT
ADYLLMAAAPSLLWLYIGRIFAGITGANMAVATAYVSDITPAHERAKRFGLLGAVFGIGF
IAGPVIGGVLGEWNLHAPFFAAAFMNGINLIMTAVLLKESKHSNKMTEKVQEQSILKKLS
YLITQPNMAPLLGIFLIITLVSQVPATLWVIYGQDRYGWSIFIAGVSLASYGICHSIAQA
FAIAPMVKRFGEKNTLLCGIACDAIGLLLLSIAVEEWVPFALLPLFALGGVAVPALQAMM
SRGISDERQGELQGLLSSFNSLGAIIGPVLVTSLYFMTQASAPGMVWALAAILYVITLPL
LLKYRLNKYSGVP
>YP_003610753.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGSARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALE
GDAEWEAKIIELAGYLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
EEVEIVGIKETAKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGSIK
PHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMV
VTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>AAY43209.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib10|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTCSDA
>AKF41840.1|FEATURES|megares|beta_lactam|OXA-23|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAVALNMEMRSEMPASIRNELLMKSLKQLNII
>ABX45065.1|FEATURES|megares|beta_lactam|OXA-130|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNTDIGTQVDNFWLMGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAQ16273.1|FEATURES|megares|glycopeptide|vanWG|antibiotic target alteration|1
MKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIE
PKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVER
HGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSS
VNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCKIAYKLPDDVK
IEERGV
>WP_007611767.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MARKQQFDYNEDAIQVLEGLEAVRKRPGMYIGSTDARGLHHLVYEIVDNSVDEVLAGYGD
HIIVTIHKDNSISVQDRGRGMPTGMHKLGKPTPEVIFTVLHAGGKFGQGGYKTSGGLHGV
GASVVNALSEWLTVTIERDGYVYKQRFENGGKPVTSLEKIGTTKKTGTLTHFKPDPSMFS
ATVYNFDTLSERLRESAFLLKGLKIELIDERNGVKEVFYYENGIEAFVAYLNEEKDALCE
VVSFEGEHHDIEVDFAFQFNDGYSENMLSFVNNVRTKDGGTHESGAKTAMTRAFNEYARK
VALLKEKDKNLEGADIREGLSAIISVRIPEELLQFEGQTKGKLGTSEARSAADAVISENL
AYFLEENRDTATLLVKKAIKASQAREAARKAREEARSGKKRKKSEATLSGKLTPAGSRNP
AKNELYLVEGDSAGGSAKQGRDRKFQAVLPLRGKVINTEKAKLADIFKNEEINTIIHAIG
GGVGADFEIDDINYDKIIIMTDADTDGAHIQVLLLTFFYRYMKPLIEHGKVFIALPPLYK
VSKGSGKKEIIEYAWSDEEMDGVLKKVGKGYTIQRYKGLGEMNADQLWETTMNPESRTLV
RVKIDDAARVERRVTTLMGDKVEPRRKWIEKNVAFGLDEESNILENENLSVAEEV
>YP_003614297.1|FEATURES|megares|multidrug|acrR|antibiotic efflux|0
MARKTKQQALETRQHILDVAIRLFSQQGVSSTSLAQIAQAAGVTRGAIYWHFKDKSDLFS
EIWELSESSISDLESEYRAKFPDDPLSVLREILVYILEATVVEERRRLMMEIIFHKCEFV
GEMAVVQQAQRSLSLESYDRIEQNLNQCMQAKLLPANLLTRRAAILMRSYISGLMENWLF
APQSFDLKAEARSYVAILLEMLQLCPTLRSDAPSLTA
>CAP70016.1|FEATURES|megares|aminoglycoside|ant6|antibiotic inactivation|1
MRTENEILSLVSEFAYQQSNIKIITLEGSRTNKNIKKDKFQDYDFTFFVSDVDYFTSEES
WLSLFGELLFIQKPEDMELFPPDLDYGYSYIMYFKDGIKMDITLINLKDLNRYFNDSDGL
VKILVDKDNLVTKEIVPDDSNYWLKKPTEREFHDCCNEFWSVSTYVAKGVFRREILFALD
HFNNILRP
>YP_003615180.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGSARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALE
GEAEWEEKIIELAGYLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
EEVEIVGIKETAKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGYNQ
ATHQVRI
>AAF40441.1|FEATURES|megares|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MDSQINTQTSPAAAKLPREVVVVLSILVVSAMIMILNETILSVALPSIMEDFSVPETTAQ
WLTTGFMLTMAVVIPTTGYLLDRFSTKTIFVTALLFFTVGTLTAALAPTFAVLLGARIVQ
AVGTALVMPLLMTVTLTVVPAERRGSMMGIISIVISVAPALGPTLSGVILNSLTWHWLFW
MMLPIVVIALVIGFFLIKNIGETKITPLDVLSVILSVFAFGGLVYGFSSFGAILEGEGTV
GIFAIVVGAIALLIFALRQHQLGKQDKALMDLRAFKVRNFSFSLTTILLAFGAMLGTVMV
LPIYLQTSLGVTALVTGLVVMPGGLLQGLISPFIGRFYDKVGPRPLLIPGAIALAIAASS
MTFLNENSPVWMVVVMHVVFSIGMCLMMTPLMTTALGALPKHLYGHGSAILNTFQQLAGA
AGTAIMIAALSFGTSIAASSGSAHAEAVAAGTKVAFIAGAIIAVIALVVSLFVTRVEEEA
H
>CAD11598.1|FEATURES|megares|tetracycline|tetA|antibiotic efflux|1
MPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAA
VDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGM
VAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHIGERRPLRREALNPLASFR
WARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQA
MITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAML
SRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPA
LRRGLWSGAGQRADR
>ABX45062.1|FEATURES|megares|beta_lactam|OXA-106|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>NP_252955.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MAKEKFERNKPHVNVGTIGHVDHGKTTLTAALTKVCSDTWGGSARAFDQIDNAPEEKARG
ITINTSHVEYDSAVRHYAHVDCPGHADYVKNMITGAAQMDGAILVCSAADGPMPQTREHI
LLSRQVGVPYIVVFLNKADMVDDAELLELVEMEVRDLLNTYDFPGDDTPIIIGSALMALE
GKDDNGIGVSAVQKLVETLDSYIPEPVRAIDQPFLMPIEDVFSISGRGTVVTGRVERGII
KVQEEVEIVGIKATTKTTCTGVEMFRKLLDEGRAGENVGILLRGTKREDVERGQVLAKPG
TIKPHTKFECEVYVLSKEEGGRHTPFFKGYRPQFYFRTTDVTGNCELPEGVEMVMPGDNI
KMVVTLIAPIAMEDGLRFAIREGGRTVGAGVVAKIIE
>WP_000202252.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MTSLAHHATENRSVAEFTEQAYLNYAMYVIMDRALPHISDGLKPVQRRIVYAMSELGLKS
SGKPKKSARTVGDVLGKYHPHGDLACYEAMVLMAQPFSYRYPLIEGQGNWGSPDDPKSFA
AMRYTEAKLSAYSELLLSELGQGTSEWQDNFDGSLKEPITLPARVPNILLNGTTGIAVGM
ATDIPPHNLREVVKGTIALIRNPQTSDEKLAEYIPAPDLPTKAEIITPPEELLKIQTTGR
GSYRMRAVYTIEKNEIVITELPYQVSGSKVITQIADQMQAKKLPLVVDVRDESDHENPTR
LVIVLRSNRIDAEAVMSHLFATTDLESSYRVNLNMIGEDGRPQVKSIRRILLEWIEIRKK
TVTRRLQYHLNRIEKRLHILAGLLIAYLDIDTVIRIIREEDQPKPVLMEHFNIDEIQAEA
ILELKLRHLAKLEEMEIRHEQDELSAKAAIIREQLENPESLKNLIIGELKEDAKKFGDER
RSPIVARAEAVQIKEQDLMPAETVTVVLSEAGWVRAAKGADVDAENLNYRAGDQYLSHAV
GKTNQRVYFLDETGRSYALPISNLPSARGLGDPLSSKLSPASGVSFIQVYLDDDESELIA
ASSAGYGFKTQTKQLDTNAKAGKTFLTVPDKAKALPLISAQNMTHLAVLSSAGRLLILDL
AELPNLNKGKGNKLIQLEGKEQILSMTTLNLDEIIQVVAGQQHLKLKGDDLQKYMGKRAS
KGQLLPRGYQKANKLLIQR
>CBX07047.1|FEATURES|megares|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>EEM84592.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MEEIKMNTLKVKQLANKEGLNILEDSIEINESGVDFQVAHVKEQNGDKWILRIPRRRESM
RHALREKEALEIMKKHAEFQVPDWSIFSEELIAYKQLSGVPAATIDIEQQGYISTFNEKD
VPTEYYISLGKVLANLHSLPQQKFNSIGVEILTANELRTSMKQRMNRVKEQYHINQNLWD
RWQAWLAEDSFWPSHVGVKHGDIHPGHILIDNKNKVTGLIDWTEVGIGDVSIDFTSHYLL
F
>WP_015891553.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MLSNQIINQSFAEIMGKRFGDYANLVILSRAIPDARDGLKPVQRRILYAMYQEGNTNDKP
YRKSAKTVGYVMGTYHPHGDSAIYETMVRMAQWWKMRQVLIQGHGNFGSLDADPPAAMRY
TESRLSALANELLRDIEKDTVTFIPNYDNSAQQPAVLPSRFPNLLVNGAAGIAVGFATDI
PTHNLGEVIDAAVAQMKNPNISLDELMQHVKGPDFPTGGIVQGLSGIRKAFETGRGQFII
RGKTHVEEPKGGKIKKIVVSEIPYEVVKSKLVGQIDELVMERKIEGALAVRDETGRKEAE
QKKVRIVVDIRKEADEQAILNYLYKNTDLQIYYNYNMNVIHEGTIRQMGLKALLGAYIDH
QKEVVTNRCQYDLDRKQSREHIVEGLIRAKSILRQIVDTIMDSEDRADAKKNIMEKYGFT
DNQADAILSIQLASLTRLDIVKLEKELATLAKEIEELKSILASEKKLIQVITGELNEIKK
KYAEERLTEIQGEIEEIKIDIAMQINAEDCIVTLTNEGYIKRTSPRSFKSVGGTLETCGV
KEGDRVRYFMETNTSHTALFFTQDGKYFATLVNAFPDDKWKDIGSALVNIIPLEKNQRIV
GFTIVENFKQPLYVYHVSKNGLMKKTALSEYETNRSSALVAAKLKGGDDEFMNVFVADEA
GAILGATKDGMGIRFQRSEVSATGRASSGVKAIALAPGDDVITMLPIEEVDSRAFSLLTA
EGVVKRTAIGAIPLQARAGKGVQLIRKRKNNPHELVAMFLEETVYAWTSQNEWTLVETEQ
VIVNEQGGIGRQLIEGGVKAVAFETILPTDEPKDEATAKGSGDGSGTAGQQKTSNVQANL
FDGDHRK
>AAY52017.1|FEATURES|megares|glycopeptide|vanXA|antibiotic target alteration|1
MEKGFVFLDEILHGVRWDAKYATWDNFTGKPVDGYEVNRIVGTHALALALLKAQKQAAAL
GYGLLLWDGYRPKRAVDCFLRWSEQPEDNLTKERYYPNIERTEMVSKGYVASKSSHSRGS
AIDLTLYRLDTGELVPMGSGFDFMDERSHHAAKGIASMEAQNRRRLRSIMENSGFEPYSF
EWWHYVLRNETIPQ
>AAS18387.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSGGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIERIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFS
LGAAPETSLSVLARFDELRLRLDLPVLLSVSRKSFLRAPTGRGPGDVGAATLAAGLAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>ACO86898.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MIIELNKNSFPEEFNKIEVHEGSVNIFMNKNSITPLKIFNVLAPAANIIKQEILALGGDC
AVNKYCINCKVETSDIILLGTKRQYKKLLQKLKCMTFFRIEEIVGELENYINNHKKIKTV
LRDGREINYENLKVMGIINCTPDSFYEGSRKNSIEEALKTAEKMLKEGAEILDIGGESTR
PGSDPVDEEEEIKRVVPVIREIKNKFKDVIISIDTYRANTAKAAIEAGADIVNDISAMKY
DENMVKVVKEYNIPVILMHVKGKPKDMQIDPVYENLMKEIHLYFNERIEYCKSHGITEDK
IILDPGIGFGKTVEHNLKIMNRLEELKSFNLPVLLAASRKATIGKVLGNLSTEERLEGTI
ALSCLAVNSGLQMVRVHDVKENVRAIRMLEAVRKI
>AAO47227.1|FEATURES|megares|aminocoumarin|gyrB|antibiotic target alteration|0
MYIGSTGERGLHHLVQELVDNSVDEALAGVADRIDVTVLADGGVRVVDNGRGIPVGMHPV
EKRPAVEVVLTVLHAGGKFGGGGYTVSGGLHGVGLSVVNALSARLSAEIWTDGHRWTQDY
RDGAPTAPLVRREATSRTGTSLTFWADGSIFETTDYSFETLARRFQEMAFLNRGLTLTLT
DERASARATAATDEVHPDPAAKTVSYRYDGGITDFVAYLNSRKGEPVHPSVVTIAADDTE
RLLSAEIALQWNGQYTDSVYSYANAIHTHEGGTHEEGFRTALTTVVNRYARDKKLLREKD
ANLAGEDIREGLTAIISVKLREPQFEGQTKTKLGNTEVRTFVQKVVHEHLTDWFDRNPNE
AADIVRKAVQAATARVAARKARDLTRRKGLLETASLPGKLSDCQSNDPAMSEIFIVEGDS
AGGSAKSGRNPQYQAILPIRGKILNVEKARIDRILQNQEIQALISAFGTGMHEDFDIAKL
RYHKVILMADADVDGQHINTLLLTVLFRFMRPLIEEGHVYLSRPPLYKIKWSRDHVEYAY
SDRERDTLLELGRRDGRRVRDDSIQRFKGLGEMNAEELRVTTMDPDHRVLGRVALDDAAV
ADDLFSVLMGEDVEARRHFIQRNAKDVRFLDI
>AEE65537.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MPYSYTEKKRIRKSFAKREDVQNVPFLLATQLQSYLTFLQADTATSDRVNEGLQAAFSSI
FPIVSHNGMARLEFVSYALGEPVFDVKECQQRGLTYASPLRAKVRLVLLDREVSKPTIKE
VKEQEVYMGEIPLMTGTGSFVINGTERVIVSQLHRSPGVFFEHDRGKTHSSGKLLFSARV
IPYRGSWLDFEFDPKDVLFFRVDRRRKMPVTILLKAIGMTPESILAHFFDFDNFELKSEG
GMMEFVAERWKGEMARFDIADRDGKVIVEKDKRINAKHLRDLAAGGIQRVSVPEDFLYGR
VLAKNIVDPDTGEVVAHANDEITESVLNAMRAANVRDIQTLYTNDLDRGPYISQTLRADE
TADQMAARVAIYRMMRPGEPPTEEAVEALFQRLFYSEETYDLSRVGRMKVNSRLGRGDDS
TGPMTLTNEDILETIKVLVELRNGRGQIDDIDHLGNRRVRCVGELAENQFRAGLVRVERA
VKERLGQAETENLMPHDLINSKPISAAIKEFFGSSQLSQFMDQTNPLSEITHKRRVSALG
PGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSMALYARLNEYGFLETPYRKI
IDGKVSDQIDYLSAIEESHYVIAQANAALDDEGRFVDDLVACREAGETMLTAPGNVHYMD
VAPSQIVSVAASLIPFLEHDDANRALMGANMQRQAVPCLRPEKPLVGTGVERTVAVDSGT
TVQALRGGVVDHVDADRVVIRVNDEENVAGEVGVDIYNLIKYTRSNQNTNINQRPIVARG
DKVAKGDVLADGASTDLGELALGQNMLIAFMPWNGYNFEDSILISERVVADDRYTSIHIE
ELTVVARDTKLGPEEITRDISNLAETQLNRLDDSGIVYIGAEVSADDVLVGKVTPKGETQ
LTPEEKLLRAIFGEKASDVKDTSLRVPSGMTGTVIDVQVFTREGIVRDKRAQSIIDDELR
RYRQDLNDQLRIVENDQFDRIEKMLVGKTVNGGPRKLAKGATLTKAYLADLDRWQWFDIR
LADEQHAVVLEQAKESLEQKRHQFDLAFEEKRKKLTQGDELPPGVLKMIKVYLAVKRRLQ
PGDKMAGRHGNKGVVSRITPVEDMPHMADGTPADIVLNPLGVPSRMNVGQVLEVHLGWAA
KGVGYRIADMLRDERTAQAKSVRGYLEKVYNTTGSSAHIDSLTDEEVLELANNLKKGVPF
ATPVFDGATEEEIGKMLELAYPDDVAARMRLTASRSQAWLYDGRTGEQFERPVTIGYMHY
LKLHHLVDDKMHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGASYTLQEMLT
VKSDDITGRTKVYENIVKGDHVIDAGMPESFNVLVKEIRSLALDMDLERN
>ABQ56814|FEATURES|megares|multidrug|pmrA|antibiotic efflux|0
MKKLMEYGGKIKEYLLRLKPKRWLTLTNVIIFIGFLTAIIYVFSYLIPFTDNAFVVNNVR
PVAALTSGYITELYVKNGDAVRKGQKLFTVFKKPYEYTVEQLSADLAGAQAKLAVLKATY
ERDLKLSENEQKIYKKLAQDDQKYLKGYAIKSVSLITLQNSQQETKAAKDKWQASLKQLE
IDQHQITVQENEIKSIQARLKNAKVNLDLTDVYAQGNGVIQNLFFTIGTPVNINQPLFSL
VDQDNIYIQANFNETDLRDVRKGSKVLIFPRMYLGRKIFHGVIDSDYWSANRQLVDDRTQ
LQNVINENQWILLPQRLPVIIKVTDPDPKYPLRVGASAYVYVEVY
>AAF24088.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vatA|antibiotic inactivation|1
MNGANHRMDGSTYPFHLFRMGWEKYMPSLKDLPLKGDIEIGNDVWIGRDVTIMPGVKIGD
GAIIAAEAVVTKNVAPYSIVGGNPLKFIRKRFSDGVIEEWLALQWWNLDMKIINENLPFI
INGDIEMLKRKRKLLDDT
>AGS60939.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQSSYNAKDIEVLNGLEPVRRRPGMYTDTTRPNHLAQEVIDNSVDEALAGHATKVEVIL
YADQSIEVIDNGRGMPVDIHPELKVSAIELILAHLHAGGKFSNKNYQYSGGLHGVGISVV
NALSKRIEVTVRREGKIYQIAFENGDKVEELHQIGTCAKRDTGTSVHFWPDSTYFDIPRF
SSKSLSHVLKAKAVLCPGVNVSFTDKVNNTQETWCYADGLTDYLSEAVAEFVRLPEEPFT
GKFEGDNEAVEWSMLWLPEGGDLLTESYVNLIPTVQGGTHVNGLRQGVLDAMREFCEFHN
LLPRGIKLTADDTWERCAYVLSVKMQDPQFAGQTKERLSSRQTSAFVASAVKNAFSLWLN
QNVQVGELLAEMAISSAQRRMRAAKKVVRKKLTSGPALPGKLADCTSQDLRYTELFLVEG
DSAGGSAKQARDREYQAIMPLRGKILNTWEVSSDEVLASQEVHDISVAIGMDPDSDDLSQ
LRYGKICILADADSDGLHIATLLCALFVRHFPALVKQGHVYMAMPPLYRIDLGKEVSYAL
DEAEKNAILQRLSRKKGKPNVQRFKGLGEMNPLQLRETTLDPNTRRLVQLVIDDENYQET
LGMMDMLLAKKRSEDRRNWLQEKGDEVDIEV
>WP_012683946.1|FEATURES|megares|sulfonamide|folp|antibiotic target replacement|1
MPAKLRARRELNCGQYVLPLGERTLVMGILNVTPDSFSDGGRYVNVEAALAQARAMVEAG
ADLIDIGGESTRPGSEAVDEATELDRVLPVIRMLSQELSVPLSIDTYKAAVAERAILEGA
HIINDVWGAKRDPRMAEVAARLDVPIILMHNREDTDYHDFFPNYIKDLRESVQIALQAGV
KQERIILDPGIGFVRTVEQNLETMRRLDDLVGLGYPVLLATSRKRMIGHVLDLPVDERVE
GTAATVALGAAKGCHMVRVHDVKEMKRVTKMMDAMLKGGI
>AAY52005.1|FEATURES|megares|glycopeptide|VanSA|antibiotic target alteration|0
MAAVVFVLFLRLFIKGTLGEWIVRFLENSYHLERQDAMKIYQYTIRNNIEIFIYVAIAIS
ILILCRVMLSKFAKYFDEINTGIDILIQNEDKQIELSAEMEFMEQKLNTLKRTLEKREQD
AKLAEQRKNDVVMYLAHDIKTPLTSVIGYLSLLDEAPDMPVEQKAKYVHITLDKAYRLEQ
LIDEFFEITRYNLQTITLTKKHIDLYYMLVQMTDEFYPQLAANGKQAVIHASEDLTVSGD
PDKLARVFNNILKNAAAYSEDNSVIDITAGLSGDVVSIVFKNAGSIPKDKLAAIFEKFYR
LDDARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFTVELPALPDLVDKRSS
>WP_000195976.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MYTDTSRPNHLAQEVIDNAVDEALAGHADKICVTVYKDGSLSVEDNGRGMPVDIHPEYGQ
SGIEIILTKLHAGGKFSTDNYQFSGGLHGVGISVVNALSTRVEVEVQRQGNLYQMAFEQG
EPVAPLAVLEGKAPKRATGTTVRFWPEAKYFDSPKFALKALKHNLKAKAVLAAGLKITYI
DQINDEKIEWQFENGLVDYLMDELQDREILPNPAFVSSGQADRAACEFAICWNVEGGEQV
QESYVNLIPTAQGGTHVNGLRSGVTEALREFCELRNLLPRNLKLSAEDVWDGVNYILSLK
FQEPQFSGQTKERLSSREAANIVLNIAKDAFALWLNQHAEIAMQLAEMAISKAGRRLKAA
KKVERKKIVSGPALPGKLADCVGQTREESELFIVEGDSAGGSAKQARDKNFQAIMPIRGK
ILNTWEVSSDEVLASSQEVHDIAIAIGVDPGSDDLSELRYGKICILADADSDGLHIATLL
CALFVKHFPALVEEGHLYVAMPPLFRIDIGKDVHYALDDEELETILKNVKGNKNPQITRF
KGLGEMNAIQLRETTMDPNTRRLVQLDLDDAHLTAGLLDKLLAKKRAADRKQWLEQKGNL
ADITV
>ABB63227.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKF
KKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRY
TESRLSKYSELLLSELGQGTADWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDI
PPHNLREVAQAAIALIDQPKTTLDQLLDIVQGPDYPTEAEIITSRAEIRKIYENGRGSVR
MRAVWKKEDGAVVISALPHQVSGARVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIV
PRSNRVDMDQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRR
RLNYRLEKVLKRLHILEGLLVAFLNIDELIEIIRNEDEPKPALMSRFGLTETQAEAILEL
KLRHLAKLEEMKIRCEQSELEKERDQLQGILASERKMNNLLKKELQADAQAYGDDRRSPL
QEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSN
QPVVFVDSTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVDHILMESDDQKLLMASDA
GYGFVCTFNDLVARNRAGKALITLPENAHVMPPVVIEDASDMLLAITQAGRMLMFPVSDL
PQLSKGKGNKIINIPSAEAARGEDGLAQLYVLPSQSTLTIHVGKRKIKLRPEELQKVTGE
RGRRGTLMRGLQRIDRVEIDSPRRASSGDSEE
>ACH43053.1|FEATURES|megares|aminoglycoside|AAC(6')-IIa|antibiotic inactivation|1
MPSTAPEVTQRLMVKRDLVMLHEWLNRPHIVEWWGGEEARPTLQEVQSHYLPRVLAEEAV
TPYIAMLGSEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQSLANPEQLGKGLGTRLVCT
LVKTLFNDPSVTKIQTDPAPNNVRAIRCYEKAGFRQQKVITTPDGPAVYMVQTRASFEAA
RGAA
>AGS60314.1|FEATURES|megares|multidrug|gyrA|antibiotic target alteration|0
MSDIAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMNVLGNDWN
KPYKKSARVVGDVIGKYHPHGDSAVYETIVRLAQPFSMRYMLVDGQGNFGSVDGDSAAAM
RYTEVRMAKIAHELLADLEKETVDFVPNYDGTENIPAVMPTRIPNLLVNGSSGIAVGMAT
NIPPHNLGEVIDGCLAYVDNEDITIEELMEYITGPDFPTAAIINGRRGILDAYRTGRGKI
YIRAQADIETDEKTGRETIIVTEIPYQVNKARLIEKIAELVKDKRIEGISGLRDESDKDG
MRIVVEIKRDAVGEVVLNHLFSQTQMQVSFGINMVALHQGQPKLLNLKEIIAAFIRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPVIELIRQAPTPAEAKAALIAQPWDLGSV
STMLERAGDSNVARPEWLEPQFGVHDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYR
ELLLQIAELLHILRSPERLMDVIREELTAIKTQYNDPRRTEITENTADINIEDLINEENV
VVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRL
YWMKVYQLPEASRGARGRPIINLLPLEQDERITAILPVREYEEGKFVFMATASGTVKKTP
LQDFSRPRSAGIIAVNLNDGDELIGVDLTDGSNEAMLFSADGKVVRFAEECVRPMGRTAT
GVRGMKLVDDDKVVSLIIPRGEGDILTVTENGYGKRTVQSEYPTKNRATQGVISIKVSER
NGKVVGAIQVEETDQIMMITNAGTLVRTRVSEVSIVGRNTQGVTLIRTTEDELVVGLQRV
EDEDDALDDDEVDEMISDNISDVPESEPTDDADSEEE
>AAN40996.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGGPYLNNIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>ABQ56921.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAVAEAKPQYSHAEKKRFRKSFGKQTDIMPIPNLLEIQLKSYRDFLQTDTKLSEQLNTGL
HAAFSSVFPIESFSGNARLEYVGYKLGEPAFDVRECKLRGLTYSAPLRVKIRLVVLDKDA
SDDPKPIKDIREQDVFMGEIPLMTDVGTFVVNGTERVVVSQLHRSPGVIFEHDKGKTHSS
GKLLYSARIIPYRGSWLDFEFDPKDCVYVRIDRRRKLPVTILLRALGYEAEDILSEFFET
TRCHLKNGEYHIDLIPQRLRGEIASFDIHVPETGELIVEQGRRITARHIKQMEKSQMQDL
VVPRDYLIGKTLAKNIIDTSTGEFLAQANDEITEELLDAMANHGILQIDMIYTNDLDHGS
YISDTLKIDPTGSQLEALVEIYRMMRPGEPPTKEAAEALFKNLFFVEERYDLSAVGRMKF
NRRVGIKSDEGPGTLTKEDILSVIKTLIDIRNGIGMVDDIDHLGNRRVRSVGEMTENQFR
VGLVRVERAVKERLSLVESENLMPQDLINAKPVSAAIKEFFGSSQLSQFMDQVNPLSGVT
HKRRVSALGPGGLTRERAGFEVRDVHTTHYGRVCPIETPEGPNIGLINSLSVYARTNEYG
FIETPCRKVVNGRVTDEVEYLSAIEEVDQYIAQSNVELDAQGNILADLVPCRHQNEFSLT
TPDKINYMDVSPKQIVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRSEKPLVGTGME
RIVASDSGVSVVAKRGGVIDLVDASRIVVRVNDDETTAGETGVDIYNLTKYFRSNQDTCI
NQRPIVSTGDRIQRGDVLADGPCTDMGELALGQNLLVAFMPWNGYNFEDSILISERIVHD
DRFTTIHIEELTCIARDTKLGTEEITADIPNVGESALSNLDESGVVYIGAEVKAGDILVG
KVTPKGETQLTPEEKLLRAIFGEKASDVKDSSLRVPSGMNGTVIDVQVFTRDGLEKDARA
KSIEEEHLARVRKDLIDERRIREEDIYHRVSHLLLDKVATGGPGSLKPGSKITQDYLDKV
EREKWFDIRIEDDAVSQQLEQLSKQLELLTKEMEKRFNDSRKKIIQGDDLAPGVLKIVKV
YLAVKRRIQPGDKMAGRHGNKGVISIVVPVEDMPHMEDGTAVDIVLNPLGVPSRMNIGQV
LETHLGLAAKGLGRKIAQMLDERQTPEAIKAYLEKIYNHDGVQRVNLKCLNDDELMTLAD
NLRAGVPMATPVFDGATEQEIKSMLQLADLPADGKTVLIDGRTGNKFDNPVTVGYMYMLK
LNHLVDDKMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVK
SDDVGGRTKIYKNIVDGDHRMDPGMPESFNVLLKEIRALGIDIELEHD
>WP_000918675.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MFRDISPIEDFTGNLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVK
EQEVFMGDFPLMTDTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRG
AWLEYETDAKDVVYVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTE
NTEQALLEIYERLRPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFN
QKLAEPIVNTETGEIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSI
KVYVPNDDEGRTTTVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRR
LRSVGELLQNQFRIGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLS
QFMYQSNPLSDLTHKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLI
NSLSSYARVNEFGFIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFM
DDEVVCRFRGNNTVMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAV
PLMNPEAPFVGTGMEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELD
RYPLAKFKRSNSGTCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDG
YNYEDAVIMSERLVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRG
IVYIGAEVKDGDILVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVL
DVKVFNREEGDDTLSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYL
PDGRPIDIMLNPLGVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEA
GMARDGKTVLYDGRTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGK
AQFGGQRFGEMEVWALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPES
FRVLMKELQSLGLDVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>CAI47809.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib'|antibiotic inactivation|1
MTEHDLPMLHDWLNRPHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA
>AAK91786.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAVYPNLILIELDFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>CDO20205.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MFERGLENVTREDIANLAGVSLRTFTNYFNGKYDALAYRQVERMRRSIETLRNRPVGEPL
WTSVIEAVLEPLDEDFEDMYGAENVLPTRQQLAEVRKLLMVPEIRDATFRAMFDEWVAVI
AERTGTDPAHDMYPRLVVAVVRAVGDVAMDQYANADPPVSFTELLRQGFAAVTAGLPEPE
RKK
>AAR12142.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib'|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA
>BAP18874.1|FEATURES|megares|beta_lactam|CTX|antibiotic inactivation|0
LKDQITYLPDNADRSVAKQKFKITNWPTYNKALINRGSITFWLDDEAIQAWYESATPSSR
GRPQRYSDLAITTVLVIKRVFRLTLRAAQGFIDSIFSLMNVPLRCPDYSCVSRRAKSVNI
SFKTPTRGEIAHLVIDSTGLKVFGEGEWKVKKHGQERRRIWRKLHLAVDSKTHEIICADL
SLNNVTDSEAFPGLIRQTHRKIRSAAADGAYDTRLCHDELRRKKISALIPPRKGAGYWPG
EYADRNRAVANQRMTGSNARWKWTTDYNRRSIAETAMYRVKQLFGGSLTLRDYDGQVAEA
MALVRALNKMTKAGX
>ADZ05750.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGADVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>ABC68329.1|FEATURES|megares|aminoglycoside|APH(3'')-Ic|antibiotic inactivation|1
IAAVGCVLSWIAAATTIEVAPVLEGEPATTAISYSSPLLVLALALAGLAGVLAVLGIARL
RRSVTEWLPVTRGESGAGVFRNSDGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAV
IDWRVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLD
DMLARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRREEAADWVVCHGDLCL
PNILVDPDRHTVEGFIDLGRLGLADRHADLA
>WP_000196697.1|FEATURES|megares|beta_lactam|BLAZ|antibiotic inactivation|1
LKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALNTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>ABX79412.1|FEATURES|megares|glycopeptide|VanSC|antibiotic target alteration|0
MLLLILIPLTVRFVAGLRVWYGYEPIYQILRLFADYWLVCLAIGALLIWASTTIYYMSKA
ISYLNETIQATNQLIAEPTKRIILSSNLNDVQEEMNQLREKNLQDQRAAKEAEQRKNDLI
VYLAHDLRTPLTSVIGYLTLLEEEPQLSTELRARYTKIALQKAQRLELLISEFFEITRFN
LTTIALQTETTDLSLMLEQLTFEFLPLLEEKNLHWQLQLQKKVFATVDTEKMERVFDNLI
RNAINYSYTDSPLHLAISASDDILIRLTNHGKTIPAEKIGLIFEPFYRMDASRATATGGT
GLGLPIAREIVEALGGKIWAESRDETIVFSIRLPKAAMEKNEQRSKPHPSEPTA
>ABX79410.1|FEATURES|megares|glycopeptide|vanTC|antibiotic target alteration|0
MKKNQGIDQFRVILAMMVVAIHCLPLHRLWPDGDILITLTLFRIAVPFFFMISGYYVFSD
LATQNSYPARQRVWHFIKKQLQVYLIATLLFLPLAWYSGMLGLNMPLGTFIQTLLVNGIL
YHLWYFPAIITGSLLVMGLLTRLSFKQVFFIAVGLYVVGLGGDSWSGLAAQTPLASLYSL
IFQLLAGTRNGIFFAPLFLLLGVLARRFAQKPASPHRYSYLMISLICLLLESYLLHHFTT
PKHDSMYVFLPFVLLFLFPIIQQWQAPMIWKQAGRLSLWLYLLHPYTIAVTHFLSQKLPL
LQNNLINYIVVLGLTIGLIYGLFALQKLFSFPKKTPPHLQRATKEFSAPALLHNLQEIKR
VIPSTTKVMAVVKADAYGCDAKTVAGTLERAGVDFFAVATIEEAIELRRAGIKSRLLILG
YTSAQRAKELNRYSLIQTVVSEAHGQALARTGLPIECHLAVDTGMHRLGVAPDLETVRKL
FALPSLKITGIFSHLGSSDQLDTASILRTQAQITCFDDLLAGLSARNIAYGLTHLQSSYG
ILNYPEKHYDYVRPGILLTGSLSVPNEPTKQKINVQPILTLKALLVDKKTVAAGEAIGYG
LGTVFDRPATIGIVSIGYCDGVPRALSNQGFQLSYQGVLLPQIGLVCMDMLLIDLTDYPE
LAVESSLEVISDWTTAADQAQTITNELISRLGSRITSSAK
>CAA55770.1|FEATURES|megares|macrolide-lincosamide-streptogramin|lmrB|antibiotic target alteration|1
MRRILVAPAWVSAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPS
VDGGILVIERRPEPLVRERREYQDFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHG
VSPQALPKDLTAEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG
>ABP87779.2|FEATURES|megares|beta_lactam|OXA-72|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMDVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGIIX
>AAA25634.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKSNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPRVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_000167936.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MTKTKIMGILNVTPDSFSDGGKFNNVESAVTRVKAMMDEGADIIDVGGVSTRPGHEMITV
EEELNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDIINDQWAGLYDHRMFQVVAK
YDAEIVLMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKEMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNFS
>AAG12998.1|FEATURES|megares|macrolide-lincosamide-streptogramin|msrD|antibiotic target protection|1
MELILKAKDISVEFKGHDVLDINELEVYDYDRIGLVGANGAGKSTLFKVLLGELIPPGCK
MNHLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHG
ILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGN
YSDYLRQKEEERKRQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEGGG
RLAHQKSIGSKEKKMHNAAKSLENRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGA
EINKVFGDKALFENASFQIPLGAKVALTGGNGTGKTTLIQMILNHEEGISISPKAKIGYF
AQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLA
KMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRD
KKIKLKH
>AEM66522.1|FEATURES|megares|chloramphenicol|catB3|antibiotic inactivation|1
MKNFFESPFKGKIIKDHITNPNIISGKYSYYSGYYHGHSFDDCARYLFPDRNDVDKLIIG
SYCSIGSGASFIMAGNQGHKYDWISSFPFFYMSEFDVFSKSQDGFQKAGDTVVGNDVWIG
SEAMIMPGVQIGDGAVIGSRALVTKDVEPYSIVGGNPAKLIKKRFSDDDIQKLQEMKWWE
WDEETLFEAMPILCSNKIDLLYKFFRKMK
>CAD11595.1|FEATURES|megares|trimethoprim|dfrA1|antibiotic target replacement|1
MVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGD
VYFSEIPSNFRPVFTQDFASNINYSYQIWQKG
>ABO21417.1|FEATURES|megares|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFMFICLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETGAKFYA
DKADADVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKITLGNTILTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDLWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>ABM67077.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA
>WP_011245006.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MTGQLIQYGRHRQRRSYARINEVLELPNLIEIQTASYQWFLDEGLREMFQDISPIQDFTG
NLVLEFIDYSLGEPKYPVDESKERDVTFAAPLRVKVRLINKETGEVKEQEVFMGDFPLMT
ETGTFIINGAERVIVSQLVRSPSVYYSQKLDKNGKKGFTATVIPNRGAWLELETDAKDIV
YVRIDRTRKIPVTVLLRALGFGSDQEIVDLLGENEYLRNTLEKDNTDSTDKALLEIYERL
RPGEPPTVENAKSLLESRFFDPKRYDLANVGRYKINKKLHIKNRLFNQRLAEKLVDPETG
EVLAEEGTLLDRRTLDKLIPHLEKNVGFRTARTSGGVLEESDVEIQSVKIYVADDYEGER
VISVISNGMVERDVKHIAPADIIASISYFFNLLHGVGDTDDIDHLGNRRLRSVGELLQNQ
FRIGLSRMERVVRERMSIQDPNVITPQALINIRPVIASIKEFFGSSQLSQFMDQTNPLAE
LTHKRRLSALGPGGLTRERAGMEVRDVHYSHYGRMCPIETPEGPNIGLINTLSSYAKVNE
FGFMETPYRRVDPETGKVTSRIDYLTADEEDNYVVAQANAKLNDDGSFVDDNIIARFRGE
NTVVPCDRVDYMDVSPKQVVSAATSCIPFLENDDSNRALMGANMQRQAVPLLVPEAPLVG
TGMEHVSAKDSGAAVVSKYAGIVERVTAKEIWVRRIEEVDGKETKGDLDKYKLQKFVRSN
QGTSYNQRPIVREGDRIEKREILADGPSMEMGEMALGRNVLVAFMTWDGYNYEDAIILSE
RLVKDDVYTSIHIEEYESDARDTKLGPEEITRDIPNVGEDALRNLDERGIIRIGAEVKDG
DILVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRAPHGGDGIVLDVKIFNREDGD
ELPPGVNQLVRVYIVQKRKINQGDKMAGRHGNKGVISRILPEEDMPFLPDGTPVDIMLNP
LGVPSRMNIGQVLELHLGMAARKLGIHVASPVFDGASEEDVWGTLEEAGMARDGKTILYD
GRTGEPFDNRVSVGIMYMIKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEME
VWALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGENVPEPGVPESFKVLIKELQSLG
MDVKMLSSNEEEIEMRELDDEEDQTSEKLNLNLETNESQL
>WP_001289546.1|FEATURES|resfam|quinolone|parC|antibiotic target alteration|0
MSEIIQDLSLEDVLGDRFGRYSKYIIQERALPDVRDGLKPVQRRILYAMYSSGNTHDKNF
RKSAKTVGDVIGQYHPHGDFSVYEAMVRLSQDWKLRHVLIEMHGNNGSIDNDPPAAMRYT
EAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGSTGISAGYATDIP
PHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKKAYESGKGRIIVR
SKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEVRDETDRTGLRIA
IELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIIDSYLNHQIEVVAN
RTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIEVFEFTEEQAEAI
VMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEELNEIKKKFKSERL
SLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVEDIGLKDGDSLLKH
QEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDEVVINVFNEKDFN
TDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRFEKDQLITVITNK
GMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMATQRGSLKRISFKI
LQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHGLINDIHKSEQYT
NGSFIVDTDDFGEVIDMYIS
>CAJ65910.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQARSARGHPLATFMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGF
FLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAA
AGGADFIRTHEPRPLRDGLAVLAALKETARIR
>AVH49725.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MSKKDIAPQRLTREIVLRTALDMLNEEGIDSITTRKLAQRLGIKSPTLYWHFKNKSLLME
AMAETIINEHHLVSLPIDGMTWQDWLLANSVSFRRALLAYRDGARLHARTSPSQGHFNTI
EAQVALLSHAGFSPVEAVALLMTLGRFIVGWVLEEQQEEIRSDPPFEADPTIYPLMLQGV
NTLQNMNADDIFENGIRMVIIGAERQLDIKMQT
>YP_002344422.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MENIFSKDSDIELVDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAMQNDEA
KSRTDFVKSARIVGAVIGRYHPHGDTAVYDALVRMAQDFSMRYPSITGQGNFGSIDGDSA
AAMRYTEAKMSKLSHELLKDIDKDTVDFVPNYDGSESEPDVLPSRVPNLLLNGSSGIAVG
MATNIPPHSLNELIDGLLYLLDNKDASLEEIMQFIKGPDFPTGGIIYGKKGIIEAYRTGR
GRVKVRAKTHIEKKTNKDVIVIDELPYQTNKARLIEQIAELVKERQIEGISEVRDESNKE
GIRVVIELKREAMSEIVLNNLFKSTTMESTFGVIMLAIHNKEPKIFSLLELLNLFLTHRK
TVIIRRTIFELQKARARAHILEGLKIALDNIDEVIALIKNSSDNNTARDSLVAKFGLSEL
QANAILDMKLGRLTGLEREKIENELAELMKEIARLEEILKSETLLENLIRDELKEIRSKF
DVPRITQIEDDYDDIDIEDLIPNENMVVTITHRGYIKRVPSKQYEKQKRGGKGKLAVTTY
DDDFIESFFTANTHDTLMFVTDRGQLYWLKVYKIPEGSRTAKGKAVVNLINLQAEEKIMA
IIPTTDFDESKSLCFFTKNGIVKRTNLSEYQNIRSVGVRAINLDENDELVTAIIVQRDED
EIFATGGEENLENQEIENLDDENLENEESVSTQGKMLFAVTKKGMCIKFPLAKVREIGRV
SRGVTAIKFKEKNDELVGAVVIENDEQEILSISAKGIGKRTNAGEYRLQSRGGKGVICMK
LTEKTKDLISVVIVDETMDLMALTSSGKMIRVDMQSIRKAGRNTSGVIVVNVENDEVVSI
AKCPKEENDEDELSDENFGLDLQ
>WP_001176042.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MQLISLPKQILQCGQLQLDLSQPHVMGILNVTPDSFSDGGKHNQLDQAVDHALSMIEQGA
TIIDIGGESTRPGASEVVVEEEVRRVVPVVEALSYHNVILSIDTSQPEVIRAAKAAGAHI
WNDVRALTRPNALKTAVELDIPVVIMHMRGEPTTMNQLDQYTDVTLDVMQELQQRIDEAL
AAGVKKHNIIVDPGFGFAKNAQQNLKLLKEFWKLNELGYPILSGLSRKRFIGEALQGVPA
DQRAVGSVTGHLLSIQQGASIVRAHDVKEMHEAILVWKAMQQA
>AAM21660.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYHPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>WP_001047619.1|FEATURES|megares|multidrug|mexT|antibiotic efflux|0
MNLERVDLNLLIYLDVLLREKNVTRAAEQLGVTQPAMSNILRRLRNLFNDPLLIRSSEGM
TPTERALELQPRIRDALSDLSMILEPRTEFRPYTSNRVFRIMTSDYAEATLVPRLVKALR
SEAPNVVLDFLTPSDVSYRDMEQGKVDLAINRFNEIPQSFHQVLVWRDSFSCILNDKHPA
VTHLNLKSYLDAQHIWVSKTGMGVGFGVNPDKQGGLGWIDQALERIGQRRKISVFTRHYQ
MPALLAQNVDLIATLPTRMARLQAQNPKLVIKDPPFYIPEFELKMAWCPLLHHHPAHRWL
RQLILFVARQMIEEENREFLTNNSQFSHY
>AAF85648.1|FEATURES|megares|beta_lactam|mecA|antibiotic target replacement|1
IDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKL
GVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINA
PHLLKDTKNKVWKKNIISKENINLLTDGMPQVVNKTHKEDIYRSYANLIGKSGTAELKMK
QGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDI
DE
>CCQ20405.1|FEATURES|megares|multidrug|MepA|antibiotic efflux|0
MKHSDNYYLTKASIPKAIAHLSIPMMLGMSVGVIYNIVNAFFIGLLHDTSMLTAVTLGLP
MFTILMAIGNMFGVGGGTYISRLLGKEEGTKAKQVSAFVLYGSLVAF
>AJG06173.1|FEATURES|megares|beta_lactam|blc|antibiotic inactivation|0
MRILPVIAAVTAAFLVVACSSPTPPPSVTVVSNFDAQRFLGTWYEIARMDHQFERGLEKV
TASYSARDDGGIQVINR
>AAM09852.1|FEATURES|megares|glycopeptide|vanYD|antibiotic target alteration|0
MRYCIKKNGTDRIAPASTAKMITALTVLEYCSPEEEMRVGAEIEMIHSDSSTAWLMKGDT
LTVRQLLIALMLPSGNDAAYTLAVNTGKVIAGDNSLSNQQAIQIFMDKVNEKARAIGVTD
SNFVVPDGYDAEGQYTTAYDLAIIAKACLEDPIISEIVASNTSYEKWPNGREVTYNNSNE
LLDPNSPYYRPEVIGLKTGTSSLGGACVVSAAVIDGETYICVVMGSTKESRFQDSVAILD
KIKAQ
>AEY90465.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MADENTPVTPEEGGELVMRVEPVGLETEMQRSYLDYAMSVIVSRALPDVRDGLKPVHRRV
LYAMYDGGYRPERGFYKCARVVGDVMGNYHPHGDSSIYDALVRLAQPWSMRMPLVDSNGN
FGSPGNDPAAAMRYTECKMAPLSMEMVRDIDEETVDFTDNYDGRSQEPTVLPARFPNLLI
NGSAGIAVGMATNIPPHNLREVAAGAQWYLENPEVSHEELLDALMERIKGPDFPTGALVV
GRKGIEEAYRTGRGSITMRAVVEVEEIQGRQCLVVTELPYQVNPDNLAQKIADLVKDGKI
GGIADVRDETSSRTGQRLVIVLKRDAVAKVVLNNLYKHTDLQTNFGANMLALVDGVPRTL
SLDAFIRHWVTHQIEVIVRRTRFRLRKAEERAHILRGLLKALDAIDEVIALIRRSETVEI
ARSGLMGLLEIDEIQANAILEMQLRRLAALERQKIVQEHDELQAKINEYNEILASPVRQR
GIVSEELAAIVEKYGDDRQTKLIPYEGDMSIEDLIAEEDIVVTVTRGGYVKRTKTDDYRA
QKRGGKGVRGTKLKEDDIVDHFFVSTTHHWLLFFTNKGRVYRAKAYELPEAGRDARGQHV
ANLLAFQPDEAIAEILAIRDYEAAPYLVLATKSGLVKKTPLKDYDSPRSGGVIAINLRER
EDGSDDELIGAELVSADDDLLLISKKAQSIRFTASDESLRPMGRATSGVKGMSFREGDEL
LSMNVVRPGTFVFTATDGGYAKRTAVDEYRVQGRGGLGIKAAKIVEDRGSLVGALIVEEN
DEILAITLSGGVIRTRVSEVRETGRDTMGVQLINLGKRDAVVGIARNAEAGREAEEVDGD
VAVDETAEGAAITGTDEGEAPSAE
>ABB63219.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQTYNADAIEVLTGLEPVRRRPGMYTDTTRPNHLGQEVIDNSVDEALAGHAKRVDVILH
ADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVVN
ALSKRVEVNVRRDGQIYNIAFENGEKVQDLQVVGTCGKRNTGTSVHFWPDETFFDSPRFS
VSRLTHVLKAKAVLCPGVEITFKDEINNTEQRWCYQDGLNDYLAEAVNGLPTLPEKPFIG
NFAGDTEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRNI
LPRGVKLSAEDIWDRCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFILWLNQ
NVQAAELLAEMAISSAQRRMRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEGD
SAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQL
RYGKICILADADSDGLHIATLLCALFVKHFRALVKHGHVYVALPPLYRIDLGKEVYYALT
EEEKEGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLTIDDEDDQRTD
AMMDMLLAKKRSEDRRNWLQEKGDMAEIEV
>ABG12898.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMNVLGNDWN
KPYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSVDGDSAAAM
RYTEIRMSKIAHELLADLEKDTVDFVPNYDGTEQIPAVMPTRIPNLLVNGSSGIAVGMAT
NIPPHNLSEVIDGCLAYIEDENISIEGLMEYIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEADAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEIKRDAVGEVVLNNLYSLTQLQVTFGINMVALSQGQPKLLNLKDILVAFVRHRRE
VVTRRTIFELRKARDRAHILEALAIALANIDPIIELIRRASTPAEAKAGLIASPWELGNV
ASMLERAGDDAARPEWLEAEFGIRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLTLIGELIFILENPDRLMEVIREELVAIKEQYNDLRRTEITANTSDINIEDLINQEDVV
VTLSHQGYVKYQPLSDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLY
WMKVYQLPEASRGARGRPIVNLLPLEPNERITAILPVREYEEGCHVFMATASGTVKKTAL
TEFSRPRSAGIIAVNLNEGDELIGVDLTDGSNEVMLFSALGKVVRFPEGQVRSMGRTATG
VRGINLNGDDRVISLIIPRGDGEILTVTENGYGKRTAVAEYPTKSRATQGVISIKVSERN
GKVVGAVQVAPTDQIMMITDAGTLVRTRVSEVSVVGRNTQGVTLIRTAEDEHVVGLQRVA
EPEEDDDILDGESSEGEEGSEENAALNAPSDDVADEDTDAEDDTDVEDDNA
>CAW30930.1|FEATURES|megares|rifampin|arr-3|antibiotic inactivation|1
MSSDWTPISHENCQQVRGPFYHGTKAHLSIGDLITTGHLSHFEDGRALKHVYFSALMEPA
IWGAELAMSLSRLDGRGYIYIVEPTGPFEDDPNLTNKRFPGNPTKSYRTCDPLRIVGSVE
DWQGHPADVLQQMLESLEDLERRGLAIIED
>WP_000167924.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MTKTKIMGILNVTPDSFSDGGKFNNVESAINRVKAMIDEGADIIDVGGVSTRPGHEMVSL
EEEMNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDMINDQWAGLYDHRMFQIVAK
YDAEIILMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKEMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNLS
>ALC76810.1|FEATURES|megares|beta_lactam|VEB-1a|antibiotic inactivation|1
MQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILN
YTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPT
AMNKLLINTYNNKNQLLSKKSYDFFWKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINN
GIAAATNDVGVITLPNGQLIFISVFVAES
>ACO84027.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MAKKIVIPKDNNIISFPLEEAMPENYLPYAVEVSKERALPDVRDGLKPVQRRIVYGSYML
KAFPDKPYYKSARIVGDILGKYHPHGDSSVYDAMVILAQDFTTRMPLIDGHGNWGSQDGD
SAAAMRYTEARLTPIAMEMIRDIDKDVVNMVDNYSNSEKEPEVLPAKYPNILVNGAFGIA
VGLATNIPPHNLVEVIDGTLAYIDKNEITTKELLNYIKGPDLPTGGVIIGKKSMLSAYET
GEGRVTLRAKTTIEKLENGRLSIVITEFPFRKNKAKLLQFISEMTADKKHSKALENITDI
RDESDRNGIRAVIEFKKIATEDIVEKTLKYLYKKTDLQSNISFNMVALADGKPKTLGLKS
MLKYYVEHQKEVITRRTKRELEIAEKRFHIVEGFIKAIGIMDEIIKTIRESKSKKNAREN
LIEKFSFTDIQAEAILELMLYKLTGLEVVAFEKEYKELEKLINKLTKILKSEKELLKVIK
KELIEVKETYNDKRRTAIIEDDEKAKIDVEEIIVEEDVVLTLSNEGFTKRIALKSYNRSS
ANVEDIEYREGDFNRFLIQCNTKDTLCLVTKEGNMYQIKVINIPEFKWKEKGVKLDEIIK
TIDLSETIIEAFSIEDFTAQKDMLFITDSGYIKKTTLDKFNTNYTKIMALKLKKGESLVK
SDLVDRTREEKFFNIKTQKGLSFNIEEPSLEPVDRNIIGYKLFDILPNDSIKKVDFCDNY
EYKSFYVNISKEGLITISDLKDNKSHISLFTDSSKTLVLFDDEGKAYYIPAFMLQSIKEE
GVNISAFTGDKISLLNAISTFRFEEDISIYFSSEKGLIKRTLLGELKIEGNSTQVYKFKH
KDDKLVSILIKEHEEQKNILIITEKAMVIRFKSEAVNPMGKMASGVTGISLKDLDKVILA
LIIDENDTRKIKIKTKAKDKGTIEINKIKVQNRAGIGNSLMPLLLNDFVEVVEFKK
>ABX79409.1|FEATURES|megares|glycopeptide|VanXYC|antibiotic target alteration|1
MNPYLQLVSKEFPLEKKQEPPHLVLAAFSEEEVYLQPEAAKQWERLVKALKLENEICLLD
GYRTEKQQRYLWEYSLKENGLAYTKQFVALPGCSDHQLGLAIDVGLKGSQNDLICPRFRD
SAAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIMANQQWTLEEYHQ
YLEQTTRQFA
>ABR78057.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDYAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTERIPDVMPTKIPNLLVNGASGIAVGMAT
NIPPHNLTEVINGCLAYVDDEDISIEGLMAHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEVDAKSGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALVAQAWDLGNV
AAMLERAGDDAARPEWLEPEFGVRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLEQIAELLHILGSADRLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVV
VTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLY
WMKVYQLPEASRGARGRPIVNLLPLEADERITAILPVREYEEGVNVFMATASGTVKKTAL
TEFSRPRSAGIIAVNLNEGDELIGVDLTSGQDEVMLFSAAGKVVRFKEDAVRAMGRTATG
VRGIKLAENDSVVSLIIPRGEGAILTVTQNGYGKRTAAAEYPTKSRATQGVISIKVTERN
GSVVGAVQVDDCDQIMMITDAGTLVRTRVSEVSIVGRNTQGVILIRTAEDENVVGLQRVA
EPVDDEELDAIDGSAAEGDDDIAPEADTDDDIAEDEE
>ABY60427.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDTRPADSTRAAATMPHCNKVR
>ACH58979.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MPKVLSDEDVGEFRQRLLKTAEAAFATHGVDGVSMRQLAQQLGCSATTPYRYFKNKDEIL
AAVTAAALNRFSATLEKAFAAKGSSAEKAVAVRKAYIRFAFKNPKAYRLMFDAPHPSLLD
YADLSEASSRADRIMAAPLALLAQEGIVKGDSRLLGRVFWSAIHGAVSLQLAGKLAAKPT
FEAVLEQTLQLIMAGAMATRHSA
>ABR77935.1|FEATURES|megares|multidrug|asmA|antibiotic inactivation|0
MILLAVIVAGLTSLVLLVNPNDFRAYMVHEVAERSGYQLDLDGPLRWHVWPQLSILSGRM
TLTARGAEEPVIRADNMRLDVALLPLLSHQLQVKQVMLKGAVIQLTPKTEAVRDSSAPVV
PHDNTLPLAPEDRGWSYDVRQLQVADSVLFFQHENGEQVTVRDIRLQMEQDENHRATVDF
SGRVNRDQRDLALNFSATVQGGDYPHSLKADFTQLSWQLRGAELPPDGINGQGSLQASWQ
EDDKTLRFDNLNLMANRSTVTGSGSVVLGDRPDWSLDLHATTLDLDSLLAQRSPATDSSA
SQQGQSQTRPLRPVIADSDEREDYQSLRGFNGRMALSADQLQWRGLNFTQVQSEISNQQG
LLTVSKMQGNLDGGQLSLPGTLDARGDTPLATFQPALQNVEIGSLIKAFNYSLNLTGKLS
LSGEFSGTRIDADDFRRHWQGQAQLQMADTRTEGLNFQQLVQQAVERSTNVRAQENYDNA
TRLDSVSSRLTLDNGLVTLNRLQGQSDVMAMTGEGQLDLQKENCDMRFNVRVLGGWKGEG
KLIDRLKQTAIPLRIYGEWQSLSYSLQVDQILRKQLQDEAKQRLNDWVERNKGSKDGNDA
KKLLDKL
>AJG01379.1|FEATURES|megares|beta_lactam|OXA-208|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSDEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>BAB86848.1|FEATURES|megares|chloramphenicol|catII|antibiotic inactivation|1
MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAETDYKFYPVMIYLISR
VVNQFPEFRMAMKDNALIYWDQTDPVFTVFHKETETFSALFCRYCPDISEFMAGYNAVMA
EYQHNTALFPQGALPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEDNRVL
LPVSVQVHHAVCDGFHAARFINTLQMMCDNILK
>AFH54425.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_021018480.1|FEATURES|NCBI|bleomycin|bleomycin|antibiotic inactivation|0
DQATPNLPSRDFDSTAAFYEKLGFRSVFRDSGWMILQRGDLILEFFAHPELDPLASWFSC
CLRLDDLAGFYERCKSVGIQETSRGYPRIHAPELQEWGGTMAALVDSDGTLLRLIQN
>WP_018641422.1|FEATURES|NCBI|bleomycin|bleomycin|antibiotic inactivation|0
DLAIPNLPSRSFDRTQEFYRRLGFTLAYRDDEWMILNRGRVVLEFFAHPGLDPLASWFSC
CLRLDELSEFYELCKSAGLEEKGSGYPRLHPPEEQDGGGRMGALIDLDGTLLRLIQN
>SCJ62418.1|FEATURES|NCBI|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKRELELY
RFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILNNAV
LFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF
>WP_049204401.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWATRLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_049241494.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGVFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTVEHARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_019453091.1|FEATURES|NCBI|aminoglycoside|AAY84_08625|antibiotic inactivation|1
MIVICDHDNLDAWLALRAALWPSSSPEDHRAEMREILASPHHTAFMARGLDGAFIGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWATRLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_048234935.1|FEATURES|NCBI|aminoglycoside|ERS381490_00812|antibiotic inactivation|1
MIVICDHDNLDAWLALRTALWPSSSPEDHRAEMREILASPHHSAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVEGARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETELVVFYRKTLV
>WP_028378894.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQQLIELLKVYYGIDIHAVQLIVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGIKEIIFPIYTRDAKLFQQIDHFKIIVYPFIDAPNGFTQNLTEKQWQQ
LGKVLRQIHETSVPAAIQQRLRKETYSPKWREIVRSFYSKIGFDDSDDQITADFKSFFNQ
NIDSIHRLVDSSEELYKKIQPDLDKYVLCHSDVHAGNVLVVNEESIYIIDWDEPMLAPKE
RDLMFIGGGIGNVWNKHHEINYFYEGYGKINVDKIILSYYRHERIVEDIAVYGQDLLSSD
QNDESRLESFKHFKSMFDPNNVVEIALSSD
>ACO89576.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|erm|antibiotic target alteration|1
MSGQRSRRQWGWYPLTDDWAARIVAESGVRSGEFVVDLGAGHGALTAHLVAAGARVLAVE
LHPGRARHLRSRFAEEDVRVAEADLLAFRWPRRPFRVVASPPYQVTSALIRSLLTPESRL
LAADLVLQRGAVHKHAKRALVRHWTLRAGITLPRSAFHHPPQVDSSVLVIRRR
>ACX29951.1|FEATURES|NCBI|aminoglycoside|aadB|antibiotic inactivation|1
MDTTQVTLIHQILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAM
VEMLGGRVTEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPV
RCNSWGAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA
>NG_048515.1|FEATURES|NCBI|glycopeptide|vanY|antibiotic target alteration|0
MRRSEGDDEPRTLPPRARDRVYTAVTRVLAVLLLPVAFVRQPGRARELACGWALRMRFPA
EDLTGLTDGARAAFTAARAEALWRHGQLVGLTSGYRDPRVQQRMFEEEVRRSGSVAAARM
FVAPPAESNHVKGMALDVRPHEGARWLEAHGARYDLYRIYDNEWWHFEHRPECGGTPPRR
LPHPGAAWASRNGGRV
>WP_000622778.1.|FEATURES|NCBI|quinolone|qacB|antibiotic efflux|1
MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIV
DIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIA
GALIMPTTLSMIRVIFENPKERATALAVWSIVSSIGAVFGPIIGGALLEQFSWHSAFLIN
VPFVIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIP
WVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMTSVLLLASQW
LQVVEELSPFKAGLYLLPMEIGAMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFF
GHPLSYSTMALALILVGAGTASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAV
LGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFND
AFVATALVGGIIMIIISIVVYLLIPKSLDITKQK
>WP_010494170.1|FEATURES|NCBI|fosfomycin|fosA|antibiotic inactivation|1
MKATGFNHVTIRVSDLSRSLLFYESLLGMKLVHRGRLDVYLEWGSAWICLIERSCESSEK
PSYGVDHIAFSITEEDFHDAAVKLQGSGVPIVRGPLERGGGYSINFLDPDGTELELFTGS
LAERMKGWS
>WP_023260570.1|FEATURES|NCBI|aminoglycoside|A670_03335|antibiotic inactivation|1
MDIRQMNKTHLELWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHLALGFEETERVIFYRKRC
>WP_053529047.1|FEATURES|NCBI|aminoglycoside|L287_02619|antibiotic inactivation|1
MDIRQMNKTNLEHWRGLRKQLLPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKIHQALGFEETERVIFYRKRC
>WP_048590989.1|FEATURES|NCBI|aminoglycoside|CFSAN001590_08465|antibiotic inactivation|1
MDIRQMNKTNLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVPIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGLAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHLALGFEETERVIFYRKRC
>WP_000182645.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MTNKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>WP_063856689.1|FEATURES|NCBI|glycopeptide|vanD|antibiotic target alteration|1
MFKIKVAVLFGGCSEEHNVSIKSAMEIAANIDTKKYQPYYIGITKSGVWKMCEKPCLGWE
QYAGDPVVFSPDRSTHGLLIQKDTGYEIQPVDVVFPMIHGKFGEDGSIQGLLELSGIPYV
GCDIQSSVICMDKALAYTVVKNAGIAVPGFRILQEGDRLETEDLVYPVFVKPARSGSSFG
VNKVCKAEELQAAIREARKYDSKILIEEAVTGSEVGCAILGNENDLMAGEVDQIELRHGF
FKIHQEAQPEKGSENAVIRVPAALPDEVRERIRKTAMKIYRILGCRGLARIDLFLREDGC
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIEFSLR
>WP_016575755.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGDDVVLRPVADGEGEVLDRIVREPEVAAWWSPPEDFAGMLAIVFEGEVVGAIQFYEE
TDPEFHHAGIDVFLTARHQGKGLGTDAVRTLARWLVAERGHHRLTIDPAAANTAAIRSYR
KVGFRPVGIMRAYGRDHRTGRWQDALLMDLLADELT
>WP_046502149.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGNEVVLRTTAEGDSEVLDRILREPEVAAWWPPLDDYEGMLAVVFGGEVIGAVTFDEE
TDPEFRRAGIDIFLTASHHGKGLGADTVRTLARWLLQERGHHRLTIDPAAANTAAIRSYS
RAGFKPVGIMRAYWRDRRTGTWQDGLLMDLLADELT
>WP_023417224.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTTPADTALLDRIVREPEVALWWPPPQGYARMLAVVVDGEVIGAIQFSEE
TDPEFRHAGIDLFLSARWQGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANAHAIRSYR
KVGFAPVGIMRAYWRNHRTGEWEDGLLMDLLAGELT
>WP_010642533.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTTPADTAALDRIVREPEVALWWPPPQGYARMLAVVVDGEVIGAIQFSEE
TDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTYAVRSYR
KVGFAPVGIMRAYWRNHRTGEWEDGLLMDLLAAELT
>WP_037790839.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|1
ELRGDRIVLRPVMADDTPTLHRIVREPEVAAWWGTPEGFDDMLAVVLDGEVIGSVQYEEE
DDPDYRHAGIDLFLSARHHGRGLGAETVRTLARWLIDARGHHRLTIDPAAANTTAVRSYT
RVGFRPVGVLRAYERDPLTGDWRDGLLMDLLADELA
>WP_021459390.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTQHNEIIKCAEKYQLHIQPQTIALNESGLDFQVAFGEDEHGVEWVLRLPRRPDVYKRTK
SEKQTVDFLQKNVSFEVPKWKIHEQDLIAYPKLTGQPAATIDPELQDYVWEIEHKPVPEN
FINTLAETLVDLHNIPEENISAQHIKIKNIQEVKDDFQRRMNKVKETYGVADDLWNRWQR
WLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEAIHSDPSMDFMGHHRVFGDE
GLEQLITAYGKAGGETWPRMKEHIIELNAVFPMFIAEFAMESGEAAYEKMALKELGMEA
>CDH98055.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MTHEGYDISASEWEIMNTIWNKKLISANDVIEIVQQRKEWSPKTIRTLINRLYKKKFIDR
ISRNKIFEYFPRVEEKDMKYKTSKVFLDKVYEGGLNSLVLNFVENEELSEDDIEELKNIL
NTKKD
>CCM44123.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MKNEGYDISASEWEIMNTIWNKKLISANEVIEIVQQHKEWSPKTIRTLINRLYKKKFIDR
TNRNKIFEYFPIVEEKNMKYKTSKVFLDKVYEGGLNSLVLNFVENEELSEEEIEELKNIL
NKKKD
>WP_009317659.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWGLNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDAK
>WP_008976876.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAIVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMYISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKFDLK
>WP_009246943.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVWGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMYISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKFDLK
>CDL74288.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITQISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>WP_032461793.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQIAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>AAQ62548.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKFKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSIASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIISPAAAALLYSVWKLNAIIAIDVLGAVI
ASITVAIVSIPKLGDQVQSLKPNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPSSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFYADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>AAQ62545.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKFKFYTIWAGQAVSLITSAILAMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIISPAAAALLYSVWKLNAIIAIDILGAMI
ASITVAIVSIPKLGDQVQSLKPNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>WP_031577801.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYINWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSVQSISYIISPAAAALLYSVWKLNAIIAIDVLGAVI
ASITVAIVSIPKLGDQVQSLELNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMECFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>WP_031899433.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|0
MTKKYLNTQNEILAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHTGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_063854492.1|FEATURES|NCBI|nitroimidazole|nimD|antibiotic inactivation|1
MFREMPRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGKIYFHSAMQG
PKVDAILRNDKVSFCVVEQDEVKPAEFTTYFRSVIVFGKARILTDENEKRNALNLLADKY
SHGEAGMEAEMAKGFNHLLMIEITVEQMTGKEA
>WP_005041180.1|FEATURES|NCBI|beta_lactam|OXA-332|antibiotic inactivation|1
MYKKALIAATSILFLSACSSNTVKQHQIHSISANKNSEEIKSLFDQAQTMGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETLF
AYQLAHKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQSQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>WP_064161975.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLAISIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIVSGVVVLN
>WP_046181458.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDALGFVGMGLIIAAFLLAR
>WP_064907052.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWLGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_031995338.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLATSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_052925775.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDSWGFVGMGLIIAAFLLAR
>ABQ96628.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLRSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_046612238.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
DGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_050956219.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAQ
>WP_063101704.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAALLLAR
>YP_009075630.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|0
MPYLYLLLSIVSEVIGSAFLKSSDGFSKLYPTITTIISFLICFYFLSKTMQHLPLNITYA
SWAGLGLVLTTIVSVLIFKEQINLISIISIILIIFGVVLLNTFGSSH
>WP_024530279.1|FEATURES|NCBI|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKNTLRQTTLMVATVMPLLFGSAPLWAQSANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRADERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDKRDTTSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>ACN76562.1|FEATURES|NCBI|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLTSAVVSASYSLGTLAGANRDDASFQDRLAKLEQQLNGRLGVCAIDTAN
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRTPVVLALYSALENQQAEARNDVLADAARIVAEWVTG
>ACN76563.1|FEATURES|NCBI|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTAN
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLMYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRAPVVLALYSALENQQAEARNDVLADAARIVAEWVTG
>ACN76566.1|FEATURES|NCBI|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTAD
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALSDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRAPVVLALYSALESQQAEARNDVLADAARIVAEWVTG
>ACN76564.1|FEATURES|NCBI|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTAN
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRAPVVLALYSALESQQAEARNDVLADAARIVAEWVTG
>WP_007793725.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
LSGLNHLTLAVRDVARSLAFYQTLLGLRLHARWDGGAYLSCGDLWLCLSLDDNAGQPARD
YTHYAFTVSEADFPLMVDTLTAAGVKTWKSNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRARPYRGMTFFD
>WP_032970145.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
LSGLNHLTLAVRDVAQSLAFYHSLLGLRLHARWDGGAYLSCGDLWLCLSQDDNAGQPARD
YTHYAFTVSEADFPLMVDILTAAGVKTWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRARPYRGMTFFD
>WP_069682229.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
LSGLNHLTLAVRDVAQSLAFYHSLLGLRLHARWDGGAYLSCGDLWLCLSQDDSAGQPAAD
YTHYAFTVSETDFPLMVDKLTAAGVKTWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRAEPYKGMRFYD
>AEU08355.1|FEATURES|NCBI|fusidic_acid|fusB|antibiotic inactivation|1
MKTMIYPHQYNYIRSVILRLKNVYKTVNDKETVKVIQSETYNDISEIFGHIDDDIEESLK
VLMNIRLSNKEIEAILNKFLEYVVPFELPSPQKLQKVFKKVKKIKIPQFEEYDLKVSSFV
GWNELASNRKYIIYYDEKKQLKGLYGEISNQVVKGFCTICNKESNVSLFMKKSKTNSDGQ
YVKKGDYICRDSIHCNKQLTDINQFYNFIDKLD
>WP_035302981.1|FEATURES|NCBI|aminoglycoside|kamB|antibiotic target alteration|1
MRRVTGKQVVQVDRAEFAALRGRYTAALLDVGTGDGKHALHLARAHPDLLVIGLDAATDN
MRRAATKAAASPKKGGLPNLLYLWAAAEQPPAELSDITEVHVLMPWGSLLRGVLGSDPAM
LTALAALCAPDTPFLITLNLHAWRPPVPEVGTHPEPTPDSAAEDLGPALKAAHWHLHAAE
YLDDAGIAALATSWTRRLNSSRDRLDVLALRGLINP
>WP_018211347.1|FEATURES|NCBI|glycopeptide|SCO3595|antibiotic target alteration|1
MNKLKIAIIFGGCSEEHPVSVKSAQEVADNLDLEKYEPFYIGITKSGVWKLCHRPEANWE
KGSCLPAILSPDRSVQGLLVLEHGHYKTIPLDMVFPVLHGKFGEDGAMQGLLELSGIPYA
GCDVPSSALCMDKALAYIVAGSAGIATPNFRTVTAEEDIDADGLAYPVFVKPARSGSSFG
VTKVCRKEDLLSAVASAREYDTKVLIEEAVAGSEVGCAIFGNDPDLVAGEVDQICLSHGF
FKIHQEDEPEKGSENSKLIVPSDIPAEARLQVQETAKAIYRALGCRGLARVDMFLKEDGE
VILNEVNTLPGMTSYSRFPKMVAAAGLPFAEVLDRIISLAL
>WP_030867848.1|FEATURES|NCBI|glycopeptide|vanJ|antibiotic target alteration|0
MVLRSAARPELWKRAPVLTVSALFLGLVMMLHAQIPNRFGSVGSLVETFLPWFGLFVPVL
AAGALWRRSPAAVTALVLPVTVWLSLFGGLLGDKSGAGGDLTMASHNVGAENPDPAGTAR
DLAASGVDVLALEEITAQDREVYEKGLAREYPYHTVQGTVGLWSKLPLSGTRPVDIATDY
GPLADTKPADVTMAGNRALRTTVATEKGPLVVYVAHLGSVRLNPRAGFWTDSRDRNAWAL
GEALAADRSERIALLGDLNGTVDDRALAGITSQLHSVQEAAGNGFGFTWPAKFPVARIDQ
ILVRGVEPTGSWTLPATGSDHLPVAAGVSW
>WP_033632530.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
LDPAQPLSSAPPYSLFEEWAQPIAPFQIFEQVYYVGTSNLSSVLLSTPQGLILIDAGLES
SAPGIKANIERLGFSIKDLKYILNSHARLDQAGGIAQLKRWSGARLVASAANARQLALGG
RQDFALGDTLTFPAVQTDIVVADGDSITLGGLTLTAMMTPGHLPGATSWLTTLRHNGKPY
RFIYADSLATPGYYLIGNKNYPQLIEDIRGSFARLARVQADIFIANKGTRFALADKWRRL
QAGDTQAFIDPAGLQRYVQESQQGFEEQLK
>BAJ14745.2|FEATURES|NCBI|beta_lactam|mecC|antibiotic target replacement|1
MKKIIIALLILIVAAAGVGTYFYASKDKKINETVDAIEDKNFKQVYKDSTYRSKNDNGEV
EMTDRPIKIYESLGVKDINIQDRKIKKVSKNKKQVDAQYKIKTNYGTIDRNVRFNFVKED
GKWKLDWNQSVIIPDMQKDQSIHIEPVKSERGKILDRNNVELANTGTAHEIGIVPTSVSK
EDYKAIAQKLSISEDHINQQMNQDWVQDDTFVPLKTVKTMDKDLSDFVKKHHLTTNETES
RNYPLEKATSHLLGYVGPINSEELKKKEFKGYEDDAVVGKKGLEKLYDKKLQHKDGYRVT
IMDDNSNKVAHTLVEKKKKDGKDIQLTIDANVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMNGMSDEAYKKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DQTNYKINGKGWQKDKSWGDYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKQFE
KGMKKLGVGEDIPSDYPFYNAQISNKDLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHVLKDTKNKVWKKNIISAENINLLTDGMQQVVNKTHREDIYRPYANLVGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDDLYENG
DKKFDIDK
>CAJ15588.2|FEATURES|NCBI|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVAAAGVGTYFYASKDKKINETVDAIEDKNFKQVYKDSTYRSKNDNGEV
EMTDRPIKIYESLGVKDINIQDRKIKKVSKNKKQVDAQYKLKTNYGTIDRNVRFNFVKED
GKWKLDWNQSVIIPDMQKDQSIHIEPVKSERGKILDRNNVELANTGTAHEIGIVPTSVSK
EDYKAIAQKLSISEGHINQQMNQDWVQDDTFVPLKTVKTMDKDLSDFVKKHHLTTNETES
RNYPLEKATSHLLGYVGPINSEELKKKEFKGYEDDAVVGKKGLEKLYDKKLQHKDGYRVT
IMDDNSNKVAHTLVEKKKKDGKDIQLTIDANVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMNGMSDEAYKKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DQTNYKINGKGWQKDKSWGDYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKQFE
KGMKKLGVGEDIPSDYPFYNAQISNKDLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNISAPHVLKDTKNKVWKKNIISEENINLLTDGMQQVVNKTHREDIYRPYANLVGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDDLYENG
NKKYDIDE
>ENV74419|FEATURES|NCBI|beta_lactam|blaOXA-280|antibiotic inactivation|1
MKTLQLGLIVLITTFGSACTIIRSPSIETAKNHEQQSAQQQIQQAFDQLQTTGVIVIKDK
HGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKNSFPAWEKDMT
LGQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEV
LFVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETAT
GEKVYFALNMHMKTGISASVREQLVKQSLTALGII
>WP_016927879.1|FEATURES|NCBI|beta_lactam|classC|antibiotic inactivation|1
MTKMNRLASALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFTQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWREALTATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYRIVQALDKR
>WP_047575941.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDRPFIQAMEQGMLPALGMSHTYIQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQAKVAQPWREALAATHVGYYKAGVFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALDKR
>ENV13583|FEATURES|NCBI|beta_lactam|blaOXA-276|antibiotic inactivation|1
MKILILWPLLSYLSLTACSFPVSNSPSQITSTQSIQAIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYVPASTFKIFNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGHQVDNFWLVGPLKVTPKQEVEFAS
ALAQEQLAFDPRVQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG
>WP_025125210.1|FEATURES|NCBI|beta_lactam|MUS-1|antibiotic inactivation|1
MRKILSAITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSCNSMYVLTDEGV
ILIDTPWDKDQYEPLVDYIRTNHNKEIKWVITTHFHEDRSGGLGYFNSTGVQTYTYALTN
KILKERNEPQAQHSFNKEKQFTFGNEKLTVYFLGEGHSLDNTVVWFPKEEVLFGGCLIKS
AEATTIGNIADGNVIAWPKTIEAIKQKFKNAKVIIPGHDEWDMTGHIENTERILSAYNQQ
HSTKND
>CRV25694.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILNTFNSRDTTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSKKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>AAZ14834.1|FEATURES|NCBI|fosfomycin|FosC2|antibiotic inactivation|1
MLRGLNHITIAVSDLGRSLAFYTDIVGMLAHVRWDNGAYLSLGGVWFCLSCDKVMPSKDY
SHIALDISEDDFASFLEKLRRADVTEWKQNSSEGYSVYFLDPDGNKLEAHSGSLQSRLSS
LKDKPYPGLVWL
>WP_048260993.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
ATAHTFPSQGTETKGTKTNSPATTSLTGCGPSSTINQLFNQFGNSGKMPAELGSWLNDAK
AQTVEPYQAFDNVYYVGICWVSAWLIKTSEGPVLIDTLYGEFTDQLIDNIKKIGVEPADI
KMVLLTHGHFDHVGGVSKLKSFTNARFVMSEKGWKEAQADANKTQGKPNAWTMPDPATTD
ILVKDGSALSVGDTTFYAYITPGHTWGTTSYVFDVKEGNNTYHAMTIGGLGLNAIDGPQQ
VEAYIRSIDRIKEMVEDAKHPITVHLTAHPFSNGQIEIQNQLKVRQPNQPHPMVDAEGLL
KQLATLRARAVERLAVEQAR
>WP_006595860.1|FEATURES|NCBI|tetracycline|tetA(46)|antibiotic efflux|1
MIRAIWEYIRERKWRYISIAVVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVL
LVGSAILNYLTAFYWQLRLFQSSVHFKATLQGQAFRKLVAMRRPFFEKFRSGDLLTRFTT
DVDGMADMAGYGMMVLLFGGGLFAFIIPTMFFISWRLTLISFIPMIFLIVSTYFLSRKQE
DYVEQNREAVAQLNDEVLESIEGIRVMRAYSKRDQQVKQFQKKTASLSKTGDKIASIQYS
FGPLALMFIGFSTVLLLVFGGQSLAIGQLSLGKLLALQLYLVFLIEPMWMMADLILVYQT
GQMSYKKLKEVIDETDDLEPDGPNYLEQIDSVQFKDYSFSYPGAERKSLSGIDWTIQKGQ
TVGIVGRTGAGKTSLIRQFLRQYPVGEGEFLVNQQPIVDYNRHSIEAKIGYVSQEHILFS
KSIRDNIALGKNGASEEDLVEAVAQAAFADDLERMSQGMDTMIGEKGVSVSGGQKQRISL
ARAFLRDADLLLLDDSLSAVDAKTEQAIIDTIQTERKGKTTLIVSHRLSAVHQADWIIVL
DQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE
>WP_023027111.1|FEATURES|NCBI|tetracycline|tetA(46)|antibiotic efflux|1
MIRAIWEYIRERKWRYISIAVVLILYDYTLLIPTQVIQRLVDHLSQQTLTKSNFVWDMVL
LVGSAILNYLTAFYWQLRLFQSSIHFKSTLQEQAFRKLVAMRRPFFEKFRSGDLLTRFTT
DVDGMADMAGYGMMIILYGGGLFTFIILAMFFLSWQLTLICFIPMIFLVVSTYFLSKKQE
DYIEQNREAVAQLNDEVLESIEGIRVMRAYSRRDQQVKQFQTKTASLAKTGDKIASIQYS
FGPLALLFIGVSTVLLLVFGGQSLASGQLSLGKLLALQLYLVFLVEPMWMLSDFILVYQT
GQMSFKKLKEVIDETDDLEPDGPHFLEQIDSVEFKDYSFRYPGAERESLSGIDWTVQKGQ
IVGIVGRTGSGKTSLVRQFLRQYPVGEGEFLVNQQPIVAYNRRSIEDKIGYVSQEHILFS
KSIRDNIALGKNGASEEDLVEAVAQAAFADDLERMSQGMDTMIGEKGVSVSGGQKQRISL
ARAFLRDADLLLLDDSLSAVDAKTEQAIIDSIQTERKGKTTIIVSHRLSAVHQADWIIVL
DQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE
>WP_041826406.1|FEATURES|NCBI|tetracycline|tetB(46)|antibiotic efflux|1
MKVLKRLLSRITLYPTVFLAGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLL
QMGGFYLLVLSLGQLISYMGNRILLHGSNQVTASLRDQAFQVMQGMPISYFDDKPAGKIA
TRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLY
KVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRIL
LADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLS
RQFPNIRRSLETGSRVLAFLDQPLEADGALELKIEKAEVVFDDVQFAYEEGKPVLRDIAF
QASPGQTIALVGHTGSGKSSIMNLLYRFYDPQEGAILIDGQDIRQVSRESLRSHMGIVLQ
DPYLFTGTIASNVAMSQEHIDRDAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGE
RQLISFARTLYMNPQILILDEATSHIDTETEEIIQKAMAVLQKGRTTFIIAHRLSTIQDA
DQILVLSEGRIVERGRHEELVAQGGIYAQMNAIQQTVV
>WP_040276885.1|FEATURES|NCBI|thiostrepton|tsnr|antibiotic target alteration|0
MADLETITSKSDPAVQRIMDVTKHSRASVKTTLIEDTEPLLECIGAGVEFIEVYGSDNAE
ISGELLDLCREKDIPVRLVDFSIVNQIFKGERKAKTFGIARVPRPAKFGDIAALDGDVVV
LDGVKIVGNVGAIVRTAYGLGASGMVLVDSDLTTIADRRLLRSSRGYVFSLPIVLAEREE
AAAFVRDSGMPLTVLDSHGDISVKELGGKQERLALLFGSEKGGHSDPFDEASATTVSIPM
LSAAAESLNVSVAVGIALHERAERNLS
>AGV79343.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MDIRKTIEEKCNIVIESIKLIGEGYDSKAYIVNNEYVFKIKFSANKKKGYEKEKAVYDFL
NKKLHTSVNIPNIEYSYISDEISILGYKEIKGTFLTPEIYFSMSLEQQDLLKQDIAMFLR
QMHDLDFDEISSYTIDNKQNVLEEYQLLRETIYESLTDIEKQYIEEFMQRLYSTTIFDGK
KCLCHNDFSCNHLLLDDNNRLVGVIDFGDSGIIDEYCDFIYLLEDSEEEIGVSFGEDILK
LYGNIDISKAKEYQDVVEQYYPIETIVYGVKNNRDDFIEKGRKEIYLRTRKDEKTRK
>YP_004552835.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
QSLLPPPPRYMVSESAMKSVRNPKEIESESGGRLGVALVDSKGALILGFNRDERFAMCST
FKAPLAAAVLSGAEGNKFGLEGQIGFTKADLLDHAPVVKKNARRGRMSMEELAAAAVEVS
DNSAANLLLPMIGGPEGFTRYVRAHGDNVTRLDRTEPALNENAEGDERDTTSPAAMAGLM
RRLIFTDLKPESAARLRGWLNASTTGGNRIKAGLPKDWTSGSKTGTCGTAYNDVALVKAP
SGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFVGKAQKTGLE
>YP_003545618.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
QSLLPPPPRYMVSESAMKSVRNPKEIETESGGRLGVALVDGKGALILGFNRDERFAMCST
FKAPLAAAVLAGAEGGKFGLEGQISFAKADLLDYAPVVRKNVKRGRMSMEELAAAAVEVS
DNSAANLLLPMVGGPEGLTRFIRAHGDMVTRLDRNEPSLNENAEGDERDTTSPAAMAGLM
GRLIFRDLAPESAGKLRGWLNASTTGANRIKAGLPKGWISGSKTGSCGTAYNDVALVKAP
SGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFVDKAQKTGLE
>WP_003036826.1|FEATURES|NCBI|beta_lactam|blaA|antibiotic inactivation|1
MRLLVTTLSLIPSIILAAPQLDDSFKNLENKYDGKIGIYTLNTDDKTNIKYNESYHFPIC
SVFKFLLVGAILDYDMHNQGFLDKKIPINQNDIGKLGYAPITAKNVGKTLTISQLNYAAI
LSDNPAANILVRELGGLQNLNKFIKKLGDNDTIITADEPEVNYTQPHSNINKTTPKAITK
DIYKLAFGNILDKKHKDIFIKYLQDNNTGANRIAFGMPKDWIIGDKTGTCGQYAATNDVA
IIWPKNQQPIALGILYTNPNDKNAPSNEEIIQQAAKLIANNLTKTYK
>WP_045904844.1|FEATURES|NCBI|beta_lactam|III_02866|antibiotic inactivation|1
MKKIVNSKLKVNKFKMCIFISILIFSLTGCGNVENKTSENTKPEIQYNSAFSKIESDYGV
KLGVYAFDTETNKEVTYNADKRFAYCSTFKSLISGAILQKYSSDQLKQVIKYSPKDVLSY
APVTKNHVDKGMTIEELCDAAVRFSDNTAANLLINLIGGPNGFKSALNQLGDTVTEPARI
EPELNVATPGDNRDTSTPRQLSIDLKEYTTGNILSDDKKKILINWMSGNATGDKLIRAGA
PKDWMVSDKSGTGSYGTRNDIAIVIPSNKKPIFIAILSSKNDKDAKYDDKTISEASKIVF
DYFINTRK
>ENX38336.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKRLKTLALSASFTFALPLVACQSFGDQTQHIMAQKSEQQNIATLFQQAQTSGVLVIYD
GKKIQKYGNDTSRAEQRYIPASTFKMLNALIGIQHHKTTPNEVFKWDGQKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEE
VRFAYALAKQKLPFDQSTQQQVKGMLLIDEVQGTKIYAKSGWGMDVNPQVGWWTGWIEQA
NGKVTAFSLNMEMNRPEHADARKAIVYQALQQLDLLAN
>WP_060596701.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKYIKWLITGMMLMALCISQPSSTEGASPAWSVDEFMKDREGTFVIQEVKEKSPWVYN
KKRAKERFAPQSTFKVANSLIGLQTGAVRDEYHIKYWDGVKREIDNWNRDHTLGSGMRDS
VVWYYQAMARDIGEERMNHWVKAIHYGNKDISGGIDQFWLSSTLRISPIEQVRFLKQLYE
ETLPFDLKNMRTVKRMMVQEEEKHATLYGKTGSGSDIGWYVGFIKHEHKTYIFATNIKGT
GIEAKDITYRILKKYHLIEASV
>WP_048003296.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MQKKKMKWLIAGVMLAALCMSKPASSEGTSPKWSVDEFMKEREGTFVIQEVKEKSPWVYN
KKRANKRFAPQSTFKIANALIGLQTGAVKDEYDIKYWDGVKREIDNWNKDHTLGSGMRDS
VVWYYQAMARDIGEERMGHWIKAIHYGNQDISGGIDQFWLSSTLRISPVEQVHFLKQLYE
ESLPFDLSVMRTVKRMMIQEEEKHATLYGKTGSGSGIGWYAGFIKHENKTYIFATNIEGT
GLEAKEITYRILKKYHLVEASV
>WP_001728085.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
TQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDIYQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPAAQLLKALRYPLDLWQSAADVQ
GDKYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEEYAATLRAAQREYLGLEQQDWH
ILLPAVVRFVDFAKAHIPTQFT
>WP_023184937.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQRQTDAACRLITRVTGDTLRAIHLYGSAVTGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLALSSPSGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPVPAAQLLKALRYPLDFWQSAADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRAAQREYLGLEKKDWR
ILLPAVIRFVDFAKAHIPTQFT
>WP_025403994.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIARHAGYSKWHLQQLFLQYKGESLGRYIRERKLL
LAARDLRDTDQRVYDICLKYGFDSQQTFTRVFTRTFNQPPGAYRKENH
>WP_041144482.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIETIVGWIDDNLHQPLRIDDIARHSGYSKWHLQRLFLQYKGESLGRYIRERKLR
LAARDLRDTDQRVYDICLKYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_045901073.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLNQPLRIDDIARHAGYSKWHLQRLFMQYKGESLGRYVRERKLK
LAARDLRDTDQKVYDICLKYGFDSQQTFTRVFTRTFNLPPGAYRKEKH
>WP_039058858.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIAAHAGYSKWHLQRLFLQYKGESLGRYIRERKLS
RAAQDLVTTDQKVYDICLKYGFDSQQTFTRIFTRTFNQPPGAYRRENH
>WP_015965440.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIARHAGYSKWHLQRLFLQYKGESLGRYIRQRKLS
LAAQELRTTNQRVYDICLKYGFDSQQTFTRVFTRTFNQSPGAYRRENY
>WP_029882604.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIEDIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLL
LAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_038254648.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISTQVIETIVEWIDDNLHQPLRIDDIARHAGYSKWHLQRLFLQHKGESLGRYIRERKLQ
SAARDLRDTDQKVYDICLKYGFDSQQTFTRIFTRAYKQPPGAWRKAHH
>WP_024555500.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETLTGWIDDNLHKPLRIDDVARHAGYSKWHLQRLFHHHKGESLGRYIREKKLN
LAARDLRATDERVLDISLKYGFESQQTFTRLFTRHFRLSPGSYRRQAN
>WP_032742463.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TIPAKVIDYVVKWIDKNLDQPLRIDHIALYSGYSKWHLQRLFLKHKGESLGRYIRKRKLF
MAAQDLRNTDVKICDISIKYGYESQQTFTRIFTRTFHYPPGLYRHINK
>WP_063978070.1|FEATURES|NCBI|beta_lactam|HMB-1|antibiotic inactivation|1
HLWISLGLLLLTNIVLAEEPLPELEVKKIDEGVYLHTSYENYPSWGLVASHGLVFVDGKD
AYIIDTPATVKDTEVLVQWINDQGFKPKASISTHFHDDSTIGIAYLNSKSIPTYASEQTN
ELLNKEVAAQATHSFKKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFVKPE
GLGNLSHAVVSEWPASAEKLINRYSDAKIVVPGHGTMGDASLLEKTKQRALEAVAKKK
>WP_062058075.1|FEATURES|NCBI|beta_lactam|BL3_cit|antibiotic inactivation|1
APILSFCLLLLANIVSADEPLPELEIKKIEDGVYLYTAYENVKGWGLVGSNGLVVVDNKD
AYLIDTPISATDTEKLVQWIDAQGFTAKASISTHFHSDSTRGIAFLNSKSIPTYVSKLTN
KLLKNKGEAQATHSFSENPFWLLNKKIEVFYPGAGHTSDNVVVWLAEQKILFGGCFVKPE
GLGYLGDAVIADWPASAEKLIARYGTAKIVVPGHGKIGDASLLEKTKQRALEAVTAKK
>WP_007639185.1|FEATURES|NCBI|beta_lactam|O59_000556|antibiotic inactivation|1
KAFLAAILFLLSNITFAEDPLPELEIKKIEEGVYLYTAYEKIEGWGLVGSNGLVVLDNKD
AYLIDTPISAKDTEVLLQWIDAQGLTAKASISTHFHSDSSGGIAFLNSKSIPTYASKLTN
KLLKNKGEAQATHSFIKNPFWLVNKKIEVFYPGAGHTSDNVVVWMPEQKILFGGCFVKPE
GLGNLSHAVIEEWPASAEKLITRYGTAKLVVPGHGKVGDASFLEKTKQRAFEATAAKK
>CAD37801.1|FEATURES|NCBI|beta_lactam|SPM-1|antibiotic inactivation|1
KSRALLGFMGAFCLLLVAGAPLSAKSSDHVDLPYNLTATKIDSDVFVVTDRDFYSSNVLV
AKMLDGTVVIVSSPFENLGTQTLMDWVAKTMKPKKVVAINTHFHLDGTGGNEIYKKMGAE
TWSSDLTKQLRLEENKKDRIKAAEFYKNEDLKRRILSSHPVPADNVFDLKQGKVFSFSNE
LVEVSFPGPAHSPDNVVVYFPKKKLLFGGCMIKPKELGYLGDANVKAWPDSARRLKKFDA
KIVIPGHGEWGGPEMVNKTIKVAEKAVGEMRL
>WP_005816789.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDESVYPVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIGLVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAEPCLIQGLSHQHPALKSSVRPDKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQEASSKAITDLQKMMSEIEDISCNNEWCRIKGKVPLNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGGYSDNIRMNENDKLLFMFQKSM
>WP_042987717.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGSVYPICSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTVIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIADFRIGDYLGAKPCLIQGLSHQHPALKSSVRPDKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQVASSKAITDLQKMMSEIEDISCNNDWCHIKGKVPLNTSKDYVSEVSSYTKG
LGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSM
>WP_005796948.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGCVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIALVEKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDMEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPDKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLALEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQMASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSM
>WP_063856409|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLCMQTVVDGSVYPVCSQTYIKEEYKEFV
CDHDDNILERYLADSEIPPTDYWNTIIALVAKAKVYPVLHGSAMFNIGINELMDAITSFI
LPPASVSDRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKSIKIKNLKTIY
QGREINVDEVGANDIAIVEDMEDFRIGDYLGAEPCLIQGLSHQHPALKSSVRPDKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQEASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSM
>CAB41476.2|FEATURES|NCBI|aminoglycoside|aadA4|antibiotic inactivation|1
AQISEQLSHARGVIERHLAATLDTIHLFGSALDGGLKPDSDIDLLVTVSAAPNDSLRQAL
MLDLLKVSSPPGDGGPWRPLEVTVVARSEVVPWRYPAIRELQFGEWLRHDILSGTFEPSV
LDHDLAILLTKARQHSLALLGPSAVTFFEPVPNEHFSKALFDTIAQWNSESDWKGDERNV
VLALARIWYSASTGLIAPKDVAAAWVSERLPAEHRPIICKARAAYLGSEDDDLAMRVEET
AAFVRYAKATIERILR
>WP_049412369.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHARLWPVLTATGAPAMLKIADETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERASGQSLRQRSIDGADDACTTILCQVLQRLHRPRSAPPADLVCLR
RWFADLLQPRAALPPLLEQCRSLAEGVLQEEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARAEQVTALAGLERTRLLRWVAASAG
LSAVWFRDDGDPADVDESVARMALQALAEA
>WP_032127359.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHARLWPVLTATGKPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIKGDDDTCTTVLCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALQPLLEQCRSLAEGLLQQEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFATRLEQVGALAGLERTRLLRWIAANAG
LSAVWFRDDGDPAEVDEAVARMALEALAEG
>WP_049399366.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHARLWPVLTAAGAPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIEGDDDTCTTVLCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAPLPSLLEQCGLLAAALLQEEHEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASMA
LSAAWFRDDGDPADVDEAVARMALEALAEG
>KLO00119.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTADGEPAMLKVSSETEEQNGHRLLRWWDGDG
AARLLAHEGPAILIERADGDSLRQRSIEGDDDACTTILCQVLRQLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAERVLREEHEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLQQVSALAGLERTRLLRWIAASTA
LSAVWFRDDGDPADIDEAVARMALEALAEA
>WP_049457662.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGASIRTPHAQLWPVLTAAGEPAMLKVASETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERARGDALRQRSIDGDDDACTTILCQVLQRLHRPRSAPPAELACLR
TWFADLLQPRAVLPPLLEQCRSLAEGVLQDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVSTLAGLERGRLLRWIAASMG
LSAVWFRDDGDPADVDEAVARMALEALAEG
>CCP11623.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGASIKTPHAQLWPVLTAAGAPAMLKVSSETEEQNSHRLLRWWDGDG
AAHLLAHEGPAILIERARGDSLRQRSIDGDDDACTTILCQVLRRLHRPRSTPPAELVCLS
TWFADLLQPRAALSPLLEQCRSLAEELLQDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVSTLAGLERRRLLRWIAASMG
LSAVWFRDDGDPADVDEAVARMALEALAAG
>WP_057496342.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSHWRLRRDGAAIETPHARLWPVLTAAGEPAMLKVSDEAEEQNAHRLLRWWDGDG
AARLLAHEGPAILIERAAGDSLRQRSINGEDDTCTTLLCQVLQRLHRPRSTAPSDLVRLR
TWFADLLQPRAALPPLLEQCRSLALTLLQDEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLQQVSALAGIEPRRLLRWIAASAG
LSAVWFRDDGDPADIDEAVARMALEALAEG
>ACH43055.1|FEATURES|NCBI|aminoglycoside|aac(6')-IIa|antibiotic inactivation|1
VTQRLMVKRDLVMLHEWLNRPHIVEWWGGEEARPTLQEVQSHYLPRVLAEEAVTPYIAML
GSEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQSLANPEQLGKGLGTRLVCTLVKTLFN
DPSVTKIQTDPAPNNVRAIRCYEKAGFRQQKVITTPDGPAVYMVQTRASFEAARGAA
>WP_035346186.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
NRLPSISEAEWEIMKVLWKNGSQTAHQVIQAIQKQTDWKPKTIRTLLDRLMKKQVVGVNK
EQKVYIFFPLYSEDECKRAETQSFIKRIYGGTFKPMLVQFIEEESLTKEELDELRSILER
K
>WP_019380241.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
DRIPSISESEWEVMTVLWHGAPKTANEVILSLQESTDWKPKTIRTLLDRLVHKNVVGVNK
NQRIYTFFPLYSQDECQRAEAQSFIKRIYGGTVKSMLVQFIQEDSLSDEEINELQTILAK
K
>WP_060669155.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KEIPNISESEWEIMHVLWEKSPRTASEVISSMQEKTDWKPKTIRTLLDRLTKKKAVGVNK
DQRVYTFYPLYSQEECQRAEARSFVDRIYGGTLKSMLVQFIQEESLSEDDIKELRSILDK
K
>WP_040739251.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
EQVPKISEAEWEVMNVLWERSPLTASEVIQALQEKTDWKPKTIRTLLDRLVKKEVVGVNQ
NQKVYTFTPLYSQSECQRAEAKSFLNRIYGGTMKSMLVHFFEEESLTEEEIKELRNMLNE
K
>WP_064127842.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|0
MPYLYLAIAIITEIIGTSFLKSAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNISYA
TWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH
>WP_017201638.1|FEATURES|NCBI|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAVNGLCAFLAAPFLGRLS
DRFGRRPVIIVAAFGAALSMALFGVGGALWILVLARVIQGLTAGDLPALFAYLADITPPE
KRAQRFGLLGALSGIGTMIGPALGGLLAAVSIQLPVFLTAAVALTIAILSIFLLPESLKP
GNRISTITLRDVQPFAVFKEAFGRRELRGLMIGFGLLALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAAVGIIDILIQGVLLGILLPRIGERGVIVSGIVAQLIGLAALAVVASFFAQPW
VFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTAAPLIAGALYA
LVSHAAPYWLGVALMVVAVIVVSRAHIANTAKRPAGETTGDAPAALVETAG
>CAA30827.1|FEATURES|NCBI|tetracycline|tet(L)|antibiotic efflux|1
MNTSYSQSTLRHNQVLIWLCVLSFFSVLNEMVLNVSLPDIANEFNKLPASANWVNTAFML
TFSIGTALYGKLSDQLGIKNLLLFGIMVNGLGSIIGFVGHSFFPILILARFIQGIGAAAF
PALVMVVVARYIPKENRGKAFGLIGSLVAMGEGVGPAIGGMVAHYIHWSYLLLIPTATII
TVPFLIKLLKKEERIRGHIDMAGIILMSAGIVFFMLFTTSYRFSFLIISILAFFIFVQHI
RKAQDPFVDPELGKNVFFVIGTLCGGLIFGTVAGFVSMVPYMMKDVHHLSTAAIGSGIIF
PGTMSVIIFGYIGGLLVDRKGSLYVLTIGSALLSSGFLIAAFFIDAAPWIMTIIVIFVFG
GLSFTKTVISTVVSSSLKEKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIGFLDHRLLPI
DVDHSTYLYSNMLILFAGIIVICWLVILNVYKRSRRH
>WP_062814523.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTTPHSATGFIKKSLCFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVACYFKQKSPILKKFPS
>AKG19644.1|FEATURES|NCBI|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKHT
>WP_015328224.1|FEATURES|NCBI|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKNK
>ABR77055.1|FEATURES|NCBI|multidrug|marA|antibiotic efflux|0
MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
RKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLH
PLNN
>WP_024160909.1|FEATURES|NCBI|chloramphenicol|cmlA5|antibiotic efflux|1
MRSKDFSWRYSLAATLLLLSPFDLLASLGMDMYLPVVPFMAGALGAGAGTIQLTLTVYLV
LLGAGQLLFGPLSDLLGRRPVLLGGGITYILASFGLAAASSPEVFLSFRILQACGASACL
VSTFATVRDIYSGSEESNVIYGLLGSMLAMVPAIGPLLGALVDAWLGWRAIFGLLGIAMI
GAVTAAWRFWPETRRQRTADLQWSQLLLPVKCLNFWLYTLCYSAGMGSFFVFFSTAPWLM
MGRQALSQLSFSLLFATVAIAMMATARIMGRLIPRWGSLNTLRVGMGCLVVGALLLAVGE
TLIPNSVLGFIAPMWLVGVGIATAASVAPNGALRGFDHIAGTATAVYFCLGGLLLGGIGT
FIIALLPSDTTWPIIAYCLILAIAVLCLSCFNPNRHHPSDDEHDSLA
>EEI47439.1|FEATURES|NCBI|tetracycline|tet(J)|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTAPHSATGFIKKSLCFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPI
>ABX79441.1|FEATURES|NCBI|glycopeptide|vanC1|antibiotic target alteration|1
MKKIAVLFGGNSPEYSVSLTSAESVIQAINPLKYEVMTIGIAPTMDWYWYQGNLANVRND
TWLEDHKNCHQLTFSSQGFILGEKRIVPDVLFPVLHGKYGEDGCIQGLLELMNLPYVGCH
VAASALCMNKWLLHQLADTMGIASAPTLLLSRYENDPATIDRFIQDHGFPIFIKPNEAGS
SKGITKVTDKTALQSALTTAFAYGSTVLIQKAIAGIEIGCGILGNEQLTIGACDAISLVD
GFFDFEEKYQLISATITVPAPLPLALESQIKEQAQLLYRNLGLTGLARIDFFVTNQGAIY
LNEINTMPGFTGHSRYPAMMAEVGLSYEILVEQLIALAEEDKR
>OAE14554.1|FEATURES|NCBI|beta_lactam|TU73_12825|antibiotic inactivation|1
KLINILSVISLACITSQVFANKSDLTLTHFKGPLYIVEDKEYVQENSMVYVGEQHITVIG
ATWTPATAEKLEQEIRKISPLPIKEVINTNYHTDRAGGNAYWKKLGASIVSTQMTYDLEK
SQWRSIVDFTRQGMEHYPILEQSLPDQVYPGNFDLQNGHVRALYLGASHTEDGIFVYFPE
ERVLYGNCILKEKLGNMTFANRSEYPKTLKKLQGLIRSGELPVEAIIAGHNSPIQNVELI
DHYLTLLEHGEQ
>WP_063252610.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQSGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLAQCRERPYSGMRFGPGK
>WP_039187979.1|FEATURES|NCBI|aminoglycoside|LA66_00505|antibiotic inactivation|1
DREESCAIPFVPSNMSVEVHGYKWARDTIGQAGGAVYRLYGRVGAPDLFLKHGRDEVADD
VTDEMVRLRWLAGYTSVPSVQNFVRTKDEAWLLMTAIPGKTVYQVLEENADARFIVVDAI
AAFLRRVHAIPVCECPFNSDYTYRLSRARARIDSGLVDADDFDTEREGLTPEQVWEEMQH
LLPFPADPVVTHGDFSPDNLLMNEGEILGCIDVGRVGIADRYQDLAILWNRLEEFGSPLQ
ERFFQRYGVADVDRRKLQFHLMLDEFF
>WP_055823613.1|FEATURES|NCBI|aminoglycoside|HMPREF9710_02755|antibiotic inactivation|1
ERDILCVPAAVPAGLADAVAGYRWARDQVGESGGAVYRLSGKADAPDLFLKQGQGSVADD
IVDEMVRLRWLAGKVPVPRLVGFVATADDAWLLTTALAGETAWQLLDRAPEQREPVVDAL
AALLQQLHALPVAACPFDSGFERRLRLARQRIDAGLVDADDFDEQRAGWSAEQVWDALQR
HRPLTPDPVVTHGDFSLDNILLREGRVTGCIDLGRVGVADRYQDLAILSANLAEFDDALP
QRLFARYGIDTIDTAKVEAHLLLDELF
>WP_030646682.1|FEATURES|NCBI|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYPGCEWVAVQDGASGAGVYRLRGGGRELFAKVAALGAGVGLLGEAERLV
WLAEVGIPVPRVVESGGDERVAWLVTEAVPGRPASARWPRGQRLDVAVALAGLARSLHAL
DWERCPFDRSLVVTVPQAARAVAEGSVDLEDLDEEREGWSGERLLAELERTRPADEDLAV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALVLRELAHEEDPWFGPECSAAF
LREYGRGWDGAVSEEKLAFYRLLDEFF
>WP_031191644.1|FEATURES|NCBI|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYPGCEWVAVEDGASGAGVYRLRGGGRELFAKVAALGAGVGLLGEAERLV
WLAEVGIPVPRVVESGGDERVAWLVTEAVPGRPASARWPRGQRLDVAVALAGLARSLHEL
DWERCPFDRSLAVTVPQAARAVAEGSIDLEDLDEEREGWSGERLLAELERTRPADEDLAV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALMLRELDHEEDPWFGPECAAAF
LREYGRGWDGAVSEEKLAFYRLLDEFF
>WP_053699462.1|FEATURES|NCBI|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYSGCEWAAVGDGASGADVYRLRGGGRELFVKVAAAGPGVGLLGEAERLG
WLAGEGISVPRVVESGGDGRVAWLVTEAVPGRPASARWPRRQRLDVAVALAGLARSLHAL
DWERCPFDRSLAVTVPQAARAVAEGSVDLEDLDEEREGWSGERLLAELERTRPADEDLAV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALVLRELAHEEDPWFGPECVAAF
LREYGRGWEGEVSEEKLAFYRLLDEFF
>WP_063840320.1|FEATURES|NCBI|aminoglycoside|aac(6')-ib-cr|antibiotic inactivation|1
MTNCNDSVTLRLMTEHDLAMLYGWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERT
RSDA
>WP_063840281.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RRFA
>WP_049646085.1|FEATURES|NCBI|aminoglycoside|ERS008437_00710|antibiotic inactivation|1
IKKLSSANINLWIALREQLWPHHPENANRSDGKNIILSDELASFIAVDEDGLGIGFADAS
IRNDYVNGCIHSPVAFLEGIFIVPPSRRGGVAKQLVDAVQAWGLEKGCQELASDTALDNV
LSQQVHEALGFKETERVVYYRK
>WP_063838853.1|FEATURES|NCBI|aminoglycoside|AAC(6')-30/AAC(6')-Ib'|antibiotic inactivation|1
LIRPVEQSDAESWERLRNLLWEGDDHKSEITQFFNGEVEEPNEVLLAVTEENDAIAHIEL
SLRYDIDGLTGIKTGYIEGLFVEERHRAAGVVLKLLRAAEFWARDQGCLAFASDRDDRVI
IYARYTGAP
>AEX88635.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iaf|antibiotic inactivation|1
IYNIINIADSEKNKEDAAQILYSAFRGKGKDAWPTLDSAREEIAECIASPNICLGITLDD
RLVGWGGLRPMYETTWELHPLVIDPDYQGNGLGKLLLSKIESTATTNRIIGIMLGTDDET
LSTSLSMTDIDESNIFQEIKNIINIKNHPFEFYKKCGYIIVGIVPNANGYRKPDIWMWKN
L
>WP_056320428.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MNTKETIAADLERLGVQSGDLVMVHASLKAMGPVDGGAASVVSALLDAVGPNGTLMGYAS
WDRSPYEETLNGAEMDAELRHRWPPFDPVTSGTYRGFGLLNQFLLQAPEARRSAHPDASM
VVVGPLAGKLTQPHELGQAFGPGSPLERFLEYSGKVLLLGAPLDSVTVLHYTEAIAYIPN
KRRVTYEMPIRNKDGGVRWERAEDFDSNGILDYFAIDGKPDAVETIASAYVELRRHREGI
VGQAFSYLFEARDIVSFGVDYLERHFGS
>WP_062562100.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHGKATITADLRRLGLQPGDLVMVHASLKALGPVEGGAAGVAQALMDAVGPGGTVMGYAS
WDRSPYEETLNGARMDEDLRRDWPAFDPRTAGIYRGFGLLNQFLAELPGARRSAHPDASM
VAVGPLAGILVEPHRLGQALGEGSPLERFVRLGGKILLLGAPLDAVTVLHYAEAIADIPG
KRRVSYEMPMLGPDGRTIWEAATDFDSNGILDCFAVEGRPDAVETIARAYVATGRHREGV
VGAAHCHLFDAQDIVAFGVEWLERQFGS
>WP_052171736.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MKSRASVIADLHRLGVRPGDLLMVHASLKALGPVEGGATGLLTALLEAVGPTGTLMGYAS
WDRSPYEETLNGASLDEEKRRAWPAFDSDTAGTYRGFGLLNQFLADFPGARRSAHPDASM
VALGAYARELTEQHPLGQALGRGSPLERLVHLGGRVLLLGAPLDAVTVLHYAEAIADIPG
KRRVTYEMPLRGPDGGAVWVRVEDFDTNGILDCFAIEGQPDAVETIAKAYVDLGRHREGR
VGDAHCHLFEAPEIVAFGVHFLEQHFGG
>WP_022652262.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTEAAITKALEELGVEKGNLLMLHASLKAIGPVEGGAETIVRALRSAVGPSGTLMGYAS
WDRSPYEETLNGVQLDDEVRASWPPFNPATADIYCGFGLLNRFLVQAPGARRSPHPDASM
VAIGPLAANLIEPHELGHAFGQGSPTERFVRWAGKVLLLGAPLDSVTVLHYAEAVADIPN
KRRVTYEMPIAGSDGEVVWKAASDFDSNGILDCFAIEGKPDAVETIACAYVELGRHRAGI
VGSAPCYLFDAQDLVSFGVTYLEQNFGS
>WP_057205564.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MNDKATITGNLRALGVQSGDLLMVHASLKAIGAVEGGPPAIVASILKAVGPNGTLMGYAS
WDRSPYDETLNGAQLSEERRRNWPPFHPETAGTYRGFGVLNQYLVDTPDALRSAHPDASM
VAVGSLAREMIEPHVLGRAFGQGSPLERFVKRGGKVLLLGAPLDAVTVLHYAEAIAEIPG
KRRVTYEMPLLDPQGQTIWAHTEDFDSNGILSCFAIDGEPDAVETIANAYVLLGRHREGP
VARAHSYLFDAKDIVEFGVEYLERNFGA
>WP_053993359.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RKENELITLFETIIIDDDRIRLAVLEGSRTNTNIPKDNFQDYDISFFVTDIESYKKSDHW
LNVFGGIVFMQKPEAMELYPAELGNWFSYIMYFSDGIKIDLTLIPLNEVDQYIADSDGLV
EVLIDKDKRIKEKIIPNDTKYWIKRPSEREFDDCCNEFWNVSAYVAKGLLRKELLYALDH
FNQILRPELLRMMSWDIGIREGCHFSVGKNYKFIGKYLPEKELERLVQTFSLAGYKVTWN
SFNLCCEMFRFYSKKVASLLNYTYPDYDEKMTNIIQNIYI
>AFJ49145.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
REENEMINLFKNIVMNDDTIRLSVLEGSRTNKNIPKDDFQDYDISFFVTNMESYKKDDLW
LDIFGDLVFMQKPEDMELFPSELGNWFSYIMYFNDGIKVDLTLIPLNELDDYLSNSDGLV
EILIDKDNRINKRIVPSDEKYWIEKPSGQEFDDCCNEFWSVSSYVAKGLLRKEFFFALDH
FNQILRPELLRMMSWEVGIREGFNFSVGKNYKFIDNYLPKAELEKLIDTYSQSGYIESWE
SFELCCELFRAYSKKVASSLGYRYPEYDEKMTNFIQNNYT
>WP_028596644.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSKQEMMELGMNFAQSCEQIRIFTLEGSLTNVNIPNDEFQDYDFSYFVTDMEHFKRNDDW
LNYFGKRIMMQKPEAMELFPPELGNWFSYIMIFEDGTKMDLTLIPLHEYADYFANSDGLV
EVLLDKDNLILEPIIPTDQMYHIDKPSCQSFDDCCNEFWMSSTYVAKGLARNELLFAADM
MNQVFRPNLLTMLRWKVGIETEFSLSIGKSDKFLEKYVSSETWITLLATYEMGSRENIWE
ALYTSYALFRKSAQFVADQLGYSYPDYDENVSPYIDSIRR
>WP_035400726.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSKKEMMDLGMNFALNCEKIRLFTLEGSLTNTNIPKDEFQDYDFSYFVTDMDYFKKSDDW
LSSFGERIIMQKPEAMELYPPELGNWYSYLMIFEDGTKIDLTLIPLNEYEDYFKNSDGLV
EVLLDKDNLIQNSVIPTDSMYHIQKPSEQSFDDCCNEFWMTSTYVVKGLARREILFAIDI
MNNAFRPSLHTMLRWKVGMETGFSLSIGKSDKFLKEYISEDMWNKVLSTYDMGSYKKMWE
ALNTSIELFRETSHFIAETFGFKYPNYDEKVSMYIESIRK
>AAK53749.2|FEATURES|NCBI|beta_lactam|BLA1|antibiotic inactivation|1
VLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATGDKLIR
AGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAE
VIVNAFR
>WP_033691456.1|FEATURES|NCBI|beta_lactam|penPC|antibiotic inactivation|1
ILKNKRMLKIGICVGILGISLTSLEVFKGGTLQVEAKEKTGQVKHKNQATHKEFSKLEQK
FDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKEDL
VDYSPVTEKHVDTGMKLGEIAEAAVRYSDNTAGNILFHKIGGPKGFEKALRKMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIARNLKDFTIGNALPHQKRNILTDWMKGNATGDKLIR
AGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAE
VVIDAIK
>WP_033665770.1|FEATURES|NCBI|beta_lactam|BcI|antibiotic inactivation|1
ILKNKRMLKIGMCVGILGLSVTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDL
VDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIASNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIR
AGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATE
VLVKALR
>EJS76559.1|FEATURES|NCBI|beta_lactam|ICY_02429|antibiotic inactivation|1
VLKNKKMLKLGMCVGILGLSITSLATFTGGALQVEAKKKPGQVKHKNHATYQEFSQLEKK
FDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKDDL
VEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMS
DRLETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPDHKRKVLTEWMKGNATGDKLIR
AGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAE
VVIDAIR
>WP_068987176|FEATURES|NCBI|beta_lactam|AT258_18160|antibiotic inactivation|1
ILKNKRMLKIGICVGILGLSISSLQAFTGGASQVEAKEKTEPVKHNNHATYKDFSQLEKK
FDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQKNSTEKLNEVVTYTKEDL
VDYSPVTEKHVDTGMKLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQIGDRVTMS
DRLETELNEAIPGDNRDTSTAKAIATNLKDFTVGNALPDKKRNILTDWMRGNATGDKLIR
AGVPKDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATE
VIVNAIR
>AMP53257.1|FEATURES|NCBI|beta_lactam|CfxA6|antibiotic inactivation|1
MKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIG
VAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTW
SPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQI
AYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIV
APLLDKEGVVIAHKTGSGDVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQAS
QFVAHISAVVYSLLINTAL
>WP_030892446.1|FEATURES|NCBI|beta_lactam|BL2d_moxa|antibiotic inactivation|1
MRIRPTRRLLLGAVAPLALVPLVACGQASGSESAGSSPASAVRTSAHGSADAHEKEFRAL
EKKFDATLGVYAIDTADGQEITHRADERFAYGSTFKALQAGAILRKFSETGAKSGAGAEA
DGMDKVVHYGQDAILPNSPVTEKHVADGMSLRELCDAVVRYSDNTAANLLFDQLGGPKGL
NAVLKQLGDHTTSMDRYEQELGSAVPGDPRDTSTPRAFAEDLRAFAVEDGKKAALAPNDR
EQLNDWMSGNATGDALIRAGVPKDWKVADKSGQVKYGTRNDIAVVRPPGRAPIVVSVMSH
GDTEDAEPHDELVAEAASVVADGLK
>WP_032593664.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLKTQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNKNLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIACNDIGFILLPSGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_034848068.1|FEATURES|NCBI|beta_lactam|BlaB|antibiotic inactivation|1
KNIMRALILVFGFMSFFMFGQENPDVKIEKLRDNLYVYTTYNTFNGTKYAANAVYLVTDK
GVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKM
TDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCII
KSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINEYQ
QKQKASN
>WP_058877933.1|FEATURES|NCBI|beta_lactam|D505_09853|antibiotic inactivation|1
KNIMRALILVFGFMSFFMFGQENPDVKIDKLKDNLYVYTTYNTFNGTKYAANAVYLVTDK
GVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKM
TDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLAGGCII
KSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINEYQ
QKQKASN
>WP_049287941.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNIITTKPVQEFATDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIHSPTTFWYGKYII
LIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFNIFSIAMSYNPLIQIVKRKMIHD
NEVEADRFVLNNINKNEFKSYAEAIMDSVLKTPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHNHYP
FDSWNKDQDLNTAIQNSVNWYFERISNQISKNYTSDQLKQLNYGNKNLGSYKAYWLEDSL
KISNLEQVIVLKNMMEQNNHFSKNEKKQLSSSLLIRKNENYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDEKASGENAKLINEKILKEMGVLNGQ
>WP_031922911.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEKESRKRYSPDSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_031925325.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMSKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_031771022.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCRSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>ABI95380.2|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEA
MKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLEN
DTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQ
VDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQ
NEIEMFKPDFTFQQLLNV
>OBP63446.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEA
MKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRAILLNSLEN
DTVIWDRKLVALEPDKEKWVLSFEDKPNETADLVIIANGGMSKVRKYVTDTEVEETGTFN
IQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQ
VDFQNRNSVVDFLLKKFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQEESTQ
NEIEMFKPDFTFQQLLNV
>SAM46405.1|FEATURES|NCBI|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVFADKEPQALYKITNGSIQYVRESGGIYEYAQDKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>WP_061100012.1|FEATURES|NCBI|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
IGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFPFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYAQVKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>CBL15929.1|FEATURES|NCBI|glycopeptide|vanWG|antibiotic target alteration|1
KRKRLTQVFPFLLPIRKWQRKKLFYLEMLIDGNKYAKNKSEALLPNTVFETSSLMLNENS
GFDMKYQINKVHNLKLAARTINKVIIEPNETFSFWQLVRWADHHEKYKDGLNLVDGKIVG
SYGGGLCQLSNMLFWLFLHTPLTVVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKIR
NDTDNTFQIEISFDDKYMYGRILSQSPVNIEYSVFNSSVSYFKREEKIYQIASVCRTEKD
KMTGRQTEKELYVNQCEIAYKLPDDIKIEERGV
>BAD10980.1|FEATURES|NCBI|bacitracin|BacA|antibiotic inactivation|0
MKEKVVVDNAISLYTESFGDPAHEPIILIMGAMSSAVWWPDEFCSQLAKMGRYVIRYDHR
DTGKSTSYEPGQAPYSVEELADDVVRVIDGYGLEAAHLVGMSLGGFLSQLVALKYPKRVK
SLTLIASERLADADPDMPAFDPAIIEYHQRAESLDWSDRDAVVAYQVGAWRINSGTAHAF
DAEKIQNIAELNFDRTPNILTTFNHTTLGGGERWLGRLNEIAVPTLIIHGTEDPVLPYVH
GLALKDAIRGSKMLTLEGTGHELHHEDWPRIIQAIKGQTS
>EHJ00311.1|FEATURES|NCBI|glycopeptide|vanZA|antibiotic target alteration|0
GKVLSRGLLALYLGILIWLVLFKLQYNILSVFNYHHRSLNLDPFTFPLKLNGSINFGELI
DNIIIFIPFGVLLNVNFKKVRFLSKLTLILVFSITCELIQFIFAIGAADITDVITNTVGG
FLGLVLYSLSNKYVNNKKLDRVIIFVGILLLILLLYYRIHVLILKY
>ODA40045.1|FEATURES|NCBI|glycopeptide|vanZA|antibiotic target alteration|0
GKILSRGLLALYLVILIWLVLFKLQYNILSVFNYHHRSLNLNPFAAPLNINGRINFGEMI
DNVIIFIPFGLLLNVNFKKIGFLPKFALILVFSLTCELIQFIFAIGATDITDVITNTVGG
FLGLELYSLSNKYINNKRLDRVIIFVGPLLLVLLLYYRIHILRLKY
>AAN41409.1|FEATURES|NCBI|aminoglycoside|aadA1aq|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LINDLLETSASPGVSEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRTWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>CCF70752.1|FEATURES|NCBI|aminoglycoside|aadA1br|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LFNDLLETSASAEESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>AIA09138.1|FEATURES|NCBI|aminoglycoside|aadA8|antibiotic inactivation|1
TIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRA
LLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
MIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERN
VVLTLSRICYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADQ
LEEFVHYVKGEITKVVGK
>WP_039227222.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWIFLSAAIICEVIATSSLKSSEGFTKLAPSLLVVAGYGAAFYLLSLTLKSIPVGIAYA
IWSGLGIVLVTLVAWLMHGQKLDLWGAVGMAFIVTGVVVLNLLSKASAH
>WP_009836365.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKGWLFLAIAIVGEVVATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAY
AVWSGLGVVIITAIAWLLYGQKLDAWGFVGMGLIVSGVVVLNLLSKASAH
>ACN22639.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKGWLLLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVMKSIPVGVAY
AVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIVSGVVVLNLLSKASAH
>WP_031916968.1|FEATURES|NCBI|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>WP_048792890.1|FEATURES|NCBI|beta_lactam|blaZ|antibiotic inactivation|1
MKKLLFLIALALLLSACSTKKSTNDEIKKIEKKHNANIGMYALNTKNGKALSFNKDKRFA
YASTFKTISSAMLLEKTPHNKLDKKIHITKDDIVPYSPVLEKYIGKDITLHKLIEANMLY
SDNTANNKIIDELGGYKQVKNRLENLGDTTTHPSRKEPNLNLYAPKDKRDTSTPLAYGKT
LNKLITDGKLSKTNKDFLLDLMLKNKSGDTLIKDGAPSNFKVKDKSGQALTYGSRNDVAF
VYPKGQDKPIILVIFTNKDKKDAKPNDKTVSEVAKVVLKNI
>WP_024433862.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFAQNSSGTTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTATLNIERVQQQYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPASTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNISQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHVIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATSSTYKLSMARYKAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGTSKV
>WP_000048141.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKVAIVSRGLVVSALSVALVACVNMQAPQPAITSHIPQNFAQISSGTTIAEKSYKEFIS
DPKLLQVIEIGLNNNRDLRTATLNIERVQQQYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDVLATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGISKV
>WP_032063003.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSVTLVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLLQVIEISLNNNRDLRTATLNIERVQQEYQVTKNNQLPTIGVMGSAVRQVNPSINPN
NPASTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSASEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQLDSYHLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGYSVPQNLLPDHSIQNITIEKNFAAGLPSDLLNHRPDLKVAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASTELKDLFKTGNFAWSIGPSIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATSATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGSLALEQMKLNNQIELYKALGGGISKG
>WP_016805753.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPVITSHIPLNFSQNASGKTIAEQSYKEFIS
NPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKIQLDSYRLNKKRFEVGIDSEVPLKQAQISVEIARNDVATYKTQIQQ
AKNLLDLLAGYPVPQNLLPDHSIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPSVDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATDATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQDLLALEQMKFNNQIEIYKALGGGISKS
>EDS78926.1|FEATURES|NCBI|tetracycline|tet(44)|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAV
TSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMN
IPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVIS
RNDKLLKKYIAGEKLTIQELTYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCS
EMNENGSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNG
EMIQTKIVCSGDIFIIPNNTLRLNDIIGNEKILPCNVWNDNTAPILRTRIEPIKIEEREK
LLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIY
LEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREG
INYGLEQGLYGWKVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYL
SFILFTPQEYFSRAYNDAQKHCAIIETSQSKNDEVIFTGHIPARCINEYRNTLTLYTNGQ
AVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKE
>ODU72116.1|FEATURES|NCBI|chloramphenicol|chloramphenicol_hydrolase|antibiotic inactivation|1
MALNAQVEALLAMFAQMPPVDFAAISARALREINDQRPVQMGPPPAVAIAEDLSLDLAGR
TIPARLYVPEGSGENPPLVLYYHGGGWVIGTLDTHDGTCRALARASGAAVLSIGYRLAPE
HPFPAPFDDCYDALVWARDHASDLGVDGTRIAVAGDSAGGNLAAAVAIRARDEGGPALRH
QLLIYPVTDADFSLPSYAANGGGQYFLSTAAMRWFWNQYVGTEADGHIHGATVLRTENLA
GLPSATVITAQYDPLRDEGVAYAERLAAAGVPVEAEEAPGMIHGFFSMFAFVPDAVAYID
RAGARLKAALA
>WP_038893172.1|FEATURES|NCBI|beta_lactam|y56|antibiotic inactivation|1
MKHSSLRRSLLLAGITLPLVSFALPAWANALPASVDKQLAELERNANGRLGVAMINTGNG
TKILYRAAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLIKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTARPN
DPRDTTTPAAMAARMNKLVLGDALRPAQRSQLAVWLKGNTTGDATIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASVTKIILSQIS
>WP_050334115.1|FEATURES|NCBI|beta_lactam|y56|antibiotic inactivation|1
MKHSSLRRALLLAGITLPLVNFSLPTWAAAISGSLDKQLAALEHSANGRLGIAMINTGNC
TKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPN
DPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIILSQIS
>WP_063311740.1|FEATURES|NCBI|beta_lactam|OKP-A-6|antibiotic inactivation|1
RVFSCTLAIVWGLPAAAVSGELMDTVTRLESEVGGRIGVVLQHTGSEWGIEHREDERFPM
ASTFKALLCGAVLSRVDRGEESLDDLVTYKATELVSYSPVTKNHVASGMSVGQLCEATVT
MSDNTAANLLLKRVDGPEGLTRFLRGLGDRVTRLDRNEPALNEAKHGDSRDTTTPSAVLK
TLDRLLFEDVLLPSSRAQLQQWMVDDKVADELIRKHLPKGWRIADKSGGGQNGSRGIISV
IWPETGKPYLASVYMMGSDASFKQRNAVIADIGKAMIEEIKQR
>WP_026290570.1|FEATURES|NCBI|aminoglycoside|Aac3VIII|antibiotic inactivation|1
MNEMELLERAGGPVTRSRIVNDLTTLGVHRGDTVMVHTRMSAIGFVPGGTRTVVEALAET
VGDTGTLMAYCGWNDAPPYSLADWPENWREAARSAWPAFDPLLSEADHGVGRVPEALRRW
PGAVRSRHPDASCVAAGPAAHRLLDDHPWDDPHGPDSPLARLTAIGGRVLLLGAPLDTLT
LLHHAEALAEAPGKRYVTYEQPITVAGKRVWRRFRDVDTETEAFDYGQVLPSGVWPFTAI
AQEVLDAGLGRTGMVGAARSHLFEAADVVRFGVDWIESHLGAAAPA
>ANV82483.1|FEATURES|NCBI|beta_lactam|RD02_10175|antibiotic inactivation|1
MKHFRLCLIPVLAAFSLPVFAHPATLDTIKDAESRLHGRVGYAELDLVSGKMMDSYRSDE
RFPMMSTFKVILCGAVLARVDAGQEQLDRRIRYRQNDLVEYSPVTEKHLAEGMNVGELCH
AAITMSDNTAANLLISTLGGPSGLTAFLRKTGDSVSRLDRWETALNEALPGDERDTTTPE
SMARTLHNLLTGDALSAESRRQLMRWMEMDNVAGPLLRSVLPAGWFIADKTGAGERGSRG
IVAALGPDGKPSRIVVIYLTGTKATMDERNKQIADIGAALINHW
>WP_072229212.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
MQNQDKFLKQFKKLALCDENIRLVTLEGSRVNKKAKKDKYQDYDVSFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPDLPQNWISFLVLFESGMR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYTNILEFLEEKE
VKIILKSFNTATLEHIKKARKKLEILFHKNAKFVAKKSDFKLFPYRKNVKKYCKILRKL
>WP_072216485.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
MQNQDKFLKQFKKLALCDENIRLVTLEGSRVNKRAIQDRYQDYDVSFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPDLPQNWISFLVLFESGVR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYANILEFLEEKE
VKIILKSFNTATLEHIKKARKKLEILFHKNAKFVAKKSDFKLFPYRKNVKRYCKILGKL
>WP_072228818.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
MQNQDKFLKQFKKLALCDENIRLVTLEGSRVNKRAIQDRYQDYDVSFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPDLPQNWISFLVLFESGVR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYANILEFLEEKE
VKIILKSFNTTSIKQIKKTRKKLEILFHKNAKFVAKKNDFKLFPYRKNVKRYCKILGKL
>WP_080669011.1|FEATURES|NCBI|quinolone|QnrB|antibiotic target protection|1
MALIFEGEKIGRTRFTGEKIENAIFRNCDFSGTDLTSTEFIGCQFYDRESQQGGKFTRAQ
LKDAIFKNCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCSAYITKNN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGELDVRGIDLQGVKLDSYQIAQLMERLGIVVLG
>WP_027373595.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
KIREDKLEQIIQWATDNRDVRVVLLTSSLVNPYAPVDDFSDLDVELVFESRKPYEDDHQW
ISLFGQPISMVEEGDEVFEGKHAMKMVLYKDHVKVDFKLYQLSDFIAEIKAEKLPDDWDL
GYKVLVDKDELTTEMKPPSYRSIMIHQPEEKEFRQLLNDFWWDTTYVAKCLKRGDIFYAK
FMSENILRTDYLVPLIEWYIASSHDWNNITTNKHGRLFKKYLSQELWNKVELTFSGSNIE
ENWAALFAFADLVHELGTALAYQLNFTYPVTLENDIRNYLAEVRE
>WP_005066968.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
MKLSGLNHLTISVANVDRSFSFYKDVLGFTPRAKWNKGAYLSLGELWLCLSLDEVSITSD
YTHYCFSISEDHIDAFRQKIKLLNIREWKNNQSEGESIYFLDPDGHKLEVHLGNLSSRLE
SCKKNPYEGMVFFDE
>WP_086261308.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
MKLSGLNHLTISVANVDRSFNFYKDILGFTPKAKWKKGAYLSLGELWLCLSLDEVSISSD
YTHYCFSISEDNIDEFRQKIKMMNIPEWKTNQSEGESIYFLDPDGHKLEVHVGNLSTRLE
SCRKNPYEGMVFFDE
>WP_065801616.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDENRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>WP_042021679.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
VKIRVVPFILLLALVFAFLLNWPVLLHFYEIFTNMEHFKIGFAISIPVLLVAALNFVFMP
FSVRYLIKPFFAFLFVAGSIVSYTMLKYRVLFDRDMIQNIFETNQSEAYSYISLPIVAWV
LLAGVVPAVLLFFVKIEYPKKWYTGLFQRGLSMLGSLAIVGIIAAFYYQDYVSVGRNNQT
LNREIVPANFVYSTTKYLYKRYLAEPVPFTTLGDDAKRVVTNEEKPTLMFLVVGETARGK
NFSMNGYEKETNAFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMVRKEYDDNRARNSEG
LLDVLHKTGVSVFWKENDGGCKGVCDRVLNIEIKPKDHPQFCDNNTCYDEVVLQNLDDEV
AQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFLPDCPRSDIENCTDEELVNTYDNTIRYT
DFVIAELIAKLKTYEEKYNTALIYVSDHGESLGALGLYLHGTPYKFAPDDQTRVPMQVWM
SPGFSREKGLDMGCLQQKATDTRYSHDNLFSSVLGIWDVKTAVYDQGLDIFSQCRT
>WP_011638903.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALS
FLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLA
SITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFGR
NNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVFVVGE
TARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRAN
AQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKL
DKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDN
TILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVP
MLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCR
Y
>WP_094698575.1|FEATURES|NCBI|beta_lactam|blaAQU-2|antibiotic inactivation|1
MKQTSPLSLLALSALLLSSLTQAAPADPLAGVVDDVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGGIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDGVESVAQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYVDVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPISE
QALLAGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHAILSKLAP
>WP_036693005.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
IGPNPNEKYPVPGNTNVQFIRNTITKPNIIVGDYSYYDAVNGESFEDQVLYHYEVIGTKL
IIGKFCSIAPEVRFMMDGGNHRMDGSTFPFNIFGNGWEKHTPSLEQLPIKGDTIVGNDVW
IGRRATIMPGVRIGDGAIIAAEAVVVKDVEPYTIVGGNPAREIRKRFSPEVIQELLDIKW
WDSDIELISQYIGSIVSGDMDTLRKMKQ
>WP_028406647.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
LGPDPNEKVPIPGNPNVQFIKNTITKPNIVVGDYTYYDAANGELFEDQVLYHYEVIGTKL
IIGKFCSIAPEVRFIMDGGNHRMDGSTYPFNIFGNGWEAHTPSLDNLPIKGDTIVGNDVW
IGRRATIMPGVRIGDGAVIAAEAVVVSDVEPYTIVGGNPAKVIRKRFSTQDIQEWLDIRW
WDADIERIHSYIGAIVSGDLESLRKMKD
>WP_048947910.1|FEATURES|NCBI|trimethoprim|dfrC|antibiotic target replacement|1
MLAAIWTQDEQGVIGKEGKLPWHLPNDLKFFKEKTIHNTLVLGRATFEGMGCRPLPNRTT
IVLTSNPDYQAEGVLVMHSVEEILAYADKYEGVTVIGGGSVVYKELIPACDVLYRTMIHE
TFEGDTFFPEIDWSVWEKVATVPGVVDEKNLYAHDYETYHRNDK
>WP_001070729.1|FEATURES|resfam|multidrug|msbA|antibiotic efflux|1
MNQDFKVYLRLISYLKPYWGVALLVLIGFGMNSATEVSVAKLIKFIIDAIQNASRADLDW
FPLLIILLVFFRGLGLFMGGYYTAVISRSLVFSIRQEVYAKLLRLPAQYYLDNSSGHITA
KIMYNVEQLTAASSESLKTIVRDGMITLGLLGYLFYTNWRLTICIMVFLPVIGILVRKAS
KRMRKLSMQVQDTMGDVNHVVQESINGNAVVKSFAGEESEQERFYKSSEENLKRGLKMVI
VQNLNSPVVQVVMACAMALIVWLALRPQILGNTTAGEFVAYITAAGLLSKPVKNLTDVNE
KLQRGLAAAHSVFELLDLPEEQNSGELKPQLQGAIRFDHVVLNYADGTQAIKDFSLDIRP
GETVALVGRSGAGKTSLVNMLVRFQEVSSGQIYLDDLPIRDIELSSLRTQIAMVNQQVVL
FNRTVRENIAYGQLHNASDEDVIAAAKAAYAHDFIMNLPNGYDTVLGAQGLNLSGGQRQR
IAIARAILKNAPILILDEATSALDNESEHFIQQAFDEAMQDRTTIVIAHRLSTIENADRI
VVMDRGQIVEQGTHQELLAKHGAYYQLHQRNFEDH
>CBW28895.1|FEATURES|resfam|aminoglycoside|rpsL|antibiotic target alteration|0
MATINQLVRKPRVKKVVKSNVPALEACPQKRGVCTRVYTTTPKKPNSALRKVCRIRLTNG
FEVTSYIGGEGHNLQEHSVVLIRGGRVKDLPGVRYHTVRGALDCAGVKDRKQGRSKYGVK
RPKA
>WP_023434793.1|FEATURES|resfam|aminoglycoside|RmtF-2|antibiotic target alteration|1
MDERAQAALDALLSAKNLRDVCPETVRRVFMELLPRYRKPKDAEKAARTHLHQITGAFMT
ADAQEKARALLARWNEGDESALAAALSLHASTRERLPGADEWMRRVSPFLGADARVLDLA
CGLNPILLGSMGVTNALGMDIHLGCVRLVNETARARGWHTRARACDLLSEIPAEEADAAL
LMKLLPVLEAQKTGRAAELLASLRAPRLVVTFPTRTLGGRGVGMEKHYADWFERILPDTL
SVRDRFTVSDELVYLVERT
>resfam_RmtF-3|FEATURES|resfam|aminoglycoside|RmtF-3|antibiotic target alteration|1
VPKAALARPLPTRQTRQKGRLNFLYPELLPRYRKPKDAEKAARTHLHQITGAFMTADAQK
KARALLARWNEGDESALAAALSLHASTRERLPGADEWMRRVSPFLGADARVLDLACGLNP
ILLGSMGVTNALGMDIHLGCVRLVNETARARGWHTRARACDLLSEIPAEEADAALLMKLL
PVLEAQKTGRAAELLASLRAPRLVVTFPTRTLGGRGVGMEKHYADWFERILPDTLSVRDR
FTVSDELVYLVERT
>YP_003388071.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MRTLLTLLFFSGLIVSLQAQSAKKPGLLVTPLNKQVFVHTTYGLYKNEAVPSNGLIIKTK
GGIVLVDTGWDTDTNTDNTRELLRWVSTNLHQPVRLCIVTHAHEDRVGGISELRKAGVRV
VSTPLTAQKSVKLGFESPEAVLPNDTTFSIGNEPIRCYFPGQGHTPDNIVVWLPNQKILY
GGCLVKSVAAFGMGNLADANLNEWGNSIQNLMTQFKSARIVVPGHDEWTDTRSLAHTLQL
LKKHAEAKK
>3FCZ_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
KTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSSGLVLNTSKGLVLVDSSWDDKLTK
ELIEMVEKKFQKRVTDAIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLG
DLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAY
VNEWSTSIENVSKRYRNINAVVPSHGEVGDKGLLLHTLDLLK
>3KNR_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGDLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>3I14_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
KTVIKNETGTISISQLNKNVWVHTELVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVE
KKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTN
LKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGXCLVKSTSAKDLGNVADAYVNEWST
SIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>WP_003302143.1|FEATURES|NCBI|beta_lactam|IK7_02258|antibiotic inactivation|1
MVEKKFQKRVTDFIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQT
ITSLKFGNTKVETFHPGKGRTEDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEW
STSIENVLKRYGNINSVVPGHGEVGDKGLLLHTLDLLK
>NP_386095.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
MKSGCNPGRIVILNGAPRSGKSSIAEAIQETFDGPWMNLGVDAYMERVMPRRCLPGIGLR
PGGELPEIEALVPLFYAALYESVAAHSRLGLNVVADVGHHDAYGEPRHILPDCARRLLGL
PVLFVGVRCPVETIMERRNRGQPGREGGYLTGSEAEPVPRQVLAWQREVHRPGIYDLAVD
TSMMTPDECAALIRKRLEAEPMAPTAFQRLARMASISQPD
>WP_015630486.1|FEATURES|resfam|chloramphenicol|Chloramphenicol_3-O-phosphotransferase|antibiotic inactivation|0
MINPTRARRMRYRLAAMAGMPEGKLILLNGGSSAGKTSLALAFQDLAAECWMHIGIDLFW
FALPPEQLDLARVRPEYYTWDSAVEADGLEWFTVHPGPILDLAMHSRYRAIRAYLDNGMN
VIADDVIWTREWLVDALRVFEGCRVWMVGVHVSDEEGARRELERGDRHPGWNRGSARAAH
ADAEYDFELDTTATPVHELARELHESYQACPYPMAFNRKLRKRFLS
>ABO21413.1|FEATURES|NCBI|beta_lactam|IND-2|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTAADLGYTGEANVKQWPETMRKLKMKYAQATLVIPGHDEWKGGGHVQHTLDLLDKNK
KPE
>YP_004346432.1|FEATURES|NCBI|beta_lactam|PEDO-3|antibiotic inactivation|1
MRAFLFSLACFFSIGSNAQLDFKKISDSSYVFSTYHTFDSVRYSAHGFLKITDLGVVMID
TPWDSLQFQPLLDSIKVKFHQSVILVVSTHWHEDRTAGLDYYNQKGISTYSTYATKNLCV
ENHLPQAKYTFEGDTTFRIGNTIFETYYPGAGHSSDNIVVYFPKEKILVGGCFVKSIEAK
DLGNLSDANIGMWPIAAKNLIKKYPKVKTVIPGHQKISSGKKALKYTLKLTKAKYKGRKL
DKKKAKH
>WP_002614052.1|FEATURES|NCBI|beta_lactam|VIM-29|antibiotic inactivation|1
MDPAGHLSGGSWHASAGGNRRWICQSVRADVRHAMLILYLPASIGAQPPCRSLTHGAHHI
RSPHERGALPPGAGMLSPSMHPPLRPHPLWCSLRPATLALLLGVFGCRTSVPAPRPAAEP
FTSITEDLRIQPLAPGVWRLVALSGEEWGHIPANGLVIAEGGGVLLVDPGWTEAQGERLL
QWVEDTLKVPVHAGVATHFHADRTGGLRALQARGIPTHALALTAALTSQQDRPAPTHLFP
GPAQQLGPVELFFPGPGHAPDNITVWHAASGILFGGCMVKDLKASSLGNLSDADLASWPR
SVESLQARYPAARTVIPGHGEPGDTSLLAHTLELLRAGSR
>YP_927055.1|FEATURES|NCBI|beta_lactam|SLB-1|antibiotic inactivation|1
MRIAISWCTALMIGTIANTQALEITPLSDGLFLHQSEKEVEGFGKVSANGLIIVDGKEAF
VVDTPWTDADAEALLEWTKAKDLTVKAVLATHWHEDRAGSFGVFERAGIATLSSEATQAL
LRQHQKTLATHTFSGDEIQYFGNKVEVFYPGAGHAMDNLVVYLPHEKLLFGGCLVREAST
RFMGFYGDGSLPDWPESMSRLIAKFPEVITVVPGHGALGDKRLLEHTRGLAEAALKAQ
>ACU65240.1|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILYGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>ACU65236.1|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPVHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>2FHX_A|FEATURES|NCBI|beta_lactam|SPM-1|antibiotic inactivation|1
SDHVDLPYNLTATKIDSDVFVVTDRDFYSSNVLVAKMLDGTVVIVSSPFENLGTQTLMDW
VAKTMKPKKVVAINTHFHLDGTGGNEIYKKMGAETWSSDLTKQLRLEENKKDRIKAAEFY
KNEDLKRRILSSHPVPADNVFDLKQGKVFSFSNELVEVSFPGPAHSPDNVVVYFPKKKLL
FGGXMIKPKELGYLGDANVKAWPDSARRLKKFDAKIVIPGHGEWGGPEMVNKTIKVAEKA
VGEMRL
>CBX26624.1|FEATURES|NCBI|beta_lactam|VIM-17|antibiotic inactivation|1
RSLPVHGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVD
VLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAH
>WP_004874166.1|FEATURES|NCBI|beta_lactam|cphA8|antibiotic inactivation|1
MLKTILQFFVLFTVTQGAYASKIALVKLSDNLYVVEDDYYYRENSMVYIGKDYITVIGAT
WTPDTAKELDAQIKKISKKPIAEVINTNYHTDRAGGNLYWKSIGAELISTKMTYNLMEKH
WQDILETTRKGYDGFPDIPLVLPTKTFDNNFELQNGEIKAIYTGESHTPDGIFVYFPKEK
TLYGNCIIKEKLGNLASANIKEYPKTLQKLKNLNLDIKTVVGGHDSPIHGSELIDSYKKL
IEAANK
>ACF39942.1|FEATURES|NCBI|beta_lactam|cphA|antibiotic inactivation|1
YFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKV
VSTRQTRELMKSDWAE
>ABO60992.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTPLALAATLVFDVAAADAPPPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVRTTEGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRRT
GAQVVANAETAVLLPRGGSNDLHFGDDITYPPASADRIIMDGERVTVGGMAFTAHFMPGH
TPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQYNARYPRLVEDYRRSFTTVRGLPCDL
LLTPHPGASRWNYAAGAEAGANVLTCKAYADAAEKAFDAQLAKETTGAR
>ABO60987.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTTLALTATLAFDVTAADAPLLQLQAYTVDASWLQPMAPLQIADRTWQIGTEDLTA
LLVQTADGAVLLDGGMPQMAGHLLDNMKARGVAAQDLRLILLSHAHADHAGPVAELKRRT
GASVAANAESAVLLARGGSNDLHFGDSITFPPASADRIIMDGEEVTVGGIAFTAHFMPGH
TPGSTAWTWTDTRDGQPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDL
LLTPHPGASNWNYAAGAEAGANALTCKAYADAAEKKFDAQLAKETATAR
>2QJS_A|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
AEVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMA
SHLLDNMKARGVTPRDLRLILLSHAHANHAGPVAELKRRTGAKVAANAESAVLLARGGSD
DLHFGDGITYPPANADRIVMDGEVITVGGIVFTAHFMAGHTPGSTAWTWTDTRNGKPVRI
AYADSLSAPGYQLQGNPRYPHLIEDYRRSFATVRALPCDVLLTPHPGASNWDYAAGARAG
AKALTCKAYADAAEQKFDGQLAKETAGAR
>ADC79565.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITALLVK
TPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATGAQL
VSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHTPGS
LSWTWTDHRDGKPLRIAYSDSLSAPGYSLWMKPRFPKIAEAFRSGFAAVRALPCDLLITP
HAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAELKKQRGG
>CAB94701.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMAS
HLLDNMKARGVTPRDLRLILLSHAHADHAGPVAELKRRTGAKVAANAESAVLLARGGSDD
LHFGDGITYPPANADRIVMDGEVITVGGIVFTVHFMAGHTPGSTVWTWTDTRNGKPVRIA
YADSLSA
>CAB94703.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMAS
HLLDNMKARGVTPRDLRLILLSHAHADHAGPVAELKRRTGAKVAANAESAVLLARGGSDD
LHFGDGITYPPANADRIVMDGEVITVGGILFTVHFMAGHTPGSNAWTWTDTRNGKPVRIA
YAGSLSA
>ADC79561.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTFGLALLLAQPAMAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFSKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEA
>ABX23698.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MFKAWAKPIEPFQITEGVWYVGTENLSSILLTTPAGHILIDAGLDESAPQIKANIETAGF
RLTDVRYLLNSHARLDQAGGMARLKAWSGAQLVASQPNAEQMARGGRQDFALGDALPFPP
VTTDKIIHDRESISLGGITVTALFTPGHLPGATSWRVTLRNGKTLIYADSLATPDYLLIN
NKNYPDLVTDIQHSFKTLDAQYVDIFIANKGDRFGLLEKRQQLRNGDTQAFFDPNGLQQY
VERSRQRFITQLTAQQP
>YP_006888122.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQRVD
IFIANKGDRFGLLEKRQQLRNGDTHAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_002042986.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQGSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_001479485.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MKKNLGYLTAMTVALCFGAQAQLNPAQPLSSAPPYSLFEQWAQPVAPFQMFPHVYYVGTR
NLSSVLLSTPEGLILIDAALDASAPAIRAHIEALGFNIKDLRYILNSHARLDQAGGIARL
QVWSGAKVVASAANAQQLALGGKQDFALGDALSFPPVKVDIIVGEGDSITLGDLKLTALM
TPGHLPGATSWLTTLHQGGQSYRLVYADSLATPDYYLIDNKNYPSLVQDIRGSFARLAQQ
QADIFIVNKGTRFDLDNKMQRLQAGDLDAFVDRQGLQQYVQQSQQTFEAQLKQQQSKM
>WP_001528135.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDIRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGEITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTGQQP
>YP_002245625.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPTPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHHQESIILGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQGSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>WP_007413547.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MGIQNRIIRGVGMLMLAAGLPLTSLAQTNAPVDPGNAAVKKMWESWNAPFKPFRIINNVY
YVGATGVSSFLITTPEGHILIDTGFESTVPRIRASVAQLGFRPEDIKIILSSHAHLDHTG
GHALMKQLTGAKVMISKADADLLASGGTKDYTPYAPKMMAYSPVKADRILVDEEKVSLGK
TTLTCHLTPGHTKGCTTWTMDTTEAGKVYHVLFFGSTSVLSDVKLVNNPKYPNIAEDYLH
SYQKLKTLQCDVFLAPHGSFFGLSEKAEKLAQGGKTNPFIDSESYRNFIQKAENTFLEQL
AQERAKASRALGN
>YP_003559460.1|FEATURES|NCBI|beta_lactam|THIN-B|antibiotic inactivation|1
MIATMTIAASLAISPAAAATGPEPEAMAAADRAGGARPSDDPLTRPMAVERAKEWLAPLP
PERIFGNSYLVGFAGLSVALIDTGAGLVLIDGALPQAAPMILSNVRKLGFDPRDIKFILS
TEPHYDHAGGIAALARDTGATVVASRRGAEGLRAGAHAKDDPQFDYGGAWPAVSRLRVVK
DGEVLRIGRASIAAHATPGHTMGSMTWNWNACEGKRCKAIVFASSLNPVSADRYRFTAPS
SAPIVKGFEASYRRMGALNCDILISAHPDNAGAGRYGSGSGACRSYAERSRRLLAKRLAE
ERRETSK
>YP_005055871.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MSPCRKLLCLVVILFSFGGLHAQMNPDWTTPVSPFRIADNLYYVGSRDLASYLVTTPAGN
ILINANLPSSPPQIRASVEQLGFRWKDTKILLNGQAHFDHMGGSAQILRETHAKNMVMEG
DADVVRSGGRTDFAAGTPGILQYAPARVDRVLHDGDTLSLGGVILTAHKTGGHTRGCTTW
AFRVHIPSDPPGKLRDVVIIGGFTVLSQYRLTAIAPQPGYYPGIAQDYAHTFATLRALPC
DLFLADHGSHFGLLEKLARLPKEGATVWLDPEGYKRAVAEHQKDFEDELEKQRRGGL
>AAP40275.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MKLRSQAVMVAVLASAYSLGAVAAPDVETTVSQAIKPLIDQQNIPGMAVAVLVKGKPYYF
TWGMADKEQHLPVTQDTLFELGSVSKTFTGVLGGVAVAKGEIALNDRASQYWPALNLPQW
RNITLLQLATYTAGGLPLQVPDAVTDEDRLKNFYQQWQPQWAPGETRQYANSSIGLFGML
AVKPTGLSFEQAMQQRVLTPLKLTHTFITVPEASENAYAWGYRDGKPVRVSPGMLDAESY
GVKSSIKDMLRWMQANMNPEQVGDKTLQQGLALAQTRYYRTDALYQGLGWEMLDWPEQST
LAIRGADSPMALGPQQVRDAQSHPRVKASWVHKTGATGGFGAYVAFIPQKQIGIVMLANK
NYPNTLRVKVAMQIVKALE
>CAC85359.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MKKSLSCALLLSVACSAFAAPMSEKQLANVVERNVTPLMKAQAIPGMAVAVIYQGQPHYF
TFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQW
QGIRLLDLATYTAGGLPLQVPDAVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSL
AVKPSGMRFEEAMTERVFKPLKLNHTWINIPHAEEPHYAWGYREGKAVHVSPGLLDAEAY
GVKSNVKDMASWVMANMAPETIQQPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAK
TVVDGSDNKVALAPLPAAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLAN
KSYPNPLRVETA
>CAD32304.2|FEATURES|NCBI|beta_lactam|CMY-34|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNRPITQNTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTRYWPELTGKQ
WQNISLLHLATYTAGGLPLQIPNEVTNKTALLRFYQNWQPQWAPGAKRLYANSSIGLFGV
LAVKPSGMSYEEAMIRRVLQPLKLTHTWITVPQSEQRDYAWGYRDGKPVHVSPGQLDAEA
YGVKSSIMDMARWVQANMDASHVQEKTLQQGIGLAQSRYWRIGEMYQGLGWEMLNWPVKA
DTIINGSDSKIALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVDAAWRILEKLQ
>NP_900980.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MMQSLKFRTLAGMLGCLTFLPLAAQAANDAGKSDLDAAVEATIPPLMKAKDIPGMAVAVL
ADGKAHYFNYGVASRETGQPVTQDTLFELGSISKTFTGILGGYALAQGKLSLADKASRYQ
PELKGSVFDRVSLLQLATYSAGGLPLQFPDAVAGQASMLAYYRGWKPDYAPGERRLYSNP
SIGLFGHLAARSLGQPFDQAMERGLLPKLGLSHTFIHVPEAEQSRYAWGYAKAGKPIRVG
AGVLDAEAYGIKSSAADLLKYLAINMSPPADPALQRALDASHAAYYRVGDMRQGLGWEGY
RYPISLERLLAGNSNEIAFQPQKVEWLNPPRLAEGDVLLNKTGSTSGFGAYVLFVPARKV
GIVMLANRNYPNAERVRAAYRILSAVDPSLVRRRGD
>YP_001084546.1|FEATURES|resfam|beta_lactam|OXA-100|antibiotic inactivation|1
MLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIPVYQDLARRIGLEL
MSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSM
LFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEI
TYKSLEQLGIL
>YP_007078965.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MDPRDAGASGAGMNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLA
KISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQ
IIKKVVFESHASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKV
NSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTY
EQVLSIFNSYLLFNGRK
>YP_788912.1|FEATURES|NCBI|multidrug|mexi|antibiotic efflux|1
MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQ
GFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLP
ERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQ
RLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDF
REMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIR
KLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLI
PVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPV
AAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTL
SPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPL
LYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTD
GPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMV
LRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDI
GESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVR
VELQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQY
TQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIY
TQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGL
VPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLA
EADLLVNKA
>YP_005977049.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLP
PDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQ
VFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAF
AAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVR
AKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLI
PVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPF
EAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTL
SPMMCSRLLRHEENPSGLAHRLDLIFEGLKRRYQRALHGTLDTRPVVLVFAVLVLALIPV
LLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYN
GVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFV
LNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDL
GVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSHNGQLVALSTLIE
THERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYV
QEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYT
QVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVI
PLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH
>YP_001350280.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MAFTDPFIRRPVLACVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLP
PDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQ
VFAMRLWLDPVKMAAFGVTAGEINQAVRQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAF
AAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVR
AKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLI
PVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKTPF
DAALEGAREIAIPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTL
SPMMCSRLLRHEENPSGLAHRLDLLFEGLKRRYQRALHGTLETRPVVLVFAVLVLALIPL
LLMFTKKELAPEEDQGIVFLMTSSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYN
GVQAGIGGMLLKPWDEREKSQMELLHAVQARLNEIPGVQIFAFNLPSLPGTGEGLPFQFV
LNTANDYESLLQVAQRVKQRATESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDL
GVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSSDGQLVALSTLIE
TRERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYV
QEGNALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALVPLFLGVSSLNIYT
QVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVI
PLILASGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAAGAH
>YP_001186705.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MAFTDPFIRRPVLATVVSLLIVLLGFQAFSKLSIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSSSQQNLSTISIYAHIGADTDRLFTELLAKANEVKNQLP
QDAEDPVLSKEAADASALMYVSFYSDELSNPQITDYLSRVIQPKLATLPGMAEAQILGNQ
VFAMRLWLDPVKMAAYGITAGDLNSAVRKYNFLSAAGEVKGQYVVTSINASTDLKSAEAF
GAIPVKTLGDTRVLVRDIARVEMGAENYDSISSFDGIPSVYIAIKGTPSANPLDVIKEVR
GILPELEAQLPPNLKVAIAYDATLFIQASIDEVVKTLVEAVLIVIVVVFLFLGAFRSVLI
PVITIPLSMIGVLFFMQLMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKTPF
DAAIEGAREIAVPVVSMTITLAAVYAPIGFLEGLTGALFKEFALTLAGAVIISGIVALTL
SPMMCAKLLRHDENPSGLAHRLDMIFDRLKQRYQKMLHGTLNTRPVVVVFGVIVMALIPV
LLSFTESELAPEEDQGVVFLFANAPQPTNLDYVNAYTDQFVEIFKSFPEYYSSFQINGFD
GVQSGIGGFLLTPWNDRERTQMEILPEVQARLNHIPGLQIFGFNLPSLPGTGEGLPFQFV
VNTPNDYESLLQVAERVKARALESGKFAFLNIDLAFDKPEIVVDIDRAKAAQMGVSMEDL
GATLASLLGEGEINRFTIDGRSYKVIAQVERAYRDNPGWLDNYHVRSESGAMVPLGTLIS
LSDRARPTKLKQFQQLNSAIIEGVPIVSQGEAIDTITAIAREEAPRGYSFDYAGASRQYI
QEGSALFVTFALALAIIFLVLAAQFESFRDPLVILVTVPLSICGALVPIFLGFSTMNIYT
QVGLVTLIGLISKHGILIVEFANQLRHEKGLPLREAIEEAAAIRLRPVLMTTAAMVFGMV
PLILASGAGAVSRFDIGLVIATGMSVGTLFTLFVLPCVYSLLAKPDAEPQAQAVPVH
>NP_743067.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MAFTDTFIQRPVLASVVSLLILLLGFQAWNKLQIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNFSIISIYARIGADSDRLFTELLAKANEVRNKLP
QDSEDPVLSKEAADASALMYVSFYSKEMSNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRLWLDPVKLAGFGLSATDVTNAVRRYNFLSAAGEVKGEYVVTSVNASTELKSAEAF
AALPLKTSGDSRVLLGDVARVEMGAENYDTVSSFDGTPSVYIGIKATPAANPLDVIKEVR
RIMPELESQLPSALNVSIAYDATRFIQASIDEVIKTLGEAVLIVIVVVFLFLGALRSVLI
PVVTIPLSMIGVLFFMQMMGYSLNLLTLLAMVLAIGLVVDDAIVVVENIHRHMEEGKSPF
DAALEGAREIAMPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVIISGIVALTL
SPMMCALLLRREQNPSGLAHRLDQLFERLKGRYQRLLHATLDSRPVVLVFAVIILCLIPV
LLKFTQNELAPNEDQGVIFMMSSSPQPANLDYLNAYTDQFTPLFKAFPEYYSSFQINGFN
GVQTGIGGFLLKPWNERERTQMELLPLVQAKLEEISGLQIFGFNLPSLPGTGEGLPFQFV
INTAGDYPALLDVAQRIKTRAQESGKFAFLDIDLAFDKPEVVVDIDRAKAAQMGVSMDTL
GGTLATLLGEAEINRFTLEGRSYKVIAQVERPYRDNPGWLNNYYVKNDQGQLLPLSTLIT
LTDRARPRQLNQFQQLNAAIIQGVPMVSLGEALKTVQDIAREEAPEGFAFDYAGAARQYV
QEGSALWVTFGLALAIIFLVLAAQFESFRDPLVILVTVPLSICGALLPLFLGVSSMNIYT
QVGLVTLIGLISKHGILIVEFANQLRDERGLSVREAIEEAAAIRLRPVLMTTAAMVFGMV
PLILASGAGAVSRFDIGMVIATGMSIGTLFTLFVLPCIYTLLAHKASAKAPAIA
>YP_001747848.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MAFTDPFIRRPVLASVVSLLILLLGFQAWNKLQIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNFSIISIYARIGADSDRLFTELLAKANEVRNQLP
QDAEDPVLSKEAADASALMYISFYSKEMSNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRIWIDPVKLAAFGLAATDVTSAVRRYNFLAAAGEVKGEYVVTSINANTELKSAEAF
AALPLKTSGDSRVLLGDVARVEMGAENYDTVSSFDGTPSVYIGIKATPAANPLEVIKEVR
RIMPELESQLPSALKGSIAYDATLFIQASIDEVVKTLGEAVLIVIVVVFLFLGALRSVLI
PVVTIPLSMIGVLFFMQMMGYSLNLLTLLAMVLAIGLVVDDAIVVVENIHRHMEEGKSPL
DAALEGAREIAMPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVIISGVVALTL
SPMMCALLLRREHNASGLAHRLDVLFERIKGRYQRLLHSTLNSRPVVLVFAVIILCLIPV
LLKFTQNELAPNEDQGVIFMISSSPQPANLDYLNAYTDQFTPLFKAFPEYYSSFQINGFS
GVQSGIGGFLLKPWNERDRTQMELLPLVQAKLDNISGLQIFGFNLPSLPGTGEGLPFQFV
INTAGGYPALLEVAQRVKERAQASGKFAFLDIDLAFDKPEVVVDIDRAKAAQMGVSMDVL
GGTLATLLGEGEINRFTLEGRSYKVIAQVERPYRDNAGWLNSYYVKNDQGQLLPLSTLIT
LSDRARPRQLNQFQQLNSAIIQGVPLVSIGEALQTVRDIAAEQAPEGFSFDYAGAARQYI
QEGSALWVTFGLALAIIFLVLAAQFESFRDPLVILVTVPLSICGALLPLFLGVSSMNIYT
QVGLVTLIGLISKHGILIVEFANQLREEKGLSARDAIEEAAAIRLRPVLMTTAAMVFGMV
PLILATGAGAVSRFDIGTVIATGMSIGTLFTLFVLPCIYTLLAHKTAPTEPVVA
>WP_011766066.1|FEATURES|resfam|multidrug|mdtc|antibiotic efflux|1
MSLAARFIRRPVATVLLTLGVALVGLAAFFQLPAALLPQVDYPVISVRASLPGASPDTMA
ASVAMPLERALGSIAGVNEITSRSSLGSTEVVLQFDLSRDIDGAARDIQAAINASRSQLP
SGMAGNPTLRKSNPNDSPILILAMTSDVLSRTQIYDAAVTILAQKLAQVEGVGQVSVGGS
SLPAVRVELNPLALARSGVSAETVRGAIASGNVNRPKGFVEDGGRHWQIGANDQALSAAD
YTPMIVRWQQGAALRLSDVAEVRDGAQELRNAGVASGRPAVLLMVNRQPNANIIATVDHI
LKLLPELQAAIPPQIRLEVSQDRSTTVRASLRDVGVCLVLSVLLVVLVVIGFLRDRRAAL
IPAVTVPVALVGTLALMYLAGFSINNLSLMALTVAAGFVVDDIVVVLENTTRHIEHGLSP
LQAALRGVGEVSGTLVSMALSLAAVFIPIIFMEGVVGRLFGEFALTLVAAIGVSLLLSIA
TAPMLCSRLLRPTTALPAPGRFGRLRERTLAALLAAYRRSLGWALDHRATMLLALAGVVG
LNVYLYTVVPKGFLPQQDTGRLIAFIEGDQSSSFQAMYEHLTVIDSILRQDPAVLRTSGS
VGGNGPGGGTVTSARMFVTLKPLGERREPAQAVIERLRPRLARVAGARVFVMSAQEIRIG
GRGGSSDYLYTLQSDDLDALRAWEPKIRTALAALPQLADVNTDTRDKGLQTRLVVDREAA
ARLGLSQRAIDLALNNYFGERLVSTIHHPLNQYRVVMGAAPHFWRSPTVLADIVLVAEDG
SRVPLSAVAHWEPGNAPLTVNHQSQFAASTVSFALAPGVPLGEATRAITAAMAQLGVPSS
IFGSFEGAARAFQSAGNSQLLLILAAIVAVYLVLGILYESLLHPLTILSTLPSAGIGAVL
ALLAFGTEFTVIALIGVILLAGIVMKNAIMMIDFALHAQRSRGLAPREAILDACVLRFRP
IMMTTAAAILGALPLALGSGDGAELRQPLGIAIVGGLLVGQWLTLYTTPVVYLALDRLRL
RLARQAHKRIAAPAAAPAPAVDPA
>resfam_SHV-20|FEATURES|resfam|beta_lactam|SHV-20|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-106|FEATURES|resfam|beta_lactam|SHV-106|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-125|FEATURES|resfam|beta_lactam|SHV-125|antibiotic inactivation|1
MRYIRLNIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-126|FEATURES|resfam|beta_lactam|SHV-126|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERTVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACL01091.1|FEATURES|resfam|beta_lactam|SHVL-11|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIELWQR
>ABY66124.1|FEATURES|resfam|beta_lactam|SHVL-59|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASXRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEH
>ABQ14362.1|FEATURES|resfam|beta_lactam|TEML-48|antibiotic inactivation|1
RLIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14391.1|FEATURES|resfam|beta_lactam|TEML-62|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIYYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14405.1|FEATURES|resfam|beta_lactam|TEML-80|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNAAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDEHDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14431.1|FEATURES|resfam|beta_lactam|TEML-93|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RRLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSEAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAERGA
>ABQ14388.1|FEATURES|resfam|beta_lactam|TEML-94|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERGTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLCSALPAGWLIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14407.1|FEATURES|resfam|beta_lactam|TEML-104|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILGSFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHCSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLTSRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAE
>resfam_TEM-74|FEATURES|resfam|beta_lactam|TEM-74|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>WP_047028173.1|FEATURES|resfam|beta_lactam|TEM-26|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-13|FEATURES|resfam|beta_lactam|TEM-13|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>WP_094353585.1|FEATURES|resfam|beta_lactam|TEM-103|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDELNRQIAEIGASLIKHW
>resfam_TEM-58|FEATURES|resfam|beta_lactam|TEM-58|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVIIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-50|FEATURES|resfam|beta_lactam|TEM-50|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AAA72841.1|FEATURES|resfam|beta_lactam|TEML-113|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWLEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>1ZG6_A|FEATURES|resfam|beta_lactam|TEM-116_with_artificial_S70G_mutation_[_S70G_V84I_A184V]|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMGTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ95767.1|FEATURES|resfam|beta_lactam|TEML-121|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGHSLIKHW
>AAV27316.1|FEATURES|resfam|beta_lactam|TEML-123|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPFRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ95768.1|FEATURES|resfam|beta_lactam|TEML-124|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGLSLIKHW
>AAD28611.1|FEATURES|resfam|beta_lactam|TEML-128|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDPGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABI20750.1|FEATURES|resfam|beta_lactam|TEML-143|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAKPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADTSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAR29973.1|FEATURES|resfam|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSATLCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGQPVIQPRRPNNRLDKVRHMFQKVM
>YP_001706328.1|FEATURES|resfam|multidrug|adeK|antibiotic efflux|0
MMQKVWSISGRSIAVSALALALAACQSMRGPEPVVKTDIPQSYAYNSASGTSIAEQGYKQ
FFADPRLLEVIDLALANNRDLRTATLNIERAQQQYHITQNNQLPTIGASGSAIRQVSQSR
DPNNPYSTYQVGLGVTAYELDFWGRVRSLKDAALDSYLATQSARDSTQISLISQVAQAWL
NYSFATANLRLAEQTLKAQLDSYNLNKKRFDVGIDSEVPLRQAQISVETARNDVANYKTQ
IAQAQNLLNLLVGQPVPQNLLPTQPVKRIAQQNVFTAGLPSDLLNNRPDVKAAEYNLSAA
GANIGAAKARLFPTISLTGSAGYASTDLSDLFKSGGFVWSVGPSLDLPIFDWGTRRANVK
ISETDQKIALSDYEKSVQSAFREVNDALATRANIGERLTAQQRLVEATNRNYTLSNARFR
AGIDSYLTVLDAQRSSYAAEQGLLLLQQANLNNQIELYKTLGGGLKANTSDTVVHQPSSA
ELKKQ
>WP_001174793.1|FEATURES|resfam|multidrug|adeK|antibiotic efflux|0
MMQKVWSISGRSIAVSALALALAACQSMRGPEPVVKTDIPQSYAYNSASGTSIAEQGYKQ
FFADPRLLEVIDLALANNRDLRTATLNIERAQQQYQITQNNQLPTIGASGSAIRQVSQSR
DPNNPYSTYQVGLGVTAYELDFWGRVRSLKDAALDSYLATQSARDSTQISLISQVAQAWL
NYSFATANLRLAEQTLKAQLDSYNLNKKRFDVGIDSEVPLRQAQISVETARNDVANYKTQ
IAQAQNLLNLLVGQPVPQNLLPTQPVKRIAQQNVFTAGLPSDLLNNRPDVKAAEYNLSAA
GANIGAAKARLFPTISLTGSAGYASTDLSDLFKSGGFVWSVGPSLDLPIFDWGTRRANVK
ISETDQKIALSDYEKSVQSAFREVNDALATRANIGERLTAQQRLVEATNRNYTLSNARFR
AGIDSYLTVLDAQRSSYAAEQGLLLLQQANLNNQIELYKTLGGGLKANTSDTVVHQPSSA
ELKKQ
>YP_001715978.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTMLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTPFSNKNILSHSFNGKKSLLKSRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHKHYL
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNDQ
>WP_072416042.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MSKKQKLTMIITMLMGGFFGLLNETLLVTALPSIMKDFEISYTQVQWLTTAFLLTNGIVI
PLSALVIQRYTTRQVFLVGISIFFLGTLLGGLSPHFATLLVARIIQALGAGIMMPLMMTT
ILDVFQPHERGKYMGIFGLVIGLAPAIGPTLSGYLVEYLNWRSLFHVVAPIAAVTFLIGF
KTIKNVGTTIKVPIDFISVIFSVLGFGGLLYGTSSISEKGFDNPIVLVSMIGGVVLVALF
VLRQYRLSTPLLNFAVFKNKQFTVGIIIMGVTMVSMIGSETILPIFVQNLLHRSALDSGL
TLLPGAIVMAFMSMTSGALYEKFGPRKLALVGMAIVVITTAYFVVMDEQTSTIMLATVYA
IRMVGIALGLIPVMTHTMNQLKPEMNAHGSSMTNTVQQIAGSIGTAALITILSHASKNFS
PTMSDYNGMNKIDMMNQIKVDTMLHGYHAGFLFALLITVVSFFCSFMLQGKKKEVDSRQ
>WP_001124213.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|0
MPKIKPIKLVIIVVCIAIIAVLAWKFLKPKQQQPQYITAEVTRGDIENNVLATGTLDATK
LISVGAQVSGQVKKMYVQLGDQVKQGQLIAQIDSTTQENSLKTSDANIKNLEAQRLQQIA
SLNEKQLEYRRQQQMYAQDATPRADLESAEAAYKTAQAQVKALDAQIESAKITRSTAQTN
IGYTRIVAPTDGTVVAIVTEEGQTVNANQSAPTIVKIAKLQNMTIKAQVSEADIMKVEKG
QQVYFTTLGDETKRYATLRQIEPAPDSISSESNSTTSSTTSSAVYYNALFDVPNTDGKLR
IDMTAQVYIVLNSAKNALLVPSSALSSKQFSGQRKQGQSADKASSTPSAERKHQGNGVRL
ERLNLTPEQKQLIEQGKATLSVVRVLQADGTTKPTQILVGINNRVNAQVLAGLKQGDQVV
IADSSENSAASANSGNNRRRGPMGM
>WP_001347297.1|FEATURES|NCBI|multidrug|marA|antibiotic efflux|0
MTMSRRNTDAITIHSILDWIEDNLESPLSMEKVSERSGYSKWHLQRMFKKETGHSLGQYI
RSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRF
LHPLNHYNS
>YP_188509.1|FEATURES|NCBI|peptide|mprF|antibiotic target alteration|0
MTQELKSKLLSFFKFIFATALFIFVIFTLYRELSHINFKETFIQFGKINRLWLVLLFAGG
GLSLILLSLYDIILVKALKLKMPLIRVFRVSYIINALNSIIGFGGFIGAGVRAFVYKNYT
NDTKKLVQYISIILVSMLTGLSLLSILVVLRIFNASHMIDEISWVRWILYIVALFLPIFI
FYTVARPVDRNNRYMGVYCTVVSCVEWMAAATVLYFAALIVDIHISFMTFVGIFVIAALS
GLVSFIPGGFGAFDLVVLLGLKSLGISEEKILLALVLYRFAYYFVPVMIALILSSFEFGN
TAKKYLDNSKYFIPVKDFTSFLRSYQKDILAKVPSFSLAILIFLTSIIFFINNLTIVYDG
LYDGNHFAYYIALAIQTSACLLLILNVRGIYKGSRRAIIYAFISIILIASATIYTYASFL
LLSWLIIIFVLLILAYQRAQVLKRPLRFKKLAFMLLLSIFILYLNHILISGTLYALDVYH
IEIDTSLLRYYFWMTIVIIMLLVGVIAWLFDYKYKRPHHSIDLTLCDAIIQKYGGNYLSH
LVYSGDKDCFFNENKDSFIMYRYKSNALVVLGDPIGNTKSFESLLEAFYQFAEYQGYEII
FYQISDQYMPLYHNFGNQFFKLGEEAIIDLTTFTTSGKKRRGFRATLNKFDDLNINFEII
EPPFTQDFFDELKFVSDKWLDGRSEMHFSVGQFTQTYLSKAPIGVMRDHSGKMIAFCSLM
PTYSNNAISVDLIRWLPELDLPLMDGLYLHMLLWSKEKGYKAFNMGMATLSNVGQLHYSY
LRERMAGRVFEHFNGLYRFQGLRRYKEKYSPNWEPRFLVYQKHYSLWESMLKVMRVIRHK
>WP_006177023.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
MMNQRAEGERNMTISAQVIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGK
SLGRYIRERKLLLAARDLRESDERVYDICLRYGFDSQQTFTRIFTRTFHQPPGAYRKENH
TRAH
>NP_671020.1|FEATURES|NCBI|multidrug|robA|antibiotic efflux|0
MDQASIIRDLLSWLESHLDQPLALDNVAAKAGYSKWHLQRMFKDVTGNAIGAYIRARRLS
KAAVALRLTSRPILDIALQYRFDSQQTFTRAFKKQFAQTPALYRRAEDWHSSGICPPIRL
GTYTLPQPEFITLPEQHLVGITQSYSCTLEQISTHRAELRLHFWQQYLGDADQLPPVLYG
LHHSRPNPEKDDEQEIFYTTAIEPQHIPCNVPEGQPVILQGGEYVQFSYDGPLDGLQNFI
LTLYGTILPQLALIRRRGYDIERFYPQGRPKDGPPATLKCDYFIPIRR
>WP_006177022.1|FEATURES|NCBI|tetracycline|tet37|antibiotic inactivation|0
MKKPLFICVVFVMIIASAASLPFVLNAGFGQPPQGDQLSGLQASPQYRDGAFHNALPTPG
YNGDKNMLVAMWEFLTKKTENARPAQPLPLVNTDLASLPLAQDTLVWLGHSSWYLQLAGK
RILIDPVLGNYAAPFSFLNKAFEGDYPWRAASMPEIDLLIISHDHYDHLDYATIKALLPK
VKRVVTPLGVGSHLRYWGMDPTIIDERDWNQSVRISEALTVHVLPARHFSGRGIKRNQTL
WGSFMFVTPEQKVYYSGDSGYGPHFRDIGEQFGAVDLAIMENGQYDQDWKYIHMLPDETA
QAAADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASRDKGYRLLTPELGEPVRVNDTAQ
QFRPWWE
>1613275A|FEATURES|NCBI|beta_lactam|romA|antibiotic inactivation|0
MKKTLFICVVFVMIIASAASLPFVLNAGFGQPPQGAQLTEVEASPHYYEGKFHNTLPTPG
FTGQQNMLVAWWQFLTRKTENARPAQPLPLVKTDLASLPLEQDTLVWLGHSSWYLQLAGK
RILIDPVLGNYAAPFSFLNKAFAGEYPWRAASMPEIDLLIISHDHYDHLDYATIRALLPK
VKRVVTPLGVGSHLRYWGMKPEIIDERDWNQSVHISDALTVHLLPARHFSGRGIKRDQTL
WGSFMFVTPEQKIYYSGDSGYGPHFKAIGEQFGDVDLAIMENGQYDQDWKYIHMLPEETA
QASVDLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEPVRVSDTTQ
TFRQWWE
>WP_011766345.1|FEATURES|resfam|multidrug|golS|antibiotic efflux|0
MSLDIAEVARQSGVPASTLRYYEEKGLIAALGRQGQRRVFADGVLERLALIALGRASGFS
LDEIAAMFAPDGGLQIDRALLRRRADELDQRIRQLSAMRDGLRHAAQCSAPSHLECPTFR
RILRAAAIGALGPRPRQTPRRPGAT
>WP_011764584.1|FEATURES|resfam|multidrug|TolC|antibiotic efflux|0
MKRSLAAKLFAAGLAAAFGAPAAAADLLQTYRDALANDARYAAARAERDAGMERVVQARA
GLLPNLTASASTAYNDGEARTSAVSVDRRYNSNGYAVQLTQPLFRWQNWVQYKQGELQTA
LAETQFGQARQDLILRVAEAYFNVLNAQDALDAVVQLRTAAAEQLELARRSFEVGTVTIT
DVHEAQSRYDLASAQEIAARNDLDVQRQTLAQIIGREPDPLAPLRAGVELQRPQPDSIAD
WVGAAEQGSFGVQGQQLNREIAAREVERARAGHLPTLDLVASRGLNQRPSITTERSEASS
IGLQLNVPLYQGGAVSSRERETAALKLKADADLEDARRGAALAARQSYLGVTSGLAQIRA
LEAARISSASALEANRLGYEVGVRINIDVLNAQTQLADTQQRLARARYDTLLAQLRLKAA
AGTLGDEDVQAINALLAP
>AAM80541.1|FEATURES|resfam|glycopeptide|vanRO|antibiotic target alteration|0
MRVLIVEDELYMAEAIRDGLRLEAIAADIAGDGDTALELLSVNAYDIAVLDRDIPGPSGD
EVAERIVATGSGMPILMLTAADRLDDKASGFQLGADDYLTKPFELRELILRIRALDRRRA
HIRPPVREIAGLRLDPFRREVYRDDRYIALTRKQFAVLEVLVAAEGGVVSAEELLERAWD
ENADSFTNAVRITVSALRKRLGEPQIIATVPGVGYRIATPTDIRREGDAGA
>ADO66792.1|FEATURES|NCBI|glycopeptide|vanYA|antibiotic target alteration|1
MKMKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTI
TEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSE
MVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKM
ERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEY
MDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTH
TNSRR
>AAG44836.1|FEATURES|NCBI|beta_lactam|penP|antibiotic inactivation|1
MTFSALPFRRADRRRLLAAALAACALTLTAACDSGTVTVPVTDSVTTSAVADPRFAELET
TSGARLGVFAVDTGSGRTVAHRADERFPMASTFKGLACGALLREHPLSTGYFDQVIHYSA
AELVEYSPVTETRVETGMTVRELCDAAITVSDNTAGNQLLKLLGGPEGFTASLRSLGDAT
SRLDRWETDLNTAIPGDERDTTTPAALAADYRALVVGDVLGAPERDQLKAWLVANTTGAT
RIRAGLPADWTVGDKTGSPAYGSALDVAVAWPPGRAPIVIAVLSTKSEQDAEPDNALLAE
ATRVVVDALG
>CAD11597.1|FEATURES|NCBI|trimethoprim|dfrA7|antibiotic target replacement|1
MKISLISATSENGVIGNGPDLPWSAKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSRKGISSSNENVLVFPSIEIALQELSKITDHLYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDINFPKIPENFNLVFEQFFLSNIITHIRFGKKANKSFQHQPALLGQFLSRGFMVFC
AKVFHKTTT
>AAO42741.1|FEATURES|NCBI|tetracycline|fusA|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSATLCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFNKLA
>AAP46576.1|FEATURES|NCBI|beta_lactam|pbp2b|antibiotic target alteration|1
MLIKSEYKPRMLPKEEQVKKPMTSNGRISFVLMAIAVLFAGLIARGLYLQTVTYNFLKEQ
GDNRIVRTQTLPATRGTVSDRNGAVLALSAPTESLFAVPKEMKEMPSAAQLERLSELVDV
PVDVLRNKLEQKGKSFIWIKRQLDPKVAEEVKALGLENFVFEKELKRHYPMGNLFAHVIG
FTDIDGKGQEGLELSLEDSLHAEEGAEVVLRDREGNIVDSLDSPRNKAPQNGKDIILSLD
QRIQTLAYEELNKAVEYHQAKAGTVVVLDARTGEILALVNTPAYEPNKPGQADSEQRRNR
AVTDMIEPGSAMKPFTIAKALDSGKVDATDTFNTLPYKIGPATVQDTHVYPTLDVRGIMQ
KSSNVGTSKLSAMFTPKEMYDFYHDLGVGVRMHSGFPGETAGLLRSWRRWQKIEQATMSF
GYGLQLSLLQLARAYTVLTHDGELLPVSFEKQAVAPKGKRVIKASTAKKVRELMVSVTEP
GGTGTAGAVDGFDVGAKTGTARKLVNGRYVDNKHVATFIGFAPAKNPRVIVAVTIDEPTA
NGYYGGVVTGPPFKKIMGGSLNILGVSPTKPLTAAAVKTPS
>ACR40099.1|FEATURES|NCBI|nitroimidazole|nimI|antibiotic inactivation|1
MFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKG
HKVDAIRGCDKASFCVIEQDEVHGEEYTTYFRSVIAFGRIRILEDEAERMAAARLLGDRY
HPHHEEALGRELAKSFGHMLVICLDIEHMTGK
>ACR40104.1|FEATURES|NCBI|chloramphenicol|ND00_04320|antibiotic inactivation|1
MFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKG
HKVDAIRGCDKASFCVIEQDEVHGEEYTTYFRSVIAFGRIRILEDETERMAAARLLGDRY
HPHHEEALGRELAKSFSHMLVICLDIEHMTGKEA
>EIA84095.1|FEATURES|NCBI|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCIPSNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>AFK31669.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>WP_004657207.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MIMSKKLTCLALFTAIFFAIPMAACQSFSQQKQQLSTQKNEQQQISSLFQSAQTSGVLVI
YDGKKIQSYGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEVFKWDGKKRAFSSWEK
DLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPV
EEVRFAYALAKQKLPFDQPTQQQVKAMLLVDQIQGTKIYAKSGWGMDVSPQVGWWTGWIE
QPNGKITAFSLNMQMSQPEHADARKAIVYQALQQLGLLAH
>WP_005011312.1|FEATURES|NCBI|beta_lactam|OXA-331|antibiotic inactivation|1
MNPFTKYCAILCPIIFLGACTISPFSHDQAHSAHASQLTDAATIRNLFNQANVQGVILIK
SGNDLQAYGNAIQRADQPFIPASTFKMLNALIGIEHNKTSPDEVFKWNGEKRSFPAWEKD
LTLAQAMTASAVPVYQELAHRIGLELMQNEVKRVQFGNGDIGAQVDNFWLMGPLKITPRQ
EVQFADQLSHLQLPFRKSTQQQVIQMLFIEQIGSKALYAKSGWGMDVEPQVGWYTGWVED
AQGKTTAFSLNLEMDQSTPASLRKELVISSLKQLKIL
>WP_005227858.1|FEATURES|NCBI|beta_lactam|F889_02977|antibiotic inactivation|1
MLFNFIVMPKKLKLLVLSVVVMPSIILLGCQNIQPHVQTLVTQKQTEDQIATAFENIQTS
GVLVTYDGKAIQKYGNALNRANQRYIPASTFKMLNALIGIQHHKTSPNEVFKWDGQKRVF
TSWEKDLTLAEAMQASAVPVYQELARRIGLELMASEVKRVGYGNQSIGTQVDNFWLVGPL
EITPVEEVKFAYALAKKQLAFDSSTQQQVKDMLLIEDIQGTKIYAKSGWGMDVKPQVGWW
TGWVEQPNGQVTAFSLNMEMKKAAHAEARKAIVYQALQQLGLLPQ
>WP_007708339.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
MAVRKSLSFAALTACLLVAMPLSAAPKKKAPAKKAEDVPVLPTQLPPAPRYLVPQSALTS
VRNPKEIEEETGGRMGIALVDRDGALILGFNRDDRFAMCSTFKAPLAAAVLIGAEGGKFG
LDGEIPFTKDDILDYAPVVKKNRKRGRMSMAELAQAAVEVSDNSAANLLLPMLGGPEGLT
AFMRAHGDKITRLDRNEPALNENIEGDGRDTTSPAAMAGLMSRLLFRDMQAADADRLRGW
LNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKAPSGEEYILAIYLDRPTVDQK
AAEAAIAEAAHSALEFVSKAKKSGLD
>AGV79344.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MDIKKIIEEKCKIVVDSIKLIGEGYDSKAYIVNNEYVFKIKFSANKKKGYEKEKAIYDFL
NKKLNTTINIPNIEYSYISDDISILGYKEIKGTFLTPEIYFTLSKEKQDLLKQDIAMFLK
QMHNLDYSEISSYTIDNKQNVLEEYQLLKETIYDSFTDIEKQYVENFMQILHNTTIFDGR
KCLCHNDFSCNHLLLDDNRLVGVIDFGDSGIIDEYCDFIYLLEDSKEEIGVSFGEDILRL
YGNIDISKAKEYQDVVEQYYPIETIVYGIKNNKPDFIEKGRKEIYIRTHKEEKLRK
>AJO67548.1|FEATURES|NCBI|tetracycline|tetD|antibiotic efflux|1
MNKFAITALTITALDAMGIGLIMPVLPALLREYVSIEHLANHYGILLALYAIMQVFFAPL
LGRWSDKFGRRPILLISLAGAALDYTLLALSSSLWMLYLGRLASGITGATGAVAASVIAD
HTQPQQRTKWFGRLGAAFGVGLIAGPAIGGFAGQLSPHLPFVIAAVLNACSFVVIWVIFK
DQRKAVIQDAQHGDQPSPIPFMQIIKPIIQLLFVFFMAQLIGQIPATTWVLFTEGRFQWD
SMQVGLSLAGLGVMHALFQAFVAGAIAKKFNEKVTIIVGFALDGSAFIILSLLAEGWLIY
PTLILLAGGSIALPALQSLMSAQVNQANQGKLQGVLVSLTNATGVIGPLLFSVIFGQTLT
MWDGWVWVIGAIMYVFLIVFILSFYRSSRPTIKQQTDN
>AKI29908.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFKRAKQAFSPASTF
KIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKIQEEVK
EIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELL
NKYLANFFNNNRIKSFY
>AKI29910.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKIILFLWILNFAFGQDKILEDFFKDYNTSGIFIIFDGKNYASNDFQRAKQTFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KLLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKHIKNIKIREELL
EKYLAIITN
>AKI82195.1|FEATURES|NCBI|quinolone|QnrB3|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAM
LKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AKO62870.1|FEATURES|NCBI|quinolone|QnrB13|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG
>AKO62872.1|FEATURES|NCBI|quinolone|QnrB16|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>AKQ05892.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFG
IAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIE
ILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKE
EYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDN
IRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSG
YCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINET
FLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK
>AKQ05896.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMG
IYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVP
LQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAY
FSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRR
VLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQ
GNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSK
EVAEERSNNIMEQVKIASNMIVLQDYANPH
>ALA99188.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKRILSHWCRAAVVLRLASAVVAHGLLPSPAHALELSRASAAAAPSVAAPVHVTERADWG
KFFAAENVKGTVVVLDGKTQTYQAYDSARAERRMSPASTYKIFNSLLALESGALDNERET
IPWDGKPRRIKAWNAELNLRDAFRVSCYPCYQVVSHKIPRAYAQAKLDAVGYGNRTIGRV
NDTYWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQISIVEANADYVLHGKTGWF
VDKKPDIGWWVGWLERDGNLTMIALNIDMNGDADGPKRARIVREVLKNLKLI
>ALV83428.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
EKKMKQLIDKMENQWDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSVSELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGASALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYKGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
ESTYGEYEKKRLNSEKPFNYINVEKKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISQPNNSSDYIVLTELQKSIDEVKRCQGIYFNEWEQLMGELEVM
>AMM74551.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
PNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AMM74583.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRKVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AND62509.1|FEATURES|NCBI|quinolone|QnrD2|antibiotic target protection|1
MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLVGCDFNRAK
LKNASFKSCDLSMSNFKNISALGLEISECLAQGVDFRGANFMNMITTRSWFCSAYITKTN
LSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGV
LGELDARRTNLDGVKLDGEQALQLVESLGVIVHR
>ANJ15621.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKVSQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>AON96416.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVNKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYMVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>APM87143.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDNFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>WP_078254299.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MTSQHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVALMGA
MLLIVVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNAMQTDQAESKDLMN
LAFFVRIIGLGVLPSVLVAFAKVNYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASF
FRVHKPVRFYINPITPIYSVGKLASIEYKKATAPTDTIYHAKDAVQTTKPSERKPRLVVF
VVGETARADHVQFNGYGRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYD
VDTAKYQENVLDTLDRLGVDILWRDNNSDSKGVMDKLPTTQYFDYKSATNNTICNTNPFN
ECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTPVCEGNELAKC
EHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPN
AFAPKEQRAVPAFFWSNNTTFKPTASDTVLTHDAITPTLLKLFDVTADKVKDRTAFIQ
>AQY61516.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMRHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>ATQ63392.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IGWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNLARN
SEGLLDVLQKTGVSIFWKENDGGCKGVCDRVPNIEIKPKDYPKFCDKNTCYDEVVLQELD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYKFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>ATU31384.1|FEATURES|NCBI|quinolone|QnrA3|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMDSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>ALMH01000001_optrA_18|FEATURES|resfinder|multidrug|salA|antibiotic target protection|1
LSEATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIDIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>ALMN01000021_optrA_19|FEATURES|resfinder|multidrug|salA|antibiotic target protection|1
LSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
